{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for the non‑qualified defined‑benefit pension plans fell from **$1.0 billion at year‑end 2023 to $905 million at year‑end 2024** (a $95 million decline)【page_86】.  Correspondingly, the actuarial losses (and unrecognized prior‑service credits) recorded in accumulated other‑comprehensive loss dropped from **$347 million in 2023 to $303 million in 2024** (a $44 million reduction)【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) Gross benefit obligation 2023: $1.0 billion ✓, 2024: $905 million ✓; (2) Actuarial losses 2023: $347 million ✓, 2024: $303 million ✓. The calculations are accurate: $1.0B - $905M = $95M decline ✓, $347M - $303M = $44M reduction ✓. The answer correctly identifies the company (LMT), the specific pension plan type (nonqualified defined benefit), and the time period (2023-2024). The multi-hop synthesis is sound, combining data from multiple pages (page_86 and page_90) to show the evolution of both metrics. The answer provides clear context by noting both the absolute values and the year-over-year changes, demonstrating that both the liability and actuarial losses decreased. The only minor observation is that the LLM includes parenthetical calculations and page citations, which adds transparency but goes slightly beyond the ground truth answer's presentation style. However, this is a strength rather than a weakness as it provides additional verification. The semantic meaning is fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 319,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "The weighted‑average long‑term return assumption for GM’s U.S. pension plan assets slipped to **5.4 % at Dec 31 2021** (down from 5.6 % a year earlier) in the 2022 filing【page_86】, and then rose to **6.5 % at Dec 31 2024** (up from 6.3 % at Dec 31 2023) in the 2024 filing【page_88】.  This higher assumption coincides with a strategic re‑allocation – equity exposure grew from about **9 % to 11 %**, debt fell from roughly **68 % to 60 %**, and “other” assets (private‑equity, real‑estate, hedge‑fund strategies) increased from **≈23 % to 29 %**【page_86】【page_89】—signalling GM is shifting its pension portfolio toward higher‑return, more growth‑oriented assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All key numeric values are correct: 5.4% (Dec 31, 2021), 5.6% (Dec 31, 2020), 6.5% (Dec 31, 2024), 6.3% (Dec 31, 2023). (2) The temporal evolution is accurately captured across both 2022 and 2024 filings. (3) The multi-hop reasoning correctly synthesizes information from multiple pages (86, 88, 89) to connect rate assumptions with strategic asset allocation changes. (4) Asset mix percentages are provided with appropriate precision (equity 9%→11%, debt 68%→60%, other 23%→29%), showing detailed understanding of the strategic shift. (5) The conclusion about moving toward 'higher-return, more growth-oriented assets' is logically sound and well-supported by the data presented. (6) The answer goes beyond the ground truth by providing specific asset allocation details that substantiate the strategic shift claim. MINOR CONSIDERATIONS: The ground truth uses slightly different phrasing ('more conservative assumption in 2022 to more optimistic projection in 2024') while the LLM uses 'slipped' and 'rose' with more specific asset allocation evidence. Both convey the same strategic insight but the LLM provides richer supporting detail. The page citations add credibility and transparency. No calculation errors detected. All entities (General Motors, U.S. pension plan, dates, metrics) correctly identified. The answer fully addresses the multi-part question about evolution and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 417,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "In 2023 Chevron completed the acquisition of PDC Energy, reporting it as a wholly‑owned subsidiary whose revenues accounted for about five percent (and one percent of net income) of the consolidated figures 【page_31】. By 2024 the legacy PDC assets were fully in production, adding a full‑year of PDC output that lifted U.S. upstream net oil‑equivalent production by 250,000 boe/d (≈19 %) and contributed $2.2 billion of sales volume, which together drove a $3.5 billion increase in upstream earnings and eliminated $1.9 billion of decommissioning charges 【page_44】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Chevron's PDC Energy acquisition and integration but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) Acquisition completed in 2023 - correct; (2) PDC reported as wholly-owned subsidiary - correct; (3) 19% increase in net oil-equivalent production - correct; (4) $2.2 billion attributed to legacy PDC assets - correct; (5) Full-year contribution from PDC in 2024 - correct; (6) Integration progression from acquisition to operational phase - correct. PROBLEMATIC ELEMENTS: (1) The LLM states '$2.2 billion of sales volume...drove a $3.5 billion increase in upstream earnings' - this appears to conflate or misstate the financial impact. The ground truth indicates $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, not that $2.2B sales volume drove $3.5B earnings increase. This is a calculation/interpretation error; (2) The mention of '$1.9 billion of decommissioning charges' eliminated is not mentioned in the ground truth and appears to be additional information not verified against the source; (3) The 250,000 boe/d production figure is specific but not confirmed in ground truth; (4) The 5% revenue and 1% net income figures for 2023 are not addressed in ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution from 2023 acquisition to 2024 integration, showing understanding of the temporal progression. However, the financial impact synthesis appears flawed - the relationship between $2.2B and $3.5B is unclear and potentially incorrect. SEMANTIC ISSUES: The answer conflates 'sales volume' with earnings impact, which are different financial metrics. The ground truth is clearer that $2.2B was the earnings increase attributed to legacy PDC assets. The additional decommissioning charge detail, while potentially relevant, cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 523,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "In the 2022 filing Southern Company still classified its energy‑related contracts as regulatory hedges, cash‑flow hedges and non‑designated contracts, and it reported a net unrealized gain on the regulatory‑hedge portfolio of about **$155 million** at year‑end 2021 (with a $34 million gain in OCI and a $17 million gain re‑classified to earnings)【page_324】【page_325】【page_326】. By the 2024 filing the same three categories are used, but the balance‑sheet now shows the regulatory‑hedge position as a **net liability** (e.g., $45 million of assets offset by $554 million of liabilities for Southern Company) and the company notes that any unrealized gains or losses from cash‑flow hedges are immaterial and expected to be re‑classified to earnings in future periods【page_283】【page_281】. This reflects a shift from a net unrealized‑gain presentation in 2022 to a net‑liability presentation in 2024, with the impact of unrealized gains/losses on earnings becoming immaterial.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantive response that captures the core change in Southern Company's derivative treatment between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from net unrealized gains in 2022 to net liability presentation in 2024, which aligns with the ground truth's statement about 'change in both the valuation approach and the presentation'; (2) Accurately notes the three classification categories (regulatory hedges, cash-flow hedges, non-designated) used consistently across both periods; (3) Provides specific quantitative details ($155 million net unrealized gain in 2021, $34 million OCI gain, $17 million reclassification, and $45 million assets vs $554 million liabilities in 2024) that demonstrate concrete evidence of the shift; (4) Correctly identifies the balance sheet presentation change and notes that unrealized gains/losses became immaterial; (5) Multi-hop reasoning is sound - synthesizes information about classification, valuation, and presentation across two filing periods. WEAKNESSES: (1) The ground truth mentions a shift to 'fair value' presentation in 2024, but the LLM answer doesn't explicitly emphasize this terminology change; (2) The specific dollar amounts provided ($155M, $34M, $17M, $45M, $554M) cannot be verified against the ground truth, which provides no specific numbers - this is a risk if these figures are inaccurate, though they appear plausible and are presented with source citations; (3) The ground truth mentions presentation 'under Other or separately as Risk Management Activities' but the LLM doesn't address this specific balance sheet line item detail; (4) Minor: The ground truth references 'December 31, 2021, and 2020' data in the 2022 filing, while the LLM focuses on 2021 year-end. CALCULATION/VERIFICATION: The LLM's statement about the shift from gains to liabilities is logically consistent and the relative magnitudes ($155M gain vs $554M liability) represent a substantial directional change that supports the narrative. The answer demonstrates understanding of derivative accounting mechanics and regulatory hedge treatment. Overall, the answer substantially addresses the question's core inquiry about changes in treatment and valuation between 2022 and 2024, with good multi-hop synthesis, though some specific disclosure details from the ground truth are not fully captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 633,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron’s book value of its 50 % stake in Tengizchevroil grew to about $27.4 billion at year‑end 2024 (up from a lower balance shown in the 2022 filing), while the equity earnings it recorded from the joint‑venture fell from $4.386 billion in 2022 to $3.033 billion in 2024.  The premium of the carrying amount over TCO’s underlying net‑asset equity also narrowed, from roughly $100 million in 2021 to about $73 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. Verification of key claims: (1) Equity earnings figures are correct: $4.386 billion in 2022 and $3.033 billion in 2024 match ground truth exactly. (2) The 2024 investment carrying value of approximately $27.4 billion aligns with the ground truth figure of $27,368 million ($27.368 billion). (3) The premium narrowing from roughly $100 million to about $73 million is accurately captured, though the LLM references 2021 as the baseline year while ground truth references 2022 - this is a minor discrepancy but the directional trend and approximate values are correct. (4) The 50% stake reference is appropriate context. Multi-hop synthesis is sound: the answer correctly combines investment carrying value data with equity earnings data across the 2022-2024 period, showing both the growth in investment and the decline in earnings. The answer addresses all key aspects of the question: investment carrying value evolution, equity earnings decline, and the premium compression. The only minor weakness is the reference to 2021 for the premium baseline rather than 2022, but this doesn't materially affect the accuracy of the core findings. The semantic equivalence is strong - 'book value' and 'carrying value' are appropriate synonyms in this context, and the presentation clearly conveys the financial relationship evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 395,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart did not own Alert Innovation outright until fiscal 2023, when it completed a $0.4 billion acquisition that turned the former variable‑interest entity into a 100 %‑owned subsidiary【page_65】. The ownership remained at 100 % through fiscal 2024, with the acquisition being the specific transaction that altered the company’s relationship with Alert Innovation (the entity was later sold in fiscal 2025).",
      "correctness_score": 2,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core question about how Walmart's ownership stake evolved between fiscal 2023 and fiscal 2024. (1) QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount is correct, and the 100% ownership in fiscal 2023 is accurate. However, the numeric facts alone don't address the main question. (2) MAJOR FACTUAL ERROR - OWNERSHIP EVOLUTION: Ground truth states that by fiscal 2024, Walmart had 'subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity.' The LLM answer claims 'The ownership remained at 100% through fiscal 2024,' which is directly contradictory to the ground truth. This is the core of the question and the LLM got it wrong. (3) TRANSACTION IDENTIFICATION: The LLM correctly identifies the $0.4 billion acquisition in fiscal 2023 as the transaction that changed the relationship, but fails to identify the subsequent sale/deconsolidation in fiscal 2024 as the critical transaction that answers the question about how the stake 'evolved' between the two years. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution BETWEEN fiscal 2023 and fiscal 2024. The ground truth shows a two-step process: acquisition in 2023 (100% ownership) → sale/deconsolidation in 2024 (0% ownership). The LLM only captures the first step and misses the second, critical transformation. (5) TEMPORAL ACCURACY: The LLM mentions the entity was 'later sold in fiscal 2025' in parentheses, which contradicts both the ground truth (which says it was sold by fiscal 2024) and undermines the answer's credibility. The question specifically asks about the evolution between fiscal 2023 and 2024, and the answer should reflect that the ownership went from 100% to 0% during this period, not remain at 100%.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 493,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks’ “foreign‑currency – other” hedge went from a large net‑asset position in FY 2022 to a modest net‑liability position in FY 2023. In 2022 the company held about **$73 million of designated foreign‑currency‑other derivative assets** (‑$39.9 m prepaid + $33.5 m long‑term) and only **$0.3 m of liabilities** (see 2022 page 68); by FY 2023 the assets had fallen to roughly **$3.6 million** (‑$1.9 m prepaid + $1.7 m long‑term) while liabilities rose to **$8.8 million** (‑$4.7 m accrued + $4.1 m long‑term) (see 2023 page 72). This shift from a net‑asset hedge to a net‑liability hedge suggests Starbucks trimmed its asset‑based foreign‑currency hedges and is now relying more on liability‑based or net‑ting arrangements, reflecting a strategic adjustment in how it manages foreign‑exchange exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CRITICAL ISSUES: (1) FY 2022 numbers are substantially incorrect - LLM claims $73M in assets ($39.9M prepaid + $33.5M long-term) but ground truth shows $55.3M in AOCI with $32.5M expected reclassification. The LLM's breakdown doesn't match the ground truth structure. (2) FY 2023 asset calculation is correct ($1.9M + $1.7M = $3.6M), but the liability calculation contains an error - LLM states $8.8M ($4.7M + $4.1M) which is arithmetically correct but the ground truth shows $4.7M current + $4.1M long-term = $8.8M total, so this is actually correct. (3) The LLM mischaracterizes the 2022 position - it claims $0.3M in liabilities, but ground truth doesn't mention liabilities in 2022, only assets in AOCI. (4) The LLM's interpretation of 'prepaid' and 'accrued' terminology differs from ground truth's 'current assets/liabilities' and 'long-term assets/liabilities' classification. STRENGTHS: The LLM correctly identifies the directional shift from net-asset to net-liability position and provides reasonable strategic interpretation about hedge management. The multi-hop synthesis attempt is present. WEAKNESSES: The 2022 baseline numbers are wrong, the accounting structure is misrepresented, and the comparison lacks the precision required for financial analysis. The answer would mislead someone trying to verify the actual numbers from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 399,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "By fiscal 2022 Medtronic had eliminated its A Preferred Shares – it redeemed the 1,872 shares then outstanding for $0.075 million, leaving the class with no shares outstanding at April 29, 2022【page_81】. The 2024 filing shows the same situation: the 500 k authorized A Preferred Shares remain authorized but none are issued or outstanding, indicating no re‑issuance after the 2022 redemption【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 1,872 A Preferred Shares redeemed for $0.075 million in fiscal 2022, with no shares outstanding by April 29, 2022. The answer correctly identifies the fiscal year 2024 status showing 500k authorized shares but none issued or outstanding. The multi-hop reasoning is sound - the answer synthesizes information across fiscal years 2022 and 2024 to demonstrate the evolution (redemption in 2022, no re-issuance by 2024). The semantic meaning matches the ground truth perfectly: both convey that Medtronic eliminated A Preferred Shares through redemption in 2022 and did not reintroduce them by 2024. The only minor distinction is that the LLM answer provides slightly more detail about the 500k authorized shares remaining (which adds helpful context), while the ground truth focuses more narrowly on the outstanding shares. This additional detail does not contradict the ground truth and enhances the answer. All entities (Medtronic, A Preferred Shares, fiscal years 2022 and 2024) are correctly identified. The answer directly addresses both parts of the question: (1) how treatment evolved between 2022-2024, and (2) what specific action was taken in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 350,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast’s equity‑income from its investment in Atairos swung from a loss in 2022 to a gain in 2023. In 2022 the company recorded a net equity loss of $537 million, reflecting a $434 million fair‑value loss on Atairos’s underlying investments; in 2023 that turned into a $789 million equity gain, driven by a $1.1 billion fair‑value gain at Atairos【page_39】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CRITICAL ERRORS: (1) The 2022 equity loss is stated as $537 million in the LLM answer, but the ground truth clearly states it was $(434) million - this is a major discrepancy of $103 million. (2) The 2023 equity gain is stated as $789 million in the LLM answer, but the ground truth indicates the income was $1.1 billion - a difference of $311 million. These are not minor rounding differences but substantial numerical errors. CORRECT ELEMENTS: The LLM correctly identifies that there was a swing from loss to gain between 2022 and 2023, correctly identifies the $434 million fair value loss component in 2022, and correctly identifies the $1.1 billion fair value gain in 2023. The directional narrative (loss to gain turnaround) is accurate. MULTI-HOP REASONING: The answer demonstrates understanding of the multi-hop synthesis required (connecting Comcast's equity income to Atairos's fair value adjustments), but the execution is flawed due to the incorrect total equity figures. The answer appears to conflate or misstate the total equity income/loss figures while getting the fair value adjustment components correct. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about the evolution of the financial relationship and the role of fair value adjustments. However, the fundamental quantitative errors (particularly the 2023 figure being off by 28%) make this answer unreliable for financial analysis purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 420,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East region slipped from 312 billion cubic feet at year‑end 2023 to 296 billion cubic feet at year‑end 2024 (the developed portion fell from 305 bcf to 289 bcf)【page_145】. The modest decline, even though the 2024 filing notes “extensions and discoveries in our equity affiliates were in the Middle East and Australia”【page_146】, indicates that ConocoPhillips is maintaining a modest, largely static presence in the region rather than aggressively expanding its gas portfolio there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more comprehensive information than the ground truth baseline. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 312 bcf (2023) to 296 bcf (2024) matches ground truth exactly. The additional detail about developed reserves (305 bcf to 289 bcf) is accurate and adds valuable context. The decline calculation is implicit but correct (16 bcf total decline, 16 bcf developed decline). (2) COMPLETENESS: The answer addresses both parts of the question - evolution of reserves (with specific numbers and breakdown) and strategic positioning interpretation. The LLM goes beyond the ground truth by providing additional context about extensions and discoveries mentioned in the 2024 filing. (3) ENTITY ACCURACY: Company name (ConocoPhillips/COP), metric (proved natural gas reserves in bcf), region (Asia Pacific/Middle East), and years (2023-2024) are all correctly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the reserve decline with the company's strategic positioning, noting that despite extensions and discoveries, the overall modest decline indicates a 'largely static presence' rather than aggressive expansion. This interpretation is logical and well-supported. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the decline as 'modest' and the strategic positioning as 'maintaining a modest, largely static presence' is semantically equivalent to the ground truth's 'minor decrease suggests limited growth or strategic reallocation.' The LLM actually provides more nuanced analysis by incorporating filing language about extensions and discoveries. Minor deduction only because the LLM adds interpretive details (extensions/discoveries context) that, while accurate and relevant, go slightly beyond what was explicitly in the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 506,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL’s Canadian sales fell sharply, from $73 million in 2022 to $47 million in 2023 (‑36 %) and then to $28 million in 2024 (‑40 % YoY, roughly a 62 % decline from 2022)【page_71】. This steep, accelerating drop indicates a contracting Canadian market for ENBREL, suggesting weakening demand and increasing pressure on its sales trajectory.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provides an incorrect 2022 baseline figure. Ground truth states ENBREL Canada revenue was $113 million in 2022, but the LLM claims $73 million. This is a $40 million discrepancy (35% understatement) on the starting value, which is a fundamental factual error. The 2023 ($47M) and 2024 ($28M) figures are correct. CALCULATION ERRORS: The LLM calculates a -36% decline from 2022 to 2023 based on the incorrect $73M figure. Using the correct $73M→$47M would yield -36%, but the actual decline from $113M→$47M is -58%, not -36%. The 2024 calculation of -40% YoY is correct ($47M→$28M = -40.4%). The stated '62% decline from 2022' is approximately correct for the incorrect baseline ($73M→$28M ≈ -62%), but would be -75% from the actual 2022 figure ($113M→$28M). REASONING QUALITY: The qualitative assessment of 'contracting market' and 'weakening demand' is appropriate and matches the ground truth interpretation. The multi-hop synthesis correctly identifies the downward trend pattern. However, the fundamental numerical error undermines the entire analysis. COMPLETENESS: The answer addresses the revenue evolution question and market trajectory interpretation, but the incorrect starting point makes the analysis factually unreliable. The inclusion of percentage calculations shows analytical effort but compounds the error through propagation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 385,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "In the 2023 filing Qualcomm said the Board’s HR and Compensation Committee would take progress on human‑capital initiatives into account when setting executive bonuses, but it did not attach a quantified adjustment 【page_15】. By fiscal 2024 the company refined that practice, using a non‑financial performance modifier that could raise or lower an executive’s bonus by a multiple of 0.9 to 1.1 times the target amount 【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Qualcomm's evolution in linking human capital advancements to executive compensation. STRENGTHS: (1) Correctly identifies the fiscal 2023 approach as a general consideration without quantified adjustment, (2) Accurately states the fiscal 2024 evolution to a defined non-financial performance modifier, (3) Correctly specifies the modifier range as 0.9 to 1.1, (4) Properly characterizes this as a shift from qualitative to quantified approach, (5) Accurately synthesizes information across two fiscal years. QUANTITATIVE VERIFICATION: The modifier range of 0.9 to 1.1 matches the ground truth exactly. The characterization of this as a multiplier applied to target bonus amounts is semantically equivalent to the ground truth's description. MULTI-HOP REASONING: The answer successfully synthesizes information from fiscal 2023 and fiscal 2024 filings, correctly identifying the evolution and the specific mechanism introduced in fiscal 2024. MINOR CONSIDERATIONS: The answer uses slightly different phrasing than the ground truth (e.g., 'raise or lower' vs 'adjust') but this is semantically equivalent and actually provides clearer explanation. The citation references (page_15, page_16) add credibility though they are not part of the ground truth evaluation. The answer is complete, accurate, and directly responsive to all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 399,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "In the 2022 filing Breyanzi was only listed as a pipeline product being studied in third‑line chronic lymphocytic leukemia (CLL) and third‑line follicular lymphoma (FL) (see the Hematology pipeline table on page 20). By the 2024 filing the drug had moved to multiple approved indications – an FDA accelerated approval for relapsed/refractory CLL/SLL (March 2024), an FDA accelerated approval for relapsed/refractory mantle‑cell lymphoma (May 2024), and a Japanese Ministry approval for relapsed/refractory FL (August 2024) – expanding its therapeutic scope to three distinct B‑cell malignancies (see approval tables on pages 44‑45).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) INCORRECT INDICATION: The LLM states Breyanzi received FDA accelerated approval for 'relapsed/refractory mantle-cell lymphoma (May 2024)' but the ground truth clearly documents the May 2024 approval was for Follicular Lymphoma (FL), not mantle-cell lymphoma. This is a critical error in identifying the specific indication. (2) INCORRECT JURISDICTION: The LLM mentions a 'Japanese Ministry approval for relapsed/refractory FL (August 2024)' which is not mentioned in the ground truth at all. The ground truth only documents FDA accelerated approvals (March 2024 for CLL/SLL and May 2024 for FL). (3) INCOMPLETE 2022 DATA: The LLM correctly identifies the 2022 pipeline trials (3L+ CLL and 3L+ FL) but lacks the specific trial names (TRANSCEND-CLL-004 and TRANSCEND-FL) mentioned in ground truth. (4) CORRECT ELEMENTS: The LLM correctly identifies the March 2024 CLL/SLL approval and the general evolution from pipeline to approved status. The 2022 positioning as pipeline product is accurate. (5) MULTI-HOP REASONING: The LLM fails to accurately synthesize the specific approvals across the 2022-2024 period, introducing false information about mantle-cell lymphoma and Japanese approval that are not in the ground truth. The core narrative of evolution from trials to approvals is present but undermined by factual errors in the specific indications and jurisdictions. The answer demonstrates partial understanding of the question structure but fails on factual accuracy of the key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 439,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney’s Resorts and Vacations revenue rose from $7.949 billion in 2023 to $8.375 billion in 2024 – a 5% increase year‑over‑year【page_47】.  The Parks & Experiences segment overall also grew 5%, climbing from $32.549 billion to $34.151 billion in the same period【page_47】, so the Resorts and Vacations line performed in line with the segment’s total revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - Resorts and Vacations revenue of $7.949 billion (2023) and $8.375 billion (2024) match ground truth exactly; Parks & Experiences segment revenue of $32.549 billion (2023) and $34.151 billion (2024) are accurate; the 5% growth calculation for both segments is correct (($8.375-$7.949)/$7.949 = 5.36% ≈ 5% and ($34.151-$32.549)/$32.549 = 4.92% ≈ 5%). Number formatting is appropriate (billions vs millions - both acceptable). MULTI-HOP REASONING: The answer correctly synthesizes information across the two segments, properly comparing Resorts and Vacations performance to the overall Parks & Experiences segment performance. The conclusion that both grew at 5% is accurate. COMPLETENESS: The answer addresses all parts of the question - evolution from 2023 to 2024, the comparison between segments, and the relative performance. MINOR OBSERVATION: The ground truth states the Resorts and Vacations growth was 'slightly below' the overall segment growth, while the LLM states it performed 'in line with' the segment's total growth. Given both are rounded to 5%, this is a semantic difference rather than a factual error - the actual calculations show Resorts and Vacations at ~5.36% vs Parks & Experiences at ~4.92%, so technically the LLM's characterization of 'in line' is reasonable when both round to 5%. This represents a very minor interpretive difference that does not materially affect the answer's correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 426,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "In 2023 CVS completed a $2.0 billion fixed‑dollar ASR with Citibank that was accounted for as an initial treasury‑stock purchase of $1.6 billion plus a $0.4 billion forward contract recorded as an equity instrument in capital surplus and later re‑classified to treasury stock when the final shares were delivered 【page_75】. In 2024 the company entered a larger $3.0 billion ASR with Morgan Stanley, but used the same structure—a $0.4 billion forward contract initially placed in capital surplus and then moved to treasury stock at settlement 【page_73】. Thus, the forward‑contract structure stayed the same, and its value remained $400 million despite the underlying ASR size increasing from $2.0 billion to $3.0 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial facts and demonstrates sound multi-hop reasoning across the 2023-2024 comparison. Strengths: (1) All dollar amounts are accurate ($2.0B and $3.0B ASR sizes, $1.6B and $2.6B initial treasury stock, $0.4B forward contracts); (2) Correct identification of counterparties (Citibank for 2023, Morgan Stanley for 2024); (3) Accurate accounting treatment (forward contracts classified as equity instruments in capital surplus, later reclassified to treasury stock); (4) Sound synthesis showing the forward contract value remained constant despite ASR size increase; (5) Proper characterization of the structural evolution. Minor weaknesses: (1) The answer omits specific share delivery timing details mentioned in ground truth (final 20% in February 2023, remaining 15% in March 2024), which provides important context about the temporal evolution; (2) Does not explicitly note the shift in proportion (20% vs 15% of shares in forward contracts), which is a meaningful structural difference highlighted in the ground truth; (3) The phrase 'later re-classified' and 'moved to treasury stock at settlement' is accurate but slightly less precise than the ground truth's explicit mention of delivery dates. The core answer is factually sound and addresses the main question about how the structure and value evolved, but lacks some granular temporal and proportional details that would make it more complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 401,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "In the 2023 filing Duke Energy explained that the Master Retirement Trust’s assets are valued using the fair‑value hierarchy (Level 1, 2, 3) and that “certain investments that are measured at fair value using the net‑asset‑value‑per‑share practical expedient have not been categorized in the fair‑value hierarchy” (see page 219). The 2024 filing retained the same valuation approach but now presents a distinct “Not Categorized (b)” column in the fair‑value table and repeats the footnote clarifying those un‑categorized items, thereby making the fair‑value categorization more explicit and transparent (see page 228).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Duke Energy disclosed the Master Retirement Trust's fair value hierarchy approach in 2023, correctly notes the practical expedient language about un-categorized investments, and correctly identifies that 2024 added more explicit disclosure. The general direction of increased transparency is accurate. (2) QUANTITATIVE ACCURACY ISSUES: The page numbers cited (219 and 228) cannot be verified against the ground truth and may be incorrect or document-specific. More critically, the LLM answer mentions a 'Not Categorized (b)' column in a fair value table, which is not mentioned in the ground truth. (3) MISSING KEY INFORMATION: The ground truth specifically mentions that 2024 added 'a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3).' This is a concrete, specific disclosure enhancement that the LLM answer completely omits. Instead, the LLM focuses on a 'Not Categorized (b)' column which may be a different disclosure element. (4) MULTI-HOP REASONING: The answer attempts to synthesize 2023 vs 2024 changes but appears to have identified the wrong specific disclosure change. The ground truth points to a Level 3 reconciliation as the key new transparency element, while the LLM identifies a 'Not Categorized' column presentation change. (5) SEMANTIC ISSUES: While both answers discuss increased transparency, they identify different mechanisms for that transparency, suggesting the LLM may have accessed different sections or misidentified the disclosure evolution. The answer is partially correct in direction but materially incomplete and potentially inaccurate in the specific disclosure changes identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 516,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "In 2023 Pfizer booked a $3.5 billion non‑cash revenue reversal for Paxlovid in Q4, reflecting the expected return of about 6.5 million EUA‑labeled treatment courses from the U.S. government, and carried $3.4 billion of Paxlovid‑related deferred revenue (‑$1.5 billion current, $1.9 billion non‑current) and $3.4 billion of performance‑obligation liability ​【page_112】. In 2024 the actual return was lower (5.1 million courses), producing a $771 million favorable adjustment in Q1 and a $442 million revenue credit for the creation of a 1‑million‑course U.S. Strategic National Stockpile (recorded with no cash consideration), which together cut deferred Paxlovid revenue to $2.2 billion ($1.4 billion current, $785 million non‑current) and reduced Paxlovid performance obligations to roughly $1 billion ​【page_109】【page_110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop financial question. STRENGTHS: (1) All key numeric values are correct: $3.5 billion revenue reversal (2023), 6.5 million EUA-labeled courses expected return, 5.1 million actual return (2024), $771 million favorable adjustment, $442 million SNS revenue recognition, 1.0 million SNS treatment courses. (2) Deferred revenue figures are accurately cited: $3.4 billion in 2023 ($1.5B current, $1.9B non-current) and $2.2 billion in 2024 ($1.4B current, $785M non-current). (3) Performance obligation liabilities correctly identified: $3.4 billion in 2023 and approximately $1 billion in 2024. (4) Multi-hop synthesis is sound: the answer correctly traces the relationship between inventory returns, revenue adjustments, and SNS creation across both years. (5) Temporal sequencing is accurate: Q4 2023 reversal, Q1 2024 adjustment, and SNS recognition in 2024. (6) The answer properly contextualizes the shift from revenue reversal to revenue recognition. MINOR CONSIDERATIONS: The LLM provides additional contextual details (deferred revenue breakdown, performance obligation liabilities) beyond the ground truth answer, which adds value without introducing errors. The phrase \"recorded with no cash consideration\" for the SNS revenue is a helpful clarification. All calculations implied in the answer (e.g., the reduction from $3.4B to $2.2B deferred revenue) are mathematically consistent with the stated figures. The answer fully addresses all components of the multi-part question regarding financial obligations and revenue recognition changes between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 453,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA’s sales climbed from $1.9 billion in 2022 to $2.4 billion in 2023 – a 26.9% (≈27%) year‑over‑year increase (see page 31). The MD&A notes that this growth was driven by “continued share gains and market growth in Metastatic Castration‑Resistant Prostate Cancer” (page 32), indicating that ERLEADA has become a key growth driver and an increasingly important pillar of Johnson & Johnson’s oncology portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the sales growth from approximately $1.9B (2022) to $2.4B (2023), which matches the ground truth figures of $1,881M and $2,387M when rounded. (2) The 26.9% growth percentage is accurate and matches the ground truth exactly. (3) The LLM correctly identifies ERLEADA as a key growth driver in J&J's oncology portfolio. (4) The citation of MD&A pages and specific market drivers (share gains in mCRPC) adds credibility and demonstrates document-level synthesis.\n\nWEAKNESSES: (1) The LLM answer omits critical comparative context from the ground truth - specifically that the overall oncology segment grew only 10.5% in 2023, making ERLEADA's 26.9% growth significantly outpace the segment average. This is an important analytical insight about ERLEADA's relative importance. (2) The answer fails to mention the decline in competing products like IMBRUVICA and ZYTIGA, which the ground truth uses to contextualize ERLEADA's rising prominence. This represents incomplete multi-hop synthesis - the question asks what the performance indicates about ERLEADA's role, and comparative product performance is key evidence. (3) While the LLM provides specific market drivers, it doesn't synthesize the broader portfolio implications as thoroughly as the ground truth.\n\nNUMERIC VERIFICATION: $1.9B ≈ $1,881M (acceptable rounding), $2.4B ≈ $2,387M (acceptable rounding), 26.9% growth is mathematically correct. No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully connects ERLEADA's sales growth to its portfolio role, but incompletely. It identifies ERLEADA as important but misses the comparative analysis (outperforming segment growth, contrasting with declining products) that fully answers what this indicates about its role.\n\nCONTEXTUAL RELEVANCE: The answer addresses the core question but lacks the comparative portfolio context that would fully demonstrate understanding of ERLEADA's strategic importance relative to other oncology assets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 541,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA’s worldwide sales grew from $1.881 billion in 2022 to $2.387 billion in 2023 – a year‑over‑year increase of about 27 % (operations‑driven growth of 27.5% with a modest ‑0.6% currency impact)【page_31】. The company attributes this rise to “continued share gains and market growth in Metastatic Castration‑Resistant Prostate Cancer,” indicating a strong, upward market trajectory for the drug【page_32】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the 2022 sales figure. Ground truth states ERLEADA had $1,291 million in worldwide sales in 2022, but the LLM claims $1.881 billion ($1,881 million) - a difference of $590 million or 45.7% overstatement. This is a fundamental error that undermines the entire answer. The 2023 figure of $2,387 billion is correct. The growth rate calculation in the LLM answer (27%) is approximately correct for the 2022-2023 period ($2,387M vs $1,291M = 84.8% growth, not 27%), but this calculation is based on the wrong 2022 baseline. The ground truth indicates 26.9% growth from 2022 to 2023, which the LLM approximates as 27% - this is acceptable rounding. However, the LLM completely omits the critical 2022 context: the 70.0% growth rate from 2021 to 2022, which is essential to understanding the market trajectory shift from accelerating to decelerating growth. The LLM does correctly identify the qualitative narrative about market adoption and share gains, and appropriately characterizes the growth as strong. The breakdown of operations-driven growth (27.5%) and currency impact (-0.6%) adds useful detail not in the ground truth. However, the fundamental error in the 2022 baseline number is disqualifying for a financial analysis question where precision is paramount. The answer fails the primary requirement of quantitative accuracy in multi-hop financial questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 401,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "In FY 2023 NVIDIA still had the $1.25 billion of 0.584 % notes due 2024 on its balance sheet (shown as a short‑term liability)【page_72】.  By the end of FY 2024 the same $1.25 billion remained outstanding, indicating the company chose to keep the low‑cost debt through FY 2024 rather than retire it early (the notes were only repaid in FY 2025)【page_72】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - $1.25 billion (or $1,250 million) balance in FY2023, same amount in FY2024, repaid in FY2025. (2) The 0.584% interest rate is correctly cited. (3) The classification as short-term liability is accurate. (4) The timeline and sequence of events (held through FY2024, repaid in FY2025) is correct. (5) Number formatting is acceptable ($1.25 billion vs $1,250 million). WEAKNESSES: (1) The LLM answer characterizes the strategy as 'chose to keep the low-cost debt through FY 2024 rather than retire it early,' which is a reasonable interpretation but differs from the ground truth's framing of 'shift in debt management strategy' and 'chose to retire the obligation before or shortly after the due date.' (2) The ground truth emphasizes that NVDA did NOT roll over or extend the debt (implying a deliberate retirement strategy), while the LLM answer frames it as keeping the debt through FY2024. These are subtly different interpretations of the same facts. (3) The LLM answer lacks mention of the effective interest rate (0.66%) that was in the ground truth. (4) The reasoning about debt management strategy evolution is less developed - the LLM answer describes what happened but doesn't fully articulate the strategic shift. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across FY2023 and FY2024 filings, properly identifying the same debt instrument across years and tracking its disposition. The logic is sound regarding the timeline. OVERALL: The factual content is accurate, but the characterization of the strategic intent and the completeness of the analysis falls slightly short of the ground truth's more nuanced interpretation of NVDA's debt management approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 473,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell cut its mortgage‑backed securities holdings. For U.S. pension plans the balance fell from $1,119 million at 12/31/2022 to $676 million at 12/31/2023 (a $443 million drop) 【page_109】, and for non‑U.S. plans it fell from $31 million to $10 million (a $21 million drop) 【page_110】. Overall, the company’s mortgage/asset‑backed securities investment declined by roughly $464 million between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: U.S. Plans had $982 million in 2022 declining to $10 million in 2023 (a $972 million reduction of 98%). The LLM reports U.S. Plans at $1,119 million in 2022 and $676 million in 2023 (a $443 million drop) - these numbers are completely different from the ground truth figures. The LLM also reports Non-U.S. Plans at $31 million in 2022 declining to $10 million in 2023 (a $21 million drop), whereas ground truth indicates the $10 million in 2023 was under Non-U.S. Plans with no 2022 Non-U.S. figure mentioned. The LLM's total calculated decline of $464 million is incorrect; the ground truth shows a $972 million reduction. The LLM correctly identifies that there was a decline in mortgage/asset-backed securities holdings and attempts to break down the change by plan type (U.S. vs. Non-U.S.), which shows appropriate multi-hop reasoning structure. However, the specific numeric values are materially wrong - off by hundreds of millions of dollars. The magnitude of the change is dramatically understated ($464M vs. $972M actual). This represents a critical failure in quantitative accuracy, as the numbers are the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 351,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "In 2022 Capital One’s securitized debt obligations were already a core part of its long‑term funding mix, with $16.97 billion outstanding and measured at Level 2 of the fair‑value hierarchy (Table 16.6, p. 211); the company also noted it could issue up to $25 billion of credit‑card and $20 billion of auto‑loan securitizations (p. 112). By year‑end 2023 the balance had risen to $18.04 billion, showing a larger share of the funding mix, and the instruments continued to be classified as Level 2 fair‑value assets (Table 16.6, p. 212).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Capital One's securitized debt obligations evolution. STRENGTHS: (1) Quantitative accuracy is excellent - the 2022 figure of $16.97 billion and 2023 figure of $18.04 billion are correctly stated and match the ground truth values ($18,043 million ≈ $18.04 billion). The year-over-year increase is accurately characterized. (2) Fair value classification is correctly identified as Level 2 for both years, matching the ground truth. (3) Multi-hop synthesis is sound - the answer successfully combines information about the funding mix role, specific dollar amounts, fair value hierarchy classification, and the evolution between years. (4) The answer adds valuable context by noting the securitization capacity limits ($25B credit card, $20B auto loan), which provides additional insight into the company's funding strategy. (5) Entity accuracy is perfect - Capital One is correctly identified, years are correct (2022 and 2023), and financial metrics are properly labeled. MINOR CONSIDERATIONS: The ground truth mentions 2023 carrying value of $18,043 million with fair value of $18,067 million, while the LLM rounds to $18.04 billion (which is semantically equivalent and acceptable). The ground truth emphasizes a 'shift toward more detailed disclosure and potentially more structured risk management,' while the LLM focuses more on the quantitative increase and continued Level 2 classification. However, the LLM's characterization of 'larger share of the funding mix' is a reasonable inference from the data. The answer is well-structured, provides specific page references, and directly addresses all components of the question regarding evolution, funding mix role, and fair value classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 490,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "In 2023 JPMorgan’s CET1 capital included a $1.4 billion benefit from the CECL capital‑transition provisions, but by 2024 that benefit had fallen to $720 million as the transition provision was being phased out under the U.S. capital rules 【page_99†b】. The CECL‑related capital benefit therefore dropped by $680 million from 2023 to 2024 【page_105†b】【page_104†a】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: (1) 2023 CECL benefit of $1.4 billion - CORRECT, (2) 2024 CECL benefit of $720 million - CORRECT, (3) Year-over-year change calculation of $680 million ($1.4B - $720M = $680M) - CORRECT. All numeric values match the ground truth exactly. Entity accuracy: JPMorgan, CET1 capital, CECL capital transition provisions, U.S. capital rules - all correctly identified. Multi-hop reasoning: The answer successfully synthesizes information across multiple years and documents (referenced pages 99, 105, 104) to show the evolution of the CECL benefit from 2023 to 2024. The answer correctly characterizes this as a 'phased reduction' or 'phased out' transition, which aligns with the ground truth statement about phased reduction under U.S. capital rules. Minor note: The LLM uses 'phased out' while ground truth says 'phased in' - this is a subtle semantic difference. The ground truth states the provisions were 'being phased in' with full phase-in by January 1, 2025, while the LLM says 'phased out.' However, in the context of CECL transition provisions, 'phasing out' the benefit (reducing it from $1.4B to $720M) is the correct characterization of what's happening to the capital benefit itself, even though the provision itself is being phased in. The LLM answer is more precise in describing what's happening to the benefit. The answer directly addresses all parts of the question: (1) how treatment evolved (phased reduction), (2) quantitative change ($680 million decrease). The citation references add credibility. Overall, this is a comprehensive, accurate, and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 456,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "In the 2023 filing Salesforce’s revolving loan credit agreement was the “Prior Credit Agreement” entered in December 2020, which gave the company an unsecured $3.0 billion revolving facility that matures in December 2025 and had only immaterial administrative amendments in 2022 and 2023 (no borrowings were outstanding)【page_53】. By the 2024 filing the company had replaced that agreement with a new revolving loan credit agreement signed in October 2024, expanding the facility to $5.0 billion and extending its maturity to October 2029, also with no borrowings outstanding【page_49】【page_51】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Fiscal 2023 facility: $3.0 billion unsecured revolving credit, maturing December 2025 - CORRECT; (2) Fiscal 2024 facility: $5.0 billion unsecured revolving credit, maturing October 2029 - CORRECT; (3) The agreement was replaced/renewed between these periods - CORRECT; (4) No borrowings outstanding in either period - CORRECT. The answer provides additional valuable context by identifying the prior agreement as entered in December 2020 with only immaterial amendments, and specifying the new agreement was signed in October 2024. The multi-hop synthesis is sound: the model correctly identified the evolution across two fiscal years, compared the key terms (capacity increase from $3.0B to $5.0B, maturity extension from December 2025 to October 2029), and explained the strategic significance. All numeric values are accurate with proper formatting. The inclusion of page references adds credibility. The only minor consideration is that the answer provides slightly more granular detail than the ground truth (specific signing dates, prior agreement origin date), but this is supplementary information that enhances rather than contradicts the core answer. The semantic meaning fully aligns with the ground truth regarding the evolution of terms and capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 376,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "In 2022 Coyote was still part of UPS – it operated as a Coyote‑branded subsidiary within the Truckload Brokerage business of the Supply Chain Solutions segment, giving customers access to UPS’s network and third‑party carriers (see page_7). By 2024 UPS had sold the business; the divestiture was completed in the third quarter of 2024 and generated a pre‑tax gain of $156 million (about $152 million after tax) that was recorded in “Other expenses” for the year (see page_31 and page_29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of $152 million match the ground truth exactly. The timing (Q3 2024 completion) is accurate. QUALITATIVE ACCURACY: The answer correctly identifies the evolution of the relationship: (1) 2022 status as a branded subsidiary within Truckload Brokerage/Supply Chain Solutions segment, (2) 2024 divestiture completion, and (3) the financial impact ($156M pre-tax gain). The multi-hop reasoning is sound - the answer synthesizes information about the business relationship change and its financial consequences. COMPLETENESS: The answer addresses all parts of the multi-part question: how the relationship evolved (from subsidiary to divested), the timeline (2022 to 2024), and the financial impact (specific gain amounts). MINOR OBSERVATIONS: The LLM answer provides slightly more operational detail (mentions third-party carriers, specific segment placement) and includes page references to source documents, which adds credibility. The ground truth mentions 'U.S. and Europe' operations in 2022, while the LLM answer doesn't explicitly state geographic scope, but this is a very minor omission that doesn't affect the core answer. The characterization of the business as 'Coyote-branded subsidiary' and the recording of the gain in 'Other expenses' are accurate details that enhance the answer. No calculation errors detected. All entities (UPS, Coyote, Supply Chain Solutions) correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 429,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "In 2023 Union Pacific reported a chassis fleet of 48,340 units, of which 30,635 were owned and 17,705 were leased【page_19】. By 2024 the fleet had shrunk to 5,553 chassis, with 4,356 owned and 1,197 leased【page_19】—a dramatic drop in total units and a shift to a higher proportion of owned chassis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 2023: 48,340 total (30,635 owned + 17,705 leased), 2024: 5,553 total (4,356 owned + 1,197 leased). The arithmetic checks out perfectly (30,635 + 17,705 = 48,340 and 4,356 + 1,197 = 5,553). (2) ENTITY ACCURACY: Union Pacific correctly identified, years 2023 and 2024 properly specified, chassis units and ownership structure (owned vs. leased) correctly categorized. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two fiscal years and compares the evolution of the relationship with chassis, noting both the dramatic reduction in total units and the shift in ownership structure. (4) REASONING QUALITY: The characterization of the change as a 'dramatic drop' and 'shift to a higher proportion of owned chassis' is accurate - owned chassis went from 63.4% to 78.4% of the fleet. The interpretation that this represents a strategic shift is reasonable and supported by the data. (5) COMPLETENESS: The answer addresses all aspects of the question - total units, ownership structure, and the evolution between the two years. Minor note: The LLM could have been slightly more explicit about the percentage shift in ownership structure (as the ground truth answer emphasizes 'shifting from heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint'), but the core insight is captured. The citation references (【page_19】) add credibility, though they cannot be independently verified in this evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 441,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "In the 2022 Form 10‑K Boeing noted that its agreements to purchase and sell aluminum are accounted for as **derivative instruments** (not designated for hedge accounting) and that changes in their fair value are recorded in earnings; the filing only described them as supporting “long‑term strategic sourcing objectives.” By the 2024 filing the classification is unchanged – the aluminum contracts are still **non‑hedged derivatives** – but Boeing now explicitly states that the commodity contracts (including the aluminum agreements) hedge forecasted transactions **through 2028** and provides detailed notional‑amount and fair‑value disclosures for those contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about Boeing's aluminum agreement disclosures across 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 classification as derivative instruments not designated for hedge accounting, with fair value changes recorded in earnings - matches ground truth exactly. (2) Accurately captures the 2024 evolution showing the same non-hedged derivative classification but with the new explicit disclosure of hedging forecasted transactions through 2028 - this key temporal shift is correctly identified. (3) The multi-hop synthesis is sound: the answer properly traces the evolution from 'strategic sourcing objectives' language in 2022 to the more structured 'hedging forecasted transactions through 2028' framework in 2024. (4) All dates (2022, 2024, 2028) are correct. (5) Entity identification is accurate (Boeing, aluminum agreements/contracts, derivatives). (6) The answer appropriately emphasizes that the classification remained unchanged while the disclosure framework evolved - a nuanced point that shows careful reading. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth ('non-hedged derivatives' vs 'not designated for hedge accounting treatment') but these are semantically equivalent and both accurate. The LLM mentions 'detailed notional-amount and fair-value disclosures' which adds helpful context about the enhanced disclosure quality in 2024, though this level of detail wasn't explicitly in the ground truth statement. This addition is reasonable and doesn't contradict the ground truth. No quantitative errors detected. The answer fully addresses both the classification aspect and the time horizon evolution that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 487,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble’s currency‑rate risk profile was essentially unchanged from FY 2023 to FY 2024.  The company still relies on its natural‑hedge portfolio and “primarily use[s] forward contracts and currency swaps with maturities of less than 18 months” to manage financing‑related exchange‑rate exposure, and it states that “our market risk exposures … have not changed materially versus the previous reporting period” 【page_31】.  Moreover, management continues to be confident that, at a 95 % confidence level based on historical movements, a near‑term change in currency rates “would not materially affect our financial statements” 【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that P&G's currency rate risk exposure remained materially unchanged between FY 2023 and FY 2024, accurately describes the hedging instruments (forward contracts and currency swaps with maturities less than 18 months), and correctly states the 95% confidence level assessment. (2) QUANTITATIVE ACCURACY: The 95% confidence level is correctly cited. No calculations are required for this question, and all numeric references are accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer synthesizes information across two fiscal years and correctly identifies the key elements: (a) unchanged risk exposure, (b) hedging instruments used, (c) confidence level and its basis (historical currency rate movements), and (d) the conclusion about materiality to financial statements. The reference to 'natural-hedge portfolio' adds appropriate context. (4) ENTITY ACCURACY: Procter & Gamble is correctly identified, fiscal years ended June 30, 2023 and June 30, 2024 are correct, and all financial metrics/terms are properly identified. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially unchanged' and 'materially unchanged' are semantically equivalent. The quote 'would not materially affect our financial statements' directly matches the ground truth language. Minor strength: The LLM provides direct citations to source pages (page_31), which adds credibility. The answer is well-structured and directly addresses all components of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 447,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K (pages 95‑99) there is no specific discussion of Frame.io, indicating it was not highlighted as a core, integrated part of Adobe’s portfolio at that time. By the 2024 filing, Frame.io is positioned as a cloud‑native creative‑collaboration platform that goes beyond post‑production to support casting, location scouting, footage reviews, marketing‑campaign management, still‑image, design‑file and PDF workflows, and offers “Camera‑to‑Cloud” uploads; it is now directly embedded in Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and Adobe GenStudio for large‑scale content production 【page_95】【page_12】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about Frame.io's evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies that Frame.io was not prominently featured in 2022 filings, aligning with the ground truth statement that it was 'listed among Adobe's trademarks' with 'no detailed description'; (2) Accurately describes the 2024 positioning as a 'cloud-native creative collaboration platform' with specific capabilities including real-time upload, review and approval, frame-accurate commenting, and Camera-to-Cloud functionality; (3) Correctly identifies all product integrations: Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and Adobe GenStudio; (4) Properly synthesizes the multi-hop information showing evolution from 2022 to 2024; (5) Includes additional contextual details (casting, location scouting, marketing-campaign management, still-image and design-file workflows) that expand on the ground truth without contradicting it. MINOR WEAKNESSES: (1) The LLM answer states Frame.io was 'not highlighted as a core, integrated part' in 2022, which is slightly more definitive than the ground truth's 'listed among trademarks with no detailed description' - though semantically equivalent; (2) The answer provides more granular functional details than the ground truth (e.g., specific use cases like casting and location scouting), which adds value but represents a slight expansion beyond the ground truth scope. QUANTITATIVE ACCURACY: No numerical data, dates, or calculations are present in either answer, so this dimension is not applicable but receives high marks for not introducing any errors. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and multiple product integrations, demonstrating sound logical progression. The comparison structure effectively highlights the evolution. No calculation errors or logical inconsistencies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 533,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "In FY 2022 AMD said its 15 % equity stake in the ATMP joint venture was carried at roughly $69 million; by FY 2023 the carrying amount had risen to about $99 million. The 2023 filing adds more granular detail—showing higher purchase volumes ($1.7 bn), larger payables ($363 m vs $463 m a year earlier), higher receivables ($9 m vs $2 m), and bigger equity‑income gains—while still noting that the investment is accounted for under the equity method and that AMD has no funding obligation to the JV.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims the carrying value 'rose to about $99 million' in FY 2023, but the ground truth explicitly states the 2023 filing 'omits any mention of the carrying value of the investment.' This is a major factual error - the LLM invented a number that doesn't exist in the source material. The ground truth shows FY 2022 had $69M (Dec 2021) and $63M (Dec 2020), but there is NO carrying value disclosed in 2023. (2) TRANSACTION FIGURES REVERSED: The LLM claims 2023 shows 'higher purchase volumes ($1.7 bn)' but the ground truth indicates 2022 had purchases of $1.1B in 2021 and $831M in 2020. The LLM appears to have fabricated the $1.7B figure for 2023. (3) PAYABLES/RECEIVABLES CONFUSION: The LLM provides specific payables ($363M vs $463M) and receivables ($9M vs $2M) figures that are not mentioned in the ground truth at all. These appear to be invented details. (4) DIRECTIONAL CLAIM WRONG: The LLM claims disclosure became 'more granular' in 2023, but the ground truth explicitly states the opposite - there was a 'reduction in the level of financial disclosure regarding the ATMP JV' in 2023. (5) CORE FINDING INVERTED: The ground truth's key insight is that 2023 omitted specific financial metrics that were disclosed in 2022. The LLM reversed this, claiming 2023 added more detail. The LLM fundamentally misunderstood the evolution of disclosures and fabricated specific numbers to support an incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 427,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell’s Commercial Aviation Original Equipment revenue slipped from $2.397 billion in 2023 to $2.223 billion in 2024 – a decline of roughly $174 million (about 7 %)【page_68】. While the dip reflects a modest slowdown in OEM sales, the still‑large dollar amount underscores Honeywell’s continued prominence as a key supplier in the aerospace sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - $2.397 billion (2023) and $2.223 billion (2024) match the ground truth values of $2,397 million and $2,223 million respectively (format variation is acceptable). The calculated decline of $174 million is accurate ($2,397M - $2,223M = $174M), and the percentage decline of approximately 7% is correct (174/2,397 ≈ 7.26%). ENTITY ACCURACY: Honeywell correctly identified, Commercial Aviation Original Equipment segment correctly specified, years 2023-2024 correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the revenue trend data and connects it to Honeywell's broader aerospace position, addressing both parts of the question (evolution of revenue AND what it indicates about position). SEMANTIC EQUIVALENCE: The LLM's interpretation that the decline 'reflects a modest slowdown in OEM sales' while maintaining 'continued prominence' is semantically consistent with the ground truth's assessment of 'contraction in this segment' indicating 'potential weakening in original equipment demand.' The LLM provides slightly more nuanced interpretation by characterizing it as 'modest' rather than emphasizing supply constraints, but this represents reasonable analytical judgment rather than factual error. MINOR CONSIDERATIONS: The LLM answer is slightly more optimistic in tone ('continued prominence') compared to the ground truth's more cautious framing ('potential weakening'), but both interpretations are defensible from the data. The citation reference [page_68] adds credibility. No calculation errors detected. All factual claims are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 475,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The Heart‑Failure devices business grew from $1.161 billion of total (U.S. + international) sales in 2023 to $1.279 billion in 2024 【page_53】.  That represents roughly a 10 percent rise in the segment’s revenue year‑over‑year (a 10.2 % total‑change increase) 【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. QUANTITATIVE VERIFICATION: (1) 2023 revenue of $1.161 billion ($1,161 million) - CORRECT; (2) 2024 revenue of $1.279 billion ($1,279 million) - CORRECT; (3) Percentage change calculation: ($1,279M - $1,161M) / $1,161M = $118M / $1,161M = 10.16% ≈ 10.2% - CORRECT. The LLM properly identifies both the 'roughly 10 percent' approximation and the precise '10.2%' figure. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) evolution between 2023-2024 with specific dollar amounts, and (2) percentage change calculation. ENTITY ACCURACY: Correctly identifies Heart Failure Devices segment, U.S. and international markets, and fiscal years 2023-2024. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points (two years of revenue data and percentage calculation). MINOR OBSERVATIONS: The LLM answer omits the contextual detail about 'minimal impact from exchange rate fluctuations' and 'strong underlying demand and market expansion' mentioned in the ground truth, but these are supplementary context rather than core factual requirements. The use of page citations (page_53, page_29) adds credibility. The wording variation (e.g., 'Heart‑Failure' vs 'Heart Failure') is inconsequential. Overall, the answer demonstrates accurate financial synthesis and correct multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 395,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "In IBM’s 2022 filing the 0.300 % Notes due 2028 are not referenced in any of the excerpts provided (the compensation, accounting‑fees and exhibit sections contain no mention of those notes). By the 2023 Form 10‑K, however, the notes appear in the Section 12(b) securities table as “0.300 % Notes due 2028” (ticker IBM 28B) 【page 1】. This shows that IBM moved from omitting the notes in the disclosed sections to explicitly listing them as a registered, outstanding security in the later filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - 2022 FILING CLAIM: The LLM states the notes are 'not referenced in any of the excerpts provided' in the 2022 filing, but the ground truth explicitly states they WERE referenced in the 2022 filing as part of a list of debt instruments with rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020. This is a fundamental mischaracterization of the 2022 filing content. (2) PARTIAL CORRECTNESS - 2023 FILING: The LLM correctly identifies that the notes appear in the Section 12(b) securities table in 2023 with ticker IBM 28B, which aligns with the ground truth's statement about formal listing and explicit disclosure. (3) INCORRECT CHARACTERIZATION OF EVOLUTION: The LLM describes the evolution as moving from 'omitting the notes' to 'explicitly listing them,' but the ground truth describes it as moving from 'incorporation by reference' to 'explicit disclosure and formal registration.' These are fundamentally different narratives - the ground truth indicates the notes were present in 2022 but referenced indirectly, not absent. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the treatment across both years. It appears to have misread or misinterpreted the 2022 filing content, leading to an incorrect comparison. (5) MISSING CONTEXT: The LLM omits the important detail about the Form 8-K filing date (February 10, 2020) and the incorporation by reference mechanism that characterized the 2022 treatment. The answer demonstrates a fundamental misunderstanding of how the notes were treated in 2022, making the core comparison invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 458,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple’s Rest of Asia Pacific segment saw net sales climb from $29,375 million in 2022 to $29,615 million in 2023 (≈ + $240 million). Operating income rose from $11,569 million to $12,066 million over the same period (≈ + $497 million), indicating modest sales growth but a more pronounced improvement in profitability【page_50】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: net sales figures ($29,375M in 2022 → $29,615M in 2023), operating income figures ($11,569M in 2022 → $12,066M in 2023), and calculated changes ($240M increase in sales, $497M increase in operating income) match the ground truth exactly. The percentage calculations are accurate (0.8% for sales growth and 4.3% for operating income growth, though the LLM uses approximate notation). The multi-hop reasoning is sound—the answer correctly synthesizes data across two years and two metrics to characterize the segment's evolution. Entity identification is correct (Apple, Rest of Asia Pacific segment, 2022-2023 period). The qualitative assessment that sales growth was 'modest' while profitability improvement was 'more pronounced' is appropriate and well-supported by the data (0.8% vs 4.3% growth rates). The only minor deviation from the ground truth is the use of '≈' notation for the dollar changes, which is semantically equivalent but slightly less precise than stating exact figures. The citation reference [page_50] adds credibility. Overall, the answer fully addresses the question with accurate synthesis of multi-hop financial information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 351,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The 2022 10‑K notes that “stock options granted prior to 2022 … generally vest pro rata over a **five‑year** period” (see page 116). The 2024 10‑K updates this, stating that “stock options granted subsequent to December 31, 2021 … generally vest pro rata over a **four‑year** period” (see page 96). Thus, the vesting schedule was shortened from five years for pre‑2022 grants to four years for grants made after December 31, 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key vesting period changes (5-year to 4-year) and accurately cites the relevant 10-K filings (2022 and 2024). The numeric values are correct: pre-2022 grants vested over 5 years, post-December 31, 2021 grants vested over 4 years. However, there are significant issues with completeness and synthesis: (1) The LLM answer only addresses the 2022 10-K and 2024 10-K separately, failing to properly synthesize the comparison across both filings as required by the multi-hop question. The ground truth explicitly states that the 2024 10-K 'confirms' the same vesting periods continued, showing consistency over time. The LLM answer presents the information as if it's only describing what each filing says individually, rather than synthesizing how the vesting periods evolved and remained consistent between the two filings. (2) The LLM answer lacks the contextual framing that the ground truth provides - that this represents 'a consistent reduction in the vesting period' and 'a structural change in the incentive plan's vesting terms.' (3) The LLM answer doesn't explicitly confirm that both the 2022 and 2024 filings show the same vesting structure for each grant category, which is crucial to answering how the vesting period 'evolved' (or remained stable). The answer reads more as a simple comparison of what each filing states rather than a synthesis showing the evolution across time. While the factual numbers are correct, the multi-hop reasoning and synthesis across the two filings is incomplete, making this a partially correct answer that misses the deeper analytical requirement of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 450,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "In both the 2022 and 2023 filings CVS says it obtains one price for each Level 2 debt security, reviews a quarterly sample, and compares those prices to a secondary source (flagging any variance that exceeds a set threshold). In 2022 it noted that no prices were adjusted at December 31, 2022 (or 2021), and the 2023 filing repeats the same practice, stating no adjustments were made at December 31, 2023 (or 2022). Thus the validation process – price‑comparison to a secondary source and the policy of not adjusting year‑end prices – remained unchanged, with only the reference years updated.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core validation methodology (one price per Level 2 debt security, quarterly sample comparisons to secondary sources, variance threshold reviews, no price adjustments). The dates and years are accurately referenced. However, there are significant issues with completeness and accuracy relative to the ground truth: (1) The LLM states no adjustments were made at December 31, 2022 (or 2021) in the 2022 filing, but the ground truth specifies December 31, 2021 or 2020 for the 2022 filing - this is a factual error in the year references. (2) The LLM answer fails to capture the key insight from the ground truth that the approach 'evolved' or remained 'stable' - the ground truth emphasizes that despite maintaining the same process, there was a 'sustained but unchanging approach,' which suggests the question was asking about whether there were meaningful changes. The LLM's conclusion that the process 'remained unchanged, with only the reference years updated' is partially correct but misses the nuance about the evolution (or lack thereof) in emphasis and validation rigor. (3) The ground truth mentions 'emphasis on consistent internal validation by the investment team appears to have remained stable' - the LLM completely omits this contextual detail about the investment team's role. (4) The LLM correctly identifies that the validation methodology was consistent across both years, but frames it as merely 'reference years updated' rather than addressing whether the approach actually evolved. The answer is partially correct on the mechanics but incomplete on the analytical interpretation of how the approach evolved (or didn't evolve) between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 466,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "In both the 2022 and 2023 10‑K filings CVS continued to classify privately‑placed equity securities as Level 3 assets because there is no active market for them. The fair‑value of these securities is still determined internally, using unobservable inputs such as earnings and revenue multiples, a discount for lack of marketability and comparability adjustments; the methodology and the reliance on these unobservable inputs did not change from 2022 to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: CVS classified privately-placed equity securities as Level 3 in both years, used internal analysis with unobservable inputs (earnings/revenue multiples, discount for lack of marketability, comparability adjustments), and maintained consistent methodology. However, the answer has a critical omission that significantly undermines its completeness. The ground truth explicitly states that in 2023, CVS added 'an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.' This represents an evolution in the valuation methodology between 2022 and 2023 - specifically, enhanced disclosure or analysis of sensitivity to input changes. The LLM answer explicitly states 'the methodology and the reliance on these unobservable inputs did not change from 2022 to 2023,' which directly contradicts the ground truth's identification of this evolution. The question specifically asks about how the methodology 'evolved' between the two years, and the ground truth identifies a meaningful evolution in emphasis and scrutiny, while the LLM answer claims no evolution occurred. This is a significant semantic and factual error that goes to the heart of what the question is asking. The numeric and entity accuracy are sound (correct years, correct company, correct classification levels, correct input types), but the failure to identify and articulate the evolution in valuation emphasis represents a major gap in answering the multi-part question about evolution and change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 454,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "Total net revenue from Alphagan/Combigan fell from $272 million in 2023 to $248 million in 2024—a decline of roughly $24 million (about 9%). By contrast, international revenue rose modestly, increasing from $151 million in 2023 to $153 million in 2024, indicating a slight upward trend.【page_43】",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Verification of key metrics: (1) Total revenue 2023: $272M ✓, 2024: $248M ✓, decline of $24M ✓. (2) Percentage decline: LLM states 'about 9%' vs ground truth 8.8% - this is a minor rounding difference (9% is reasonable approximation of 8.8%), acceptable given the 'roughly' qualifier used. (3) International revenue 2023: $151M ✓, 2024: $153M ✓, increase of $2M ✓. (4) International growth rate: LLM describes as 'modest' and 'slight upward trend' which semantically matches the ground truth's 1.5% growth characterization. The multi-hop synthesis is sound: the answer correctly identifies the inverse trends (total revenue declining while international revenue increasing), which is the key insight from the data. All entities are correctly identified (Alphagan/Combigan product, years 2023-2024, revenue metrics). The only minor deviation is the percentage calculation (9% vs 8.8%), but this falls within acceptable rounding and the LLM appropriately qualified it with 'roughly' and 'about.' The answer is well-structured, complete, and directly addresses both sub-questions about total revenue change and international revenue trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 346,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "In 2023 Chevron completed a business combination that made PDC Energy a wholly‑owned subsidiary, with PDC’s revenues representing only a few percent of Chevron’s consolidated amounts and its results excluded from internal‑control assessments (2023 10‑K, p.31‑30). By 2024 the legacy PDC Energy assets were fully integrated into Chevron’s operations, and Chevron said worldwide oil‑equivalent production rose about 7 % (from 2.714 MBD in 2023 to 2.925 MBD in 2024), the increase being driven largely by the full‑year of PDC Energy production (2024 10‑K, p.9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - the 7% production increase is accurate, and the specific production figures (2.714 MBD in 2023 to 2.925 MBD in 2024) are precise and verifiable. The calculation is mathematically sound: (2.925-2.714)/2.714 ≈ 7.8%, which rounds to approximately 7% as stated. ENTITY ACCURACY: Chevron and PDC Energy are correctly identified, years 2023-2024 are properly sequenced, and the metric (worldwide oil-equivalent production in MBD) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two documents (2023 and 2024 10-Ks), correctly tracing the evolution from acquisition to integration. The connection between PDC's full-year contribution and the 7% production increase is logically sound and well-supported. COMPLETENESS: The answer addresses both parts of the question - the relationship evolution (acquisition to integration) and the operational impact (7% production increase). The mention of PDC's exclusion from internal control assessments in 2023 adds appropriate context. MINOR CONSIDERATIONS: The answer uses slightly different phrasing than the ground truth (e.g., 'business combination' vs 'acquired') but these are semantically equivalent and actually more precise. The inclusion of specific production figures (2.714 MBD and 2.925 MBD) provides additional quantitative detail beyond the ground truth, enhancing the answer's value. The citation format (10-K page references) demonstrates proper sourcing. No factual errors, calculation errors, or omissions of significance were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 452,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS grew its cold‑chain logistics in 2023 by buying MNX Global Logistics, a temperature‑sensitive, time‑critical logistics provider, which complemented the earlier Bomi Group acquisition that had already expanded its cold‑chain footprint (see page 6 & page 104). In 2024 the company made no new cold‑chain purchases – the only acquisition reported was franchise‑development areas for The UPS Store (≈ $71 million) – showing that cold‑chain investment stalled and the focus shifted to other assets (see page 103).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) MAJOR ERROR - The LLM claims 'In 2024 the company made no new cold-chain purchases' when the ground truth explicitly states UPS acquired Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million in 2024. This is a fundamental misrepresentation of the core facts. (2) QUANTITATIVE ERROR - The LLM mentions a $71 million UPS Store franchise acquisition but fails to identify the $440 million cold-chain acquisitions in 2024, which are the primary focus of the question. (3) ENTITY ACCURACY - The LLM correctly identifies Bomi Group and MNX Global Logistics as 2023 acquisitions, but completely misses Frigo-Trans and Biotech & Pharma Logistics in 2024. (4) REASONING FLAW - The LLM's conclusion that 'cold-chain investment stalled' directly contradicts the ground truth narrative of intensified strategic focus with high-value international acquisitions. The ground truth shows evolution from general expansion (2023) to targeted, high-value international acquisitions (2024), representing acceleration, not stalling. (5) MULTI-HOP SYNTHESIS - The LLM failed to synthesize the complete picture of UPS's cold-chain evolution across both years. The answer demonstrates incomplete research or misinterpretation of source documents, as it presents a narrative opposite to the actual acquisition activity. The only partially correct elements are the identification of 2023 acquisitions (Bomi Group and MNX Global Logistics), but this is overshadowed by the complete omission of the major 2024 cold-chain acquisitions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 449,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "In the 2022 Form 10‑K the company’s non‑employee director RSU awards were issued simply as part of the 2021 Long‑Term Incentive Plan (exhibit *10.0e) and, for grants after 2019, under the legacy 2009 Praxair Long‑Term Incentive Plan (exhibit *10.11h) with no separate deferral or performance‑based structure 【page 105】【page 107】. By the 2024 filing the Board had amended the LTIP (exhibit *10.03e) and adopted a stand‑alone Non‑employee Director Deferral Program (exhibit *10.16), introducing a deferral component and linking awards to long‑term metrics such as total shareholder return, thereby tightening governance oversight and aligning director compensation more closely with shareholders’ long‑term interests 【page 94】【page 96】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Linde's RSU program evolution. STRENGTHS: (1) Correctly identifies the 2021 Long-Term Incentive Plan as the foundational framework in 2022, (2) Accurately references the legacy 2009 Praxair LTIP for pre-2019 grants, (3) Correctly identifies the July 30, 2024 Board adoption of the Non-employee Director Deferral Program, (4) Properly synthesizes the evolution from basic RSU awards to a more sophisticated deferral mechanism with performance metrics, (5) Appropriately cites exhibit numbers and page references, (6) Correctly identifies governance enhancements and shareholder alignment as key outcomes. MINOR WEAKNESSES: (1) The LLM answer mentions 'total shareholder return' as a linked metric, which is not explicitly confirmed in the ground truth (ground truth mentions 'long-term performance metrics' more generally), though this is a reasonable inference about typical director compensation structures, (2) The answer could have been slightly more explicit about the 'stand-alone' nature of the 2024 deferral program versus the integrated 2022 approach, though this distinction is adequately conveyed. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and multiple documents/exhibits, correctly identifying the progression from a basic equity compensation framework to an enhanced governance structure. The reasoning about governance strengthening and shareholder alignment is sound and well-supported. QUANTITATIVE ACCURACY: The date (July 30, 2024) is correct; no calculations are required for this qualitative question. ENTITY ACCURACY: Linde plc correctly identified; all plan names and exhibit references appear accurate based on typical SEC filing structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 498,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "In the 2022 filing GM reported that part of its non‑operating income came from a $0.2 billion gain on Stellantis N.V. warrants, reflecting a modest investment upside with Stellantis (see page 36). By the 2024 filing the focus had shifted to a legal exposure: GM Holdings agreed, under the 2017 Opel/Vauxhall sale to PSA (now Stellantis), to indemnify Stellantis for losses tied to representations, warranties, emissions, product‑liability and recall claims—subject to time limits, thresholds and caps (see page 93). Thus, the relationship moved from a small investment gain in 2022 to a primarily indemnification‑obligation‑driven arrangement by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes the multi-hop financial and legal relationship evolution between GM and Stellantis across 2022-2024. STRENGTHS: (1) Quantitative accuracy is perfect - correctly identifies the $0.2 billion warrant gain in 2022 and accurately characterizes the 2024 indemnification obligations without overstating or understating amounts. (2) Entity identification is correct - properly names General Motors, Stellantis N.V., and references the 2017 Opel/Vauxhall sale to PSA (correctly noting PSA is now Stellantis). (3) Multi-hop synthesis is sound - effectively connects the 2022 investment gain to the 2024 legal obligations, showing the evolution from financial benefit to contingent liability. (4) Key details are captured - mentions specific liability categories (emissions, product liability, recalls), time limits, thresholds and caps on indemnification. (5) Semantic equivalence is maintained - conveys the same core narrative as ground truth about the relationship shift. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting mention of 'ongoing investigations into Opel's historical conduct in Europe' as a source of potential future liabilities. However, this omission is minor and doesn't materially affect the core answer about the indemnification obligations. (2) The answer appropriately cites page references (36, 93) which adds credibility, though these cannot be independently verified in this evaluation. (3) The characterization of the 2022 gain as 'modest investment upside' is reasonable interpretation rather than direct quote, but semantically accurate. The answer successfully addresses all parts of the multi-part question regarding financial relationship (2022 gains), legal relationship (2024 indemnification), and the evolution between these periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 509,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "In the 2022 filing Southern Company disclosed energy‑related derivatives only through the effects on AOCI and earnings – cash‑flow hedges were shown as OCI gains/losses that are later re‑classified to income, and non‑designated contracts were recognized directly in the income statement, with only cumulative fair‑value adjustments noted on the balance sheet. By the 2024 filing the company added a distinct “regulatory‑hedge” category, separated cash‑flow and fair‑value hedges, and began presenting energy‑related derivatives on the balance sheet as separate current and non‑current assets and liabilities (showing gross amounts, offsets and net amounts), clearly differentiating regulatory, cash‑flow and non‑designated positions. This reflects a shift to a more granular categorization and explicit balance‑sheet presentation of energy‑related derivative exposures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces details not supported by the ground truth. Key issues: (1) The ground truth states that in 2022, Southern Company reported pre-tax effects on income statements for prior years (2021, 2020, 2019), focusing on income statement impacts. The LLM incorrectly characterizes 2022 disclosure as involving AOCI and cash-flow hedges with OCI gains/losses, which is not mentioned in the ground truth. (2) The LLM introduces a 'regulatory-hedge' category for 2024 that is not mentioned in the original answer. The ground truth only mentions categorization under 'Other' or 'Risk Management Activities'. (3) The LLM provides excessive detail about 'gross amounts, offsets and net amounts' presentation that is not corroborated by the ground truth. (4) While both answers correctly identify a shift from income-focused to balance sheet-oriented reporting, the LLM's characterization of the 2022 baseline is inaccurate. The ground truth emphasizes a shift from 'pre-tax effects on income statements' to 'fair value on balance sheets', whereas the LLM discusses AOCI/OCI mechanics not mentioned in the original. (5) The LLM's claim about 'separating cash-flow and fair-value hedges' in 2024 is not explicitly stated in the ground truth. The answer demonstrates partial understanding of the evolution but introduces unsupported details and mischaracterizes the 2022 baseline, reducing overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 403,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "In 2023 Gilead owned about 19.9 % of Arcus’s voting stock and had two of Arcus’s board seats (see page 77). In January 2024 Gilead announced a $320 million equity investment that lifted its stake to roughly 33 % and added a third Gilead‑designated director to Arcus’s board (see page 77). This amendment markedly increased both Gilead’s equity ownership and its governance influence over Arcus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: (1) 2023 ownership of 19.9% is correct, (2) two board designees in 2023 is correct, (3) January 2024 $320 million investment amount is correct, (4) resulting 33% ownership stake is correct, (5) expansion to three board designees is correct. The multi-hop reasoning is sound - the answer correctly synthesizes the evolution of the relationship across two time periods and two dimensions (equity ownership and governance influence). The entity identification is accurate (GILD/Gilead and Arcus are correctly identified). The wording is clear and semantically equivalent to the ground truth, effectively conveying the 'significant increase' in both financial commitment and governance influence. Minor note: The LLM includes page references (page 77) which adds helpful sourcing but is not contradicted by the ground truth. The answer directly addresses all parts of the multi-part question regarding how the strategic relationship evolved between 2023 and 2024, particularly in equity ownership and governance influence. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 333,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "In the 2022 Form 10‑K the 2021 Multicurrency Credit Facility was reported to have a maturity of June 30 2025 and a total borrowing commitment of $6.0 billion (including a $3.5 billion sub‑limit for multicurrency borrowings)【page_49】.  By the 2023 filing the facility’s maturity had been extended one year to July 1 2026, while the total commitment remained unchanged at $6.0 billion (still with a $3.5 billion multicurrency sub‑limit)【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) 2022 maturity date of June 30, 2025 matches ground truth exactly; (2) 2023 maturity date of July 1, 2026 matches ground truth exactly; (3) borrowing capacity of $6.0 billion for both years is correct; (4) the one-year extension is correctly identified. The answer goes beyond the ground truth by providing additional context about the $3.5 billion multicurrency sub-limit, which is relevant detail that enhances understanding without contradicting the original answer. The multi-hop synthesis is sound - the LLM correctly compared the facility across two different fiscal years and identified the evolution (extension of maturity date while maintaining commitment amount). The reasoning is logical and the conclusion about maintaining financial flexibility is appropriate. Minor formatting differences (e.g., 'June 30 2025' vs 'June 30, 2025') are inconsequential. The inclusion of page references adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 303,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s mix of imported versus domestic crude at its U.S. refineries was essentially unchanged – imported crude made up roughly 60 percent of the company’s U.S. refinery inputs in both 2023 and 2024. At the same time, U.S. crude‑unit distillation capacity utilization fell, dropping from about 90.8 percent in 2023 to roughly 86.6 percent in 2024 (a decline of about 4 percentage points).【page_18†L9-L13】【page_17†L9-L13】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) imported crude oil at ~60% of U.S. refinery inputs in both 2023 and 2024 - correct; (2) crude unit distillation capacity utilization of 90.8% in 2023 - correct; (3) utilization declining to 86.6% in 2024 - correct; (4) the calculated decline of approximately 4 percentage points (90.8% - 86.6% = 4.2%) - correct. The multi-hop synthesis is sound: the answer correctly identifies that imported crude reliance remained stable while refinery operational intensity declined. The semantic equivalence is strong - the LLM uses 'essentially unchanged' and 'roughly 60 percent' which appropriately conveys the consistency noted in the ground truth. The answer addresses both parts of the multi-part question: (1) evolution of imported crude utilization (stable at ~60%), and (2) changes in refinery capacity utilization (decline from 90.8% to 86.6%). The reasoning is logical and the conclusion that 'the company's dependency on imported crude oil remained stable' while 'overall operational intensity of its U.S. refineries declined slightly' is well-supported. Minor note: the LLM includes citation references which adds credibility but are not part of the core answer evaluation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 368,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS’s notional hedge for the British Pound fell from $663 million at the end of 2023 to $536 million at the end of 2024—a drop of roughly $127 million (≈19%)【page_130】【page_137】. This reduction signals that UPS is actively scaling back its GBP exposure, likely adjusting the hedge to match revised cash‑flow forecasts or to tighten its currency‑risk management as market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - UNIT MISMATCH: The LLM answer incorrectly states the hedge positions in dollar amounts ($663 million, $536 million, $127 million), when the ground truth clearly specifies these are in UNITS (663 million units, 536 million units, 127 million units). This is a fundamental factual error that misrepresents the nature of the hedging data. The ground truth explicitly identifies these as 'units' of British Pound Sterling, not dollar values. The LLM's use of dollar signs ($) is misleading and incorrect. CORRECT ELEMENTS: (1) The numeric values themselves are accurate (663, 536, 127), (2) The percentage calculation of ~19% is correct, (3) The year-over-year comparison (2023 to 2024) is properly identified, (4) The interpretation that this represents a reduction/scaling back of GBP exposure is reasonable and aligns with the ground truth's assessment. REASONING QUALITY: The LLM's qualitative analysis about 'scaling back GBP exposure' and 'adjusting hedge to match revised cash-flow forecasts' is sound and consistent with the ground truth's conclusion about 'reassessing currency risk' and 'more conservative hedging approach.' However, the fundamental unit error undermines the credibility of the answer. The multi-hop synthesis (comparing two years, calculating the change, interpreting strategic implications) is logically sound, but the unit misidentification is a serious factual error that would mislead readers about what is actually being measured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 408,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Bank of America’s money‑market holdings rose from a fair value of **$1.2 billion at 12/31/2023** to **$1.3 billion at 12/31/2024** (up about $0.1 billion)【page_113】. The modest increase shows the bank is slightly expanding its ultra‑short‑term, low‑risk assets, underscoring a continued emphasis on liquidity and conservative cash‑management in its short‑term investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - opening balance of $1.2 billion at 12/31/2023, closing balance of $1.3 billion at 12/31/2024, and the calculated difference of $0.1 billion increase. Dates are accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of fair value between the two years, and (2) what this shift indicates about investment strategy. ENTITY ACCURACY: Bank of America is correctly identified, the metric (fair value of money market investments) is correct, and the fiscal years are accurate. REASONING QUALITY: The LLM correctly synthesizes the quantitative data and draws a logical inference about the company's strategy - that the modest increase reflects expanded liquidity management and conservative cash-management emphasis. This interpretation aligns with the ground truth's characterization of 'modest growth' and 'slight expansion in liquidity management.' SEMANTIC EQUIVALENCE: The LLM's phrasing of 'ultra-short-term, low-risk assets' and 'continued emphasis on liquidity and conservative cash-management' conveys the same strategic implications as the ground truth's 'modest growth' and 'expansion in liquidity management or short-term capital deployment strategies.' The only minor distinction is that the LLM adds slightly more specific characterization ('ultra-short-term, low-risk') which enhances rather than detracts from accuracy. The citation reference [page_113] adds credibility. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 440,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural‑gas that could be sold back under physical supply contracts fell from 26 million mmBtu in 2022 (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power) to 15 million mmBtu in 2024 (4 mmBtu for Alabama Power, 6 mmBtu for Georgia Power, 2 mmBtu for Mississippi Power and 3 mmBtu for Southern Power) – a reduction of 11 million mmBtu across the subsidiaries【page_319†L31-L38】【page_281†L31-L38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental unit error that invalidates the entire response. The ground truth specifies volumes in 'million mmBtu' (e.g., '6 million mmBtu'), but the LLM answer omits the word 'million' from the subsidiary-level figures, stating only '6 mmBtu for Alabama Power' instead of '6 million mmBtu for Alabama Power.' This represents a 1,000,000x understatement of each subsidiary's volume. While the company-wide totals (26 million mmBtu and 15 million mmBtu) are correctly stated with units, the subsidiary breakdowns are presented without the 'million' qualifier, creating a critical inconsistency and factual error. The calculation of the 11 million mmBtu reduction (26 - 15 = 11) is mathematically correct, and the identification of all four subsidiaries and the 2022-2024 timeframe is accurate. However, the unit error in presenting subsidiary-level data is a serious factual mistake that would mislead readers about the actual volumes involved. The answer does address all parts of the question and correctly identifies the direction of change (reduction), but the presentation error significantly undermines the accuracy and reliability of the response. The inclusion of citation references suggests proper sourcing, but the unit inconsistency indicates either a transcription error or misunderstanding of the data format.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 383,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "In fiscal 2023 Adobe launched the Firefly Vector Model as part of the Firefly family, letting users create fully editable vector graphics from text prompts and embedding the capability in core Creative Cloud apps such as Photoshop, Illustrator, Express and Stock 【page_11】. By fiscal 2024 the model’s reach had broadened – it was woven into additional tools (e.g., Acrobat and InDesign), exposed through Firefly Services and Custom Models for enterprise use, and its outputs were made commercially safe with Content Credentials and generative‑credit tracking, signaling a deeper, enterprise‑grade integration across the Adobe suite 【page_12】【page_13】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) INCORRECT 2023 CLAIMS: The LLM states that in fiscal 2023, Firefly Vector Model was embedded in 'core Creative Cloud apps such as Photoshop, Illustrator, Express and Stock.' However, the ground truth explicitly states it was integrated into Adobe Express in 2023, with NO mention of Photoshop or Illustrator integration in 2023. This is a critical factual error. (2) INCORRECT 2024 CLAIMS: The LLM claims expansion to 'Acrobat and InDesign' in 2024, but the ground truth only mentions integration into Adobe Illustrator by 2024 (specifically the Generative Recolor feature). There is no mention of Acrobat or InDesign integration in the ground truth. (3) FEATURE MISIDENTIFICATION: The LLM mentions 'fully editable vector graphics from text prompts' as a 2023 capability, but the ground truth specifies 'custom images and text effects' for 2023, with the vector-specific feature (Generative Recolor) appearing in 2024 with Illustrator. (4) MISSING KEY DETAIL: The ground truth emphasizes the expansion from 'single-app integration to multiple professional-grade applications,' which the LLM partially captures but with wrong app names. (5) ADDED UNVERIFIED CLAIMS: The LLM adds details about 'Firefly Services,' 'Custom Models,' 'Content Credentials,' and 'generative-credit tracking' that are not present in the ground truth and cannot be verified. While these may be accurate, they represent information synthesis beyond what the ground truth supports. The LLM demonstrates poor multi-hop reasoning by conflating different time periods and incorrectly attributing features to wrong applications and years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 466,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "In 2023 Biktarvy generated $11.85 billion in sales – roughly two‑thirds of Gilead’s $18.2 billion HIV revenue and a major share of total product sales (page 65). The 2024 filing, while not giving a new sales number, continues to stress the centrality of its HIV products and the need to sustain sales amid competition and pricing pressure (pages 18‑20), indicating that Biktarvy remains a cornerstone of the portfolio. Consequently, Gilead’s HIV strategy will keep Biktarvy at the forefront, focusing on protecting its market share and using it as the primary growth engine for the HIV business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Biktarvy's 2023 sales figure of $11.85 billion ($11,850 million), matching the ground truth exactly. (2) The calculation that Biktarvy represents roughly two-thirds of GILD's $18.2 billion HIV revenue is mathematically sound (11.85/18.2 ≈ 65%). (3) The LLM appropriately recognizes Biktarvy's centrality to GILD's HIV portfolio and the company's focus on protecting market share. (4) Entity identification is correct (GILD/Gilead, Biktarvy, HIV business). WEAKNESSES: (1) The LLM fails to address the critical evolution from 2023 to 2024 regarding increased risks and competitive pressures. The ground truth emphasizes that by 2024, GILD highlighted 'increased risks around its reliance on HIV products...due to potential shifts in treatment paradigms and growing generic competition.' The LLM mentions 'competition and pricing pressure' but does not capture the specific concern about TAF-containing products or the paradigm shift risks. (2) The LLM does not mention the 2022 comparison ($10,390 million) that demonstrates growth trajectory, which provides important context for understanding the evolution. (3) The LLM's conclusion that Biktarvy will 'keep...at the forefront' and be 'the primary growth engine' somewhat contradicts the ground truth's implication that GILD needs to 'diversify or innovate within its HIV pipeline to sustain revenue growth.' The ground truth suggests mounting pressure to move beyond reliance on Biktarvy, not simply protect it. (4) The LLM does not adequately address the strategic implications regarding the need for diversification, which is a key part of the original question about implications for HIV business strategy. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings but incompletely captures the evolution in risk profile and strategic necessity for diversification that distinguishes the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 522,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018‑1A securities remained outstanding in both years. In the 2022 filing they carried a 3.652 % coupon and $496.1 million of principal, and the 2023 filing shows the principal had risen slightly to $496.8 million while the coupon stayed at 3.652 % 【page_118】【page_108】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding the principal amounts. According to the ground truth: (1) 2022 principal was $500.0 million, NOT $496.1 million as stated by LLM; (2) 2023 principal was $496.8 million, which the LLM correctly states. The LLM reversed the direction of change - it claims principal 'rose slightly' from $496.1M to $496.8M (a $0.7M increase), when in fact the ground truth shows a DECREASE from $500.0M to $496.8M (a $3.2M decrease). This is a fundamental error in both the baseline numbers and the directional analysis. The interest rate of 3.652% is correctly stated for both years. The LLM correctly identified that the coupon remained unchanged. However, the core quantitative findings are substantially incorrect. The question asks about evolution between 2022 and 2023, and the LLM failed to accurately capture the principal amount trajectory. The semantic framing of 'slight rise' contradicts the actual data showing a decline. While the answer addresses the question's structure and correctly identifies the interest rate stability, the principal amount errors are severe enough to make the overall answer materially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 342,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "In 2023 UPS still owned Coyote, recorded a $111 million impairment charge on the Coyote trade name and began evaluating strategic alternatives for the truck‑load brokerage business【page_54】. By 2024 UPS completed the September divestiture of Coyote, booked a $156 million gain on the sale and reduced Forwarding operating expenses by roughly $949 million (and Coyote‑related revenue fell $976 million), signalling a shift from retaining the asset to exiting the business【page_43】【page_41】【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) $111 million impairment charge in 2023 - CORRECT, matches ground truth exactly; (2) September 2024 divestiture - CORRECT, matches ground truth; (3) $156 million gain on sale - CORRECT, additional detail not contradicted by ground truth; (4) $949 million reduction in Forwarding operating expenses - CORRECT, specific detail provided; (5) $976 million Coyote-related revenue decline - CORRECT, specific detail provided. Multi-hop reasoning: The LLM successfully synthesized information across multiple years and documents, correctly identifying the evolution from 2023 (impairment and strategic evaluation) to 2024 (divestiture completion). The answer properly connects the financial metrics to strategic direction, showing the progression from asset retention with impairment to full exit. Entity accuracy: All entities correctly identified (UPS, Coyote, Supply Chain Solutions/Forwarding segments, years 2023-2024). The answer goes beyond the ground truth by providing additional quantitative details (gain on sale, specific expense reductions, revenue impact) that enhance understanding without contradicting the original answer. The semantic equivalence is strong - both answers convey the same core narrative of strategic shift from impairment to divestiture. Minor note: The LLM provides more granular financial detail than the ground truth, which is a strength rather than a weakness, as it demonstrates deeper synthesis of the filing data. The page citations add credibility and traceability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 435,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "In the 2022 filing the Performance Share Unit Awards for grants that began in 2019 were issued under the **Amended and Restated 2009 Praxair Inc. Long‑Term Incentive Plan**, and the awards were offered with either a **Return‑on‑Capital** or a **Total Shareholder Return** performance metric (*10.11k* and *10.11l* on page 107). By the 2024 filing those same two metric options appear under the newer **2021 Linde plc Long‑Term Incentive Plan** (exhibits *10.03c* and *10.03d* on page 94), which was subsequently amended in early 2024 (*10.03e*), showing that the award framework moved to Linde’s newer plan while retaining the same performance‑metric choices.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) EXHIBIT NUMBERS WRONG: The LLM claims 2024 exhibits are '10.03c' and '10.03d' on page 94, but the ground truth specifies exhibits '10.10l' and '10.10m' for 2024. This is a major error in entity identification. (2) PLAN STRUCTURE MISREPRESENTATION: The LLM states the awards 'moved to Linde's newer plan' (2021 Linde plc Long-Term Incentive Plan), but the ground truth explicitly states the same forms remained in place under the Amended and Restated 2009 Praxair plan in both 2022 and 2024. The LLM incorrectly introduces a plan migration narrative that doesn't exist in the ground truth. (3) MISSING CORE FINDING: The ground truth's key conclusion is that the company 'maintained the same dual structure...without introducing new metrics or eliminating existing ones.' The LLM's framing of a plan transition obscures this stability finding. (4) REFERENCE ACCURACY: While the LLM correctly identifies the 2022 exhibits (10.11k and 10.11l) and correctly names the performance metrics (Return-on-Capital and Total Shareholder Return), the 2024 exhibit citations are fundamentally wrong. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022-to-2024 comparison. Instead of showing continuity in the same plan structure with the same metrics, it incorrectly suggests a plan migration occurred. This represents a failure in the core multi-hop reasoning required by the question. The answer is internally coherent but factually incorrect regarding the actual filing exhibits and plan structure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 449,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "In 2023 Trodelvy was already on the market under FDA‑accelerated approval for triple‑negative and HR⁺/HER2‑ breast cancer (and for metastatic urothelial cancer) and, that year, the FDA also approved it for HR⁺/HER2‑ breast cancer while the European Commission granted a matching indication 【page_7†L31-L38】. By 2024 the drug had earned a **second** FDA Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer, a new investigational indication 【page_8†L9-L13】, showing that Gilead is expanding Trodelvy’s clinical program into additional cancer types and receiving expedited regulatory support, indicating a continued, upward development trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Trodelvy's 2023 indications for triple-negative breast cancer, HR+/HER2- breast cancer, and urothelial cancer are accurately stated; (2) The 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer is correct; (3) The characterization of this as expansion into new oncology indications with high unmet medical need aligns with ground truth; (4) The overall development trajectory assessment is sound. PROBLEMATIC ELEMENTS: (1) The LLM states Trodelvy received 'a second FDA Breakthrough-Therapy designation' in 2024, implying it had received one previously. The ground truth does not mention a prior Breakthrough Therapy designation in 2023 - only the existing approved indications. This is a factual error that mischaracterizes the regulatory history; (2) The LLM adds details about 2023 FDA approval for HR+/HER2- breast cancer and European Commission approval that are not mentioned in the ground truth, which could represent either additional accurate information or unsupported claims; (3) The reference to 'page_7†L31-L38' and 'page_8†L9-L13' suggests source citations, but these cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between 2023 and 2024, comparing regulatory statuses across years. However, the claim about a 'second' designation introduces an error in the synthesis. The core conclusion about expansion trajectory is valid but based on partially inaccurate characterization of the regulatory history. The answer is more detailed than ground truth but contains at least one clear factual error regarding the 'second' designation claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 472,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "In the 2023 filing, Vertex AI was presented as the Google Cloud developer platform that lets customers **train, tune, augment, test and deploy** applications using Gemini and other leading generative‑AI models, with added services such as vector search, grounding and model distillation 【page_8】. By the 2024 filing, the platform had broadened its model suite to include **Gemini, Imagen and Veo**, and introduced **Gemini for Google Cloud pre‑packaged AI agents** that help developers write, document, test and operate software and also support cybersecurity teams, reflecting a deeper, more application‑focused integration of generative AI 【page_6】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IN TEMPORAL ATTRIBUTION: The LLM answer fundamentally reverses the timeline and misattributes capabilities to the wrong years. (1) CRITICAL ERROR - 2023 vs 2024 REVERSAL: The LLM claims that in 2023, Vertex AI supported 'train, tune, augment, TEST and deploy' with 'vector search, grounding and model distillation' - these are actually the 2024 capabilities per the ground truth. The ground truth explicitly states 2023 had 'train, tune, augment, and deploy' (no 'test'), while 2024 added 'test' and the advanced services. (2) GEMINI ATTRIBUTION ERROR: The LLM states Gemini was mentioned in 2023, but the ground truth indicates Gemini support was a 2024 evolution. The 2023 description mentions 'generative AI models and services' generically, not specifically Gemini. (3) NEW MODELS ERROR: The LLM introduces Imagen and Veo as 2024 additions, which are not mentioned in the ground truth at all. This appears to be hallucinated information not supported by the source documents. (4) GEMINI FOR GOOGLE CLOUD AGENTS: While the LLM mentions this as a 2024 development, the ground truth does not include this detail, suggesting either hallucination or information from outside the specified knowledge graph. (5) MISSING CORE EVOLUTION: The ground truth emphasizes the shift from generic 'generative AI models and services' (2023) to 'specifically support Gemini' (2024), which the LLM completely inverts. The LLM's answer reads as if it has the years backwards or confused the filing years. The semantic meaning is fundamentally incorrect due to temporal misattribution, which is a critical error in a question specifically asking about evolution 'from 2023 to 2024.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 458,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed that the “premium and intrinsic value associated with weather derivatives” are immaterial and therefore are excluded from the fair‑value measurement of its energy‑related derivative contracts (the note also excluded cash‑collateral balances of $3 million, $28 million and $99 million). The 2024 Form 10‑K repeats the same approach, stating that net derivative amounts “exclude immaterial premium and intrinsic value associated with weather derivatives” for all periods presented, again without quantifying a dollar amount—so the treatment of weather derivatives remains unchanged, with the amounts still deemed immaterial and omitted from valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific dollar amounts ($3 million, $28 million, $99 million) for cash-collateral balances in 2022 that are NOT mentioned in the ground truth. The ground truth explicitly states that in 2022, SO 'did not specify exact amounts.' The LLM then cites $17 million and $62 million for 2024/2023, which ARE correct per ground truth, but the 2022 figures appear to be fabricated or misattributed. (2) INCOMPLETE COMPARISON - The LLM states the treatment 'remains unchanged' between 2022 and 2024, which contradicts the ground truth's key finding that there WAS a meaningful change: in 2024, SO provided 'more specific context' by disclosing the cash collateral amounts ($17M and $62M), whereas 2022 did not provide these specifics. This is a critical difference in disclosure detail that the LLM missed. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the evolution of disclosures across the two years. The ground truth emphasizes that while the weather derivative treatment remained immaterial in both years, the 2024 disclosure was MORE DETAILED and STRUCTURED, providing specific collateral figures. The LLM's conclusion that treatment 'remains unchanged' misses this important nuance about enhanced disclosure quality. (4) FACTUAL ACCURACY - The introduction of unexplained cash-collateral figures for 2022 ($3M, $28M, $99M) without ground truth support is a significant error that undermines credibility. The correct figures for 2024/2023 ($17M/$62M) are accurate, but the 2022 figures appear incorrect or misplaced. (5) SEMANTIC ISSUE - The LLM correctly identifies that weather derivatives remain immaterial in both years, but fails to capture the key insight that disclosure QUALITY and SPECIFICITY improved from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 492,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "In the 2023 filing Gilead only noted that Biktarvy’s core patents remain in force until 2033 in both the U.S. and the EU, with no new regulatory actions reported for the product (2023 10‑K p. 9). By the 2024 filing the company disclosed that the FDA approved an expanded indication for Biktarvy—allowing use in patients with suppressed viral loads who have known or suspected M184V/I resistance and adding an updated label confirming safety and efficacy in pregnant people—and that its patent protection still runs through 2033, reflecting both an enhanced therapeutic label and continued market exclusivity (2024 10‑K p. 8 & 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numeric values are correct - patent expiration year of 2033 is accurately stated for both 2023 and 2024. The specific resistance mutation (M184V/I) is correctly identified. Page references (2023 10-K p. 9, 2024 10-K p. 8 & 9) are appropriately cited. ENTITY ACCURACY: Company name (Gilead/GILD) correctly identified, product name (Biktarvy) accurate, FDA correctly identified as regulatory body, years (2023 vs 2024) properly distinguished. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings, correctly identifying the evolution from patent protection focus in 2023 to expanded regulatory indications in 2024. The comparison structure effectively shows the shift from 'primarily patent protection' to 'expanded therapeutic application and broader patient eligibility.' COMPLETENESS: The answer addresses all key elements from the ground truth: (1) 2023 patent status, (2) 2024 FDA expanded indication for M184V/I resistance, (3) 2024 updated label for pregnant people with HIV-1, (4) continued patent protection through 2033. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, using slightly different but equivalent phrasing ('core patents remain in force' vs 'patent expiration year of 2033'). The characterization of the evolution is accurate and well-articulated. Minor note: The LLM answer explicitly states 'no new regulatory actions reported for the product' in 2023, which is a reasonable inference from the ground truth's statement that 2023 showed 'primarily patent protection' with no mention of regulatory actions, though this specific negative statement isn't explicitly confirmed in the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 488,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "In 2022 AMT only took modest net borrowings under the 2021 Multicurrency Credit Facility – about **$850 million** (the only post‑2021 borrowing disclosed)【page_44】. By contrast, in 2023 the company **borrowed $3.0 billion** and repaid $6.1 billion on that facility, and in June 2023 the facility was **amended** – extending its maturity to July 1 2026, reaffirming a $6.0 billion commitment (with a $3.5 billion multicurrency sub‑limit, $200 million letters‑of‑credit and $50 million swing‑line sub‑limits) and switching the benchmark from LIBOR to SOFR【page_52】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all major components of the question. STRENGTHS: (1) All key numeric values are accurate: $850 million net borrowings in 2022, $3.0 billion borrowed and $6.1 billion repaid in 2023, $6.0 billion facility commitment, July 1, 2026 maturity date, and LIBOR-to-SOFR transition. (2) The multi-hop synthesis is sound, correctly comparing 2022 vs 2023 usage patterns and identifying the facility amendments. (3) Additional detail provided about sub-limits ($3.5 billion multicurrency, $200 million letters-of-credit, $50 million swing-line) adds helpful context. (4) The characterization of 2022 as 'modest' borrowings versus 2023's more substantial activity is appropriate and reflects the ground truth. MINOR OMISSION: The LLM answer does not mention the specific EUR repayment of 842.6 million EUR ($919.1 million) that occurred in 2023, which was explicitly noted in the ground truth. This is a notable detail that demonstrates the multicurrency nature of the facility's usage. However, this omission does not fundamentally undermine the answer's accuracy regarding the overall borrowing/repayment amounts and facility amendments. The answer correctly captures the 'significant transformation' in facility usage and structure between the two years. The quantitative data is precise and the reasoning about the facility's evolution is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 389,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "In the 2023 filing, Google Ad Manager was listed as one of the platforms (alongside Google Ads, Display & Video 360, etc.) through which advertisers purchase inventory, and revenue from ads on Google Network properties—including those run via Ad Manager—was recognized on a gross or net basis depending on whether Alphabet was deemed the principal (see 2023 Note 1, “Advertising Revenues,” p. 58). By the 2024 filing, Alphabet explicitly integrates Google Ad Manager into its revenue‑reporting model as part of the Google Network properties, consistently treating the amounts billed to customers as gross revenue and the payments to network partners as cost of revenue—thereby formalizing Ad Manager’s role as a principal channel within the overall advertising revenue recognition framework (see 2024 Note 1, “Advertising Revenues,” p. 57).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Google Ad Manager is a platform through which advertisers purchase inventory in both 2023 and 2024. (2) The answer accurately references the relevant SEC filing sections (Note 1, 'Advertising Revenues') and correctly notes page numbers (2023 p. 58, 2024 p. 57). (3) The LLM correctly captures that revenue is recognized on a gross basis with payments to network partners treated as cost of revenue. (4) The temporal comparison between 2023 and 2024 is attempted and structured appropriately.\n\nWEAKNESSES: (1) The LLM answer misses the core evolution described in the ground truth: the shift from a 'transactional reporting model' to a 'control-driven justification.' The ground truth emphasizes that by 2024, Alphabet shifted to explicitly asserting its role as principal based on control factors (controlling inventory, being primarily responsible, having pricing discretion). The LLM answer mentions 'principal' but doesn't capture this nuanced evolution in the justification framework. (2) The LLM states that in 2023, revenue was recognized 'on a gross or net basis depending on whether Alphabet was deemed the principal,' which is technically correct but doesn't highlight the specific evolution in how this principal determination is justified. (3) The ground truth emphasizes a 'strategic evolution' and 'more nuanced control-based evaluation' that the LLM answer doesn't adequately convey. The LLM treats the 2024 position as a 'formalization' rather than an evolution in reasoning approach. (4) The LLM answer lacks the specific control-based language that the ground truth emphasizes: 'controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing.' These are the key differentiators between 2023 and 2024 approaches.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years and identifies Google Ad Manager's role in both periods. However, it fails to fully synthesize the evolution in the reasoning framework (from transactional to control-based), which is the core of the question.\n\nNUMERIC/FACTUAL VERIFICATION: Page numbers and filing references appear reasonable but cannot be independently verified. No calculations are required. The characterization of revenue recognition methods is generally accurate but incomplete in capturing the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 643,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "In 2023 UPS recorded a $56 million goodwill impairment on Roadie, indicating that the unit’s fair‑value had fallen below its carrying amount after the 2021 acquisition. By 2024 no new impairment was booked, but UPS’s goodwill‑testing flagged Roadie (along with two other units) as having only a limited cushion of fair value—so a 100‑basis‑point rise in cost of capital or a 10 % drop in projected cash flows could trigger an impairment, and the company now monitors Roadie as a higher‑risk reporting unit while still believing its fair value exceeds book value.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "In the 2022 filing (pages 70‑74) Linde makes no mention of helium, implying the gas was not a material line‑item at that time【page_70】. By the 2024 filing helium is disclosed under the “Other” segment; lower helium volumes cut “Other” sales by $32 million (‑2 %) while operating profit in “Other” rose $19 million (a 44 % increase) despite higher helium‑related costs【page_28】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CONTRADICTORY CLAIMS ON OPERATING PROFIT: The LLM states operating profit in 'Other' segment 'rose $19 million (a 44% increase) despite higher helium-related costs,' which directly contradicts the ground truth stating 'operating profit in the 'Other' segment saw increased costs related to helium.' The ground truth indicates helium created cost pressure and negative impact, not profit improvement. (2) QUANTITATIVE ACCURACY ISSUES: The LLM cites specific numbers ($32 million sales decrease, $19 million operating profit increase, 44% increase) that cannot be verified against the ground truth. The ground truth only confirms '2% underlying sales decrease in the Other segment primarily due to lower volumes in global helium' but does NOT provide the $32M or $19M figures cited by LLM. The LLM appears to have fabricated specific dollar amounts. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies the shift from 2022 (no mention) to 2024 (negative impact), but fails to properly characterize the nature of the impact. The ground truth emphasizes helium as a 'source of cost pressure' with 'increased costs,' while the LLM claims operating profit rose despite these costs - a fundamental mischaracterization. (4) MISSING CONTEXT: The LLM omits mention of LAMT (Linde Advanced Materials Technology) and the insurance recovery that partially offset costs, which are important contextual details in the ground truth. (5) REASONING FLAW: The claim that operating profit increased while helium costs increased contradicts the stated relationship and suggests either calculation error or misreading of source data. The multi-hop reasoning fails because the conclusion about profit improvement is inconsistent with the documented cost pressure narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 484,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The 10‑K shows that the long‑term credit‑protection agreements with FNMA and FHLMC covered **$8.7 billion of residential‑mortgage loans at 31 Dec 2023** and **$8.0 billion at 31 Dec 2024** – a decline of roughly **$700 million** (see page 118). The drop means a slightly smaller share of the mortgage portfolio is fully insured, indicating a modest rise in the amount of residential‑mortgage credit risk that is not protected, even though the covered loans remain fully shielded from severe delinquency.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial figures: $8.7 billion in 2023 and $8.0 billion in 2024, with an accurate calculation of the $700 million decline. The entities (FNMA, FHLMC, residential mortgage loans) are correctly identified, and the multi-hop synthesis across years is sound. The answer appropriately references page 118 as a source. However, there are minor differences in interpretation and emphasis compared to the ground truth: (1) The LLM's interpretation that the decline indicates 'a modest rise in the amount of residential-mortgage credit risk that is not protected' is slightly different from the ground truth's framing that it indicates 'a reduction in the Corporation's reliance on full credit protection' and 'a potential decrease in the volume of high-risk residential mortgage loans.' The LLM's phrasing suggests increased unprotected risk, while the ground truth suggests reduced high-risk loans overall. (2) The LLM states the covered loans 'remain fully shielded from severe delinquency,' which is accurate but doesn't explicitly mention that no allowance for credit losses is recorded on these loans, a detail provided in the ground truth. (3) The LLM's characterization of the change as 'modest' is reasonable but not explicitly stated in the ground truth. Overall, the quantitative data is correct, the multi-hop reasoning is sound, and the answer addresses the question's core components, though the qualitative interpretation of what the decline indicates could be more precisely aligned with the ground truth's emphasis on reduced reliance and potentially lower high-risk loan volumes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 459,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "In the 2023 filing Adobe presented Firefly as a core generative‑AI suite that is natively embedded in Creative Cloud and Experience Cloud, emphasizing its “commercially‑safe” text‑to‑image, vector‑graphic and design‑template capabilities as a key competitive differentiator (2023 p.9‑11). By the 2024 filing the company still positions Firefly as a strategic AI differentiator, but now explicitly flags rising regulatory risk – citing the EU AI Act and other emerging AI‑specific rules that could increase compliance costs, limit product availability or create liability for its AI offerings (2024 p.23‑24).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies Adobe Firefly's 2023 positioning emphasizing native integration, commercial safety, and competitive differentiation, and accurately captures the 2024 shift toward regulatory risk awareness, specifically citing the EU AI Act. The characterization of Firefly as 'commercially-safe' and highlighting its text-to-image, vector-graphic, and design-template capabilities matches the ground truth positioning. (2) QUANTITATIVE ACCURACY: While the question is primarily qualitative, the LLM appropriately references page numbers (2023 p.9-11, 2024 p.23-24) which provide specificity without introducing numerical errors. No calculations are required for this question. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and correctly identifies the evolution from competitive emphasis to risk-aware positioning. The logical progression is sound: 2023 focused on product differentiation through AI capabilities, while 2024 introduced regulatory concerns. (4) ENTITY ACCURACY: Adobe, Firefly, Creative Cloud, Experience Cloud, and EU AI Act are all correctly identified and contextualized. The temporal distinction between 2023 and 2024 filings is properly maintained. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, using slightly more specific language ('commercially-safe' in quotes, specific product features) while maintaining fidelity to the core message. Minor differences in wording ('rising regulatory risk' vs 'new concerns around regulatory risks') are semantically equivalent. The answer is comprehensive, addressing both competitive differentiation and regulatory risks as requested in the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 509,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "In 2023 Trodelvy’s commercial performance accelerated, with product sales jumping 56 % to roughly $1.1 billion and its contribution pulling down the overall product‑gross‑margin because of amortization and manufacturing write‑offs tied to the February 2023 FDA approval for HR⁺/HER2‑ metastatic breast cancer【page_41】. In 2024 the drug’s regulatory momentum continued – the FDA granted a second Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer and the European Commission approved Trodelvy as a monotherapy for HR⁺/HER2‑ breast cancer, expanding its label beyond the earlier U.S. approval【page_8】【page_39】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor presentation differences from the ground truth. QUANTITATIVE VERIFICATION: The 2023 sales figure of 'roughly $1.1 billion' is semantically equivalent to the ground truth's '$1,063 million' (within reasonable rounding for 'roughly'); the 56% growth rate is correctly stated. The 2024 regulatory milestone (second Breakthrough Therapy designation for extensive-stage small cell lung cancer) is accurately reported. STRENGTHS: (1) Both financial and regulatory dimensions are addressed, directly answering the two-part question about 'financial performance and regulatory trajectory'; (2) Multi-hop synthesis is sound - correctly connects 2023 sales data with 2024 regulatory approvals; (3) Additional context provided (February 2023 FDA approval for HR+/HER2- breast cancer, European Commission approval) adds relevant detail without contradicting ground truth; (4) Numeric accuracy is high - 56% growth and sales magnitude are correct. MINOR ISSUES: (1) The LLM provides additional contextual information about manufacturing write-offs and amortization impacts that, while relevant to financial performance, goes slightly beyond the ground truth's scope; (2) The phrasing 'roughly $1.1 billion' vs. the precise '$1,063 million' represents acceptable rounding variation for a 'roughly' qualifier; (3) The answer includes European Commission approval information not mentioned in ground truth, though this doesn't contradict it and actually enhances completeness. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024, properly connecting financial metrics to regulatory milestones and showing the evolution requested. The logic flow is clear and accurate. The answer fully addresses both components of the question (financial performance AND regulatory trajectory) with appropriate temporal progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 513,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron’s stake in Angola LNG has been trimmed and its earnings contribution has fallen. In 2022 the company carried a $1.86 billion investment in Angola LNG and recorded $1.86 billion of equity‑in‑earnings from the affiliate (Note 15, 2022 10‑K p. 44; MD&A p. 42). By the end of 2024 the investment had slipped to $1.66 billion and the share of earnings dropped to $405 million (Note 15, 2024 10‑K p. 84), while Chevron still holds a 36.4 % ownership interest in the project, underscoring its continued strategic, minority‑partner role (Note 15 description, 2024 10‑K p. 85).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific financial data with proper citations that demonstrates detailed knowledge of Chevron's Angola LNG involvement. Strengths: (1) The 36.4% ownership stake is correctly identified and matches the ground truth; (2) The answer provides concrete investment values ($1.86B in 2022, $1.66B in 2024) and earnings figures ($1.86B in 2022, $405M in 2024) with specific 10-K page references; (3) The multi-hop synthesis correctly compares 2022 vs 2024 positions; (4) The characterization of Chevron's role as a 'continued strategic, minority-partner' aligns with the ground truth's emphasis on 'continued strategic emphasis.' Weaknesses: (1) The ground truth emphasizes that 2022 showed 'improved income from equity affiliates' contributing to $5,657M total, but the LLM focuses only on Angola LNG's specific contribution without this broader context; (2) The LLM's framing that the stake was 'trimmed' and earnings 'fell' is accurate but more negative in tone than the ground truth's neutral description of 'evolution' and 'continued strategic emphasis'; (3) The ground truth notes that 2024 showed 'more defined and stable long-term positioning' with 'clear quantification,' while the LLM emphasizes the decline in earnings rather than the clarity of positioning; (4) The specific investment and earnings numbers provided by the LLM cannot be verified against the ground truth provided, which only mentions the 36.4% stake and general earnings contribution. The answer is factually detailed but may overstate the decline narrative compared to the ground truth's emphasis on strategic continuity. The quantitative data appears reasonable and properly sourced, though the ground truth doesn't provide these specific dollar amounts for verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 481,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "Meta’s fixed‑rate senior unsecured notes rose from $18.5 billion of principal outstanding (fair‑value $18.48 billion) at year‑end 2023 to $29.0 billion of principal (fair‑value $27.83 billion) at year‑end 2024, reflecting the addition of a $10.5 billion issuance in August 2024【page_80】【page_110】. In 2023 the company issued $8.5 billion of notes in May 2023, generating about $8.46 billion of net proceeds【page_79】【page_110】, and in 2024 it issued a further $10.5 billion of notes, expanding the total pool of senior unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Principal amounts: $18.5B (end 2023) and $29.0B (end 2024) match ground truth exactly. (2) 2023 issuance: $8.5B issued in May 2023 with $8.46B net proceeds - matches ground truth. (3) 2024 issuance: $10.5B in August 2024 - matches ground truth. (4) Calculation verification: $18.5B + $10.5B = $29.0B, which is correct. (5) Fair values provided ($18.48B and $27.83B) add useful context not in ground truth but are accurate supplementary details. The LLM successfully synthesized multi-hop information: tracking the evolution across two years, identifying specific issuance dates and amounts, and showing the progression from 2023 activity through 2024 activity. The answer addresses all parts of the question about how value and issuance activity evolved. Minor note: The LLM rounded $8.46B to $8.5B in one reference but correctly cited $8.46B in another, showing slight inconsistency in presentation but not in factual accuracy. The inclusion of page references and fair value data demonstrates thorough sourcing. The semantic meaning and factual content align perfectly with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 335,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "In the 2023 filing helium was disclosed only as part of the broader “raw materials and supplies” line, which was valued at $614 million. By the 2024 filing the company re‑characterized helium as a critical dependency, and the “raw materials and supplies” balance fell to $529 million – an $85 million reduction – signalling that the company’s exposure shifted from a generic supply cost to a more focused reliance on helium.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($614M in 2023, $529M in 2024, $85M reduction) that are NOT supported by the ground truth. The ground truth provides specific percentage metrics (4.2% of raw material expenses in 2023, 6.8% in 2024) which the LLM completely omits. The LLM's dollar figures appear to be fabricated or misattributed. (2) MISSING KEY DATA: The LLM fails to cite the actual cost percentages (4.2% vs 6.8%) that are central to the ground truth answer and directly answer the question about how financial exposure changed. These percentages are the specific quantitative evidence requested in the question. (3) REASONING FLAW: The LLM attempts to infer the shift from categorization by citing a reduction in 'raw materials and supplies' balance, but this logic is flawed. The ground truth shows the shift was evidenced by explicit cost percentage disclosures (4.2% to 6.8%), not by balance sheet line item reductions. The LLM's reasoning conflates balance sheet changes with cost exposure changes. (4) ENTITY/METRIC ACCURACY: While the LLM correctly identifies LIN and the 2023-2024 timeframe, it misses the critical metric (helium as percentage of raw material expenses) that defines the answer. (5) SEMANTIC ISSUES: The LLM correctly identifies the conceptual shift from 'supply' to 'dependency,' but undermines this by providing unsupported financial figures instead of the actual disclosed percentages. The answer reads plausibly but is factually incorrect on the specific numbers that matter most.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 446,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s approved pool of European customer balances earmarked for credit activities fell from $3.8 billion at 12/31/2022 to $3.0 billion at 12/31/2023, a drop of roughly $0.8 billion or ≈ 21 % decline. Although the absolute amount fell, the share of European balances designated rose modestly from about 37 % to 39 % of the total available 【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) 2022 approved amount of $3.8 billion - correct; (2) 2023 approved amount of $3.0 billion - correct; (3) percentage of European customer balances: 37% in 2022 and 39% in 2023 - both correct; (4) the calculated decline of $0.8 billion ($3.8B - $3.0B) - correct; (5) the percentage change calculation of approximately 21% decline (0.8/3.8 ≈ 21.05%) - correct and properly calculated. The LLM successfully synthesized the multi-hop information by comparing the two years and identifying the paradox that while absolute amounts decreased, the percentage utilization increased slightly. The reasoning is sound and logically presented. The answer addresses all parts of the question: the evolution between years, the absolute amounts, the percentages, and the percentage change. The characterization of this as a 'more conservative approach' aligns with the ground truth interpretation. Minor note: The LLM uses the notation '≈ 21%' which is appropriate for an approximation. The citation reference [page_49] adds credibility. The answer is well-structured and clearly communicates the key insight about the inverse relationship between absolute amounts and percentage utilization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 355,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "In 2023 Starbucks reported foreign‑currency‑other derivative assets of $32.0 million (current) and $22.9 million (long‑term) with only $2.0 million of accrued liabilities (no long‑term liability). By September 29 2024 those asset balances had collapsed to $1.9 million and $1.7 million, while the liability side grew to $4.7 million (accrued) and $4.1 million (long‑term), shrinking the net fair‑value exposure from roughly a $53 million asset position to a net liability of about $5 million. The AOCI balance for “foreign currency – other” fell from $39.6 million in 2023 to $11.5 million in 2024, and Starbucks now expects to reclassify a $9.5 million gain from AOCI into earnings within the next 12 months.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. CRITICAL ISSUES: (1) The LLM provides detailed balance sheet line items (current/long-term assets and liabilities totaling $32.0M, $22.9M, $1.9M, $1.7M, $4.7M, $4.1M) that are NOT present in the ground truth answer. The ground truth specifically references 'fair value of $1,164 million' for 2023 and '$920 million' for 2024 - these are the correct aggregate fair values that the LLM completely omits. (2) The LLM's calculation of 'roughly a $53 million asset position' ($32.0M + $22.9M - $2.0M = $52.9M) and 'net liability of about $5 million' ($1.9M + $1.7M - $4.7M - $4.1M = -$5.2M) appears to be based on balance sheet components, but these numbers are NOT validated against the ground truth and represent a fundamentally different interpretation of the data. (3) The LLM correctly identifies the AOCI balance change ($39.6M to $11.5M) and the reclassification amount ($9.5M), which matches the ground truth. However, these correct figures are embedded within an otherwise incorrect narrative. (4) The ground truth explicitly states the fair value decreased from $1,164 million to $920 million - a $244 million decline - which is the primary metric requested in the question. The LLM's focus on derivative asset/liability line items misses this critical aggregate fair value metric entirely. (5) Multi-hop reasoning: The LLM failed to synthesize the correct fair value metrics across years and instead provided granular balance sheet details that don't align with the ground truth's aggregate fair value approach. The question asks about 'fair value' evolution, and the ground truth provides the correct fair values ($1,164M and $920M), which the LLM completely omits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 482,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "In 2022 Alabama Power held $55 million of energy‑related derivatives as assets and $11 million as liabilities, while Georgia Power held $75 million of assets and $8 million of liabilities【SO_10k_2022.pdf page 311】. By 2023 those asset values had collapsed to $15 million (Alabama) and $13 million (Georgia) and the liability balances had surged to $110 million and $124 million respectively, turning each subsidiary’s position from a net‑asset to a net‑liability【SO_10k_2023.pdf page 281】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: Alabama Power 2022 ($55M assets/$11M liabilities), Georgia Power 2022 ($75M assets/$8M liabilities), Alabama Power 2023 ($15M assets/$110M liabilities), and Georgia Power 2023 ($13M assets/$124M liabilities). The multi-hop synthesis is sound, correctly comparing the two companies across both years and identifying the directional shift from net-asset to net-liability positions. The answer properly addresses all components of the question: the evolution of fair values, the directional changes, and the asset versus liability positioning for both entities. The reasoning is logical and well-structured, moving chronologically from 2022 to 2023 and comparing both companies. The inclusion of source citations (SO_10k_2022.pdf page 311 and SO_10k_2023.pdf page 281) adds credibility. The characterization of the shift as 'substantial' and the description of asset values as having 'collapsed' while liabilities 'surged' appropriately conveys the magnitude of change. Minor note: The answer could have been marginally enhanced by explicitly stating the net position changes (e.g., Alabama Power moved from +$44M net to -$95M net), but this is not required by the question and the current answer fully addresses what was asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 370,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan was invested roughly 65 % in fixed‑income securities (and cash equivalents) and 35 % in equity securities. By 2023 the weighted‑average mix had shifted to about 80 % fixed‑income and 20 % equity, moving the portfolio toward the higher end of its target fixed‑income range【page_48】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: 2022 allocation of 65% fixed income/35% equity, and 2023 allocation of 80% fixed income/20% equity. The answer correctly identifies the evolution of the asset allocation strategy and accurately characterizes the shift as moving toward a more conservative investment approach. The LLM answer adds valuable context by noting the portfolio moved 'toward the higher end of its target fixed-income range,' which provides additional insight beyond the ground truth while remaining factually consistent. The multi-hop reasoning is sound - the answer successfully synthesizes the allocation data across both years and draws the appropriate conclusion about the strategic shift. The only minor distinction is that the ground truth explicitly states 'more conservative investment strategy' while the LLM conveys this through the phrase 'moving the portfolio toward the higher end of its target fixed-income range,' but this is semantically equivalent and arguably more precise. All entities are correctly identified (U.S. Retiree Health Care Plan, fixed income securities, equity securities, years 2022 and 2023). The citation reference [page_48] adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 369,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "In the 2022 Form 10‑K, Trodelvy (sacituzumab govitecan‑hziy) was listed as an FDA‑accelerated‑approval product for two cancers – unresectable locally advanced or metastatic triple‑negative breast cancer and locally advanced or metastatic urothelial cancer【page_6】. By the 2023 filing, Gilead reported that Trodelvy received new approvals (both FDA and European Commission) for a third indication: monotherapy in adult patients with unresectable or metastatic hormone‑receptor‑positive, HER2‑negative breast cancer who have progressed after endocrine‑based therapy and at least two additional systemic treatments【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 indications correctly identified - TNBC (unresectable locally advanced or metastatic) and urothelial cancer (locally advanced or metastatic) after platinum-based chemotherapy and PD-1/PD-L1 inhibitor. The LLM slightly simplifies the urothelial cancer description by omitting the specific prior therapy requirements (platinum-based chemotherapy and PD-1/PD-L1 inhibitor), but this is a minor omission. (2) 2023 new indication correctly identified - HR+/HER2- breast cancer with the specific treatment history (endocrine-based therapy and at least two additional systemic therapies). The LLM's phrasing 'progressed after endocrine-based therapy and at least two additional systemic treatments' is semantically equivalent to the ground truth's 'who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting.' (3) Regulatory approvals correctly noted - both FDA and EC approval in 2023. (4) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from 2022 to 2023, identifying the baseline indications and then the new expansion. The characterization as 'significant expansion' aligns with the ground truth. Minor deduction: the 2022 urothelial cancer indication description could have been more complete regarding prior therapy requirements, but this does not materially affect the answer's accuracy regarding the main question about evolution and new 2023 indications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 421,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "In the 2023 Form 10‑K Meta called out user perception as a **stand‑alone risk** – it warned that if people did not view its products as useful, reliable or trustworthy, or if concerns arose about content, privacy, safety or well‑being, user growth and engagement could fall, cutting ad impressions and revenue (see 2023 pages 16‑17 and the “negative publicity” bullet on page 19). By the 2024 filing the company had **removed that explicit user‑sentiment risk** and folded perception‑related worries into broader litigation‑ and regulator‑risk sections, citing class‑action suits alleging “social‑media addiction” and privacy violations that could trigger fines, forced product changes or other operational disruptions (see 2024 page 34). Thus the focus shifted from a direct threat to user engagement to an indirect threat of legal and regulatory fallout from adverse public perception.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Meta's risk disclosure between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from user perception as a 'stand-alone risk' in 2023 to a de-emphasized factor in 2024 - this matches the ground truth's statement that 'explicit mention of user perception as a direct risk factor was notably reduced in 2024.' (2) Accurately characterizes 2023 risks as focused on privacy, safety, content quality, and user sentiment/engagement impact on ad revenue - semantically equivalent to ground truth's 'privacy, safety, content quality, and regulatory changes' with emphasis on 'decreased user sentiment and engagement.' (3) Correctly identifies 2024 shift toward 'broader litigation and regulator-risk sections' with specific examples (class-action suits, addiction allegations, privacy violations, fines, forced product changes) - this aligns with ground truth's 'integration challenges from acquisitions, tax liabilities, and investor sentiment' as broader operational/financial risks. (4) Page references (2023 pages 16-17, 19; 2024 page 34) are specific and appear reasonable for 10-K filings, though cannot be independently verified from ground truth. (5) The multi-hop reasoning is sound: correctly synthesizes the evolution across two years and identifies the strategic communication shift. MINOR WEAKNESSES: (1) The LLM answer emphasizes litigation/regulatory fallout more heavily than the ground truth, which mentions 'integration challenges from acquisitions' and 'tax liabilities' - these are not explicitly mentioned in the LLM response. However, the LLM's focus on litigation/regulatory is still consistent with 'broader operational and financial risks.' (2) The ground truth mentions 'investor sentiment' as part of 2024 risks, which the LLM does not explicitly address. (3) The characterization of 2024 risks as 'indirect threat' vs. direct is a reasonable interpretation but adds analytical framing not explicitly in ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The page numbers cited by LLM cannot be verified against ground truth but appear plausible. SEMANTIC EQUIVALENCE: The LLM's description of the shift is semantically equivalent to ground truth - both convey that user perception moved from a primary risk factor to a secondary/embedded concern within broader risk categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 666,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Lockheed Martin’s aggregate notional amount of interest‑rate swaps grew from about **$500 million at 12/31/2021** (the 2022 10‑K) to **$1.3 billion at 12/31/2023 and again at 12/31/2024** (the 2024 10‑K)【page_66】【page_52】. The more‑than‑doubling of the swap notional indicates the company has markedly expanded its use of variable‑rate swaps—converting fixed‑rate borrowings to variable or hedging variable‑rate debt—to more actively manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $500 million at 12/31/2021 matches the ground truth, and $1.3 billion at 12/31/2023 and 12/31/2024 is accurate. The characterization of this as 'more-than-doubling' is mathematically correct (1.3B/0.5M = 2.6x). Dates are properly specified with fiscal year-end references. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of notional amounts from 2021 to 2024, and (2) what this indicates about interest rate risk management strategy. ENTITY ACCURACY: Lockheed Martin is correctly identified, the metric (notional amount of variable interest rate swaps) is precise, and fiscal years are properly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple 10-K filings (2022 10-K for 2021 data, 2024 10-K for 2023-2024 data) and draws appropriate conclusions about the company's strategic shift toward variable-rate swaps. SEMANTIC EQUIVALENCE: The LLM's explanation that the company is 'converting fixed-rate borrowings to variable or hedging variable-rate debt' aligns well with the ground truth's characterization of 'converting fixed-rate borrowings to variable-rate borrowings.' The reasoning about response to interest rate environment changes is consistent with the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more nuanced language ('converting fixed-rate borrowings to variable or hedging variable-rate debt') compared to the ground truth, but this represents appropriate elaboration rather than deviation. Citation references are included, demonstrating source documentation. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 479,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "In the 2022 Form 10‑K PayPal only described its seller‑protection program in narrative form, noting that transaction‑loss rates had ranged between 0.09 % and 0.15 % of total payment volume but did not disclose a specific allowance for those losses (see “Customer protection programs” on page 51). By the 2023 filing the company began reporting a detailed allowance for transaction losses – a $64 million allowance (versus $66 million in 2022) backed by a higher provision of $1.192 billion (up from $1.170 billion) and lower realized losses ($1.313 billion vs. $1.417 billion), showing a modest increase in the financial reserve for seller‑related claims (see “PROTECTION PROGRAMS” and the allowance table on page 113).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) ALLOWANCE DIRECTION ERROR: The LLM states the allowance was '$64 million (versus $66 million in 2022)' which correctly shows a decrease, but then contradicts this by claiming 'showing a modest increase in the financial reserve for seller-related claims.' This is logically inconsistent - a decrease from $66M to $64M is not an increase. (2) PROVISION NUMBERS UNVERIFIED: The LLM introduces specific provision figures ($1.192 billion in 2023 vs $1.170 billion in 2022) and realized losses ($1.313 billion vs $1.417 billion) that are NOT mentioned in the ground truth answer. These numbers cannot be verified against the original answer and appear to be hallucinated or incorrectly sourced. (3) STRUCTURAL DISCREPANCY: The ground truth clearly states that in 2022 PayPal 'did not disclose a specific allowance for those losses' but the LLM claims the 2023 allowance was '$64 million (versus $66 million in 2022)' - implying a 2022 allowance existed, which contradicts the ground truth. (4) CORRECT ELEMENTS: The LLM correctly identifies the 0.09%-0.15% loss rate range and the $64 million 2023 allowance figure. The narrative vs. quantified approach distinction is also correct. (5) MULTI-HOP REASONING: The synthesis attempt is present but undermined by the internal contradiction about whether reserves increased or decreased. The core evolution narrative (qualitative to quantitative) is captured but the financial details are either contradictory or unverifiable. The answer demonstrates partial understanding but fails on factual accuracy regarding the direction of change and introduces unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 472,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks’ foreign‑currency‑other derivative assets fell dramatically, from $54.9 million in FY 2023 (‑$32.0 m prepaid + $22.9 m other‑long‑term) to $3.6 million in FY 2024 ($1.9 m + $1.7 m), a drop of about $51 million (page_72). At the same time, the related liabilities rose from $2.0 million (accrued) in FY 2023 to $8.8 million in FY 2024 ($4.7 m accrued + $4.1 m other‑long‑term), an increase of roughly $6.8 million, turning a net $53 million asset position into a $5 million net liability – a balance‑sheet swing of roughly $58 million (page_72).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) Derivative assets: Ground truth states FY2023 was $1,164 million (not $54.9 million as LLM claims), and FY2024 was $1.9 million (LLM correctly identifies this but misses the $1,164M starting point). The LLM's breakdown of $54.9M into prepaid and other components is incorrect and not supported by ground truth. (2) Derivative liabilities: Ground truth shows FY2023 at $2.0 million and FY2024 at $4.7 million. The LLM incorrectly states FY2024 liabilities as $8.8 million ($4.7M + $4.1M), adding a non-existent $4.1M other-long-term component. (3) Calculations: The LLM calculates a $51M drop in assets (from $54.9M to $3.6M), but the correct change is from $1,164M to $1.9M, a decrease of approximately $1,162M. The liability increase calculation of $6.8M is also wrong; the correct increase is from $2.0M to $4.7M, or $2.7M. (4) Net position swing: The LLM claims a $58M balance-sheet swing, but the correct magnitude is approximately $1,165M in asset reduction plus $2.7M in liability increase, totaling roughly $1,167M in unfavorable movement. The LLM appears to have confused or misread the balance sheet line items, inventing component breakdowns that don't match the ground truth. While the LLM correctly identifies the direction of change (assets down, liabilities up) and attempts multi-hop synthesis, the fundamental numbers are drastically incorrect, making this answer unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 419,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "In 2022 the energy‑related derivatives produced a $65 million pre‑tax loss on the cost of natural gas and modest gains on the revenue‑hedge side (e.g., a $3 million gain for Southern Company and a $18 million gain for Southern Company Gas)【page_295】. By 2023 the cost effect had reversed to a $59 million pre‑tax gain, while the cash‑flow hedges swung to sizable losses – $81 million for Southern Company, $18 million for Southern Power and $63 million for Southern Company Gas【page_293】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - 2022 cost impact: LLM states $65 million loss vs. ground truth $27 million negative impact (error of $38M). 2022 revenue impact: LLM claims $3M and $18M gains vs. ground truth $117 million negative impact (completely contradictory direction and magnitude). 2023 cost impact: LLM correctly identifies $59 million gain (CORRECT). 2023 revenue impact: LLM states $81M, $18M, and $63M losses vs. ground truth $0 neutral impact (major error - wrong direction and magnitude). (2) ENTITY CONFUSION - The LLM breaks down impacts by subsidiary (Southern Company, Southern Power, Southern Company Gas) while the ground truth presents consolidated figures for natural gas revenues and cost of natural gas. This subsidiary-level detail is not in the original answer and appears to be from a different data source or misinterpretation. (3) MULTI-HOP SYNTHESIS FAILURE - The question asks about evolution from 2022 to 2023 for natural gas cost and revenue hedging. The LLM fails to correctly synthesize the consolidated impact across both years. The 2022 figures are substantially wrong (off by tens of millions), and the 2023 revenue figures are completely inverted (losses instead of neutral). (4) SEMANTIC MISMATCH - The ground truth describes a 'transformation' from negative to positive/neutral impacts. The LLM's narrative of 'reversal' on cost side is partially correct but the revenue side is entirely wrong, undermining the overall narrative. The LLM appears to have accessed different or subsidiary-level data rather than the consolidated natural gas hedging positions requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 467,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K Walmart listed the Deferred Compensation Matching Plan as a filed exhibit (the “*” designation) and noted it was amended and restated effective November 8 2023【page_84】. In the 2024 Form 10‑K the same plan is no longer attached as an exhibit but is incorporated by reference to Exhibit 10.1, while the effective date remains November 8 2023【page_84】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: (1) the effective date of November 8, 2023 is accurate in both filings, (2) the shift from being a filed exhibit in 2023 to being incorporated by reference in 2024 is correctly captured, and (3) the plan name and amendment/restatement status are accurate. The numeric/date information is entirely correct (9/10 quantitative accuracy). However, there are some qualitative differences from the ground truth: (1) The LLM uses technical terminology ('filed exhibit' with '*' designation, 'incorporated by reference to Exhibit 10.1') which is more precise but differs from the ground truth's framing of 'newly introduced' vs. 'established, ongoing plan.' (2) The LLM answer is more technical/mechanical in describing the documentation change, while the ground truth provides more interpretive context about what this shift means (integration into long-term compensation framework). (3) The LLM answer doesn't explicitly state that the plan was 'newly introduced' in 2023, which is a key characterization in the ground truth. The multi-hop reasoning is sound—the answer correctly synthesizes the evolution across two years and identifies the substantive change in how the plan is documented. The answer is contextually relevant and addresses the core question about how treatment evolved, though it emphasizes the technical/procedural aspects rather than the strategic/organizational implications. Minor deduction for not fully capturing the 'newly introduced' characterization and the interpretive framing about what the shift represents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 437,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "In the 2023 filing the company disclosed that LTIP units were “potentially dilutive securities” but had no material dilutive effect for 2023 (and the prior two years) and that “we accrue distributions when they are declared” (page 112). The 2024 filing repeats this language – LTIP units remain potentially dilutive with no material impact for 2024 (and 2023‑2022) – and adds that “we have not adjusted net income … or weighted‑average shares … as doing so would have no dilutive impact,” while still accruing dividends when declared (page 114).  Thus, the treatment of LTIP units has not changed materially; they continue to be listed as non‑material potentially dilutive securities and are accrued in the same manner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Strengths: (1) Correctly identifies that LTIP Units were described as 'potentially dilutive securities' in both 2023 and 2024 filings; (2) Accurately states no material dilutive effect was reported for the respective years (2023, 2022, 2021 in 2023 filing; 2024, 2023, 2022 in 2024 filing); (3) Correctly captures the accrual policy language ('distributions/dividends accrued when declared'); (4) Properly synthesizes the multi-hop comparison showing consistency between years; (5) Includes specific page references (112 and 114) that add credibility; (6) Accurately conveys that the company does not adjust net income or weighted average shares due to no dilutive impact. The answer directly addresses all parts of the question: disclosure evolution, dilutive effect treatment, and accrual policy. Minor observation: The LLM uses 'dividends' in one instance while the ground truth uses 'distributions,' but this is semantically equivalent and both terms appear in SEC filings. The conclusion that treatment 'has not changed materially' is well-supported by the evidence presented. No numerical errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings to demonstrate consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 370,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "In its 2023 filing Meta said it had begun implementing steps to meet the new EU‑U.S. Data‑Privacy Framework and the Irish regulator’s corrective orders, while formally appealing the IDPC’s decision and treating the adequacy decision as a “welcome milestone.” By the 2024 filing Meta’s language had shifted to a more ongoing, risk‑aware stance—emphasizing that the EU‑U.S. DPF now replaces the two prior frameworks, noting that any further CJEU invalidation would create material uncertainty, and reaffirming its continued engagement with regulators and readiness to take additional compliance actions as needed.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the temporal evolution between 2023 and 2024 filings and accurately captures Meta's shift from implementing compliance steps to a more risk-aware stance. It correctly references the EU-U.S. DPF framework and the IDPC's corrective orders. The mention of potential CJEU invalidation creating material uncertainty is accurate and relevant. WEAKNESSES: (1) The LLM answer omits critical quantitative details from the ground truth—specifically the EUR €1.2 billion fine amount, which is a key factual element demonstrating the severity of regulatory action. (2) The answer fails to mention the 'subscription for no ads' alternative introduced in November 2023, which is explicitly noted in the ground truth as a key compliance model development. (3) The answer does not address the European Commission's formal proceedings into DMA compliance or the July 2024 preliminary findings of non-compliance, which represent a significant evolution in regulatory scrutiny beyond the EU-U.S. DPF framework itself. (4) While the LLM captures the shift in Meta's language/stance, it misses the substantive regulatory escalation from data transfer compliance issues to business model compliance under the DMA. MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting 2023 and 2024 filings and identifying a shift in approach, but fails to fully synthesize the complete regulatory landscape including the fine amount, specific business model developments, and DMA proceedings. The answer is narrower in scope than the ground truth, focusing primarily on language/tone shifts rather than substantive regulatory developments. QUANTITATIVE ACCURACY: The LLM provides no specific numbers, missing the EUR €1.2 billion fine entirely. ENTITY/TEMPORAL ACCURACY: Correctly identifies Meta, IDPC, EU-U.S. DPF, and 2023-2024 timeframe, but incompletely addresses the regulatory actors (European Commission, DMA) and specific dates (November 2023, July 2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 539,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "In the 2023 filing Linde said green hydrogen could be made either by electrolysis powered with renewable electricity **or** by steam‑methane reforming of biomethane (LIN_10k_2023.pdf: page_4). By the 2024 filing the company narrowed the definition to electrolysis using renewable energy and water only, placing a stronger emphasis on renewable‑energy‑driven production (LIN_10k_2024.pdf: page_4).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Linde's green hydrogen approach between 2023 and 2024. STRENGTHS: (1) Accurately captures the 2023 definition including both electrolysis with renewable energy AND steam methane reforming of biomethane as production methods; (2) Correctly identifies the 2024 narrowing to focus primarily on electrolysis using renewable energy and water; (3) Properly notes the shift in emphasis toward renewable-energy-driven production; (4) Correctly identifies the years and company (Linde); (5) Appropriately cites source documents with page numbers. WEAKNESSES: (1) The answer states 2024 'narrowed the definition to electrolysis using renewable energy and water only' which is slightly incomplete - the ground truth indicates the 2024 approach still included the broader context of 'renewable hydrogen' and differentiation from blue hydrogen, not just a simple narrowing; (2) Missing the important detail about Linde's increased emphasis on 'carbon intensity metric' as a differentiator between production methods in 2024, which represents a more strategic/refined framing; (3) Does not fully capture that in 2024, green hydrogen was 'clearly differentiated from low-carbon (blue) hydrogen' - the answer focuses on the production method change but misses the comparative positioning aspect. The answer demonstrates solid multi-hop reasoning by synthesizing information across two years of filings, but falls short of capturing the full strategic evolution, particularly the carbon intensity metric emphasis and the clearer differentiation strategy that the ground truth highlights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 446,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company’s wholesale‑gas services segment – the business that had been operated through Sequent – was eliminated after the July 1 2021 sale; the 2022 filing already notes that “wholesale gas services is no longer a reportable segment in 2022” and the 2023 filing repeats that it “is no longer a reportable segment in 2023” (pages 301‑302).  The divestiture produced a pre‑tax gain of $121 million (≈$92 million after tax) and generated an additional $85 million of tax expense, while the segment’s operating revenue ($188 million in 2021) disappeared from the 2022 and 2023 results (pages 57, 300‑302).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the timing of the Sequent divestiture. The LLM states the sale occurred on July 1, 2021, but the ground truth clearly indicates the sale was completed in 2022 (with financial implications reflected in 2023). This is a major chronological error that undermines the entire answer's credibility. QUANTITATIVE ISSUES: (1) The LLM correctly identifies the $121 million pre-tax gain and $85 million additional tax expense, which match the ground truth. (2) However, the LLM provides an after-tax gain calculation of approximately $92 million, which is not mentioned in the ground truth and appears to be an unsupported calculation. (3) The LLM mentions $188 million in 2021 operating revenue, which is not part of the ground truth answer and introduces information not verified. COMPLETENESS PROBLEMS: The question specifically asks about the evolution of the relationship 'between 2022 and 2023,' implying a comparison of the two years. The ground truth clearly states the relationship evolved from 'business ownership relationship in 2022' to 'completed divestiture in 2023.' The LLM fails to properly address this 2022-to-2023 evolution, instead focusing on a 2021 sale date that contradicts the ground truth. REASONING ISSUES: The LLM's multi-hop synthesis is flawed because it anchors the narrative to an incorrect date (2021 vs. 2022), which cascades through the entire answer. While some financial figures are correct, the temporal framework is wrong, making the answer fundamentally misleading about when the relationship changed. The ground truth emphasizes the 2022-2023 transition; the LLM emphasizes a 2021 event that doesn't align with the question's timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 475,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings list Allswell alongside Walmart’s other private‑label names in the Walmart U.S. segment description (see page 7 of each filing). The brand’s continued presence shows that Walmart has kept Allswell as a core private‑brand offering, reinforcing its strategy of expanding a broad, low‑price private‑label portfolio to drive value and margin.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Allswell appears in both 2023 and 2024 Form 10-K filings and accurately conveys that the brand's continued presence indicates it has been retained as a core private-brand offering. The answer appropriately references the specific location (page 7 of each filing) and correctly identifies the strategic context of Walmart's private label portfolio expansion.\n\nSTRENGTHS:\n- Correctly identifies Allswell's presence in both 2023 and 2024 filings\n- Accurately characterizes the brand as a 'core private-brand offering'\n- Properly contextualizes within Walmart's broader private label strategy\n- Correctly notes the strategic purpose (driving value and margin)\n- Appropriately synthesizes the multi-hop information (brand evolution across years)\n\nWEAKNESSES:\n- The answer does not explicitly characterize the evolution from 'newly introduced' (2023) to 'established/mature' (2024) as clearly as the ground truth does\n- Missing the comparative framing that emphasizes Allswell's transition status alongside other mature brands like 'bettergoods,' 'Equate,' and 'Great Value'\n- Does not explicitly state that Allswell 'likely gained traction' or use language suggesting the brand has matured from initial introduction\n- The answer focuses more on retention/continuity rather than the specific evolution/progression implied by the ground truth\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is not directly testable. The filing references (page 7) are reasonable but not verified against actual documents.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across two years (2023 and 2024) and correctly identifies the strategic implication. However, it could have been more explicit about the progression from new to established.\n\nSEMANTIC EQUIVALENCE: While the core message is similar, the ground truth emphasizes 'transition' and 'evolution' more explicitly, whereas the LLM answer emphasizes 'retention' and 'continuity.' These are related but not identical framings of the same phenomenon.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 573,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "Embedded Processing revenue grew from $3.261 billion in 2022 to $3.368 billion in 2023—a 3 % increase that lifted its share of total sales and helped offset the decline in analog revenue (see 2023 segment table, p. 20). TI’s MD&A stresses that analog and embedded‑processing products are the cornerstone of its strategy, with embedded processing singled out as a key growth engine for industrial and automotive markets, underscoring a heightened strategic importance relative to 2022 (see MD&A, p. 19).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides specific revenue figures ($3.261 billion in 2022 and $3.368 billion in 2023) that directly contradict the ground truth. The ground truth explicitly states 'no specific revenue figures were disclosed' for Embedded Processing in 2022, and does not provide the specific 2023 figure of $3.368 billion cited by the LLM. The LLM's claim of a 3% increase cannot be verified against the ground truth and appears to be fabricated data. The LLM also cites specific page references (p. 20, p. 19) without verification against actual filing content. While the LLM correctly identifies that Embedded Processing maintained strategic importance and helped offset Analog revenue decline (which aligns with ground truth), the introduction of unverified specific numbers is a fundamental factual error. The qualitative assessment about strategic emphasis and market focus (industrial and automotive) may be reasonable but cannot be verified against the provided ground truth. The multi-hop reasoning structure is sound (comparing 2022 to 2023, discussing revenue composition and strategic emphasis), but the factual foundation is compromised by the invented financial figures. This represents a severe accuracy problem where the LLM appears to have hallucinated specific data points rather than acknowledging the absence of disclosed segment revenue figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 384,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "In 2022 Chevron’s accounting for Angola LNG showed a $1.857 billion investment and $1.857 billion of equity earnings, with the project’s output counted in Chevron’s Angola production share【page_8】. By 2024 the investment had slipped to $1.665 billion and equity earnings fell to $405 million, although Chevron still holds a 36.4 % equity interest in Angola LNG【page_84】【page_85】. The decline in capital and earnings alongside a retained sizable stake indicates Chevron is keeping a strategic foothold in the LNG market while moderating its exposure to this particular asset.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to provide specific financial data to support the evolution narrative, which is more detailed than the ground truth. However, there are significant issues with quantitative accuracy that prevent a higher score:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM provides specific investment figures ($1.857B in 2022, $1.665B in 2024) and equity earnings ($1.857B in 2022, $405M in 2024) that are NOT present in the ground truth answer\n- These numbers cannot be verified against the provided ground truth, which only mentions the 36.4% stake in 2024\n- The ground truth does not provide any 2022 financial figures for Angola LNG investment or earnings\n- Without access to the actual SEC filings referenced (page_8, page_84, page_85), these specific numbers cannot be confirmed as accurate\n- The claim that equity earnings \"fell to $405 million\" represents a calculation/comparison, but the underlying data cannot be verified\n\n(2) COMPLETENESS:\n- The LLM answer does address the evolution from 2022 to 2024 as requested\n- It provides more granular financial detail than the ground truth\n- Both answers identify the 36.4% stake in 2024\n\n(3) ENTITY ACCURACY:\n- Correctly identifies Chevron and Angola LNG\n- Correctly identifies the 36.4% equity interest in 2024\n- Years (2022, 2024) are correct\n\n(4) REASONING AND SYNTHESIS:\n- The LLM's interpretation that \"decline in capital and earnings alongside a retained sizable stake indicates Chevron is keeping a strategic foothold while moderating exposure\" is logically sound and represents reasonable multi-hop reasoning\n- This conclusion aligns with the ground truth's assertion of \"strategic shift toward securing a stable position\"\n- The reasoning quality is good, but depends on unverified financial data\n\n(5) SEMANTIC EQUIVALENCE:\n- Both answers convey that Chevron has a defined 36.4% stake in Angola LNG by 2024\n- Both suggest strategic positioning in the LNG market\n- The LLM provides additional interpretation about moderating exposure, which is a reasonable inference but goes beyond the ground truth\n\nKEY CONCERN: The LLM introduces specific financial figures that are not in the ground truth and cannot be independently verified from the provided context. While the reasoning is sound IF these numbers are correct, the inability to confirm them against the knowledge graph represents a significant risk. The answer would score higher (8-9) if these specific numbers could be verified as accurate from the actual SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 671,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "In 2021 the CH‑53K was a major driver of RMS growth – higher production volume and risk‑retirements on the Sikorsky helicopter line added roughly **$540 million of net‑sales** and **about $140 million of operating profit** to the RMS segment (page 50). By 2024 the program was still ramping up, with “higher production volume on the CH‑53K program” cited as a key factor behind the **$1.1 billion increase in RMS product sales** (page 34). Together, these trends show the CH‑53K evolving from a strong profit contributor in 2021 to an even larger growth engine in 2024, confirming its status as a cornerstone of RMS’s helicopter portfolio and a central source of revenue and earnings for the division.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $540 million net sales increase in 2021, $140 million operating profit increase in 2021, and $1.1 billion product sales increase in 2024. Numbers match ground truth exactly with acceptable format variations. COMPLETENESS: The answer addresses both time periods (2021 and 2024) and synthesizes the evolution of the CH-53K program across these years. It captures the key metrics and contextual drivers (production volume, risk retirements, production ramp-up). ENTITY ACCURACY: Correctly identifies Lockheed Martin, RMS division, CH-53K program, and Black Hawk/CRH programs. Fiscal years are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, correctly identifying the progression from 2021 contribution to 2024 status. The logical flow from 'strong profit contributor' to 'larger growth engine' is sound and well-supported by the data. SEMANTIC EQUIVALENCE: The LLM's characterization of the program's evolution ('from a strong profit contributor in 2021 to an even larger growth engine in 2024') aligns well with the ground truth's description of transition 'from a developing program with growing financial impact to a key growth driver.' The phrase 'cornerstone of RMS's helicopter portfolio' effectively captures the program's strategic importance. MINOR OBSERVATIONS: The LLM includes page references (pages 50 and 34) which add credibility but weren't in the ground truth - this is a positive addition. The answer is slightly more interpretive in tone ('confirming its status') but remains factually grounded. No calculation errors detected. All dates and metrics are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 483,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "In the 2022 filing, PayPal said its revolving‑consumer‑credit loss curves were built on historical loss experience and an externally‑sourced macro‑economic scenario that mainly projected **unemployment trends and benchmark credit‑card charge‑off rates**, using a supportable forecast horizon of roughly **two years** for revolving products【page_54】.  \n\nBy the 2023 filing, the company had **broadened the macro inputs** for the revolving‑credit portfolio to include **forecasted household disposable‑income and retail e‑commerce sales** (with unemployment still used through Q1 2023), and it **extended the forecast period to about five years (7 months‑3.5 years)**; the models were refreshed in Q2 2023, though the changes were not material to the year‑end provision【page_70】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PayPal's macroeconomic factors between 2022 and 2023 correctly: the shift from unemployment/credit card charge-off rates to household disposable income and retail e-commerce sales, with unemployment retained through Q1 2023. The qualitative reasoning about broadening macro inputs is sound and well-synthesized. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific forecast horizon numbers ('roughly two years' for 2022, 'about five years (7 months-3.5 years)' for 2023) that are NOT present in the ground truth answer. The ground truth makes no mention of forecast periods or their extension. (2) The LLM adds detail about 'Q2 2023' model refresh and materiality assessment ('not material to year-end provision') that goes beyond the ground truth and cannot be verified against it. (3) The parenthetical '(7 months-3.5 years)' is confusing and appears to be an unsupported interpolation. These additions, while potentially accurate to the source filings, represent information not in the ground truth and introduce quantitative specificity that cannot be validated. The core answer about the evolution of macroeconomic factors is correct, but the LLM has added unverified quantitative details that reduce confidence in the response. The answer is directionally correct but contains factual claims beyond the ground truth scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 392,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks’ net gain on foreign‑currency‑denominated debt that remains in AOCI fell from **$140.2 million in fiscal 2023 to $135.2 million in fiscal 2024**, a decline of about $5 million (see Net Investment Hedges – “Foreign currency debt” in the AOCI table)【page_70】.  The positive balance in both years shows the company still has material exposure to foreign‑currency movements, but its hedging program is generating net gains, albeit slightly less in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2023 = $6.3 million LOSS, 2024 = $135.2 million GAIN. LLM states: 2023 = $140.2 million GAIN, 2024 = $135.2 million GAIN. This is a critical error - the LLM reversed the sign on the 2023 figure (showing a gain instead of a loss) and provided a completely different number ($140.2M vs $6.3M). The LLM's calculation of a $5 million decline is mathematically correct given its stated numbers ($140.2M - $135.2M = $5M), but these numbers are wrong. The LLM completely missed the key insight from the ground truth: a dramatic reversal from a $6.3 million loss to a $135.2 million gain, which is the most significant finding about the company's foreign currency exposure change. The LLM's interpretation that 'positive balance in both years' is incorrect - 2023 had a loss, not a gain. While the LLM correctly identified that the company has material exposure to foreign currency movements and that hedging is generating gains, it failed to capture the fundamental shift in the company's position. The answer demonstrates poor multi-hop synthesis by not correctly identifying the nature of the change (loss to gain) and misrepresenting the magnitude of exposure in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 363,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "In 2023 Alabama Power held energy‑related derivative assets of $15 million and liabilities of $110 million, while Georgia Power held $13 million of assets and $124 million of liabilities (page 281). By contrast, the 2022 filing shows a total energy‑related derivative liability of $210 million for the company (page 283). Adding the two subsidiaries together, their liabilities rose from $210 million in 2022 to $234 million in 2023, indicating an overall increase.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical errors in both numbers and reasoning: (1) QUANTITATIVE ERRORS: The LLM states combined liabilities 'rose from $210 million in 2022 to $234 million in 2023,' but this is incorrect. Ground truth shows: 2022 combined net liability was $255 million (Alabama Power $144M + Georgia Power $111M implied), and 2023 combined net liability was $206 million (Alabama Power $95M net + Georgia Power $111M net). The LLM's calculation of $234M in 2023 is wrong: $110M + $124M = $234M, but this ignores the asset positions ($15M + $13M = $28M), which should be netted. The correct 2023 net liability is $206M ($234M liabilities - $28M assets). (2) TREND DIRECTION ERROR: The LLM concludes liabilities 'rose' from 2022 to 2023, but the ground truth shows they DECREASED from $255M to $206M - a reduction of $49M. This is a fundamental error in the overall trend analysis. (3) INCOMPLETE ANALYSIS: The LLM fails to properly account for derivative assets in both years, treating only gross liabilities rather than net positions. The ground truth explicitly addresses net liabilities by subtracting assets from liabilities. (4) 2022 DATA MISHANDLING: The LLM cites '$210 million for the company' in 2022 but doesn't properly explain this figure or reconcile it with the multi-entity analysis required. The ground truth shows Alabama Power had $144M net liability in 2022, and the combined figure was $255M. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the two-company data across two years, arriving at an incorrect conclusion about trend direction. The answer demonstrates poor synthesis of multi-hop information across entities and years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 459,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart bought Alert Innovation in fiscal 2023, completing a $0.4 billion acquisition that gave it roughly 100 % ownership of the company【WMT_10k_2024.pdf: page 45】.  The 2024 filing shows no additional purchase or sale of Alert Innovation during that year – Walmart simply retained the subsidiary – and it discloses that the Alert Innovation entity was later sold and de‑consolidated in fiscal 2025【WMT_10k_2024.pdf: page 44】.  Thus the relationship moved from an acquisition in 2023 to continued ownership in 2024, with the disposition deferred to the following fiscal year.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN TIMELINE: The LLM answer fundamentally misrepresents when the disposition occurred. The ground truth clearly states that in fiscal 2024, Walmart 'sold and deconsolidated the Alert Innovation entity,' representing a complete exit within one year of acquisition (fiscal 2023 to fiscal 2024). However, the LLM answer claims the disposition was 'deferred to the following fiscal year' (fiscal 2025), stating 'the Alert Innovation entity was later sold and de-consolidated in fiscal 2025.' This is a major factual error that directly contradicts the question's focus on the evolution 'between fiscal 2023 and fiscal 2024.' The LLM also incorrectly states that in 2024 'Walmart simply retained the subsidiary' with 'no additional purchase or sale,' when the ground truth explicitly indicates a sale and deconsolidation occurred in fiscal 2024. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and ~100% ownership figures are correct. QUALITATIVE ACCURACY: The multi-hop reasoning is fundamentally flawed because the LLM misidentified the fiscal year of the disposition event. The question asks specifically about the evolution between fiscal 2023 and 2024, and the correct answer shows a complete acquisition-to-divestiture cycle within that period. The LLM's answer extends the timeline to fiscal 2025, which is outside the scope of the question and contradicts the ground truth. CONTEXTUAL RELEVANCE: The answer addresses Alert Innovation and Walmart but fails to correctly characterize the key evolution requested - the one-year cycle from acquisition to complete exit. The answer is contextually relevant to the companies and general topic but factually incorrect on the critical timing element.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 469,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "In 2022 Trodelvy was already on the market for metastatic triple‑negative breast cancer (full FDA approval and EU marketing authorization) and had an FDA accelerated approval for urothelial cancer, but it had no label for HR⁺/HER2‑ disease【page_39】. By 2023 Gilead had secured both European Commission and FDA approvals for Trodelvy as a monotherapy in HR⁺/HER2‑ breast cancer, adding a new indication to its label【page_39】. This label‑expansion shows Gilead’s oncology strategy of deepening and broadening its cancer portfolio by leveraging Trodelvy’s platform to capture additional breast‑cancer sub‑populations and drive growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional context beyond the ground truth but contains a critical factual discrepancy. CORRECT ELEMENTS: (1) The 2023 approvals for HR+/HER2- breast cancer by both FDA and EC are accurately stated; (2) The characterization of this as label expansion and strategic broadening of the oncology portfolio is sound; (3) The multi-hop reasoning connecting regulatory progress to Gilead's strategy is logical and well-articulated. PROBLEMATIC ELEMENTS: (1) The LLM claims Trodelvy had 'full FDA approval and EU marketing authorization' for metastatic triple-negative breast cancer in 2022, but the ground truth makes no mention of triple-negative breast cancer as an approved indication in 2022. The ground truth only states Trodelvy was 'part of Gilead's marketed product portfolio' in 2022 without specifying which indications were approved; (2) The LLM also mentions 'FDA accelerated approval for urothelial cancer' in 2022, which is not mentioned in the ground truth at all. These additions appear to be factually accurate based on actual Trodelvy history, but they go beyond what the ground truth documents state, potentially introducing information not verifiable from the provided source material; (3) The ground truth emphasizes that 'no specific regulatory updates were mentioned' for 2022, whereas the LLM provides specific indications. MULTI-HOP REASONING: The LLM successfully synthesizes the regulatory evolution and connects it to strategic implications, which is appropriate for the question. However, the introduction of unverified indications (triple-negative breast cancer, urothelial cancer) creates uncertainty about source accuracy. The core answer about HR+/HER2- approvals in 2023 and strategic implications is correct, but the 2022 baseline contains potentially unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 494,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "In 2023 Simon gradually pared back its ABG holding – it sold partial interests (e.g., a $157.1 million pretax gain in Q4 2023) and was repeatedly diluted by ABG‑initiated capital transactions that cut its ownership to roughly 9‑10% and generated modest non‑cash gains (e.g., $10.3 million, $12.4 million and $36.4 million gains)【page_73】. By Q1 2024 Simon completed the exit, selling its remaining ABG stake for $1.2 billion and recording a $414.8 million pretax gain, signalling a strategic decision to fully divest from ABG【page_73】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not present in the ground truth, fundamentally misrepresenting SPG's relationship with ABG. Key issues: (1) QUANTITATIVE ERRORS - The LLM cites a '$157.1 million pretax gain in Q4 2023' which does not appear in the ground truth. The ground truth specifically mentions $36.4 million (Q2 2023) and $145.8 million (Q3 2023) gains from dilution, but no $157.1 million figure. The LLM also claims SPG 'completed the exit, selling its remaining ABG stake for $1.2 billion and recording a $414.8 million pretax gain' in Q1 2024 - this is entirely absent from the ground truth, which explicitly states 'SPG no longer reported active capital transactions with ABG' in 2024 and only referenced historical transactions. (2) MULTI-HOP REASONING FAILURE - The LLM fundamentally misunderstands the evolution described in the ground truth. The ground truth shows a shift FROM active transactions in 2023 TO historical references only in 2024, indicating a completed exit sometime before 2024. The LLM incorrectly places the exit in Q1 2024 with fabricated numbers. (3) MISSING CONTEXT - The LLM omits the strategic partnership context (Forever 21, Brooks Brothers, Eddie Bauer licensing ventures) that was central to SPG's ABG relationship. It also fails to mention the 2021 and 2022 historical transactions that were referenced in 2024 filings. (4) ENTITY/TIMELINE CONFUSION - While the LLM correctly identifies the companies and general timeframe, it invents specific transactions and amounts that contradict the ground truth. The claim of a '$1.2 billion' sale and '$414.8 million' gain in 2024 appears to be fabricated data not supported by the knowledge graph. The answer presents a false narrative of a Q1 2024 exit when the ground truth indicates the relationship had already stabilized by 2024 with only historical references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 512,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "In the 2022 10‑K Chevron reported that it owned 50 % of Chevron Phillips Chemical Company LLC, carrying the equity‑method investment at roughly $7.8 billion and recognizing $867 million of equity earnings for the year (Note 15)【page_84】. By the 2024 filing the investment balance had risen to $8.571 billion and equity earnings to $903 million, and the note now spells out a $669 million loan to CPC for the Golden Triangle Polymers Project, showing a higher reported value and a more detailed disclosure of the joint‑venture relationship【page_84】【page_85】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Chevron's relationship with Chevron Phillips Chemical Company LLC but contains significant discrepancies with the ground truth. CORRECT ELEMENTS: (1) The 2024 investment value of $8.571 billion is accurate; (2) The 2023 investment value of $7.765 billion is correctly referenced in ground truth and the LLM's $7.8 billion is a reasonable approximation; (3) The equity method investment classification is correct; (4) The 50% ownership stake is accurate; (5) The mention of increased equity earnings and additional loan disclosure details is relevant. CRITICAL ERRORS: (1) The LLM states the 2022 investment was 'roughly $7.8 billion' but the ground truth indicates Chevron Phillips Chemical was a CONSOLIDATED SUBSIDIARY in 2022, not an equity method investee. This is a fundamental mischaracterization of the 2022 relationship; (2) The LLM does not acknowledge the key structural change from consolidation to equity method investment between 2022 and 2024, which is the core insight of the ground truth answer; (3) The equity earnings figures ($867M and $903M) are provided but not verified against ground truth; (4) The loan disclosure ($669 million) is mentioned but not verified. MULTI-HOP REASONING: The LLM failed to synthesize the critical evolution described in the ground truth - the shift from consolidated subsidiary status in 2022 to equity method investee in 2024. Instead, it presents the relationship as consistently equity method across both years. This represents a failure in the primary multi-hop synthesis required by the question. The answer reads as if Chevron always used equity method accounting for this investment, missing the structural change that is the essence of the question. QUANTITATIVE ISSUES: While some numbers appear reasonable, the lack of verification against ground truth and the presentation of 2022 as equity method (when it was consolidated) suggests potential data accuracy problems.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 533,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "At the end of 2023 Meta said the facilities‑consolidation component of its 2022 restructuring was “substantially completed” but still in progress, and it had incurred about **$2.5 billion of pre‑tax restructuring charges** for that effort (cost of revenue $177 m, R&D $1.58 b, marketing $396 m, G&A $352 m)【page_104】【page_105】. By December 31 2024 the company reported the 2022 restructuring—including the facilities‑consolidation plan—was **fully completed**, and the remaining facilities‑consolidation expense for the year was only **$389 million in total pre‑tax charges** (cost of revenue $31 m, R&D $254 m, marketing $54 m, G&A $50 m)【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Meta's Facilities Consolidation Strategy evolution. STRENGTHS: (1) Correctly identifies the status progression from 'substantially completed' at end of 2023 to 'fully completed' at end of 2024, matching the ground truth characterization. (2) Provides specific financial data with detailed breakdowns by expense category for both periods, showing quantitative rigor. (3) The 2023 figures ($2.5B total with components: $177M cost of revenue, $1.58B R&D, $396M marketing, $352M G&A) sum correctly to approximately $2.5B. (4) The 2024 figures ($389M total with components: $31M cost of revenue, $254M R&D, $54M marketing, $50M G&A) sum correctly to $389M. (5) Correctly synthesizes the multi-hop information showing the progression and completion status across two fiscal years. (6) Appropriately contextualizes both figures as pre-tax restructuring charges. (7) Includes source citations indicating document references. MINOR CONSIDERATIONS: The ground truth mentions 'a retrospective quantification of the financial impact that was not explicitly detailed in 2023,' which the LLM answer doesn't explicitly call out, though it does provide the comparative financial data. However, this is a minor omission of interpretive context rather than a factual error. The answer focuses on the concrete financial and status evolution, which directly addresses the question. The specific dollar amounts and categorical breakdowns appear consistent with SEC filing disclosures and demonstrate proper multi-hop synthesis across the 2023 and 2024 reporting periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 452,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "In the 2022 filing, hypersonics was mentioned only as a “key area for growth” – a strategic priority whose progress would depend on budget‑environment and the transition of development programs to production [page_14]. By the 2024 filing, hypersonics has become an explicit part of Lockheed Martin’s Advanced Development (Skunk Works) focus and is listed under multiple business segments, with several active U.S. Air Force, Army and Navy programs to design, develop and build hypersonic strike weapons [page_4] [page_5]. This shows a shift from a broad growth aspiration in 2022 to concrete, multi‑segment development and fielding efforts in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the 2022 status as a 'key growth area' dependent on government authorization/funding and the 2024 status as active production of hypersonic strike weapons across multiple programs. The characterization of the evolution from development-phase/funding-dependent to active production is accurate. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this question, and none were incorrectly stated. The temporal references (2022 vs 2024) are correct. (3) ENTITY ACCURACY: All entities are correctly identified - Lockheed Martin, U.S. Air Force, Army, Navy, and Skunk Works (Advanced Development) are all properly referenced. The mention of multiple business segments is accurate. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the progression from strategic aspiration to concrete implementation. The logic connecting funding uncertainty in 2022 to active production in 2024 is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - a shift from uncertain future development to active production - while using slightly different phrasing ('broad growth aspiration' vs 'key growth area dependent on funding'). The addition of specific details about Skunk Works and multiple business segments adds helpful context without contradicting the ground truth. Minor note: The LLM answer includes page references which, while helpful for verification, are not part of the ground truth but do not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 474,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "In the 2022 Form 10‑K Southern Company still recorded its energy‑related contracts as regulatory cash‑flow hedges, reporting a $34 million gain in OCI and a modest $9 million unrealized regulatory‑hedge gain on the balance sheet (see 2022 pp. 322‑326). By the 2023 filing the company had re‑classified most of those contracts as non‑designated derivatives, which produced an $81 million loss in OCI, a $257 million unrealized loss on regulatory hedges and a $44 million loss on cash‑flow hedges (partly offset by a $59 million gain on natural‑gas cost) (see 2023 pp. 293‑295).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and numerical errors that fundamentally misrepresent Southern Company's derivative treatment evolution. Key issues: (1) QUANTITATIVE ERRORS - The LLM provides specific dollar amounts ($34M gain, $9M unrealized gain, $81M loss, $257M loss, $44M loss, $59M gain) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these specific numerical values, suggesting the LLM hallucinated financial figures. (2) CONCEPTUAL MISALIGNMENT - The ground truth describes a shift from 'regulatory hedging instruments' disclosure to including 'non-designated hedging instruments' disclosure, representing an expansion of reporting scope. The LLM incorrectly characterizes this as a 'reclassification' of contracts from regulatory cash-flow hedges to non-designated derivatives, which is a different concept entirely. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes the evolution in disclosure practices (what was reported in each year), while the LLM focuses on specific financial impacts without establishing clear evidence these numbers come from the actual filings. (4) PAGE REFERENCES - The LLM cites specific page numbers (2022 pp. 322-326, 2023 pp. 293-295) that cannot be independently verified and may be incorrect. (5) MISSING CORE INSIGHT - The LLM fails to clearly articulate the main point: Southern Company expanded its derivative disclosure framework from 2022 to 2023 to provide broader coverage of energy-related derivatives. The answer addresses the right companies and years but provides unreliable numerical data and mischaracterizes the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 460,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "In the 2022 Form 10‑K Gilead called out that Truvada’s U.S. exclusivity had already expired in October 2020 and discussed the resulting sales impact, indicating that the company was still tracking the product’s IP status (2022 p. 39). By the 2023 Form 10‑K the patent‑expiration tables no longer list Truvada (2023 p. 8‑9), and the patent discussion focuses on other products, showing that Gilead has moved from actively defending Truvada patents to accepting its generic status and no longer discloses any enforceable Truvada patents.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The October 2020 loss of exclusivity date is accurate and matches the ground truth. (2) The reference to 2022 Form 10-K discussing Truvada's expired exclusivity is correct. (3) The general timeline of 2022 vs 2023 comparison is appropriate. PROBLEMATIC ELEMENTS: (1) The core claim that Truvada 'no longer list[s]' in the 2023 patent-expiration tables contradicts the ground truth, which states that 2023 provided 'structured disclosures regarding the patent expiration dates of its principal products, including Truvada.' The ground truth explicitly says Truvada WAS included in 2023 disclosures. (2) The LLM's conclusion that Gilead 'no longer discloses any enforceable Truvada patents' misrepresents the evolution described in the ground truth. The ground truth indicates a shift from acknowledging PAST loss of exclusivity (2022) to PROACTIVELY DISCLOSING FUTURE IP TIMELINES (2023), not a removal of Truvada from disclosures. (3) The LLM's interpretation that this represents 'accepting its generic status and no longer discloses' is a mischaracterization - the ground truth shows the opposite: more structured, forward-looking disclosure. MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution between years. It misread the 2023 disclosure pattern as exclusion rather than as more structured inclusion with patent expiration dates. QUANTITATIVE ACCURACY is good (dates are correct), but QUALITATIVE ACCURACY is compromised by the fundamental misinterpretation of what the 2023 disclosures actually contained regarding Truvada.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 448,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "In the 2022 filing SPG disclosed that it had drawn $1.05 billion from the Supplemental Facility on December 14 2021 (after a $750 million repayment in 2020) and then used proceeds from newly issued senior notes to repay the entire $1.05 billion on January 12 2022, leaving essentially no balance on the facility at year‑end (see 2022 p. 71‑73). By the 2024 filing the only remaining Supplemental Facility debt was a Euro‑denominated borrowing that was swapped to a fixed 3.81 % rate in January 2023 and was fully retired with proceeds from a €750 million bond issuance on November 17 2023, with no new draws reported for 2024 (see 2024 p. 70).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states the 2022 borrowing was on December 14, 2021, but ground truth clearly states January 2022\n   - LLM claims repayment was January 12, 2022, but ground truth indicates it was 'shortly after issuance' without specifying this exact date\n   - LLM omits the critical detail that the $1.05 billion was used to fund early extinguishment of nine mortgages with $1.16 billion principal balance\n   - LLM states the Euro borrowing was €750 million swapped to 3.81% in January 2023, but ground truth shows it was borrowed in November 2023 and repaid November 17, 2023 - no mention of a January 2023 swap\n   - LLM incorrectly states the Euro borrowing was 'fully retired with proceeds from a €750 million bond issuance' - ground truth shows it was repaid on November 17, 2023, but doesn't explicitly state the bond issuance was the repayment source\n\n2. COMPLETENESS ISSUES:\n   - LLM fails to mention the 2024 issuance of new senior unsecured notes to redeem other outstanding notes at maturity, which ground truth identifies as indicating a shift in financing strategy\n   - LLM mentions a 2020 $750 million repayment that isn't in the ground truth answer\n   - LLM provides page references (p. 71-73, p. 70) that cannot be verified against ground truth\n\n3. ENTITY/TIMING ACCURACY:\n   - The 2022 borrowing date is wrong (December 2021 vs January 2022)\n   - The 2023 Euro borrowing timing is confused (January 2023 swap vs November 2023 borrowing/repayment)\n   - Missing the November 2023 borrowing date entirely in the narrative flow\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is incomplete - fails to connect the 2024 senior note issuance strategy to the overall evolution\n   - The narrative about the Euro swap in January 2023 appears to be fabricated or misinterpreted\n   - Doesn't adequately explain the evolution from 2022 to 2024 as requested\n\n5. SEMANTIC ISSUES:\n   - While the general concept of short-term facility usage is mentioned, the specific strategic evolution described in ground truth (shift toward more structured refinancing) is not clearly articulated\n   - The answer suggests no new draws in 2024, which aligns with ground truth, but the overall narrative is confused about timing and events",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 632,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "In the 2022 filing MetLife’s capital‑management approach was centered on keeping a large liquidity cushion – $12.4 billion of short‑term liquidity and $223 billion of overall liquid assets – to meet cash‑flow needs and stress‑scenario requirements, with the cash buffer treated as an implicit safety net for operations and capital adequacy【page_122】. By the 2024 filing the company explicitly calls out “cash‑buffer needs” as a strategic constraint, noting that maintaining or increasing the buffer can limit the capital available for growth initiatives, acquisitions and shareholder returns and may even prevent dividend payments or share repurchases【page_33】. This shift reflects a move from viewing liquidity primarily as a protective reserve to recognizing the buffer as a direct factor in capital‑allocation decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of MetLife's capital management evolution. QUANTITATIVE VERIFICATION: All financial figures are correct - $12.4 billion short-term liquidity (2022), $223.0 billion total liquid assets (2022), and the year references (2022 vs 2024) are accurate. No calculation errors detected. COMPLETENESS: The answer addresses all key aspects of the question: (1) 2022 position with specific liquidity metrics, (2) 2024 shift in narrative, (3) impact on capital allocation decisions, and (4) the evolution from protective reserve to strategic constraint. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two filing years, identifying the conceptual shift from viewing liquidity as a safety net to recognizing it as a direct constraint on capital deployment. The connection between cash buffer maintenance and limitations on innovation, acquisitions, and shareholder returns is properly established. ENTITY ACCURACY: MetLife is correctly identified, years are accurate, and financial metrics are properly labeled. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift ('from protective reserve to recognizing the buffer as a direct factor in capital-allocation decisions') aligns well with the ground truth's description of the narrative shift and its implications. MINOR OBSERVATIONS: The LLM includes page references (page_122, page_33) which add specificity but are not contradicted by the ground truth. The phrasing about 'preventing dividend payments or share repurchases' is a reasonable inference from the constraint discussion and is consistent with the ground truth's mention of 'shareholder returns.' The answer is well-structured, clear, and demonstrates sound reasoning across the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 492,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "In 2022 Starbucks reported roughly $73 million of designated “Foreign currency – other” derivative assets—$39.9 million in prepaid expenses and $33.5 million in other long‑term assets—and only $0.3 million of designated liabilities (accrued) 【page_68】. By the 2023 balance sheet the same category had shrunk to about $3.6 million of assets ($1.9 million prepaid, $1.7 million other long‑term) while liabilities rose to roughly $8.8 million ($4.7 million accrued plus $4.1 million other long‑term) 【page_72】. This reflects a sharp drop in asset exposure and a shift to a larger, more diversified liability exposure for “Foreign currency – other” derivatives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. CRITICAL ERRORS: (1) 2022 Asset Values: LLM claims $73 million total in 'Foreign currency - other' derivative assets ($39.9M prepaid + $33.5M other long-term), but ground truth shows NO asset value in 2022, only $0.3M in liabilities. This is a massive discrepancy - the LLM invented $73M in assets that did not exist. (2) 2023 Asset Values: LLM claims $3.6M total assets ($1.9M prepaid + $1.7M other long-term), but ground truth shows only $1.9M asset (prepaid expenses), with no mention of $1.7M in other long-term assets. (3) 2023 Liability Values: LLM claims $8.8M total liabilities ($4.7M accrued + $4.1M other long-term), but ground truth shows only $4.7M in accrued liabilities with no mention of $4.1M in other long-term liabilities. (4) Overall Narrative: LLM describes a 'sharp drop in asset exposure' from $73M to $3.6M, which is completely fabricated. The actual evolution per ground truth is: 2022 had minimal exposure ($0.3M liability only), while 2023 showed emergence of both asset ($1.9M) and liability ($4.7M) positions - a significant INCREASE in exposure, not a decrease. The LLM fundamentally misunderstood the data structure and invented numbers across multiple line items. The reasoning about 'shift to larger, more diversified liability exposure' is directionally opposite to the ground truth narrative of 'shift toward more balanced treatment.' This answer fails on quantitative accuracy (wrong numbers throughout), entity accuracy (misidentified which line items contained values), and multi-hop synthesis (failed to correctly extract and compare data across two years).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 464,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "In the 2023 filing Coca‑Cola FEMSA was described as the company’s largest independent bottling partner – one of the five bottlers that together accounted for 42 % of worldwide unit‑case volume and that operates under long‑term bottler agreements covering Mexico, Central‑ and South‑America【page_7】.  By the 2024 filing the relationship had deepened: Coca‑Cola now holds a 28 % equity interest in Coca‑Cola FEMSA under the equity‑method, generating $1.77 billion of equity income in 2024 and reflecting a more direct financial stake alongside the ongoing bottler partnership【page_87】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key numeric values are correct: 28% equity stake, 42% unit case volume, $1.77 billion equity income in 2024. (2) The multi-hop synthesis is sound - correctly identifies the 2023 status (one of five largest bottlers), the 2024 transition (equity method investee), and the evolution of the relationship. (3) Entity identification is accurate: Coca-Cola FEMSA, The Coca-Cola Company, geographic scope (Mexico, Central/South America). (4) The answer captures the strategic shift from traditional bottler-concentrate supplier model to deeper financial commitment through equity ownership. (5) Contextual relevance is excellent - directly addresses both the strategic engagement evolution and financial stake changes. MINOR CONSIDERATIONS: (1) The LLM answer adds the specific equity income figure ($1.77 billion) which, while accurate and helpful, goes slightly beyond the ground truth answer's scope but enhances rather than detracts from the response. (2) The ground truth mentions 'multiple countries including Mexico, Brazil, and Argentina' while the LLM says 'Mexico, Central- and South-America' - these are semantically equivalent geographic descriptions. (3) Both answers correctly convey the fundamental shift in the relationship structure. The answer is well-structured, factually accurate, and provides appropriate detail with proper sourcing notation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 405,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "In the 2022 Form 10‑K Intel described FPGAs as part of its “adjacent products” – the non‑platform items (PSG/PLD) that complement its CPU‑centric platform solutions and sit alongside its eASIC bridge technology (see the definition of Adjacent products and FPGA on page 113 and the xPU grouping on page 114). By the 2024 filing Intel still defines FPGA as a field‑programmable gate array (page 102) and lists it as one of the four xPU architectures (page 103), but it no longer groups them under “adjacent products,” indicating that FPGAs have moved from a peripheral adjunct role to a core element of Intel’s broader architecture and production strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of FPGAs as 'adjacent products' within Intel's organizational structure (CCG, DCG, IOTG context implied through the PSG/PLD reference). (2) Accurately captures the 2024 shift where FPGAs are no longer grouped under 'adjacent products' but are instead positioned as core xPU architectures. (3) Properly synthesizes the multi-hop evolution: from supplementary/peripheral role → to core product offering. (4) Provides specific page references (113, 114, 102, 103) that add credibility and demonstrate detailed filing analysis. (5) Uses precise terminology ('field-programmable gate array,' 'xPU architectures,' 'eASIC bridge technology') consistent with SEC filing language. (6) The semantic meaning matches ground truth: both convey transformation from 'supporting role' to 'central production focus.' MINOR CONSIDERATIONS: (1) The LLM answer includes additional contextual details (eASIC bridge technology, PSG/PLD references, page numbers) not explicitly in the ground truth, but these are supplementary and enhance rather than contradict the core answer. (2) The phrasing 'no longer groups them under adjacent products' is semantically equivalent to 'explicitly listed under direct product definitions' - both convey the same strategic shift. (3) All temporal references (2022 vs 2024) are correct. No quantitative errors, calculation errors, or factual inaccuracies detected. The answer fully addresses the multi-part question regarding FPGA evolution and production focus shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 447,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "ConocoPhillips stepped up its spending on the Lower 48 in 2023, recording $6.5 billion of capital expenditures and investments versus $5.6 billion in 2022 (≈ $0.9 billion increase)【page_135】.  At the same time, depreciation, depletion and amortization for the Lower 48 rose to $5.7 billion in 2023, up from $4.9 billion in 2022【page_133】, indicating higher expense on the newly acquired assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about ConocoPhillips' Lower 48 financial activity evolution from 2022 to 2023. STRENGTHS: (1) Depreciation, depletion, and amortization numbers are accurate - $4.9 billion (2022) and $5.7 billion (2023) match the ground truth of $4,854M and $5,729M respectively (minor rounding acceptable). The $0.8-0.9 billion increase is correctly calculated. (2) The answer correctly identifies the Concho acquisition context. (3) Multi-hop synthesis is sound - connecting asset acquisition to depreciation expense. (4) Proper formatting and citation references provided. WEAKNESSES: (1) The LLM introduces capital expenditures data ($6.5B vs $5.6B) that is not mentioned in the ground truth answer. While this may be factually correct from the filings, it goes beyond what was asked and what the ground truth emphasized. The question specifically asks about 'asset acquisition and depreciation, depletion, and amortization expenses' - the ground truth focuses on the latter metric. (2) The LLM's framing around 'capital expenditures and investments' is somewhat tangential to the core depreciation/depletion/amortization focus of the original answer. (3) Minor rounding differences: LLM states $4.9B vs ground truth $4,854M (acceptable), and $5.7B vs $5,729M (acceptable). The $0.9B increase stated by LLM is slightly rounded from the exact $875M difference. OVERALL: The answer is substantially correct on the primary metric (depreciation, depletion, amortization) with accurate numbers and proper year-over-year comparison. The inclusion of capital expenditure data, while potentially accurate, dilutes focus from the specific question asked and represents a minor deviation from the ground truth's emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 474,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "After the May 2022 transaction Emerson contributed its two industrial‑software businesses and $6 billion in cash, receiving 55 % of the newly‑combined AspenTech and leaving a 45 % non‑controlling interest for former Heritage AspenTech shareholders (see 2022 10‑K p. 56). By fiscal 2024 Emerson’s stake had risen to about 57 % and the company announced a proposal to purchase the remaining shares – effectively moving toward 100 % ownership (2024 10‑K p. 25). The AspenTech deal added roughly 0.6 percentage‑points to Emerson’s gross margin in 2023, helping lift margin from the low‑mid‑40 % range in 2022 to 49 % in 2023 and to 50.8 % in 2024 (see 2024 10‑K p. 26).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of Emerson's evolving relationship with AspenTech but contains several significant quantitative discrepancies that reduce accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies May 2022 transaction timing\n- Correctly states $6 billion cash contribution\n- Correctly identifies 55% initial ownership stake and 45% non-controlling interest\n- Correctly notes AspenTech continued operating under its name/ticker\n- Correctly identifies 0.6 percentage point margin impact in 2023\n- Correctly states 50.8% gross margin in 2024\n- Correctly identifies the proposal to purchase remaining shares\n- Good multi-hop synthesis across 2022-2024 period\n\nSIGNIFICANT ERRORS:\n1. OWNERSHIP STAKE DISCREPANCY: LLM states Emerson's stake \"had risen to about 57%\" by 2024, but ground truth clearly states \"55% on a fully diluted basis\" in 2024. This is a material factual error (2 percentage point difference).\n2. MISSING CRITICAL FINANCIAL DETAIL: LLM completely omits the $231 million inventory step-up amortization and its 1.3 percentage point negative margin impact in 2024. This is a significant omission that understates the complexity of the margin story.\n3. MISSING ACQUISITION PRICE: LLM does not mention the $87.69 per share price paid to Heritage AspenTech stockholders, which is a key detail of the acquisition structure.\n4. MISSING BALANCE SHEET DETAIL: LLM does not mention the $168 million retained in AspenTech's balance sheet.\n5. INCOMPLETE MARGIN ANALYSIS: While LLM correctly identifies the 0.6 point contribution in 2023 and final 50.8% in 2024, it fails to explain that the 1.8 percentage point total contribution in 2024 was partially offset by the $231M inventory step-up amortization (1.3 points), which is crucial context for understanding the financial impact.\n\nQUANTITATIVE ACCURACY ISSUES:\n- Ownership percentage error (57% vs 55%) is a direct factual error\n- Missing the $231M amortization figure and 1.3 percentage point impact\n- Missing $87.69 per share and $168M balance sheet figures\n\nQUALITATIVE ASSESSMENT:\nThe LLM demonstrates good understanding of the multi-hop relationship evolution and correctly synthesizes information across years. The narrative flow is logical and addresses the ownership structure evolution. However, the omission of key financial details (inventory step-up amortization) and the ownership percentage error suggest incomplete data extraction or synthesis.\n\nCONTEXTUAL RELEVANCE:\nThe answer appropriately addresses both ownership structure and financial impact dimensions of the question, though incompletely on the financial impact side.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 701,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "- In the 2022 Form 10‑K the company said that 31.5 million shares had been recovered for issuance under the 2015 Director Stock Plan (28.96 M for 2015‑2020 + 2.58 M for 2021) and, after subtracting 32.9 million shares already covered by new awards and imputed reinvested dividends, 34.1 million shares remained available for future issuance (see page 334).  \n\n- By the 2024 Form 10‑K the cumulative recoveries had risen to 37.6 million shares (35.77 M for 2015‑2023 + 1.84 M for 2024) while shares covered by new awards and imputed dividends grew to 42.3 million, leaving only 30.7 million shares available for future issuance (see page 311).  \n\n- The recovery and issuance mechanics have not changed: recovered shares (from forfeitures, cash settlements, tax‑withholding, etc.) are added back to the pool, each share issued under the 2015 Director Stock Plan (including net‑of‑tendered shares for share‑settled SARs) reduces the pool by one, and corporate events trigger adjustments to preserve participants’ rights (see pages 312 and 335).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. Verification of key numbers: (1) 2022 data: 31.5M shares recovered (28.96M + 2.58M = 31.54M ✓), 32.9M covered by awards, 34.1M available - these align with ground truth's 2022 baseline; (2) 2024 data: 37.6M cumulative recoveries matches ground truth exactly (37,608,213 ≈ 37.6M ✓), 42.3M shares covered matches ground truth (42,343,146 ≈ 42.3M ✓), 30.7M available matches ground truth (30,660,961 ≈ 30.7M ✓). The LLM correctly synthesized multi-hop information by: (a) comparing 2022 vs 2024 positions, (b) showing the evolution of share recovery mechanics, (c) demonstrating the net reduction in available shares despite ongoing recovery (from 34.1M to 30.7M). The mechanics explanation is accurate and complete, covering forfeitures, cash settlements, tax-withholding, net-of-tendered shares, and corporate event adjustments. Minor deduction: The LLM uses rounded figures (31.5M, 37.6M, 42.3M, 30.7M) rather than exact figures from ground truth, but this is appropriate for readability and the rounding is accurate. The answer directly addresses all aspects of the question: treatment evolution, share recovery mechanics, and issuance mechanics. Page citations add credibility. The semantic meaning perfectly matches the ground truth's conclusion about the shift in balance between new issuances and recovered shares.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 391,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "In fiscal 2022 Starbucks highlighted the Global Coffee Alliance as a growth engine for its Channel‑Development segment, noting that product‑sales and royalty revenue from the Alliance added about $216 million (the bulk of a $249 million rise in “other” revenues) and helped lift the segment’s revenue by $250 million 【page_32】. By fiscal 2023 the filing describes the Alliance mainly as a licensing channel with Nestlé—still a core part of its “licensed‑store and grocery/food‑service” strategy—but it no longer breaks out a separate revenue figure, indicating the partnership remains strategically important but its contribution is now embedded in broader licensing revenues 【page_6】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Starbucks' Global Coffee Alliance relationship between FY2022 and FY2023, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the shift from explicit revenue reporting in FY2022 to embedded/non-separated reporting in FY2023; (2) Accurately captures the strategic evolution from 'growth engine' to 'licensing channel'; (3) Properly synthesizes information across multiple fiscal years; (4) Correctly identifies Nestlé as the key partner; (5) Appropriately notes the transition from separate revenue attribution to integrated licensing revenues. QUANTITATIVE ACCURACY ISSUES: The LLM states the Alliance contributed 'about $216 million' to the $250 million Channel Development segment increase, which is close to but slightly different from the ground truth's statement of '$250 million increase in revenue driven by product sales and royalty income.' The ground truth presents the $250M as the total Channel Development increase, while the LLM breaks this into $216M from the Alliance plus other components. This is a minor discrepancy in how the numbers are presented/interpreted. The LLM's figure of $249 million for 'other' revenues appears to be a separate metric. QUALITATIVE STRENGTHS: The answer effectively captures the semantic meaning of the evolution—from viewing the alliance as a distinct revenue driver to positioning it as a strategic distribution channel. The reasoning about why separate revenue figures disappeared (embedded in broader licensing revenues) is sound and adds valuable context. MINOR WEAKNESSES: The exact revenue attribution ($216M vs. the ground truth's presentation) creates slight ambiguity, though both answers agree on the approximate magnitude and the $250M Channel Development increase. The LLM provides more specific detail about revenue composition, which could be seen as either more precise or potentially introducing minor discrepancies depending on source interpretation. Overall, the answer correctly addresses both parts of the multi-part question (strategic emphasis evolution and revenue contribution changes) with appropriate synthesis across fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 594,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "- In the 2022 filing NEE disclosed that it had taken a $1.5 billion impairment and, in the first quarter of 2022, “completely write‑off[ed] its investment in Mountain Valley Pipeline” (2022 10‑K, p. 97).  \n- By the 2023 filing the pipeline still appears in the equity‑method investment table, but the footnote shows a $2.4 billion negative adjustment “associated with Mountain Valley Pipeline, primarily reflecting impairment charges in 2022 and 2020” (2023 10‑K, p. 8).  \n\nThis shift from a full write‑off to a heavily‑impaired, essentially valueless holding shows NEE’s willingness to cut losses on non‑core, high‑risk pipeline assets and focus capital on its core regulated and clean‑energy investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims NEE 'completely write-off[ed] its investment in Mountain Valley Pipeline' in Q1 2022 and took a $1.5 billion impairment, but the ground truth shows NEE maintained equity method investments totaling $6,159 million in 2022 and $6,156 million in 2023, with the Mountain Valley Pipeline explicitly listed among key equity method investees in both years. The ground truth indicates NEE's interest in MVP ranged from 32%-55% in 2022 and 32.8%-52.6% in 2023. (2) QUANTITATIVE INACCURACY: The $1.5 billion impairment figure and $2.4 billion negative adjustment cited by the LLM cannot be verified against the ground truth data provided. More critically, these figures are inconsistent with NEE maintaining MVP as an active equity method investment with relatively stable valuations ($6,159M to $6,156M total). (3) CONTRADICTORY NARRATIVE: The LLM's conclusion that NEE 'cut losses' and the investment became 'essentially valueless' directly contradicts the ground truth showing MVP remained a principal equity method investee with meaningful ownership stakes (32.8%-52.6% in 2023). (4) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the correct information across 2022 and 2023 filings. The ground truth shows a slight refinement in ownership ranges (32%-55% to 32.8%-52.6%), suggesting strategic adjustment, not abandonment. The LLM's interpretation of a complete write-off is factually incorrect. (5) MISSING KEY INFORMATION: The LLM completely missed the ground truth's key finding about the narrower ownership range in 2023 and the notation of MVP in Nonrecurring Fair Value Measurements, which would have provided proper context for the investment's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 488,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "In 2022 Medtronic’s InterStim portfolio consisted of the InterStim II, InterStim Micro (newly launched) and InterStim X neurostimulators, all marketed for over‑active bladder, urinary retention and bowel‑incontinence symptoms【page_42】. By 2024 the line had been updated to include recharge‑free versions of InterStim II and InterStim X and a rechargeable InterStim Micro, and the therapeutic claim was broadened to explicitly cover chronic fecal incontinence in addition to over‑active bladder and urinary retention【page_39】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about InterStim product evolution between 2022 and 2024, but contains a significant factual discrepancy that undermines accuracy. CORRECT ELEMENTS: (1) Correctly identifies 2022 products: InterStim II, InterStim Micro, and InterStim X; (2) Correctly notes 2024 includes recharge-free versions of InterStim II and InterStim X; (3) Correctly identifies therapeutic indications in both years: overactive bladder and urinary retention; (4) Correctly notes expansion to chronic fecal incontinence by 2024; (5) Properly synthesizes multi-hop information across the 2022-2024 timeframe. CRITICAL ERROR: The LLM states that by 2024 there is 'a rechargeable InterStim Micro,' but the ground truth makes no mention of InterStim Micro existing in 2024 or being rechargeable. The ground truth explicitly states the 2024 line 'continued to include InterStim II and InterStim X' with no mention of InterStim Micro. This is a significant factual error that suggests the LLM either hallucinated this product detail or misinterpreted source material. ADDITIONAL ISSUE: The LLM describes InterStim Micro as 'newly launched' in 2022, which is not explicitly stated in the ground truth and may be an inference not supported by the source documents. The ground truth describes the 2022 portfolio more neutrally without characterizing the Micro as 'newly launched.' MULTI-HOP REASONING: The answer does successfully synthesize information across the two-year period and correctly identifies the evolution in product positioning (recharge-free labeling) and therapeutic scope expansion. However, the introduction of an unsupported product variant (rechargeable Micro in 2024) represents a failure in accurate information synthesis. The page citations provided (page_42 and page_39) suggest source documentation, but the content about rechargeable Micro in 2024 appears to contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 519,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "In 2022 Simon owned roughly a 10 % non‑controlling stake in Authentic Brands Group after swapping its Forever 21 and Brooks Brothers licensing assets for ABG equity and buying an additional $100 million of shares, leaving it with about a 10.4 % interest (2022 10‑K p.67). By 2023 ABG’s capital transactions had diluted Simon’s holding to roughly 9‑10 % and Simon sold a portion for a $157.1 million pre‑tax gain, and in the first quarter of 2024 it sold its remaining ABG interest for $1.2 billion, realizing a $414.8 million pre‑tax gain and ending the licensing/joint‑venture relationship (2024 10‑K p.73).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) OWNERSHIP PERCENTAGES: The LLM claims Simon owned ~10% and ~10.4% in 2022, but the ground truth states 1.37% in 2022. This is a massive discrepancy (off by ~7-9 percentage points). (2) FINANCIAL GAINS: The LLM reports a $157.1 million pre-tax gain in 2023 and $414.8 million in Q1 2024, totaling ~$572M, but the ground truth mentions only an $18.8 million gain in 2024. The LLM's numbers are dramatically inflated and appear to reference a complete exit rather than the partial stake sales described in ground truth. (3) EXIT TIMING: The LLM claims Simon sold its remaining ABG interest for $1.2 billion in Q1 2024, which is not mentioned in the ground truth at all. The ground truth describes a more measured evolution with partial stake sales, not a complete exit. (4) TRANSACTION DETAILS: The LLM mentions a $100 million share purchase in 2022, which aligns with ground truth, but the context and surrounding facts are wrong. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution from 2022-2024. It appears to have confused or fabricated major transaction details, possibly conflating different transactions or misreading filing data. The ground truth describes a dynamic but measured relationship evolution; the LLM describes a complete exit with massive gains. These are fundamentally different narratives. The LLM's citation format (2022 10-K p.67, 2024 10-K p.73) suggests confidence in sources, but the numbers don't match ground truth, indicating either misreading or hallucination of specific figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 452,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips’ Lower 48 asset base has been expanding – its depreciation, depletion and amortization (DD&A) expense rose from **$4.07 billion in 2021** to **$4.85 billion in 2022** and **$5.73 billion in 2023**【page_133】.  That upward trend mirrors higher capital spending in the region, which jumped from **$3.13 billion in 2021** to **$5.63 billion in 2022** and **$6.49 billion in 2023**【page_135】, indicating increasingly aggressive investment activity in the Lower 48.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) DD&A expenses - 2021: $4,067M ($4.07B) ✓, 2022: $4,850M ($4.85B) ✓, 2023: $5,729M ($5.73B) ✓. All three years of DD&A data match the ground truth exactly (with appropriate format conversion from millions to billions). (2) Capital spending figures provided ($3.13B in 2021, $5.63B in 2022, $6.49B in 2023) are additional supporting data that strengthen the answer, though not explicitly mentioned in the ground truth. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution of investment activity across three years and connects DD&A trends to capital spending patterns. (4) The answer goes beyond the ground truth by providing intermediate year (2022) data and capital expenditure context, which enhances understanding without contradicting the original answer. (5) Entity identification is correct (ConocoPhillips, Lower 48 region, DD&A metric, fiscal years 2021-2023). (6) The conclusion about 'increasingly aggressive investment activity' is well-supported by the data trends shown. Minor note: The ground truth only explicitly mentions 2021 and 2023 DD&A figures, while the LLM provides all three years including 2022, which is additional but not contradictory information. The semantic meaning and core factual content align perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 382,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "In 2023 Verizon held $341 million of international bonds in its pension plan ( $3 million Level 1 and $338 million Level 2) and $12 million in its other post‑retirement benefit plans ( $10 million Level 1, $2 million Level 2)【page_92】; by 2024 the pension‑plan holding fell to $113 million and is now entirely Level 2 (no Level 1), while the other‑plan holding remained $12 million with the same Level 1/Level 2 split【page_93】. Across both years Verizon’s valuation methodology for international bonds did not change – they are valued using matrix prices with input from independent third‑party valuation sources【page_95】【page_93】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR DISCREPANCY - Numbers: The LLM claims Verizon held $341 million of international bonds in pension plans in 2023 and $113 million in 2024, but the ground truth states international bonds were valued at $12 million total in 2024 ($10M Level 1, $2M Level 2). The LLM appears to have conflated or misidentified different bond categories entirely. The ground truth explicitly states the 2024 value is $12 million, not $113 million. (2) STRUCTURAL ERROR - The LLM introduces a distinction between 'pension plan' holdings ($341M/$113M) and 'other post-retirement benefit plans' ($12M) that is not present in the ground truth. The ground truth focuses on the $12 million valuation in 2024 as the key disclosure point. (3) INCOMPLETE ANSWER TO QUESTION - The original question asks about the 'evolution' and 'shift' in treatment/disclosure approach. The ground truth correctly identifies this as a shift from 'general description in 2023 to more transparent and segmented valuation approach in 2024.' The LLM answer misses this key insight about disclosure evolution and instead provides incorrect numerical comparisons. (4) VALUATION METHODOLOGY - The LLM correctly states that the valuation methodology (matrix prices with third-party sources) remained consistent, which aligns with ground truth. However, this correct statement cannot offset the fundamental numerical errors. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the 2023 vs 2024 comparison. The ground truth shows a clear evolution in disclosure transparency, while the LLM presents numbers that don't match the source documents. The citation references (page_92, page_93, page_95) suggest the LLM attempted to ground its answer but extracted incorrect values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 495,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "In 2022 Emerson closed the Heritage AspenTech transaction, contributing its Open Systems International and Geological Simulation Software businesses and cash and emerged with a 55 % equity stake in the newly created AspenTech entity; the company also extended a $240 million revolving term‑loan facility to AspenTech (see EMR 2022 10‑K p. 63 and 2024 10‑K p. 26). By 2024 Emerson’s ownership had risen to roughly 57 % and it announced a $240‑per‑share cash offer to buy the remaining shares, moving toward full acquisition (see 2024 10‑K p. 25), while AspenTech now operates under the Aspen Technology name and is fully integrated into Emerson’s Software & Control segment, contributing to higher sales and margin growth (see 2024 10‑K p. 26 and 24).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM describes a 2022 'Heritage AspenTech transaction' where Emerson contributed OSI and Geological Simulation Software businesses and emerged with 55% stake. This is INCORRECT. The ground truth states that in 2022, Emerson had an $8,326 million financial stake in AspenTech (a balance sheet investment), not a transaction creating a new entity.\n   - The LLM claims ownership 'rose to roughly 57%' by 2024 and mentions a $240-per-share cash offer for full acquisition. This contradicts the ground truth which states that by 2024, Emerson contributed the AspenTech Industrial Software Business plus $6.0 billion in cash to form 'New AspenTech' with a 55% ownership stake - this was a restructuring event, not a gradual ownership increase.\n   - The LLM's narrative describes a progression from 55% to 57% ownership with an acquisition offer, which is fundamentally different from the ground truth's 2024 restructuring event.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - Missing the critical $8,326 million valuation from 2022\n   - Missing the $6.0 billion cash contribution in 2024\n   - The $240 million revolving facility and $240-per-share offer are not mentioned in the ground truth and appear to be confabulated or from different contexts\n   - The 57% ownership figure contradicts the ground truth's 55% stake in New AspenTech\n\n3. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to correctly synthesize the evolution from a financial investment (2022) to an operational restructuring (2024)\n   - The answer conflates different transaction types and timelines\n   - Does not properly connect the 2022 stake to the 2024 restructuring as a strategic evolution\n\n4. ENTITY AND TIMELINE CONFUSION:\n   - Mischaracterizes the nature of Emerson's relationship in both years\n   - Incorrectly describes the 2024 event as an acquisition progression rather than a restructuring\n   - The operational integration claim is partially correct but built on incorrect foundational facts\n\n5. WHAT WAS CORRECT:\n   - Correctly identifies that the relationship evolved between 2022 and 2024\n   - Correctly notes operational integration into Software & Control segment\n   - Correctly identifies AspenTech/Aspen Technology as the entity involved\n\nThe answer demonstrates significant misunderstanding of the actual financial and operational evolution, presenting a narrative of gradual acquisition that contradicts the ground truth's description of a 2022 investment followed by a 2024 restructuring event.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 694,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "In 2022 Starbucks reported interest‑rate swaps only as liabilities – $12 million in accrued liabilities and $34 million in other long‑term liabilities (a total of about $46 million) with no swap asset, and the contracts were not shown as a designated fair‑value hedge【page_68】. By fiscal 2023 the swaps were re‑designated as a fair‑value hedge, appearing under “Designated Derivative Instruments” with a $0.4 million asset in prepaid expenses and a $41.4 million liability in other long‑term liabilities, reducing the net liability and changing the classification【page_72】【page_71】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n(1) QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n- 2022 Classification: LLM claims $12M in accrued liabilities + $34M in other long-term liabilities (total $46M). Ground truth shows ONLY $34.0M in long-term liability with NO current liability component.\n- 2023 Classification: LLM claims $0.4M asset in prepaid expenses and $41.4M liability. Ground truth shows $0.4M in accrued liabilities (current) and $19.2M in other long-term liabilities (total $19.6M).\n- The LLM's 2023 liability figure of $41.4M is completely incorrect; ground truth is $19.2M in long-term liabilities.\n- Net liability change: LLM implies an increase or different structure, but ground truth shows clear decrease from $34.0M to $19.6M.\n\n(2) CLASSIFICATION ERRORS:\n- 2022: LLM incorrectly adds a $12M current liability that doesn't exist in ground truth. Ground truth shows only long-term classification.\n- 2023: LLM mentions a $0.4M asset in prepaid expenses, but ground truth shows $0.4M in accrued liabilities (a liability account, not an asset). This is a fundamental accounting error.\n- The LLM's characterization of the 2023 position as having both asset and liability components misrepresents the actual structure.\n\n(3) MULTI-HOP REASONING:\n- The LLM failed to correctly synthesize the year-over-year evolution. While it attempts to show a transition from non-designated to designated hedges, the underlying numbers are wrong.\n- The claim about \"reducing the net liability\" is contradicted by the LLM's own figures ($46M to $41.4M is only a $4.6M reduction, not the $14.4M reduction shown in ground truth).\n\n(4) SEMANTIC/CONCEPTUAL ISSUES:\n- The LLM correctly identifies that there was a shift in classification/designation between years, but the specific details are fundamentally incorrect.\n- The mention of hedge designation is a reasonable inference but doesn't compensate for the numerical inaccuracies.\n\nThe answer demonstrates a pattern of inventing or misremembering specific dollar amounts rather than accurately reflecting the ground truth data. This is particularly problematic for a financial question where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 602,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "In the 2022 Form 10‑K, NextEra Energy Resources recorded a major loss on its Mountain Valley Pipeline investment – a $0.8 billion impairment (about $0.6 billion after tax) that wrote off the entire equity‑method carrying amount and created a $0.2 billion liability for estimated future ARO costs【page_92】.  \n\nBy the 2023 filing, the company still held a 32.8 % equity stake and disclosed that it will make equity contributions in 2024 and has entered into a 20‑year, roughly $70 million‑per‑year natural‑gas transportation agreement with the pipeline, showing a renewed financial commitment that is contingent on the project’s completion【page_109】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of NextEra's involvement in MVP from 2022 to 2023. STRENGTHS: (1) All major numbers are accurate: $0.8 billion impairment in 2022, 32.8% equity stake in 2023, $70 million annual obligation, and 20-year agreement term. (2) The answer correctly identifies the 2022 impairment charge and its components (pre-tax amount and tax effects). (3) Multi-hop synthesis is sound: the answer traces the evolution from 2022 (write-off) to 2023 (continued investment with new commitments). (4) Entity identification is correct (NextEra Energy Resources/NEER, Mountain Valley Pipeline). (5) The answer appropriately captures the contingency nature of the 20-year transportation agreement. MINOR WEAKNESSES: (1) The LLM provides additional detail about the $0.2 billion ARO liability that, while accurate and relevant, goes slightly beyond what the ground truth explicitly states. (2) The phrase 'renewed financial commitment' could be interpreted as suggesting a reversal of the 2022 write-off, when in fact the company maintained its position despite challenges - though the answer does clarify this is 'contingent on project completion.' (3) The mention of 'equity contributions in 2024' adds forward-looking detail not explicitly in the ground truth, though this appears to be accurate supplementary information from the 2023 filing. The answer successfully addresses all parts of the multi-part question regarding how the financial commitment evolved between the two years, showing both the 2022 impairment and the 2023 continued involvement with new obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 457,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The captive insurance company’s solvency‑capital portfolio of equity and debt securities grew from **$1.643 billion at 12/31/2023** to **$1.883 billion at 12/31/2024**—an increase of roughly **$240 million (about 15 %)**【page_81】. This rise shows Coca‑Cola has allocated more marketable securities to the captive that reinsures its European and Canadian group‑annuity insurance contracts【page_80】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $1.643 billion (2023) and $1.883 billion (2024) match the ground truth values of $1,643 million and $1,883 million respectively (format variation is acceptable). The calculated increase of $240 million is accurate ($1,883M - $1,643M = $240M), and the percentage calculation of approximately 15% is correct ($240M / $1,643M ≈ 14.6%, reasonably rounded to 15%). COMPLETENESS: The answer addresses the core question about the evolution of investments between 2023 and 2024, providing both the starting and ending values, the change amount, and the percentage growth. ENTITY ACCURACY: Correctly identifies The Coca-Cola Company, the captive insurance company, group annuity insurance contracts, and the relevant time periods (12/31/2023 and 12/31/2024). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - comparing values across two years, calculating the difference, and contextualizing the growth. The additional detail about European and Canadian group-annuity insurance contracts adds relevant context without introducing errors. MINOR CONSIDERATIONS: The answer includes page references and slightly more contextual detail than the ground truth (mentioning geographic scope), which enhances rather than detracts from accuracy. The semantic meaning is fully aligned with the original answer. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 414,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "In the 2022 filing (pages 22‑26) Intel’s process discussion is limited to the Intel 7 node – there is no reference to an Intel 4 node, indicating that the first EUV‑based “Intel 4” was still a future technology under development and not yet in production. By the 2024 filing, Intel 4 is described as the company’s first EUV lithography node, with the Intel Core Ultra client processor already shipping in 2023 and the node moved to high‑volume manufacturing in Ireland in 2024, making Intel 4 a central, high‑volume production platform and a cornerstone of the roadmap ahead of Intel 3 and the upcoming 18A node【page_22】【page_10】【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies that Intel 4 was not mentioned in 2022 filings, indicating it was still under development - this aligns with the ground truth's characterization of 'early-stage production challenges and investment' in 2022. (2) Accurately describes the 2024 status: Intel 4 as first EUV lithography node, high-volume manufacturing in Ireland, and integration with Intel Core Ultra processor. (3) Properly synthesizes the evolution narrative from future technology (2022) to production reality (2024). (4) Correctly identifies Intel Core Ultra as shipping in 2023 and Intel 4 moving to high-volume manufacturing in 2024. (5) Appropriately contextualizes Intel 4's position within the broader roadmap (ahead of Intel 3 and 18A). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning EUV lithography explicitly, specific 2023 shipping date for Core Ultra), but these additions are factually accurate and enhance rather than contradict the ground truth. The answer directly addresses both temporal dimensions of the question (2022 vs 2024) and covers both production status and strategic positioning. The multi-hop reasoning correctly synthesizes information across multiple filing years and sections. No numerical errors or calculation issues present. The semantic meaning fully aligns with the ground truth's core message about the transition from investment/ramp-up to high-volume production and strategic importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 442,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "In 2022 Emerson entered a joint‑venture with AspenTech, contributing its Open Systems International and Geological Simulation software businesses to create “Heritage AspenTech” and receiving a non‑controlling equity interest in the new entity (see pages 5‑7). By 2024 Emerson had turned that stake into a majority holding – a cash infusion gave it 55 % of the newly‑named AspenTech (page 26) and, after the November 2024 proposal, it owned about 57 % and planned to acquire the remainder (page 25) – and the AspenTech assets were fully consolidated, adding roughly 3 % of net sales in 2023 and driving a 48 % jump in Software & Control sales, higher SG&A and increased intangible‑amortization in 2024 (pages 24‑26).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Emerson's relationship with AspenTech but contains some inaccuracies and adds details not in the ground truth. CORRECT ELEMENTS: (1) The 55% ownership stake by 2024 is accurate; (2) The shift from partnership to majority ownership is correctly identified; (3) Financial integration and impact on margins/SG&A is mentioned appropriately; (4) The multi-hop synthesis across 2022-2024 is sound. INACCURACIES/ISSUES: (1) The LLM describes 2022 as a 'joint-venture' with 'non-controlling equity interest,' while the ground truth states AspenTech was simply a 'strategic partner' with 'no mention of ownership stakes' in 2022 - this is a material difference in characterizing the 2022 relationship; (2) The LLM mentions 'Heritage AspenTech' and specific business contributions (Open Systems International, Geological Simulation) which are not in the ground truth and may be inaccurate; (3) The LLM adds details about a November 2024 proposal and 57% ownership that go beyond the ground truth's 55% figure - while potentially accurate from filings, they exceed the scope of the ground truth answer; (4) The LLM states the acquisition added 'roughly 3% of net sales in 2023' and caused a '48% jump in Software & Control sales' - these specific metrics are not mentioned in the ground truth, making verification impossible; (5) The ground truth mentions 'gross margins by 0.6 percentage points in 2023' but the LLM does not reference this specific metric. MULTI-HOP REASONING: The LLM correctly synthesizes information across years and identifies the structural evolution, though the characterization of the 2022 starting point appears incorrect. The financial integration discussion is present but with different metrics than ground truth. QUANTITATIVE ACCURACY: The 55% figure is correct, but the 57% and 48% figures cannot be verified against ground truth and may introduce inaccuracy. The 0.6 percentage point gross margin impact is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 540,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "In the 2022 filing Intel only introduced “Intel 4” as a new name for its upcoming 7 nm node – a roadmap‑only change with no production status disclosed (see the naming‑structure table on page 115). By the 2024 filing the node had become Intel’s first EUV‑lithography process, delivering roughly a 20 % performance‑per‑watt gain versus Intel 7, and it had entered high‑volume manufacturing in Ireland (with the Intel Core Ultra client product already shipping in 2023) (see performance details on page 10 and the manufacturing‑readiness discussion on page 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Intel 4's evolution from 2022 to 2024. QUANTITATIVE ACCURACY: All numeric values are correct - the 20% performance-per-watt improvement is accurately stated, and the timeline references (2022 introduction, 2023 Core Ultra shipping, 2024 HVM status) are all factually correct. No calculation errors present. ENTITY ACCURACY: All entities correctly identified - Intel 4 process node, Intel 7 comparison, EUV lithography technology, Intel Core Ultra processor, Ireland manufacturing location. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: (1) temporal evolution from 2022 roadmap status to 2024 production reality, (2) technical specifications (EUV lithography, performance metrics), (3) manufacturing readiness progression, and (4) product application (Core Ultra). The reasoning chain is logical and complete. COMPLETENESS: The answer addresses all aspects of the question - manufacturing readiness evolution (from roadmap to HVM), performance improvements (20% per-watt), and the timeline of changes. The inclusion of specific page references (115, 10, 11) adds credibility and demonstrates source verification. SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth with slightly more precise language and better structural organization. The phrase \"roadmap-only change\" effectively captures the 2022 status, and \"entered high-volume manufacturing\" accurately reflects the 2024 position. Minor observation: The LLM answer uses \"roughly a 20%\" while ground truth states \"20%\" - this is a negligible difference that actually reflects appropriate caution in reporting. Overall, this is a high-quality response that correctly synthesizes complex multi-hop information across years and technical domains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 514,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "In the 2022 filing, InterStim Micro was mentioned only as one of three InterStim neurostimulators (InterStim X, InterStim Micro and InterStim II) that together address overactive bladder, non‑obstructive urinary retention and chronic fecal incontinence【page_10】. By the 2024 filing, InterStim Micro is highlighted as a **rechargeable** neurostimulator within the InterStim therapy suite, positioned alongside recharge‑free InterStim X and InterStim II and called out as a driver of continued acceptance and growth of Medtronic’s Pelvic Health therapies【page_39】. This shows a shift from a generic product listing to a differentiated, rechargeable solution emphasized for market expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies the three InterStim neurostimulators (InterStim X, InterStim Micro, InterStim II) and their indications (overactive bladder, urinary retention, fecal incontinence) in 2022. It accurately describes the 2024 positioning of InterStim Micro as the rechargeable variant, contrasted with recharge-free alternatives. The characterization of the evolution from 'generic product listing' to 'differentiated, rechargeable solution' aligns with the ground truth's description of 'more defined strategic positioning.' (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this criterion is not applicable but the answer correctly references 2022 and 2024 timeframes. (3) ENTITY ACCURACY: All entities are correctly identified - MDT (Medtronic), InterStim Micro, InterStim X, InterStim II, and Pelvic Health therapies. The company name 'Medtronic' is used appropriately. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years (2022 and 2024) and correctly identifies the evolution in product positioning. The logic is sound: the comparison between years demonstrates how the product's role changed from being one of several options to being specifically highlighted as the rechargeable option. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different wording ('shift from a generic product listing to a differentiated, rechargeable solution' vs. 'more defined strategic positioning'). Both convey the same meaning. The inclusion of page references (page_10, page_39) adds helpful sourcing detail. Minor note: The LLM uses 'non-obstructive urinary retention' while ground truth uses 'urinary retention' - this is a more precise specification that doesn't contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 535,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "In the 2022 Form 10‑K the company said that LTIP units are “potentially dilutive” but that “no securities had a material dilutive effect for the years ended December 31, 2021, 2020 and 2019” (the same language appears for the Operating Partnership). The 2024 Form 10‑K repeats that phrasing, updating the periods to “the years ended December 31, 2024, 2023 and 2022” and again confirming that LTIP units had no material dilutive effect. Thus, the disclosure has been refreshed to cover the most recent three years, but the assessment of material impact remains unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The years cited are accurate - 2022 disclosure covered 2021, 2020, 2019; 2024 disclosure covers 2024, 2023, 2022. (2) The core conclusion that no securities had material dilutive effect is correct for both periods. (3) The observation that disclosure was refreshed to cover most recent three years is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces the phrase 'potentially dilutive' which does not appear in the ground truth answer. The ground truth states LTIP units were 'exchangeable for common stock' but does not characterize them as 'potentially dilutive.' This is a factual inaccuracy. (2) The LLM states the 2024 disclosure 'repeats that phrasing' from 2022, but the ground truth indicates the opposite - that the 2024 disclosure SIMPLIFIED and no longer explicitly referenced the exchangeability feature. This is a significant mischaracterization of the evolution. (3) The LLM misses the key insight from the ground truth: there was a REDUCTION in detail about LTIP units' conversion features between 2022 and 2024. The LLM frames this as merely 'refreshing' the periods rather than identifying the substantive change in disclosure approach. MULTI-HOP REASONING: The LLM correctly synthesizes that both years show no material dilutive effect, but fails to properly identify the evolution in disclosure detail level, which is the core of the question. The answer is partially correct on the outcome but misses the nuanced change in how the information is presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 430,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "In the 2022 filing MetLife said its board had authorized a $3 billion share‑repurchase program and that about $1.5 billion remained available at year‑end 2021, but it also warned that it “maintains a buffer of cash and other liquid assets, and may increase it,” which could reduce the capital it can devote to buybacks【page_50】. By the 2024 filing the company no longer cites a specific remaining‑authorization amount; instead it stresses that preserving liquidity and meeting cash‑buffer needs—especially in volatile markets and under regulatory constraints—may limit its ability to repurchase stock, reflecting a more cautious, liquidity‑first stance【page_31】【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about MetLife's evolving approach to cash buffers and stock repurchases from 2022 to 2024. QUANTITATIVE ACCURACY: All numbers are correct - $3 billion authorization, $1.5 billion remaining at year-end 2021, and the years cited (2022 and 2024 filings) are accurate. No calculation errors present. COMPLETENESS: The answer addresses all key aspects of the question: (1) 2022 position with specific authorization amounts, (2) 2024 position with emphasis on liquidity constraints, (3) the evolution/shift in approach from more active to more conservative. ENTITY ACCURACY: MetLife correctly identified, fiscal years properly referenced (2021 year-end data in 2022 filing, 2024 filing), and financial metrics properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and demonstrates the causal relationship between regulatory/market conditions and the shift in capital allocation strategy. The comparison is logical and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth - the shift from 'significant but partially utilized capacity' (2022) to 'more conservative liquidity strategy' (2024) is clearly articulated. The inclusion of the quote about maintaining/increasing cash buffers effectively illustrates the constraint mechanism. MINOR CONSIDERATIONS: The LLM answer includes page citations (【page_50】, 【page_31】, 【page_33】) which add specificity and verifiability, though these weren't in the ground truth. The phrasing 'liquidity-first stance' is a reasonable characterization of the shift described. The answer is slightly more detailed and document-grounded than the ground truth while maintaining complete accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 498,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "In FY 2022 Starbucks held foreign‑currency‑other derivative assets of $39.9 million in prepaid expenses and other current assets and $33.5 million in other long‑term assets (total $73.4 million) and only a $0.3 million accrued liability (no long‑term liability)【page_68】. By FY 2023 the asset balances fell to $32.0 million (current) and $22.9 million (long‑term), totaling $54.9 million, while the liability grew to $2.0 million accrued liabilities (still no long‑term liability)【page_72】. The balance‑sheet classification remained the same—current‑asset items recorded under prepaid expenses and other current assets, long‑term items under other long‑term assets, and liabilities under accrued liabilities—though the amounts in each category changed as shown.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all key metrics. Specific errors: (1) FY 2022 current assets: LLM states $39.9M vs. ground truth $103.9M (off by $64M or 62%); (2) FY 2022 long-term assets: LLM states $33.5M vs. ground truth not explicitly stated but implied to be much lower; (3) FY 2023 current assets: LLM states $32.0M vs. ground truth $1.9M (off by $30.1M or 1,584%); (4) FY 2023 long-term assets: LLM states $22.9M vs. ground truth $1.7M (off by $21.2M or 1,247%); (5) FY 2023 liabilities: LLM states $2.0M accrued with no long-term liability vs. ground truth $4.7M accrued + $4.1M long-term ($8.8M total). The LLM completely misses the critical finding that FY 2023 shows a 'significant reduction in asset positions' - the ground truth shows assets declining from $103.9M to $3.6M total ($1.9M + $1.7M), while the LLM shows assets declining from $73.4M to $54.9M, which is a much smaller reduction and in the wrong direction for the long-term component. The LLM also fails to mention the $22.0M reclassified from AOCI to earnings in FY 2022, which is a key component of the answer. The balance sheet classification discussion is correct in principle but is built on incorrect underlying numbers. The multi-hop synthesis is fundamentally flawed due to incorrect source data extraction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 380,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024 P&G’s global cash‑management framework remained anchored in operating‑cash generation, undrawn credit facilities and tax‑efficient foreign‑subsidiary cash balances, but it was adjusted to absorb a much larger restructuring outlay and a shift from a $485 million corporate profit in 2022 to a $1.4 billion loss in 2024. Accordingly, cash held abroad rose modestly from $5.8 billion to $6.1 billion, the excess of current liabilities over assets narrowed, and the company continued to rely on its strong short‑ and long‑term debt capacity to fund the $659 million restructuring program while preserving liquidity for dividends, share repurchases and acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR - LLM states corporate earnings 'shift from a $485 million corporate profit in 2022 to a $1.4 billion loss in 2024.' Ground truth shows corporate net earnings DECREASED BY $1.0 billion (not that 2024 was a $1.4 billion loss). The $1.4 billion figure refers to the Gillette impairment charge, not the corporate net earnings result. This is a fundamental misinterpretation. (2) MISSING KEY NUMBERS - LLM provides cash abroad figures ($5.8B to $6.1B) and restructuring cost ($659M) that are not in the ground truth, making verification impossible. These appear to be fabricated or from different sources. (3) INCOMPLETE RESTRUCTURING DATA - Ground truth specifies fiscal 2022 had $147M in restructuring accruals and costs within $250-500M range; fiscal 2024 had $659M including $216M in non-cash FX losses. LLM only mentions the $659M figure without the breakdown or 2022 comparison. (4) MISSING CRITICAL CONTEXT - Ground truth emphasizes the shift toward 'more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria' and the specific impact of the Gillette impairment. LLM omits these important contextual details. (5) MULTI-HOP REASONING - While LLM attempts to synthesize cash management strategy with restructuring and earnings, the core synthesis is flawed due to the misstatement of the 2024 earnings figure. The reasoning about liquidity management and debt capacity is reasonable but built on incorrect premises. (6) QUANTITATIVE VERIFICATION - The $659M restructuring figure is correct, but the characterization of 2024 as a '$1.4 billion loss' is incorrect and conflates the impairment charge with net earnings. The $485M 2022 figure is correct. The cash abroad figures cannot be verified against ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 488,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse mainly as a virtual‑world, real‑time 3‑D design‑collaboration platform offered as a subscription for enterprise (and free for individuals) and highlighted early enterprise pilots such as virtual car showrooms, surgical‑training and architectural walkthroughs. By the 2023 filing the company had repositioned Omniverse as an enterprise‑grade “Omniverse Enterprise” operating system for industrial digitalization—used to build digital twins, real‑time 3‑D product configurators and to power NVIDIA DRIVE Sim for testing autonomous robots and vehicles—showing tighter integration with its AI Enterprise suite and data‑center‑based simulation solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS OF FACTS: All major factual claims are accurate - the 2022 positioning as a virtual-world, real-time 3D design-collaboration platform with subscription/free model is correct; the 2023 evolution to enterprise-grade operating system for industrial digitalization is correct; specific use cases mentioned (virtual car showrooms, surgical training, architectural walkthroughs, digital twins, product configurators) all match ground truth; DRIVE Sim integration is correctly identified in both years. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension scores perfectly - the question itself doesn't require quantitative data. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The LLM correctly synthesizes the evolution across two years by: identifying the 2022 positioning, identifying the 2023 repositioning, and explaining the progression from early pilots to enterprise-grade solutions. The connection to AI Enterprise suite and data-center-based solutions in 2023 is accurate and represents proper synthesis. (4) ENTITY ACCURACY: NVIDIA is correctly identified; years 2022 and 2023 are correct; Omniverse Enterprise, DRIVE Sim, and related technologies are all correctly named and contextualized. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as ground truth with slightly more concise wording. The phrase 'enterprise-grade \"Omniverse Enterprise\" operating system' effectively captures the evolution. The mention of 'tighter integration with its AI Enterprise suite' adds relevant context that aligns with the ground truth's reference to 'accelerated computing infrastructure.' Minor difference: Ground truth mentions 'on-premises and in the cloud' while LLM says 'data-center-based' - these are semantically equivalent in context. The answer fully addresses the multi-part question about positioning evolution, enterprise integration, and simulation technology integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 563,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "In 2023 AMT’s capital‑expenditure plan called for roughly $1.8 billion of spending, of which $849.3 million was earmarked for discretionary projects that included the construction of 3,198 communications sites worldwide and $154 million for ground‑lease purchases (total capex ≈ $1.83 billion)【page_48】. For 2024 the company lowered its target to $1.545‑$1.655 billion, allocating $790‑$820 million to discretionary projects that will build about 2,500‑3,500 sites and $70‑$90 million to ground‑lease purchases, and it now quantifies future lease commitments for those sites at roughly $987 million in 2025 (and $925 million in 2026)【page_49】【page_56】. This reflects a modest reduction in near‑term site‑related spend while adding a clearer picture of longer‑term operating‑lease obligations tied to the communications‑site portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and fails to address the core question. Critical issues: (1) WRONG FOCUS: The LLM discusses general capital expenditure plans ($1.8B in 2023, $1.545-$1.655B in 2024) and near-term lease commitments ($987M in 2025, $925M in 2026), but the ground truth specifically addresses communications site-related financial commitments and asset retirement obligations. (2) MISSING KEY METRIC: The ground truth's central finding is the $4.5 billion undiscounted future cash outlay for asset retirement obligations in 2024 - this is completely absent from the LLM answer. This is a massive omission ($4.5B is the primary metric showing the evolution of financial commitments). (3) INCORRECT 2023 FIGURE: The ground truth states AMT anticipated ~$450 million for data center assets related to 2,500-3,500 communications sites in 2023. The LLM cites $849.3 million for discretionary projects building 3,198 sites, which appears to be a different metric or misidentification. (4) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from near-term capital allocation ($450M) to long-term obligations ($4.5B), representing a significant increase in financial exposure. The LLM describes a 'modest reduction' in near-term spend, which is the opposite narrative and misses the substantial long-term obligation structure. (5) WRONG OBLIGATION TYPE: The LLM focuses on operating-lease obligations for 2025-2026 (~$987M, $925M), while the ground truth emphasizes asset retirement obligations (~$4.5B undiscounted). These are different liability categories. The LLM answer appears to be discussing general capex and lease commitments rather than the specific communications site financial commitments and retirement obligations that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 492,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "In the 2023 filing ExxonMobil spelled out the cash‑flow line as “proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments,” noting that assets are divested when they no longer meet the corporation’s strategic objectives or can be sold for a higher value. In the 2024 filing the description was streamlined to “proceeds from asset sales and returns of investments,” still emphasizing a disciplined review process and strategic alignment, but using broader, less‑itemized language for the proceeds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about ExxonMobil's evolving characterization of asset divestitures between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 language as 'proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments' - this matches the ground truth exactly. (2) Accurately captures the 2024 streamlined language as 'proceeds from asset sales and returns of investments' - also matches ground truth. (3) Properly synthesizes the evolution narrative: from itemized/specific language to consolidated/generalized language. (4) Correctly identifies the strategic rationale in both years (disciplined review, strategic alignment). (5) Appropriately characterizes the shift as moving toward 'broader, less-itemized language' which aligns with the ground truth's observation about 'more consolidated framing.' (6) No quantitative errors or date misidentifications. MINOR CONSIDERATIONS: The LLM answer adds a detail about assets being 'sold for a higher value' which appears to be an additional contextual element not explicitly mentioned in the ground truth answer, though this is a reasonable inference from strategic divestiture practices and doesn't contradict the ground truth. The answer is semantically equivalent to the ground truth while using slightly different phrasing ('cash-flow line' vs. the ground truth's more general reference). The multi-hop reasoning is sound - the answer successfully compares the two years' language and identifies the evolution pattern. All core facts are correct, and the answer fully addresses the question's focus on language evolution and strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 474,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast’s consolidated balance sheet showed that its stake in Universal Beijing Resort was worth $8.5 billion in assets and $7.5 billion in liabilities at 12/31/2022 (CMCSA 2022 10‑K, p. 103). By 12/31/2023 those amounts had fallen to $7.8 billion of assets and $7.2 billion of liabilities (CMCSA 2023 10‑K, p. 87), meaning the company’s exposure declined by roughly $0.7 billion on the asset side and $0.3 billion on the liability side.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 figures. Ground truth states 2022 assets were $9.7 billion and liabilities were $8.1 billion. The LLM claims 2022 assets were $8.5 billion and liabilities were $7.5 billion - both are materially incorrect (understatements of $1.2B in assets and $0.6B in liabilities). The 2023 figures ($7.8B assets, $7.2B liabilities) are correct. The calculated changes are therefore wrong: LLM states $0.7B asset decline and $0.3B liability decline, but the correct figures should be $1.9B asset decline ($9.7B to $7.8B) and $0.9B liability decline ($8.1B to $7.2B). POSITIVE ASPECTS: The LLM correctly identified the company (Comcast/CMCSA), the correct time periods (12/31/2022 and 12/31/2023), the correct entity (Universal Beijing Resort), and provided appropriate page citations. The reasoning structure is sound - comparing year-over-year changes and drawing conclusions about exposure reduction. The semantic approach to the question is appropriate. MULTI-HOP SYNTHESIS: The answer demonstrates proper multi-hop reasoning by synthesizing data from two different 10-K filings across two years, but the foundational data is incorrect, undermining the entire analysis. The calculation methodology is correct, but applied to wrong base numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 372,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar framed customer‑demand volatility mainly as a macro‑economic and pandemic‑driven uncertainty that could depress sales and raise credit‑related expenses (e.g., higher allowances for doubtful accounts) (CAT_10k_2023 page_13). By the 2024 filing the discussion had broadened to stress that material‑ and component‑shortages, logistics constraints and labor inefficiencies now amplify demand swings, creating excess inventories, higher costs and margin pressure that directly threaten both financial performance and supply‑chain stability (CAT_10k_2024 pages 13‑14).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the evolution of Customer Demand Volatility as a risk factor for Caterpillar between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 framing as pandemic-driven macro-economic uncertainty with supply chain disruptions and labor inefficiencies, matching the ground truth description. (2) Accurately captures the 2024 shift to include material/component shortages, logistics constraints, and labor inefficiencies as amplifying factors. (3) Properly synthesizes the multi-hop reasoning across two fiscal years and two 10-K filings. (4) Correctly identifies the broadening of the risk profile from demand-side to include supply-side challenges. (5) Appropriately references specific impacts on financial performance (excess inventories, margin pressure, credit expenses) and supply chain stability. (6) Page citations (pages 13-14 for 2024, page 13 for 2023) are reasonable and specific. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'excess inventories' and 'higher costs' as consequences, while the ground truth focuses more on the risk factors themselves (commodity price changes, material price increases) rather than their consequences. This is a subtle distinction but represents a slight reframing rather than direct alignment. (2) The ground truth explicitly mentions 'commodity price changes' as a 2024 addition, which the LLM answer does not explicitly call out, though 'material price increases' is mentioned. (3) The LLM answer frames the impact somewhat differently (focusing on consequences like margin pressure) versus the ground truth's focus on the risk factors themselves. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2023 vs 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and two separate 10-K filings, correctly identifying the evolution and shift in emphasis. The logical progression from pandemic-driven to supply-chain-driven risks is sound. SEMANTIC EQUIVALENCE: The core message aligns well - risk profile broadened from demand volatility to include supply-side challenges. The wording differs but conveys essentially the same information as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 625,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The net derivative assets (liabilities) measured at fair value rose from **$58 million at 12/31/2022** to **$69 million at 12/31/2023** and stayed at **$69 million at 12/31/2024**【page_216】【page_215】. Throughout this period the company continued to value these items at **Level 3** using a **discounted‑cash‑flow model with swap rates as the primary unobservable input**; the swap‑rate range widened and the weighted‑average swap rate increased (roughly 2 % in 2022 to about 4 % by 2024)【page_217】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM states fair value was $58M at 12/31/2022, but ground truth shows $19M as of 12/31/2021 (different year)\n   - LLM states $69M at 12/31/2023 and 12/31/2024, but ground truth shows $58M as of 12/31/2023\n   - The progression claimed by LLM ($58M → $69M → $69M) does not match ground truth ($19M in 2021 → $58M in 2023)\n   - LLM provides no mention of the 2022 intermediate year values or the derivative activity components (issuances $68M, settlements -$37M, transfers $6M) that were part of the evolution\n\n2. TEMPORAL ACCURACY:\n   - Ground truth references 12/31/2021 and 12/31/2023 as key dates\n   - LLM references 12/31/2022, 12/31/2023, and 12/31/2024, which are different years\n   - The question asks about 2022-2024 evolution, but ground truth data appears to span 2021-2023\n   - This creates fundamental misalignment in the time periods being compared\n\n3. VALUATION METHODOLOGY:\n   - LLM correctly identifies Level 3 classification and discounted cash flow model\n   - LLM correctly notes swap rates as inputs and the increase from ~2% to ~4%\n   - However, ground truth emphasizes a SHIFT in methodology from \"realized and unrealized gains/losses reported in net income\" to \"discounted cash flows with observable inputs\"\n   - LLM fails to capture this methodological evolution/shift, only describing the final state\n   - LLM describes swap rates as \"unobservable input\" while ground truth emphasizes \"observable inputs like swap rates\"\n\n4. COMPLETENESS:\n   - LLM misses the derivative activity breakdown (issuances, settlements, transfers) that explains the value evolution\n   - LLM does not address the shift from income-based to DCF-based valuation methodology\n   - LLM does not explain HOW or WHY the values changed, only stating the numbers\n\n5. MULTI-HOP REASONING:\n   - The answer fails to synthesize the complete evolution story\n   - Does not connect the derivative activities to value changes\n   - Does not explain the methodological transition\n   - Appears to reference different fiscal years than the ground truth, suggesting data source confusion\n\nThe LLM answer provides some correct elements (Level 3, DCF model, swap rate ranges) but fundamentally fails on the core quantitative facts and the narrative of how the fair value and methodology evolved. The year-to-year progression is incorrect, and the explanation lacks the depth of the methodological shift that was central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 697,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "In the 2022 Form 10‑K, GeForce NOW is described mainly as a cloud platform that, together with vGPU, lets interactive graphics‑intensive applications—including games—be accessed on “almost any device, almost anywhere,” positioning it as a broad cloud‑enabled extension of NVIDIA’s GPU ecosystem. By the 2023 filing, GeForce NOW is listed as a distinct product line within the Graphics segment—grouped with GeForce RTX/GTX GPUs and vGPU—emphasizing its role as a game‑streaming service that leverages NVIDIA’s GPU and cloud infrastructure to bring PC games to under‑powered devices. This reflects a shift from a general cloud‑platform mention to a defined, integrated offering within the company’s GPU‑centric cloud strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of GeForce NOW's evolution from 2022 to 2023 and correctly identifies the key shift in positioning. Strengths: (1) Accurately captures the 2022 positioning as a cloud platform for interactive graphics applications accessible on 'almost any device, almost anywhere' - this matches the ground truth language; (2) Correctly identifies the 2023 shift toward more specific integration within the Graphics segment and emphasis on game-streaming service; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Correctly identifies vGPU as a related offering mentioned in 2022. Weaknesses: (1) The LLM answer mentions GeForce NOW being 'listed as a distinct product line within the Graphics segment' in 2023, which is a specific structural claim not explicitly confirmed in the ground truth; (2) The ground truth emphasizes integration with 'AI training platforms like NVIDIA DGX Cloud' as part of the broader accelerated computing narrative, but the LLM answer focuses more narrowly on the GPU-centric cloud strategy without explicitly mentioning this AI/DGX Cloud connection; (3) The ground truth describes a shift toward 'accelerated computing platform narrative' which is a broader strategic positioning that the LLM answer doesn't fully capture - the answer focuses on Graphics segment positioning rather than the company-wide accelerated computing strategy. The LLM answer is factually sound and addresses the core evolution question, but misses some nuance about the broader strategic context (accelerated computing, AI platforms) that the ground truth emphasizes. No quantitative errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 456,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "In 2023 Inlyta generated $1,036 million of revenue, up from $1,003 million in 2022 – a modest 3% overall increase (about 4% in the U.S. and 3% internationally)【page_44】. The rise was driven mainly by stronger U.S. adoption of Inlyta in combination with immune‑checkpoint inhibitors for first‑line advanced renal‑cell carcinoma, while lower volumes and net‑price pressure in some European markets partially offset the growth and international growth reflected continued expansion in emerging markets【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: 2022 revenue of $1,003 million, 2023 revenue of $1,036 million, and the 3% growth calculation are all accurate. The answer correctly identifies the U.S. growth rate (approximately 4%) and international growth rate (3%), showing precise understanding of the revenue breakdown. The multi-hop reasoning is sound, synthesizing information across multiple dimensions: (1) the revenue figures and growth rate, (2) the primary driver (U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC treatment), (3) the offsetting factors (lower volumes and net price pressure in European markets), and (4) the emerging markets expansion. The answer properly attributes growth to specific therapeutic uses and geographic regions. The only minor observation is that the LLM provides slightly more granular detail (breaking out U.S. vs. international growth rates) than the ground truth explicitly states, though this is consistent with the information provided and adds helpful context rather than introducing errors. The semantic equivalence is excellent - the wording differs from the ground truth but conveys identical factual information. Entity identification is correct (Inlyta, RCC, immune checkpoint inhibitors, U.S., European markets, emerging markets). The answer directly addresses all parts of the multi-part question regarding revenue evolution and influencing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 416,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "In the 2023 filing the Company said that acquired network‑location intangibles are amortized on a straight‑line basis over the shorter of the ground‑lease term (including renewal options) and a maximum of 20 years (2023 p. 103‑105). In the 2024 filing the Company extended the useful life of its towers to 30 years and now amortizes those intangibles on a straight‑line schedule over up to 30 years, consistent with the tower life (2024 p. 95‑96), and it added a specific impairment test that reviews each tower’s network‑location intangible on an individual‑tower basis, using projected undiscounted cash‑flows and discounted‑cash‑flow analysis when a recoverability trigger is identified (2024 p. 96).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) AMORTIZATION PERIOD CONFLICT: Ground truth states 2023 had a weighted average amortization period of 15 years, but LLM claims 2023 used 'maximum of 20 years.' For 2024, ground truth does not mention extension to 30 years for network location intangibles specifically - it mentions a $470 million increase in asset retirement obligations due to revised settlement dates, which is a different accounting treatment. LLM incorrectly conflates tower asset useful life changes with network location intangible amortization periods. (2) MISSING KEY INFORMATION: Ground truth emphasizes the relationship between network location intangibles and tower assets in terms of revenue growth from leasing excess capacity - LLM omits this context entirely. Ground truth specifically mentions the $470 million increase in liability due to revised settlement dates in 2024, which indirectly impacts valuation assumptions - LLM completely misses this critical detail. (3) IMPAIRMENT REVIEW: While LLM correctly identifies that 2024 added individual tower basis impairment testing with triggers like lack of tenant leases or expenses exceeding revenues, it adds unsupported details about 'projected undiscounted cash-flows and discounted-cash-flow analysis' that are not mentioned in the ground truth. (4) NUMERIC ERRORS: The shift from 15 years (2023) to 20 years (LLM's claim for 2023) to 30 years (LLM's claim for 2024) represents a fundamental misreading of the source documents. The ground truth's mention of $470 million is completely absent from LLM answer. (5) MULTI-HOP SYNTHESIS: LLM failed to properly synthesize the connection between asset retirement obligations changes and their impact on intangible asset valuation assumptions, which is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 511,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "In the 2023 filing ExxonMobil highlighted Guyana as a core element of its upstream growth portfolio – reporting four new Stabroek Block discoveries, the start‑up of the Prosperity FPSO (reaching name‑plate in Jan 2024), Liza Destiny and Liza Unity running above name‑plate, combined output of >390 kbd in 2023 and almost 440 kbd in Q4 2023, and plans for additional FPSOs (six in operation by 2027) and a sixth project at Whiptail (2023 p. 52). In the 2024 filing Guyana is still flagged as a strategic “advantaged asset” alongside Permian and LNG, showing it remains a priority but now is presented at a higher‑level portfolio view rather than with detailed production‑capacity updates (2024 p. 37).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. STRENGTHS: (1) Correctly identifies four Stabroek Block discoveries in 2023; (2) Accurately names Prosperity FPSO startup and its timing (Jan 2024); (3) Correctly cites production figures: >390 kbd in 2023 and ~440 kbd in Q4 2023, matching ground truth; (4) Properly identifies the strategic shift from 2023 to 2024 where Guyana moves to 'Advantaged Assets' category; (5) Correctly notes Permian and LNG as peer assets in the 2024 portfolio; (6) Accurately describes the transition from detailed production updates to higher-level portfolio presentation; (7) Mentions Liza Destiny and Liza Unity operating above nameplate; (8) References six FPSOs by 2027 and Whiptail project. MINOR ISSUES: (1) The LLM states Liza Destiny and Liza Unity were 'running above name-plate' in 2023 - while this may be accurate, the ground truth doesn't explicitly confirm this detail, creating slight uncertainty; (2) The answer provides more granular detail than the ground truth (mentioning specific page numbers, Whiptail project details) which, while potentially accurate, goes slightly beyond what was confirmed in the knowledge graph. MULTI-HOP REASONING: Excellent synthesis across 2023 and 2024 filings, correctly identifying the evolution from discovery/early production phase to mature, strategically elevated asset status. The comparison between years is logically sound and well-articulated. QUANTITATIVE VERIFICATION: All key numbers (440 kbd Q4 2023, >390 kbd 2023, six FPSOs by 2027) align with ground truth. No calculation errors detected. The answer appropriately conveys the same strategic evolution as the ground truth while providing additional supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 474,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "In the 2022 filing the X1 platform was described as a gateway that “operates across content in customers’ cable video service packages and content from internet‑based streaming services” and the streaming integration was delivered through the separate Flex streaming device, which gave customers access to third‑party DTC services such as Disney+ and Netflix and generated commission revenue (2022‑p7). By the 2023 filing the integration had been folded directly into X1 (and the re‑branded Xumo Stream Box) with “integrated search functionality … across content … and content from internet‑based streaming services” and a broader set of DTC partners—including Peacock, Disney+ and Netflix—as well as the new NOW streaming service, again earning commissions (2023‑p6; 2023‑p5). This evolution shows Comcast is embedding OTT content into its core X1 experience to keep cord‑cutters on its platform and monetize streaming through commissions, a strategy aimed at reducing churn and lifting average revenue per user.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2022 X1 platform's integration with Disney+, Netflix, and Peacock with commission revenue generation; (2) Accurately describes the 2023 evolution including Xumo Stream Box rebranding, expanded DTC partners (Peacock, Disney+, Netflix), and NOW streaming service; (3) Properly synthesizes the strategic pivot toward broadband value enhancement and ARPU increase through commission-generating partnerships; (4) Correctly identifies the core strategic intent: reducing churn/cord-cutting and monetizing streaming; (5) Includes specific filing references (2022-p7, 2023-p6, 2023-p5) that demonstrate source verification; (6) Accurately characterizes the evolution from separate Flex device to integrated X1 experience. MINOR GAPS: (1) The ground truth mentions 'Xumo Play, NBC, and Sky as part of the NOW TV service' while the LLM answer mentions 'NOW streaming service' but doesn't explicitly list NBC and Sky as separate components—though this is a minor omission that doesn't affect the core narrative; (2) The LLM answer provides more technical detail about the integration mechanism (search functionality, device rebranding) which adds value but wasn't explicitly in the ground truth, though it's not contradictory. MULTI-HOP REASONING: Excellent synthesis across 2022 and 2023 filings, correctly connecting platform evolution to strategic business objectives (ARPU, churn reduction). SEMANTIC EQUIVALENCE: The answer conveys the same fundamental insights as the ground truth while providing additional technical context. No calculation errors or date inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 465,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "In 2023 Caterpillar reported that the FG Wilson‑branded electric power‑generation systems were sold through a worldwide network of **108 distributors covering 158 countries**【page_66】. By the 2024 filing the network had **grown to 110 distributors**, but the geographic reach had **shrank to 109 countries**【page_65】. Thus, the partnership added a few more distributors while the overall country coverage contracted.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a complete reversal of the factual data from the ground truth. Specific errors: (1) QUANTITATIVE ERRORS - The LLM states 2023 had 108 distributors covering 158 countries, but ground truth shows 110 distributors covering 109 countries in 2023. The LLM states 2024 had 110 distributors covering 109 countries, but ground truth shows 108 distributors covering 158 countries in 2024. The numbers are inverted between years. (2) DIRECTIONAL ERRORS - The LLM claims the network 'added a few more distributors' (108→110) when actually it contracted (110→108). The LLM claims 'country coverage contracted' (158→109) when actually it expanded (109→158). This is a complete inversion of the trend analysis. (3) MULTI-HOP REASONING - While the LLM correctly identifies the Caterpillar-FG Wilson relationship and attempts to synthesize 2023 vs 2024 data, the synthesis is fundamentally incorrect due to the reversed data assignment. (4) CONTEXTUAL RELEVANCE - The answer appropriately addresses the question about how the relationship evolved and attempts to characterize the strategic shift, but the characterization is backwards. The ground truth indicates optimization with geographic expansion; the LLM suggests optimization with geographic contraction. This is a critical failure in factual accuracy that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 377,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One’s securitized‑debt liability balance fell from roughly $15.2 billion in the 2022 filing (the total consolidated liabilities of its securitization‑related VIEs) to about $14.3 billion in the 2024 filing 【page_179†L13-L20】.  In 2024 the company also disclosed an estimated fair value of $14.3 billion for those obligations, a small premium to the carrying amount, whereas the 2022 filing did not provide a comparable fair‑value estimate 【page_219†L13-L20】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims 2024 securitized debt obligations were $14.3 billion, but the ground truth clearly states $18,043 million ($18.043 billion) for carrying value and $18,067 million ($18.067 billion) for fair value. This is a difference of approximately $3.7-3.8 billion, representing a ~26% understatement. The LLM also claims 2022 was ~$15.2 billion, but provides no ground truth comparison figure for 2022 to verify this claim. (2) DIRECTIONAL ERROR: The LLM suggests a DECREASE from 2022 to 2024 (from $15.2B to $14.3B), but the ground truth indicates Capital One maintained significant exposure with 2024 values around $18 billion, suggesting either stability or an increase depending on 2022 baseline. (3) FAIR VALUE CHARACTERIZATION: The LLM states 2024 fair value was $14.3 billion with 'a small premium to the carrying amount,' but the ground truth shows fair value of $18,067M vs carrying value of $18,043M - a difference of only $24 million (0.13%), which is indeed a small premium but based on the correct $18B figures, not $14.3B. (4) MISSING CONTEXT: The LLM fails to mention the Level 2 fair value hierarchy classification, which is relevant detail from the ground truth. (5) MULTI-HOP SYNTHESIS: The LLM attempted to synthesize 2022 vs 2024 comparison but used fundamentally incorrect 2024 figures, undermining the entire analysis. The core answer is factually wrong on the primary metric (2024 carrying and fair values), making this response unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 450,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "In the 2023 filing McDonald’s said it could meet short‑term funding needs “through its continued access to commercial paper borrowings and line‑of‑credit agreements,” but gave no detail on the amount of credit available. The 2024 filing repeats the reliance on those facilities and adds that the company has **$4 billion available under a committed line of credit** (with $7.4 billion of its $15 billion borrowing authority still unused) and that the prior borrowing authority was terminated and replaced with a new $15 billion authority, indicating a more explicit, quantified use of the line of credit to support financing activities and cash‑flow management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides useful information about McDonald's line of credit evolution between 2023 and 2024, but has significant gaps and some accuracy issues when compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies that 2023 filing mentioned reliance on commercial paper and line-of-credit agreements without specific amounts\n2. Correctly notes that 2024 filing provides more explicit quantification\n3. Accurately states $4 billion available under committed line of credit in 2024\n4. Correctly identifies the $15 billion borrowing authority and $7.4 billion unused amount\n5. Appropriately notes the replacement of prior borrowing authority with new $15 billion authority\n6. Captures the shift toward more explicit use of credit facilities\n\nWEAKNESSES:\n1. MAJOR OMISSION: Fails to address the core financing activities metrics from ground truth:\n   - 2023: $4.4 billion cash used for financing activities\n   - 2024: $7.5 billion cash used for financing activities\n   - The $3.1 billion increase between years\n2. MAJOR OMISSION: Does not mention cash and equivalents balances:\n   - 2023: $4.6 billion\n   - 2024: $1.1 billion\n   - This is critical context for understanding the shift to cash-constrained environment\n3. MAJOR OMISSION: Fails to explain the drivers of financing activity changes (bond issuances timing)\n4. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution \"in relation to its financing activities and cash flow management\" - the LLM answer focuses only on line of credit details but ignores the broader financing activities and cash flow context\n5. The answer is more of a line-of-credit-specific detail rather than a comprehensive answer to how the use of line of credit agreements evolved in relation to overall financing and cash flow\n\nQUANTITATIVE ACCURACY ISSUES:\n- The specific numbers provided ($4B, $7.4B, $15B) appear correct for 2024\n- However, the answer is incomplete because it omits critical cash flow and financing activity numbers that are essential to answering the question\n- No calculation errors in what is presented, but significant data omissions\n\nMULTI-HOP REASONING:\n- The LLM correctly synthesized information about line of credit evolution\n- However, it failed to synthesize the broader picture of how financing activities and cash flow management changed\n- The answer should have connected line of credit usage to the increased financing cash outflows and decreased cash balances\n\nCONTEXTUAL RELEVANCE:\n- The answer is relevant to the question but incomplete\n- It addresses one aspect (line of credit evolution) but misses the broader context of financing activities and cash flow management\n- A complete answer would integrate both the line of credit details AND the financing activity metrics",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 739,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "In the 2022 filing the Worldwide Business Conduct Manual was described as the “objective … reinforced through our Worldwide Business Conduct Manual,” setting out the company’s commitment to integrity and serving as the cornerstone of its internal‑control system (see 2022 p. 38). The 2024 filing repeats the same language, now paired with a formal COSO‑based assessment that the controls remain effective (see 2024 p. 34), indicating that the manual continues to be the foundational tool for control reinforcement while the company adds systematic, ongoing evaluation of its control environment. This consistency shows P&G’s governance approach is anchored in the manual’s ethical framework and is continuously validated through formal internal‑control assessments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate information but has significant gaps and misses key elements of the ground truth. STRENGTHS: (1) Correctly identifies the Worldwide Business Conduct Manual as foundational to P&G's internal controls in both years; (2) Accurately notes that 2024 includes COSO-based assessment language; (3) Correctly identifies the years 2022 and 2024; (4) Page references (2022 p. 38, 2024 p. 34) are specific and appear plausible. WEAKNESSES: (1) CRITICAL OMISSION - The ground truth explicitly mentions the Global Leadership Council and Disclosure Committee as governance frameworks tied to the manual in 2024, but the LLM answer completely omits these entities. This is a significant multi-hop synthesis failure; (2) The LLM answer emphasizes 'consistency' and 'same language' between 2022 and 2024, but the ground truth indicates a 'shift toward emphasizing structured governance mechanisms' - this represents a different interpretation of the evolution; (3) The LLM answer focuses heavily on COSO-based assessment validation, which is not mentioned in the ground truth as a key differentiator; (4) The ground truth's key insight about 'more integrated approach to internal control over time' and the shift from general ethical conduct to 'structured governance mechanisms' is not captured in the LLM answer. QUANTITATIVE ACCURACY: Page numbers are provided but cannot be independently verified; no calculations or metrics are involved. QUALITATIVE ACCURACY: The reasoning about consistency and validation is sound, but it misses the core evolution narrative about governance integration that the ground truth emphasizes. MULTI-HOP REASONING: The answer fails to synthesize the connection between the manual and specific governance bodies (Global Leadership Council, Disclosure Committee) that evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 501,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "In the 2023 Form 10‑K ExxonMobil listed Guyana as a major long‑lived asset – $9.7 billion of property, plant and equipment (up from $6.8 billion in 2022) 【page_115】. By the 2024 filing, the company’s new earnings‑driver framework explicitly places Guyana in the “Advantaged Assets” group (with Permian and LNG), signaling that Guyana has moved from being a large asset on the balance sheet to a highlighted, high‑growth driver in Exxon’s strategic narrative 【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Exxon's strategic positioning in Guyana between 2023 and 2024. STRENGTHS: (1) Quantitative accuracy is excellent - the $9.7 billion figure for 2023 matches the ground truth's $9,689 million (minor rounding difference is acceptable and expected), and the additional context of $6.8 billion in 2022 provides useful comparative data. (2) The multi-hop synthesis is sound: the answer correctly identifies the transition from 2023 (quantitative asset disclosure) to 2024 (strategic earnings driver framework). (3) Entity accuracy is correct - properly identifies ExxonMobil, Guyana, Permian, and LNG as the relevant entities. (4) The reasoning captures the core insight: Guyana evolved from a 'large asset on the balance sheet' to a 'highlighted, high-growth driver,' which semantically matches the ground truth's characterization of moving from 'quantitatively notable' to 'strategically emphasized growth engine.' (5) The answer appropriately references both long-lived asset disclosures and earnings driver definitions as requested. MINOR CONSIDERATIONS: The LLM answer includes the 2022 comparison ($6.8 billion) which, while not in the ground truth, adds relevant context and demonstrates deeper analysis. The page citations (page_115, page_37) suggest specific sourcing, which enhances credibility. The terminology 'Advantaged Assets' is correctly identified as the new framework category. The answer is well-structured and directly addresses all components of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 435,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "In the 2022 Form 10‑K Capital One noted that its long‑term funding “primarily consists of securitized debt obligations and senior and subordinated notes” and that it added $6.25 billion of new securitized‑debt issuances in 2021, lifting total long‑term debt to $42.3 billion – a clear increase in reliance on securitizations. By the 2024 filing, securitized debt obligations appear on the balance sheet at $14.3 billion (fair‑value $14.3 billion), down from $18.0 billion a year earlier, showing that while securitizations remain a core funding source, the outstanding amount has contracted as maturities have been repaid and new issuance has slowed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites a 2022 figure of $6.25 billion in new securitized-debt issuances in 2021 and $42.3 billion total long-term debt, but these are not verified against the ground truth and appear to be from a different year's filing context.\n   - The LLM states 2024 securitized debt obligations at $14.3 billion (fair value $14.3 billion), which roughly matches the ground truth of $14,264 million carrying value and $14,335 million fair value - this is approximately correct.\n   - CRITICAL ERROR: The LLM claims securitized debt was $18.0 billion \"a year earlier\" (implying 2023), but this figure is not provided in the ground truth and cannot be verified. This is a major factual claim without support.\n   - The comparison showing a decline from $18.0B to $14.3B is unsubstantiated and contradicts the ground truth narrative.\n\n2. COMPLETENESS ISSUES:\n   - The ground truth explicitly states that in 2022, \"no specific dollar value was disclosed,\" but the LLM provides specific 2022 figures without acknowledging this disclosure gap.\n   - The ground truth emphasizes the evolution from qualitative description (2022) to quantified disclosure (2024), but the LLM misses this key distinction.\n   - The LLM does not address the 2022 context of diversified funding mix (deposits, senior/subordinated notes, federal funds, FHLB advances) mentioned in ground truth.\n\n3. REASONING QUALITY:\n   - The LLM's conclusion that securitizations \"have contracted\" is based on an unverified $18.0B figure, making the entire comparative analysis suspect.\n   - The narrative about \"maturities repaid and new issuance slowed\" is speculative and not grounded in the provided ground truth.\n   - The multi-hop synthesis fails because it introduces unsupported intermediate data points.\n\n4. ENTITY AND TEMPORAL ACCURACY:\n   - Company (Capital One) is correct.\n   - Years are mentioned (2022, 2024) but the 2023 intermediate year figure is problematic.\n   - The metric (securitized debt obligations) is correct.\n\n5. SEMANTIC ISSUES:\n   - The ground truth emphasizes \"increased transparency\" as a key evolution, which the LLM misses entirely.\n   - The ground truth's point about strategic importance in 2022 is not reflected in the LLM answer.\n\nThe LLM answer appears to have fabricated or misremembered the $18.0 billion 2023 figure, which is a critical error in a financial analysis question where precision is paramount. While the 2024 figure is approximately correct, the overall narrative is undermined by unverified claims about prior-year amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 709,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "In FY 2022 NVIDIA described Omniverse as a virtual‑world simulation and collaboration platform for 3‑D workflows – offered as a software subscription for enterprise (and free for individuals) and already being woven into a “growing number of enterprise applications” such as virtual car showrooms, surgical training and architectural walkthroughs【page_9】. By FY 2023 the company had repositioned Omniverse as the core “industrial digitalization” platform, noting that industrial enterprises are now adopting its 3‑D and simulation technologies to digital‑twins factories, build real‑time product configurators and test/validate autonomous robots and vehicles on‑premises and in the cloud, reflecting deeper enterprise uptake【page_5】【page_4】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing NVIDIA's Omniverse evolution between FY 2022 and FY 2023. STRENGTHS: (1) Correctly identifies the fiscal years and temporal comparison required by the question. (2) Accurately describes FY 2022 positioning as a virtual-world simulation and collaboration platform for 3D workflows with subscription/free model. (3) Correctly identifies FY 2023 repositioning toward 'industrial digitalization' platform. (4) Provides specific enterprise use cases for both years (virtual car showrooms, surgical training, architectural walkthroughs in FY 2022; digital twins, product configurators, autonomous robot/vehicle testing in FY 2023). (5) Correctly synthesizes the strategic shift from creative collaboration to enterprise simulation/digital twin focus. (6) Includes appropriate source citations. MINOR CONSIDERATIONS: (1) The LLM answer mentions FY 2022 already had 'growing number of enterprise applications' which slightly differs from the ground truth's emphasis on FY 2022 being primarily a 'creative collaboration tool' - however, this is not factually incorrect, just a different emphasis. (2) The ground truth emphasizes the shift from 'real-time 3D design collaboration' to 'enterprise-focused development platform and operating system,' while the LLM answer frames it as 'virtual-world simulation and collaboration platform' to 'industrial digitalization platform' - these are semantically equivalent descriptions of the same evolution. (3) All specific use cases mentioned are accurate and well-supported. The answer successfully addresses the multi-hop requirement of comparing positioning across two fiscal years and demonstrating enterprise adoption evolution. No numerical errors or calculation issues present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 482,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Pfizer’s payable to Viatris under the separation‑distribution, agency, MSA and TSA arrangements fell sharply – it was $94 million at 12/31/2022 and dropped to $33 million at 12/31/2023, a $61 million reduction【page_73】.  The reciprocal receivable from Viatris has also been shrinking, having fallen from $401 million at 12/31/2020 to $53 million at 12/31/2021【page_75】, underscoring a broader contraction of the inter‑company balances.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core financial relationship evolution between Pfizer and Viatris for the 2022-2023 period. The key numbers are accurate: payables fell from $94 million (12/31/2022) to $33 million (12/31/2023), representing a $61 million reduction. The calculation of the $61 million difference is correct. However, there are significant issues with scope and relevance: (1) The question specifically asks about the evolution 'between 2022 and 2023,' yet the LLM introduces data from 2020-2021 regarding receivables from Viatris ($401M to $53M), which is outside the requested timeframe and creates confusion about what period is being analyzed. (2) The introduction of receivable data, while potentially contextually interesting, dilutes focus from the direct answer about net amounts due (payables), which is what the question asks about. (3) The ground truth answer focuses on net amounts due (payables only), while the LLM expands to discuss both payables and receivables, mixing two different financial directions. (4) The LLM's characterization of the trend as 'shrinking' and 'contraction' is reasonable interpretation, but the inclusion of 2020-2021 data makes the answer less focused on the 2022-2023 evolution requested. The core 2022-2023 payables data is accurate and the calculation is correct, but the answer loses focus by introducing out-of-scope historical data that wasn't requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 395,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "In the 2023 filing ExxonMobil described Guyana mainly as a development region – it held 4.6 million offshore acres, completed 12.6 net exploratory‑and‑development wells, launched the Payara development with the Prosperity FPSO and continued work on Yellowtail and the newly‑funded Uaru project. By the 2024 filing, Guyana is no longer just listed among ongoing projects; it is explicitly grouped under “Advantaged Assets” (alongside Permian and LNG) in the earnings‑driver framework, signalling that the company now treats Guyana as a core, high‑value growth asset rather than a purely developmental focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All specific numbers are correct - 4.6 million offshore acres, 12.6 net exploratory-and-development wells completed in 2023, and the project names (Payara, Prosperity FPSO, Yellowtail, Uaru) are all accurately cited. No calculation errors or numeric discrepancies. ENTITY ACCURACY: ExxonMobil correctly identified, years 2023 and 2024 properly distinguished, and all project/asset names accurately referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years, correctly identifying the shift from operational/developmental reporting (2023) to strategic classification (2024). The connection between specific well completion data and the broader strategic reclassification is logically sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution - from 'development region' to 'core, high-value growth asset' within the 'Advantaged Assets' framework - directly mirrors the ground truth's description of 'shift from operational reporting to strategic prioritization.' The mention of Permian and LNG as peer assets in the Advantaged Assets category adds appropriate context. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed in describing the 2023 operational specifics (mentioning the Prosperity FPSO explicitly) and provides clearer narrative flow, though this represents enhancement rather than deviation from ground truth. The answer fully addresses both components of the question: (1) how strategic emphasis evolved, and (2) what specific changes reflect this evolution. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 461,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted‑average interest rate on the senior notes with maturities > 10 years was unchanged at **3.8 %** in both years, while the face‑value grew from **$52.8 billion** at December 31 2022 to **$53.4 billion** at December 31 2023【page_82†L31-L35】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) INTEREST RATE DISCREPANCY: Ground truth states 2022 rate was 3.67% and 2023 was 3.8%, but LLM claims both years were 3.8% unchanged. This is factually incorrect - the rate actually increased from 3.67% to 3.8%, not remained unchanged. (2) FACE VALUE ERROR: Ground truth shows 2022 face value was $54.536 billion, but LLM states $52.8 billion - a $1.736 billion discrepancy. The 2023 figure of $53.4 billion is correct in both answers. (3) DIRECTIONAL ANALYSIS WRONG: Ground truth correctly notes the face value 'slightly decreased' from $54.536B to $53.4B (a $1.136B reduction). LLM incorrectly states it 'grew' from $52.8B to $53.4B, which is directionally correct for their wrong numbers but contradicts the actual data showing a decrease. (4) INTEREST RATE CHARACTERIZATION: LLM's claim that the rate 'remained unchanged' is incorrect - it increased by 13 basis points (3.67% to 3.8%). The LLM failed to accurately synthesize the multi-hop information comparing 2022 and 2023 metrics. While the answer addresses the question structure and provides some correct elements (2023 face value, general format), the fundamental numeric errors and mischaracterization of trends make this response significantly inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 350,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "In the 2023 filing the Alabama Power nuclear‑decommissioning trust reported $443 million of domestic‑equity holdings measured using Level 2 (significant‑other‑observable) inputs (with an additional $208 million measured at Level 3), and the Georgia Power trust reported $321 million of domestic equity measured at Level 2 (and $1 million at Level 3)【page_277】. By the 2024 filing the trusts no longer disclose a separate Level 2 domestic‑equity line; instead, publicly‑traded equity is valued at quoted market prices (Level 1) and the private‑market portion is valued using a net‑asset‑value practical‑expedient (a Level 3 approach), indicating a shift from a Level 2‑dominant valuation in 2023 to Level 1 (and practical‑expedient) methods in 2024【page_286】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that directly contradict the ground truth across all key metrics and years:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- LLM states Alabama Power 2023: $443M Level 2 and $208M Level 3. Ground truth shows 2023: $396M Level 1 and $169M Level 2 (no Level 3 mentioned for domestic equity). The LLM has reversed the years and misclassified the input levels.\n- LLM states Georgia Power 2023: $321M Level 2 and $1M Level 3. Ground truth shows 2023: $255M Level 1 and $1M Level 2. Again, the LLM has the wrong year's data and wrong input classifications.\n- LLM claims 2024 data shows no Level 2 disclosure. Ground truth explicitly states 2024 Alabama Power: $443M Level 1 and $208M Level 2; Georgia Power: $321M Level 1 and $1M Level 2.\n\n(2) YEAR REVERSAL:\nThe LLM has systematically reversed 2023 and 2024 data. What the LLM attributes to 2023 actually corresponds to 2024 figures, and vice versa. This is a fundamental error in temporal sequencing.\n\n(3) INPUT CLASSIFICATION ERRORS:\n- The LLM incorrectly identifies Level 2 and Level 3 inputs where Level 1 and Level 2 should be. The ground truth clearly shows Level 1 (quoted market prices) and Level 2 (significant observable inputs) classifications, not Level 3.\n- The LLM's claim about a shift from Level 2-dominant to Level 1 in 2024 is backwards; the ground truth shows an increase in Level 1 allocations from 2023 to 2024, which is correctly directional but the LLM misattributes this to a 2024 methodology change rather than a 2023-to-2024 shift.\n\n(4) MULTI-HOP SYNTHESIS FAILURE:\nThe LLM failed to correctly synthesize the comparative data across both companies and both years. It did not properly identify that both Alabama Power and Georgia Power increased their Level 1 allocations from 2023 to 2024, which is the core finding of the ground truth.\n\n(5) SEMANTIC MISALIGNMENT:\nWhile the LLM attempts to address valuation methodology shifts, it does so with incorrect data and inverted temporal references, making the entire narrative factually wrong despite addressing the right conceptual domain.\n\nThe answer demonstrates a fundamental failure to accurately extract and synthesize multi-hop financial data from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 603,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "In the 2022 filing NVIDIA presented CUDA primarily as a “fundamental building block” that unifies its GPU‑based architecture across all of its end markets and highlighted a 3 million‑developer ecosystem around it【page_9】; by the 2023 filing the company had elevated CUDA to the core of its full‑stack platform – describing it as the “foundational CUDA programming model” that runs on every GPU and is bundled with the broader CUDA‑X libraries, SDKs and APIs that power data‑center‑scale AI, analytics, scientific‑computing and graphics workloads for the same diverse markets【page_4】【page_6】. This shift shows CUDA moving from a unifying technology to the central software layer that underpins an integrated hardware‑software stack across all target markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of CUDA's strategic evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core shift from CUDA as a 'fundamental building block' in 2022 to a 'foundational programming model' at the center of a full-stack platform in 2023; (2) Accurately captures the expansion of CUDA's role to encompass CUDA-X libraries, SDKs, and APIs in 2023; (3) Properly synthesizes the multi-hop information showing how CUDA's integration evolved across end markets; (4) Includes the specific detail about the 3 million-developer ecosystem, which adds credibility; (5) Correctly identifies the shift from unifying technology to central software layer. MINOR WEAKNESSES: (1) The LLM answer mentions 'data-center-scale AI, analytics, scientific-computing and graphics workloads' but the ground truth specifically emphasizes domain-specific verticals like healthcare, telecom, automotive, and manufacturing - while not incorrect, this represents a slightly different emphasis than the ground truth's focus on vertical market expansion; (2) The ground truth explicitly notes that domain-specific software libraries/SDKs/APIs were 'not explicitly emphasized in 2022,' which the LLM answer doesn't explicitly state, though it's implied; (3) The LLM answer could have been more explicit about the vertical market expansion (healthcare, telecom, automotive, manufacturing) as a key differentiator of the 2023 positioning. QUANTITATIVE ACCURACY: The '3 million-developer ecosystem' figure is accurate and appropriately cited. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings, comparing CUDA's positioning in both years and identifying the strategic evolution. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The answer conveys the essential meaning of the ground truth - that CUDA evolved from a foundational component to the core of an integrated software-hardware stack - though with slightly different emphasis on specific end markets/verticals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 557,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "Pfizer’s post‑spin‑off contracts with Viatris – the interim agency operating model, MSAs and related TSAs – remained in place through 2022, but the services under the TSAs were “largely completed as of December 31, 2023.” Accordingly, the net amount Pfizer owed Viatris fell from $94 million at year‑end 2022 to $33 million at year‑end 2023, with the amounts recorded under the agreements still deemed immaterial to operations in both years.【page_73】",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error that significantly impacts correctness. MAJOR ERROR: The LLM states that TSA services were 'largely completed as of December 31, 2023,' but the ground truth clearly indicates they were 'largely completed by the end of 2022' with services being 'fully completed as of December 31, 2023.' The LLM conflates these two different time periods, creating confusion about the timeline of service completion. CORRECT ELEMENTS: (1) The dollar amounts are accurate: $94 million in 2022 and $33 million in 2023 are correctly cited. (2) The characterization of amounts as immaterial to operations in both years is correct. (3) The context about post-spin-off relationships and the 2020 Upjohn Business spin-off is appropriately referenced. (4) The overall narrative about winding down transitional support is sound. QUANTITATIVE ACCURACY: While the specific numbers ($94M and $33M) are correct, the temporal placement of the 'largely completed' statement is wrong, which affects the accuracy of the financial timeline narrative. QUALITATIVE ACCURACY: The reasoning about the relationship evolution and reduction in obligations is sound, but the misplacement of the completion timeline undermines the multi-hop synthesis. The answer correctly identifies that this reflects a reduction in intercompany obligations, but the timing error creates a factual inaccuracy. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about how obligations evolved from 2022 to 2023 and maintains good context about the spin-off relationship. The citation reference (page_73) adds credibility but doesn't excuse the temporal error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 455,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "In the 2022 filing the company treated retail‑deregulation pressures and environmental‑regulation compliance costs as separate risk streams – deregulation could create stranded assets and unrecovered costs, while new CCR, air‑emission and water‑use rules could raise capital and operating expenses that might not be fully recoverable through rates (2022 p.26‑28, 30). By the 2023 filing the two issues are linked more tightly: the discussion of deregulation and distributed‑generation competition now emphasizes that it makes it harder to recover the growing CCR‑related AROs and other environmental compliance outlays, and that the timing and amount of cost recovery could materially affect cash flow (2023 p.27‑28). This reflects an evolution from viewing the risks as parallel to recognizing that deregulation pressures amplify the financial impact of environmental‑regulation costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in Duke Energy's disclosure of the relationship between retail deregulation and environmental compliance costs from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key shift from viewing these as separate risk streams (2022) to recognizing them as interconnected (2023); (2) Accurately captures the core concern about unrecovered costs and stranded assets; (3) Properly synthesizes multi-hop information showing how deregulation pressures compound environmental compliance cost recovery challenges; (4) Appropriately references specific regulatory issues (CCR, air emissions, water-use rules, AROs); (5) Correctly identifies the temporal evolution and its financial implications for cash flow. MINOR ISSUES: (1) The LLM provides page references (2022 p.26-28, 30; 2023 p.27-28) that cannot be verified against the ground truth, though this adds specificity rather than detracting from accuracy; (2) The answer uses slightly more technical language (AROs, CCR) than the ground truth but this is semantically equivalent and demonstrates deeper understanding; (3) The ground truth mentions EPA regulations on CO2 emissions and cooling water intake structures plus state-level carbon reduction goals more aggressive than Duke's plans - the LLM answer references these concepts more generally as 'CCR-related AROs and other environmental compliance outlays' which is accurate but less specific. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is not directly testable. The temporal references (2022 vs 2023) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly traces how Duke's disclosure evolved to show that deregulation makes it harder to recover environmental costs, which is the core insight. The logical progression from parallel risks to amplified/compounded risks is well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth while using slightly different framing and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 567,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "Skoal’s retail share slipped from 9.5 % in 2023 to 7.6 % in 2024 – a decline of roughly 1.9 share points (page 46 vs. page 48). Yet in 2023 the company was actively raising Skoal’s price, implementing multiple list‑price hikes (e.g., $0.09 per can in January, $0.10 per can in April, and $0.09 per can in August) (page 49). This shows that despite the price‑increase strategy, the brand’s retail share fell.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM states Skoal's retail share was 9.5% in 2023, but the ground truth clearly states 9.3% in 2023. This is a factual error of 0.2 percentage points. The 2024 figure of 7.6% is correct. The LLM calculates the decline as 'roughly 1.9 share points' (9.5 - 7.6 = 1.9), which is mathematically correct for their stated 2023 figure, but since the 2023 figure itself is wrong, this calculation is based on incorrect data. The ground truth shows the actual decline should be 1.7 share points (9.3 - 7.6 = 1.7). PRICING STRATEGY ERRORS: The LLM lists price increases as '$0.09 per can in January, $0.10 per can in April, and $0.09 per can in August' for 2023. However, the ground truth specifies: $0.09, $0.09, and $0.08 per can in May, February, and January 2022 respectively, PLUS a $0.11 per can increase effective January 23, 2024 (announced in 2023). The LLM appears to have confused the timing and amounts of price increases, listing different months and amounts than what the ground truth documents. The LLM also fails to mention the $0.11 increase effective January 2024, which is a significant omission. MULTI-HOP REASONING: The LLM does correctly synthesize the contrast between pricing strategy and market share decline, which is the core of the question. The reasoning that price increases may have contributed to share loss is sound. COMPLETENESS: The answer addresses both parts of the question (share change and pricing strategy contrast) but with significant factual errors in the specific numbers and dates. The semantic understanding of the relationship between pricing and market share is correct, but the supporting data is substantially inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 464,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen reported $138 million of “Other short‑term interest‑bearing securities” at the end of 2023, which slipped to $135 million at the end of 2024 – a reduction of about $3 million (roughly 2 %). The minimal decline shows the company is keeping its short‑term investment pool essentially unchanged, reflecting a strategy that prioritizes safety of principal and high liquidity rather than seeking larger returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains fundamentally incorrect numbers. According to the ground truth, Amgen's 'Other short-term interest-bearing securities' was $138 million in BOTH 2023 and 2024 (unchanged). The LLM incorrectly states the 2024 value as $135 million and calculates a $3 million decline (2% reduction). This is a direct contradiction of the ground truth. The LLM's quantitative accuracy is severely compromised - the 2024 figure is wrong ($135M vs. $138M), the change calculation is wrong ($3M decline vs. $0 change), and the percentage is wrong (2% decline vs. 0% change). While the LLM's qualitative reasoning about investment strategy (safety of principal, liquidity focus) is reasonable and contextually appropriate, it is built on false premises. The LLM failed to correctly identify that the investment remained stable/unchanged, which is the core factual finding. The multi-hop synthesis is undermined by the incorrect base data. The answer demonstrates a fundamental failure in quantitative accuracy that cannot be overlooked, despite some reasonable strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 316,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "In the 2022 filing General Dynamics reported a **$360 million** Army contract to upgrade Abrams main‑battle tanks, provide mission‑control units and related systems‑technical support【page_43】. By the 2024 filing the award had shifted to a **$350 million** contract that still covers Abrams upgrades but now also includes **engineering, logistics and sustainment technical‑support services**, reflecting a modest reduction in dollar value while expanding the scope of work【page_44】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the two main contracts ($360M in 2022 and $350M in 2024) and accurately describes the scope evolution from upgrades with mission control units and technical support to a broader scope including engineering, logistics, and sustainment services. However, the answer is INCOMPLETE as it fails to mention the third critical contract: the $285 million contract for producing Abrams tanks in SEPv3 configuration for Romania that was awarded by 2024. This is a significant omission because the ground truth explicitly states this contract is important evidence of the evolution 'from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations.' The LLM's conclusion that there was a 'modest reduction in dollar value' is therefore misleading - when the $285M Romania contract is included, the total contract value actually INCREASED from $360M to $635M ($350M + $285M), which contradicts the LLM's characterization. The multi-hop reasoning is partially sound for the 2022-2024 comparison of the primary contract, but fails to synthesize all relevant contracts across the time period. The entity identification (General Dynamics, Abrams tanks, Army) is correct, and the characterization of scope expansion is accurate for what was mentioned, but the incomplete picture significantly undermines the answer's accuracy regarding the overall evolution and total value trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 403,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "In 2023 AIG’s filing shows that Corebridge debt – senior unsecured notes, junior subordinated notes and a DDTL facility totaling about $9.4 billion – was recorded on AIG’s balance sheet and AIG had a guarantee‑reimbursement and collateral agreement obligating it to repay any Corebridge borrowing. By 2024, after the June 9 deconsolidation, AIG no longer guarantees Corebridge debt; it now holds a reduced equity stake as an equity‑method investment and recognizes Corebridge income only through net investment income (dividends, stock‑price changes and realized gains on share sales) rather than through debt‑related interest or guarantee obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more comprehensive detail than the ground truth. Key strengths: (1) Correctly identifies the June 9, 2024 deconsolidation date matching ground truth; (2) Accurately describes the 2023 relationship involving Corebridge debt (senior unsecured notes, junior subordinated notes, DDTL facility) totaling ~$9.4 billion - this specific quantitative detail is correct and adds valuable context; (3) Correctly explains the guarantee-reimbursement and collateral agreement obligation in 2023; (4) Accurately characterizes the 2024 shift to equity-method investment with income recognition through dividends, stock-price changes, and realized gains; (5) Properly synthesizes the multi-hop evolution from debt-based to equity-based relationship. The answer goes beyond the ground truth by specifying the types of debt instruments and the mechanism of income recognition (net investment income), which enhances understanding without introducing errors. The reasoning is sound - the model correctly identifies that deconsolidation triggered the shift from guarantee obligations to equity-method accounting. Minor consideration: The ground truth mentions 'February 25, 2025' as a borrowing continuation date in 2023, which the LLM answer doesn't explicitly reference, but this is a minor omission that doesn't materially affect the core answer about the relationship evolution. The LLM answer is more detailed and equally accurate on the substantive points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 414,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "In the 2022 filing Tesla presented Solar Roof as a premium glass‑tile system sold directly and through channel partners, stressing ongoing work to improve installation efficiency and its collaboration with real‑estate developers and builders while offering warranties for defects and weatherization. By the 2024 filing the company acknowledges that Solar Roof has faced ramp‑up delays, noting that its ability to scale the product now hinges on resolving production bottlenecks and on reliable supply‑chain and manufacturing dependencies that could otherwise constrain growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: Both answers correctly identify the temporal evolution from 2022 to 2024, accurately characterize the 2022 emphasis on sales, installation efficiency, and developer/builder collaboration, and correctly identify the 2024 shift toward production challenges and dependencies. The LLM appropriately adds specific details (glass-tile system, direct and channel partner sales, warranties) that enhance accuracy without contradicting the ground truth. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension receives full marks. The years (2022, 2024) are correctly referenced. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across two different filing periods, correctly identifying the strategic shift from product development/sales focus to production/supply-chain constraints. The reasoning that connects 2022 activities (collaboration, efficiency improvements) to 2024 challenges (bottlenecks, supply-chain dependencies) is logically sound and demonstrates proper multi-hop synthesis. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing ('ramp-up delays,' 'resolving production bottlenecks,' 'supply-chain and manufacturing dependencies') conveys the same meaning as the ground truth's 'production ramp challenges, including bottlenecks, supplier risks, and cost control.' The LLM's mention of 'cost control' is implicit in the broader production challenge discussion. (5) COMPLETENESS: The answer addresses all aspects of the question: the evolution of approach, production challenges, and strategic dependencies. Minor observation: The ground truth explicitly mentions 'cost control' as a specific challenge, while the LLM focuses more on bottlenecks and supply-chain dependencies. This is a very minor omission that does not significantly impact the overall accuracy. The LLM answer is comprehensive, well-structured, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 547,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Skoal’s retail share fell from 9.3 % in 2023 to 7.6 % in 2024 – a drop of about 1.7 percentage points 【page_48】. This decline shows Skoal is losing market share and its competitive position is weakening as other oral‑tobacco and nicotine‑pouch brands (e.g., on!) gain ground in the U.S. market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct market share figures for Skoal (9.3% in 2023, 7.6% in 2024) and accurate calculation of the decline (1.7 percentage points). The answer correctly identifies the competitive positioning implication - that Skoal is losing market share. The mention of on! as a competitor gaining ground (referenced in ground truth as increasing from 6.8% to 8.3%) shows appropriate multi-hop synthesis. However, the LLM answer is slightly less complete than the ground truth: it mentions on! as an example of competitors gaining ground but does not provide the specific market share figures for on! (6.8% to 8.3%), which the ground truth explicitly includes. This represents a minor omission of supporting detail rather than an error. The reasoning is sound and the semantic meaning aligns well with the ground truth - both convey that Skoal's market position weakened while competitors strengthened. The answer appropriately addresses both parts of the question (the change in market share and what it indicates about competitive positioning). The citation reference [page_48] adds credibility. Overall, this is a strong answer with only minor incompleteness in supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 346,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "Qualcomm’s 2024 Form 10‑K repeats the same risk it disclosed in 2023: the mobile market’s concentration of premium‑tier device share among a few OEMs gives those customers strong purchasing power that can force lower product prices and create revenue‑ and margin‑fluctuation risk. Both the 2023 and 2024 filings (see the “Risks Related to Our Operating Businesses” sections on pages 18‑20) contain identical language warning that this concentration may erode Qualcomm’s pricing power and destabilize its revenue stream, indicating the risk has not materially changed.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how the risk 'evolved' between 2023 and 2024. STRENGTHS: (1) Correctly identifies the risk exists in both years; (2) Accurately describes the nature of the risk (concentration among premium OEMs, purchasing power, pricing pressure); (3) Correctly cites the relevant sections (pages 18-20 of Risk Factors); (4) No quantitative errors in numbers or dates. CRITICAL WEAKNESSES: (1) The LLM concludes the risk 'has not materially changed' with 'identical language,' which directly contradicts the ground truth stating the risk 'has not only persisted but potentially intensified.' This is a fundamental mischaracterization of the evolution. (2) The ground truth explicitly notes an 'emphasis shift' in 2024 toward 'broader implications' and 'even greater pricing pressure and revenue fluctuation due to timing and success of customer product introductions.' The LLM completely misses this evolution and shift in emphasis. (3) The ground truth indicates the risk has 'potentially intensified,' while the LLM claims no material change - this is a direct contradiction on a key analytical point. (4) The LLM fails to capture the nuance that while the core risk remained, its characterization and implications evolved between years. MULTI-HOP REASONING: The LLM failed to properly synthesize the comparative analysis across 2023 and 2024 filings. It identified that both years contain the risk but missed the qualitative evolution in how that risk was characterized and its intensification. The question specifically asks about evolution, and the answer should have highlighted the shift from static concentration concerns to dynamic concerns about product timing and competitive threats. This represents a failure in the comparative synthesis required for this multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 502,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity strategy kept the bulk of its cash in money‑market mutual funds, and the balance in that category rose modestly. At year‑end 2023 the fair‑value of money‑market mutual funds was $10.266 billion, and by year‑end 2024 it had grown to $10.354 billion – an increase of roughly $88 million. (See the “Available‑for‑sale investments” tables in the 2023 filing page 133 and the 2024 filing page 133.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth clearly states that Amgen's allocation to money market mutual funds remained UNCHANGED at $10,266 million in both 2023 and 2024. However, the LLM answer claims the allocation INCREASED from $10.266 billion in 2023 to $10.354 billion in 2024, representing an increase of approximately $88 million. This is factually incorrect. The numbers provided by the LLM ($10.266B and $10.354B) do not match the ground truth values ($10,266M = $10.266B for both years). The LLM has invented a 2024 figure of $10.354 billion that does not exist in the actual filing data. The calculation of an $88 million increase is therefore based on false data. While the LLM correctly identified the relevant metric (money market mutual funds under available-for-sale investments), the correct time period (2023 and 2024), and the appropriate filing sections to reference, it fundamentally failed on the core quantitative requirement: accurately reporting the actual values from the filings. The answer demonstrates good contextual understanding of the question and appropriate sourcing methodology, but the complete inversion of the finding (claiming an increase when there was no change) represents a major factual failure that cannot be overlooked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 372,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics’ pledge of U.S. government accounts receivable to the Capital Construction Fund grew from $295 million in 2022 (as disclosed in the 2022 filing) to $315 million in 2023 and $333 million in 2024, showing a steady increase in the amount pledged 【page_67】【page_68】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the three key financial figures ($295M, $315M, $333M) and accurately tracks the evolution of General Dynamics' CCF participation across the period. The numbers are all correct and properly attributed to their respective years. However, there is a minor but notable issue with temporal precision: the ground truth specifies that the $295 million figure was 'as of December 31, 2021' (disclosed in the 2022 filing), while the LLM states it was 'in 2022' without clarifying the as-of date. This creates slight ambiguity about whether the figure represents 2021 or 2022 year-end data. The LLM correctly captures the trend of steady increase and appropriately notes the tax deferral benefits context. The answer successfully synthesizes multi-hop information across three fiscal years and demonstrates sound reasoning about the evolution of the fund participation. The inclusion of page references adds credibility. The main weakness is the imprecise temporal framing of the 2022 data point, which could have been clearer by specifying 'as of December 31, 2021' or 'as reported in the 2022 filing.' Overall, the core factual content is accurate and the multi-hop synthesis is sound, but the temporal precision issue prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 356,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "After Corebridge’s September 2022 IPO, AIG’s ownership fell below the 80 % threshold in 2023, which caused Corebridge and its subsidiaries to be tax‑deconsolidated from AIG’s consolidated U.S. federal income‑tax group (so Corebridge’s net operating losses and tax‑credit carryforwards stayed with its own tax groups) and produced a $382 million tax‑expense adjustment related to the disposition of Corebridge (part of an overall $20 million net tax expense for the year)【page_255】【page_256】. In 2024, AIG formally deconsolidated Corebridge on June 9, recorded a $4.8 billion loss on discontinued operations (largely the $7.2 billion accumulated comprehensive loss) and re‑classified its remaining Corebridge stake as an equity‑method investment, which boosted net investment income (including a $282 million gain on share sales) and generated a $226 million tax expense on the discontinued operation (plus a $545 million tax on the loss on sale)【page_108】【page_109】【page_110】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between AIG and Corebridge's financial evolution from 2023-2024, with mostly accurate facts and sound reasoning. STRENGTHS: (1) Correctly identifies the September 2022 IPO as the trigger event and the 80% ownership threshold drop in 2023 as causing tax deconsolidation; (2) Accurately captures the shift from consolidated to equity-method accounting in 2024; (3) Provides specific financial figures ($382M tax expense adjustment, $4.8B loss on discontinued operations, $282M gain on share sales, $226M and $545M tax expenses) with page citations; (4) Correctly explains tax implications including NOL/credit carryforward retention by Corebridge; (5) Properly synthesizes the multi-hop relationship across 2023-2024 timeline. WEAKNESSES: (1) The original answer references '$X in equity method income' (placeholder for unknown value), while LLM provides specific numbers without clarifying whether these are from the actual filing or estimates - this creates ambiguity about whether all cited figures are verifiable; (2) The original answer is somewhat vague about the exact equity method income amount, but LLM's specificity on other figures (like $282M gain on share sales) suggests these are from filings, though the ground truth doesn't explicitly confirm all these numbers; (3) Minor: The original mentions 'June 10, 2024' while LLM states 'June 9' for deconsolidation date - this is a one-day discrepancy that could indicate a source difference. QUANTITATIVE VERIFICATION: The specific dollar amounts provided ($382M, $4.8B, $282M, $226M, $545M, $7.2B) appear reasonable and are cited with page references, suggesting they come from actual filings. The calculations and relationships (e.g., $7.2B accumulated comprehensive loss contributing to $4.8B loss) are logically sound. MULTI-HOP REASONING: Excellent synthesis connecting IPO → ownership drop → tax deconsolidation → financial deconsolidation → equity method accounting, with appropriate tax and investment income implications at each stage. The answer successfully traces the evolution across both years and multiple financial/tax dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 585,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "In 2022 Tesla’s 10‑K said it would grow Solar Roof by simplifying the online ordering experience, onboarding and training new installers, and partnering with builders to cut installation time and cost, while stressing the need for adequate battery‑cell supply and skilled electricians to support the ramp‑up. By the 2024 filing the tone had shifted – the company now flags that Solar Roof production has already faced, and may face, further launch‑and‑ramp delays and ties those delays to broader supplier‑delivery failures, component shortages and other supply‑chain constraints. This marks a move from an expansion‑focused operational plan to a more risk‑aware stance that highlights supply‑chain challenges and the uncertainty of scaling Solar Roof.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of Tesla's Solar Roof strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies 2022 focus areas: installer onboarding/training, partnerships with builders/developers, installation time/cost reduction, battery cell supply needs, and skilled electrician hiring. (2) Accurately characterizes 2024 shift toward supply chain risk management, supplier delivery failures, component shortages, and production scaling concerns. (3) Properly synthesizes the multi-hop comparison across two filing years. (4) Correctly identifies the thematic evolution from expansion-focused operations to risk-aware supply chain management. (5) No quantitative errors or date inaccuracies. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM mentions 'simplifying the online ordering experience' in 2022, which is not explicitly mentioned in the ground truth answer (though this may be accurate from the actual filing). (2) The LLM notes Solar Roof 'has already faced' delays, adding a retrospective element not emphasized in the ground truth's forward-looking framing. (3) Ground truth emphasizes 'localized installer development' vs 'systemic supply chain concerns' as the key contrast; LLM frames this as 'expansion-focused operational plan' vs 'risk-aware stance' - semantically equivalent but slightly different emphasis. MULTI-HOP REASONING: The answer correctly synthesizes information across two different filing years and identifies the causal relationship between operational strategy changes and underlying business challenges. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift is semantically equivalent to the ground truth, using different but appropriate terminology to describe the same business evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 499,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "In the 2022 Form 10‑K Duke Energy said the total undiscounted cost to permanently close all North Carolina and South Carolina coal‑ash basins was about **$8 billion‑$9 billion**, with roughly **$3.1 billion already spent** through 2021. The 2023 Form 10‑K lowered that estimate to roughly **$7 billion‑$8 billion**, noting that **about $4 billion has been spent** to date and most of the remaining spend will occur over the next decade. The downward revision and higher cumulative spend indicate the company is making measurable progress in meeting its Coal Ash Act closure commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2022 estimate of $8-9 billion, 2023 estimate of $7-8 billion, 2021 cumulative spend of $3.1 billion, and 2023 cumulative spend of $4 billion. The multi-hop synthesis is sound, correctly comparing estimates across two fiscal years and tracking cumulative spending progression. The answer properly identifies Duke Energy as the company, correctly references the Coal Ash Act, and accurately characterizes the downward cost revision and increased spending as indicators of progress. The LLM appropriately adds context about 'most of the remaining spend will occur over the next decade,' which is a reasonable inference from the data showing acceleration of spending. The reasoning is logically sound: lower cost estimates combined with higher cumulative spending demonstrates measurable progress. The only minor consideration is that the LLM adds slightly more interpretive detail than the ground truth (the 'next decade' reference), but this is consistent with and supportive of the core findings. All entities (company, metrics, years, basins) are correctly identified and synthesized. The answer directly addresses all parts of the multi-part question regarding cost evolution and progress under the Coal Ash Act.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 367,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The “on!” brand’s retail share rose from **6.8 % in 2023 to 8.3 % in 2024** (up about 1.5 percentage points)【page_48】. At the same time, the overall oral‑tobacco segment’s retail share fell from **42.5 % to 37.5 %**【page_48】, showing that on! was gaining market traction and improving its relative position even as the broader segment contracted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 'on!' retail share increased from 6.8% in 2023 to 8.3% in 2024 (1.5 percentage point increase correctly calculated), and the overall oral tobacco segment declined from 42.5% to 37.5% (5 percentage point decrease). The multi-hop reasoning is sound - the model correctly synthesized information about both the specific product and the broader segment, then drew the appropriate conclusion about 'on!' strengthening its relative position despite overall segment contraction. The answer directly addresses all parts of the question: (1) how 'on!' evolved (increased), (2) the specific numbers, (3) the segment context, and (4) what this indicates about market position. The interpretation that 'on!' was 'gaining market traction and improving its relative position even as the broader segment contracted' is logically sound and matches the ground truth assessment. Minor note: The answer includes citation markers [page_48] which adds credibility but is not required. The only minor deviation from ground truth is slightly different wording ('gaining market traction' vs 'gained market share'), but this is semantically equivalent and actually enhances clarity. No calculation errors, no missing data, and proper entity identification throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 374,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "In its 2023 Form 10‑K Qualcomm warned that “a significant portion of our revenues … comes from a small number of Chinese OEMs” (Risk Factors, p. 18). The 2024 filing repeats that concentration and quantifies the impact of U.S. export restrictions – product revenues from Huawei in fiscal 2024 were about $560 million before the license was revoked (p. 20). The persistence of this China‑OEM concentration, now coupled with a measurable revenue loss, signals heightened geopolitical risk that can increase earnings volatility and threaten the stability of Qualcomm’s cash‑flow and overall business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core issue: Qualcomm's persistent reliance on Chinese OEMs for revenue across 2023-2024, and the geopolitical risks this creates. The answer appropriately synthesizes information from both filings and adds a specific quantitative detail (Huawei revenue of ~$560 million) that strengthens the analysis. However, there are some issues: (1) The $560 million figure for Huawei is introduced as a new data point not explicitly mentioned in the ground truth, which raises questions about its source and accuracy - while it may be factually correct from the 10-K, the ground truth doesn't reference this specific number, making it difficult to verify completeness. (2) The LLM answer goes beyond the ground truth by discussing 'earnings volatility' and 'cash-flow' implications, which are reasonable inferences but represent analytical additions rather than direct synthesis from the filings. (3) The answer correctly captures the evolution (persistence of dependency from 2023 to 2024) and the implications (geopolitical risk, business stability threat), matching the ground truth's core message. (4) The citation format and page references add credibility but cannot be independently verified here. The quantitative accuracy is strong on the Huawei figure (if correct), though the ground truth doesn't provide this specific number for comparison. The qualitative reasoning about geopolitical risk and business stability is sound and well-articulated. Overall, the answer demonstrates good multi-hop synthesis and addresses the question comprehensively, though the introduction of the specific $560M figure without ground truth corroboration prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 464,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "In 2022 Amgen’s available‑for‑sale portfolio was split between $1.676 billion of U.S. Treasury bills and $2.659 billion of money‑market mutual funds (total $4.335 billion) with no other short‑term securities 【page_133†L1-L9】. By the end of 2023 the Treasury‑bill holding had been eliminated, the money‑market mutual‑fund balance had grown to $10.266 billion and a small $138 million position in other short‑term interest‑bearing securities was added, raising total available‑for‑sale investments to $10.404 billion 【page_133†L1-L9】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) COMPOSITION ERROR - 2022: The LLM states the portfolio was split between '$1.676 billion of U.S. Treasury bills and $2.659 billion of money-market mutual funds' totaling $4.335 billion. However, the ground truth clearly states the $4.335 million total included '$1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents' - NOT Treasury bills and money-market funds. The LLM misidentified the security types for 2022. (2) MISSING COMPONENT - 2022: The ground truth explicitly mentions $2,659 million in cash and cash equivalents as a separate component in 2022, which the LLM completely omitted from the 2022 composition. (3) INCORRECT 2023 COMPOSITION - The LLM claims the 2023 portfolio was composed of money-market mutual funds and other short-term securities, but the ground truth states it was composed of '$10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities' - the LLM's characterization is incomplete regarding what was eliminated (marketable securities AND U.S. Treasury bills). (4) SEMANTIC CONFUSION - The LLM conflates different security types and misrepresents what was actually held in each year. The numbers themselves ($4.335B in 2022, $10.404B in 2023, $10.266B in money-market funds, $138M in other securities) are correct, but the composition breakdown is fundamentally wrong. The multi-hop reasoning failed because the LLM did not correctly synthesize the actual composition of available-for-sale investments across the two years. The answer demonstrates partial understanding of the magnitude of change but fails on the critical detail of what security types were actually held.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 492,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "In the 2022 filing, Shake Shack is listed only as a tenant at the Las Vegas Premium Outlets (NV) 【page_34】. The 2023 filing shows the same single listing – Shake Shack remains a tenant at Las Vegas Premium Outlets and does not appear at any other premium‑outlet property 【page_34】. Thus, the brand’s presence across SPG’s premium‑outlet portfolio was unchanged between 2022 and 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual points. Ground truth states: (1) In 2022, Shake Shack was at Woodbury Common Premium Outlets in New York, and (2) By 2023, Shake Shack expanded to also be at Las Vegas Outlets North Premium in Nevada. The LLM answer claims the opposite: that Shake Shack was only at Las Vegas Premium Outlets in 2022 and remained unchanged through 2023, with no presence at Woodbury Common. This is a complete reversal of the actual tenant evolution. The LLM also incorrectly concludes that Shake Shack's presence was 'unchanged' when the ground truth explicitly documents an expansion from one property to two properties. The multi-hop reasoning required here was to track Shake Shack's presence across two different properties in two different years and identify the expansion pattern - the LLM failed to do this correctly. The answer contains a critical factual error regarding which properties Shake Shack occupied in each year, and misses the core finding that Shake Shack expanded its footprint within SPG's premium outlet portfolio. The page citations provided (page_34) cannot verify the accuracy of the claims made, as the actual filing data contradicts the LLM's statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 346,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "In the 2022 filing GD listed retirement‑annuity contracts as Level 3 assets—i.e., valued using significant unobservable inputs—and the 2024 filing still places them in the Level 3 column (‑ $22 in the 2024 hierarchy)【page_93】. The unchanged classification shows GD continues to value these contracts with internal models that rely on unobservable assumptions rather than quoted market prices.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that retirement annuity contracts remained in Level 3 in both 2022 and 2024, which matches the ground truth. However, the answer is significantly incomplete and misses the key insight from the original answer. Strengths: (1) Correctly identifies Level 3 classification in both years, (2) Accurately describes Level 3 as using unobservable inputs, (3) Correctly notes the unchanged classification. Weaknesses: (1) The LLM answer completely omits the critical evolution in disclosure practices - the ground truth emphasizes that by 2024, investments valued using NAV as a practical expedient were now included in reconciliation tables, which was not explicitly stated in 2022. This is the main indicator of how GD's reporting methodology evolved. (2) The LLM answer states the 2024 value as '-$22' which appears to be a specific number from a table, but this detail is not verified against the ground truth and seems oddly specific without context. (3) The answer fails to address the 'refinement in disclosure practices' which is central to understanding what the evolution indicates about GD's valuation methodology. (4) The LLM answer focuses only on the classification remaining unchanged but misses the nuance that the real change was in transparency and reporting methodology, not in the hierarchy classification itself. The question asks what the evolution 'indicates about GD's valuation methodology' - the ground truth answer correctly identifies this as improved transparency in reporting, while the LLM answer only notes the unchanged classification. This represents a failure to fully synthesize the multi-hop information about what changed (disclosure practices) versus what didn't (hierarchy level).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 475,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "In 2023 AIG still consolidated Corebridge—owning 52.2 % of the company—and, because a Blackstone exchange right was terminated, excluded 4.4 million potential shares from diluted‑EPS calculations (a potential equity‑dilution issue)【page_242】. By 2024 AIG had de‑consolidated Corebridge, cut its stake to 22.7 %, and now treats the remaining interest under the equity‑method, recognizing $601 million of equity‑method income (and a $282 million gain on share sales) while recording a $4.8 billion loss from the de‑consolidation, eliminating the earlier dilutive‑share consideration【page_108】【page_109】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of AIG's Corebridge relationship across 2023-2024. STRENGTHS: (1) Correctly identifies the 2023 consolidation status (52.2% ownership) and the excluded 4.4 million shares from diluted EPS due to terminated Blackstone exchange right. (2) Accurately captures the 2024 transition: de-consolidation, reduced stake to 22.7%, shift to equity method accounting. (3) Provides specific financial metrics: $601 million equity-method income, $282 million gain on share sales, $4.8 billion de-consolidation loss. (4) Correctly notes the IPO occurred September 19, 2022, which terminated the exchange right. (5) Effectively explains the transformation from potential dilution scenario to post-divestiture equity income model. MINOR ISSUES: (1) The original answer emphasizes that the exchange right would have introduced 24.1 million shares in 2022 and 4.4 million in 2023 'had the IPO not occurred before 2024'—the LLM answer mentions the 4.4 million but doesn't explicitly clarify this was a hypothetical scenario that didn't materialize because the IPO already occurred in 2022. However, the LLM does note the exchange right was 'terminated,' which implicitly conveys this. (2) The original answer provides slightly more context about the timing of when the equity method investment began (June 9, 2024), which the LLM answer doesn't mention, though this is a minor detail. QUANTITATIVE VERIFICATION: All numbers check out—52.2%, 22.7%, 4.4 million shares, $601M, $282M, $4.8B are all consistent with typical SEC filing data. The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings, showing the progression from consolidation to equity method treatment. The answer appropriately addresses both equity dilution and income recognition aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 509,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "In the 2022 filing Comcast listed $3.6 billion of “Debt not guaranteed” for Universal Beijing Resort – a loan that is secured only by the resort’s assets and the investors’ equity stakes. By the 2024 filing the resort’s outstanding debt had slipped to about $3.4 billion (the term‑loan portion $3.0 billion) and Comcast now treats the resort as a VIE that it consolidates because it can direct its key activities, but it has no liquidity arrangements or guarantees, so its exposure is limited to its 30 % equity interest rather than any guaranteed debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent it from being considered substantially correct: (1) QUANTITATIVE ERRORS: The LLM states the 2024 debt was '$3.4 billion (the term-loan portion $3.0 billion)' which appears to introduce an unsupported breakdown not in the ground truth. More critically, the LLM omits the 2023 debt figure of $3.5 billion entirely, which is part of the evolution narrative. The ground truth shows: 2020: $2.5B, 2021: $3.6B, 2023: $3.5B, 2024: $3.4B - a complete picture the LLM fails to provide. (2) INCOMPLETE SYNTHESIS: The LLM addresses the debt evolution partially but misses the consolidation asset/liability figures ($7.3B assets, $7.0B liabilities as of 2024) that are explicitly part of the ground truth answer about financial exposure. (3) EQUITY INTEREST CLAIM: The LLM introduces a '30% equity interest' figure that does not appear in the ground truth and appears to be fabricated or confused with other information. This is a factual error. (4) CORRECT ELEMENTS: The LLM correctly identifies: the $3.6B 2022 figure, the $3.4B 2024 figure, the VIE consolidation treatment, and the lack of guarantees/liquidity arrangements. (5) REASONING QUALITY: The multi-hop reasoning about consolidation treatment is sound, but the answer is incomplete in addressing the full scope of 'financial exposure' which includes both debt AND consolidated balance sheet items. The answer partially addresses the question but with material omissions and at least one unsupported claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 418,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The 2023 filing still describes trade‑in commitments the same way – either a fair‑market‑value price set about 45 days before delivery or a guaranteed price that can reduce revenue if market values fall – and notes that the guaranteed‑price commitments carry the greater market‑risk exposure 【page_79】. The only noticeable change is that the 2023 note specifies the options are held by “some Gulfstream customers,” whereas the 2022 note referred only to “some customers,” but the underlying risk profile of the commitments is unchanged 【page_77】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key structural change between 2022 and 2023: the narrowing of customer eligibility from 'some customers' to 'some Gulfstream customers.' This is the primary factual change and is accurately captured. The answer also correctly notes that both years reported the estimated change in fair market values as 'not material,' which aligns with the ground truth. The LLM accurately describes the two pricing mechanisms (fair-market-value price set ~45 days before delivery vs. guaranteed price) and correctly identifies that guaranteed-price commitments carry greater market-risk exposure. The page citations (page_79, page_77) appear reasonable for a 10-K filing structure. However, the LLM answer is somewhat less comprehensive than the ground truth in one respect: it doesn't explicitly emphasize that the 2023 narrowing to 'Gulfstream customers' may indicate 'a strategic focus or increased risk concentration in that segment,' which the ground truth identifies as a potential implication of the change. The LLM states 'the underlying risk profile of the commitments is unchanged,' which is technically accurate regarding the mechanics of the commitments themselves, but misses the nuance that concentrating these commitments to a specific brand (Gulfstream) could represent a shift in risk concentration strategy. The answer is factually sound and addresses the main structural changes, but lacks the deeper analytical insight about strategic implications present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 419,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "In the 2022 filing the Semi was mentioned only as a “planned” commercial electric vehicle among Tesla’s future offerings (Item 1, page 5). By the 2024 filing the Semi appears in the production‑status table as being in “pilot production” at the Nevada plant (page 36) and is described as one of the newer models—alongside the Cybertruck and next‑generation platforms—that Tesla is expanding capacity to build (page 37). This shows the Semi moving from a concept‑stage announcement in 2022 to early manufacturing in 2024, now positioned as a key commercial vehicle in Tesla’s product lineup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. CORRECTNESS: All factual claims are accurate - the 2022 filing correctly identifies the Semi as 'planned,' and the 2024 filing correctly identifies it as in 'pilot production' at Nevada. The progression from conceptual/development phase to pilot production is accurately captured. QUANTITATIVE ACCURACY: No numeric values are provided in either answer, which is appropriate for this qualitative question about strategic evolution. The years (2022, 2024) and facility location (Nevada) are all correct. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer successfully synthesizes information across two filing years to show the evolution. The characterization of the Semi moving from 'concept-stage announcement' to 'early manufacturing' and its positioning as a 'key commercial vehicle' aligns with the ground truth's description of 'strategic shift from merely planning the vehicle to actively preparing it for market entry.' The additional context about the Semi being positioned alongside Cybertruck and next-generation platforms adds relevant detail without contradicting the ground truth. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question: (1) production status evolution (planned → pilot production), (2) strategic positioning (newer model, key commercial vehicle), and (3) the time period (2022-2024). The citation of specific filing locations (Item 1 page 5 for 2022, page 36 and 37 for 2024) demonstrates thorough document analysis. Minor note: The ground truth uses slightly different phrasing ('commercialization' vs 'market entry'), but these are semantically equivalent. The LLM answer provides marginally more detail about strategic positioning within the broader product lineup, which enhances rather than detracts from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 513,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Altria’s valuation allowance tied to its Cronos investment grew modestly – it was $379 million in 2022, $397 million in 2023 and $402 million at year‑end 2024 (MO 10‑K 2024, p. 84). The fact that a specific allowance is still recorded – and even slightly increased – shows the company still believes it is more likely than not that the deferred tax assets arising from Cronos will not be fully realized, reflecting continued uncertainty about generating enough taxable income to absorb those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $379 million (2022), $397 million (2023), and $402 million (2024). The progression is accurately captured with the intermediate 2023 figure, which the ground truth did not explicitly mention but the LLM correctly identified. The source citation (MO 10-K 2024, p. 84) adds credibility. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) how the valuation allowance evolved between 2022-2024, and (2) what this indicates about Altria's expectations regarding deferred tax asset realizability. ENTITY ACCURACY: Correctly identifies Altria, Cronos investment, and deferred tax assets. REASONING QUALITY: The LLM correctly synthesizes the information to conclude that the steady increase in the allowance reflects continued uncertainty about the company's ability to realize these deferred tax assets. The interpretation that 'more likely than not' the assets won't be fully realized is the correct accounting standard interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation of the allowance's meaning ('company still believes it is more likely than not that the deferred tax assets...will not be fully realized') is semantically equivalent to the ground truth's statement about 'continued uncertainty regarding the realizability' and 'did not expect the temporary difference to reverse in the foreseeable future.' The only minor difference is that the LLM provides the intermediate 2023 figure ($397 million) which adds value beyond the ground truth's 2022-2024 comparison, demonstrating more thorough research. No calculation errors detected. The answer is well-structured, properly sourced, and conveys the appropriate level of caution about tax asset realization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 491,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023 Amgen switched its BeiGene stake from the equity‑method to a fair‑value basis, so the change in fair value was recorded as a gain in earnings and drove the rise in other income (net) for that year 【page_78】. By 2024 the fair‑value of the investment had declined, producing a net unrealized loss on strategic equity investments—including BeiGene—that offset the prior‑year gains and lowered other income (net) 【page_77】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amgen's BeiGene investment evolution. Key strengths: (1) Correctly identifies the 2023 accounting method change from equity method to fair value basis; (2) Accurately describes the 2023 outcome as gains recognized in earnings/other income; (3) Properly characterizes the 2024 reversal as net unrealized losses on the investment; (4) Correctly synthesizes the multi-hop reasoning showing the temporal evolution and valuation reversal between years; (5) Appropriately cites source pages (77-78) indicating document verification. The answer uses semantically equivalent language to the ground truth ('fair-value basis' vs 'fair value', 'net unrealized loss' vs 'net unrealized losses') while maintaining factual accuracy. No quantitative errors detected - no specific dollar amounts were required for this question, and the directional changes (gains to losses) are correctly stated. The reasoning properly connects the accounting method change to the financial statement impacts across both years. Minor consideration: The answer could have been marginally more explicit about the 'market or valuation changes' driving the reversal, though this is implied in the fair-value decline statement. Overall, this is a high-quality response that correctly synthesizes information across multiple filing periods and accurately conveys the investment's financial treatment evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 408,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "In the 2023 filing Disney+ Hotstar is described simply as a direct‑to‑consumer streaming service “primarily in India” that offers general‑entertainment, family and sports programming. By the 2024 filing the brand remains Disney+ Hotstar for India and certain Southeast Asian markets, but the company now positions it as a standalone product—explicitly noting that Disney+ Hotstar is not included in any multi‑product bundles (such as Combo+) and is kept separate from the merged Disney+ offering elsewhere. This shift underscores a strategy to keep the Hotstar brand distinct and unbundled in its core regional market.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE NARRATIVE: The LLM answer fundamentally contradicts the ground truth on the key strategic shift. Ground truth states that by 2024, Disney merged Star+ and Disney+ in Latin America into a single Disney+ product, representing consolidation under the Disney+ brand umbrella. The LLM answer instead claims the opposite—that Disney+ Hotstar is being kept 'distinct and unbundled' and 'not included in any multi-product bundles.' This is a major factual error that inverts the actual strategic direction. CORRECT ELEMENTS: (1) 2023 positioning as DTC service in India with general entertainment/family/sports content is accurate; (2) Brand remains Disney+ Hotstar in India and Southeast Asia is correct; (3) Dates (2023, 2024, June 2024) are accurate. MISSING/INCORRECT ELEMENTS: (1) The LLM completely omits the Latin America consolidation of Star+ and Disney+ into a single Disney+ offering—this is the central strategic shift mentioned in ground truth; (2) The LLM mischaracterizes the strategy as maintaining separation/distinctness when the actual strategy was consolidation and merger; (3) The mention of 'Combo+' bundles appears to be fabricated or misapplied—ground truth makes no reference to this; (4) The LLM's interpretation of 'unbundled' positioning contradicts the ground truth's emphasis on consolidation. MULTI-HOP REASONING: The LLM failed to synthesize the multi-regional evolution correctly. It focused narrowly on India/Southeast Asia positioning while missing the critical Latin America consolidation that represents the broader strategic shift. SEMANTIC EQUIVALENCE: The LLM answer conveys the opposite meaning from ground truth regarding strategic direction—consolidation vs. separation. This is not a wording difference but a fundamental factual contradiction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 489,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "In the 2023 filing PayPal described its merchant‑ and consumer‑protection programs simply as “programs … intended to protect … from loss primarily due to fraud and counter‑party performance,” noting that the associated costs are estimated and recorded as transaction‑ and credit‑losses when the payment is completed (​page 77​). By the 2024 filing the company emphasizes that those programs now generate “substantial losses” from customer disputes, that recovery from merchants is often incomplete (e.g., when a merchant is unwilling or unable to pay or can prove delivery), and that external factors such as card‑issuer reimbursements, charge‑back rule changes and regulator‑driven scope expansions increase PayPal’s exposure and could even jeopardize its ability to accept payment cards (​page 24​). This reflects a shift from a routine risk‑mitigation expense to a more explicit disclosure of heightened loss exposure and limited loss‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2023 approach where costs were recorded in 'transaction and credit losses' when payment completed, matching ground truth language; (2) Accurately captures the 2024 shift toward 'substantial losses' disclosure and explicit risk acknowledgment; (3) Properly synthesizes multi-hop information about loss recovery challenges (merchant unwillingness/inability to pay, delivery proof issues); (4) Correctly identifies external risk factors: card-issuer reimbursements, chargeback rule changes, and regulatory scope expansions; (5) Appropriately characterizes the evolution as moving from 'routine risk-mitigation expense' to 'heightened loss exposure and limited loss-recovery mechanisms'; (6) Includes specific page references (77 for 2023, 24 for 2024) that ground the answer in actual filings; (7) Uses semantically equivalent language to ground truth ('substantial losses' matches, 'challenges in recovering losses' matches 'recovery from merchants is often incomplete'). MINOR CONSIDERATIONS: The answer is slightly more detailed and specific than the ground truth (e.g., mentioning 'card-issuer reimbursements' and 'delivery proof' as specific recovery barriers), but these details are consistent with and supportive of the ground truth narrative rather than contradictory. The characterization of the shift is accurate and well-articulated. No quantitative errors detected. The multi-hop reasoning correctly synthesizes 2023 vs 2024 disclosures and identifies the evolution in PayPal's risk communication strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 450,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources was actively selling solar assets – it transferred full ownership of a six‑plant solar portfolio (and other solar projects) to third‑party investors, leaving redeemable non‑controlling interests and contract‑liability balances of roughly $668 million that could require the company to return proceeds or repurchase the facilities. By the 2024 filing the company’s solar holdings have shifted to a VIE structure: eight indirect subsidiaries now own 50‑67 % of solar‑generation entities (consolidated as VIEs) and additional VIEs hold differential membership interests, resulting in consolidated solar‑related assets of about $1.7 billion and liabilities of roughly $0.5 billion, indicating that NextEra’s exposure to solar is now reflected through VIE‑related balance‑sheet obligations rather than redeemable non‑controlling interests.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a reasonable understanding of NextEra's strategic shift from direct ownership/divestiture to VIE structures, and correctly identifies the key transition between 2022 and 2024. However, there are significant quantitative discrepancies that reduce accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 divestiture activity (selling solar assets to third parties)\n- Accurately describes the shift to VIE consolidation by 2024\n- Properly characterizes the change from redeemable non-controlling interests to VIE-based structures\n- Correctly notes the eight VIEs owning solar facilities\n- Appropriately identifies the strategic move toward more complex financial structures\n\nQUANTITATIVE ISSUES:\n- Ground truth mentions \"approximately 765 MW of capacity\" for the eight consolidated VIEs; LLM provides no MW capacity figures\n- Ground truth mentions \"10% direct ownership interest in additional solar facilities\"; LLM states \"50-67% of solar-generation entities\" which appears to contradict the ground truth's 10% figure\n- LLM provides specific balance sheet figures ($1.7 billion assets, $0.5 billion liabilities, $668 million contract liabilities) that cannot be verified against the ground truth, which does not provide these specific numbers\n- The $668 million figure for redeemable non-controlling interests is introduced without ground truth confirmation\n\nMULTI-HOP REASONING:\n- The LLM successfully synthesizes information across 2022 and 2024 filings\n- Correctly traces the evolution of financial structures\n- Appropriately connects ownership changes to balance sheet implications\n- However, the ownership percentage discrepancy (50-67% vs. 10%) suggests potential misinterpretation of the VIE structure details\n\nSEMANTIC ISSUES:\n- The LLM's characterization of the shift is semantically aligned with the ground truth's intent\n- Both answers convey increased financial leverage and complexity\n- The emphasis on balance sheet obligations vs. redeemable interests is appropriate\n\nOVERALL ASSESSMENT:\nThe answer captures the strategic narrative correctly but introduces specific quantitative claims that either lack ground truth support or contradict it (particularly the ownership percentages). The lack of MW capacity figures and the unexplained balance sheet numbers reduce confidence in the quantitative accuracy, though the qualitative understanding of the structural shift is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 651,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "In 2022 Accenture held $379,989 of mutual‑fund debt securities, which were measured as Level 2 fair‑value assets (using observable inputs) in the defined‑benefit plan table (2022 p. 89). The 2023 filing (pages 81‑85) contains no line for mutual‑fund debt securities, indicating the investment was eliminated (or reduced to $0) and the Level 2 valuation is no longer applied.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS: The LLM answer contains a critical factual error regarding the 2023 value. The ground truth clearly states that in 2023, ACN's Mutual Fund Debt Securities were valued at $253,025 (not eliminated or reduced to $0 as the LLM claims). The LLM incorrectly states 'the investment was eliminated (or reduced to $0)' and that 'the 2023 filing contains no line for mutual-fund debt securities,' which directly contradicts the ground truth showing a 2023 value of $253,025. This is a fundamental misreading of the source material. CORRECT ELEMENTS: (1) The 2022 value of $379,989 is correct. (2) The Level 2 classification for 2022 is correct. (3) The description of Level 2 as using observable inputs is accurate. (4) The company identification (Accenture/ACN) is correct. INCORRECT ELEMENTS: (1) The 2023 value is completely wrong - should be $253,025, not $0 or eliminated. (2) The claim that 2023 filing contains 'no line' for mutual-fund debt securities is false. (3) The conclusion about elimination is incorrect. MULTI-HOP REASONING: The LLM failed to properly synthesize the 2022-to-2023 comparison. The question asks about evolution and change in valuation methodology - the correct answer shows a decrease from $379,989 to $253,025 while maintaining Level 2 classification. The LLM's answer suggests complete elimination, which is factually incorrect. The quantitative error is severe (missing the actual 2023 figure entirely), and the qualitative reasoning about what happened to the investment is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 422,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron’s 50 % equity interest in Tengizchevroil remained unchanged, but the carrying amount of the investment rose modestly from $26.5 billion at year‑end 2022 to $27.0 billion at year‑end 2023 (page 82). During the same period its share of TCO’s earnings fell from $4.4 billion in 2022 to $3.4 billion in 2023 (page 82), while the loan to TCO that funds the FGP/WPMP project stayed at the same $4.5 billion level (page 78).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) CARRYING VALUE ERROR: Ground truth states 2022 carrying value was $23,727 million ($23.7 billion), but LLM claims $26.5 billion - a $2.8 billion overstatement. For 2023, ground truth indicates approximately $23,807 million (23.7B + 80M), but LLM claims $27.0 billion - a $3.2 billion overstatement. (2) EARNINGS ERROR: Ground truth states 2022 equity in earnings was $1,238 million, but LLM claims $4.4 billion - a 255% overstatement. The 2023 figure of $3.4 billion in the LLM answer also appears inconsistent with ground truth data. (3) LOAN AMOUNT: The $4.5 billion loan figure is correct and matches ground truth. (4) EQUITY INTEREST: The 50% equity interest statement is reasonable but not explicitly verified against ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and metrics, the fundamental numerical errors undermine the entire analysis. The LLM correctly identifies the FGP/WPMP project context but fails on the core financial metrics that are central to answering how Chevron's financial stake evolved. The ground truth emphasizes a more complex valuation approach in 2023 with the $80 million premium disclosure, which the LLM completely misses. The answer demonstrates poor data accuracy despite reasonable structural organization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 393,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "In the 2023 Form 10‑K Disney presented ABC simply as a component of its Entertainment segment’s linear‑network portfolio – a domestic broadcast outlet with eight owned stations and a large affiliate base (see page 78). By the 2024 filing, ABC is framed as a strategic hub that not only airs Disney’s primetime, daytime, news and unscripted shows but also carries ESPN’s sports daypart (“ESPN on ABC”) and generates fee‑based cross‑segment revenue for Hulu Live and Disney+ (see page 5), reflecting tighter integration of the broadcast network with Disney’s sports and direct‑to‑consumer businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of ABC Network's strategic positioning between 2023 and 2024, with several strengths and some notable gaps:\n\nSTRENGTHS:\n1. Correctly identifies ABC's 2023 positioning within the Linear Networks segment with eight owned stations\n2. Accurately notes the shift toward direct-to-consumer integration by 2024\n3. Correctly mentions Hulu and Disney+ as key platforms for ABC content distribution\n4. Appropriately identifies the strategic move away from traditional linear distribution\n5. Mentions ESPN on ABC integration, which represents a valid cross-segment strategic development\n6. References fee-based revenue models for streaming services\n\nWEAKNESSES/GAPS:\n1. The LLM answer introduces 'ESPN on ABC' and cross-segment revenue generation, which while potentially accurate, is NOT explicitly mentioned in the ground truth answer. This represents potential over-specification or introduction of information not in the knowledge graph baseline.\n2. The ground truth specifically mentions 'one day after linear airing' for Hulu SVOD availability - the LLM answer does not include this specific timing detail\n3. The ground truth explicitly notes the shift from 'affiliate fees in 2023' to 'streaming services contribution in 2024' - the LLM answer mentions fee-based revenue but doesn't clearly articulate this specific transition\n4. Page references (page 78, page 5) are provided by LLM but cannot be verified against ground truth\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across 2023 and 2024 filings and identifies the strategic evolution. However, it adds dimensions (ESPN integration, cross-segment revenue) that may exceed what the ground truth knowledge graph explicitly supports.\n\nNUMERIC ACCURACY:\nThe eight owned stations figure is correct and matches ground truth. No calculations are required for this question.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns: ABC evolved from standalone linear network to integrated streaming-focused platform. However, the LLM's emphasis on ESPN integration and cross-segment revenue generation represents a different framing than the ground truth's focus on Hulu/Disney+ integration and the shift away from linear revenue models.\n\nThe answer is substantially correct on the main evolution narrative but introduces additional strategic elements not explicitly confirmed in the ground truth, and omits the specific 'one day after airing' timing detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 659,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "In the 2022 filing the ASCOD is presented simply as “a highly versatile tracked combat vehicle…with multiple versions, including the Spanish Pizarro and the Austrian Ulan” under European Land Systems, with no specific growth emphasis (GD 2022 10‑K p. 10). By the 2023 filing the ASCOD is still listed in the ELS product line, but the narrative now highlights a larger shift toward higher‑volume programs—LAV output rose from 360 to 399 units (2022 p. 10 → 2023 p. 11)—and new investments in robotic and autonomous platforms, indicating that General Dynamics is keeping the ASCOD in its portfolio while directing production and capital toward faster‑growing platforms and next‑generation technology rather than expanding ASCOD output (GD 2023 10‑K p. 11).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite attempting to address the question's core themes. Key issues: (1) QUANTITATIVE ERRORS: The LAV production numbers cited (360 to 399 units) cannot be verified against the ground truth and appear to be fabricated or misattributed. The answer provides specific page references (2022 p. 10, 2023 p. 11) but these citations are unverifiable and likely incorrect. (2) CORE FACTUAL DIVERGENCE: The ground truth explicitly states that in 2022 GD was 'producing and upgrading' ASCOD, while by 2023 it shifted to simply 'offering' ASCOD—a critical distinction indicating reduced investment. The LLM answer misses this key linguistic shift entirely, instead describing ASCOD as merely 'listed in the ELS product line' in both years without capturing the meaningful change in language that signals strategic reallocation. (3) INCOMPLETE SYNTHESIS: The ground truth identifies specific competing programs (Piranha 5, AJAX) that received increased focus, with explicit mention of 'continued production and international deployments.' The LLM answer mentions 'robotic and autonomous platforms' as the new investment focus but fails to identify the specific vehicle programs (Piranha 5, AJAX) that the ground truth emphasizes. (4) REASONING QUALITY: While the LLM correctly infers a shift toward higher-volume/next-generation platforms, it does so without the precise evidence from the filings that the ground truth provides. The answer relies on inferred LAV production increases rather than the documented language change about ASCOD's positioning. (5) MISSING CRITICAL DETAIL: The ground truth's key insight—that the shift from 'producing and upgrading' to merely 'offering' indicates resource reallocation—is completely absent from the LLM response. This represents a failure in multi-hop synthesis of the actual filing language changes. The answer demonstrates partial understanding of the strategic shift but lacks the documentary evidence and precise textual analysis that grounds the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 559,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal’s internal funding pool from European customer balances fell sharply – the amount it had approved to use for credit activities dropped from $3.0 billion (about 39 % of the European balances) at 12/31/2023 to $2.0 billion (about 26 % of the balances) at 12/31/2024【page_71】【page_46】. This reduction signals that the company is scaling back its reliance on customer‑deposit funds for credit extensions and is likely turning to external financing or a more conservative liquidity stance for its credit‑funding needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All primary quantitative data is accurate - the $3.0B (39%) in 2023 and $2.0B (26%) in 2024 figures are correct, with proper percentage calculations verified. (2) The core multi-hop synthesis is sound - the LLM correctly identified the shift from 2023 to 2024 and linked it to PayPal's strategic pivot. (3) Entity identification is correct (PayPal, European customer balances, credit activities). (4) The reasoning about reduced reliance on customer deposits and shift toward external financing is logically sound. (5) Dates are properly identified (12/31/2023 and 12/31/2024). WEAKNESSES: (1) SIGNIFICANT OMISSION - The LLM answer completely fails to mention the critical evidence supporting the strategic shift: the multi-year agreement to sell consumer installment receivables, with $20.8B in loans sold in 2024 vs $5.5B in 2023. This is a major piece of the ground truth answer that demonstrates the 'what this shift indicates' part of the question. (2) The LLM's conclusion about 'more conservative liquidity stance' is somewhat speculative and less precise than the ground truth's specific reference to external financing sources evidenced by the receivables sales program. (3) While the LLM correctly identifies the strategic shift, it doesn't provide the concrete supporting evidence that validates this interpretation. The answer is approximately 70% complete - it captures the quantitative evolution accurately but misses the qualitative evidence that explains the 'what does this shift indicate' portion of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 428,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "In the 2022 filing, NEE’s Special Use Funds listed equity securities only at Level 1 (direct market‑price holdings) and Level 2 (commingled‑fund holdings) – $2.538 bn + $2.973 bn = $5.511 bn in total – indicating that the equity portion was fully observable. By the 2024 filing the same line shows $2.349 bn at Level 1, $2.742 bn at Level 2 and a new $0.199 bn at Level 3, with the total equity balance slipping to about $5.29 bn, signaling that a slice of the fund now relies on unobservable inputs and that the composition has shifted toward less‑transparent, potentially less‑liquid equity holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - LLM claims 2022 figures: $2.538bn (Level 1) + $2.973bn (Level 2) = $5.511bn total\n   - Ground truth shows 2022: $906M for NEE and $672M for FPL (approximately $1.578bn combined), NOT $5.511bn\n   - LLM claims 2024 figures: $2.349bn (Level 1) + $2.742bn (Level 2) + $0.199bn (Level 3) = $5.29bn\n   - Ground truth shows 2024: $2.614bn (Level 1) for NEE and $1.028bn (Level 1) for FPL = $3.642bn in Level 1 alone, plus additional Level 2/3 data not fully specified but clearly different from LLM's numbers\n   - The LLM's 2022 total ($5.511bn) is approximately 3.5x larger than the ground truth ($1.578bn)\n   - The LLM's 2024 total ($5.29bn) is significantly different from the ground truth's disclosed Level 1 amounts\n\n2. ENTITY/CATEGORIZATION ACCURACY:\n   - Ground truth explicitly states 2022 had NO detailed categorization by valuation levels (no Level 1/2/3 breakdown)\n   - LLM incorrectly claims 2022 already had Level 1 and Level 2 categorization\n   - This is a fundamental misrepresentation of the evolution described in the ground truth\n\n3. DIRECTIONAL ANALYSIS - CONTRADICTORY:\n   - Ground truth: Equity securities INCREASED from ~$906M (NEE) in 2022 to $2.614bn (NEE) in 2024 - a significant growth\n   - LLM: Claims total decreased from $5.511bn to $5.29bn - a decline\n   - These are opposite directional conclusions\n\n4. TRANSPARENCY NARRATIVE - INVERTED:\n   - Ground truth: Evolution shows INCREASED transparency (from no categorization to detailed Level 1/2/3 breakdown)\n   - LLM: Concludes shift toward LESS transparency and less-liquid holdings\n   - The LLM's interpretation directly contradicts the ground truth's conclusion about transparency improvements\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the comparison between 2022 and 2024 data\n   - The LLM appears to have used incorrect source data entirely\n   - The reasoning about Level 3 indicating less transparency is backwards - the addition of Level 3 categorization actually represents MORE detailed disclosure, not less\n\n6. SEMANTIC EQUIVALENCE:\n   - The LLM's answer conveys fundamentally different information from the ground truth\n   - Not a wording difference but a factual contradiction on nearly every metric and conclusion",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 641,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "In fiscal 2022 Accenture purchased 1,964,612 shares under its publicly announced open‑market repurchase program and 97,251 shares in employee‑related transactions (e.g., payroll‑tax withholdings), and the Board increased total outstanding repurchase authority to $6.129 billion after a $3 billion addition【page_33】. The excerpts from the 2023 filing (pages 81‑85) do not provide a comparable breakdown of shares bought, indicating that the authorized authority remained at the $6.129 billion level and the public program continued to account for the bulk of repurchases, with employee‑related purchases still representing only a modest share.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fiscal 2022 share purchase numbers (1,964,612 shares under public program for $576 million aggregate price, and 97,251 shares in employee-related transactions). The mention of the Board increasing total outstanding repurchase authority to $6.129 billion is accurate. The LLM correctly notes that fiscal 2023 filing excerpts do not provide comparable breakdown of shares bought.\n\nWEAKNESSES: (1) The LLM's characterization of fiscal 2023 is problematic. The ground truth explicitly states 'there is no mention of shares purchased under the public program' in fiscal 2023, indicating a shift to zero public program activity. The LLM instead claims 'the public program continued to account for the bulk of repurchases,' which directly contradicts the ground truth and represents a significant interpretive error. (2) The LLM provides additional information about the $6.129 billion authorization that, while potentially accurate, goes beyond what the ground truth emphasizes and may represent over-interpretation of incomplete data. (3) The LLM fails to clearly articulate the key finding: that there was a shift from active public program purchases in fiscal 2022 to no public program activity in fiscal 2023, while employee-related transactions continued. This is the core insight the question seeks.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across fiscal years but makes an unsupported inference about fiscal 2023 activity. The reasoning that 'lack of comparable breakdown' means the program 'continued' is flawed—absence of data does not confirm continuation, especially when the ground truth explicitly states no mention of public program purchases.\n\nNUMERIC VERIFICATION: All fiscal 2022 numbers are correct ($576M, 1,964,612 shares, 97,251 shares, $6.129B authorization). However, the interpretation of what these numbers mean for fiscal 2023 is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 522,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "In the 2022 filing Chevron disclosed that its 50 % stake in Chevron Phillips Chemical Company LLC was treated as a joint‑venture investment – CPChem was **not consolidated** and was accounted for using the **equity method** (see page 33). The 2023 filing makes the same treatment clear: Chevron still holds a 50 % equity interest, does not consolidate CPChem, and continues to use the equity‑method approach (see page 75 Note 6), although a separate note now presents summarized 100 % CPChem financial data for reference (page 75 Note 8).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, Chevron Phillips Chemical Company LLC WAS CONSOLIDATED into Chevron's financial statements, but in 2023 it transitioned to equity method accounting and was NO LONGER CONSOLIDATED. The LLM answer reverses this evolution, claiming that in 2022 CPChem was NOT consolidated and was accounted for using the equity method, and that this same treatment continued in 2023. This is a critical misrepresentation of the key finding - the entire point of the question is to identify the CHANGE in consolidation status between the two years. The LLM correctly identifies the 50% ownership stake and the equity method treatment in 2023, but completely mischaracterizes the 2022 status. The LLM also provides page references that cannot be verified against the ground truth source material. The answer fails to capture the 'significant structural change' that is the core of the original answer - the transition FROM consolidation TO equity method accounting. This is not a minor wording difference but a substantive factual error about the nature of the financial reporting relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 346,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In the 2022 filing the Combat Systems segment’s Hydra‑70 activity was limited to a single $175‑million Army contract to produce the rockets (see 2022 p. 42). By 2023 the rockets are described as a market‑leading product in OTS’s munitions portfolio, and OTS secured awards to expand its metal‑parts capacity for Hydra‑70 rockets from 18,000 to 86,000 rounds per month (and to boost propellant capacity), signaling a major scale‑up of production (see 2023 p. 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Hydra-70 rockets' evolution in General Dynamics' Combat Systems segment from 2022 to 2023. QUANTITATIVE VERIFICATION: All numbers are correct - the $175 million contract in 2022 is accurately cited, and the production capacity expansion from 18,000 to 86,000 rounds per month is correctly stated. The answer properly identifies the timeframe (2022 to 2023) and maintains numerical precision throughout. ENTITY ACCURACY: General Dynamics, Combat Systems segment, OTS (Orbital Technologies Corporation), and Hydra-70 rockets are all correctly identified. The answer appropriately contextualizes OTS as part of Combat Systems. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, showing the evolution from a single contract award in 2022 to expanded production capacity and market positioning in 2023. The logical progression from contract receipt to capacity expansion is clear and well-reasoned. COMPLETENESS: The answer addresses both key aspects of the question: (1) contract involvement (the $175M contract in 2022, market-leading position in 2023) and (2) production capacity expansion (18,000 to 86,000 rounds per month). The mention of propellant capacity expansion adds relevant context. MINOR OBSERVATIONS: The answer includes specific page references (2022 p. 42, 2023 p. 12) which enhance credibility, though these weren't explicitly required. The phrasing 'market-leading product' accurately reflects the ground truth's 'market-leading position.' The answer could have been marginally more explicit about the 2025 target date for the capacity expansion, though this is a very minor omission that doesn't significantly impact the overall quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 489,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 Form 10‑K PayPal listed the Global Restricted Stock Unit (RSU) Award Grant Notice as Exhibit 10.07+, incorporated by reference to a Form 10‑12B/A filed on May 14 2015 and tied to the 2015 Equity Incentive Award Plan【page_124】. The 2024 Form 10‑K shows the same Exhibit 10.07+ with identical documentation status (still a Form 10‑12B/A dated May 14 2015)【page_121】, while the only change is the addition of an updated performance‑based RSU grant notice (Exhibit 10.08+, now filed 4/30/2024)【page_121】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the key evolution of PayPal's RSU documentation between 2023 and 2024. STRENGTHS: (1) All dates are correct (May 14, 2015 for the original 10-12B/A filing; April 30, 2024 for the updated performance-based notice). (2) Exhibit numbers are accurate (10.07+ for base RSU, 10.08+ for performance-based). (3) The core finding is correct: the base RSU grant notice (10.07+) remained unchanged between years, while a new performance-based variant (10.08+) was added in 2024. (4) The multi-hop synthesis is sound - correctly identifying that the 2024 filing shows continuity in the base form but introduces an updated performance-based variant. (5) Numeric/date formatting is consistent and clear. MINOR WEAKNESSES: (1) The LLM answer slightly simplifies the ground truth's nuance about the performance-based notice being 'linked to a more recent 10-Q filing on April 30, 2024' - the LLM states it was 'filed 4/30/2024' which is semantically similar but less precise about the reference type. (2) The ground truth emphasizes that the performance-based variant was 'under the amended and restated plan' while the LLM doesn't explicitly mention this distinction, though it does note the 2024 update. (3) The phrase 'only change' in the LLM answer could be interpreted as slightly understating the significance of adding an entirely new exhibit form, though the answer does acknowledge this addition. The answer correctly addresses all parts of the multi-part question regarding documentation status and associated agreements evolution. The reasoning is logically sound and the synthesis across the two filing years is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 457,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "In the 2022 filing Opdivo was already a top‑selling asset, generating about $7.5 billion in net product sales and ranking just behind Revlimid and Eliquis in the company’s portfolio【page_110】. By the 2024 filing the drug’s role had broadened dramatically: BMS added a sub‑cutaneous Opdivo Qvantig formulation, new approvals in Japan for urothelial carcinoma, FDA approval for neoadjuvant NSCLC, and combination approvals with Yervoy and chemotherapy, positioning Opdivo as a growing, multi‑indication immuno‑oncology platform central to BMS’s strategy【page_44】【page_45】【page_46】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Opdivo's 2022 revenue at approximately $7.5 billion (ground truth: $7,523 million), with appropriate format flexibility. (2) Correctly identifies Opdivo as a major portfolio contributor ranking behind Revlimid and Eliquis. (3) Appropriately addresses the evolution question by discussing both revenue performance and regulatory approvals. (4) Mentions the March 2024 FDA approval for urothelial carcinoma, which matches the ground truth. WEAKNESSES: (1) The LLM significantly overstates the scope of new approvals and formulations. The ground truth specifically mentions only ONE new FDA approval in March 2024 (urothelial carcinoma combination therapy), but the LLM claims multiple approvals including: subcutaneous Opdivo Qvantig formulation, Japan approvals for urothelial carcinoma, FDA approval for neoadjuvant NSCLC, and combination approvals with Yervoy and chemotherapy. These additional claims are not supported by the ground truth and appear to be hallucinations or conflations with other information. (2) The ground truth explicitly states Opdivo showed 'no significant revenue increase from earlier years,' but the LLM characterizes the role as having 'broadened dramatically' and describes it as a 'growing' platform, which contradicts the ground truth's assessment of revenue stagnation. (3) The LLM provides page citations (page_44, page_45, page_46, page_110) without verification that these pages actually contain the claimed information. (4) Multi-hop reasoning is partially flawed: while the LLM correctly synthesizes 2022 and 2024 data, it overstates the magnitude of change and introduces unverified regulatory approvals. The core insight about evolution is present but the specific details are largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 483,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "In 2022 Chevron’s role in CPChem was essentially that of a 50 percent equity owner – the equity‑method investment was $6.843 billion – while CPChem was moving ahead with two new projects (a world‑scale 1‑hexene unit at Old Ocean, Texas and a C3‑splitter at Cedar Bayou) slated to start up in 2023. By 2023 Chevron’s equity investment had risen to $7.765 billion and it added direct project financing – a $387 million loan (reflected in a $608 million advance balance, down from $867 million a year earlier) to fund the Golden Triangle Polymers project – showing a larger capital commitment and a shift toward targeted funding of CPChem’s growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across 2022-2023 filings. STRENGTHS: (1) All key numbers are correct: 50% ownership in 2022, $6.843 billion equity investment in 2022, $7.765 billion in 2023, $387 million loan for Golden Triangle Polymers project, and the advance balance figures ($608 million down from $867 million). (2) Project details accurately identified: 1-hexene unit at Old Ocean Texas, C3 splitter at Cedar Bayou, both with 2023 start-up targets, and Golden Triangle Polymers project with CPChem's 51% ownership. (3) Multi-hop synthesis is sound: correctly traces the evolution from equity ownership model in 2022 to direct project financing in 2023, showing the strategic shift. (4) The answer provides additional context (equity investment amounts, advance balance reconciliation) that enriches understanding without contradicting the ground truth. (5) Semantic equivalence is maintained throughout - the characterization of the shift from 'general equity ownership and project announcements' to 'direct financial support and structured investment' is accurately reflected in the LLM's description of moving from equity-method investment to 'direct project financing' and 'targeted funding.' MINOR CONSIDERATIONS: The LLM provides more granular financial detail (equity investment amounts, advance balance figures) than the ground truth, but this represents enhancement rather than error. All core facts align perfectly with the original answer. The reasoning about capital commitment increase and strategic shift is logically sound and well-supported by the numbers presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 454,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "In the 2023 Form 10‑K PayPal only described its merchant‑ and consumer‑protection programs qualitatively, noting that the costs are estimated and recorded as “transaction and credit losses” but providing no specific reserve amounts (see 2023 page 77). By the 2024 filing the company began quantifying those commitments: it disclosed an allowance for transaction losses of $86 million at year‑end 2024 (up from $64 million at year‑end 2023) and a total protection‑program balance of $342 million versus $282 million a year earlier, reflecting a larger financial reserve to cover potential losses (see 2024 page 110).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of PayPal's protection program disclosures between 2023 and 2024, with accurate characterization of the shift from qualitative to quantitative disclosures. However, there are significant quantitative discrepancies that reduce the overall score. CORRECT ELEMENTS: (1) The allowance for transaction losses figures are accurate: $64 million (2023) and $86 million (2024). (2) The characterization of 2023 disclosures as qualitative-only is correct. (3) The general narrative about increased financial commitments is sound. QUANTITATIVE ERRORS: (1) The LLM states 'total protection-program balance of $342 million versus $282 million a year earlier' but the ground truth specifies the allowance for negative customer balances separately: $256 million (2024) vs $218 million (2023). The $342M and $282M figures appear to be derived from adding transaction loss allowances to negative customer balance allowances ($86M + $256M = $342M and $64M + $218M = $282M), which is a reasonable interpretation but differs from how the ground truth presents the data. (2) The ground truth explicitly mentions the allowance for negative customer balances ($218M to $256M), which the LLM answer omits entirely, instead presenting only a combined 'total protection-program balance.' This is a material omission of specific disclosure information. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the key evolution in disclosure practices. The logic connecting increased reserves to increased risk exposure is sound. SEMANTIC ISSUES: While the LLM's approach of combining the two allowance categories into a 'total protection-program balance' is mathematically defensible, it diverges from the ground truth's presentation of separate line items, which is important for understanding the specific nature of PayPal's protection commitments. The ground truth distinguishes between transaction losses and negative customer balances, while the LLM conflates them into a single metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 553,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "In the 2022 filing McDonald’s described its franchise system mainly as a component of the overall business – “The Company franchises and operates … All restaurants are operated either by the Company or by franchisees” (p. 43) and noted that it “may share in the cost of certain restaurant improvements with its franchisees” (p. 44). By the 2024 filing the company re‑frames franchising as its defining model, stating “The Company is primarily a franchisor and believes franchising is paramount … The heavily franchised business model is designed to generate stable and predictable revenue” (p. 4) and emphasizing that “ownership of real estate, combined with the co‑investment by franchisees, enables it to achieve restaurant performance levels that are among the highest in the industry” and that it “may co‑invest with franchisees to fund improvements” (p. 5). Thus, franchising moves from a descriptive element in 2022 to a core strategic priority in 2024, with franchisee co‑investment highlighted as a deliberate growth and performance lever.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024 in McDonald's strategic framing; (2) Accurately captures the 2022 framing as neutral/structural with specific quotes about franchised arrangements and cost-sharing; (3) Precisely articulates the 2024 evolution with the key term 'paramount' and the emphasis on franchising as a core business model; (4) Correctly synthesizes the role of franchisee co-investment as a deliberate strategic lever in 2024; (5) Provides specific page references (p. 43-44 for 2022, p. 4-5 for 2024) that ground the analysis; (6) Uses direct quotes that effectively illustrate the shift from descriptive to strategic framing; (7) Multi-hop reasoning is sound - successfully connects the evolution across two years and multiple conceptual dimensions (franchising importance, co-investment role, performance outcomes). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and provides more textual evidence than the ground truth answer, but this represents added value rather than error. The characterization of the shift as 'from descriptive to strategic' aligns perfectly with the ground truth's 'from descriptive to more strategic and value-laden framing.' All factual claims are verifiable and accurate. No quantitative errors, calculation errors, or entity misidentifications detected. The answer fully addresses all parts of the multi-part question regarding strategic framing changes, franchising as core business model, and franchisee co-investment role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 442,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "In the 2022 filing Altria noted that the FDA had not granted a marketing order for Marlboro HeatSticks – the products remained subject to an ITC cease‑and‑desist ban and were not exempted from the FDA’s graphic‑warning rule. By the 2023 filing the FDA had approved PMTAs for three new tobacco‑flavored Marlboro HeatSticks (January 2023), showing that Altria is making tangible regulatory progress in getting its heated‑tobacco products authorized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2023 filings. STRENGTHS: (1) All key dates are correct - specifically January 2023 for FDA PMTA approvals, and the 2022 vs 2023 comparison timeline is accurate. (2) Numeric accuracy is perfect - correctly identifies three new tobacco-flavored varieties approved in January 2023. (3) Entity identification is correct - properly names Marlboro HeatSticks, Altria, and FDA throughout. (4) Multi-hop synthesis is sound - the answer correctly traces the regulatory evolution from 2022 (no marketing order, ITC cease-and-desist ban, graphic warning requirements) to 2023 (PMTA approvals). (5) The conclusion about 'tangible regulatory progress' appropriately reflects the significance of moving from no authorization to PMTA approvals. (6) The answer includes additional relevant context (ITC cease-and-desist ban, graphic warning rule) that enriches understanding beyond the ground truth while remaining accurate. MINOR CONSIDERATIONS: The LLM answer provides slightly more regulatory detail (mentioning the ITC cease-and-desist ban and graphic warning rule) compared to the ground truth's more general statement about 'case-by-case basis regarding graphic health warnings.' This additional specificity is factually correct and enhances rather than detracts from the answer. The semantic meaning is fully aligned with the ground truth - both convey that Altria progressed from no FDA authorization in 2022 to PMTA approvals for three varieties in January 2023, indicating meaningful regulatory progress. No calculation errors, no date discrepancies, and no entity confusion detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 463,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "In 2022 Accenture’s defined‑benefit pension plans reported a fair‑value of **$239  thousand** for mutual‑fund equity securities (page 89). By 2023 the company’s target allocation for equity securities in its non‑U.S. plans rose to **27 % of assets**, up from **21 % in 2022** (page 88), signalling a deliberate move to increase equity exposure and position the pension portfolio more aggressively toward growth‑oriented assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that make it largely incorrect. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states '$239 thousand' for 2022 mutual fund equity securities, but the ground truth shows $239,293 million (approximately $239.3 billion). This is a massive unit error - off by a factor of 1,000,000. The LLM completely misses the 2023 figure of $196,226 million and the $43,067 million decline. (2) INCOMPLETE ANSWER: The LLM fails to provide the core quantitative comparison requested - the evolution of mutual fund equity securities valuations between 2022 and 2023. Instead, it pivots to discussing target allocation percentages (27% vs 21%) for equity securities in non-U.S. plans, which is a different metric entirely and not what was asked. (3) MULTI-HOP SYNTHESIS FAILURE: The question asks specifically about 'mutual fund equity securities' valuations. The LLM conflates this with broader 'equity securities' allocation percentages, which are different concepts. The target allocation percentages may relate to overall equity positioning but do not address the specific mutual fund equity securities valuation trend. (4) ENTITY/METRIC CONFUSION: While the company (Accenture/ACN) is correctly identified, the financial metrics are confused. The LLM discusses target allocations and non-U.S. plans rather than the actual fair-value holdings of mutual fund equity securities. (5) REASONING QUALITY: The LLM's conclusion about 'deliberate move to increase equity exposure' may be reasonable in isolation, but it's based on the wrong metric and doesn't address the actual decline in mutual fund equity securities holdings shown in the ground truth. The ground truth indicates a REDUCTION ($43,067 million decline), suggesting a strategic shift AWAY from this category, which is the opposite implication of the LLM's answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 508,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "In the 2022 filing Chevron emphasized that its 36.4 % stake in Angola LNG Limited is an operating interest in the on‑shore liquefaction plant and that work was progressing to develop non‑associated gas to feed the facility. The 2023 filing shows the same 36.4 % ownership, but equity earnings from the affiliate fell (from $1.96 bn in 2022 to $1.76 bn in 2023) and new capital outlays plunged (investments/advances dropped from $1.86 bn in 2022 to $0.5 bn in 2023), indicating a shift from expansion‑focused spending to a more maintenance‑oriented operational focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific financial metrics (equity earnings and capital outlays) that are NOT present in the ground truth answer, which is problematic. The ground truth focuses on disclosure emphasis shifts and portfolio integration, while the LLM introduces specific dollar amounts ($1.96bn to $1.76bn in equity earnings, $1.86bn to $0.5bn in investments) that cannot be verified against the provided ground truth. This represents a critical issue: the LLM appears to have fabricated or hallucinated specific financial figures. The 36.4% ownership stake is correctly stated in both answers. The LLM correctly identifies the shift from expansion to maintenance focus, which aligns with the ground truth's characterization of a shift from operational development emphasis to financial stake emphasis. However, the introduction of unverified financial metrics significantly undermines credibility. The reasoning about the shift in operational focus is sound and well-supported by the financial data presented, but the source of those financial figures is questionable. The answer does address the evolution from 2022 to 2023 and discusses both operational focus and investment emphasis as requested. The semantic interpretation of the shift (expansion to maintenance) is reasonable and consistent with the ground truth's disclosure shift narrative, but the specific numbers used to support this interpretation cannot be confirmed and may be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 403,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM’s holdings of certificates of deposit/time deposits rose from **$21 million at the end of 2022 to $49 million at the end of 2023**【page_64】—an increase of **$28 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 baseline figure. Ground truth states MMM held $14 million in Certificates of Deposit/Time Deposits in 2022, but the LLM claims $21 million. This is a $7 million discrepancy (50% error on the baseline). While the 2023 figure of $49 million is correct, the incorrect 2022 starting point cascades into an incorrect change calculation. The LLM calculates a $28 million increase ($49M - $21M), but the correct increase is $35 million ($49M - $14M). The LLM also fails to provide the percentage change (approximately 250%), which was included in the ground truth answer. The question asks about evolution and magnitude of change - the LLM addresses magnitude but with wrong numbers, and omits the percentage context. The answer is contextually relevant to the question asked and addresses the right company (MMM) and time period (2022-2023), but the fundamental numerical errors make this answer substantially incorrect. The multi-hop reasoning is straightforward (comparing two years) and the LLM performed this correctly in structure, but with wrong input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 328,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "In 2021, 37,295 of McDonald’s 40,031 restaurants – about 93 % – were franchised. By year‑end 2024, the system comprised roughly 95 % franchised locations out of 43,477 restaurants. Thus, the share of franchised restaurants has risen modestly, indicating an even greater reliance on franchisees over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2021 data - 37,295 franchised out of 40,031 total = 93.2%, which rounds to 93% ✓; (2) 2024 data - approximately 95% franchised out of 43,477 total restaurants ✓; (3) The trend from 93% to 95% is correctly identified as a modest increase ✓. The answer provides additional context by including absolute restaurant counts (40,031 in 2021 and 43,477 in 2024), which enhances understanding beyond the ground truth's percentage-only approach. Multi-hop reasoning is sound: the answer correctly synthesizes the temporal comparison (2021 vs 2024) and draws the appropriate conclusion about McDonald's strategic shift toward greater franchisee reliance. Entity accuracy is perfect - McDonald's is correctly identified, years are accurate, and the franchising metric is properly defined. The semantic meaning aligns perfectly with the ground truth: both convey that McDonald's has deliberately increased its reliance on franchisees through a modest percentage increase from 93% to 95%. The only minor distinction is that the LLM provides more granular detail (absolute numbers) which is actually a strength, not a weakness. No calculation errors detected. The conclusion about 'even greater reliance on franchisees' is logically sound and matches the ground truth's characterization of this as a 'deliberate shift.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 386,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "In the 2022 Form 10‑K the “2015 Stock Compensation Plan for Non‑Employee Directors” was described as **amended and restated effective March 31 2021** and it carried **703,256 shares** available for issuance (see 2022 Exhibit 10.21 and the share‑availability table). By the 2023 Form 10‑K the same plan had been **amended and restated again, now effective October 26 2022**, and the pool of shares was **reduced to 589,927** (see 2023 Exhibit 10.22 and the 2023 share‑availability table). This shows the plan’s effective date moved later and its share‑allocation structure was tightened.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the key evolution of the 2015 Stock Compensation Plan for Non-Employee Directors between 2022 and 2023: (1) The 2022 effective date was March 31, 2021 - CORRECT; (2) The 2023 effective date was October 26, 2022 - CORRECT. The answer goes beyond the ground truth by adding valuable supporting details: (1) Share availability figures (703,256 in 2022, reduced to 589,927 in 2023) - these specific numbers cannot be verified against the ground truth but are presented with appropriate exhibit citations; (2) The observation that shares were 'reduced' or 'tightened' provides useful context about the structural change. The multi-hop reasoning is sound: the model correctly synthesized information across two fiscal years (2022 and 2023 10-Ks) and identified the progression of amendments. The answer directly addresses both parts of the question (effective date evolution AND structural evolution). The only minor consideration is that the share numbers, while plausibly cited to specific exhibits, cannot be independently verified against the provided ground truth, but they are presented with appropriate caveats and citations that suggest careful sourcing. The semantic equivalence is excellent - the answer conveys the same core information as the ground truth while providing additional substantive detail that enhances understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 392,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "In fiscal 2022 Accenture’s 16 % equity‑method stake in Duck Creek Technologies was carried at $138.9 million, with an estimated fair value of $223.2 million (page 70). By fiscal 2023 the investment had risen enough to generate a $253 million gain that was recognized in the results of operations, boosting earnings and affecting the effective‑tax‑rate and EPS adjustments (page 42). This reflects a marked increase in the investment’s valuation and a positive financial impact on Accenture’s 2023 results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - the 16% ownership stake, $138.9 million carrying amount (matches $138,902 in thousands), $223.2 million fair value (matches $223,166 in thousands), and the $253 million gain are all accurate. The format variations ($138.9M vs $138,902 in thousands) are properly handled. COMPLETENESS: The answer addresses both fiscal years (2022 and 2023) and covers the key aspects of the question: investment valuation evolution, ownership percentage, carrying amount, fair value, and financial impact. ENTITY ACCURACY: Accenture and Duck Creek Technologies are correctly identified, fiscal years are correct, and financial metrics (equity method, fair value, gain, EPS, effective tax rate) are properly used. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, showing the progression from a long-term equity stake to a realized gain event. The connection between the investment increase and the resulting $253 million gain is logically sound. SEMANTIC EQUIVALENCE: The phrase 'shift from a long-term equity stake to a more active financial realization event' in the ground truth is captured by 'marked increase in the investment's valuation and a positive financial impact' in the LLM answer - semantically equivalent. The only minor observation is that the LLM answer could have been slightly more explicit about the 'shift' or 'realization' aspect, but this is a very minor point. Page references (70, 42) add credibility and demonstrate source awareness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 441,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "In the 2022 filing Breyanzi was described only for “adult patients with certain types of relapsed or refractory **large B‑cell lymphoma** after two or more lines of systemic therapy”【page_72】. By 2024 the CAR‑T product had been cleared for several additional B‑cell cancers: FDA accelerated approval for **mantle‑cell lymphoma (MCL)** (May 2024)【page_44】, FDA accelerated approval for **follicular lymphoma (FL)** after ≥2 prior lines (May 2024)【page_45】 and a Japanese approval for **FL after one prior line in high‑risk patients** (August 2024)【page_44】, and FDA accelerated approval for **chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)** after ≥2 prior lines (March 2024)【page_45】. These new indications broaden Breyanzi’s market from a single large‑B‑cell lymphoma use to multiple lymphoma subtypes and CLL, substantially expanding its commercial potential.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that reduce its correctness despite addressing the general structure of the question. CRITICAL ERRORS: (1) The LLM claims FDA accelerated approval for mantle-cell lymphoma (MCL) in May 2024, but the ground truth makes no mention of MCL approval - this is a major factual error. (2) The LLM mentions a Japanese approval for FL after one prior line in high-risk patients in August 2024, which is not mentioned in the ground truth. These additions are not supported by the original answer. CORRECT ELEMENTS: (1) The 2022 indication for large B-cell lymphoma is correctly stated. (2) The March 2024 CLL/SLL approval with ≥2 prior lines is correct. (3) The May 2024 FL approval with ≥2 prior lines is correct. (4) The dates (March 2024, May 2024) are accurate for the correct indications. (5) The overall narrative structure about expansion from single indication to multiple indications is sound. MISSING/INCOMPLETE: The ground truth specifies exactly two new approvals in 2024 (CLL/SLL in March, FL in May), but the LLM adds two additional approvals (MCL and Japanese FL approval) that are not in the ground truth. This represents a significant deviation from the factual record. The quantitative accuracy is compromised by the inclusion of unsupported approvals. The qualitative reasoning about market expansion is sound, but the factual foundation is weakened by the erroneous additions. The answer demonstrates partial understanding but fails on strict factual accuracy, which is critical for financial/regulatory information from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 437,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "In the 2022 Form 10‑K, 3M’s disclosure on legal proceedings (see page 36) limited its ASC 450 discussion to accruing probable and reasonably estimable liabilities, with no separate treatment of insurance recoveries. By the 2023 filing, the company added a detailed ASC 450/ASC 610‑30 methodology for estimating insurance receivables—analyzing policy terms, exclusions, case law and claim characteristics (page 80)—and recorded an immaterial insurance receivable for its respirator‑mask/asbestos litigation, while also increasing the liability accrual and continuing to pursue coverage from insolvent insurers (page 82).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in 3M's approach between 2022 and 2023, accurately noting the shift from basic ASC 450 compliance discussion to explicit application of ASC 450/ASC 610-30 methodology for estimating insurance receivables. The qualitative description of the 2023 approach (analyzing policy terms, exclusions, case law, claim characteristics) aligns with the ground truth. The answer appropriately contextualizes the discussion within respirator mask/asbestos litigation and mentions the company's pursuit of coverage from insolvent insurers.\n\nCRITICAL ERRORS: The LLM answer completely omits the specific quantitative data about claimant numbers that is central to the ground truth answer. The ground truth explicitly states that individual claimants increased from approximately 4,028 in 2022 to 4,042 in 2023—a key metric demonstrating growing exposure that influenced the more detailed 2023 approach. This omission is significant because the question specifically asks about evolution \"particularly in relation to respirator mask/asbestos litigation,\" and the claimant count is the primary quantitative indicator of this evolution.\n\nMINOR ISSUES: The LLM answer references specific page numbers (36, 80, 82) which cannot be verified against the ground truth and may introduce unnecessary specificity that could be incorrect. The phrase \"recorded an immaterial insurance receivable\" adds detail not explicitly confirmed in the ground truth, though it doesn't contradict it.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting the methodological evolution (2022 vs 2023) with the litigation context and insurance recovery considerations. However, the failure to synthesize the claimant number data across years represents incomplete multi-hop analysis.\n\nQUANTITATIVE ACCURACY: Score of 4 reflects the complete absence of the 4,028 to 4,042 claimant number comparison, which is a quantifiable metric essential to answering the question fully.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 547,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In 2022 PepsiCo sold the Naked juice brand to PAI Partners but retained a 39 % non‑controlling interest in the newly formed joint‑venture (later called Tropicana Brands Group) and became the exclusive U.S. distributor for that joint‑venture’s portfolio—including Naked—through chilled direct‑store‑delivery (see 2022 Europe segment and PBNA description). By 2023 the same structure remained: PepsiCo still holds the 39 % non‑controlling stake and continues to act as the exclusive distributor for the joint‑venture’s brands, so its operational role stayed limited to distribution while its financial ownership stayed at 39 % (see 2023 PBNA and Europe segment).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) ENTITY NAME ERROR: LLM states the joint venture was 'later called Tropicana Brands Group' but ground truth clearly identifies it as 'The Beachbody Company (TBG)'. This is a critical factual error that fundamentally misidentifies the entity. (2) GEOGRAPHIC SCOPE ERROR: LLM claims PepsiCo became 'exclusive U.S. distributor' but ground truth specifies distribution was for 'small-format and foodservice customers via chilled direct-store-delivery' across 'North America and Europe' - the LLM incorrectly limits scope to U.S. only. (3) CRITICAL OMISSION ON 2023 CHANGE: The LLM's most significant error is claiming 'By 2023 the same structure remained' and that PepsiCo 'continues to act as the exclusive distributor.' This directly contradicts the ground truth which explicitly states 'By 2023, PepsiCo no longer directly distributed Naked products' and 'no further operational involvement in the distribution of Naked products.' This is the core evolution the question asks about - the shift from active distribution to purely financial stake. The LLM completely misses this key transition. (4) NUMERIC ACCURACY: The 39% noncontrolling interest percentage is correct in both answers. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution between 2022 and 2023. It correctly identifies 2022 details but fundamentally fails to capture the 2023 change, which is the entire point of the question asking about how the relationship 'evolved.' The answer suggests continuity when the ground truth shows a significant operational shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 434,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings describe ExtraBucks Rewards as a separate performance obligation. The company allocates part of the transaction price to the reward based on its relative standalone selling price, recognizes reward‑related revenue only when the rewards are redeemed, and records any unredeemed balance as a contract liability (2023 Loyalty and Other Programs pp. 131‑133; 2024 Loyalty and Other Programs pp. 125). The 2024 note repeats the same policy and continues to disclose the contract‑liability balance for ExtraBucks Rewards, indicating no material change in accounting treatment or disclosure from 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant errors in addressing the core question about evolution of accounting treatment between 2023 and 2024. CRITICAL ISSUES: (1) The LLM concludes there was 'no material change in accounting treatment or disclosure from 2023,' which directly contradicts the ground truth that describes meaningful evolution in disclosure language and approach. The ground truth explicitly states the 2024 filing included 'more refined' language, 'more structured language,' and a 'more mature and formalized approach' - these represent substantive changes in disclosure that the LLM failed to identify. (2) The LLM misses the key distinction that 2024 language became more specific about performance obligations being 'tied to customers who accumulate ExtraBucks based on historical spending levels' - this represents a refinement in how the determination of performance obligations is articulated. (3) The LLM correctly identifies the core mechanics (separate performance obligation, relative standalone selling price allocation, revenue recognition upon redemption, contract liability treatment) but fails to capture the evolution in how these are disclosed and formalized. POSITIVE ASPECTS: The page references provided (2023 pp. 131-133; 2024 pp. 125) appear reasonable and the basic accounting mechanics are correctly described. The identification of the program as a separate performance obligation is accurate. REASONING FAILURE: The LLM's multi-hop synthesis failed because it focused only on consistency of core accounting treatment while missing the question's specific focus on how disclosure and language evolved - the 'evolution' aspect is the central point of the question, not whether the fundamental treatment remained the same. The answer demonstrates a fundamental misunderstanding of what constitutes meaningful evolution in accounting disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 508,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "In the 2023 filing Netflix said that “other operations costs include customer‑service and payment‑processing fees, including those we pay to our integrated payment partners” and that cost of revenues was $19.7 billion – 58 % of streaming revenue【page_25†L31-L38】. The 2024 filing repeats the same description of payment‑processing fees to integrated partners, but cost of revenues rose to $21.0 billion (up $1.3 billion) while falling to 54 % of revenue【page_23†L31-L38】【page_23†L45-L48】. Thus Netflix still uses integrated payment partners, but the relative weight of those fees in its cost structure has slipped slightly, indicating a modest reduction in reliance on a per‑revenue basis.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and percentages. Verified numbers: 2023 cost of revenues $19.7B (58% of streaming revenue) and 2024 cost of revenues $21.0B (54% of revenue) are accurate, as is the $1.3B increase calculation. The answer correctly identifies that both years reference integrated payment partners in the cost of revenues section. The multi-hop synthesis is sound: the LLM properly compared disclosure language across years and calculated the relative weight change (58% to 54%), drawing a logical conclusion about reduced per-revenue reliance. However, the LLM answer goes slightly beyond the ground truth by introducing quantitative analysis (the percentage point decline and per-revenue basis calculation) that, while mathematically correct and insightful, represents interpretation rather than explicit ground truth statements. The ground truth emphasizes a 'shift in disclosure strategy' and 'decreased explicit detail,' while the LLM emphasizes 'modest reduction in reliance on a per-revenue basis' - these are complementary but not identical framings. The LLM answer is more analytically rigorous but slightly diverges from the ground truth's focus on disclosure changes rather than substantive operational changes. All core facts are correct, and the reasoning is sound, making this a strong answer with minor interpretive differences from the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 398,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "In the 2022 filing 3M described its work in Minnesota as largely remediation‑focused under the 2007 Settlement Agreement and Consent Order (SACO): it was evaluating PFAS releases, providing alternative drinking water only if a Health‑Based Value (HBV) or Health‑Risk Limit (HRL) was exceeded, and completing remediation at the Oakdale, Woodbury and Cottage Grove sites with only operational‑maintenance activities remaining (page 127). By the 2023 filing the company had added a storm‑water component – developing a MPCA‑approved plan in December 2022, responding to a March 2023 Notice of Violation for PFAS‑laden stormwater at its Hutchinson plant, and, in light of the Minnesota Department of Health’s new, more stringent HBVs for PFOA and PFOS (issued Jan 2024), was actively evaluating how those tighter standards affect its SACO obligations (page 98).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2023 filings. STRENGTHS: (1) All dates are correct (May 2007 SACO, December 2022 MPCA order, March 2023 NOV, January 2024 HBVs). (2) All Minnesota sites correctly identified (Cottage Grove, Oakdale, Woodbury, Hutchinson). (3) Multi-hop reasoning is sound: the answer correctly traces the evolution from 2022 remediation focus to 2023 stormwater component and regulatory tightening. (4) Key regulatory developments properly synthesized (MPCA orders, NOV, new HBVs). (5) Correctly captures the shift from health-based value thresholds to more stringent standards. MINOR OMISSIONS: (1) The LLM answer does not mention the Decatur, Alabama facility and 2020 interim Consent Order with ADEM, which the ground truth includes as part of 3M's broader PFAS management approach. While this is geographically outside Minnesota, the ground truth presents it as relevant context for understanding 3M's overall PFAS contamination management evolution. (2) The ground truth mentions that the January 2024 MPCA permit proposal included 'significantly revised, often below-quantification-level limits on PFAS' - the LLM answer references tighter standards but doesn't specify the below-quantification-level detail. (3) The ground truth notes 3M 'substantially completed' remediation at Cottage Grove in 2022, while the LLM says 'completing remediation' - a minor semantic difference suggesting ongoing vs. completed work. QUANTITATIVE ACCURACY: All dates and numeric references are correct. No calculation errors. QUALITATIVE ACCURACY: The reasoning correctly identifies the evolution from remediation-focused (2022) to stormwater-focused (2023) with regulatory tightening. The synthesis across multiple regulatory actions and health standard changes is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how 3M's approach evolved in response to regulatory changes and new health-based standards, with appropriate focus on Minnesota operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 557,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo’s foreign‑currency derivative program grew substantially – the total notional amount of forward contracts rose from **$3.0 billion at year‑end 2022 to $3.8 billion at year‑end 2023** (and the notional of debt used as net‑investment hedges increased from $2.9 billion to $3.0 billion)【page_103】.  The company notes that it manages FX exposure by sourcing locally, negotiating contracts in local currencies, and using short‑term forward contracts (≤ 2 years) plus net‑investment hedges【page_102】, so the higher notional reflects a more expansive, proactive hedging approach to offset its foreign‑exchange risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - forward contracts increased from $3.0 billion (2022) to $3.8 billion (2023), matching the ground truth exactly. The additional detail about net-investment hedges ($2.9 billion to $3.0 billion) is accurate and adds valuable context not explicitly in the ground truth but consistent with it. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the derivatives evolved (quantitative change with specific figures), and (2) what this indicates about FX risk management strategy (expansion and proactive approach). ENTITY ACCURACY: PepsiCo correctly identified, years 2022-2023 correct, financial metrics properly labeled. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical increase to strategic implications (more expansive, proactive hedging approach). The explanation of management methods (local sourcing, local currency contracts, short-term forwards ≤2 years, net-investment hedges) provides comprehensive context. SEMANTIC EQUIVALENCE: The LLM's characterization of 'substantial growth' and 'more expansive, proactive hedging approach' semantically matches the ground truth's 'strategic expansion' and 'increased exposure or volatility.' The mention of 'no material net impact on earnings in 2023' from the ground truth is not explicitly stated in the LLM answer, but this is a minor omission that doesn't affect the core answer quality. The inclusion of page references adds credibility. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate contextual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 464,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Both 2022 and 2023 filings note that rising living standards are driving faster‑than‑GDP growth in chemical demand, but the way ExxonMobil adds capacity has shifted. In 2022 the company’s primary move was a final‑investment decision for a multi‑billion‑dollar Dayawan petrochemical complex in Huizhou, Guangdong, making China the focal point for new capacity. By 2023 it broadened its approach, launching two new Gulf‑Coast units in Baytown, Texas—a 400 k t/yr performance‑polymers line and a 350 k t/yr linear‑alpha‑olefins unit—while still advancing the Dayawan project, expanding its geographic focus from China‑centric to a dual‑region (U.S. and China) capacity‑expansion strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) TIMELINE REVERSAL: The LLM claims the Dayawan complex was a 2022 focus with a final-investment decision, but ground truth shows it was a 2023 development. The LLM incorrectly characterizes 2022 as 'China-centric' when ground truth shows 2022 focused on domestic U.S. projects (Corpus Christi ethane cracker completion and Baytown advanced recycling plans). (2) QUANTITATIVE ERRORS: The LLM provides capacity figures (400 k t/yr performance polymers, 350 k t/yr linear alpha olefins) that are not mentioned in the ground truth. Ground truth specifies 500,000 metric tons annually for advanced recycling capacity by 2026 and 'over 2.5 million metric tons per year' for the Dayawan complex, but does not provide the specific 400/350 k t/yr breakdown the LLM cites. (3) MISSING KEY DETAILS: The LLM omits the Corpus Christi ethane cracker completion (a major 2022 achievement) and the specific 2026 timeline for Baytown advanced recycling capacity. (4) GEOGRAPHIC FOCUS MISCHARACTERIZATION: The LLM reverses the strategic evolution—claiming 2022 was China-centric when it was actually U.S.-domestic focused, and 2023 broadened to dual-region. Ground truth shows the opposite: 2022 was domestic-focused, 2023 shifted toward China expansion. (5) REASONING FLAW: While the LLM correctly identifies that living standards drive demand, it fundamentally misrepresents the chronological evolution of ExxonMobil's strategy. The answer demonstrates partial understanding of the dual-region strategy but fails on the critical temporal and geographic sequencing that defines the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 462,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M’s holdings of certificates of deposit/time deposits more than doubled, rising from **$21 million at year‑end 2022 to $49 million at year‑end 2023** (Note 12 – Marketable Securities). This increase shows the company is shifting a larger portion of its cash into short‑term, highly liquid, low‑risk securities, emphasizing liquidity preservation and modest return generation on excess cash.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All numbers are correct - $21 million in 2022 and $49 million in 2023 match the ground truth exactly. The characterization of 'more than doubling' is mathematically accurate (49/21 = 2.33x). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: the evolution of CD/Time Deposits holdings AND what this indicates about short-term investment strategy. (3) ENTITY ACCURACY: Company (3M), metric (Certificates of Deposit/Time Deposits), years (2022-2023), and filing reference (Note 12 – Marketable Securities) are all correct. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified the trend (doubling) and provided logical interpretation about liquidity preservation and return generation. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('shifting a larger portion of its cash into short-term, highly liquid, low-risk securities, emphasizing liquidity preservation and modest return generation') is semantically equivalent to the ground truth's 'strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments.' The LLM provides slightly more detailed reasoning about the strategic implications. Minor note: The LLM adds the specific filing reference (Note 12) which enhances credibility, though this wasn't in the ground truth. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 404,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "In the 2022 Form 10‑K Mastercard said its value‑added services “provide proprietary insights, drawing on Mastercard’s **principled use of consumer and merchant data**” (2022 10‑K, p. 71). By the 2023 filing the language had been expanded to “provide proprietary insights, drawing on our **principled and responsible use of secure consumer and merchant data**,” explicitly adding “responsible” and “secure” to stress data stewardship and build trust (2023 10‑K, p. 49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the 2022 language as 'principled use of consumer and merchant data' and the 2023 evolution to 'principled and responsible use of secure consumer and merchant data' - matching the ground truth exactly. (2) Accurately cites specific page numbers (2022 10-K p. 71 and 2023 10-K p. 49) which adds credibility and verifiability. (3) Properly synthesizes the multi-hop comparison across two years, identifying the key additions of 'responsible' and 'secure' language. (4) Correctly interprets the semantic meaning of these changes as emphasizing data stewardship and trust-building, which aligns with the ground truth's interpretation about data security and stakeholder confidence. (5) The reasoning is sound - the model correctly identifies this as an evolution in language reflecting broader corporate narrative around cybersecurity. Minor consideration: The LLM answer uses slightly different phrasing ('data stewardship' vs. the ground truth's 'data security and trust as a core component') but these are semantically equivalent interpretations of the same linguistic shift. The LLM's inclusion of specific page citations actually enhances the answer beyond the ground truth by providing verifiable sources. No numerical errors, no entity confusion, and complete address of all question components.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 386,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "In 2022 the company reported a 0.3 % positive impact from its pension and retiree‑medical estimates (see 2022 ROIC table – “Pension and retiree medical‑related impact (0.3)”), whereas the 2023 filing shows a dash (no impact) for the same line item (see 2023 ROIC table – “Pension and retiree medical‑related impact ‑”). The change reflects that the assumptions driving those estimates—discount rates, inflation expectations and other macro‑economic inputs—have been altered by a tougher external environment, namely higher interest rates, rising inflation and ongoing geopolitical uncertainty (Ukraine‑Middle‑East conflicts) that the 2023 critical‑accounting‑policies discussion highlights. This shift signals that the external conditions affecting pension and retiree‑medical plans have become more volatile and less favorable, neutralizing the prior modest benefit.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core qualitative evolution correctly—shifting from COVID-19 pandemic concerns in 2022 to geopolitical and macroeconomic uncertainties (Ukraine-Middle East conflicts, high interest rates, inflation) in 2023. The reasoning about external environment changes is sound and well-articulated. However, there are significant quantitative accuracy issues: (1) The LLM cites a '0.3% positive impact' from 2022 pension estimates, but the ground truth does not mention this specific metric or percentage. The LLM appears to be referencing ROIC table data that may not directly relate to the accounting estimates question. (2) The LLM's interpretation of the ROIC table line items ('Pension and retiree medical-related impact (0.3)' vs dash in 2023) introduces quantitative claims not present in the ground truth answer. (3) The ground truth focuses on what influenced the accounting estimates themselves (COVID-19 vs geopolitical/macro factors), while the LLM shifts focus to ROIC impacts and changes in those impacts, which is a different analytical lens. The LLM does correctly identify the key external factors (Ukraine-Middle East conflicts, higher interest rates, inflation) that the ground truth mentions. The multi-hop synthesis is partially successful—the LLM connects 2022 vs 2023 data and identifies the shift in external environment—but it introduces unsupported quantitative details that weaken the answer. The answer would be stronger if it stuck to the qualitative evolution of influencing factors without the specific ROIC percentage claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 432,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil’s undeveloped land in the “Other Americas” fell modestly – from 25,096 gross and 11,977 net thousand acres in 2022 to 24,221 gross and 11,548 net thousand acres in 2023 (a drop of roughly 875 gross and 429 net thousand acres)【page_24】.  The slight reduction suggests the company has relinquished or begun developing a small portion of its holdings, yet it still retains a very large undeveloped base, underscoring continued exploration upside in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 2022 figures (25,096 gross, 11,977 net thousand acres) and 2023 figures (24,221 gross, 11,548 net thousand acres) match the ground truth exactly. The calculated differences are also accurate: 875 thousand acres gross (25,096 - 24,221 = 875) and 429 thousand acres net (11,977 - 11,548 = 429). (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes how the acreage evolved (with specific numbers and year-over-year comparison) and interprets what this indicates about exploration potential. (3) ENTITY ACCURACY: Company (ExxonMobil), region (Other Americas), years (2022-2023), and metrics (gross/net undeveloped acreage in thousands of acres) are all correctly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical decline to business implications (relinquishment or development of properties) and appropriately characterizes the significance (modest reduction, continued large base, exploration upside). The interpretation aligns with the ground truth's assessment that this indicates focus on higher-potential properties. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('fell modestly,' 'slight reduction,' 'retains a very large undeveloped base') conveys the same meaning as the ground truth ('decreased,' 'reduction in total acreage,' 'continues to focus on properties with higher exploration potential'). Minor note: The LLM includes a citation reference [page_24] which adds credibility but is not present in the ground truth - this is a minor enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 464,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "The company still relied on foreign‑exchange forwards and options that are **not** designated as cash‑flow or fair‑value hedges to offset the value changes of non‑functional‑currency items, so the fair‑value gains or losses on those contracts continue to be recorded directly in earnings (see 2022 discussion of “foreign currency contracts not designated in hedging relationships” on page 45 and the 2023 “Derivatives Not Designated as Hedging Instruments” tables on pages 76‑78).  However, the scale and impact of those contracts shrank markedly: the gross notional amount fell from about **$2.8 billion at year‑end 2022** to roughly **$1.0 billion at year‑end 2023**, and the earnings impact improved from a **pretax loss of $76 million (a $45 million net loss recognized in income) in 2022** to only a **$9 million loss (or a $21 million gain in income) in 2023** (page 76).  Likewise, the OCI gain on cash‑flow hedges for foreign‑currency forwards/options dropped from **$159 million in 2022** to **$81 million in 2023** (page 75).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) GROSS NOTIONAL AMOUNT MISMATCH: Ground truth states $3.7 billion in 2022, but LLM claims $2.8 billion in 2022 and $1.0 billion in 2023. This is a major quantitative error - the LLM's 2022 figure is off by $900 million (24% understatement). (2) FINANCIAL IMPACT ERRORS: The LLM provides specific earnings impact figures ($76 million pretax loss, $45 million net loss in 2022; $9 million loss/$21 million gain in 2023) that are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these specific earnings impact numbers. (3) OCI GAINS CLAIM: The LLM introduces OCI (Other Comprehensive Income) gains of $159 million (2022) and $81 million (2023) for cash-flow hedges, which are not mentioned in the ground truth and appear to be unsupported. (4) CONCEPTUAL ACCURACY: The LLM correctly identifies that the company used foreign exchange contracts not designated as hedges, and that fair value gains/losses impact earnings directly. However, the claim about a 'marked' shrinkage in scale is contradicted by the ground truth's $3.7 billion figure. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and document sections, the synthesis is built on incorrect numerical foundations. The reasoning structure is sound, but the data inputs are wrong. (6) PAGE REFERENCES: The LLM cites specific pages (45, 76-78, 75) which adds apparent credibility but the numbers cited do not align with ground truth, suggesting either hallucination or misreading of source documents. The answer demonstrates partial understanding of the topic but fails on the primary metric of factual accuracy for quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 492,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "In the 2022 10‑K, cyber and intelligence solutions were mentioned only as one item in a catch‑all “other value‑added services” category (“…other value‑added services comprised of … cyber and intelligence solutions…” – page 81). By the 2023 filing, Mastercard highlights them in its Business Overview and lists “Cyber and intelligence solutions fees” as a separate revenue line, stressing fraud‑prevention, transaction safety and secure data‑driven insights (“…cyber and intelligence solutions designed to allow all parties to transact securely, easily and with confidence…” – page 49; “Cyber and intelligence solutions fees are for products and services … to prevent, detect and respond to fraud…” – page 80). This reflects a shift from a peripheral offering in 2022 to a prominently featured, strategic component of Mastercard’s value proposition in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Cyber and Intelligence Solutions as part of a broader 'other value-added services' category, accurately capturing the supporting/peripheral role. (2) Accurately describes the 2023 evolution showing more prominent positioning with explicit mention in Business Overview and as a separate revenue line. (3) Provides specific, relevant quotes from both 2022 (page 81) and 2023 (pages 49 and 80) filings that substantiate the claims. (4) Correctly synthesizes the multi-hop comparison across two years, identifying the strategic shift from peripheral to core component. (5) Uses appropriate terminology ('catch-all category,' 'peripheral offering,' 'strategically featured') that accurately reflects the evolution. (6) No quantitative errors - all page references and year citations are appropriate. MINOR CONSIDERATIONS: The answer is slightly more detailed than the ground truth (includes specific page numbers and additional context about fraud prevention), but this adds value rather than detracting. The semantic meaning is fully preserved and enhanced. The multi-hop reasoning correctly connects 2022 positioning → 2023 positioning → strategic shift conclusion. All entities (Mastercard, years 2022-2023, Cyber and Intelligence Solutions) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 398,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "In the 2022 filing the company’s critical‑accounting‑policy section actually spells out the tax policy – it explains that the annual tax rate is based on statutory rates, transfer‑pricing and other factors, that significant judgment is required, and that reserves (and related interest) are set up and adjusted for positions that may be challenged (PEP 2022 p. 61). In the 2023 filing the same “Income Tax Expense and Accruals” item is still listed among the critical accounting policies (PEP 2023 p. 33) but only the heading is shown, with the detailed narrative apparently moved to the dedicated Income Taxes note (Note 5, p. 84), indicating the policy remains unchanged in substance but the disclosure has been streamlined.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Income Tax Expense and Accruals disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies that the policy was explicitly listed in both years; (2) Accurately captures the key shift: from detailed narrative explanation in 2022 to a streamlined heading-only approach in 2023 with details moved to Note 5; (3) Provides specific page references (2022 p. 61, 2023 p. 33, Note 5 p. 84) that add credibility; (4) Correctly notes the substance remained unchanged while disclosure structure evolved; (5) Includes relevant details about the 2022 content (statutory rates, transfer pricing, judgment requirements, reserves/interest adjustments); (6) Accurately characterizes the 2023 change as 'streamlined' disclosure. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth, providing actual policy content rather than just describing the structural change; (2) The ground truth emphasizes 'more structured presentation' and 'deeper transparency,' while the LLM characterizes it as 'streamlined' - these are subtly different framings, though both are defensible interpretations of moving detailed content to a dedicated note; (3) The LLM's characterization of the change as 'streamlined' could be seen as slightly different from the ground truth's emphasis on 'more detailed and organized reporting,' though both accurately describe the shift from inline narrative to dedicated note structure. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023 filings and identifies the relationship between the critical accounting policies section and Note 5. QUANTITATIVE ACCURACY: Page numbers and references appear reasonable for typical 10-K filings, though cannot be independently verified from the question context. No calculations required. Overall, the LLM answer provides a more granular and substantive response than the ground truth while remaining factually consistent with the core finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 547,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "In the 2023 filing Intel said it was actively “driving … standards … including the Universal Chiplet Interconnect Express* standard … which was demonstrated in silicon in 2023” as a pillar of its systems‑of‑chips strategy【page_37】. By the 2024 filing the company repeats that message, now embedding UCIe in the description of its advanced packaging and foundry roadmap (Intel 18A, 3, 7, etc.) and stressing that it continues to “drive … the Universal Chiplet Interconnect Express* standard … which we demonstrated in silicon in 2023” as a core component of its broader systems‑of‑chips capabilities【page_22】. This shows the standard moving from a 2023 proof‑of‑concept demonstration to a highlighted, integrated element of Intel’s commercial packaging and foundry offerings in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about UCIe's evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 demonstration phase and 2024 production/integration phase, matching the ground truth's core narrative; (2) Accurately cites specific page references (page_37 for 2023, page_22 for 2024) showing proper source documentation; (3) Properly synthesizes the progression from 'proof-of-concept demonstration' to 'integrated element of commercial offerings,' which aligns with ground truth's 'demonstration phase' to 'actively producing' evolution; (4) Correctly identifies UCIe as a pillar/core component of systems-of-chips strategy in both years; (5) Accurately captures the contextual shift from standalone standard discussion to integration within advanced packaging/foundry roadmap. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing ('proof-of-concept' vs ground truth's 'initial phase') but these are semantically equivalent; (2) Ground truth emphasizes 'advanced semiconductor assembly and test offerings' while LLM emphasizes 'advanced packaging and foundry offerings' - these are closely related but not identical descriptions, though both capture the commercial integration aspect; (3) LLM provides more specific textual evidence from filings with direct quotes, which adds credibility beyond the ground truth's summary. QUANTITATIVE ACCURACY: All dates (2023, 2024) and temporal references are correct. No calculations required. MULTI-HOP REASONING: Successfully synthesizes information across two years of filings and correctly identifies the progression in Intel's strategic positioning. The answer properly connects UCIe development to the broader systems-of-chips strategy in both periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 490,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "In the 2023 10‑K the $3.0 billion Morgan Stanley ASR was described only as a partial delivery (85 % of the shares received in January 2024) with the remaining 15 % “may be received” and no explicit split‑accounting was given; the $2.0 billion Citibank and $1.5 billion Barclays ASRs were each recorded as an initial treasury‑stock purchase plus a forward contract recorded in capital surplus, with the forward contract re‑classified to treasury stock when the final shares were delivered (February 2023 and February 2022). The 2024 10‑K updates the Morgan Stanley ASR to show it was initially booked as $2.6 billion of treasury stock and a $0.4 billion forward contract (equity instrument in capital surplus) and confirms that the remaining 8.3 million shares were received in March 2024, at which point the forward contract was re‑classified to treasury stock, completing the transaction. The accounting and completion timing for the Citibank and Barclays ASRs remain unchanged from the prior filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - LLM claims the 2023 10-K described a $3.0 billion Morgan Stanley ASR, but ground truth shows Morgan Stanley ASR was completed in 2024, not 2023\n   - LLM mentions a $1.5 billion Barclays ASR with no mention in ground truth\n   - LLM states Morgan Stanley received 85% of shares in January 2024 (partial delivery), but ground truth shows 85% received initially with remaining 8.3 million in March 2024\n   - LLM claims $2.6 billion treasury stock and $0.4 billion forward contract split for Morgan Stanley, but ground truth shows $3.0 billion total ASR\n   - LLM references February 2022 completion for Barclays, which is not in ground truth\n\n2. ENTITY AND TIMELINE CONFUSION:\n   - Ground truth clearly states: 2023 had $2.0B Citibank ASR (completed in Feb 2023) and 2024 had $3.0B Morgan Stanley ASR (completed in March 2024)\n   - LLM incorrectly places Morgan Stanley ASR in 2023 10-K filing\n   - LLM introduces Barclays ASR with no ground truth support\n\n3. SHARE COUNT ERRORS:\n   - Ground truth: 2023 Citibank received 17.4M shares initially + 5.4M final = 22.8M total\n   - Ground truth: 2024 Morgan Stanley received 31.4M shares initially + 8.3M final = 39.7M total\n   - LLM does not provide clear share counts and conflates different transactions\n\n4. ACCOUNTING TREATMENT:\n   - While LLM correctly describes the general accounting pattern (treasury stock + forward contract reclassification), it applies this to wrong transactions and years\n   - The core accounting principle is correct but applied to incorrect ASR transactions\n\n5. MULTI-HOP REASONING:\n   - Failed to correctly synthesize information across 2023 and 2024 filings\n   - Confused which ASRs appeared in which year's filing\n   - Did not properly track the evolution of accounting treatment for the same transaction across filings\n\nThe answer demonstrates fundamental misunderstanding of the filing structure and transaction timeline, making it largely unreliable despite some correct accounting concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 573,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "In the 2022 Form 10‑K UPS disclosed a **$5.1 billion pre‑tax actuarial gain** for “coordinating benefits attributable to the Central States Pension Fund,” showing that its best‑estimate liability for the CSPF had been reduced. In the 2023 filing the company no longer reported a separate gain/loss; instead it folded the CSPF exposure into a **quantitative sensitivity analysis** – a 25‑basis‑point change in the discount rate would swing the projected benefit obligation by about **‑$1.55 billion** (rate increase) or **+$1.64 billion** (rate decrease) – and it directs readers to Note 5 for the detailed potential coordinating‑benefits liability, reflecting a shift to scenario‑based reporting of the pension‑fund exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains critical inaccuracies that fundamentally contradict the ground truth. (1) SIGN ERROR ON 2022 FIGURE: The ground truth states UPS disclosed a '$2.3 billion pre-tax actuarial LOSS' in 2022, but the LLM claims a '$5.1 billion pre-tax actuarial GAIN' - this is both wrong in magnitude ($5.1B vs $2.3B) and opposite in sign (gain vs loss). This is a fundamental error that misrepresents UPS's financial position. (2) MISSING 2022 SENSITIVITY ANALYSIS: The ground truth indicates the 2022 disclosure focused on 'quantifying a specific obligation' (the $2.3B loss), while the LLM introduces discount rate sensitivity analysis ($1.55B/$1.64B swings) as part of 2023 reporting. The LLM does not clearly distinguish that the sensitivity analysis is a 2023 development, not a 2022 feature. (3) INCOMPLETE CHARACTERIZATION: The ground truth emphasizes a 'shift from quantifying a specific obligation to emphasizing sensitivity of returns on overall liability,' but the LLM conflates this by discussing both the gain/loss AND sensitivity analysis without clearly separating the 2022 vs 2023 approaches. (4) CORRECT ELEMENTS: The LLM correctly identifies (a) the shift from separate gain/loss reporting to sensitivity analysis between years, (b) the 25 basis point assumption, (c) the reference to Note 5, and (d) the general concept of scenario-based reporting. However, these correct elements are overshadowed by the magnitude and sign errors on the 2022 figure. The multi-hop reasoning about the evolution is partially sound in structure but fails on the foundational numbers that anchor the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 448,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "In the 2022 filing, Mastercard presented its Cyber & Intelligence solutions as a component of its value‑added services that “allow all parties to transact easily and with confidence,” and even cited them as a primary driver of revenue growth. By the 2023 filing, the messaging was sharpened to say the solutions are “designed to allow all parties to transact securely, easily and with confidence,” adding an explicit focus on security and the principled, responsible use of consumer and merchant data—signaling a stronger, security‑centric value proposition to stakeholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces problematic claims not supported by the ground truth. CORRECT ELEMENTS: (1) The 2022 quote about 'allow all parties to transact easily and with confidence' is accurate; (2) The 2023 messaging shift toward security emphasis ('transact securely, easily and with confidence') aligns with ground truth; (3) The mention of principled/responsible use of data is correct; (4) The overall narrative of evolution between years is sound. PROBLEMATIC ELEMENTS: (1) The LLM claims Cyber & Intelligence solutions were 'cited as a primary driver of revenue growth' in 2022 - this specific claim is NOT present in the ground truth and appears to be an unsupported assertion; (2) The ground truth emphasizes linking solutions to 'strategic investments in new networks like open banking and digital identity' in 2023, which the LLM answer completely omits - this is a significant gap in capturing the full scope of the evolution; (3) The ground truth describes solutions as 'central to enabling secure transactions and confidence in the payments ecosystem' with broader infrastructure integration, but the LLM focuses narrowly on the security-centric messaging without capturing this broader strategic positioning. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings and identifies the evolution in messaging, but fails to capture the full strategic context (open banking, digital identity linkages) that distinguishes the 2023 positioning. The answer is partially correct but incomplete in scope and contains at least one unsupported claim about revenue drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 451,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo listed the 4.450 % Senior Note that matures in 2046 as a stand‑alone exhibit (Exhibit 4.11) and also in the exhibit table as Exhibit 4.13, both “incorporated by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed on October 14 2015 (the table cites a February 24 2016 filing). By the 2023 Form 10‑K the 4.450 % ‑ 2046 note no longer appears as a separate exhibit; the 4.450 % series is shown only for newer maturities (2028 and 2033) and each is referenced to Exhibit 4.3/4.4 to a Current Report on Form 8‑K filed on February 15 2023. Thus the older 2046 note and its 2015/2016 documentation were removed and replaced with updated exhibit references and more recent filing dates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBERING ERROR: Ground truth states the 2022 filing showed Exhibit 4.12, but LLM claims it was listed as both Exhibit 4.11 and 4.13 - this is incorrect. (2) FORM 8-K DATE DISCREPANCY: Ground truth clearly states 2022 filing referenced October 14, 2015 Form 8-K, while 2023 referenced February 24, 2016. The LLM conflates these dates and incorrectly suggests the 2022 filing cited both dates ('the table cites a February 24 2016 filing'). (3) FUNDAMENTAL MISUNDERSTANDING: The LLM claims the 2046 note 'no longer appears as a separate exhibit' in 2023 and was 'removed and replaced with updated exhibit references,' but the ground truth indicates the same note was simply reclassified from Exhibit 4.12 to 4.13 with a different Form 8-K reference. The note itself was not removed. (4) INCORRECT SCOPE: The LLM introduces information about 2028 and 2033 maturities and a February 15, 2023 Form 8-K filing that are not mentioned in the ground truth and appear to be fabricated or confused with other disclosures. (5) MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the evolution between 2022 and 2023 filings - it should show a simple reclassification (4.12→4.13) with a Form 8-K date change (Oct 14, 2015→Feb 24, 2016), not a removal and replacement scenario. The core narrative is fundamentally incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 398,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel’s approach to Positive Technologies has not changed. In its 2023 filing Intel noted that after the firm was placed on the U.S. sanctions list, it “resumed such communications based on a license issued by OFAC” and that it “plans to continue these communications in accordance with the terms and conditions of the OFAC license” with no gross revenues or net profits 【page_71】. The 2024 filing repeats the same disclosure, stating that Intel “resumed such communications based on a license issued by OFAC” and again “plans to continue these communications in accordance with the terms and conditions of the OFAC license” with no revenue impact 【page_54】. Thus, between 2023 and 2024 Intel’s relationship with Positive Technologies remained consistent—ongoing, license‑authorized communications with no financial gain.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the central question about how the relationship 'evolved.' The ground truth explicitly states that Intel's relationship 'evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions' - indicating a meaningful change between 2023 and 2024. However, the LLM answer claims 'Intel's approach to Positive Technologies has not changed' and that the relationship 'remained consistent.' This is a direct contradiction of the ground truth's core finding. The LLM mischaracterizes the evolution as 'no change' when the ground truth identifies a shift from retrospective disclosure (2023) to forward-looking intent (2024). QUANTITATIVE ACCURACY: The LLM correctly identifies that both years show no gross revenues or net profits, and accurately cites the OFAC license language. Page citations appear reasonable. QUALITATIVE ACCURACY: The LLM fails to recognize the semantic distinction between (1) disclosing that communications 'resumed' under OFAC license (2023 framing) versus (2) stating intent to 'continue' such communications (2024 framing). This distinction is the essence of the 'evolution' the question asks about. The LLM treats these as identical statements when they represent different postures - one retrospective, one prospective. MULTI-HOP REASONING: The LLM does not synthesize the year-over-year comparison correctly. It identifies the same language in both years but fails to recognize that the framing evolved from past action (resumed) to future commitment (plans to continue). CONTEXTUAL RELEVANCE: The answer addresses the OFAC licensing and financial impact correctly but misses the primary analytical point about relationship evolution that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 500,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The table of borrowings shows that CVS carried $5 billion of its 4.78 % senior notes due March 2038 at both December 31 2023 and December 31 2024 (page 161), the same amount reported for 2023 in the prior filing (page 168). This unchanged balance indicates that the company has left this tranche of fixed‑rate senior debt untouched, making it a stable, sizable component of CVS’s long‑term debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative fact that CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million ($5 billion) in both 2023 and 2024. The number is accurate and properly formatted. The LLM also correctly notes this represents an unchanged balance and characterizes it as a stable component of long-term debt.\n\nWEAKNESSES: The LLM answer is INCOMPLETE in addressing the full scope of the question. The original answer provides important comparative context by mentioning the 2.7% senior notes due August 2040, which decreased from $1,250 million to $367 million, demonstrating selective debt management and refinancing activity. This comparative analysis is crucial to answering 'what does this indicate about the company's long-term debt structure?' The LLM's answer only addresses the stability of the 4.78% notes in isolation, without providing the contrasting example that illustrates CVS's broader debt management strategy.\n\nMULTI-HOP REASONING: The question requires synthesizing information about (1) the specific debt instrument's balance evolution, and (2) what this indicates about overall debt structure. The LLM addresses part 1 adequately but fails to fully address part 2 by omitting the comparative analysis with other debt instruments that would demonstrate selective debt management.\n\nQUANTITATIVE VERIFICATION: All numbers cited are correct ($5 billion/5,000 million for both years, 4.78% rate, March 2038 maturity date). Page references are provided but cannot be independently verified from the question context.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of the debt as 'stable' and 'sizable' is semantically equivalent to the ground truth's description, but the answer lacks the critical insight about selective debt management that distinguishes this instrument from others in the portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 507,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 (ticker XOM32) were listed in the 2022 Form 10‑K’s “Securities registered pursuant to Section 12(b)” table, showing they were an outstanding, NYSE‑listed debt instrument【page_1】. The same 0.835% Notes due 2032 appear again in the 2024 Form 10‑K’s registration table, indicating they remain outstanding and listed with no change in status【page_1】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the 0.835% Notes due 2032 (XOM32) appeared in both 2022 and 2024 filings with no change in status - this factual information is accurate. The numeric values (0.835%, 2032 maturity date, ticker XOM32) are all correct. However, the answer is significantly incomplete in addressing the full scope of the question about how the status 'evolved.' The ground truth emphasizes a critical multi-hop comparison: while the 0.835% Notes remained consistent, the 0.142% Notes due 2024 (XOM24B) disappeared between filings, indicating a meaningful change in debt composition. The LLM answer mentions 'no change in status' for the 0.835% Notes but completely fails to address the comparative analysis of other debt instruments that changed. The question asks how the status 'evolved' - implying a need to identify changes or developments. By only confirming the 0.835% Notes remained the same and omitting the context about the 2024 notes being removed, the LLM provides an incomplete synthesis of the multi-hop information required. The answer is factually accurate for what it states but fails to capture the fuller narrative of debt composition evolution that the ground truth emphasizes. This represents a partial answer that misses the key insight about comparative changes in the debt structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 371,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "In the 2022 filing American Express still held a large Treasury portfolio – about $1.7 billion at fair value (cost $1.68 billion) with roughly $832 million maturing within one year, $862 million in the 1‑to‑5‑year window and a small $10 million tranche beyond five years 【page_120†L13-L16】【page_121†L13-L20】. By the 2024 filing that exposure had been trimmed to roughly $287 million fair value (cost $289 million) and was concentrated in $189 million of securities due within one year and $98 million due in 1‑5 years, with no longer‑dated Treasury holdings 【page_124†L13-L16】【page_126†L13-L19】. This reflects a strategic shift away from larger, longer‑dated Treasury positions toward a much smaller, short‑term Treasury allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth. QUANTITATIVE ISSUES: (1) 2022 figures are completely wrong - LLM claims $1.7 billion total fair value with $832M short-term and $862M intermediate-term, but ground truth shows ONLY $477 million in short-term treasuries with NO long-term exposure in 2022. The LLM's 2022 numbers are off by a factor of 3-4x. (2) 2024 figures are correct ($189M short-term, $98M intermediate-term, $287M total), matching ground truth. (3) The LLM incorrectly describes 2022 as having 'roughly $862 million in the 1-to-5-year window' when ground truth explicitly states there was 'no long-term exposure' in 2022. REASONING ERRORS: The LLM fundamentally mischaracterizes the 2022 portfolio composition. Ground truth shows a simple, short-term-only strategy in 2022 that evolved to include intermediate-term holdings by 2024. The LLM inverts this narrative by claiming 2022 already had significant intermediate-term exposure ($862M), making the 'shift' described inaccurate. MULTI-HOP SYNTHESIS: While the LLM correctly identifies the 2024 position and attempts to compare it to 2022, the comparison is based on incorrect 2022 data, invalidating the entire analysis. The core finding - that 2022 was short-term only and 2024 became diversified - is reversed in the LLM's narrative. ENTITY/METRIC ACCURACY: Company (American Express) and metrics (fair value, maturity distribution) are correctly identified, but the actual values are severely misreported for 2022. The answer demonstrates citation formatting but the underlying data is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 451,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon first disclosed the 2.500 % Note due 2050 in its 2022 Form 10‑K, where it appeared as Exhibit 4.5 – an Officers’ Certificate dated June 3 2020 that listed the note (along with a 2.700 % Note due 2060). In the 2024 Form 10‑K the same certificate and note were still outstanding, now shown as Exhibit 4.6 (still referencing the June 3 2020 Officers’ Certificate), indicating the note remained on Amazon’s books with no amendment, redemption or removal between the two filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Verification of key facts: (1) The 2.500% Note due 2050 is correctly identified with the exact percentage; (2) The Officers' Certificate date of June 3, 2020 is correctly cited in both the ground truth and LLM answer; (3) The exhibit progression from Exhibit 4.5 (2022) to Exhibit 4.6 (2024) is accurately described; (4) The characterization that the note remained unchanged between filings is correct. The LLM answer adds helpful context by mentioning the 2.700% Note due 2060 that appeared alongside it, which provides additional detail not contradicting the ground truth. The multi-hop reasoning is sound: the model correctly synthesized that the same certificate appeared in different exhibits across years, and correctly concluded no modification occurred. The statement that the note 'remained on Amazon's books with no amendment, redemption or removal' accurately captures the evolution (or lack thereof) between 2022 and 2024. Minor differences from ground truth: the LLM uses slightly different phrasing ('reintroduced' vs 'remained outstanding') but the semantic meaning is equivalent. The LLM's answer is more concise while maintaining all essential information. No calculation errors, no date errors, and all entities (Amazon, the specific note, the exhibits, the dates) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 380,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The 2022 Form 10‑K lists the eighth, ninth and tenth amendments (10.8.8‑10.8.10), showing that ten amendments to the Citibank, N.A. Co‑Branded Credit Card Agreement had been filed by the end of 2022【page_68†L7-L13】. The 2023 filing adds the eleventh and twelfth amendments (10.8.11 and 10.8.12), bringing the total to twelve amendments as of 2023【page_68†L13-L18】. Thus, the agreement saw two additional amendments in 2023, increasing the count from ten to twelve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a different interpretation of the amendment evolution than the ground truth, creating a significant discrepancy. QUANTITATIVE ISSUES: The ground truth states the Eighth Amendment was the most recent in 2022 and the Twelfth Amendment was filed in 2023, indicating 4 additional amendments (8→12). The LLM claims 10 amendments existed by end of 2022 (eighth, ninth, tenth) and 12 by 2023 (adding eleventh and twelfth), also showing 2 additional amendments in 2023. This is a fundamental contradiction - the ground truth says 4 amendments were added between 2022 and 2023, while the LLM says only 2 were added. The LLM's statement that 'ten amendments...had been filed by the end of 2022' contradicts the ground truth's claim that the Eighth Amendment was the most recent in 2022. REASONING QUALITY: The LLM does correctly identify the amendment numbers and provides a logical synthesis of the data (showing progression from 10 to 12 amendments). However, the underlying data interpretation appears incorrect. The LLM references specific page citations and exhibit numbers (10.8.8-10.8.10, 10.8.11, 10.8.12), suggesting detailed source review, but these citations don't align with the ground truth narrative. ENTITY ACCURACY: Both answers correctly identify Citibank, N.A. Co-Branded Credit Card Agreement and the relevant years (2022-2023). COMPLETENESS: The LLM addresses the evolution question but with incorrect numbers. The core issue is that the LLM's amendment count progression (8→10→12) differs materially from the ground truth's progression (8→12), representing a 50% error in the number of amendments added during the period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 453,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "In the 2022 filing NVIDIA described CUDA as the core programming model that, together with its GPUs, formed the unified foundation for its data‑center, gaming, professional‑visualization and automotive platforms and supported a large developer community (≈3 million) (2022 p.7‑9, 11). By the 2024 filing CUDA is presented as the foundational layer of a full‑stack platform that now runs on all NVIDIA GPUs and is tightly integrated with the new Grace CPUs, DPUs and the Blackwell GPU architecture, and is packaged with an expanded CUDA‑X library suite, APIs, SDKs and AI‑Enterprise services, showing deeper coupling with emerging hardware and a broader software ecosystem (2024 p.4‑6).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of CUDA as foundational across Gaming, Data Center, Professional Visualization, and Automotive markets; (2) Accurately captures the 2024 evolution to a full-stack platform with CUDA-X libraries, APIs, SDKs; (3) Properly synthesizes the multi-hop information about new hardware integration (Grace CPUs, DPUs, Blackwell GPU); (4) Correctly notes the expansion from GPU-only to heterogeneous computing architectures; (5) Appropriately references the developer community scale (~3 million) as supporting context; (6) Uses specific filing page references (2022 p.7-9, 11; 2024 p.4-6) demonstrating source verification. MINOR CONSIDERATIONS: (1) The LLM answer includes the specific developer count (3 million) which, while accurate and supportive, is not explicitly mentioned in the ground truth statement, though this represents added value rather than error; (2) The mention of 'AI-Enterprise services' is a minor addition not explicitly in the ground truth but represents reasonable inference from the broader ecosystem expansion described. QUANTITATIVE ACCURACY: The numeric reference (3 million developers) is accurate and properly contextualized. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution from 2022 to 2024, properly identifying the shift from foundational building block to full-stack platform integration. MULTI-HOP REASONING: Successfully combines information about CUDA's role, hardware evolution, software ecosystem expansion, and market positioning across two time periods. The answer demonstrates clear understanding of how CUDA's strategic positioning evolved within NVIDIA's broader architecture strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 488,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "In 2023 Pfizer recorded only $1.279 billion of Paxlovid revenue because most sales were still under government‑supply contracts and a $3.5 billion non‑cash revenue reversal was taken for the expected return of EUA‑labeled inventory, leaving $5.1 billion of Paxlovid‑related deferred revenue on the balance sheet. By 2024 the product had shifted to commercial sales, generating $5.716 billion of revenue, a $771 million favorable adjustment to the reversal, $442 million of “SNS” supply revenue, and deferred revenue fell to $2.2 billion, with roughly $1 billion of remaining performance‑obligation contracts still to be recognized in future periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - CRITICAL FAILURES: The LLM claims 2024 Paxlovid revenue was $5.716 billion, but the ground truth provides no such figure and this appears to be fabricated. The LLM also claims $5.1 billion in 'deferred revenue on the balance sheet' for 2023, which contradicts the ground truth - the $5.1 million figure in ground truth refers to treatment courses actually returned (5.1 million courses), not deferred revenue. The LLM invents a $2.2 billion deferred revenue figure for 2024 with no basis in the ground truth. (2) CORRECT ELEMENTS: The LLM correctly identifies the $1.279 billion 2023 revenue, the $3.5 billion non-cash reversal, the $771 million favorable adjustment, the $442 million SNS revenue, and the ~$1 billion remaining performance obligations. (3) MULTI-HOP REASONING - FLAWED: While the LLM attempts to synthesize the evolution between years, it does so by introducing fabricated numbers ($5.716B revenue, $5.1B and $2.2B deferred revenue) that are not in the ground truth. The reasoning about shift from government-driven to commercial model is partially sound but undermined by false data. (4) ENTITY/METRIC CONFUSION: The LLM confuses '5.1 million treatment courses actually returned' (a unit count) with a revenue or deferred revenue figure, fundamentally misinterpreting the ground truth data. (5) MISSING CONTEXT: The LLM fails to properly convey that the 2023 reversal was specifically tied to expected returns of EUA-labeled U.S. government inventory, and that the 2024 adjustment reflected actual returns being lower than expected. The characterization of 2024 as 'commercial sales' generating $5.716B is unsupported and appears to be hallucination. The answer demonstrates partial understanding of the core narrative but introduces significant fabricated financial data that makes it substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 509,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "In 2022 the 2003 Incentive Program had roughly 65.8 million shares remaining for grant (restricted‑stock or other stock‑based awards) 【page_43†L31】, while by year‑end 2024 that pool had fallen to about 47 million shares 【page_102†L5】. The program’s structure has stayed essentially the same – a non‑term plan that can issue up to 220 million shares of stock options, SARs, restricted stock and other awards, with options and SARs priced at no less than market value, a 10‑year life, and forfeitures or cash settlements not counting against the share limit 【page_102†L5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are accurate: 65.8 million shares in 2022 (correctly formatted from 65,754,069), 47 million remaining in 2024, and 220 million maximum capacity. (2) The answer correctly identifies the evolution of share availability between the two years. (3) Multi-hop synthesis is sound - the model properly connected information about share availability across years and program structure details. (4) Proper citation of sources (page references) demonstrates document tracing. (5) Semantic equivalence is maintained throughout. MINOR WEAKNESSES: (1) The answer omits the restricted stock unit grant data mentioned in the ground truth (9,392 thousand in 2022 increasing to 10,393 thousand in 2024), which represents a modest but notable detail about actual usage patterns. (2) The phrase 'roughly 65.8 million' is slightly less precise than the ground truth's exact figure, though this is a minor formatting choice. (3) The answer focuses more on program structure details (options, SARs, pricing, 10-year life) which, while relevant and accurate, somewhat shifts emphasis away from the core question about share availability evolution. The ground truth emphasizes the contrast between capacity expansion (to 220M) and moderate usage growth, while the LLM answer emphasizes structural consistency. QUANTITATIVE VERIFICATION: 65.8M ≈ 65,754,069 ✓; 47M remaining ✓; 220M maximum ✓. No calculation errors detected. The answer is substantially correct but could have been more complete by including the RSU grant progression data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 453,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "In the 2022 filing AdSense was called out as a key pillar of the Google Network – together with AdMob and Google Ad Manager it drove the $8.6 billion increase in Google Network revenue and was specifically noted for a decline in its impression share【page_35】. By the 2024 filing AdSense is no longer highlighted as a separate growth engine; it is folded into the broader “Google Network properties” that now sit alongside a suite of AI‑driven ad solutions such as Demand Gen, Performance Max and Product Studio, reflecting a shift toward a more integrated, AI‑focused advertising technology portfolio【page_8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the $8.6 billion year-over-year revenue increase is accurately cited, and the 2022 and 2024 timeframes are properly identified. No calculation errors present. ENTITY ACCURACY: All entities are correctly identified - AdSense, AdMob, Google Ad Manager, Demand Gen, Performance Max, and Product Studio are all accurately named and positioned. Google Network is correctly referenced as the relevant revenue stream. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years (2022 vs 2024) and correctly identifies the strategic evolution: (1) 2022 positioning as explicit growth driver with quantified contribution, (2) 2024 positioning as foundational offering within broader AI-focused portfolio. The logical progression from 'key pillar' to 'folded into broader properties' is sound. COMPLETENESS: The answer addresses all aspects of the question - AdSense's role evolution, its relationship to the broader advertising technology portfolio, and the shift toward AI-powered solutions. MINOR OBSERVATION: The LLM answer includes a note about 'decline in its impression share' from the 2022 filing, which adds contextual detail not explicitly mentioned in the ground truth answer. This is a minor enhancement that doesn't contradict the ground truth but provides additional nuance. The semantic equivalence is strong - 'no longer specifically quantified as a growth lever' matches 'no longer highlighted as a separate growth engine,' and 'foundational, mature offering' aligns with 'folded into the broader properties.' The answer effectively conveys the strategic shift from explicit prominence to integration within a larger AI-driven ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 496,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "In the 2022 filing the UPS Retirement Plan was still a non‑contributory defined‑benefit plan that continued to accrue future service‑ and compensation‑based benefits for non‑union participants. Effective January 1 2023 the company ended those accruals – the plan “will cease accruals of additional benefits for future service and compensation for non‑union participants” (page 92) – and moved those employees into a defined‑contribution model, providing a retirement contribution of 5%‑8% of eligible compensation to the UPS 401(k) Savings Plan (up from 3%‑8% for hires after July 1 2016) (page 83).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information about the UPS Retirement Plan's evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies that the plan was non-contributory and continued accruing benefits for non-union participants in 2022; (2) Accurately states the effective date of January 1, 2023 for the cessation of accruals; (3) Provides the specific quote from the filing about ceasing accruals; (4) Correctly identifies the shift to a defined-contribution model; (5) Provides accurate percentage ranges (5%-8% for the new contribution structure and 3%-8% for hires after July 1, 2016); (6) Includes specific page references (pages 92 and 83) showing source documentation. MINOR WEAKNESSES: (1) The answer goes slightly beyond the ground truth by providing additional detail about the 401(k) Savings Plan contribution percentages and the comparison to prior contribution levels. While this information appears accurate and relevant, the ground truth answer focuses more on the structural change itself rather than the replacement benefit details; (2) The ground truth emphasizes this as a \"transformational change\" and \"significant strategic shift,\" while the LLM answer is more factual/neutral in tone, though it does characterize the change appropriately. QUANTITATIVE VERIFICATION: The percentages cited (5%-8% and 3%-8%) appear consistent with typical UPS filing disclosures and are presented correctly. The date (January 1, 2023) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022 and 2023 filings, comparing the before-and-after states of the plan and explaining the specific changes made. The connection between the cessation of DB accruals and the shift to DC contributions is logically sound and well-explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 493,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Amazon’s short‑term credit picture changed dramatically. In 2022 the company relied on a $1.0 billion secured revolving facility (LIBOR + 1.40%) with $803 million of borrowings and a $7.0 billion unsecured revolving credit agreement (benchmark + 0.50%) that had no borrowings, plus a commercial‑paper program of up to $10 billion that carried $725 million of debt【page_56】【page_57】. By 2024 it had replaced those with a $15.0 billion unsecured revolving credit agreement and a new $5.0 billion 364‑day revolving facility, both priced at SOFR + 0.45% and bearing a 0.03% commitment fee, with no borrowings under either, while an $8.0 billion 364‑day term loan (SOFR + 0.75%) was fully repaid and only $147‑$151 million of other short‑term facilities remained outstanding; the commercial‑paper capacity was expanded to $20 billion (with no balances)【page_58】【page_57】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth:\n\n1. MAJOR ERRORS - 2022 FACILITIES:\n   - LLM claims a \"$1.0 billion secured revolving facility (LIBOR + 1.40%)\" with \"$803 million of borrowings\" - NO MENTION in ground truth\n   - LLM claims \"$10 billion commercial-paper program\" with \"$725 million of debt\" - NOT in ground truth\n   - Ground truth shows only: $7.0 billion unsecured facility (benchmark + 0.50%) with NO borrowings, plus $7.2 billion unused letters of credit\n\n2. MAJOR ERRORS - 2024 FACILITIES:\n   - LLM claims \"$8.0 billion 364-day term loan (SOFR + 0.75%) was fully repaid\" - NO MENTION in ground truth\n   - LLM claims \"commercial-paper capacity was expanded to $20 billion\" - NOT in ground truth\n   - Ground truth shows: $15.0 billion unsecured facility (SOFR + 0.45%), $5.0 billion 364-day facility (SOFR + 0.45%), $147-151 million other short-term borrowings, $8.3 billion unused letters of credit\n\n3. CORRECT ELEMENTS:\n   - $15.0 billion unsecured revolving credit facility (correct)\n   - $5.0 billion 364-day facility (correct)\n   - SOFR + 0.45% rate (correct)\n   - 0.03% commitment fee (correct)\n   - No borrowings under main agreements (correct)\n   - $147-151 million other short-term facilities (correct)\n\n4. MULTI-HOP REASONING:\n   The LLM failed to properly synthesize the ground truth information. It appears to have fabricated or confused details about secured facilities, commercial paper programs, and term loans that are not supported by the source documents. The answer presents a fundamentally different credit structure than what the ground truth indicates.\n\n5. COMPLETENESS:\n   While the answer attempts to address evolution between 2022-2024, it does so with largely incorrect information. The ground truth shows a cleaner evolution (expansion of unsecured capacity, improvement in rates/fees, introduction of 364-day facility), but the LLM's narrative includes non-existent facilities and programs.\n\nThe answer demonstrates poor factual accuracy despite some correct individual data points. The fabricated details about secured facilities, commercial paper balances, and term loans represent fundamental errors that significantly undermine the response's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 611,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "In the 2022 Form 10‑K Costco disclosed that it “enter[s] into variable‑priced contracts for some purchases of **electricity and natural gas**, in addition to some fuel for its gas stations” on an index basis【page_31】. By the 2023 filing the company’s disclosure was narrowed to “variable‑priced contracts for some purchases of **natural gas**, in addition to fuel for its gas stations,” with no mention of electricity【page_47】. This change suggests Costco is shifting electricity exposure into fixed‑price contracts—tightening its commodity‑price risk management by locking in electricity costs while still using index‑based contracts for natural‑gas where it prefers flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer makes a fundamental claim that contradicts the ground truth. The LLM states that by 2023, Costco's disclosure was 'narrowed' to exclude electricity, suggesting a shift toward fixed-price electricity contracts. However, the ground truth explicitly states that 'By 2023, Costco continued this approach' with 'no significant shift away from index-based pricing mechanisms' and that 'The strategy remains consistent.' The LLM's interpretation that electricity was removed from variable-priced contracts and moved to fixed-price contracts is NOT supported by the ground truth and represents a misreading of the filing disclosures. The ground truth indicates continuity and stability in the strategy, not a shift. SPECIFIC ISSUES: (1) The LLM incorrectly infers a strategic shift (electricity to fixed-price) that the ground truth explicitly contradicts. (2) The LLM's characterization of the change as 'tightening its commodity-price risk management' is speculative and unsupported by the ground truth. (3) While the LLM correctly identifies that electricity was mentioned in 2022 and not in 2023, it draws an incorrect causal inference about why (assuming a shift to fixed-price rather than simply a change in disclosure emphasis). (4) The ground truth emphasizes 'continued reliance' and 'consistency,' while the LLM emphasizes 'shifting' and 'tightening'—opposite conclusions. WHAT WAS CORRECT: The LLM accurately identifies the specific commodities mentioned in each year (electricity and natural gas in 2022; natural gas and fuel in 2023) and correctly notes they were index-based contracts. However, the interpretation of what this change means is fundamentally wrong. The multi-hop reasoning failed because the LLM made an unsupported inference about strategy shift rather than recognizing the ground truth's emphasis on continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 510,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "In the 2022 filing (see pages 78‑82) NVIDIA’s 10‑K does not call out NVIDIA AI Enterprise as a distinct product – it is only part of the broader data‑center software stack and receives no dedicated discussion. By the 2024 filing the company is positioning AI Enterprise as a standalone, paid‑license suite that serves as the “operating system” for enterprise‑grade AI (page 4) and is listed alongside DGX Cloud as a core data‑center offering (page 5). The 2024 filing further details AI Enterprise’s commercial role, describing it as a comprehensive software package that includes NVIDIA NIM, NEMO and AI Blueprints to simplify development and deployment of generative‑AI workloads (page 7), showing its evolution from a background component to a strategic, revenue‑generating solution within NVIDIA’s data‑center portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of NVIDIA AI Enterprise's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as part of broader data center software stack without dedicated discussion, matching the ground truth's 'foundational role' characterization. (2) Accurately describes the 2024 evolution to a 'standalone, paid-license suite' and 'comprehensive software package,' which aligns with ground truth's 'more prominent commercial offering' and 'key monetization vehicle.' (3) Properly synthesizes multi-hop information across filing years and segments. (4) Correctly identifies specific 2024 components (NIM, NEMO, AI Blueprints) and positioning alongside DGX Cloud. (5) Page citations (78-82, 4, 5, 7) demonstrate document-specific sourcing. (6) The characterization of the shift from 'background component to strategic, revenue-generating solution' semantically matches the ground truth's 'move from strategic initiative to key monetization vehicle.' MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing ('operating system' language) compared to ground truth's 'comprehensive suite of enterprise-grade AI software,' though both convey similar meaning. (2) Ground truth mentions 'expansion into CPUs and DPUs' as context for the broader platform evolution, which the LLM answer does not explicitly address, though this is a minor contextual omission rather than a factual error. (3) No quantitative metrics provided in either answer, so quantitative accuracy is based on correct identification of years and product names. The answer successfully addresses all parts of the question regarding strategic positioning evolution and commercial role changes between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 485,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "By the end of 2023 Pfizer still had about $5.1 billion of Paxlovid‑related deferred revenue (roughly $2.6 billion in current liabilities and $2.5 billion in non‑current) 【page 110】. At year‑end 2024 that balance had fallen to roughly $2.2 billion ($1.4 billion current and $785 million non‑current) and the company reported only about $1 billion of remaining performance‑obligation revenue for Paxlovid 【page 109】. The drop shows that most advance payments have now been recognized as sales as Paxlovid shifts to commercial markets, indicating a lower‑volume, longer‑term revenue outlook for the product.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Paxlovid contractual obligations and their evolution, but contains significant discrepancies with the ground truth that affect overall accuracy. STRENGTHS: (1) Correctly identifies the key metric of remaining performance obligations (~$1 billion for 2024), which matches ground truth; (2) Appropriately discusses the shift from deferred revenue to recognized sales; (3) Correctly interprets the trend as indicating a transition to commercial markets with lower-volume, longer-term outlook; (4) Provides specific breakdowns of current vs. non-current liabilities for both years. CRITICAL ISSUES: (1) The LLM completely omits the $3.5 billion non-cash revenue reversal in Q4 2023 related to the expected return of 6.5 million treatment courses under EUA - this is a major factual omission that was central to the ground truth's explanation of 2023 uncertainty; (2) The deferred revenue figures ($5.1B in 2023, $2.2B in 2024) are presented without context about the revenue reversal, making the narrative incomplete; (3) The LLM's explanation attributes the decline primarily to 'advance payments being recognized as sales' rather than acknowledging the significant impact of the EUA return reversal, which fundamentally changes the interpretation of what happened in 2023. QUANTITATIVE VERIFICATION: The $1 billion remaining performance obligation for 2024 is correct. However, the absence of the $3.5B reversal figure is a major omission. The deferred revenue figures appear to be from the balance sheet but lack the critical context of the revenue reversal. REASONING QUALITY: While the LLM correctly synthesizes that the contractual obligations evolved and interprets this as indicating stabilization, it misses the key insight from ground truth - that 2023 showed significant uncertainty (evidenced by the large reversal) while 2024 shows stabilization. The LLM's narrative is incomplete because it doesn't explain WHY the deferred revenue dropped so dramatically between 2023 and 2024 (the reversal being a major factor). This represents a failure in multi-hop synthesis of the complete picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 576,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "In the 2022 Form 10‑K, Google warned that an “evolving foreign‑policy landscape” could expose it to new regulatory costs and challenges largely tied to data‑privacy, anti‑corruption, foreign‑ownership limits and other general compliance issues in the markets where it operates (2022 p.16). By 2024 the filing still notes those baseline risks but broadens the scope, adding “new customer requirements,” AI‑related legislation, EU‑UK data‑transfer rules, heightened geopolitical tensions and cyber‑security scrutiny, showing that regulatory exposure has expanded from traditional privacy and compliance concerns to technology‑specific and more detailed international regulatory regimes (2024 p.16; 2024 p.17).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH ACCURACY: The LLM answer introduces significant factual errors and unsupported claims that diverge substantially from the ground truth. SPECIFIC PROBLEMS: (1) The LLM claims the 2022 filing mentions 'data-privacy, anti-corruption, foreign-ownership limits' but the ground truth specifically states 2022 focused on 'data transfers between the EU and the UK, as well as new customer requirements' - these are different regulatory concerns. The LLM appears to have fabricated or conflated details not present in the ground truth. (2) The LLM introduces 'AI-related legislation' and 'heightened geopolitical tensions and cyber-security scrutiny' as 2024 additions, but the ground truth makes no mention of these specific elements. Instead, the ground truth emphasizes 'uncertainty regarding regulatory outcomes' and 'risk of other liabilities under local laws that may not offer due process or clear legal precedent' - fundamentally different concerns. (3) The LLM cites specific page numbers (2022 p.16, 2024 p.16; 2024 p.17) without verification against the ground truth, which is problematic. (4) CORE CONCEPTUAL ERROR: The ground truth describes a shift from 'primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024,' emphasizing uncertainty and lack of due process. The LLM instead describes an expansion from 'traditional privacy and compliance concerns to technology-specific and more detailed international regulatory regimes,' which misses the key insight about unpredictability and due process concerns. (5) The LLM answer does correctly identify that regulatory exposure expanded between 2022 and 2024, which is the core thesis, but the specific nature of that expansion is mischaracterized. STRENGTHS: The answer does address the comparison/contrast structure of the question and attempts multi-hop synthesis across years. However, the factual inaccuracies and introduction of unsupported details significantly undermine the response quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 543,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "In the 2022 10‑K (page 109) UPS said that expected post‑retirement medical benefit payments would be funded from both the plan trusts and corporate assets. The 2023 10‑K (page 92) repeats the same statement – payments will be paid from plan trusts and corporate assets – showing that UPS’s funding mix for post‑retirement medical benefits has not changed between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Strengths: (1) Correctly identifies that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, matching the ground truth conclusion; (2) Accurately states that both years indicate funding from 'plan trusts and corporate assets' - the exact same sources; (3) Properly cites the relevant 10-K pages (2022: page 109, 2023: page 92) showing multi-hop synthesis across two years of filings; (4) Correctly identifies the company (UPS) and the specific benefit type (postretirement medical benefits); (5) The reasoning is sound - comparing the language across years and concluding no change occurred. Minor consideration: The answer includes specific page numbers which, while helpful for verification, are not strictly necessary to answer the question, but this is a positive addition rather than a detraction. The semantic meaning perfectly matches the ground truth - both conclude there was no evolution or change in the funding approach between 2022 and 2023. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 326,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "In the 2022 filing NVIDIA AI Enterprise was introduced as a new paid‑license software product, listed under the Compute & Networking segment and grouped with other data‑center software and DGX Cloud offerings【page_5】【page_6】. By the 2024 filing it had grown into a comprehensive, enterprise‑grade AI suite—including NIM, Nemo and AI Blueprints—and is positioned as a core component of NVIDIA’s data‑center platform and AI‑training‑as‑a‑service portfolio, supporting broader generative‑AI deployments and integration across customers’ infrastructure【page_6】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS OF FACTS: The answer correctly identifies NVIDIA AI Enterprise's introduction in 2022 as a paid-license software product within the Compute & Networking segment, and accurately describes its 2024 evolution into a comprehensive suite including NIM, NeMo, and AI Blueprints. All entity names and organizational classifications are correct. (2) QUANTITATIVE ACCURACY: While the ground truth mentions a specific '2.5x increase in token throughput' performance metric, the LLM answer does not include this specific number. However, this is a minor omission rather than an error—the LLM correctly captures the timeframe (2022 to 2024) and the general trajectory of enhancement without misrepresenting any numbers. No calculations are required for this question, and no numeric values are incorrect. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years (2022 and 2024) and correctly traces the evolution from 'foundational offering' (implied by 'new paid-license software product') to 'full-stack, production-grade generative AI platform' (captured as 'comprehensive, enterprise-grade AI suite'). The logical progression is sound and well-articulated. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing ('core component of NVIDIA's data-center platform and AI-training-as-a-service portfolio') effectively conveys the same meaning as the ground truth's 'full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.' The emphasis on 'broader generative-AI deployments and integration across customers' infrastructure' aligns well with the ground truth's description of broader deployment options. (5) MINOR GAPS: The only substantive omission is the specific 2.5x token throughput improvement metric, which represents a minor detail rather than a core factual error. The answer captures the essential evolution narrative and all major components accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 552,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "ExxonMobil’s equity‑company proved reserves grew to 1,481 million barrels of oil‑equivalent in 2024, with the bulk in Asia (≈1,276 million barrels) and a sizable share in Africa (≈143 million barrels) (2024 reserves table, page 10). The 2022 filing excerpts do not provide a comparable equity‑company reserve total, but the 2024 regional concentration shows a clear strategic emphasis on expanding equity‑based assets in high‑growth, non‑U.S. markets—particularly Asia and Africa.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM reports 2024 reserves as 1,481 million barrels of oil-equivalent with Asia at ~1,276 million barrels, but the ground truth specifies 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas. These are fundamentally different numbers and cannot be reconciled as simple unit conversions. The LLM's oil-equivalent conversion appears incorrect or based on different source data. (2) MISSING 2022 COMPARISON: While the LLM acknowledges that 2022 data wasn't provided in excerpts, the ground truth clearly states 2022 had 14 million barrels gross (1 million net). The LLM fails to capture this critical baseline for assessing the evolution/growth trajectory. (3) REGIONAL BREAKDOWN ERRORS: The ground truth indicates 2024 growth was concentrated in Asia but also mentions United States, Europe, and Africa in 2022. The LLM's regional percentages (Asia ~1,276M, Africa ~143M) don't align with the ground truth's specific commodity breakdown. (4) INCOMPLETE COMMODITY BREAKDOWN: The ground truth provides three distinct commodity types (crude oil, NGLs, natural gas) for 2024, but the LLM collapses these into a single oil-equivalent figure, losing important specificity. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the 2022-to-2024 evolution, which is central to the question. The ground truth shows growth from 14M barrels (2022) to 467M crude + 120M NGLs + 5,367 Bcf gas (2024), indicating substantial expansion. The LLM's inability to provide 2022 comparison data and its incorrect 2024 figures represent a fundamental failure in answering the comparative question. The strategic positioning conclusion about Asia emphasis is directionally correct but built on incorrect numerical foundations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 519,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "In the 2022 filing Alphabet explained that ads on Google Network properties are recorded on a gross basis – the full amount billed to advertisers is shown as revenue, and the amounts paid to Google Network partners are reflected as cost of revenues (TAC) 【page_55】. The 2024 filing still treats advertising from Google Network properties as a major source of operating cash, and explicitly lists payments to Google Network partners as a primary cash outflow from operating activities (i.e., a cost‑of‑revenues item) 【page_42】. Thus, the relationship has remained consistent—partners continue to drive a sizable share of advertising revenue while their payments remain a key cost line—though the cash paid to partners has risen in line with higher overall operating cash inflows.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that in 2022, Google Network Partners' payments were recorded as cost of revenues (TAC), and that the gross basis accounting treatment was used. It also correctly notes that 2024 filings reference payments to partners as a cash outflow from operating activities. The general characterization of the relationship as 'consistent' is partially supported. (2) CRITICAL ERRORS: The LLM answer fundamentally misinterprets the ground truth's key insight. The ground truth explicitly states there was a SHIFT in focus from 'revenue generation process' framing in 2022 to 'net cash flow impact' framing in 2024 - a shift in emphasis and reporting perspective. The LLM incorrectly claims the relationship 'remained consistent' when the ground truth indicates a meaningful evolution in how the relationship is characterized and reported. (3) MISSING NUANCE: The ground truth emphasizes that 2022 focused on Google's role as 'principal' with 'gross basis' reporting of revenues, while 2024 shifted to emphasizing the 'cost-centric framing.' The LLM treats both years similarly without capturing this important distinction in reporting emphasis. (4) QUANTITATIVE ISSUES: The LLM mentions 'cash paid to partners has risen in line with higher overall operating cash inflows' but provides no specific numbers or evidence from the filings to support this claim. The ground truth does not make this assertion, and the LLM appears to have added unsupported quantitative reasoning. (5) PAGE REFERENCES: While the LLM provides page citations, these cannot be verified against the ground truth, and the interpretation of what those pages say appears to diverge from the ground truth's characterization. The answer is partially correct on surface facts but misses the core evolution in financial relationship framing that the question and ground truth emphasize.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 532,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS reduced the earnings impact of its non‑designated foreign‑currency forward contracts. In 2022 the company recorded a $69 million loss from such contracts in the income statement, whereas in 2023 the loss fell to only $7 million (page 132), indicating that the firm shifted more of its exposure into designated hedges and thereby dampened earnings volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. (1) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific dollar amounts ($69 million loss in 2022, $7 million loss in 2023) without verification against the actual filings. These numbers cannot be confirmed from the ground truth provided and appear to be fabricated or misattributed. The ground truth does not mention these specific figures. (2) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes that UPS's strategy evolution involved changes in disclosure practices and presentation structure - moving toward more explicit linkage of undesignated derivative settlements to earnings volatility and more transparent side-by-side reporting. The LLM instead interprets this as a shift toward designated hedges to reduce earnings impact, which is a fundamentally different claim not supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth indicates the evolution was primarily about disclosure transparency and structured presentation improvements, not about a strategic shift in hedging approach. The LLM mischaracterizes the nature of the evolution. (4) UNSUPPORTED CLAIMS: The assertion that UPS 'shifted more of its exposure into designated hedges' is not mentioned in the ground truth and appears to be an inference not supported by the source material. (5) PAGE REFERENCE: The LLM cites 'page 132' without verification that this reference is accurate or that the numbers cited appear on that page. The ground truth does not provide page-specific citations for the financial figures mentioned. The answer demonstrates a fundamental misunderstanding of what changed between 2022 and 2023 in UPS's disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 471,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Costco’s 2022 filing describes the membership format as “integral” to profitability – it is meant to reinforce member loyalty and generate ongoing fee revenue, and that year fee revenue rose 9 % to $4.2 billion thanks to new sign‑ups, executive upgrades and a higher renewal rate【page_23】【page_24】. The 2023 filing repeats the same description of the format’s role in driving loyalty and fee income, but shows the growth in fee revenue slowing to roughly a 5 % increase (to $4.8 billion) in the subsequent period【page_24】【page_25】, indicating that while the loyalty‑centric strategy remains unchanged, the pace of fee‑revenue expansion has moderated.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct directional information but contains significant factual errors and omissions that undermine its accuracy. STRENGTHS: (1) Correctly identifies that membership format is described as 'integral' to profitability in both years; (2) Correctly notes that fee revenue increased in both periods; (3) Appropriately addresses the slowdown in fee revenue growth rate between years; (4) Maintains relevance to the question about evolution of membership strategy. CRITICAL ERRORS: (1) Fee revenue figures appear incorrect or unverified - claims $4.2B in 2022 and $4.8B in 2023, but these specific numbers cannot be confirmed against ground truth; (2) Growth rate calculations are problematic - claims 9% growth to $4.2B in 2022 and 5% growth to $4.8B in 2023, but the math doesn't align ($4.2B to $4.8B is actually ~14.3% growth, not 5%); (3) MAJOR OMISSION: The LLM answer completely fails to address the key evolution identified in the ground truth - the emergence of concerns about renewal rates in newer markets in 2023 that were not present in 2022. This is a critical distinction that shows the company faced emerging challenges. (4) The LLM answer misses the nuance that while the membership model remained central, the company explicitly identified new risks around renewal rates in newer markets. MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2023 comparisons but does so incompletely, focusing only on fee revenue growth rates while missing the strategic shift regarding renewal rate challenges. The reasoning about 'loyalty-centric strategy remains unchanged' contradicts the ground truth which shows the company's concerns evolved. QUANTITATIVE ISSUES: The fee revenue numbers and growth percentages need verification; the 5% growth claim appears mathematically inconsistent with the stated figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 502,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "In the 2022 filing NVIDIA presented CUDA as the core programming model that runs on every GPU and serves as the “fundamental building block” of its unified accelerated‑computing architecture, supported by roughly 3 million developers. By the 2024 filing CUDA is no longer described only as a GPU‑only language but as a central piece of a full‑stack data‑center platform that now includes CPUs, DPUs, networking and the CUDA‑X collection of libraries, APIs and SDKs, with the developer ecosystem growing to about 5.9 million—showing a deeper, broader integration of CUDA across hardware and software layers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution of CUDA between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning with ~3 million developers - matches ground truth exactly. (2) Accurately describes the 2024 evolution to a full-stack data center platform including CPUs, DPUs, and networking - aligns with ground truth. (3) Correctly identifies CUDA-X collection of libraries, APIs, and SDKs as part of the 2024 positioning. (4) Properly synthesizes the multi-hop information across two filing years. (5) Adds valuable detail about developer ecosystem growth to 5.9 million, which represents quantitative evidence of the evolution. (6) Correctly characterizes the shift from GPU-only to broader hardware integration. MINOR CONSIDERATIONS: (1) The ground truth emphasizes the shift from 'developer-focused tool' to 'core infrastructure layer for enterprise-scale computing solutions' - the LLM answer captures this conceptually but uses slightly different framing ('GPU-only language' to 'full-stack platform'). This is semantically equivalent but frames the evolution slightly differently. (2) The ground truth mentions specific programs (Deep Learning Institute, Inception program) that the LLM answer does not include, though these are contextual details rather than core to the evolution narrative. (3) The LLM answer adds the developer count growth (3M to 5.9M) which is not explicitly in the ground truth but represents valid supporting evidence of the evolution. QUANTITATIVE VERIFICATION: 3 million developers (2022) - correct; 5.9 million developers (2024) - appears accurate based on filing data; CUDA-X components correctly identified. The answer successfully demonstrates multi-hop reasoning by synthesizing information across 2022 and 2024 filings to show the evolution trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 504,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "In 2023 Pfizer was carrying a large “pre‑pay” balance for Paxlovid – $5.1 billion of deferred revenue (about $2.6 billion classified as current and $2.5 billion as non‑current) that reflected advance payments from governments and other customers and was expected to be recognized as the drug was delivered in 2024 【page_110】. By year‑end 2024 that balance had fallen to $2.2 billion ($1.4 billion current, $785 million non‑current) and the company now reported roughly $1 billion of remaining performance‑obligation revenue for Paxlovid, with the existing contracts calling for product shipments from 2025 through 2028 (subject to renegotiation) 【page_109】. This shows a shift from a large upfront cash commitment in 2023 to a smaller, longer‑term delivery schedule and revenue stream in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer introduces significant financial figures that are NOT present in the ground truth and appear to be incorrect or from different contexts. Specifically: (1) The LLM claims $5.1 billion in deferred revenue in 2023 ($2.6B current + $2.5B non-current), but the ground truth makes no mention of these deferred revenue figures for Paxlovid. Instead, the ground truth specifically references a $3.5 billion NON-CASH REVENUE REVERSAL in Q4 2023 due to expected returns of 6.5 million treatment courses - these are fundamentally different accounting treatments. (2) The LLM claims the deferred revenue balance fell to $2.2 billion by end of 2024, but again this figure does not appear in the ground truth. (3) The ground truth clearly states the 2023 event was a revenue REVERSAL (negative impact), not a deferred revenue balance to be recognized. (4) The LLM correctly identifies the ~$1 billion remaining performance obligations for Paxlovid in 2024 and the 2025-2028 delivery timeline, which matches the ground truth. (5) The LLM's conclusion about the shift from 'large upfront cash commitment' to 'smaller, longer-term delivery schedule' is conceptually reasonable but is based on incorrect financial figures that don't align with the ground truth's characterization of the 2023 situation as a revenue reversal due to expected returns. The LLM appears to have confused or conflated different financial metrics (deferred revenue vs. revenue reversal). While the 2024 forward-looking information is accurate, the 2023 baseline is fundamentally mischaracterized, undermining the validity of the year-over-year comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 454,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "In the 2022 Form 10‑K, ExxonMobil only noted that “extensions and discoveries, primarily in the United States, Brazil, and **Guyana**, resulted in an addition of approximately 1.3 billion oil‑equivalent barrels of proved undeveloped reserves” (page 14), treating Guyana as one of several regions contributing to reserve growth. By the 2024 filing, the company places Guyana in its “Advantaged Assets (Advantaged growth projects)” – listed alongside Permian and LNG as a driver of Advantaged Volume Growth (page 37) – indicating that Guyana has been elevated to a core, high‑value strategic focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about ExxonMobil's evolving strategic emphasis on Guyana. STRENGTHS: (1) Quantitative accuracy is perfect - the 1.3 billion oil-equivalent barrels figure is correctly cited and matches the ground truth exactly; (2) The temporal comparison (2022 vs 2024) is properly structured and clearly delineates the evolution; (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across two different filing years and identifies the strategic shift from 'reserves growth region' to 'core advantaged asset'; (4) Entity identification is accurate - ExxonMobil, Guyana, Permian, and LNG are all correctly identified; (5) The answer provides specific page references (page 14 for 2022, page 37 for 2024) which adds credibility and verifiability; (6) The semantic meaning aligns perfectly with the ground truth - both convey that Guyana transitioned from being one of several contributors to reserves to being explicitly positioned as a strategic 'Advantaged Asset' driving earnings. MINOR CONSIDERATIONS: The LLM answer includes slightly more contextual detail (mentioning Permian and LNG as comparable assets, providing page numbers) which enhances rather than detracts from the answer. The phrasing 'elevated to a core, high-value strategic focus' effectively captures the same meaning as the ground truth's 'transition from reserves growth region to recognized source of advantaged production and earnings visibility.' No calculation errors, no factual inaccuracies, and the reasoning chain is logically sound throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 446,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "In the 2022 filing FedEx said it was committed to buy **24 ATR 72‑600F** turboprop freighters – 11 in 2023, 6 in 2024, 6 in 2025 and 1 in 2026【page_114】. By the 2024 filing the commitment had been cut to **10 ATR 72‑600F**, with deliveries now only in 2025 (7) and 2026 (3)【page_117】. The shrink‑age and later delivery schedule indicate that the ATR 72‑600F has moved from a major near‑term expansion piece to a more limited, niche role in FedEx’s overall fleet‑modernization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the ATR 72-600F fleet evolution. STRENGTHS: (1) All quantitative data is correct - the 2022 projection of 24 total units (11+6+6+1) and 2024 projection of 10 total units (7+3) match the ground truth. The year-by-year breakdown is accurate: 2023: 11, 2024: 6, 2025: 6, 2026: 1 for 2022 filing; 2025: 7, 2026: 3 for 2024 filing. (2) The multi-hop synthesis is sound - correctly comparing projections across two different filing years (2022 vs 2024) and drawing logical conclusions about the shift in strategy. (3) Entity identification is correct - properly identifies FedEx and the specific aircraft model. (4) The qualitative interpretation is insightful and accurate - correctly characterizes the shift from \"major near-term expansion\" to \"limited, niche role\" which aligns with the ground truth's observation about \"more sustained, albeit reduced, role.\" (5) The answer directly addresses both parts of the question: how utilization evolved AND what it indicates about fleet strategy. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific detail (actual delivery schedule breakdown) than the ground truth, but this is additive and enhances rather than detracts from accuracy. The page references (page_114, page_117) add credibility though cannot be independently verified. The semantic meaning is fully equivalent to the ground truth - both convey that the aircraft went from a larger near-term commitment to a smaller, later-scheduled commitment, indicating a strategic shift toward a more limited role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 441,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse mainly as a stand‑alone virtual‑world and real‑time 3‑D collaboration platform – offered as an enterprise subscription (free for individuals) and used for VR/AR, virtual car showrooms, surgical training and for synthetic‑data generation and testing of autonomous‑driving via the DRIVE Constellation and Omniverse Avatar tools【page_9】,【page_7】,【page_11】. By the 2024 filing the company had repositioned Omniverse as a core piece of its “industrial digitalization” strategy, bundling it with the NVIDIA AI Enterprise suite and integrating it with data‑center AI services (DGX Cloud) and the DRIVE autonomous‑driving stack, turning it from a separate collaboration tool into a unified AI‑driven simulation and digital‑twin platform【page_4】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Omniverse as a virtual-world/3D collaboration platform with enterprise subscription and free individual access; (2) Accurately captures 2022 use cases including VR/AR, virtual car showrooms, surgical training, and autonomous driving testing; (3) Properly identifies the 2024 evolution toward industrial digitalization and digital twin focus; (4) Correctly notes integration with NVIDIA AI Enterprise, DGX Cloud, and DRIVE stack; (5) Accurately characterizes the shift from standalone collaboration tool to unified AI-driven platform; (6) Includes specific product references (DRIVE Constellation, Omniverse Avatar, DGX Cloud) that add credibility and detail. MINOR WEAKNESSES: (1) The LLM answer mentions 'synthetic-data generation' as a 2022 use case, which while plausible, is not explicitly mentioned in the ground truth answer (though not contradicted); (2) The ground truth emphasizes 'digital twins of factories' and 'testing autonomous robots and vehicles' as 2024 examples, while the LLM answer focuses more on the bundling/integration strategy rather than specific application examples; (3) The LLM answer could have been slightly more explicit about the shift from 'general 3D collaboration' to 'specialized, enterprise-focused simulation' as stated in ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the evolution trajectory. The connection between 2022 capabilities and 2024 platform positioning is logically sound. No quantitative errors detected (no specific numbers or calculations required for this qualitative question). The answer demonstrates good understanding of NVIDIA's strategic repositioning of Omniverse.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 505,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "In the 2022 filing, Google Play was mentioned as one of several non‑advertising revenue sources—sales of apps, in‑app purchases and digital content—grouped under “Google other revenues” and cited as part of the overall growth in non‑advertising revenue (2022 p.30‑31). By the 2023 filing, Google Play is singled out as the core component of the “platforms” line within the broader “Google subscriptions, platforms, and devices” segment, indicating a more explicit and central role in driving non‑advertising revenue (2023 p.33). This shift shows Google Play moving from a general non‑advertising contributor to a distinct, highlighted revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of Google Play from 2022 to 2023, capturing the shift from being part of 'Google other revenues' to a more prominent role within 'platforms' segment. (2) Accurately characterizes the 2022 positioning as part of broader non-advertising revenue diversification (apps, in-app purchases, digital content). (3) Correctly identifies the 2023 transition to explicit categorization under 'platforms' within 'Google subscriptions, platforms, and devices' segment. (4) Provides specific page references (2022 p.30-31, 2023 p.33) that add credibility and verifiability. (5) The semantic meaning matches ground truth: both describe a movement from general contributor to distinct, highlighted revenue driver. (6) Multi-hop reasoning is sound—synthesizes information across two fiscal years and correctly identifies the strategic shift in categorization and emphasis. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth ('singled out as the core component' vs 'transitioned into a more defined revenue stream') but conveys equivalent meaning. The LLM provides more specific filing references than ground truth, which enhances rather than detracts from accuracy. No quantitative errors detected. The answer fully addresses the question's requirement to explain evolution between 2022 and 2023. VERIFICATION: Both answers agree on the fundamental narrative: Google Play moved from a component of general non-advertising revenue to a more explicitly defined and central revenue stream. The LLM's characterization of this as moving from 'general non-advertising contributor to a distinct, highlighted revenue driver' is semantically equivalent to the ground truth's 'strategic shift toward solidifying Google Play's role as a key monetization platform.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 517,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "In the 2022 filing AIG explained that its expected‑loss‑ratio approach was applied *mainly* to the most recent accident year for guaranteed‑cost workers‑comp claims, while for excess‑of‑deductible policies the same method could carry significant weight over the most recent five accident years. The 2023 filing still emphasizes expected‑loss‑ratio use for excess‑of‑deductible business (still weighted for the last five accident years) but no longer calls out a special weighting for guaranteed‑cost business, suggesting AIG has shifted away from relying on expected‑loss‑ratio estimates for that segment and is likely using other development methods instead.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. CRITICAL ERRORS: (1) The LLM claims that in 2023 AIG 'no longer calls out a special weighting for guaranteed-cost business,' suggesting a shift away from expected-loss-ratio methods for that segment. However, the ground truth explicitly states that 'the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy' and that 'the reserving methodology remained broadly consistent.' The LLM incorrectly infers a methodological change when the ground truth indicates continuity. (2) The LLM states the 2023 filing 'still emphasizes expected-loss-ratio use for excess-of-deductible business' but provides no evidence this emphasis continued or changed from 2022. The ground truth indicates the methodology 'remained broadly consistent' but doesn't support the LLM's specific claim about 2023 emphasis. (3) The LLM completely omits important context from the ground truth: the 2022 note about changes in claims strategy and loss mitigation efforts accelerating settlements and increasing paid losses, and the 2023 observation about large deductible business slowing reporting patterns. (4) The LLM's interpretation that AIG 'shifted away from relying on expected-loss-ratio estimates' for guaranteed-cost business is not supported by the ground truth, which indicates methodology remained 'broadly consistent' between years. PARTIAL CREDIT: The LLM correctly identifies the 2022 application to 'most recent accident year' for guaranteed-cost and 'most recent five accident years' for excess-of-deductible business. The multi-hop synthesis is weak, failing to properly integrate the nuanced evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 506,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco’s product‑revenue reporting shifted from a six‑category layout in FY 2022—Secure Agile Networks; Internet for the Future; Collaboration (Meetings, Collaboration Devices, Calling, Contact Center and CPaaS); End‑to‑End Security; Optimized Application Experiences; and Other Products【page_44】—to a streamlined four‑category format in FY 2024—Networking; Security; Collaboration (now Webex Suite, Collaboration Devices, Contact Center and CPaaS) and Observability, with prior periods retro‑fit to this new structure【page_41】.  The Collaboration segment’s revenue fell from $4.472 billion in FY 2022 to $4.113 billion in FY 2024 (a 9% decline versus FY 2022 but a 2% rise versus FY 2023)【page_44】【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the segmentation evolution from six categories in FY2022 to four categories in FY2024. (2) Accurately lists all six FY2022 categories: Secure Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. (3) Correctly identifies the four FY2024 categories: Networking, Security, Collaboration, and Observability. (4) Provides specific Collaboration revenue figures: $4.472 billion (FY2022) and $4.113 billion (FY2024), with accurate percentage calculations (9% decline vs FY2022, 2% rise vs FY2023). (5) Notes the retroactive restatement of prior periods to the new structure. (6) Provides additional detail on Collaboration sub-components (Webex Suite, Collaboration Devices, Contact Center, CPaaS) that adds valuable context. (7) Correctly synthesizes multi-hop information across fiscal years and product categories. MINOR CONSIDERATIONS: The answer goes slightly beyond the ground truth by providing specific revenue numbers and sub-category details, but these appear to be accurate supplementary information from the source documents (as indicated by page references). The ground truth focuses on structural changes while the LLM answer adds quantitative context, which enhances rather than detracts from the response. All numeric values are presented with appropriate precision and the calculations are mathematically correct. The answer directly addresses the question about how segmentation evolved and specifically addresses the Collaboration category's role in this evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 450,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "In the 2022 Form 10‑K Amgen listed the 3.125 % 2025 Notes with a $1 billion notional amount and disclosed that the interest‑rate‑swap that hedges those notes had an effective rate of **LIBOR + 1.8 %** (see page 132). In the 2023 Form 10‑K the same $1 billion of 3.125 % 2025 Notes is shown, but the swap‑rate table now reports an effective rate of **SOFR + 2.1 %** (see page 144), reflecting the company’s transition from a LIBOR‑based to a SOFR‑based benchmark and a modest increase in the spread.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INTEREST RATE FRAMEWORK ERROR - The LLM claims the 2022 rate was 'LIBOR + 1.8%' but the ground truth explicitly states 'no specific interest rate framework was disclosed' in 2022. This is a fundamental misrepresentation of what was actually disclosed. (2) SWAP MECHANISM CONFUSION - The LLM frames the disclosure as being about 'interest-rate-swap' hedges with 'effective rates,' but the ground truth indicates the 2023 disclosure was about the actual interest rate mechanism of the notes themselves (SOFR + 2.1%), not swap rates. The LLM appears to have confused or conflated the notes' interest rate structure with hedging swap information. (3) CORRECT ELEMENTS - The LLM correctly identifies: the $1 billion notional amount, the 3.125% coupon, the 2025 maturity, the transition from LIBOR to SOFR, the 2.1% spread in 2023, and the general concept of evolution between 2022 and 2023. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize information across two years, it does so incorrectly by introducing information (LIBOR + 1.8% in 2022) that was not disclosed according to the ground truth. The core error is presenting a 2022 interest rate framework that did not exist in the actual disclosure. (5) SEMANTIC MISMATCH - The ground truth emphasizes a shift from 'purely quantitative disclosure' (just the carrying value) to 'more detailed qualitative and quantitative presentation' (including the interest rate mechanism). The LLM misses this key distinction about the nature of the disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 443,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP’s total proved natural‑gas reserves in the Asia Pacific/Middle East fell from **326 billion cubic feet (BCF) at year‑end 2022** to **312 BCF at year‑end 2023** and **296 BCF at year‑end 2024** – a net decline of roughly 30 BCF (≈ 9 %) over the period【page_145】. Nevertheless, the 2024 filing notes that equity‑affiliate reserves in the region were boosted by higher LNG spot prices, technical revisions and recent acquisitions, and that extensions and discoveries occurred in the Middle East and Australia【page_146】, signaling that ConocoPhillips continues to view Asia Pacific/Middle East as a strategic focus despite the modest reserve contraction.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "In 2022 Alphabet repurchased 469 million Class C shares for about $52.6 billion, while in 2023 it bought back 450 million Class C shares for roughly $52.9 billion (Note 11, page 81). The slight decline in share count but increase in dollar outlay – together with the rise in total buy‑back spend from $59.3 bn to $62.2 bn – shows the company is maintaining an aggressive share‑repurchase program, using cash to return value to shareholders even as share prices rise.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate information but has some notable gaps and presentation issues: (1) CORRECT ELEMENTS: The total repurchase amounts of $59.3B (2022) and $62.2B (2023) are accurate and match ground truth. The share count figures (469M and 450M Class C shares) and per-share costs (~$52.6B and ~$52.9B) appear reasonable and internally consistent. The reasoning about aggressive share repurchase programs and capital allocation is sound. (2) MISSING INFORMATION: The LLM answer omits the April 2023 Board authorization of $70.0B in additional repurchase authority and the $36.3B remaining available as of December 31, 2023. This is significant context for understanding the company's capital allocation strategy going forward. (3) FOCUS ISSUE: The ground truth emphasizes that repurchases included BOTH Class A and Class C shares, while the LLM answer focuses narrowly on Class C shares only. The question specifically asks about 'Class C Capital Stock,' so this narrow focus is technically responsive, but it misses the broader context that the $59.3B and $62.2B figures represent combined Class A and C repurchases. (4) QUANTITATIVE VERIFICATION: The numbers provided ($59.3B, $62.2B, 469M, 450M shares, ~$52.6B, ~$52.9B) are internally consistent and appear accurate based on the ground truth figures. The calculation logic (share count × price ≈ total spend) is sound. (5) REASONING QUALITY: The multi-hop synthesis connecting share count decline, dollar increase, and rising share prices is logical and demonstrates good analytical thinking about capital allocation strategy. However, the answer would be stronger with the additional authorization details. The answer correctly identifies the strategic intent but incompletely captures the full scope of the company's repurchase program.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 492,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "In the 2022 filing AIG said it applied frequency‑/severity‑based reserving only to short‑tail classes such as U.S. Property (and similar program‑property lines), while it explicitly avoided those methods for high‑severity lines like aviation because the claim mix and severity varied widely from year to year【page_273】. By the 2023 filing the company is using frequency‑/severity analysis as part of a combined approach for U.S. Workers’ Compensation – a long‑tail, risk‑sharing line whose large‑deductible business and slower reporting pattern make frequency and severity trends useful for reserve setting【page_202】. The shift shows AIG expanding the use of frequency‑/severity methods from primarily short‑tail property exposures to more complex, long‑tail lines where claim emergence is slower and the mix of deductible‑retention structures drives reserve uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about AIG's evolution in frequency/severity methods between 2022 and 2023. STRENGTHS: (1) All factual claims are correct - accurately identifies 2022 application to short-tail U.S. Property, explicit avoidance for aviation due to high severity and varying claim mix, and 2023 expansion to U.S. Workers' Compensation. (2) Correctly characterizes the methodological shift from short-tail to long-tail applications. (3) Accurately explains the reasoning: 2022 avoidance of aviation due to claim mix variability; 2023 adoption for Workers' Comp due to risk-sharing features, large deductible business, and slower reporting patterns. (4) Properly synthesizes multi-hop information across two years of filings, showing understanding of how the company's approach evolved. (5) Correctly identifies Workers' Compensation as a long-tail line and explains why frequency/severity methods became applicable there. (6) Includes appropriate contextual details about deductible-retention structures and claim emergence patterns. (7) Page citations provided (273, 202) add credibility. MINOR CONSIDERATIONS: The answer is slightly more detailed and interpretive than the ground truth (e.g., explaining 'why' frequency/severity became useful for Workers' Comp), but this represents value-added explanation rather than error. The semantic meaning aligns perfectly with the ground truth. No numerical errors, date errors, or entity misidentifications present. The reasoning chain is sound and demonstrates proper synthesis of information across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 452,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "In 2023 Amgen’s collaboration with BeiGene showed a mixed trend versus 2022: cost‑recovery from BeiGene fell sharply to **$109 million** (down from **$199 million** in 2022)【page_131】, while Amgen’s product sales to BeiGene more than doubled to **$125 million** (up from **$64 million** in 2022)【page_131】.  At the same time, profit‑and‑loss‑share expenses for the initial commercialization period declined to **$40 million** from **$53 million** a year earlier【page_131】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: (1) Cost recovery: $199M (2022) → $109M (2023) ✓, (2) Product sales: $64M (2022) → $125M (2023) ✓, (3) Profit and loss sharing expenses: $53M (2022) → $40M (2023) ✓. The calculations and directional changes are accurate (cost recovery decreased, product sales more than doubled, P&L expenses declined). The multi-hop synthesis correctly identifies the evolution across all three financial relationship dimensions from 2022 to 2023. The LLM appropriately characterizes the trend as a 'mixed trend' and correctly interprets the pattern as indicating collaboration maturation with increased product commercialization and reduced R&D cost sharing. The answer is well-structured with clear citations to source material. Minor deduction (1 point) only because the LLM answer doesn't explicitly state the interpretive conclusion about 'maturation of the collaboration' as clearly as the ground truth, though the data presentation implicitly supports this interpretation. The semantic meaning and factual content are fully aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 328,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves fell from 326 BCF at year‑end 2022 to 312 BCF at year‑end 2023 and to 296 BCF at year‑end 2024 (direct‑operation totals)【page_145】. During the same span the region saw modest upward revisions of +6 BCF in 2022 and +9 BCF in 2023, turning into a ‑2 BCF downward revision in 2024, while production drawdowns reduced reserves by 24 BCF (2022), 25 BCF (2023) and 24 BCF (2024)【page_145】. The company made no direct purchases, but equity‑affiliate holdings in the region grew by 4 BCF in 2022 and surged to 1,534 BCF in 2023 before showing no new purchases in 2024 (all affiliate reserves are in Asia Pacific/Middle East)【page_146】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detail than the ground truth, including year-by-year progression and affiliate holdings information. However, there are critical quantitative discrepancies that lower the overall score:\n\n(1) CORRECT ELEMENTS:\n- End-year reserves correctly stated: 326 BCF (2022), 312 BCF (2023), 296 BCF (2024)\n- 2023 revisions: +9 BCF matches ground truth\n- 2024 production: 24 BCF stated (ground truth says 25 BCF - minor discrepancy)\n- No purchases in 2024 correctly identified\n- Multi-hop synthesis across revisions, production, and purchases is sound\n\n(2) QUANTITATIVE ERRORS:\n- Production in 2022: LLM states 24 BCF, but ground truth doesn't mention 2022 production figures\n- Production in 2023: LLM states 25 BCF, but ground truth doesn't mention 2023 production figures\n- 2024 production: LLM states 24 BCF, ground truth states 25 BCF (1 BCF discrepancy)\n- 2022 revisions: LLM states +6 BCF, but ground truth doesn't mention 2022 revisions\n- 2024 revisions: LLM states -2 BCF, but ground truth doesn't mention 2024 revisions\n- Affiliate holdings data (4 BCF in 2022, 1,534 BCF in 2023) is not mentioned in ground truth\n\n(3) MULTI-HOP REASONING:\nThe LLM correctly synthesizes information across multiple years and categories (revisions, production, purchases, affiliate holdings). The logic connecting reserve changes to underlying drivers is sound. However, the ground truth appears to focus only on direct-operation reserves, while the LLM introduces affiliate holdings data that may not be directly responsive to the original question.\n\n(4) COMPLETENESS ISSUE:\nThe ground truth is notably sparse, providing only 2022 and 2024 endpoints with limited detail on 2023. The LLM provides year-by-year progression (2022→2023→2024) which is more complete, but introduces data points not in the ground truth. The discrepancy in production figures (24 vs 25 BCF for 2024) is a material error that affects correctness.\n\nThe answer demonstrates good synthesis and contextual understanding but contains quantitative inaccuracies that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 564,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "In the 2022 Form 10‑K FedEx said it was committed to buying **14 Boeing 767‑300 Freighters in 2023 and another 14 in 2024 (plus 10 in 2025)** – a large near‑term boost to that aircraft type【page_40】. By the 2024 Form 10‑K the schedule had been revised to **only 11 B767Fs for delivery in 2025 and 3 in 2026**, with the 2023‑2024 deliveries removed【page_117】. This reduction and postponement signals that FedEx is scaling back and delaying B767F acquisitions, likely shifting focus toward newer, more fuel‑efficient aircraft and a more cost‑controlled, modernized fleet strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental misinterpretation of the ground truth. The original answer states FedEx projected 14 B767F aircraft for BOTH 2023 and 2024 (meaning 14 per year), but the LLM incorrectly interprets this as '14 in 2023 and another 14 in 2024' (28 total), then adds 'plus 10 in 2025' for a total of 38 aircraft. This is a major factual error. The ground truth clearly indicates: 2022 projection was 14 for 2023, 14 for 2024, and 10 for 2025. By 2024, projections changed to 11 for 2025 and 3 for 2026. The LLM's statement about '2023-2024 deliveries removed' is also incorrect - the ground truth doesn't indicate removal but rather a shift in the projection timeline. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution from 2022 to 2024 and draws a reasonable strategic conclusion about fleet modernization, which shows some understanding of the multi-hop nature. However, this reasoning is built on incorrect numerical foundations. ENTITY ACCURACY: Correctly identifies FedEx and B767F aircraft, correctly references 2022 and 2024 Form 10-Ks. SEMANTIC ISSUES: The interpretation of what changed between 2022 and 2024 is fundamentally flawed due to the quantitative misreading. The conclusion about 'scaling back and delaying' is partially supported by the actual data (reduction from 14 to 11 to 3), but the framing of what was originally planned is wrong. The answer demonstrates some contextual understanding of fleet strategy but fails on the core numerical accuracy required for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 434,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "In the 2022 Form 10‑K AIG explained that expected‑loss‑ratio (ELR) methods were used “to determine the loss reserves for the latest accident year” on short‑tail classes such as U.S. Property, aviation and program business, especially where loss‑development patterns were inconsistent, losses were low‑frequency/high‑severity or there was little loss history (see page 273). By the 2023 filing the company broadened ELR use – it now applies the method to Workers’ Compensation (page 202) and to excess‑of‑deductible casualty lines, giving ELR “significant weight in the most recent five accident years” and adjusting the ratios for rate changes, loss‑trend inflation and market conditions (see page 200), indicating a more line‑specific and forward‑looking rationale.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the evolution of AIG's Expected Loss Ratio Methods between 2022 and 2023. STRENGTHS: (1) Correctly identifies 2022 usage focused on latest accident year for short-tail classes (U.S. Property, aviation, program business), matching the ground truth's emphasis on high-severity contexts. (2) Accurately captures the 2023 expansion to Workers' Compensation and excess-of-deductible casualty lines, which aligns with the ground truth's shift to long-tail applications. (3) Provides specific page references (273, 202, 200) that add credibility and detail. (4) Correctly identifies the reasoning evolution: from handling inconsistent loss-development patterns and low-frequency/high-severity claims to a more sophisticated approach accounting for rate changes, loss-trend inflation, and market conditions. (5) The characterization of the shift as 'more line-specific and forward-looking' is semantically equivalent to the ground truth's description of moving from 'short-term forecasting in high-severity contexts to broader application in long-tail, structurally complex lines.' MINOR WEAKNESSES: (1) The LLM answer mentions 'excess-of-deductible casualty lines' which is not explicitly mentioned in the ground truth, though this represents additional detail rather than contradiction. (2) The ground truth specifically emphasizes 'complex risk-sharing features in policies' for 2023, which the LLM answer doesn't explicitly mention, though it does reference 'structurally complex' implicitly through the forward-looking adjustments. (3) The ground truth's specific mention of 'extended loss emergence periods' for long-tail lines is not explicitly stated in the LLM answer, though the Workers' Compensation classification as long-tail is correct. QUANTITATIVE ACCURACY: No numerical errors detected. Page references appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple lines of business, correctly identifying the evolution pattern. The logic connecting specific methodological changes to business line characteristics is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 585,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "In the 2022 filing Cisco described the enterprise data‑center as undergoing a “fundamental transformation” driven by the convergence of compute, networking, storage and software, and warned that rivals were using acquisitions and new strategic alliances to build end‑to‑end data‑center solutions—creating heightened competition even from some of Cisco’s own long‑term alliance partners (2022 p.11). By the 2024 filing the same transformation is still highlighted, but the emphasis shifts to the risk that Cisco’s strategic‑alliance partners may themselves partner with competitors and erode Cisco’s business, underscoring a more acute focus on alliance‑driven competitive threats (2024 p.8). This reflects an evolution from noting external competitive moves to stressing the dual‑edged nature of Cisco’s alliances in the data‑center market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core theme of enterprise data center transformation in both 2022 and 2024. (2) Accurately captures that Cisco warned about rivals using acquisitions and alliances to build end-to-end solutions in 2022. (3) Correctly notes the shift in emphasis between years regarding alliance partner risks. (4) Appropriately references page numbers (2022 p.11, 2024 p.8) showing document-specific sourcing. (5) The semantic understanding of the evolution from external competitive moves to alliance-driven threats is sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to mention Nvidia Corporation, which the ground truth explicitly identifies as a new entrant in the competitive landscape by 2024. This is a significant factual gap in addressing the 'competitive landscape' component of the question. (2) The ground truth emphasizes that Cisco 'expanded its focus on strategic alliances aimed at industry advancement and new market creation' by 2024, but the LLM answer focuses primarily on the risks/threats from alliances rather than the positive expansion of alliance strategy. This represents an incomplete characterization of the 2024 positioning. (3) The LLM answer frames the evolution as 'from noting external competitive moves to stressing dual-edged nature of alliances,' but the ground truth suggests a more nuanced evolution that includes both continued emphasis on transformation AND expanded focus on new alliance opportunities and market creation.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across the two years (2022 vs 2024) and correctly identifies the shift in messaging. However, it fails to fully synthesize all required elements: the competitive landscape evolution (missing Nvidia), the strategic alliance expansion (missing new market creation focus), and the complete picture of how Cisco's positioning evolved.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on factual claims. The page references appear plausible but cannot be independently verified. The core factual claims about transformation and alliances are directionally correct but incomplete.\n\nOVERALL ASSESSMENT: The answer demonstrates partial understanding of the evolution but misses key elements (Nvidia, expanded alliance focus on market creation) that are explicitly mentioned in the ground truth. The characterization of the evolution is somewhat accurate but incomplete and slightly misframed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 678,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "In both 2022 and 2023 Amgen’s interest‑rate swap for the 3.125 % 2025 notes carried a notional amount of $1 billion and an effective rate of SOFR + 2.1%, meaning the rate and notional amount were unchanged from 2022 to 2023【page_144】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Notional Amount Evolution: The ground truth clearly states the notional amount was $5.2 billion in 2022 and decreased to $1.0 billion in 2023. The LLM claims it was $1 billion in BOTH years and remained unchanged. This is a fundamental misrepresentation of the key evolution being asked about. (2) CRITICAL ERROR - 2022 Context: The ground truth indicates in 2022 there were new interest rate swaps entered into after termination of previous swaps on a $5.2 billion principal amount, reflecting a dynamic hedging strategy. The LLM completely omits this important context and the $5.2 billion figure. (3) PARTIAL CORRECTNESS - Effective Interest Rate: The LLM correctly identifies the 2023 effective rate as SOFR + 2.1%, which matches the ground truth. However, the ground truth does not specify what the effective rate was in 2022, so the LLM's claim that it was unchanged cannot be verified and appears to be an assumption. (4) MULTI-HOP REASONING FAILURE: The question asks how the metrics 'evolved' between 2022 and 2023, implying change. The LLM's answer that nothing changed directly contradicts the ground truth's narrative of reduction in hedged notional exposure and shift in interest rate environment. The LLM failed to synthesize the temporal comparison correctly. (5) The LLM provides a citation (page_144) but the answer content is factually incorrect regardless of source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 414,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "In the 2022 filing Cisco described AppDynamics as a “key element” of its full‑stack observability push – naming it alongside ThousandEyes and Intersight for application‑performance monitoring【page_5】. By the 2024 filing Cisco has folded AppDynamics into a dedicated “Observability” product category (the Observability Suite) and is spotlighting that category’s strong growth – a 27% year‑over‑year increase driven by the Observability Suite and ThousandEyes【page_41】【page_42】 – showing that AppDynamics has moved from a highlighted component to a core part of a revenue‑focused observability offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic evolution of AppDynamics within Cisco's portfolio from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of AppDynamics as a 'key element' of full-stack observability alongside ThousandEyes and Intersight - matches ground truth language and entities. (2) Accurately captures the 2024 shift to a dedicated 'Observability' category/suite that subsumed AppDynamics. (3) The 27% year-over-year growth figure for the Observability Suite is specific and appears factually grounded, adding quantitative support to the strategic shift narrative. (4) The multi-hop reasoning is sound: correctly synthesizes the evolution from 'highlighted component' (2022) to 'core part of revenue-focused offering' (2024). (5) All entity names are correct (Cisco, AppDynamics, ThousandEyes, Intersight, Observability Suite). MINOR CONSIDERATIONS: (1) The ground truth uses 'formalized and integrated strategic emphasis on observability as a standalone pillar' while the LLM uses 'revenue-focused observability offering' - these are semantically equivalent but emphasize slightly different aspects (formalization vs. revenue focus). Both are valid interpretations of the strategic shift. (2) The LLM provides more specific quantitative evidence (27% YoY growth) than the ground truth, which strengthens the answer without contradicting it. (3) Page citations are included in the LLM answer, which adds credibility though cannot be independently verified here. The answer comprehensively addresses both the 2022 baseline and 2024 evolution, correctly identifying the shift from component-level emphasis to category-level integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 468,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The interest‑rate swap protecting the 4.663 % 2051 Notes continued to cover $1.5 billion of notional in both years【page_132†L31-L34】.  In 2022 the swap’s effective rate was LIBOR + 4.1%, while by 2023 it had been reset to SOFR + 4.3%【page_144†L13-L16】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the notional amount ($1.5 billion) for both 2022 and 2023, and accurately captures the effective interest rate evolution from LIBOR + 4.1% in 2022 to SOFR + 4.3% in 2023. The multi-hop synthesis across years is sound. However, there are some discrepancies with the ground truth: (1) The ground truth states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged, not that the swap specifically covered $1.5 billion in 2022. The LLM claims the notional was $1.5 billion in 'both years,' which appears to contradict the ground truth's indication that the 2022 situation involved a $5.2 billion principal amount. (2) The ground truth mentions that swaps were 'terminated and replaced at then-current interest rates' in 2022, suggesting a transition event, whereas the LLM presents the 2022 rate as LIBOR + 4.1% without explicitly noting this termination/replacement context. (3) The ground truth provides more nuanced context about the hedging strategy evolution, while the LLM focuses narrowly on the rate change. The quantitative data for 2023 (SOFR + 4.3%, $1.5 billion) is accurate, but the 2022 characterization appears incomplete or potentially inaccurate regarding whether the $1.5 billion notional applied in 2022. The answer demonstrates good multi-hop reasoning in connecting the rate changes across years but lacks the full contextual accuracy regarding the 2022 hedging structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 408,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K AIG applied expected‑loss‑ratio techniques across a range of lines—U.S. Workers’ Compensation, U.S. Excess Casualty, U.S. Other Casualty and U.S. Financial Lines (D&O)—primarily through loss‑cost‑trend assumptions and Bornhuetter‑Ferguson/Cape‑Cod methods, with segmentation only at the broad line‑of‑business or “year‑and‑subset” level (see page 66 and the sensitivity tables on page 68). By the 2023 filing the firm stresses expected‑loss‑ratio methods especially for business written in excess of a deductible, giving them significant weight for the most recent five accident years, and now segments those exposures much more granularly—by guaranteed‑cost versus excess‑of‑deductible, by state and industry, by deductible size and by whether the claim is handled by AIG or a third‑party administrator (see page 200, page 202 and the U.S. Workers’ Compensation discussion). This reflects a shift from a broad, line‑level application in 2022 to a more targeted, recent‑year‑focused approach with detailed segmentation in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) The LLM claims that in 2022, AIG applied expected-loss-ratio methods across multiple lines including U.S. Workers' Compensation, U.S. Excess Casualty, U.S. Other Casualty, and U.S. Financial Lines (D&O). However, the ground truth explicitly states that in 2022, AIG only referenced expected loss ratio methods in a 'general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business.' The LLM's claim about 2022 application to specific lines of business directly contradicts this. (2) The LLM provides specific page references (pages 66, 68, 200, 202) that cannot be verified against the ground truth and appear to be fabricated details. (3) The LLM's characterization of 2022 as having 'broad line-of-business or year-and-subset level' segmentation is not supported by the ground truth, which indicates NO detailed segmentation was specified in 2022. (4) While the LLM correctly identifies that 2023 shows more granular segmentation (risk-sharing features, state and industry subsets, deductible size, claim handling entities), it incorrectly backdates this specificity to 2022. (5) The core evolution narrative is inverted - the LLM suggests 2022 had broader application with less detail, when the ground truth indicates 2022 had minimal specification and 2023 introduced the detailed application. The answer demonstrates hallucination of specific filing details and misrepresents the 2022 baseline, making the comparison fundamentally unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 445,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo’s board listed the 2.850 % Senior Notes due 2026 among the series of notes it was authorizing at that time (see the board‑resolution line that includes “…the 2.850 % Senior Notes due 2026…”【page_129†L4-L7】). By the 2024 filing the same 2.850 % Senior Notes due 2026 remained on the authorized list, but PepsiCo also added a new tranche of higher‑coupon, longer‑dated senior notes—4.500 % due 2029, 4.800 % due 2034 and 5.250 % due 2054—showing that the company broadened its debt‑issuance strategy beyond the original 2026 issue【page_130†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the specific senior notes introduced in 2024. The ground truth states PepsiCo added '7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035' in 2024, but the LLM claims the new notes were '4.500% due 2029, 4.800% due 2034 and 5.250% due 2054.' These are completely different coupon rates and maturity dates—not minor formatting variations. For example: (1) 7.00% vs 4.500% for 2029 notes is a 250 basis point difference, (2) 5.50% vs 4.800% for the 2030s maturity is a 70 basis point difference, (3) the ground truth mentions 2035 maturity while LLM states 2034 and 2054. MULTI-HOP REASONING: The LLM correctly identifies the core concept that PepsiCo maintained the 2.850% Senior Notes due 2026 while expanding its debt strategy with higher-yielding instruments. However, the specific instruments cited are factually wrong, undermining the credibility of the analysis. COMPLETENESS: The answer addresses the evolution between 2023 and 2024 and discusses the broader debt issuance strategy, but the incorrect specific numbers make the answer materially inaccurate. SEMANTIC EQUIVALENCE: While the general narrative about diversification and longer-term strategy is conceptually similar to the ground truth, the specific financial instruments are wrong, which is critical in a financial analysis context. The citation format (page references) suggests the LLM attempted to ground its answer in source material, but the actual numbers provided do not match the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 435,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s channel‑partner financing guarantees have been trimmed. In FY 2022 the company said the maximum potential future payments on those guarantees were about **$188 million** (net total $179 million after accounting for $9 million of deferred revenue) and $1.4 billion of partner financing was subject to guarantees (see 2022 10‑K p. 94). By FY 2024 the same metric fell to roughly **$127 million** of maximum potential payments, with about $13 million recorded as deferred revenue (see 2024 10‑K p. 50). The reduction signals that Cisco is actively tightening its guarantee commitments and limiting contingent credit exposure, reflecting a more conservative financial‑risk‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims FY2022 'maximum potential future payments' were $188 million, but the ground truth explicitly states the balance of financing subject to guarantees was $1.4 billion. These are vastly different figures ($188M vs $1.4B - a 7.4x discrepancy). The LLM also cites $127 million for FY2024, but the ground truth indicates that by FY2024, these figures were 'no longer explicitly quantified in the disclosures.' The LLM appears to have confused or misidentified the relevant metrics entirely. (2) METRIC CONFUSION: The ground truth distinguishes between (a) volume of channel partner financing ($27.9B in FY2022) and (b) balance subject to guarantees ($1.4B in FY2022). The LLM conflates these with 'maximum potential future payments' which is a different metric altogether. The LLM's cited figures ($188M, $127M) do not appear in the ground truth at all. (3) DISCLOSURE CHANGE MISCHARACTERIZATION: The ground truth notes that by FY2024, specific volumes were 'no longer explicitly quantified,' indicating reduced transparency. The LLM claims to have found FY2024 figures ($127M) that allegedly exist in the 2024 10-K, contradicting the ground truth's statement that these were no longer disclosed. (4) REASONING FLAW: The LLM's conclusion about 'tightening guarantee commitments' is based on comparing numbers that appear to be incorrect or misidentified. The ground truth's more cautious conclusion ('prevents definitive conclusions about the actual change in exposure') is more appropriate given the disclosure changes. (5) SOURCE CITATION ISSUES: The LLM cites specific page numbers (2022 10-K p. 94, 2024 10-K p. 50) but the numbers provided do not align with the ground truth data, suggesting either fabricated citations or severe misreading of source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 518,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45 % 2030 Notes were still outstanding in both years and continued to be hedged with a $1 billion interest‑rate‑swap position.  As shown in the 2023 filing, the swap gave the notes an effective rate of SOFR + 1.3 % for both December 31 2022 and December 31 2023, meaning the amount covered and the floating‑rate structure did not change between 2022 and 2023【page_144】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. CRITICAL ERROR: The LLM states that the effective rate was 'SOFR + 1.3% for both December 31 2022 and December 31 2023,' implying no change in the interest rate structure between the two years. However, the ground truth clearly indicates that in 2022, the swap converted the fixed-rate interest to a 'floating LIBOR-based coupon,' while by 2023, it had 'transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%.' This is a material difference - the benchmark changed from LIBOR to SOFR between 2022 and 2023. The LLM's claim that 'the amount covered and the floating-rate structure did not change between 2022 and 2023' is factually incorrect. CORRECT ELEMENTS: (1) The $1.0 billion notional amount is correct for both years, (2) The 2.45% 2030 Notes remained outstanding in both years, (3) The SOFR + 1.3% rate is correct for 2023. INCORRECT ELEMENTS: (1) The LLM incorrectly states the 2022 rate was SOFR + 1.3% when it was actually LIBOR-based, (2) The LLM incorrectly concludes there was no change in the floating-rate structure between years when there was a significant benchmark transition from LIBOR to SOFR. The multi-hop reasoning fails because the LLM did not properly synthesize the evolution of the interest rate structure across the two years. The answer demonstrates partial understanding of the notes' status but fundamentally misses the key evolution that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 410,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "In the 2022 Form 10‑K FedEx disclosed that it had issued $970 million of Series 2020‑1AA pass‑through certificates, secured by 19 Boeing aircraft, and that “the payment obligations of FedEx Express in respect of the Certificates are fully and unconditionally guaranteed by FedEx” 【page_94】. In the 2023 filing the same series is still described as fully guaranteed 【page_96】, but the company also adds that “the pass‑through certificates are not direct obligations of, or guaranteed by, FedEx or FedEx Express” because they are funded through leveraged operating leases 【page_98】. Thus, while the specific Series 2020‑1AA certificates remain guaranteed, FedEx’s overall relationship to pass‑through certificates has shifted to emphasize that they are indirect liabilities supported by lease payments rather than direct corporate guarantees.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - FUNDAMENTAL CONTRADICTION: The LLM answer contains a major logical contradiction that undermines its core claim. It states that 'the specific Series 2020-1AA certificates remain guaranteed' in 2023, but then acknowledges that FedEx added language saying 'pass-through certificates are not direct obligations of, or guaranteed by, FedEx or FedEx Express.' These two statements are mutually exclusive and cannot both be true. The ground truth clearly indicates a SHIFT from guaranteed (2022) to NOT guaranteed (2023), but the LLM tries to reconcile this by claiming both are true simultaneously, which is factually incorrect.\n\nQUANTITATIVE ACCURACY (8/10): The dollar amount ($970 million), aircraft count (19 Boeing aircraft), and net book value ($1.8 billion) are all correct. Numbers are accurate.\n\nQUALITATIVE ACCURACY (3/10): The reasoning is fundamentally flawed. The LLM misinterprets the evolution by suggesting the 2020-1AA certificates remained guaranteed while also being not guaranteed. This is a critical synthesis error. The ground truth shows a clear evolution: 2022 = direct guarantee by FedEx; 2023 = no direct guarantee. The LLM's attempt to say 'the specific Series 2020-1AA certificates remain guaranteed' contradicts the 2023 clarification that pass-through certificates are NOT guaranteed. The LLM appears to have conflated different statements or misread the 2023 filing.\n\nCONTEXTUAL RELEVANCE (5/10): The answer addresses the question about evolution between years but arrives at an incorrect conclusion about what that evolution was. The framing about 'indirect liabilities supported by lease payments' is somewhat relevant but doesn't resolve the fundamental contradiction.\n\nKEY ERRORS: (1) Claiming Series 2020-1AA 'remain guaranteed' in 2023 when the ground truth explicitly states they are NOT guaranteed in 2023; (2) Failing to clearly articulate the shift from direct guarantee to no guarantee; (3) The citation references (page numbers) cannot be verified but the semantic content contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 555,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "In 2023 Mastercard offset $12.2 billion of its $75.0 billion gross settlement exposure with risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) 【page_112】, and in 2024 it increased both the exposure to $78.4 billion and the mitigation to $13.5 billion 【page_105】. The rise in mitigation alongside higher gross exposure shows the company is actively scaling its collateral and credit‑enhancement tools to match growing settlement risk, underscoring a disciplined, proactive risk‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - 2023 gross settlement exposure of $75.0 billion (vs. ground truth $75,023 million), risk mitigation of $12.2 billion (vs. $12,167 million), 2024 gross settlement exposure of $78.4 billion (vs. $78,385 million), and mitigation of $13.5 billion (vs. $13,466 million). The number format variations ($75.0B vs $75,023M) are acceptable and demonstrate proper rounding conventions. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two fiscal years and multiple data points, properly comparing the evolution of both metrics. The calculation of the trend (both exposure and mitigation increased) is accurate. ENTITY ACCURACY: Mastercard is correctly identified, fiscal years 2023 and 2024 are correct, and the financial metrics (gross settlement exposure and risk mitigation arrangements) are properly identified. REASONING QUALITY: The interpretation that increased mitigation alongside higher exposure indicates a 'disciplined, proactive risk-management approach' is sound and well-supported by the data. The mention of specific mitigation tools (cash collateral, letters of credit, guarantees) adds helpful context. COMPLETENESS: The answer addresses all aspects of the question - the evolution from 2023 to 2024 and what it indicates about risk management strategy. The only minor consideration is that the ground truth uses slightly more precise numbers ($12,167M vs $12.2B), but the LLM's rounding is standard practice and does not constitute an error. The answer is comprehensive, accurate, and demonstrates strong understanding of the multi-hop financial analysis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 472,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike’s liabilities for foreign‑exchange forwards and options that are formally designated as cash‑flow hedges rose sharply – from about **$48 million in FY 2022** (the sum of $37 million accrued liabilities and $11 million deferred‑tax liabilities) to roughly **$115 million in FY 2024** (about $110 million accrued plus $5 million deferred‑tax liabilities)【page_83】.  The $67 million increase signals that Nike has expanded its hedging program, likely to cover a larger foreign‑currency exposure and to more aggressively lock in cash‑flow protection for its global operations【page_83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - FY2022 total of $48 million ($37M accrued + $11M deferred), FY2024 total of $115 million ($110M accrued + $5M deferred), and the calculated increase of $67 million. The arithmetic is accurate and properly presented. ENTITY ACCURACY: Nike is correctly identified, fiscal years 2022 and 2024 are correct, and the financial metrics (foreign exchange forwards/options designated as hedging instruments) are properly categorized across accrued liabilities and deferred income tax accounts. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple balance sheet line items and years, properly combining the two liability categories for each year and calculating the year-over-year change. REASONING QUALITY: The interpretation that the $67 million increase signals expanded hedging activity and larger foreign-currency exposure is sound and aligns with the ground truth's assessment. The characterization of this as 'more aggressively lock in cash-flow protection' is a reasonable inference from the data. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing ('cash-flow hedges' vs 'hedging instruments') but this is semantically equivalent and actually more specific. The citation references (page_83) add credibility. The answer fully addresses both parts of the question: the change in liabilities and what it indicates about Nike's strategy. No factual errors, calculation errors, or omissions were identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 431,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 filing Bounty was already called out as a key Family‑Care brand within the Baby, Feminine & Family Care segment (listed among the “Major Brands” and noted as having “over 40%” market share in North America)【page_18】【page_20】. The 2023 filing repeats the same placement – Bounty appears again in the segment’s brand list and the North‑American share is still described as “over 40%”【page_18】【page_20】. This unchanged treatment signals that Bounty’s visibility and importance within the segment remained strong and stable from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states: In 2022, Bounty was NOT explicitly listed among key brands, but in 2023 it WAS explicitly included - representing an increase in visibility. The LLM answer claims the opposite: that Bounty was already called out as a key brand in 2022 and remained unchanged in 2023. This is a fundamental factual error that undermines the entire answer. Additionally, the LLM introduces specific quantitative claims (\"over 40% market share in North America\") that are not mentioned in the ground truth, which explicitly states 'the filings do not provide specific market share or sales figures.' The LLM cites page references (page_18, page_20) but these citations cannot be verified against the ground truth provided. The LLM's conclusion that visibility 'remained strong and stable' directly contradicts the ground truth's finding of an increase in visibility between 2022 and 2023. While the answer is contextually relevant to the question asked, it fails on the primary metric of factual accuracy regarding the evolution of Bounty's representation between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 329,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "In fiscal 2022 Oracle said that its hardware business – which includes Oracle Engineered Systems – records product revenue when the hardware and any related software are delivered to the customer, while hardware‑support contracts are recognized ratably over the contract term (2022 10‑K p. 105). In fiscal 2023 the company kept the same point‑in‑time recognition for the combined hardware‑software performance obligation, but now describes Engineered Systems as a core, integrated offering and notes that the hardware segment represents about 6 % of total revenue (down from roughly 7 % in FY‑2022) even as it continues to invest in R&D for new hardware products (2023 10‑K p. 43).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Oracle's hardware business approach between fiscal 2022 and 2023, including the revenue recognition methodology (point-in-time for hardware/software combined, ratable for support contracts) and the strategic emphasis on R&D investments. The answer appropriately synthesizes multi-hop information across two fiscal years and documents.\n\nSTRENGTHS:\n- Correctly identifies that revenue recognition remained consistent (point-in-time for hardware/software delivery)\n- Accurately notes the shift toward describing Engineered Systems as a \"core, integrated offering\"\n- Properly captures the emphasis on R&D investments in 2023 that wasn't explicitly mentioned in 2022\n- Provides specific page references (2022 10-K p. 105, 2023 10-K p. 43)\n- Good multi-hop synthesis across fiscal years\n\nWEAKNESSES:\n- The quantitative claims about revenue percentages (6% in FY2023 vs \"roughly 7% in FY2022\") are presented with specificity but cannot be verified against the ground truth provided. The ground truth does not mention these specific percentages, making it unclear if these numbers are accurate or inferred.\n- The ground truth emphasizes \"more detailed explanation\" of hardware and software as a \"combined performance obligation\" in 2023, which the LLM answer captures but could have emphasized more explicitly as a methodological evolution\n- The LLM answer adds specific page numbers that, while helpful, are not mentioned in the ground truth and cannot be independently verified\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across two fiscal years and identifies the evolution in both revenue recognition practices and strategic emphasis. The reasoning is sound and logically structured.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys the same essential information as the ground truth regarding the evolution of Oracle's hardware business approach, though with additional quantitative details that may or may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 545,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA’s sales grew from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% increase (27.5% operational growth, partially offset by a 0.6% currency headwind) (page_31). The company says this rise was driven by continued share‑gain and market growth in metastatic castration‑resistant prostate cancer, signalling a strong, upward market trajectory for the product (page_32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $1.881 billion (2022) and $2.387 billion (2023) match the ground truth values of $1,881 million and $2,387 million respectively (format variation is acceptable). The 26.9% growth calculation is accurate and correctly stated. The additional operational growth detail (27.5%) and currency headwind (-0.6%) are accurate supplementary information not contradicting the ground truth. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the sales evolution (numbers and growth rate) and explains the market trajectory implications. (3) ENTITY ACCURACY: ERLEADA is correctly identified, years (2022-2023) are correct, and the financial metrics are properly labeled. The mention of metastatic castration-resistant prostate cancer market context is accurate and relevant. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected sales data across two years, calculated the growth rate, and drew logical conclusions about market trajectory based on the performance data. The attribution to share-gain and market growth demonstrates understanding of underlying drivers. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while providing additional context (operational vs. currency impacts) that enhances rather than contradicts the original answer. The conclusion about 'strong, upward market trajectory' matches the ground truth's assessment. Minor deduction (1 point) only because the additional operational/currency breakdown, while accurate, goes slightly beyond what was explicitly in the ground truth statement, though this represents added value rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 490,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "In the 2023 filing Comcast framed local broadcast stations mainly as **affiliation partners** – it competes to win their agreements because they are “necessary to ensure the effective distribution of broadcast‑network programming to a nationwide audience” and it even competes with them for content and talent【page_14】. By the 2024 filing the tone has shifted to a **cost‑and‑negotiation focus**: Comcast now highlights rising programming expenses tied to “payments to certain local broadcast television stations in exchange for their required consent for the retransmission of broadcast network programming,” and stresses the need to secure and maintain affiliation and retransmission‑consent agreements, showing greater dependency on and leverage from those stations【page_23】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in CMCSA's relationship with local broadcast television stations from 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift from competition/affiliation focus in 2023 to dependency/cost-negotiation focus in 2024; (2) Accurately captures the key operational change regarding retransmission consent requirements; (3) Properly synthesizes multi-hop information across two fiscal years; (4) Uses appropriate terminology ('affiliation partners,' 'retransmission consent,' 'programming expenses'); (5) Correctly identifies CMCSA as Comcast; (6) Provides specific page references showing source documentation. MINOR WEAKNESSES: (1) The LLM answer frames the 2023 relationship as 'affiliation partners' with competition, while the ground truth emphasizes 'direct competition' more prominently - though both characterizations are compatible, the emphasis differs slightly; (2) The LLM answer could be slightly clearer that the 2024 shift represents movement from competition to dependency, though this is implied; (3) The phrase 'leverage from those stations' in the LLM answer is somewhat ambiguous - it could be read as CMCSA having leverage over stations, when the ground truth emphasizes CMCSA's dependency on stations. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension scores high (9/10) for accurate date/year references and proper fiscal period identification. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct (8/10) - minor deduction for the slight ambiguity in framing leverage dynamics. CONTEXTUAL RELEVANCE: Excellent alignment with the question's focus on competitive positioning and dependency evolution (9/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 486,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "MA’s held‑to‑maturity securities dropped sharply from **$306 million at the end of 2023** to **$38 million at the end of 2024**【page_86】, a decline of roughly $268 million. This large reduction shows the company is shedding its low‑yield, time‑deposit HTM portfolio and reallocating capital to other assets (e.g., available‑for‑sale or equity investments), indicating a strategic move toward a more flexible, potentially higher‑return investment approach【page_83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - HTM securities of $306 million in 2023 and $38 million in 2024 match the ground truth exactly. The calculated decline of $268 million is accurate ($306M - $38M = $268M). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of HTM securities values between 2023-2024, and (2) what this shift indicates about investment strategy. ENTITY ACCURACY: Company (MA), metric (HTM securities), and years (2023-2024) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical decline to strategic implications. The interpretation that the company is moving toward more flexible/higher-return investments is consistent with the ground truth's characterization of a shift toward more liquid or short-term positions. The additional detail about 'shedding low-yield, time-deposit HTM portfolio' and 'reallocating to available-for-sale or equity investments' provides reasonable elaboration on the strategic shift, though this specific detail is not explicitly stated in the ground truth. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as 'more flexible, potentially higher-return investment approach' is semantically equivalent to the ground truth's 'move toward more liquid or short-term investment positions.' Minor note: The page references (page_86, page_83) cannot be verified against the ground truth but do not affect factual accuracy. The answer is comprehensive, well-reasoned, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 447,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "In the 2022 filing the Always brand was listed under the Baby, Feminine & Family Care segment’s **Feminine‑Care** sub‑category (grouped with “Adult Incontinence, Feminine Care”) alongside a separate **Baby‑Care** sub‑category for diapers and wipes【page_19】. By the 2023 filing the brand is still a key name in the same segment, but the sub‑category is now labeled **Feminine‑Care (Adult Incontinence, Menstrual Care)** and the Baby‑Care sub‑category is no longer shown, indicating a shift to a more focused categorization on menstrual‑care products【page_18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues with accuracy and interpretation. CORRECT ELEMENTS: (1) Always was positioned in Baby, Feminine & Family Care segment in both years - correct; (2) The shift from broader categorization to more specific 'Menstrual Care' focus is accurately identified; (3) The 2023 sub-category label 'Feminine-Care (Adult Incontinence, Menstrual Care)' appears accurate. PROBLEMATIC ELEMENTS: (1) The claim that 'Baby-Care sub-category is no longer shown' in 2023 is misleading and potentially incorrect - the ground truth does not state Baby-Care was removed, only that Always' positioning shifted within Feminine Care; (2) The LLM conflates the removal of Baby-Care from Always' categorization with the removal of Baby-Care as a sub-category entirely, which is not supported by the ground truth; (3) The statement 'grouped with Adult Incontinence, Feminine Care' in 2022 is awkwardly phrased and could be misinterpreted as Always being grouped with those categories rather than being part of a Feminine Care category that includes those sub-categories. MULTI-HOP REASONING: The answer attempts to synthesize information across 2022 and 2023 filings but makes an unsupported leap regarding Baby-Care elimination. The core insight about the strategic shift toward 'Menstrual Care' positioning is sound, but the supporting details contain inaccuracies. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, so this scores well on what is present. QUALITATIVE ACCURACY: The reasoning about strategic positioning is partially sound but undermined by the incorrect claim about Baby-Care sub-category removal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 460,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "In the 2022 filing Oracle grouped Engineered Systems with its broader hardware revenues and said that “the hardware product and related software … are accounted for as a combined performance obligation. The revenues … are generally recognized at the point in time that the hardware product is delivered and ownership is transferred to the customer” (2022 p. 74). By the 2023 filing the company was positioning Engineered Systems as a core component of a distinct hardware segment that “represented 6 % of our total revenues in each of fiscal 2024 and 2023” and emphasized ongoing R&D investment in these products, while still recognizing revenue at the point of delivery of the hardware and its software (2023 p. 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Oracle Engineered Systems' evolution between 2022 and 2023. STRENGTHS: (1) All quantitative data is correct - the 6% revenue figure for fiscal 2023 and 2024 is accurately cited, matching the ground truth. (2) The revenue recognition methodology is correctly identified for both years - point-in-time recognition upon delivery of hardware and software as a combined performance obligation. (3) The multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (grouped with broader hardware, no specific percentage disclosed) to 2023 (explicit 6% disclosure, clearer positioning). (4) Strategic emphasis is properly captured - the answer notes R&D investment emphasis in 2023 and the positioning as a 'core component of a distinct hardware segment.' (5) Page citations (2022 p. 74, 2023 p. 43) add credibility and specificity. MINOR CONSIDERATIONS: (1) The ground truth mentions 'more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings' - the LLM answer doesn't explicitly detail these factors, though it does mention 'ongoing R&D investment.' This is a minor omission of contextual detail rather than a factual error. (2) The ground truth emphasizes that 2022 had 'no specific percentage of total revenue provided' while 2023 showed 'clearer and more consistent measurement' - the LLM captures this distinction well through the contrast between the two filings. The answer is semantically equivalent to the ground truth while being more concise and better structured with direct quotes from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 474,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "In the 2023 filing Comcast said it “represents the advertising sales efforts of certain third parties” and “works with representation firms as an extension of our sales force,” recording the ad revenue net of agency commissions. By the 2024 filing the language shifts to “enter into representation agreements under which we sell advertising on behalf of third parties,” indicating a more formal, principal‑based partnership while still using representation firms to sell a portion of its allocated ad inventory. This reflects a move from an informal representation role to a structured agreement where Comcast acts as the principal seller for third‑party ads.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Comcast's relationship with representation firms between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 model where Comcast 'works with representation firms as an extension of our sales force' and records revenue net of agency commissions; (2) Accurately captures the 2024 shift to 'representation agreements under which we sell advertising on behalf of third parties'; (3) Properly synthesizes the multi-hop comparison across both years; (4) Correctly interprets the semantic shift from informal to formal arrangements; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language ('principal-based partnership,' 'principal seller') that goes slightly beyond what the ground truth explicitly states - the ground truth describes it as 'deeper strategic alignment and expanded role' and 'shift from co-selling model to formalized representation structure' without explicitly using 'principal' terminology; (2) The phrase 'while still using representation firms to sell a portion of its allocated ad inventory' in the LLM answer could be seen as slightly ambiguous - it's not entirely clear if this refers to the same arrangement or a continuation of a separate arrangement. However, this is a minor interpretive difference rather than a factual error. The core message and multi-hop reasoning are sound and align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 408,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle still accounts for its industry‑specific hardware (and the associated firmware or operating system) as a single performance‑obligation and records the hardware revenue at the point in time the product and software are delivered and ownership transfers, while hardware‑support fees are recognized ratably over the contract term – the same treatment disclosed for fiscal 2022 (see 2022 p. 105 and 2023 p. 43). However, the strategic weight of the hardware line has slipped: it represented roughly 7‑8 % of total revenue in FY 2022 (≈ $3.2 b of $42.4 b) but fell to about 6 % of total revenue in FY 2023 (see 2023 p. 43), indicating a modest de‑emphasis even as Oracle continues to invest in R&D to improve and expand its industry‑specific hardware portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the question's core components but contains significant quantitative errors that undermine its credibility. STRENGTHS: (1) Correctly identifies that revenue recognition methodology remained consistent between FY2022 and FY2023 (point-in-time recognition for hardware plus software as combined performance obligation); (2) Accurately notes that hardware-support fees are recognized ratably over contract term; (3) Correctly identifies the strategic shift toward R&D investment in hardware innovation; (4) Appropriately synthesizes multi-hop information about both revenue recognition and strategic emphasis. CRITICAL WEAKNESSES: (1) The revenue percentages and absolute dollar amounts are problematic. The LLM states hardware was ~7-8% of total revenue in FY2022 (≈$3.2B of $42.4B), but this calculation is internally inconsistent: $3.2B/$42.4B = 7.5%, which is within the stated range, so that part checks out. However, the claim that hardware fell to ~6% in FY2023 lacks supporting numbers and cannot be verified against the ground truth; (2) The ground truth emphasizes that Oracle introduced MORE DETAILED explanation of revenue recognition in 2023 (specifically mentioning 'combined performance obligations'), whereas the LLM suggests the treatment was 'the same' - this misses the nuance that while the underlying principle remained consistent, the disclosure became more explicit and detailed; (3) The LLM's characterization of hardware as experiencing 'de-emphasis' contradicts the ground truth's emphasis on 'ongoing investments in R&D' and 'more strategic focus on innovation' - the ground truth suggests increased strategic emphasis on innovation, not de-emphasis. MULTI-HOP REASONING: The LLM attempts to synthesize revenue recognition policy consistency with strategic emphasis changes, but the conclusion about 'de-emphasis' appears to be based solely on revenue percentage decline rather than the strategic R&D investment narrative emphasized in the ground truth. CALCULATION VERIFICATION: The FY2022 calculation ($3.2B/$42.4B = 7.5%) is mathematically sound, but the FY2023 percentage claim lacks supporting detail. The answer would benefit from explicit FY2023 dollar amounts to verify the 6% claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 599,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a drop of roughly 13.7% (about $520 million)【page_31】. The decline was attributed to heightened global competitive pressures, including competition from newer oral agents, which offset its prior growth【page_32】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - sales figures ($3.784B in 2022, $3.264B in 2023) are correct, the percentage decline (13.7%) is correctly calculated, and the dollar amount difference ($520M) is accurate. (2) The LLM correctly identified the product (IMBRUVICA/ibrutinib) and the relevant time period (2022-2023). (3) The core finding about competitive pressures from novel oral agents is correctly identified. WEAKNESSES: (1) The answer is incomplete regarding contributing factors - it mentions competitive pressures and newer oral agents but omits other important contextual factors mentioned in the ground truth, specifically: pandemic-related delays in new patient starts in 2022 and market saturation/treatment shifts in 2023. (2) The answer lacks the temporal nuance present in the ground truth - it doesn't explain that 2022 already showed growth being offset by competitive pressures, and that 2023 represented a continuation/acceleration of this downward trend. (3) The answer is somewhat superficial in its analysis of 'factors' - it identifies competition but doesn't provide the fuller picture of market dynamics and structural changes affecting the product. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points (2022 and 2023 sales figures, competitive landscape) but fails to fully synthesize all contributing factors across the time period. The reasoning is sound but incomplete. SEMANTIC EQUIVALENCE: The wording differs from ground truth but conveys similar core information about the decline and competitive pressures, though with less depth on causative factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 450,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast continues to own a 30 % equity stake in Universal Beijing Resort, and the resort’s debt has slipped slightly – from $3.5 billion of outstanding debt (including a $3.1 billion term loan) at year‑end 2023 to about $3.4 billion (including a $3.0 billion term loan) at year‑end 2024 【page_56】【page_86】. The debt is not cross‑guaranteed by Comcast and there are no liquidity, guarantee or other financial commitments linking the two, so Comcast’s financial risk remains confined to its 30 % equity interest in the venture 【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Comcast's Universal Beijing Resort involvement. QUANTITATIVE VERIFICATION: All financial figures are correct - 2023 debt of $3.5 billion (including $3.1 billion term loan) and 2024 debt of $3.4 billion (including $3.0 billion term loan) match the ground truth exactly. The 30% ownership stake is correctly stated. COMPLETENESS: The answer addresses all three sub-components of the question: (1) debt levels evolution (correctly shows slight decrease), (2) ownership structure (30% stake maintained, VIE consolidation implied through context), and (3) financial risk exposure (correctly limited to 30% equity interest). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing pages (56 and 86) and correctly connects the debt reduction trend with the stable risk profile and unchanged ownership structure. MINOR GAPS: The answer does not explicitly mention that Comcast 'consolidates' Universal Beijing Resort as a VIE, though this is implied by the context and the reference to page 86. The ground truth explicitly states 'consolidated by Comcast' and 'consolidate Universal Beijing Resort as a VIE,' which adds a governance/accounting detail that the LLM answer omits. However, the LLM does note that 'the debt is not cross-guaranteed by Comcast and there are no liquidity, guarantee or other financial commitments,' which provides additional relevant context about the risk structure. SEMANTIC EQUIVALENCE: The phrase 'financial risk remains confined to its 30% equity interest' is semantically equivalent to 'maximum financial risk exposure for Comcast remains limited to its 30% equity interest.' The characterization of the evolution as showing 'slight reduction in debt' with 'no change in ownership or governance structure' is accurately conveyed. The answer is well-sourced with specific page references, enhancing credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 533,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "FedEx reported that the undiscounted future payments for build‑to‑suit facilities and equipment dropped from about **$3.4 billion** in the 2022 filing (as of May 31 2022) to roughly **$0.9 billion** in the 2023 filing (as of May 31 2024)【page_96】【page_98】. The sharp reduction indicates FedEx is scaling back large, long‑term build‑to‑suit lease commitments and moving toward a more restrained or flexible leasing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures ($3.4 billion in 2022 dropping to $0.9 billion in 2023) and accurately characterizes the strategic shift toward a more restrained leasing approach. The numbers match the ground truth precisely. However, there are notable omissions in completeness: (1) The LLM does not specify the expected commencement date ranges (2023-2024 for the 2022 commitment vs. 2025-2027 for the 2023 commitment), which is an important detail that distinguishes the nature of the strategic shift. (2) The LLM characterizes the shift as moving toward 'flexibility' but the ground truth emphasizes 'fewer long-term commitments' and 'extended timeline for asset utilization' - the extended timeline aspect is not captured. (3) The fiscal year dates provided (May 31, 2022 and May 31, 2024) appear reasonable for FedEx's fiscal calendar but the ground truth references 2022 and 2023 filings without specific dates. The quantitative accuracy is strong with correct dollar amounts and the multi-hop synthesis is sound (comparing across two years). The reasoning about scaling back commitments is logically sound and semantically equivalent to the ground truth's characterization. The answer would be stronger with the specific commencement date ranges and clearer articulation of the extended timeline aspect of the strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 378,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard’s tie‑up with Dynamic Yield has not changed – it remains a 2022 acquisition (a 100 % equity purchase for $325 million) and there were no new transactions involving Dynamic Yield in either 2023 (the 2023 filing notes that the company “did not complete any material business acquisitions”) or 2024 (the 2024 filing merely references the 2022 purchase while reporting other 2024 acquisitions such as Recorded Future)【page_82】【page_79】. The static relationship, together with the 2024 emphasis on new data‑driven buys, indicates Mastercard is preserving its earlier investment in Dynamic Yield while strategically expanding its digital‑identity, fraud‑prevention and threat‑intelligence capabilities through additional acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - $325 million acquisition price (2022), 100% equity purchase, no material acquisitions in 2023, Recorded Future acquisition in 2024. All dates are accurate (2022 acquisition, 2023 filing reference, 2024 filing reference). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the relationship evolved (remained stable, no new transactions), and (2) what this indicates about strategic focus (shift toward cybersecurity/threat intelligence via Recorded Future). ENTITY ACCURACY: All entities correctly identified - Mastercard, Dynamic Yield LTD, Recorded Future. Fiscal years properly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and documents: connects the 2022 acquisition details to 2023 filing statements about no material acquisitions, then to 2024 filing references showing the shift to Recorded Future. The logical conclusion about strategic pivot is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, using slightly different phrasing ('tie-up' vs 'relationship', 'static relationship' vs 'stable') but maintaining semantic equivalence. The emphasis on 'preserving earlier investment while expanding capabilities' captures the same strategic insight as the ground truth's 'integration completed, focus shifted.' MINOR OBSERVATIONS: The LLM answer provides slightly more detail about the nature of the strategic shift (digital-identity, fraud-prevention, threat-intelligence capabilities) which adds helpful context without contradicting the ground truth. Citation references are appropriately included. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 503,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers was last amended and restated on May 26 2022, and the most recent filing of that amendment is a Form 10‑Q filed on November 27 2024 (shown as Exhibit 10.1) in both the 2022 and 2024 10‑K exhibit tables, indicating no further amendment after the 2022 restatement【page_79】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant errors and inconsistencies when compared to the ground truth: (1) EXHIBIT NUMBER ERROR: The LLM states the filing is 'Exhibit 10.1' but the ground truth clearly indicates it should be 'Exhibit 10.28'. This is a factual error in document identification. (2) FILING TYPE ERROR: The LLM claims it's a 'Form 10-Q' but the ground truth indicates it was filed on November 27, 2024, which would be part of a 10-K filing (annual report), not a quarterly 10-Q. This is a significant mischaracterization of the filing type. (3) INCOMPLETE HISTORICAL CONTEXT: The LLM fails to mention the earlier 2020 amendment ('amended and restated May 29, 2020' filed August 26, 2020 as Exhibit 10.29), which is important for showing the evolution of the plan between 2022 and 2024. The question specifically asks about how the plan 'evolved' between these years, requiring historical context. (4) CORRECT ELEMENTS: The LLM correctly identifies the May 26, 2022 amendment date and the November 27, 2024 filing date. It also correctly notes that there was no further amendment after 2022. (5) REASONING ISSUE: The statement about the filing appearing 'in both the 2022 and 2024 10-K exhibit tables' is confusing and not clearly explained in the ground truth context. The multi-hop reasoning is incomplete because it doesn't properly synthesize the evolution of the plan across the time period. Overall, while some dates are correct, the exhibit number error, filing type misidentification, and omission of the earlier amendment significantly undermine the answer's accuracy and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 441,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair‑value of the 6.375 % senior notes fell from **$999 million at 12/31/2021** to **$872 million at 12/31/2023** – a decline of about $127 million (≈13 %)【page_56 (2022)】【page_56 (2023)】.  \nThis drop indicates that investors were willing to pay less for Netflix’s debt, reflecting a weaker market view of the company’s credit risk or higher yields demanded on its notes over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - the fair value decreased from $999 million (12/31/2021) to $872 million (12/31/2023), representing a decline of $127 million. The percentage calculation of approximately 13% is accurate ($127M / $999M ≈ 12.7%, rounded to 13%). ENTITY ACCURACY: Netflix, the 6.375% Senior Notes, and the correct fiscal year dates are all properly identified. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) identifying the two fair values from different years, (2) calculating the absolute change ($127M) and percentage change (13%), and (3) interpreting what this decline means for market perceptions. The interpretation that the decline indicates 'investors were willing to pay less for Netflix's debt' and reflects 'weaker market view of the company's credit risk or higher yields demanded' is logically sound and semantically equivalent to the ground truth statement about 'decline in market confidence or increase in required yields.' MINOR OBSERVATION: The LLM's phrasing 'weaker market view of the company's credit risk' is slightly more nuanced than the ground truth's 'decline in market confidence,' but both convey the same fundamental insight. The answer is complete, addresses all parts of the question, and provides appropriate context with source citations. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 402,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a decline of about 13.7% (operational drop of 13.2%)【page_31】. This contraction came even as total oncology sales grew 10.5% to $17.7 billion, indicating that while IMBRUVICA remains a major oncology product, its market share is being pressured by competition and other dynamics in the segment【page_32】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 sales figure. Ground truth states IMBRUVICA sales were $4,369 million in 2022, but the LLM claims $3.784 billion ($3,784 million). This is a $585 million discrepancy (13.4% understatement of 2022 sales). The 2023 figure of $3,264 million is correct. CALCULATION ERROR: Based on the LLM's incorrect 2022 figure ($3,784M), the decline would be approximately 13.7%, which the LLM correctly calculates from its wrong baseline. However, using the correct 2022 figure of $4,369M, the actual decline is 25.2% (as stated in ground truth), not 13.7%. This is a massive calculation error stemming from the wrong starting number. PARTIAL CREDIT: The LLM correctly identifies that IMBRUVICA's sales declined year-over-year and correctly states the 2023 figure. The qualitative assessment that IMBRUVICA's market position weakened is directionally correct, and the mention of competitive pressures is appropriate. The reference to total oncology sales growth ($17.7B, +10.5%) provides useful context showing relative underperformance. However, the failure to mention that other products like DARZALEX and ERLEADA experienced significant growth (as noted in ground truth) represents incomplete synthesis. MULTI-HOP REASONING: The LLM demonstrates some multi-hop reasoning by comparing IMBRUVICA's decline against overall oncology segment growth, but the foundation is built on incorrect numbers, undermining the entire analysis. The conclusion about market share pressure is reasonable but based on faulty premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 439,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "- In fiscal 2022 the company reported an inventory‑shrink reserve of **$414 million** and an LCNRV (lower‑of‑cost‑or‑net‑realizable‑value) reserve of **$168 million** 【page_33】.  \n- By fiscal 2024 those balances had moved to **$427 million** for the shrink reserve and **$222 million** for the LCNRV reserve 【page_34】.  \n\nThe larger reserves increase expense and therefore depress net earnings; Lowe’s notes that a 10 % change in the LCNRV reserve would shift net earnings by roughly **$17 million**, while a 10 % change in the shrink reserve would shift net earnings by about **$32 million** in fiscal 2024 【page_34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: inventory shrink reserve increased from $414M (2022) to $427M (2024), LCNRV reserve increased from $168M (2022) to $222M (2024). The sensitivity analysis figures are accurate: 10% change in LCNRV would impact net earnings by ~$17M, and 10% change in shrink reserve would impact net earnings by ~$32M in fiscal 2024. The multi-hop reasoning is sound - the answer correctly synthesizes the reserve evolution across years and connects this to earnings implications. The explanation that larger reserves increase expense and depress net earnings demonstrates proper understanding of the accounting mechanics. The answer addresses all parts of the question: (1) how reserves evolved between 2022-2024, (2) the specific dollar amounts, and (3) the implications for net earnings through both the sensitivity analysis and the conceptual explanation. Minor observation: the ground truth mentions 'growing need for reserves' and 'increasing sensitivity' as implications, while the LLM focuses more on the mechanical impact on earnings. However, the LLM's explanation of the earnings impact is more concrete and directly answers the question. The citation references to pages are appropriate. No calculation errors detected. All entities (LOW/Lowe's, fiscal years, reserve types) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 384,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "In the 2022 Form 10‑K Qulipta was still a pipeline asset – it appeared only in the intangible‑asset footnote as a product that had not yet been commercialized and generated no revenue 【page_100】. By 2023 AbbVie announced FDA approval in April and EC approval in August, launched the drug, and Qulipta’s net sales more than doubled, rising over 100 % year‑over‑year (U.S. sales $405 million in 2023 versus $158 million in 2022) and becoming a notable new revenue contributor 【page_40】【page_44】【page_42】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error that contradicts the ground truth. The ground truth states that in 2023, Qulipta generated $405 million in U.S. revenue and $3 million internationally. However, the LLM answer claims U.S. sales were $158 million in 2022 and $405 million in 2023, implying Qulipta had revenue in 2022. This directly contradicts the ground truth which explicitly states that in 2022, Qulipta was still a developmental asset with no revenue contribution. The LLM's claim that 'U.S. sales $405 million in 2023 versus $158 million in 2022' is factually incorrect - there were no 2022 sales. The LLM also states sales 'more than doubled, rising over 100% year-over-year,' which is mathematically inconsistent with the numbers provided ($158M to $405M is approximately 156% growth, not 'over 100%' in the way presented, but more importantly, the 2022 baseline figure is entirely wrong). The LLM correctly identifies the 2023 U.S. revenue of $405 million and mentions the regulatory approvals (FDA in April, EC in August), which aligns with ground truth. However, the fundamental error regarding 2022 revenue ($158M claimed vs. $0 actual) is a severe factual mistake that undermines the entire answer. The ground truth also mentions the $1.0 billion reclassification of indefinite-lived R&D intangible assets in 2022, which the LLM answer completely omits. The LLM does correctly characterize the transition from development to commercialization and mentions the international revenue context, but the quantitative errors are too significant to overlook.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 439,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell’s indemnification agreement with a Resideo subsidiary continued to deliver the full $140 million annual reimbursement in both 2022 and 2023, but the related receivable grew from $157 million in 2022 to $187 million in 2023, indicating a larger share of its environmental costs is now expected to be covered by Resideo【page_98】. This rising reliance on Resideo’s payments reduces Honeywell’s direct cash‑flow exposure to environmental liabilities, although the $140 million cap and the agreement’s eventual termination mean the company still retains some residual risk【page_97】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES BETWEEN LLM ANSWER AND GROUND TRUTH: (1) QUANTITATIVE ERRORS: The LLM claims the receivable grew from $157M (2022) to $187M (2023), but provides no source verification for these specific numbers. More critically, the LLM states Resideo 'continued to deliver the full $140 million annual reimbursement in both 2022 and 2023' - this is a factual claim not supported by the ground truth, which states the arrangement obligates Resideo to pay '90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year.' These are fundamentally different statements. The LLM mischaracterizes the payment structure as a fixed $140M reimbursement rather than a variable 90% payment capped at $140M. (2) CORE FINDING CONTRADICTION: The ground truth explicitly states the financial dependency 'remained consistent between 2022 and 2023' with 'no change' in the risk mitigation strategy. The LLM contradicts this by claiming 'the related receivable grew from $157 million in 2022 to $187 million in 2023, indicating a larger share of its environmental costs is now expected to be covered by Resideo' - this suggests evolution/change, directly contradicting the ground truth's finding of consistency. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key finding that the arrangement remained unchanged year-over-year. Instead, it introduced receivable figures that, even if accurate, would suggest change rather than consistency. (4) SEMANTIC MISALIGNMENT: The LLM's interpretation that 'a larger share of environmental costs is now expected to be covered' contradicts the ground truth's assessment that dependency 'remained consistent.' The LLM appears to have misunderstood or misrepresented the nature of the indemnification agreement. (5) PARTIAL CREDIT: The LLM correctly identifies the $140M cap and acknowledges residual risk, which aligns with ground truth. However, these correct elements are overshadowed by fundamental errors in the main findings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 550,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K state that cash equivalents are “highly liquid investments with an original maturity of three months or less from the time of purchase” (and include card‑transaction receivables that settle in five days). The wording and threshold are unchanged, indicating that Target has kept a consistent cash‑management approach—continuing to rely on short‑term, highly liquid assets to preserve liquidity and limit risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERROR: The LLM claims card-transaction receivables settle in 'five days,' but this detail is not mentioned in the ground truth answer and appears to be an unsupported addition. (2) CORE FACTUAL CONTRADICTION: The ground truth explicitly states that by 2024, Target 'added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach.' The LLM answer claims 'The wording and threshold are unchanged,' which directly contradicts the ground truth's assertion that there was an evolution in how Target discusses and evaluates short-term financial instruments. (3) INCOMPLETE SYNTHESIS: The question asks about how the definition/treatment has 'evolved' between 2022 and 2024. The ground truth identifies a meaningful evolution (addition of broader fair value discussion), while the LLM concludes there was no evolution ('unchanged'). This is a fundamental misunderstanding of the multi-hop comparison required. (4) MISSING CONTEXT: The LLM fails to capture the ground truth's key finding that Target moved toward 'a more comprehensive approach to short-term financial instruments' and 'a broader financial framework.' Instead, it simply restates the three-month threshold without acknowledging the additional context added in 2024. (5) REASONING FLAW: The LLM's conclusion that Target 'kept a consistent cash-management approach' contradicts the ground truth's indication of 'potential refinement' in how Target evaluates and manages cash and near-cash assets. The answer demonstrates poor multi-hop reasoning by failing to identify and synthesize the evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 481,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "In the 2023 Form 10‑K the 3.50 % notes due 2040 were listed under “Liabilities” as a Level 2 fair‑value item with a net carrying amount of **$870 million** [page_67]. By the 2024 filing the same notes are shown in the debt schedule as a **$1 billion** long‑term obligation (effective interest 3.54 %, 15.2 years remaining) that is included in the long‑term portion of total debt ($8.459 billion) [page_72]. The higher carrying amount and the move from a Level‑2 liability disclosure to a distinct long‑term debt line indicate that NVIDIA is expanding and emphasizing low‑cost, fixed‑rate financing to lock in cheap capital for an extended horizon as part of its long‑term debt strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states the 2023 carrying value as $870 million, but the ground truth specifies $851 million. This is a $19 million discrepancy (2.2% error). The 2024 value of $1,000 million/$1 billion is correct. (2) CLASSIFICATION ACCURACY - The LLM correctly identifies the notes as Level 2 fair-value items in 2023 and accurately reports the 2024 metrics (3.54% effective interest rate, 15.2 years remaining). However, the ground truth indicates the notes were 'listed under liabilities' in 2023 with Level 2 classification, while the LLM describes a transition 'from a Level-2 liability disclosure to a distinct long-term debt line' - this characterization of a 'move' or 'transition' is not clearly supported by the ground truth, which doesn't explicitly state a change in classification methodology between years. (3) MULTI-HOP REASONING - The LLM successfully synthesizes information across 2023 and 2024 filings and correctly interprets the strategic implications regarding long-term fixed-rate financing. The conclusion about 'expanding and emphasizing low-cost, fixed-rate financing' aligns with the ground truth's statement about 'strategic emphasis on long-term financing with stable interest rate structures.' (4) COMPLETENESS - The LLM addresses all parts of the question: valuation evolution, classification, and strategic implications. However, the specific numeric error on the 2023 carrying value ($870M vs. $851M) is a material factual mistake that undermines confidence in the answer's accuracy. The reasoning quality is sound, but the quantitative precision is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 450,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Venclexta’s worldwide net revenue grew from $2.009 billion in 2022 to $2.288 billion in 2023 – an increase of about $279 million.  This represents a growth rate of roughly 14 % (the filing notes a 13.9 % increase at actual rates and cites a 15 % rise in the narrative).【page_42】【page_43】",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct revenue figures and growth rates. Verification of key numbers: (1) 2022 revenue of $2.009 billion ($2,009 million) - CORRECT; (2) 2023 revenue of $2.288 billion ($2,288 million) - CORRECT; (3) Absolute increase calculation of ~$279 million - CORRECT (2,288 - 2,009 = 279); (4) Growth rate of 13.9% - CORRECT and matches ground truth exactly; (5) The LLM notes 'roughly 14%' which is a reasonable rounding of 13.9%, and appropriately cites the filing's notation of 13.9% at actual rates. The mention of a '15% rise in the narrative' adds context but is not part of the ground truth answer - this appears to be additional information from the filing that doesn't contradict the core answer. The LLM successfully synthesizes multi-hop information by comparing 2022 and 2023 data, calculating the absolute change, and identifying the growth rate trend. The answer addresses all parts of the question: total global revenue for both years, growth rates for both years, and the evolution/trend between them. Minor deduction: The ground truth explicitly states growth rates for both 2022 (10.4%) and 2023 (13.9%), while the LLM focuses primarily on the 2023 growth rate and doesn't explicitly mention the 2022 growth rate of 10.4%, which was part of the original answer's completeness. However, the LLM does capture the upward trend by noting the increase from 2022 to 2023. The use of billion vs. million format variation is handled appropriately and doesn't affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 422,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Netflix reported that its Executive Severance and Retention Incentive Plan had been “Amended and Restated” on September 10 2021 (see Exhibit 10.7 on page 66 of the 2022 filing). The 2023 Form 10‑K shows the company filed a new amendment on December 8 2023, creating an “Executive Severance and Retention Incentive Plan as Amended and Restated” that will become effective January 1 2024 (Exhibit 10.16 on page 68 of the 2023 filing), together with a separate Executive Officer Severance Plan (Exhibit 10.15, also page 68). This reflects a shift from the 2021 amendment to a fresh, forward‑looking amendment that takes effect at the start of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Netflix's executive severance plan evolution. STRENGTHS: (1) All dates are correct - September 10, 2021 for the 2022 filing reference, December 8, 2023 for the 2023 filing, and January 1, 2024 for the effective date. (2) Plan names are accurately cited with proper terminology ('Amended and Restated' language). (3) The multi-hop synthesis is sound - correctly connecting the 2022 filing's reference to a 2021 amendment with the 2023 filing's new amendment effective 2024. (4) Exhibit numbers and page references are provided (10.7 page 66 for 2022; 10.16 and 10.15 page 68 for 2023), adding specificity. (5) The answer captures the evolution narrative - from 2021 amendment to 2024 forward-looking amendment. (6) Additional context about the separate Executive Officer Severance Plan (Exhibit 10.15) provides supplementary relevant information not in the ground truth but consistent with it. MINOR CONSIDERATIONS: The LLM answer includes specific exhibit numbers and page references that go slightly beyond the ground truth statement but are consistent with it and enhance credibility. The characterization of the shift as 'from the 2021 amendment to a fresh, forward-looking amendment' accurately captures the temporal and strategic evolution. All factual claims align with the ground truth, and the reasoning correctly synthesizes information across the two filing years. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 423,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "In the 2022 10‑K the Benefit Restoration Plan is mentioned only in the employee‑retirement‑plan note, where it is described in a few sentences as a supplemental 401(k)‑style plan that allows salary deferrals and a company‑match for participants whose benefits are limited by the tax code. By the 2024 filing the plan is listed as a separate exhibit (Exhibit 10.3) titled “Benefit Restoration Plan, as amended and restated as of January 1, 2025,” indicating that the company has formally amended and restated the plan’s terms. This shift from a brief narrative description to a formally documented, updated plan shows Lowe’s is actively refining and strengthening its retirement‑benefit safety net for employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct - the 2022 mention in the employee-retirement-plan note, the 2024 filing with Exhibit 10.3, and the January 1, 2025 effective date all match the ground truth precisely. No calculation errors or date discrepancies. ENTITY ACCURACY: Correctly identifies Lowe's, the Benefit Restoration Plan, the 401(k) Plan, and the specific exhibit designation (10.3). MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and correctly traces the evolution from narrative description to formal documentation. The logical connection between the shift in documentation approach and the company's strategic intent is sound. COMPLETENESS: Addresses all parts of the question - how the documentation evolved (from brief narrative to formal exhibit), the structural changes (amendment and restatement), and what this indicates about the company's approach (active refinement, strengthening the retirement benefit safety net). SEMANTIC EQUIVALENCE: The LLM's characterization of the plan as a 'supplemental 401(k)-style plan' and 'safety net for employees' aligns well with the ground truth's description of it supplementing benefits for employees affected by IRS limitations. The phrase 'actively refining and strengthening' captures the same strategic intent as the ground truth's 'deliberate effort to formalize and likely enhance.' MINOR CONSIDERATIONS: The LLM uses slightly different language ('safety net for employees' vs 'managing executive and high-earner compensation') but both interpretations are valid given the plan's supplemental nature. The ground truth emphasizes the executive/high-earner angle while the LLM takes a broader employee perspective - both are reasonable interpretations of the same plan's purpose. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 529,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA’s liability for the 0.584 % notes due 2024 rose modestly from $1.185 billion at fiscal‑year‑end 2023 to $1.228 billion at fiscal‑year‑end 2024 – an increase of about $43 million【page_67】.  In FY 2024 the notes were shown as a $1.250 billion short‑term liability on the balance sheet, and the company repaid the entire issue in FY 2025【page_72】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Numbers: The LLM claims the liability INCREASED from $1.185 billion in FY2023 to $1.228 billion in FY2024, but the ground truth explicitly states the obligation was FULLY REPAID by FY2024 (meaning it should be $0 or not listed). The LLM's reported figures of $1.185B and $1.228B are factually incorrect for FY2024. (2) CRITICAL ERROR - Timing: The LLM states the notes were repaid in FY2025, but the ground truth indicates they were fully repaid BY FY2024 (the 2024 10-K filing shows the obligation was resolved). This is a significant temporal error. (3) CALCULATION ERROR: The LLM calculates an increase of $43 million ($1.228B - $1.185B), but this calculation is based on incorrect underlying numbers. (4) MULTI-HOP REASONING FAILURE: The question asks how the obligation 'evolved' between FY2023 and FY2024. The correct answer is that it went from $1.185B liability to $0 (fully repaid), representing complete resolution. The LLM instead reports a modest increase, which is the opposite of what occurred. (5) The LLM does correctly identify the security (0.584% Notes Due 2024) and the company (NVDA), and the answer is contextually relevant to the question asked, but the core factual content is inverted. The ground truth shows complete repayment; the LLM shows continued liability with an increase. This is a fundamental misrepresentation of the financial obligation's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 414,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Mavyret’s global net revenue fell from $1.541 billion in 2022 to $1.430 billion in 2023 – a drop of roughly 7 % (about 5‑6 % on a constant‑currency basis)【page_43†L45-L48】.  In the United States the product’s sales fell sharply, from $755 million to $659 million (≈13 % decline)【page_43†L45-L46】, whereas internationally the revenue was essentially flat – slipping about 2 % in actual‑currency terms (from $786 million to $771 million) but showing a modest 1 % increase on a constant‑currency basis【page_43†L46-L47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) Global revenue 2022: $1.541 billion ($1,541 million) ✓; (2) Global revenue 2023: $1.430 billion ($1,430 million) ✓; (3) U.S. revenue 2022: $755 million ✓; (4) U.S. revenue 2023: $659 million ✓; (5) International revenue 2022: $786 million ✓; (6) International revenue 2023: $771 million ✓. Calculation verification: (1) Global decline: ($1,541M - $1,430M)/$1,541M = 7.2% ≈ 7% ✓; (2) U.S. decline: ($755M - $659M)/$755M = 12.7% ≈ 13% ✓; (3) International decline: ($786M - $771M)/$786M = 1.9% ≈ 2% ✓. The LLM answer correctly synthesizes multi-hop information across both U.S. and international markets for both years. The answer appropriately addresses all parts of the question: global revenue evolution, U.S. market trends, and international market trends. The inclusion of constant-currency basis information adds valuable context beyond the ground truth. Minor note: The LLM states U.S. decline as '≈13%' while ground truth specifies '12.7%' - this is a rounding difference (12.7% rounds to 13%) and is acceptable. The answer demonstrates sound reasoning, correct entity identification (Mavyret product, fiscal years 2022-2023), and proper synthesis of comparative data across regions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 358,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "In the 2022 Form 10‑K Netflix said it was in compliance with all covenant restrictions on its senior notes – limits on creating liens, entering sale‑and‑lease‑back deals, incurring additional subsidiary debt and undertaking major mergers or asset transfers – but it did not report any specific note repayment [page_56]. By the 2024 filing the company still met those same covenants (with some notes also restricting sale‑and‑lease‑back and subsidiary indebtedness) and additionally disclosed that it had repaid the $400 million principal of its 5.750 % senior notes at maturity [page_54].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key facts and figures. Strengths: (1) All numeric values are correct - $400 million repayment amount, 5.750% interest rate on Senior Notes are accurate; (2) Years correctly identified (2022 vs 2024); (3) Covenant restrictions properly listed in both years - liens, sale-and-lease-back transactions, subsidiary indebtedness, mergers/asset transfers; (4) Multi-hop synthesis is sound - correctly connects compliance status across years with evolution of restrictions; (5) Debt management action (repayment at maturity) properly identified. Minor weaknesses: (1) The LLM answer states 'with some notes also restricting sale-and-lease-back and subsidiary indebtedness' in 2024, which is slightly ambiguous phrasing compared to ground truth's clearer statement that 'certain Senior Notes no longer referenced restrictions on sale and lease-back transactions' - this represents a narrowing rather than addition of restrictions, though the LLM's phrasing could be interpreted as acknowledging some notes still had these restrictions; (2) The LLM omits mention of the euro-denominated tranches totaling €5,170 million from 2022, which was included in the ground truth as contextual detail about the scope of notes; (3) Page references provided by LLM ([page_56], [page_54]) cannot be verified against ground truth but appear reasonable. The answer correctly addresses the evolution of compliance and covenant scope between the two years, with accurate financial figures and proper multi-hop reasoning connecting 2022 compliance status to 2024 compliance status with debt repayment action.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 452,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "In 2022 Honeywell reported a distinct “Safety and Retail” line within its Safety and Productivity Solutions segment (sales ≈ $2.4 billion) 【page_69】. By 2023 the company had merged that unit with its Advanced Sensing Technologies group, creating a new “Sensing and Safety Technologies” business unit (sales ≈ $2.7 billion) 【page_68】—a structural realignment that combined Safety and Retail with advanced sensing capabilities to reflect a more integrated safety‑sensing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural evolution: Safety and Retail as a standalone unit in 2022 that was merged with Advanced Sensing Technologies in 2023 to form Sensing and Safety Technologies. The qualitative reasoning about the strategic shift toward integrated safety-sensing capabilities is sound and well-articulated. However, there are quantitative discrepancies that prevent a higher score: (1) The 2022 revenue figure is approximated as '$2.4 billion' when the ground truth specifies $2,387 million ($2.387 billion)—while the approximation is reasonable, it lacks precision. (2) The 2023 revenue is stated as '$2.7 billion' but the ground truth does not provide a specific 2023 revenue figure for the merged unit, making this number unverifiable and potentially inaccurate. (3) The LLM states the structural change was 'introduced in July 2022 but reported in the 2023 filing,' which aligns with the ground truth's timeline, though the LLM doesn't explicitly mention the July 2022 introduction date. The multi-hop synthesis is correct: the answer successfully connects the 2022 standalone status with the 2023 merger and explains the strategic rationale. The entity identification (Honeywell, Safety and Retail, Advanced Sensing Technologies, Sensing and Safety Technologies, Safety and Productivity Solutions segment) is accurate. The main weakness is the unsubstantiated 2023 revenue figure, which introduces uncertainty about data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 406,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "In the 2023 filing Visa reported that no Class B‑2 common‑stock shares were outstanding, but the class was described as “will become convertible into Class A common stock” and, although its voting rights are limited, holders can vote on certain significant transactions such as a merger, which could dilute existing Class A voting power【page_34】. By the 2024 filing a Class B‑1 exchange offer created 49 Class B‑2 shares (total B‑1 + B‑2 shares fell from 245 to 125) and the new shares are still subject to conversion into Class A common stock, preserving those limited voting rights that trigger affirmative votes on consolidations or mergers and thus continue to affect corporate‑governance dynamics【page_59】【page_58】【page_61】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant contradictions with the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims '49 Class B-2 shares' were created and that 'total B-1 + B-2 shares fell from 245 to 125' - these specific numbers are not verified in the ground truth and appear to be fabricated or misread. The ground truth states 'no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer' in 2024, which contradicts the LLM's claim that 49 B-2 shares were created. (2) STRUCTURAL CONTRADICTION: The LLM fundamentally misrepresents the evolution. The ground truth indicates Class B-2 went from having a conversion feature in 2023 to being non-outstanding in 2024 (a reduction in role). The LLM claims new B-2 shares were created in 2024 and that conversion rights were 'preserved,' which directly contradicts the ground truth's statement about non-outstanding status. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the transformation described in the ground truth - from 'active governance and conversion position' to 'non-outstanding status.' Instead, it inverted this narrative by suggesting an increase in B-2 shares. (4) CITATION ISSUES: While the LLM provides page references, the specific numbers cited (49 shares, 245 to 125) cannot be verified against the ground truth and appear to be incorrect interpretations. (5) PARTIAL CREDIT: The LLM correctly identifies that Class B-2 shares have conversion features and limited voting rights on significant transactions like mergers, which aligns with the ground truth. However, this correct element is overshadowed by the fundamental mischaracterization of the 2023-2024 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 470,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "In fiscal 2023 Home Depot focused on creating a frictionless, interconnected shopping experience by investing heavily in its website and mobile apps to improve navigation, search, “shopability,” checkout speed and fulfillment options, and by adding in‑store conveniences such as way‑finding signage, self‑service lockers, curbside pickup, electronic shelf‑label capabilities, refreshed front‑end layouts, expanded self‑checkout and digital handheld tools for associates (hdPhones, Computer Vision)【page_8】【page_9】. In fiscal 2024 the company built on that foundation, further enhancing its digital platforms with richer product content, customer‑review summaries and data‑driven personalization, while continuing to expand store‑level upgrades—including expanded self‑checkout, refreshed signage and mobile‑app‑enabled store navigation—demonstrating an evolution toward an even more integrated, personalized and technology‑enabled shopping experience【page_8】【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the fiscal years (2023 and 2024) and accurately captures the evolution of Home Depot's shopping experience strategy. (2) All specific capabilities mentioned are factually accurate: mobile app-enabled store navigation, electronic shelf labels, self-checkout expansion, curbside pickup, digital handheld tools (hdPhones, Computer Vision), way-finding signage, and self-service lockers in 2023. (3) Accurately reflects the 2024 enhancements: richer product content, customer review summaries, data-driven personalization, and continued store-level upgrades. (4) The multi-hop synthesis is sound—correctly comparing and contrasting the two years to show evolution from foundational digital/in-store improvements to more sophisticated personalization and integration. (5) Properly emphasizes the shift toward data-driven insights and personalization in 2024, matching the ground truth's characterization of 'deeper integration of data-driven insights.' (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and comprehensive than the ground truth (e.g., mentions specific tools like hdPhones and Computer Vision, curbside pickup, self-service lockers, way-finding signage), but these additions are factually accurate and enhance rather than contradict the answer. The semantic meaning and core message align perfectly with the ground truth. The answer effectively addresses both the 2023 baseline and 2024 evolution, demonstrating clear understanding of the multi-hop comparison required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 456,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "In the 2022 Form 10‑K the Long‑Term Incentive Plan was described as offering a mix of equity awards – non‑qualified and price‑vested stock options, restricted stock units, performance‑based RSUs, performance‑share units and cash‑retention awards 【page_68】. By the 2024 filing the plan had been reshaped around RSU‑type awards, adding separate agreements for restricted stock units, performance‑based RSUs, performance‑share units, non‑employee‑director RSUs, cliff‑vested RSUs and performance‑award performance‑share units, while the stock‑option forms are no longer listed 【page_73】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the years (2022 and 2024) and the company (Target Corporation). It accurately captures several equity award types from 2022 including non-qualified stock options, price-vested stock options, restricted stock units, performance-based RSUs, and performance share units. It correctly identifies new forms added by 2024 including cliff-vested RSUs and performance-award performance-share units. The answer demonstrates multi-hop reasoning by comparing the two time periods and noting the evolution of the plan.\n\nWEAKNESSES: (1) The LLM mentions 'cash-retention awards' in 2022, which is not mentioned in the ground truth answer and appears to be an unsupported claim. (2) The LLM states that 'stock-option forms are no longer listed' by 2024, which is a significant claim not explicitly confirmed in the ground truth. The ground truth simply notes what was added (cliff-vested RSUs and performance-award performance-share units) but doesn't explicitly state that options were removed. (3) The LLM characterizes the 2024 plan as 'reshaped around RSU-type awards,' which is an interpretation not directly stated in the ground truth. (4) The LLM omits mention of 'Non-Employee Director Non-Qualified Stock Options' from the 2022 list, which was explicitly mentioned in the ground truth.\n\nMULTI-HOP REASONING: The answer appropriately synthesizes information across two different years and filing documents, correctly identifying the evolution of the plan structure. However, the reasoning includes some unsupported inferences (removal of options, cash awards) that go beyond what the ground truth confirms.\n\nFACTUAL ACCURACY: Most equity award types are correctly identified, but the inclusion of 'cash-retention awards' and the claim about removal of stock options introduce factual uncertainty. The core comparison between 2022 and 2024 is sound, but with these caveats.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 516,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "AbbVie first announced FDA approval of Qulipta (atogepant) in September 2021, but the product generated no revenue that year (2021 10‑K)【page_60】.  In 2022 Qulipta began selling, reporting about $158 million of U.S. net revenue (with limited international sales)【page_42】, and by 2023 its U.S. sales had risen to $405 million (and roughly $408 million internationally), a rise of more than 100 % year‑over‑year driven by strong market‑share uptake and the April 2023 FDA approval for chronic migraine (and subsequent EC approval)【page_40】【page_44】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding 2023 international revenue. The ground truth states Qulipta generated $3 million internationally in 2023, but the LLM claims it generated 'roughly $408 million internationally' in 2023. This is a severe misstatement - the LLM appears to have confused the total revenue ($408 million) with international revenue. The correct breakdown is: $405M U.S. + $3M international = $408M total in 2023. The LLM incorrectly attributed the $408M figure to international sales alone, which is factually wrong by a factor of ~136x. Additionally, the LLM states the 2023 U.S. sales figure as '$405 million (and roughly $408 million internationally)' which directly contradicts the ground truth that $408M is the TOTAL (U.S. + international combined). CORRECT ELEMENTS: (1) FDA approval in September 2021 - correct; (2) No revenue in 2021 - correct; (3) 2022 U.S. revenue of ~$158 million - correct; (4) 2023 U.S. revenue of $405 million - correct; (5) Growth trajectory and market adoption narrative - correct; (6) April 2023 FDA approval for chronic migraine - correct. MULTI-HOP REASONING: The model successfully synthesized information across multiple years and identified the progression from approval through commercialization. However, the critical error in interpreting the international revenue figure undermines the entire answer's reliability. The calculation of 'more than 100% year-over-year' growth for U.S. sales is mathematically sound ($158M to $405M ≈ 156% growth), but this cannot redeem the fundamental misstatement about international revenue. The answer demonstrates partial understanding of the commercial trajectory but fails on a core quantitative fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 475,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2020 Stock Plan is mentioned only as an exhibit (Def 14A) – e.g., “2020 Stock Plan” appears in the exhibit list on pages 65‑66 – with no narrative description of its structure or quantitative equity‑compensation data. By the 2024 Form 10‑K the plan is described in a dedicated “Stock Option Plan” section (page 60) as a stockholder‑approved vehicle that grants incentive stock options, non‑statutory options, stock‑appreciation rights, restricted stock and RSUs to employees, directors and consultants, and the filing now includes detailed tables of option grants, exercises, expirations and RSU activity together with stock‑based compensation expense (pages 60‑61). This reflects a shift from a simple reference to a comprehensive structural description and explicit reporting of the plan’s equity‑compensation activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024 filings, capturing the shift from minimal disclosure (exhibit list reference) to comprehensive description. (2) Accurately names the specific document referenced in 2022 (Def 14A, filed April 22, 2020) and correctly identifies page numbers for both filings (pages 65-66 for 2022 exhibit list, pages 60-61 for 2024 detailed disclosure). (3) Properly enumerates the equity compensation instruments covered: incentive stock options, nonstatutory/non-statutory stock options, stock appreciation rights, restricted stock, and RSUs - all matching ground truth. (4) Correctly identifies beneficiary classes (employees, directors, consultants). (5) Accurately describes the 2024 additions: dedicated section, detailed tables of option grants/exercises/expirations, RSU activity tracking, and stock-based compensation expense reporting. (6) Multi-hop reasoning is sound: synthesizes information across two different filing years and correctly identifies the structural and disclosure evolution. (7) Semantic equivalence is maintained throughout - 'nonstatutory stock options' vs 'non-statutory options' is a minor formatting variation that doesn't affect accuracy. MINOR CONSIDERATIONS: The LLM provides slightly more specific page references and structural details (e.g., 'Stock Option Plan' section name, specific table types) than the ground truth, but these additions are accurate enhancements rather than errors. The answer fully addresses the question's focus on 'treatment and disclosure evolution' and 'structural description and associated equity compensation activities.' No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 492,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "In the 2022 filing Boeing said its aluminum purchase‑and‑sale agreements were “derivative instruments” that **did not receive hedge‑accounting treatment** and were used to meet long‑term strategic‑sourcing objectives and non‑U.S. business requirements【page_121】. The 2023 filing repeats the same classification and purpose, but the disclosed notional amount of commodity contracts not designated as hedges fell sharply from $412 million in 2022 to $115 million in 2023, indicating the company scaled back its reliance on those non‑hedged aluminum contracts while maintaining the same strategic rationale【page_103】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific quantitative data (notional amounts of $412M in 2022 declining to $115M in 2023) that adds concrete detail beyond the ground truth. However, there are significant issues with the response: (1) The LLM introduces information about 'hedge-accounting treatment' and 'non-hedged' classification that is not mentioned in the ground truth answer, potentially adding unsupported claims. (2) The ground truth emphasizes the evolution toward 'more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions,' highlighting that quantities offset each other and are priced at prevailing market prices. The LLM answer mentions the notional amount decline but does not adequately address the key evolution point about offsetting positions and market pricing alignment that the ground truth emphasizes. (3) The LLM correctly identifies that the classification and purpose remained the same between years, which aligns with ground truth. (4) The quantitative data provided ($412M to $115M) appears plausible and represents a ~72% reduction, but cannot be verified against the ground truth which does not provide these specific numbers. (5) The multi-hop reasoning is partially sound - the LLM correctly synthesizes that the company maintained strategic rationale while changing scale, but misses the nuance about offsetting positions and market pricing that represents the actual evolution. The answer is more detailed than ground truth but potentially introduces unsupported details about hedge accounting while missing the core strategic evolution point about offsetting and market pricing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 454,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "In the 2023 Form 10‑K the Directors’ Code of Conduct was described as applying to all directors of BNY and was referenced only by a partial web path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ) 【page_13】. The 2024 filing still limits the code to all directors—now explicitly of BNY Mellon—but provides a complete HTTPS link ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ) 【page_13】, making the document more readily accessible while leaving its scope unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) URL DISCREPANCY - The LLM states the 2023 URL was only a 'partial web path' (bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf) and the 2024 URL is the complete HTTPS link (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf). However, the ground truth explicitly states the 2023 URL was the FULL URL (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf) and the 2024 URL changed to a DIFFERENT domain structure (https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf). The LLM mischaracterized both URLs and missed the critical domain change from bnymellon.com to bny.com. (2) MISSING KEY EVOLUTION - The ground truth emphasizes that in 2024, a NEW SECTION titled 'INSIDER TRADING POLICIES AND PROCEDURES' was introduced, which was NOT present in 2023. This represents a significant expansion in scope and compliance focus. The LLM completely omits this important development, stating instead that 'scope unchanged.' (3) INCOMPLETE ANALYSIS - The question asks about evolution in 'accessibility and scope.' While the LLM addresses accessibility (though incorrectly), it fails to identify the actual scope expansion through the new insider trading section. The LLM's conclusion that scope remained unchanged directly contradicts the ground truth's finding of expanded focus on compliance mechanisms. WHAT WAS CORRECT: The LLM correctly identifies that both years reference the Directors' Code of Conduct applying to directors of BNY/BNY Mellon. The general framing of discussing accessibility is appropriate. However, the execution is fundamentally flawed with incorrect URL details and a critical omission of the new insider trading policies section.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 524,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In the 2023 filing Home Depot’s 4.95 % senior notes were limited to a single $750 million tranche maturing in September 2026, with a carrying amount of roughly $744 million as of January 29 2023 (see page 59). By the 2024 filing the 2026 tranche was essentially unchanged (carrying $745 million on January 28 2024, page 62) and the company added a new $1.75 billion tranche of 4.95 % senior notes due June 2034, issued at a $16.7 million discount (page 63). This expansion and lengthening of the 4.95 % series shows Home Depot is deliberately locking in low‑coupon, fixed‑rate debt and extending maturities to broaden its long‑term financing capacity and diversify its debt profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth. (1) WRONG DEBT TRANCHE: The LLM claims HD added a $1.75 billion tranche of 4.95% senior notes due June 2034, but the ground truth indicates the company added $980 million in 4.95% senior notes due September 2052 - completely different maturity date and amount. This is a critical error in multi-hop synthesis. (2) CARRYING VALUE DISCREPANCIES: The LLM reports carrying amounts of $744M (Jan 29, 2023) and $745M (Jan 28, 2024) for the 2026 notes, but ground truth shows $747M as of February 2, 2025. While the 2023 figure is close, the 2024 figure differs and the final 2025 figure is not mentioned. (3) MISSING KEY INFORMATION: The LLM completely misses the 2052 maturity notes ($980M), which is central to understanding HD's debt strategy shift toward much longer-term maturities. The ground truth explicitly states this represents extending debt maturities to a much longer horizon. (4) INCORRECT DEBT STRATEGY CONCLUSION: While the LLM correctly identifies a strategy of locking in fixed rates and extending maturities, it attributes this to a 2034 maturity when the actual strategy involves extending to 2052 - a fundamentally different time horizon that changes the strategic implication. (5) DISCOUNT AMOUNT ERROR: The LLM mentions a $16.7M discount on the (incorrect) 2034 notes, but ground truth shows the 2026 notes had a $1.6M discount. The reasoning about debt strategy is partially sound but built on incorrect factual foundation. The answer demonstrates poor multi-hop synthesis across the 2023-2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 443,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "In 2021 Intel recorded a $471 million observable‑price adjustment to its stake in Beijing Unisoc Technology Ltd., contributing to a $750 million adjustment for non‑marketable equity securities that year【page_43】. By 2023 the annual observable‑price adjustment for non‑marketable equity securities had fallen to only $17 million, and Intel carried the Unisoc investment on its balance sheet at a net book value of about $1.1 billion (the same as at the end of 2022)【page_96】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but includes additional information not in the ground truth that requires verification. CORRECT ELEMENTS: (1) The $471 million observable price adjustment in 2021 is accurate. (2) The $1.1 billion net book value as of December 30, 2023 (same as December 31, 2022) is correct. (3) The characterization of Unisoc as a non-marketable equity security is accurate. (4) The overall narrative of stable valuation over the period is sound. ADDITIONAL INFORMATION PROVIDED: The LLM adds two details not in the ground truth: (1) That the $471 million contributed to a $750 million total adjustment for non-marketable equity securities in 2021, and (2) That by 2023 the annual observable-price adjustment for non-marketable equity securities had fallen to $17 million. These appear to be factually accurate supplementary details from the 10-K filings (as indicated by page citations), but they go beyond the ground truth answer. MULTI-HOP REASONING: The LLM correctly synthesizes information across years (2021 vs 2023) and properly identifies the evolution of the investment treatment. The comparison of price adjustments over time is logically sound. MINOR ISSUES: The ground truth focuses specifically on the Unisoc investment evolution, while the LLM broadens the context to include the broader non-marketable equity securities category. This is contextually relevant but slightly shifts the focus. The additional data about the $17 million 2023 adjustment and $750 million 2021 total, while appearing accurate, are not explicitly confirmed in the ground truth provided. QUANTITATIVE VERIFICATION: All core numbers match ($471M, $1.1B, years 2021-2023). The additional figures ($750M, $17M) cannot be contradicted by the ground truth but are not confirmed either. The answer demonstrates strong understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 508,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In the 2022 Form 10‑K AbbVie already treated Qulipta as a commercial product – it was re‑classified to a developed‑product right after receiving regulatory approval and generated about **$158 million of U.S. net revenue** that year【page_100】. By the 2023 filing AbbVie reported **new regulatory clearances** – FDA approval for chronic migraine in April 2023 and EC approval in August 2023【page_40】 – and U.S. sales had risen to roughly **$405 million**, showing an expanded commercial rollout【page_42】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key regulatory milestones and revenue figures. STRENGTHS: (1) Correctly identifies FDA approval in April 2023 and EC approval in August 2023 for migraine prevention; (2) Provides specific revenue figures ($158M in 2022, $405M in 2023) that show commercial growth trajectory; (3) Accurately captures the evolution from asset reclassification to active commercial product; (4) Properly synthesizes multi-hop information across 2022 and 2023 filings. MINOR ISSUES: (1) The ground truth mentions $1.0 billion of indefinite-lived R&D intangible assets reclassified to developed product rights in 2022, which the LLM answer omits - this is a material detail about the regulatory/commercial transition; (2) The LLM answer focuses heavily on revenue figures (which are accurate and relevant) but doesn't explicitly mention the asset reclassification aspect that was part of the 2022 evolution; (3) The ground truth emphasizes this as a shift from 'asset reclassification to active regulatory and commercial advancement,' while the LLM frames it more as 'already treated as commercial product' in 2022. QUANTITATIVE VERIFICATION: The revenue figures ($158M in 2022, $405M in 2023) appear reasonable and consistent with typical product launch trajectories, though they cannot be independently verified from the provided context. The dates (April 2023 FDA, August 2023 EC) match the ground truth exactly. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple regulatory jurisdictions, showing clear understanding of the product's progression. The comparison of 2022 vs 2023 status is logically sound and well-structured. SEMANTIC EQUIVALENCE: While the LLM uses slightly different framing than the ground truth (emphasizing commercial revenue rather than asset reclassification), the core narrative of evolution from 2022 to 2023 is captured accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 533,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "In the 2022 filing, Boeing’s Global Services segment description merely listed “upgrades and conversions” as one item in a broad inventory of services (e.g., supply‑chain, engineering, maintenance, etc.) 【page_3】. By the 2023 filing, the same line still appears, but the narrative also pairs upgrades with modifications and highlights them in the competition discussion as a core element of its lifecycle‑service strategy and a driver of market‑share growth (e.g., “modifications and upgrades…gate‑to‑gate operations”) 【page_3】【page_4】. This reflects a shift from a simple service‑offering mention in 2022 to a more strategic emphasis on upgrades as a growth lever within Global Services in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Boeing's framing of 'upgrades and conversions' between 2022 and 2023. STRENGTHS: (1) Accurately captures the shift from a simple listing in 2022 to a more strategic emphasis in 2023; (2) Correctly identifies that the service was grouped with other offerings (supply chain, engineering, maintenance) in 2022; (3) Properly notes the 2023 positioning within a lifecycle-service strategy narrative; (4) Appropriately emphasizes the shift from general service offering to core capability/growth lever; (5) No quantitative errors or date inaccuracies. WEAKNESSES: (1) The LLM answer introduces additional details about 'modifications' and 'gate-to-gate operations' that, while potentially accurate, go slightly beyond what the ground truth explicitly states - the ground truth focuses on the positioning within the segment narrative rather than specific competitive language; (2) The ground truth emphasizes 'integrated and strategic role' and 'more deliberate positioning,' while the LLM frames it as a 'growth lever' - these are semantically similar but the LLM's framing is slightly more specific/interpretive; (3) The citation references (page_3, page_4) cannot be verified against the ground truth provided, though they appear plausible. MULTI-HOP REASONING: The answer successfully synthesizes the comparison across two years and identifies the strategic shift, which is the core requirement. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth - that there was an evolution from a general listing to a more strategic positioning - though with slightly different emphasis and some additional contextual details that enhance rather than contradict the core finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 492,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "In the 2022 filing Intel reported that its non‑marketable equity portfolio included a $1.1 billion stake in Beijing Unisoc Technology Ltd. (up from $658 million a year earlier) and that this amount was carried on the balance sheet as of December 25 2021【page_52】. The 2023 filing shows the same investment still recorded at a net book value of $1.1 billion as of December 30 2023, noting that Intel recognized a $471 million observable‑price adjustment to the Unisoc holding in 2021 but reported no further impairment or valuation change through 2023【page_96】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about Intel's financial relationship with Beijing Unisoc Technology Ltd. between 2021 and 2023. STRENGTHS: (1) All key financial figures are accurate: $1.1 billion net book value as of both December 25, 2021 and December 30, 2023; $471 million observable price adjustment in 2021; the prior year figure of $658 million is correctly cited. (2) Dates are correct (December 25, 2021 and December 30, 2023). (3) The multi-hop synthesis is sound - the answer correctly traces the investment evolution across both the 2022 and 2023 filings. (4) The key insight about the $471 million revaluation in 2021 with no further adjustments through 2023 is accurately captured. (5) The semantic meaning matches the ground truth regarding investment stabilization. MINOR WEAKNESSES: (1) The LLM answer includes the intermediate figure of $658 million (prior year to 2021), which while accurate, adds a detail not explicitly mentioned in the ground truth answer. This is not incorrect but represents slightly different framing. (2) The phrasing 'no further impairment or valuation change through 2023' is slightly more specific than the ground truth's 'lack of significant observable price changes in 2023,' though both convey the same essential meaning. (3) The answer could have been slightly more explicit about the 'evolution' aspect by emphasizing the contrast between the 2021 revaluation event and the 2023 stability, though this is implied. CALCULATION VERIFICATION: No calculations required; all cited figures are direct from filings and are accurate. MULTI-HOP REASONING: Correctly synthesized information from 2022 filing (reporting 2021 data) and 2023 filing (reporting 2023 data) to show the evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 484,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "In fiscal 2023 the filing described self‑service lockers as a new store‑refresh element that gave shoppers a convenient “online‑order pickup” option alongside BOPIS, BOSS, BODFS and BORIS 【page_8】. By fiscal 2024 the lockers are portrayed as a fully‑integrated front‑entrance fixture at many stores, explicitly tied to the four interconnected retail programs and used for pickup, return and delivery fulfillment as a core part of Home Depot’s interconnected shopping experience 【page_9】【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Self-Service Lockers from 2023 to 2024 and correctly identifies the shift from a convenience feature to a more integrated fulfillment component. The qualitative description of the progression is largely accurate - the answer correctly notes the 2023 positioning as a store-refresh element for online order pickup and the 2024 positioning as a fully-integrated fixture tied to interconnected retail programs (BOPIS, BOSS, BODFS, BORIS). However, there is a critical omission: the ground truth specifically mentions that 'approximately 50% of U.S. online orders were fulfilled through a store' in 2024, which is a key quantitative metric that demonstrates the operational significance of this shift. The LLM answer completely omits this important statistic. Additionally, the LLM answer slightly mischaracterizes the 2023 description by suggesting lockers were presented 'alongside BOPIS, BOSS, BODFS and BORIS' in 2023, when the ground truth indicates these programs were primarily referenced in the 2024 context as part of the more strategic positioning. The multi-hop reasoning is sound in connecting the evolution across years, but the missing quantitative data (50% fulfillment metric) represents a significant gap in completeness. The page citations provided appear reasonable but cannot be independently verified. Overall, the answer demonstrates good understanding of the qualitative evolution but fails to capture important quantitative evidence that supports the significance of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 425,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "In the 2023 Form 10‑K Costco’s note on insurance/self‑insurance liabilities was relatively brief – it said the liabilities are not discounted and are “estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions” (2023 p.46‑47). The 2024 filing expands that discussion, still noting the same actuarial inputs but now explicitly stating that claim costs are “highly unpredictable” and can fluctuate because of inflation, regulatory or legal changes, and that historically adjustments have been immaterial, thereby providing a more detailed and specific description of the estimation methodology (2024 p.31).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION - The LLM answer directly contradicts the ground truth by claiming that 2023 ALREADY contained the specific language about 'historical claims experience, demographic factors, severity factors, and other actuarial assumptions.' The ground truth explicitly states that 2023 'did not specify the factors used in estimating liabilities' and that 2024 'significantly expanded its disclosure, detailing that liabilities are estimated using' these factors. The LLM incorrectly attributes this detailed language to 2023. (2) INCOMPLETE CHARACTERIZATION OF CHANGE - While the LLM correctly identifies that 2024 added discussion of unpredictability and claim cost fluctuations, it fundamentally misrepresents the evolution by suggesting both years contained the same actuarial inputs language ('still noting the same actuarial inputs'). This is factually wrong according to the ground truth. (3) PAGE REFERENCE ISSUES - The LLM provides specific page numbers (2023 p.46-47, 2024 p.31) which cannot be verified against the ground truth and may be inaccurate. (4) CORE REASONING FAILURE - The multi-hop synthesis fails because the LLM did not correctly identify that the key evolution was the INTRODUCTION of specific estimation methodology details in 2024 that were absent in 2023, not merely an expansion of existing language. The answer demonstrates a fundamental misunderstanding of the comparative analysis required by the question. The only partially correct element is the acknowledgment that 2024 added discussion of unpredictability, but this is overshadowed by the major factual error regarding 2023's content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 454,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "In 2022 the Aldevron deal was only adding a modest, lower‑incremental inventory adjustment – the fair‑value inventory charge that had boosted cost of sales by $59 million in 2021 was much smaller in 2022 and only partially offset the rise in cost of sales 【page_46】. By 2023 that acquisition‑related inventory effect had essentially disappeared, and the company instead recorded a $87 million excess‑inventory charge in the Biotechnology segment, driving a larger inventory‑related cost impact 【page_46】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its accuracy. CRITICAL ISSUES: (1) The LLM incorrectly references a $59 million fair-value inventory charge in 2021, when the ground truth clearly states this charge occurred in 2022. The LLM states 'the fair‑value inventory charge that had boosted cost of sales by $59 million in 2021 was much smaller in 2022' - this is factually wrong. The ground truth explicitly says the $59 million increase was IN 2022, not 2021. (2) The LLM's characterization of 2022 as having 'only a modest, lower‑incremental inventory adjustment' contradicts the ground truth which identifies a clear $59 million acquisition-related cost in 2022. (3) The LLM correctly identifies the $87 million excess inventory charge in 2023 and correctly notes the shift from acquisition-driven to operational inventory challenges. CORRECT ELEMENTS: The answer properly identifies that the Aldevron acquisition-related inventory effect disappeared by 2023, correctly cites the $87 million charge in the Biotechnology segment, and appropriately characterizes the shift from acquisition-driven to operational challenges. MULTI-HOP REASONING: The answer attempts to synthesize information across 2022-2023 but fails on the temporal accuracy of when the $59 million charge occurred. The core logic about the transition is sound, but the foundational facts are misplaced. The answer demonstrates understanding of the overall narrative but executes poorly on specific year attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 416,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Costco’s 2024 filing still records shop‑card balances as a liability “net of estimated breakage,” with revenue recognized only when cards are redeemed and the unredeemed portion estimated and deducted from the liability. The language is identical to the 2023 discussion, showing that Costco has not altered its policy but continues to treat unclaimed card balances conservatively—recognizing them as a current liability reduced by data‑driven breakage estimates.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer states that the treatment of shop card liabilities EVOLVED between 2023 and 2024, with 'estimated breakage' and methodology becoming 'more emphasized in 2024' and indicating 'a more refined or formalized approach.' The LLM answer explicitly contradicts this by stating 'The language is identical to the 2023 discussion, showing that Costco has not altered its policy.' This is a fundamental misreading of the ground truth's core claim about evolution and change. The LLM correctly identifies that both years use 'net of estimated breakage' language and that revenue is recognized upon redemption, but it misses the key insight that the 2024 filing shows MORE emphasis on the methodology and estimation techniques. The LLM's conclusion that there was 'no alteration' directly opposes the ground truth's assertion of improved estimation techniques and more formalized approaches. While the LLM's description of the accounting mechanics is accurate (liability treatment, breakage estimates, redemption-based recognition), it fails to capture the evolution aspect that is central to the question. The answer demonstrates poor multi-hop reasoning by not synthesizing the comparative analysis between years that the question explicitly asks for. The LLM appears to have focused only on describing the 2024 treatment rather than comparing it to 2023 to identify changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 408,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "In 2022 Intel introduced Foundry Services (IFS) as a new pillar of its IDM 2.0 strategy, highlighting the launch of the U.S. Department of Defense’s RAMP‑C program that positioned IFS to provide domestic, leading‑edge capacity and an IP‑rich, advanced‑packaging offering backed by U.S. and European fabs. By 2023 the offering had moved from launch to active execution: Intel secured four Intel 18A design wins, more than doubled its IFS Accelerator Ecosystem Alliance to over 40 strategic agreements—including multigenerational deals with ARM and a definitive agreement with Synopsys—and expanded RAMP‑C partnerships to marquee customers such as Nvidia, IBM, Microsoft, Boeing and Northrop Grumman, while also signing a commercial agreement with Tower for 300 mm analog‑processing capacity. This evolution shows a shift from establishing the service and a single government partnership to building a broad ecosystem of technology partners and engaging a growing roster of high‑profile customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and comprehensive response than the ground truth, but introduces several factual issues that reduce accuracy. STRENGTHS: (1) Correctly identifies 2022 as introduction of IFS within IDM 2.0 strategy; (2) Accurately states four Intel 18A design wins in 2023; (3) Correctly mentions over 40 strategic agreements in IFS Accelerator Ecosystem Alliance; (4) Properly identifies ARM and Synopsys partnerships; (5) Good narrative structure showing evolution from 2022 to 2023; (6) Appropriate contextual framing of the shift from intent to execution. WEAKNESSES: (1) RAMP-C program attribution is problematic - while mentioned in 2022 context, the ground truth does not specifically attribute RAMP-C as a 2022 launch initiative for IFS; (2) The claim about 'more than doubled' the ecosystem alliance is unsupported by ground truth (ground truth only states 'over 40' in 2023, with no baseline for 2022 comparison); (3) Specific customer names (Nvidia, IBM, Microsoft, Boeing, Northrop Grumman) are mentioned in LLM answer but NOT present in ground truth - this represents potential hallucination or information from outside the provided knowledge graph; (4) Tower semiconductor agreement and '300 mm analog-processing capacity' detail is not mentioned in ground truth; (5) Ground truth mentions 'five new design wins in advanced packaging' which LLM answer omits entirely; (6) Ground truth mentions 'major high-performance computing customer' which LLM answer doesn't explicitly reference. QUANTITATIVE ISSUES: The '40 strategic agreements' number matches, but the 'more than doubled' claim cannot be verified against ground truth. The four design wins number is correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2023 timeline and identifies the strategic evolution, though it adds details not in the ground truth. The reasoning about shift from intent to execution is sound and matches ground truth intent. CONCLUSION: While the LLM answer is well-structured and captures the main narrative arc, it introduces unverified details (specific customer names, Tower agreement) and omits some ground truth elements (five advanced packaging wins), suggesting either hallucination or reliance on information outside the provided knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 615,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K show the Aldevron acquisition still recorded at roughly $6.1 billion of goodwill and $9.6 billion of net cash consideration. The acquisition note tables list goodwill of $6,149 million and net cash consideration of $9,561 million for Aldevron in each filing, indicating no material change in the financial impact between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN REASONING: The LLM fundamentally misunderstood the question and provided an incorrect conclusion. While the numeric values are accurate ($6.1 billion goodwill, $9.561 billion net cash consideration), the LLM's interpretation of what these numbers represent across years is wrong.\n\nGROUND TRUTH INTERPRETATION: The original answer correctly identifies that in 2022, DHR preliminarily recorded ~$6.1 billion of goodwill, and by 2023, the net cash consideration was $9.561 billion. This represents an EVOLUTION showing the financial commitment increased, with the cash outlay being significantly higher than the initial goodwill estimate.\n\nLLM'S INCORRECT INTERPRETATION: The LLM states 'no material change in the financial impact between 2022 and 2023' and claims both metrics appear 'in each filing.' This is factually wrong. The question asks about how the relationship EVOLVED between years, and the ground truth shows a significant evolution: the preliminary 2022 goodwill of $6.1B versus the 2023 net cash consideration of $9.561B demonstrates a substantial increase in financial commitment.\n\nNUMERIC ACCURACY: The numbers themselves are correct ($6,149M ≈ $6.1B and $9,561M = $9.561B), so quantitative accuracy scores well. However, the semantic interpretation is fundamentally flawed.\n\nMULTI-HOP REASONING FAILURE: The LLM failed to synthesize the temporal evolution across 2022-2023 filings. It incorrectly concluded there was 'no material change' when the ground truth explicitly shows an evolution from preliminary goodwill estimates to a higher net cash consideration figure, indicating a revised/more detailed financial assessment.\n\nCONCLUSION: While numbers are cited correctly, the LLM's core conclusion contradicts the ground truth's interpretation of how the financial impact evolved. This is a major reasoning error that makes the answer fundamentally incorrect despite accurate citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 522,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The 1.800 % Global Notes are listed with a maturity of **September 5 2026** in both filings – the 2022 10‑K shows “AT&T Inc. 1.800 % Global Notes due September 5 2026” (page 2) and the 2024 10‑K repeats the same entry (page 1). Because the maturity date has not been extended or altered, AT&T’s debt structure for this tranche has remained stable, indicating the company has kept its existing long‑term borrowing schedule rather than reshaping it.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. According to the ground truth, the maturity date of AT&T Inc. 1.800% Global Notes changed from September 5, 2026 (2022 filing) to September 14, 2039 (2024 filing) - a 13-year extension. The LLM claims both filings show September 5, 2026 with no change, which directly contradicts the ground truth. This is a critical factual error on the primary question. The LLM's conclusion that 'the maturity date has not been extended or altered' and that 'AT&T's debt structure for this tranche has remained stable' is completely wrong. The ground truth explicitly states this represents 'a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.' The LLM failed to identify the key change (September 5, 2026 → September 14, 2039) and therefore provided an entirely incorrect interpretation of what the data indicates about the company's debt structure evolution. The LLM also cites specific page numbers (page 2 for 2022, page 1 for 2024) without verification, which appears to be fabricated support for an incorrect claim. This represents a complete failure in multi-hop reasoning and factual accuracy on a straightforward comparative question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 355,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target said it was **in compliance with its debt‑leverage covenant in both years** – the 2023 Form 10‑K notes “We are, and expect to remain, in compliance with these covenants” and the 2024 Form 10‑K repeats the same statement【page_54】【page_35】.  The company’s credit‑facility structure changed: it added a new $1.0 billion 364‑day revolving facility (replacing the prior short‑term facility) and extended its $3.0 billion five‑year revolving facility to 2028, giving it greater borrowing capacity and liquidity that helps sustain covenant compliance【page_54】【page_35】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Target was in compliance with its debt leverage covenant in both 2023 and 2024, and accurately notes the renewal of the 364-day facility and maintenance of the $3.0 billion five-year facility. However, there are significant quantitative accuracy issues: (1) The LLM states the company 'added a new $1.0 billion 364-day revolving facility (replacing the prior short-term facility)' and 'extended its $3.0 billion five-year revolving facility to 2028' - but the ground truth indicates the $3.0 billion five-year facility was ALREADY expiring in October 2028 in 2023, not newly extended to 2028 in 2024. The LLM misrepresents this as a change when it was already in place. (2) The LLM says the 364-day facility was 'replaced' when the ground truth indicates it was 'renewed' with an extended expiration from October 2024 to October 2025 - this is a meaningful distinction about continuity vs. replacement. (3) The LLM's characterization of 'added a new' facility is imprecise; the ground truth indicates the existing facility was renewed/extended. The reasoning about how these changes support covenant compliance is sound and relevant, but the factual description of what changed between years contains errors. The multi-hop synthesis is partially correct (identifying both years' compliance and facility structure) but mischaracterizes the nature of the changes. The answer demonstrates understanding of the general concept but fails on precise quantitative/structural accuracy regarding what actually changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 426,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "In 2022 Intel first embedded digital‑readiness into its RISE agenda by launching the **RISE Technology Initiative** (renamed from the Pandemic Response Technology Initiative) and rolling out global “Intel Digital Readiness” programs such as **AI for Youth** and **AI for Workforce**, which were **scaled in partnership with governments, institutions and other stakeholders** to give millions of people new digital skills 【page_16】. By 2023 the company had **deepened and broadened those external collaborations**—continuing the RISE Technology Initiative, working with the **Alliance for Global Inclusion** and other partners, and funding projects that make technology more inclusive while further expanding digital‑readiness worldwide, positioning it as a core pillar of its 2030 RISE goals 【page_19】【page_18】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the general topic of Intel's digital readiness evolution but contains significant factual discrepancies with the ground truth. CRITICAL ERRORS: (1) The LLM introduces specific program names ('AI for Youth', 'AI for Workforce', 'RISE Technology Initiative') that are not mentioned in the ground truth, and the renaming claim ('renamed from Pandemic Response Technology Initiative') cannot be verified against the provided knowledge graph. (2) The LLM completely omits the key quantitative finding from the ground truth: the third global inclusion index survey with 18 organizations recognized out of 27 respondents scoring 50% or higher. This is a critical metric that demonstrates the evolution from 2022 to 2023. (3) The LLM fails to mention the 'Inclusion Index' and the transition to a formal index system with defined benchmarks, which is central to understanding the maturation of Intel's approach. (4) The LLM's characterization of the evolution differs from ground truth: ground truth emphasizes the shift from 'establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks,' while the LLM focuses on scaling and deepening partnerships without capturing the measurement/recognition component. PARTIAL CREDIT: The LLM correctly identifies the Alliance for Global Inclusion as a partner and correctly notes the 2022-2023 timeframe and the connection to RISE strategy. The answer is contextually relevant to the question but fundamentally incomplete and introduces unverified details while omitting critical quantitative data that defines the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 453,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson’s AspenTech subsidiary had been negotiating to buy Micromine, but in August 2023 AspenTech announced the agreement was mutually terminated and no termination fee was paid【page_52】.  By 2024 the Micromine deal was completely off‑the‑table, and the only financial effect was the unwind of the foreign‑currency hedges tied to the aborted purchase, which generated a $24 million mark‑to‑market gain in 2023 (shown in the foreign‑currency transaction line) and avoided any purchase‑price or termination‑cost expense【page_55】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Emerson's relationship with Micromine evolving from acquisition attempt to termination, with accurate identification of key facts: (1) AspenTech subsidiary involvement, (2) mutual termination in August 2023, (3) no termination fee paid, (4) $24 million mark-to-market gain in 2023 from foreign currency forward contracts, and (5) unwinding of hedges by 2024. STRENGTHS: All major financial figures are correct ($24M gain, no termination fee). The timeline is accurate (2023 acquisition attempt, 2024 termination of contracts). The multi-hop synthesis is sound - correctly connecting AspenTech to Emerson, linking the acquisition termination to the FX hedge impacts, and showing the progression from 2023 to 2024. WEAKNESSES: The LLM answer omits the original acquisition price (AU$900 million, approximately $623 USD), which was mentioned in the ground truth as context for understanding the deal's scope. While not critical to answering the question about how the relationship 'evolved,' this detail provides important context about the magnitude of the failed transaction. The answer also doesn't explicitly state that Russian regulatory approval uncertainty was the reason for termination, though it does note the termination was mutual. The phrase 'completely off-the-table' is colloquial but semantically equivalent to 'full withdrawal.' CALCULATION VERIFICATION: The $24M figure is correctly identified as a mark-to-market gain (not loss), properly attributed to 2023, and correctly linked to foreign currency forward contracts. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023-2024 timeline and connects the acquisition attempt to its financial consequences (FX hedges), demonstrating proper multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 496,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The Home Depot’s U.S. ESPP had roughly 17 million shares available at the end of fiscal 2022 (January 30 2022) and this pool contracted to about 15 million shares by the end of fiscal 2023 (January 28 2024)【page_70】. The most recent disclosed average purchase price fell from $305.14 per share (the last average price shown in the 2022 filing) to $277.19 per share in fiscal 2023【page_70】【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key components of the question. Verification of facts: (1) Shares available: 17 million in 2022 → 15 million in 2023 ✓ (2) Shares purchased: approximately 1 million in both years ✓ (3) Average purchase prices: $305.14 in 2022 → $277.19 in 2023 ✓ All numeric values match the ground truth exactly. The LLM correctly synthesized the multi-hop information comparing the two fiscal years across multiple metrics (share availability, purchase volume, and average price). The answer properly identifies the trend of decreasing share availability and declining average purchase price. Minor note: The LLM provides specific fiscal year end dates (January 30, 2022 and January 28, 2024) which adds helpful context, though the ground truth answer uses simpler year references. The LLM's statement about 'the most recent disclosed average price' is slightly awkward phrasing but semantically accurate. The answer includes citation references to source pages which demonstrates proper documentation. The reasoning is sound and the synthesis across the two fiscal years is correct. No calculation errors detected. The answer fully addresses the question's request to show how availability and average purchase price changed from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 359,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "In the 2022 filing Danaher only noted impairment triggers in the Diagnostics unit (Q1 2021) and in Diagnostics and Environmental & Applied Solutions (Q1/Q3 2020), which produced modest charges of $10 million in 2021 and $22 million in 2020 and no charge for 2022【page_99】. The 2023 filing adds new triggers in the Biotechnology segment (Q2 2023) and again in Diagnostics (Q4 2023), resulting in a $77 million impairment charge for 2023 (with 2022 still reporting none)【page_89】. This evolution shows risk shifting from earlier, smaller‑scale diagnostics‑related intangibles to larger, technology‑focused intangibles in the Biotechnology business, indicating heightened exposure in that segment’s intangible‑asset portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces incorrect numbers not in the ground truth: claims $22 million impairment charge in 2020 and mentions Environmental & Applied Solutions segment impairments in Q1/Q3 2020, neither of which appear in the original answer. The ground truth only mentions $10 million in 2021 (Diagnostics) and $77 million in 2023. The LLM's addition of 2020 data and the $22 million figure is factually incorrect. (2) SEGMENT ACCURACY - The LLM incorrectly identifies 'Environmental & Applied Solutions' as having impairment triggers, which is not mentioned in the ground truth. The ground truth clearly states impairments were in Diagnostics (2021, 2023) and Biotechnology (2023 only). (3) TEMPORAL ACCURACY - The LLM correctly identifies Q1 2021 for Diagnostics, Q2 2023 for Biotechnology, and Q4 2023 for Diagnostics, which aligns with ground truth. However, the addition of Q1/Q3 2020 data is extraneous and incorrect. (4) KEY NUMBERS - The $10 million (2021) and $77 million (2023) figures are correct, but the $22 million (2020) is not supported by the ground truth. (5) MULTI-HOP REASONING - The LLM does attempt to synthesize the evolution across filings and draw conclusions about risk shifting, which is appropriate. However, the conclusion about 'risk shifting from earlier, smaller-scale diagnostics-related intangibles' is partially undermined by the incorrect historical data. (6) CORE INSIGHT - The LLM correctly identifies that Biotechnology became a new focus for impairments in 2023 and that this represents growing risks, which matches the ground truth conclusion. However, the factual errors regarding 2020 data and the Environmental & Applied Solutions segment significantly compromise the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 484,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The company’s outstanding letters of credit grew from $362 million at January 30 2022 (2022 filing) to $598 million at January 28 2024 (2023 filing) – an increase of roughly $236 million. This rise signals that Home Depot’s exposure to, and reliance on, business transactions such as trade contracts has expanded, reflecting greater involvement in and support for larger or more numerous contract‑related activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Both key financial figures are accurate: $362 million (2022) and $598 million (2023) match the ground truth exactly. (2) The calculated increase of $236 million is mathematically correct ($598M - $362M = $236M). (3) The multi-hop synthesis is sound - the answer correctly identifies the change between two fiscal years and interprets what this indicates about the company's business activities. (4) The qualitative interpretation aligns with the ground truth: both answers recognize this as a 'significant increase' indicating 'growing involvement' or 'expansion' in trade contract activities. (5) The answer appropriately identifies the company as Home Depot, providing helpful context. MINOR CONSIDERATIONS: (1) The LLM provides slightly more specific date information (January 30, 2022 and January 28, 2024) which adds precision but is not required by the question. (2) The wording differs slightly from the ground truth ('exposure to, and reliance on' vs. simply 'involvement') but conveys equivalent meaning and is actually more detailed in explaining the business implications. (3) The answer goes slightly beyond the ground truth by mentioning 'larger or more numerous contract-related activities,' which is a reasonable inference but represents minor elaboration. Overall, the answer demonstrates accurate financial data synthesis, correct calculations, and sound reasoning about what the change indicates about business operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 417,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "In the 2023 Form 10‑K IBM only referenced the 0.300 % Notes due 2028 as an incorporated exhibit – “the instruments defining the rights of the holders of the 0.300 % Notes due 2028 … are Exhibit 4.1 to Form 8‑K filed February 10 2020.” In the 2024 Form 10‑K the same notes are listed in the Section 12(b) securities‑registration table as “0.300 % Notes due 2028 (IBM28B),” confirming they remain outstanding and are now disclosed as a registered security. This evolution shows IBM’s continued and increasingly explicit disclosure of its debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All specific details are correct - the 0.300% Notes due 2028, the February 10, 2020 date for the Form 8-K filing, the trading symbol IBM28B, and the New York Stock Exchange registration are all accurately stated. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution of disclosure from 2023 (referenced as an incorporated exhibit) to 2024 (listed in Section 12(b) securities-registration table). (3) The interpretation is accurate - both answers recognize this as a shift from passive reference to active registration/disclosure. (4) Quantitative accuracy is perfect - all dates, percentages, and identifiers match the ground truth. MINOR DIFFERENCES: (1) The LLM uses slightly different framing - it emphasizes 'increasingly explicit disclosure' rather than 'increased market engagement or liquidity,' but both interpretations are semantically valid and supported by the facts. (2) The LLM provides more specific context about Section 12(b) registration, which adds precision without contradicting the ground truth. (3) The LLM's phrasing 'remain outstanding and are now disclosed as a registered security' is slightly more cautious than the ground truth's 'actively traded,' but this is a reasonable interpretation of the same underlying facts. The answer demonstrates clear understanding of the multi-hop nature of the question (comparing 2023 vs 2024 filings) and correctly synthesizes the information about the instrument's evolving disclosure status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 432,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In the 2023 Form 10‑K, IBM only referenced the 1.750 % Notes due 2031 by incorporating the related 8‑K exhibit (filed January 30 2019) into the filing, without listing the notes in its Section 12(b) securities‑registration table. By the 2024 Form 10‑K, IBM explicitly includes the 1.750 % Notes due 2031 (ticker IBM31) in the “Securities registered pursuant to Section 12(b)” table, showing that the notes are now disclosed as a NYSE‑registered security. This reflects a shift from a purely incorporated‑by‑reference disclosure to an active registration and listing on the exchange.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about IBM's 1.750% Notes due 2031 evolution between 2023 and 2024. STRENGTHS: (1) All numeric values are correct - the interest rate (1.750%), the maturity year (2031), the filing date (January 30, 2019), and the ticker symbol (IBM31) are all accurate. (2) The multi-hop synthesis is sound: the answer correctly traces the evolution from 2023 (incorporated by reference, not in Section 12(b) table) to 2024 (explicitly registered with ticker IBM31 in Section 12(b) table). (3) Entity identification is precise - IBM is correctly identified, the specific debt instrument is properly characterized, and the NYSE registration is accurately noted. (4) The reasoning about the shift from 'incorporated-by-reference disclosure' to 'active registration and listing' correctly captures the substantive change in treatment. (5) The answer directly addresses both disclosure and registration aspects of the question. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical language (e.g., 'Section 12(b) securities-registration table') compared to the ground truth's more general phrasing, but this is actually more precise and adds value. The ground truth mentions the instrument was 'incorporated by reference as part of an exhibit' while the LLM specifies it was 'incorporating the related 8-K exhibit' - both convey the same information accurately. The LLM's explicit mention of the Section 12(b) table provides additional helpful context that aligns with SEC filing conventions. No calculation errors, date errors, or factual inaccuracies detected. The answer fully addresses the question's multi-part structure regarding both disclosure evolution and registration status changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 485,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "In 2023 Eli Lilly booked Zyprexa as product revenue – the $1.45 billion sale of the olanzapine‑portfolio rights (including Zyprexa) was reflected in net product revenue, lifting Zyprexa’s total sales to roughly $1.7 billion. By the 2024 filing that same rights‑sale is shown under “collaboration and other revenue,” meaning Lilly now treats Zyprexa as a licensing/collaboration arrangement rather than a direct product sale, shifting the revenue‑recognition approach and business model toward partnership‑based income.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core shift in Eli Lilly's financial relationship with Zyprexa between 2023 and 2024 - from product sales to collaboration/licensing revenue recognition. The qualitative reasoning about the business model transformation is sound and well-articulated. However, there is a significant quantitative accuracy issue: The LLM introduces an unsupported figure of 'roughly $1.7 billion' as Zyprexa's total sales in 2023. The ground truth only mentions the $1.45 billion from the rights sale; the LLM appears to have added an additional ~$250 million without justification or source. This is a material discrepancy that cannot be verified against the ground truth. The LLM correctly identifies: (1) the $1.45 billion rights sale amount, (2) the 2023 timing, (3) the shift to collaboration/other revenue in 2024, and (4) the conceptual transformation from direct product sales to licensing arrangements. The multi-hop reasoning is sound - the model synthesized the year-over-year change and understood the revenue recognition shift. However, the introduction of the unsubstantiated $1.7 billion figure represents a factual error that undermines confidence in the quantitative accuracy, even though the core narrative and primary numbers are correct. The answer is contextually relevant and addresses all parts of the question, but the unsupported additional number prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 396,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023 AT&T recorded the Mobility Preferred Interests as a redemption liability (about $2.7 bn in current liabilities and a similar amount in non‑current liabilities) and then eliminated the instrument by repurchasing the 213 million interests in April 2023 for roughly $5.4 bn, leaving no outstanding Mobility preferred interests at year‑end 2023 【page_90】. As a result, the 2024 earnings‑per‑share reconciliation no longer includes Mobility Preferred Interests as dilutive potential common shares (the diluted‑EPS denominator shows zero Mobility shares, whereas 2023 included 71‑72 shares), so the redemption and repurchase have removed any EPS impact that previously required a dilutive adjustment 【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key financial figures are correct: $2.7 billion in current and noncurrent liabilities (matches $2,670M in ground truth when accounting for millions vs billions notation), $5.4 billion repurchase price (matches $5,414M), and April 2023 timing. (2) The multi-hop synthesis is sound: correctly traces the evolution from 2023 liability classification through repurchase to 2024 EPS impact. (3) Quantitative details are accurate: mentions 213 million interests repurchased and correctly identifies the shift from 71-72 dilutive shares in 2023 to zero in 2024. (4) The reasoning about ASU 2020-06 treatment and the shift from active obligations to retrospective accounting is implicit and correct. (5) Page citations (page_90, page_53) add credibility. MINOR CONSIDERATIONS: (1) The LLM uses 'bn' notation while ground truth uses millions, but this is a formatting variation and both are mathematically equivalent ($2.7bn = $2,700M ≈ $2,670M with rounding). (2) The LLM doesn't explicitly mention ASU 2020-06 by name, though it correctly describes the accounting treatment. (3) The phrase 'no outstanding Mobility preferred interests at year-end 2023' is slightly imprecise since they were repurchased in April 2023, but this is a minor semantic issue. The answer fully addresses all parts of the multi-part question: treatment evolution, financial impact, redemption obligations, and EPS calculation effects across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 421,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 0.875 % Notes due 2030 were disclosed only by reference to the instrument that defines the holders’ rights (Exhibit 4.1‑4.5 to a Form 8‑K filed Feb 8 2022) and were not shown in the Section 12(b) securities table, implying they were not separately listed or registered as a public security【page_20】. By the 2024 Form 10‑K, the same notes appear in the “Securities registered pursuant to Section 12(b)” table with ticker IBM30A and listed on the New York Stock Exchange, indicating that IBM now treats them as a listed, registered security【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about IBM's 0.875% Notes due 2030 evolution between 2023 and 2024. STRENGTHS: (1) All numeric values are correct - the interest rate (0.875%), maturity year (2030), and ticker symbol (IBM30A) are accurately stated. (2) Dates are precise - correctly identifies the Form 8-K filing date of February 8, 2022, and distinguishes between 2023 and 2024 Form 10-K filings. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution from referenced disclosure (via Exhibit 4.1-4.5 to Form 8-K) in 2023 to explicit listing in the Section 12(b) securities table in 2024. (4) Entity identification is accurate - correctly names IBM, identifies the specific notes, and references the New York Stock Exchange. (5) The reasoning about the shift from implicit/referenced status to explicit registration is logically sound and matches the ground truth's characterization of moving from 'referenced disclosure to fully listed and registered financial instrument.' (6) The answer appropriately cites specific sections (Section 12(b) securities table) and provides page references. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical language ('Section 12(b) securities table' vs. 'table of registered securities') but this is semantically equivalent and arguably more precise. The answer fully addresses both the 'listing' and 'registration status' aspects of the question. No calculation errors or factual inaccuracies detected. The response demonstrates clear understanding of the disclosure evolution and regulatory context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 449,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "In 2023 AT&T’s Telco LLC held $7.25 billion of non‑convertible cumulative preferred interests split into two existing series – Class A‑1 (4.25% initial preferred distribution, reset every seven years) and Class A‑2/A‑3 (6.85% initial preferred distribution, reset on Nov 1 2027 and every seven years thereafter)【page_90】【page_87】. By 2024 the same structure and terms remained, but the company entered an agreement to issue a new $2.25 billion Class A‑4 tranche that will pay 5.94% initially and reset on Nov 1 2028 and every four years thereafter【page_88】, indicating AT&T is deliberately expanding its preferred‑equity financing platform with staggered rates and reset schedules to raise cash while preserving flexibility and limiting impact on other cash‑flow commitments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the 2023 total was $7.25 billion, but the ground truth shows 2023 had only $7.25 billion total ($2,000M Class A-1 + $5,250M Class A-2/A-3 = $7,250M). However, the LLM incorrectly presents this as already existing in 2023, when the ground truth indicates the Class A-2/A-3 were only issued in April 2023. More critically, the LLM introduces a Class A-4 tranche of $2.25 billion with 5.94% rate and a Nov 1 2028 reset schedule, which is NOT mentioned in the ground truth at all. This appears to be fabricated information. (2) STRUCTURAL ISSUES: The ground truth explicitly states that in 2023 there were only Class A-1 ($2,000M) and Class A-2/A-3 ($5,250M) interests, totaling $7,250M. The LLM's claim about a new $2.25 billion Class A-4 tranche is entirely unsupported by the ground truth and represents a fundamental factual error. (3) MISSING KEY INFORMATION: The LLM fails to mention the important 2024 clarification that failure to pay distributions would not restrict cash movements or AT&T's ability to pay dividends or repurchase shares - a significant governance point in the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about evolution from 2023 to 2024, it does so by introducing false data points rather than accurately comparing the actual structures. The reasoning about 'staggered rates and reset schedules' is partially sound conceptually but is based on incorrect numbers. (5) SEMANTIC ISSUES: The LLM's conclusion about AT&T 'deliberately expanding its preferred-equity financing platform' is contradicted by the ground truth, which shows the structure remained consistent and only clarified existing terms in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 491,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "In 2022 Capital One already originated and serviced multifamily commercial‑real‑estate loans that it sold to the government‑sponsored enterprises, but the loss‑sharing liability on its balance sheet for those agreements was only **$82 million**【page_98】. By year‑end 2023 the same business continued, yet the liability recorded for loss‑sharing agreements had risen to **$137 million**【page_217】—an increase of about $55 million, reflecting a materially higher risk exposure under the GSE loss‑sharing arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: (1) 2022 liability of $82 million - CORRECT, matches ground truth exactly; (2) 2023 liability of $137 million - CORRECT, matches ground truth exactly; (3) Calculated increase of $55 million ($137M - $82M = $55M) - CORRECT and properly computed. Entity accuracy: Capital One correctly identified, GSEs (government-sponsored enterprises) correctly referenced, fiscal years 2022 and 2023 correctly specified, loss sharing agreements properly identified. Multi-hop reasoning: The answer successfully synthesizes information across two fiscal years, correctly identifying the evolution of Capital One's involvement in multifamily commercial real estate loans and the corresponding increase in risk exposure under loss sharing agreements. The answer addresses all components of the question: (1) Capital One's involvement in multifamily CRE loans, (2) the evolution between 2022-2023, (3) risk exposure specifically under loss sharing agreements with GSEs. The semantic meaning is equivalent to the ground truth - both convey that Capital One originated/serviced these loans, sold them to GSEs, and experienced a significant increase in loss sharing liability from $82M to $137M. Minor note: The LLM includes page citations which add credibility but are not part of the ground truth evaluation. The characterization of the increase as 'materially higher' is a reasonable qualitative assessment supported by the 67% increase in liability ($55M/$82M ≈ 67%).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 422,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "In the 2022 Form 10‑K Amazon treated its co‑branded credit‑card programs mainly as a payment‑offering risk – noting they could hurt operating results if the agreements were renewed on less‑favorable terms or terminated (2022 p. 13‑14). The 2023 filing still flags that same risk but adds that the programs are now subject to “additional regulations and compliance requirements (including obligations to implement enhanced‑authentication processes)” and other licensing‑ and capital‑maintenance rules, meaning new compliance obligations that could raise costs, fines or even force termination and therefore have a larger‑than‑before impact on operating results (2023 p. 13‑14). This reflects a shift toward greater strategic and regulatory significance for the co‑branded credit‑card programs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core shift in Amazon's co-branded credit card programs from 2022 to 2023, noting the progression from basic payment offering risks to expanded compliance obligations. The answer accurately captures that 2022 focused on renewal/termination risks while 2023 added new compliance requirements. The mention of enhanced-authentication processes and licensing/capital-maintenance rules aligns with the ground truth's emphasis on expanded regulatory scope. The page references (p. 13-14) are appropriately cited. The semantic understanding that compliance obligations increased and could impact operating results is sound.\n\nWEAKNESSES: The LLM answer is INCOMPLETE on a critical element. The ground truth specifically emphasizes DATA LOCALIZATION RULES as a key new compliance obligation in 2023 that was NOT mentioned in 2022. This is explicitly stated in the original answer as a major shift: 'data localization rules, which were not mentioned in 2022' and 'particularly in international jurisdictions.' The LLM answer mentions 'enhanced-authentication processes' and generic 'licensing-and capital-maintenance rules' but FAILS to identify data localization as the specific new regulatory risk. This is a significant omission because data localization is highlighted in the ground truth as the primary example of how the regulatory landscape expanded, particularly regarding cross-border data transfers. The LLM answer also doesn't emphasize the international/cross-border dimension that the ground truth stresses.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis across 2022 and 2023 filings, correctly comparing the two years and identifying the progression. However, the failure to identify the specific data localization compliance obligation weakens the multi-hop analysis.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is not directly testable. Page references appear reasonable but cannot be independently verified.\n\nOVERALL ASSESSMENT: The answer captures the general direction and significance of the shift but misses a key specific regulatory development (data localization) that the ground truth emphasizes as central to understanding the expanded compliance burden.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 619,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "In the 2022 Form 10‑K, PMI disclosed that Rothmans, Benson & Hedges (RBH) had been **deconsolidated** from its consolidated financial statements since the March 22 2019 CCAA filing and that the remaining stake was carried as an equity security “without readily determinable fair value,” with no impairment recognized (see Note 20 on deconsolidation). By the 2024 Form 10‑K, the deconsolidation remained, but PMI **valued** the RBH equity investment, concluded it was impaired, recorded a **$2.3 billion non‑cash impairment** and reported a **fair‑value estimate of $714 million** based on a discounted‑cash‑flow analysis and the expected allocation of the global settlement (see Note 6/Impairment of RBH equity investment).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2019 CCAA filing date (March 22, 2019) and deconsolidation status in 2022; (2) Accurately reports the 2024 impairment charge of $2.3 billion and fair value estimate of $714 million; (3) Properly synthesizes the multi-hop evolution from deconsolidated subsidiary (2022) to valued equity investment with impairment analysis (2024); (4) Correctly notes the shift from 'without readily determinable fair value' to DCF-based valuation; (5) Appropriately references the global settlement consideration in the valuation; (6) Correctly cites relevant note disclosures (Note 20 for 2022, Note 6 for 2024). MINOR GAPS: (1) The ground truth mentions the CAD 3.1 billion allocation of compensatory damages from Canadian tobacco litigation, which the LLM answer does not explicitly include (though it references 'global settlement'); (2) The ground truth emphasizes 'significant judgment' around discount rates, sales volumes, operating margins, and tax treatment assumptions, which the LLM answer mentions only implicitly through 'DCF analysis.' QUANTITATIVE VERIFICATION: The $2.3 billion impairment and $714 million fair value are specific numbers that align with the ground truth's description of impairment analysis and valuation. The dates (2019, 2022, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly traces the evolution of PM's relationship with RBH from deconsolidation through to equity investment valuation. The logical flow from 2022 status to 2024 changes is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential information about the relationship evolution and captures the key shift in accounting treatment and valuation approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 501,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "In 2023 Baqsimi generated $677.6 million of total revenue ( $645.7 m U.S. + $31.9 m outside U.S.) — about 2 % of Lilly’s $34.1 billion consolidated revenue — and this figure was heavily bolstered by a one‑time $579 million sale of the product’s rights (see page 47 & page 48). By 2024 the rights‑sale cash inflow had disappeared; Baqsimi now appears only in the “collaboration and other” line (which fell to $4.29 billion from $5.31 billion, the 2023 amount that included the Baqsimi rights sale) and its product‑sale contribution is a modest, non‑core part of the portfolio as Lilly’s growth is now driven by higher‑growth brands such as Mounjaro, Verzenio and Jardiance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core 2023 revenue figures ($677.6M total, $645.7M U.S., $31.9M outside U.S.) and accurately captures the strategic shift from direct product sales to collaboration/other arrangements in 2024. The answer appropriately contextualizes Baqsimi's role within LLY's broader portfolio and mentions the rights sale transition. The reasoning about the shift from internal commercialization to divested asset is sound.\n\nWEAKNESSES & ERRORS: (1) QUANTITATIVE ISSUE - The LLM states the $579M rights sale was a 'one-time' component of 2023 revenue, but the ground truth does not explicitly break down the $677.6M into product sales vs. rights sale components. The LLM appears to be inferring or adding information not clearly stated in the ground truth. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes that Baqsimi was 'no longer reported as a direct revenue contributor through product sales' in 2024 and was instead 'disclosed as part of collaboration and other arrangements.' The LLM mentions this but adds unsupported detail about the $579M rights sale being included in the 2023 figure and then disappearing in 2024. (3) CONTEXTUAL ADDITION - The LLM adds comparative context about Mounjaro, Verzenio, and Jardiance driving growth, which is relevant but goes beyond what the ground truth explicitly states about Baqsimi's role. (4) COLLABORATION LINE FIGURES - The LLM provides specific numbers for the collaboration line ($4.29B in 2024 vs $5.31B in 2023), which are not mentioned in the ground truth and cannot be verified against it.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the 2023-to-2024 transition and identifies the strategic shift. However, the introduction of the $579M rights sale breakdown and the specific collaboration line figures represent additions beyond the ground truth that may or may not be accurate.\n\nOVERALL: The core answer is directionally correct and captures the essential evolution of Baqsimi's role. However, the introduction of unverified quantitative details (the $579M breakdown, collaboration line figures) and the inference that the rights sale was embedded in the 2023 revenue figure creates uncertainty about factual accuracy. The answer would score higher if it stuck to the ground truth without adding these specific financial details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 623,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "In the 2022 filing Union Pacific listed 48,962 owned containers and 1,856 leased containers (≈96 % owned) and 29,875 owned chassis with 14,148 leased chassis (≈68 % owned)【page_24】. By 2024 the fleet had shrunk to 46,375 owned containers and only 288 leased containers (≈99 % owned) and 4,356 owned chassis with 1,197 leased chassis (≈79 % owned)【page_19】, pushing the owned‑to‑leased ratio for containers from roughly 26 : 1 to about 161 : 1 and for chassis from about 2 : 1 to roughly 3.6 : 1.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth across multiple data points. (1) OWNED CONTAINERS: LLM states 48,962 in 2022 and 46,375 in 2024, but ground truth indicates total owned units were 78,837 in 2022 and 50,731 in 2024. The LLM appears to have only captured container data, not the full picture. (2) LEASED CHASSIS: LLM claims 14,148 leased chassis in 2022, but ground truth shows total leased units were only 16,004 across ALL equipment in 2022. This is mathematically impossible - leased chassis alone cannot exceed total leased equipment. (3) LEASED CHASSIS 2024: LLM states 1,197 leased chassis in 2024, but ground truth shows only 1,485 total leased units in 2024 across all equipment. Again, this is internally inconsistent. (4) OWNED CHASSIS: LLM correctly identifies 29,875 in 2022 and 4,356 in 2024, matching ground truth. (5) LEASED CONTAINERS: LLM correctly identifies 1,856 in 2022 and 288 in 2024, matching ground truth. (6) RATIO CALCULATIONS: The ratios provided (26:1 to 161:1 for containers, 2:1 to 3.6:1 for chassis) are mathematically derived from the incorrect leased chassis numbers, making them unreliable. The LLM demonstrates partial understanding of the question's structure and correctly identifies some specific data points (leased containers, owned chassis), but fundamentally misrepresents the composition of the fleet by providing numbers that violate the constraint that component parts cannot exceed the whole. The answer fails to accurately synthesize the multi-hop information required to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 447,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Capital One’s securitized‑debt program expanded modestly.  The balance of securitized debt obligations rose from **$16.97 billion** at 12/31/2022 to **$18.04 billion** at 12/31/2023 – an increase of roughly $1.1 billion (about 6 %)【page_211】【page_210】.  Although still a small slice of the firm’s funding mix—well below deposits (which grew from $45.9 billion to $83.0 billion) and senior/subordinated notes—the higher balance indicates securitized debt is a growing, though still secondary, source of capital for the company【page_211】【page_210】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate quantitative data and addresses the evolution of Capital One's securitized debt obligations between 2022 and 2023. Strengths: (1) The dollar amounts are correct ($16.97B in 2022, $18.04B in 2023), matching the ground truth's $18.043 billion figure for 2023. (2) The calculation of the increase (~$1.1 billion or ~6%) is accurate. (3) The answer correctly identifies securitized debt as part of the funding structure and notes its secondary role relative to deposits and other funding sources. (4) The comparison showing deposit growth from $45.9B to $83.0B provides useful context. Weaknesses: (1) The LLM answer focuses primarily on quantitative growth and relative size within the funding mix, but does not address the qualitative shift mentioned in the ground truth regarding the change in fair value hierarchy classification (from explicit key funding source description to Level 2 fair value hierarchy categorization). (2) The ground truth emphasizes a shift toward 'more standardized valuation methods' and a 'more structured and possibly less volatile role,' which represents an important qualitative evolution that the LLM answer omits. (3) The LLM answer doesn't fully capture the nuance that the evolution involved a change in how these obligations were categorized/valued, not just their balance sheet growth. The answer is factually sound on numbers and provides relevant context about the funding structure, but incompletely addresses the full scope of the question regarding how the role of securitized debt evolved beyond just its quantitative growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 438,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "In the 2023 filing Zyprexa appears in the product‑revenue schedule and is footnoted as “sale of the rights for the olanzapine portfolio” — i.e., a one‑time product‑sale line item (see page 67). In the 2024 filing that same transaction is no longer shown as product revenue; it is bundled into “collaboration and other revenue” and is accounted for as a net gain/loss on the sale of rights, recognized when control of the asset transfers to the buyer (see pages 64 and 66). Thus the source shifted from product‑sale revenue to a one‑off rights‑sale under collaboration revenue, and the recognition moved from product‑sale timing to the point‑of‑transfer accounting for the rights sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the key evolution of Zyprexa revenue between 2023 and 2024: (1) In 2023, Zyprexa appeared as product revenue from the sale of rights for the olanzapine portfolio; (2) In 2024, this same transaction was reclassified as collaboration and other revenue rather than product sales. The answer accurately captures both the SOURCE shift (product sales → collaboration revenue) and the RECOGNITION METHOD shift (product-sale timing → point-of-transfer accounting for rights sale). The LLM provides specific page references (pages 67, 64, and 66) which adds credibility and demonstrates multi-hop synthesis across the 2023 and 2024 filings. The explanation of the accounting treatment (net gain/loss on sale of rights recognized at control transfer) is accurate and shows understanding of the underlying accounting principles. The answer is more detailed and specific than the ground truth while remaining semantically equivalent and factually correct. No numerical errors are present. The multi-hop reasoning correctly synthesizes information across two different fiscal years' filings and explains the categorization change clearly. Minor: The answer could have been slightly more concise, but the additional detail about accounting treatment strengthens rather than weakens the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 379,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "Both the 2022 and 2024 filings state that Federal Government Securities are valued using a **bid‑evaluation process with bid data from independent pricing sources**, and they are **classified as Level 2** assets in the fair‑value hierarchy. The description of the methodology (page 70 of the 2022 filing and page 56 of the 2024 filing) and the classification (Level 2 shown on the asset tables on pages 72 and 57) are unchanged; only the dollar amount of the holdings increased.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Federal Government Securities are classified as Level 2 assets and valued using a bid-evaluation process with independent pricing sources in both years. However, there is a critical omission: the LLM fails to mention the 2022 valuation amount of $742 million, which is explicitly stated in the ground truth as a key data point for understanding the evolution. The ground truth emphasizes that the 2022 amount was $742 million, which is important context for comparing the holdings across years. The LLM states 'only the dollar amount of the holdings increased' but provides no specific numbers to support this claim, making it impossible to verify the quantitative evolution. The LLM correctly identifies that the methodology and classification remained unchanged (continuation), which aligns with the ground truth's statement about 'continuation in classification but adds specificity in methodology explanation.' However, the LLM misses the nuance that 2024 added 'specificity in methodology explanation' - the ground truth suggests there was an evolution in how the methodology was explained/clarified, not just that it remained the same. The page references provided (70, 72 for 2022 and 56, 57 for 2024) cannot be verified against the ground truth but appear reasonable. The reasoning about the unchanged classification and methodology is sound, but the answer is incomplete without the 2022 dollar amount and without acknowledging the clarification/specificity added in 2024's explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 423,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One’s 2022 filing already said that borrower credit‑score information is “used … in some cases to drive product‑segmentation decisions” (2022 10‑K, p. 103) and the 2023 filing repeats the same language (2023 10‑K, p. 95).  Between the two years the score mix shifted modestly – the share of domestic credit‑card balances with scores ≤ 660 rose from 31 % in 2022 to 32 % in 2023 (and the >660 segment fell from 69 % to 68 %) (Table 21, p. 95) – suggesting that Capital One’s credit‑risk models are increasingly leveraging score data to fine‑tune product segmentation and manage risk across a slightly broader credit‑quality spectrum.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps compared to the ground truth. CORRECT ELEMENTS: (1) The percentages cited are accurate - 31% for scores ≤660 in 2022 rising to 32% in 2023, with >660 segment falling from 69% to 68%. (2) The reference to Table 21 and page numbers is correct. (3) The observation that credit score data is used for product segmentation decisions is accurate. (4) The characterization of the shift as 'modest' is reasonable. SIGNIFICANT GAPS AND ISSUES: (1) The LLM answer focuses primarily on the year-over-year shift in credit score distribution (2022 to 2023) but MISSES the critical multi-hop element that the ground truth emphasizes: the underlying DATA SOURCES changed. In 2022, Capital One used historical credit score distributions from 2020-2021, while in 2023 they updated to use distributions from 2022-2023. This is a fundamental difference in their modeling approach that the LLM completely overlooks. (2) The ground truth explicitly states this shift 'indicates a more current and dynamic credit risk modeling strategy' - the LLM's conclusion about 'fine-tuning product segmentation' is weaker and doesn't capture the strategic evolution of moving to more recent data. (3) The LLM answer doesn't synthesize the multi-hop reasoning about WHY this matters: the shift from 2020-2021 data to 2022-2023 data represents a proactive approach to managing credit risk in evolving economic conditions, which is the key insight about their credit risk modeling strategy. QUANTITATIVE ACCURACY: The percentages and table references are correct (7/10). QUALITATIVE ACCURACY: The answer identifies correct facts but fails to synthesize the deeper multi-hop insight about the evolution of data sources and what that indicates about strategy (5/10). CONTEXTUAL RELEVANCE: The answer addresses part of the question but misses the core evolution being asked about (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 519,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "In the 2022 filing Amazon framed AWS mainly as a **technology‑and‑content investment priority**, noting that “we are investing in AWS… to take advantage of advances in technology” and that the bulk of its capital‑expenditure growth was “in technology infrastructure (the majority of which is to support AWS)”【page_19】【page_21】. By the 2023 filing, AWS had been elevated to a **core operating segment** alongside North America and International, with its own CEO and a clear market‑facing role “serving developers and enterprises… through AWS, which offers a broad set of on‑demand technology services”【page_3】【page_5】. This shift signals that AWS moved from being a major infrastructure investment focus to a distinct, strategically central business unit that drives Amazon’s overall growth agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of AWS as a technology-and-content investment priority with emphasis on infrastructure spending, accurately capturing the language and framing from the 2022 filing. (2) Accurately describes the 2023 evolution where AWS became a core operating segment alongside North America and International, matching the ground truth's characterization of this transformation. (3) Properly synthesizes the multi-hop comparison showing AWS's transition from 'strategic investment area' to 'standalone, mission-critical business segment,' which is the core insight of the question. (4) Correctly identifies AWS's market-facing role serving developers and enterprises with on-demand technology services (compute, storage, database, analytics, machine learning). (5) Uses appropriate citations to page numbers, suggesting source verification. (6) The reasoning is sound and logically structured, moving chronologically from 2022 to 2023 and clearly articulating the strategic shift. MINOR CONSIDERATIONS: (1) The LLM answer doesn't explicitly mention all the specific service categories (analytics, machine learning) that appear in the ground truth, though it references 'broad set of on-demand technology services' which captures the essence. (2) The LLM answer doesn't explicitly mention 'geographic expansion' and 'new product categories' as 2022 investment priorities, though these are secondary details. (3) No quantitative metrics (dollar amounts, percentages) are provided in either answer, so this is not a deficiency. VERIFICATION: The core factual claims are accurate - AWS was indeed positioned differently in 2022 vs 2023, moving from investment priority to core segment status. The multi-hop synthesis correctly connects information across two fiscal years and demonstrates understanding of the strategic evolution. The semantic meaning aligns perfectly with the ground truth despite slightly different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 553,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "In the 2022 Form 10‑K PMI said that Rothmans, Benson & Hedges (RBH) had been **de‑consolidated** from its statements since the 2019 CCAA filing and that, because a comprehensive stay of all Canadian tobacco litigation was in place through 31 Mar 2022, the company **accrued no loss** – its only exposure was the CAD 226 million security deposit and any future judgment that might arise. By the 2024 filing PMI still held an **equity investment** in RBH, but the proposed CAD 32.5 billion settlement and the unresolved allocation of that amount led PMI to **recognize a $2.3 billion non‑cash impairment** (≈$1.49 per diluted share), reflecting a substantially larger potential financial exposure than in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of PMI's evolving relationship with RBH. STRENGTHS: (1) Correctly identifies the 2022 deconsolidation status and the CCAA filing context; (2) Accurately states the comprehensive stay of litigation through March 31, 2022; (3) Correctly notes no loss accruals were made in 2022; (4) Properly identifies the shift to equity investment model by 2024; (5) Accurately cites the CAD 32.5 billion proposed settlement; (6) Correctly states the $2.3 billion (≈$2,316 million) non-cash impairment charge in 2024; (7) Provides additional context with the per-share impact ($1.49 per diluted share) not in ground truth but consistent with it; (8) Effectively synthesizes the multi-hop evolution from deconsolidation to equity investment with quantified impairment. MINOR CONSIDERATIONS: (1) The LLM mentions 'CAD 226 million security deposit' as PMI's only exposure in 2022 - this detail is not explicitly contradicted by ground truth but adds specificity not confirmed in the provided ground truth statement; (2) The phrasing 'since the 2019 CCAA filing' is accurate but ground truth emphasizes 2022 deconsolidation timing; (3) Number formatting ($2.3 billion vs $2,316 million) is acceptable variation. MULTI-HOP REASONING: Excellent synthesis across 2022 and 2024 filings, correctly tracing the accounting treatment evolution and financial exposure changes. The answer properly connects the litigation stay, deconsolidation, equity investment model, and impairment charge as a coherent narrative. All key financial metrics are accurate and properly contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 446,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "Biktarvy was a major driver of Gilead’s sales in the 2022 filing, generating $8.6 billion in total product sales (U.S. $7.0 bn, Europe $969 m, other $606 m) – roughly half of the company’s HIV portfolio and a large share of overall revenue【page_70】. In the 2024 filing the product is still highlighted as a core HIV therapy, but the risk‑factor section now stresses that HIV drugs such as Biktarvy are subject to intensified competition, pricing‑ and reimbursement pressures and possible shifts away from nucleoside‑based regimens, indicating that its commercial importance remains high while its exposure to product‑specific risks has grown【page_18】【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: The 2022 Biktarvy revenue figure of $8.6 billion ($8,624 million) is correctly stated and matches the ground truth. The regional breakdown (U.S. $7.0 bn, Europe $969 m, other $606 m) is accurate and adds helpful detail beyond the ground truth. The characterization of Biktarvy as roughly half of the HIV portfolio is a reasonable inference from the data. QUALITATIVE ACCURACY: The answer correctly identifies the evolution from 2022 to 2024, noting that while Biktarvy remains a core product, risk exposure has increased. The specific risks mentioned (intensified competition, pricing/reimbursement pressures, shifts away from nucleoside-based regimens) align with the ground truth's reference to 'competitive and regulatory pressures' and 'potential shifts in treatment paradigms.' The answer properly synthesizes the multi-hop requirement by comparing both revenue contribution (2022 data) and associated risks (2024 disclosures). MULTI-HOP REASONING: The answer successfully combines information across two different years and two different types of disclosures (revenue statements and risk factors), demonstrating sound synthesis. The logical connection between high revenue importance and growing risk exposure is clearly articulated. MINOR CONSIDERATIONS: The answer provides slightly more specific detail than the ground truth (regional breakdown, specific risk types) but this represents enhancement rather than error. The page references cited (page_70, page_18, page_19) suggest proper source documentation. The only minor limitation is that the answer doesn't explicitly state that 2024 'specific revenue figures are not provided' as the ground truth does, but this is a minor omission that doesn't affect the core accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 505,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific’s equity stake in TTX has risen modestly – the 2022 filing shows a 36.79 % economic interest with a $1.6 billion investment on the balance sheet, while the 2024 filing reports a 37.03 % interest and a $1.9 billion investment 【page_88】【page_89】→【page_68】.  At the same time, the cost of hiring TTX rail cars has increased from $402 million in 2022 to $432 million in 2024 (up from $399 million in 2023) 【page_68】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the investment value increase from $1.6B to $1.9B, matching ground truth. (2) Correctly reports the 2024 car hire expense of $432 million. (3) Provides additional context with percentage ownership (36.79% to 37.03%) and intermediate year data (2023: $399M). (4) Properly synthesizes multi-hop information across multiple filings. (5) Appropriately addresses both investment value and operational relationship components of the question.\n\nWEAKNESSES: (1) CRITICAL ERROR: Reports 2022 car hire expenses as $402 million, but ground truth shows $375 million in 2021 (the baseline year referenced in 2022 filing). The LLM appears to have confused the starting point - it should reference 2021 data ($375M) as the ground truth does, not 2022 data ($402M). (2) The comparison is therefore incomplete/incorrect - should show $375M (2021) → $432M (2024), not $402M (2022) → $432M (2024). (3) While the intermediate 2023 data ($399M) is helpful context, it doesn't correct the fundamental error in the baseline comparison.\n\nCALCULATION VERIFICATION: The LLM states car hire expenses rose from $402M to $432M (a $30M increase). However, the ground truth baseline is $375M to $432M (a $57M increase). This is a significant discrepancy in the magnitude of change being reported.\n\nMULTI-HOP REASONING: The synthesis across filings is sound in structure, but the starting point for the car hire expense comparison is incorrect, which undermines the accuracy of the trend analysis.\n\nOVERALL: The answer demonstrates good understanding of the question and mostly correct information, but contains a material error in the baseline car hire expense figure that affects the accuracy of the financial evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 477,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "In 2022 Tesla’s 10‑K said its Solar Roof scale‑up would be driven by expanding the installer base – “on‑boarding and training new installers, as well as collaborating with real‑estate developers and builders … and hiring additional skilled electricians to support the ramp of Solar Roof” (2022 p. 34). By the 2023 filing the focus had shifted to caution about possible production delays and to tightening supply‑chain risk controls, stressing that “we may experience delays … ramping … Solar Roof” and that “our suppliers may fail to deliver components … and we must manage supply‑chain constraints” (2023 p. 16), with no longer a specific emphasis on installer‑training initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 focus on installer training, on-boarding, collaboration with real estate developers, and hiring skilled electricians - all core elements from the original answer. (2) Accurately captures the 2023 shift toward supply chain risk management, supplier reliability concerns, and production ramp challenges. (3) Properly synthesizes the multi-hop comparison across two years, showing the transition from installer-focused growth to supply chain resilience. (4) Uses appropriate citations to filing pages (2022 p. 34, 2023 p. 16) that lend credibility. (5) Correctly identifies the de-emphasis of installer training initiatives in 2023. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly paraphrased language compared to ground truth (e.g., 'caution about possible production delays' vs. 'shift from installer-focused growth to risk-averse strategy'), but the semantic meaning is equivalent and accurate. (2) The answer could have been marginally more explicit about the strategic shift from growth-oriented to risk-management-oriented approach, though this is clearly implied. (3) No quantitative metrics or specific dollar amounts were required for this question, so quantitative accuracy is not a limiting factor. VERIFICATION: All factual claims check out - 2022 emphasis on installer training and hiring, 2023 focus on supply chain constraints and production delays, and the clear shift in strategic emphasis between years. The multi-hop reasoning correctly synthesizes information across two separate 10-K filings to show the evolution of Tesla's Solar Roof strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 466,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "The 2022 filing notes that U.S. bottlers are **not authorized to manufacture fountain syrups**; instead, Coca‑Cola “manufactures and sells fountain syrups to authorized fountain wholesalers (including certain authorized bottlers) and some fountain retailers,” with the wholesalers delivering the syrups to restaurants and other retailers【page_7】. The 2023 filing repeats this model, stating that the Company “manufactures fountain syrups and sells them to fountain retailers … or to authorized fountain wholesalers or bottling partners who in turn sell and distribute the fountain syrups to fountain retailers”【page_37】. Thus, between 2022 and 2023 the core relationship has remained unchanged – Coca‑Cola continues to be the sole U.S. manufacturer of fountain syrups and supplies them directly or via authorized wholesalers/bottlers, while bottlers still cannot produce those syrups.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that U.S. bottlers are not authorized to manufacture fountain syrups in both years. (2) Accurately captures that Coca-Cola manufactures and sells fountain syrups directly to authorized fountain wholesalers and certain fountain retailers. (3) Correctly notes the 2023 language includes 'bottling partners' in the distribution chain. (4) Properly cites page references. (5) Numeric accuracy is sound - no calculation errors or date mismatches.\n\nWEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM concludes that 'the core relationship has remained unchanged' between 2022 and 2023, directly contradicting the ground truth which explicitly states there is 'a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.' (2) The LLM misses the key distinction that the 2023 filing provides a CLARIFICATION or EXPANSION of the distribution model by explicitly naming 'bottling partners' as intermediaries, whereas 2022 language was less explicit about this tiered approach. (3) The LLM's conclusion that the relationship 'remained unchanged' fails to recognize the semantic shift from 2022's description to 2023's more detailed articulation of the bottling partner role. (4) The ground truth emphasizes this as 'a potential expansion' or at minimum a 'clarification of roles,' but the LLM dismisses any evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years and correctly identifies the key entities (Coca-Cola, bottlers, wholesalers, retailers). However, the comparative analysis is flawed - the model fails to recognize the nuanced difference in how the relationship is described across the two years, which is the core of the question asking how the relationship 'evolved.'\n\nSEMANTIC EQUIVALENCE: While the LLM's factual statements about what each year says are largely accurate, the interpretation of what those statements mean for the evolution of the relationship is incorrect. The ground truth identifies an evolution (clarification/expansion); the LLM identifies stasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 587,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "In the 2022 Form 10‑K IBM did not list the 0.950 % Notes due 2025 as a separate security; the instrument was only reflected in the aggregate “notes payable/long‑term debt” balances and no specific registration or exhibit was provided (see the exhibit list on page 31, which mentions only the 7 % debentures). By the 2024 filing IBM explicitly discloses the 0.950 % Notes due 2025 as a distinct, registered debt security (ticker IBM25B) on the NYSE under Section 12(b) of the Securities Act (see the securities registration table on page 1), indicating a shift to a more detailed classification and public‑registration disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 0.950% Notes due 2025 and the ticker symbol IBM25B, and accurately captures the general evolution from less detailed disclosure in 2022 to more explicit registration in 2024. However, there are significant issues with the answer's accuracy and specificity: (1) The LLM claims the 2022 Form 10-K did not list the notes separately and references 'page 31' and '7% debentures' - these specific page references and details cannot be verified against the ground truth and may be fabricated. (2) The LLM references 'Section 12(b) of the Securities Act' which is imprecise terminology (should likely be Section 12(b) of the Securities Exchange Act of 1934, not the Securities Act). (3) The ground truth specifically mentions the Form 8-K filing from May 22, 2017 with Exhibit 4.1, which the LLM answer completely omits. (4) The LLM answer invents specific page references ('page 31', 'page 1') that cannot be verified and may be hallucinated. (5) The core narrative about the evolution is directionally correct - from less prominent disclosure to explicit NYSE listing with ticker - but the supporting details appear unreliable. The answer demonstrates understanding of the general concept but fails on specificity and introduces potentially false details, which is problematic for financial document analysis where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 381,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "In the 2022 Form 10‑K Gilead simply listed Biktarvy as one of its marketed products, underscoring its role as a core HIV therapy in the company’s portfolio (2022 p. 63). By the 2024 filing the company treats Biktarvy as a key pillar of its HIV franchise that now faces heightened financial‑risk exposure—from pricing reforms, rebate obligations, inventory‑forecasting challenges, and the threat of generic competition—and stresses protecting its clinical differentiation (once‑daily, single‑pill regimen) to preserve market share (2024 p. 18‑20, especially the HIV risk‑factor discussion and competition section).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution of Biktarvy's positioning from 2022 to 2024; (2) Accurately captures the shift from simple product listing to heightened risk awareness; (3) Properly synthesizes multi-hop information showing how financial risks (pricing reforms, rebates, generic competition) emerged as concerns; (4) Correctly identifies specific competitive differentiation factors (once-daily, single-pill regimen); (5) Appropriately cites page references (2022 p. 63, 2024 p. 18-20) suggesting proper document sourcing; (6) Maintains semantic equivalence with ground truth regarding TAF-based regimen concerns and generic competition threats. MINOR WEAKNESSES: (1) The LLM answer provides more granular detail about specific risk factors (pricing reforms, rebate obligations, inventory-forecasting challenges) than the ground truth explicitly states, though these are reasonable inferences from 10-K risk disclosures; (2) The ground truth emphasizes 'nucleoside-based therapies' and 'TAF-based regimens' more explicitly, while the LLM focuses on the once-daily single-pill differentiation angle—both are valid but represent slightly different emphasis; (3) The LLM doesn't explicitly mention the 'shift in HIV treatment paradigms away from TAF-based regimens' that the ground truth highlights, though it does reference changing therapeutic preferences implicitly. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Page citations appear reasonable for 10-K documents. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2022 and 2024) and connects product positioning to financial risk exposure and competitive dynamics—the core multi-hop requirement. The logical flow from 'listed product' to 'key pillar with heightened risks' is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 544,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "In 2022 Lockheed Martin completed a large group‑annuity transaction that transferred about **$4.3 billion** of gross defined‑benefit pension obligations (and related assets) to an insurer, which generated a **non‑cash pension settlement charge of roughly $1.5 billion** (recorded as a $1.47 billion settlement charge in the FAS expense table) and produced a net pension expense of **$1.058 billion** for the year【page_82†L1-L9】【page_82†L31-L38】. By 2023 the company had moved to **smaller, voluntary lump‑sum settlements of $414 million** for about 6,500 former employees, with **no settlement charge recorded** and a net pension income of **$378 million**, indicating a shift toward winding down defined‑benefit obligations as it relies more on its defined‑contribution retirement savings plans【page_82†L9-L15】【page_83†L1-L9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution between 2022 and 2023 and captures the main strategic shift from large annuity transfers to smaller lump-sum settlements. However, there are significant quantitative accuracy issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- 2022: $4.3 billion pension obligation transfer is correct\n- 2022: $1.5 billion noncash pension settlement charge is correct (LLM notes $1.47 billion in FAS table, which is a minor rounding variation)\n- 2023: $414 million in settlement payments is correct\n- 2023: Approximately 6,500 former employees is correct\n- Strategic shift narrative is accurate and well-articulated\n- Multi-hop synthesis across 2022-2023 is sound\n\nPROBLEMATIC ELEMENTS:\n- LLM states 2022 net pension expense was $1.058 billion - this figure is not provided in the ground truth and cannot be verified\n- LLM states 2023 had \"no settlement charge recorded\" - the ground truth does not explicitly confirm this, and the claim needs verification\n- LLM states 2023 net pension income was $378 million - this figure is not in the ground truth and appears to be unsupported\n- The additional financial metrics ($1.058B net pension expense, $378M net pension income) are introduced without ground truth support, suggesting potential hallucination or citation of unreliable sources\n\nMULTI-HOP REASONING:\nThe reasoning correctly synthesizes the evolution between years and identifies the strategic shift. The connection between pension obligation transfers and defined contribution plan reliance is appropriately made, though the ground truth doesn't explicitly state the defined contribution connection.\n\nSEMANTIC EQUIVALENCE:\nThe core answer semantically matches the ground truth regarding the main facts and strategic evolution. However, the introduction of unverified financial metrics undermines confidence in the response's reliability.\n\nJUSTIFICATION:\nThe score of 6 reflects that while the core narrative and primary numbers are correct, the introduction of multiple unverified financial figures (net pension expense, net pension income) represents significant quantitative accuracy issues that cannot be overlooked, even though the main answer structure and reasoning are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 603,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "In the 2022 Form 10‑K the “Securities registered pursuant to Section 12(b)” table shows three notes maturing in 2025 – the 2.875 % Notes (IBM 25A), the 0.950 % Notes (IBM 25B) and the 0.875 % Notes (IBM 25C) – plus the 7.00 % debentures due 2025 (IBM 25)【page_1】. The 2024 filing still lists the 2.875 % Notes (IBM 25A) and the 7.00 % debentures due 2025, but the 0.875 % Notes (IBM 25C) are no longer shown, indicating that instrument was retired or redeemed while the 2.875 % Notes remain unchanged【page_1】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All key financial instruments are correctly identified with accurate percentages: 2.875% Notes (IBM 25A), 0.950% Notes (IBM 25B), 0.875% Notes (IBM 25C), and 7.00% debentures. (2) The multi-hop synthesis is sound - correctly comparing 2022 and 2024 filings to identify which instruments remained and which were retired. (3) The core finding is accurate: the 0.875% Notes (IBM 25C) were retired/redeemed between 2022 and 2024, while the 2.875% Notes remained. (4) The reasoning about strategic decisions to maintain certain instruments while retiring others is logical and well-supported. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer includes the 7.00% debentures due 2025 (IBM 25), which the ground truth does not explicitly mention. However, this is not an error - it's additional accurate information that enhances the answer rather than contradicting it. (2) The ground truth focuses specifically on the three Notes (25A, 25B, 25C) while the LLM provides a more complete picture by including the debentures. (3) The LLM answer is slightly more detailed and comprehensive than the ground truth, providing additional context about the 7.00% debentures. QUANTITATIVE VERIFICATION: All percentages and instrument identifiers are correct. The comparison between 2022 and 2024 is accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across two different years (2022 and 2024) and multiple debt instruments to identify the evolution in composition. The conclusion about retirement/redemption of the 0.875% Notes is well-supported. The only minor consideration is that the inclusion of the 7.00% debentures, while accurate, slightly expands beyond the specific focus on the three Notes mentioned in the ground truth, though this represents added value rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 507,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "In the 2022 filing Gilead portrayed Biktarvy as the centerpiece of its HIV recovery – sales were rising “driven by higher demand” and a new low‑dose pediatric tablet was approved, helping offset the loss of Truvada/Atripla and positioning Biktarvy as the primary growth engine for the franchise (2022 p. 41; p. 38; p. 40). By the 2024 filing the company’s risk discussion treats Biktarvy (and its other TAF‑based HIV products) as increasingly vulnerable: it flags “market‑share gains by competitive products, including generics” and warns that “if there are any changes to the treatment or prevention paradigm for HIV, and nucleoside‑based therapeutics do not remain the preferred regimen, our HIV product sales would be adversely impacted” (2024 p. 18; p. 20). Thus, while Biktarvy remains a key HIV asset, its strategic importance has shifted from a clear growth driver in 2022 to a product whose revenue outlook is now more exposed to competition and a possible shift away from nucleoside‑based regimens by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution of Biktarvy's strategic positioning from 2022 (growth driver) to 2024 (vulnerable asset), matching the ground truth's core narrative. (2) Accurately captures the 2022 positioning with references to 'continued growth' and new pediatric formulation, consistent with ground truth's mention of 'continued growth in all geographies.' (3) Properly synthesizes the 2024 risk profile, including specific competitive threats (generics, market-share gains) and paradigm shift risks (nucleoside-based therapy vulnerability), which directly parallels the ground truth's discussion of TAF-based product vulnerability. (4) The multi-hop reasoning is sound: connects 2022 growth narrative → 2024 competitive/paradigm risks → conclusion about strategic repositioning. (5) Correctly identifies the key risk factor (shift away from nucleoside-based therapies) that appears in both the LLM answer and ground truth. (6) Page references (2022 p. 41, 38, 40; 2024 p. 18, 20) are provided, adding specificity. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more granular detail about competitive pressures (generics specifically mentioned) compared to the ground truth's more general framing, but this represents appropriate elaboration rather than error. (2) The LLM answer mentions the pediatric tablet approval, which is not explicitly in the ground truth but represents reasonable inference from 'continued growth' narrative. (3) Both answers converge on the essential finding: Biktarvy shifted from growth asset to vulnerable asset due to competitive and paradigm risks. QUANTITATIVE ACCURACY: No specific financial figures are provided in either answer (no revenue numbers, percentages, or dollar amounts to verify), so this dimension relies on conceptual accuracy rather than numeric precision. The 11% revenue increase mentioned in ground truth is not referenced in LLM answer, but this is a minor omission that doesn't affect the core narrative about strategic positioning. SEMANTIC EQUIVALENCE: The LLM answer's phrasing ('centerpiece of recovery,' 'primary growth engine,' 'increasingly vulnerable') conveys the same meaning as ground truth's 'key growth driver' and 'more precarious' positioning. The conclusion about paradigm shift vulnerability is semantically equivalent across both answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 650,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow balance rose from **$1.449 billion at the end of FY 2022** (the “balance as of beginning of period” for 2023) to **$1.764 billion at the end of FY 2023**, a net increase of about $315 million【page_73】.  The company **deposited $850 million into the escrow during FY 2022**【page_102】 and **$1.0 billion during FY 2023**【page_73】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) ENDING BALANCE FY2023: LLM states $1.764 billion, but ground truth shows $3.089 billion - a massive discrepancy of $1.325 billion (43% error). (2) ENDING BALANCE FY2022: LLM correctly identifies $1.449 billion, matching ground truth. (3) DEPOSIT FY2022: LLM states $850 million, but ground truth shows $1.000 billion - a $150 million error (15% understatement). (4) DEPOSIT FY2023: LLM states $1.0 billion, but ground truth shows $1.500 billion - a $500 million error (33% understatement). (5) NET INCREASE CALCULATION: LLM calculates $315 million increase ($1.764B - $1.449B), but ground truth shows $1.640 billion increase ($3.089B - $1.449B) - the LLM's calculation is internally consistent with its wrong numbers but completely misses the actual magnitude of change. The LLM appears to have confused or misread the escrow account figures, possibly conflating different accounts or misinterpreting source documents. While the answer addresses the question structure (comparing FY2022 to FY2023, discussing deposits), the numerical accuracy is severely compromised across all key metrics. This is a multi-hop question requiring synthesis of balance sheet data and cash flow information, and the LLM failed to correctly synthesize the actual figures from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 385,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "The description of fountain‑syrup sales in the North America segment is unchanged from 2022 to 2023. In both filings Coca‑Cola says it **manufactures fountain syrups in the United States and sells them either directly to fountain retailers or to authorized fountain wholesalers/bottling partners that then sell the syrups to retailers**, and those sales continue to be recorded in the North America operating segment【page_36】【page_37】. No new manufacturing or distribution responsibilities were added between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. The ground truth explicitly states there WAS an evolution/shift between 2022 and 2023, while the LLM claims the description is 'unchanged.' Specific errors: (1) The LLM states 'No new manufacturing or distribution responsibilities were added between the two years' - this directly contradicts the ground truth which describes a 'nuanced evolution' and 'shift' in how the company described its operations. (2) The ground truth indicates that by 2023, Coca-Cola 'indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates' - this is a key distinction the LLM completely misses. (3) The ground truth emphasizes a 'more decentralized, authorization-based model, particularly outside the U.S.' - the LLM fails to capture this important evolution. (4) The LLM's statement that descriptions are 'unchanged' is factually incorrect based on the ground truth's explicit discussion of how the 2023 description 'shifted' from 2022. The LLM did correctly identify that within the U.S., Coca-Cola manufactures and sells fountain syrups, but it failed to recognize and articulate the key evolution regarding the authorization-based model for bottling partners outside the U.S. that emerged in 2023. The answer demonstrates a failure in multi-hop reasoning - it did not properly synthesize the comparative analysis between 2022 and 2023 filings that the question explicitly asks for.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 412,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "In the 2022 Form 10‑K IBM listed four securities that mature in 2025 – 2.875% notes (IBM 25A), 0.950% notes (IBM 25B), 0.875% notes (IBM 25C) and a 7.00% debenture (IBM 25)【page_1】. By the 2024 filing the 0.875% notes (IBM 25C) were no longer shown, leaving only the 2.875% notes, the 0.950% notes and the 7.00% debenture, so the 0.950% Notes due 2025 (IBM 25B) persisted unchanged while the 0.875% notes were dropped【page_1】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims IBM had FOUR securities maturing in 2025 in 2022, including a '7.00% debenture (IBM 25)'. The ground truth explicitly states THREE sets of notes: 2.875%, 0.950%, and 0.875%. The introduction of a 7.00% debenture is NOT mentioned in the ground truth and appears to be a factual error. This is a significant discrepancy that undermines the answer's credibility. (2) ENTITY ACCURACY - The ground truth identifies only three debt instruments in 2022 (IBM 25A, 25B, 25C), not four. The LLM's addition of a fourth instrument (7.00% debenture) is not supported by the ground truth. (3) MULTI-HOP REASONING - While the LLM correctly identifies that the 0.875% notes (IBM 25C) were removed between 2022 and 2024, and that the 0.950% Notes (IBM 25B) persisted, the inclusion of the 7.00% debenture in both years creates confusion about what actually changed. The ground truth shows a clear reduction from 3 to 2 instruments (removal of 0.875% only), but the LLM's answer suggests a different composition. (4) COMPLETENESS - The LLM does address the evolution of the 0.950% Notes specifically (correctly noting it persisted unchanged), but the overall composition analysis is compromised by the erroneous inclusion of the 7.00% debenture. (5) SEMANTIC EQUIVALENCE - The core finding about the 0.875% notes being dropped and the 0.950% notes persisting is correct, but the broader context about composition is distorted by the additional instrument claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 417,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "In the 2022 10‑K Disney described its cruise‑ship strategy as an investment phase—adding new ships, bearing launch costs, and even taking a write‑down after the Star Wars: Galactic Starcruiser concept failed, signaling cautious expansion with risk awareness【DIS_10k_2022 page_22】【DIS_10k_2022 page_25】. By the 2024 10‑K the company shifted to a growth‑focused approach, announcing plans to further expand the Disney Cruise Line fleet and to open a new destination at Lighthouse Point, Eleuthera, underscoring a more aggressive commitment to cruise‑ship development【DIS_10k_2024 page_22】【DIS_10k_2024 page_21】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's cruise ship strategy evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from cautious expansion in 2022 to growth-focused approach in 2024, matching the ground truth's core narrative; (2) Accurately mentions specific initiatives like Lighthouse Point, Eleuthera expansion and Disney Cruise Line fleet expansion; (3) Properly synthesizes multi-hop information across two filing years; (4) Appropriately characterizes 2022 as investment/cautious phase and 2024 as aggressive/growth phase; (5) Includes relevant context about Star Wars: Galactic Starcruiser write-down showing risk awareness. MINOR ISSUES: (1) The LLM answer provides more specific details (Lighthouse Point, Galactic Starcruiser write-down) than the ground truth, which is not incorrect but represents additional information not explicitly mentioned in the original answer; (2) The ground truth emphasizes the shift from 'general dependence on consumer demand' to 'active investment and growth strategy,' while the LLM frames it as 'investment phase' to 'growth-focused approach'—semantically similar but slightly different framing; (3) The LLM answer doesn't explicitly mention the 'uncertain returns' aspect noted in the ground truth, though it does reference 'risk awareness.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not heavily tested. The dates (2022, 2024) are correct. MULTI-HOP REASONING: Both answers successfully synthesize information across two different 10-K filings and identify the strategic evolution. The LLM's reasoning is sound and logical. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly more operational detail and a marginally different framing of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 512,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "In the 2022 filing Lockheed Martin emphasized that it had already used pension‑risk‑transfer deals to off‑load roughly $11.6 billion of defined‑benefit obligations (the 2021 GAC purchase generated a $1.7 billion non‑cash settlement charge) and said it would keep looking for additional GAC transactions to reduce pension‑plan volatility. By the 2023 filing the company still pursues GAC purchases, but now stresses that some contracts leave it still responsible for paying benefits and exposed to insurer‑default risk, and warns that future transfers could require extra contributions and trigger non‑cash settlement charges—showing a more cautious, risk‑aware strategic stance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core facts and numbers. Quantitative verification: (1) $11.6 billion in transferred obligations - CORRECT; (2) $1.7 billion noncash settlement charge from 2021 GAC - CORRECT; (3) August 3, 2021 transaction date - NOT MENTIONED but not required by LLM's framing; (4) 95,000 retirees - OMITTED from LLM answer. The LLM correctly identifies the evolution from 2022 to 2023: 2022 emphasis on past accomplishments and future intent to continue GAC transactions, versus 2023's more cautious stance acknowledging residual liabilities and insurer default risk. Multi-hop reasoning is sound: the answer synthesizes information across two years and correctly identifies the strategic shift from optimistic risk reduction to more nuanced risk awareness. The LLM accurately captures that 2023 introduced new concerns about GAC contracts that don't fully relieve obligations and insurer default exposure. Minor omissions: (1) The specific mention of 95,000 retirees affected is absent, though this is a detail rather than a core fact; (2) The August 3, 2021 date is not mentioned, though the answer correctly references the 2021 transaction. The semantic equivalence is strong - 'off-load roughly $11.6 billion' = transferred $11.6 billion; 'non-cash settlement charge' = noncash pension settlement charge; 'more cautious, risk-aware strategic stance' captures the shift from 2022 to 2023 accurately. The answer successfully addresses the evolution question by contrasting the two years' approaches and strategic intents. No calculation errors detected. The framing is slightly more concise than the ground truth but maintains factual integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 459,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "In the 2022 filing Tesla’s financing partners were described mainly through its accounts‑receivable line – amounts owed by banks, leasing companies and other counterparties – which the company managed with an allowance for doubtful accounts, periodic write‑offs and a note that payments can take up to about two weeks and that no single partner accounted for more than 10 % of the balance. By the 2023 filing the focus shifts to the broader financing‑program risk: Tesla now relies on external partners to fund its vehicle‑ and solar‑leasing programs, faces residual‑value and credit‑risk exposure on those leases, and warns that an inability to secure or maintain partner financing could curtail leasing growth and generate credit losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The LLM correctly identifies the two-week settlement timeframe from 2022 and the 10% single-partner concentration threshold. These specific numbers match the ground truth. No calculation errors detected. QUALITATIVE ACCURACY: The answer successfully synthesizes the multi-hop evolution between 2022 and 2023. It correctly identifies the 2022 focus on operational cash flow timing (two-week settlement, accounts receivable management) and the 2023 shift toward broader financing program risks (residual value, credit risk, partner dependency). The reasoning is sound and captures the progression from tactical liquidity management to strategic risk management. ENTITY ACCURACY: Tesla is correctly identified, fiscal years 2022 and 2023 are properly distinguished, and relevant metrics (accounts receivable, leasing programs, residual value, credit risk) are accurately referenced. COMPLETENESS: The answer addresses all parts of the question - the evolution of the relationship, accounts receivable management in 2022, and leasing program risks in 2023. The multi-hop synthesis across two years and multiple risk dimensions is complete. SEMANTIC EQUIVALENCE: The LLM's phrasing ('shift from operational cash flow timing to broader financing-program risk') effectively conveys the same conceptual evolution as the ground truth's 'shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023.' Minor note: The LLM mentions 'compliance' risks implicitly through credit and regulatory context, though the ground truth explicitly mentions compliance. This is a very minor omission that does not materially affect the overall accuracy. The answer is well-structured, factually precise, and demonstrates clear understanding of the multi-hop financial analysis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 528,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "In the 2022 filing Coca‑Cola said that U.S. bottlers were generally **not** permitted to manufacture fountain syrups; the Company produced the syrups and sold them to authorized fountain wholesalers (including a few authorized bottlers) and directly to some fountain retailers, with the wholesalers delivering the syrups to restaurants and other outlets【page_8】. By the 2023 filing the Company still manufactures the syrups but now sells them to fountain retailers **or** to authorized fountain wholesalers **or** to bottling partners that are expressly authorized to sell and distribute the syrups to fountain retailers, expanding the bottlers’ role from limited wholesaler participation to a broader distribution function【page_37】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key facts correctly but has significant gaps and misses critical information from the ground truth. CORRECT ELEMENTS: (1) Accurately states that in 2022, U.S. bottlers were generally NOT permitted to manufacture fountain syrups; (2) Correctly identifies that Coca-Cola sold to authorized fountain wholesalers in 2022; (3) Correctly notes the evolution by 2023 where bottlers gained expanded roles. SIGNIFICANT OMISSIONS AND ERRORS: (1) The LLM answer completely fails to mention the critical geographic distinction that is central to the ground truth - that the 2023 changes applied specifically to bottlers OUTSIDE THE UNITED STATES. The ground truth explicitly states 'outside the United States, bottlers were typically authorized to manufacture fountain syrups' - this is a fundamental distinction that the LLM answer omits entirely; (2) The LLM answer does not clearly articulate that in 2023, bottlers outside the U.S. were authorized to MANUFACTURE fountain syrups using Coca-Cola concentrates, which is a more significant evolution than just being authorized to 'sell and distribute'; (3) The answer lacks the characterization of this as a shift from 'centralized syrup distribution model to a more integrated one' which provides important strategic context; (4) The LLM answer mentions selling 'directly to some fountain retailers' in 2022, which is not explicitly stated in the ground truth and may introduce inaccuracy. MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2023 changes but fails to properly integrate the geographic dimension that is essential to understanding the evolution. The reasoning is incomplete because it doesn't explain WHY the roles evolved differently (U.S. vs international markets). NUMERIC/DATE ACCURACY: No calculation errors present; years (2022, 2023) are correct. The answer includes page references which adds credibility but doesn't compensate for the missing geographic distinction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 531,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "In 2023 AMD’s 15 % equity stake in the ATMP joint venture was reflected by a $99 million equity‑method investment, $9 million of receivables and $363 million of payables to the JV (2023 10‑K, p. 78). By year‑end 2024 the relationship deepened: the equity investment rose to roughly $149 million after a $17 million additional contribution, receivables increased to $12 million (with a new $100 million one‑year term loan to the JV) and payables grew to $476 million (2024 10‑K, p. 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 receivables of $9 million - CORRECT; (2) 2024 receivables of $12 million - CORRECT; (3) New $100 million one-year term loan in 2024 - CORRECT; (4) 2023 equity-method investment of $99 million - CORRECT; (5) 2024 equity investment of roughly $149 million - CORRECT (represents ~$50M increase, though LLM states $17M additional contribution which appears to be a partial contribution during the year); (6) 2023 payables of $363 million - CORRECT; (7) 2024 payables of $476 million - CORRECT. The LLM answer goes beyond the ground truth by providing additional context about the 15% equity stake, the equity-method investment amounts, and payables information, which enriches the answer without contradicting the core facts. The multi-hop synthesis is sound: the answer correctly traces the evolution from 2023 to 2024 across multiple financial dimensions (receivables, equity investment, term loan, payables). The characterization of the relationship shift from transactional to more financially integrated is implicitly supported by the data presented. Minor note: The LLM mentions a $17 million additional contribution in 2024, which when added to the $99M base would yield $116M, not $149M, suggesting either additional contributions beyond the stated $17M or other adjustments not explicitly detailed. However, this does not materially affect the accuracy of the core answer regarding receivables and the new loan, which are the primary focus of the question. The answer directly addresses all parts of the question regarding receivables evolution and new investment activities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 456,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Lockheed Martin moved from large‑scale insurer transfers in 2022 to modest direct cash settlements in 2023. In the second quarter of 2022 the company bought group‑annuity contracts that moved about $4.3 billion of gross pension obligations to an insurance company and recorded a non‑cash pension‑settlement charge of roughly $1.5 billion (shown as a $‑1,470 million settlement charge) 【page_82】【page_83】. By the fourth quarter of 2023 it instead made voluntary lump‑sum payments of $414 million to roughly 6,500 former participants, cutting the benefit obligation but generating no settlement charge or FAS‑pension expense impact 【page_82】【page_84】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Lockheed Martin's pension management evolution. QUANTITATIVE VERIFICATION: All numbers are correct - $4.3 billion in gross pension obligations transferred in 2022, $1.5 billion noncash settlement charge (with the LLM noting the specific figure of $1,470 million), and $414 million in voluntary settlements to 6,500 former employees in 2023. The number format variations are appropriately handled. ENTITY ACCURACY: Correctly identifies Lockheed Martin, the specific time periods (Q2 2022 vs Q4 2023), and the relevant financial metrics (group annuity contracts, settlement charges, lump-sum payments). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple time periods and filing sections, correctly identifying the strategic shift from large-scale insurer transfers to targeted direct settlements. The reasoning about the evolution of approach is sound and well-supported. COMPLETENESS: Addresses all aspects of the question - the 2022 approach (group annuity purchase), the 2023 approach (voluntary settlements), the scale difference, and the financial impacts (settlement charge in 2022 vs. no charge in 2023). SEMANTIC EQUIVALENCE: The characterization of the shift as moving from \"large-scale insurer transfers\" to \"modest direct cash settlements\" accurately captures the strategic evolution described in the ground truth. The note about \"no settlement charge or FAS-pension expense impact\" in 2023 adds valuable context. MINOR OBSERVATIONS: The inclusion of specific page references and the notation of the exact settlement charge figure ($1,470 million) demonstrates thorough documentation. The explanation of why there was no settlement charge in 2023 (targeting former employees who had not yet started receiving benefits) is implicit in the answer and aligns with ground truth. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 529,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "AMD’s equity‑method investment in the ATMP joint venture rose from roughly $99 million at December 30 2023 to about $149 million at December 28 2024 (including a $17 million capital contribution in August 2024)【page_78】【page_75】.  Correspondingly, the equity‑income AMD recorded from the JV more than doubled, increasing from $16 million in 2023 to $33 million in 2024【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) Carrying value increased from $99 million (Dec 30, 2023) to $149 million (Dec 28, 2024) - correctly stated; (2) $17 million capital contribution in August 2024 - correctly identified; (3) Equity income rose from $16 million (2023) to $33 million (2024) - correctly stated; (4) The characterization of equity income 'more than doubling' is accurate (16 to 33 is a 106% increase). The multi-hop reasoning is sound: the answer synthesizes information across multiple data points (investment carrying values, capital contributions, and equity income across two fiscal years) and correctly identifies the evolution of AMD's financial relationship with the ATMP JV. The answer addresses all parts of the question regarding both investment and equity income changes. The dates are precise (December 30, 2023 and December 28, 2024) and the August 2024 contribution timing is noted. The only minor observation is that the answer could have been slightly more explicit about the calculation showing the doubling (e.g., '106% increase'), but the characterization 'more than doubled' is semantically accurate and appropriate. The citation references to pages 78 and 75 add credibility. Overall, this is a well-synthesized, factually correct answer that fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 381,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "In 2023 Johnson & Johnson went from owning about 89.6 % of Kenvue at the IPO to retaining only roughly 9.5 % (≈182 million shares) after the August 23, 2023 exchange offer, which was recorded at a fair‑value of $4.3 billion and generated a $2.8 billion gain on the retained Kenvue stock (part of a $21 billion gain on the overall exchange)【page_108】【page_109】. In May 2024 the company completed a debt‑for‑equity exchange of those remaining shares, eliminating its Kenvue ownership and recognizing an approximately $0.4 billion loss in other (income) expense【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 ownership evolution: Correctly states J&J went from ~89.6% to 9.5% after August 23, 2023 exchange offer - CORRECT. (2) Share count: States approximately 182 million shares retained, matching the ground truth's 182,329,550 shares - CORRECT. (3) Valuation: $4.3 billion fair value of retained stake - CORRECT. (4) Gains: $2.8 billion gain on retained shares and $21 billion overall gain - CORRECT. (5) 2024 transaction: Debt-for-equity exchange completed in May 2024 eliminating remaining ownership - CORRECT. (6) Loss: Approximately $0.4 billion loss recognized - CORRECT. The multi-hop reasoning is sound: the answer successfully synthesizes the evolution across two years, showing the progression from majority ownership to 9.5% stake to complete exit. All financial metrics, dates, and percentages are accurate. The answer includes helpful contextual details (IPO reference, exchange offer date, transaction type) that enhance understanding. Minor note: The answer uses 'approximately $0.4 billion loss' which matches the ground truth's 'approximately $0.4 billion' - appropriate use of approximation language. The inclusion of page references adds credibility. No calculation errors detected. The answer fully addresses all aspects of the multi-part question regarding the evolution of J&J's financial stake and ownership relationship with Kenvue between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 404,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "In AT&T’s 2022 Form 10‑K (see pages 133‑137) there is no disclosure of a guarantee covering Southwestern Bell Telephone Co., indicating the company did not list such a guarantee in that filing. By the 2023 Form 10‑K, the exhibit schedule includes a “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” (Exhibit 4‑c) on page 103, showing that AT&T now explicitly includes a guarantee for Southwestern Bell in its guarantee agreements.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. Key issues: (1) FACTUAL ERROR - The LLM claims there was NO disclosure of a guarantee for Southwestern Bell in the 2022 Form 10-K, but the ground truth explicitly states the guarantee was listed in Exhibit 4-c in 2022. (2) CONTRADICTORY CONCLUSION - The LLM concludes that AT&T 'now explicitly includes a guarantee' in 2023, implying this is a NEW addition, when the ground truth indicates the guarantee was ALREADY present in 2022 and remained consistent through 2023. (3) MISCHARACTERIZATION OF EVOLUTION - The question asks how the relationship 'evolved,' and the ground truth answer correctly identifies that it remained consistent/unchanged. The LLM incorrectly portrays this as a change from no guarantee in 2022 to inclusion in 2023. (4) PAGE REFERENCE ISSUES - While the LLM provides specific page numbers, the core claim about 2022 lacking the guarantee is factually wrong according to the knowledge graph. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the year-over-year comparison, arriving at the opposite conclusion (change vs. consistency). The correct answer is that the guarantee relationship remained stable across both years with Southwestern Bell Telephone Co. consistently included in Exhibit 4-c.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 369,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "In the 2022 Form 10‑K, hypersonics were mentioned only as a “key growth area” in the risk‑factors section, with the company noting that its ability to expand in hypersonics programs would depend on government funding and budget decisions. By the 2023 filing, hypersonics had become a central strategic pillar: Lockheed Martin’s Skunk Works (Aeronautics), Missiles & Fire Control and Space segments are each tasked with designing, developing, testing and building hypersonic strike weapons, and the company says it is actively performing on multiple hypersonics programs that are moving toward early‑production, reflecting a far more integrated and responsible role.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a 'key growth area' dependent on government funding/authorization, matching the ground truth characterization. (2) Accurately describes the 2023 evolution showing hypersonics as a more concrete, active program portfolio. (3) Properly identifies the specific segments involved (Skunk Works/Aeronautics, Missiles & Fire Control, Space) in the 2023 role. (4) Correctly captures the shift from potential growth area to clearly defined active programs. (5) Appropriately notes the progression toward early-production status. (6) No quantitative errors - no specific numbers, dates, or calculations to verify, and none were incorrectly stated. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about specific segments and production status than the ground truth statement, but this represents elaboration rather than contradiction. (2) The phrase 'central strategic pillar' in the LLM answer is slightly more emphatic than the ground truth's 'explicitly listed among major programs,' but both convey the same essential evolution from peripheral to core. (3) The mention of 'multiple hypersonics programs' and 'early-production' status adds helpful context that aligns with but slightly exceeds the ground truth's scope. MULTI-HOP REASONING: The answer correctly synthesizes the evolution across two fiscal years (2022 to 2023) and properly identifies the strategic shift in positioning and program development responsibilities. The comparison between the two years is logically sound and well-articulated. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental information as the ground truth - a clear progression from growth potential to active program execution with defined responsibilities across multiple segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 514,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The U.S. litigation escrow account grew from roughly **$1.4 billion at September 30 2022** to **$1.764 billion at September 30 2023**. During fiscal 2022 the company deposited **$850 million** into the escrow (page 46), and in fiscal 2023 it deposited **$1.0 billion** (page 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the ending balance. The ground truth states the balance reached $3.089 billion as of September 30, 2023, but the LLM claims it was only $1.764 billion - a difference of $1.325 billion (43% understatement). This is a fundamental factual error that undermines the entire answer. The opening balance of $1.4 billion as of September 30, 2022 is correct. The deposit amounts are both correct: $850 million in fiscal 2022 and $1.0 billion in fiscal 2023. However, the closing balance error is severe and cannot be overlooked. The LLM correctly identified the dates (September 30, 2022 and 2023) and the fiscal years, and appropriately addressed all parts of the multi-part question (opening balance, closing balance, and deposits for both years). The reasoning structure is sound and the answer is contextually relevant to the question asked. The inclusion of page references adds credibility but does not compensate for the significant numerical inaccuracy in the key metric (ending balance). This appears to be either a data retrieval error or calculation error that resulted in substantially understating the account growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 341,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "In the 2022 Form 10‑K, Outdoor Garden was part of the Hardlines merchandising department (which then comprised Hardware, Indoor Garden, Outdoor Garden and Tools) and produced $10.0 billion of net sales, about 6.4 % of total net sales【page_56†L9-L12】【page_57†L31-L34】. By the 2024 filing the Hardlines group was re‑structured to include Power and Storage & Organization (Tools were removed) while still housing Outdoor Garden, and its sales rose to $10.3 billion, roughly 6.5 % of net sales【page_56†L9-L13】【page_57†L31-L34】—showing modest growth and a more focused positioning within a broader Hardlines strategy that now emphasizes outdoor‑living and power‑related products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states 2022 Outdoor Garden sales were '$10.0 billion' (6.4% of total), but ground truth shows $10,317 million (6.8% of total). The LLM's 2024 figure of '$10.3 billion' (6.5%) is closer but still slightly off from the ground truth's $10,317 million reference. More critically, the LLM rounds and misrepresents these figures. (2) CLASSIFICATION ERROR - CRITICAL: The LLM claims that in 2022, Outdoor Garden was 'part of the Hardlines merchandising department,' but the ground truth explicitly states it was 'disclosed as a distinct product line' in 2022, NOT grouped under Hardlines. This is a fundamental misunderstanding of the strategic evolution. The ground truth shows the OPPOSITE trajectory: 2022 = separate/distinct, 2024 = grouped under Hardlines. The LLM reverses this relationship. (3) STRUCTURAL CHANGES: The LLM discusses changes to Hardlines composition (Tools removed, Power and Storage & Organization added) which may be accurate but is not mentioned in the ground truth and appears to be extraneous detail that doesn't address the core question about Outdoor Garden's positioning shift. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the key insight: the strategic shift FROM a distinct product line TO integration within Hardlines. Instead, it presents Outdoor Garden as already being in Hardlines in 2022, missing the entire point of the evolution. (5) SEMANTIC MEANING: The ground truth emphasizes a strategic repositioning/integration, while the LLM describes structural changes within an already-consolidated category, fundamentally misrepresenting the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 476,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD kept its focus on an engaging, open culture even as its headcount rose from roughly 26,000 employees in 2023 to about 28,000 in 2024 by continuing annual workforce surveys that consistently rank its culture among the top 10 percent of technology firms, emphasizing inclusivity, open communication, employee‑resource groups, flexible benefits, mentoring and leadership‑development programs 【page_15†L1-L7】【page_16†L1-L7】【page_13†L1-L7】【page_14†L1-L7】. This shows that AMD’s talent‑retention strategy leans on a strong, inclusive culture and competitive total‑rewards to attract and keep top talent in a fiercely competitive semiconductor market.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNSUPPORTED CLAIMS: The LLM answer introduces specific details NOT present in the ground truth, including: 'annual workforce surveys that consistently rank its culture among the top 10 percent of technology firms,' 'employee-resource groups,' 'flexible benefits,' 'mentoring and leadership-development programs,' and 'competitive total-rewards.' These claims appear fabricated or hallucinated, as the ground truth makes no mention of these specific programs or survey rankings. (2) QUANTITATIVE ACCURACY: The employee numbers (26,000 in 2023 and 28,000 in 2024) are correct, matching the ground truth exactly. The 7.7% growth calculation is mathematically sound. (3) CORE MESSAGING ACCURACY: The LLM correctly identifies that AMD maintained focus on culture and inclusivity, which aligns with the ground truth's emphasis on 'engaging and open environment' and 'culture of innovation.' (4) MULTI-HOP REASONING FLAW: While the LLM attempts to synthesize information about talent retention strategy, it does so by inventing supporting details rather than relying on what the ground truth actually states. The ground truth's key insight is that AMD used IDENTICAL MESSAGING across both years despite workforce growth—a deliberate preservation strategy. The LLM misses this critical point about message consistency. (5) CITATION ISSUES: The LLM provides page citations that cannot be verified against the ground truth provided, suggesting potential fabrication of sources. The ground truth does not reference these specific page numbers or the detailed programs mentioned. WHAT WAS CORRECT: Employee headcount figures, general direction about culture and talent retention, and the competitive semiconductor industry context. WHAT WAS WRONG: Introduction of unsubstantiated specific programs, survey rankings, and benefits without ground truth support; failure to emphasize the key insight about identical messaging consistency; apparent hallucination of supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 536,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "AT&T’s link to The Ohio Bell Telephone Company stayed the same – the company continued to “guarantee certain obligations of … The Ohio Bell Telephone Company” as part of a broader guarantee covering many Bell subsidiaries in its 2022 filing (see page 133) and the identical guarantee language appears again in the 2023 filing (see page 103). No new guarantee was added or any existing guarantee removed, indicating the guarantee relationship was unchanged between 2022 and 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that AT&T maintained a guarantee obligation for The Ohio Bell Telephone Company in both 2022 and 2023; (2) Accurately states that the guarantee language remained identical between the two years; (3) Properly concludes that no new guarantees were added or removed, indicating stability in the relationship; (4) Provides specific page references (page 133 for 2022, page 103 for 2023) which adds credibility; (5) Correctly synthesizes the multi-hop information showing continuity across years. MINOR WEAKNESSES: (1) The LLM answer is more concise and direct than the ground truth, which provides slightly more context about the exhibit reference being updated to reflect current documentation practices and the original 2011 filing date - however, this is a matter of completeness rather than accuracy; (2) The ground truth mentions the guarantee was part of 'Exhibit 4-c' and references the 2011 original filing, which the LLM answer does not explicitly mention, though this is contextual detail rather than factual error. QUANTITATIVE ACCURACY: The page numbers provided (133 and 103) cannot be independently verified from the ground truth but are presented with appropriate specificity. No calculations or dollar amounts are involved in this question. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years (2022 and 2023) and properly identifies the relationship evolution (or lack thereof) between AT&T and The Ohio Bell Telephone Company. The conclusion that the relationship remained stable is logically sound and matches the ground truth's assessment. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - that the guarantee relationship was maintained without change - though with slightly different emphasis and detail level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 522,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "In 2023 GE booked a **$5.8 billion gain** on retained and sold ownership interests – a boost that was “primarily related to our AerCap … investments”【page_13】. By 2024 that upside had **fallen by about $5.2 billion**, wiping out most of the prior‑year benefit and leaving only a modest (near‑zero) gain from the AerCap stake【page_9】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core narrative of GE's AerCap-related gains evolution between 2023 and 2024, with generally sound multi-hop reasoning. However, there is a minor quantitative discrepancy: the LLM states a '$5.8 billion gain' in 2023, while the ground truth specifies '$5.7 billion.' This $0.1 billion difference is relatively small but represents a factual error in a key metric. The LLM correctly identifies the $5.2 billion decrease from 2023 to 2024, which matches the ground truth exactly. The answer appropriately synthesizes information across years and correctly attributes the gains to AerCap investments. The characterization of the 2024 position as 'modest (near-zero) gain' is semantically consistent with the ground truth's description of 'significant reduction.' The answer demonstrates solid understanding of the multi-hop relationship between GE's corporate operating profit, gains on investments, and AerCap's role. The inclusion of page references adds credibility. The main weakness is the $5.8B vs $5.7B discrepancy in the 2023 figure, which should have been $5.7 billion. This is a material error for a financial metric, though the overall narrative and year-over-year comparison remain substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 349,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "In the 2022 filing, HD Supply is mentioned only as an acquisition completed in fiscal 2020, with Home Depot emphasizing the integration risks and potential synergies of that transaction rather than any specific role for professional‑customer or MRO sales. By the 2024 filing, the company positions HD Supply as a core subsidiary that delivers MRO products and value‑added services to its “Pros” – including multifamily, hospitality, healthcare and government‑housing customers – and even operates a dedicated e‑commerce site (hdsupply.com) for those offerings, showing a shift from a generic acquisition to a focused platform for professional‑customer and MRO growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All core facts are correct - the 2022 filing emphasized integration risks and synergies from the 2020 acquisition, while the 2024 filing positions HD Supply as a strategic platform for professional customers. The specific customer segments mentioned (multifamily, hospitality, healthcare, government housing) match exactly. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable, but the temporal references (2022, 2024, fiscal 2020) are all accurate. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across two filing periods, identifying the shift from post-acquisition integration concerns to mature strategic positioning. The reasoning chain is sound: 2022 (acquisition focus) → 2024 (strategic platform). (4) ENTITY ACCURACY: Home Depot, HD Supply, and all customer segments are correctly identified. (5) SEMANTIC EQUIVALENCE: The LLM answer adds valuable detail (hdsupply.com e-commerce site, 'Pros' terminology) that enhances understanding without contradicting the ground truth. The characterization of the shift from 'generic acquisition' to 'focused platform' effectively captures the strategic evolution. Minor strength: The LLM answer provides slightly more operational detail (dedicated e-commerce site) which adds context. No factual errors or omissions detected. The answer fully addresses the question's focus on strategic evolution between 2022 and 2024 regarding professional customers and MRO services.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 442,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD’s cross‑licensing strategy remained a cornerstone of its IP approach in both years, but the underlying patent base grew modestly. In the 2023 filing the company reported roughly 12,800 issued patents (about 18,500 worldwide patent matters) and “numerous cross‑licensing and technology‑exchange agreements” (page 15). By the 2024 filing the portfolio had expanded to about 13,200 issued patents (≈ 18,800 worldwide matters) while the same language about extensive cross‑licensing agreements persisted (page 13), indicating that AMD is leveraging a larger patent pool to deepen its technology‑exchange relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 2023: 12,800 issued patents (18,500 worldwide matters), 2024: 13,200 issued patents (18,800 worldwide matters). The format variations are handled appropriately (≈ 18,800 vs approximately 18,800). COMPLETENESS: The answer addresses all key aspects of the question: (1) evolution of cross-licensing reliance between 2023-2024, (2) patent portfolio size changes, and (3) implications for technology exchange. ENTITY ACCURACY: Correctly identifies AMD, the two fiscal years (2023 and 2024), and the relevant metrics (issued patents, worldwide patent matters, cross-licensing agreements). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years and correctly draws the logical conclusion that the expanded patent portfolio (300 additional issued patents) strengthens AMD's position in cross-licensing negotiations. The reasoning that a larger patent pool enables 'deeper technology-exchange relationships' is sound and supported by the data. MINOR CONSIDERATIONS: The LLM includes page references (page 15, page 13) which adds specificity but cannot be verified against the ground truth provided. The characterization of pending applications (5,600 in both years) is omitted from the LLM answer, though this is a minor detail that doesn't affect the core narrative about issued patents and cross-licensing evolution. The semantic equivalence is strong - both answers convey that AMD's reliance on cross-licensing remains important and is enhanced by portfolio growth. The LLM's phrasing 'leveraging a larger patent pool to deepen its technology-exchange relationships' effectively captures the implication stated in the ground truth about 'more strategically advantageous' positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 499,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "In 2023, after the May IPO and the August 23 exchange offer, Johnson & Johnson retained a 9.5 % stake in Kenvue – recorded as an equity investment of roughly $4.3 billion on the balance sheet (see page 108 and the equity‑investment table on page 69). During fiscal 2024 the company eliminated that holding by swapping its remaining 182.3 million Kenvue shares for $3.6 billion of commercial paper in a debt‑for‑equity exchange (May 17 2024), incurring a ~$0.4 billion loss and reducing its “readily‑determinable” equity‑investment balance from $4.473 billion to $0.451 billion (pages 68‑69). The strategic relationship continues through transition‑service and manufacturing agreements, but J&J no longer owns any Kenvue equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 stake of 9.5% valued at $4.3 billion - CORRECT; (2) August 23 exchange offer date - CORRECT; (3) 2024 debt-for-equity exchange in May with 182.3 million shares (ground truth states 182,329,550 shares, LLM rounds to 182.3 million - acceptable format variation) - CORRECT; (4) $3.6 billion commercial paper satisfaction - CORRECT; (5) ~$0.4 billion loss - CORRECT; (6) Complete exit from Kenvue - CORRECT. The LLM provides additional context with specific page references (pages 108, 69, 68-69) and mentions the equity investment balance reduction from $4.473 billion to $0.451 billion, which adds valuable detail not explicitly stated in the ground truth but is consistent with the narrative. The multi-hop reasoning is sound: the answer correctly synthesizes the 2023 retention event, the 2024 disposal event, and the strategic relationship continuation. The answer addresses all parts of the question regarding financial stake evolution and strategic relationship. Minor note: The LLM mentions \"fiscal 2024\" while the ground truth uses \"2024\" - this is a semantic equivalence issue with no impact on accuracy. The inclusion of transition-service and manufacturing agreements adds relevant context about the ongoing relationship. No calculation errors detected. All entities (J&J, Kenvue, dates, amounts) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 399,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In the 2022 Form 10‑K (see pages 133‑137) AT&T’s guarantee disclosures do not mention Indiana Bell Telephone Co. Inc. by name. By contrast, the 2023 Form 10‑K lists Indiana Bell Telephone Co. Inc. as one of the entities covered by a “Guaranty of certain obligations” (Exhibit 4‑c, shown on page 103), indicating that AT&T now explicitly includes Indiana Bell in its guarantee disclosures.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) CORE FACTUAL ERROR: The ground truth states Indiana Bell Telephone Co. Inc. WAS listed in 2022 and remained listed in 2023 with NO CHANGE. The LLM claims the opposite - that Indiana Bell was NOT mentioned in 2022 but WAS added in 2023. This is a complete reversal of the actual relationship evolution. (2) EXHIBIT REFERENCE ERROR: The ground truth specifies Exhibit 4-d for both years. The LLM cites Exhibit 4-c for 2023, which is incorrect. (3) PAGE REFERENCE ERRORS: The LLM provides specific page numbers (133-137 for 2022, page 103 for 2023) that cannot be verified against the ground truth and appear to be fabricated details. (4) LOGICAL CONTRADICTION: The LLM's conclusion that Indiana Bell was 'now explicitly included' contradicts the ground truth's finding of continuity and no modification. The LLM fundamentally misunderstood or inverted the relationship evolution. The answer fails on the primary metric - factual correctness - by presenting the opposite conclusion from what the ground truth establishes. This is not a minor wording difference but a substantive factual error about the nature of the guarantee relationship between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 355,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "In 2023 GE still had an active cash relationship with AerCap – it paid a net $203 million to AerCap and held an equity‑and‑note position that was worth about $944 million (down sharply from $7.4 billion the year before)【page_51】【page_53】. By 2024 the 10‑K no longer reports any cash outflow to AerCap, and the AerCap stake helped drive a $5.2 billion decline in gains on retained and sold ownership interests, signaling that the earlier investment gains had turned into a loss【page_9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2023-2024 periods. STRENGTHS: (1) All key numbers are correct: $203 million net cash payment to AerCap in 2023, $944 million equity-and-note position valuation, $7.4 billion prior year comparison, and $5.2 billion decline in gains on retained/sold ownership interests. (2) Correctly identifies the strategic transition from operational involvement (note receivable, product leases, transition services) in 2023 to investment-only position in 2024. (3) Accurately captures the financial impact - the shift from cash outflows to no cash involvement, and the investment gains turning negative. (4) Multi-hop reasoning is sound: connects the AerCap stake to the broader $5.2 billion decline in gains on retained/sold ownership interests. (5) Proper entity identification and year-to-year comparison. MINOR WEAKNESSES: (1) The phrase 'earlier investment gains had turned into a loss' is slightly imprecise - the ground truth states a 'decrease in gains' rather than explicitly stating gains turned to losses, though the semantic meaning is similar. (2) Could have been more explicit about the specific operational elements (note receivable, product leases, transition services) that characterized 2023 involvement, though the answer does reference these implicitly. (3) The answer doesn't explicitly state that GE 'no longer had continuing operational involvement' in 2024, though this is clearly implied. Overall, the answer correctly addresses all parts of the multi-part question with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 446,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "In its 2022 filing Home Depot said that store location, appearance and presentation are core competitive levers and launched a multi‑year refresh that added way‑finding signage, redesigned front‑end areas, electronic shelf‑label tags, self‑service lockers, curb‑side pickup and mobile‑app navigation to make stores easier to shop (2022 p. 9‑10). By 2024 the same emphasis on store appearance remains, but the refresh is now tightly coupled with new digital tools—hdPhone handheld devices, computer‑vision inventory visibility, expanded app‑based store maps and broader self‑checkout options—creating a digitally‑enabled store hub that reinforces the brand’s competitive edge (2024 p. 8‑9).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Home Depot's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 emphasis on store location, appearance, and presentation as competitive factors; (2) Accurately lists specific 2022 initiatives (way-finding signage, redesigned front-end areas, electronic shelf-label tags, self-service lockers, curbside pickup, mobile-app navigation); (3) Properly synthesizes the 2024 evolution showing integration of digital tools (hdPhone devices, computer-vision inventory, expanded app-based store maps, self-checkout options); (4) Correctly characterizes the strategic shift from physical aesthetics alone to digitally-enabled integrated experience; (5) Appropriately cites page references (2022 p. 9-10, 2024 p. 8-9) suggesting source verification; (6) Uses clear comparative language ('remains...but now tightly coupled') to show evolution. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer provides more specific tactical details (hdPhone, computer-vision) than the ground truth, which is actually a strength for comprehensiveness but slightly exceeds the ground truth's level of abstraction; (2) The ground truth emphasizes 'interconnected shopping experience' as a conceptual framework, while the LLM uses 'digitally-enabled store hub'—semantically equivalent but slightly different framing; (3) The LLM answer could have more explicitly stated the shift from 'physical store aesthetics alone' to 'holistic, digitally-enhanced' as a conceptual evolution, though this is clearly implied. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. Page references appear reasonable. MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2022 and 2024) and correctly identifies the causal relationship between store appearance initiatives and digital integration. The logical progression from 2022 baseline to 2024 evolution is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth—Home Depot evolved from emphasizing physical store appearance to integrating it with digital platforms for a more comprehensive customer experience.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 611,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "In 2023 AMD’s purchases from the ATMP JV stayed at about $1.7 billion but its resales to the JV were only $14 million; in 2024 the purchases remained $1.7 billion while resales jumped to $121 million. During 2024 AMD also deepened the relationship – it made a $17 million equity contribution (lifting its equity‑method investment to roughly $149 million from $99 million) and entered a new one‑year, $100 million term loan with the JV (secured by the JV’s receivable from AMD).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of AMD's financial relationship with ATMP JV between 2023-2024, including the key resales figures ($14M in 2023, $121M in 2024) and the $100M term loan in October 2024. However, there are significant issues with additional information introduced that is not in the ground truth: (1) The LLM mentions AMD's 'purchases from the ATMP JV' at $1.7 billion in both years - this information is not present in the original answer and appears to be extraneous detail that may or may not be accurate; (2) The LLM states AMD made a '$17 million equity contribution' lifting its equity-method investment from $99M to $149M - this specific equity contribution figure and investment balance information is not mentioned in the ground truth answer; (3) The LLM adds detail about the loan being 'secured by the JV's receivable from AMD' - this security detail is not in the original answer. While the core facts about resales growth and the term loan are correct, the introduction of unverified additional financial details (purchases, equity contributions, investment balances, loan security terms) creates uncertainty about accuracy. The answer demonstrates good multi-hop synthesis and contextual understanding of the relationship evolution, but the addition of information not in the ground truth, combined with the lack of verification for these additional claims, reduces confidence in overall correctness. The answer is partially correct on the main points but introduces potentially inaccurate supplementary information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 430,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "In the 2023 filing J&J noted that it already had “privacy‑compliance programs and controls” in place to meet existing global privacy and data‑protection rules, and warned that a wave of new privacy statutes and tougher enforcement of data‑localisation and cross‑border‑flow requirements would create additional risk. By the 2024 filing the company had broadened those programs to cover the entire data‑life‑cycle (collection, possession, use, storage, access, disclosure, transfer, deletion and protection), made privacy training mandatory for all employees, and reinforced governance – with the board’s Regulatory‑Compliance & Sustainability Committee and the CISO providing regular (quarterly) updates – to keep pace with the expanding suite of new privacy laws and stricter international data‑flow regulations. 【page_22 (2023)】【page_22 (2024)】【page_23 (2024)】",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed and specific information than the ground truth answer. Key strengths: (1) Correctly identifies that J&J had privacy-compliance programs in place in 2023 with focus on new privacy laws and data localization/cross-border flow requirements; (2) Accurately describes the 2024 expansion to cover the entire data lifecycle (collection, possession, use, storage, access, disclosure, transfer, deletion, protection); (3) Correctly notes mandatory employee privacy training was implemented; (4) Accurately identifies governance enhancements including board's Regulatory-Compliance & Sustainability Committee and CISO quarterly updates; (5) Properly cites page references (page_22 for 2023, pages 22-23 for 2024). The answer successfully synthesizes multi-hop information across 2023 and 2024 filings and demonstrates the evolution from baseline compliance programs to more comprehensive, governance-enhanced programs. Minor considerations: (1) The ground truth emphasizes the shift from 'other territories' to 'globally' in regulatory scope, which the LLM answer addresses implicitly through 'expanding suite of new privacy laws' but doesn't explicitly highlight this geographic expansion; (2) The LLM provides more granular operational details (data lifecycle specifics, quarterly updates) than the ground truth, which is appropriate and adds value without contradicting the original answer. No quantitative errors detected. The answer correctly interprets the evolution as a broadening and deepening of compliance focus, matching the ground truth's characterization of 'broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 477,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "GE’s estimate of borrower‑litigation losses on the Bank BPH mortgage portfolio fell to $2.461 billion at 31 Dec 2024, down from $2.669 billion at 31 Dec 2023 – a $208 million reduction【page_48】.  Correspondingly, the valuation allowance on the financing receivables was $1.594 billion in 2024 versus $1.963 billion in 2023, with the portion tied to litigation losses dropping from $1.712 billion to $1.517 billion【page_50】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its accuracy. CRITICAL ERRORS: (1) The valuation allowance figures are incorrect. The LLM states $1.594 billion in 2024 vs $1.963 billion in 2023, but the ground truth shows $1.517 million in 2024 and $1.712 million in 2023 for the litigation-related portion. The LLM appears to have cited different/broader valuation allowance figures rather than the specific litigation-related amounts. (2) The LLM correctly identifies the total estimated losses ($2.461B in 2024 vs $2.669B in 2023) and the $208M reduction, which is accurate. (3) The LLM correctly identifies the litigation-related valuation allowance portion ($1.517B in 2024 vs $1.712B in 2023), which matches ground truth. MISSING INFORMATION: The LLM answer fails to address several key elements from the ground truth: (1) No mention of the $944 million in other liabilities for 2024 or $957 million for 2023, which are material components of the total exposure. (2) No discussion of the strategic shift where the valuation allowance fully offset the financing receivables balance by end of 2024. (3) No mention of the settlement program context. (4) The answer is incomplete in addressing 'related valuation allowances' as a complete picture of GE's exposure. MULTI-HOP REASONING: The answer attempts to synthesize information across years and metrics but fails to comprehensively capture the full exposure picture. The inclusion of broader valuation allowance figures ($1.594B/$1.963B) alongside the litigation-specific figures ($1.517B/$1.712B) creates confusion about which numbers are being referenced. The answer partially addresses the evolution but misses the strategic context and complete liability breakdown. POSITIVE ASPECTS: Correct identification of total estimated losses, correct calculation of the $208M reduction, correct identification of the litigation-related valuation allowance portion, and appropriate date references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 531,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "In fiscal 2022 the Indoor Garden line produced $10.1 billion of net sales, representing roughly 6.4 % of Home Depot’s total net sales【HD_10k_2024.pdf page_57】. By fiscal 2024, after a merchandising‑department realignment, Indoor Garden is placed in the Hardlines major product line—grouped with hardware, outdoor garden, power and storage & organization—showing that it remains a core hard‑line offering within the newly structured merchandising hierarchy【HD_10k_2024.pdf page_56】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect financial figures. Ground truth states Indoor Garden generated $15,546 million (10.3% of total revenue) in 2022, but the LLM claims $10.1 billion (6.4% of total). This is a major discrepancy - the LLM's figure is approximately 35% lower than the actual value ($10.1B vs $15.546B). The percentage is also wrong (6.4% vs 10.3%). These are not minor rounding differences but substantial factual errors that undermine the entire answer's credibility. QUALITATIVE ASSESSMENT: The LLM correctly identifies the 2024 repositioning of Indoor Garden under the Hardlines merchandising department and accurately describes the strategic shift from standalone category to integrated product line grouping. The reasoning about the reclassification is sound and well-articulated. However, this qualitative accuracy cannot compensate for the severe quantitative failures. MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information across 2022 and 2024 data points and correctly identifies the evolution from standalone to integrated status. The logic connecting financial performance to merchandising categorization is appropriate. COMPLETENESS: The answer addresses both parts of the question (2022 financial performance and 2024 categorization), but the foundational financial data is wrong, making the comparison invalid. The citation format suggests source documentation, but the numbers cited do not match ground truth. VERDICT: While the qualitative analysis of the strategic shift is reasonable, the fundamental quantitative errors (wrong sales figures and percentages) represent a critical failure in accuracy that cannot be overlooked in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 473,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "In the 2022 filing Colgate‑Palmolive said it “manages its raw‑material exposures through a combination of cost‑containment measures, **sourcing strategies**, ongoing productivity initiatives and the limited use of commodity‑hedging contracts” (2022 10‑K pp. 90‑91). By the 2024 filing the company still relies on **sourcing strategies**, but now frames them as one element of a broader response that also includes price‑increases, wider cost‑efficiency programs and acknowledges that sourcing “may not fully offset” renewed commodity‑price pressures (2024 10‑K pp. 16‑17). Thus, the approach has evolved from a primary reliance on sourcing to a more integrated strategy that couples sourcing with pricing and productivity actions to manage commodity volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Colgate-Palmolive's evolving sourcing strategies from 2022 to 2024. STRENGTHS: (1) Correctly identifies the company and time period (2022 to 2024); (2) Accurately cites specific page numbers from 10-K filings (pp. 90-91 for 2022, pp. 16-17 for 2024); (3) Properly synthesizes the evolution of strategy by contrasting 2022 approach (cost-containment, sourcing strategies, productivity initiatives, limited hedging) with 2024 approach (sourcing + pricing increases + cost-efficiency programs); (4) Captures the key shift from primary reliance on sourcing to integrated multi-faceted strategy; (5) Correctly notes the 2024 acknowledgment that sourcing 'may not fully offset' commodity pressures. MINOR GAPS: (1) The LLM answer does not explicitly mention specific commodities (resins, essential oils, soybeans) that the ground truth identifies as being managed in 2024; (2) Does not explicitly reference geopolitical and climatic disruptions mentioned in ground truth as drivers of the shift toward more defensive tactics; (3) Does not mention derivative instruments and local currency borrowings from 2022 framework. QUANTITATIVE ACCURACY: All dates and page citations appear accurate and properly formatted. No calculations required. QUALITATIVE ACCURACY: The reasoning about the evolution from sourcing-primary to integrated strategy is sound and well-supported. The multi-hop synthesis across two filing years is correctly executed. CONTEXTUAL RELEVANCE: The answer directly addresses the question about how sourcing strategies evolved in relation to commodity price fluctuations, with appropriate emphasis on the shift in approach. The omissions are contextual details rather than core factual errors, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 496,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA’s revenue rose from $3.147 billion in 2023 to $3.670 billion in 2024 – a 16.6% increase (≈ $523 million) 【page_31】.  The boost came from overall market growth and share gains, underpinned by continued strength in its psoriasis/psoriatic‑arthritis indications and a favorable patient‑mix profile 【page_32】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial metrics and growth trajectory of TREMFYA. Strengths: (1) All primary numbers are accurate - $3.147 billion (2023), $3.670 billion (2024), and 16.6% growth rate are correct; (2) The calculation of ~$523 million absolute increase is accurate ($3.670B - $3.147B = $0.523B); (3) Correctly identifies the therapeutic areas (psoriasis/psoriatic arthritis) and favorable patient mix as contributing factors; (4) Appropriately cites market growth and share gains. Weaknesses: (1) The answer omits the specific operational contribution of 18.1% and the negative currency impact of 1.5% that were mentioned in the ground truth - these are important contextual details explaining the composition of the growth; (2) Does not explicitly state that the 18.1% operational change was partially offset by currency headwinds, which provides important nuance about the underlying business performance; (3) The answer is somewhat less comprehensive than the ground truth in explaining the factors - it mentions market expansion and patient mix but doesn't quantify the operational vs. currency breakdown. The core answer is factually sound and addresses the main question, but lacks the analytical depth of the ground truth regarding the specific drivers of growth (operational vs. currency effects).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 372,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "In Disney’s 2022 Form 10‑K the A+E joint‑venture was described as “owned 50 % by the Company and 50 % by Hearst” and the filing included a table of domestic subscriber counts for A+E’s channels (e.g., 69 million for A&E, 70 million for HISTORY, 69 million for Lifetime, etc.)【page_12】. In the 2023 Form 10‑K the same 50 % equity interest is noted (“A 50 % equity investment in A+E Television Networks”) but the subscriber‑count table for A+E is no longer presented (no A+E numbers appear in the 2023 pages)【page_4】, indicating that while Disney’s ownership percentage remained unchanged, it stopped reporting A+E’s subscriber numbers as a separate disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, Disney reported A&E as a PARTNER (not a 50% equity stake), and the relationship EVOLVED into a 50% equity stake by 2023. The LLM incorrectly claims the 50% equity interest existed in 2022 ('owned 50% by the Company and 50% by Hearst'), which misrepresents the structural change that is central to the question. QUANTITATIVE ISSUES: (1) The LLM cites 69 million subscribers for A&E in 2022, which matches ground truth, but then claims the 2023 subscriber count is not presented. The ground truth states A+E's channels had 58 million domestic subscribers in 2023, indicating this data WAS available and should have been mentioned. (2) The LLM provides additional subscriber numbers (70 million for HISTORY, 69 million for Lifetime) not mentioned in ground truth, which may be accurate but are not verified against the source. REASONING FLAWS: The LLM's core conclusion is backwards - it states 'Disney's ownership percentage remained unchanged' when the ground truth indicates the relationship structure fundamentally changed FROM partnership TO joint ownership. This is a critical multi-hop synthesis error. The LLM correctly identifies that subscriber reporting changed, but misses the causal relationship: the structural change from partnership to equity stake is what drove the reporting change. WHAT WAS CORRECT: The LLM correctly identifies that A+E is a 50/50 joint venture with Hearst in 2023, and correctly notes that subscriber count reporting changed between years. However, these correct elements are undermined by the incorrect characterization of 2022 as already being a 50% equity stake. The answer fails to capture the key structural evolution that is the heart of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 500,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023 GE reported a modest net gain of $129 million (realized + unrealized) on its investment and note with AerCap. By 2024 that turned negative – the company said gains on its retained and sold ownership interests, primarily from the AerCap investment, fell by about $5.2 billion, converting the small gain into a large loss.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $129 million unrealized gain in 2023 and the $5.2 billion decline in 2024. (2) The numeric values are accurate and properly formatted. (3) The answer correctly identifies AerCap as a primary contributor to the decline. (4) The temporal comparison between 2023 and 2024 is properly structured.\n\nWEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM states the 2023 figure was a 'net gain of $129 million (realized + unrealized)' but the ground truth specifically identifies this as an 'unrealized gain.' The LLM's parenthetical suggests it combined realized and unrealized gains, which is not supported by the ground truth. (2) The LLM characterizes the 2024 outcome as 'converting the small gain into a large loss,' but the ground truth more carefully states it was 'a loss or significantly reduced gain.' The LLM's definitive claim of a 'large loss' goes beyond what the ground truth explicitly states - the ground truth indicates a 'significant decrease' but doesn't definitively confirm whether 2024 resulted in a loss or just a much smaller gain. (3) The phrase 'realized + unrealized' in parentheses is misleading because the ground truth only mentions the unrealized gain for 2023, not a combined figure. (4) The LLM's characterization of the 2023 gain as 'modest' is subjective and not explicitly stated in the ground truth.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the relationship evolution between 2023 and 2024, properly connecting the AerCap investment to the broader gains/losses on retained and sold ownership interests. The logic of comparing year-over-year performance is sound.\n\nNUMERIC VERIFICATION: Both the $129 million (2023) and $5.2 billion decline (2024) are accurate. The $5.2 billion figure represents the magnitude of change, not the absolute 2024 value, which is correctly interpreted.\n\nOVERALL: The answer captures the essential financial evolution but makes an unsupported inference about the nature of the 2023 gain (combining realized and unrealized when only unrealized is mentioned) and overstates the certainty of a 'large loss' in 2024 when the ground truth is more cautious about the final outcome.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 590,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "In its 2022 filing, Mastercard described a multi‑layered security framework built around internal Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, third‑party assessments and public‑private partnerships to protect its network【page_11】. By the 2024 filing, the same framework now explicitly includes monitoring and response to threats and incidents tied to services provided by third‑party providers, adding a dedicated supply‑chain risk focus【page_11】. This evolution signals a strategic tightening of Mastercard’s cyber‑defense posture, expanding its safeguards to address emerging threats from the broader ecosystem and third‑party dependencies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Mastercard's security approach between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 framework components (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center, third-party assessments, public-private partnerships); (2) Accurately captures the 2024 evolution adding explicit third-party provider risk management; (3) Properly synthesizes the multi-hop information showing the progression from implicit to explicit third-party focus; (4) Correctly interprets the strategic shift toward ecosystem-wide resilience; (5) No quantitative errors in dates or metrics. MINOR WEAKNESSES: (1) The LLM answer adds specific component names (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center) that are not explicitly mentioned in the ground truth, though these appear to be accurate details from the actual filings (indicated by the citation 'page_11'); (2) The phrase 'strategic tightening of cyber-defense posture' is slightly more emphatic than the ground truth's 'strategic shift toward strengthening ecosystem-wide resilience,' though semantically equivalent; (3) The ground truth explicitly notes 'no explicit mention' of third-party risks in 2022, while the LLM answer doesn't emphasize this absence as clearly, though it does convey the evolution. MULTI-HOP REASONING: The answer correctly synthesizes information across two filing years and identifies the progression in security strategy. The connection between the evolution and strategic response to emerging threats is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'strategic tightening' and 'expanding safeguards to address emerging threats from the broader ecosystem' is semantically equivalent to the ground truth's description of 'strategic shift toward strengthening ecosystem-wide resilience.' Overall, this is a high-quality answer with accurate core facts and sound reasoning, with only minor stylistic and emphasis differences from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 562,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target said it was **in compliance with its debt‑leverage covenant in 2022** after replacing its $2.5 billion revolving credit facility with a new $3.0 billion unsecured facility and noted it “expects to remain” in compliance【page_30】. In 2023, after extending that $3.0 billion facility to 2028 and adding a new $1.0 billion 364‑day revolving facility (while terminating the prior short‑term facility), the company again confirmed it “is, and expects to remain, in compliance” with the same debt‑leverage covenant【page_33】. Thus, despite the credit‑facility changes, Target’s covenant compliance remained unchanged – it stayed compliant in both years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the 2022 credit facility details. Ground truth states Target had a '$3.0 billion unsecured revolving credit facility set to expire in October 2026' in 2022, but the LLM claims Target 'replaced its $2.5 billion revolving credit facility with a new $3.0 billion unsecured facility' in 2022. This is a material discrepancy - the ground truth does not mention a $2.5 billion facility being replaced; it only references the $3.0 billion facility. The LLM appears to have introduced incorrect information about a facility replacement that is not supported by the ground truth. The 2023 details are accurate: the $3.0 billion facility was extended to October 2028, and a new $1.0 billion 364-day facility was added. The covenant compliance assertion is correct for both years. The multi-hop reasoning is sound in structure (comparing 2022 vs 2023 compliance status and facility changes), and the conclusion that compliance remained consistent is correct. However, the factual error about the 2022 facility transition significantly undermines the answer's reliability. The answer correctly identifies that despite credit facility changes, Target maintained compliance in both years, which is the core insight requested. The page references provided suggest the LLM attempted to cite sources, though verification of these specific page numbers cannot be performed here.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 394,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "In 2023 Salesforce’s filing warned that its AI work – especially the shift from AI‑based classification to generative and “agentic” tools such as Agentforce – created **technical‑and‑ethical** risks, including the possibility of inaccurate, biased or toxic output, privacy‑ and security‑related data‑provenance issues, and the attendant brand‑reputational and legal liability if those outputs were used (2023 10‑K p. 22). By the 2024 filing the focus had broadened to **commercial‑and‑regulatory** uncertainties: Agentforce (and Data Cloud) are described as “relatively new and uncertain” products sold on a consumption‑based model, with limited pricing experience, risk of lower customer consumption, and exposure to platform‑change, competition and regulatory scrutiny that could affect revenue and margins (2024 10‑K p. 20). Thus the risk narrative has shifted from primarily technical/ethical concerns to a wider set of market‑adoption, pricing, competition and regulatory risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 in Salesforce's AI risk disclosures; (2) Accurately names Agentforce as the key product; (3) Correctly identifies 2023 risks as technical/ethical (inaccurate, biased, toxic output, privacy/security concerns); (4) Correctly identifies 2024 risks as including regulatory scrutiny and commercial/market adoption concerns; (5) Properly cites 10-K filings with page numbers; (6) Demonstrates sound multi-hop reasoning by synthesizing information across two years. WEAKNESSES: (1) The LLM answer's characterization of 2023 risks is somewhat narrower than the ground truth - it focuses heavily on technical/ethical risks but underemphasizes the third-party integration liability risks that were primary in 2023; (2) The ground truth explicitly mentions 'potential claims or liabilities stemming from customer expectations for warranties' regarding third-party offerings in 2023, which the LLM answer does not address; (3) The LLM answer's framing of the shift as 'technical-and-ethical' to 'commercial-and-regulatory' is somewhat reductive - the ground truth indicates the risks EXPANDED to include new categories rather than shifted away from previous ones; (4) The ground truth emphasizes 'increased costs related to AI governance, compliance, and testing' as a new 2024 risk, which the LLM answer does not explicitly mention; (5) The LLM answer introduces specific details about 'consumption-based model' and 'limited pricing experience' that, while potentially accurate, are not verified in the ground truth and may represent over-specification. QUANTITATIVE ACCURACY: Page numbers (p. 22 for 2023, p. 20 for 2024) are cited but cannot be independently verified against the ground truth provided. No calculations are required. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, but the synthesis is incomplete - it misses the third-party integration liability component that was central to 2023 risks. The answer correctly identifies that risks EXPANDED rather than simply shifted, but frames this as a shift rather than an expansion. SEMANTIC EQUIVALENCE: The core insight about evolution is present, but the characterization of what evolved is incomplete and somewhat misaligned with the ground truth's emphasis on expansion of risk categories rather than replacement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 658,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "In FY 2023, Lowe’s could deliver most parcel‑eligible items within two business days at standard shipping rates, with a gig network providing same‑day delivery for certain products and a market‑based delivery model active in 16 geographic areas【2023 page_6】. By FY 2024 the company had finalized the market‑based delivery model rollout, expanded it to additional regions, increased distribution capacity for big and bulky items, broadened the gig‑provider network, and added next‑day delivery for major appliances in almost every U.S. zip code, while still delivering most parcel‑eligible items within two business days or less【2024 page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more comprehensive detail than the ground truth. Key strengths: (1) All core facts are accurate - FY2023 two-business-day delivery for parcel-eligible items, FY2024 improvements to two business days or less, and next-day delivery for major appliances in nearly every U.S. zip code are all correctly stated. (2) Numeric accuracy is strong - the answer correctly references 16 geographic areas for market-based delivery in 2023 and 'almost every U.S. zip code' for 2024 appliance delivery, which aligns with 'nearly every zip code' in ground truth. (3) Multi-hop synthesis is sound - the answer properly synthesizes evolution across two fiscal years and identifies specific improvements. (4) The LLM provides additional context beyond ground truth (gig network for same-day delivery, market-based model rollout finalization, distribution capacity expansion, gig-provider network broadening) that adds value without contradicting the ground truth. Minor considerations: (1) The ground truth uses 'within two business days or less' while LLM uses 'within two business days or less' - semantically identical. (2) The ground truth describes the 2024 capability as 'enabling delivery of most parcel-eligible items within two business days or less' while LLM states 'still delivering most parcel-eligible items within two business days or less' - the word 'still' is slightly different in connotation but not factually incorrect. (3) The LLM's additional details about gig networks and market-based model expansion are not contradicted by ground truth and represent legitimate enhancements from the source documents. The answer fully addresses the question's request for evolution and specific improvements between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 484,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The Dermstore sale produced a one‑time $335 million pretax gain in 2021 and “represented less than 1 percent of our consolidated revenues, operating income and net assets”【page_21】, so it did not materially affect the later years. Target’s consolidated revenue slipped from $109.1 billion in 2022 to $107.4 billion in 2023, while operating income rose from $3.8 billion to $5.7 billion over the same period【page_25】—the Dermstore transaction therefore had essentially no ongoing impact on these figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. Verification of key facts: (1) The $335 million pretax gain is correctly cited and attributed to 2021. (2) The 'less than 1 percent' characterization of Dermstore's impact on consolidated revenues, operating income, and net assets is accurately stated and matches the ground truth. (3) The revenue figures ($109.1B in 2022, $107.4B in 2023) and operating income figures ($3.8B in 2022, $5.7B in 2023) are correct. (4) The multi-hop reasoning is sound: the answer correctly synthesizes that the sale occurred in 2021, had a one-time gain impact, and then had minimal ongoing impact in 2022-2023. (5) The conclusion that Dermstore 'had essentially no ongoing impact' on the 2022-2023 figures is logically sound and consistent with the ground truth statement that 'no significant post-sale financial contribution or change was observed in either year.' The answer directly addresses the question about how the financial impact evolved from 2022 to 2023 by demonstrating that it remained minimal/negligible in both years. Minor note: The answer could have been slightly more explicit in stating that the impact remained consistent (minimal) across both 2022 and 2023, but this is a very minor omission that doesn't affect the overall correctness. All factual claims are accurate and properly supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 378,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "In the 2023 filing, Data Cloud is described as the “hyperscale, trusted data engine” that lives inside the Customer 360 platform – a core component that pulls together disconnected enterprise data so customers can get a unified 360‑degree view and deliver personalized experiences. By the 2024 filing, Data Cloud is being positioned as a stand‑alone, AI‑enabled, consumption‑based offering that Salesforce is expanding as a growth engine, with the filing calling out new pricing‑model risks and intensified competition in the data‑and‑AI market. This marks a shift from a platform‑centric data‑engine to a revenue‑focused, usage‑priced service within Salesforce’s broader suite.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Data Cloud's positioning between 2023 and 2024 with generally accurate information. STRENGTHS: (1) Correctly identifies 2023 positioning as 'hyperscale, trusted data engine' integrated within Customer 360 platform; (2) Accurately notes the 2024 shift toward consumption-based, AI-enabled positioning; (3) Properly identifies the transition from platform-centric to revenue-focused messaging; (4) No quantitative errors or incorrect dates/numbers. WEAKNESSES: (1) The LLM describes Data Cloud as 'stand-alone' in 2024, which is not explicitly supported by the ground truth and may overstate the separation from Salesforce's broader offerings; (2) The ground truth emphasizes 'competitive risk' and 'uncertain markets' as key 2024 positioning elements, while the LLM frames it more as 'growth engine' expansion - this is a subtle but meaningful difference in emphasis; (3) The ground truth specifically mentions 'limited experience in pricing consumption-based models' as a strategic acknowledgment, while the LLM frames this as 'new pricing-model risks' - semantically similar but the ground truth's framing is more about capability gaps; (4) Missing explicit mention of the 'relatively new and uncertain' market characterization from 2024 filings. The answer demonstrates solid multi-hop synthesis across years and correctly identifies the shift in strategic messaging, but slightly mischaracterizes the nature of that shift by emphasizing growth/expansion over risk/uncertainty that the ground truth highlights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 428,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "In 2023 Lowe’s still held forward‑rate‑swap contracts that were classified as cash‑flow hedges (about $1.29 billion of notional) and the resulting gains or losses were reported in other‑comprehensive income 【page_60†L1-L4】. By the 2024 fiscal year those swaps had been settled – for example, the March 2023 notes triggered a $2.0 billion swap settlement that produced a $247 million cash receipt – and the forward‑swap line was removed from the cash‑flow‑hedge table (notional $0) so any gain/loss was now recognized in earnings rather than OCI 【page_60†L9-L13】. The fair‑value hedge of fixed‑to‑floating swaps remained unchanged at $850 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM states forward-rate-swap contracts had \"about $1.29 billion of notional\" in 2023, but the ground truth specifies $2.0 billion notional for the March 2023 Notes contracts. This is a major discrepancy.\n   - The LLM correctly identifies the $247 million cash receipt and $2.0 billion settlement amount, which matches ground truth.\n   - The LLM mentions \"$850 million\" for fair-value hedges remaining unchanged, but this figure is not mentioned in the ground truth and appears to be unsupported.\n\n2. HEDGE DESIGNATION MISINTERPRETATION:\n   - The LLM fundamentally mischaracterizes the evolution. It claims the 2023 contracts were \"settled\" by 2024 and removed from the cash-flow-hedge table, suggesting they no longer exist.\n   - The ground truth indicates a different evolution: In 2023, there were forward interest rate swap contracts (cash flow hedges). By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as FAIR VALUE HEDGES using the shortcut method.\n   - The LLM's interpretation that gains/losses moved from OCI to earnings due to settlement is not the same as the ground truth's explanation of a shift from cash flow hedge designation to fair value hedge designation.\n\n3. ACCOUNTING TREATMENT MISUNDERSTANDING:\n   - The ground truth emphasizes a shift in HEDGE DESIGNATION (cash flow hedge → fair value hedge) and ACCOUNTING METHOD (shortcut method for fair value hedges with assumed perfect effectiveness).\n   - The LLM focuses on settlement and removal from tables, missing the key point about the change in hedge accounting classification and the use of the shortcut method.\n   - The ground truth states fair value hedges resulted in \"no net impact on consolidated statements of earnings,\" which is a critical detail the LLM does not address.\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to synthesize the key evolution: the company's accounting treatment changed from one type of hedge designation to another, not simply that contracts were settled.\n   - The LLM correctly identifies that there was a change between years but mischaracterizes the nature of that change.\n\n5. MISSING CRITICAL INFORMATION:\n   - The LLM does not mention the shortcut method for fair value hedges.\n   - The LLM does not explain the \"no net impact\" on earnings from fair value derivatives in 2024.\n   - The LLM does not properly convey that both types of hedges appear to exist (forward swaps as cash flow hedges in 2023, fixed-to-floating as fair value hedges in 2024).\n\nThe answer demonstrates partial understanding but contains fundamental errors in interpreting the accounting evolution and includes unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 749,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "In 2022 Target treated its owned‑and‑exclusive brands as a core differentiation pillar, noting that they accounted for roughly one‑third of total sales and were listed alongside a broad assortment of national brands【page_3】; the focus was on using owned brands to set Target apart from competitors【page_5】. By 2023 the strategy shifted to “strengthening our owned brands portfolio” as a primary growth lever, emphasizing newness, style and value and expanding the breadth and depth of signature partnerships to make owned brands a central driver of relevance and traffic【page_3】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM claims owned brands accounted for 'roughly one-third of total sales' in 2022, but the ground truth states 'over 40 such brands' were listed without specifying a one-third sales figure. This is a significant factual discrepancy - the LLM introduced a specific percentage claim not supported by the ground truth. (2) DIRECTIONAL CONTRADICTION - The ground truth explicitly states that in 2022 Target had 'a strong but descriptive presence' and was 'simply showcasing owned brands,' whereas the LLM claims in 2022 they 'treated its owned-and-exclusive brands as a core differentiation pillar.' This contradicts the ground truth's characterization of 2022 as less strategically focused. (3) MULTI-HOP SYNTHESIS - The LLM correctly identifies the evolution from 2022 to 2023 and captures the shift toward 'strengthening our owned brands portfolio' and emphasis on 'newness, style and value,' which aligns with ground truth. (4) PARTIAL CREDIT - The LLM does correctly identify that 2023 represented a strategic elevation and mentions relevant concepts like 'traffic' and 'relevance,' which are present in the ground truth. However, the mischaracterization of 2022's strategic positioning and the unsupported quantitative claim ('one-third of sales') are material errors that undermine the answer's reliability. The answer demonstrates some understanding of the evolution but contains factual inaccuracies that would mislead readers about Target's 2022 positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 417,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "In the 2022 filing GM only noted that it “provides software‑enabled services worldwide,” citing basic offerings such as OnStar, vehicle‑connectivity and after‑sale warranties with revenue recognized over the service term. By the 2023 filing the company describes an end‑to‑end, OTA‑updatable software platform that bundles OnStar, Super Cruise and a growing menu of security, climate, comfort and EV‑ownership features—already deployed on the 2024 Cadillac LYRIQ and Chevrolet Silverado EV and slated for rollout across most models. This evolution from a modest connectivity suite to a comprehensive, subscription‑driven platform signals GM’s deepening investment in scalable digital solutions that enable software‑defined vehicles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 baseline as general language about 'software-enabled services worldwide' with specific examples (OnStar, vehicle connectivity, warranties); (2) Accurately describes the 2023 evolution to an end-to-end OTA-updatable platform with specific features (Super Cruise, active safety, infotainment, EV ownership); (3) Correctly names the specific 2024 model deployments (Cadillac LYRIQ and Chevrolet Silverado EV); (4) Properly synthesizes the multi-hop comparison showing progression from general services to concrete platform deployment; (5) Accurately characterizes the strategic shift toward scalable, software-defined vehicles and subscription-driven models; (6) All dates (2022, 2023, 2024) are correct. MINOR CONSIDERATIONS: The LLM answer adds some contextual details not explicitly in the ground truth (e.g., 'subscription-driven platform,' specific feature categories like 'security, climate, comfort'), but these are reasonable inferences from the filing language and enhance rather than contradict the core narrative. The characterization of 2022 offerings as 'modest connectivity suite' is interpretive but semantically consistent with the ground truth's description of 'general terms.' No quantitative errors, no date errors, no entity misidentifications. The multi-hop reasoning correctly synthesizes the evolution across years and connects it to investment in scalable digital solutions as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 426,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The Optimized Application Experiences category grew $75 million (≈11 %) in FY 2022, a rise the filing attributes to growth in the ThousandEyes offering【page_45】. In FY 2023 the renamed Observability category rose $80 million (≈14 %) and the filing again cites “growth in our ThousandEyes” as a driver【page_42】—showing that ThousandEyes’ contribution increased both in absolute dollars and as a larger share of the category year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: FY2022 Optimized Application Experiences category grew $75 million (11%), and FY2023 Observability category grew $80 million (14%). The answer correctly identifies ThousandEyes as a key driver in both years and properly notes the category name change from 'Optimized Application Experiences' to 'Observability' between fiscal years. The multi-hop reasoning is sound—the answer synthesizes information across two fiscal years and correctly identifies the evolution of ThousandEyes' contribution. The conclusion that ThousandEyes' contribution increased 'both in absolute dollars and as a larger share of the category year-over-year' is logically sound given the data (growth from $75M/11% to $80M/14%). The answer includes appropriate citations to source pages. Minor note: The ground truth mentions 'monitoring and analytics offerings' as additional drivers in FY2023, which the LLM answer omits, but this is a minor contextual detail that doesn't affect the core answer about ThousandEyes' evolution. The use of approximate symbols (≈) for percentages is appropriate given rounding. Overall, the answer directly addresses the question about how ThousandEyes' revenue contribution evolved between the two fiscal years with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 378,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 Form 10‑K the exhibit list for the Executive Severance Plan stops at Amendment No. 3 (see page 103) and makes no reference to Amendment No. 4. By contrast, the 2024 Form 10‑K lists Amendment No. 4 as Exhibit 10.34 (and again as 10.36) incorporated by reference to a 2022 quarterly report (see pages 104 and 105). This change shows that Lockheed Martin moved the amendment from being omitted to being explicitly disclosed, reflecting a broader, more detailed disclosure strategy for updates to its executive severance plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors: (1) CORE FACTUAL ERROR - The LLM claims Amendment No. 4 was OMITTED in 2023 and ADDED in 2024, but the ground truth states the opposite: Amendment No. 4 WAS disclosed in 2023 (as Exhibit 10.34, incorporated from September 2022 10-Q) and remained in 2024 (as part of a sequence including amendments 2, 3, 4, and 5). This is a complete reversal of the actual evolution. (2) EXHIBIT NUMBERING - The LLM mentions Amendment No. 4 appearing as both 10.34 and 10.36 in 2024, but provides no clear explanation of this dual listing or its significance. The ground truth indicates it was 10.34 in both years. (3) PAGE REFERENCES - The LLM cites pages 103-105 but these cannot be verified against the ground truth provided, and the page numbers may be incorrect. (4) DISCLOSURE STRATEGY INTERPRETATION - The LLM concludes this represents 'moving from omitted to explicitly disclosed,' which is the opposite of what the ground truth indicates. The ground truth describes a shift from 'highlighted disclosure' to 'integrated part of broader history,' not from absent to present. (5) MULTI-HOP REASONING - The LLM failed to correctly synthesize the comparative analysis between 2023 and 2024 filings. The answer demonstrates a fundamental misunderstanding of the document evolution. The only partially correct element is that both years reference incorporation from a 2022 quarterly report, but this is overshadowed by the major factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 422,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "In 2023 JPMorgan reported a Tier 1 leverage ratio of **7.2 %** and a Standardized CET1 capital ratio of **15.0 %**【page_98】. By year‑end 2024 the Tier 1 leverage ratio was unchanged at **7.2 %**—still well above the 4.0 % regulatory floor—while the Standardized CET1 ratio rose to **15.7 %**【page_104】, comfortably exceeding the 12.3 % minimum for that period. This shows the firm maintained strong leverage‑ratio compliance and improved its CET1 capital position.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "ANALYSIS: The LLM answer contains a significant factual discrepancy that undermines its accuracy. (1) CORRECT ELEMENTS: The LLM correctly identifies JPMorgan as the subject company, correctly states the 2023 Standardized CET1 ratio of 15.0%, correctly identifies the 2024 Tier 1 leverage ratio of 7.2%, and correctly notes regulatory minimums (4.0% for leverage ratio, 12.3% for 2024 CET1). The reasoning about compliance and capital strength is sound. (2) CRITICAL ERROR: The LLM claims the 2023 Tier 1 leverage ratio was 7.2%, but the ground truth only specifies this metric for 2024. The original answer does not provide a 2023 Tier 1 leverage ratio figure. This represents a factual error where the LLM appears to have either conflated years or introduced unsupported data. (3) ADDITIONAL DISCREPANCY: The LLM states the 2024 Standardized CET1 ratio rose to 15.7%, but the ground truth does not provide a 2024 CET1 ratio—it only mentions the 2024 Tier 1 leverage ratio of 7.2%. This is another unsupported claim. (4) MULTI-HOP REASONING: The LLM demonstrates good synthesis by comparing ratios across years and relating them to regulatory requirements, but this reasoning is built on partially incorrect data. (5) QUANTITATIVE ACCURACY PENALTY: While individual numbers that are stated in the ground truth are correct (15.0% for 2023 CET1, 7.2% for 2024 leverage, 4.0% and 12.3% minimums), the LLM introduces numbers not in the ground truth (2023 leverage ratio of 7.2%, 2024 CET1 of 15.7%), which significantly impacts quantitative accuracy. The answer partially addresses the question but with material factual errors regarding which metrics apply to which years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 456,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "In the 2022 filing GM Financial was shown chiefly as a separate reportable segment – its results were evaluated on an EBT‑adjusted basis and presented in the segment tables (see Note 23 – segment reporting [p. 98] and the GM Financial segment numbers in the tables [p. 100‑101]). By the 2023 filing the financing business is woven into the consolidated statements: purchases of finance receivables and collections appear in the cash‑flow statement [p. 61], detailed accounting policies for GM Financial’s receivables, loan‑loss allowances and amortized‑cost measurement are disclosed [p. 64‑65], and the segment note still lists GM Financial but now emphasizes its contribution to overall cash flows and the adjustments for its deferred‑tax position [p. 63]. This shift shows GM Financial moving from a stand‑alone segment view toward tighter integration within GM’s consolidated financial presentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains numerous specific page number citations that cannot be verified and appear to be fabricated. The answer cites 'Note 23 – segment reporting [p. 98]', 'GM Financial segment numbers in the tables [p. 100‑101]', 'cash‑flow statement [p. 61]', 'detailed accounting policies [p. 64‑65]', and 'segment note [p. 63]' - these specific page references are presented as facts but lack verification against actual filings. This is a critical error in a financial document evaluation context where precision is paramount. SEMANTIC ALIGNMENT: The LLM answer does capture the general conceptual evolution described in the ground truth - moving from a more separate segment presentation toward tighter integration with consolidated statements and emphasis on tax adjustments. The core narrative about increased integration and explicit focus on deferred tax positions aligns with the ground truth. COMPLETENESS: The LLM answer addresses both 2022 and 2023 and discusses the evolution in financial presentation, which matches the question's requirements. However, the specific details provided (page numbers, specific line items) cannot be verified. REASONING QUALITY: The multi-hop reasoning is sound in concept - comparing segment presentation across years and identifying a shift toward integration - but is undermined by unverifiable specific citations. The answer demonstrates understanding of the general evolution but fails on factual precision. CRITICAL FLAW: In financial document analysis, citing specific page numbers and document locations that cannot be verified is a serious error that would mislead users. This significantly reduces confidence in the answer despite its conceptual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 481,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "In the 2022 filing the lease note only described the basic lease options (renewal, purchase, right‑of‑first‑refusal) and did not discuss step‑rent or index‑linked escalations 【page_44】. By the 2024 filing the company added that some leases contain free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the lease term (including reasonably certain renewal periods), and that periodic rent increases tied to price indices or the greater of a minimum guarantee or sales volume are accounted for as variable lease payments 【page_45】. Thus the accounting treatment (straight‑line for step‑rent and variable‑payment accounting for index‑based escalations) remains the same, but the disclosure has been expanded to explicitly describe these provisions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that there was a SHIFT in accounting treatment between 2022 and 2024: in 2022, step-rent provisions were accounted for on a straight-line basis, while by 2024 they are recognized as variable lease payments. The LLM answer explicitly states the opposite - that 'the accounting treatment...remains the same' and that the change was only in disclosure expansion. This is a critical error that misrepresents the evolution of accounting treatment, which is the core of the question. The LLM correctly identifies that 2024 disclosures mention both straight-line treatment for step-rent AND variable payment accounting for index-based escalations, but fails to recognize that the 2022 treatment was different (straight-line for both). The LLM also incorrectly claims the 2022 filing 'did not discuss step-rent or index-linked escalations,' when the ground truth indicates these were discussed but accounted for differently. The page references provided (page_44, page_45) cannot be verified but appear to be fabricated citations. The answer demonstrates a failure in multi-hop reasoning by not properly comparing the 2022 and 2024 treatments to identify the actual evolution in accounting policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 366,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "In the 2023 Form 10‑K Lockheed Martin said it expected to pay about **$1.86 billion** in 2025 and roughly **$10.02 billion** over the 2029‑2033 period for its qualified defined‑benefit pension plans【page_88】.  \nThe 2024 Form 10‑K lowered those forecasts to **$1.80 billion** for 2025 and about **$9.99 billion** for the long‑term horizon (with $1.99 billion in 2029 and $9.99 billion for 2030‑2034)【page_89】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine its credibility. (1) For 2023: The LLM correctly states $1.86 billion for 2025 and $10.02 billion for 2029-2033, matching ground truth. (2) For 2024: The LLM claims the 2025 projection 'lowered' to $1.80 billion, but ground truth shows it remained at $1.860 million (no change). This is a factual error - the LLM incorrectly reports a decrease that did not occur. (3) The LLM states $9.99 billion for 2030-2034, which matches ground truth's $9,990 million, so this is correct. (4) The LLM introduces an unexplained figure of '$1.99 billion in 2029' which is not part of the ground truth answer and appears to be extraneous information that confuses the narrative. (5) The LLM's characterization of the 2025 payment as 'lowered' is factually incorrect since it remained unchanged at $1.860 million. MULTI-HOP REASONING: The answer attempts to synthesize data across 2023 and 2024 filings, which is appropriate for the question. However, the incorrect claim about the 2025 payment decreasing represents a failure in accurate data synthesis. COMPLETENESS: The answer addresses both the 2025 short-term and long-term projections as requested, but the inaccuracies in the 2024 figures significantly detract from overall quality. The conclusion about 'marginal reduction in long-term pension obligations' is partially supported (the long-term did decrease slightly from $10,020M to $9,990M), but the false claim about the 2025 payment change undermines this analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 432,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K state that actions taken to satisfy JPMorgan Chase’s resolution‑plan obligations can increase its funding costs. In each filing the bank says it would manage this liquidity risk by raising alternative funding if deposits or cheap borrowings are limited and by meeting its liquidity‑coverage‑ratio and net‑stable‑funding‑ratio requirements, so the 2024 disclosure essentially repeats the 2023 language without material change. (2023 p. 22; 2024 p. 22)",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fundamentally misses the core evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2024 disclosure 'essentially repeats the 2023 language without material change,' which directly contradicts the ground truth that shows a meaningful evolution in how JPMorgan Chase framed resolution-related liquidity risks. (2) The LLM completely omits the key 2024 expansion regarding 'dynamic regulatory expectations and systemic events' and how 'changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements.' This is the central evolution the question asks about. (3) The LLM fails to capture the shift in framing from 2023 (focused on specific regulatory requirements like LCR/NSFR and subsidiary liquidity pre-positioning) to 2024 (broader context of regulatory evolution and macroeconomic uncertainty). QUANTITATIVE ACCURACY: The page references (p. 22 for both years) appear plausible but cannot be verified as correct without the actual filings. The LLM correctly identifies the general categories of liquidity management (alternative funding, LCR/NSFR requirements) but misses the substantive differences. QUALITATIVE ACCURACY: The LLM's reasoning is fundamentally flawed—it concludes there is 'no material change' when the ground truth explicitly describes an evolution and expansion of disclosures. This represents a failure in multi-hop synthesis and comparative analysis across the two years. CONTEXTUAL RELEVANCE: The answer addresses the general topic but fails to answer the specific question about how disclosures 'evolved,' instead claiming they remained static. The question explicitly asks about evolution/change, and the LLM's conclusion that there was no material change is incorrect according to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 513,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "In 2022 Optum Rx reported $7.1 billion of accounts receivable for its pharmacy‑care products and services; by year‑end 2023 that balance had risen to $8.6 billion, a $1.5 billion increase. The company’s revenue‑recognition model did not change – product revenue is recorded when a prescription is dispensed and services revenue when the service is performed, with no material contract assets, liabilities or deferred contract costs in either year and no material revenue from prior‑period performance obligations. These points are detailed in the 2023 filing (see page 46, which references both 2022 and 2023 figures).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All numbers are correct - accounts receivable of $7.1 billion in 2022 and $8.6 billion in 2023 match the ground truth exactly, and the calculated $1.5 billion increase is accurate. ENTITY ACCURACY: Optum Rx is correctly identified, years 2022-2023 are correct, and the financial metrics (accounts receivable, revenue recognition) are properly specified. COMPLETENESS: The answer addresses both key aspects of the question: (1) revenue recognition model evolution (showing it remained consistent with gross revenue reporting tied to prescription dispensing), and (2) accounts receivable changes (quantified with specific figures and the $1.5 billion increase). MULTI-HOP REASONING: The answer correctly synthesizes information across multiple dimensions - connecting the revenue recognition model to the accounts receivable figures and explaining the relationship between them. The statement that the model 'did not change' aligns with the ground truth's characterization that the structure 'remained aligned with this model.' ADDITIONAL STRENGTHS: The LLM answer provides supplementary context about contract assets, liabilities, and deferred costs being immaterial, and cites the specific filing page (page 46 of 2023 filing), which adds credibility and specificity beyond the ground truth. MINOR CONSIDERATIONS: The ground truth mentions the model was 'due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection,' which the LLM answer doesn't explicitly restate, though this is a minor omission that doesn't affect the core accuracy. The LLM answer's explanation of the increase as 'either increased transaction volume or changes in payment timing' is implicit rather than explicit in the LLM response, but the LLM does note the increase without speculating on causes, which is appropriate. Overall, the answer is factually sound, well-structured, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 554,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS’s floating‑to‑fixed interest‑rate swap exposure has been essentially flat, with the hedged portion of long‑term debt and finance‑lease liabilities reported at roughly $280 million in the 2022 filing and $279 million in 2024 (see the balance‑sheet hedge table, page_138). The company’s risk‑management policy remains unchanged – it continues to designate floating‑to‑fixed swaps as cash‑flow hedges, uses fair‑value hedges for fixed‑to‑floating swaps, and supplements with forward‑starting swaps or interest‑rate locks as needed (see the interest‑rate risk discussion, page_136). The hedge impact on earnings has modestly improved, with the reclassification loss on interest‑rate contracts falling from $10 million in 2023 to $5 million in 2024 (page_138).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM reports $280 million and $279 million in notional amounts for floating-to-fixed swaps, but the ground truth explicitly states $28 million in 2022. This is a 10x magnitude error - the LLM appears to have confused or misread the actual notional amounts. (2) CONTRADICTORY NARRATIVE: The ground truth describes an evolution from 'limited use' ($28M in 2022) to a 'more comprehensive' strategy in 2024, indicating growth and strategic shift. The LLM claims the exposure has been 'essentially flat' at ~$280M, which contradicts both the magnitude and the narrative of evolution. (3) MISSING KEY INFORMATION: The LLM fails to address the strategic evolution aspect of the question - the shift from a minor quantitative hedge to a more intentional, comprehensive approach. Instead, it focuses on operational details (cash-flow hedges, fair-value hedges, reclassification losses) that, while potentially accurate, don't answer the core question about how the strategy evolved. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution between 2022 and 2024, requiring synthesis of strategic intent across years. The LLM's claim of 'unchanged' policy and 'flat' exposure directly contradicts the ground truth's narrative of strategic evolution. (5) PAGE REFERENCES: The LLM cites specific page numbers (138, 136) which cannot be verified against the ground truth, raising questions about source accuracy. The ground truth provides no such citations, suggesting the LLM may be hallucinating or misinterpreting source material. The answer demonstrates a fundamental misunderstanding of the quantitative data and fails to capture the strategic evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 493,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "In the 2022 filing GM described its partnership with LG Energy Solution as an **equally‑owned joint venture, Ultium Cells LLC**, created to mass‑produce battery cells at several U.S. sites (Lordstown, Ohio; Spring Hill, Tennessee; Lansing, Michigan)【page_4】. By the 2023 filing the relationship had expanded to include a **reimbursement arrangement for the Chevrolet Bolt battery‑fire recall** – LG Energy Solution agreed to reimburse GM, leading GM to accrue **$2.6 billion**, record **$1.6 billion of receivables**, and retain a **$0.6 billion remaining accrual** for those recall costs, while also resolving other commercial matters tied to the Ultium Cells joint venture【page_92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about GM's evolving relationship with LG Energy Solution. QUANTITATIVE VERIFICATION: All financial figures are correct - $2.6 billion accrual, $1.6 billion receivables, and the implied $0.6 billion remaining accrual ($2.6B - $1.6B = $0.6B) are all accurate. The calculation is sound and properly explained. ENTITY ACCURACY: Correctly identifies GM, LG Energy Solution, Ultium Cells LLC, and the Chevrolet Bolt EV battery recall. Years (2022 vs 2023) are properly distinguished. MULTI-HOP SYNTHESIS: The answer effectively synthesizes information across two filing periods, showing the transition from strategic collaboration (2022: joint venture formation) to financial liability management (2023: recall costs and reimbursement arrangements). The logic is clear and well-reasoned. COMPLETENESS: Addresses all aspects of the question - joint venture activities (Ultium Cells LLC with specific plant locations), recall-related costs ($2.6B accrual), and the reimbursement arrangement ($1.6B receivables). The answer goes slightly beyond the ground truth by providing specific plant locations (Lordstown, Ohio; Spring Hill, Tennessee; Lansing, Michigan), which adds helpful context without contradicting the original answer. SEMANTIC EQUIVALENCE: The characterization of the relationship shift from 'strategic collaboration to transactional/cost-driven dynamic' is well-captured through the detailed explanation of the reimbursement arrangement and accrual structure. Minor note: The LLM answer includes page references and slightly more operational detail than the ground truth, but this enhances rather than detracts from accuracy. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 478,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The Observability product category grew from $581 million in fiscal 2022 to $661 million in fiscal 2023 – a $80 million (14 %) increase – and Cisco said that growth was driven by the performance of its ThousandEyes offering (along with other monitoring and analytics products)【page_41】【page_42】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the ground truth information. Key issues: (1) WRONG NUMBERS: The LLM states Observability grew from $581M to $661M (an $80M increase), but the ground truth indicates the category increased by $80M in FY2022 and then by $176M in FY2023 - these are different metrics and time periods. The LLM conflates two separate fiscal years' growth figures. (2) WRONG PERCENTAGE: The LLM calculates 14% growth ($80M/$581M), but the ground truth explicitly states FY2023 saw a 27% increase. (3) INCOMPLETE ANALYSIS: The LLM completely omits the critical FY2023 information about the 27% growth, the $176M increase, and the Splunk acquisition's contribution to Observability. It also fails to mention the 15% organic growth excluding Splunk, which is important context for understanding ThousandEyes' standalone performance. (4) MISSING EVOLUTION: The question asks how revenue contribution 'evolved' from FY2022 to FY2023, requiring comparison of both years. The LLM only provides one growth figure and misattributes it. (5) SYNTHESIS FAILURE: This is a multi-hop question requiring synthesis of ThousandEyes' contribution across two fiscal years. The LLM fails to properly synthesize the FY2022 and FY2023 data, instead presenting conflicting/confused numbers. The answer demonstrates partial understanding that ThousandEyes drove growth, but the quantitative foundation is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 401,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS’s $276 million 7.620 % debentures were described in both filings as fully callable at UPS’s option, with the redemption price equal to the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps, and interest continues to be paid semi‑annually in April and October. The 2022 10‑K notes that the rate was reduced from 8.375 % to 7.620 % on April 1 2020 【page_120】, while the 2024 10‑K simply references the current 7.620 % rate, indicating that the redemption and payment terms have not changed, only the emphasis on the historical rate cut. 【page_108】",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the principal amount ($276 million), the interest rate (7.620%), the maturity date (April 1, 2030 implied), the redemption terms (callable at UPS's option with the greater of principal+accrued interest or present value calculation), and the semi-annual payment schedule (April and October). The numeric values are accurate.\n\nWEAKNESSES: (1) The LLM introduces information about a rate reduction from 8.375% to 7.620% on April 1, 2020, which is NOT mentioned in the ground truth answer and appears to be extraneous detail that may not be directly relevant to the evolution between 2022-2024. This is a factual claim that cannot be verified against the provided ground truth. (2) The LLM states that 'redemption and payment terms have not changed' between 2022 and 2024, which contradicts the ground truth's key finding that there was an 'evolution' from 'a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.' The ground truth emphasizes that UPS 'clarified' and 'specified' these terms in 2024, suggesting they were not as explicitly detailed in 2022. (3) The LLM misses the core insight of the ground truth: the evolution represents a shift from less detailed to more detailed disclosure, not that the terms remained unchanged. (4) The carrying value of $280 million in 2022 mentioned in the ground truth is omitted from the LLM answer.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2024 filings but reaches an incorrect conclusion about the nature of the evolution. The ground truth indicates a disclosure evolution (more detail provided in 2024), while the LLM suggests the terms themselves were unchanged, which is a different interpretation that misses the question's intent.\n\nCONCLUSION: While individual financial facts are mostly correct, the LLM fundamentally misinterprets the nature of the 'evolution' being asked about and introduces unverified historical information about the 2020 rate change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 557,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "In 2022 MetLife’s Fixed‑Maturity Securities (AFS) were valued at **$6.8 billion**.  The portfolio included **$1.5 billion of U.S. government bonds** (Level 1 $1,462 m + Level 2 $45 m) and **$3.0 billion of corporate securities** (Level 2 $2,946 m + Level 3 $55 m)【page_308】.  \n\nBy year‑end 2023 the total fair value slipped slightly to **$6.7 billion**, but the composition shifted: **U.S. government bonds rose to $1.58 billion** (Level 1 $1,537 m + Level 2 $38 m) and **corporate securities grew to $3.08 billion** (Level 2 $3,029 m + Level 3 $54 m)【page_308】.  The modest gains in government‑bond and corporate holdings were more than offset by declines in other fixed‑maturity categories, resulting in a net decrease in total fair‑value.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct information with good multi-hop synthesis, but contains a critical discrepancy regarding the 2022 baseline figure. STRENGTHS: (1) The 2023 figures are accurate: total fair value of $6.7 billion ($6,714M), U.S. government bonds at $1.58 billion ($1,575M with Level 1 at $1,537M), and corporate securities at $3.08 billion ($3,083M with Level 2 at $3,029M). (2) The detailed breakdown by fair value hierarchy levels is correct and well-presented. (3) The multi-hop reasoning correctly synthesizes composition changes across the two years. (4) The narrative explanation of the shift in portfolio composition is logical and appropriate. CRITICAL ISSUE: The LLM states 2022 Fixed Maturity Securities AFS were valued at $6.8 billion, but the ground truth indicates the 2022 carrying amount was $2,164 million ($2.164 billion). This is a significant discrepancy—the LLM's 2022 figure appears to be approximately 3x higher than the ground truth. This creates confusion about the actual year-over-year evolution. The ground truth suggests a substantial increase from 2022 to 2023 (from ~$2.2B to $6.7B), but the LLM presents it as a slight decrease (from $6.8B to $6.7B), fundamentally misrepresenting the portfolio evolution. MINOR ISSUES: The Level 2 figure for U.S. government bonds in 2023 is stated as $38M in the LLM answer, but ground truth shows $1,537M under Level 1 with the remainder implied to be Level 2, suggesting the Level 2 amount should be approximately $38M ($1,575M - $1,537M), which is correct. The reasoning quality is sound, but the incorrect 2022 baseline significantly undermines the accuracy of the year-over-year comparison, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 469,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "In the 2022 Form 10‑K GM recorded a $0.5 billion cash outflow as its “Investment in Ultium Cells LLC” (see 2022 p. 42 / 41), indicating a capital‑investment relationship with the joint‑venture and no disclosed regulatory issues. By the 2023 filing the focus had shifted to compliance: GM disclosed that Ultium Cells LLC was the subject of potential TSCA violations, which were settled with the EPA in November 2023, resulting in civil penalties of about $5.1 million assessed jointly on GM and Ultium Cells (see 2023 p. 28).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about GM's evolving relationship with Ultium Cells LLC from 2022 to 2023. QUANTITATIVE VERIFICATION: All numbers are correct - $0.5 billion investment in 2022, $5.1 million in joint civil penalties from November 2023 settlement. Dates are accurate (February 2023 self-disclosure, November 2023 settlement). ENTITY ACCURACY: All entities correctly identified (General Motors, Ultium Cells LLC, EPA, TSCA). MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, showing the transition from investment-based relationship (2022) to operationally integrated partnership with regulatory implications (2023). The logic is sound - the shift from passive investment to active operational involvement is clearly demonstrated through the regulatory disclosure and settlement. COMPLETENESS: The answer addresses both financial involvement ($0.5B investment, $5.1M penalties) and regulatory implications (TSCA violations, EPA settlement). MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'shift from a passive investment to a more active and operationally entangled partnership' from the ground truth is conveyed semantically through the LLM's description of the transition from 'capital-investment relationship' to 'compliance' focus. The LLM appropriately cites specific page references (2022 p. 42/41, 2023 p. 28), adding credibility. No calculation errors or factual inaccuracies detected. The answer demonstrates clear understanding of the question's multi-part nature and successfully synthesizes the evolution across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 472,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The 2022 filing notes that the Company “enters into variable‑priced contracts for some purchases of natural gas, in addition to fuel for its gas stations, on an index basis” and that these contracts qualify for the normal‑purchases‑and‑normal‑sales exception (COST 10‑K 2022 p. 46). The 2024 filing repeats the same description—still using index‑based variable‑priced contracts for natural‑gas and fuel purchases with the same accounting treatment (COST 10‑K 2024 p. 47). Thus, the company’s use of such contracts has remained essentially unchanged between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims that in 2022, the company's variable-priced contracts 'qualify for the normal-purchases-and-normal-sales exception,' but the ground truth explicitly states that in 2022, 'the specific volume or value of these contracts was not disclosed' and makes NO mention of the normal purchases/sales exception being applied in 2022. (2) CRITICAL ERROR - The LLM concludes that 'the company's use of such contracts has remained essentially unchanged between 2022 and 2024,' directly contradicting the ground truth which states there was 'a shift in how these contracts are managed or accounted for' and describes a 'more formalized or strategic use' by 2024. (3) The ground truth indicates an evolution: 2022 had basic variable-priced contracts with no specific disclosure, while 2024 showed explicit alignment with derivative accounting frameworks and the normal purchases/sales exception. (4) The LLM misrepresents the 2022 filing by attributing accounting treatment language that the ground truth indicates only appeared in 2024. (5) The LLM's conclusion of 'essentially unchanged' is fundamentally incorrect—the ground truth describes a clear evolution in formalization and accounting treatment. The LLM failed to capture the key distinction between 2022 (basic contracts, no detailed accounting framework mentioned) and 2024 (formalized derivative treatment with explicit exception application). This represents a failure in multi-hop reasoning and synthesis of the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 443,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco’s segment reporting for APJC did not change from FY 2022 to FY 2023. In both years the company states that it does **not** allocate research‑and‑development, sales and marketing, general‑and‑administrative expenses, amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, asset‑impairment and restructuring charges, or other charges to the segment’s gross‑margin measurement (FY 2022 §19(a) page 105; FY 2023 §19(a) page 104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about Cisco's APJC segment financial reporting evolution between fiscal 2022 and fiscal 2023. STRENGTHS: (1) Correctly identifies that there was NO CHANGE in the exclusion approach between the two fiscal years, which is the core finding. (2) Accurately lists all excluded expense categories: R&D, sales and marketing, G&A, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairment and restructuring charges. (3) Properly cites specific document references (§19(a) page 105 for FY2022; §19(a) page 104 for FY2023), demonstrating multi-hop synthesis across two fiscal years. (4) Uses precise language ('does not allocate') matching the regulatory terminology. (5) Correctly identifies the segment as APJC and fiscal years as FY2022 and FY2023. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth provides slightly more narrative context about 'financial decisions and resource allocations,' but the LLM answer's focus on the specific exclusions from 'gross-margin measurement' is equally valid and perhaps more precise. Both answers correctly convey that consistency was maintained across the two years. No numerical errors, calculation errors, or entity misidentifications present. The answer successfully synthesizes information across two fiscal years to demonstrate the consistency in reporting approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 428,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "In 2022 UNH said it managed medical‑cost trends mainly through underwriting criteria, product design, competitive provider‑contract negotiations and care‑management programs, plus value‑based arrangements with commercial payers (2022 p. 17). By 2023, after seeing a surge in senior outpatient procedures, UNH shifted to a more proactive approach—engaging physicians and members with data‑driven information, expanding integrated and virtual care delivery, and accelerating fully accountable, value‑based plans to curb those outpatient costs (2023 p. 27‑29).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about UNH's evolution in managing medical cost trends from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 approach focusing on underwriting, product design, provider negotiations, care management, and value-based arrangements; (2) Accurately captures the 2023 shift toward proactive strategies including data-driven engagement with physicians and members; (3) Properly identifies rising senior outpatient procedure costs as the key trend; (4) Correctly synthesizes the evolution from general concern to targeted intervention; (5) Provides specific page references (2022 p. 17, 2023 p. 27-29) showing document grounding; (6) Mentions concrete 2023 strategies: integrated/virtual care delivery and accountable value-based plans. MINOR GAPS: (1) The LLM answer doesn't explicitly mention the 2022 concern about deferred care during the pandemic and higher demand for services among chronic condition patients, which the ground truth emphasizes; (2) Doesn't explicitly mention the importance of accurate cost prediction under risk-based arrangements that was emphasized in 2022; (3) The phrase 'surge in senior outpatient procedures' is slightly more colloquial than the ground truth's 'rising outpatient procedure costs for seniors,' though semantically equivalent. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this is not a differentiating factor. The years (2022, 2023) and page references are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and identifies the strategic evolution, demonstrating sound multi-hop reasoning. The comparison between the two years is logical and well-structured. SEMANTIC EQUIVALENCE: The core message matches the ground truth—UNH moved from general cost management approaches to targeted, data-driven interventions for senior outpatient costs. The LLM provides more operational detail about specific tactics (virtual care, accountable plans) which adds value without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 570,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "By 2022 UPS already marketed itself as a leader in time‑definite, guaranteed small‑package delivery, offering same‑day, next‑day, two‑day and three‑day air options and a day‑definite ground service that moved roughly 16 million packages each day, all coordinated through a single global air‑ground network【2022 p.5】. By 2024 the company had broadened the scope—daily ground volume grew to > 17 million packages, seven‑day same‑day pickup and a network of about 188,000 entry points (including 20,000 U.S. Access‑Point locations) were added, and the network was further unified with RFID‑enabled Smart‑Facility technology and digital tools (Digital Access Program) so that every air, ground, domestic, international, commercial and residential service runs on one technology‑driven smart logistics network【2024 p.6】【2024 p.3】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about UPS's time-definite delivery services evolution but contains significant issues when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 as baseline year with integrated global air/ground network\n- Accurately notes expansion of same-day pickup to seven days a week by 2024\n- Correctly mentions growth in daily ground volume (16M to >17M packages)\n- Appropriately references network expansion and technology integration (RFID, Smart-Facility, Digital Access Program)\n- Correctly identifies approximately 150 countries for returns services expansion\n- Properly synthesizes multi-hop information across 2022 and 2024 timeframes\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- The ground truth specifically mentions UPS's insourcing of final delivery for non-urgent, lightweight residential shipments previously handled by USPS through UPS SurePost as a KEY evolution point. The LLM answer completely omits this critical strategic shift, which represents a major change in service scope and control.\n- The LLM mentions \"188,000 entry points (including 20,000 U.S. Access-Point locations)\" but the ground truth does not provide these specific numbers, making verification impossible. These appear to be unsupported claims.\n- The LLM focuses heavily on technology infrastructure (RFID, Smart-Facility, Digital Access Program) which, while relevant to network integration, is not mentioned in the ground truth answer and may represent over-specification.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022 and 2024, comparing service offerings and network capabilities. However, it misses the critical strategic evolution regarding SurePost insourcing, which is a fundamental aspect of how UPS's approach to time-definite delivery changed.\n\nQUANTITATIVE ACCURACY ISSUES:\n- Package volume numbers (16M to >17M) appear reasonable but cannot be verified against ground truth\n- The 188,000 entry points figure is not mentioned in ground truth\n- The 150 countries for returns services is mentioned in ground truth but not explicitly in LLM answer\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good understanding of the general evolution and provides relevant details about network expansion and technology integration. However, the omission of the SurePost insourcing strategy—a major strategic shift in service scope and control—represents a significant gap in addressing the core question about how UPS's approach evolved. The introduction of unverified specific numbers (188,000 entry points) also raises concerns about accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 697,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 Form 10‑K Lowe’s disclosed its 2.50 % notes due April 2026 as part of the Thirteenth Supplemental Indenture (Exhibit 4.14) – a separate, outstanding debt instrument【page_82】. The 2023 Form 10‑K lists the same 2.50 % notes under the identical Exhibit 4.14, indicating the notes remained outstanding and were still reported in the same way, with no amendment or retirement noted【page_75】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains accurate numeric and date information (2.50% interest rate, April 2026 maturity, Thirteenth Supplemental Indenture, Exhibit 4.14) and correctly identifies the company and years. However, it fundamentally fails to address the core question about how the treatment or recognition of these notes EVOLVED between 2022 and 2023. The ground truth indicates a significant shift: in 2022 the notes were referenced in a historical/documentation context, while in 2023 they were explicitly recognized as issued/outstanding instruments - representing a procedural or administrative transition in disclosure treatment. The LLM answer instead claims the notes 'remained outstanding and were still reported in the same way, with no amendment or retirement noted' - directly contradicting the ground truth's assertion of an evolution in treatment. The LLM misses the key distinction between how the notes were characterized (historical documentation vs. active recognition) and incorrectly concludes there was no meaningful change in treatment. While the factual details about the notes themselves are correct, the multi-hop reasoning required to synthesize the evolution across two filings is absent. The answer reads as a static comparison rather than identifying the procedural/administrative transition that actually occurred. This represents a critical failure in addressing the 'how did it evolve' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 398,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "In the 2022 Form 10‑K, Costco listed sovereign‑debt crises as one of several macro‑economic headwinds that could depress demand, force a change in product mix, or raise the cost or availability of inventory, thereby pressuring its merchandise‑sourcing and gross‑margin outlook【page_15】. By the 2024 filing, the same risk is still highlighted, but it is framed within a larger international footprint and greater foreign‑exchange exposure, suggesting that while the nature of the risk has not changed, its potential impact on sourcing and cost structure may be more material as Costco’s global operations grow【page_14】.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains partially correct information but misses critical elements of the ground truth evolution from 2022 to 2024.\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 framing: sovereign debt crises as macroeconomic headwinds affecting demand, product mix, and inventory cost/availability\n- Correctly identifies that the risk is still highlighted in 2024\n- Appropriately notes Costco's growing global operations\n- Years (2022, 2024) are correct\n- Company (Costco) is correctly identified\n\nCRITICAL OMISSIONS & ERRORS:\n1. MISSING KEY EVOLUTION: The ground truth explicitly states that by 2024, the framing 'shifted' with sovereign debt crises now 'explicitly stated to negatively impact' Costco's business. The LLM answer claims 'the nature of the risk has not changed,' which directly contradicts the ground truth's emphasis on a meaningful shift in how the risk is characterized.\n\n2. INCOMPLETE SYNTHESIS: The ground truth highlights that 2024 filings emphasize 'a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability.' The LLM answer mentions only foreign-exchange exposure and global operations growth, missing the expanded scope of supply chain concerns.\n\n3. TONE/SEVERITY MISCHARACTERIZATION: The ground truth emphasizes 'heightened concern' and more explicit negative impact language in 2024. The LLM answer suggests continuity ('the nature of the risk has not changed'), which understates the evolution.\n\n4. MISSING CONTEXT: The ground truth mentions specific 2022 factors (tariff rates, timing, product mix changes) that provide important context for understanding the evolution. The LLM answer lacks this specificity.\n\nMULTI-HOP REASONING: The LLM attempted to synthesize across 2022 and 2024 filings but failed to capture the qualitative shift in risk characterization that is central to the ground truth answer. The reasoning is incomplete and somewhat contradicts the actual evolution described in the ground truth.\n\nQUANTITATIVE ACCURACY: No specific numbers were required or provided, so this scores reasonably well. Page references are cited but cannot be verified against the actual documents.\n\nQUALITATIVE ACCURACY: Moderate issues. The answer captures some correct elements but fundamentally misses the key insight about the shift from general macroeconomic risk to explicit negative impact language and expanded supply chain concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 657,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "UnitedHealth’s 2020 Stock Incentive Plan had 64 million shares available for future grants at 12/31/2021 (​page 67​), but that pool fell to 53 million shares by 12/31/2023 (​page 72​, footnote 3). The 11‑million‑share decline shows the company has drawn down its award pool, leaving a smaller capacity to issue new share‑based awards under the 2020 plan unless additional shares are authorized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 64 million shares in 2021, 53 million shares in 2023, and the calculated 11-million-share decline. The dates are properly specified (12/31/2021 and 12/31/2023), and the company is correctly identified as UnitedHealth Group. The multi-hop reasoning is sound—the answer correctly synthesizes information about the plan's available shares across two years and draws the logical conclusion about reduced capacity for future awards. The LLM goes slightly beyond the ground truth by adding the contextual note about needing additional authorized shares, which is a reasonable inference but not explicitly stated in the original answer. The answer directly addresses both parts of the question: (1) the change in available shares (64M to 53M, an 11M decline), and (2) what this indicates about capacity (reduced ability to issue new awards). The citation references to specific pages and footnotes add credibility. The only minor distinction from the ground truth is the slightly more detailed explanation of implications, but this enhances rather than detracts from the answer's quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 331,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "In the 2022 filing UPS’s agreement with the IAM National Pension Fund/National Pension Plan was linked to a collective‑bargaining contract that expired on July 31 2024, and UPS was identified as contributing more than 5 % of the plan’s total funding (about $48 million in 2021). By the 2024 filing a new IAM master agreement pushed the expiration out to July 31 2029, and UPS continued to be a material contributor—still providing over 5 % of total contributions and increasing its annual payment to $53 million in 2024. This reflects a five‑year extension of the agreement’s term while UPS’s contribution remained significant and grew modestly.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dollar amounts ($48 million in 2021 and $53 million in 2024) that are NOT present in the ground truth answer. These numbers appear to be fabricated or hallucinated, as the original answer only states that UPS contributed 'more than 5%' without providing specific dollar figures. This is a significant factual error that violates the principle of strict evaluation on numbers. CORRECT ELEMENTS: (1) The expiration dates are accurate: July 31, 2024 in 2022 filing and July 31, 2029 in 2024 filing. (2) The >5% contribution threshold is correctly identified for both periods. (3) The five-year extension calculation is correct. (4) The characterization of UPS as a 'material/significant contributor' is appropriate. INCORRECT/UNSUPPORTED ELEMENTS: (1) The specific dollar amounts ($48M and $53M) are not mentioned in the ground truth and appear to be invented. (2) The claim about 'increasing its annual payment' cannot be verified from the ground truth, which only states contribution percentages. (3) The reference to 'a new IAM master agreement' adds interpretive language not in the original answer. MULTI-HOP REASONING: The answer correctly synthesizes the evolution between 2022 and 2024 filings and properly identifies the relationship between expiration date changes and contribution significance. However, the introduction of unsupported numerical data undermines the credibility of the synthesis. The answer demonstrates good structural understanding but fails on factual precision regarding specific financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 433,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "In FY 2022 the five‑year unsecured revolving facility dated March 23, 2020 (the “2020 Credit Agreement”) had been amended in December 2021 to raise its aggregate availability to $2 billion, to mature in March 2025 and to bear interest at a Base‑Rate or Eurocurrency‑Rate plus a margin; together with the third‑amended $2 billion facility the total available borrowing capacity was $4 billion【page_56】. By FY 2023 the same agreement was again amended and restated in September 2023 (now called the “2023 Credit Agreement”), extending its term to September 2028 while keeping the $2 billion availability and the $4 billion combined pool (with an optional $1 billion increase) and the company remained in covenant compliance【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) FY 2022 details - correctly identifies the 2020 Credit Agreement with $2.0 billion availability and March 2025 maturity date; mentions December 2021 amendment (additional context not in ground truth but not contradictory); (2) FY 2023 details - correctly states the September 2023 amendment/restatement creating the 2023 Credit Agreement with September 2028 maturity and maintained $2.0 billion availability; (3) Combined availability - correctly identifies $4.0 billion total with both agreements, and adds the optional $1 billion increase feature (additional detail enhancing the answer); (4) Covenant compliance statement is relevant contextual information. All numeric values are accurate ($2B, $4B, dates March 2025, September 2028). The multi-hop synthesis is sound - the answer correctly traces the evolution of the credit agreement across two fiscal years and identifies the key amendment event. The only minor distinction from ground truth is the inclusion of additional details (December 2021 amendment context, optional $1B increase, covenant compliance status) which represent value-added information rather than errors. The answer directly addresses how terms and availability evolved between FY 2022 and FY 2023, showing clear before-and-after comparison with specific dates and amounts. Page citations provided add credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 395,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ’s net‑investment hedge program expanded in size. The aggregate notional amount of its NIH derivative contracts was $7.456 billion at year‑end 2023 and rose to $8.647 billion at year‑end 2024, an increase of roughly $1.2 billion. The 2022 filing does not disclose a comparable notional figure for NIH contracts, but the later figures show a clear upward trend in the use of these hedges.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 and 2024 notional amounts ($7.456 billion and $8.647 billion respectively) and accurately calculates the year-over-year increase of approximately $1.2 billion. The reasoning about the upward trend is sound and the characterization of the program expansion is appropriate. However, there are significant completeness issues: (1) The LLM states that '2022 filing does not disclose a comparable notional figure' but the ground truth explicitly provides 2022 data showing $3,915 million as of December 31, 2021 and $4,551 million as of December 31, 2020. This is a material omission that undermines the multi-hop synthesis required by the question. (2) The question specifically asks about evolution 'between 2022 and 2024,' which requires showing the progression across all three years (2022, 2023, 2024), but the LLM only addresses 2023-2024. (3) The LLM's claim that comparable figures aren't available in the 2022 filing appears to be incorrect based on the ground truth. The quantitative accuracy is reduced due to this incomplete data presentation, though the numbers provided are correct. The qualitative reasoning about the trend is sound, but the failure to synthesize the full multi-hop information (2022→2023→2024 progression) is a significant weakness for a question explicitly asking about evolution over this period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 381,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "In the 2022 filing Microsoft 365 was portrayed as a suite that “brings together Office 365, Windows, and Enterprise Mobility + Security to help organizations empower their employees with **AI‑backed tools** that unlock creativity, increase collaboration, and fuel innovation”【page_4】, with early Copilot‑based assistance and AI‑enhanced features in Teams, Viva and the Power Platform【page_4】.  \n\nBy the 2024 filing the company re‑positioned Microsoft 365 as an **AI‑first platform**, embedding Copilot directly into the Microsoft Graph and all 365 apps (“Copilot for Microsoft 365 combines AI with business data in the Microsoft Graph and Microsoft 365 applications”)【page_4】, adding **Copilot Studio** so customers can customize or build their own Copilot experiences【page_4】, and extending AI‑driven capabilities across Teams and Viva to further boost productivity and collaboration【page_4】. These new 2024 capabilities deepen AI integration and give users more personalized, real‑time assistance within the productivity suite.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Microsoft 365's AI evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning with Office 365, Windows, Enterprise Mobility + Security integration with AI-backed tools; (2) Accurately captures the 2024 shift to 'AI-first platform' positioning; (3) Correctly names Copilot for Microsoft 365 as the key 2024 innovation; (4) Properly describes the integration with Microsoft Graph and business data; (5) Mentions role-specific extensions implicitly through the broader Copilot ecosystem; (6) Includes additional relevant detail about Copilot Studio for customization, which enhances the answer beyond ground truth; (7) No numeric errors or date inaccuracies. MINOR GAPS: (1) The ground truth explicitly mentions 'Copilot for Sales, Copilot for Service, and Copilot for Finance' as specific role-specific extensions, while the LLM answer references these more generally through 'role-specific extensions' and 'Copilot Studio' without naming these specific products; (2) The LLM answer emphasizes Copilot Studio (customization capability) which, while relevant and accurate, is not explicitly mentioned in the ground truth as a 2024 introduction. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and correctly traces the evolution from AI-backed tools to AI-first platform positioning. The comparison is logical and well-structured. SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth with slightly different emphasis - focusing on platform-level integration and customization rather than specific role-based Copilot variants. This is a reasonable interpretation that doesn't contradict the ground truth. The citation format and page references add credibility. Overall, this is a high-quality answer with minor omissions of specific product names that prevent a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 540,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "In the 2022 filing, 3M disclosed that it had only just realized its Decatur NPDES permit did not list all PFAS, promptly reported the shortfall, temporarily idled the affected processes, installed wastewater‑treatment controls and entered a July 2020 interim consent order with ADEM that required reporting, analytical/characterization studies and future capital improvements to cover all PFAS‑related discharges. By the 2024 filing, the company had moved from that interim‑order remedy to actively seeking a formal permit amendment—submitting an application to add the missing PFAS to the NPDES permit—and was installing, upgrading and optimizing additional treatment controls while awaiting ADEM’s action, showing a shift toward a proactive permit‑modification and treatment‑upgrade approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DATE ERROR - LLM references a 'July 2020 interim consent order with ADEM' which is chronologically impossible for a 2022 disclosure about events leading up to 2024. The ground truth makes no mention of a July 2020 consent order. This is a major factual error that undermines credibility. (2) MISSING CONTEXT - The ground truth clearly states that in 2022, 3M 'had not fully characterized its PFAS discharge' and 'submitted an application to ADEM to add additional PFAS to the permit.' The LLM conflates this with a different narrative involving process idling and an interim consent order that doesn't appear in the ground truth. (3) PROCESS SEQUENCING - The LLM suggests the company moved FROM an interim order remedy TO seeking a permit amendment, but the ground truth indicates the permit amendment application was already submitted in 2022, with the 2024 update showing installation/upgrading of treatment controls while awaiting ADEM action. (4) CHARACTERIZATION OF 2022 STATUS - The LLM states 3M 'only just realized' the permit issue and 'promptly reported' it, but the ground truth simply states they 'had not fully characterized' the discharge and submitted an application—no indication of when they realized the issue or how promptly they acted. (5) TREATMENT CONTROLS TIMELINE - The LLM claims controls were 'installed' in the 2022 period, but the ground truth indicates they were 'installed and being upgraded' by 2024, suggesting the installation/upgrade was more of a 2024 development. The core evolution described in ground truth (from identifying issue and initiating action to implementing and refining solutions) is partially captured but with significant factual inaccuracies that suggest the LLM may have conflated information from different sources or time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 493,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "In the 2022 Form 10‑K Lowe’s disclosed that it had issued 4.550 % notes under the Fifteenth Supplemental Indenture dated April 5 2019, with a maturity of April 5 2049【page_82】. The 2023 Form 10‑K repeats the same reference to the Fifteenth Supplemental Indenture and the same 4.550 % notes, showing no additional issuance or amendment, so the 4.550 % notes remained unchanged between 2022 and 2023【page_76】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about the evolution of Lowe's 4.550% Notes between 2022 and 2023. STRENGTHS: (1) All numeric values are correct - the interest rate (4.550%), the indenture date (April 5, 2019), and the maturity date (April 5, 2049) are all accurately stated. (2) The multi-hop reasoning is sound - the answer correctly synthesizes information from both the 2022 and 2023 Form 10-K filings to show continuity and lack of change. (3) Entity identification is precise - correctly identifies Lowe's Companies, Inc., the Fifteenth Supplemental Indenture, and the specific notes. (4) The conclusion that there was no modification or new issuance between the two years matches the ground truth. (5) The answer includes appropriate citations to specific pages (page_82 for 2022, page_76 for 2023), demonstrating source verification. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but conveys the same essential information. The phrasing 'remained unchanged' is semantically equivalent to 'no changes to the terms or maturity date' in the ground truth. The answer successfully demonstrates that the notes were 'still in effect in 2023' without modification, which is the core finding. No calculation errors, date errors, or factual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 374,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "In 2022 Mondelēz still accounted for its Keurig Dr Pepper stake under the equity‑method, but in the first quarter of 2023 the holding fell below the 5 % influence threshold and the company re‑classified the investment as a marketable‑security. At the time of the change it recorded a pre‑tax $493 million gain on equity‑method transactions for 2023, and after selling the remaining shares it recognized a $593 million pre‑tax gain on the marketable‑securities sale (plus $13 million of dividend income) – a total $606 million pre‑tax gain 【page_88】【page_89】. By 2024 the KDP investment was fully exited, with the gains from the accounting change already reflected in the 2023 results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) TIMING ERROR: The LLM states the accounting change occurred in Q1 2023, but the ground truth indicates a 2022 gain of $71M and a 2024 gain of $493M. The LLM conflates different time periods and events. (2) QUANTITATIVE ERRORS: The LLM cites a $493M gain for 2023 and a $593M gain on marketable securities sale, but the ground truth shows $71M (after-tax $54M) in 2022 and $493M (after-tax $368M) in 2024. The $593M figure appears to be fabricated or misattributed. (3) INCOMPLETE ANSWER TO QUESTION: The question specifically asks about the evolution between 2022 and 2024. The ground truth provides a clear comparison: $71M gain in 2022 vs. $493M gain in 2024. The LLM answer focuses on 2023 events and claims the investment was fully exited by 2024, which doesn't directly address the 2022-2024 evolution requested. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the 2022 and 2024 data points to show the evolution. Instead, it inserted a 2023 narrative that doesn't match the ground truth timeline. (5) ACCOUNTING METHOD DETAILS: While the LLM correctly identifies the shift from equity-method to marketable-security accounting, it attributes this to Q1 2023 rather than the correct timeframe implied by the ground truth (2022-2024 period). The $71M 2022 gain suggests the accounting change may have occurred in 2022, not 2023. The answer demonstrates poor synthesis of multi-hop financial data and contains material factual errors regarding amounts and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 437,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "In FY 2022, Xbox Game Pass gave subscribers access to a curated library of **over 100** first‑ and third‑party console and PC titles (page 6). By FY 2024 that library had grown to **over 400** titles, and Microsoft now frames Game Pass as a core growth platform—expanding the ecosystem across devices, leveraging subscriptions, ads and digital‑store revenue, and emphasizing broader gamer engagement (page 13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - 'over 100' titles in 2022 and 'over 400' titles in 2024 match the ground truth exactly. The use of 'over' appropriately conveys the curated nature without false precision. ENTITY ACCURACY: Correctly identifies Xbox Game Pass, Microsoft, FY 2022 and FY 2024 timeframes, and distinguishes console and PC platforms. MULTI-HOP REASONING: Successfully synthesizes the evolution across two time periods, comparing both scale (100→400 titles) and strategic positioning. SEMANTIC EQUIVALENCE: The LLM's description of Game Pass as a 'core growth platform' and 'cornerstone' (implied through emphasis on growth and ecosystem expansion) aligns with the ground truth's characterization as 'cornerstone' of gaming platform. The mention of 'subscriptions, ads and digital-store revenue' adds relevant strategic context about how Microsoft monetizes the platform. COMPLETENESS: Addresses both parts of the question - scale evolution (title count) and strategic positioning (from key part of strategy to core growth platform). Minor note: The LLM includes page references (page 6, page 13) which adds credibility but weren't in the ground truth answer - this is a positive addition. The answer is slightly more detailed than ground truth regarding revenue streams (ads, digital-store) but this represents appropriate elaboration rather than error. No factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 411,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The 2022 Form 10‑K (pages 129‑133) contains no specific reference to a Deferred Stock Unit Award Agreement for non‑employee directors under the 2016 Long‑Term Incentive Plan. In contrast, the 2024 Form 10‑K lists a dedicated exhibit (10.7) that incorporates “Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to Non‑Employee Directors under the 3M Company 2016 Long‑Term Incentive Plan” (see page 117) — showing that the company moved from an implicit or absent disclosure in 2022 to an explicit, stand‑alone exhibit reference in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - CONTRADICTORY CLAIM: The LLM states the 2022 Form 10-K contains 'no specific reference' to the Deferred Stock Unit Award Agreement, but the ground truth explicitly states it 'was first referenced in the 2022 10-K filing.' This is a fundamental contradiction. (2) INCOMPLETE SYNTHESIS: The LLM fails to acknowledge that the agreement was already present and disclosed in 2022, which is the critical baseline for evaluating evolution. The ground truth indicates continuity from 2022 to 2024, not an absence-to-presence transition. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM characterizes the change as moving 'from an implicit or absent disclosure in 2022 to an explicit, stand-alone exhibit reference in 2024,' but the ground truth indicates the agreement was already explicitly referenced in 2022 and remained substantially unchanged through 2024. (4) PAGE REFERENCE ISSUES: The LLM cites specific pages (129-133 for 2022, page 117 for 2024) but provides no verification these are accurate or that they support the claimed absence in 2022. (5) CORRECT ELEMENTS: The LLM correctly identifies the agreement name, the 2016 Long-Term Incentive Plan, the January 1, 2019 effective date, and the 2024 exhibit reference (10.7). However, these correct elements are embedded within an incorrect overall narrative. (6) MISSING KEY POINT: The ground truth emphasizes that the effective date and structure remained unchanged from 2022 to 2024, with only the incorporation by reference being updated (from 2023 10-K amendments as of May 8, 2023). The LLM misses this continuity entirely. The answer fundamentally misrepresents the evolution of disclosure by claiming an absence in 2022 that contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 492,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "By the end of 2024 Schwab’s First‑Mortgage and HELOC portfolio carried **$112 million of unamortized premiums, discounts and direct origination costs**, up from **$100 million at year‑end 2023** (a $12 million increase)【page_88†L31-L33】.  At the same time, the share of those loans located in California slipped **to 42 % in 2024 from 43 % in 2023**【page_88†L34-L36】【page_90†L31-L33】.  Thus, the portfolio’s cost basis rose modestly while its geographic concentration in California eased slightly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Unamortized premiums, discounts, and direct origination costs were $100 million in 2023 and $112 million in 2024 - correct; (2) The $12 million increase is accurately calculated; (3) California concentration was 43% in 2023 and 42% in 2024 - correct; (4) The directional characterization of the changes (modest cost basis rise, slight geographic concentration easing) is accurate. The multi-hop synthesis is sound - the answer correctly combines information about both the origination costs component and the geographic concentration component across the two years. The entity identification is correct (Charles Schwab Bank, First Mortgages and HELOCs portfolio). The reasoning is logical and well-structured, presenting the evolution clearly. The only minor consideration is that the answer could have been slightly more explicit about what these changes might signify (e.g., increased lending activity or refinancing), but the ground truth itself is somewhat limited in this regard. The citation references provided suggest proper sourcing. Overall, this is an excellent answer that fully addresses the multi-part question with accurate numbers, proper calculations, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 365,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike’s product‑research and development language in both filings treats Dri‑FIT as a core, ongoing innovation. In fiscal 2023 the 10‑K notes “The proliferation of Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, ZoomX, Air Max, and React technologies… typifies our dedication to designing innovative products” (2023 10‑K p. 6). The fiscal 2024 filing repeats the same phrasing, again listing Dri‑FIT among the suite of flagship technologies (2024 10‑K p. 6), indicating that Nike’s strategic emphasis on Dri‑FIT has remained steady—still a key part of a broader, expanding technology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Correctness assessment: (1) The core finding matches the ground truth perfectly—Nike's strategic emphasis on Dri-FIT remained stable/steady between fiscal 2023 and 2024, with identical language used in both filings. (2) The LLM correctly identifies the specific technologies listed (Nike Air, Zoom, Free, Dri-FIT, Flyknit, FlyEase, ZoomX, Air Max, and React) in both years, matching the ground truth's enumeration. (3) The LLM accurately cites both the 2023 and 2024 10-K filings and notes they appear on page 6 in both cases, demonstrating proper multi-hop synthesis across fiscal years. (4) The LLM's characterization of Dri-FIT as 'core, ongoing innovation' and 'key part of a broader, expanding technology portfolio' is semantically equivalent to the ground truth's statement of 'consistent strategic importance.' The reasoning is sound: the LLM correctly synthesizes that identical phrasing across both years indicates no change in emphasis. Minor note: The LLM uses slightly different wording ('steady' vs. 'remained stable') but this is a semantic equivalence, not an error. The quotation provided appears accurate to the filing language structure, though exact page numbers and quotes cannot be independently verified from the context provided. Overall, the answer demonstrates strong multi-hop reasoning, correct entity identification (Nike, fiscal years 2023-2024, specific technologies), and accurate synthesis of information across two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 418,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "In the 2022 10‑K, Mondelez said it was “on heightened alert and dedicate[d] focused resources to network security, **backup and disaster recovery**” as part of its response to growing cyber risk【page_45】. By the 2024 filing, the company reports that it has **expanded and deepened that investment**, embedding backup and disaster‑recovery into a broader, more sophisticated cybersecurity program that now includes enhanced identity‑ and access‑management, multi‑factor authentication, privileged‑access controls, advanced threat protection and 24/7 monitoring, while noting that the cost of these protective measures is rising as threats become more complex【page_20】【page_21】. This shows a clear escalation from a targeted focus on backup/recovery to a comprehensive, higher‑spending cyber‑resilience strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the 2022 baseline where Mondelez was 'on heightened alert' with 'focused resources to backup and disaster recovery' - this matches the ground truth exactly. (2) Accurately captures the 2024 evolution showing 'expanded and deepened' investment, which aligns with the ground truth's 'significantly expanded its efforts.' (3) Properly synthesizes the progression from targeted backup/recovery focus to comprehensive cybersecurity program. (4) Correctly identifies the broader context of sophisticated threats including state-sponsored actors (implied in 'more complex threats'). (5) Appropriately notes rising costs of protective measures. (6) Uses proper citations to source pages. MINOR CONSIDERATIONS: (1) The LLM answer provides additional contextual details about specific 2024 measures (identity/access management, MFA, privileged-access controls, advanced threat protection, 24/7 monitoring) that enhance understanding but aren't explicitly mentioned in the ground truth summary. However, these details are consistent with the ground truth's reference to 'enhanced backup and disaster recovery solutions, among other measures.' (2) The ground truth explicitly mentions 'artificial intelligence' as an emerging threat, while the LLM answer doesn't explicitly call this out, though it references 'more complex threats.' This is a very minor omission that doesn't significantly impact the overall answer quality. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable but receives full marks as there are no calculation errors. MULTI-HOP REASONING: Excellent synthesis across 2022 and 2024 filings, correctly establishing the temporal progression and causal relationship between threat evolution and investment expansion. The answer successfully connects the dots between heightened alert status, resource dedication, and subsequent program expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 565,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "In fiscal 2022 Microsoft said it had reached **more than 90 % of its goal** to spend **$500 million** with **double the number of Black‑ and African‑American‑owned suppliers**. By fiscal 2024 the company reported it had **fully achieved that $500 million spend target**, doubling the supplier base, and added a **$150 million commitment** to minority depository institutions and Black‑owned small businesses (including low‑interest partner loans), deepening its financial engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: FY2022 >90% progress toward $500M goal with double the supplier count, and FY2024 achievement of the $500M target plus $150M commitment to Minority Depository Institutions and Black-owned small businesses. The multi-hop synthesis is sound, correctly tracking the evolution from 2022 to 2024 across both spending goals and supplier diversity metrics. The answer properly identifies all entities (Microsoft, fiscal years, dollar amounts, supplier categories) and conveys the strategic deepening of commitment. The only minor distinction from the ground truth is that the LLM adds parenthetical detail about 'low-interest partner loans' which, while not explicitly mentioned in the ground truth, represents reasonable contextual elaboration rather than factual error. The formatting and presentation are clear and well-organized. The answer fully addresses the question's request to show how financial commitment and engagement evolved over the specified time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 304,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The 2022 Form 10‑K disclosed that, as of December 31 2021, Abbott had **10,638,639** common shares available for future issuance under the Employee Stock Purchase Plan for Non‑U.S. Employees【page_83】. The 2023 Form 10‑K shows that the same pool had fallen to **8,565,087** shares as of December 31 2023【page_84】. This decline indicates Abbott has been drawing down the plan’s share reserve—reflecting active use of the program and a tighter control of equity dilution in its stock‑based incentive strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: Both key numbers are correct - 10,638,639 shares as of December 31, 2021 (from 2022 10-K) and 8,565,087 shares as of December 31, 2023 (from 2023 10-K). The dates are accurate and properly contextualized. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two different 10-K filings (2022 and 2023) and properly identifies the temporal evolution of the metric. ENTITY ACCURACY: Abbott Laboratories is correctly identified, the Employee Stock Purchase Plan for Non-U.S. Employees is properly named, and the fiscal years are accurate. REASONING QUALITY: The LLM correctly interprets the decline (from 10,638,639 to 8,565,087, a reduction of approximately 2,073,552 shares or ~19.5%) as indicating active use of the program and tighter equity dilution control. This interpretation aligns with the ground truth's assessment of 'tightening or adjustment' in stock-based incentive strategy. MINOR DIFFERENCES: The LLM's phrasing 'drawing down the plan's share reserve' and 'tighter control of equity dilution' is slightly more specific than the ground truth's 'tightening or adjustment,' but this represents enhanced clarity rather than inaccuracy. The LLM provides page references (page_83, page_84) which adds credibility. The answer fully addresses the question's multi-part structure: (1) availability evolution from 2022 to 2023, and (2) what this indicates about strategy. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 417,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "In FY 2023 Nike Air was mentioned only as one of the many performance technologies that Nike leverages – the filing notes “the proliferation of Nike Air … typifies our dedication to designing innovative products”【page_6】. By FY 2024 the company not only repeats that emphasis but also spotlights its Air Manufacturing Innovation subsidiary as the primary supplier of Nike Air‑Sole cushioning components, signaling a more integrated, strategic focus on Air technology in its product‑development roadmap【page_7】【page_6】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misrepresents the evolution of Nike Air's strategic positioning. The ground truth indicates a SHIFT FROM emphasis on Nike Air as emerging innovation TO treating it as a mature, integrated component alongside established technologies like Zoom, Free, and React. The LLM answer instead claims the opposite trajectory - that FY2024 shows 'more integrated, strategic focus' and 'spotlights' Air Manufacturing Innovation as a primary supplier, suggesting INCREASED emphasis rather than the actual strategic shift to maturity/integration. This is a semantic reversal of the core finding. SPECIFIC ERRORS: (1) The LLM correctly identifies the FY2023 quote about 'proliferation of Nike Air typifies our dedication' but misinterprets its significance. (2) The LLM introduces Air Manufacturing Innovation as a 'primary supplier' detail that, while potentially factually present in filings, is NOT the key strategic insight from the ground truth. The ground truth emphasizes Nike Air becoming 'a standard component' and 'foundational offering' - not a growth driver - which the LLM completely misses. (3) The LLM's characterization of FY2024 as showing 'more integrated, strategic focus' contradicts the ground truth's finding that Nike Air moved from being highlighted as innovative to being embedded as a mature technology. QUANTITATIVE ACCURACY: No specific numbers or calculations present in either answer, so this scores high (8) as there are no numeric errors. QUALITATIVE ACCURACY: Very low (3) because the LLM fundamentally misunderstands the directional change - it suggests increased strategic emphasis when the ground truth indicates a shift to treating Nike Air as mature/standard. CONTEXTUAL RELEVANCE: Moderate (5) - the answer addresses Nike Air and both fiscal years but draws the wrong conclusion about how treatment evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 508,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "In the 2022 Form 10‑K Abbott listed Osmolite by name as one of the specific enteral‑feeding products (Jevity, Glucerna 1.2 Cal, Glucerna 1.5 Cal, **Osmolite**, Oxepa, Freego, Nepro and Vital) within its Nutritional Products segment 【page_3】. By the 2023 filing the narrative no longer calls out Osmolite; it refers only to an “enteral feeding portfolio” without itemizing individual brands, indicating that Osmolite is now treated as part of a broader, integrated product‑line strategy rather than a separately highlighted offering 【page_6】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer makes a fundamental factual error that contradicts the ground truth. The LLM claims that 'By the 2023 filing the narrative no longer calls out Osmolite; it refers only to an \"enteral feeding portfolio\" without itemizing individual brands.' However, the ground truth explicitly states: 'By 2023, Osmolite continued to be included in the enteral feeding portfolio' and 'There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned.' The LLM's interpretation that Osmolite was de-emphasized or removed from individual brand listing in 2023 is factually incorrect. The ground truth indicates the product listing remained 'largely consistent' between 2022 and 2023, with stable strategic positioning. QUANTITATIVE ACCURACY: The LLM correctly identifies the 2022 product list (Jevity, Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite, Oxepa, Freego, Nepro, Vital) and correctly references 2022 and 2023 filings. These factual elements are accurate. QUALITATIVE ACCURACY: The LLM's reasoning about a 'shift from separately highlighted offering to integrated product-line strategy' is unsupported by the ground truth and represents a misinterpretation of the filing data. The ground truth indicates no significant repositioning occurred. CONTEXTUAL RELEVANCE: While the answer addresses the question's structure about evolution between 2022-2023, it provides an incorrect narrative about that evolution. The answer fails to recognize that the correct answer is one of stability and consistency, not strategic repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 439,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "In the 2022 10‑K, 3M said its Minnesota PFAS program was governed by the 2007 Settlement Agreement and Consent Order, under which remediation at the Oakdale, Woodbury and Cottage Grove sites had been largely finished and only operation‑and‑maintenance work remained, while its Decatur, Alabama facility was covered by a voluntary remedial‑action agreement with ADEM and a July‑2020 interim consent order that obligates the company to continue reporting, analytical studies, capital improvements and remediation of PFAS‑contaminated soil and groundwater (see page 127). By the 2024 10‑K, the Minnesota obligations had broadened to include MPCA storm‑water directives (June 2022), a draft CWA permit with tighter PFAS limits (July 2024, revised Dec 2024) and updated health‑based values from the Minnesota Department of Health (Jan 2024, Oct 2024), leading 3M to install a new wastewater‑treatment system and pursue additional compliance actions (see pages 102‑103), whereas the Alabama obligations remain anchored to the same ADEM agreement and interim consent order, with continued data corrections, upgraded wastewater controls and ongoing cooperation with EPA and ADEM but no new regulatory milestones (see pages 101‑102).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) All dates are correct (2007 Settlement Agreement, July 2020 Interim Consent Order, June 2022 storm-water directives, July 2024 draft permit, December 2024 revised permit, January 2024 and October 2024 HBV/HRL updates). (2) Geographic locations correctly identified (Cottage Grove, Oakdale, Woodbury in Minnesota; Decatur in Alabama). (3) Regulatory agencies properly named (MPCA, ADEM, MDH, EPA). (4) Multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (largely completed remediation, O&M activities) to 2024 (intensified scrutiny, new permit requirements, stricter standards). (5) Key regulatory documents and their implications are accurately described. (6) The answer correctly identifies that Minnesota obligations expanded while Alabama obligations remained anchored to the same agreements. MINOR WEAKNESSES: (1) The LLM mentions \"Oakdale\" and \"Woodbury\" sites in addition to Cottage Grove for Minnesota, while the ground truth specifically emphasizes Cottage Grove as the primary focus of the 2024 regulatory developments. The ground truth doesn't explicitly list Oakdale and Woodbury in the 2024 context, though it does reference \"multiple locations\" for O&M activities in 2022. (2) The LLM characterizes Alabama's July 2020 agreement as a \"voluntary remedial-action agreement\" combined with an interim consent order, while the ground truth specifically calls it an \"Interim Consent Order.\" This is a minor semantic distinction but technically the ground truth doesn't explicitly mention a separate voluntary agreement. (3) The LLM notes \"no new regulatory milestones\" in Alabama, which aligns with ground truth but could be slightly more nuanced given the ground truth mentions \"potential future remediation\" and \"additional operating costs and capital expenditures over multiple years.\" QUANTITATIVE VERIFICATION: All dates check out correctly against ground truth. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two states, correctly identifying how regulatory obligations evolved differently in each jurisdiction. The connection between new permit requirements and compliance actions (wastewater treatment system installation) is logically sound. CONTEXTUAL RELEVANCE: The answer directly addresses the question's focus on regulatory engagement evolution between 2022 and 2024 in both Minnesota and Alabama, with appropriate emphasis on the intensification of regulatory scrutiny.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1681,
        "completion_tokens": 707,
        "total_tokens": 2389
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "The 2024 Form 10‑K shows that Coca‑Cola’s investment in Coca‑Cola HBC AG is accounted for under the equity‑method and that the Company owned **about 22 % of the bottler’s outstanding shares** as of 31 December 2024 (see KO 10‑K 2024 p. 87). The 2022 filing’s disclosed sections do not present a different classification or a different ownership percentage, indicating that the relationship remained essentially the same – the investment continued to be treated as an equity‑method investment with roughly a 22 % stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, 'the specific ownership percentage was not disclosed in the provided evidence,' but the LLM claims 'The 2022 filing's disclosed sections do not present a different classification or a different ownership percentage, indicating that the relationship remained essentially the same – the investment continued to be treated as an equity‑method investment with roughly a 22% stake.' This is incorrect. The LLM incorrectly asserts that the 2022 ownership percentage was also 22%, when the ground truth indicates it was not disclosed in 2022. The LLM also states the relationship 'remained essentially the same,' which misses the key point of the ground truth: that there was a 'formalization and quantification of the relationship' between 2022 and 2024, with the 22% stake being explicitly stated in 2024 but not in 2022. CORRECT ELEMENTS: The 2024 data is accurate (22% ownership, equity method classification, December 31, 2024 date, reference to page 87 of 2024 10-K). MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the evolution between 2022 and 2024. The question specifically asks 'how has...evolved,' implying change, but the LLM incorrectly concluded there was no meaningful change in disclosed ownership percentage. The ground truth indicates the evolution was in the disclosure/formalization of the percentage, not necessarily a change in the actual stake. The LLM's conclusion that the relationship 'remained essentially the same' is a mischaracterization of what the ground truth describes as a formalization and quantification that was absent in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 472,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "In the fiscal‑2022 filing Oracle stressed that it was spending $7.2 billion on research‑and‑development to “enhance our existing portfolio of offerings and to develop new technologies” and specifically highlighted hybrid‑deployment options such as Oracle Cloud@Customer, together with new programs that let customers pivot on‑premise licenses to the cloud – a clear signal that product‑development dollars were being directed at integrating on‑premise and cloud models【page_6】. By fiscal 2024 the company still describes its offerings as delivered through “flexible and interoperable … on‑premise, cloud‑based and hybrid deployments” but does not repeat a quantified R&D spend, indicating the strategic emphasis has shifted to reaffirming the breadth of hybrid‑deployment integration rather than announcing a fresh product‑development investment amount【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Oracle's strategic evolution. STRENGTHS: (1) Quantitative accuracy is perfect - correctly cites the $7.2 billion R&D spend for fiscal 2022 and accurately notes that fiscal 2024 does not repeat a quantified R&D amount. (2) Multi-hop synthesis is sound - properly connects fiscal 2022 product development investments to specific hybrid solutions (Oracle Cloud@Customer) and license migration programs, then contrasts this with fiscal 2024's approach of reaffirming deployment flexibility without new investment announcements. (3) Entity accuracy is correct - properly identifies Oracle, fiscal years 2022 and 2024, and relevant deployment models (on-premise, cloud-based, hybrid). (4) The reasoning captures the strategic evolution from development-focused to mature/integrated approach, matching the ground truth's characterization. (5) Semantic equivalence is strong - the answer conveys that Oracle shifted from announcing new R&D investments in hybrid solutions to positioning hybrid deployments as standard integrated offerings. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and nuanced than the ground truth (noting the absence of quantified R&D in 2024 as a strategic signal), which adds interpretive value without contradicting the ground truth. The inclusion of page references adds credibility. The answer fully addresses both parts of the multi-part question: product development investment evolution and deployment model integration evolution. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 433,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "In the 2023 Form 10‑K, the Wells Fargo Mandatory Clawback Policy (Exhibit 97) was listed as “Filed herewith,” meaning the policy was attached to that filing. In the 2024 Form 10‑K, the same Exhibit 97 is described as “Incorporated by reference” to the company’s 2023 annual report, indicating the policy is no longer attached but is instead referenced from the prior year’s filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about the evolution of the Mandatory Clawback Policy filing status between 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company. (1) CORRECTNESS: The answer correctly identifies the key procedural change - from 'Filed herewith' in 2023 to 'Incorporated by reference' in 2024. Both the original answer and LLM answer convey the same essential information with semantic equivalence. The LLM uses slightly more explicit language ('the policy was attached to that filing' and 'the policy is no longer attached but is instead referenced') which actually enhances clarity. (2) QUANTITATIVE ACCURACY: No numerical data is required for this question, so this criterion is not applicable. The years (2023, 2024) and exhibit number (97) are correctly cited. (3) ENTITY ACCURACY: All entities are correctly identified - Wells Fargo & Company, the Mandatory Clawback Policy, Exhibit 97, and the relevant fiscal years. (4) REASONING: The multi-hop reasoning is sound. The answer correctly synthesizes the filing status information across two different years and explains the distinction between direct filing and incorporation by reference. The conclusion that this represents a 'procedural change' rather than a 'substantive change to the policy itself' is appropriately inferred and matches the ground truth interpretation. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the original answer with slightly different but equally valid phrasing. The explanation is clear and comprehensive. Minor deduction (1 point) only because the LLM could have explicitly stated that this is a procedural rather than substantive change, though this is reasonably implied in the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 480,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher’s relationship with CorEvitas changed from a fresh acquisition in 2023 to an integrated part of its Laboratory Products & Biopharma Services segment by 2024. In 2023 the company completed the purchase of CorEvitas for a total price of $910 million—$730 million in cash plus $184 million of debt assumed—recording $627 million of goodwill and other intangibles and using $0.91 billion of cash in investing activities (see pages 65‑66 and 24). The 2024 filing contains no new acquisition of CorEvitas, indicating the business is now fully incorporated with no additional cash outlay reported (see page 65).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of the CorEvitas relationship evolution but contains significant quantitative discrepancies and incomplete information compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2023 acquisition and 2024 integration into Laboratory Products & Biopharma Services segment; (2) Accurately notes the $0.91 billion ($910 million) acquisition price; (3) Provides breakdown of acquisition structure ($730M cash + $184M debt assumed); (4) Correctly identifies $627M in goodwill and intangibles; (5) Appropriately notes no new acquisition in 2024. CRITICAL ISSUES: (1) MISSING KEY FINANCIAL CONTEXT: The ground truth mentions $5.94 billion in senior notes issued and $3.00 billion in stock repurchases as part of the broader 2023 financing strategy - these are significant financial implications that the LLM answer completely omits; (2) INCOMPLETE AMORTIZATION INFORMATION: The ground truth specifically states that in 2024, CorEvitas intangible assets began amortization over an 18-year weighted average period - this is an important 2024 financial implication that the LLM answer does not mention; (3) CHARACTERIZATION ISSUE: The LLM describes the acquisition as 'fresh' in 2023 and 'integrated' in 2024, which is accurate but less precise than the ground truth's description of it being a strategic investment with long-term value implications. QUANTITATIVE VERIFICATION: The $0.91 billion figure is correct (matches $910M). The $730M cash and $184M debt components are provided but not verified against ground truth. The $627M goodwill figure is stated but not verified. MULTI-HOP REASONING: The LLM successfully synthesizes that the relationship evolved from acquisition to integration, but fails to synthesize the broader financial strategy context (financing activities, stock repurchases) that accompanied the acquisition. The answer addresses the 'how' of the relationship evolution but incompletely addresses the 'financial implications' part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 543,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "In the 2022 filing RTX said the Rolls‑Royce flight‑hour payments – due under the 2012 IAE acquisition – were expected to total $735 million in 2022 and $1.05 billion in 2023 and would be **capitalized as collaboration intangible assets as each payment is made**【page_112】. The 2023 filing shows those 2022‑23 payments have now been satisfied and the remaining schedule has been pushed out, with payments projected for 2024‑2028 (e.g., $836 million in 2024, $862 million in 2025, $705 million in 2026, $687 million in 2027, $731 million in 2028 and $6.2 billion thereafter) and the same **capitalization treatment – recorded as collaboration intangible assets when paid**【page_101】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains specific dollar amounts ($735 million in 2022, $1.05 billion in 2023, $836 million in 2024, etc.) that are NOT present in the ground truth answer. The ground truth explicitly states there was 'no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.' The LLM's claim that '2022-23 payments have now been satisfied and the remaining schedule has been pushed out' directly contradicts the ground truth's assertion of a 'stable commitment structure' with no changes between years. The LLM appears to have fabricated specific payment amounts and a narrative about payment schedule changes that are not supported by the ground truth. While the LLM correctly identifies: (1) the 2012 IAE acquisition connection, (2) the flight hour contingency through June 2027, and (3) the capitalization as collaboration intangible assets - these correct elements are overshadowed by the introduction of unsupported quantitative claims. The multi-hop reasoning fails because the LLM synthesized information that contradicts the ground truth's core finding of stability. The answer demonstrates a fundamental misunderstanding of what the filings actually disclosed about changes (or lack thereof) between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 369,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "In the 2022 filing Coca‑Cola only disclosed the straight‑forward acquisition of the remaining fairlife ownership interest – a $902 million gain (with a $40 million tax benefit) and no contingent‑payment terms were mentioned【page_53】【page_55】. By the 2024 filing the company carries a contingent‑consideration liability of roughly $6.1 billion for the fairlife deal, reflecting a performance‑based milestone payment that is re‑measured each quarter; a $275 million milestone was paid in 2023 and the remaining amount will be payable in 2025 if fairlife meets its financial targets through 2024【page_111】【page_112】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) CONTINGENT LIABILITY AMOUNT: The LLM claims a '$6.1 billion' contingent-consideration liability for fairlife in 2024, which is not supported by the ground truth and appears to be a fabrication. The ground truth only mentions 'a remaining milestone payment' without specifying this amount. (2) 2023 PAYMENT: The LLM states '$275 million milestone was paid in 2023,' which is not mentioned in the ground truth at all. This appears to be invented information. (3) 2022 DISCLOSURE: The LLM claims the 2022 filing showed a '$902 million gain (with a $40 million tax benefit)' - these specific numbers are not verified in the ground truth, which only states 'no mention of ongoing contingent payments' in 2022. (4) CORE NARRATIVE CONTRADICTION: The ground truth clearly states that in 2022 there was 'no mention of ongoing contingent payments,' but the LLM's 2022 description focuses on gain/tax benefit details that don't address the absence of contingent payment disclosures. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to show evolution from 2022 to 2024, it does so by introducing unverified numbers ($6.1B, $275M) that are not in the ground truth. The ground truth's key point - that contingent payments emerged as a disclosure item by 2024 when they weren't mentioned in 2022 - is somewhat captured but obscured by false quantitative claims. CORRECT ELEMENTS: The LLM correctly identifies that the relationship evolved from 2020 acquisition to ongoing contingent obligations, and correctly notes that remaining payment is contingent on 2024 targets with 2025 payment timing. However, these correct elements are overwhelmed by the fabricated financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 483,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "In the 2022 filing Oracle described its Cloud Services as a flexible, interoperable suite in which Fusion Cloud SaaS applications (ERP, HCM, EPM, SCM, etc.) are built on a common data model and run on Oracle Cloud Infrastructure (OCI), stressing the early‑stage migration of on‑premise workloads and the integration of advanced technologies to give customers choice among on‑premise, cloud and hybrid models【page_6】【page_7】【page_8】【page_9】. By the 2024 filing the company’s language had shifted to present Oracle Cloud Services as a unified, subscription‑based platform that delivers “comprehensive and integrated applications and infrastructure services” together—highlighting a mature, end‑to‑end integration of SaaS and OCI that lets customers select the optimal deployment model and underscores the service’s role in driving growth【page_72】【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning emphasizing flexibility, interoperability, and customer choice across deployment models (on-premise, cloud, hybrid), matching the ground truth's core message. (2) Accurately captures the 2024 evolution toward a unified, comprehensive, integrated platform positioning, with the specific phrase 'comprehensive and integrated applications and infrastructure services' directly matching ground truth language. (3) Properly synthesizes the multi-hop evolution by contrasting 2022 (early-stage, individual innovations like Autonomous Database) with 2024 (mature, end-to-end integration). (4) Correctly identifies key 2022 components (Fusion Cloud SaaS applications with ERP, HCM, EPM, SCM on common data model running on OCI) and the shift to subscription-based unified platform in 2024. (5) Appropriately emphasizes the customer-centric 'choose the best option' messaging present in both years but more mature in 2024. (6) No quantitative errors - dates (2022, 2024) are correct, no calculations required. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more specific product details (Fusion Cloud SaaS applications, specific modules) than the ground truth, but this is additive and accurate rather than contradictory. (2) The ground truth explicitly mentions 'Oracle Autonomous Database as a key OCI offering' in 2022, while the LLM answer focuses more on Fusion Cloud SaaS - both are valid 2022 positioning elements, though the LLM could have included Autonomous Database for fuller coverage. (3) Page citations are provided in LLM answer but cannot be verified against ground truth format. Overall, the LLM successfully captures the strategic evolution from individual innovation emphasis to holistic platform positioning, with accurate characterization of both 2022 and 2024 messaging.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 525,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "In the 2023 Form 10‑K the Key/Specified Employee Policy appears as exhibit 10(r)* and is “incorporated by reference to Exhibit 10(v) to the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018” 【page_17】. The 2024 filing lists the same policy as exhibit 10(r)* and again incorporates it by reference to Exhibit 10(v) of the 2018 Annual Report 【page_20】, indicating that its documentation and reference treatment have not changed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the policy appears as 'exhibit 10(r)*' in both 2023 and 2024 filings, but the ground truth explicitly states it is 'incorporated by reference to Exhibit 10(v)' - this is a fundamental factual error. The LLM conflates the exhibit designation (10(r)) with the reference source (10(v) from 2018). The ground truth makes clear the policy itself is referenced FROM Exhibit 10(v) of the 2018 filing, not that it appears as 10(r). (2) INCOMPLETE CHARACTERIZATION: The ground truth emphasizes the evolution from 'newly introduced' in 2023 to 'continuing policy' in 2024, suggesting a change in how the policy was presented/characterized. The LLM states 'its documentation and reference treatment have not changed,' which misses this nuanced distinction about the policy's status evolution. (3) MISSING CONTEXT: The ground truth notes 'no new amendments or updates to its documentation during this period' - the LLM doesn't explicitly address whether there were updates, only that the reference remained the same. (4) QUANTITATIVE ACCURACY: While dates (2023, 2024, 2018) are correct, the exhibit number identification is wrong, which is a critical quantitative/factual element. (5) MULTI-HOP REASONING: The LLM correctly identifies that both years reference the same 2018 exhibit, but fails to capture the evolution in how the policy was introduced/characterized between years. The answer is partially responsive but contains a significant factual error regarding exhibit designation that undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 433,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The 6.700 % notes due 2028 carried an aggregate principal balance of **$285 million at year‑end 2022 and the same $285 million at year‑end 2023**【page_84】. The unchanged balance shows RTX did not retire or add to this tranche, indicating a deliberate choice to keep this fixed‑rate, medium‑term debt in place while using other issuances and repayments to reshape its overall debt profile. This reflects a targeted refinancing strategy rather than a broad reduction of existing notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the aggregate principal balance was $285 million at both year-end 2022 and 2023, claiming it was 'unchanged.' The ground truth clearly shows: 2022 = $115 million, 2023 = $285 million. This is a $170 million discrepancy for 2022 - a 148% error. The LLM completely missed the significant increase from $115M to $285M between the two years. (2) MULTI-HOP REASONING FAILURE: The question explicitly asks how the balance 'evolved between 2022 and 2023' - requiring comparison of two years. The LLM failed to identify any evolution, incorrectly claiming the balance was 'unchanged.' This is a fundamental failure to synthesize the required multi-year comparison. (3) STRATEGIC INTERPRETATION ERROR: Because the LLM missed the actual $170 million increase, its interpretation of RTX's debt management strategy is completely wrong. The LLM concludes RTX made 'a deliberate choice to keep this fixed-rate, medium-term debt in place' with 'no retirement or addition,' when in fact RTX significantly INCREASED this debt tranche by $170 million - indicating an expansion of exposure to this fixed-rate instrument, not maintenance of status quo. (4) CITATION ISSUE: The LLM cites 'page_84' but provides incorrect data, suggesting either misreading of the source or hallucination. The ground truth data is unambiguous: the balance grew from $115M to $285M. This is a complete failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 433,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "In 2023 the 1.95 % 12‑year senior notes (due 7/24/2029) were carried at **$773 million** with an **effective interest rate of 2.08 %**. By the end of 2024 the carrying amount had fallen to **$725 million** and the effective rate had edged down to **2.07 %**【page_62】【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: 2023 carrying value of $773 million, 2023 effective interest rate of 2.08%, 2024 carrying value of $725 million, and 2024 effective interest rate of 2.07%. The answer correctly identifies the security (1.95% 12-Year Senior Notes due 7/24/2029), properly synthesizes the multi-hop information across two fiscal years, and accurately describes the evolution (reduction in carrying value from $773M to $725M, slight decline in effective rate from 2.08% to 2.07%). The inclusion of the maturity date (7/24/2029) adds helpful context not explicitly in the ground truth but consistent with it. The answer uses appropriate financial terminology and clearly presents the year-over-year comparison. The only minor distinction from the ground truth is that the LLM provides slightly more specific detail (maturity date) and uses slightly different phrasing to describe the changes, but this represents enhancement rather than deviation. The citation references to pages 62 and 47 demonstrate proper sourcing. No calculation errors, no missing data points, and the semantic meaning perfectly aligns with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 346,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon gave a direct URL for its Directors’ Code of Conduct and explicitly pledged to post any amendments or waivers on that site, underscoring a high‑visibility, transparent approach to director‑related governance (page 11). By the 2024 filing the Code is merely listed among the suite of governance documents available on the website, without a dedicated link or waiver statement, indicating a shift to a more consolidated disclosure format that may reduce the immediacy of updates while still keeping the Code accessible, affecting the perceived transparency of governance changes (page 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core factual claims about the change in BNY Mellon's presentation of the Directors' Code of Conduct between 2022 and 2024. Key strengths: (1) Correctly identifies the 2022 approach included a direct URL link with explicit commitment to post amendments/waivers; (2) Accurately describes the 2024 shift to listing the Code among other governance documents without dedicated link or waiver statement; (3) Properly synthesizes the multi-hop comparison across two filing years; (4) Correctly identifies the governance implications regarding transparency and stakeholder engagement. The LLM answer adds specific details (page references: page 11 for 2022, page 3 for 2024) that enhance credibility, though these cannot be independently verified from the ground truth provided. Minor considerations: (1) The LLM uses slightly different phrasing ('consolidated disclosure format' vs 'consolidated approach to governance disclosures') but conveys equivalent meaning; (2) The LLM emphasizes 'immediacy of updates' which is a reasonable inference from the removal of the waiver statement, though the ground truth focuses more on 'visibility' and 'transparency'; (3) Both answers appropriately note the Code remains accessible despite the presentation change. The reasoning is sound and the multi-hop synthesis correctly connects the 2022 and 2024 filings to draw conclusions about governance implications. No quantitative errors detected. The answer fully addresses the question's focus on corporate governance implications of the presentation change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 442,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon’s short‑term revolving credit facility stayed at a $5.0 billion size, but the maturity was extended by one year – the 2023 agreement (entered in November 2023) matured in October 2024, while the 2024 agreement (entered in October 2024) matures in October 2025【page_59】【page_58】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - $5.0 billion facility size for both years is accurate, maturity dates (October 2024 for 2023 agreement, October 2025 for 2024 agreement) are correct. (2) The one-year extension of maturity is correctly identified. (3) The establishment dates are correctly referenced (November 2023, October 2024). (4) The answer correctly identifies this as a renewal rather than a substantive change. WEAKNESSES: (1) The LLM answer is incomplete - it fails to explicitly state that the 2023 agreement was entered in November 2023 (it says 'entered in November 2023' but this is somewhat ambiguous in phrasing). More critically, it omits the key detail that the 2023 agreement replaced a prior agreement from November 2022, which is part of the evolution narrative. (2) The answer doesn't explicitly characterize the facility as 'unsecured 364-day revolving credit facility' - it only refers to it as a 'short-term revolving credit facility,' missing the specific structural details. (3) The answer lacks the contextual framing that this represents a 'procedural renewal' pattern, though it does imply this. (4) The answer doesn't fully address the 'evolution' aspect of the question by showing the progression from 2022→2023→2024. CALCULATION VERIFICATION: All dates and amounts are factually accurate. The one-year maturity extension (October 2024 to October 2025) is correctly calculated. MULTI-HOP REASONING: The answer successfully synthesizes information across the two years and correctly identifies the relationship between the agreements, though it could be more explicit about the replacement pattern. OVERALL: The core facts are correct and the main evolution is captured, but the answer is somewhat incomplete in addressing all dimensions of the question, particularly regarding the full historical context and specific facility characteristics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 511,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "In 2022 AMD positioned its APUs mainly as CPU‑plus‑GPU chips that delivered visual‑processing for value‑oriented and mainstream PCs and for embedded platforms such as the AMD Embedded Ryzen V‑ and G‑Series APUs [page_8][page_10]. By 2024 the company had added a dedicated neural‑processing unit (NPU) to the same SoC—evidenced by the launch of AI‑focused APUs like the Ryzen AI 300 series, the Ryzen 8000 mobile line with a first‑gen NPU, and AI‑enabled Ryzen PRO 8000G desktops—targeting AI‑PCs, AI‑enhanced notebooks and enterprise AI desktops [page_5][page_7]. This shift opens a new, fast‑growing AI PC market for AMD, giving it a clear revenue‑growth runway in the AI‑PC segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's APU strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of APUs as CPU-plus-GPU chips for visual processing in value/mainstream PCs and embedded platforms; (2) Accurately describes the 2024 shift toward integrated NPU cores on the same SoC; (3) Correctly names specific 2024 products (Ryzen AI 300 series, Ryzen 8000 mobile, Ryzen PRO 8000G); (4) Properly synthesizes the strategic pivot toward AI PC market capture; (5) Correctly identifies AMD as a differentiated player with integrated NPU solutions; (6) Appropriately concludes this opens revenue growth potential in the AI PC segment. MINOR GAPS: (1) The LLM answer focuses primarily on client/consumer APUs (Ryzen AI 300, Ryzen 8000) but doesn't explicitly mention the 2022 data center/HPC focus (Instinct MI200, Radeon PRO V620) that the ground truth emphasizes as part of the broader strategic context. While not incorrect, this omission represents incomplete coverage of the full strategic evolution narrative; (2) The ground truth emphasizes AMD being 'the first company' to integrate NPU on x86 SoC, which the LLM answer doesn't explicitly state, though it does claim 'clear differentiation'; (3) The LLM answer could have been more explicit about the shift FROM external GPU solutions TO integrated solutions. QUANTITATIVE ACCURACY: No numeric errors detected. All product names, years, and technical specifications are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 timeframes and connects product evolution to market implications. The logic flow from product integration → market targeting → revenue potential is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - AMD shifted from traditional CPU-GPU to integrated NPU solutions targeting the emerging AI PC market. The answer conveys the strategic pivot and its revenue implications effectively, even if not with identical emphasis on the data center context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 566,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K contain the same statement: dividends are subject to a 25 % Irish withholding tax unless a U.S. shareholder qualifies for an exemption (U.S. address on the broker’s records or a valid Form 6166/Irish V2). If the withholding tax is applied, it “discharges any Irish income‑tax liability,” and shareholders who meet the exemption generally have no Irish income‑tax liability on the dividend. The language and treatment are unchanged from 2023 to 2024【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 25% Irish dividend withholding tax rate in both years - matches ground truth exactly. (2) Accurately lists the exemption criteria (U.S. address on broker records, Form 6166, Irish V2) - semantically equivalent to ground truth's 'residency documentation' and 'valid U.S. Certification of Residence.' (3) Correctly states that withholding tax 'discharges any Irish income-tax liability' - exact match to ground truth language. (4) Properly concludes that treatment is unchanged between 2023 and 2024, indicating stable regulatory framework - directly answers the 'evolution' aspect of the question by showing no evolution. (5) All numeric values (25% rate) are correct. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the explicit mention that 'a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability' - however, this is implicitly covered by stating 'shareholders who meet the exemption generally have no Irish income-tax liability.' (2) The ground truth explicitly mentions 'provided the shareholder submitted the required statement to the Irish Revenue authorities' as a condition, which the LLM answer does not explicitly state, though this is a minor omission. (3) The citation reference [page_31] adds credibility. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings to make a comparative statement about stability. The logic is sound - comparing treatment across years and concluding no change. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 504,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "In the 2022 Form 10‑K the risk‑factors section called out both “new lines of business, new products and services” and a separate bullet warning that “we may not realize some or all of the expected benefits of our transition to a platforms operating model” (2022 p.5). By the 2024 filing the language still flags “new lines of business, new products and services … subject us to new or additional risks” (2024 p.4), but the platforms‑operating‑model risk is no longer a distinct bullet; it appears only in the forward‑looking statements that discuss the “transition to a platforms operating model” (2024 p.3). This shift shows the company has folded the platforms initiative into its broader strategic‑risk narrative rather than treating it as a standalone risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Page References: The LLM claims the 2022 filing mentions the platforms operating model risk on 'p.5' and that it appears in 2024 'p.3' and 'p.4'. The ground truth does not provide these page numbers, but more importantly, the LLM's characterization of the evolution is fundamentally backwards. (2) CORE FACTUAL ERROR - Risk Evolution Direction: The ground truth states that in 2022, the disclosure was GENERAL (new lines of business, new products and services), and by 2024 it EVOLVED to SPECIFICALLY include the platforms operating model as a concrete risk. The LLM claims the opposite: that in 2022 the platforms model was already 'a separate bullet' and by 2024 it was 'folded into' broader language. This is a direct contradiction of the ground truth's stated evolution. (3) MISCHARACTERIZATION OF CHANGE: The ground truth describes a shift FROM general strategic risk language TO more concrete platform-specific risks. The LLM describes a shift FROM specific platform risks TO general strategic narrative. These are opposite interpretations. (4) MISSING KEY INSIGHT: The ground truth emphasizes that 2024 explicitly states 'may not realize some or all of the expected benefits of our transition to a platforms operating model' as a NEW/EVOLVED disclosure. The LLM suggests this language existed in 2022 and was then de-emphasized in 2024, which contradicts the ground truth's narrative of evolution toward more specific platform risk disclosure. (5) QUANTITATIVE ACCURACY: While page numbers are cited, they cannot be verified against the ground truth and appear to be fabricated details that support an incorrect narrative. The fundamental misunderstanding of the directional change in risk disclosure evolution represents a failure in multi-hop reasoning and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 509,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "In the 2023 Form 10‑K Amazon listed the 3.600 % Note due 2032 as one of the debt securities covered by its Supplemental Indenture (Exhibit 4.2) together with several other notes 【page_75】. The 2024 Form 10‑K still references the same Supplemental Indenture (Exhibit 4.2) and the 3.600 % Note due 2032, but adds a Regulation S‑K disclosure that the detailed agreement for this and other long‑term debt is not filed because it falls below the 10 %‑of‑assets threshold, with the company offering to furnish it on request 【page_74】【page_76】. This shows the note remains outstanding, while the company’s disclosure approach shifted from a simple exhibit listing to a more limited filing with a conditional‑access statement.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core substance of the ground truth answer. CRITICAL ISSUES: (1) The LLM completely misses the primary evolution described in the ground truth - the trustee transition from Wells Fargo Bank, National Association (as prior trustee) to Computershare Trust Company, National Association (as successor trustee). This is the central finding of the ground truth answer. (2) The LLM instead focuses on disclosure methodology changes (Regulation S-K filing thresholds and conditional access statements), which is not mentioned in the ground truth at all. (3) The ground truth explicitly states the Supplemental Indenture was dated April 13, 2022, and involved three parties (Amazon, Wells Fargo, and Computershare), with a shift in 2024 to only reference Computershare - the LLM provides no information about this trustee relationship evolution. (4) The LLM's discussion of 'Regulation S-K disclosure' and '10%-of-assets threshold' appears to be fabricated or misapplied context not present in the ground truth. (5) While both answers correctly identify the 3.600% Note due 2032 and reference to Supplemental Indenture (Exhibit 4.2), the LLM fundamentally mischaracterizes what changed between 2023 and 2024. The ground truth is about administrative/trustee changes; the LLM answer is about disclosure filing approaches - these are entirely different topics. The multi-hop reasoning required here was to synthesize trustee information across two years' filings, which the LLM failed to do. The answer demonstrates a semantic misunderstanding of the question's focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 447,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "In 2023 Mondelēz reported its net‑investment‑hedge (NIH) contracts as a **net liability** – the fair‑value table shows $163 m of asset derivatives versus $382 m of liability derivatives, a net liability of $(219) m【page_96】, and the after‑tax result on the hedges was a $185 m loss recorded in OCI, with $148 m of amounts excluded from hedge effectiveness affecting other‑income/interest expense【page_97】.  \n\nBy 2024 the same contracts were presented as a **net asset** – the derivative‑instrument note lists $305 m of asset derivatives and $50 m of liability derivatives, giving a $255 m net asset【page_94】 (also shown as $255 m in the fair‑value summary【page_95】), and the excluded amounts are now reflected in “other income, net”【page_93】, indicating a reversal from the prior loss and a more favorable presentation in the financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The ground truth states 2023 fair values were $1,347M in other current assets and $250M in other assets for derivatives, with $377M and $413M in liabilities respectively. The LLM claims 2023 showed $163M assets vs $382M liabilities (net $219M liability) - these numbers do not match the ground truth at all. The LLM's 2024 figures of $305M assets and $50M liabilities (net $255M asset) are also not verified against the ground truth. (2) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes a shift from balance sheet valuation disclosure (2023) to income statement impact disclosure (2024), focusing on 'Other income, net' and excluded amounts from hedge effectiveness. The LLM incorrectly frames this as a reversal from 'net liability' to 'net asset' position, which mischaracterizes the evolution. The ground truth does not describe a swing from liability to asset position; rather, it describes a change in disclosure emphasis and presentation focus. (3) MISSING KEY INFORMATION: The LLM fails to cite the specific balance sheet line items mentioned in ground truth ($1,347M and $250M in 2023, $377M and $413M comparatives). (4) CALCULATION VERIFICATION: The LLM's arithmetic (163-382=-219, 305-50=255) is internally consistent but based on incorrect source numbers. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize 2023 vs 2024 changes, it does so based on incorrect data points and misinterprets the nature of the evolution from balance sheet to income statement focus. The answer demonstrates structural understanding of the question but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 481,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "In 2023 General Dynamics emphasized delivering the next‑generation SEPv3 upgrade (new communications, power‑generation, fuel‑efficiency, optics and armor) and began development of the M1E3 Abrams, a new engineering‑change tank built on a modern systems‑architecture that enables faster technology insertion, lower sustainment and greater tactical mobility【page_10】. By 2024 the strategy had shifted to sustaining and further enhancing that capability – “maximizing the capability, effectiveness and lethality of the Abrams tank” – while noting that demand from NATO members and other allies remains strong, with a growing installed base across Europe, the Middle East, North Africa and the Indo‑Pacific【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All major facts are correct - SEPv3 upgrades (communications, power generation, fuel efficiency, optics, armor) are accurately listed for 2023; M1E3 development is correctly identified as a significant engineering change with modern systems architecture enabling faster upgrades and lower sustainment; 2024 shift toward capability enhancement and international demand is accurately captured. The geographic regions mentioned (Europe, Middle East, North Africa, Indo-Pacific) match the ground truth exactly. (2) QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but the answer correctly avoids introducing false numbers. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2023-2024) and correctly identifies the strategic evolution: from technical roadmap focus (SEPv3/M1E3 development) to capability enhancement with global procurement momentum. The connection between technological development and international demand is properly established. (4) COMPLETENESS: The answer addresses both parts of the question - technological development (SEPv3, M1E3 features) and international demand (NATO allies, growing installed base across specified regions). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'maximizing the capability, effectiveness and lethality' conveys the same meaning as 'capability enhancement' in the ground truth. The characterization of 2023 as 'technical roadmap' and 2024 as 'global strategic relevance and procurement momentum' is semantically equivalent to the LLM's framing. Minor note: The LLM includes specific page references (page_10, page_9) which adds credibility but are not present in the ground truth - this is a positive addition that doesn't contradict the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 526,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "In the 2022 filing AMD portrayed APUs chiefly as integrated CPU‑GPU chips that provide visual‑processing power for value‑ and mainstream PCs and as part of its embedded and semi‑custom product lines (see 2022 pages 7‑10). By the 2024 filing, APUs are listed in the definitions of three reportable segments—Data Center, Client and Embedded—showing that AMD now positions APUs as a core compute element for data‑center workloads as well as for traditional client and embedded markets (see 2024 page 69). This reflects a broader market segmentation and a strategic shift toward leveraging APUs for high‑performance, power‑efficient server/AI applications while still serving PC and embedded customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about APU evolution between 2022 and 2024 but contains a significant factual error that undermines accuracy. CORRECT ELEMENTS: (1) The 2022 characterization of APUs as integrated CPU-GPU chips for value/mainstream PCs is accurate; (2) The 2024 positioning of APUs in multiple segments is correct; (3) The strategic shift toward data center and AI applications is accurately captured; (4) The overall narrative of evolution from general product line to strategic segment integration is sound. CRITICAL ERROR: The LLM states APUs are listed in THREE reportable segments (Data Center, Client, and Embedded) in 2024, but the ground truth explicitly states TWO segments (Data Center and Client). The ground truth notes that in 2022, APUs were part of 'Enterprise, Embedded and Semi-Custom' portfolio but does NOT indicate they were formally part of a distinct 'Embedded' reportable segment in 2024. This is a material factual error regarding segment classification. ADDITIONAL ISSUES: (1) The LLM references specific page numbers (2022 pages 7-10, 2024 page 69) which cannot be verified against the ground truth and may be inaccurate; (2) The characterization of APUs for 'high-performance, power-efficient server/AI applications' adds interpretive language not explicitly stated in the ground truth, though it's a reasonable inference; (3) The ground truth emphasizes a 'more structured and strategic integration' while the LLM emphasizes 'broader market segmentation'—slightly different framings of the same evolution. The segment count error is significant enough to lower the correctness score substantially, as it represents a factual miscount of reportable segments, which is a quantifiable, verifiable element of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 481,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K contain the same statement that, under the Irish Financial Transfers Act 1992, the Irish Minister for Finance may restrict “financial transfers” between Ireland and third‑countries, that such restrictions already apply to a number of jurisdictions, and that the list of restricted countries is subject to ongoing change. The 2024 filing repeats this language verbatim and adds no new detail, indicating that Medtronic’s disclosure on the Act’s implications has remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCY BETWEEN ANSWERS: The LLM answer directly contradicts the ground truth on the key finding. Ground truth states that by 2024, Medtronic 'no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment.' However, the LLM answer claims the 2024 filing 'repeats this language verbatim' and that disclosure 'has remained essentially unchanged.' This is a fundamental factual error on the core question about how the disclosure EVOLVED. The LLM states the 2024 filing contains identical language about 'the list of restricted countries is subject to ongoing change,' but the ground truth explicitly indicates this emphasis was removed or de-emphasized in 2024. The LLM failed to identify the key evolution: the shift from emphasizing the dynamic/changing nature of the list in 2023 to no longer emphasizing this in 2024. While the LLM correctly identifies the basic regulatory framework (Financial Transfers Act 1992, Irish Minister for Finance, restrictions on third countries), it completely misses the nuanced but critical difference in how Medtronic presented this information across the two years. The quantitative accuracy is reasonable (correct years, correct act name, correct entities), but the qualitative reasoning about the evolution of disclosure is fundamentally wrong. This is a multi-hop question requiring comparison of 2023 vs 2024 disclosures, and the LLM failed to perform this comparison correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 421,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In the 2023 Form 10‑K, General Dynamics said the ultra‑long‑range G700 was still awaiting FAA certification and was expected to enter service in early 2024【page_5】. By the 2024 Form 10‑K, the company reported that the G700 had already begun deliveries in the second quarter of 2024 and that inventories rose as production of the model ramped up【page_70】. This shows the aircraft moved from a “planned‑for‑early‑2024 entry into service” status in 2023 to an active production and delivery phase in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All key facts are correct - G700 awaiting FAA certification in 2023 with early 2024 entry expected, and deliveries beginning in Q2 2024. (2) Dates are accurate (early 2024 expected entry, Q2 2024 actual deliveries). (3) The multi-hop synthesis is sound - correctly connects 2023 status to 2024 status across two different 10-K filings. (4) Properly identifies the evolution from planned/development phase to active production and delivery. (5) Includes relevant supporting details (inventories rising, production ramping up) that add context. (6) Citation references (page_5, page_70) demonstrate source documentation. MINOR CONSIDERATIONS: The answer uses slightly more technical/formal language than the ground truth (e.g., 'planned-for-early-2024 entry into service' vs. 'expectations for it to enter service'), but this is a stylistic difference that enhances clarity rather than detracting from accuracy. The semantic meaning is fully preserved. The answer comprehensively addresses the question about how status and production outlook evolved from 2023 to 2024, demonstrating clear understanding of the multi-hop reasoning required to synthesize information across two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 354,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "In 2023 PMI announced a renewal and extension of its exclusive, fifteen‑year worldwide collaboration with KT&G, giving PMI “continued exclusive access to KT&G’s smoke‑free brands and product‑innovation pipeline” and making the Korean partner a strategic source of new smoke‑free products (2023 p. 57‑59). By 2024 that partnership is reflected in PMI’s product mix – its heat‑not‑burn portfolio now includes “licensed KT&G heat‑not‑burn products” and the KT&G‑licensed brands Fiit and Miix are listed among its HTU offerings, indicating the collaboration has matured into a licensing arrangement that embeds KT&G technology as a core component of PMI’s commercial smoke‑free portfolio (2024 p. 40‑41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the PMI-KT&G relationship evolution. STRENGTHS: (1) All quantitative facts are correct - the 15-year agreement duration is accurate, the January 29, 2038 end date is correctly implied through the 2023 announcement timing, and the worldwide exclusivity (excluding South Korea) is properly captured. (2) The multi-hop synthesis is sound: the answer correctly traces the relationship from 2023 (exclusive collaboration announcement with access to smoke-free brands and pipeline) to 2024 (integration of KT&G products into PMI's portfolio). (3) Entity accuracy is excellent - PMI and KT&G are correctly identified, fiscal years 2023 and 2024 are properly referenced, and specific product names (Fiit, Miix) are accurately cited. (4) The semantic evolution is well-captured: the answer correctly identifies the shift from 'exclusive distribution' to 'licensing arrangement' and 'core component' integration, which aligns with the ground truth's characterization of 'deeper strategic alignment and operational integration.' (5) Page citations (2023 p. 57-59, 2024 p. 40-41) add credibility and specificity. MINOR CONSIDERATIONS: The LLM uses 'licensing arrangement' terminology while the ground truth emphasizes 'operational integration' - these are semantically compatible but represent slightly different framings. The LLM's characterization of the relationship as 'matured into a licensing arrangement' is accurate and perhaps more precise than the ground truth's general 'integrated dependency.' The answer fully addresses both parts of the question (strategic dependency and product commercialization) with clear evidence of evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 473,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "In the 2022 filing AMD described its semi‑custom SoCs mainly as a fee‑based service – non‑recurring engineering fees and product sales that depend on third‑party customers actually integrating the chips into their own products, with AMD having little control over the downstream success of those products. By the 2024 filing AMD has repositioned semi‑custom SoCs as a strategic, co‑engineered offering that draws on its core CPU, GPU and AI IP and is embedded across its Gaming, Data‑Center and Embedded segments – e.g., in leading consoles, handhelds and other platforms – making the semi‑custom line a core part of a broader, integrated product ecosystem rather than a peripheral services business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing AMD's evolution of semi-custom SoC strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning as fee-based (non-recurring engineering fees) with third-party dependency and lack of downstream control - this matches the ground truth characterization of risk and dependency. (2) Accurately describes the 2024 shift to a strategic, integrated approach with co-engineered offerings leveraging CPU, GPU, and AI IP. (3) Properly identifies specific application areas (Gaming, Data Center, Embedded segments, consoles, handhelds) that demonstrate the broader ecosystem integration. (4) The multi-hop reasoning is sound - correctly synthesizes the evolution from a peripheral services model to a core product strategy. (5) No quantitative errors; dates (2022, 2024) are correct. MINOR GAPS: (1) The LLM answer does not explicitly mention the dedicated neural processing unit (NPU) on the same SoC as x86 CPU for AI PCs, which is a specific strategic detail highlighted in the ground truth. (2) Does not explicitly mention 'cloud services' as one of the application areas, though it does mention Data Center which partially covers this. (3) The phrase 'product leadership strategy' from ground truth is not explicitly stated, though the concept is conveyed through 'strategic, co-engineered offering.' These are relatively minor omissions that don't fundamentally undermine the answer's accuracy. The core narrative of evolution from dependency/fee-based model to integrated ecosystem strategy is correctly captured with appropriate supporting details. The answer demonstrates solid multi-hop synthesis across the two filing periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 465,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "The 2023 filing said that U.S. shareholders were exempt from the 25 % Irish dividend‑withholding tax only when their shares were held through the Depository Trust Company (DTC) and, if exempt, they would not incur Irish income‑tax on the dividend unless they had other Irish connections. The 2024 filing keeps the 25 % rate but expands the exemption – U.S. record owners can also avoid withholding by providing a U.S. Certificate of Residence (Form 6166) or an Irish Non‑Resident Form V2, and confirms that any shareholder who meets an exemption and does not trade through an Irish branch has no Irish income‑tax liability, with any withholding that does apply discharging the Irish tax due.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific details NOT present in the ground truth, particularly regarding DTC (Depository Trust Company) holdings in 2023 and Form 6166/Irish Non-Resident Form V2 in 2024. The ground truth makes no mention of these specific mechanisms or forms. This represents fabrication of details. (2) QUANTITATIVE ACCURACY - The 25% withholding tax rate is correctly stated and matches ground truth. However, the LLM adds unverified specifics about exemption mechanisms. (3) MULTI-HOP REASONING - The LLM fails to accurately synthesize the actual evolution described in ground truth. Ground truth shows: 2023 = general exemption for U.S. residents with no Irish connection; 2024 = more structured conditions with clarified post-withholding procedures. The LLM instead describes specific exemption mechanisms (DTC, Form 6166, Form V2) that are not mentioned in the ground truth. (4) SEMANTIC EQUIVALENCE FAILURE - While the LLM attempts to describe an evolution from 2023 to 2024, it does so by inventing details rather than accurately representing what the ground truth states. The ground truth emphasizes clarification and structure in 2024, not expansion of exemption mechanisms via specific forms. (5) ENTITY/CONTEXT ISSUES - The LLM correctly identifies Medtronic as the source company (implied) and the 25% rate, but misrepresents the actual conditions and mechanisms. The introduction of DTC, Form 6166, and Form V2 appears to be hallucinated details not supported by the ground truth. This is a critical failure in accuracy for a financial/tax compliance question where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 453,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "In 2023 the Marine Systems segment’s ship‑construction revenue rose on higher Columbia‑class submarine volume, but its operating margin fell because supply‑chain cost pressures hit the Virginia‑class submarine schedule and cost growth hit the DDG‑51 destroyer program【page_37】. For 2024 the company is shifting its focus to the Columbia‑class program, projecting ship‑construction revenue of about $12.8‑$12.9 billion and an operating‑margin rebound to roughly 7.6%, indicating a more positive revenue outlook despite the prior year’s cost challenges【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about General Dynamics' ship construction performance. STRENGTHS: (1) All key financial metrics are correct: $12.8-$12.9 billion revenue projection for 2024 Marine Systems segment matches ground truth exactly; 7.6% operating margin projection is accurate. (2) Quantitative accuracy is high - the answer correctly identifies the 110 basis point margin decline in 2023 (implied through 'operating margin fell') and the rebound to 7.6% in 2024. (3) Multi-hop synthesis is sound: the answer correctly connects 2023 challenges (supply chain disruptions on Virginia-class, cost overruns on DDG-51) with 2024 projections, showing the progression from margin pressure to recovery. (4) All entities are correctly identified: General Dynamics, Marine Systems segment, Virginia-class submarine, DDG-51 destroyer, Columbia-class submarine. (5) The answer captures the strategic shift from cost-driven challenges to Columbia-class growth focus. (6) Temporal accuracy is correct (2023 vs 2024 comparison). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrasing 'operating margin fell' effectively conveys the 110 basis point decline without explicitly stating the number, which is semantically equivalent. The answer appropriately emphasizes the shift from challenges to optimism. No calculation errors detected. The answer directly addresses all three sub-components of the question: cost pressures on Virginia-class and DDG-51, revenue outlook for Columbia-class, and the strategic shift between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 459,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "The 2023 Form 10‑K shows that online accommodation reservation services – primarily Booking.com – accounted for roughly **89 % of total revenue in both 2022 and 2023**. Thus, BKNG’s financial reliance on Booking.com remained essentially unchanged, with the share of revenue from accommodation reservations staying flat year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. (1) CORRECTNESS: All factual information is correct. The LLM correctly identifies that accommodation reservations (primarily Booking.com) accounted for 89% of total revenue in both 2022 and 2023, matching the ground truth exactly. The conclusion that dependency remained unchanged is accurate. (2) QUANTITATIVE ACCURACY: The 89% figure is correct for both years with no calculation errors. The year-over-year comparison (flat/unchanged) is accurate. (3) QUALITATIVE ACCURACY: The LLM properly synthesizes the multi-hop information by comparing the same metric across two fiscal years and correctly identifies this as indicating sustained and concentrated dependency. The reasoning is sound - flat percentages across years demonstrate unchanged reliance. (4) ENTITY ACCURACY: BKNG ticker is correct, Booking.com is correctly identified as the primary service, fiscal years 2022 and 2023 are correct, and the metric (accommodation reservations as % of total revenue) is properly identified. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'remained essentially unchanged' and 'staying flat year-over-year' conveys the same meaning as the ground truth's 'remained unchanged' and 'sustained and concentrated dependency.' The only minor difference is that the LLM uses slightly more concise language while the ground truth provides marginally more contextual elaboration, but both communicate the same core finding. The answer fully addresses the evolution question by demonstrating no evolution occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 431,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "In 2023 PMI listed a Swiss‑franc note (1.625 % due 2024) with a carrying amount of about **$299 million** among its foreign‑currency obligations【page_105】. By the 2024 balance sheet the Swiss‑franc note is shown as “‑”, indicating it is no longer outstanding【page_102】. Thus the company eliminated its Swiss‑franc debt, reducing its foreign‑currency exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative accuracy is perfect: the $299 million figure for the 2023 Swiss Franc note is correct, and the identification that it was eliminated by 2024 (shown as '-') is accurate. The answer correctly identifies the specific note details (1.625% due 2024) and provides page references to the source documents. Multi-hop reasoning is sound: the answer synthesizes information across two years (2023 and 2024 balance sheets) and correctly interprets what the elimination means (debt repayment/restructuring and reduced foreign currency exposure). The semantic meaning matches the ground truth perfectly - both convey that the company had a $299M Swiss Franc obligation in 2023 that was completely removed by 2024, indicating strategic management of foreign currency exposure. The only minor distinction is that the LLM uses slightly more specific language ('eliminated its Swiss-franc debt') compared to the ground truth's more general phrasing ('either repaid or restructured'), but this is actually more precise and doesn't contradict the ground truth. The answer directly addresses both parts of the question: how the position evolved (from $299M to $0) and what it indicates about foreign currency obligations (strategic reduction of exposure). Page citations add credibility and verifiability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 377,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs listed the director equity awards as separate exhibits – a standard Non‑Employee Director RSU Award Agreement (exhibit 10.31), a cash‑settled version (exhibit 10.32), a pre‑2015 form (exhibit 10.8) and a distinct “Amendments to Certain Non‑Employee Director Equity Award Agreements” exhibit (10.17) 【page_6】. In the 2024 filing the same agreements re‑appear but are renumbered (standard RSU as 10.32, cash‑settled as 10.33, pre‑2015 as 10.9) and the separate amendment exhibit (10.17) is no longer shown, indicating that the amendments have been incorporated into the updated award forms 【page_246】【page_247】. This reflects a consolidation and renumbering of the Non‑Employee Director RSU Award Agreements between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBERING ERRORS: The LLM claims 2023 had exhibits 10.31, 10.32, 10.8, and 10.17, but the ground truth only references 10.8 (pre-2015 form). The LLM provides specific exhibit numbers (10.31, 10.32, 10.17) that are not mentioned in the ground truth. (2) CORE NARRATIVE REVERSAL: The ground truth states that the 'Amendments to Certain Non-Employee Director Equity Award Agreements' (Exhibit 10.18) was INTRODUCED in 2024 and was NOT present in 2023. The LLM claims the opposite - that this amendment exhibit (10.17) existed in 2023 but disappeared in 2024. This is a fundamental contradiction. (3) INCORRECT CONCLUSION: The LLM concludes amendments were 'incorporated into the updated award forms,' but the ground truth indicates amendments were newly added as a separate exhibit in 2024, representing expanded disclosures rather than consolidation. (4) MISSING INFORMATION: The LLM fails to mention that the pre-2015 form (10.8 in 2023) was retained in 2024 (as 10.9), which is part of the ground truth narrative. (5) EXHIBIT NUMBER INCONSISTENCIES: The LLM provides renumbering details (10.31→10.32, 10.32→10.33, 10.8→10.9) that are not verified in the ground truth and appear to be fabricated. The ground truth is clear and specific: 2023 had Exhibit 10.8, and 2024 added Exhibit 10.18 as a new disclosure. The LLM's answer fundamentally misrepresents the evolution of these agreements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 413,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "In 2023 PMI carried €6.1 billion of Euro‑denominated credit‑facility borrowings that were specifically linked to the Swedish Match acquisition (shown as “Euro credit facility borrowings related to Swedish Match AB acquisition” on the long‑term‑debt schedule)【PM_10k_2023 page_102】. By the end of 2024 that balance had fallen to €2.6 billion after PMI prepaid roughly €3 billion of the three‑year tranche of the senior unsecured term‑loan facility, leaving only the five‑year tranche (≈€2.5 billion) outstanding【PM_10k_2024 page_102】. Thus, the acquisition‑related long‑term debt was sharply reduced between 2023 and 2024, even as PMI’s overall long‑term debt grew modestly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed context than the ground truth. Key verification: (1) QUANTITATIVE ACCURACY: The core numbers are correct - 2023 debt of €6.1 billion (matches $6,121 million in ground truth when converted), 2024 debt of €2.6 billion (matches $2,610 million), and the €3 billion prepayment amount. The LLM correctly identifies the reduction from €6.1B to €2.6B. Currency presentation (EUR vs USD) is a minor variation but semantically equivalent since the ground truth uses USD and LLM uses EUR - both refer to the same underlying amounts. (2) COMPLETENESS: The answer fully addresses the question about how PM's financial relationship evolved, covering both years and the debt obligations. (3) ENTITY ACCURACY: Correctly identifies PM/PMI, Swedish Match AB acquisition, long-term debt, and the specific credit facility. Correctly cites page 102 of both 2023 and 2024 10-K filings. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly traces the debt reduction across years, identifies the specific mechanism (prepayment of three-year tranche), and notes the remaining five-year tranche. The conclusion that acquisition-related debt was 'sharply reduced' is well-supported. (5) ADDED VALUE: The LLM provides superior context by explaining the specific tranches (three-year vs five-year), the prepayment mechanism, and noting that overall PMI debt grew modestly despite this reduction. Minor deduction (1 point) only because currency presentation differs from ground truth (EUR vs USD), though this is a presentation choice rather than a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 444,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "In 2023 BMS announced that it would acquire Mirati, a move intended to give it a “best‑in‑class” KRAS inhibitor—Krazati—already approved for second‑line NSCLC and being readied for first‑line PD‑1‑combination studies (see page 88). By the 2024 filing the Mirati deal was closed, Krazati was recorded as a definite‑life marketed‑product right and BMS was actively expanding its KRAS portfolio, using Krazati in combination regimens and pursuing additional KRAS‑mutated indications while also gaining access to other KRAS inhibitors and enabling programs (see pages 93‑94). Thus BMS shifted from a planned acquisition in 2023 to a commercial KRAS leader with an approved product and broader development pipeline in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of BMY's KRAS inhibition strategy evolution but contains one significant factual error and lacks one key approval detail. CORRECT ELEMENTS: (1) The answer accurately captures that in 2023 BMY announced the Mirati acquisition (not yet closed), while in 2024 the deal was completed; (2) Correctly identifies Krazati as a KRAS G12C inhibitor; (3) Accurately notes Krazati's second-line NSCLC approval and first-line PD-1 combination development; (4) Properly characterizes the strategic shift from planned to completed acquisition; (5) References appropriate document pages (88, 93-94) suggesting source verification. CRITICAL ERROR: The LLM states the acquisition price was not disclosed or omitted entirely, when the ground truth clearly specifies the acquisition was for $4.8 billion. This is a material quantitative omission. MISSING DETAIL: The answer does not mention Krazati's FDA approval for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab in 2024, which represents an important expansion of the therapeutic footprint and is explicitly noted in the ground truth. REASONING QUALITY: The multi-hop synthesis is sound—the answer correctly traces the evolution from 2023 announcement to 2024 completion and portfolio expansion. The characterization of BMY shifting from 'planned acquisition' to 'commercial KRAS leader' accurately captures the strategic positioning change. SEMANTIC EQUIVALENCE: The answer conveys the core narrative correctly, though the omission of the $4.8B figure and the colorectal cancer indication represent material gaps in completeness. The answer would score higher (8-9) if it included the acquisition price and the colorectal cancer approval.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 474,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "In the 2023 Form 10‑K the “Goldman Sachs Amended and Restated Restricted Partner Compensation Plan” was disclosed as Exhibit 10.3 (see page 5) and was presented alongside older compensation documents, with the Group’s claw‑back policy noted separately as Exhibit 97.1 (page 7). In the 2024 Form 10‑K the same plan is listed as Exhibit 10.4 (page 246) but now follows a newly highlighted Clawback Policy (exhibit 10.1, page 246) and is grouped with the updated 2021 Stock Incentive Plan (exhibit 10.2) and the Partner Compensation Plan (exhibit 10.3), indicating that Goldman Sachs has repositioned the Restricted Partner Compensation Plan within a tighter, more formal compensation‑governance framework introduced in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) EXHIBIT NUMBER ERRORS: The ground truth states the Clawback Policy was introduced in 2024 as Exhibit 10.1, but the LLM claims it was Exhibit 97.1 in 2023 - this is a major discrepancy. The LLM also incorrectly identifies the 2024 exhibits, stating the plan is Exhibit 10.4 when ground truth confirms this, but then claims the Clawback Policy is Exhibit 10.1 and Partner Compensation Plan is Exhibit 10.3, creating confusion about the actual exhibit numbering structure. (2) PAGE REFERENCES: The LLM provides specific page numbers (page 5, page 7, page 246) that cannot be verified against the ground truth and appear potentially inaccurate. (3) CORE CONCEPT ACCURACY: The LLM does correctly identify the key evolution - that the Restricted Partner Compensation Plan shifted from Exhibit 10.3 (2023) to Exhibit 10.4 (2024), and that a new Clawback Policy was introduced in 2024. However, it mischaracterizes the 2023 clawback policy location. (4) MULTI-HOP REASONING: The LLM attempts to synthesize the repositioning narrative and does capture the essence that compensation governance was reorganized, but the specific exhibit number errors and the false claim about a 2023 Exhibit 97.1 clawback policy significantly damage the answer's reliability. (5) SEMANTIC ALIGNMENT: While the LLM's conclusion about strategic repositioning toward risk mitigation aligns with the ground truth's interpretation, the factual errors in exhibit numbers and policy timing undermine this conclusion's foundation. The answer demonstrates partial understanding but contains too many specific factual errors to be considered substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 469,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "In the 2022 filing PMI treated heat‑not‑burn (HNB) items as a distinct “HTU” group of reduced‑risk products – HEETS, HEETS Creations/Dimensions, Marlboro HeatSticks, Parliament HeatSticks, TEREA and the KT&G‑licensed Fiit and Miix brands – and described them separately from its combustible‑tobacco portfolio【page_5】. By the 2023 filing the company had folded HNB consumables into a broader “Smoke‑free products” category, expanded the HTU definition to include new lines such as BLENDS, DELIA, LEVIA (zero‑tobacco) and again noted that licensed KT&G HNB products are now part of its integrated smoke‑free business, a change reflected in the net‑revenue table for smoke‑free products【page_39】【page_41】. This shift shows PMI moving from a narrowly defined HNB segment to a more integrated, revenue‑tracked smoke‑free portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about PMI's heat-not-burn product evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 categorization as 'Reduced-Risk Products' with specific HTU examples (HEETS, Marlboro HeatSticks, Parliament HeatSticks, TEREA). (2) Accurately describes the 2023 shift to 'Smoke-free products' category. (3) Properly notes the inclusion of KT&G-licensed products (Fiit and Miix in 2022; broader KT&G integration in 2023). (4) Correctly identifies new product lines added by 2023 (BLENDS, DELIA, LEVIA). (5) Effectively synthesizes the multi-hop information showing the evolution from a narrowly defined segment to integrated portfolio. (6) References specific filing pages, adding credibility. (7) The semantic meaning aligns well with ground truth - both describe a shift from RRP/HTU categorization to smoke-free products integration. MINOR AREAS FOR IMPROVEMENT: (1) The ground truth emphasizes 'Reduced-Risk Products (RRPs)' terminology more explicitly in 2022, while LLM uses 'HTU group of reduced-risk products' - slightly different framing but semantically equivalent. (2) The LLM provides more granular product examples (BLENDS, DELIA, LEVIA, Fiit, Miix) than the ground truth, which is actually more comprehensive and accurate. (3) The LLM's mention of 'zero-tobacco' for LEVIA adds helpful context not in ground truth. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The dates (2022 vs 2023) are correct. QUALITATIVE ACCURACY: The reasoning about the evolution from distinct categorization to integrated portfolio is sound and well-articulated. The multi-hop synthesis correctly combines information about product categorization changes and business integration. CONTEXTUAL RELEVANCE: The answer directly and thoroughly addresses all aspects of the question regarding product categorization evolution and business integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 545,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "In the 2023 Form 10‑K BMS disclosed that, to satisfy the 2004 SEC Consent Order, it **established a business‑risk‑and‑disclosure group** as one of several new controls—including a formal review‑and‑certification process for its SEC filings and a policy to monitor and limit sales to direct customers (2023 p. 63‑65). The 2024 filing repeats that the group remains in place **but is now embedded in a company‑wide policy and governance‑escalation process that regularly monitors compliance and routes any questions or concerns to senior management**, showing the evolution from merely creating the group to integrating it into ongoing oversight (2024 p. 63‑65).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Bristol-Myers Squibb and the 2004 SEC Consent Order as the regulatory context. (2) Accurately captures the 2023 establishment of the business risk and disclosure group with specific controls mentioned (formal review-and-certification process, sales monitoring policy). (3) Properly synthesizes the evolution from 2023 to 2024, showing progression from group creation to integration into broader governance framework. (4) Correctly identifies the shift toward embedding the group in company-wide policy and governance-escalation processes. (5) Appropriately cites page references (p. 63-65) for both years, suggesting proper source documentation. (6) Multi-hop reasoning is sound: connects SEC Consent Order compliance → group establishment → integration into ongoing oversight. MINOR CONSIDERATIONS: (1) The LLM answer adds slightly more specific detail about the governance-escalation process routing to senior management, which is consistent with but slightly more granular than the ground truth's description of 'governance mechanism to escalate and resolve compliance-related questions.' (2) The mention of 'sales to direct customers' policy is an additional control detail not explicitly mentioned in the ground truth summary, though it doesn't contradict it. (3) The characterization of the evolution as 'from merely creating the group to integrating it into ongoing oversight' is semantically equivalent to the ground truth's 'fully integrated this group into its ongoing compliance framework.' QUANTITATIVE ACCURACY: No numerical calculations or specific dollar amounts are required for this question; page references are appropriately cited. QUALITATIVE ACCURACY: The reasoning correctly identifies the temporal evolution and the shift in governance approach, properly synthesizing information across two fiscal years. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the specific question about how BMS's approach evolved between 2023 and 2024 regarding SEC Consent Order compliance and the business risk and disclosure group's role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 588,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP’s 2023 and 2024 filings both say that the pension‑plan’s expected long‑term return is derived from the plan’s asset‑allocation mix and its historical returns (adjusted for current market conditions), targeting a 5.25% average return. The mix – roughly 24 % equity, 75 % debt and 1 % real‑estate – and the language tying expected return to that allocation are unchanged, so the company’s treatment of the relationship has remained consistent from 2023 to 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) CORE CLAIM REVERSAL: The ground truth states there WAS a shift/evolution in UNP's treatment between 2023 and 2024 (from comprehensive explanation to narrower focus), but the LLM claims the treatment 'remained consistent' - this is a direct contradiction of the question's premise and the ground truth answer. (2) QUANTITATIVE ERRORS: The LLM cites a 5.25% average return target and specific asset allocation percentages (24% equity, 75% debt, 1% real estate), but the ground truth mentions 6% actual return for 2023 with no mention of 5.25% or these specific percentages. These numbers appear to be fabricated or from incorrect sources. (3) MISSING KEY EVOLUTION: The ground truth explicitly identifies that 2024 language shifted to 'depends on' asset allocation with NO mention of historical returns or market conditions, and NO disclosure of actual 2024 return. The LLM completely misses this evolution and incorrectly claims both years mention 'historical returns (adjusted for current market conditions).' (4) FACTUAL INACCURACY: The LLM states the language is 'unchanged' when the ground truth clearly documents a meaningful shift in disclosure approach and comprehensiveness. (5) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the year-over-year comparison correctly, missing the key distinction between 2023's comprehensive disclosure and 2024's narrower focus. The answer demonstrates a fundamental misunderstanding of the question and provides information that contradicts established ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 446,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "In the 2022 Form 10‑K, BNY Mellon mentioned the Directors’ Code of Conduct only in the “Code of Ethics” section of Item 10, giving a direct URL to the PDF and noting that any amendments or waivers would be posted on the website. By the 2023 Form 10‑K, the Directors’ Code of Conduct was moved into the formal corporate‑governance package—listed alongside the bylaws, governance guidelines and committee charters as a document incorporated by reference and made freely available on the company’s website—making it more accessible and fully integrated into its governance reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of BNY Mellon's disclosure approach between 2022 and 2023. STRENGTHS: (1) Correctly identifies the two years being compared (2022 vs 2023); (2) Accurately captures the core evolution: from a standalone reference in the 'Code of Ethics' section to integration into the formal corporate governance package; (3) Correctly notes the shift from simple website posting to incorporation by reference alongside other governance documents; (4) Properly identifies the enhanced accessibility and integration as the key change; (5) No quantitative errors or date inaccuracies. WEAKNESSES: (1) The LLM answer provides more specific implementation details (e.g., 'direct URL to the PDF,' 'incorporated by reference,' 'Code of Ethics section of Item 10') that go beyond what the ground truth explicitly states, suggesting possible inference or additional source material not in the knowledge graph; (2) The ground truth emphasizes the documents being 'listed among governance materials available on our website' and 'more directly tied to the company's overall governance framework,' while the LLM answer uses slightly different framing ('moved into the formal corporate-governance package,' 'incorporated by reference'); (3) Minor semantic difference: ground truth emphasizes 'more structured and centralized approach' while LLM emphasizes 'incorporated by reference' - these are related but not identical concepts. MULTI-HOP REASONING: The answer correctly synthesizes the comparison across two years and identifies the governance reporting evolution. The logic is sound and the conclusion about increased accessibility and integration is valid. The answer successfully addresses all parts of the question regarding accessibility and integration within corporate governance reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 498,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "In the 2023 filing Oracle framed the Oracle Database as a “flexible, multi‑environment” platform that can run in the Oracle Cloud, on‑premise data centers or hybrid models, and it highlighted engineered systems such as Exadata as pre‑built solutions offered on‑premise, as a cloud service in OCI, or as a hybrid cloud offering (2023 p.10, p.12, p.13). The 2024 filing builds on that theme by naming concrete hybrid services—Oracle Exadata Cloud@Customer, OCI Dedicated Region and OCI Sovereign Cloud—and again stressing that engineered systems are delivered through on‑premise, OCI cloud, and hybrid options (2024 p.11, p.12, p.13). This evolution signals Oracle’s sharpened strategy to use the Oracle Database and its engineered systems as a bridge for cloud migration while fully supporting hybrid and multicloud IT environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's strategic evolution between 2023 and 2024, with generally accurate factual content and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies key offerings in both years (Exadata, Exadata Cloud@Customer, OCI Dedicated Region, OCI Sovereign Cloud); (2) Accurately captures the multi-deployment model positioning (on-premise, OCI cloud, hybrid); (3) Properly synthesizes the evolution from flexible deployment to more integrated engineered systems; (4) Correctly interprets the strategic shift toward hybrid and multicloud support; (5) Appropriately cites page numbers from filings (though not verifiable in this context). WEAKNESSES: (1) The LLM answer mentions specific page numbers (2023 p.10, p.12, p.13; 2024 p.11, p.12, p.13) which cannot be verified and may be hallucinated; (2) Slightly less emphasis on the 'holistic, performance-optimized solutions' aspect that the ground truth highlights as central to the strategic shift; (3) Does not explicitly mention Oracle Roving Edge Infrastructure, which the ground truth identifies as a 2023 offering; (4) The phrase 'sharpened strategy' is somewhat vague compared to ground truth's more specific characterization of 'maturation of Oracle's cloud migration strategy'; (5) Missing the explicit connection to 'simplified maintenance' as a benefit of engineered systems. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings and identifies the evolution pattern. The logic connecting deployment flexibility to engineered systems integration is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—Oracle moved from emphasizing flexible deployment options to emphasizing integrated engineered systems as a bridge for cloud migration. The characterization of this as supporting hybrid and multicloud environments is accurate. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is not heavily tested. The years (2023, 2024) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 558,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings describe the same formal review‑and‑certification framework that was instituted under the 2004 SEC Consent Order. In each year the company notes a governance process that escalates any compliance questions to senior management and that the policy’s adherence is “monitored on a regular basis,” indicating that the procedures have been maintained rather than materially altered between 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) both years describe a formal review-and-certification framework, (2) the framework was instituted under a Consent Order (though the LLM specifies 2004 while ground truth doesn't specify the year), (3) governance procedures escalate compliance concerns to senior management, and (4) compliance is monitored regularly. However, the LLM answer has significant weaknesses: (1) It characterizes the evolution as 'maintained rather than materially altered,' which contradicts the ground truth's explicit statement that there was 'a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.' (2) The ground truth emphasizes that by 2024, the process was 'integrated into company-wide sales policies to ensure adherence to inventory and sales limitations' - a specific operational integration detail that the LLM answer completely omits. (3) The ground truth describes an 'evolution' while the LLM describes 'maintenance,' which are semantically different conclusions about the same data. The LLM answer is partially correct on the baseline facts but fails to capture the key distinction between initial implementation (2023) and sustained enforcement with broader integration (2024). The answer is too focused on similarities and misses the substantive evolution in how the procedures were operationalized across the company. The reference to 2004 Consent Order is accurate but not verified against ground truth which doesn't specify that date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 428,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "In the 2022 filing PMI described heat‑not‑burn as part of its generic “Platform 1” reduced‑risk product (a heating device that inserts a proprietary tobacco unit) and grouped it under the broader “RRPs” umbrella without a separate market‑segment label (2022 p.76). By the 2023 filing the company had repositioned heat‑not‑burn as a distinct element of its “Smoke‑free products” line, creating a dedicated “Heated Tobacco Units (HTU)” category that now includes licensed KT&G brands and emphasizing a 14‑15% rise in HTU shipments and market‑share growth (2023 p.39‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PMI's heat-not-burn product evolution from 2022 to 2023 and correctly identifies the key strategic shift. STRENGTHS: (1) Accurately captures the 2022 positioning within RRPs umbrella with Platform 1 device reference; (2) Correctly identifies the 2023 shift to explicit 'Smoke-free products' categorization; (3) Properly notes the inclusion of licensed KT&G heat-not-burn products in 2023; (4) Appropriately characterizes the evolution as moving from internal development focus to integrated commercialization; (5) Good multi-hop synthesis across both years. WEAKNESSES: (1) The specific quantitative claim of '14-15% rise in HTU shipments' cannot be verified against the ground truth provided, which does not mention this specific percentage. This is a potential factual error or unsupported detail; (2) Page references (2022 p.76, 2023 p.39-41) are provided but cannot be verified; (3) The term 'Heated Tobacco Units (HTU)' is introduced as a new category name in 2023, but the ground truth uses 'heat-not-burn products' terminology without explicitly confirming the HTU acronym was used in filings. VERIFICATION ISSUES: The quantitative accuracy is marked down because the 14-15% shipment growth figure is not corroborated by the ground truth answer, which focuses on strategic positioning rather than specific performance metrics. The core narrative about product categorization evolution is sound and well-articulated. The answer demonstrates good contextual understanding of PMI's strategic direction and market positioning changes, making it highly relevant to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 448,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "In 2023 Oracle presented the Oracle Database primarily as a licensable product that could be run “in cloud‑based, on‑premise or other IT environments” and stressed that giving customers “choice and flexibility … when and how they deploy Oracle applications and infrastructure technologies” was a core part of its strategy (2023 p. 42; 2023 p. 41). By 2024 the company repositioned the database as a cloud‑native, tightly integrated service—highlighting the Autonomous Database’s built‑in integration with Oracle Cloud services such as Java Cloud and APEX, and expanding deployment options to include OCI shared or dedicated clouds, Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud and other hybrid/edge models (2024 p. 12‑13; 2024 p. 11). This evolution shows a shift from broad licensing flexibility toward deeper integration with Oracle’s cloud ecosystem and a richer set of flexible deployment choices.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023 positioning emphasizing deployment flexibility across cloud, on-premise, and other environments with perpetual licensing. (2) The LLM correctly identifies 2024 evolution toward deeper integration with Oracle's ecosystem. (3) Specific deployment options mentioned for 2024 (OCI shared/dedicated clouds, Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud) are plausible and show detailed knowledge. (4) The general narrative arc from flexibility to integration is sound. (5) Page citations (2023 p. 41-42; 2024 p. 11-13) add credibility.\n\nWEAKNESSES: (1) CRITICAL DISCREPANCY: The LLM emphasizes 'cloud-native' and 'Autonomous Database' as the 2024 evolution, but the ground truth specifically highlights 'Oracle Exadata Database Machine' as the key 2024 positioning. The ground truth emphasizes integration with 'storage, operating system software, and hardware components' within engineered systems, not cloud-native autonomous services. (2) The LLM's framing of 2024 as 'cloud-native, tightly integrated service' differs from ground truth's emphasis on 'foundational component within broader engineered systems.' (3) The LLM mentions Java Cloud and APEX integration, which are not mentioned in the ground truth. (4) The ground truth emphasizes Oracle Engineered Systems as the strategic positioning, while the LLM emphasizes cloud ecosystem integration—these are different strategic narratives. (5) The LLM's characterization of the shift as 'from broad licensing flexibility toward deeper integration with Oracle's cloud ecosystem' is partially misaligned; the ground truth suggests the shift is toward engineered systems integration (which includes on-premise, cloud, and hybrid), not specifically cloud ecosystem integration.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 documents and identifies an evolution in positioning. However, the specific nature of that evolution appears to be mischaracterized—focusing on cloud-native/autonomous database services rather than engineered systems integration.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations to verify. Page citations appear reasonable but cannot be independently verified. The core factual claim about the shift in positioning is partially incorrect in its characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 631,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "In the 2023 filing BMS only highlighted Krazati as a “strategic fit” in its NSCLC portfolio – noting it would be obtained through its pending Mirati deal 【page_43】. By the 2024 filing BMS had completed the Mirati acquisition, securing full U.S. and global rights to commercialize Krazati, and committed roughly $4.8 billion in cash (plus $205 million of equity awards and a $248 million contingent‑value right) for a total consideration of about $4.9 billion, of which $640 million was allocated to the definite‑lived marketed‑product rights for Krazati 【page_93】【page_94】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the Mirati acquisition and financial commitments, but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The 2023 characterization of Krazati as a 'strategic fit' in BMY's NSCLC portfolio is accurate; (2) The 2024 completion of the Mirati acquisition is correct; (3) The $4.8 billion acquisition price is correct; (4) The mention of contingent value rights is appropriate; (5) The multi-hop reasoning connecting 2023 positioning to 2024 acquisition is sound. CRITICAL ERRORS: (1) The LLM states total consideration of 'about $4.9 billion' with breakdown of $4.8B cash + $205M equity + $248M CVR, which sums to $5.253 billion, not $4.9 billion - this is a calculation error; (2) The $640 million allocation to Krazati's definite-lived marketed-product rights appears to be an additional detail not mentioned in the ground truth, which could be accurate but cannot be verified against the provided ground truth; (3) The ground truth specifically mentions '$1.0 billion in contingent value rights tied to PRMT5 Inhibitor development,' but the LLM only mentions '$248 million contingent-value right' without specifying it relates to PRMT5 Inhibitor - this is a significant omission of a key financial commitment that demonstrates long-term investment strategy. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the evolution from 2023 (pending deal) to 2024 (completed acquisition), but fails to capture the full scope of contingent commitments. The answer addresses the question's core requirements but misses the PRMT5 Inhibitor CVR commitment, which is explicitly mentioned in the ground truth as reflecting 'long-term investment in the acquired assets.' The quantitative breakdown provided by the LLM appears to be from detailed SEC filings but introduces calculation inconsistencies and omits the critical PRMT5 Inhibitor CVR detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 521,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the 6.244 % Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (ticker BK/P) under Section 12(b) as a NYSE‑registered security that is “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation.” The language and classification are identical in each filing, showing that the security’s registration and guarantee status remained unchanged between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about the evolution of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities between 2022 and 2023. STRENGTHS: (1) All numeric values are correct - the 6.244% rate is accurately cited, (2) Entity identification is precise - correctly identifies the security name, ticker symbol (BK/P), issuer (Mellon Capital IV), and guarantor (The Bank of New York Mellon Corporation), (3) Regulatory details are accurate - correctly identifies Section 12(b) registration and NYSE listing status, (4) Multi-hop synthesis is sound - the answer properly compares the 2022 and 2023 filings and correctly concludes no change occurred, (5) The conclusion that the security's status remained unchanged is factually correct and matches the ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, which explicitly states the securities were \"introduced\" in 2022 and \"remained\" in 2023. However, this is a stylistic difference rather than a factual error - the LLM's phrasing \"Both the 2022 and 2023 Form 10-K filings list\" effectively conveys the same information about continuity. The answer demonstrates proper understanding of the question's requirement to synthesize information across two fiscal years and identify whether changes occurred. All factual claims are verifiable and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 393,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "PMI’s short‑term credit capacity rose from roughly $1.9 billion at 12/31/2022 to about $2.7 billion at 12/31/2023, while borrowings under those arrangements slipped from $295 million to $283 million. The larger unused line and lower drawdown indicate PMI has expanded its liquidity cushion and is keeping short‑term debt utilization modest, signaling a more conservative near‑term liquidity posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: short-term credit capacity increased from $1.9 billion (12/31/2022) to $2.7 billion (12/31/2023), and utilization decreased from $295 million to $283 million. The numbers match the ground truth exactly, with appropriate format variations (using 'roughly' and 'about' to indicate approximate values while maintaining precision). The multi-hop reasoning is sound: the model correctly synthesized the capacity increase and utilization decrease to draw the appropriate conclusion about PMI's more conservative liquidity posture. The interpretation that the larger unused line and lower drawdown signal expanded liquidity cushion and modest short-term debt utilization is logically sound and matches the ground truth's assessment. The only minor distinction is that the LLM uses slightly more colloquial phrasing ('slipped,' 'cushion') compared to the ground truth's more formal tone, but this represents stylistic variation rather than factual error. The answer fully addresses all components of the multi-part question: capacity change, utilization change, and implications for near-term liquidity posture. Entity identification is correct (PMI), time periods are accurate (2022 to 2023), and financial metrics are properly identified (short-term credit arrangements, capacity, utilization/borrowings).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 389,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "In the 2023 filing Oracle framed the Autonomous Database as a self‑driving, machine‑learning‑optimized service that automates routine DBA tasks (maintenance, tuning, patching, scaling, security and backup) and is already integrated with OCI and key cloud services such as Java Cloud and the APEX low‑code platform (2023 p.12). By the 2024 filing the company still stresses those automation capabilities but expands the narrative to show tighter, broader integration across the OCI portfolio—including AI services, open interfaces, and new deployment options (shared or dedicated, Exadata Cloud@Customer, OCI Dedicated Region)—positioning Autonomous Database as a core, automated component of a unified Oracle Cloud ecosystem (2024 p.12‑13; 2024 p.11).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's Autonomous Database positioning evolution between 2023 and 2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies key 2023 positioning elements (self-driving, ML-optimized, automation of DBA tasks like maintenance, tuning, patching, scaling, security, backup). (2) Accurately notes 2023 integration with Java Cloud and APEX. (3) Correctly captures 2024 expansion narrative emphasizing broader OCI portfolio integration, AI services, and open interfaces. (4) Appropriately synthesizes the evolution from 2023 to 2024 across multiple dimensions. (5) Page references (2023 p.12, 2024 p.12-13, 2024 p.11) add credibility. WEAKNESSES: (1) The LLM answer claims 2023 filing already mentioned integration with Java Cloud and APEX, while the ground truth indicates these were emphasized MORE in 2024 as part of the expansion. The ground truth states 2023 emphasized 'automated database operations' and 'reducing IT process time and resources' without specifically mentioning Java Cloud/APEX integration in 2023. This represents a potential factual discrepancy. (2) The LLM answer mentions deployment options (shared/dedicated, Exadata Cloud@Customer, OCI Dedicated Region) as 2024 additions, which are not mentioned in the ground truth. While not contradictory, this adds details not in the original answer. (3) The ground truth emphasizes 2024's focus on 'machine learning capabilities' for diagnostics, fault prediction, error handling, and threat detection—the LLM answer mentions ML but doesn't specifically highlight these diagnostic/predictive capabilities. (4) The ground truth mentions 'data lake houses and real-time analysis of transactional data' as 2024 positioning elements, which the LLM answer omits. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this qualitative question, so this dimension scores well based on correct year identification and appropriate temporal framing. QUALITATIVE ACCURACY: The reasoning is generally sound in showing evolution, but the potential misplacement of Java Cloud/APEX integration timing and omission of specific 2024 ML capabilities (diagnostics, fault prediction) and use cases (data lake houses) slightly weakens the qualitative assessment. CONTEXTUAL RELEVANCE: The answer directly addresses the question about positioning evolution and integration/automation capabilities across the specified time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 663,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "In 2023 GM’s exposure to Ultium Cells Holdings LLC included a $0.8 billion committed‑capital contribution and, although it was a key financing partner, the company “lacked the power through voting or similar rights to direct the activities of these entities” (i.e., it was a non‑controlling investor)【page_80】. By 2024 GM’s capital stake had slipped to about $0.7 billion – a modest reduction in its investment – but it remained a strategic, non‑controlling partner in the battery‑cell venture, still without voting control over Ultium Cells’ operations【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of GM's evolving relationship with Ultium Cells Holdings LLC. QUANTITATIVE ACCURACY: Both key financial figures are correct - the $0.8 billion committed contribution in 2023 and the $0.7 billion investment stake in 2024 match the ground truth exactly. The characterization of the $0.7 billion as a 'modest reduction' is accurate and appropriately contextualizes the change. QUALITATIVE ACCURACY: The LLM correctly identifies the critical distinction between 2023 and 2024: the shift from a 'committed capital contribution' (contingent obligation) to a realized 'capital stake' (actual investment). The answer accurately captures GM's non-controlling investor status in both years, correctly noting the lack of voting control and inability to direct activities. The terminology used ('non-controlling investor,' 'variable interest entity' concept implied through voting control discussion) aligns with the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple dimensions (capital amounts, control structure, strategic positioning). The logical progression from contingent commitment to realized investment is clearly articulated. COMPLETENESS: The answer addresses all aspects of the question - capital involvement evolution, strategic positioning, and the nature of the relationship in both years. The inclusion of direct quotes from source documents (page references) adds credibility. MINOR CONSIDERATIONS: The ground truth mentions 'potentially greater influence' as a possibility from the transformation, while the LLM answer emphasizes the continued 'non-controlling' status. This is not contradictory but represents a slight difference in emphasis - the LLM appropriately focuses on what actually occurred (continued non-controlling status) rather than speculative potential. The answer is semantically equivalent to the ground truth while being more precise about the actual control dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 549,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "The Litigation Management Deed’s releases have shrunk: the sixth‑anniversary release in 2022 freed $3.5 billion of as‑converted value and issued 176,655 series A preferred shares, while the eighth‑anniversary release in 2024 freed $2.7 billion and issued 99,264 series A shares. Thus, the value released fell by about $0.8 billion and the share issuance dropped by roughly 77 k shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - 2022 sixth anniversary release: $3.5 billion and 176,655 shares; 2024 eighth anniversary release: $2.7 billion and 99,264 shares. The calculated differences are accurate: $3.5B - $2.7B = $0.8B decrease, and 176,655 - 99,264 = 77,391 shares (LLM rounded to ~77k, which is acceptable). ENTITY ACCURACY: Correctly identifies Visa, the Litigation Management Deed, series A preferred stock, and the specific anniversary releases (sixth in 2022, eighth in 2024). MULTI-HOP REASONING: Successfully synthesizes information across two different time periods and compares the financial impacts, drawing the logical conclusion that both metrics decreased. COMPLETENESS: Addresses all parts of the original question - the evolution between 2022 and 2024, the as-converted value released, and the number of shares issued. SEMANTIC EQUIVALENCE: The phrase 'freed' is semantically equivalent to 'released,' and the overall narrative matches the ground truth's conclusion about reduction in financial burden. MINOR CONSIDERATIONS: The LLM uses slightly more concise language ('shrunk,' 'freed') compared to the ground truth's more formal tone, but this is a stylistic difference that enhances clarity without sacrificing accuracy. The rounding of 77,391 to '77k shares' is a reasonable approximation for comparative purposes. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 404,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "In 2023, after reconsolidating the Aearo Entities, 3M booked a $4.2 billion pre‑tax charge for the CAE Settlement, raised its Combat Arms Earplugs accrual by $4.3 billion and saw corporate‑special‑item costs surge as litigation‑related expenses were reflected in both the Safety & Industrial segment (Aearo‑related respirator‑mask costs) and corporate accounts. By 2024 the settlement was amended to require cash payment of the $1 billion equity portion, corporate‑special‑item costs fell, operating‑margin pressure eased, and the Aearo Entities’ impact was now shown as divestiture/acquisition adjustments in the Transportation & Electronics segment rather than as large litigation charges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific dollar amounts ($4.2 billion pre-tax charge, $4.3 billion accrual increase, $1 billion equity portion) that are NOT present in the ground truth answer. The ground truth explicitly states the reconsolidation had 'an immaterial income statement impact' - directly contradicting the LLM's claim of massive charges. These numbers appear to be fabricated or from incorrect sources. (2) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2023 reconsolidation and CAE Settlement, it adds unverified financial details not in the ground truth. The ground truth focuses on the NATURE of the relationship shift (litigation-focused to strategic financial treatment), not specific charge amounts. (3) SEGMENT ACCURACY - The LLM mentions 'Safety & Industrial segment (Aearo-related respirator-mask costs)' but the ground truth references 'Transportation and Electronics segment' for the 2024 treatment. This is a factual error in segment identification. (4) CORRECT ELEMENTS - The LLM does correctly identify: (a) 2023 reconsolidation after bankruptcy dismissal, (b) CAE Settlement involvement, (c) 2024 shift to divestiture/acquisition adjustments, (d) general trend from litigation charges to financial treatment adjustments. (5) REASONING QUALITY - The multi-hop synthesis structure is sound (comparing 2023 vs 2024), but it's built on incorrect quantitative foundations. The ground truth emphasizes the shift in HOW Aearo was treated (litigation impact vs. segment adjustments), not the magnitude of charges. CRITICAL FLAW: Introducing specific financial figures contradicts the ground truth's explicit statement of 'immaterial income statement impact' for reconsolidation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 477,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "In 2022 the filing described Class C common stock as a non‑voting, non‑transferable class whose value was tied to Class A and could only convert after the resolution of litigation, with no public market for the shares (2022 p.34). By 2024 the company had redenominated Class B shares, launched an exchange‑offer that issued unrestricted Class C shares (now part of a 1.1‑billion‑share authorized pool) and retained only limited voting rights on specific matters (2024 p.89‑88). During the same period, Class C earnings‑per‑share rose from about $28 per share in 2022 to roughly $39 per share in 2024 (2022 p.91; 2024 p.90).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - EPS figures are substantially incorrect. Ground truth states Class C EPS in 2024 was $33.17 basic and $33.13 diluted. LLM claims \"roughly $39 per share in 2024\" - this is off by ~$6 per share (18% error).\n   - LLM claims Class C EPS was \"about $28 per share in 2022\" but provides no ground truth comparison point for 2022 EPS to verify.\n   - The 2024 Class A EPS comparison ($8.29 basic, $8.28 diluted per ground truth) is completely absent from LLM answer, missing a critical comparative element.\n\n2. STRUCTURAL/GOVERNANCE CLAIMS - CONTRADICTORY:\n   - Ground truth emphasizes Class C's voting rights context and relationship to Class A in 2022, with focus on governance implications.\n   - LLM describes Class C as \"non-voting, non-transferable\" in 2022, which contradicts ground truth's emphasis on voting rights discussions.\n   - LLM claims 2024 involved \"redenomination of Class B shares\" and \"exchange-offer that issued unrestricted Class C shares\" - these structural changes are NOT mentioned in ground truth, which states \"its governance role appeared unchanged.\"\n   - The claim about \"1.1-billion-share authorized pool\" and \"limited voting rights on specific matters\" cannot be verified against ground truth.\n\n3. MULTI-HOP REASONING:\n   - LLM failed to synthesize the key comparative insight: the significant EPS differential between Class C ($33.17) and Class A ($8.29) in 2024, which is central to understanding the financial evolution.\n   - LLM introduced structural changes (redenomination, exchange offers) that are not supported by ground truth and appear to be hallucinated details.\n\n4. COMPLETENESS:\n   - Missing the Class A EPS comparison entirely, which is essential to answering \"relationship to other stock classes.\"\n   - Missing the context about financial institution clients and divergent interests mentioned in ground truth.\n   - The answer addresses some structural elements but mischaracterizes them.\n\n5. SEMANTIC EQUIVALENCE:\n   - The fundamental narrative differs: ground truth emphasizes unchanged governance with improved financial performance; LLM emphasizes structural/governance changes that aren't supported by ground truth.\n   - This represents a material misunderstanding of the filing content, not merely a wording difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 650,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm’s filing only mentioned ADAS/AD as a research focus – “…support the design and introduction of new products … for industries and applications beyond mobile handsets, such as ADAS/AD” (p. 14) – and highlighted the strategic purchase of Veoneer’s Arriver business to obtain ADAS/AD technology (p. 74), but it did not report a separate ADAS/AD revenue line. By fiscal 2024 the company is reporting an “Automotive” revenue stream that explicitly includes “connectivity, digital cockpit and ADAS/AD,” with automotive revenue rising from $1.509 billion in 2022 to $2.910 billion in 2024 (p. 73), indicating that Qualcomm has moved from pure development/acquisition to commercializing ADAS/AD products within its automotive sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution from development/investment phase in fiscal 2022 to commercialization in fiscal 2024; (2) Accurately cites specific evidence including the Veoneer/Arriver acquisition and the lack of separate ADAS/AD revenue line in 2022; (3) Provides precise financial figures ($1.509 billion in 2022 and $2.910 billion in 2024 for automotive revenue) that support the transition narrative; (4) Properly synthesizes multi-hop information across fiscal years and revenue categorization changes; (5) Correctly identifies the QSI segment and strategic investment context; (6) Accurately characterizes the shift from pure development to commercialization with explicit revenue categorization. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes page references and direct quotes), which adds credibility and specificity without contradicting the ground truth. The financial figures provided ($1.509B and $2.910B) represent the automotive segment revenue and correctly illustrate the growth trajectory. The reasoning chain is sound: development/acquisition in 2022 → commercialization with explicit revenue reporting in 2024. All entities (Qualcomm, ADAS/AD, automotive segment, fiscal years) are correctly identified. The answer fully addresses the question's requirement to explain evolution based on 'specific changes in strategic activities and revenue categorization.' No calculation errors detected. The semantic meaning perfectly matches the ground truth assertion that ADAS/AD transitioned from investment/development to revenue-generating product line.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 473,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "In the 2022 filing Visa’s U.S. Retrospective Responsibility Plan was described mainly as a **U.S. litigation escrow account** (to which the company deposited $850 million in fiscal 2022, with a $1.4 billion balance) and a **loss‑sharing agreement** that reduced its exposure to certain lawsuits 【page_46】. By the 2024 filing the plan had been expanded into a **multi‑component framework** that still includes the escrow agreement but now also incorporates a **conversion feature on class B shares**, **make‑whole agreements** tied to the class‑B exchange offer, **indemnification obligations of Visa U.S.A. members**, an **interchange judgment‑sharing agreement**, a **loss‑sharing agreement**, and an **omnibus agreement** that allocates settlement amounts between Visa and Mastercard 【page_72】【page_73】【page_74】. This evolution shows Visa has moved from a relatively simple escrow‑based shield to a more sophisticated, layered structure that combines funding, equity‑dilution, contractual indemnities and sharing arrangements, indicating a proactive and increasingly granular approach to managing and containing litigation risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Visa's U.S. Retrospective Responsibility Plan between 2022 and 2024, with accurate identification of the key mechanisms and a sound multi-hop synthesis across the two time periods. STRENGTHS: (1) Correctly identifies all major components of the 2024 plan (escrow agreement, conversion feature on Class B shares, make-whole agreements, indemnification obligations, interchange judgment-sharing agreement, loss-sharing agreement, omnibus agreement), matching the ground truth comprehensively. (2) Accurately characterizes the 2022 plan as primarily escrow-based with a loss-sharing agreement. (3) The reasoning about evolution from simple to sophisticated, layered structure is sound and well-articulated. (4) Multi-hop synthesis is correct - properly comparing 2022 vs 2024 mechanisms and drawing appropriate conclusions about Visa's risk management approach. (5) Semantic equivalence is strong throughout. WEAKNESSES: (1) The specific dollar amounts cited ($850 million deposit in fiscal 2022, $1.4 billion balance) cannot be verified against the ground truth provided, which does not include these quantitative details. While these numbers may be accurate from the actual filings, they represent additional information not in the ground truth answer. (2) The reference to an 'omnibus agreement that allocates settlement amounts between Visa and Mastercard' introduces a detail (Mastercard involvement) not explicitly mentioned in the ground truth, though this may be accurate from the actual filing. (3) Page citations are provided but cannot be independently verified. The quantitative accuracy score is reduced slightly due to the inability to verify the specific dollar amounts against ground truth, though they appear reasonable and are presented with appropriate context. Overall, the answer successfully addresses the multi-part question about mechanisms, evolution, and implications for risk management strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 536,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck’s share of Lynparza’s profits grew from $1.199 billion in 2023 to $1.311 billion in 2024 – a 9 % rise (11 % when foreign‑exchange effects are excluded)【page_53】.  The 2023 filing shows Lynparza represented roughly $1.5 billion of Merck’s net “licenses and other” intangible assets, highlighting its strategic significance【page_101】, and the 2024 discussion notes that the alliance‑revenue increase was driven by higher demand in most international markets and a new Chinese regulatory approval for an adjuvant indication, indicating both stronger performance and growing importance of the product【page_55】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 9% growth in alliance revenue between 2023 and 2024, mentions the $1.5 billion net intangible asset in 2023, and appropriately notes the China regulatory approval and international market demand drivers. The multi-hop synthesis across financial metrics, strategic importance, and regulatory developments is sound. The answer addresses all parts of the question about financial stake evolution and performance indicators.\n\nCRITICAL ERRORS: The LLM introduces specific profit-sharing numbers ($1.199 billion in 2023 to $1.311 billion in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states 'the financial stake amount was not explicitly stated' for 2024, yet the LLM provides precise figures with page citations. This represents a significant factual error - the LLM appears to have fabricated or misinterpreted financial data. The 11% figure (excluding FX effects) is also not mentioned in the ground truth.\n\nNUMBER VERIFICATION: Ground truth confirms $1.5 billion intangible asset in 2023 and 9% growth in alliance revenue - these are correct in the LLM answer. However, the $1.199B and $1.311B figures cannot be verified against the ground truth and appear to be either hallucinated or misattributed.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across multiple dimensions (financial metrics, market performance, regulatory approvals) and properly connects them to strategic importance. The logic flow is sound.\n\nCONCERN: The page citations (page_53, page_101, page_55) suggest the LLM is claiming specific sourcing for numbers that don't appear in the ground truth, which is problematic for financial accuracy where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 477,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "In the 2022 filing Skoal was listed as one of USSTC’s premium moist‑snuff brands (alongside Copenhagen) that helped keep the oral‑tobacco segment’s total shipment volume flat at about 820 million units year‑over‑year. By 2024, Skoal’s performance had weakened – shipment volume fell to 147 million cans/packs (down from 163 million in 2023) and its retail share dropped to 7.6% (from 9.3% in 2023), ceding ground to Copenhagen (still the segment leader at 19.1% share) and to the fast‑growing on! nicotine‑pouch brand (up to 8.3% share), prompting modest price hikes on Skoal in 2023‑24.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and problematic information. CORRECT ELEMENTS: (1) Skoal's retail share decline from 9.3% to 7.6% is accurate; (2) Copenhagen's position as segment leader at 19.1% in 2024 is correct; (3) on!'s growth to 8.3% share is accurate; (4) The characterization of Skoal as a premium moist-snuff brand is correct; (5) The overall narrative about Skoal losing market share to both Copenhagen and on! is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces shipment volume data (147 million cans/packs in 2024, down from 163 million in 2023) that is NOT present in the ground truth answer. This appears to be fabricated or from an unreliable source, as the ground truth focuses on retail share percentages, not unit shipments; (2) The claim about 'modest price hikes on Skoal in 2023-24' is not mentioned in the ground truth and cannot be verified; (3) The reference to 2022 shipment volume of '820 million units' is not in the ground truth; (4) The LLM conflates 2023 data (9.3% share) with 2022 in the opening statement ('from 9.3% in 2023'), when the ground truth indicates 9.3% was the 2022 figure. MULTI-HOP REASONING: The LLM correctly synthesizes the competitive dynamics across three brands (Skoal, Copenhagen, on!) and identifies the key trend of Skoal underperforming. However, the introduction of unverified shipment volume data and price information undermines the reliability of the analysis. The core insight about market share evolution is sound, but the answer adds unsupported details that create factual uncertainty. QUANTITATIVE ACCURACY PENALTY: The shipment volume figures cannot be verified against ground truth and appear to be hallucinated, significantly reducing confidence in the quantitative accuracy despite the retail share percentages being correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 491,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Dynamics 365 (reported as “Dynamics products and cloud services”) generated $4.687 billion in fiscal 2022 and rose to $5.437 billion in fiscal 2023 – an increase of roughly $750 million, or about 16% year‑over‑year【page_93】. That growth helped lift total Microsoft Cloud revenue from $91.4 billion in FY 2022 to $111.6 billion in FY 2023【page_93】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific revenue figures for Dynamics 365 ($4.687B in FY2022 and $5.437B in FY2023) with a calculated 16% YoY growth, which represents a more granular level of detail than the ground truth. However, there are critical discrepancies: (1) The ground truth states Microsoft Cloud revenue was $91.2B in FY2022, but the LLM claims $91.4B - a $200M discrepancy that suggests potential data source error. (2) The ground truth mentions a 39% increase in Dynamics 365 for FY2022, but the LLM provides only the 16% growth rate for FY2023, missing the FY2022 growth metric entirely. (3) The ground truth explicitly states the $91.2B figure, making the $91.4B claim factually incorrect. (4) The LLM's calculation of the $750M increase ($5.437B - $4.687B = $750M) is arithmetically correct, and the 16% growth rate is accurately calculated from those figures. The answer does address the evolution between the two fiscal years and provides concrete revenue numbers, which is more specific than the ground truth's acknowledgment that exact growth percentages for 2023 are not explicitly stated. However, the Microsoft Cloud revenue discrepancy ($91.4B vs $91.2B) is a material factual error that undermines confidence in the data sources cited. The multi-hop reasoning (connecting Dynamics 365 revenue to overall Microsoft Cloud growth) is sound, but the quantitative foundation contains at least one verifiable error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 396,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "In the 2023 filing Merck’s balance‑sheet risk‑management program relied mainly on forward exchange contracts (recorded as non‑designated hedges and marked‑to‑market through other‑income) to offset transaction‑type FX exposure, supplemented by purchased local‑currency put and collar options, and a smaller set of forward contracts designated as net‑investment hedges plus euro‑denominated notes used as economic hedges (see 2023 pages 94‑97). By 2024 the company still uses forward contracts as the primary tool but has broadened the currency coverage to include the Swiss franc, increased the notional amounts of both designated and non‑designated forwards, and retained the same accounting treatment—non‑designated forwards continue to flow through other‑income while designated net‑investment forwards are recorded in OCI—signalling a larger scope of hedging activity (see 2024 pages 95‑99).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION ON 2023 INSTRUMENTS: The LLM answer claims that in 2023 Merck used 'purchased local-currency put and collar options' as part of the program, but the ground truth explicitly states these options were INTRODUCED in 2024, not present in 2023. The ground truth clearly indicates 2023 'primarily used forward exchange contracts' with no mention of put/collar options in that year. This is a critical factual error. (2) INCOMPLETE 2023 CHARACTERIZATION: The ground truth specifies that 2023 focused on 'forward exchange contracts' for specific currencies (euro, Swiss franc, Japanese yen, Chinese renminbi), but the LLM answer adds details about 'designated net-investment hedges' and 'euro-denominated notes' that are not mentioned in the ground truth for 2023. (3) CURRENCY COVERAGE CLAIM: The LLM states the company 'broadened the currency coverage to include the Swiss franc' in 2024, but the ground truth indicates Swiss franc was already included in 2023. This is a factual error. (4) MISSING KEY EVOLUTION DETAIL: The ground truth emphasizes a crucial 2024 development: 'more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.' The LLM answer completely omits this important evolution in hedging strategy. (5) PAGE REFERENCES: The LLM provides specific page numbers (2023 pages 94-97, 2024 pages 95-99) that cannot be verified against the ground truth and may be inaccurate. (6) ACCOUNTING TREATMENT: While the LLM correctly identifies the accounting treatment for non-designated forwards (marked-to-market through other income) and designated hedges (OCI), this information is not explicitly confirmed in the ground truth provided. The core narrative structure is inverted - the LLM presents 2023 as more complex than it was, and understates the 2024 evolution. The answer demonstrates some understanding of FX hedging mechanics but fails on the fundamental factual comparison between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 551,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "In 2022 PayPal’s allowance for merchant loans and advances was $248 million (merchant loans $230 M + interest $18 M) and it recorded $42 million of gross charge‑offs on those receivables (see page 103 for the $230 M/​$18 M beginning balance and page 102 for the $42 M charge‑off). By the end of 2024 the allowance had fallen to $113 million (merchant loans $107 M + interest $6 M) and charge‑offs dropped to $10 million, while PayPal’s direct investment in merchant financing grew to $1.8 billion of merchant receivables purchased in 2024 (up from $1.7 billion in 2023) (page 103 for the $107 M/​$6 M ending balance and page 101 for the $1.8 B purchase amount). This reflects a shift toward lower credit‑loss provisioning and a larger deployment of capital into merchant‑financing products.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial factual information with mostly accurate numbers and good multi-hop synthesis, but has some discrepancies with the ground truth that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the shift from credit risk disclosure to active merchant receivables investment\n2. Accurately reports 2024 merchant receivables purchased at $1.8 billion\n3. Correctly notes the decline in allowance for credit losses from 2022 to 2024 ($248M to $113M)\n4. Properly synthesizes information across multiple years and metrics\n5. Appropriately cites specific page references\n6. Captures the strategic shift toward merchant financing products\n\nDISCREPANCIES WITH GROUND TRUTH:\n1. CRITICAL: Ground truth states merchant receivables purchased in 2023 were $1.7 billion, but LLM claims this figure. Ground truth does not provide 2023 purchase amount, only outstanding balance of $1.2 billion as of Dec 31, 2023. The LLM's $1.7B figure for 2023 purchases cannot be verified against ground truth.\n2. Ground truth mentions principal and interest coverage ratio (9% in 2021, 23% in 2020) which LLM does not address\n3. Ground truth specifically names products (PPWC and PPBL) which LLM does not mention\n4. Ground truth provides outstanding balance context ($1.5B as of Dec 31, 2024, up from $1.2B in 2023) which LLM omits\n5. LLM provides specific allowance breakdowns ($230M loans + $18M interest in 2022; $107M + $6M in 2024) and charge-off data ($42M in 2022, $10M in 2024) that are not in ground truth but appear to be from actual filings\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022-2024 and connects credit loss provisioning trends with direct investment growth. However, it introduces specific numbers (2023 purchases of $1.7B) not present in ground truth, which raises questions about source accuracy.\n\nQUANTITATIVE ACCURACY:\nThe 2024 figures ($1.8B purchases, $113M allowance) align with ground truth. The 2022 allowance ($248M) and charge-offs ($42M) appear reasonable but cannot be directly verified against ground truth. The 2023 purchase figure ($1.7B) is problematic as ground truth only provides outstanding balance, not purchase amount.\n\nCONTEXTUAL RELEVANCE:\nThe answer directly addresses the question about evolution of merchant receivables involvement, credit loss provisions, and direct investment. It appropriately frames the strategic shift, though it misses some nuances from ground truth (coverage ratios, specific product names).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 670,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "Altria’s 2022 filing shows that the smokeable‑products segment carried $99 million of goodwill (and essentially no change thereafter) – the same amount reported in the 2024 filing (Note 4, p. 66).  At the same time, the segment’s operating income (OCI) rose modestly, from roughly $10.7 billion in the prior year (2023) to $10.821 billion in 2024 (p. 31), indicating that while the goodwill base has stayed flat, the smokeable business continues to generate slightly higher earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and directly addresses the multi-hop question about smokeable products' financial significance evolution from 2022 to 2024. QUANTITATIVE VERIFICATION: (1) Goodwill allocation of $99 million in 2022 - CORRECT, matches ground truth. (2) Claim that goodwill remained essentially unchanged through 2024 - CORRECT, aligns with ground truth's statement that 'no updated goodwill figure is disclosed specifically for smokeable products' and implies stability. (3) Operating income figures: $10.7 billion (2023) and $10.821 billion (2024) - CORRECT, matches ground truth's $10,670 million (2023) and $10,821 million (2024) with appropriate rounding. (4) The modest increase calculation is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two key dimensions: (a) goodwill allocation trends (asset valuation perspective) and (b) operating income performance (operational significance perspective). The model correctly identifies the contrast between stable goodwill and rising operating income, demonstrating sound multi-hop synthesis. COMPLETENESS: The answer addresses both components of the question - goodwill allocation evolution and operating income performance - and provides appropriate context about what the divergence suggests. MINOR CONSIDERATIONS: The LLM states goodwill was 'essentially no change thereafter' and 'the same amount reported in the 2024 filing,' which is a reasonable interpretation given the ground truth's statement that no updated figure is disclosed. The LLM's citation references (Note 4, p. 66; p. 31) add credibility though cannot be independently verified. The semantic meaning aligns perfectly with the ground truth's conclusion about sustained profitability and potential reporting focus shift. No calculation errors detected. All entities (MO/Altria, smokeable products segment, years 2022-2024) correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 521,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Microsoft Cloud revenue – which bundles Azure, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365 and other cloud properties – rose from **$91.2 billion in FY 2022** to **$111.6 billion in FY 2023**, a jump of roughly $20 billion (about a 22 % increase)【page_96†L14-L18】【page_93†L23-L27】. This growth indicates a markedly larger contribution from the commercial LinkedIn segment within the overall cloud business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data is correct: FY 2022 Microsoft Cloud revenue of $91.2 billion, FY 2023 revenue of $111.6 billion, and the calculated increase of approximately $20.4 billion (22% increase). The calculation is accurate: ($111.6B - $91.2B) / $91.2B = 22.4%, which rounds to 22%. The answer correctly identifies all components of Microsoft Cloud (Azure, Office 365 Commercial, commercial LinkedIn, Dynamics 365, and other cloud properties), demonstrating proper multi-hop synthesis across the relevant financial segments. The temporal comparison between FY 2022 and FY 2023 is precise and directly addresses the question. The answer appropriately contextualizes LinkedIn's commercial portion within the broader Microsoft Cloud portfolio and correctly interprets the growth as indicating stronger revenue contribution from LinkedIn's commercial services. The inclusion of source citations adds credibility. The only minor consideration is that the answer could have been slightly more explicit about isolating LinkedIn's specific contribution (though the ground truth also doesn't provide this granular breakdown), but this is not a deficiency since the question asks about evolution of revenue contribution, which the answer addresses by showing the overall Microsoft Cloud growth that includes LinkedIn. The semantic meaning and factual content align perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 399,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "In 2023 Lynparza’s rollout was anchored by two new geographic clearances – an FDA approval in the United States and a Japanese MHLW approval (both for the abiraterone‑based mCRPC indication) 【page_7】. By 2024 the product’s alliance revenue had risen 9 % to $1.311 billion, driven by “higher demand in most international markets” as Lynparza was marketed for several cancer types worldwide 【page_53】【page_55】, showing a clear expansion of both its geographic footprint and sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023 FDA and Japan MHLW approvals for the abiraterone-based mCRPC indication. (2) The 9% alliance revenue growth figure is accurate. (3) The reference to higher demand in international markets is correctly cited. (4) The overall narrative of geographic and market expansion is sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the January 2025 China NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. This is a significant geographic and therapeutic area expansion that directly addresses the question's focus on evolution between 2023-2024 and beyond. The ground truth explicitly highlights this as 'indicating a significant geographic and therapeutic area expansion.' (2) The LLM provides a specific revenue figure ($1.311 billion) that is not present in the ground truth answer, making it difficult to verify accuracy without access to source documents. (3) The LLM's answer is somewhat vague about the specific therapeutic indications beyond mCRPC, whereas the ground truth provides clear context about the OlympiA trial approval for early breast cancer. (4) The answer lacks the temporal clarity about the January 2025 approval timing, which represents a key milestone in the product's evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about geographic approvals and revenue growth across 2023-2024, but fails to complete the full picture by omitting the 2025 China approval that represents the culmination of the expansion narrative. This is a significant gap in addressing the question's scope.\n\nNUMERIC VERIFICATION: The 9% growth figure matches ground truth. The $1.311 billion figure cannot be verified against the provided ground truth but appears reasonable for alliance revenue context.\n\nSEMANTIC EQUIVALENCE: While the wording differs, the core narrative about FDA/MHLW approvals and international market growth is semantically equivalent to the ground truth for the 2023-2024 period. However, the omission of the China approval represents a material incompleteness rather than a wording difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 591,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "In 2023 RTX recorded the Powder Metal Matter as a distinct sales reduction – a $5.4 billion negative line in the Pratt & Whitney segment (see the “Powder Metal Matter” entry in the 2023 segment table) – and it generated a $644 million deferred‑tax asset for future income‑tax benefits. By the 2024 filing the sales line no longer appears, and the deferred‑tax asset tied to the Powder Metal Matter fell to $455 million, indicating a smaller expected future tax benefit.【page_110】【page_98】",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial metrics ($644 million in 2023, $455 million in 2024) and accurately describes the shift in financial treatment from a sales reduction to a recognized tax benefit. The year-over-year comparison is correct, and the characterization of the deferred-tax asset is accurate. The answer properly synthesizes information across multiple filing years.\n\nWEAKNESSES: (1) The LLM introduces a specific $5.4 billion figure for the Powder Metal Matter as a sales reduction in the Pratt & Whitney segment, which is NOT mentioned in the ground truth answer. This appears to be an unsupported claim that adds detail not verified by the knowledge graph. (2) The ground truth explicitly states the decrease was $189 million (or about 29.3%), but the LLM does not calculate or mention this specific decrease amount, missing a key analytical component. (3) The LLM's citation references (【page_110】【page_98】) cannot be verified against the ground truth provided.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution across 2023-2024, properly identifying that the Powder Metal Matter transitioned from appearing as a sales reduction to being recognized as a deferred-tax asset. However, the introduction of the $5.4 billion figure without ground truth support suggests potential hallucination or over-specification.\n\nCALCULATION VERIFICATION: The core numbers ($644M → $455M) are correct. The decrease of $189 million (644 - 455 = 189) and the percentage decrease of 29.3% (189/644 = 0.293) are mathematically accurate but not mentioned by the LLM.\n\nOVERALL: The answer captures the essential evolution and key metrics but introduces unsupported details and omits the calculated decrease amount that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 485,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "In the 2022 Form 10‑K the Paidy Credit Agreement was described as a **secured revolving credit facility of about $198 million**, with roughly **$100 million of borrowing capacity still available** as of Dec 31 2021【page_50】.  \nBy the 2024 filing the same agreement (originally entered Feb 2022) had been **re‑structured as an unsecured revolving facility of ¥60 billion that was amended in Sep 2022 to ¥90 billion (≈ $574 million)**, with interest **at TIBOR + a margin of 0.40 %–0.60 %** and a maturity in Feb 2027; the facility was fully drawn by year‑end 2024, leaving **no borrowing capacity remaining**【page_105】【page_106】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall evolution of the Paidy Credit Agreement from 2022 to 2024 and correctly identifies key structural changes (secured to unsecured, increase in capacity, interest rate terms, maturity date). However, there are several quantitative discrepancies that reduce accuracy:\n\n1. QUANTITATIVE ISSUES:\n   - 2022 capacity: LLM states \"$198 million\" (correct) but then says \"roughly $100 million of borrowing capacity still available\" - this appears to conflate the total facility size with available capacity. Ground truth states \"$98 million outstanding as of December 31, 2021\" which is different from available capacity.\n   - 2024 capacity progression: LLM correctly identifies the amendment from ¥60 billion to ¥90 billion (≈$574 million), which matches ground truth.\n   - Interest rate: LLM correctly states \"TIBOR + 0.40%-0.60%\" matching ground truth.\n   - Maturity: LLM correctly identifies \"Feb 2027.\"\n   - Utilization: LLM adds detail that facility was \"fully drawn by year-end 2024\" with \"no borrowing capacity remaining\" - this is not explicitly stated in ground truth but is a reasonable inference.\n\n2. COMPLETENESS:\n   - LLM addresses the main evolution points: facility type change, capacity increase, interest rate terms, and maturity date.\n   - LLM adds the intermediate ¥60 billion step (Feb 2022) and Sep 2022 amendment to ¥90 billion, providing more granular timeline than ground truth.\n   - LLM mentions the financial covenant requirement is missing (ground truth notes \"maximum consolidated leverage ratio\" covenant).\n\n3. ENTITY ACCURACY:\n   - All entities correctly identified (Paidy Credit Agreement, dates, currencies, rates).\n   - Proper reference to Form 10-K filings.\n\n4. REASONING:\n   - Multi-hop synthesis is sound: correctly traces evolution across 2022-2024 period.\n   - Logical progression from secured to unsecured, capacity increase, and rate structure changes.\n   - Citation references suggest proper source documentation.\n\n5. SEMANTIC EQUIVALENCE:\n   - Core message matches: agreement evolved from smaller secured facility to larger unsecured facility with specific terms.\n   - Wording differs but conveys same information.\n\nKEY DISCREPANCY: The treatment of \"$100 million of borrowing capacity\" in 2022 is ambiguous and potentially inaccurate compared to ground truth's \"$98 million outstanding.\" This suggests either a calculation error or misinterpretation of available vs. outstanding amounts. The missing mention of the financial covenant (leverage ratio requirement) is a minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 688,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "In the 2022 Form 10‑K Altria still emphasized that a key component of its capital resources was the ability to issue long‑term senior unsecured notes – it had issued $5.5 billion of such notes in 2020‑21 and used the proceeds to fund the purchase and redemption of other senior notes. By the 2024 filing the company’s financing mix had shifted: it was repaying senior notes (about $1.1 billion in Q1 2024) and had no new senior‑note issuances (the next issue is slated for 2025), relying more on cash, commercial paper and its $3 billion revolving credit facility, indicating a reduced reliance on long‑term senior unsecured notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and reaches a conclusion that contradicts the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites $5.5 billion in senior notes issued in 2020-21, which is not mentioned in the ground truth and appears to be unsupported. The LLM mentions $1.1 billion in Q1 2024 repayments, which is not in the ground truth. The ground truth provides specific cash figures ($4.5B in 2022, $3.1B in 2024) that the LLM completely omits. (2) DIRECTIONAL CONTRADICTION: The ground truth states that the reduction in cash reserves 'suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes.' The LLM concludes the opposite - 'indicating a reduced reliance on long-term senior unsecured notes.' This is a fundamental misinterpretation of the trend. (3) MISSING KEY DATA: The LLM fails to mention the $4.5B and $3.1B cash figures that are central to understanding the capital resource evolution. The LLM also doesn't address the $3.0B Credit Agreement mentioned in the ground truth. (4) UNSUPPORTED CLAIMS: The statement about 'no new senior-note issuances (the next issue is slated for 2025)' is not in the ground truth and appears to be fabricated or from unreliable inference. (5) INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution between years, it fails to properly synthesize the relationship between declining cash reserves and increased reliance on external financing. The answer demonstrates poor multi-hop reasoning by drawing an incorrect conclusion about the direction of reliance change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 442,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "In the 2023 Form 10‑K RTX booked the Powder Metal Matter as a one‑time charge – a $5.4 billion net‑sales reduction (page 36) that also produced a $2.9 billion pretax loss and a $2.5 billion cost‑of‑sales reduction (page 38), which lowered the effective tax rate by about 4 percentage points (page 40). By the 2024 filing the company had moved the remaining tax effect into a deferred‑tax asset, showing a future income‑tax benefit of $455 million (down from $644 million in 2023, page 98), indicating that the large immediate charge has been absorbed and the tax advantage is now being recognized over time and is diminishing as the temporary differences are utilized.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core financial evolution of the Powder Metal Matter between 2023 and 2024, with the key numbers matching the ground truth: $644 million in 2023 declining to $455 million in 2024. The answer demonstrates strong multi-hop synthesis by connecting the one-time charge in 2023 to the deferred tax asset treatment in 2024, and correctly interprets the decline as indicating diminishing tax benefits over time. STRENGTHS: (1) Both key figures ($644M and $455M) are accurate and properly attributed to their respective years; (2) The reasoning about the shift from immediate charge to deferred tax asset is sound and explains the evolution well; (3) The conclusion about diminishing impact is correct and well-supported; (4) Additional context about the 2023 charge ($5.4B net sales reduction, $2.9B pretax loss, $2.5B cost-of-sales reduction) provides helpful background. WEAKNESSES: (1) The LLM provides substantial additional detail about the 2023 charge mechanics (net sales reduction, pretax loss, cost-of-sales reduction, effective tax rate impact) that, while accurate and contextually relevant, goes beyond what the ground truth explicitly addresses - this is not incorrect but represents scope expansion; (2) The page references cited (36, 38, 40, 98) cannot be verified against the ground truth provided; (3) Minor: The phrasing about tax benefits being \"recognized over time\" and \"utilized\" is interpretive rather than directly stated in the ground truth. The answer correctly addresses both parts of the question (how the treatment evolved AND what it indicates about future impact), demonstrating proper multi-hop reasoning across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 464,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "In the 2022 filing the Paidy Credit Agreement was a secured revolving facility of roughly $198 million, with about $98 million already drawn and roughly $100 million of borrowing capacity still available 【page_110】. By the 2024 filing the facility had been enlarged to ¥90 billion (≈ $574 million) and the entire amount was drawn down in 2024, leaving no unused borrowing capacity 【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) 2022 figures: $198 million borrowing capacity, $98 million outstanding, ~$100 million available - all correct and match ground truth exactly. (2) 2024 figures: ¥90.0 billion (~$574 million) with full drawdown and zero available capacity - all correct. (3) The answer correctly identifies this as a secured revolving facility and properly synthesizes the evolution across the two-year period. (4) Multi-hop reasoning is sound: the model correctly compared 2022 vs 2024 positions, identified the increase in facility size, and noted the change from partial to full utilization. (5) Currency conversion is appropriately handled (¥90 billion ≈ $574 million). (6) The citation references [page_110] and [page_45] add credibility. Minor note: The answer uses slightly different phrasing than ground truth ('enlarged' vs 'increased', 'drawn down in 2024' vs 'drawn down') but these are semantically equivalent and represent appropriate variation. The answer fully addresses all aspects of the question regarding borrowing capacity evolution and actual drawdown between 2022 and 2024. No calculation errors detected. All entities (PayPal, Paidy Credit Agreement, years, amounts) correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 358,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "In the 2023 filing Accenture plc disclosed that the only ownership stake in its subsidiary Accenture Canada Holdings Inc. held by current and former members of Accenture Leadership was a “non‑controlling interest” of less than 1 percent of the subsidiary (see page 20). By the 2024 filing the relationship is defined through “exchangeable shares” issued by Accenture Canada Holdings Inc. that may be swapped on a one‑for‑one basis for Accenture plc Class A ordinary shares (or cash) and are covered by a share‑purchase/redemption program, while the non‑controlling interest remains under 1 percent (see pages 100‑101).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The noncontrolling interest percentage (<1%) is correctly stated for both 2023 and 2024; (2) The exchangeable shares mechanism is accurately described with the one-for-one exchange ratio for Accenture plc Class A ordinary shares and cash redemption option; (3) The subsidiary name (Accenture Canada Holdings Inc.) and parent company (Accenture plc) are correctly identified; (4) The timeframe comparison between 2023 and 2024 filings is appropriate. However, there are minor gaps in completeness: The LLM answer does not explicitly mention the Class X ordinary shares restriction that ties the number of Class X shares to the number of exchangeable shares held, which was highlighted in the ground truth as a key structural evolution. The ground truth emphasizes this as part of the 'more formalized and structured equity relationship,' whereas the LLM focuses primarily on the exchangeable shares mechanism itself. The LLM's characterization of the evolution as moving from 'simpler noncontrolling interest disclosure' to a more detailed exchangeable shares structure is semantically equivalent to the ground truth's description, though less explicit about the Class X share restriction. The page references provided (pages 20, 100-101) appear reasonable for SEC filing structure but cannot be independently verified. Overall, the answer captures the essential evolution of the ownership structure accurately but omits one structural detail (Class X shares restriction) that represents a meaningful part of the 2024 formalization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 447,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "In the 2022 filing Merck said its balance‑sheet risk program “principally utilizes forward exchange contracts … in developed‑country currencies, primarily the euro, Japanese yen, British pound, Canadian dollar and Swiss franc,” and would only hedge a developing‑country currency such as the Chinese renminbi when a cost‑benefit analysis (exposure size, volatility and hedging cost) deemed it economical. By the 2024 filing the focus had narrowed to “primarily the euro, Swiss franc, Japanese yen and Chinese renminbi,” with the same cost‑benefit test still applied to decide whether to enter into a forward contract. Thus the company has shifted to a tighter set of core currencies—adding the renminbi as a primary exposure and dropping the pound and Canadian dollar—while retaining the magnitude‑, volatility‑, and cost‑driven assessment for hedging.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific currency details and attempts to characterize the evolution between 2022 and 2024, but contains a significant factual error that contradicts the ground truth. CORRECT ELEMENTS: (1) The 2022 filing correctly identifies the primary developed-country currencies (euro, Japanese yen, British pound, Canadian dollar, Swiss franc); (2) The cost-benefit analysis framework is correctly identified for 2022 (exposure size, volatility, hedging cost); (3) The 2024 filing correctly identifies the shift to include Chinese renminbi; (4) The cost-benefit test is correctly noted as still being applied in 2024. CRITICAL ERROR: The LLM states that by 2024 'the same cost-benefit test still applied to decide whether to enter into a forward contract,' but the ground truth explicitly states that 'the detailed discussion around cost-benefit analysis...was omitted' by 2024. This is a fundamental mischaracterization of the evolution. The ground truth indicates a SHIFT AWAY from emphasizing the cost-benefit framework in 2024, while the LLM claims it was retained. ADDITIONAL ISSUE: The LLM characterizes the renminbi as being 'added as a primary exposure' in 2024, but the ground truth suggests it was mentioned in 2022 as a developing-country currency subject to cost-benefit analysis, and by 2024 it appears in the primary list—this is a more nuanced shift than the LLM captures. The LLM's interpretation that the cost-benefit framework was 'retained' directly contradicts the ground truth's assertion that discussion of this framework was 'omitted' in 2024. This represents a failure in multi-hop reasoning about the evolution of disclosure emphasis between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 462,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "In the 2023 filing RTX described the Powder Metal Matter as a huge $5.3‑$5.4 billion sales charge and a $2.9 billion hit to operating profit, but in the 2024 filing it appears only as a deferred‑tax‑asset line item that fell from $644 million in 2023 to $455 million in 2024. The drop in the deferred‑tax benefit shows the tax advantage from the matter is being used up, indicating its ongoing financial impact on future income‑tax benefits is diminishing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial figures and the evolution of the Powder Metal Matter disclosure. Strengths: (1) Correctly identifies the 2023 net sales charge of $5.3-$5.4 billion (ground truth states $5.3 billion; LLM's range is reasonable given potential rounding variations across filings), (2) Accurately cites the deferred tax asset values of $644 million (2023) and $455 million (2024), matching ground truth exactly, (3) Properly synthesizes the multi-hop information showing the shift from operational loss to deferred tax asset treatment, (4) Correctly interprets the $189 million decline ($644M - $455M) as indicating diminishing tax benefits. Minor considerations: (1) The LLM adds a $2.9 billion operating profit impact not explicitly mentioned in the ground truth answer, though this appears to be additional accurate detail from the filings rather than an error, (2) The reasoning about 'tax advantage being used up' is a reasonable interpretation of the declining deferred tax asset, though the ground truth uses slightly different language ('reduction in immediate negative impact and potential long-term recovery'). Both interpretations are logically sound. The LLM answer effectively addresses the core question about what the change suggests regarding ongoing financial impact on future income tax benefits, demonstrating solid multi-hop reasoning across 2023 and 2024 disclosures. The answer is more concise than ground truth while maintaining accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 427,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "In 2022 PayPal’s merchant‑receivable activity was centered on its PP Working Capital (PPWC) and PP Business Loan (PPBL) products, which were funded through a program agreement with WebBank – WebBank extended credit to U.S. merchants and PayPal purchased and serviced the resulting receivables, while overseas working‑capital advances were made through its own subsidiaries (see page 72). By 2024 the WebBank partnership remained in place, but the scale had grown sharply: PayPal purchased about $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and the outstanding pool of merchant loans, advances and fees rose to roughly $1.5 billion (up from $1.2 billion) (see page 101).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key financial metrics: $1.8 billion in 2024 merchant receivables purchases (vs $1.7 billion in 2023), and the outstanding pool reaching $1.5 billion (vs $1.2 billion in 2023). The WebBank partnership is correctly identified as the core mechanism in both 2022 and 2024. The answer accurately conveys the evolution from 2022 to 2024 and demonstrates sound multi-hop reasoning by synthesizing information across years and entities. The mention of overseas working capital advances through subsidiaries adds helpful context. WEAKNESSES: The LLM answer omits a significant detail from the ground truth - the participation interest sold to the partner institution, which increased from $44 million in 2023 to $53 million in 2024. This is an important metric that demonstrates the 'growing level of investment in and collaboration' mentioned in the ground truth. The ground truth also explicitly notes PayPal's accounting treatment (sale and derecognition of participation interests), which the LLM answer does not address. Additionally, the LLM answer doesn't fully explain the structural evolution of the relationship - specifically how PayPal could both purchase receivables AND sell back participation interests, which is a key aspect of how the relationship evolved. QUANTITATIVE VERIFICATION: All dollar amounts cited are accurate ($1.8B, $1.7B, $1.5B, $1.2B). No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022, 2023, and 2024, correctly identifying the WebBank partnership as the consistent mechanism while showing growth in scale. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The answer conveys the main narrative correctly, though it misses the participation interest detail which is material to understanding the full evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 508,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck’s alliance revenue from Lynparza increased from $1.116 billion in 2022 to $1.199 billion in 2023 and $1.311 billion in 2024 – a 9 % rise in 2024 and roughly a 17 % gain versus 2022【page_53†L16】.  The boost was driven mainly by higher demand in most international markets as the AstraZeneca‑partnered PARP inhibitor saw broader adoption and expanded indications【page_55†L9】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 revenue was $1.116 billion, but ground truth shows $989 million - a discrepancy of $127 million (12.8% overstatement). The 2023 figure of $1.199 billion and 2024 figure of $1.311 billion are also not verified in ground truth. The ground truth only confirms 2022 at $989 million and indicates 9% growth by 2024, which would be approximately $1.078 billion in 2024, not $1.311 billion. (2) CALCULATION ERROR: The LLM claims a 17% gain versus 2022 ($1.311B vs $1.116B = 17.5%), but this calculation is based on incorrect baseline numbers. Using ground truth figures ($1.078B vs $989M = 9%), the actual growth is 9%, not 17%. (3) MISSING CRITICAL CONTEXT: The ground truth specifically mentions the January 2025 China approval for adjuvant treatment in early breast cancer based on the OlympiA trial as a forward-looking factor. The LLM mentions 'expanded indications' generically but misses this specific, important approval detail. (4) MULTI-HOP REASONING: While the LLM correctly identifies the AstraZeneca partnership and international market demand as drivers, it fails on the core factual synthesis - the actual revenue numbers from the 10-K filings. (5) ENTITY ACCURACY: Correctly identifies Merck, Lynparza, and AstraZeneca partnership, but the financial metrics are substantially wrong. The answer demonstrates a pattern of inflated revenue figures that suggest either hallucination or reliance on incorrect source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 440,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "By 2022 PayPal’s merchant‑finance business was centered on roughly $1.4 billion of loans and advances (net of participation interest), with 91.8 % of the receivables current and a net charge‑off rate of 4.7%, and the company was actively originating, modifying and tightening the terms of those loans to manage risk (2022 10‑K, pp. 44‑45). By 2024 the portfolio had grown modestly to about $1.5 billion, the allowance for credit losses fell to $113 million (down from $160 million a year earlier) and gross charge‑offs dropped to $10 million, while PayPal’s role shifted to buying merchant receivables from partner institutions and servicing them through its PPWC and PPBL financing products that are repaid from future PayPal payment volume (2024 10‑K, pp. 101‑103).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of PayPal's merchant receivables involvement from 2022 to 2024, accurately captures the shift from risk management focus to active purchasing and servicing, correctly names the products (PPWC and PPBL), and provides relevant operational details about repayment mechanisms. The qualitative narrative about the business evolution is sound and well-reasoned.\n\nCRITICAL ISSUES WITH NUMBERS: (1) 2022 baseline: LLM states ~$1.4 billion in loans/advances vs. ground truth which doesn't explicitly state this figure for 2022 but focuses on 2024 metrics. This creates ambiguity about whether the LLM is accurately representing 2022 data. (2) 2024 outstanding balance: LLM correctly states $1.5 billion, matching ground truth. (3) MISSING KEY METRIC: Ground truth explicitly mentions $1.8 billion in purchases in 2024 and $1.7 billion in 2023—the LLM completely omits these purchase volume figures, which are central to understanding the evolution of PayPal's financial exposure. (4) Allowance for credit losses: LLM provides $113 million (2024) and $160 million (prior year), but ground truth doesn't mention these specific figures, making verification impossible. (5) Gross charge-offs: LLM states $10 million but ground truth doesn't provide this specific number.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the operational shift. However, it fails to incorporate the most important quantitative evolution metric—the actual purchase volumes ($1.8B and $1.7B) that directly demonstrate expanded financial exposure.\n\nSEMANTIC ACCURACY: The answer correctly conveys that PayPal moved from passive risk management to active merchant receivables purchasing and servicing, which is the core insight. However, the omission of purchase volume figures represents a significant gap in demonstrating the magnitude of the evolution in financial exposure.\n\nVERIFICATION ISSUES: Several numbers provided by LLM (allowance for credit losses, gross charge-offs) cannot be verified against the ground truth, suggesting either the LLM is drawing from actual filings or introducing unsupported details. The 2022 baseline of $1.4 billion is also not explicitly confirmed in the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 619,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "In 2022 Merck’s role with Lynparza was still largely regulatory – the FDA had accepted a supplemental NDA for the adjuvant‑breast‑cancer indication for priority review (with a Q1‑2022 PDUFA date) and the drug was under EU review for metastatic castration‑resistant prostate cancer【page_22】. By 2024 Lynparza is fully approved for its core oncology uses, is being commercialized worldwide, and Merck’s alliance‑revenue share grew from $1.116 billion in 2022 to $1.311 billion in 2024 – a 9 % increase driven by higher demand in international markets【page_53】【page_55】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on most key points but has some notable issues: (1) CORRECT ELEMENTS: The 2022 regulatory status (supplemental NDA with Q1 2022 PDUFA date) is accurate. The 9% growth figure is correct. The revenue figures ($1.116B in 2022 to $1.311B in 2024) are mathematically consistent with a 9% increase and appear accurate. The characterization of 2024 status as 'fully approved for core oncology uses' and 'commercialized worldwide' is appropriate. The mention of international market demand driving growth aligns with ground truth. (2) ISSUES: The LLM answer mentions EU review for metastatic castration-resistant prostate cancer in 2022, which is not mentioned in the ground truth and may introduce extraneous information not directly relevant to the question's focus on the adjuvant breast cancer indication. The ground truth specifically highlights the China approval in January 2025 for the adjuvant breast cancer indication, which the LLM answer completely omits - this is a significant regulatory milestone that should have been included. (3) MULTI-HOP REASONING: The answer correctly synthesizes regulatory progress (2022 pending approval → 2024 approved) with revenue growth (specific dollar amounts and percentage), demonstrating sound multi-hop reasoning across regulatory and commercial dimensions. (4) QUANTITATIVE VERIFICATION: The 9% calculation is correct ($1.311B / $1.116B = 1.1747 or ~17.5% growth, but the answer states 9% - this appears to be the year-over-year growth rate rather than cumulative, which is reasonable). The dollar amounts are specific and appear consistent with SEC filing data. (5) MAIN WEAKNESS: The omission of the China approval in January 2025 is a material gap, as the ground truth explicitly identifies this as evidence of 'continued global regulatory momentum' - a key part of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 511,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Boeing’s 2022 filing shows it relied on commodity swaps and purchase contracts to hedge price risk but gave no explicit forward‑looking horizon, quantifying exposure as a $46 million unrealized gain or loss for a 10 % price move【page_60】. By the 2024 filing the company states its commodity contracts now hedge forecasted purchases through 2028, with notional amounts of $388 million (designated as hedges) and $129 million (non‑hedged) and unrealized results shifting from a $78 million gain in 2022 to modest losses of $10 million in 2024, indicating a longer‑term, more tightly managed risk‑management approach and reduced financial exposure【page_111】【page_112】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Boeing's evolving commodity hedging strategy between 2022 and 2024, but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the shift from general hedging in 2022 to extended horizon in 2024; (2) Properly notes the $46 million sensitivity metric for 10% price moves in 2022; (3) Accurately captures the extension to 2028 (close to ground truth's 2031); (4) Identifies notional amounts ($388M designated, $129M non-hedged) and 2024 unrealized losses ($10M); (5) Correctly synthesizes multi-hop information across years and filing documents. CRITICAL ERRORS: (1) States 2022 unrealized results as '$78 million gain' but ground truth indicates $46 million impact (not specified as gain vs. loss); the LLM appears to have confused or misread the 2022 baseline; (2) The comparison of '$78 million gain in 2022 to modest losses of $10 million in 2024' is not supported by ground truth, which only mentions the $46M sensitivity metric for 2022; (3) Ground truth mentions 2031 as the horizon, but LLM states 2028 - this is a material discrepancy in the risk management timeline. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the evolution from shorter-term to longer-term hedging and connects this to production planning. However, the quantitative foundation is shaky due to the unrealized gain/loss confusion. The conclusion about 'reduced financial exposure' is reasonable but not fully supported by the numbers presented. MISSING ELEMENTS: The ground truth emphasizes 'cost predictability for strategic business stability' as the underlying rationale, which the LLM touches on but doesn't fully articulate. The answer would benefit from clearer distinction between the 2022 sensitivity metric and 2024 actual unrealized results.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 505,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Schwab’s pledged‑asset‑line (PAL) portfolio rose from roughly $12.7 billion at 12/31/2021 (‑ $12,698 M current + $3 M 30‑59 days + $8 M 60‑89 days = $12,709 M; see 2022 10‑K p. 91) to about $17.0 billion at 12/31/2024 ($16,726 M within 1 year + $298 M 1‑5 years = $17,024 M; see 2024 10‑K p. 141). In both periods Schwab reported that PALs were fully collateralized by securities whose fair values exceeded the borrowings (2022 10‑K p. 89 and note on p. 91) and therefore recorded no allowance for credit losses on PALs (2022 10‑K explicitly states “no allowance…required”; the 2024 loan table shows no allowance entry, implying the same treatment).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states that by 2024, Schwab 'observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics.' However, the LLM claims 'no allowance entry' in 2024, implying zero allowance both years. This is a fundamental misreading of the 2024 data. (2) The LLM's quantitative analysis of PAL growth ($12.7B to $17.0B) appears reasonable in magnitude and the calculations shown are arithmetically correct, but this detail is secondary to the core question about allowance evolution. (3) The LLM correctly identifies that 2021 PALs were fully collateralized with no allowance required, which matches ground truth. (4) However, the LLM fails to capture the key insight: the evolution from 2021 to 2024 involved a SHIFT in risk assessment methodology - from relying solely on collateralization to incorporating broader credit quality metrics and loss projections that resulted in a decreased allowance. (5) The LLM's statement that 2024 shows 'no allowance entry, implying the same treatment' as 2021 directly contradicts the ground truth's assertion of decreased allowance in 2024. This represents a failure in multi-hop synthesis - the model did not properly integrate information about the allowance change across the time period. The answer partially addresses the question structure but fundamentally misses the evolution narrative that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 425,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "In the 2022 filing Boeing noted that the 777X program had driven higher cost‑of‑sales charges in 2020 and that R&D spending was cut in 2021, reflecting reduced investment in the aircraft. By the 2024 filing the company was still recognizing a reach‑forward loss on the 777X in cost of sales, but R&D outlays rose sharply – up $525 million in 2023 and $435 million in 2024 – largely due to the 777X, signalling a strategic shift to reinvest in and position the program as a key future product.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key R&D spending increases ($525 million in 2023 and $435 million in 2024) and accurately captures the strategic shift from cost burden to investment priority. The numbers are correct and properly formatted. The answer demonstrates understanding of the multi-hop synthesis required (comparing 2022 vs 2024 positions). WEAKNESSES: (1) The LLM introduces temporal confusion by referencing 2020 and 2021 data when the question specifically asks about 2022-2024 evolution. The ground truth focuses on 2022 as the starting point, not 2020-2021. (2) The LLM states 'the company was still recognizing a reach-forward loss on the 777X in cost of sales' in 2024, but the ground truth indicates the program had 'transitioned' away from being a cost burden by 2024 - this suggests the reach-forward loss characterization may not apply to 2024 in the same way. (3) The answer lacks clarity about the 2022 baseline (the ground truth explicitly states 2022 showed negative impact with reach-forward loss, but the LLM's framing of 2020-2021 context obscures this). CALCULATION VERIFICATION: R&D increases are correct ($525M in 2023, $435M in 2024). MULTI-HOP REASONING: The answer does synthesize the evolution across years and connects financial treatment to strategic positioning, but the temporal framing is imprecise. The core insight about the shift from cost burden to strategic investment is present but somewhat muddled by the 2020-2021 references that fall outside the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 420,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "In 2022 Schwab classified Portfolio‑Against‑Loans (PALs) as a distinct segment of its bank‑loan portfolio and measured the allowance for credit losses using a practical‑expedient that relied on the collateral‑maintenance provisions of the over‑collateralized, daily‑monitored securities pledged by borrowers 【page_78】. By 2024 the PAL segment—now shown as “pledged asset lines”—had expanded to about $17 billion (≈ $16.7 billion in the 1‑year bucket) 【page_141】, but the company still manages the risk with the same collateral‑based practical‑expedient and daily monitoring approach that limits credit‑loss exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key aspects of Schwab's PAL risk management evolution but has some gaps in completeness. STRENGTHS: (1) Correctly identifies the practical expedient methodology used in 2022 based on collateral maintenance and over-collateralization; (2) Accurately describes the daily monitoring and collateral-based approach; (3) Provides specific 2024 portfolio size ($17 billion / $16.7 billion in 1-year bucket) with proper source citations; (4) Correctly notes the terminology shift from 'PALs' to 'pledged asset lines'; (5) Accurately conveys that risk management approach remained consistent. WEAKNESSES: (1) Missing the key insight from ground truth about the 2023 decrease in portfolio before 2024 growth - the answer only mentions expansion to $17B without noting the prior year decline; (2) Does not address the 'slight decrease in 2023' mentioned in ground truth; (3) Lacks discussion of the allowance for credit losses ratio changes and what drove the decrease (improved credit quality metrics and lower projected loss rates per ground truth); (4) Does not explicitly connect the reduced risk profile to improved credit quality metrics. QUANTITATIVE ACCURACY: The $17 billion figure appears reasonable and is cited, though the ground truth doesn't provide specific dollar amounts to verify against. The 1-year bucket reference ($16.7B) adds specificity. MULTI-HOP REASONING: The answer successfully synthesizes information about methodology consistency (2022-2024) and portfolio evolution, but incompletely addresses the full evolution narrative including the 2023 dip and credit quality improvements. The answer is directionally correct but omits material details about credit loss allowance ratio changes and the drivers of improved risk metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 484,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ recorded a $45 million after‑tax gain on its British‑pound‑sterling net‑investment hedge in 2022, but the 2023 column shows a dash (i.e., $0) for that line【page_98】. The disappearance of the GBP‑denominated hedge suggests the company has unwound or eliminated its pound‑sterling exposure, reflecting a move to reduce or re‑balance its foreign‑exchange risk in that currency.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims MDLZ recorded a $45 million after-tax gain on a GBP net-investment hedge in 2022 with $0 in 2023. However, the ground truth states the opposite: $3 million in 2022 and $45 million in 2023. The LLM has reversed the years and misidentified the nature of the values (treating them as gains rather than note values). (2) ENTITY/METRIC CONFUSION: The LLM appears to be discussing 'after-tax gains on net-investment hedges' while the ground truth refers to 'British pound sterling notes' - these are different financial instruments/metrics. The LLM conflates hedging gains with the value of currency notes. (3) DIRECTIONAL ERROR: The LLM concludes the company unwound/eliminated GBP exposure (moving from $45M to $0), when the ground truth shows the opposite trend - an increase from $3M to $45M, indicating increased exposure. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison. The ground truth clearly indicates a significant increase in GBP exposure from 2022 to 2023, suggesting strategic hedging or increased UK operations. The LLM's conclusion about unwinding exposure is directly contradicted by the data. (5) MISSING CONTEXT: The LLM provides no accurate comparison of the 2022 vs 2023 values and misinterprets what the shift indicates about FX risk management strategy. The answer is fundamentally incorrect on both the numbers and their interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 420,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 Form 10‑K Amgen disclosed that the $1 billion of 3.125 % 2025 notes were hedged with interest‑rate swaps that produced an effective floating rate of **LIBOR + 1.8 %** (see page 132). The 2024 Form 10‑K shows the same $1 billion of notes now hedged at **SOFR + 2.1 %** (see page 149). This consistency of using swaps to convert the fixed‑coupon notes to floating‑rate exposure, together with the shift from LIBOR to the newer SOFR benchmark, reveals that Amgen actively manages interest‑rate risk and adapts its financing strategy to evolving market conventions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth states that in 2022, the 3.125% 2025 Notes had NO mention of variable rate terms (purely fixed-rate), but the LLM claims they were hedged with interest-rate swaps producing LIBOR + 1.8%. This is a direct contradiction. The LLM also introduces information about hedging with swaps that is not present in the ground truth answer, which specifically states the 2022 filing showed a fixed interest rate with no variable rate terms mentioned. Additionally, the LLM provides specific page numbers (132 and 149) that cannot be verified against the ground truth. The core narrative is inverted: the ground truth indicates a shift FROM fixed-rate (2022) TO floating-rate via SOFR (2024), while the LLM suggests both years used swaps to create floating-rate exposure, just with different benchmarks. The SOFR + 2.1% figure for 2024 matches the ground truth, but the 2022 LIBOR + 1.8% figure contradicts the ground truth's statement that 2022 showed no variable rate terms. The LLM's interpretation about active interest-rate risk management is reasonable, but it's based on incorrect premises about what the 2022 filing actually disclosed. The answer demonstrates a significant failure in multi-hop synthesis and factual accuracy regarding the key comparison between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 389,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "In the 2022 filing Schwab described its commercial‑paper issuance program as one of several external‑financing tools, warning that a credit‑market disruption could make that source unavailable (2022 p. 23). By the 2024 filing the program is still listed, but the company stresses that the rapid rise in short‑term rates in 2022‑23 has forced it to rely more on supplemental, higher‑cost funding (e.g., FHLB advances, repos, brokered CDs) and that commercial‑paper availability may be limited, reflecting a more cautious, diversified use of the program (2024 p. 16).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of Schwab's Commercial Paper Issuance Program between 2022 and 2024. STRENGTHS: (1) Correctly identifies the program's introduction in 2022 as one of several external financing tools; (2) Accurately notes the warning about credit market disruption constraining access; (3) Properly synthesizes the shift by 2024 toward increased reliance on supplemental funding sources; (4) Correctly identifies the causal factor (rapid rise in short-term rates in 2022-23); (5) Accurately lists complementary funding mechanisms (FHLB advances, repos, brokered CDs); (6) Appropriately characterizes the shift as more cautious and diversified. MINOR WEAKNESSES: (1) The answer uses page references (2022 p. 23, 2024 p. 16) which cannot be verified against the ground truth and may or may not be accurate - this is a minor issue as it doesn't affect the factual content; (2) The phrase 'commercial-paper availability may be limited' is slightly more cautious in tone than the ground truth's statement that the company 'noted' these constraints, though semantically equivalent; (3) Could have been slightly more explicit about the specific mechanism (client cash outflows outpacing cash from maturities/paydowns) though this is implied. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly connects the causal chain: rising rates → higher client cash outflows → need for supplemental funding → increased reliance on commercial paper program alongside other sources. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is not directly testable, but the temporal references (2022, 2023, 2024) are all correct. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 522,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "In the 2022 filing the 3.625 % 2022 Notes had already been redeemed (the $750 million issue was retired in 2021) and the $1.4 billion 3.625 % 2024 Notes remained outstanding, with the company using interest‑rate swaps to convert the fixed 3.625 % coupon to a floating LIBOR‑plus‑3.2 % rate【page_130】【page_132】. By 2023 the swaps on the 2024 notes were re‑priced to SOFR‑plus‑3.4 % and, as disclosed in the 2024 filing, those swap contracts and the underlying 3.625 % 2024 Notes were fully repaid when the swaps matured in 2024【page_149】【page_148】. This progression shows Amgen’s strategy of actively hedging fixed‑rate debt with floating‑rate swaps, transitioning to the SOFR benchmark, and retiring the notes at maturity to manage interest‑rate risk and maintain a disciplined debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. Verified facts: (1) $1.4 billion carrying value of 3.625% 2024 Notes in 2022 - CORRECT; (2) 3.625% fixed rate - CORRECT; (3) Notes fully paid off by 2024 - CORRECT; (4) Transition from fixed to floating rates - CORRECT. The LLM provides additional valuable context beyond the ground truth: it specifies the interest rate swap mechanics (LIBOR-plus-3.2% in 2022, SOFR-plus-3.4% in 2023), explains the 2021 redemption of the $750 million 2022 Notes, and clarifies that the company used swaps to manage the fixed-rate debt rather than simply replacing it. This additional detail is accurate and enhances understanding of the debt management strategy. The multi-hop reasoning is sound: the answer correctly synthesizes information across 2022, 2023, and 2024 filings to show the evolution of the debt structure. Minor differences from ground truth: (1) The ground truth states the shift indicates 'potentially reducing interest costs in a declining rate environment,' while the LLM focuses on 'managing interest-rate risk and maintaining a disciplined debt profile' - both are valid interpretations but emphasize different aspects; (2) The LLM provides more granular detail about swap mechanics, which is more comprehensive than the ground truth. The answer fully addresses the question about status evolution, interest rate structure changes, and debt management strategy implications. All numeric values are accurate, and the synthesis across multiple years and documents is correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 441,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "In the 2022 Form 10‑K Schwab explicitly stated that it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide,” and that any funding of its remaining VIE commitments would be made only if “certain conditions” were met and was expected to be satisfied between 2022‑2025【page_98】. By the 2024 filing, Schwab’s language had shifted to a discretionary stance: it says the company “may decide for competitive or other reasons to provide credit, liquidity or other support” to its proprietary funds (VIEs) when “significant declines in valuation…or significant redemption activity” arise, indicating that support is now conditional on adverse events rather than a blanket refusal【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively captures the evolution of Schwab's approach to VIE support between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 stance with accurate quote about not providing or intending to provide support beyond contractual requirements; (2) Accurately characterizes the 2024 shift to discretionary support language; (3) Properly identifies the key conditional triggers (significant declines in valuation, significant redemption activity); (4) Correctly synthesizes the multi-hop comparison across two filing years; (5) Appropriately notes the shift from 'blanket refusal' to conditional support based on market conditions; (6) Includes specific page references (page_98 for 2022, page_19 for 2024) that ground the answer in source material. MINOR CONSIDERATIONS: (1) The 2022 answer mentions 'certain conditions' and a 2022-2025 timeframe for satisfaction of commitments - this additional detail about the specific conditions and timeline is present in the LLM answer but could be seen as slightly tangential to the core evolution question, though it does provide useful context about the 2022 position; (2) The characterization of the shift as moving from 'blanket refusal' to 'conditional support' is semantically accurate and captures the essence of the evolution, though the original answer uses slightly different framing ('more proactive stance'). MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years (2022 and 2024) and correctly identifies the directional change in Schwab's stated approach. The reasoning is sound and logically structured. ENTITY ACCURACY: Schwab is correctly identified, years are correct (2022 and 2024), and VIEs are properly referenced throughout. No calculation errors or date inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 499,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "In 2022 MDLZ recorded a $48 million cost for the JDE Peet’s transaction, issued €300 million of zero‑interest exchangeable notes that can be redeemed for cash or JDE Peet’s shares, and logged a $740 million equity‑method gain on the investment (2022 pg 45‑46). By 2023 the company was generating cash from JDE Peet’s share sales, describing the investment as “providing us additional flexibility” with no material negative effect on liquidity, and its overall capital structure improved as total debt fell to $19.4 billion from $22.9 billion and the debt‑to‑capitalization ratio dropped from 0.46 to 0.41 (2023 pg 54‑55).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific financial numbers and metrics that cannot be verified against the ground truth knowledge graph, and appears to introduce information not present in the original answer. Critical issues: (1) QUANTITATIVE PROBLEMS: The LLM cites specific figures ($48 million cost, €300 million exchangeable notes, $740 million equity-method gain, $19.4 billion total debt, $22.9 billion prior debt, 0.46 and 0.41 debt-to-capitalization ratios) with page references (2022 pg 45-46, 2023 pg 54-55). These cannot be verified against the ground truth, which makes no mention of these specific numbers. The ground truth does not provide quantitative details about transaction costs, exchangeable notes, equity-method gains, or debt levels. (2) RELATIONSHIP CLASSIFICATION MISMATCH: The LLM answer does not address the key relationship reclassification from 'Has_Stake_In' (2022) to 'Invests_In' (2023) that is central to the ground truth. Instead, it focuses on transaction mechanics and debt metrics. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information about how the investment impacts liquidity and capital structure, which is relevant to the question. However, it does so by introducing specific financial metrics not present in the ground truth rather than addressing the relationship evolution and strategic positioning described in the original answer. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes a 'shift' in relationship classification indicating 'more strategic and stable investment posture' and 'long-term capital planning.' The LLM answer focuses on transaction details and debt reduction metrics, which are tangentially related but not the core insight about relationship evolution. (5) MISSING CONTEXT: The LLM answer does not mention the proportionate share of operating/non-operating items from JDE Peet's or the restructuring and acquisition-related costs that characterized the 2022 relationship. The answer appears to conflate transaction mechanics with relationship characterization. Without access to the actual 10-K filings to verify the cited numbers, and given the significant divergence from the ground truth's focus on relationship classification evolution, this answer cannot be considered accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 604,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "In the 2022 filing the company hedged the $1 billion of 3.125 % 2025 Notes with a LIBOR‑based swap that paid **LIBOR + 1.8 %** (see page 132). By the 2024 filing the same notional amount was still hedged, but the swap reference had moved to **SOFR + 2.1 %** (see page 149). Thus the hedging strategy shifted from a LIBOR benchmark to a SOFR benchmark and the spread rose slightly from +1.8 % to +2.1 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a significant factual error regarding the 2022 swap rate. The LLM claims the 2022 swap was at LIBOR+1.8%, but the ground truth explicitly states that 'the exact rate for the 3.125% 2025 Notes was not disclosed' in 2022. This is a fundamental factual error - the LLM fabricated a specific rate (LIBOR+1.8%) that was not actually disclosed in the filing. The LLM also incorrectly assumes the 2022 swap was LIBOR-based, when the ground truth only indicates that swaps were terminated and reentered at 'then-current interest rates' without specifying the benchmark. The 2024 rate of SOFR+2.1% is correct and matches the ground truth. The notional amount of $1 billion is correct for both years. The reasoning about the shift from LIBOR to SOFR is logical and the spread comparison (1.8% to 2.1%) is mathematically sound, but this is based on an incorrect 2022 baseline. The LLM also provides specific page references (132 and 149) which cannot be verified against the ground truth but appear to be fabricated details. The answer demonstrates understanding of the general concept of interest rate hedging evolution but fails on the most critical requirement: factual accuracy of the disclosed rates. The ground truth explicitly notes that 2022 rates were not disclosed, making the LLM's specific claim of LIBOR+1.8% a material factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 383,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart’s fair‑value of equity investments measured using Level 2 inputs fell from $5,819 million at fiscal‑year‑end 2022 to $5,570 million at fiscal‑year‑end 2023, a decline of roughly $249 million.【page_72】【page_71】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question. Verification of key elements: (1) Quantitative accuracy - All numbers are correct: FY2022 value of $5,819 million, FY2023 value of $5,570 million, and the calculated decline of $249 million ($5,819M - $5,570M = $249M). The calculation is mathematically accurate. (2) Entity accuracy - Correctly identifies Walmart, the specific metric (fair value of equity investments measured using Level 2 inputs), and the correct fiscal years (2022 and 2023). (3) Multi-hop synthesis - The answer properly synthesizes information across two fiscal years and correctly compares the values to determine the evolution and magnitude of change. (4) Completeness - The answer addresses all parts of the question: how the values evolved (decreased), the specific values for each year, and the magnitude of change ($249 million). (5) Wording - The LLM uses 'fell' and 'decline' which are semantically equivalent to the ground truth's 'decreased' and 'decline.' The phrase 'roughly $249 million' is appropriate given the exact calculation. The inclusion of page references adds credibility. Minor note: The ground truth describes the decline as 'moderate' while the LLM uses 'roughly,' but both convey the same factual information without material difference. Overall, this is a comprehensive and accurate answer with no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 385,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple’s description of its reliance on marketing has not changed. Both the 2023 Form 10‑K (page 6) and the 2024 Form 10‑K (page 6) state that, although Apple holds a broad IP portfolio, “the Company relies primarily on the innovative skills, technical competence and **marketing abilities** of its personnel” 【page_6】【page_6】.",
      "correctness_score": 1,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. The question asks how Apple's characterization of its reliance on marketing abilities EVOLVED between 2023 and 2024. The ground truth clearly documents a significant evolution: from 'relies primarily' (2023) to 'depends heavily' (2024), with the 2024 version explicitly tying these factors to ensuring 'a continual and timely flow of competitive products, services, and technologies to the marketplace.' The LLM explicitly states 'Apple's description of its reliance on marketing has not changed' and claims both years use identical language ('relies primarily'), which directly contradicts the ground truth. The LLM correctly identifies that both filings mention the three factors (innovative skills, technical competence, marketing abilities) and correctly cites page 6 for both years, but completely misses the critical linguistic shift from 'relies primarily' to 'depends heavily.' This is a major factual error that goes to the heart of answering the question. The LLM failed to perform the required multi-hop comparison across the two years' filings and missed the nuanced but important evolution in Apple's characterization. The quantitative accuracy score is relatively high only because the page numbers are correct; the qualitative accuracy is extremely low because the core reasoning and conclusion are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 384,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "In the 2022 filing Amgen reported $1.4 billion of interest‑rate swap contracts covering the 3.625 % 2024 notes, with the floating leg tied to LIBOR + 3.2 % (2022 10‑K, p. 132). By the end of 2024 those swaps had been unwound – the notional fell to $0 and the hedge no longer existed (2024 10‑K, p. 149), after a brief SOFR‑based version (SOFR + 3.4 % in 2023) (2024 10‑K, p. 149). This transition shows Amgen initially used floating‑rate swaps to offset the fixed‑rate interest‑rate exposure of the 2024 notes, but terminated the hedge as the notes matured and were repaid, reflecting a targeted, maturity‑driven hedging strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the hedging strategy and correctly identifies the key narrative (swaps unwound as notes matured), but contains a significant quantitative error that undermines accuracy. CRITICAL ERROR: The LLM states the 2022 notional was $1.4 billion with LIBOR+3.2%, but the ground truth indicates the 2022 termination involved $5.2 billion in notional amount across multiple notes (including the 3.625% 2024 Notes), not just $1.4 billion. The $1.4 billion figure appears to be the 2023 notional amount, not 2022. The LLM conflates the 2022 swap termination/re-entry event with the 2023 position. CORRECT ELEMENTS: (1) The 2024 notional correctly identified as $0; (2) The 2023 SOFR+3.4% rate correctly cited; (3) The conclusion about maturity-driven unwinding is sound; (4) The overall hedging strategy narrative is accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022, 2023, and 2024 filings and correctly identifies the progression from fixed-rate notes with floating-rate swaps to full unwinding. However, the temporal sequencing of the 2022 termination event is misrepresented. The answer would have been stronger with explicit mention of the $5.2 billion 2022 termination and re-entry, which provides important context about Amgen's proactive hedging management. The semantic understanding of the strategy is correct, but the quantitative foundation is flawed for the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 403,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "In the 2022 filing Schwab said it would **retain** TD Ameritrade Institutional’s customizable portfolio‑rebalancing tool iRebal as part of its offering for independent‑advisor (RIA) clients【page_6】. By the 2023 filing the company reported that it had **incorporated** iRebal into its own platform for those advisor clients【page_4】. This deeper integration signals that Schwab is strengthening its technology suite for RIAs—leveraging the iRebal capability to differentiate its platform and sharpen its competitive edge in the RIA market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of iRebal integration from 2022 (retention) to 2023 (incorporation), which matches the ground truth. The factual claims about the timeline and strategic positioning are accurate. However, the answer is notably incomplete in several ways: (1) It omits the significant context about the broader TD Ameritrade integration, including the $1.6 trillion in client assets and 15+ million client accounts transferred by 2023, which the ground truth identifies as important context for understanding Schwab's competitive positioning. (2) It does not mention Schwab's strategic advantage of introducing new products credibly through its strong brand and corporate reputation, which the ground truth identifies as a key competitive factor. (3) The answer is more concise but lacks the fuller picture of how iRebal fits into Schwab's broader integration strategy. The LLM correctly uses the transition from 'retain' to 'incorporate' as the key differentiator, which is semantically accurate and well-reasoned. The reasoning about differentiation and competitive edge is sound but could be strengthened with the additional context. No numerical errors are present, and the entity identification (Schwab, TD Ameritrade Institutional, iRebal, RIAs) is correct. The answer addresses the main question but misses important supporting details that would provide fuller context for understanding the competitive positioning implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 407,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "In Apple’s 2023 Form 10‑K the iMac is only referenced as one of the existing desktop models within the broader “Mac” product line (see 2023 page 4). By contrast, the 2024 Form 10‑K lists the iMac as a distinct new product announced in the first quarter of fiscal 2024 (see 2024 page 24), indicating that Apple moved from merely describing iMac as a legacy offering to actively refreshing and promoting the iMac line. This shift reflects a renewed focus on updating the iMac portfolio in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative: Apple's iMac evolved from a standard product line mention in 2023 to a highlighted product announcement in 2024. Both answers correctly identify this shift and attribute it to a product refresh/redesign warranting special mention.\n\nSTRENGTHS:\n1. Correctly identifies the 2023 positioning (iMac as part of broader Mac line)\n2. Correctly identifies the 2024 positioning (distinct new product announcement in Q1 FY2024)\n3. Accurately characterizes the shift from legacy offering to actively refreshed product\n4. Provides specific page references (2023 page 4, 2024 page 24) that add credibility\n5. Maintains semantic equivalence with ground truth regarding strategic importance\n6. Multi-hop reasoning is sound: synthesizes information across two fiscal years correctly\n\nMINOR CONSIDERATIONS:\n1. The LLM uses \"legacy offering\" language which is slightly more interpretive than the ground truth's \"actively manufacturing and marketing\" description for 2023, though both convey similar meaning\n2. The LLM specifies \"first quarter of fiscal 2024\" while ground truth says \"2024\" more generally - this is actually more precise and not contradictory\n3. The LLM's characterization of the shift as moving from \"merely describing\" to \"actively refreshing\" is slightly more interpretive than ground truth's neutral observation, but still factually supported\n\nNUMERIC/DATE VERIFICATION:\n- 2023 and 2024 fiscal years: Correct\n- Q1 FY2024 timing: Consistent with ground truth's \"2024\" reference\n- Page numbers cited: Cannot verify from provided context but appear reasonable\n\nMULTI-HOP SYNTHESIS:\nThe answer successfully synthesizes information across two 10-K filings (2023 and 2024) and correctly identifies the evolution in how iMac was presented. The reasoning chain is logical and well-supported.\n\nThe answer is substantively correct and well-reasoned, with only minor stylistic differences from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 545,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX’s 2.820 % notes due 2051 were carried at a $1 billion principal balance at year‑end 2022 (​page 95​) and remained at the same $1 billion balance at year‑end 2024 (​page 89​), indicating the company has not retired or refinanced this issuance since it was issued in 2021. The continued holding of this low‑coupon, 30‑year‑maturity tranche shows RTX’s strategy of preserving a long‑dated, low‑cost component in its debt mix, contributing to a diversified long‑term debt structure despite an overall average maturity that has shortened to about 12 years by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the principal balance of the 2.820% Notes Due 2051 as $1 billion in both 2022 and 2024, matching the ground truth. The statement that no repayment or refinancing occurred is accurate. The characterization of this as a low-coupon, long-dated debt instrument is appropriate.\n\nWEAKNESSES: (1) The LLM states the notes were 'issued in 2021,' but the ground truth indicates they were 'introduced in 2022.' This is a factual error regarding the issuance date. (2) The LLM fails to address the broader long-term debt structure evolution that is central to the question. The ground truth explicitly notes that total principal long-term debt increased from $40,078 million (2022) to $41,146 million (2024), representing a $1,068 million increase. The LLM completely omits this critical multi-hop synthesis showing how the 2051 notes fit within the expanding overall debt portfolio. (3) The LLM mentions 'average maturity that has shortened to about 12 years by 2024,' which is not mentioned in the ground truth and appears to be unsupported information. (4) The LLM's answer is more focused on strategic interpretation (preserving low-cost debt) rather than providing the factual evolution of the debt structure requested.\n\nMULTI-HOP REASONING: The question requires synthesizing information about: (a) the specific 2051 notes across two years, and (b) how this relates to overall long-term debt structure changes. The LLM addresses (a) adequately but largely fails on (b), missing the key insight that while the 2051 notes remained static, RTX increased total debt by over $1 billion through other issuances.\n\nNUMERIC VERIFICATION: The $1 billion principal balance is correct for both years. However, the omission of the total long-term debt figures ($40,078M to $41,146M) represents incomplete quantitative analysis of the question's core requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 511,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "The 2022 filing notes that the amended IDA agreement cut the service fee on client cash deposits held at the TD Depository Institutions to **15 basis points**, down from the **25 basis‑point** fee that TD Ameritrade paid under the prior IDA agreement (see 2022 10‑K p. 85). By the 2023 filing, Schwab had further revised the IDA agreement to **replace its LIBOR‑based reference rates with alternative benchmark rates**, completing the transition away from LIBOR (see 2023 10‑K p. 54).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Schwab's IDA agreement evolution. QUANTITATIVE ACCURACY: All numeric values are correct - the service fee reduction from 25 basis points to 15 basis points is accurately stated, matching the ground truth. The basis point figures are presented clearly and correctly. ENTITY ACCURACY: All entities are correctly identified - Schwab, TD Depository Institutions, LIBOR, and the IDA agreement are all properly named and contextualized. The fiscal years (2022 and 2023) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings, showing the evolution from fee structure changes (2022) to reference rate modifications (2023). The logical progression is clear and accurate. COMPLETENESS: The answer addresses both key aspects of the question - service fee changes and reference rate adjustments - with appropriate detail. The inclusion of specific page references (2022 10-K p. 85, 2023 10-K p. 54) adds credibility and specificity. SEMANTIC EQUIVALENCE: The LLM's phrasing \"replace its LIBOR-based reference rates with alternative benchmark rates\" accurately conveys the same meaning as the ground truth's \"transitioned reference rates previously tied to LIBOR to other appropriate benchmarks.\" The characterization of the evolution as \"a shift from adjustments in fee structure to modifications in financial reference mechanisms\" is implicitly captured in the LLM's structured presentation. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The addition of document citations enhances rather than detracts from the answer's quality. No factual errors, calculation errors, or misidentifications were detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 501,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "In the 2023 filing Filorga was identified as its own reporting unit with $221 million of goodwill, meaning the company treated it as a distinct, strategically important asset that required separate goodwill‑impairment testing (page 59). By the 2024 filing Filorga is only mentioned among the company’s many global trademarks and the goodwill was re‑allocated to broader segments, indicating that the brand is now viewed as part of an aggregated brand portfolio and is valued at the segment level rather than as a standalone unit (page 79; note on goodwill reallocation, page 81). This shift suggests the company has downgraded Filorga’s standalone strategic importance and is using a more holistic, segment‑wide valuation approach for its brand assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $221 million goodwill figure for Filorga in 2023 as a standalone reporting unit; (2) Accurately describes the shift to 2024 where Filorga is listed among other trademarks without separate goodwill figures; (3) Properly synthesizes the multi-hop information showing the change in reporting structure and valuation approach; (4) Correctly interprets the strategic implications - that the company downgraded Filorga's standalone importance and shifted to segment-level valuation; (5) Appropriately references page numbers (59, 79, 81) suggesting document verification. MINOR WEAKNESSES: (1) The LLM answer uses slightly more definitive language ('downgraded') compared to the ground truth's more measured 'may have been integrated' and 'could signal' - the ground truth presents this as a potential interpretation while the LLM is more assertive; (2) The ground truth mentions this 'could influence future strategic decisions such as divestiture, investment, or brand prioritization' which the LLM answer doesn't explicitly address, though this is a minor omission; (3) The ground truth emphasizes 'reducing its visibility as a standalone asset' which the LLM captures but frames slightly differently. QUANTITATIVE VERIFICATION: The $221 million figure is correct and properly cited. The year-to-year comparison (2023 vs 2024) is accurate. No calculation errors detected. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and connects the reporting structure change to strategic implications. The logic flow from standalone unit → aggregated portfolio → segment-level valuation is sound and well-articulated. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - both convey that Filorga's status changed from a distinct, separately-valued asset to part of a broader brand portfolio, suggesting reduced strategic focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 539,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "In the 2023 Form 10‑K Apple’s discussion of the iPhone was limited to the overall product category and sales figures – the filing only refers to “iPhone” net sales in aggregate and does not name any future model (see the iPhone net‑sales commentary in the 2023 filing 【page_26】). By contrast, the 2024 Form 10‑K explicitly lists the iPhone 16 Pro as a distinct product in its MD&A product announcements 【page_24】 and even includes it in the iPhone line description 【page_4】. This shift from a generic, category‑level mention to a specific, model‑level disclosure signals that Apple has moved from merely reporting iPhone performance to highlighting the development and launch of a new flagship generation, reflecting a more granular, forward‑looking reporting strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - CONTRADICTORY CLAIMS: The ground truth states that in the 2023 10-K, Apple 'announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup,' indicating forward-looking disclosure. However, the LLM claims the 2023 filing 'does not name any future model' and only refers to 'iPhone' in aggregate. This is a direct contradiction of the ground truth's core assertion. (2) MISCHARACTERIZATION OF 2023 FILING: The LLM incorrectly characterizes the 2023 10-K as containing only generic, category-level mentions without specific model references. The ground truth explicitly states the iPhone 16 Pro was announced in the 2023 filing. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the 2024 filing lists iPhone 16 Pro explicitly, it fails to properly synthesize the comparison with 2023. The LLM's narrative suggests the iPhone 16 Pro first appeared in the 2024 filing, which contradicts the ground truth's timeline. (4) REASONING FLAW: The LLM's conclusion that Apple moved from 'merely reporting iPhone performance to highlighting the development and launch' misses the actual evolution described in the ground truth: from forward-looking announcement (2023) to retrospective inclusion as an established product (2024). (5) PAGE REFERENCES: The LLM cites specific page numbers (page_26, page_24, page_4) but these cannot be verified against the ground truth, and the claims made about these pages contradict the ground truth's assertions. The answer demonstrates a fundamental misunderstanding of the product disclosure timeline and fails the multi-hop reasoning requirement by incorrectly synthesizing information across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 483,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "In the 2022 filing the firm described EVE as a “static‑balance‑sheet” tool that measures the long‑term impact of an instantaneous rate shift on the net present value of assets and liabilities, using third‑party term‑structure, pre‑payment and cash‑flow models and assumptions such as rate‑floor scenarios, non‑maturity deposit behavior and reinvestment of matured securities, but it did not model client‑cash reallocation or derivative effects [page_54, page_52]. By the 2023 filing the EVE framework had been expanded to incorporate both proprietary and third‑party models, include the impact of interest‑rate swap derivatives, and use internally built run‑off models for deposits and credits; it now explicitly reflects balance‑sheet dynamics—most notably a shortening liability duration and shifts in the asset‑liability mix as rates rose [page_53, page_51].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed and specific information than the ground truth answer. Key strengths: (1) Both answers correctly identify the 2022-2023 timeframe and the evolution of EVE simulations; (2) The LLM answer accurately captures the 2022 framework as 'static-balance-sheet' with specific modeling assumptions (rate-floor scenarios, non-maturity deposit behavior, reinvestment of matured securities); (3) The LLM correctly identifies that 2022 did NOT model client-cash reallocation, which aligns with the ground truth stating this was added in 2023; (4) The LLM accurately describes 2023 expansions including derivative effects, internally built run-off models, and explicit balance-sheet dynamics; (5) The LLM provides additional specificity about 'shortening liability duration and shifts in asset-liability mix as rates rose' which represents sound interpretation of balance sheet dynamics. Minor considerations: (1) The ground truth mentions 'prepayment speeds of mortgage-related investments' while the LLM uses 'pre-payment' models more generally - these are semantically equivalent; (2) The ground truth mentions 'deposit beta assumptions in a declining interest rate environment' for net interest revenue simulation, while the LLM focuses on the EVE framework expansion itself - the LLM's answer is more directly focused on EVE evolution as asked; (3) The LLM provides page references which adds credibility but cannot be verified; (4) The LLM answer is more comprehensive and detailed than the ground truth, providing better context about the specific modeling changes. The multi-hop reasoning is sound - the answer correctly synthesizes the evolution across years and identifies the key differences in modeling approaches. No numerical errors detected. The answer fully addresses the question about how EVE simulations evolved in terms of modeling assumptions and balance sheet dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 527,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "In its 2022 filing Qualcomm framed wireless‑access‑point technology as a market it was **enabling** – it highlighted growing demand for “wireless access points” and its role in Wi‑Fi‑Alliance standards but did not list the devices themselves as products (2022 p. 8). By the 2023 filing the QCT segment explicitly includes “wireless access points and routers” among its networking product lines, showing that Qualcomm now **produces** these devices (2023 p. 11). This shift moves Qualcomm from a pure licensor/enabler to a direct competitor with other networking‑equipment vendors, broadening its portfolio from chips and IP to complete Wi‑Fi, Ethernet, PON and gateway solutions and strengthening its competitive positioning in the broader networking market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the strategic shift from 'enabling' wireless access point technology in 2022 to 'producing' them in 2023, matching the ground truth's core narrative. (2) Accurately captures the competitive positioning change - from pure component supplier to direct competitor with vendors like Broadcom and Intel. (3) Properly synthesizes multi-hop information: references specific filing years (2022, 2023), identifies the QCT segment as the relevant business unit, and traces the portfolio evolution. (4) Correctly identifies the expanded product portfolio including Wi-Fi chips, routers, Ethernet, PON, and gateway solutions. (5) Uses appropriate page references (2022 p. 8, 2023 p. 11) suggesting proper source documentation. (6) The characterization of the shift from 'licensor/enabler' to 'direct competitor' aligns well with the ground truth's description of moving from 'enabling' to 'full-system solutions.' MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more specific product categories (Ethernet, PON, gateway solutions) than explicitly mentioned in the ground truth, though these are consistent with the broader networking market context and don't contradict the ground truth. (2) The phrase 'pure licensor/enabler' is the LLM's interpretation, while ground truth uses 'enabling the technology through foundational wireless innovations and chipset solutions' - semantically equivalent but slightly different framing. (3) The mention of Wi-Fi-Alliance standards in the LLM answer adds context not explicitly in the ground truth, but this is supplementary rather than contradictory. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The year references (2022, 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the strategic evolution and its market implications. The logic connecting the portfolio shift to competitive positioning is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 585,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "In the 2022 filing, about 28 % of Schwab’s adjustable‑rate mortgages were interest‑only, and roughly 89 % of those interest‑only loans were not scheduled to reset for three or more years. By the 2023 filing, the interest‑only share had slipped to about 27 % and the portion not resetting for three or more years fell to roughly 86 %, showing a slight decline in both the prevalence of interest‑only HELOCs and the length of their rate‑reset periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022: 28% interest-only with 89% not resetting for 3+ years; 2023: 27% interest-only with 86% not resetting for 3+ years. The percentages match the ground truth exactly. COMPLETENESS: The answer addresses all required components of the multi-hop question: (1) the interest-only percentage in 2022, (2) the reset period metric in 2022, (3) the interest-only percentage in 2023, (4) the reset period metric in 2023, and (5) the comparative analysis showing the evolution. ENTITY ACCURACY: Correctly identifies Schwab, the HELOC product, adjustable-rate mortgages, and the specific metrics requested. Years are correctly identified as 2022 and 2023. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly combined data from two different years and two different metrics to show the evolution. The interpretation that both metrics declined slightly is accurate and logically supported by the data. SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth (e.g., 'slipped' vs 'shifted,' 'fell' vs 'decreased') but conveys identical meaning. The phrase 'showing a slight decline in both the prevalence of interest-only HELOCs and the length of their rate-reset periods' accurately captures the ground truth's conclusion about the evolution. Minor deduction (1 point) only for very slight stylistic differences in phrasing, though the substance is entirely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 419,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm’s QSI (Qualcomm Ventures) arm continued to list XR as a priority area for early‑stage strategic investments in both FY 2022 and FY 2023 (QSI segment description)【page_14】.  At the same time, XR is counted within the IoT revenue stream, which fell from $7.353 billion in FY 2022 to $5.94 billion in FY 2023, showing a decline in XR‑related product sales despite the ongoing investment focus【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The ground truth explicitly states that by 2023, XR was 'explicitly listed among the industries and applications for which Qualcomm sold products,' indicating a shift from investment to commercialization. The LLM answer incorrectly claims XR is 'counted within the IoT revenue stream' without evidence this is accurate or that this represents the evolution described. (2) QUANTITATIVE ISSUES: The LLM provides IoT revenue figures ($7.353B in FY2022 declining to $5.94B in FY2023) but these numbers are not verified against the ground truth and the claim that XR is 'within' IoT revenue is not substantiated. The ground truth makes no mention of XR being part of IoT revenue. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies QSI/Qualcomm Ventures' continued investment focus in both years, but fails to capture the critical evolution - the shift from strategic investment-only (2022) to direct revenue generation (2023). This is the core answer to the question. (4) REASONING FLAW: The LLM's conclusion about 'decline in XR-related product sales' contradicts the ground truth's narrative of evolution toward commercialization. The ground truth indicates growth in XR commercialization (moving from no product revenue to explicit listing), not decline. (5) MISSING CONTEXT: The answer omits the fundamental shift from investment to commercialization that defines the evolution from 2022 to 2023. The ground truth emphasizes this transition as 'significant change in Qualcomm's engagement with XR,' which the LLM answer completely misses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 461,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The 3.030 % notes due 2052 were issued in November 2021 for $1.1 billion and were not repaid thereafter, so the aggregate principal balance was $1.1 billion at the end of 2022 and remained $1.1 billion at year‑end 2023 and 2024 (issuance shown on page 94; balance $1,100 m in 2021 on page 95 and unchanged $1,100 m for 2023‑2024 on page 89). This unchanged balance indicates that this tranche of senior debt has been a stable, unchanged component of RTX’s long‑term debt structure over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numbers are correct - $1.1 billion (or $1,100 million) principal balance is accurately stated for 2022, 2023, and 2024. The issuance date of November 2021 is correct. The note rate of 3.030% is correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the aggregate principal balance evolved between 2022-2024, and (2) what this indicates about RTX's long-term debt structure. The LLM provides specific page references (pages 94, 95, 89) which adds credibility and demonstrates source verification. ENTITY ACCURACY: RTX is correctly identified, the specific debt instrument (3.030% Notes Due 2052) is correctly named, and the fiscal years (2022, 2023, 2024) are all correct. REASONING: The multi-hop synthesis is sound - the LLM correctly traces the debt from issuance through the period and concludes that the unchanged balance indicates strategic consistency. The logic that no repayments or additional issuances occurred is properly inferred from the stable balance. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that the balance remained stable at $1,100 million and this reflects strategic consistency in capital structure management. The LLM's phrasing 'stable, unchanged component' is semantically equivalent to the ground truth's 'maintained its long-term commitment' and 'strategic consistency.' Minor difference: The LLM provides additional context about the 2023 balance (which wasn't explicitly mentioned in the ground truth but is consistent with it), and includes specific page references that enhance credibility without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 474,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "In 2023 American Express said it would “evolve our card value propositions, further differentiate our corporate card and accounts‑payable expense‑management solutions” as part of its commercial‑payments push【page_8】. By the 2024 filing the language stresses an even stronger differentiation of corporate‑card offerings and the rollout of new financing, banking and payment products for business customers, signaling that corporate cards have become a core pillar of its commercial‑payments growth strategy【page_8】. This shift is reflected in the Delta cobrand portfolio – a key corporate‑card channel – which grew from roughly 10 % of worldwide billed business in 2023 to about 12 % in 2024【page_7】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of AXP's Corporate Card strategy between 2023 and 2024, with accurate quotes from both years' filings. The 2023 quote about 'evolve our card value propositions, further differentiate our corporate card and accounts‑payable expense‑management solutions' is accurate. The 2024 shift toward 'innovative products and features, including financing, banking and payment solutions for our business customers' is also correctly identified. The quantitative data about Delta cobrand portfolio growth (10% in 2023 to 12% in 2024) appears reasonable and is presented with appropriate precision. However, there are some limitations: (1) The LLM answer adds specific Delta cobrand metrics that, while potentially accurate, are not explicitly mentioned in the ground truth answer, which focuses on the broader strategic shift rather than specific product channel performance. This represents additional detail beyond the ground truth rather than an error. (2) The LLM answer effectively synthesizes the multi-hop reasoning by connecting the strategic language evolution to concrete business metrics (Delta cobrand growth), which strengthens the argument about the shift toward integrated solutions. (3) The answer maintains semantic equivalence with the ground truth by conveying that AXP moved from product differentiation to a more integrated, solution-oriented approach. Minor deduction because the ground truth emphasizes the conceptual shift toward 'embedding the Corporate Card into a wider suite of business financial services' and 'holistic commercial needs,' while the LLM answer focuses more on product rollout and channel performance metrics. The LLM answer is factually sound and well-reasoned but slightly shifts emphasis from the strategic integration concept to operational metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 498,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "PCA SKIN remains positioned as a skin‑health brand inside the Personal‑Care portion of Colgate‑Palmolive’s Oral, Personal and Home Care segment, and its sales continue to be directed “primarily to a variety of traditional and e‑Commerce retailers, wholesalers, distributors, dentists and, in some geographies, skin‑health professionals.” The 2024 filing repeats the same distribution‑channel description that appeared in the 2023 filing, indicating no material change in its strategic positioning or channel mix【page_79】.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer directly contradicts the ground truth on the core finding. The ground truth explicitly states that by 2024, PCA SKIN's distribution channels EXPANDED to include 'sales to skin health professionals in some geographies' - representing a material change from 2023. The LLM answer incorrectly claims 'the 2024 filing repeats the same distribution-channel description that appeared in the 2023 filing, indicating no material change.' This is factually wrong. The LLM states the distribution channels are 'primarily to a variety of traditional and e-Commerce retailers, wholesalers, distributors, dentists and, in some geographies, skin-health professionals' - but then incorrectly concludes this is identical to 2023, when the ground truth indicates 'skin health professionals' was a NEW addition in 2024. The LLM has the correct final distribution list but fundamentally misunderstood the evolution/change between years. The question specifically asks about how positioning 'evolved' - the answer should highlight the expansion to skin health professionals as a refinement in positioning. Instead, the LLM negates the evolution entirely by claiming no material change. This is a major reasoning failure on a multi-hop temporal comparison question. Numbers and entities are correct, but the synthesis and conclusion are inverted from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 382,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "In the 2022 filing, Opdivo was already marketed in a wide range of tumor types (bladder, CRC, RCC, lung, melanoma, etc.) and the company’s commercial plan centered on “broadening the use of Opdivo… expanding into new tumors” and on growing the Opdivo + Yervoy combination while pursuing additional registrational studies (page 71). By 2023 the strategy had shifted to earlier‑line and adjuvant/neoadjuvant settings—evidenced by FDA approval for adjuvant melanoma (Oct 2023) and EC approvals for neoadjuvant NSCLC (June 2023), a sub‑cutaneous formulation, the fixed‑dose Opdualag (Opdivo + Yervoy) and integration with new NSCLC assets such as Augtyro and Krazati (pages 43 & 42). The 2023 results note that “an increase in demand for Opdivo… partially offset” the overall revenue decline, indicating that the expanded indication and combo portfolio is expected to sustain or accelerate Opdivo’s revenue growth trajectory (page 45).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across 2022-2023 filings. STRENGTHS: (1) Correctly identifies 2022 baseline indications (bladder, CRC, RCC, lung, melanoma, etc.) matching ground truth; (2) Accurately cites specific 2023 approvals with dates (adjuvant melanoma Oct 2023, neoadjuvant NSCLC June 2023); (3) Properly synthesizes the strategic evolution from broad indication expansion to earlier-line/adjuvant/neoadjuvant settings; (4) Correctly identifies new formulations and combinations (subcutaneous formulation, Opdualag fixed-dose, integration with Augtyro and Krazati); (5) Appropriately references page numbers (43, 42, 45, 71) suggesting document verification; (6) Correctly interprets the revenue implications, noting that increased Opdivo demand 'partially offset' overall decline, indicating strategic positioning for future growth. MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth (includes specific approval dates, page references, and asset names like Augtyro/Krazati), which adds value but goes slightly beyond the ground truth scope; (2) The ground truth mentions 'blood' and 'stomach' cancers in 2022 while LLM focuses on the major indications listed—this is a minor omission but not factually incorrect; (3) The LLM answer provides stronger evidence of the strategic shift through specific regulatory milestones, which enhances credibility. QUANTITATIVE VERIFICATION: All dates cited (Oct 2023, June 2023) are plausible and specific; no mathematical calculations required; page references appear consistent with typical 10-K structure. MULTI-HOP REASONING: Excellent synthesis connecting 2022 baseline → 2023 strategic shift → revenue implications across multiple documents. The answer correctly identifies the causal relationship between expanded indications/formulations and revenue trajectory expectations. SEMANTIC EQUIVALENCE: The answer conveys the same core message as ground truth while providing more granular detail and stronger evidentiary support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 558,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express’s foreign‑government bond portfolio was valued at $770 million at the end of 2023 and slipped slightly to $765 million at the end of 2024 (Table 4.1, Note 4)【page_124】. The maturity mix remained overwhelmingly short‑term, with $768 million due within one year and $2 million due in the 1‑to‑5‑year bucket in 2023, shifting to $764 million due within one year and $1 million in the 1‑to‑5‑year bucket in 2024 (Tables 4.4 for 2023 and 2024)【page_120】【page_126】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) 2023 Fair Value: LLM states $770 million, but ground truth shows $549 million - a $221 million discrepancy (40% error). (2) 2024 Fair Value: LLM correctly states $765 million, matching ground truth. (3) 2023 Maturity Distribution: LLM claims $768 million due within one year and $2 million in 1-5 year bucket. Ground truth states ALL $549 million matured in 12 months or more (meaning 0 in <1 year bucket, all in ≥1 year). This is a fundamental mischaracterization of the maturity profile. (4) 2024 Maturity Distribution: LLM correctly states $764 million within one year and $1 million in 1-5 year bucket, matching ground truth. (5) Trend Analysis: LLM incorrectly characterizes 2023-2024 as a 'slight slip' from $770M to $765M, when the actual evolution was a significant INCREASE from $549M to $765M (+$216M or +39%). The LLM completely missed this substantial growth. (6) Unrealized Loss: Ground truth mentions a $1 million gross unrealized loss in 2023, which the LLM omits entirely. The LLM's statement that maturity 'remained overwhelmingly short-term' in 2023 is factually incorrect - the ground truth shows the opposite (all maturing in 12+ months in 2023). The answer demonstrates poor multi-hop synthesis and contains multiple critical numerical errors that fundamentally misrepresent the investment evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 399,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "In the 2022 filing, Walmart said that about **$4.3 billion** of cash and cash equivalents “may not be freely transferable to the U.S. due to local laws or other restrictions,” and **$2.2 billion** of that amount could be accessed only through dividends or inter‑company financing that required **approval of Flipkart’s minority shareholders**【page_60】. By the 2024 filing, the non‑transferable balance had fallen to **$3.5 billion**, and the restriction is described more broadly as cash “may not be freely transferable … due to local laws or other restrictions **or is subject to the approval of the non‑controlling‑interest shareholders**”【page_43】. The company continues to rely on inter‑company financing to move cash where needed at minimum cost, but the amount of cash subject to these constraints has decreased and the approval requirement has shifted from a specific Flipkart minority‑shareholder consent to a general non‑controlling‑interest‑shareholder approval.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and correctly identifies the evolution of Walmart's intercompany financing arrangements between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 amount of $4.3 billion in non-transferable cash and the $2.2 billion specifically tied to Flipkart minority shareholder approval - these match the ground truth exactly. (2) Accurately captures the shift in language from Flipkart-specific approval to broader noncontrolling interest shareholder approval. (3) Properly synthesizes the multi-hop information across two filing years. (4) Correctly explains the intercompany financing mechanism and its purpose. (5) Contextually relevant and addresses all parts of the question. WEAKNESSES: (1) CRITICAL DISCREPANCY: The LLM states the 2024 amount is $3.5 billion, but the ground truth specifies $3.3 billion. This is a material factual error of $200 million difference. (2) The LLM provides page references (page_60, page_43) which add credibility but cannot be verified against the ground truth provided. The quantitative error on the 2024 figure is the primary issue preventing a higher score. The reasoning quality and semantic understanding are sound, but the specific numeric accuracy on the 2024 figure is incorrect, which is a strict evaluation criterion for financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 376,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "In the 2023 Form 10‑K the U.S. Retiree Health Care Plan was invested about 80 % in fixed‑income securities and cash equivalents and roughly 20 % in equity securities 【page_45】. The 2024 filing reports the same weighted‑average mix – 80 % fixed‑income/cash and 20 % equity 【page_48】. Thus, the plan’s asset composition remained essentially unchanged between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the asset composition remained unchanged between 2023 and 2024 filings, which matches the ground truth conclusion. However, there are significant quantitative accuracy issues: (1) The LLM reports percentages as 'about 80%' and 'roughly 20%' rather than the precise figures of 79.5% and 20.5% stated in the ground truth. While these are approximations that convey the general allocation, the question specifically asks about 'evolution' and composition details, making precision important. (2) The LLM completely omits the specific dollar amounts ($210 million in fixed income and $54 million in equity, totaling $264 million) that are central to understanding the actual asset composition. The ground truth emphasizes these exact figures as evidence of the unchanged allocation. (3) The LLM provides no absolute dollar values, only percentages, which represents incomplete information synthesis. The reasoning is sound - correctly concluding no evolution occurred - but the answer lacks the quantitative specificity needed for a complete response to a question about asset composition. The multi-hop synthesis is adequate (comparing 2023 and 2024 filings), but the omission of dollar amounts is a material gap in addressing 'composition' of plan assets. The page citations suggest proper source documentation, though they cannot be verified here.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 385,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "In both the 2022 and 2024 Form 10‑K the 2006 Stock Plan for Non‑Employee Directors is described only with a **Form of Option Agreement** (Exhibit 10.3) and an **Omnibus Amendment – Form of Option Agreement** (Exhibit 10.1) 【page_123】. No new award‑type forms (e.g., RSU agreements) appear in the 2024 filing, indicating that Honeywell’s compensation for non‑employee directors under the 2006 plan remains focused on stock‑option grants and has not been broadened to other equity instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) EXHIBIT NUMBER ERRORS: The LLM cites 'Exhibit 10.3' and 'Exhibit 10.1' for the Form of Option Agreement, but the ground truth specifies Exhibit 10.30 (2022) and Exhibit 10.29 (2024). These are significantly different exhibit numbers and represent a fundamental factual error. (2) MISSING KEY INFORMATION: The ground truth explicitly states that in 2022, the 'Form of Restricted Unit Agreement' (Exhibit 10.32) was listed but was no longer mentioned in 2024. The LLM completely fails to identify this critical evolution - it states 'No new award-type forms (e.g., RSU agreements) appear in the 2024 filing' which is misleading because the ground truth shows RSU agreements WERE present in 2022 but disappeared by 2024. This is the core finding of the question. (3) INCORRECT CONCLUSION: The LLM concludes that compensation 'remains focused on stock-option grants and has not been broadened to other equity instruments,' which misses the actual story: there was a NARROWING from two award types (options + RSUs) to one (options only). This represents a shift away from RSUs, not a static situation. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution BETWEEN 2022 and 2024, requiring comparison across years. The LLM fails to properly synthesize this temporal comparison and instead presents a misleading narrative of consistency. (5) SEMANTIC MISALIGNMENT: While the LLM attempts to address the question's structure, it fundamentally misrepresents the data, suggesting no change when the ground truth shows a clear change in award types offered.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 454,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "In fiscal 2022 Walmart sold a slice of its Flipkart holding, receiving about $3.2 billion in new equity funding and lowering its ownership from roughly 83 % to 75 %. By the 2024 filing the company’s remaining stake was being examined by Indian regulators—a foreign‑direct‑investment show‑cause notice and an antitrust probe that could impose fines, restrictions on share ownership or force further divestiture—so the strategic focus shifted from cash‑generating stake reduction to managing heightened regulatory exposure on the residual investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct financial figures ($3.2 billion equity funding, 83% to 75% ownership stake reduction in 2022) and proper temporal framing (fiscal 2022 and 2024 filings). The multi-hop synthesis correctly connects the financial transaction to regulatory exposure evolution. However, there are notable omissions and minor inaccuracies in qualitative details: (1) The ground truth specifies the show cause notice was issued in July 2021 with information requests related to alleged FDI violations during 2009-2015 (pre-acquisition period), while the LLM answer mentions 'an antitrust probe' without clearly distinguishing between the FDI regulatory scrutiny and potential antitrust concerns—this conflates different regulatory issues; (2) The ground truth emphasizes Walmart's inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders, which is a critical financial risk disclosure that the LLM answer omits; (3) The LLM answer mentions 'force further divestiture' as a potential consequence, which is not explicitly stated in the ground truth; (4) The ground truth's characterization of the evolution as 'from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history' is more nuanced than the LLM's 'from cash-generating stake reduction to managing heightened regulatory exposure.' The core narrative is correct—Walmart reduced its stake while facing regulatory risks—but the specific nature of those risks and the financial implications of unquantifiable liabilities are incompletely captured. The answer is substantially correct on the main points but lacks precision on regulatory details and omits important financial risk disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 483,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "In the 2022 10‑K Honeywell said it held $11.5 billion of cash and cash equivalents (2021) and highlighted U.S. cash balances as a core liquidity source, stressing safety of principal, secondary yield‑maximisation and diversification across counterparties【page_41】. By the 2024 10‑K total cash and cash equivalents were $11.0 billion, but $8.0 billion was held in non‑U.S. subsidiaries, leaving roughly $3.0 billion in U.S. cash—showing a shift toward a larger overseas cash pool while keeping the same safety‑first, yield‑second strategic emphasis【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of multi-hop information across HON's 2022 and 2024 10-K filings. QUANTITATIVE VERIFICATION: All key numbers are correct - $11.5 billion (2021 cash), $11.0 billion (2024 total cash), $8.0 billion (non-U.S. subsidiaries in 2024), and the implied $3.0 billion U.S. cash calculation (11.0 - 8.0 = 3.0) is accurate. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) composition evolution between 2022 and 2024, (2) total cash holdings comparison, and (3) geographic distribution shift. ENTITY ACCURACY: Correctly identifies HON (Honeywell), proper fiscal years (2021 data in 2022 10-K, 2024 data in 2024 10-K), and appropriate financial metrics. MULTI-HOP REASONING: Successfully synthesizes information across two different filing years to show the evolution of cash positioning and geographic distribution. The answer correctly identifies the strategic shift from U.S.-focused liquidity to a larger overseas cash pool while maintaining consistent safety-first principles. MINOR CONSIDERATIONS: The LLM mentions 'secondary yield-maximisation' which is not explicitly stated in the ground truth answer, though this appears to be a reasonable inference from typical cash management practices. The page citations provided (page_41, page_39) add credibility but cannot be independently verified. The calculation of $3.0 billion U.S. cash is implicit in the LLM answer but correctly derived. Overall, the answer demonstrates strong factual accuracy, proper synthesis of multi-hop information, and clear communication of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 448,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "In the 2023 filing the company recorded a “Membership Rewards liability” and a net “Deferred card and other fees” line (which nets deferred acquisition costs and cancellation reserves) and estimated the liability by applying an ultimate‑redemption‑rate (URR) and a weighted‑average‑cost (WAC) per point derived from 12 months of redemptions and actuarial models that consider spend, tenure, product type and credit attributes【page_128】. The 2024 filing keeps the same accounting treatment but expands the disclosure of the liability‑estimation process: it still uses URR and WAC per point, but now quantifies the sensitivity of the liability to assumption changes (e.g., a 25‑bp URR shift would add ≈ $197 million; a 1‑bp WAC shift would add ≈ $220 million) and reiterates that deferred fees are net of acquisition costs and cancellation reserves【page_86】. Thus, while the underlying modeling assumptions remain unchanged, the 2024 report adds explicit sensitivity analysis and clearer net‑deferred‑fee presentation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several issues that prevent it from fully matching the ground truth:\n\n1. FACTUAL ACCURACY - MAJOR ISSUE: The LLM claims that in 2023, the company already used URR and WAC per point methodology with detailed actuarial models. However, the ground truth explicitly states that in 2023, the company only \"recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect\" without the detailed methodology. The ground truth indicates a clear EVOLUTION from 2023 (simple deferred fees mention) to 2024 (comprehensive model-driven approach). The LLM incorrectly suggests the methodology was the same in both years.\n\n2. QUANTITATIVE ACCURACY: The specific dollar amounts are correct ($197 million for 25 bp URR increase, $220 million for 1 bp WAC increase), and the basis point figures are accurate. These numbers match the ground truth.\n\n3. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution narrative. It states \"the underlying modeling assumptions remain unchanged\" which contradicts the ground truth's core finding that there was a shift from \"simpler mention of deferred fees to a comprehensive, model-driven approach.\"\n\n4. COMPLETENESS: The LLM answer does address both 2023 and 2024, and mentions sensitivity analysis, but mischaracterizes what was disclosed in 2023. The ground truth emphasizes the EVOLUTION and shift in disclosure detail, while the LLM suggests continuity with only expanded disclosure.\n\n5. SEMANTIC ISSUE: The phrase \"the underlying modeling assumptions remain unchanged\" is problematic because the ground truth indicates the 2023 filing didn't disclose these detailed assumptions at all - they weren't \"unchanged,\" they were newly detailed in 2024.\n\nThe answer demonstrates partial understanding but fundamentally misrepresents the nature of the change from 2023 to 2024, treating it as an expansion of existing methodology rather than an evolution from simple deferral accounting to detailed model-driven estimation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 553,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "In the 2022 Form 10‑K Adobe described Frame.io mainly as a newly‑acquired, cloud‑based video‑collaboration platform that it would “begin integrating … into our Digital Media segment” (see 2022 p. 41‑42). By the 2024 filing the company is positioning Frame.io as a core, cloud‑native collaboration hub that is “directly integrated with Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom and Adobe Workfront” and is offered through Adobe GenStudio to enable content production at scale (2024 p. 12). This shows a shift from a standalone acquisition added to the Digital Media business to a strategic component woven into multiple Creative Cloud apps and the broader Adobe ecosystem, reinforcing cross‑product workflows and AI‑driven content creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric references are correct - the $1.18 billion acquisition price is accurately cited (though not explicitly stated in the LLM answer, this is not an omission since the question doesn't require it), and the year references (2022 and 2024) are accurate. The filing page citations (2022 p. 41-42 and 2024 p. 12) add credibility and specificity. ENTITY ACCURACY: All companies and products are correctly identified - Adobe, Frame.io, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and Adobe GenStudio are all accurately named and positioned. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and demonstrates the evolution of Frame.io's strategic positioning from a newly-acquired standalone platform to an integrated ecosystem component. The reasoning correctly identifies the progression from initial integration phase to full ecosystem incorporation. COMPLETENESS: The answer addresses all aspects of the question - strategic positioning, integration evolution, and alignment with the broader product ecosystem. The LLM adds valuable context about AI-driven content creation and cross-product workflows that reinforces the strategic narrative. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly enhanced detail and specificity (e.g., mentioning Lightroom in addition to the other apps, explicitly noting the shift from standalone to ecosystem-integrated). The characterization of the evolution as moving from 'newly-acquired integration' to 'core component' matches the ground truth's framing. MINOR CONSIDERATIONS: The LLM answer includes Lightroom in the list of integrated applications, while the ground truth lists Premiere Pro, After Effects, Photoshop, and Workfront. This is not an error but rather additional accurate information that enhances the answer. The LLM's emphasis on 'cloud-native' and 'AI-driven content creation' provides appropriate contextual depth without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 580,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "In the 2022 filing (page 99) equity‑like funds were measured using Level 3 inputs for **$25.4 million** in the defined‑benefit pension plan and **$2.4 million** in the retiree‑health plan (total ≈ $27.8 million). In the 2023 filing (page 98) the Level 3 amount fell slightly to **$25.1 million** for the pension plan while remaining **$2.4 million** for the retiree‑health plan (total ≈ $27.5 million), indicating only a marginal decline in the Level 3 component of equity‑like funds.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth states: 2022 Level 3 equity-like funds = $5.5 million, 2023 = $25.4 million (a fivefold increase). The LLM answer provides completely different numbers: 2022 = $25.4 million (pension) + $2.4 million (retiree health) = $27.8 million total, and 2023 = $25.1 million + $2.4 million = $27.5 million total. The LLM has inverted the year-over-year comparison - it claims a marginal decline when the ground truth shows a significant fivefold increase. The LLM also introduces additional complexity by breaking down the values by plan type (pension vs. retiree health), which is not part of the ground truth answer and appears to be fabricated or from a different context. The core factual errors are severe: (1) 2022 value is wrong ($5.5M vs. $27.8M claimed), (2) 2023 value is wrong ($25.4M vs. $27.5M claimed), (3) the directional trend is completely reversed (increase vs. decrease), and (4) the magnitude of change is mischaracterized (fivefold increase vs. marginal decline). The LLM failed to correctly synthesize the multi-hop information about how equity-like funds' Level 3 valuations evolved between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 337,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "In the 2022 filing Adobe only reported that, after buying Frame.io for about $1.18 billion in late 2021, it had “begun integrating” the cloud‑based video‑collaboration platform into its Digital Media segment. By the 2024 filing, Frame.io is described as a fully‑integrated, cloud‑native collaboration platform that is embedded directly in Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and Adobe GenStudio, positioning it as a core component of Adobe’s Digital Media suite and a strategic engine for end‑to‑end content production. This shows the shift from early integration to deep product embedding and a broader, central role within Digital Media.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Adobe's Frame.io integration evolution. STRENGTHS: (1) Correctly identifies the October 2021 acquisition timing and $1.18 billion purchase price, which matches ground truth; (2) Accurately captures the 2022 status as 'begun integrating' the cloud-based video collaboration platform into Digital Media segment; (3) Comprehensively lists all integrated products by 2024 (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe GenStudio) matching ground truth exactly; (4) Correctly characterizes the evolution from 'early integration' to 'deep product embedding' and 'core component'; (5) Properly synthesizes multi-hop information across 2022 and 2024 filings; (6) Uses appropriate terminology ('cloud-native collaboration platform,' 'end-to-end content production') that aligns with ground truth framing. MINOR CONSIDERATIONS: The LLM answer adds slightly more interpretive language ('fully-integrated,' 'strategic engine') compared to the ground truth, but this represents reasonable inference from filing language rather than factual error. The answer is semantically equivalent and arguably more descriptive. QUANTITATIVE VERIFICATION: The $1.18 billion figure is correct (minor format variation from ground truth but acceptable). The timeline (late 2021 acquisition, 2022 early integration, 2024 deep embedding) is accurate. MULTI-HOP REASONING: Successfully synthesizes information across two different filing years and multiple product integrations to show progression. All entities correctly identified. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 453,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "In 2022 CVS’s medication‑management approach was built around core clinical programs such as Pharmacy Advisor, Drug Savings Review, utilization‑management and the NovoLogix online pre‑authorization tool, with digital connectivity that gave members visibility of lower‑cost alternatives and analytics support (page_11, page_13). By 2024 the company had layered those services onto an AI‑enabled, data‑rich platform—Canopy and the Health Engagement Engine claim‑adjudication system, real‑time benefits information at the point of prescribing, an integrated device hub for in‑home medication reviews, and expanded virtual MinuteClinic scheduling—providing more proactive adherence outreach and deeper cost‑efficiency insights (page_10, page_12, page_13).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) INCORRECT TOOLS/PROGRAMS: The LLM claims NovoLogix was a 2022 tool ('Pharmacy Advisor, Drug Savings Review...NovoLogix'), but the ground truth states NovoLogix was introduced BY 2024 as a new digital tool expansion. The LLM also mentions 'Canopy' and 'Health Engagement Engine' which are not mentioned in the ground truth at all, suggesting potential hallucination. (2) MISSING CRITICAL 2024 DEVELOPMENTS: The LLM completely omits the CVS Weight Management program with GLP-1 medication optimization and lifestyle coaching, which is a major 2024 evolution mentioned in ground truth. The LLM also fails to mention Oak Street Health's 239 primary care centers across 27 states, which represents a significant structural shift in CVS's medication management approach. (3) INCOMPLETE 2022 BASELINE: The LLM's description of 2022 programs lacks the specific mention of the National Pharmacy and Therapeutics Committee, formulary management emphasis, and the industry-leading seven-day opioid supply limit policy that characterized CVS's 2022 approach. (4) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes a shift from 'cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model' - the LLM captures some digital expansion but misses the fundamental strategic evolution and the integration of primary care through Oak Street Health. (5) UNVERIFIABLE CLAIMS: References to 'Canopy,' 'Health Engagement Engine,' 'integrated device hub,' and expanded 'virtual MinuteClinic scheduling' are not substantiated in the ground truth and appear to be fabricated details. The LLM answer demonstrates poor multi-hop synthesis, introducing unverified tools while omitting documented major initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 501,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 filing Adobe described the acquisition of Frame.io (Oct 2021) and said it was “more deeply integrating and enhancing Frame.io’s review and approval capabilities in Premiere Pro and After Effects to deliver a native collaborative platform for video editing”【page_6】. By the 2024 filing Frame.io is positioned as “our cloud‑native creative collaboration platform” that is now “directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom and Workfront” and is available in GenStudio, with added features such as real‑time upload, frame‑accurate commenting, annotations, Camera‑to‑Cloud automatic footage ingestion and support for still images, design files and PDFs across broader production workflows【page_12】. This reflects a shift from a limited video‑editing add‑on in 2022 to a cross‑app, end‑to‑end collaboration hub within the Creative Cloud ecosystem by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2022 acquisition timing (October 2021) and initial positioning focused on Premiere Pro and After Effects integration; (2) Accurately describes the 2024 evolution to a 'cloud-native creative collaboration platform' with expanded integrations across Photoshop, Lightroom, and Workfront; (3) Correctly lists specific enhancements: real-time upload, frame-accurate commenting, annotations, Camera-to-Cloud functionality, and support for multiple file types (still images, design files, PDFs); (4) Properly synthesizes the multi-hop information showing progression from video-specific tool to broader creative asset platform; (5) Appropriately cites source documents (page_6 for 2022, page_12 for 2024); (6) Captures the strategic shift narrative that matches the ground truth. MINOR CONSIDERATIONS: (1) The LLM answer notes the acquisition was in October 2021 while the ground truth states 2022 acquisition - however, the LLM's dating is more precise and technically correct (the acquisition occurred in Oct 2021, announced/discussed in 2022 filings); (2) The answer includes GenStudio mention which adds relevant context not explicitly in ground truth but represents accurate additional detail from the filings; (3) All specific features mentioned (Camera-to-Cloud, frame-accurate commenting, real-time upload) are accurately described. The answer successfully addresses all parts of the multi-part question: integration evolution, positioning within Creative Cloud, and specific enhancements. The reasoning connecting 2022 to 2024 progression is sound and well-supported by cited evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 468,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "In the 2023 filing the firm said that the fair‑value of corporate loans, corporate bonds and even state‑municipal securities is “determined using **recently executed transactions**” as the primary observable input, with market quotes and proprietary models used only when such transactions are unavailable (see 2023 p. 99 ‑ Loans & Lending Commitments and 2023 p. 98 ‑ State and Municipal Securities). By 2024 the language still cites recently executed transactions, but now frames them as one of several inputs in **non‑recurring fair‑value measurements** for loans, lending commitments and other assets (e.g., “based on … recently executed transactions, market price quotations, valuation models …” – 2024 p. 103) and notes that they are used alongside market quotations and model‑derived yields across a broader set of asset classes, indicating an expanded but still central role in Level 3 fair‑value determinations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of recently executed transactions in fair value determination from 2023 to 2024, with several strengths and minor weaknesses: STRENGTHS: (1) Correctly identifies that recently executed transactions were a primary input in 2023 for corporate loans and related instruments; (2) Accurately notes the shift in 2024 to a more integrated approach where recently executed transactions are one of several inputs; (3) Properly identifies the expansion to other asset classes (other investments) in 2024; (4) Correctly references page numbers (2023 p. 99, 2024 p. 103) and specific asset categories; (5) Accurately characterizes the 2024 approach as involving non-recurring fair-value measurements and Level 3 determinations; (6) Correctly notes the use of discounted cash flow models and comparable company multiples alongside transaction data. WEAKNESSES: (1) The LLM answer slightly overstates the 2023 characterization by suggesting recently executed transactions were the 'primary' input with other methods used 'only when unavailable' - the ground truth indicates they were 'a key input' used 'alongside' other methods, suggesting more parallel usage than sequential fallback; (2) The answer provides more specific page citations and filing language than the ground truth, which while potentially accurate, goes beyond what can be verified against the provided ground truth; (3) Minor semantic difference: the ground truth emphasizes 'more targeted application' in 2024, while the LLM emphasizes 'expanded but still central role' - these are not contradictory but represent slightly different framings. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and multiple asset categories, properly identifying the evolution in methodology. The comparison between 2023 and 2024 approaches is logically sound. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is not directly testable. Page references appear reasonable but cannot be independently verified. OVERALL: The answer captures the essential evolution described in the ground truth with good detail and appropriate nuance, though with minor characterization differences in how the 2023 approach is described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 619,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K (pages 95‑99) the filing makes no specific reference to the Substance 3D Stager product, focusing instead on financial and governance disclosures. By the 2024 Form 10‑K, Adobe explicitly positions Stager as a core component of the Substance 3D Collection—an integrated ecosystem of desktop apps that includes Painter, Sampler, Designer and Modeler and is used to build and assemble 3D scenes【page_12】. This reflects a shift from no explicit mention in 2022 to a clear strategic placement of Stager within the broader Substance 3D suite in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Adobe's Substance 3D Stager evolution. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and the shift in positioning; (2) Accurately names the related products in the ecosystem (Painter, Sampler, Designer, Modeler); (3) Correctly characterizes Stager's function as a tool for building and assembling 3D scenes; (4) Properly identifies the strategic shift from minimal/no explicit mention to integrated ecosystem positioning; (5) Appropriately cites 2024 Form 10-K as source. MINOR WEAKNESSES: (1) The LLM states the 2022 Form 10-K 'makes no specific reference' to Substance 3D Stager, while the ground truth indicates it was 'listed among Adobe's trademarks' - this is a subtle but meaningful distinction. The ground truth suggests Stager existed in 2022 but lacked detailed strategic positioning, whereas the LLM implies complete absence of mention; (2) The LLM's characterization of 2022 as having 'no explicit mention' is slightly stronger than the ground truth's 'without detailed information about its functionality or strategic positioning,' which implies the product was acknowledged but not elaborated upon. MULTI-HOP REASONING: The answer correctly synthesizes information across two time periods and identifies the evolution pattern. The comparison between years is logically sound and addresses the core question about ecosystem integration. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative accurately - that Stager moved from a less-prominent position to being explicitly positioned within a broader 3D ecosystem. The distinction between 'listed as trademark' vs 'no specific reference' is a minor semantic nuance that doesn't fundamentally alter the correctness of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 494,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "In the 2022 filing (p. 64) GE said that deep‑decarbonisation will “likely depend in part on technologies … such as **grid‑scale batteries** or other storage solutions,” noting that these are not yet deployed and would require significant future investment but are not a core focus today. The 2023 filing (p. 29) repeats the same point – grid‑scale batteries are again listed among emerging, not‑yet‑widely‑adopted technologies that could become important for the energy‑transition, with the same caveat that they will need substantial R&D and infrastructure spending. Thus, GE’s positioning on batteries stayed essentially unchanged: they remain a long‑term, peripheral component of the transition strategy rather than a primary, strategically‑relied‑upon asset.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE INTERPRETATION: The LLM answer fundamentally misinterprets the evolution described in the ground truth. The ground truth clearly states a SHIFT from 2022 to 2023: in 2022, batteries were mentioned as 'may become more important' (speculative), while in 2023, they were 'integrated into the company's strategic narrative as a dependency' with language stating goals would 'depend in part' on such technologies. This represents movement toward greater strategic reliance. However, the LLM concludes the opposite - that positioning 'stayed essentially unchanged' and batteries remain 'peripheral' rather than 'primary.' This is a fundamental misreading of the multi-hop comparison. SPECIFIC ISSUES: (1) The LLM correctly identifies page numbers (p. 64 for 2022, p. 29 for 2023) and acknowledges both filings mention grid-scale batteries, but fails to detect the qualitative shift in language and strategic positioning. (2) The LLM characterizes both years identically ('emerging, not-yet-widely-adopted technologies'), missing the ground truth's distinction that 2023 elevated batteries to a strategic dependency. (3) The phrase 'depend in part' in the ground truth indicates increased strategic reliance, not peripheral status - the LLM misinterprets this as evidence of unchanged positioning. (4) The LLM's conclusion that batteries are 'long-term, peripheral' contradicts the ground truth's finding of integration into 'strategic narrative as a dependency.' QUANTITATIVE ACCURACY is rated 8 because the page numbers appear correct and the LLM accurately cites that both years mention grid-scale batteries, but QUALITATIVE ACCURACY is 2 because the core reasoning about the evolution is inverted. The answer fails the primary multi-hop requirement: comparing strategic positioning across two years and identifying how it evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 501,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "In both the 2022 and 2024 10‑K filings CVS notes that it “did not have any broker‑quoted debt securities” for the years covered – 2021‑2020 in the 2022 filing (page 148) and 2024‑2023 in the 2024 filing (page 146). Because no broker quotes were used, Level 3 debt securities were valued either by outside brokers for other securities or internally for private placements, and the absence of broker‑quoted securities had no impact on the company’s fair‑value measurements or its financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that CVS had no broker-quoted debt securities in both 2022 and 2024 filings, and accurately cites the page numbers (148 for 2022, 146 for 2024). The years covered are also correct (2021-2020 in 2022 filing, 2024-2023 in 2024 filing). However, there are significant issues with the answer's completeness and interpretation: (1) The LLM states that the absence of broker-quoted securities 'had no impact on the company's fair-value measurements or its financial statements,' which contradicts the ground truth that notes the 2024 disclosure 'no longer mentions any negative impact or specific review process.' This suggests the LLM may be conflating the absence of impact with the absence of disclosure language about impact. (2) The ground truth emphasizes an evolution in disclosure emphasis - that the 2024 filing shows 'reduced emphasis or relevance' of this topic - but the LLM presents the information as static and factual rather than highlighting this disclosure evolution. (3) The LLM's statement about Level 3 debt securities being valued 'by outside brokers for other securities or internally for private placements' is somewhat unclear and doesn't directly address the evolution question. (4) The ground truth specifically notes that the 2022 filing mentioned 'internal pricing for certain private placements' while the 2024 filing no longer emphasizes this, but the LLM doesn't capture this nuance. The answer is partially correct on the core facts but misses the key insight about how the disclosure itself has evolved in emphasis and language between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 442,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "In 2023 BlackRock reported $1.585 billion of equity securities / mutual‑fund holdings at FVTNI, which rose to $1.950 billion in 2024 – an increase of about $365 million【page_87†L31-L34】【page_94†L31-L34】.  The equity‑method portfolio grew only modestly, from $2.756 billion in 2023 to $2.783 billion in 2024; the increase reflects a shift from mainly NAV‑measured investments ($2.510 billion in 2023) to a larger share measured at quoted prices (Level 1 rose from $246 million to $347 million) and the addition of $131 million of Level 2 assets, while the NAV‑measured portion fell to $2.305 billion【page_87†L37-L44】【page_94†L38-L45】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect numbers that contradict the ground truth across both key metrics. (1) EQUITY SECURITIES/MUTUAL FUNDS: Ground truth states 2023: $1,211 million and 2024: $1,950 million. LLM claims 2023: $1.585 billion ($1,585 million) and 2024: $1.950 billion ($1,950 million). The 2023 figure is wrong by $374 million (31% error). The 2024 figure is correct. (2) EQUITY METHOD INVESTMENTS: Ground truth states 2023: $1,895 million and 2024: $2,783 million. LLM claims 2023: $2.756 billion ($2,756 million) and 2024: $2.783 million. The 2023 figure is drastically wrong by $861 million (45% error). The 2024 figure is correct. (3) CALCULATION ERROR: LLM calculates the equity securities increase as $365 million ($1,950M - $1,585M = $365M), which is mathematically correct for their stated numbers, but the 2023 baseline is wrong. The correct increase should be $739 million ($1,950M - $1,211M). (4) MULTI-HOP SYNTHESIS: While the LLM attempts to provide additional detail about fair value hierarchy levels (Level 1, Level 2, NAV-measured), this additional information appears to be either fabricated or from incorrect sources, as it contradicts the ground truth baseline figures. The LLM provides more granular breakdown than the ground truth but this is undermined by the fundamental errors in the core numbers. (5) ENTITY ACCURACY: BlackRock and FVTNI are correctly identified, years 2023-2024 are correct. (6) SEMANTIC ISSUE: The question asks about 'composition change' - the LLM attempts to address this with fair value hierarchy details, but the incorrect baseline numbers make this analysis unreliable. The ground truth answer is simpler and focuses on the direct comparison of the two categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 478,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "In the 2022 filing UnitedHealth Group disclosed that its available‑for‑sale debt portfolio carried **$274 million of gross unrealized losses** (see page 56) and that, after evaluating credit quality and cash‑flow expectations, **the allowance for credit‑related losses on those securities was “not material”** (page 57). By the 2024 filing the company still **evaluates each available‑for‑sale security for credit‑related impairment using the same cash‑flow, fair‑value‑vs‑amortized‑cost and issuer‑credit‑quality criteria**, records unrealized gains and losses in OCI, and **recognizes any credit‑related impairment as an allowance** (page 49), but again provides no indication that the allowance has become material—showing that the evaluation method and treatment of unrealized losses remain essentially unchanged from 2022 to 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of UnitedHealth Group's credit impairment evaluation methodology from 2022 to 2024, with several strengths and minor limitations:\n\nSTRENGTHS:\n1. Correctly identifies the $274 million gross unrealized losses figure from 2022 filing\n2. Accurately captures that the allowance for credit losses was 'not material' in 2022\n3. Correctly identifies the consistent evaluation methodology across both years (cash flow analysis, fair value vs. amortized cost, issuer credit quality)\n4. Properly notes that credit-related impairments are recorded as an allowance account\n5. Accurately synthesizes the multi-hop comparison showing methodological consistency\n6. Correctly identifies that unrealized gains/losses are recorded in OCI\n7. Appropriately cites specific page numbers from filings\n\nWEAKNESSES:\n1. The LLM answer emphasizes that the allowance 'again provides no indication that the allowance has become material,' which somewhat contradicts the ground truth's characterization of a 'shift from qualitative, low-risk assessment to a more formalized impairment accounting framework.' The ground truth suggests a more substantive evolution in how credit risk is recognized (from implicit/qualitative to explicit/formalized), while the LLM answer emphasizes continuity\n2. The LLM answer doesn't fully capture the nuance that by 2024, the allowance is 'explicitly described as being recorded as a separate component through an allowance account,' suggesting a more structured recognition framework than existed in 2022\n3. The conclusion that treatment 'remains essentially unchanged' may understate the evolution from a qualitative assessment to a more formalized impairment accounting framework\n\nQUANTITATIVE VERIFICATION:\n- $274 million unrealized losses: Appears accurate based on citation\n- 'Not material' allowance in 2022: Correctly stated\n- No specific 2024 allowance figures provided: Consistent with ground truth indicating no materiality disclosure\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022 and 2024 filings, comparing evaluation methodologies and allowance treatments. The reasoning is sound in identifying continuity in methodology while noting the formalization of the allowance account structure.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys the core factual information accurately, though it may slightly underweight the significance of the shift toward more formalized impairment accounting that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 678,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "In 2022 AMD’s 15 % equity interest in the ATMP joint venture was carried at roughly **$83 million** and generated **$14 million** of equity‑income. By year‑end 2023 the carrying amount had risen to about **$99 million** and the equity‑income increased to **$16 million**, showing a modest increase in both the investment’s value and AMD’s share of the JV’s earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2022 carrying value of $83 million, 2022 equity income of $14 million, 2023 carrying value of $99 million, and 2023 equity income of $16 million. The additional detail about AMD's 15% equity interest adds valuable context not explicitly stated in the ground truth but is factually accurate and relevant. The multi-hop synthesis is sound, correctly comparing the two years and drawing the appropriate conclusion about the growing financial stake and increased profitability. The wording 'modest increase' is semantically equivalent to the ground truth's 'growing financial stake and increased profitability.' The answer properly addresses all parts of the question regarding investment value evolution and equity income changes. Minor deduction from perfect score only because the ground truth uses slightly different phrasing ('growing financial stake' vs 'modest increase'), though both characterizations are accurate given the percentage increases (19% for carrying value, 14% for equity income).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 313,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth’s tort‑claim exposure continues to be dominated by medical‑malpractice and other professional‑liability suits tied to the delivery of health‑care services by its affiliates and network providers, and the company remains largely self‑insuring those risks (2022 p.20; 2024 p.15‑16). Both the 2022 and 2024 filings stress that the number of such actions is increasing, that new liability theories are being used, and that actual losses could exceed the reserves recorded, leaving the potential financial impact material and possibly growing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies core facts about UnitedHealth's tort exposure: (1) medical malpractice and professional liability claims dominate, (2) the company is largely self-insuring, (3) the number of actions is increasing, (4) new liability theories are emerging, and (5) actual losses could exceed reserves. The page citations (2022 p.20; 2024 p.15-16) appear reasonable for a 10-K filing structure. However, the answer has significant gaps compared to the ground truth: (1) It fails to capture the evolution/shift in focus between 2022 and 2024 - the ground truth emphasizes that 2022 focused on 'self-insured liabilities related to medical malpractice claims against affiliated physicians' while 2024 shifted to 'broader legal risks tied to delivery of health care services, including claims related to clinical quality and patient safety standards.' The LLM treats both years as essentially the same. (2) The ground truth specifically mentions 'litigants seeking recoveries under new theories of liability that might not be subject to damage caps' in 2022, which the LLM omits. (3) The ground truth highlights that 2024 introduced emphasis on 'reputational harm and adverse effects on business relationships' as part of a 'broader and more systemic risk profile' - the LLM completely misses this evolution in risk characterization. (4) The LLM answer is more static and doesn't adequately address 'how has exposure evolved' - it presents a snapshot rather than a trajectory. The question specifically asks about evolution between 2022 and 2024, and the ground truth provides a clear narrative of change, while the LLM answer suggests continuity rather than evolution. The quantitative accuracy is reasonable (no specific numbers to verify, dates are correct), but the qualitative synthesis of how the risk profile changed is incomplete and misses the key insight about the shift from narrowly-defined to broader systemic risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 524,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Boeing’s legacy three‑year revolving credit facility was unchanged – it remains a $3 billion commitment that expires in August 2025, and the company’s total undrawn revolving‑credit capacity stayed at roughly $10 billion (2023: $10.0 bn unused capacity; 2024: $10.0 bn available)【page_43】【page_94】.  In 2024 Boeing terminated the $0.8 bn 364‑day line and a $3.2 bn five‑year line and added a larger $4 bn five‑year facility, showing a liquidity strategy that preserves a sizable, undrawn back‑up line while simplifying and extending its credit portfolio for greater flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of Boeing's credit facility evolution. Verification of key claims: (1) Legacy three-year revolving credit agreement: Correctly identified as $3.0 billion with August 2025 expiration - matches ground truth exactly. (2) 2024 changes: Correctly identified termination of $0.8 billion 364-day line and $3.2 billion five-year line, and addition of new $4.0 billion five-year facility expiring May 2029 - all numbers and dates align with ground truth. (3) Undrawn capacity: Correctly stated as $10.0 billion in both 2023 and 2024, demonstrating consistency. (4) Multi-hop synthesis: The answer successfully synthesizes information across multiple credit facilities and years, correctly identifying the strategic shift from the ground truth (extending maturity timelines, enhancing liquidity capacity, simplifying portfolio). The LLM answer goes slightly beyond the ground truth by providing additional context about the specific facilities terminated ($0.8bn and $3.2bn) and their terms, which adds valuable detail without contradicting the original answer. The interpretation of liquidity strategy is sound and semantically equivalent to the ground truth's characterization of 'strategic shift to enhance liquidity capacity and extend maturity timelines.' Minor note: The answer uses slightly different phrasing ('preserves a sizable, undrawn back-up line while simplifying and extending' vs. 'enhance liquidity capacity and extend maturity timelines') but conveys the same strategic intent. All quantitative data is accurate, calculations are implicit but correct, and entity identification (Boeing, specific facility amounts and dates) is precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 470,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "In 2023 the 2017 performance‑based options generated **$56 million of fair‑value for the options that vested** and **$44 million of intrinsic value for the options that were exercised**【page_101】. By 2024 the **fair‑value of vested options fell slightly to $52 million**, while the **intrinsic value of exercised options jumped dramatically to $373 million**【page_109】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: 2023 fair value of vested options ($56 million), 2023 intrinsic value of exercised options ($44 million), 2024 fair value of vested options ($52 million), and 2024 intrinsic value of exercised options ($373 million). The answer correctly identifies the slight decline in vested option fair value (from $56M to $52M) and the dramatic increase in intrinsic value of exercised options (from $44M to $373M). The multi-hop reasoning is sound, synthesizing information across two fiscal years and comparing the evolution of both metrics. The characterization of the changes as 'fell slightly' and 'jumped dramatically' accurately reflects the magnitude of the movements. The answer includes appropriate source citations (page references). The only minor distinction from the ground truth is that the LLM answer uses slightly more concise phrasing ('fell slightly' vs 'decreased slightly'), but this is semantically equivalent and actually enhances clarity. The answer fully addresses all parts of the multi-part question regarding the financial impact evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 336,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "AMD’s method for estimating the revenue adjustments tied to product‑return rights was essentially unchanged from 2022 to 2023. In both years the company said it “utilizes relevant, trended actual historical product‑return‑rate information…adjusted for actual known information or events (and, where appropriate, current economic conditions)” when estimating the contract‑price adjustments for OEM and distributor returns【page_44†L13-L18】【page_45†L15-L20】【page_49†L13-L20】. No new methodology or specific change to that estimation process was disclosed in the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The question asks how AMD's approach EVOLVED between 2022 and 2023, and the LLM explicitly states the method was 'essentially unchanged' with 'no new methodology or specific change' disclosed. However, the ground truth clearly identifies significant evolution: (1) In 2022, AMD used 'trended actual historical product return rate information, adjusted for known information or events.' (2) In 2023, AMD maintained historical data BUT added explicit emphasis on 'rights of return and rebates' as variable consideration under ASC 606-10-32-8 through 14, with specific reference to 'most likely amount' methodology. This represents a material change in how the estimates were framed and codified within accounting standards. The LLM's citation of identical language from both years ('utilizes relevant, trended actual historical product-return-rate information...') actually masks the key evolution: the 2023 filing added explicit ASC 606 standard references and structured the approach around 'most likely amount' consideration, which is a methodological refinement even if the underlying data source remained similar. The LLM failed to identify this structural and codification evolution, instead concluding no change occurred. This is a critical failure in multi-hop reasoning - the model needed to synthesize not just the surface-level language but the accounting framework changes between years. The quantitative accuracy score is higher because the LLM correctly identified that both years used historical data, but the qualitative accuracy is very low because it missed the essential evolution in methodology framing and ASC 606 alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 466,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 performance‑based options fell sharply, from 1,549,080 shares outstanding at 12/31/2023 to 625,825 shares outstanding at 12/31/2024 – a decline of about 923 k shares【page_100†L1-L7】. The drop was driven almost entirely by a massive exercise of 905,219 options in 2024, with only 18,036 shares forfeited, showing that the reduction reflects employee exercise rather than forfeiture【page_108†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) Starting shares 1,549,080 at 12/31/2023 - CORRECT; (2) Ending shares 625,825 at 12/31/2024 - CORRECT; (3) Shares exercised 905,219 - CORRECT; (4) Shares forfeited 18,036 - CORRECT; (5) Decline calculation: 1,549,080 - 625,825 = 923,255 shares, LLM states 'about 923 k shares' - CORRECT (appropriate rounding). Multi-hop reasoning: The answer correctly synthesizes data from multiple time periods (2023 and 2024) and identifies the two key drivers of the decline (exercise and forfeiture). The interpretation is sound - the large exercise relative to forfeiture indicates employees were exercising their vested options rather than losing them, suggesting normal lifecycle completion. The answer directly addresses both parts of the question: (1) how the number evolved (decreased from 1.55M to 626k), and (2) what this indicates about trends (exercise-driven reduction, not forfeiture-driven). The semantic meaning matches the ground truth perfectly. Minor note: The LLM uses 'about 923 k' while ground truth states 'decreased significantly' - both convey the same magnitude of change appropriately. The citation references (page_100, page_108) suggest proper source documentation. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 362,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024 Optum Rx expanded from a $112 billion pharmacy‑spend platform (about $45 billion in specialty) that operated roughly 67,000 retail pharmacies, home‑delivery, infusion and a direct‑to‑consumer business, to a $178 billion platform (about $74 billion in specialty) that now also offers rare‑disease and gene‑therapy support, richer digital tools, and a strategy that embeds pharmacists in integrated medical‑pharmacy‑behavioral care teams. While it continues to serve UnitedHealthcare’s health‑benefits customers through brokers and direct sales, the 2024 filing positions Optum Rx as a broader, data‑driven pharmacy‑care engine that deepens UnitedHealth Group’s end‑to‑end health‑care ecosystem and cost‑management capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims Optum Rx managed $178 billion in pharmaceutical spending by 2024 and $74 billion in specialty spending. However, the ground truth explicitly states 'While specific spending figures were not provided in 2024,' indicating these 2024 numbers are fabricated and not supported by the source documents. The 2022 figures ($112 billion total, $45 billion specialty) are correctly cited from ground truth. (2) UNSUPPORTED CLAIMS - The LLM introduces several service offerings not mentioned in the ground truth: 'rare-disease and gene-therapy support' and 'pharmacists embedded in integrated medical-pharmacy-behavioral care teams.' These appear to be hallucinated details not present in the original answer. (3) MULTI-HOP REASONING FAILURE - While the LLM attempts to show evolution between 2022 and 2024, it does so by inventing 2024 metrics that contradict the ground truth's explicit statement that specific spending figures were unavailable in 2024. (4) PARTIAL ACCURACY - The LLM correctly identifies the 2022 baseline ($112B/$45B), correctly mentions the network of 67,000+ retail pharmacies, home delivery, specialty pharmacies, and infusion services. It also correctly captures the strategic positioning around data-driven integration into UnitedHealth's ecosystem. (5) SEMANTIC ISSUES - While the LLM's framing of strategic evolution is conceptually reasonable, it is built on a foundation of fabricated numbers that undermine the entire answer's credibility. The ground truth's careful distinction between what was reported in 2022 versus what was reported in 2024 (without specific spending figures) is violated by the LLM's invention of 2024 spending data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 493,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "In 2023 BlackRock reported $1.585 bn of equity securities/mutual‑fund holdings and $2.756 bn of equity‑method investments, of which $241 m were “investments related to deferred cash‑compensation plans” (page 87). By 2024 the equity‑securities component grew to $1.950 bn and total equity‑method assets rose modestly to $2.783 bn, but the deferred‑cash‑compensation hedge fell to $173 m (page 94), a $68 m decline. Overall the equity‑security portfolio increased by roughly $0.39 bn, with a larger share in equity‑mutual‑fund and real‑asset funds and a reduced share in private‑equity and hedge‑fund exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core point of the question. CRITICAL ERRORS: (1) The ground truth states that in 2023, BlackRock reported $9 million in Equity Securities at FVTNI for deferred cash compensation plans, but the LLM reports $241 million in 'investments related to deferred cash-compensation plans' - this is a different category and wrong number. (2) The LLM claims the deferred-cash-compensation hedge 'fell to $173 m' with a '$68 m decline' from $241m, but this math is correct ($241m - $68m = $173m), yet the baseline number of $241m appears to be incorrect or from a different category than what the ground truth identifies. (3) The ground truth specifically addresses the reclassification of $9 million from 'Equity Securities at FVTNI' in 2023 to 'Investments related to deferred cash compensation plans' in the Equity Method section in 2024 with a value of $173 million - a major compositional change. The LLM completely misses this reclassification narrative and instead discusses broader portfolio changes ($1.585bn to $1.950bn in equity securities). (4) The LLM provides extensive information about overall equity portfolio composition changes (mutual funds, real assets, private equity, hedge funds) that is not relevant to the specific question about deferred cash compensation plan investments. (5) The question asks specifically about 'investments held for deferred cash compensation plans' within Equity Securities at FVTNI, but the LLM conflates different investment categories and time periods. The core insight - that $9 million was reclassified from one category to another with a final value of $173 million - is entirely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 468,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The 2022 filing shows that, as of August 31 2022, Accenture had **$3,129,296** of aggregate available authorization for its publicly announced open‑market share purchase program (and related purchase programs)【page_93】. By August 31 2024 that amount had fallen to **$2,694,281**【page_100】—a reduction of roughly $435 k (about 14%). This decline indicates the company has been exercising its buy‑back authority and is gradually using up the authorized pool, reflecting a disciplined capital‑allocation strategy that balances share repurchases with other priorities such as dividends and growth investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: Both key figures are correct—$3,129,296 (2022) and $2,694,281 (2024). The calculated reduction of approximately $435,000 (or ~$435k) is accurate: $3,129,296 - $2,694,281 = $435,015, which rounds to $435k. The percentage calculation of ~14% is also correct: ($435,015 / $3,129,296) × 100 = 13.9%, appropriately rounded to 14%. ENTITY ACCURACY: Accenture is correctly identified, the fiscal years (August 31, 2022 and August 31, 2024) are accurate, and the metric (aggregate available authorization for open-market share purchase program) is precisely stated. MULTI-HOP REASONING: The answer successfully synthesizes information across two different fiscal years and correctly interprets the trend. The reasoning that a declining authorization pool indicates active use of buyback authority is sound and logically connects the numerical change to capital allocation strategy. INTERPRETATION: The LLM's characterization of this as reflecting a \"disciplined capital-allocation strategy that balances share repurchases with other priorities\" is a reasonable and slightly more nuanced interpretation than the ground truth's \"more conservative approach.\" Both interpretations are valid—the declining authorization does suggest the company is using its buyback authority while maintaining balance with other capital priorities. The answer is comprehensive, addressing both the quantitative change and its strategic implications. Minor note: The ground truth uses slightly different language (\"reduction in capital allocated\" vs. \"exercising buyback authority\"), but both convey the same fundamental insight about capital deployment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 471,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "In the 2022 Form 10‑K the MD&A only said that Accenture’s open‑market repurchase program “may be made … in respect of purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares” and that the program could be accelerated, suspended or discontinued, but it gave no quantitative detail or specific description of the shares’ rights (see 2022 p. 43). By the 2024 filing the company provides a much more detailed disclosure: it lists a $2.694 billion aggregate authorization for the open‑market program (including exchangeable‑share purchases), reports that 47,752 exchangeable shares were actually repurchased for $15,254 in fiscal 2024 (see 2024 p. 101), and spells out that each exchangeable share can be exchanged one‑for‑one for an Accenture plc Class A ordinary share (or cash) and receives the same dividends, with redemption of related Class X shares limited to protect exchangeable‑share holders (see 2024 p. 100). This reflects a shift from a generic mention of possible repurchases to a quantified repurchase activity and a clear articulation of the holders’ exchange and dividend rights.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the evolution in disclosure practices and correctly identifies the shift from generic to quantified disclosures. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n(1) QUANTITATIVE ERRORS:\n- The LLM states '$2.694 billion aggregate authorization' but the ground truth specifies '$2,694,281 remaining authorization' as of August 31, 2024. These are vastly different figures ($2.694 billion = $2,694,000,000 vs. $2,694,281). This is a critical error - the LLM appears to have misread or misinterpreted the authorization amount by approximately 1,000x.\n- The LLM provides specific repurchase data: '47,752 exchangeable shares were actually repurchased for $15,254' - this specific data is not mentioned in the ground truth, which only references the authorization amount. While this detail may be accurate from the filing, it cannot be verified against the ground truth provided.\n\n(2) QUALITATIVE STRENGTHS:\n- Correctly identifies the evolution from 2022 to 2024\n- Accurately describes the shift from generic language to specific quantified disclosures\n- Properly identifies the one-for-one exchangeability feature\n- Correctly notes the dividend rights and Class X share redemption protections\n- Appropriately cites page numbers from filings\n- Sound multi-hop reasoning connecting disclosure evolution across years\n\n(3) MULTI-HOP REASONING:\n- Successfully synthesizes information across 2022 and 2024 filings\n- Correctly identifies the comparative evolution in disclosure practices\n- Properly connects share repurchase activity to shareholder rights disclosures\n\n(4) CONTEXTUAL ISSUES:\n- The authorization amount discrepancy is a fundamental factual error that undermines credibility\n- The specific repurchase numbers (47,752 shares for $15,254) cannot be verified against the ground truth but appear plausible\n- Overall narrative and structure are appropriate and relevant to the question\n\nThe answer would score higher if the authorization amount were correct. The $2.694 billion figure appears to be a significant misreading of the $2,694,281 figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 579,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The Electrophysiology Devices segment generated **$2.195 billion in 2023** and **$2.467 billion in 2024** (U.S. + International totals)【page_53】. Excluding foreign‑exchange effects, this represents a **14.4 % increase** year‑over‑year【page_29】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely accurate with correct financial figures and the key percentage metric. Verification of numbers: 2023 revenue of $2.195 billion ($2,195 million) is correct, 2024 revenue of $2.467 billion ($2,467 million) is correct, and the 14.4% increase excluding FX effects is correct. The number format variation (billion vs million) is acceptable and semantically equivalent. The answer correctly identifies the segment, years, and provides the FX-adjusted percentage change. However, there is one notable omission: the LLM answer does not mention the total percentage change of 12.3% (the reported change including FX effects), which was explicitly requested in the question asking 'how did the revenue evolve' - this implies showing both the total change and the FX-adjusted change. The question asks for 'the percentage change in this revenue, excluding the impact of foreign exchange fluctuations' which the LLM correctly provides (14.4%), but the question's phrasing about 'how did the revenue evolve' suggests a complete picture would include both metrics. The multi-hop reasoning is sound - the answer correctly synthesizes data from multiple pages (page 53 for revenue figures, page 29 for FX-adjusted percentage). The answer is well-structured and directly addresses the core question about FX-adjusted growth, though it could have been more complete by also noting the 12.3% total change for full context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 396,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "In fiscal 2022 Accenture’s equity‑method investment in Duck Creek Technologies – representing about a 16 % ownership – was carried at $138.9 million, with an estimated fair value of $223.2 million (page 70). By fiscal 2024 the stake had appreciated enough that Accenture recorded a $253 million gain on the investment in fiscal 2023, a gain that was highlighted in the 2024 MD&A as boosting earnings and affecting the effective‑tax‑rate adjustment (page 40). This reflects a substantial increase in the investment’s valuation and a material positive impact on Accenture’s financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Accenture's Duck Creek Technologies investment evolution. STRENGTHS: (1) Quantitative accuracy is excellent - the LLM correctly identifies the fiscal 2022 carrying value of $138.9 million and fair value of $223.2 million (matching the ground truth's $223,166 thousand = $223.2 million), the 16% ownership stake, and the $253 million gain. (2) The answer properly synthesizes information across multiple fiscal years (2022, 2023, 2024) and correctly attributes the $253 million gain to fiscal 2023 while discussing its impact in the 2024 MD&A. (3) Entity identification is accurate - correctly names Accenture and Duck Creek Technologies, uses proper accounting terminology (equity-method investment), and identifies the correct fiscal periods. (4) The multi-hop reasoning is sound, connecting the investment valuation change to financial performance impact through the gain recognition. (5) The answer addresses both quantitative (valuation increase) and qualitative (shift in contribution to earnings) aspects of the question. MINOR CONSIDERATIONS: The ground truth states the fiscal 2022 investment was valued at '$223,166' which appears to be in thousands (matching the LLM's $223.2 million), though the ground truth's phrasing is slightly ambiguous. The LLM's interpretation as $223.2 million is consistent with standard SEC filing conventions and the context. The LLM provides additional helpful context (page references, effective tax rate impact) that enhances the answer without introducing errors. All calculations and temporal relationships are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 456,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Union Pacific’s 2022 proxy showed that its retention awards were essentially all shares – about 389 000 retention shares were outstanding under the 2021 Plan, with no separate retention‑unit count disclosed (UNP_10k_2022.pdf p.65). By 2023 the company reported a mixed pool of roughly 954 000 retention shares plus 366 000 retention units (non‑exercisable awards), expanding the total pool to over 1.3 million awards (UNP_10k_2023.pdf p.75). The introduction of a sizable unit component and the overall increase in awards suggest a strategic shift toward performance‑linked, non‑exercise‑price unit awards to better align executive pay with long‑term company performance and retention goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All key numbers are correct - 389,207 retention shares in 2022 (LLM rounded to ~389,000, acceptable format variation), 954,405 retention shares in 2023 (LLM stated ~954,000, acceptable), and 366,046 retention units in 2023 (LLM stated ~366,000, acceptable). The calculated total of 1.3+ million awards is accurate (954,405 + 366,046 = 1,320,451). ENTITY ACCURACY: Union Pacific correctly identified, years 2022 and 2023 properly distinguished, metrics (retention shares vs. retention units) accurately characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and two document sources, correctly identifying the shift from share-only to mixed share-and-unit structure. The interpretation that retention units lack exercise prices is accurate per ground truth. STRATEGIC INTERPRETATION: The LLM's characterization of the shift as moving toward 'performance-linked, non-exercise-price unit awards' and 'better align executive pay with long-term company performance' represents sound reasoning about compensation strategy, though the ground truth uses slightly more cautious language ('possible expansion or refinement'). This is a reasonable inference rather than an error. MINOR CONSIDERATIONS: The LLM provides specific page references (p.65, p.75) which cannot be verified from the ground truth but add credibility. The answer is slightly more interpretive than the ground truth but remains factually grounded. No calculation errors detected. All core facts match the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 456,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife’s definition of adjusted earnings as a GAAP‑consistent segment measure has stayed the same – it continues to strip out market‑volatility items (net investment gains/losses, net derivative gains/losses, MRB remeasurement gains/losses and goodwill impairments) and asymmetrical, non‑economic accounting (in‑force reinsurance effects, basis‑adjustment amortizations, inflation‑indexed benefit adjustments and non‑economic losses at contract inception). In the 2024 filing the company simply clarifies the exclusions, adding that net investment income also removes equity‑method earnings from joint‑ventures and that interest credited to policyholder account balances excludes periodic credit‑rate adjustments and related asymmetrical accounting, but the fundamental GAAP‑based exclusions have not changed.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant conceptual and factual errors that undermine its core thesis. MAJOR ISSUES: (1) The LLM claims the definition of adjusted earnings 'has stayed the same' between 2023 and 2024, which directly contradicts the ground truth stating MetLife 'continued to refine these exclusions' and 'expanded the scope' of certain exclusions. This is a fundamental mischaracterization of the evolution requested in the question. (2) The LLM fails to mention the critical 2023 LDTI adoption context, which was a major driver of changes to adjusted earnings calculations. The ground truth explicitly states 'In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI' - this is a key multi-hop connection the LLM missed. (3) The LLM does correctly identify some exclusions (MRBs, in-force reinsurance asymmetrical accounting, net investment gains/losses, derivatives) that appear in both years, but frames them as unchanged rather than refined. (4) The LLM correctly notes the 2024 addition of equity-method earnings from joint ventures in net investment income exclusions, which aligns with ground truth. (5) However, the LLM's characterization of 'simply clarifies the exclusions' minimizes what the ground truth describes as meaningful refinement and expansion of scope. MULTI-HOP REASONING: The LLM failed to synthesize the LDTI adoption as a driver of 2023 changes and the subsequent refinements in 2024. The question specifically asks about 'evolution' between years, and the LLM's answer that nothing fundamentally changed is factually incorrect per the ground truth. POSITIVE ASPECTS: The LLM correctly identifies several specific exclusion categories and does mention the joint venture equity method addition in 2024. The answer demonstrates some knowledge of MetLife's adjusted earnings framework but misses the temporal evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 518,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "In 2022 Accenture’s Industry X narrative framed “compressed transformations” around a core set of emerging tools—digital twins, AI, IoT, cloud/edge, 5G, advanced robotics and the metaverse—to redesign product design, engineering, sourcing, manufacturing and service. By 2024 the playbook had broadened: generative AI, AR/VR, AI‑Navigator platforms and the ability to design and build advanced automation hardware were added, and the transformation scope now also covers testing, capital‑project digitization and the creation of specialized robotics equipment, all woven into its Strategy, Technology, Operations and Industry X service lines.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of technologies and evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies 2022 technologies: digital twins, AI, IoT, cloud/edge, 5G, advanced robotics, metaverse - all match ground truth. (2) Accurately captures 2024 additions: generative AI, AR/VR, advanced automation hardware - all correct. (3) Properly notes the expansion of transformation scope to include capital projects and infrastructure. (4) Uses appropriate terminology (Industry X narrative, service lines) that adds context. (5) No quantitative errors or date inaccuracies. MINOR ISSUES: (1) The LLM introduces 'AI-Navigator platforms' and 'testing' as 2024 additions, which are not explicitly mentioned in the ground truth answer. While these may be accurate from the source documents, they represent additions beyond what the ground truth specifies, creating slight divergence. (2) The ground truth specifically mentions 'plant and asset construction, public infrastructure, power grids, and data centers' as capital project examples, while the LLM uses more general language ('capital-project digitization'). This is less specific but not incorrect. (3) The LLM mentions 'specialized robotics equipment' which aligns with ground truth's 'advanced robotics' but adds specificity about equipment creation. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across the two-year period, comparing 2022 vs 2024 approaches and showing how both technologies and scope expanded. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message matches - Accenture expanded its technological toolkit and broadened transformation scope from 2022 to 2024. The LLM's framing around 'Industry X narrative' and service lines provides helpful context. The minor additions (AI-Navigator, testing) and slight generalization of examples prevent a perfect score, but the answer remains substantially correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 537,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "In 2023 Abbott reported that it had roughly $2.2 billion of interest‑rate hedge contracts, but $700 million of those contracts matured that year, which cut the fair‑value liability on the swaps from $156 million in 2022 to $95 million in 2023 (the payable position fell from (156) to (95))【page_66】. By the end of 2024 the company again disclosed $2.2 billion of interest‑rate hedge contracts, indicating it replaced the maturing contracts and kept the same overall notional exposure to manage the fair‑value of its fixed‑rate debt【page_40】【page_64】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate core information about Abbott's interest rate hedge contracts but differs from the ground truth in emphasis and completeness. STRENGTHS: (1) Correctly identifies the $2.2 billion notional value in both 2023 and 2024, showing consistency in hedging strategy; (2) Accurately reports the fair-value liability figures ($156M in 2022, $95M in 2023) and the $700M maturity during 2023; (3) Correctly synthesizes the multi-hop concept that Abbott replaced maturing contracts to maintain the same overall notional exposure; (4) Properly cites relevant pages from filings. WEAKNESSES: (1) The ground truth mentions that these contracts were 'designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt' - the LLM answer doesn't explicitly explain this mechanism; (2) The ground truth includes important context about the average interest rate on long-term debt increasing from 3.6% in 2023 to 3.8% in 2024, which the LLM answer completely omits - this is significant contextual information about how market conditions evolved despite stable hedge amounts; (3) The LLM answer focuses more on the mechanics of contract maturity and replacement rather than the broader strategic evolution and market context. QUANTITATIVE VERIFICATION: All numbers cited ($2.2B, $700M, $156M, $95M) appear consistent with typical hedge disclosures and the LLM correctly identifies the directional change in fair-value liability. The answer demonstrates sound multi-hop reasoning by connecting the 2023 maturity event to the 2024 replacement strategy. However, the omission of the interest rate increase data represents a meaningful gap in addressing the full scope of how the hedging strategy 'evolved' between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 479,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "In the 2023 filing MetLife first framed adjusted earnings as a non‑GAAP metric that, “consistent with GAAP guidance for segment reporting, adjusted earnings and related measures are also our GAAP measures of segment performance” and noted that the adoption of LDTI changed the calculation by removing DAC/VOBA amortization adjustments (page 119‑120). By the 2024 filing the company still presents adjusted earnings as its GAAP‑aligned segment‑performance measure, but now explicitly ties it to the chief operating decision‑maker’s evaluation and resource‑allocation process and spells out a broader set of exclusions – market‑volatility gains/losses, asymmetrical and non‑economic accounting, divested‑business items and discontinued‑operation results – while reaffirming compliance with GAAP segment‑reporting guidance (page 150‑151, 152).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of MetLife's Adjusted Earnings evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 LDTI adoption as a key driver of changes to Adjusted Earnings calculation; (2) Accurately notes the removal of DAC/VOBA amortization adjustments in 2023; (3) Properly characterizes Adjusted Earnings as both a non-GAAP metric and GAAP measure of segment performance, with appropriate citations to page numbers (119-120 for 2023, 150-151, 152 for 2024); (4) Correctly identifies the broader set of exclusions in 2024 including market volatility impacts, asymmetrical/non-economic accounting, divested business items, and discontinued operations; (5) Accurately notes the 2024 tie to chief operating decision-maker evaluation and resource allocation; (6) Properly synthesizes the multi-hop information across two years and multiple filing sections. MINOR GAPS: (1) The LLM answer does not explicitly mention specific 2023 exclusions like MRBs, discount rate changes on annuitization guarantees, and in-force reinsurance asymmetrical accounting that are detailed in the ground truth; (2) Does not specifically call out 2024 exclusions such as net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, goodwill impairments, inflation-indexed benefit adjustments, and single premium annuity contract losses; (3) The characterization of the evolution as a 'refinement and expansion' is implied but not explicitly stated. QUANTITATIVE ACCURACY: No numeric errors detected; page citations appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning about GAAP alignment and segment performance measurement is sound and properly synthesized across years. The answer correctly identifies this as an evolution rather than a complete overhaul. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing both the 2023 and 2024 treatment and the relationship to GAAP guidance and segment performance measurement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 539,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "In 2022 the Board had authorized $3.13 million for the publicly announced open‑market repurchase program (with a $3 million board addition that raised total authority to $6.13 million) and used it to buy about 12.2 million shares for $4.1 million, mainly through open‑market purchases and share‑withholding for payroll‑tax obligations under employee equity plans (plus a small exchangeable‑share component)【page_93】【page_94】. By fiscal 2024 the remaining available authorization had fallen to $2.69 million (while a $4 million board addition lifted total authority to $6.69 million) and the company increased its utilization, purchasing roughly 13.9 million shares for $4.5 million via the same open‑market and payroll‑tax withholding methods (and a modest amount of exchangeable‑share purchases)【page_100】【page_101】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors that fundamentally misrepresent the ground truth. Key issues: (1) MAJOR NUMBER ERRORS: The ground truth states the 2022 available authorization was $3,129,296 (approximately $3.13 million), but the LLM incorrectly interprets this as '$3.13 million' for the program itself, then adds a '$3 million board addition' to reach '$6.13 million' - this addition is not mentioned in the ground truth. Similarly, for 2024, the LLM claims remaining authorization fell to '$2.69 million' with a '$4 million board addition' to reach '$6.69 million' - these specific figures and the board additions are not supported by the ground truth. (2) SHARE PURCHASE QUANTITIES: The LLM states '12.2 million shares for $4.1 million' in 2022 and '13.9 million shares for $4.5 million' in 2024 - these specific numbers are not mentioned in the ground truth and appear to be fabricated. (3) MISINTERPRETATION OF AUTHORIZATION: The ground truth emphasizes that the $3,129,296 was the 'aggregate available authorization' for the share purchase program in 2022, not a board authorization amount that was then added to. The LLM's framing of board additions and remaining authorization calculations is not supported by the source material. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that both years involved open-market purchases and share withholding for payroll tax obligations, it fails to capture the key distinction highlighted in the ground truth: the shift in focus from acquisitions of both Class A ordinary shares AND exchangeable shares (2022) to primarily Class A ordinary shares held as treasury for employee benefits (2024). (5) MISSING CONTEXT: The ground truth emphasizes that 2024 acquisitions 'did not impact the aggregate available authorization for the public share purchase programs,' indicating a methodological shift - the LLM does not convey this important distinction. The answer demonstrates poor data synthesis and appears to contain invented figures rather than accurate extraction from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 557,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "In the 2023 filing MetLife presented its Unit‑linked and FVO securities at **amortized cost** – i.e., the original purchase price reduced by repayments and adjusted for premium amortization or discount accretion (see Schedule I, “Unit‑linked and FVO securities” and footnote (1) on page 320).  Fair‑value changes for those securities were simply recorded in net investment income, with no detailed sensitivity analysis shown.\n\nIn the 2024 filing the company now treats Unit‑linked and FVO securities as **Level 3 assets** and values them using the same significant‑unobservable‑input techniques and pricing methods (matrix, market and consensus pricing) applied to other Level 3 securities.  MetLife explicitly notes that the **fair‑value sensitivity** of Unit‑linked securities to changes in those inputs is “similar in nature to that described in the preceding table” of Level 3 sensitivities (see Note 13, pages 249‑250).  Thus, the methodology shifted from a basic amortized‑cost presentation to a Level 3 fair‑value approach with disclosed sensitivity to key inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about MetLife's evolution in Unit-linked Securities treatment from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 approach as amortized cost-based (original purchase price adjusted for repayments and premium/discount amortization), which aligns with the ground truth's description of 'cost representing original cost for equities and amortized cost for fixed maturities.' (2) Accurately characterizes the 2024 shift to Level 3 fair value measurements with significant unobservable inputs, matching the ground truth's emphasis on 'mortality rates, lapse rates, and equity volatility.' (3) Properly synthesizes the multi-hop comparison across years, showing the evolution from static cost-based to dynamic assumption-driven valuation. (4) Correctly notes the shift in fair value sensitivity disclosure and references specific Note 13 locations. (5) Appropriately cites Schedule I and page references. MINOR WEAKNESSES: (1) The LLM answer states fair-value changes in 2023 were 'recorded in net investment income' - while this is a reasonable inference about accounting treatment, the ground truth does not explicitly confirm this detail, representing a slight extrapolation beyond the provided source material. (2) The answer could have been slightly more explicit about the specific unobservable inputs (mortality, lapse, volatility) that the ground truth emphasizes, though it does reference 'significant-unobservable-input techniques.' (3) The phrase 'similar in nature to that described in the preceding table' is appropriately quoted but could have been more directly connected to the sensitivity analysis emphasis in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The page references (320, 249-250) appear reasonable for a 10-K filing structure. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the methodological evolution, demonstrating sound multi-hop reasoning. The comparison structure (2023 vs 2024) directly addresses the question's request for evolution analysis. SEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 651,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "In FY 2022 Broadcom’s market‑based RSUs were granted with a service condition and a market condition and “generally vest over four years” with payouts tied to total‑stockholder‑return versus an index group【page_84】.  In FY 2023 the company kept that four‑year design but added a new class of market‑based RSUs that “vest over five years, subject to satisfaction of stock‑price performance milestones”【page_84】, and the weighted‑average expected term in the valuation model rose from about 3.4 years in FY 2022 to roughly 4.8 years in FY 2023【page_85】.  Thus, while the basic TSR‑based structure stayed the same, the vesting horizon was extended in 2023 to include a five‑year award and a longer overall expected term.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the FY 2022 structure: four-year vesting with TSR-based payouts ranging 0-300% relative to index group. (2) Accurately describes FY 2023 evolution: retention of four-year vesting plus introduction of new five-year vesting structure with stock price performance milestones. (3) Provides additional quantitative detail not in ground truth but factually correct: weighted-average expected term increased from 3.4 years (FY 2022) to 4.8 years (FY 2023), with proper source citations. (4) Correctly identifies Broadcom as the company. (5) Multi-hop synthesis is sound: compares vesting structures across two fiscal years and identifies both continuity (TSR-based four-year awards) and change (new five-year stock price milestone awards). (6) Semantic equivalence is strong - conveys the same core information as ground truth while adding supporting detail. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by including the weighted-average expected term data, but this is supplementary and accurate rather than contradictory. The payout range (0-300%) mentioned in ground truth is not explicitly restated in LLM answer, though the TSR-based structure is confirmed. This is a very minor omission that doesn't materially affect the answer's quality. The answer directly addresses the question about how structure and vesting timeline evolved between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 409,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "The CECL Transition Rule let Capital One treat the CECL impact as a capital add‑back, allowing it to add back the after‑tax “day 1” adoption impact and a scaled portion of the “day 2” ongoing allowance increase (25 % per year) to its regulatory capital 【page_80】. As a result, the company had only 50 % of that impact phased in by year‑end 2023, but by year‑end 2024 the phase‑in had progressed to 75 % (with $600 million added in 2024 and the final $600 million scheduled for Jan 1 2025) 【page_203】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides accurate and detailed information about the CECL phase-in treatment. STRENGTHS: (1) Correctly identifies the 25% annual phase-in rate, matching the ground truth. (2) Accurately states that 50% was phased in by year-end 2023 (2 years × 25% = 50%), demonstrating correct calculation. (3) Correctly indicates 75% by year-end 2024 (3 years × 25% = 75%), with proper calculation. (4) Provides specific dollar amounts ($600 million added in 2024, final $600 million scheduled for Jan 1, 2025), which adds concrete detail. (5) Correctly identifies the multi-year transition framework spanning from January 1, 2022 through December 31, 2024. (6) Properly distinguishes between 'day 1' adoption impact and 'day 2' ongoing impact. (7) Multi-hop reasoning is sound - synthesizes information about how the phase-in evolved between 2023 and 2024. MINOR CONSIDERATIONS: (1) The ground truth emphasizes that treatment 'remained consistent' between 2023 and 2024, while the LLM answer focuses more on the progression/evolution of the phase-in percentage (50% to 75%). Both perspectives are accurate - the treatment mechanism remained the same, but the cumulative phase-in percentage increased. (2) The LLM answer provides more granular detail about the specific dollar amounts and timing, which enhances rather than detracts from accuracy. (3) Page citations are included, suggesting source verification. The answer directly addresses both parts of the question: how the phase-in evolved (50% to 75%) and what specific treatment applied (25% annual phase-in). Calculations are mathematically correct and all entities are properly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 451,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "In the 2022 Form 10‑K the exhibit list (page 101) contains no new senior‑note indentures with Wilmington Trust, National Association, indicating that Broadcom’s senior‑note program was unchanged in that filing. By the 2023 Form 10‑K the company had added several fresh indentures with Wilmington Trust as trustee – e.g., the April 14 2022 indenture (Exhibit 4.42) issuing 4.00 % senior notes due 2029 and 4.15 % notes due 2032, and the April 18 2022 indenture (Exhibit 4.46) issuing 4.926 % notes due 2037 – alongside existing series, showing a shift toward higher‑coupon, longer‑dated senior notes while retaining Wilmington Trust as the trustee (pages 98‑100).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Broadcom's relationship with Wilmington Trust and captures the general trend toward higher-coupon, longer-dated senior notes. However, there are significant quantitative discrepancies that reduce accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies that 2022 showed no new indentures in the exhibit list\n- Correctly identifies April 18, 2022 indenture with 4.926% notes due 2037\n- Correctly identifies the shift toward higher-coupon, longer-dated debt\n- Correctly maintains Wilmington Trust as trustee throughout\n- Appropriate page references to 10-K filings\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS:\n   - States \"April 14 2022 indenture\" issuing \"4.00% senior notes due 2029 and 4.15% notes due 2032\" - Ground truth does not mention an April 14, 2022 indenture or these specific rates/dates\n   - Ground truth mentions 4.150% (due 2028) and 4.800% (due 2034) from October 2024, not April 2022\n   - The 4.00% and 4.15% rates appear to be confused or misattributed\n\n2. MISSING INFORMATION:\n   - Fails to mention the January 2021 indenture with lower rates (1.950% due 2028, 3.750% due 2051) that existed in 2022\n   - Does not mention the July 12, 2024 indenture mentioned in ground truth\n   - Does not mention October 2024 notes (4.150% due 2028, 4.800% due 2034)\n\n3. TEMPORAL ISSUES:\n   - Ground truth indicates evolution through 2024, but LLM answer only covers through 2023 Form 10-K\n   - The question asks about 2022-2023 evolution, but ground truth extends to 2024\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across 2022 and 2023 10-K filings and identifies the relationship evolution. However, the specific indenture details and rates are inaccurate, which undermines the multi-hop synthesis quality.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates understanding of the question's intent and correctly identifies the general trend, but contains material factual errors in specific interest rates and indenture dates that significantly impact accuracy. The core narrative is sound but the supporting details are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 574,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One’s CECL add‑back—an aggregate $2.4 billion—was at 50 % of the total in 2023 and increased to 75 % of the total as of January 1 2024【page_202】. Under the CECL Transition Rule the cumulative “day‑2” impact is phased in at 25 % per year: 25 % in 2022, 50 % in 2023, 75 % in 2024, and fully (100 %) by 2025【page_11】【page_202】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: the $2.4 billion aggregate add-back amount, the 50% phase-in in 2023, and the 75% phase-in as of January 1, 2024 are all accurate. The phase-in progression is correctly detailed with the 25 percentage point increase from 2023 to 2024 properly identified. The LLM goes beyond the ground truth by providing the complete five-year phase-in schedule (25% in 2022, 50% in 2023, 75% in 2024, 100% by 2025), which adds valuable context and demonstrates thorough understanding of the CECL Transition Rule mechanics. The multi-hop reasoning is sound—the answer correctly synthesizes information about the regulatory capital add-back amount, the phase-in percentages, and the annual progression pattern. Entity identification is accurate (Capital One, CECL Transition Rule). The only minor distinction from the ground truth is that the LLM provides additional detail about the complete phase-in schedule beyond what was explicitly stated in the original answer, but this is supplementary information that enhances rather than contradicts the ground truth. The answer directly addresses both parts of the question: how the add-back evolved (from 50% to 75%) and what the specific phase-in progression was during the period. Citation references are included, indicating source documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 381,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "In the 2022 Form 10‑K (page 97) Broadcom disclosed that, as part of the pending VMware merger, “all outstanding in‑the‑money VMware stock options and RSU awards held by non‑employee directors will be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts.” The 2023 Form 10‑K (page 66) reports that, after the merger closed, those same options and RSU awards “were accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts.” Thus, the treatment did not change – the planned 50/50 cash‑and‑stock conversion for non‑employee director options was carried out when the acquisition was completed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the key facts from both 2022 and 2023 filings - the planned conversion in 2022 and its realization in 2023. (2) Accurately captures the specific conversion terms: 50/50 split between cash and Broadcom shares. (3) Properly synthesizes the multi-hop information showing the evolution from 'will be accelerated' (future/planned) to 'were accelerated' (completed). (4) Correctly identifies the companies (VMware, Broadcom) and the transaction type (merger/acquisition). (5) Cites specific page numbers (97 for 2022, 66 for 2023) which adds credibility. (6) The reasoning is sound - showing that the treatment didn't change in substance but rather transitioned from planned to executed. MINOR CONSIDERATIONS: (1) The original answer emphasizes this as a 'transition from planned conversion to actualized event' while the LLM states 'the treatment did not change.' These are semantically equivalent - both convey that the same conversion mechanism was planned and then executed. (2) The LLM's conclusion that 'the treatment did not change' is accurate in substance (the conversion terms remained the same), though one could argue the 'treatment' evolved in the sense that it moved from prospective to retrospective. However, this is a matter of interpretation rather than factual error. (3) All factual elements match the ground truth: the in-the-money options and RSUs, the non-employee director scope, the equal parts cash/stock conversion, and the timing relative to acquisition completion. No numerical errors or calculation issues detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 447,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "In the 2022 Form 10‑K AbbVie highlighted Vraylar mainly as a development candidate for major depressive disorder, reporting top‑line Phase 3 results of two adjunctive‑MDD studies—one met its primary endpoint and the other showed a non‑significant trend (page 60). By the 2024 filing the company lists Vraylar as an approved dopamine‑D3‑preferring D3/D2 partial agonist with four distinct indications: acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes of bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive therapy for major depressive disorder (page 6). This shows a shift from a narrow, development‑focused positioning on MDD in 2022 to a broader, multi‑indication, established psychiatric product portfolio by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2022 positioning of Vraylar as a development candidate in Phase 3 trials for MDD, accurately noting one trial met primary endpoint and the other showed non-significant results - this matches the ground truth exactly. (2) Accurately lists all four 2024 indications: acute/maintenance schizophrenia, acute manic/mixed bipolar, acute depressive bipolar I, and adjunctive MDD - all match ground truth. (3) Properly synthesizes the multi-hop comparison showing evolution from narrow development focus (2022) to broad, established multi-indication product (2024). (4) Adds helpful context about the mechanism (dopamine-D3-preferring D3/D2 partial agonist) and approval status that enhances understanding without contradicting ground truth. (5) Correctly cites page references (page 60 for 2022, page 6 for 2024) showing document-specific sourcing. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than ground truth (e.g., 'development candidate' vs 'being evaluated', 'non-significant trend' vs 'numerical but not statistically significant improvement') but these are semantically equivalent and actually more precise. The answer fully addresses the temporal evolution question with clear before/after comparison. No factual errors, calculation errors, or entity misidentifications detected. The reasoning is sound and the synthesis across the two time periods is logical and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 419,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "In the 2022 filing GE said that long‑term services contracts in its Healthcare and Renewable‑Energy businesses were “recognized … on a straight‑line basis… We generally invoice periodically as services are provided” (2022 p. 85), while its Aviation and Power businesses used a percentage‑of‑completion approach for those contracts (2022 p. 83). By the 2024 filing the company has moved to a single percentage‑of‑completion policy for all long‑term services agreements, recognizing revenue as it performs based on costs incurred versus total‑cost estimates and on utilization forecasts, and it now explicitly updates utilization and billing estimates with cumulative catch‑up adjustments (2024 p. 17).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution from straight-line to percentage-of-completion methods and accurately describes the 2022 policy differences across segments (Healthcare/Renewable Energy using straight-line, Aviation/Power using percentage-of-completion). The 2024 shift to unified percentage-of-completion methodology is correctly stated, and the mention of cumulative catch-up adjustments and utilization forecasts is accurate.\n\nHowever, there are significant quantitative omissions. The ground truth specifies critical 2024 metrics: (1) a $6.6 billion net liability balance for long-term services agreements, (2) this represents 4.1% of total estimated life of contract billings, and (3) total estimated life of contract billings of $162 billion. The LLM answer completely omits these specific financial figures, which are material to understanding the scale and financial impact of the policy change. These numbers represent the 'more detailed and forward-looking estimation process' mentioned in the ground truth.\n\nThe LLM answer also does not explicitly mention that the shift was 'predominantly within the CES segment' in 2024, though it does note the move to a 'single' policy for 'all' long-term services agreements, which partially captures this evolution.\n\nThe multi-hop reasoning is sound in connecting the 2022 baseline to 2024 changes, and the semantic understanding of the accounting policy evolution is correct. The answer appropriately references specific page numbers from filings, demonstrating source verification. However, the failure to include the quantitative metrics ($6.6B liability, $162B total billings, 4.1% ratio) represents a substantial gap in completeness for a question specifically asking about the evolution of accounting policies with financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 493,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 1.250 % Notes due 2027 are not listed among the securities or exhibits – the exhibit table only references other debt (e.g., the 6.22 % debentures due 2027) and makes no separate entry for the 1.250 % notes【page_31】. By the 2023 Form 10‑K, IBM adds a distinct line for “1.250 % Notes due 2027” in the “Securities registered pursuant to Section 12(b)” table, indicating that the company now discloses this instrument explicitly【page_1】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - 2022 Disclosure: The LLM claims the 1.250% Notes due 2027 are 'not listed among the securities or exhibits' in the 2022 10-K, but the ground truth explicitly states they WERE disclosed as 'part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes.' This is a fundamental mischaracterization of the 2022 filing. (2) PARTIAL CORRECTNESS - 2023 Disclosure: The LLM correctly identifies that the 1.250% Notes due 2027 appear in the 2023 10-K under 'Securities registered pursuant to Section 12(b)' table, which aligns with the ground truth's statement about 'registered securities with the trading symbol IBM 27B on the New York Stock Exchange.' (3) MISSING KEY DETAIL: The LLM fails to mention the specific reference to Exhibit 4.3 from the Form 8-K filed on January 30, 2019, which is an important detail in the ground truth. (4) INCORRECT CHARACTERIZATION: The LLM suggests the notes were absent from 2022 disclosures and then 'added' in 2023, when the actual evolution was from referencing the instrument defining rights (2022) to identifying it as a registered class of securities (2023). The core multi-hop reasoning is flawed because it misrepresents the 2022 baseline, making the comparison between years fundamentally incorrect. The answer demonstrates a failure to accurately synthesize information from the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 418,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "AbbVie’s performance‑vested RSUs have not changed – in both 2022 and 2024 they vest in one‑third increments over a three‑year performance period and the vesting condition is tied to AbbVie’s return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech and life‑science companies (2022 Form 10‑K p. 113; 2024 Form 10‑K p. 92). No new vesting schedule or performance metric was added between those years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core structural elements (one-third increments over three-year period, ROIC metric, peer group comparison) and accurately cites the relevant 10-K pages. However, it significantly misses the key evolution described in the ground truth. The ground truth explicitly states that by 2024, there was a 'simplification or standardization of the performance criteria' with the description becoming 'streamlined' and no longer mentioning 'specific years tied to tranches as seen in 2022.' The LLM answer claims 'no new vesting schedule or performance metric was added' and states the structure 'have not changed,' which contradicts the ground truth's assertion of evolution/simplification in how the metrics are described and presented. The LLM answer treats the 2022 and 2024 structures as identical when the ground truth indicates a meaningful change in how the performance criteria are described and communicated, even if the underlying mechanics remained similar. The answer is partially correct on the mechanics but fails to capture the actual evolution in structure/presentation that the question specifically asks about. The numeric/structural details are accurate, but the synthesis of how things evolved between the two years is incomplete and somewhat contradictory to the ground truth's characterization of simplification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 380,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "GE’s AerCap investment went from a large loss to modest gains. In 2022 the company recorded a net unrealized loss of $(865) million on the AerCap note; in 2023 that turned positive with a $129 million realized/unrealized gain; and in 2024 the gain narrowed to $38 million, showing the investment moved from a sizable loss to small positive returns over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of GE's AerCap investment evolution but contains a significant factual error that undermines accuracy. CORRECT ELEMENTS: (1) 2022 unrealized loss of $865 million is accurate; (2) 2024 gain of $38 million is accurate; (3) Overall narrative of movement from loss to gain is correct; (4) The qualitative assessment that the investment 'moved from a sizable loss to small positive returns' is semantically sound. CRITICAL ERROR: The LLM introduces a 2023 figure of '$129 million realized/unrealized gain' that is NOT mentioned in the ground truth answer. The original answer only addresses 2022 and 2024, making no reference to 2023 data. This represents either fabrication or unsupported synthesis. REASONING ASSESSMENT: The multi-hop reasoning is generally sound - the model correctly identifies the directional change and understands the investment's trajectory. However, the introduction of unverified 2023 data suggests the model may have hallucinated or conflated information from sources not provided in the ground truth. COMPLETENESS: The answer goes beyond what was asked (adding 2023 data) while still addressing the core 2022-2024 comparison. The question asks about evolution 'from 2022 to 2024,' and while the LLM provides intermediate year data, this data cannot be verified against the ground truth. QUANTITATIVE ACCURACY: Two of three years' figures are correct ($865M in 2022, $38M in 2024), but the unverified $129M in 2023 creates uncertainty. The calculation/comparison logic is sound for the verified years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 431,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2026 do not appear in the securities‑register or exhibit schedules (e.g., the “Instruments defining the rights of security holders” list on page 31 shows only other debentures and makes no mention of a 0.300 % note). By contrast, the 2023 filing explicitly lists the 0.300 % Notes due 2026 (ticker IBM 26B) among the securities registered under Section 12(b) on page 1, giving the instrument a disclosed and visible status.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core evolution of the 0.300% Notes due 2026 between 2022 and 2023 filings - moving from less visible/not explicitly listed to explicitly listed with ticker IBM 26B on the registered securities list. However, there are significant issues with the accuracy of specific claims:\n\n1. CORRECT ELEMENTS: The LLM correctly identifies that (a) the notes were not prominently visible in 2022, (b) by 2023 they appear explicitly listed with ticker IBM 26B, and (c) this represents increased visibility and formal recognition. The general trajectory is accurate.\n\n2. PROBLEMATIC CLAIMS: The LLM states the notes \"do not appear in the securities-register or exhibit schedules\" in 2022 and specifically claims \"the 'Instruments defining the rights of security holders' list on page 31 shows only other debentures and makes no mention of a 0.300% note.\" This is contradicted by the ground truth, which explicitly states the notes WERE disclosed in 2022 as part of exhibits under Exhibit 4 to Form 8-K filed November 1, 2016. The ground truth indicates they were referenced in legal instruments defining holder rights, not absent.\n\n3. MULTI-HOP REASONING: The LLM correctly synthesizes the comparison between 2022 and 2023 filings and identifies the change in disclosure status. However, it mischaracterizes the 2022 status as completely absent rather than as referenced in exhibits.\n\n4. ENTITY ACCURACY: All entities are correctly identified (IBM, 0.300% Notes due 2026, ticker IBM 26B, Section 12(b), 2022 vs 2023 filings).\n\n5. SEMANTIC ISSUE: The answer conveys a different narrative than ground truth - suggesting the notes went from absent/unmentioned to explicitly listed, when the ground truth suggests they went from exhibit-referenced to explicitly registered/listed. This is a meaningful distinction in disclosure evolution.\n\nThe answer demonstrates partial understanding but contains a factual error about the 2022 disclosure status that undermines the accuracy of the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 543,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "In the 2022 filing GE presented RISE as a newly‑announced joint program with Safran that was “targeting more than 20 % lower fuel consumption and CO₂ emissions” and framed it as an early‑stage commitment to develop sustainable‑flight technologies【page_18】. By the 2024 filing the description had shifted to a broader, multi‑technology suite—Open‑Fan, compact‑core and hybrid‑electric concepts—backed by “significant investments” and more than 250 full‑scale engine tests, positioning RISE as a central, mature pillar of GE’s strategy for next‑generation sustainable engines【page_4】【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The 20% fuel consumption and CO2 emissions reduction target is correctly cited and matches the ground truth. The mention of '250 full-scale engine tests' adds specific quantitative detail not explicitly in the ground truth but represents appropriate elaboration from source documents. ENTITY ACCURACY: GE and Safran are correctly identified as joint program partners. Years 2022 and 2024 are correctly referenced. MULTI-HOP REASONING: The answer effectively synthesizes the evolution across two time periods, correctly identifying the 2022 phase as 'newly-announced' and 'early-stage' versus the 2024 phase as 'mature' with 'significant investments.' The progression from conceptual to concrete is well-captured. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'early-stage commitment' to 'central, mature pillar' aligns well with the ground truth's 'transition from conceptual development to active, funded R&D.' The mention of specific technologies (Open-Fan, compact-core, hybrid-electric) provides additional context that enriches the answer without contradicting the ground truth. COMPLETENESS: The answer addresses both the strategic emphasis evolution and investment focus shift requested in the question. The only minor consideration is that the LLM provides more granular technical details (specific engine concepts, test numbers) than the ground truth, but this represents appropriate elaboration rather than error. No factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 438,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "In the 2022 filing the only reference to asset securitizations is a glossary definition (see page 88), indicating that securitizations were mentioned but not positioned as a core funding source. By the 2023 filing, securitizations are highlighted as a central element of the diversified funding mix – the Funding Strategy section notes “maintaining scale … in deposits, unsecured debt **and asset securitizations**” (page 68) and the Long‑Term Debt and Asset Securitization Programs section describes periodic securitizations of Card‑Member loans and receipts, disclosing $3.5 billion of asset‑backed securities issued in 2023 (page 70, Table 21). Thus, the emphasis shifted from a peripheral mention in 2022 to an explicit, operationally‑significant funding tool in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a glossary definition (page 88 reference provided), establishing the baseline of minimal strategic emphasis. (2) Accurately captures the 2023 shift to explicit strategic positioning, citing the Funding Strategy section and the specific language about 'deposits, unsecured debt and asset securitizations' (page 68). (3) Provides concrete operational evidence with the $3.5 billion asset-backed securities issued in 2023 (page 70, Table 21), which adds quantitative specificity beyond the ground truth. (4) Correctly synthesizes the multi-hop comparison: 2022 (peripheral/definitional) → 2023 (central/operational). (5) Uses appropriate terminology ('diversified funding mix,' 'operationally-significant') that reflects the strategic nature of the evolution. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by including the specific dollar amount ($3.5 billion) and table reference, which represents enhanced specificity rather than error. The page numbers cited (88, 68, 70) appear reasonable for a 10-K filing structure. The semantic equivalence is strong: both answers convey the same core narrative of evolution from definitional disclosure to strategic emphasis. QUANTITATIVE VERIFICATION: The $3.5 billion figure is presented as a specific disclosure from the filing and is not contradicted by the ground truth. The answer maintains factual accuracy while providing additional supporting detail. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and multiple sections of the filings, demonstrating proper understanding of how to compare strategic positioning across time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 489,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "In 2022 Emerson completed the Heritage AspenTech transaction, taking a 55 % equity stake and creating AspenTech as a stand‑alone segment that posted $656 million of sales and $12 million of earnings, incurred $148 million of intangible amortization from the acquisition, and recorded a $50 million loss on the Micromine purchase‑price hedge【page_26】【page_77】【page_79】【page_27】. By 2023 the AspenTech business was fully integrated—its contribution helped drive a 20 % rise in Software and Control sales and higher SG&A—and the hedge turned into a $24 million mark‑to‑market gain, reflecting improved investment returns on the AspenTech stake【page_24】【page_27】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that contradict the ground truth:\n\n1. TIMING ERROR (Major): The LLM states 'In 2022 Emerson completed the Heritage AspenTech transaction' but the ground truth clearly indicates the acquisition occurred in 2023, not 2022. In 2022, Emerson had only a minority investment. This is a critical chronological error that undermines the entire answer.\n\n2. RELATIONSHIP CHARACTERIZATION (Major): The LLM incorrectly describes 2022 as when Emerson 'completed the Heritage AspenTech transaction, taking a 55% equity stake.' The ground truth states that in 2022, Emerson had a minority investment (not 55%), and the 55% stake acquisition happened in 2023.\n\n3. FINANCIAL METRICS - CORRECT: The LLM correctly identifies $656M in sales and $12M in earnings for AspenTech, which matches the ground truth.\n\n4. ADDITIONAL DETAILS NOT IN GROUND TRUTH: The LLM introduces information about $148M intangible amortization, $50M loss on Micromine purchase-price hedge, and $24M mark-to-market gain. While these may be accurate from the filings, they are not part of the ground truth answer and represent a different focus.\n\n5. MISSING KEY EVOLUTION: The LLM fails to clearly articulate the evolution from 2022 (minority investment) to 2023 (55% controlling stake). Instead, it incorrectly places the transaction in 2022.\n\n6. GROSS MARGIN IMPACT: The ground truth mentions a 0.6 percentage point positive impact on gross margins in 2023, which the LLM answer does not mention.\n\n7. MULTI-HOP REASONING: The answer fails to properly synthesize the year-over-year evolution because it misplaces the acquisition timing. The core requirement was to show how the relationship evolved FROM 2022 TO 2023, but the LLM conflates these years.\n\nThe answer demonstrates some knowledge of AspenTech details but fundamentally misrepresents the timeline and nature of the relationship evolution, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 532,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "In 2022 Emerson completed the Heritage AspenTech transaction, recording a $5.9 billion non‑controlling‑interest liability for the 45 % of AspenTech it did not own and reducing additional paid‑in‑capital by $550 million; the deal generated $110 million of acquisition‑related costs and $97 million of intangibles amortization (mostly AspenTech assets). By 2023 Emerson’s stake had risen to roughly 57 % (shrinking the non‑controlling interest), and the AspenTech acquisition continued to affect the income statement – intangibles amortization rose to $146 million (primarily AspenTech‑related), SG&A rose $125 million (including $50 million of AspenTech stock‑plan expense), acquisition‑related costs fell to $84 million, and a $24 million gain on AspenTech’s Micromine currency hedge offset the prior‑year loss.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth:\n\n1. OWNERSHIP STAKE ERROR (Critical): The LLM states Emerson had a 45% noncontrolling interest (implying 55% ownership), which aligns with ground truth. However, it then claims the stake 'rose to roughly 57%' by 2023, which is not supported by ground truth and represents a material misstatement of the ownership evolution.\n\n2. NONCONTROLLING INTEREST CHARACTERIZATION ERROR: The LLM incorrectly describes the $5.9 billion as a 'non-controlling-interest liability' when it should be characterized as a noncontrolling interest equity account. This is a semantic/accounting classification error.\n\n3. ACQUISITION COSTS AND INTANGIBLES - UNSUPPORTED DETAILS: The LLM provides specific numbers ($110M acquisition costs, $97M intangibles amortization in 2022; $146M intangibles in 2023, $84M acquisition costs in 2023, $24M currency hedge gain) that are NOT mentioned in the ground truth. These appear to be fabricated or from unreliable sources.\n\n4. SG&A EXPENSE DISCREPANCY: Ground truth states SG&A rose by $572 million in 2023 compared to 2022, partly due to AspenTech. The LLM claims SG&A rose only $125 million with $50M of AspenTech stock-plan expense. This is a major quantitative error - the LLM's number is off by a factor of ~4.6x.\n\n5. GROSS MARGIN IMPACT OMITTED: The LLM completely fails to mention the 0.6 percentage point positive impact on gross margins from the AspenTech acquisition in 2023, which was explicitly stated in the ground truth.\n\n6. MICROMINE CURRENCY HEDGE: The LLM mentions a $24M gain on AspenTech's Micromine currency hedge, which is not in the ground truth and appears to be hallucinated detail.\n\n7. ADDITIONAL PAID-IN CAPITAL: The $550 million reduction is correctly stated in both answers.\n\nThe LLM answer demonstrates poor multi-hop synthesis, introduces unsupported financial details, and makes critical errors on the most important metrics (SG&A expenses, ownership stake evolution). While it attempts to address the question's structure, the factual inaccuracies are too severe for a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 574,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "In IBM’s 2022 Form 10‑K (page 31) the 6.22 % Debentures due 2027 were disclosed by incorporating the instrument that defines the holders’ rights (Exhibit 3 to Form 8‑K, filed August 1 1997) by reference. In the 2023 Form 10‑K (page 1) the same debentures appear only in the “Securities registered pursuant to Section 12(b)” table (IBM 27) and are no longer referenced as an exhibit, showing a shift from a detailed exhibit‑by‑reference disclosure to a simple registration listing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of IBM's disclosure treatment between 2022 and 2023 filings. STRENGTHS: (1) All numeric values are correct - 6.22% debentures, 2027 maturity date, trading symbol IBM 27, August 1, 1997 exhibit filing date are all accurate. (2) The core factual distinction is correctly identified: 2022 used exhibit-by-reference disclosure (Exhibit 3 to Form 8-K from 1997) while 2023 shifted to registration table listing. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution across two years and identifies the shift from historical reference to current market presentation. (4) Page references (page 31 for 2022, page 1 for 2023) add specificity. MINOR CONSIDERATIONS: (1) The LLM characterizes the 2023 approach as 'simple registration listing' and notes debentures are 'no longer referenced as an exhibit' - this is accurate but slightly less nuanced than the ground truth's emphasis on 'more transparent and current market-oriented presentation.' (2) The ground truth emphasizes the debentures being 'explicitly identified...among other registered securities on the New York Stock Exchange,' while the LLM focuses more on the removal of exhibit reference. Both characterizations are correct but emphasize different aspects of the evolution. (3) The phrase 'shift from a detailed exhibit-by-reference disclosure to a simple registration listing' captures the essence accurately, though 'simple' could be interpreted as slightly reductive compared to 'more structured and visible disclosure.' Overall, the answer is factually sound with correct synthesis of multi-hop information across filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 460,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "In the 2023 filing UnitedHealth described its premium revenue as coming “primarily…from risk‑based arrangements…[in which] the Company assumes the economic risk of funding its customers’ health‑care and related administrative costs” and treated value‑based contracts as a single performance‑obligation revenue stream (2023 p.45). By the 2024 filing, risk‑based products now account for roughly 80 % of total consolidated revenue, and the company warns that while these arrangements limit exposure to rising medical costs, they expose UnitedHealth to the financial health of the providers it contracts with—making precise cost‑estimation and continual monitoring of provider solvency critical to meeting its payment and service‑delivery responsibilities (2024 p.12; p.14).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required and correctly identifies the evolution of UnitedHealth's risk exposure from 2023 to 2024. The qualitative reasoning is sound: the answer properly explains how risk-based arrangements create economic risk, how value-based contracts work, and how 2024 disclosures emphasized greater operational risk tied to provider solvency and cost estimation. The semantic equivalence is strong—the answer conveys the same core information as the ground truth about expanded exposure and increased complexity.\n\nHowever, there is a significant quantitative accuracy issue: The LLM states that \"risk-based products now account for roughly 80% of total consolidated revenue\" in 2024. This specific percentage (80%) is not present in the ground truth answer and cannot be verified against it. While the ground truth mentions increased responsibility and expanded exposure, it does not provide this specific revenue percentage metric. This represents either an unsupported claim or a potential hallucination of a specific statistic.\n\nAdditional observations:\n- The LLM correctly identifies the 2023 premium revenue structure and value-based arrangements\n- The 2024 expansion of exposure is accurately described\n- The emphasis on provider solvency monitoring and cost estimation is correctly captured\n- Page citations (2023 p.45, 2024 p.12; p.14) are provided but cannot be independently verified\n- The answer appropriately addresses both parts of the question: evolution of exposure AND implications for cost estimation and service delivery\n\nThe core answer is substantially correct in its synthesis and reasoning, but the unverified 80% statistic and specific page references create uncertainty about factual precision. The answer would score higher if the 80% figure were either verified or removed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 508,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "In 2022 Emerson’s AspenTech line‑of‑business was still modest – it generated about $656 million of sales and held roughly $14.5 billion of assets, and the Heritage AspenTech acquisition was reflected only by $148 million of intangible‑amortization expense. By 2023 Emerson turned AspenTech into a core, majority‑owned asset, investing roughly $6 billion of cash to acquire a 55 % equity stake, contributing its Open Systems International and Geological Simulation Software businesses to the deal, and using the new “New AspenTech” platform to drive a roughly 20 % lift in Software and Control sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - LLM claims $362 million was invested in 2022 (CORRECT per ground truth), but then provides completely different numbers ($656M sales, $14.5B assets, $148M intangible amortization) that are not mentioned in the ground truth and appear to be fabricated or from wrong sources\n   - LLM correctly states $6 billion cash contribution and 55% ownership stake, which matches ground truth\n   - LLM mentions a \"roughly 20% lift in Software and Control sales\" which is not in the ground truth and cannot be verified\n\n2. ENTITY/BUSINESS IDENTIFICATION ERRORS:\n   - Ground truth specifies Emerson contributed its \"Industrial Software Business\" to the deal\n   - LLM incorrectly names the contributed businesses as \"Open Systems International and Geological Simulation Software businesses\" - these are NOT the same as Industrial Software Business and appear to be incorrect entity names\n   - This is a major error in identifying what Emerson actually contributed\n\n3. STRUCTURAL MISUNDERSTANDING:\n   - LLM conflates 2022 operational metrics (sales, assets, amortization) with the investment relationship, which is confusing and not directly responsive to the question about investment magnitude evolution\n   - Ground truth clearly shows: 2022 = $362M investment (minority stake), 2023 = $6B cash + business contribution (55% controlling stake)\n   - LLM's narrative about 2022 operational metrics doesn't clearly establish the investment magnitude comparison\n\n4. MULTI-HOP REASONING:\n   - The question asks about evolution of financial relationship between 2022-2023\n   - Ground truth provides clear before/after: minority investment → controlling stake with major transaction\n   - LLM provides operational data for 2022 that doesn't clearly establish the investment relationship, then jumps to 2023 transaction details\n   - The reasoning chain is broken and doesn't effectively show the evolution\n\n5. MISSING/INCORRECT CONTEXT:\n   - LLM mentions \"Heritage AspenTech\" correctly but then incorrectly identifies contributed businesses\n   - LLM adds unsupported claims about sales lift (20%) not in ground truth\n   - LLM's framing of 2022 as \"modest\" based on operational metrics doesn't match the ground truth's focus on investment magnitude\n\nThe answer demonstrates partial understanding of the 2023 transaction but fails on: (1) correctly identifying what businesses were contributed, (2) clearly establishing the 2022 investment baseline, (3) avoiding fabricated metrics, and (4) providing coherent multi-hop synthesis of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 722,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "In the 2022 Form 10‑K Adobe Target was mentioned only as one of several tools in the “Customer journeys” group—listed with Marketo Engage, Adobe Campaign and Journey Optimizer as a capability to “manage, test, target, personalize and orchestrate campaigns and customer journeys”【page_43】. By the 2023 filing, Adobe Target is portrayed as a distinct AI‑ and machine‑learning‑driven personalization engine that automates A/B and multivariate testing and powers omnichannel, real‑time experiences for customers【page_15】. This evolution shows Adobe is elevating AI to the core of its Experience Cloud, positioning Target as a flagship solution for scalable, AI‑driven personalization across the customer journey.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the fiscal 2022 positioning of Adobe Target as one of several tools in the 'Customer journeys' group alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. (2) Accurately describes the fiscal 2023 evolution to an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and AI-powered A/B and multivariate testing. (3) Properly synthesizes the multi-hop comparison across two fiscal years and correctly identifies the strategic direction toward AI-driven personalization. (4) Includes specific page references (page_43 for 2022, page_15 for 2023) that ground the answer in source material. (5) The characterization of Target as a 'flagship solution' and the observation about 'elevating AI to the core of its Experience Cloud' appropriately interprets the strategic significance of this evolution. MINOR CONSIDERATIONS: The LLM answer uses slightly more interpretive language ('flagship solution,' 'elevating AI to the core') compared to the ground truth's more measured description, but this represents reasonable inference from the documented evolution rather than factual error. The semantic meaning is equivalent—both convey that Adobe is placing greater strategic emphasis on AI-driven personalization. No quantitative data, calculations, or dates are involved in this question, so quantitative accuracy is perfect by default. The multi-hop reasoning (comparing 2022 vs 2023 positioning and drawing conclusions about strategic direction) is sound and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 453,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson closed its acquisition of Heritage AspenTech in the third quarter of 2022, converting every unexercised Heritage AspenTech option and RSU into an AspenTech‑equivalent award and adding the deal’s goodwill (about $7.3 billion) and the $240 million AspenTech revolving‑loan to its balance sheet 【page_70†L1-L9】【page_61†L9-L14】【page_63†L1-L5】. By fiscal 2023 the relationship had moved into the integration stage – Emerson continued to treat AspenTech as a separate publicly‑traded company while maintaining its equity and debt stake, and AspenTech‑related stock‑based compensation expense rose sharply to $82 million (from $32 million in 2022) as the new compensation plans were integrated 【page_68†L9-L14】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the multi-hop question about Emerson's evolving relationship with AspenTech from 2022 to 2023, but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the Q3 2022 acquisition timing of Heritage AspenTech; (2) Properly notes the conversion of options and RSUs into AspenTech-equivalent awards; (3) Accurately captures the shift from financial stake to integrated operations; (4) Correctly identifies the increase in stock-based compensation expense from 2022 to 2023 ($32M to $82M); (5) Appropriately notes AspenTech's continued status as a separate publicly-traded company; (6) Good multi-hop synthesis connecting acquisition mechanics to integration activities. CRITICAL ERRORS: (1) The goodwill figure of $7.3 billion in the LLM answer does not match the ground truth's $8,326 million balance reported for AspenTech in 2022 - this is a substantial discrepancy ($1+ billion difference); (2) The $240 million revolving loan figure appears to be a partial or incorrect representation of the total financial stake; (3) The ground truth mentions $8,326 million as the reported balance related to AspenTech, but the LLM only cites $7.3 billion in goodwill, missing approximately $1 billion in other acquisition-related assets. REASONING QUALITY: The LLM demonstrates sound multi-hop reasoning by connecting the acquisition mechanics (option/RSU conversion) to integration activities (compensation plan alignment) and operational structure (separate public company status). However, the quantitative inaccuracies significantly undermine the answer's reliability. The semantic understanding of the relationship evolution is correct, but the financial foundation is flawed. The answer would benefit from reconciling the total acquisition cost/balance sheet impact more accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 502,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "In the 2022 filing Adobe Experience Platform was presented mainly as the data‑standardization and open‑architecture layer that feeds Adobe Sensei AI services and links the various Experience Cloud solutions (2022 p. 8). By the 2023 filing the platform had become a real‑time, AI‑driven activation hub—now supporting generative‑AI (Sensei GenAI) and directly powering cross‑channel campaign orchestration tools such as Journey Optimizer, Campaign and Marketo—so marketers can deliver personalized, omnichannel journeys in near real time (2023 p. 13‑15).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Adobe Experience Platform from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 role as data-standardization and infrastructure layer feeding Adobe Sensei AI services - matches ground truth. (2) Accurately describes the 2023 evolution toward real-time, AI-driven activation hub with cross-channel campaign orchestration - aligns with ground truth. (3) Correctly names specific tools: Journey Optimizer, Campaign, and Marketo as integration points in 2023. (4) Appropriately mentions the shift from general AI-enhanced infrastructure to specialized campaign orchestration function. (5) References generative AI (Sensei GenAI) which represents the evolution of AI capabilities. (6) Cites specific page numbers (2022 p. 8, 2023 p. 13-15) showing document grounding. MINOR GAPS: (1) Does not explicitly mention Adobe Mix Modeler, which was introduced in 2023 and is highlighted in the ground truth as a key example of the platform's evolved role in marketing investment optimization. (2) Does not mention Adobe Analytics and Adobe Audience Manager as specific 2022 applications, though this is a minor omission. (3) Does not explicitly reference 'real-time data profiles' and 'cloud-native scalability' as specific 2023 capabilities, though 'real-time' is mentioned. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The dates (2022, 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple product integrations, showing proper understanding of the evolution trajectory. The logic connecting data infrastructure → AI services → campaign orchestration is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative of platform evolution with appropriate terminology and context. The omission of Adobe Mix Modeler is the primary substantive gap, as it represents a concrete example of the platform's 2023 evolution that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 561,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In 2023 UnitedHealth said it was “accelerating the transition from fee‑for‑service care delivery and payment models to fully accountable value‑based care,” expanding in‑clinic, in‑home, behavioral and virtual services and using data and analytics to guide clinicians while also intensifying cost‑management and tweaking network composition to blunt Medicare Advantage funding pressure【page_27】. By 2024 the focus shifted to more granular, tactical actions – selectively adjusting member benefits and premiums, pulling Medicare Advantage plans from certain counties, tightening medical and operating cost controls, and reshaping the size and composition of its provider networks – to offset the tighter benchmarks while still pursuing value‑based care【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: All key facts are correct - the 2023 emphasis on value-based care transition, expansion of in-clinic/in-home/behavioral/virtual services, and the 2024 shift to tactical cost containment measures are all accurately captured. The answer correctly identifies the evolution from expansion-focused investment to strategic retrenchment. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) ENTITY ACCURACY: UnitedHealth Group is correctly identified, years 2023 and 2024 are properly distinguished, and the Medicare Advantage program context is accurately maintained throughout. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two years, showing how external funding pressures (reduced benchmarks, risk adjustment changes) drove the shift in strategy. The answer correctly connects cause (funding pressures) to effect (operational adjustments). (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing but conveys identical meaning - 'selective changes to provider networks' matches 'reshaping the size and composition of its provider networks,' 'benefit structures' aligns with 'selectively adjusting member benefits and premiums,' and 'county-level decisions about plan offerings' corresponds to 'pulling Medicare Advantage plans from certain counties.' The inclusion of page citations (page_27, page_20) adds credibility. Minor deduction from perfect score only because the LLM answer could have been slightly more explicit about the 'initial costs' aspect of the 2023 investments mentioned in the ground truth, though this is a very minor omission that doesn't affect the core accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 527,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "In the 2022 filing Thermo Fisher listed a slate of senior notes ranging from 0.75% due 2024 to 1.875% due 2049, and the 1.950% notes due 2029 were part of that series 【page_1】. The 2023 filing shows the same series still in place – the 1.950% notes due 2029 remain unchanged – but the company added two new issues (a 3.200% note due 2026 and a 3.650% note due 2034), expanding its overall debt composition 【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about TMO's debt composition evolution. STRENGTHS: (1) Correctly identifies the 1.950% Notes due 2029 as present in both 2022 and 2023 filings with the same trading symbol (TMO 29), matching the ground truth. (2) Accurately notes the continuity of this specific debt instrument across both years. (3) Correctly identifies the two new debt instruments introduced in 2023: 3.200% Notes due 2026 and 3.650% Notes due 2034, matching ground truth exactly. (4) Properly synthesizes the multi-hop information by comparing 2022 and 2023 debt portfolios and explaining the strategic shift. (5) All percentages and dates are accurate (1.950%, 2029, 3.200%, 2026, 3.650%, 2034). (6) Correctly identifies the company as Thermo Fisher (TMO). MINOR CONSIDERATIONS: The LLM answer provides slightly more context by mentioning the broader range of notes in 2022 (0.75% due 2024 to 1.875% due 2049), which adds helpful context but is not explicitly required by the ground truth. This additional detail is accurate and enhances understanding without contradicting the ground truth. The answer effectively conveys that the 1.950% Notes due 2029 remained unchanged while new instruments were added, which is the core finding. The reasoning is sound and the multi-hop synthesis across years is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 383,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "The 0.500% Notes due 2028 (TMO 28A) appear in both the 2022 and 2023 securities tables, showing that this low‑coupon series was retained unchanged (2022 list – page 1; 2023 list – page 1). The 2023 filing, however, adds two higher‑coupon series—a 3.200% note due 2026 (TMO 26B) and a 3.650% note due 2034 (TMO 34)—that were not present in the 2022 securities schedule (2023 list – page 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about TMO's debt composition evolution. STRENGTHS: (1) All numeric values are correct - the 0.500% Notes due 2028, 3.200% Notes due 2026, and 3.650% Notes due 2034 are all accurately cited with correct percentages and maturity years. (2) The temporal comparison is accurate - correctly identifies that the 0.500% Notes appeared in both 2022 and 2023, while the 3.200% and 3.650% notes were new additions in 2023. (3) The multi-hop synthesis is sound - the answer successfully combines information about what was retained (0.500% Notes) with what was introduced (new higher-coupon series), demonstrating understanding of the portfolio evolution. (4) The answer also correctly mentions the 1.375% Notes due 2028 as a maintained category, showing comprehensive knowledge of the debt portfolio. (5) The reasoning about strategic diversification with new interest rate structures and maturity timelines is logically sound and well-supported by the facts presented. MINOR CONSIDERATIONS: The LLM answer uses notation like 'TMO 28A', 'TMO 26B', and 'TMO 34' which are not explicitly mentioned in the ground truth but appear to be internal reference codes that don't contradict the factual content. The ground truth and LLM answer are semantically equivalent in all material respects - both convey the same factual information about debt instrument composition changes between 2022 and 2023. The LLM answer is slightly more detailed with specific page references and internal notation, which adds value without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 444,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "In the 2023 goodwill‑impairment test the excess of fair value over carrying value for each reporting unit was roughly **140 % to 495 %** of carrying value【page_56】. In the 2024 test the same metric fell to about **70 % to 450 %**【page_52】, so both the low‑end and high‑end of the range moved lower, narrowing the overall spread.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All numeric values are correct - 2023 range of 140% to 495% and 2024 range of 70% to 450% match the ground truth exactly. The percentages are properly formatted and comparable. (2) COMPLETENESS: The answer fully addresses the multi-part question by providing both the 2023 and 2024 ranges and explicitly comparing them. (3) ENTITY ACCURACY: DHR is correctly identified, fiscal years 2023 and 2024 are correct, and the metric (excess fair value over carrying value) is accurately described. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified that both the low-end (140% to 70%) and high-end (495% to 450%) decreased, and appropriately noted that this narrowed the overall spread. The interpretation that this represents a decline in the cushion before potential impairment aligns with the ground truth. (5) SEMANTIC EQUIVALENCE: The LLM's statement that 'both the low-end and high-end of the range moved lower, narrowing the overall spread' is semantically equivalent to the ground truth's observation of 'a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion.' Minor note: The LLM's phrasing 'both the low-end and high-end of the range moved lower' is slightly more precise than necessary (the high-end did decrease but the characterization is accurate), and the observation about narrowing the spread is a valid additional insight not contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 420,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "In Apple’s 2022 filing the 2022 Employee Stock Plan expressly states that cancelled RSUs and shares withheld for tax obligations each increase the number of shares available for grant under the plan by a factor of two times the number cancelled or withheld【page_49】. The 2023 filing continues to apply net‑share settlement – withholding about 37 million shares in 2023 to cover taxes – which likewise adds those shares back to the pool, so the treatment of cancelled RSUs and tax‑withheld shares remains effectively unchanged (the “two‑times” wording is no longer restated but the impact is the same)【page_48】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally misrepresents the evolution of the treatment. The ground truth clearly states that in 2023, the 'specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change.' The LLM answer contradicts this by claiming 'the treatment...remains effectively unchanged (the two-times wording is no longer restated but the impact is the same).' This is factually incorrect - the ground truth explicitly identifies this as a CHANGE in how these events were accounted for, not a continuation with merely different wording. The LLM conflates omission of language with unchanged impact, which is a fundamental misunderstanding of the question. QUANTITATIVE ISSUES: The LLM cites '37 million shares in 2023' for tax withholding, but this specific number is not verified against the ground truth and appears to be an unsupported detail. The ground truth does not provide this figure, so its accuracy cannot be confirmed. REASONING FLAWS: The LLM's multi-hop reasoning is flawed because it concludes 'the impact is the same' when the ground truth explicitly indicates a change in accounting treatment. The LLM appears to have misinterpreted the significance of the language change. WHAT WAS CORRECT: The LLM correctly identifies that in 2022 there was a 'two times' factor for canceled RSUs and tax-withheld shares, and correctly notes this language was omitted in 2023. However, the interpretation of what this omission means is backwards. MISSING ELEMENTS: The LLM fails to clearly articulate that this represents an actual change in plan treatment, not merely a wording difference with identical impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 464,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "In the 2023 filing Danaher still presented Aldevron as a recent, cash‑acquired business – a $9.6 billion purchase that generated about $6.1 billion of goodwill and was described as “now part of the Company’s Life Sciences segment” (2023 10‑K p. 73‑74). By the 2024 filing Aldevron is listed simply as one of the Life Sciences segment’s key brands (2024 10‑K p. 8), showing that the company has moved from a newly‑acquired asset to a fully integrated part of the Life Sciences business while retaining its 100 % ownership (no change in financial stake).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Danaher's evolving relationship with Aldevron. STRENGTHS: (1) Quantitative accuracy is excellent - the $9.6 billion purchase price is correctly stated (matches ground truth's $9,561 million with appropriate rounding), and the $6.1 billion goodwill figure is accurate. (2) Multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 filings to show the evolution from newly-acquired asset to integrated segment component. (3) Entity identification is correct - properly identifies Danaher, Aldevron, and the Life Sciences segment. (4) The answer captures the key strategic shift: from a recent standalone acquisition (2023) to full operational integration (2024) while maintaining 100% ownership. (5) Contextual details are appropriate, including page references to 10-K filings. MINOR CONSIDERATIONS: The ground truth mentions integration alongside other acquisitions (Beckman Coulter, Pall, IDT) as part of the broader portfolio, while the LLM answer focuses more narrowly on Aldevron's transition. However, this is not an error - the LLM answer directly addresses the question about Aldevron's evolution without unnecessary tangential information. The statement about 'no change in financial stake' (100% ownership) is a reasonable inference consistent with the ground truth's description of 'direct ownership interest' and full integration. All factual claims are verifiable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 415,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "In the 2023 filing Microsoft 365 was framed as an “AI‑first” platform that unites Office, Windows, Copilot and security, with Copilot for Microsoft 365 embedding generative AI to reinvent productivity (see 2023 page 4). By the 2024 filing the company had shifted to a metric‑driven positioning, reporting that Office 365 Commercial – the core of Microsoft 365 – grew 16% in seats and lifted Office Commercial revenue 14%, and that AI‑enhanced Copilot for Microsoft 365 is now explicitly counted in its commercial and Microsoft Cloud metrics (see 2024 pages 39‑42). This reflects a move from emphasizing AI integration as a strategic narrative to highlighting AI‑infused Microsoft 365 as a concrete revenue engine for the commercial business.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution from 2023 to 2024, capturing the shift from narrative emphasis on AI integration to metric-driven positioning. It accurately references the 'AI-first' platform description for 2023 and correctly notes the expansion of Microsoft 365 Consumer subscriber metrics in 2024. The semantic understanding of the strategic shift is sound.\n\nCRITICAL ERRORS: (1) The LLM introduces specific quantitative claims (Office 365 Commercial grew 16% in seats, Office Commercial revenue lifted 14%) that are NOT present in the ground truth answer. These numbers appear to be fabricated or sourced from sections not verified against the knowledge graph. (2) The LLM references specific page numbers (2023 page 4, 2024 pages 39-42) which cannot be verified and may be hallucinated. (3) The LLM distinguishes between 'Office 365 Commercial' and 'Microsoft 365' in ways that diverge from the ground truth's focus on Microsoft 365 as the unified platform.\n\nMISSING ELEMENTS: The LLM answer does not explicitly mention the key ground truth detail about expanding Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, which was a significant strategic signal in the 2024 evolution.\n\nMULTI-HOP REASONING: The multi-hop synthesis is partially sound (connecting 2023 positioning to 2024 metrics), but the introduction of unverified numerical claims undermines the reliability of the reasoning chain.\n\nQUANTITATIVE ACCURACY: The 16% and 14% figures cannot be verified against the ground truth and appear to be errors or hallucinations. This is a significant issue for a financial analysis question.\n\nQUALITATIVE ACCURACY: The qualitative understanding of the strategic shift is reasonable, but the fabrication of specific metrics significantly damages credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 501,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "In the 2023 Form 10‑K Microsoft first presented Copilot Pro as a consumer‑subscription service that “offers faster and more powerful AI assistance in Microsoft 365 apps and on the web.” The 2024 filing repeats the same language, continuing to position Copilot Pro as a core AI‑first feature embedded in the Microsoft 365 suite and web‑based experiences, showing a consistent emphasis rather than a substantive shift in its role.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) Copilot Pro was introduced in 2023 as a consumer subscription service, (2) the exact quoted language about 'faster and more powerful AI assistance in Microsoft 365 apps and on the web' is accurate, and (3) the 2024 filing repeats similar language. However, the answer significantly diverges from the ground truth in its interpretation and synthesis. The ground truth emphasizes an EVOLUTION in positioning - noting that while core definition remained consistent, the emphasis on differentiation and innovation became MORE PRONOUNCED in 2024, with Copilot Pro increasingly integrated into a broader AI-first narrative. The LLM answer instead concludes there was a 'consistent emphasis rather than a substantive shift,' which directly contradicts the ground truth's assertion of strategic evolution. The ground truth explicitly states the positioning evolved to embed Copilot Pro 'within a broader narrative of AI-driven transformation' and as 'increasingly integrated into the broader AI-first positioning' - a nuanced evolution the LLM answer misses. The LLM characterizes the change as merely repetitive ('repeats the same language'), whereas the ground truth identifies a strategic repositioning within a larger ecosystem narrative. This represents a failure in multi-hop reasoning and synthesis - the LLM correctly identified individual facts but failed to synthesize the evolution narrative that was central to the question. The answer is partially correct on surface facts but fundamentally misses the analytical insight about how the positioning evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 445,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan still operates as a broad equity‑award vehicle that authorizes roughly 135 million Danaher shares for stock options, RSUs, PSUs, SARs and cash awards, and its basic provisions have not changed between the two filings. However, the pool of shares that remain available for new grants fell from about 50 million shares at December 31 2023 to roughly 47 million shares at December 31 2024, indicating that roughly 3 million shares were used for awards during 2024【page_102†L13-L20】【page_96†L13-L20】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides useful information about the 2007 Omnibus Incentive Plan's evolution but contains a significant factual discrepancy that undermines its accuracy. CORRECT ELEMENTS: (1) The answer correctly identifies that approximately 47 million shares remained available as of December 31, 2024, matching the ground truth. (2) The calculation that roughly 3 million shares were used during 2024 (50M - 47M = 3M) is mathematically sound. (3) The answer appropriately identifies the plan as a broad equity-award vehicle for RSUs, PSUs, SARs, and other awards. (4) The multi-hop reasoning correctly synthesizes information across 2023 and 2024 filings. CRITICAL ERROR: The LLM states that 'about 50 million shares' remained available at December 31, 2023, but the ground truth explicitly states that 'no specific figure was provided regarding the remaining shares available for issuance' in 2023. This is a fundamental factual error - the LLM invented a 2023 figure that does not exist in the source documents. The ground truth emphasizes that 2024 represents a shift toward 'more transparent disclosure' of share availability, implying 2023 lacked this specific disclosure. ADDITIONAL ISSUE: The LLM mentions '135 million Danaher shares' as the total authorization, which is not mentioned in the ground truth and cannot be verified against it. This introduces unverified information. REASONING QUALITY: The multi-hop synthesis is logically sound (comparing 2023 to 2024, calculating the difference), but it's based on a false premise about 2023 data availability. The answer demonstrates good understanding of the plan's mechanics but fails on factual accuracy regarding what was actually disclosed in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 468,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft revised its accounting estimate for server and network equipment at the start of fiscal 2023, extending the assets’ estimated useful life from four years to six years, and it continued to apply that six‑year estimate in fiscal 2024. The change was driven by recent software investments that increased operational efficiency of the equipment and by broader advances in technology that allowed the assets to remain useful for a longer period【page_40】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All numeric values are accurate - correctly identifies the change from 4 years to 6 years for server and network equipment useful lives, (2) Dates are correct - properly identifies fiscal 2023 as the start of the change and fiscal 2024 as continuation, (3) Factors influencing the change are correctly identified - software investments improving operational efficiency and advances in technology, (4) Multi-hop synthesis is sound - correctly connects the policy change across two fiscal years and explains the rationale. MINOR WEAKNESSES: (1) The answer omits mention of 'cloud and AI infrastructure investments' as a supporting factor that was highlighted in the ground truth as further rationale for the extended useful lives. While this is a contextual detail rather than a core factual error, it represents incomplete coverage of the factors that influenced the decision. (2) The phrase 'continued to apply' in fiscal 2024 is accurate but slightly less explicit than the ground truth's statement that 'the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained.' The LLM answer is semantically equivalent but slightly less detailed in explaining the continuity. CALCULATION/VERIFICATION: No calculations required; all numeric values (4 years → 6 years) are factually correct. The answer demonstrates proper understanding of the multi-hop nature of the question by synthesizing information across two fiscal years. The inclusion of a page reference adds credibility. Overall, this is a strong answer with minor omissions of contextual details rather than factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 471,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "In 2022 Medtronic reported auction‑rate securities with a fair‑value of **$33 million** and, as a Level 3 asset, they were shown on the balance sheet under **Other Assets** (not under Investments)【page_71】【page_70】.  \nIn 2023 the same securities still carried a **$33 million** fair‑value and remained classified as a **Level 3 Other‑Asset** on the balance sheet, indicating no change in exposure from the prior year【page_71】【page_70】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP REASONING: The LLM answer directly contradicts the ground truth on the key evolution being asked about. Ground truth states: (1) In 2022, auction rate securities were classified under 'Total' in the investment portfolio WITHOUT specifying a separate balance sheet classification, and (2) By 2023, they were explicitly classified under 'Other Assets' - representing a SHIFT in classification. The LLM answer claims: (1) In 2022 they were already under 'Other Assets' as a Level 3 asset, and (2) In 2023 they remained in 'Other Assets' with NO CHANGE. This is fundamentally incorrect. The LLM failed to identify the key evolution: the movement FROM general investment classification TO explicit Other Assets classification. QUANTITATIVE ACCURACY: The $33 million fair value for both years is correct (8/10). QUALITATIVE ACCURACY: The LLM introduced 'Level 3' classification which is not mentioned in the ground truth answer and appears to be an inference not supported by the source material. More critically, the LLM completely missed the balance sheet reclassification that occurred between 2022 and 2023, which is the core of the question. The statement 'indicating no change in exposure from the prior year' directly contradicts the ground truth which explicitly describes a change in classification. CONTEXTUAL RELEVANCE: The answer addresses the right company (MDT/Medtronic) and years (2022-2023) but fundamentally misses the evolution being asked about - it claims no change when the ground truth shows a clear change in balance sheet classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 435,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Cisco’s “available‑for‑sale debt investments” posted a net loss of **$21 million in fiscal 2023**, which widened to a **$67 million loss in fiscal 2024** – a deterioration of **$46 million** year‑over‑year【page_46】. The larger loss signals that the portfolio’s market value fell more sharply in 2024, indicating weaker investment performance in this category, likely due to higher interest rates or other adverse market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE VERIFICATION: All numbers are correct - FY2023 loss of $21 million, FY2024 loss of $67 million, and the calculated year-over-year deterioration of $46 million ($67M - $21M = $46M). The calculation is accurate and properly presented. (2) ENTITY ACCURACY: Correctly identifies Cisco, the specific investment category (available-for-sale debt investments), and the correct fiscal years (2023 and 2024). (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two fiscal years and correctly compares the performance between them, identifying the directional change (worsening) and quantifying the magnitude of change. (4) COMPLETENESS: Addresses all parts of the question - the specific losses in each year, the change between years, and what this indicates about investment performance. (5) REASONING QUALITY: The interpretation that larger losses signal weaker investment performance and the speculation about potential causes (higher interest rates, adverse market conditions) is logical and contextually appropriate, though the latter is inference rather than stated fact. The answer goes slightly beyond the ground truth by providing plausible explanations, which adds value without contradicting the original answer. Minor note: The citation reference [page_46] is included but cannot be verified against the ground truth provided. Overall, this is a comprehensive, accurate response that correctly answers the multi-hop question with proper calculations and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 432,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Cisco still treats APJC as one of its three geographic operating segments in both filings (2023 “we manage our business by geography…APJC” – page 3; 2024 “primarily managed on a geographic basis…APJC” – page 65), but the emphasis shifted from a purely operational view in 2023 to a heavy financial‑investment focus in 2024.  In 2024 Cisco recorded a $25.9 billion acquisition total (up from $301 million in 2023) that includes the Splunk purchase (“With our acquisition of Splunk… fiscal 2024” – page 5; cash‑flow “Acquisitions, net of cash…$25,994 m” – page 63) and expanded financing/lease receivables (page 66), indicating the company is moving toward a subscription‑and‑services‑driven revenue model in APJC rather than relying mainly on one‑time hardware sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that substantially diverge from the ground truth:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - The LLM cites a $25.9 billion acquisition total in 2024 versus $301 million in 2023, attributing this to Splunk acquisition. However, the ground truth does not mention Splunk acquisition as part of APJC's operational evolution or financial investment strategy. The Splunk acquisition is a company-wide acquisition, not APJC-specific.\n   - The LLM incorrectly frames the $25.9 billion as evidence of APJC-specific strategy shift, when this is a global corporate acquisition unrelated to APJC regional evolution.\n   - The comparison of acquisition spending ($25.9B vs $301M) is misleading and not supported by the ground truth as evidence of APJC strategy evolution.\n\n2. ENTITY AND SCOPE MISALIGNMENT:\n   - The ground truth specifically discusses APJC as a geographic segment with operational presence in 2023 and financial investments (equity instruments, marketable/non-marketable securities, equity method investments) in 2024.\n   - The LLM conflates global corporate acquisitions (Splunk) with APJC regional investment strategy, which are different concepts.\n   - The ground truth does not mention Splunk or global acquisition spending as part of APJC's regional evolution.\n\n3. REASONING ERRORS:\n   - The LLM's multi-hop reasoning fails to distinguish between company-wide strategic initiatives and APJC-specific operational/investment changes.\n   - The conclusion about \"subscription-and-services-driven revenue model in APJC\" is not supported by the ground truth, which discusses equity investments and capital participation, not subscription model shifts.\n   - The LLM misinterprets financing/lease receivables expansion as APJC-specific when this appears to be a broader corporate trend.\n\n4. WHAT WAS CORRECT:\n   - The LLM correctly identifies APJC as one of three geographic operating segments in both 2023 and 2024.\n   - The general observation that emphasis shifted from operational to financial investment is directionally aligned with ground truth.\n   - Page references are cited (though some may be inaccurate).\n\n5. WHAT WAS MISSING/INCORRECT:\n   - No mention of specific equity instruments (marketable equity securities, non-marketable equity securities, equity method investments) that the ground truth emphasizes.\n   - Incorrect attribution of global acquisition spending to APJC regional strategy.\n   - Mischaracterization of the revenue model shift (subscription vs. investment returns).\n   - The ground truth explicitly states filings \"do not quantify the specific financial impact,\" but the LLM presents specific numbers as evidence of APJC strategy.\n\nThe answer demonstrates partial understanding of APJC's geographic segment status but fundamentally misinterprets the nature of the strategic evolution by conflating global corporate acquisitions with regional investment strategy changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 790,
        "total_tokens": 2232
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "In its 2022 filing Apple noted that it retained a commission on App Store sales and that “from time to time…the Company has made changes…in response to competition, market and legal conditions” and that new legislation such as the EU Digital Markets Act could require further changes (2022 10‑K p.13). By the 2024 filing Apple disclosed that it had already implemented concrete reforms – U.S. rules on how developers can promote alternative purchasing, alternative fee structures, new distribution and payment methods, and additional APIs – to comply with the EU DMA and address ongoing litigation and market pressure, reflecting a shift toward more flexible commission models and proactive regulatory compliance (2024 10‑K p.13).",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "In the 2022 filing the U.S. Retiree Health Care Plan was targeted to hold roughly 65 %‑80 % of its assets in fixed‑income securities and 20 %‑35 % in equities, and the actual year‑end mix was about 64 % fixed income and 36 % equity【page_50】. By the 2024 filing the target range had shifted to 75 %‑85 % fixed income and 15 %‑25 % equity, and the weighted‑average allocation at year‑end 2024 was about 80 % fixed income and 20 % equity【page_48】. Thus, the plan moved toward a higher proportion of fixed‑income assets and a lower proportion of equity assets between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a well-structured response that captures the evolution of the allocation strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift toward more conservative positioning with higher fixed income allocation (from ~64% to 80%) and lower equity allocation (from ~36% to 20%); (2) Appropriately includes both target ranges and actual year-end allocations, providing comprehensive context; (3) Correctly identifies the 2024 allocation as 80% fixed income and 20% equity, matching the ground truth; (4) Sound multi-hop reasoning synthesizing information across 2022 and 2024 filings; (5) Proper entity identification (Texas Instruments, U.S. Retiree Health Care Plan). WEAKNESSES: (1) The LLM provides percentage-based analysis while the ground truth includes specific dollar amounts ($248M fixed income, $137M equity in 2022) - the LLM omits these absolute values; (2) The LLM states 2022 actual mix was '64% fixed income and 36% equity' which differs slightly from the ground truth's implied percentages (248/(248+137)=64.4% and 137/(248+137)=35.6%), though this is a minor rounding difference; (3) The LLM doesn't explicitly mention the 2023 data point that the ground truth references ('relative proportions remained the same between 2023 and 2024'), though this may not have been available in the source documents; (4) The ground truth emphasizes 'capital preservation' as the strategic rationale, which the LLM doesn't explicitly state. CALCULATION VERIFICATION: The percentages provided are mathematically consistent with the dollar amounts in the ground truth. The shift from 64-36% to 80-20% is accurately characterized as moving toward fixed income. Overall, the LLM provides accurate directional analysis and correct percentage allocations for 2024, but lacks the specific dollar amounts and strategic context present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 509,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "In the 2022 filing TI’s MD&A said its “strategic focus is on analog and embedded‑processing products” and highlighted the industrial and automotive markets, reporting Embedded Processing as a separate segment that produced $3.26 billion of revenue and $1.25 billion of operating profit in 2022【page_21】【page_22】. By the 2024 filing the company still reports Embedded Processing as its own segment (revenue $2.53 billion, operating profit $352 million) but now explicitly positions it as a pillar of its four sustainable competitive advantages—“a broad portfolio of analog and embedded‑processing products” that fuels growth and free‑cash‑flow—showing a shift from a general product focus to a core advantage while retaining the same two‑segment reporting structure【page_20】【page_30】【page_31】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) SEGMENT REPORTING STRUCTURE ERROR: The LLM claims Embedded Processing was reported as 'a separate segment' in 2022 with specific revenue ($3.26B) and operating profit ($1.25B) figures. However, the ground truth explicitly states that in 2022, Embedded Processing was NOT a standalone reportable segment—it was part of a broader business model with four competitive advantages. The LLM incorrectly asserts a 'two-segment reporting structure' existed in 2022. (2) SEGMENT ELEVATION MISCHARACTERIZATION: The LLM states the company 'still reports Embedded Processing as its own segment' in 2024, suggesting continuity. The ground truth indicates the elevation to a reportable segment BY 2024 was a CHANGE, not a continuation. This is a critical distinction—the LLM missed the strategic shift entirely. (3) QUANTITATIVE ACCURACY ISSUES: The specific revenue and operating profit numbers cited for 2022 ($3.26B revenue, $1.25B operating profit) cannot be verified against the ground truth and appear to be fabricated or misattributed. The 2024 figures ($2.53B revenue, $352M operating profit) also lack verification. (4) INCOMPLETE ANALYSIS: The LLM failed to capture the core insight that Embedded Processing's elevation to a reportable segment in 2024 represents a strategic shift in how TI positions this product line—from an integrated component of a broader strategy to an explicitly called-out key driver of value. (5) REASONING FLAW: The LLM's conclusion about 'retaining the same two-segment reporting structure' directly contradicts the ground truth's emphasis on the structural change from non-reportable to reportable segment status. The answer demonstrates poor multi-hop synthesis and contains material factual errors about the fundamental business structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 511,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "In 2022 Thermo Fisher issued Euro‑denominated 2.00 % 10‑Year Senior Notes due 4/15/2025 for $728 million at par, with an effective interest rate of roughly 2.10%【page_87】. By year‑end 2024 the balance had fallen to $663 million at par and the effective rate had slipped to about 2.07%, reflecting partial redemption and a modest decline in the notes’ carrying value【page_47】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and describes a completely different debt instrument than the ground truth. Critical errors: (1) WRONG INSTRUMENT: The LLM describes Euro-denominated notes due 4/15/2025, while the ground truth specifies notes due October 15, 2031 - these are different securities with different maturity dates. (2) WRONG AMOUNTS: LLM states $728 million in 2022 declining to $663 million in 2024, while ground truth shows $1,200 million in both years with no change. (3) WRONG INTEREST RATES: LLM claims ~2.10% in 2022 declining to ~2.07% in 2024, while ground truth shows 2.23% in both years remaining constant. (4) WRONG NARRATIVE: LLM describes 'partial redemption' and 'decline in carrying value,' contradicting the ground truth which explicitly states 'no new issuances or repayments' and 'consistent position.' (5) MULTI-HOP FAILURE: The LLM failed to correctly synthesize the 2022 and 2024 data for the same debt instrument. The answer appears to reference a different debt issuance entirely (possibly a different TMO note or confused with another company's debt). The only correct element is that TMO did issue 2.00% 10-Year Senior Notes, but every specific detail about amount, maturity date, interest rate, and evolution is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 356,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "In the 2022 filing REMICADE (infliximab) is listed as one of the Pharmaceutical segment’s key immunology products (JNJ 2022 10‑K, p. 7). By fiscal 2024 its sales had fallen to $1.605 billion—a 12.8% drop from the prior year—and the 2024 filing notes that “lower sales of REMICADE…was due to continued biosimilar competition” (JNJ 2024 10‑K, p. 31‑32). This decline indicates that, although REMICADE remains a core immunology drug, its contribution to Johnson & Johnson’s Pharmaceutical segment is eroding as biosimilar rivals capture market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The 2024 sales figure of $1.605 billion matches the ground truth ($1,605 million - same value, different format). The 12.8% decline percentage is correctly calculated and matches ground truth. The prior year comparison (2023 to 2024) is accurate. ENTITY ACCURACY: REMICADE correctly identified as infliximab, Johnson & Johnson's Pharmaceutical segment correctly identified, Immunology therapeutic area correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years (2022-2024) and connects product performance to segment contribution. The causal explanation (biosimilar competition) is explicitly cited from the 2024 10-K filing, demonstrating proper source attribution. COMPLETENESS: The answer addresses all aspects of the question: (1) financial performance evolution between 2022-2024, (2) specific sales figures and decline metrics, (3) role/significance in Pharmaceutical segment. The answer goes beyond ground truth by providing the explicit reason for decline (biosimilar competition) with filing citation, which adds valuable context. MINOR CONSIDERATIONS: The LLM provides slightly more detail than the ground truth (specific citation of biosimilar competition as stated in the 10-K), which enhances rather than detracts from accuracy. The format variation ($1.605 billion vs $1,605 million) is acceptable and properly handled. The semantic meaning is fully preserved and the reasoning is sound throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 428,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE’s sales fell sharply – from $3.19 billion in fiscal 2022 (page 30, 2022 10‑K) to $1.84 billion in 2023 and further to $1.61 billion in 2024 (page 31, 2024 10‑K), a roughly 50 % decline over two years. The drop, attributed to growing biosimilar competition (page 32, 2024 10‑K), signals that REMICADE is losing market share and has become a much smaller contributor within J&J’s Immunology portfolio, overtaken by products such as STELARA and TREMFYA.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the 2022 sales figure of $3.19 billion (matching $3,190 million in ground truth). (2) The 2024 figure of $1.61 billion is accurate. (3) The overall narrative about declining market position and biosimilar competition is correct and well-reasoned. (4) The multi-hop synthesis across years and portfolio context is sound. (5) The contextual relevance is high - the answer addresses market position, competitive dynamics, and portfolio implications.\n\nWEAKNESSES: (1) CRITICAL CALCULATION ERROR: The LLM states a \"roughly 50% decline over two years\" but the actual decline from $3.19B to $1.61B is approximately 49.5%, which while close to 50%, is not precisely stated. More importantly, the ground truth specifies the 2023 figure should be verified - the LLM provides $1.84 billion for 2023, but ground truth only confirms 2022 ($3,190M) and 2024 ($1,605M) with a 12.8% decline from 2023 to 2024. This means 2023 should be approximately $1,843M ($1.843B), which the LLM states as $1.84B - this is essentially correct. (2) The ground truth emphasizes the 12.8% decline from 2023-2024 specifically, while the LLM focuses on the overall 50% two-year decline, which is a different analytical framing but not incorrect. (3) Minor: The LLM cites specific page numbers (30, 31, 32) which cannot be verified against the ground truth provided.\n\nVERIFICATION: 2022: $3.19B ✓ | 2024: $1.61B ✓ | 2023 (implied): ~$1.84B ✓ | Decline calculation: ~50% over two years is mathematically sound ($3.19B to $1.61B = 49.5% decline) ✓ | Market position narrative: Correct ✓ | Biosimilar competition attribution: Correct ✓\n\nThe answer is substantially correct with sound multi-hop reasoning across years and portfolio context. The minor discrepancy is in analytical framing rather than factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 495,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE’s sales fell sharply, from $3.19 billion in 2021 to $1.605 billion in 2024 – a drop of roughly 50 percent (2021 table shows $3,190 M 【page_30】; 2024 table shows $1,605 M 【page_31】).  The decline was driven almost entirely by the rollout of infliximab biosimilars in the United States and other markets, which eroded REMICADE’s market share and continued to suppress its sales (2021 narrative cites “lower sales of REMICADE…due to biosimilar competition” 【page_31】; 2024 narrative notes “Lower sales of REMICADE…was due to continued biosimilar competition” 【page_32】).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding the 2021 REMICADE sales figure. The LLM states $3.19 billion in 2021, but the ground truth clearly indicates $16.8 billion in 2021 (as part of total Immunology sales). This is a 5x discrepancy - a fundamental error that undermines the entire answer. The 2024 figure of $1,605 million ($1.605 billion) is correct. The LLM's calculated 50% decline is therefore incorrect; the actual decline from $16.8B to $1.605B represents approximately a 90% decrease, not 50%. CALCULATION ERROR: The percentage decline calculation is wrong due to the incorrect 2021 baseline. The ground truth mentions a 12.8% decrease from 2023 to 2024 alone, which the LLM does not address. QUALITATIVE ASSESSMENT: The LLM correctly identifies biosimilar competition as the primary driver of REMICADE's sales decline and appropriately cites supporting evidence from the filings. The reasoning about biosimilar erosion of market share is sound and well-supported. However, this qualitative accuracy cannot compensate for the severe quantitative errors. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across multiple years and documents, but the foundational data error (2021 sales figure) invalidates the entire comparative analysis. The answer fails on the most critical dimension - factual accuracy of the core financial metrics being compared.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 395,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "In the 2022 filing, STELARA was still protected by its U.S. patent (set to expire in September 2023), faced no biosimilar competition and delivered roughly $9.1 billion of worldwide sales (about $5.9 billion in the United States) driven by strong uptake in Crohn’s disease and ulcerative colitis. By the 2024 filing, sales had slipped to $10.36 billion globally (U.S. $6.7 billion), a 4‑5 % year‑over‑year decline, as European biosimilar entrants eroded share and multiple FDA biosimilar BLAs were filed, with the company expecting biosimilar launches in Europe and the U.S. in 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about STELARA's evolution but contains significant quantitative discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the 4-5% year-over-year decline between 2023-2024, matching the ground truth's 4.6% decline; (2) The 2024 sales figure of $10.36 billion is essentially correct (ground truth: $10,361 million); (3) The answer correctly identifies the transition from patent protection to biosimilar competition; (4) The contextual narrative about market dynamics is appropriate and relevant. CRITICAL ERRORS: (1) The 2022 sales figure of $9.1 billion is INCORRECT - the ground truth does not provide this specific number, and the LLM appears to have introduced unsourced data; (2) The U.S. sales breakdown ($5.9B in 2022, $6.7B in 2024) is NOT verified in the ground truth and appears to be fabricated; (3) The specific patent expiration date (September 2023) is not mentioned in the ground truth; (4) The detailed discussion of biosimilar BLAs and European biosimilar entrants is NOT present in the ground truth, which only mentions the 2022 filing stage for pediatric psoriatic arthritis. MULTI-HOP REASONING: The LLM successfully synthesizes information about the product's evolution from 2022 to 2024, but it introduces substantial information not supported by the ground truth. The answer conflates different therapeutic indications (Crohn's disease/ulcerative colitis vs. pediatric psoriatic arthritis) without clear sourcing. SEMANTIC ISSUES: While the answer conveys a coherent narrative about STELARA's market evolution, it fundamentally diverges from the ground truth's focus on regulatory status (filing stage in 2022) versus the LLM's emphasis on patent expiration and biosimilar competition. The ground truth emphasizes regulatory development and market maturation; the LLM emphasizes competitive dynamics. This represents a significant departure in framing and sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 530,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The United States net revenue from Restasis fell from $621 million in 2023 to $382 million in 2024 – a $239 million drop. That decline represents a 38.5% decrease in 2024 (versus 2023) and a 49.6% decrease in 2023 (versus 2022)【page_43】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors across all key metrics. (1) CRITICAL NUMBER ERRORS: The LLM states 2023 revenue was $621 million, but ground truth shows $382 million - a $239 million discrepancy. The LLM states 2024 revenue was $382 million, but ground truth shows $172 million - a $210 million error. (2) CALCULATION ERRORS: The LLM calculates a 38.5% decrease for 2024 vs 2023, but with correct numbers ($382M to $172M), the actual decrease is 55.2%. The LLM states 49.6% decrease for 2023 vs 2022, but ground truth shows 38.5%. (3) YEAR-OVER-YEAR CONFUSION: The LLM appears to have reversed or confused the year-to-year comparisons. It claims 2023 to 2024 shows a 38.5% decrease, when that percentage actually applies to 2022 to 2023. (4) MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the multi-year revenue trend and percentage changes. The core facts are inverted - the LLM has the 2023 figure where 2024 should be and vice versa. (5) VERIFICATION: Ground truth: 2023=$382M, 2024=$172M, with 55.2% decrease 2023-2024 and 38.5% decrease 2022-2023. LLM answer contradicts all three key data points. This is a complete factual failure with no redeeming accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 340,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "In 2022 AMT said its master‑lease agreements “provide for consistent, long‑term revenue and reduce the likelihood of non‑contractual churn,” and that the comprehensive nature of many of these agreements “build and augment strong strategic partnerships…while significantly reducing colocation cycle times,” supporting its international push on a portfolio of roughly 177,000 sites【page_34】. By 2023, with the portfolio expanded to about 182,000 sites, the company again stresses the same revenue‑stability and churn‑reduction benefits but now frames the agreements as a core lever for “leveraging…our extensive international portfolio…and the relationships we have built with our carrier tenants to drive sustainable, long‑term growth,” underscoring an elevated strategic role in enabling rapid tenant deployments worldwide【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022 portfolio of ~177,000 sites and 2023 portfolio of ~182,000 sites match the ground truth exactly. The format variations (\"roughly 177,000\" vs \"approximately 177,000\") are acceptable and semantically equivalent. ENTITY ACCURACY: Company (AMT) correctly identified, years (2022 and 2023) properly distinguished, and the evolution between periods clearly tracked. MULTI-HOP REASONING: The answer successfully synthesizes information across two years, identifying both continuities (revenue stability, churn reduction, strategic partnerships) and evolution (elevated strategic framing in 2023 emphasizing \"sustainable, long-term growth\" and international portfolio leverage). COMPLETENESS: The answer addresses all key aspects of the question - the role of master lease agreements, their strategic importance, international growth support, and tenant relationships. The evolution is clearly articulated through the shift from 2022's emphasis on \"rapid deployment\" to 2023's emphasis on \"sustainable, long-term growth\" and relationship leverage. SEMANTIC EQUIVALENCE: The LLM captures the core meaning of the ground truth while using slightly different phrasing (e.g., \"elevated strategic role\" vs \"continued strategic focus\"). The inclusion of specific quote fragments with page references adds credibility and precision. MINOR CONSIDERATIONS: The ground truth mentions \"mitigating risks such as customer consolidation and regulatory changes\" which the LLM answer does not explicitly address, though this is a relatively minor omission that doesn't significantly detract from the overall quality of the response. The answer effectively demonstrates how the strategic framing evolved from operational benefits to broader growth enablement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 514,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K the filing describes Google Marketing Platform as one of the primary channels through which advertisers purchase inventory – “Our customers generally purchase advertising inventory through Google Ads, Google Ad Manager, Google Display & Video 360, and Google Marketing Platform, among others”【page_57】.  The accounting for those sales has not changed: performance ads are recognized on user engagement, brand ads when displayed, and ads on Google Network properties are still reported on a gross basis with the amounts paid to network partners recorded as cost of revenues【page_57】【page_58】.  Thus, the role of the Marketing Platform in generating ad revenue and the way network‑property revenues are recognized and managed remained essentially the same from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and provides an answer that directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM claims 'the role of the Marketing Platform in generating ad revenue and the way network-property revenues are recognized and managed remained essentially the same from 2023 to 2024,' which directly contradicts the ground truth stating there WAS an evolution in the platform's role. (2) The ground truth explicitly states that by 2024, there was 'a more nuanced evaluation of its principal versus agent status' and 'a more detailed explanation of the platform's role' - representing a clear evolution. The LLM missed this entirely. (3) The LLM correctly identifies that Google Marketing Platform is one of several channels for purchasing advertising inventory and correctly notes that ads on Google Network properties are reported on a gross basis - these facts are accurate. (4) However, the LLM's core conclusion that nothing changed between 2023 and 2024 is factually wrong according to the ground truth. The question specifically asks 'how has...evolved' (implying change), and the ground truth confirms evolution occurred in the principal/agent evaluation and explanation detail. The LLM failed the multi-hop reasoning requirement by not synthesizing the differences between 2023 and 2024 accounting treatments. The answer demonstrates selective accuracy on individual facts but complete failure on the comparative analysis and evolution narrative that was central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 427,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "- **Volume:** The average balance of Federal funds purchased and securities loaned was $301 billion in 2023 (the “Key Performance Indicators” table) and the Level‑2 fair‑value measurement – a proxy for the size of the position – fell from $570 billion in 2023 to $482 billion in 2024, implying a roughly $90 billion drop in volume. 【page_34†L31-L33】【page_155†L13-L15】【page_156†L13-L15】\n\n- **Fair value:** The fair‑value of this short‑term liability declined from $192.9 billion in 2023 to $178.6 billion in 2024 (Level‑2 amount less netting adjustments). 【page_155†L13-L15】【page_156†L13-L15】\n\n- **Implication:** The reduction in both the amount and fair‑value of Federal Funds Purchased & Securities Loaned indicates that Bank of America is scaling back its reliance on Federal Funds as a short‑term funding source, likely shifting toward other, more stable funding channels in a higher‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Ground Truth: Fair value was $192,859 million in 2024 (a substantial INCREASE from prior year)\n   - LLM Answer: Claims fair value DECLINED from $192.9 billion in 2023 to $178.6 billion in 2024\n   - This is a complete reversal of the actual trend. The LLM reports a DECREASE when the ground truth shows an INCREASE.\n   - The LLM's 2023 figure of $192.9 billion appears to be confused with the 2024 figure from ground truth ($192,859 million = $192.859 billion)\n   - The LLM's 2024 figure of $178.6 billion is entirely unsupported by the ground truth\n\n2. VOLUME METRICS:\n   - LLM cites Level-2 fair value measurements of $570B (2023) and $482B (2024), claiming a ~$90B drop\n   - Ground truth mentions a net change of $16,466 million in 2023 and $192,859 million in 2024\n   - The LLM's volume figures appear to be from a different metric or misinterpreted data\n   - No verification that these Level-2 measurements correspond to the actual volume changes described in ground truth\n\n3. DIRECTIONAL REASONING ERROR:\n   - Ground Truth Implication: BAC \"significantly expanded its reliance on short-term secured funding mechanisms in 2024\"\n   - LLM Implication: BAC is \"scaling back its reliance on Federal Funds as a short-term funding source\"\n   - These conclusions are diametrically opposed. The LLM reached the opposite conclusion from what the data supports.\n\n4. MULTI-HOP SYNTHESIS FAILURE:\n   - The LLM failed to correctly synthesize the 2023 and 2024 data\n   - The comparison between years is inverted (showing decrease instead of increase)\n   - The strategic implication drawn is backwards\n\n5. ENTITY AND METRIC ACCURACY:\n   - Company (BAC) correctly identified\n   - Years (2023, 2024) correctly identified\n   - Metric name (Federal Funds Purchased & Securities Loaned) correctly identified\n   - However, the actual values and trends are fundamentally wrong\n\nThe LLM answer demonstrates a critical failure in data accuracy and reasoning. While it attempts to address all parts of the question and provides a structured response, the core numerical claims and strategic conclusions are factually incorrect and contradicted by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 623,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo noted that the exposure of its pension and retiree‑medical‑plan assets and liabilities — along with goodwill and other intangible assets — to market‑risk fluctuations is discussed in the “Critical Accounting Policies and Estimates” section. The 2024 Form 10‑K repeats the same reference, but now mentions only the pension and retiree‑medical‑plan assets and liabilities (omitting goodwill and other intangibles) and still provides no quantitative sensitivity analysis. Thus, the disclosure has remained essentially unchanged, with a slight narrowing of the language.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion and contradicts the ground truth on the key finding. CRITICAL ERRORS: (1) The LLM claims disclosure 'remained essentially unchanged' with only 'slight narrowing of language,' but the ground truth explicitly states the company EXPANDED disclosure by 2024 to include inflationary, deflationary, and recessionary conditions - this is a major substantive change, not a minor one. (2) The LLM focuses on what was OMITTED (goodwill and intangibles) rather than what was ADDED (explicit linkage to inflationary/deflationary/recessionary conditions), which is the opposite of what the ground truth emphasizes. (3) The LLM's characterization of the evolution is backwards - it describes a narrowing when the ground truth describes an expansion. WHAT WAS CORRECT: The LLM correctly identifies that both 2022 and 2024 filings reference pension and retiree medical plan assets/liabilities in the Critical Accounting Policies section, and correctly notes the absence of quantitative sensitivity analysis. MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key difference between the two years - the addition of macroeconomic risk context (inflation, deflation, recession) in 2024. Instead, it focused on a tangential detail about goodwill/intangibles being removed. The question asks about evolution in disclosure regarding sensitivity to market fluctuations, and the ground truth shows meaningful evolution toward broader macroeconomic risk disclosure, which the LLM completely missed. The answer demonstrates poor document synthesis and reaches an incorrect conclusion about the nature of the disclosure change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 458,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "In the 2023 filing Adobe Scan was described chiefly as a free mobile app that captures paper, turns it into PDFs and adds OCR, using Adobe Document Cloud services for instant sharing (2023 p.13). By the 2024 filing the same scanning and OCR features remain, but Adobe positions Scan as a core part of the Adobe Document Cloud subscription—integrated with Acrobat, Acrobat Sign and other Document Cloud APIs to enable end‑to‑end document creation, collaboration and e‑signature workflows (2024 p.12‑13).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misrepresentations compared to the ground truth. CORRECT ELEMENTS: (1) Correctly identifies Adobe Scan as a free mobile scanning tool in 2023 that converts paper to PDFs with OCR; (2) Correctly notes it uses Adobe Document Cloud services; (3) Correctly identifies 2024 positioning within Document Cloud ecosystem; (4) Correctly mentions integration with Acrobat, Acrobat Sign, and other Document Cloud APIs in 2024. SIGNIFICANT GAPS/ERRORS: (1) The LLM answer emphasizes traditional document workflow features (e-signature, collaboration) but FAILS to mention the critical 2024 shift toward AI-driven features like Content Credentials and Firefly-powered generative AI workflows, which the ground truth identifies as a key evolution; (2) The ground truth emphasizes 'increased emphasis on integration with cloud-based productivity tools and AI-driven features' and 'enhanced digital trust mechanisms' - these are major positioning changes that the LLM answer completely omits; (3) The LLM answer frames the evolution primarily as deeper enterprise integration for workflows, but misses the strategic pivot toward AI and digital trust that represents a more fundamental repositioning; (4) Page citations (2023 p.13, 2024 p.12-13) cannot be verified and may be fabricated. MULTI-HOP REASONING: The LLM answer does attempt to synthesize across 2023 and 2024 filings, but the synthesis is incomplete - it captures the document management integration aspect but misses the equally important AI/digital trust evolution. The answer reads as a partial understanding of the ecosystem changes. SEMANTIC EQUIVALENCE: While the wording differs from ground truth, the semantic content is substantially incomplete, missing approximately 40-50% of the key positioning evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 506,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini debuted in December 2023 as a natively multimodal model (handling text, code, audio, images and video) that first powered AI‑assistive features on Pixel devices (Gemini Nano) and was accessible through Android and Chrome OS (page 7). By 2024 the upgraded Gemini 2.0 expanded its multimodal capabilities, reduced latency and cost, and was embedded across all seven of Google’s flagship products—Android, Chrome, Gmail, Maps, Play Store, Search and YouTube—as well as Google Cloud’s Vertex AI platform and new prototypes, driving AI Overviews, the Gemini app, Workspace and other AI‑driven experiences (page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. Strengths: (1) Correctly identifies Gemini's December 2023 launch with accurate multimodal capabilities (text, code, audio, images, video); (2) Accurately lists all seven Google products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube) with proper context that these are two-billion-user products; (3) Correctly identifies Gemini 2.0 as the 2024 evolution with specific improvements (reduced latency and cost); (4) Appropriately mentions experimental prototypes (Project Astra and Project Mariner are implied through 'new prototypes'); (5) Provides additional relevant context about integration into Google Cloud's Vertex AI and specific use cases (AI Overviews, Gemini app, Workspace). Multi-hop synthesis is sound: the answer correctly traces Gemini's evolution from 2023 launch through 2024 expansion across multiple product categories. Minor considerations: (1) The answer mentions 'Gemini Nano' on Pixel devices which adds helpful specificity not explicitly in ground truth but is factually accurate; (2) References to 'page 6' and 'page 7' suggest source documentation verification; (3) The ground truth mentions 'Project Astra and Project Mariner' explicitly while LLM uses 'new prototypes'—this is a minor semantic variation that doesn't affect accuracy. All quantitative claims (seven products, multimodal types, timeline) are correct. The answer effectively addresses both parts of the multi-part question: (a) evolution of role/integration from 2023-2024, and (b) specific advancements in multimodal capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 446,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "In the 2022 filing helium was only noted as part of the “Other” segment (global helium wholesale) and was not highlighted as a material driver of results [2022 page 28]. By the 2024 filing Linde said that lower helium volumes cut “Other”‑segment sales by $32 million (≈2%) and that higher helium‑related costs partially offset a $19 million (44%) rise in operating profit for the segment [2024 page 28]. This shows that helium moved from a non‑material line‑item in 2022 to a factor that directly reduced sales and added cost pressure on profit by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022 and 2024 filings. STRENGTHS: (1) Correctly identifies the evolution of helium's impact from non-material in 2022 to material negative impact in 2024; (2) Accurately cites specific numbers: $32 million sales decrease (~2%), $19 million operating profit increase (44%); (3) Properly identifies the 'Other' segment as containing global helium wholesale; (4) Correctly notes that higher helium costs partially offset insurance recovery gains; (5) Sound multi-hop reasoning connecting segment-level data across years; (6) Appropriate use of page references (page 28) adds credibility. MINOR WEAKNESSES: (1) The ground truth mentions LAMT (Linde Advanced Materials Technology) specifically as the segment where helium costs offset insurance recovery, but the LLM answer references this more generally without naming LAMT explicitly; (2) The ground truth emphasizes a 44% overall increase in operating profit for 'Other' segment, which the LLM correctly cites but could have been slightly clearer that this 44% increase occurred despite helium cost headwinds. QUANTITATIVE VERIFICATION: All numbers check out - $32M sales impact, 2% decrease, $19M profit increase, 44% segment profit growth are all accurate. The calculations and percentages are correct. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - helium evolved from neutral/non-material to a negative factor impacting both sales and profit margins. The characterization of helium moving from 'non-material line-item' to 'factor that directly reduced sales and added cost pressure' accurately reflects the ground truth's description of the relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 483,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net carrying amount of acquired franchise rights fell from $1.891 billion at the end of 2022 to $1.858 billion at the end of 2024, a reduction of roughly $33 million (about a 1.8% decline)【page_85】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth states: 2022 value = $789 million, 2024 value = $598 million, change = $191 million decline. LLM states: 2022 value = $1.891 billion, 2024 value = $1.858 billion, change = $33 million decline. The LLM numbers are approximately 2.4x larger than the ground truth values and the calculated change magnitude is drastically different ($33M vs $191M). The LLM appears to be referencing a different metric or company entirely - possibly gross franchise rights rather than net acquired franchise rights, or data from a different entity. The percentage decline calculation (1.8%) is mathematically correct for the LLM's stated numbers but irrelevant since the base numbers are wrong. The answer fails on quantitative accuracy (all dollar amounts incorrect), entity/metric accuracy (appears to reference wrong metric), and completeness (does not match the specific metric requested: 'net value of acquired franchise rights'). This represents a complete failure to provide the correct information from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1090,
        "completion_tokens": 310,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "In the 2023 filing Chevron pledged to deliver about 746 billion cubic feet of natural gas in the United States (and 2.9 trillion cubic feet from Australia and Israel) for the 2024‑26 period, whereas the 2024 filing raised the U.S. commitment to roughly 813 billion cubic feet (and the overseas commitment to 3.2 trillion cubic feet) and shifted the delivery window to 2025‑27.  Production from its Kazakhstan affiliate Tengizchevroil was essentially unchanged – oil‑equivalent output stayed at 45 MBD and crude oil at 26 MBD, with natural‑gas output slipping only slightly from 114 MMCFD in 2023 to 113 MMCFD in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and addresses a different aspect of the question than the ground truth. Critical issues: (1) WRONG FOCUS: The LLM discusses future delivery commitments (2024-26 and 2025-27 periods) for U.S., Australia, and Israel operations, while the ground truth addresses actual production volumes and consumption metrics from Tengizchevroil operations in Kazakhstan for 2023-2024. (2) MISSING KEY DATA: The LLM completely omits the core metrics from the ground truth: 596 MMCFD consumed (2023) vs 609 MMCFD (2024), and 7,148 MMCFD sold (2023) vs 7,569 MMCFD (2024). (3) PARTIAL TENGIZCHEVROIL DATA: While the LLM does mention Tengizchevroil natural gas output (114 MMCFD in 2023 to 113 MMCFD in 2024), this represents only a small fraction of the required answer and is presented without the broader context of total consumption and sales volumes. (4) SEMANTIC MISMATCH: The question asks about 'natural gas delivery commitments and production volumes' evolution - the ground truth interprets this as actual operational metrics (consumed and sold volumes), while the LLM interprets it as future contractual commitments. These are fundamentally different concepts. (5) INCOMPLETE SYNTHESIS: The answer fails to synthesize the relationship between Tengizchevroil's contribution and Chevron's overall natural gas position. The LLM provides some accurate Tengizchevroil numbers (113-114 MMCFD) but these are disconnected from the broader narrative about how Chevron's total natural gas volumes evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 419,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "In the 2023 filing the company grouped payments to Google Network partners together with other traffic‑acquisition costs, noting that they were “amounts paid … primarily for ads displayed on their properties” (2023 10‑K p. 59). By the 2024 filing the language had shifted to treat those payments explicitly as a cost of revenue and to explain that Google now evaluates whether it is acting as a principal or an agent on Network ads – “amounts paid to Google Network partners are recorded as cost of revenues” and the principal‑agent distinction is described in the advertising‑revenue note (2024 10‑K p. 58). This change signals a more formal, transparent role for Network partners in Google’s ad model, moving from a generic TAC expense to a clearly identified cost‑of‑revenue component with principal‑agent accounting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that in 2023, payments to Google Network partners were 'grouped together with other traffic-acquisition costs' and explicitly described as 'amounts paid...primarily for ads displayed on their properties.' However, the ground truth states that in 2023, these payments were described as part of 'primary uses of cash from operating activities' as a 'standard operating expense' - NOT as TAC. This is a fundamental mischaracterization of the 2023 baseline. (2) The LLM reverses the direction of evolution: it claims the 2024 filing moved payments 'from a generic TAC expense to a clearly identified cost-of-revenue component,' but the ground truth indicates the opposite - that 2023 had them as operating expenses and 2024 moved them TO TAC categorization. (3) The LLM introduces concepts (principal-agent accounting distinction) that are not mentioned in the ground truth answer, suggesting either fabrication or misinterpretation of source material. (4) Page citations (p. 59 for 2023, p. 58 for 2024) cannot be verified against the ground truth but appear suspiciously specific given the factual errors. The LLM's core narrative about the evolution is inverted - it describes a shift TO cost-of-revenue when the ground truth describes a shift FROM operating expenses TO TAC. While the LLM correctly identifies that there was an evolution in how these payments were described, the direction and nature of that evolution are fundamentally wrong. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the 2023 vs 2024 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 458,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "In the 2023 filing Bank of America warned that a “global regulatory focus on climate change and existing and pending disclosure requirements in various jurisdictions, with jurisdictional divergence, [was] expected to impact our legal, compliance and public‑disclosure risks and costs”【page_24】. By the 2024 filing the company notes that public‑policy frameworks have continued to fragment across jurisdictions, making the compliance burden “heightened” and further increasing the potential for legal and regulatory exposure and higher compliance costs【page_24】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some key elements but has significant issues with accuracy and completeness. STRENGTHS: (1) Correctly identifies Bank of America as the subject company; (2) Correctly references 2023 and 2024 filings; (3) Accurately conveys that jurisdictional divergence is a concern in both years; (4) Correctly notes the shift from anticipated to actual impacts. WEAKNESSES: (1) The 2023 quote appears to conflate language - the ground truth indicates 2023 mentioned 'new or heightened regulatory requirements' that were 'expected to increase' risks, but the LLM quotes language about 'existing and pending disclosure requirements' which is actually characteristic of the 2024 framing per the ground truth; (2) The LLM states the 2024 filing notes 'public-policy frameworks have continued to fragment' and uses the term 'heightened' - while semantically similar to the ground truth's 'intensified,' the specific language attribution is unclear and potentially inaccurate; (3) The answer lacks the critical distinction that the ground truth emphasizes: 2023 was about ANTICIPATED/EXPECTED impacts while 2024 shows TANGIBLE/ACTIVE impacts - this is the core evolution the question asks about, and the LLM answer doesn't clearly articulate this shift; (4) Page citations (page_24) are provided but cannot be verified and may be inaccurate; (5) The answer doesn't fully capture the nuance that by 2024, the company was experiencing actual impacts rather than just expecting them. MULTI-HOP REASONING: The answer attempts to synthesize across two years but fails to clearly establish the temporal evolution from anticipation to realization, which is the key insight. The reasoning is somewhat superficial and doesn't deeply explore the jurisdictional divergence challenge or compliance risk escalation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 490,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "In the 2022 Form 10‑K GM listed “the success of our current line of full‑size SUVs and **full‑size pickup trucks**” as a key risk factor and strategic priority, underscoring the need to sustain and grow that product line (2022 10‑K, p. 48). By the 2024 filing the narrative had shifted to reporting the trucks as a primary growth driver: GMNA wholesale vehicle sales rose 10.1 % to 3.464 million units, with full‑size truck volumes increasing to 224 k units (23.7 % of total) versus 210 k (21.9 %) a year earlier, and the favorable mix from those trucks cited as a major contributor to higher EBIT‑adjusted (2024 10‑K, p. 35‑36; truck‑specific residual‑value table, p. 32). These quantitative changes signal a move from a strategic focus on maintaining the line to demonstrable gains in sales volume, market share and profitability for full‑size pickups.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic evolution of GM's full-size pickup truck emphasis from 2022 to 2024 and provides relevant quantitative indicators. However, there are significant discrepancies in the specific numbers provided:\n\n(1) CORRECT ELEMENTS:\n- Accurately identifies 2022 10-K reference to full-size pickup trucks as a key risk factor/strategic priority\n- Correctly notes the shift from risk/priority framing to demonstrated strength by 2024\n- Properly synthesizes multi-hop information across 2022 and 2024 filings\n- Correctly identifies EBIT-adjusted results as a key performance metric\n- Appropriately cites page references and document sources\n- Reasoning about the strategic evolution is sound and well-articulated\n\n(2) QUANTITATIVE ACCURACY ISSUES:\n- The LLM provides specific numbers (3.464 million units, 224k units, 23.7%, 210k units, 21.9%) that cannot be verified against the ground truth answer\n- Ground truth mentions \"variable profit of approximately 160% for trucks on a weighted-average basis\" but LLM does not include this specific profitability metric\n- Ground truth references \"significant increase in net wholesale volumes\" but LLM provides specific GMNA wholesale figures rather than net wholesale volumes (different metrics)\n- The 10.1% increase figure and specific unit volumes are presented with confidence but lack verification against ground truth\n\n(3) MULTI-HOP REASONING:\n- The synthesis across 2022 and 2024 documents is logically sound\n- The connection between strategic emphasis evolution and quantitative performance indicators is well-established\n- The answer successfully bridges the narrative shift from risk factor to growth driver\n\n(4) MISSING ELEMENTS:\n- Does not explicitly mention the 160% variable profit metric highlighted in ground truth\n- Does not clearly distinguish between different volume metrics (net wholesale vs. GMNA wholesale)\n- Ground truth emphasizes \"favorable contribution to EBIT-adjusted results\" more explicitly\n\nThe answer demonstrates strong qualitative reasoning and contextual relevance but introduces specific quantitative claims that diverge from or supplement the ground truth without clear verification. The core narrative and strategic analysis are sound, but the precision of financial metrics is questionable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 623,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "In the 2022 filing the nuclear‑decommissioning trusts held roughly $314 million of U.S. Treasury and government‑agency securities (2022 10‑K, p. 310).  That balance rose to about $369 million at year‑end 2023 (2023 10‑K, p. 276) but by year‑end 2024 the trusts’ Treasury holdings had essentially vanished, with only a $9 million residual shown in the 2024 tables (2024 10‑K, p. 275).  The steep drop indicates Southern Company is moving away from low‑risk Treasury assets toward a more diversified, higher‑yielding portfolio for its decommissioning funds.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 2022 holdings were ~$314 million total, but ground truth shows $21M (Alabama Power) + $293M (Georgia Power) = $314M, which matches. However, the LLM then claims 2024 holdings dropped to only $9 million, which is completely incorrect. Ground truth shows 2024 allocations of $20M (Alabama Power) + $349M (Georgia Power) = $369M total. The LLM's claim of a 'steep drop' to $9M is factually wrong - the actual trend shows a slight increase from $314M to $369M. (2) ENTITY IDENTIFICATION: The LLM fails to distinguish between Alabama Power and Georgia Power subsidiaries, treating them as a single 'Southern Company' portfolio. The ground truth specifically breaks down the allocation by subsidiary, which is critical context. (3) DIRECTIONAL ERROR: The LLM claims Treasury holdings 'had essentially vanished' and that the company is 'moving away from low-risk Treasury assets.' This is the opposite of what actually occurred - allocations increased from $314M to $369M. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the subsidiary-level data across years. The correct interpretation shows Georgia Power's allocation increased significantly ($293M to $349M), while Alabama Power's remained relatively flat ($21M to $20M), indicating a strategic shift toward Georgia Power's portfolio. (5) INVESTMENT STRATEGY INTERPRETATION: While the LLM attempts to characterize the strategy shift, it does so based on incorrect numbers and reaches the wrong conclusion about diversification away from Treasuries when the data actually shows increased Treasury allocations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 466,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "In 2022 PepsiCo’s filing described its link to independent bottlers mainly as a financial‑incentive program – “bottler funding” paid on an annual‑target basis and accrued as a reduction of revenue (2022 p. 60). By 2024 the company still provides bottler funding but adds that it grants bottlers exclusive manufacturing and distribution rights and relies on them for key accounts such as Walmart (≈14 % of net revenue), highlighting a much deeper strategic dependency (2024 p. 9; also 2024 p. 7).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 14% Walmart revenue figure is accurate and correctly cited; (2) The temporal evolution from 2022 to 2024 is properly captured; (3) The shift from simple incentive programs to more structured dependency with exclusive rights is accurately described. STRENGTHS: The answer correctly identifies the core evolution - from annual-target based bottler funding in 2022 to a more complex relationship in 2024 involving exclusive manufacturing/distribution rights and strategic dependency. The Walmart metric (14% of net revenue) is precisely correct. The multi-hop synthesis across years is sound. MINOR WEAKNESSES: (1) The original answer mentions specific program types in 2024 (advertising support, new product launches, vending equipment placement) which the LLM answer omits - these represent important details about the evolved relationship structure; (2) The original answer emphasizes that bottler funding is 'negotiated annually and specifically allocated' across multiple program types, while the LLM answer states funding 'still provides bottler funding' without fully capturing the enhanced specificity and structure of the 2024 allocation; (3) The original answer notes that bottler funding was 'accrued based on annual targets and historical experience' in 2022, while the LLM correctly identifies it as 'annual-target basis' but doesn't mention the historical experience component. QUANTITATIVE ACCURACY: The 14% figure is correct and properly attributed. No calculation errors detected. QUALITATIVE ACCURACY: The reasoning about increased strategic dependency is sound and well-supported. The connection between exclusive rights and dependency is logical. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of the relationship in terms of financial incentives and strategic dependency, with appropriate temporal framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 529,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "In the 2023 Form 10‑K Adobe listed “Firefly” in its trademark schedule, positioning it as a protected brand name among many of the company’s marks 【page_94】. By the 2024 filing, Firefly is called out in the risk‑factor section as a flagship generative‑AI product that drives Adobe’s AI‑focused innovation and carries regulatory, reputational and adoption risks 【page_23】—showing its shift from a mere trademark to a central element of Adobe’s product‑innovation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2023 to 2024, matching the ground truth's timeline; (2) Accurately captures Firefly's positioning in both years - as a trademark in 2023 and as a highlighted risk factor in 2024; (3) Properly synthesizes the multi-hop information by connecting trademark listings to risk disclosures across two filing years; (4) Correctly characterizes the strategic shift from 'mere trademark' to 'central element of product-innovation strategy,' which semantically matches the ground truth's description of moving from 'registered brand' to 'central part of forward-looking product development'; (5) Appropriately identifies the specific risks mentioned (regulatory, reputational, adoption) that align with the ground truth's reference to 'strategic importance'; (6) Includes specific page references (page_94 for 2023 trademark listing, page_23 for 2024 risk factors) that ground the answer in actual filing content. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('flagship generative-AI product' vs. ground truth's 'newly released generative AI product'), but this is a semantic variation that doesn't affect factual accuracy - both convey that Firefly is a significant AI product. The LLM's characterization of it as 'flagship' could be seen as slightly more emphatic than 'newly released,' but both accurately reflect its importance in the 2024 filing. No quantitative errors, calculation errors, or entity misidentifications detected. The multi-hop reasoning correctly synthesizes information across two different sections of filings (trademark schedules and risk factors) and two different years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 479,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "In 2022 the filing simply notes that most of the company’s tenant leases contain automatic rent‑escalation provisions (about a 3 % fixed increase in the United States or an inflation‑linked index) that generate recurring billing growth, and it says churn had historically been immaterial【page_32】. By 2023 the MD&A still lists “contractual rent escalations on existing tenant leases” as a primary driver of tenant‑billing growth, but now qualifies it “net of churn” and discloses that churn rose to roughly 3 % of billings – largely from T‑Mobile lease cancellations – which dampens the net impact of those escalations on overall billing growth【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies the shift in how rent escalations were presented between 2022 and 2023 - from a straightforward growth driver to one qualified 'net of churn'. (2) Accurately cites the 3% churn rate in 2023 and correctly attributes it primarily to T-Mobile lease cancellations. (3) Properly synthesizes the countervailing forces: rent escalations as a positive driver offset by elevated churn. (4) Correctly notes that 2022 churn was historically immaterial, establishing the contrast with 2023. (5) Accurately captures the specific rent escalation mechanisms (3% fixed in U.S. or inflation-linked). (6) Appropriately contextualizes the dampening effect of churn on net billing growth. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (e.g., mentioning the specific escalation percentages and mechanisms), but this adds value rather than detracting. The ground truth mentions churn 'expected to remain elevated through 2025' which the LLM answer doesn't explicitly state, but this is a minor omission that doesn't affect the core answer to the question asked. The LLM answer effectively demonstrates multi-hop reasoning by connecting: (a) 2022 escalation drivers, (b) 2023 escalation drivers, (c) 2023 churn data, and (d) the interaction between these factors. All numeric values (3% churn, 3% fixed escalation) are accurate. The semantic meaning aligns perfectly with the ground truth regarding the changed role of escalations in the context of increased churn.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 447,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "In 2023 Chevron’s affiliate‑capital spending was $3.5 billion, with a modest, unspecified portion directed to its stake in Tengizchevroil; for 2024 the company now expects $3 billion of affiliate capex and says “nearly half of Affiliate Capex is for Tengizchevroil’s FGP/WPMP Project in Kazakhstan” (≈ $1.5 billion) – a sharper, more‑focused investment in the joint‑venture (see 2024 10‑K p. 50).  At the same time Chevron’s share of Tengizchevroil’s output has been essentially unchanged, remaining at about 45 thousand barrels of oil‑equivalent per day in both 2023 and 2024 (see 2024 10‑K p. 9).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) 2023 Affiliate Capex: LLM states '$3.5 billion' but ground truth indicates the expected 2024 capex was '$3 billion' with no mention of 2023 being $3.5B. (2) 2024 Affiliate Capex: LLM correctly states '$3 billion' matching ground truth. (3) Tengizchevroil allocation: LLM correctly identifies 'nearly half' (~$1.5B) for FGP/WPMP Project, which matches ground truth. (4) Production volumes: LLM introduces '45 thousand barrels of oil-equivalent per day' for both years, which is NOT mentioned in the ground truth answer at all. This appears to be fabricated data not supported by the original answer. (5) Multi-hop reasoning: The LLM attempts to synthesize capital commitments and production involvement but introduces unsupported production data. The ground truth emphasizes a shift from investment phase (2023) to operational phase (2024), but the LLM's production volume claim undermines this narrative without evidence. (6) Citation accuracy: LLM cites '2024 10-K p. 50' and 'p. 9' but these cannot be verified against the ground truth provided. The introduction of specific production figures (45 kboe/d) that don't appear in the ground truth is a major red flag suggesting hallucination. The answer partially addresses the question's structure but fails on factual accuracy regarding 2023 capex figures and introduces unverified production data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 409,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "UPS’s description of the bond‑matching method did not become more detailed – it stayed the same. Both the 2023 and 2024 filings say that UPS determines the discount rate for its U.S. pension and post‑retirement plans by using a bond‑matching approach that selects specific bonds that would satisfy the projected benefit payments, reflecting the process it would use to settle those obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core finding of the ground truth. The question asks about how the specificity of UPS's bond matching approach EVOLVED between 2023 and 2024. The ground truth clearly indicates there WAS an evolution: the 2024 disclosure included more precise language stating that the approach 'guides' the selection process, representing a subtle shift in how the policy is framed operationally. The LLM answer explicitly states 'did not become more detailed – it stayed the same,' which directly contradicts the ground truth's finding of an evolution in language and framing. While the LLM correctly identifies the basic mechanics of the bond-matching approach and accurately names the company (UPS) and the relevant years (2023 and 2024), it fails to capture the key insight about the evolution in specificity and framing. The LLM treats both years as identical when the ground truth emphasizes a 'subtle shift' in how the policy is framed, even though the underlying practice remained consistent. This is a critical failure in multi-hop reasoning and synthesis - the model needed to identify and articulate the difference in disclosure language between the two years, not dismiss it as unchanged. The quantitative accuracy is high because there are no specific numbers to verify, but the qualitative accuracy is very low because the model missed the essential finding about the evolution of language and framing specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 401,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "By 2022 Linde’s helium activities were not highlighted in the disclosed segments, but the 2024 filing lists “global helium wholesale” as part of the “Other” segment (2024 p. 28). The lower helium volumes in 2024 reduced Other‑segment sales by roughly $32 million (≈2 %) and, although helium‑related costs rose, insurance recoveries more than offset them, driving Other operating profit up $19 million (≈44 %) (2024 p. 28).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CONTRADICTORY OPERATING PROFIT CLAIM: The LLM states 'Other operating profit up $19 million (≈44%)' but the ground truth indicates helium-related costs contributed to 'downward pressure on operating profit.' This is a fundamental contradiction. The ground truth describes negative operational impact, while the LLM claims profit increased. (2) INCOMPLETE FINANCIAL IMPACT: The ground truth explicitly states a '$32 million, or 2%, decrease in sales' which the LLM correctly identifies. However, the ground truth also emphasizes that helium-related costs created downward pressure on operating profit (partially offset by insurance recovery), not an increase. The LLM mischaracterizes the net effect. (3) RELATIONSHIP EVOLUTION MISSING: The ground truth clearly describes a shift 'from a neutral or positive relationship to one that posed operational challenges' between 2022 and 2024. The LLM states helium 'were not highlighted in the disclosed segments' in 2022 but doesn't establish the clear negative trajectory described in the ground truth. (4) CORRECT ELEMENTS: The LLM correctly identifies the $32 million sales decrease (≈2%), correctly notes lower helium volumes in 2024, and correctly mentions insurance recovery for LAMT. (5) CALCULATION/LOGIC ERROR: The claim of $19 million profit increase contradicts the ground truth's description of downward pressure on operating profit. This is not a minor wording difference but a factual inversion of the financial impact. The answer fails to capture the core narrative of deteriorating helium operations from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 440,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America’s unfunded capital contributions for renewable‑energy equity investments fell from $6.2 billion at year‑end 2023 to $4.6 billion at year‑end 2024 – a reduction of about $1.6 billion【page_132】.  In the same period, the tax credits and other tax benefits recognized on those renewable‑energy investments declined from $4.0 billion in 2023 to $3.9 billion in 2024, a drop of roughly $0.1 billion【page_132】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: (1) Unfunded capital contributions correctly stated as $6.2 billion in 2023 and $4.6 billion in 2024; (2) The calculated reduction of $1.6 billion is accurate ($6.2B - $4.6B = $1.6B); (3) Tax credits and other tax benefits correctly identified as $4.0 billion in 2023 and $3.9 billion in 2024; (4) The calculated decline of $0.1 billion is accurate ($4.0B - $3.9B = $0.1B). The multi-hop reasoning is sound, correctly synthesizing information about both the unfunded contributions and tax credits across the two-year period. Entity identification is correct (Bank of America, renewable energy investments, tax credits). The answer uses slightly different wording than the ground truth (e.g., 'renewable‑energy equity investments' vs 'renewable energy investments') but this is semantically equivalent and actually more precise. The answer appropriately addresses both parts of the multi-part question and provides clear calculations showing the year-over-year changes. The only minor distinction from the ground truth is that the LLM answer doesn't explicitly state the interpretive conclusion about 'relatively stable' tax benefits, but this is a minor omission that doesn't affect factual accuracy. The inclusion of page references adds credibility without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 386,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "In the 2022 filing GM noted that it sells vehicles to commercial‑fleet customers **both directly and through its dealer network** and that “certain fleet transactions, particularly sales to daily rental‑car companies, are generally **less profitable** than retail sales to end customers”【page_8】. By the 2024 filing the company still serves fleet customers, but stresses that **fleet sales are completed through the dealer network and, in some cases, directly with fleet customers**, without reiterating the profitability gap, suggesting a shift away from emphasizing lower‑margin fleet deals【page_103】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about GM's fleet sales evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 position: fleet sales through both direct and dealer channels, with emphasis on lower profitability vs. retail; (2) Accurately captures the 2024 position: fleet sales through dealer network and direct channels, without reiterating profitability concerns; (3) Properly synthesizes the evolution narrative - a strategic shift from emphasizing profitability gaps to a more neutral/structured approach; (4) Includes specific citations to source documents (page_8 and page_103); (5) Uses appropriate qualifiers like 'suggesting a shift' to indicate interpretation rather than stating it as fact. MINOR CONSIDERATIONS: The LLM answer is slightly more interpretive than the ground truth in characterizing the shift as 'away from emphasizing lower-margin fleet deals' - while this is a reasonable inference, the ground truth frames it more neutrally as 'balancing fleet sales with profitability by leveraging both direct and dealer-based channels.' However, both interpretations are semantically compatible and represent valid analytical conclusions from the same underlying facts. The core factual content (channels used, profitability characterization in 2022, absence of profitability emphasis in 2024) is entirely accurate. No numerical errors, date errors, or entity misidentifications present. The multi-hop reasoning correctly synthesizes information across two different filing years to show evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 437,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "In 2022 PepsiCo still owned a 50 % equity interest in the Sabra joint‑venture and, after re‑measuring that stake to fair value, recorded a pre‑tax gain of $122 million (about $92 million after‑tax) in its FLNA division【page_73】. By the 2024 filing, Sabra is no longer mentioned in the disclosed sections (pages 71‑75), indicating that PepsiCo has exited or otherwise reduced its ownership, so the equity‑revaluation gain disappears and no further financial impact from Sabra is reported.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that 'In 2022 PepsiCo still owned a 50% equity interest in the Sabra joint-venture,' but the ground truth clearly indicates that in 2022, PepsiCo owned the Sabra brand (implying full or majority ownership), and by 2024 it held a 50% equity stake. This is a reversal of the actual timeline. The LLM has the ownership structure backwards. Additionally, the LLM incorrectly attributes the $122 million gain to 2022, when the ground truth indicates this gain occurred in 2024 as a result of remeasuring the 50% stake at fair value. The LLM's statement that 'by the 2024 filing, Sabra is no longer mentioned' and that 'PepsiCo has exited or otherwise reduced its ownership' contradicts the ground truth, which explicitly states that in 2024 PepsiCo held a 50% equity stake that was remeasured at fair value. The LLM correctly identifies the $122 million pre-tax gain amount and the ~$92 million after-tax figure, but misplaces these in the timeline and misinterprets what they represent. The multi-hop reasoning is fundamentally flawed because the LLM failed to correctly synthesize the evolution of PepsiCo's relationship with Sabra between 2022 and 2024. The answer demonstrates a misunderstanding of the core narrative: a transition from full/majority ownership to a 50% joint venture stake, not an exit from the business.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 401,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "In the 2023 Form 10‑K (exhibit pages 94‑98) Adobe Scan is not described or highlighted at all, appearing only in the generic exhibit listings. By the 2024 Form 10‑K (page 13), Adobe Scan is called out as a free mobile‑scanning app that “captures paper documents … and transforms them into full‑featured PDFs via Adobe Document Cloud services,” and is listed alongside Acrobat and Acrobat Reader as a separate, cloud‑enabled offering within the Adobe Document Cloud suite. This shift shows Adobe moving Scan from an unmentioned component to a distinct, integrated product positioned as a free, stand‑alone app within the Document Cloud ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Adobe Scan's positioning between 2023 and 2024. Key strengths: (1) Correctly identifies that Adobe Scan was not prominently featured in 2023 filings, (2) Accurately describes the 2024 positioning as part of Adobe Document Cloud with specific product details (free mobile-scanning app, PDF transformation, cloud services), (3) Properly synthesizes the multi-hop comparison showing movement from unemphasized to strategically positioned product, (4) Correctly identifies related products (Acrobat, Acrobat Reader, Acrobat Sign) in the ecosystem. Minor considerations: The LLM provides more specific detail about the 2024 description (\"free mobile-scanning app,\" \"transforms them into full-featured PDFs\") which adds helpful context beyond the ground truth but remains factually consistent. The LLM's characterization of 2023 as appearing \"only in generic exhibit listings\" is a reasonable interpretation of the ground truth's \"listed among Adobe's trademarks.\" The reasoning about the shift from \"unmentioned component to distinct, integrated product\" accurately captures the evolution described in the ground truth. No numerical errors, dates are correct (2023 vs 2024), and the multi-hop synthesis across two different filing years is sound. The answer fully addresses the question about evolution and positioning within the product ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 400,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "In the 2022 filing GM said that its wholly‑owned Seller would indemnify Stellantis for any losses arising from inaccurate representations, warranty breaches, emissions‑related claims and other product‑liability matters, but it could not estimate the amount and only noted that the obligations were subject to time limits, thresholds and caps【page_89】. By the 2024 filing the same indemnification framework remains, but GM now discloses that it has already paid an immaterial amount for certain Stellantis recalls (including Takata inflator recalls) and that the maximum future undiscounted payments for the indemnification agreements total about $3.7 billion (2024) – up from $3.5 billion a year earlier – while still being unable to estimate any material loss【page_93】【page_94】. This shows that GM’s exposure has become more quantified and now includes specific historical recall liabilities, though the core nature of the indemnities has not changed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative details (maximum future undiscounted payments of $3.7 billion in 2024 vs $3.5 billion in 2023) that are not present in the ground truth, which actually states GM 'had accrued an immaterial amount' without specifying the $3.7B figure. This creates a critical discrepancy: the ground truth emphasizes immaterial accruals, while the LLM emphasizes material maximum exposure of $3.7B. These are contradictory characterizations of GM's financial exposure. The LLM correctly identifies the evolution from 2022 to 2024 and mentions specific liability types (Takata recalls, emissions claims, regulatory investigations), which aligns with the ground truth's description of the shift from operational supplies to indemnification-based relationships. However, the quantitative claims about $3.7B and $3.5B cannot be verified against the ground truth and may represent citation errors or hallucinated figures. The LLM's statement that 'the core nature of the indemnities has not changed' contradicts the ground truth's assertion that there was a 'transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.' The LLM correctly identifies the indemnification framework, time limits, thresholds and caps mentioned in 2022, and the shift toward more quantified exposure by 2024. The multi-hop reasoning across years is sound in structure, but the specific numbers introduced without ground truth support significantly undermine credibility. The answer addresses all parts of the question but introduces unverified quantitative claims that conflict with the ground truth's characterization of exposure as 'immaterial.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 465,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo disclosed that, beyond its owned and long‑term‑leased plants, it “utilizes a highly distributed network of plants, warehouses and distribution centers that are owned or leased by our contract manufacturers, **co‑packers**, strategic alliances or joint ventures” to meet its production needs【page_27】. The 2024 Form 10‑K repeats the same language, indicating that PepsiCo still relies on co‑packers as part of that distributed network and continues to involve them through strategic alliances and equity‑joint‑venture interests, with no material change in its operational dependency or strategic role【page_30】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE FINDING: The LLM answer directly contradicts the ground truth on the fundamental question. The ground truth states there was a clear evolution/shift in PepsiCo's language between 2022 and 2024 - from describing co-packers as part of a 'highly distributed network' (operational dependency focus) in 2022 to emphasizing 'strategic alliances or joint ventures in which we have an equity interest' (ownership-based strategic involvement) in 2024. However, the LLM answer claims 'the 2024 Form 10-K repeats the same language' and concludes there was 'no material change in its operational dependency or strategic role.' This is factually incorrect based on the ground truth provided. The LLM appears to have found similar language in both years but failed to recognize the nuanced shift in emphasis and framing that the ground truth identifies as significant. The LLM correctly identifies the 2022 language and cites appropriate page numbers, but fundamentally misinterprets the 2024 positioning and the evolution between the two years. The question specifically asks about how the relationship 'evolved' - implying change - and the ground truth confirms this evolution occurred. The LLM's conclusion of 'no material change' directly contradicts this. While the LLM demonstrates some ability to locate and cite relevant text, it fails at the core analytical task of identifying and explaining the strategic shift that occurred between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 405,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "In 2023 Simon Property reduced its ABG holding, selling a portion of its interest for a cash pre‑tax gain of $157.1 million and, after ABG’s capital‑transaction‑driven dilution, recorded a non‑cash pre‑tax gain of $59.1 million, cutting its ownership from 12.3% to ≈9.6%【page_65】【page_64】. By 2024 Simon exited the partnership entirely, selling its remaining ABG stake for $1.2 billion and recognizing a $414.8 million pretax cash gain (plus a $10.3 million non‑cash gain from a concurrent dilution), thereby ending its strategic investment in ABG【page_73】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims SPG \"exited the partnership entirely\" in 2024 and \"selling its remaining ABG stake for $1.2 billion,\" but the ground truth shows SPG only disclosed a $18.8 million gain from a December 2021 sale in 2024 filings - not a complete exit or $1.2 billion transaction.\n   - The LLM reports a \"$414.8 million pretax cash gain\" in 2024, which is not mentioned in the ground truth at all.\n   - The LLM states SPG's ownership went from 12.3% to \"≈9.6%\" in 2023, but provides no ground truth verification for these specific percentages.\n\n2. MISSING KEY INFORMATION:\n   - The ground truth explicitly mentions SPG's \"strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S.\" in 2024, indicating a shift toward operational collaboration. The LLM completely omits this strategic element.\n   - The ground truth mentions a \"$145.8 million gain from the dilution of its ownership in SPARC Group\" in 2023, which the LLM entirely overlooks.\n   - The ground truth's 2024 disclosure of the $18.8 million gain is mentioned but mischaracterized by the LLM as part of a complete exit strategy.\n\n3. QUANTITATIVE ACCURACY ISSUES:\n   - The $1.2 billion sale figure appears fabricated or from a different context.\n   - The $414.8 million gain is not supported by the ground truth.\n   - The $10.3 million non-cash gain is not mentioned in the ground truth.\n   - The 2023 figures ($157.1M and $59.1M) are correctly cited but the narrative around them is distorted.\n\n4. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to synthesize the evolution correctly. The ground truth shows a transition from financial gains (2023) to strategic operational partnership (2024), not a complete exit.\n   - The LLM's conclusion that SPG \"ended its strategic investment in ABG\" directly contradicts the ground truth's indication of deepening operational collaboration through the Reebok partnership.\n\n5. SEMANTIC MISALIGNMENT:\n   - The ground truth emphasizes a \"shift toward deeper operational collaboration rather than just financial transactions,\" but the LLM portrays 2024 as a complete divestment, which is fundamentally opposite in meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 617,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "In the 2022 filing Lockheed Martin said that higher production volume on several Sikorsky platforms – the Black Hawk, Seahawk, CH‑53K King Stallion and Combat‑Rescue Helicopter – lifted RMS product sales by about $735 million and added roughly $560 million of product‑costs【page_42】【page_43】. By the 2024 filing the same helicopter families remain core RMS programs, but the scope has broadened to include the VH‑92A Marine One presidential helicopter, with the final aircraft delivered in 2024, reflecting an expansion beyond pure volume growth to a new high‑profile program【page_4】【page_5】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Sikorsky helicopter programs' evolution but contains significant quantitative discrepancies. CORRECT ELEMENTS: (1) The identification of specific helicopter programs (Black Hawk, Seahawk, CH-53K King Stallion) is accurate; (2) The mention of VH-92A Marine One as an expanded program in 2024 is relevant and adds useful context; (3) The overall narrative of evolution from cost driver to strategic product line is sound; (4) The multi-hop synthesis across 2022 and 2024 filings is appropriately structured. CRITICAL ERRORS: (1) The LLM states 'higher production volume on several Sikorsky platforms...lifted RMS product sales by about $735 million' - the ground truth only mentions a $560 million increase in product costs, not a $735 million sales increase. This is a significant quantitative error; (2) The LLM correctly identifies the $560 million product cost figure but incorrectly pairs it with an unsupported $735 million sales figure; (3) The Combat-Rescue Helicopter is mentioned in the LLM answer but not in the ground truth, which may or may not be accurate but represents an addition not verified against the original answer. REASONING ASSESSMENT: The multi-hop reasoning is generally sound - the LLM correctly synthesizes information across 2022 and 2024 filings and identifies the evolution pattern. However, the introduction of the $735 million figure without ground truth support is problematic. The VH-92A addition is contextually relevant but represents information beyond the ground truth scope. The answer demonstrates good qualitative understanding but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 463,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023 Walmart completed a $0.4 billion acquisition of Alert Innovation, which gave it roughly 100 % ownership of the company【page_45】.  The 2024 filing does not record any additional purchase or sale of Alert Innovation – the “Purchases and Sales of Subsidiary Stock” table lists only Flipkart and PhonePe and makes no mention of Alert Innovation – indicating that Walmart retained the full 100 % stake and the $0.4 billion investment remained unchanged through fiscal 2024【page_65】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN CORE CONCLUSION: The LLM answer directly contradicts the ground truth on the fundamental question of how Walmart's stake evolved. Ground truth states Walmart 'had fully exited its stake, likely through a sale or divestiture' by fiscal 2024. The LLM claims Walmart 'retained the full 100% stake and the $0.4 billion investment remained unchanged through fiscal 2024.' This is a complete reversal of the correct answer. QUANTITATIVE ACCURACY: The numbers cited are correct - $0.4 billion acquisition in fiscal 2023, approximately 100% ownership. These match the ground truth. REASONING ERROR: The LLM's logic is flawed. It argues that because the 2024 'Purchases and Sales of Subsidiary Stock' table doesn't mention Alert Innovation (only lists Flipkart and PhonePe), this means Walmart retained the stake. However, the absence of Alert Innovation from this table in fiscal 2024 actually supports the ground truth conclusion that Walmart no longer owned it - there would be no reason to list it if it had been divested. The LLM misinterpreted the absence of mention as evidence of retention, when it actually indicates exit. MULTI-HOP SYNTHESIS: The model failed to properly synthesize the evolution between fiscal 2023 and 2024. It correctly identified the 2023 acquisition but then drew the wrong conclusion about 2024 status. The question specifically asks how the stake 'evolved' - implying change - and the ground truth indicates a complete exit, not retention. The LLM's answer suggests no evolution occurred, which is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 429,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "In 2023 Simon Property Group carried a €750 million balance on its Supplemental Facility, which it refinanced and fully repaid in November 2023 – the repayment was funded with proceeds from a €750 million senior unsecured bond issuance and the related Euro‑denominated interest‑rate swaps were terminated (see page 61). By 2024 the company had not drawn on the Supplemental Facility at all; the facility remained available with a $3.5‑$4.5 billion borrowing capacity but no new borrowings were recorded, indicating a shift from active borrowing to a standby‑liquidity posture (see pages 68‑69).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) €750 million borrowing in 2023 - CORRECT, matches ground truth exactly; (2) November 2023 repayment date - CORRECT; (3) Senior unsecured bond issuance funding the repayment - CORRECT; (4) Zero outstanding balance in 2024 - CORRECT; (5) $3.5-$4.5 billion facility capacity mentioned - adds detail not contradicted by ground truth. Multi-hop reasoning: The answer correctly synthesizes information across 2023-2024, showing the evolution from active borrowing (€750M drawn) to full repayment (November 2023) to standby liquidity posture (2024 with no draws). The connection between the bond issuance and facility repayment is properly established. Entity accuracy: SPG (Simon Property Group) correctly identified, years 2023-2024 properly distinguished, Supplemental Facility correctly referenced. The answer goes slightly beyond the ground truth by mentioning: (1) interest-rate swaps termination, (2) specific facility capacity range ($3.5-$4.5B), and (3) page references. These additions are contextually appropriate and don't contradict the ground truth - they enhance rather than detract from accuracy. The characterization of the shift from 'active borrowing' to 'standby-liquidity posture' is semantically equivalent to the ground truth's 'strategic reduction in reliance.' Minor note: Ground truth mentions $1.0 billion issuance in September 2024, which the LLM answer doesn't include, but this is a minor omission that doesn't affect the core narrative about the Supplemental Facility's evolution. Overall, the answer demonstrates sound multi-hop synthesis, accurate financial data, and appropriate contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 466,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings continue to list helium as a core “process gas” in Linde’s industrial‑gases portfolio 【page_100】【page_87】.  In each year helium is highlighted as a product that is most often supplied through the merchant bulk‑liquid channel—shipped long distances under three‑to‑seven‑year supply agreements that do not contain minimum‑purchase or volume commitments—while also being available via on‑site plants under long‑term total‑requirement contracts.  The 2024 filing repeats this description, showing no material change in helium’s positioning or supply strategy from 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim of the question. CRITICAL ERRORS: (1) The LLM states that helium was listed as a core 'process gas' in BOTH 2023 and 2024 with 'no material change' - this directly contradicts the ground truth which explicitly states helium was 'explicitly listed as one of Linde's primary products' in 2023 but 'was no longer specifically named as a distinct product' in 2024. (2) The LLM claims the 2024 filing 'repeats this description' of helium's positioning - the ground truth indicates the opposite: helium was 'subsumed under more general descriptions' in 2024, representing a strategic repositioning away from distinct status. (3) The LLM's core conclusion that there is 'no material change in helium's positioning or supply strategy from 2023' is the exact opposite of what the ground truth establishes - there WAS a material change, with helium losing its explicit primary product designation. ACCURACY ISSUES: The LLM correctly identifies the supply mechanisms (merchant bulk-liquid, three-to-seven-year agreements, no minimum purchase requirements, on-site plants) which are accurate details, but these details are presented to support an incorrect overall narrative about the evolution of helium's positioning. The page references provided (page_100, page_87) cannot be verified but the substantive claims they allegedly support are contradicted by the ground truth. The LLM fundamentally failed the multi-hop reasoning task by not detecting the shift in how helium was described across the two years - from explicit primary product status to subsumed/general categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 455,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "The U.S. Retiree Health Care Plan moved sharply toward bonds and cash. In 2022 the plan was about 65 % fixed‑income (≈ $182 million) and 35 % equity (≈ $98 million) 【page_48】, but by 2023 the mix had shifted to roughly 80 % fixed‑income (≈ $210 million) and 20 % equity (≈ $54 million) 【page_47】. The weighted‑average allocation table confirms the same change – fixed‑income rose from 65 % to 80 % and equity fell from 35 % to 20 % 【page_45】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2022 had $248M fixed income and $137M equity (totaling $385M); 2023 had $210M fixed income and $54M equity (totaling $264M). The LLM claims 2022 had approximately $182M fixed income and $98M equity, which are completely wrong figures that don't match the ground truth at all. The LLM's percentages (65% fixed income, 35% equity for 2022) are also incorrect when calculated from the actual ground truth numbers ($248/$385 = 64.4% and $137/$385 = 35.6% - close to LLM's percentages but based on wrong dollar amounts). For 2023, the LLM correctly states $210M fixed income and $54M equity, and the percentages (80% and 20%) are mathematically correct for those figures ($210/$264 = 79.5%, $54/$264 = 20.5%). However, the 2022 numbers are entirely fabricated. The LLM correctly identifies the directional trend (shift toward fixed income, away from equity) and correctly identifies the 2023 absolute values, but the 2022 baseline is wrong, making the comparison invalid. The answer demonstrates partial understanding of the trend but fails on quantitative accuracy for the critical 2022 baseline year. The citation references (page numbers) cannot be verified but appear to be fabricated details. The reasoning about the shift is sound, but it's built on incorrect foundational data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 390,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Trodelvy’s sales surged 56 % year‑over‑year, climbing from $680 million in 2022 to $1.06 billion in 2023 as demand expanded across new and existing geographies【page_40†L31-L38】【page_41†L1-L3】.  The 2023 filing highlights the drug’s strategic advance – it received both FDA and European Commission approvals for use as a monotherapy in HR‑positive/HER2‑negative breast cancer (adding a new label to its earlier triple‑negative indication) and, although the Phase 3 EVOKE‑01 trial missed its overall‑survival primary endpoint, it showed an encouraging trend in a patient subgroup【page_38†L13-L20】【page_39†L4-L9】.  No comparable new regulatory events were reported for Trodelvy in the 2022 filing, underscoring that the key label expansions occurred in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims Trodelvy generated $680 million in 2022 and $1.06 billion in 2023, but the ground truth explicitly states $380 million in 2022 total product sales. This is a 79% overstatement of 2022 revenue ($680M vs $380M). The 56% YoY growth calculation is based on these incorrect numbers. The ground truth does not provide 2023 revenue figures, yet the LLM confidently states $1.06 billion. (2) MULTI-HOP REASONING: While the LLM correctly identifies the regulatory milestones (FDA and EC approvals for HR+/HER2- breast cancer in 2023, and mentions the EVOKE-01 trial), it fabricates financial performance data that was not in the source documents. The regulatory information synthesis appears sound, but is overshadowed by the revenue fabrication. (3) ENTITY ACCURACY: Trodelvy is correctly identified, years are correct (2022 vs 2023), but the financial metrics are entirely wrong. (4) GROUND TRUTH ALIGNMENT: The original answer explicitly states 'specific revenue figures for 2023 are not provided,' yet the LLM provides a specific 2023 figure of $1.06 billion with page citations that cannot be verified as accurate. This represents a hallucination of financial data with false attribution to source documents. The answer demonstrates the LLM fabricated numbers rather than acknowledging data limitations as the ground truth does. This is a severe factual error that undermines the entire response despite correct regulatory milestone identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 443,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "In 2022 Chevron’s downstream segment contributed about $1.97 billion of equity earnings, with the 50 %‑owned GS Caltex joint‑venture accounting for roughly $874 million of that; by 2024 total downstream equity earnings had slipped to about $1.02 billion and GS Caltex’s share fell to only $58 million, even though Chevron still carries a roughly $4.1 billion investment in the JV. The steep drop in earnings but the continued sizable stake shows the joint‑venture is still viewed as a strategic foothold for Chevron in Korea and the broader Asian downstream market, despite its diminished short‑term profitability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains numerous factual inaccuracies that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims 2022 downstream equity earnings of ~$1.97 billion with GS Caltex at ~$874 million - NO SUPPORT in ground truth\n   - LLM claims 2024 downstream equity earnings of ~$1.02 billion with GS Caltex at ~$58 million - NO SUPPORT in ground truth\n   - LLM claims ~$4.1 billion investment in GS Caltex - NO SUPPORT in ground truth\n   - Ground truth provides DIFFERENT metrics: $16,286 million (2022) and $13,850 million (2024) in sales/operating revenues with affiliated companies, NOT equity earnings figures\n   - The LLM appears to have fabricated specific equity earnings numbers that do not appear in the source documents\n\n2. METRIC CONFUSION:\n   - Ground truth discusses 'sales and other operating revenues with affiliated companies' ($16,286M in 2022, $13,850M in 2024)\n   - LLM discusses 'downstream equity earnings' and specific GS Caltex contribution amounts\n   - These are fundamentally different financial metrics; the LLM conflated or invented data\n\n3. OWNERSHIP STAKE:\n   - Both correctly identify 50% ownership in GS Caltex (CORRECT)\n   - Both correctly identify it as a joint venture with GS Energy (CORRECT)\n\n4. MULTI-HOP REASONING:\n   - LLM's reasoning about strategic importance is sound in principle, but is built on fabricated numbers\n   - Ground truth's conclusion (revenue decreased but JV remained strategically important) is more conservative and data-driven\n   - LLM's conclusion about 'diminished short-term profitability' cannot be verified from provided ground truth\n\n5. COMPLETENESS:\n   - LLM addresses the evolution question but with wrong data\n   - LLM addresses strategic importance but based on unsupported claims\n   - Ground truth provides actual comparable metrics (revenue figures) showing the decline\n\n6. SEMANTIC EQUIVALENCE:\n   - The LLM answer is NOT semantically equivalent because it presents different financial metrics entirely\n   - Ground truth: revenues with affiliates declined from $16,286M to $13,850M (~15% decrease)\n   - LLM: equity earnings declined from $874M to $58M (~93% decrease) - different metric, different magnitude\n\nThe LLM answer demonstrates a fundamental failure to accurately extract and synthesize information from the source documents, instead appearing to generate plausible-sounding but unsupported financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 659,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "In the 2022 Form 10‑K the CH‑53K was noted as a source of **higher risk‑retirements** that lifted RMS operating profit (about $140 million of the profit increase) – the filing highlighted risk‑retirement gains rather than a production surge for the helicopter【page_50】. By the 2024 Form 10‑K the story had shifted: the CH‑53K’s **production volume rose**, contributing roughly $140 million of net‑sale revenue in 2024, while risk‑retirement benefits were no longer called out as a primary driver of profit【page_40】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims CH-53K contributed 'roughly $140 million of net-sale revenue in 2024' which is a fundamental mischaracterization. The ground truth states the $140 million figure in 2022 was profit (not revenue), driven by risk retirements and production volume combined. The LLM incorrectly attributes a revenue figure to 2024 without proper sourcing and conflates revenue with the 2022 profit figure. (2) INCOMPLETE SYNTHESIS - The LLM fails to address the critical 73% decline in RMS operating profit in 2024 mentioned in the ground truth, which is essential context for understanding the program's evolution. (3) LOGICAL INCONSISTENCY - The LLM suggests production volume rose in 2024 while risk-retirement benefits diminished, but doesn't explain or quantify the overall profit impact or the 73% decline. The ground truth explicitly states that despite higher production, overall RMS profit declined significantly in 2024. (4) MISSING KEY INSIGHT - The ground truth notes that specific 2024 profit figures for CH-53K were not disclosed, suggesting the program's contribution became less transparent. The LLM doesn't capture this important nuance. (5) ENTITY/METRIC CONFUSION - The LLM conflates revenue ($140M in 2024) with profit ($140M in 2022), which are different financial metrics. The ground truth clearly distinguishes between profit drivers in 2022 (risk retirements) versus production volume evolution. The answer partially addresses the question structure but contains significant factual errors in the quantitative claims and fails to properly synthesize the 2022-2024 evolution with the critical profit decline context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 460,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "In 2022 PayPal treated seller‑protection mainly as a risk‑management cost, reporting that losses from its buyer and seller protection programs averaged only 0.09 %–0.15 % of total payment volume and were reflected in its transaction‑loss allowances (2022 10‑K Customer protection programs, p. 51; Allowance for transaction and credit losses, p. 53). By 2023 the company had made seller‑protection a strategic pillar, stressing proprietary, data‑driven protection programs that actively reduce merchant losses, investing in technology and positioning these programs alongside its broader risk‑management and merchant‑value offerings (2023 10‑K Protecting merchants and consumers, p. 9; Merchant value proposition, p. 7; Strategy, p. 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The specific transaction loss rate range (0.09%-0.15% of TPV) is correctly cited and matches the ground truth exactly. The years (2022 and 2023) are accurate. QUALITATIVE ACCURACY: The answer correctly captures the evolution in PayPal's strategic approach - from 2022's focus on risk management and loss implications to 2023's emphasis on seller protection as a competitive differentiator and strategic pillar. The LLM appropriately identifies the shift from treating these programs as cost centers to positioning them as value propositions for merchant attraction and retention. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple documents (2022 and 2023 10-Ks) and correctly identifies the connection between risk exposure metrics and strategic positioning. The integration of seller protection with broader merchant services and analytics is properly noted. ENTITY ACCURACY: PayPal is correctly identified, fiscal years are accurate, and the specific metrics (transaction loss rates, TPV) are properly referenced. COMPLETENESS: The answer addresses both parts of the question - risk exposure evolution and strategic emphasis changes - with appropriate detail. MINOR CONSIDERATIONS: The LLM includes specific page references (p. 51, p. 53, p. 9, p. 7, p. 10) which add credibility but are not verified against the ground truth. The wording differs slightly from the ground truth but conveys semantically equivalent information. The phrase 'data-driven protection programs that actively reduce merchant losses' is a reasonable interpretation of the strategic emphasis shift, though not explicitly stated in the ground truth. Overall, this is a high-quality answer that accurately captures the nuanced evolution in PayPal's approach to seller protection programs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 518,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "In the 2023 Form 10‑K Starbucks reported that ready‑to‑drink (RTD) beverages were included in “Other revenues” and that sales of these products were generally recognized **upon shipment to customers** (see 2023 p. 65). By the 2024 filing the company still records RTD revenue at shipment, but it now explicitly notes that the drinks are **purchased from several specialty suppliers under long‑term supply contracts** and that, based on those relationships, the risk of non‑delivery is considered remote (see 2024 p. 12‑13). This reflects a shift from merely stating the revenue‑recognition policy to also highlighting and managing supplier dependency for RTD beverages.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the revenue recognition method (upon shipment) for both 2023 and 2024; (2) Accurately captures the shift in focus from revenue-centric reporting to supply chain risk management; (3) Properly identifies the key evolution: 2023 focused on revenue recognition policy while 2024 emphasized supplier relationships and long-term contracts; (4) Correctly notes that RTD beverages are sourced from specialty suppliers under long-term contracts; (5) Appropriately cites page references (2023 p. 65, 2024 p. 12-13) showing document-specific sourcing; (6) Accurately conveys the semantic meaning that risk of non-delivery is considered remote based on supplier relationships. MINOR WEAKNESSES: (1) The LLM answer is slightly more specific and detailed than the ground truth in some respects (e.g., explicitly stating 'several specialty suppliers' and 'risk of non-delivery is considered remote'), which while accurate, goes slightly beyond what the ground truth explicitly emphasizes; (2) The ground truth mentions 'without specific figures' for 2023, while the LLM doesn't explicitly address this absence of quantitative data, though this is a minor omission; (3) The ground truth emphasizes a shift from 'revenue-centric reporting to supply-chain risk management focus' more explicitly as a strategic reorientation, while the LLM frames it as 'from merely stating the revenue-recognition policy to also highlighting and managing supplier dependency' - both convey similar meaning but with slightly different emphasis. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years (2023 and 2024) and identifies the evolution in Starbucks' approach. The reasoning is sound and logically connects the revenue recognition method with the emerging focus on supplier dependency. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either the ground truth or LLM answer, so this dimension is not heavily tested. The page references appear reasonable for 10-K filings. Overall, the LLM answer is factually accurate, well-reasoned, and appropriately addresses the multi-part question about evolution in approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 608,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "In 2022 Trodelvy’s sales were still heavily U.S.‑centric – $525 million in the United States, $143 million in Europe and only $12 million in other international markets (total $680 million) 【page_40】. By 2023 the product had broadened its geographic footprint, with sales rising to $777 million in the U.S., $217 million in Europe and $68 million elsewhere (total $1.06 billion), a 56 % increase driven by demand in new and existing regions 【page_40】. The 2022 filing did not report any new regulatory clearances for Trodelvy, whereas the 2023 filing announced both European Commission approval and FDA approval for Trodelvy as a monotherapy in HR⁺/HER2‑negative breast cancer, adding a new indication to its portfolio 【page_39】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 Trodelvy sales as $525M (U.S.), $143M (Europe), $12M (other) totaling $680M. The ground truth states $370M (U.S.) and $10M (Europe) with no other international sales. These are dramatically different figures - the LLM's numbers are approximately 42% higher for U.S. sales and 1,330% higher for European sales. The 2023 figures ($777M U.S., $217M Europe, $68M other) also cannot be verified against the ground truth provided. The LLM's 56% growth calculation is based on these incorrect baseline numbers. (2) REGULATORY APPROVALS: The LLM correctly identifies FDA and EC approvals for HR+/HER2- breast cancer monotherapy in 2023, which aligns with ground truth. However, the statement that '2022 filing did not report any new regulatory clearances' is not directly addressed in the ground truth. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize geographic expansion with regulatory approvals, the foundation is built on incorrect financial data. The reasoning structure is sound (connecting sales growth to regulatory approvals), but the numbers are wrong. (4) ENTITY ACCURACY: Trodelvy is correctly identified, years are correct (2022 vs 2023), and metrics are appropriate (sales by geography, regulatory approvals). (5) SEMANTIC EQUIVALENCE: The answer addresses the question's two components (geographic reach and regulatory approvals), but the geographic reach data is factually incorrect. The ground truth shows much more limited 2022 sales ($370M U.S., $10M Europe) compared to the LLM's claims ($525M U.S., $143M Europe). This is not a wording difference but a fundamental factual error in the core data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 490,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "In 2023 Simon’s ABG ownership fell from roughly 12 % at the start of the year to about 9.6 % by year‑end, as a series of capital transactions diluted its stake and produced non‑cash pre‑tax gains of $36.4 million (Q2), $12.4 million (Q3) and $10.3 million (Q4) plus a $157.1 million cash gain from a partial sale [page 114, page 73]. In the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, realizing a pretax cash gain of $414.8 million and reducing its ownership to zero [page 73].",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims SPG sold its remaining ABG interest in Q1 2024 for $1.2 billion with a $414.8 million pretax gain, reducing ownership to zero. The ground truth explicitly states that in 2024, SPG \"no longer disclosed active changes in its ownership stake in ABG\" and \"no new transactions reported.\" This is a fundamental contradiction.\n   - The LLM introduces a $157.1 million cash gain from a partial sale in 2023 that is not mentioned in the ground truth at all.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - 2023 gains are partially correct: $36.4M (Q2), $12.4M (Q3), $10.3M (Q4) match ground truth\n   - Ownership percentages roughly correct for 2023 (12% to 9.6%)\n   - The $157.1M cash gain is not in the ground truth\n   - The entire 2024 transaction ($1.2B sale, $414.8M gain, zero ownership) is fabricated and contradicts the ground truth's explicit statement that no new transactions were reported in 2024\n\n3. MULTI-HOP REASONING FAILURE:\n   - The question asks how ownership and gains \"evolved between 2023 and 2024\"\n   - Ground truth shows: 2023 = active transactions with multiple dilutions; 2024 = passive stance with no new transactions\n   - LLM answer shows: 2023 = transactions; 2024 = major transaction (complete exit)\n   - This is a fundamental misunderstanding of the evolution described in the ground truth\n\n4. ENTITY AND TEMPORAL ACCURACY:\n   - Correctly identifies Simon Property Group and ABG\n   - Correctly identifies 2023 vs 2024 timeframe\n   - Incorrectly attributes a major 2024 transaction that the ground truth explicitly says did not occur\n\n5. SEMANTIC EQUIVALENCE:\n   - The LLM answer conveys a completely different narrative: active stake reduction in 2023 followed by complete exit in 2024\n   - Ground truth narrative: active stake reduction in 2023 followed by passive disclosure (no new transactions) in 2024\n   - These are fundamentally different stories\n\nThe LLM appears to have hallucinated the 2024 transaction entirely, which is a critical error for a financial question requiring factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 583,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "In the 2023 Form 10‑K Meta disclosed the 2012 Equity Incentive Plan “as amended” (exhibit 10.2(A)+) together with its **third amendment** (10.2(B)+) and the original award‑agreement templates (10.2(C)+ and 10.2(D)+) plus a series of additional award‑agreement forms through 10.2(L)+. The 2024 filing keeps the same base plan and third amendment but adds a **fourth amendment** (exhibit 10.2(C)+) and updates the award‑agreement exhibits, now listing the newest additional form (10.2(K)+ filed April 2024) while still referencing the earlier forms, showing that the plan has been further amended and its award‑agreement documentation expanded.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of the 2012 Equity Incentive Plan between 2023 and 2024 filings. STRENGTHS: (1) Correctly identifies Third Amendment in 2023 filing and Fourth Amendment in 2024 filing; (2) Accurately notes the August 1, 2024 date for the Fourth Amendment; (3) Correctly identifies April 2024 as the date for new award agreement forms; (4) Properly synthesizes the multi-hop information showing plan evolution across two filing years; (5) Accurately conveys that the plan has been amended and award agreement documentation expanded. WEAKNESSES: (1) The LLM provides excessive exhibit numbering detail (10.2(A)+, 10.2(B)+, etc.) that goes beyond what the ground truth specifies - the ground truth simply references 'forms of award agreements from 2012 and 2017' and 'additional forms of award agreements from April 2024' without detailed exhibit citations; (2) The exhibit numbering appears potentially inaccurate or overly specific (e.g., claiming 10.2(K)+ for April 2024 form) - while the ground truth doesn't contradict this, it also doesn't confirm these specific exhibit numbers; (3) Minor semantic issue: the LLM states the 2024 filing 'keeps the same base plan and third amendment' which is accurate but slightly different framing than ground truth which emphasizes the addition of the Fourth Amendment as the key evolution. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings, identifying amendments and award agreement forms in each year and comparing them. The logic is sound. FACTUAL VERIFICATION: All key dates (August 1, 2024 for Fourth Amendment; April 2024 for new forms) match ground truth. The identification of Third Amendment in 2023 and Fourth Amendment in 2024 is correct. The answer appropriately addresses both amendments and forms of award agreements as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 506,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The company continues to capitalize software licenses as intangible assets and amortize them on a straight‑line basis over the license term (see the accounting policy on capitalized software licenses 【page_36】).  The balance‑sheet amount rose from $152 million in 2022 to $223 million in 2023 【page_27】, and the related amortization expense increased from $54 million to $63 million 【page_28】.  This jump shows that Texas Instruments is investing more heavily in software‑licensing assets, expanding the capitalized software portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: capitalized software licenses increased from $152 million (2022) to $223 million (2023), and amortization expense rose from $54 million to $63 million. The multi-hop synthesis is sound, correctly identifying the accounting policy (straight-line amortization over license term), the balance sheet values across both years, and the amortization expense trend. The answer properly interprets what these changes indicate about the company's investment strategy. One minor distinction: the LLM answer identifies the company as Texas Instruments, which is not explicitly stated in the ground truth answer. While this appears to be correct based on the page references provided, the ground truth answer uses the generic 'the company' phrasing. The LLM answer is slightly more specific and informative by naming the company. The reasoning is logical and well-structured, moving from accounting policy to quantified assets to expense trends to strategic interpretation. The answer addresses all parts of the question: how treatment evolved (unchanged policy), how valuation evolved (specific dollar amounts), and what this indicates about investment (growing commitment to software licensing). The semantic equivalence is excellent, with the LLM answer conveying the same core information as the ground truth while adding the helpful detail of amortization expense trends, which strengthens the analysis of investment intensity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 419,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "In 2022 PayPal had $3.8 billion—about 37 % of the European customer balances held in its Luxembourg subsidiary—approved for use in credit activities; by year‑end 2023 that amount fell to $3.0 billion, representing roughly 39 % of the balances (see 2023 Form 10‑K, “Credit products” section). The reduction in the absolute amount, even as the percentage of balances used rose slightly, signals that PayPal is scaling back reliance on internal European deposits while still leveraging them, indicating a strategic move to diversify funding for its credit products with external capital sources.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative facts: $3.8 billion in 2022 (37% of balances), declining to $3.0 billion in 2023 (39% of balances). The numerical accuracy is strong, and the calculation logic is sound (absolute decrease while percentage increases). The answer correctly interprets this as a strategic shift toward external funding sources.\n\nWEAKNESSES: The LLM answer is INCOMPLETE on a critical element. The ground truth specifically mentions PayPal's €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year. This is a major strategic development that directly supports the answer's conclusion about diversifying funding sources. The LLM answer alludes to 'external capital sources' but fails to provide the specific evidence (the €40 billion agreement and $5.5 billion sold) that substantiates this claim. This is a significant omission for a multi-hop question asking about strategic approach.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between declining internal balance usage and strategic shift to external funding, but the reasoning is weakened by not citing the specific external funding mechanism (the receivables sale agreement) that demonstrates this shift.\n\nCONTEXTUAL RELEVANCE: While the answer addresses the evolution of balance utilization, it incompletely addresses the full strategic picture by omitting the concrete external funding mechanism that is central to understanding PayPal's strategic approach.\n\nNUMBER VERIFICATION: All dollar amounts and percentages are accurate. The interpretation of the trend (absolute decrease, percentage increase) is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 465,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks’ stake in Valor Siren Ventures I LP (and II LP) grew modestly between the two years.  In FY 2023 the “Other investments” line – which includes this limited‑partnership interest – was $24.2 million, and the footnote did not call out a separate carrying amount; by FY 2024 that line had risen to $39.8 million and the note disclosed a total carrying value of $211.9 million for the Valor Siren investments as of September 29 2024【page_76】.  In both periods the partnership’s share of income or loss is recorded in the “interest income and other, net” line of the consolidated statement of earnings, and the activity is described as not material to the consolidated financial statements【page_76】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The FY2024 carrying value of $211.9 million for Valor Siren Ventures I and II combined is accurate. (2) The reporting in 'interest income and other, net' is correct. (3) The characterization as non-material is accurate. (4) The identification of both Valor Siren Ventures I L.P. and II L.P. is correct. (5) The general evolution narrative is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific numbers ($24.2 million for FY2023 and $39.8 million for FY2024 in 'Other investments') that are not mentioned in the ground truth answer. While these may be from the actual filing, they represent a different analytical approach than the ground truth, which states 'the total carrying value of such investments not specifically disclosed for that year' for FY2023. This creates a factual discrepancy - the ground truth explicitly says FY2023 carrying value was not specifically disclosed, but the LLM provides specific line-item numbers. (2) The LLM conflates 'Other investments' line items with the specific Valor Siren carrying value, which may not be equivalent - the ground truth distinguishes between what was disclosed and what wasn't. MULTI-HOP REASONING: The LLM correctly synthesizes information across two fiscal years and identifies the evolution of the investment relationship. However, the introduction of the $24.2M and $39.8M figures creates confusion about whether these are the Valor Siren carrying values or broader 'Other investments' categories. QUANTITATIVE ACCURACY: The $211.9 million figure is correct, but the FY2023 numbers ($24.2M, $39.8M) are presented without clear justification against the ground truth's statement that FY2023 carrying value was not specifically disclosed. This creates a significant quantitative discrepancy in interpretation. The answer would score higher if it either: (a) acknowledged that FY2023 carrying value was not specifically disclosed (matching ground truth), or (b) clearly explained the relationship between the line-item amounts and the Valor Siren carrying value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 567,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "TI continues to position its analog portfolio as a core pillar of the business model, built on the four sustainable competitive advantages – a strong manufacturing/technology foundation, a broad analog product portfolio, extensive market‑channel reach, and diversified, long‑lived products 【page_20】. Nevertheless, the analog segment’s financial contribution slipped in 2023, with revenue falling 15 % to $13.0 billion and operating profit dropping 30 % to $5.8 billion, cutting the operating‑profit margin from 54.4 % in 2022 to 44.6 % 【page_20】. This marks a shift from a high‑margin, profit‑driving segment in 2022 to a lower‑margin, demand‑constrained position in 2023, while still remaining strategically central.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial metrics (revenue $13.0B, operating profit $5.8B, margins 54.4% to 44.6%) that appear internally consistent and plausible, but these numbers are NOT verified against the ground truth and cannot be confirmed as accurate. The answer correctly identifies the four sustainable competitive advantages framework and accurately describes the shift in Analog Products' positioning from 2022 to 2023. However, the LLM answer focuses heavily on financial decline (15% revenue drop, 30% profit drop) which represents a significant departure from the ground truth's emphasis. The ground truth emphasizes: (1) Analog Products' continued centrality with gross margin of 67.5% in 2022, (2) explicit framing within four competitive advantages in 2023, and (3) renewed emphasis on long-term free cash flow per share growth. The LLM answer instead emphasizes margin compression and demand constraints, which may be factually accurate but represents a different narrative focus. The LLM answer does address the evolution between 2022-2023 and discusses competitive advantages, but it introduces specific financial metrics not mentioned in the ground truth (operating profit margins, revenue figures) without clear sourcing. The multi-hop reasoning is sound in comparing the two years, but the semantic emphasis differs substantially - the ground truth frames evolution as strategic repositioning and emphasis shift, while the LLM frames it as financial deterioration. The answer is partially correct in structure but potentially misleading in its emphasis on decline rather than strategic repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 445,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron’s Lower 48 segment saw its depreciation, depletion, amortization and impairments rise to **$5.73 billion in 2023 from $4.85 billion in 2022** – an $875 million increase (page 133). That higher DD&A coincided with **capital expenditures and investments climbing to $6.49 billion in 2023 from $5.63 billion in 2022** (page 135), indicating that Chevron shifted to a more aggressive capital‑allocation stance in the Lower 48, investing more in assets that are now being depreciated, depleted and amortized.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. Verification of key numbers: (1) DD&A figures are correct - $4.85 billion (2022) and $5.73 billion (2023) match the ground truth values of $4,854M and $5,729M respectively (format variation acceptable); (2) The calculated increase of $875 million is accurate ($5,729M - $4,854M = $875M); (3) The LLM appropriately synthesizes additional supporting data (capex figures: $6.49B in 2023 vs $5.63B in 2022) that reinforces the main conclusion, though this additional data was not explicitly in the ground truth answer. The LLM correctly interprets the relationship between rising DD&A and capital allocation strategy - higher depreciation reflects greater asset base from increased investments. The reasoning is sound: increased capex leads to more depreciable assets, which explains the DD&A increase. The answer goes beyond the ground truth by providing capex context, which strengthens rather than contradicts the core finding. Minor deduction (1 point) because the ground truth specifically mentions the contrast with other geographic segments (Europe, Middle East and North Africa), which the LLM answer omits. However, this omission is minor as the question focuses on Lower 48 evolution specifically. The answer correctly identifies the evolution as a shift toward 'more aggressive capital-allocation stance,' which aligns with the ground truth's characterization of 'significant increase' and 'growing focus.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 411,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "In 2023 Verizon presented Fixed‑Wireless Access (FWA) as a 5G/4G‑LTE‑based broadband alternative that sits in both the Consumer and Business portfolios – it is bundled with the Consumer segment’s residential fixed‑service lineup (Fios, DSL and other wireline options) and with the Business segment’s broader communications suite, serving both home users and business customers【page_4†L9-L15】【page_5†L5-L12】. The 2024 filing repeats that same framing, still listing FWA under the Consumer segment’s wireless‑and‑wireline offerings and under the Business segment’s product set, targeting residential consumers and business clients alike and emphasizing delivery over the 5G/4G LTE network【page_100†L1-L6】【page_100†L7-L9】—so the positioning and target segments have remained essentially unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The LLM answer completely omits the 3.1 million FWA broadband connections figure reported in 2023, which is a critical metric for understanding Verizon's FWA evolution. The ground truth explicitly states this number as a key data point. (2) CONTRADICTORY CONCLUSION: The LLM concludes that positioning and target segments 'remained essentially unchanged' between 2023 and 2024, which directly contradicts the ground truth's assertion of a meaningful shift. The ground truth identifies a strategic evolution from 'provides' (2023) to 'produces' (2024), indicating a more product-centric approach. The LLM fails to capture this important distinction. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that FWA was offered in both Consumer and Business segments in both years, it misses the ground truth's key insight about the shift in positioning—from a basic offering to a more integrated, strategic product positioned as an alternative to traditional landline internet access and part of a broader portfolio including IoT and advanced services. (4) PARTIAL ACCURACY: The LLM correctly identifies that FWA was available through 5G/LTE networks and targeted both Consumer and Business segments, and correctly notes the presence in both years. However, this partial correctness is overshadowed by the missing quantitative data and the failure to identify the strategic evolution. (5) CITATION ISSUES: While the LLM provides page references, the answer's core conclusion about 'no change' appears to be an inference not supported by the ground truth, which explicitly describes an evolution in approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 454,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson combined its Open Systems International and Geological Simulation Software businesses with Heritage AspenTech in May 2022, contributing $6 billion in cash and receiving a 55 % stake in the newly created AspenTech entity【page_3】. By 2024 its holding had risen to about 57 % and the company announced a $240‑per‑share cash offer to buy the remaining shares, moving the relationship from a majority‑owned affiliate toward full ownership【page_25】. The Heritage AspenTech acquisition added roughly 0.6 percentage points to Emerson’s gross margin in 2023 (raising it to 49 %) and, together with later acquisitions, helped lift gross margin to 50.8 % in 2024【page_26】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. Verified facts: (1) May 2022 combination of OSI and GSS with Heritage AspenTech is correct; (2) $6 billion cash contribution and 55% initial stake are accurate; (3) 0.6 percentage point gross margin benefit in 2023 matches ground truth; (4) 49% gross margin in 2023 and 50.8% in 2024 are correct; (5) Ownership increase to ~57% by 2024 and $240/share offer are accurate. The multi-hop reasoning is sound, correctly synthesizing the evolution from 2022 partnership to 2024 near-full ownership, and linking this to specific financial impacts on gross margin. The answer effectively addresses both relationship evolution and financial impact components of the question. Minor gaps: (1) The answer does not explicitly mention the equity structure impacts related to stock plan gains/losses and broader restructuring mentioned in ground truth, though this is a relatively minor omission; (2) SG&A expense impacts from integration are not discussed, though the answer does reference integration-related costs implicitly. The answer provides more specific detail on the ownership progression and cash offer than the ground truth, which adds value. Overall, the core financial metrics, dates, and multi-hop synthesis are accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 378,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "In the 2022 filing the link between NEE and FPL Group Capital Inc was essentially a guarantee‑type relationship – FPL Group, Inc. acted as guarantor of the capital entity’s unsecured debt (see the Guarantee Agreement dated June 1 1999 and the October 14 1998 guarantee between FPL Group and FPL Group Capital, exhibits *4(n) and 10(uu) on pages 121‑124). By the 2023 filing that relationship had shifted to direct joint debt issuance: Florida Power & Light and NextEra Energy Capital Holdings (the successor to FPL Group Capital) created new floating‑rate notes and other series, with both NEE and FPL listed as obligors (exhibits *4(h)‑*4(k) and *4(l) on page 118), showing the obligations are now part of the consolidated capital structure rather than merely guaranteed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of the relationship from guarantee to direct capital structure involvement, which aligns with the ground truth's core narrative. However, there are several significant factual errors that reduce accuracy: (1) DATE ERROR: The LLM cites a 'Guarantee Agreement dated June 1 1999' which is not mentioned in the ground truth (which only references October 14, 1998). This is a factual inaccuracy. (2) ENTITY NAME ERROR: The LLM refers to 'NextEra Energy Capital Holdings (the successor to FPL Group Capital)' - the ground truth simply refers to 'FPL Group Capital Inc.' without mentioning a successor entity name change. This conflates or misidentifies the entity. (3) INCOMPLETE DEBENTURE DETAILS: The ground truth specifically lists multiple series of junior subordinated debentures (Series B, C, L, M, N, O, and P) with maturity dates ranging from 2057 to 2082. The LLM answer mentions 'floating-rate notes and other series' but does not provide the specific series designations or maturity dates that are central to understanding the capital structure evolution. (4) CHARACTERIZATION ACCURACY: The LLM correctly identifies the shift from guarantee to direct obligation/consolidated capital structure, which is semantically aligned with the ground truth. (5) EXHIBIT REFERENCES: The LLM provides specific exhibit citations that cannot be verified against the ground truth, and the page numbers cited (121-124 vs 118) differ from what would be expected. The multi-hop reasoning is sound in concept (comparing 2022 vs 2023 relationships), but the execution contains factual errors that undermine confidence in the answer. The answer demonstrates understanding of the relationship evolution but fails on precision of specific details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 482,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic noted that InterStim II was already part of its InterStim therapy suite and that “continued acceptance and growth” of InterStim II, together with InterStim Micro and InterStim X, was driving Pelvic Health sales. By the 2024 filing the company highlights InterStim II as a **recharge‑free** neurostimulator and again stresses its “continued acceptance and growth,” now positioned alongside the recharge‑free InterStim X and the rechargeable InterStim Micro as the core products of an expanding Pelvic Health portfolio. This shows that InterStim II has moved from an established but generic offering in 2022 to a differentiated, recharge‑free device that is maintaining and strengthening its market acceptance relative to its sibling neurostimulators and the broader Pelvic Health therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of InterStim II as part of a suite including InterStim Micro and InterStim X with emphasis on 'continued acceptance and growth'; (2) Accurately captures the 2024 evolution highlighting InterStim II as 'recharge-free' with proper differentiation of product attributes (recharge-free vs. rechargeable); (3) Properly synthesizes the multi-hop information showing progression from 2022 to 2024; (4) Correctly identifies the broader context of Pelvic Health therapies expansion; (5) No numeric errors or date inaccuracies present. MINOR CONSIDERATIONS: (1) The LLM adds interpretive language ('moved from an established but generic offering...to a differentiated, recharge-free device') that goes slightly beyond the ground truth's more neutral description of 'shift toward emphasizing device-specific attributes,' though this interpretation is reasonable and supported by the facts presented; (2) The characterization of InterStim Micro as 'rechargeable' in the 2024 context is an inference not explicitly stated in the ground truth, though it logically follows from the recharge-free positioning of InterStim II and InterStim X. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across 2022 and 2024 filings and properly contextualizing product positioning within the broader portfolio. All factual claims are accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 420,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between the 2022 and 2024 filings the Supplemental Facility remained a $3.5‑$4.5 billion revolving line, but its maturity was pushed out from Jan 31 2026 (2022) to Jan 31 2029 (2024) with an optional extension to Jan 31 2030. The facility’s pricing continued to be based on SOFR + 72.5 bps (plus a margin tied to the company’s credit rating), and Simon added interest‑rate swaps that locked the Euro‑denominated portion at a fixed 3.81 % rate. In 2023 the company repaid €750 million (≈ $815 million) of the Supplemental Facility using proceeds from a €750 million senior unsecured bond issuance, showing an active repayment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MATURITY DATE DISCREPANCY: The LLM claims the maturity date was extended from Jan 31, 2026 (2022) to Jan 31, 2029 (2024), but the ground truth states the maturity date in 2022 was January 31, 2026 with no mention of a 2024 extension to 2029. This is a major factual error that contradicts the ground truth. (2) SOFR MARGIN SPECIFICATION: The LLM specifies '72.5 bps' as the SOFR margin, but the ground truth only states 'a margin determined by the company's credit rating' without specifying the exact basis points. This appears to be an unsupported detail. (3) EURO CONVERSION: The LLM provides a conversion of €750 million to approximately $815 million, which is not mentioned in the ground truth and introduces an unverified calculation. (4) TIMING ACCURACY: The ground truth correctly identifies that the €750 million was repaid on November 17, 2023, following exchangeable bond issuance. The LLM states it was repaid using proceeds from a 'senior unsecured bond issuance' but the ground truth specifies 'exchangeable bonds' - these are different instruments. (5) CORRECT ELEMENTS: The LLM correctly identifies the $3.5-$4.5 billion borrowing capacity, the SOFR-based pricing structure, the 3.81% fixed rate from interest rate swaps, and the €750 million repayment amount. (6) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across years but introduces unsupported details (maturity extension, specific basis points) that contradict or go beyond the ground truth. The core narrative of evolution from passive availability to active utilization is present but undermined by factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "In the 2023 filing Verizon said its device‑payment plans simply let consumers purchase a handset on a non‑interest‑bearing installment note (typically up to 36 months) while staying on a month‑to‑month service contract, and it noted that it had stopped offering new fixed‑term subsidized plans for consumers (page 5). By the 2024 filing the same financing structure remains, but Verizon now adds explicit promotional incentives—such as billing credits that accrue if the customer maintains service and upgrade‑or‑trade‑in rights—and it has refined its credit‑risk accounting by pooling device‑payment‑plan receivables into “new” versus “existing” customer groups (pages 60‑62).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION ON 2023 STRUCTURE: The LLM claims that in 2023 Verizon described device-payment plans as 'non-interest-bearing installment note (typically up to 36 months)' with specific details about month-to-month service contracts. However, the ground truth explicitly states that in 2023 there was 'no mention of structured promotional incentives or trade-in rights' and the financing mechanism was general/unstructured. The LLM's attribution of detailed 36-month terms and specific structural language to 2023 contradicts the ground truth's characterization of 2023 as lacking formalized structure. (2) MISALIGNMENT ON EVOLUTION: The ground truth emphasizes a clear evolution from 2023 (general, unstructured) to 2024 (formalized with defined promotional features). The LLM states 'the same financing structure remains' which contradicts the ground truth's assertion that 2024 introduced 'a more structured and incentive-driven model' representing a shift from general to structured. (3) PAGE REFERENCES: The LLM cites specific pages (5, 60-62) which cannot be verified against the ground truth and may be fabricated or incorrect. (4) PROMOTIONAL INCENTIVES: While the LLM correctly identifies that 2024 introduced promotional incentives (billing credits, upgrade-or-trade-in rights), it fails to clearly articulate that these were absent in 2023, which is the core of the evolution narrative. (5) CREDIT-RISK ACCOUNTING: The LLM introduces information about pooling receivables into 'new' versus 'existing' customer groups, which is not mentioned in the ground truth and may represent hallucination or irrelevant detail. The ground truth focuses on customer-facing features (promotional incentives, trade-in rights), not internal accounting structures. CORRECT ELEMENTS: The LLM correctly identifies that both years involved non-interest-bearing installment plans and that 2024 added promotional features. However, the fundamental mischaracterization of 2023 as already having formalized structure undermines the entire answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 559,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings state that Coca‑Cola still “seeks a declaratory judgment that the Company has no obligation … for any past, present or future liabilities … arising from Aqua‑Chem’s asbestos‑related claims.” The litigation and insurance‑coverage actions continue unchanged, and the Georgia case remains stayed, showing that the company’s stance on liability has not shifted between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that Coca-Cola's stance SHIFTED between 2023 and 2024 - from 'outright denial of liability' to 'a more nuanced stance centered on insurance coverage and shared responsibility among insurers.' The LLM directly contradicts this by claiming 'the company's stance on liability has not shifted between the two years.' This is a critical factual error that misrepresents the evolution of the legal relationship. While the LLM correctly identifies that both years reference the declaratory judgment language and that the Georgia case remains stayed, it fails to recognize the key distinction: the 2024 disclosure includes 'more detailed description of the insurance policies' and 'involvement of multiple insurers,' representing a shift in emphasis and disclosure strategy. The LLM's statement that litigation 'continue[s] unchanged' is technically accurate but misses the nuanced change in Coca-Cola's legal positioning and disclosure emphasis regarding insurance coverage. The quantitative accuracy is high (dates, case names, and procedural status are correct), but the qualitative reasoning is severely flawed - the model failed to synthesize the multi-hop information about how the company's disclosure strategy and emphasis evolved, which is the core of the question. The answer demonstrates a fundamental misunderstanding of what constitutes a 'shift' in legal stance when the underlying litigation remains the same but the disclosure and emphasis changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 428,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel’s long‑term income‑tax payable fell dramatically – from $4.6 billion reported in the 2022 filing (as of 12/26/2020) to $1.6 billion in the 2024 filing (as of 12/28/2024) – and the 2024 note says the balance is “reduced by the associated deduction for state taxes and **non‑US tax credits**”【page_92】. The sharp decline shows Intel is actively applying foreign tax credits to offset U.S. liabilities, indicating a strategy that leverages its international earnings to lower its overall tax burden.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports $4.6 billion for 2022, but the ground truth states $4.3 billion. This is a $300 million discrepancy (6.5% error), which is material and unacceptable for financial data. The 2024 figure of $1.6 billion is correct. (2) DATE CONFUSION - The LLM includes confusing parenthetical dates '(as of 12/26/2020)' for 2022 and '(as of 12/28/2024)' for 2024. The 12/26/2020 date appears to be from a 2020 filing, not a 2022 filing, creating ambiguity about which fiscal year is being referenced. This is a significant error in entity/temporal accuracy. (3) MULTI-HOP REASONING - The LLM correctly identifies that non-US tax credits reduced liabilities and correctly synthesizes the comparison between years, showing the strategic shift. The reasoning about leveraging international earnings is sound. (4) COMPLETENESS - The LLM addresses the core question about how non-US tax credits impacted liabilities and what this indicates about strategy, though the date confusion undermines clarity. (5) SEMANTIC EQUIVALENCE - The LLM's interpretation of the strategic implications (leveraging foreign tax credits to offset U.S. liabilities) aligns with the ground truth's conclusion about strategic shift and increased effectiveness. However, the factual errors in the primary numbers are disqualifying for a high score. The $300M discrepancy in the 2022 baseline figure is a fundamental error that cannot be overlooked in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 412,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "The 2022 filing noted that pension‑ and post‑retirement‑benefit liabilities are highly interest‑rate sensitive – a decline in rates raises pension liabilities and expense, while a rise in rates lowers them – but the net effect is largely offset by the corresponding change in returns on MetLife’s fixed‑income investments (see page_59 and page_63). By the 2024 filing the company still stresses this interest‑rate exposure, but adds that evolving rules on defined‑benefit pension‑plan funding may restrict sponsors’ ability to terminate or transfer obligations, thereby altering the mix of pension‑risk‑transfer transactions and increasing exposure to non‑guaranteed funding products (see page_32). Thus, the treatment has broadened from a primarily market‑risk focus to include a growing regulatory risk component that could reshape MetLife’s pension‑risk‑transfer strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 focus on interest rate sensitivity and asset-liability management (ALM) strategies, accurately describing how rate declines increase pension liabilities while rate increases lower them, with offsetting effects on fixed-income investments. (2) Accurately captures the 2024 regulatory evolution regarding defined benefit pension plan funding rules and their impact on plan termination/transfer decisions. (3) Correctly synthesizes the shift toward non-guaranteed funding products as a consequence of regulatory changes. (4) Properly identifies MetLife as the company in question. (5) The multi-hop reasoning is sound - connecting 2022 market risk focus to 2024 regulatory risk component. (6) Page references (59, 63, 32) are provided, showing source documentation. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail about interest rate mechanics (how rate changes affect liabilities vs. returns) than the ground truth, which is supplementary rather than contradictory. (2) The ground truth emphasizes the evolution from 'Retirement and Income Solutions business' containing 'short- and long-duration products' - the LLM answer doesn't explicitly reference this business segment naming, though it captures the substantive evolution. (3) The characterization of the shift as 'broadening from primarily market-risk focus to include growing regulatory risk component' is a reasonable synthesis that aligns with the ground truth's description of 'strategic and regulatory-driven change.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information about interest rate sensitivity, regulatory changes, and product mix evolution. The logic connecting regulatory constraints to product mix changes is sound and matches the ground truth's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 561,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "In 2022 Medtronic highlighted the InterStim Micro as a **newly launched, rechargeable neurostimulator** that was already driving growth in its Pelvic Health franchise, citing “sales of the recently launched InterStim Micro neurostimulator” and positioning it alongside InterStim II and InterStim X for over‑active bladder, urinary retention and bowel‑incontinence treatment【page_41】【page_42】. By 2024 the device is presented as an **established, integral part of an expanded InterStim family**—now offered together with InterStim X and InterStim II recharge‑free systems—and the filing stresses “continued acceptance and growth of … InterStim Micro rechargeable neurostimulator” for the same pelvic‑health indications, reflecting a shift from launch‑phase promotion to a mature, differentiated portfolio strategy【page_39】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key entities (Medtronic, InterStim Micro, InterStim II, InterStim X, Pelvic Health), the correct time period (2022 vs 2024), and the correct indications (overactive bladder, urinary retention, bowel incontinence). The answer appropriately captures the evolution from launch-phase to mature product positioning. The characterization of InterStim Micro as 'rechargeable' and InterStim X/II as 'recharge-free' is accurate and represents proper differentiation strategy. The multi-hop synthesis across years is sound.\n\nWEAKNESSES: (1) FACTUAL ERROR - The LLM states InterStim Micro was 'newly launched' in 2022, but the ground truth indicates it was already part of the product line in 2022, not newly launched that year. The ground truth describes it as 'part of a growing and accepted product line' in 2022, suggesting it had been available prior. (2) CHARACTERIZATION ISSUE - The LLM describes the 2024 positioning as emphasizing 'recharge-free InterStim X and InterStim II models,' but the ground truth states these are 'recharge-free' models in contrast to the rechargeable Micro, not that 2024 emphasized them as recharge-free. The emphasis in 2024 was on distinguishing the Micro as rechargeable. (3) INCOMPLETE CONTEXT - The LLM adds detail about 'sales of the recently launched InterStim Micro' which may be accurate but goes beyond what the ground truth explicitly states about 2022 positioning.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the strategic shift, which is the core requirement. However, the characterization of 'newly launched' in 2022 contradicts the ground truth's description of it as an established part of the product line.\n\nNUMERIC/CALCULATION ACCURACY: No calculations required; no numeric errors identified.\n\nSEMANTIC EQUIVALENCE: The overall narrative of evolution from launch/growth phase to mature differentiated positioning is semantically aligned with ground truth, but the specific claim about 'newly launched' in 2022 is a factual discrepancy that undermines accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 568,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "In the 2022 filing the Operating Partnership had drawn $1.05 billion under the Supplemental Facility on December 14 2021 and then used the proceeds of a $1.05 billion senior‑note issuance to **repay the entire amount on January 12 2022**, leaving the facility with no balance (2022 p. 125). By the 2024 filing the company again had a €750 million borrowing on the Supplemental Facility (covered by a €750 million interest‑rate swap on January 10 2023) and **fully retired that debt with proceeds from a €750 million senior unsecured bond issuance on November 17 2023**, so the Supplemental Facility showed no outstanding borrowing at year‑end 2024 (2024 p. 70).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a highly accurate and detailed account of Simon Property Group's Supplemental Facility usage evolution between 2022 and 2024. STRENGTHS: (1) All specific numbers are correct: $1.05 billion drawn December 14, 2021; repaid January 12, 2022; €750 million borrowed with swap on January 10, 2023; fully retired November 17, 2023. (2) Dates are precise and verifiable. (3) The answer correctly identifies the multi-hop pattern: draw → repay with senior notes (2022 cycle) and borrow → repay with senior bonds (2023-2024 cycle). (4) The answer properly synthesizes information across multiple filing years and documents. (5) The conclusion that the facility showed no outstanding borrowing at year-end 2024 is accurate. (6) The inclusion of the interest-rate swap detail (€750 million on January 10, 2023) adds appropriate context. MINOR CONSIDERATIONS: The ground truth mentions weighted average outstanding balances ($519.9M in 2022, $311.1M in 2024) and maximum aggregate outstanding balance ($2.1B in 2022), which the LLM answer does not include. However, the LLM answer focuses on specific transaction-level detail rather than aggregate metrics, which is a different but complementary approach. The LLM answer actually provides MORE granular transaction detail than the ground truth, showing the specific draw-and-repay cycles. The €750 million repayment on November 17, 2023 matches the ground truth's reference to this date and amount (with USD equivalent of $815.4 million noted in ground truth). The answer demonstrates strong multi-hop reasoning by connecting borrowing events to repayment events across years and showing the strategic pattern of debt management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 461,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP’s depreciation, depletion, amortization and impairments expense for the Lower 48 rose from **$4.854 billion in 2022 to $5.729 billion in 2023** – an increase of about **$875 million (≈18 %)**【page_133】. The higher DD&A expense signals that the company’s investment and asset‑building activity in the Lower 48 region grew markedly between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $4.854 billion (2022) and $5.729 billion (2023) match the ground truth values of $4,854 million and $5,729 million respectively. The format variation ($4.854 billion vs $4,854 million) is acceptable and equivalent. The calculated increase of $875 million is accurate ($5,729M - $4,854M = $875M), and the percentage increase of approximately 18% is correct (875/4,854 ≈ 0.1804 or 18.04%). (2) COMPLETENESS: The answer fully addresses the question by showing the evolution of investment activity from 2022 to 2023 through DD&A expense changes. (3) ENTITY ACCURACY: COP is correctly identified, the Lower 48 region is properly specified, the years 2022 and 2023 are correct, and the financial metric (depreciation, depletion, amortization, and impairments) is accurately referenced. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly interprets that higher DD&A expenses indicate increased investment and asset-building activity, which directly answers how investment activity evolved. The logic connecting DD&A changes to investment activity is appropriate and matches the ground truth interpretation. (5) SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth, with slightly more detailed analysis (including the percentage increase and absolute dollar change) that enhances understanding without introducing errors. The citation reference [page_133] adds credibility. Minor note: The answer is slightly more comprehensive than the ground truth by including the percentage calculation, which is a positive addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 457,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "In the 2023 filing Verizon’s Business segment listed corporate networking solutions as a core part of its portfolio, describing them alongside private‑networking, private‑cloud connectivity, virtual and software‑defined networking services under the Enterprise & Public Sector line【page_4】【page_5】. The 2024 filing still includes corporate networking solutions but now groups them with “advanced communication services,” and the Business segment’s revenue mix shows a modest shift – Enterprise & Public Sector remains the largest contributor but Business Markets and Other has grown relative to Wholesale, indicating a broader market emphasis【page_100】【page_101】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ERRORS: (1) The LLM fails to mention the specific Enterprise and Public Sector revenue figure of $15.1 billion for 2023, which is a key quantitative metric in the original answer. (2) The LLM incorrectly states that 2024 groups corporate networking with 'advanced communication services' - the ground truth indicates the 2024 description became 'more streamlined, focusing on wireless and wireline communications services and products' without this specific grouping mentioned. (3) The LLM introduces unsupported claims about 'Business Markets and Other' growing relative to 'Wholesale' with page references (page_100, page_101) that cannot be verified against the ground truth, which makes no such comparison. (4) The LLM fails to capture the core insight from the ground truth: that 2024 showed a shift toward 'more generalized presentation' and 'strategic consolidation or simplification of messaging' - instead, the LLM suggests a different narrative about 'advanced communication services' grouping. PARTIAL CREDIT: The LLM correctly identifies that both 2023 and 2024 filings include corporate networking solutions and that there was some evolution in how they were presented. The LLM also correctly notes that Enterprise & Public Sector remained significant. However, the specific details about the evolution are either incorrect or unsupported. The answer demonstrates incomplete multi-hop synthesis - it fails to properly connect the 2023 detailed service descriptions with the 2024 streamlined approach as the ground truth does. The quantitative accuracy is particularly weak due to the missing $15.1 billion figure and the unsupported revenue mix claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 482,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "In the 2022 filing MetLife valued its FVO securities as Level 3 assets – using matrix pricing, offered quotes, market‑price and consensus‑price inputs – and quantified the dollar‑impact explicitly: a 10 % appreciation of the U.S. dollar would have reduced the fair value of FVO securities by roughly **$54 million** (see page 151). By the 2024 filing the company says it still applies the same Level 3 valuation techniques to FVO securities (page 248) but now reports the currency effect only in the aggregate foreign‑currency sensitivity note, stating that “changes in estimated fair value are based on long U.S.‑dollar net asset positions and will be inversely impacted for short U.S.‑dollar net asset positions” (page 250), with no separate dollar‑impact figure disclosed for FVO securities. This shows a move from a specific $‑impact estimate to a broader net‑position‑based sensitivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) The $54 million figure for 2022 is correctly cited as the impact of 10% U.S. dollar appreciation on FVO securities fair value. (2) The answer correctly identifies the shift from explicit dollar-impact disclosure in 2022 to aggregate foreign-currency sensitivity reporting in 2024. (3) The multi-hop reasoning is sound—the answer synthesizes information across two years and shows how MetLife's disclosure approach evolved. (4) The characterization of the evolution from 'specific $-impact estimate to broader net-position-based sensitivity' accurately captures the methodological shift described in the ground truth. (5) Page references (151, 248, 250) add credibility and specificity. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the $1.6 billion fair value figure for FVO securities in 2022 that appears in the ground truth, though this omission is relatively minor since the question focuses on sensitivity evolution rather than absolute valuations. (2) The answer could have been slightly more explicit about the 'duration- and currency-dependent approach' mentioned in the ground truth as the 2024 framework, though the net-position-based sensitivity description is semantically equivalent. (3) The answer provides more granular detail about Level 3 valuation techniques and specific page citations than the ground truth, which is actually a strength but slightly exceeds the scope of the original answer. QUANTITATIVE VERIFICATION: The $54 million figure is correct; the 10% appreciation threshold is correct; the years (2022 vs 2024) are correct. REASONING QUALITY: The multi-hop synthesis correctly connects 2022 and 2024 data to show evolution in methodology and disclosure practices. The logic is sound and the conclusion appropriately characterizes the shift in approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 512,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy’s power‑marketing and energy‑trading function moved from a loss‑making position in 2022 to a strong profit‑center in 2023. In 2022 the company recorded a $2.67 billion loss on non‑qualifying commodity hedges, which helped keep NEER’s net income at only $285 million, whereas in 2023 those activities produced roughly $2.53 billion of gains, contributing to a $5.95 billion increase in operating revenue and lifting NEER’s net income to $3.56 billion – a swing of about $3.3 billion year‑over‑year【page_40】. The underlying trading business is described as providing full energy‑and‑capacity services and engaging in power‑ and fuel‑marketing and trading to optimize contract values【page_77】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific numbers NOT in the ground truth: claims $2.67 billion loss on hedges in 2022, $2.53 billion gains in 2023, $5.95 billion increase in operating revenue, and $3.3 billion year-over-year swing. None of these figures appear in the original answer. The ground truth only confirms NEER net income of $285M (2022) and $3,558M (2023), which the LLM correctly cites but then adds unsupported financial details. (2) FACTUAL CONTRADICTION - The LLM characterizes 2022 as 'loss-making' when the ground truth shows $285M in net income (positive, not a loss). The LLM appears to conflate hedging losses with overall business performance. (3) MULTI-HOP REASONING - While the LLM correctly identifies the income increase ($285M to $3,558M), it fabricates intermediate calculations and hedge-related figures that cannot be verified against the ground truth. The reasoning about 'swing of about $3.3 billion' is mathematically inconsistent with stated figures and unsupported. (4) PARTIAL CREDIT - The LLM correctly identifies: (a) NEER as the subsidiary, (b) the 2022-2023 timeframe, (c) the income figures ($285M and $3.56B), (d) the business description of providing energy/capacity services and power/fuel marketing. However, the introduction of unverified financial metrics ($2.67B, $2.53B, $5.95B) and the characterization of 2022 as 'loss-making' represent significant factual errors that undermine the answer's reliability. The answer goes beyond the ground truth with specific claims that cannot be substantiated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 436,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "The Coca‑Cola Company continued to hold a roughly 28 % equity stake in Coca‑Cola FEMSA at year‑end 2024 – the same level reported in the prior year’s filing【page_87】.  That ownership contributed to a modest rise in equity‑method earnings, with the company’s equity income increasing from $1.691 billion in 2023 to $1.770 billion in 2024【page_87】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and misses key aspects of the question. STRENGTHS: (1) The 28% ownership stake figure is correct and properly formatted. (2) The equity income figures ($1.691B in 2023 and $1.770B in 2024) appear to be accurate numbers. (3) The mention of equity method accounting is appropriate. WEAKNESSES: (1) The LLM states the 28% stake was 'the same level reported in the prior year's filing,' which contradicts the ground truth that indicates a shift from an indirect dependency relationship in 2023 to a direct 28% ownership stake in 2024. The ground truth explicitly states this represents a strategic evolution from 'dependency-based relationship to direct ownership stake.' (2) The LLM fails to address the key evolution described in the original answer - the shift from 2023 (when FEMSA was referenced as a key bottler affecting credit ratings, suggesting indirect dependency) to 2024 (direct 28% ownership). (3) The answer is incomplete in addressing the 'evolution' aspect of the question - it treats the relationship as static rather than showing how it evolved. (4) The LLM provides equity income numbers but doesn't adequately contextualize how this direct ownership stake now directly impacts equity income, which was a key implication in the ground truth. (5) Missing the strategic context about the nature of the relationship change. The LLM answer reads as a snapshot of 2024 data rather than a comparison showing evolution between the two years. The multi-hop reasoning required to synthesize the relationship change across 2023-2024 is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 445,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "In 2023 Conoco Phillips raised its Lower 48 capital outlays to $6.487 billion, up $857 million (about 15 %) from 2022, and the segment’s depreciation‑depletion‑amortization rose to $5.729 billion, an $875 million (≈18 %) increase over the prior year.  At the same time, Lower 48 sales – a proxy for production volume – fell sharply from $52.9 billion in 2022 to $38.2 billion in 2023, showing that the company is investing more financially in the region even as its production‑related output has declined.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial metrics and sound multi-hop reasoning. STRENGTHS: (1) Depreciation/depletion/amortization figure of $5.729 billion for 2023 is correct and matches ground truth exactly. (2) The $875 million increase (≈18%) is accurately calculated from $4.854B (2022) to $5.729B (2023). (3) Capital outlays data ($6.487B in 2023, $857M increase) appears accurate based on filing data. (4) The multi-hop synthesis is excellent - the answer correctly connects increased financial investment (capex and depreciation) with declining production-related output (sales proxy), directly addressing the question's core inquiry about evolved focus. (5) The reasoning that 'the company is investing more financially in the region even as its production-related output has declined' is logically sound and insightful. MINOR GAPS: (1) The original answer specifically mentions 2022 production volumes (crude oil 447 kbd, natural gas 1,340 mmcf/d), which the LLM answer does not include. However, the LLM uses sales as a production proxy instead, which is a reasonable alternative metric. (2) The LLM answer doesn't explicitly state 2022 production volumes, though it does reference 2022 sales ($52.9B). The original answer emphasizes 'stable or moderate production levels' in 2022, while the LLM shows sales declined from $52.9B to $38.2B - this is a different framing but not contradictory (sales decline could reflect price changes rather than volume changes). CALCULATION VERIFICATION: $5.729B - $4.854B = $875M ✓; $875M / $4.854B ≈ 18% ✓; $6.487B - $5.630B = $857M ✓ (assuming 2022 capex was $5.630B). The answer provides more comprehensive financial context than the ground truth while maintaining accuracy on the key depreciation metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 486,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "In the 2023 filing Verizon’s 4G LTE network is not highlighted as a strategic growth platform – the 2023 sections on network equipment and operating revenues (pages 95‑99) discuss the network generally without singling out LTE. By the 2024 filing, however, Verizon explicitly positions its 4G LTE network as a core pillar of its growth strategy, noting that “our 4G LTE network and fiber infrastructure will drive innovative products and services and fuel our growth” (2024 p. 23) and that the Consumer segment offers FWA broadband “through our 5G or 4G LTE networks” (2024 p. 24). This reflects a shift from a background asset in 2023 to a central, growth‑enabling component in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Verizon's 4G LTE network evolution from 2023 to 2024. Key strengths: (1) Correctly identifies the shift from 4G LTE as a foundational/background component in 2023 to a more strategic, growth-enabling asset in 2024; (2) Accurately cites specific 2024 filing language about 4G LTE driving 'innovative products and services and fuel our growth' and mentions FWA broadband delivery; (3) Properly synthesizes multi-hop information across years and filing sections; (4) Correctly identifies both years (2023, 2024) and the company (Verizon). Minor weaknesses: (1) The LLM states that 2023 sections 'do not highlight' 4G LTE as strategic, which is slightly different from the ground truth's characterization that it was 'positioned primarily as a foundational component' specifically for FWA broadband - the ground truth actually does identify a specific 2023 role (FWA delivery), whereas the LLM suggests it wasn't highlighted at all; (2) The LLM could have been more explicit about the 2023 FWA broadband context to fully mirror the ground truth's specificity. However, the overall narrative arc and conclusion about the evolution are accurate and well-supported. The answer demonstrates sound multi-hop reasoning by comparing strategic positioning across two years and correctly identifies the integration with C-Band, millimeter wave, and fiber (implied through the broader ecosystem reference). No calculation errors or date inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 423,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson’s relationship with AspenTech began in 2022 when it contributed its Open Systems International and Geological Simulation Software businesses to the newly formed “Heritage AspenTech,” receiving a controlling equity stake that drove AspenTech’s backlog from $328 million in 2021 to $1.04 billion in 2022 and added roughly 0.6 percentage‑points to Emerson’s gross margin in 2023. By 2024 Emerson owned about 55‑57 % of AspenTech’s common stock, and a $240‑per‑share offer values the business at roughly $15.3 billion, while the integration helped lift Emerson’s overall gross margin to 49 % in 2023 and 50.8 % in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Emerson's relationship with AspenTech but contains several significant quantitative discrepancies and some conceptual confusion:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 55% ownership stake by 2024 (ground truth states 55%)\n- Correctly notes the strategic nature of the relationship and integration\n- Appropriately mentions gross margin improvements in 2023-2024\n- Correctly identifies the transaction structure involving contributed businesses\n- Provides relevant context about valuation ($15.3 billion)\n\nQUANTITATIVE ERRORS:\n1. Backlog figures: LLM states AspenTech backlog went from $328M (2021) to $1.04B (2022), but ground truth indicates Emerson held a stake with $1,042M backlog in 2022. The LLM conflates AspenTech's standalone backlog with the stake value.\n2. Gross margin impact: LLM claims 0.6 percentage points added in 2023, but ground truth states 3.3 percentage points increase in 2023 due to AspenTech acquisition - a significant discrepancy (off by ~5x).\n3. Overall gross margin: LLM states 49% in 2023 and 50.8% in 2024, but these appear to be Emerson's total gross margins, not specifically attributable to AspenTech integration impact.\n4. Missing key metric: LLM does not mention the 2024 backlog of $8,053M or the 2021 baseline of $6,533M, which are important for showing the evolution.\n\nCONCEPTUAL ISSUES:\n- The LLM conflates \"Heritage AspenTech\" (the initial 2022 structure) with \"New AspenTech\" (the 2024 structure after the transaction), suggesting some confusion about the transaction timeline and structure.\n- The ownership percentage range (55-57%) is reasonable but the ground truth specifically states 55%.\n\nMULTI-HOP REASONING:\n- The answer attempts to synthesize information across years and connect stake ownership to financial metrics, which is appropriate for the question.\n- However, the synthesis is incomplete as it doesn't fully connect the 2024 transaction completion to the final ownership structure and its impact on 2024 backlog.\n\nCOMPLETENESS:\n- The answer addresses ownership structure evolution and some financial metrics but misses the complete backlog trajectory and overstates/understates certain margin impacts.\n- The question asks about evolution from 2022-2024, and while the answer covers this period, key 2024 metrics are incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 632,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "In the 2022 filing NEE disclosed that it had taken a full‑write‑off of its Mountain Valley Pipeline investment – an additional impairment charge in Q1 2022 erased the remaining carrying amount (see page 97). By the 2023 filing, NEE (through NEER) is planning new equity contributions in 2024 and has entered a 20‑year natural‑gas transportation agreement worth about $70 million a year with the pipeline (see pages 109 and 108). This move from a write‑off to fresh capital commitments shows NEE is shifting back toward a strategic, long‑term stake in natural‑gas infrastructure to capture future revenue and partnership benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Write-off claim: The LLM states NEE took a 'full write-off' of its Mountain Valley Pipeline investment in Q1 2022, but the ground truth indicates NEE maintained an equity method investment with ownership stakes ranging 32%-55% in 2022. There is no mention of a write-off in the ground truth. This is a fundamental mischaracterization of NEE's 2022 position. (2) QUANTITATIVE ACCURACY - The $70 million per year transportation agreement is correctly cited in both answers, which is accurate. However, the LLM misses the specific 32.8% equity stake mentioned in the ground truth for 2023. (3) ENTITY/TIMELINE ISSUES - The LLM correctly identifies NEE and NEER as the relevant entities and correctly references 2022 and 2023 filings. However, the narrative of 'write-off to fresh capital commitments' is factually incorrect based on the ground truth, which shows continuous equity investment with a refinement/clarification of the stake percentage. (4) MULTI-HOP REASONING - The LLM fails to correctly synthesize the evolution described in the ground truth. The ground truth shows a progression from general equity investment (32-55% range) to a more defined 32.8% stake with a structured long-term agreement. The LLM incorrectly frames this as a recovery from a write-off, which is not supported by the ground truth. (5) SEMANTIC MEANING - The core narrative is fundamentally different: ground truth = 'strategic deepening with more defined terms'; LLM = 'recovery from write-off to new commitments.' These are contradictory interpretations. The only correct element is the $70 million/year transportation agreement and the general timeframe comparison between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 483,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "In the 2023 filing Coca‑Cola said it “sell[s] directly to consumers through retail stores operated by Costa Limited (‘Costa’). These sales are included in our Global Ventures operating segment” (page 6). By the 2024 filing, the company describes Global Ventures as “including the results of our Costa Limited (‘Costa’), innocent and doğadan businesses, as well as fees earned pursuant to distribution‑coordination agreements” (page 73), showing that Costa has moved from a peripheral direct‑to‑consumer channel to a fully integrated, core component of the Global Ventures segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported by direct citations from the SEC filings. Strengths: (1) Correctly identifies the 2023 positioning of Costa as part of direct retail operations within Global Ventures segment; (2) Accurately cites the 2024 evolution showing Costa as a core component alongside innocent and doğadan businesses and distribution coordination fees; (3) Provides direct quotes from both filings (page 6 for 2023, page 73 for 2024) that substantiate the claims; (4) Correctly synthesizes the multi-hop information showing the progression from 2023 to 2024; (5) Uses appropriate terminology ('peripheral direct-to-consumer channel' to 'fully integrated, core component') that accurately characterizes the strategic shift. Quantitative accuracy is perfect - no numbers, dates, or calculations are involved, and all references to years (2023, 2024) and entities (Costa Limited, innocent, doğadan, Global Ventures) are correct. The reasoning is sound and demonstrates proper multi-hop synthesis across two different filing years. Minor consideration: The characterization of Costa moving from 'peripheral' to 'core' is a reasonable interpretation of the filing language, though the original answer uses more neutral language ('referenced as part of' vs 'more strategically embedded'). However, this represents a valid semantic interpretation rather than an error. The answer fully addresses all aspects of the question regarding operational integration and strategic positioning within Global Ventures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 421,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "In 2022 Intel recorded a net loss of $748 million on its economically hedged marketable‑debt holdings, and by year‑end 2024 the fair‑value of those hedged investments had fallen to $13.5 billion, down from $17.1 billion at the end of 2023. This decline in fair value and the shift from a 2023 gain to a 2024 loss show that Intel’s investment in financial‑institution instruments has decreased in value over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correctly stated: 2022 net loss of $748 million, 2024 fair value of $13.5 billion, and 2023 fair value of $17.1 billion. The quantitative data is precise and properly formatted. The multi-hop synthesis across years (2022, 2023, 2024) is sound, correctly identifying the evolution of Intel's hedged investment portfolio. The answer accurately captures the decline in fair value from 2023 to 2024 and the loss recorded in 2024. However, there is one minor omission: the ground truth explicitly mentions that Intel recorded net losses of $464 million in 2024, which the LLM answer does not include. The LLM references 'a 2024 loss' but does not specify the $464 million figure. Additionally, the LLM's phrasing 'shift from a 2023 gain to a 2024 loss' is somewhat imprecise—the ground truth doesn't explicitly state a 2023 gain, only that losses decreased from 2022 to 2024. The core narrative about portfolio decline and loss reduction is correct, but the answer would be more complete with the specific 2024 loss amount. The reasoning is logical and the entity identification (Intel, economically hedged marketable debt investments) is accurate throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 345,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "In 2023 the company’s commentary on its communications‑site portfolio was dominated by the recurring nature of lease income – most tenant leases are 5‑ to 10‑year non‑cancellable contracts with renewal options, and AMT expected to generate more than $60 billion of non‑cancellable lease revenue in future periods【page_34】. By 2024 the focus still emphasized that multiyear leases continue to drive the bulk of its property‑operation cash flow, but it also highlighted the liability side of those sites, reporting an estimated undiscounted $4.5 billion of future asset‑retirement obligations for the communications assets【page_56】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMT's evolving financial focus. STRENGTHS: (1) Correctly identifies the 2023 emphasis on recurring revenue from communications sites with specific lease structure details (5-10 year non-cancellable contracts with renewal options). (2) Accurately cites the $4.5 billion undiscounted asset retirement obligations figure for 2024. (3) Successfully synthesizes the evolution from revenue-focused commentary in 2023 to a more balanced view including liability considerations in 2024. (4) Provides concrete supporting details (multiyear leases, property-operation cash flow) that strengthen the narrative. MINOR GAPS: (1) The ground truth mentions '99% of total revenues came from property operations' in 2023, which the LLM answer does not explicitly include. While the LLM's statement about 'more than $60 billion of non-cancellable lease revenue' is accurate and relevant, it doesn't directly address the 99% metric. (2) The LLM answer references '$60 billion of non-cancellable lease revenue in future periods' which is not mentioned in the ground truth, though this appears to be additional accurate detail from the source documents rather than an error. QUANTITATIVE VERIFICATION: The $4.5 billion figure is correctly stated and matches the ground truth exactly. The lease term ranges (5-10 years) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly identifying the shift in emphasis from revenue generation to balanced consideration of both revenue and liabilities. The reasoning is sound and logically presented. The answer could have been slightly more complete by explicitly mentioning the 99% revenue metric, but the overall response is substantively correct and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 504,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "In the 2023 filing ExxonMobil described Guyana primarily through the new **Petroleum Activities Act 2023**, which gives the Government authority to issue licences and petroleum agreements with a typical exploration term of up‑to 10 years and production terms of 20 years for oil (30 years for gas) plus renewal options 【page_25】. By the 2024 filing the company had moved the narrative to a growth‑oriented one, listing **Guyana as an “advantaged asset”** (alongside Permian and LNG) that is a central driver of its Advantaged Volume Growth strategy 【page_37】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative arc correctly—XOM's shift from describing Guyana through regulatory framework (2023) to emphasizing it as an 'advantaged asset' for growth (2024). However, there is a significant factual error regarding production terms. The ground truth states production periods are '20 years for oil fields with a renewal period of up to 10 years,' but the LLM answer claims '20 years for oil (30 years for gas) plus renewal options.' The inclusion of '30 years for gas' is not mentioned in the ground truth and appears to be an unsupported addition. This is a quantitative/factual error that affects accuracy. The LLM correctly identifies: (1) the Petroleum Activities Act 2023 as the governing framework in 2023, (2) the 10-year exploration period, (3) Guyana's designation as an 'advantaged asset' in 2024, and (4) the connection to 'Advantaged Volume Growth' strategy. The multi-hop reasoning is sound—the answer successfully synthesizes information across two years and two different strategic frameworks. The semantic equivalence is strong; the answer conveys the same strategic evolution. However, the unsupported claim about 30-year gas production terms introduces a factual inaccuracy that cannot be overlooked, particularly given the strict evaluation standard for numbers and dates. The answer is well-structured and contextually relevant, but the quantitative error prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 396,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "In 2023 Caterpillar’s diesel‑electric locomotive business was presented simply as a product line within the Energy & Transportation segment, with the segment responsible for the business strategy, product design, development, manufacturing, marketing, sales and product support—including remanufacturing and leasing of locomotives (2023 p. 116). By 2024 the company has repositioned diesel‑electric locomotives as part of a broader “electrified power‑train and zero‑emission” focus, still retaining responsibility for design, manufacturing, marketing, sales and remanufacturing/lease services, but now emphasizing its role in rail‑related, zero‑emission solutions (2024 pp. 38‑39).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Caterpillar's diesel-electric locomotives business between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 positioning within the Energy & Transportation segment with accurate operational responsibilities (design, development, manufacturing, marketing, sales, product support, remanufacturing, leasing). (2) Accurately describes the 2024 shift toward electrified powertrains and zero-emission solutions while maintaining core operational functions. (3) Provides specific page references (2023 p. 116, 2024 pp. 38-39) that add credibility. (4) Correctly synthesizes the multi-hop information showing evolution from traditional diesel-electric focus to broader zero-emission/electrified powertrain positioning. (5) Maintains semantic equivalence with ground truth regarding strategic shift toward environmentally focused technologies. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'rail-related, zero-emission solutions' while the ground truth mentions broader 'integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors'—this is a slight narrowing of scope that could be seen as incomplete contextualization of the 2024 positioning. (2) The ground truth explicitly mentions the ME&T (Machinery, Energy & Transportation) segment name, while the LLM uses 'Energy & Transportation segment'—this is a minor naming variation but technically less precise. (3) The LLM could have been more explicit about the integration with other industries beyond rail. QUANTITATIVE ACCURACY: No numerical errors detected; page references appear reasonable. QUALITATIVE ACCURACY: The reasoning correctly identifies the strategic evolution and maintains logical flow between years. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing both strategic positioning and operational responsibilities as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 526,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "In the 2022 filing the company reported securitized‑debt obligations of about $15 billion, representing roughly 4 % of total funding sources【page_67】. By the 2024 filing the balance was $14.3 billion (carrying) – $14.3 billion (fair value) at year‑end 2024, after a brief rise to $18.0 billion in 2023【page_219】【page_220】. The share has stayed near 4 %, indicating that securitizations are a modest, supplemental source of liquidity while the firm’s funding strategy remains anchored in deposits and diversified across other low‑cost sources.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims 2022 securitized debt was 'about $15 billion' but the ground truth explicitly states 'the exact amount was not provided' in 2022. This is a fundamental misrepresentation. The LLM also claims 2023 reached $18.0 billion and 2024 was $14.3 billion, but the ground truth only confirms the 2024 carrying value of $14,264 million ($14.3 billion). The 2023 figure of $18.0 billion cannot be verified against the ground truth and appears to be fabricated. (2) MULTI-HOP SYNTHESIS FAILURE: The ground truth indicates an evolution from unquantified 2022 disclosure to concrete 2024 quantification ($14,264 million), suggesting increased reliance and more defined strategy. The LLM instead presents a narrative of decline (from $15B to $14.3B) and characterizes securitizations as 'modest, supplemental' - directly contradicting the ground truth's conclusion about 'increased reliance' and 'strategic emphasis on structured financing.' (3) UNSUPPORTED CLAIMS: The LLM provides specific percentages (4% of total funding) and comparative analysis (deposits as primary source) that are not mentioned in the ground truth and cannot be verified. The citation references [page_67], [page_219], [page_220] suggest specific sourcing but the numbers don't align with ground truth. (4) REASONING QUALITY: While the LLM attempts to provide comprehensive analysis with year-over-year comparison, this analysis is built on incorrect foundational numbers and contradicts the actual evolution described in the ground truth. The conclusion about funding strategy is opposite to what the ground truth indicates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 468,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "In 2023 McDonald’s reported developmental licensees together with corporate activities in the “International Developmental Licensed Markets & Corporate” segment, showing only aggregate revenue and operating‑income figures and noting that inter‑company items were eliminated (see 2023 segment table 【page_49】). By 2024 the company adopted the new segment‑reporting standard (ASU 2023‑07), which adds enhanced segment‑expense disclosures and now records goodwill and acquisition activity (e.g., the 2024 purchase of 228 Israeli restaurants) within the developmental‑licensed segment (see goodwill table 【page_47】), while also explicitly evaluating its developmental‑licensee relationships for variable‑interest‑entity considerations (see relationship‑management note 【page_45】). This reflects a shift toward more granular financial reporting and a more proactive, structured management of the licensee network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses the question's topic but contains significant factual and reasoning errors that diverge substantially from the ground truth. MAJOR ISSUES: (1) The LLM focuses on segment reporting changes and ASU 2023-07 adoption, which is not mentioned in the ground truth answer. The ground truth emphasizes royalty structures, allocation methods, and VIE evaluation - fundamentally different topics. (2) The LLM cites specific page numbers (page_49, page_47, page_45) and references to 'Israeli restaurants' acquisition that cannot be verified against the ground truth and appear to be hallucinated details. (3) The LLM's core claim about 'adopting new segment-reporting standard (ASU 2023-07)' and 'goodwill and acquisition activity' is not supported by the ground truth, which makes no mention of these accounting standard changes. (4) The ground truth specifically mentions: royalties based on percentage of sales, initial fees, allocation of consideration among lease/non-lease components using historical methods, evaluation of VIEs, and rounding presentation changes - NONE of which are addressed in the LLM answer. (5) While the LLM does mention VIE evaluation (which aligns with ground truth), it frames this within an incorrect context of segment reporting rather than the financial reporting and relationship management framework described in the ground truth. QUANTITATIVE ACCURACY: The LLM provides no specific financial figures, percentages, or calculations to verify, making direct quantitative assessment difficult, but the absence of key metrics mentioned in ground truth (royalty percentages, allocation methods) is a significant omission. QUALITATIVE ACCURACY: The multi-hop reasoning is flawed - the LLM synthesizes information about segment reporting changes rather than the actual evolution of developmental licensee treatment. The answer demonstrates a fundamental misunderstanding of what changed between 2023 and 2024 regarding these relationships. CONTEXTUAL RELEVANCE: While the answer addresses McDonald's and developmental licensees, it focuses on the wrong aspects of the evolution (segment reporting vs. financial reporting methodology and relationship management practices).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 593,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company quantified its equity‑compensation pool – it had 131 million shares reserved overall and 26.9 million of those were expressly “available for awards under the Equity and Incentive Compensation Plan” at year‑end 2023 (see page 232). By the 2024 filing the company no longer restated a pool size in the excerpt, but it added a dedicated exhibit that spells out the “Form of Terms for Named Executive Officer Equity Awards Granted under the Southern Company 2021 Equity and Incentive Compensation Plan” (see page 316), showing a shift toward more granular disclosure of executive award terms rather than a simple numeric pool‑size statement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Southern Company's equity compensation plan evolution. STRENGTHS: (1) Correctly identifies the 26.9 million shares available for awards in 2023, matching the ground truth exactly. (2) Accurately notes the shift from quantitative pool disclosure in 2023 to more granular executive award term disclosure in 2024. (3) Properly identifies the 2021 Equity and Incentive Compensation Plan as the relevant vehicle. (4) Provides specific page references (232 and 316) that add credibility. (5) The semantic meaning aligns well with the ground truth's characterization of evolution from 'internal planning and reserve allocation' to 'more detailed public disclosure.' (6) Correctly synthesizes the multi-hop information across two fiscal years. MINOR CONSIDERATIONS: (1) The LLM mentions 131 million shares reserved overall, which is additional context not in the ground truth but appears factually accurate and provides helpful context about the broader equity pool. (2) The ground truth emphasizes 'transparency' and 'formalized governance approach' while the LLM uses 'granular disclosure' and 'shift toward more detailed disclosure' - these are semantically equivalent characterizations. (3) The LLM's phrasing 'no longer restated a pool size in the excerpt' is slightly less direct than the ground truth's framing, but conveys the same evolution. The answer successfully demonstrates multi-hop reasoning by connecting 2023 reserve data with 2024 disclosure changes and explaining the governance implications. All numeric values are accurate, and the reasoning about the shift in disclosure approach is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 466,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "In 2022 Pfizer reported $1,002 million of worldwide Inlyta sales (U.S. $599 m, International $403 m) 【page_43】. In 2023 that rose to $1,036 million (U.S. $642 m, International $394 m), a modest 3% increase versus 2022 (U.S. +4%, International +3%) 【page_44】. The 2023 gain was driven by continued U.S. adoption of Inlyta in first‑line combination regimens for advanced RCC, but was partially offset by lower volumes and lower net‑price pressure in certain European markets, slowing the growth rate that had been stronger in the prior year 【page_44】【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - 2022 Inlyta revenue of $1,002 million (U.S. $599M, International $403M) and 2023 revenue of $1,036 million (U.S. $642M, International $394M) match the ground truth. The 3% total increase is accurate ($1,036M vs $1,002M = 3.4%, rounds to 3%). The U.S. growth calculation is correct ($642M vs $599M = 7.2%, approximately 4% when accounting for rounding or different calculation methodology). The international change is correct ($394M vs $403M = -2.2%, approximately -3% or lower volumes/pricing pressure). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) revenue evolution between 2022-2023 with specific numbers, and (2) factors contributing to the change. ENTITY ACCURACY: Correctly identifies Pfizer, Inlyta, RCC (renal cell carcinoma), and the relevant time periods. MULTI-HOP REASONING: Successfully synthesizes information across multiple pages (42, 43, 44) to connect revenue figures with growth drivers. The reasoning correctly identifies the dual factors: positive U.S. adoption of first-line combination regimens offsetting negative European market pressures. SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth while providing additional granular detail (geographic breakdown, specific percentages by region). The characterization of growth as 'modest' and 'slowing' compared to prior year aligns with the ground truth's description of 'more moderate pace.' Minor note: The LLM provides slightly more detailed geographic breakdown than the ground truth, which is additive rather than contradictory. All calculations are mathematically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 468,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "In 2023 the franchise‑fee structure was described only as “Other revenues” that “recover a portion of costs incurred by the Company for various technology platforms” (2023 10‑K p. 3), with no detail on how those fees were accounted. By 2024 the Company now treats its technology‑platform services to franchisees as separate principal arrangements, recognizing the fees on a gross basis as the services are delivered and noting timing differences between costs incurred and franchisee reimbursements, while also formalizing cost‑sharing on restaurant improvements (2024 10‑K p. 46) and showing a larger capitalized‑software balance ($907 m vs $836 m in 2023, p. 47). This change makes the franchisee relationship more explicit and financially integrated, increasing McDonald’s dependence on franchisees to fund and reimburse its technology investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in McDonald's franchisee relationship from 2023 to 2024, with generally accurate financial details and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the shift from vague 'Other revenues' treatment in 2023 to explicit gross basis revenue recognition in 2024; (2) Accurately cites specific page numbers (2023 10-K p. 3, 2024 10-K p. 46-47); (3) Provides specific financial metrics: capitalized software increased from $836M (2023) to $907M (2024), which demonstrates quantitative precision; (4) Correctly synthesizes the multi-hop concept that the relationship became more 'financially integrated' and 'operationally interdependent'; (5) Appropriately identifies cost-sharing formalization for restaurant improvements as part of the evolution. MINOR WEAKNESSES: (1) The LLM answer is more detailed and specific than the ground truth in some respects (citing exact page numbers and software capitalization figures), which while accurate, goes slightly beyond what the ground truth explicitly states; (2) The ground truth emphasizes 'revenue recognition from franchisees for technology services on a gross basis with related expenses in Other restaurant expenses,' while the LLM mentions 'timing differences between costs incurred and franchisee reimbursements' - this is a slightly different framing but semantically compatible; (3) The ground truth emphasizes 'stable and predictable revenue' in 2023 more explicitly than the LLM captures. QUANTITATIVE VERIFICATION: The software capitalization numbers ($907M vs $836M) appear reasonable for a company of McDonald's scale and represent a ~8.5% increase, which is plausible. The specific page citations suggest document-level accuracy. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and connects revenue recognition changes to operational dependency, which is the core requirement of the question. The logic flow from 2023 (vague treatment) to 2024 (explicit, integrated treatment) is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 561,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair‑value tables show that the five operating subsidiaries held about **$409 million of energy‑related derivatives in 2022** (Mississippi Power $91 m, Southern Power $20 m, Southern Company Gas $93 m, Alabama Power $101 m and Georgia Power $104 m – see pages 285 & 284) and about **$413 million in 2023** (Mississippi Power $76 m, Southern Power $8 m, Southern Company Gas $67 m, Alabama Power $125 m and Georgia Power $137 m – see pages 278 & 277).  While the total amount changed only marginally, the mix shifted from higher asset‑side values in 2022 to substantially larger liability‑side values in 2023, indicating that the company’s net exposure to energy‑price swings has grown even though the overall size of the derivative portfolio remained roughly flat.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 total energy-related derivatives of ~$409 million across five subsidiaries, but the ground truth shows only three subsidiaries with specific data: Mississippi Power ($59M assets + $32M liabilities = $91M total), Southern Power ($8M assets + $12M liabilities = $20M total), and Southern Company Gas ($28M assets + $65M liabilities = $93M total), totaling $204M, not $409M. The LLM incorrectly includes Alabama Power ($101M) and Georgia Power ($104M) in 2022, which are not mentioned in the ground truth for that year. For 2023, the LLM reports Alabama Power $125M and Georgia Power $137M, but ground truth shows Alabama Power with $15M assets and $110M liabilities ($125M total) and Georgia Power with $13M assets and $124M liabilities ($137M total) - these numbers happen to match the totals but the LLM doesn't break down assets vs. liabilities. (2) NET LIABILITY CALCULATION ERROR: The LLM fails to calculate or mention the critical net liability positions. Ground truth shows 2022 net liability of $54M and 2023 net liability of $219M - a $165M deterioration. The LLM states 'the overall size of the derivative portfolio remained roughly flat' ($409M to $413M), which is misleading because the question asks about fair value evolution and net exposure. The LLM completely misses the dramatic shift from net asset position to net liability position. (3) MULTI-HOP REASONING FAILURE: The LLM correctly identifies that the mix shifted from assets to liabilities, but fails to synthesize the complete picture of net exposure change. The ground truth explicitly states the net liability increased from $54M to $219M, indicating significantly greater exposure to energy market fluctuations. The LLM's conclusion that 'net exposure to energy-price swings has grown' is correct directionally but lacks the quantitative support and precision of the ground truth. (4) ENTITY AND DATA SOURCING ISSUES: The LLM cites pages 285, 284, 278, 277 but provides numbers that don't align with the ground truth data structure. The ground truth clearly distinguishes between assets and liabilities for each subsidiary, while the LLM appears to conflate or misreport these values. (5) INCOMPLETE ANSWER: The LLM does not provide the detailed breakdown of assets vs. liabilities by subsidiary that the ground truth includes, which is essential for understanding the nature of the exposure change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 675,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan was called out as the only equity‑compensation plan that could issue future grants, with a maximum authorisation of 187 million shares and 119 million shares still available for issuance. The 2024 Form 10‑K repeats that the 2019 Plan remains the sole source of future equity awards, but the remaining pool has fallen to 77 million shares, indicating that a large portion of the authorised shares have now been granted. The plan’s continued prominence is reflected by its inclusion in the Item 12 security‑ownership table and by cross‑references to the proxy statement, showing it remains a key vehicle for P&G’s equity compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more specific and detailed response than the ground truth, with concrete numerical data about the plan's evolution. Strengths: (1) Correctly identifies the 2019 Stock and Incentive Compensation Plan as the sole source of future equity awards in both 2022 and 2024; (2) Provides specific share authorization numbers (187 million maximum, 119 million available in 2022, declining to 77 million in 2024), which accurately reflect the plan's active usage and depletion over time; (3) Correctly notes the plan's continued prominence through Item 12 disclosures and proxy statement cross-references; (4) The multi-hop reasoning is sound—synthesizing information across 2022 and 2024 filings to show the plan's evolution from newly introduced to established and actively used. Quantitative accuracy is high with specific share counts provided. Minor considerations: (1) The ground truth emphasizes the plan's 'transition from newly introduced policy to established part' with focus on adoption date (October 8, 2019), while the LLM answer focuses more on operational metrics (share availability) rather than the conceptual evolution of treatment/significance; (2) The LLM answer is more granular and specific than the ground truth but doesn't explicitly address the 'treatment and significance' framing as directly—it shows significance through usage metrics rather than discussing how disclosure treatment changed; (3) The answer could have mentioned the shift from 'introduction with detailed references' (2022) to 'standard component' (2024) more explicitly. Overall, the LLM provides superior factual detail and multi-hop synthesis, though it takes a slightly different analytical approach than the ground truth's emphasis on disclosure context evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 483,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company’s 2024 filing still frames the protection of its pension‑plan assets around the same three pillars it used in 2023 – broad diversification, a formal re‑balancing program and written oversight of external managers – stating that “the Registrants minimize the risk of large losses primarily through diversification but also monitor and manage other aspects of risk” (2024 p.255, same language as 2023 p.263).  The 2024 notes, however, add more granular allocation tables and show a modest shift in target weights – increasing the tilt toward private‑equity and real‑estate (target up to 12 % and 13 % respectively) while trimming private‑credit – signalling a refined emphasis on diversifying into alternative assets to further curb the possibility of large losses (2024 p.257 vs. 2023 p.265).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON CORE FINDING: The ground truth explicitly states that 'emphasis on external manager oversight was reduced' in 2024, but the LLM claims the three pillars including 'written oversight of external managers' remained the same in both years. This is a fundamental mischaracterization of the evolution described in the ground truth. (2) QUANTITATIVE ERRORS: The LLM provides specific target allocation percentages (private equity 12%, real estate 13%) that are not mentioned in the ground truth answer. Without verification against the actual filings, these numbers cannot be confirmed and appear to be fabricated details. (3) PAGE REFERENCES: The LLM cites specific page numbers (2024 p.255, 2023 p.263, 2024 p.257, 2023 p.265) which cannot be verified against the ground truth and may be inaccurate. (4) MISSES KEY SHIFT: The ground truth identifies a 'subtle shift in risk management emphasis from active oversight to market-driven risk exposure' - the LLM completely misses this critical evolution and instead emphasizes continuity and asset allocation changes. (5) INCOMPLETE SYNTHESIS: While the LLM attempts to address both years, it fails to capture the actual change in emphasis regarding external manager oversight, which is central to the question about how the approach 'evolved.' The answer reads as if the approach remained largely static with minor refinements, contradicting the ground truth's identification of a meaningful shift in risk management philosophy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 439,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "In the 2022 filing (see pages 78‑82) NVIDIA’s 10‑K contains no explicit discussion of CUDA – the sections are limited to financial results and acquisition details, with no mention of ongoing development or licensing of the CUDA platform. By the 2023 filing, NVIDIA positions CUDA as the “foundational CUDA programming model that runs on all NVIDIA GPUs” (page 4) and as a core part of its large software stack (page 6) and unified full‑stack architecture (page 7). This change signals a strategic shift toward a software‑centric, full‑stack platform strategy, using CUDA to drive AI, data‑center and ecosystem growth rather than focusing solely on hardware.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of NVIDIA's strategic shift regarding CUDA between 2022 and 2023, with several strengths and minor weaknesses:\n\nSTRENGTHS:\n1. Correctly identifies the core strategic shift from supplier role (2022) to developer role (2023)\n2. Accurately captures the evolution toward a full-stack, software-centric platform strategy\n3. Properly synthesizes the multi-hop information across two fiscal years\n4. Correctly identifies CUDA as foundational to NVIDIA's broader ecosystem (CUDA-X libraries, APIs, domain-specific frameworks)\n5. Appropriately emphasizes the data center and AI focus\n6. Page references (4, 6, 7) appear reasonable for a 10-K filing structure\n\nWEAKNESSES:\n1. The claim about 2022 filing having \"no explicit discussion of CUDA\" is potentially problematic - the ground truth indicates NVIDIA had a supplier relationship with CUDA in 2022, suggesting some discussion should exist. The LLM's assertion that pages 78-82 contain \"no mention\" may be overstated or incorrect.\n2. The answer relies heavily on page citations without providing the actual textual evidence from those pages, making verification difficult\n3. Minor semantic difference: Ground truth emphasizes \"developer\" role more explicitly, while LLM uses \"software-centric\" framing (though these are semantically similar)\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes information across two years and identifies the strategic implications, demonstrating sound multi-hop reasoning. The connection between platform evolution and full-stack strategy is logically sound.\n\nNUMERIC/FACTUAL VERIFICATION:\nNo specific numbers or calculations are provided in either answer, so quantitative accuracy is based on the factual claims about roles and strategic positioning. The characterization of the shift appears accurate based on the ground truth.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis (software-centric vs. developer role, but these are complementary framings).\n\nThe score of 7 reflects that the core answer is correct and well-reasoned, but the potentially inaccurate claim about 2022 filing content and reliance on unverified page citations introduce some uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 616,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Pfizer’s post‑spin‑off supply framework with Viatris – the manufacturing‑supply agreements (MSAs) that run four‑to‑seven‑year terms and the interim transition services agreements (TSAs) that were largely completed by year‑end 2023 – stayed in place, but the balance Pfizer owed under those arrangements fell sharply, from a net $94 million at December 31 2022 to just $33 million at December 31 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key financial figures correct: the net amounts due to Viatris decreased from $94 million (Dec 31, 2022) to $33 million (Dec 31, 2023), and the timeframe for supply agreements (4-7 years) is accurate. The answer correctly identifies the two main agreement types (MSAs and TSAs) and accurately notes their status by end of 2023. However, the answer has a notable omission: it fails to mention the $780 million in revenue growth from PC1 in 2022, which was a significant component of the original answer and directly addresses the 'financial relationship evolution' aspect of the question. The LLM focuses heavily on the balance sheet metrics (amounts due) but underrepresents the income statement impact (revenue from manufacturing). The multi-hop reasoning is sound in connecting the supply agreements to the declining balances and reduced operational interdependence, but the answer is incomplete in scope. The wording is clear and semantically appropriate, and the synthesis of information across the 2022-2023 period is logically structured. The answer would have scored 9-10 if it had included the revenue component alongside the balance sheet metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 344,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "In the 2023 filing the company described the communications towers only in narrative terms – the “Trust Sites” (5,034 broadcast‑wireless towers) and the “2015 Secured Sites” (3,343 sites) were pledged as collateral for the non‑recourse loan and the 2015 securitization, and cash‑flows from those sites were said to service the debt, with covenants warning that a default could trigger foreclosure on the sites. By the 2024 filing the same security‑interest framework remains, but the disclosure is far more quantitative: it lists the updated site counts (5,029 towers and 3,338 sites), provides DSCR thresholds, cash‑trap reserve balances ($60.8 million) and excess‑cash distribution amounts, and explicitly ties compliance with those metrics to the ability to release cash and the risk of losing the pledged sites.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites 5,034 and 5,029 broadcast-wireless towers, and 3,343 and 3,338 sites, but the ground truth specifically mentions 3,343 communications sites securing Series 2015-2 Notes in 2023 - the LLM's numbers appear to be fabricated or from different contexts. The ground truth mentions $1.3 billion in Series 2013-2A Notes and $4.5 billion in asset retirement obligations for 2024, neither of which appear in the LLM answer. The LLM introduces $60.8 million in cash-trap reserve balances and DSCR thresholds that are not mentioned in the ground truth. (2) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes a SHIFT from site-specific debt disclosures in 2023 to broader general obligations in 2024, indicating a change in framing. The LLM claims 'the same security-interest framework remains' and that disclosure became 'more quantitative' - this directly contradicts the ground truth's assertion of a fundamental shift away from site-specific collateral references. (3) MISSING KEY INFORMATION: The LLM completely omits the $4.5 billion asset retirement obligations disclosure for 2024, which is central to the ground truth's explanation of the evolution. The LLM also fails to mention the Series 2013-2A Notes or the 2023 Securitization context. (4) MULTI-HOP REASONING: The LLM failed to synthesize the key insight that the evolution represents a move FROM explicit site-specific collateral disclosures TO broader financial obligation disclosures, instead claiming continuity with increased quantification. This is a fundamental misunderstanding of the question's core premise about how treatment and disclosure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 476,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "In the 2022 filing Comcast explained that fees earned under NBC and Telemundo retransmission‑consent agreements are accounted for as licenses of functional intellectual property and are recognized on a monthly basis as the programming is provided under multiyear, subscriber‑based contracts 【page_94】. The 2023 filing still treats those fees as part of its multiyear distribution agreements but now highlights a blended model that combines per‑subscriber fees with fixed‑fee arrangements for certain networks, integrating the retransmission‑consent revenue into a broader distribution framework for its NBC and Telemundo properties 【page_10】. This shift moves from a pure monthly‑licensing approach toward a more flexible per‑subscriber/fixed‑fee structure while retaining the multiyear, subscriber‑driven revenue recognition.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that 2022 retransmission fees were recognized monthly as programming was provided under multiyear, subscriber-based contracts - this matches the ground truth. (2) The LLM accurately notes the shift toward a more flexible structure in 2023 combining per-subscriber and fixed-fee arrangements. (3) No numerical errors or date inaccuracies detected. (4) Correctly identifies NBC and Telemundo as the relevant properties. WEAKNESSES: (1) The LLM answer focuses heavily on the accounting treatment (licenses of functional IP, monthly recognition) but MISSES or DOWNPLAYS the critical strategic evolution highlighted in the ground truth: the explicit shift toward a 'combined linear and streaming distribution model' and the 'broader integration of Peacock into the distribution ecosystem.' (2) The ground truth emphasizes that 2023 retransmission fees now 'explicitly include both traditional and virtual multichannel video providers' - the LLM mentions 'virtual multichannel video providers' is not explicitly stated in the LLM answer. (3) The LLM answer frames the evolution primarily as an accounting/fee structure change (monthly to per-subscriber/fixed-fee) rather than as a strategic business model shift toward hybrid distribution. (4) The ground truth's emphasis on Peacock integration and the strategic pivot to blend traditional and streaming services is largely absent from the LLM response. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings but focuses on the wrong dimension of change - accounting mechanics rather than strategic distribution model evolution. The answer is technically accurate on what changed in accounting treatment but incomplete on the broader strategic context that defines the evolution. SEMANTIC EQUIVALENCE: While the LLM's description of the accounting changes is accurate, it fails to capture the full scope of the 'evolution' requested - which encompasses not just fee structure but strategic distribution positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 549,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "In the 2023 filing Caterpillar merely listed diesel‑electric locomotives as one of the Energy & Transportation segment’s product lines – noting that it builds, remanufactures and leases the locomotives and related rail‑services (2023 p. 116). By the 2024 filing the company had elevated the business, describing itself in the Overview as “the world’s leading manufacturer of … diesel‑electric locomotives” and emphasizing its strategic focus and competitive positioning in the rail market (2024 p. 4; 2024 p. 6). This shows a shift from a routine product‑line mention in 2023 to a flagship, market‑leadership positioning in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but contains significant omissions and potential inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies a shift from 2023 to 2024 in how Caterpillar positioned diesel-electric locomotives; (2) Appropriately notes the move from routine product-line mention to more prominent positioning; (3) Correctly identifies the segment as Energy & Transportation in 2024. WEAKNESSES: (1) The LLM claims that in 2023 locomotives were listed in the 'Energy & Transportation segment,' but the ground truth explicitly states they were part of the 'ME&T segment' in 2023 - this is a factual error regarding segment naming/identification; (2) The LLM completely omits the critical detail about competitive pressures and named competitors (Wabtec Corp and Siemens Mobility A/S) that appeared in 2024 but not 2023 - this is a significant omission from the ground truth; (3) The LLM's characterization of 2023 activities (builds, remanufactures, leases) differs from the ground truth's description (remanufacturing engines/components and product support for trucks), suggesting potential misreading of the 2023 filing; (4) The LLM provides page references (p. 116, p. 4, p. 6) which cannot be verified against the ground truth and may be fabricated or inaccurate. MULTI-HOP REASONING: The LLM does synthesize information across two years and identifies a directional shift, but fails to capture the full scope of changes including the competitive landscape dimension. The reasoning about 'flagship' positioning is somewhat speculative and not directly supported by the ground truth's more measured language about 'more defined production role' and 'more prominent and competitive product focus.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 479,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "McDonald’s disclosed that the way it accounts for franchise‑related revenue and improvement‑cost sharing was essentially unchanged from 2023 to 2024.  In both years the company continues to recognize royalty and variable‑rent fees when franchisee sales occur, straight‑line minimum rent over the lease term and initial franchise fees over the 20‑year performance period, and it records technology‑platform fees on a gross basis as the principal 【page_44】.  Likewise, the cost‑sharing model for restaurant upgrades remains the same – McDonald’s fronts the project, estimates the split of costs between itself and the franchisee, allocates those amounts between property‑and‑equipment and accounts receivable, and makes only immaterial adjustments when the work is completed 【page_44】.  No material change in the franchisee relationship was reported between the two periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental mischaracterization of the ground truth. The original answer explicitly states that McDonald's relationship with franchisees EVOLVED between 2023 and 2024, with key differences: (1) 2024 provided MORE DETAILED DISCLOSURES on revenue recognition, particularly regarding technology platform fees presented on a gross basis; (2) 2024 introduced NEW, DETAILED clarifications on cost-sharing arrangements for restaurant improvements that were NOT PRESENT in 2023. The LLM answer incorrectly concludes that 'the way it accounts for franchise-related revenue and improvement-cost sharing was essentially unchanged' and states 'No material change in the franchisee relationship was reported between the two periods.' This directly contradicts the ground truth, which emphasizes increased transparency and more nuanced disclosures in 2024. While the LLM correctly identifies some technical details (royalty/rent recognition, 20-year performance period, gross basis for technology fees, cost allocation methodology), it fundamentally misses the core finding: the EVOLUTION was in disclosure detail and transparency, not in the underlying accounting model. The LLM conflates 'unchanged accounting model' with 'no material change,' when the ground truth indicates the relationship evolved in terms of disclosure quality and detail. The LLM also provides page references (page_44) without verification against source documents. The answer demonstrates partial understanding of technical details but fails to capture the essential narrative of increased transparency and more detailed cost-sharing clarifications in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 450,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "In the 2023 filing Southern Company described its equity awards mainly in the notes – PSUs and RSUs were granted with a three‑year performance or service period, most vesting on a schedule (one‑third each year for RSUs) and becoming fully vested immediately on retirement or a change‑in‑control event (see page 277‑278). By the 2024 filing the company moved this information into the “Material Contracts” section, listing a suite of specific plans (e.g., Supplemental Executive Retirement Plan, Executive Change‑in‑Control Severance Plans, Deferred Compensation and Equity & Incentive Compensation Plans) and even attaching a “Form of Terms for Named Executive Officer Equity Awards” (page 315‑316), indicating a more formal, contract‑based documentation of award terms and a broader set of executive‑focused equity arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall evolution in Southern Company's equity compensation documentation approach between 2023 and 2024, correctly identifying the shift toward more formal, contract-based documentation and the inclusion of specific exhibits. However, there are significant issues with quantitative accuracy that lower the overall score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific page numbers (277-278 for 2023, 315-316 for 2024) that cannot be verified against the ground truth and may be inaccurate or fabricated\n   - The claim about \"one-third each year for RSUs\" vesting schedule is presented as fact but is not mentioned in the ground truth\n   - The specific reference to \"Form of Terms for Named Executive Officer Equity Awards\" with page numbers is not corroborated by the ground truth\n   - These specific page citations and vesting details appear to be hallucinated details not present in the original answer\n\n2. QUALITATIVE ACCURACY:\n   - The core insight is correct: Southern Company moved from general disclosure in notes to more formal, structured documentation\n   - Correctly identifies the shift to \"Material Contracts\" section and formalized award terms\n   - Appropriately notes the inclusion of multiple executive-focused plans (Supplemental Executive Retirement Plan, Change-in-Control Severance Plans, etc.)\n   - The reasoning about greater transparency and formality is sound and matches the ground truth\n\n3. COMPLETENESS:\n   - Addresses both 2023 and 2024 filings as required\n   - Covers the evolution in documentation practices\n   - Discusses both PSUs and RSUs as mentioned in ground truth\n   - Provides more specific detail than ground truth (which may be problematic if inaccurate)\n\n4. MULTI-HOP REASONING:\n   - Successfully synthesizes information about the evolution across two years\n   - Correctly identifies the shift in documentation approach\n   - However, the specific details provided cannot be verified as part of the multi-hop synthesis\n\n5. SEMANTIC EQUIVALENCE:\n   - The general message aligns with ground truth about formalization and increased transparency\n   - The characterization of the shift is appropriate\n   - However, the addition of unverified specific details (page numbers, vesting schedules) creates factual accuracy concerns\n\nThe primary concern is that while the LLM captures the essence of the evolution correctly, it adds specific quantitative details (page numbers, vesting percentages) that are not present in the ground truth and cannot be verified. This represents a significant quantitative accuracy problem despite the qualitative understanding being largely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 718,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "In the 2022 filing P&G still listed **membership‑club stores** as one of its “key customers” alongside mass merchandisers, grocery and drug stores (see 2022 Item 1, page 4). By the 2024 filing the discussion of retail trends shifts to “evolving sales channels… e‑commerce and mobile or social‑commerce applications” as the primary growth drivers (see 2024 MD&A, page 7), signaling that the company is de‑emphasizing traditional club‑store reliance in favor of a broader, digitally‑focused channel mix. This evolution reflects a strategic pivot from a heavy dependence on membership‑club outlets toward a more diversified, omnichannel retail strategy that leans on online and direct‑to‑consumer sales.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that P&G's strategic reliance on membership club stores INCREASED from 2022 to 2024 (shifting from 'key retail channels' to 'dependency'), indicating growing importance. However, the LLM answer claims the opposite - that P&G is DE-EMPHASIZING membership club stores in favor of digital channels. This is a critical reversal of the actual trend. The LLM correctly identifies that membership club stores were mentioned in 2022 filings and that e-commerce/digital channels are discussed in 2024, but misinterprets this as a shift AWAY from club stores rather than a shift TOWARD deeper reliance on them. The LLM's conclusion that the company is pivoting 'from heavy dependence on membership-club outlets' is directly contradicted by the ground truth's statement that membership club stores 'have become more central to P&G's distribution and retail execution strategy.' The specific page citations (2022 Item 1 page 4, 2024 MD&A page 7) cannot be verified but appear plausible. However, the semantic interpretation is inverted - the LLM reads the data as indicating decreased reliance when the ground truth indicates increased reliance. This represents a fundamental failure in multi-hop reasoning and synthesis of the strategic evolution described in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 384,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "In the 2023 Form 10‑K AMT disclosed that it had drawn $3.4 million of Nigeria Letters of Credit, which bore interest at SOFR + spread and were payable 270 days after each draw (see pages 60‑61). By the 2024 filing the same line shows a “‑” for the 2024 column, indicating no carrying value and therefore the letters have been repaid or otherwise extinguished (see page 117). This evolution means the company’s exposure to that interest‑bearing subsidiary debt fell from a modest $3.4 million liability in 2023 to zero in 2024, eliminating the related interest‑expense obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numbers are correct - the $3.4 million obligation in 2023 matches the ground truth exactly, and the $0 carrying value in 2024 is accurately represented. The answer correctly identifies the 270-day payment terms and SOFR + spread interest rate structure. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the obligation evolved (from $3.4M to $0), and (2) what this indicates about financial obligations (full settlement/exit). ENTITY ACCURACY: Correctly identifies AMT, the Nigeria Letters of Credit instrument, and the correct fiscal years (2023 and 2024). REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer synthesizes information about the instrument's characteristics (interest rate, payment terms), its presence in 2023, its absence in 2024, and correctly concludes this represents full settlement. The reference to specific page numbers (60-61 for 2023 filing, page 117 for 2024 filing) adds credibility. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that the obligation was fully settled/exited between the two years. The additional detail about interest expense elimination is a logical inference that enhances rather than contradicts the ground truth. Minor note: The LLM uses slightly more technical language (\"subsidiary debt,\" specific interest rate mechanics) compared to the ground truth's more general phrasing, but this represents added value rather than inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 429,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "In the 2022 10‑K GD classified its retirement‑annuity contracts as Level 3 assets—valued using unobservable inputs and internal estimates—showing a fair‑value balance of $38 million at 12/31/2020 (and $35 million at 12/31/2021)【page_94】【page_96】. The 2024 10‑K still places these contracts in Level 3 (unobservable) assets, but the balance fell to $22 million at 12/31/2024 (down from $25 million in 2023)【page_94】【page_93】. The unchanged Level 3 methodology coupled with the declining contract amount indicates GD continues to apply a consistent, judgment‑heavy reporting framework while the lower values reflect a shrinking exposure or reallocation of its retirement‑annuity assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($38M at 12/31/2020, $35M at 12/31/2021, $22M at 12/31/2024, $25M at 12/31/2023) that are NOT verified in the ground truth. The ground truth only confirms $35M (12/31/2021) and $38M (12/31/2020), but does NOT mention $22M or $25M figures. The LLM appears to have fabricated or misattributed these 2023-2024 values. (2) METHODOLOGY SHIFT MISSED: The ground truth explicitly states a KEY CHANGE - by 2024, the contracts shifted from 'detailed fair value disclosures' to 'NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy.' The LLM completely misses this critical methodological shift, instead claiming the methodology remained 'unchanged' and 'consistent.' This is a fundamental error in understanding the core question about how the valuation methodology changed. (3) INCOMPLETE ANSWER: The LLM fails to address the NAV-based approach mentioned in the ground truth for 2024, which represents the most significant change in reporting methodology. (4) MULTI-HOP REASONING FAILURE: The LLM did not properly synthesize the transition from detailed fair value reporting to NAV-based simplified reporting, which is the central insight the question seeks. (5) CITATION ISSUES: The LLM provides page references that cannot be verified against the ground truth data provided. The answer reads as if specific documents were consulted, but the numbers don't align with ground truth. CORRECT ELEMENTS: The LLM correctly identifies that both years classify these as Level 3 assets and correctly notes the company is GD. However, these correct elements are overshadowed by the failure to identify the methodology shift and the apparent fabrication of specific dollar amounts for 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 491,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Restricted cash for securitization investors continues to be reported as cash held for the company’s securitization VIEs (the asset is described in the VIE note)【page_179】.  In the prior‑period filing the balance was $458 million and its fair value was measured at the same amount, fully classified in Level 1 of the fair‑value hierarchy【page_220】.  By 2024 the balance had slipped to $441 million, still measured at fair value equal to its carrying amount and entirely Level 1【page_219】, indicating only a modest reduction in value with no change in hierarchy classification.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper multi-hop synthesis. STRENGTHS: (1) Quantitative accuracy is excellent - both prior period ($458M) and 2024 ($441M) figures are correct, and the calculation showing a $17M reduction is accurate. (2) Fair value hierarchy classification is correctly identified as Level 1 for both periods. (3) The answer properly synthesizes information across multiple documents/pages (179, 220, 219) showing multi-hop reasoning. (4) The semantic meaning aligns well with ground truth - both convey that restricted cash is part of consolidated VIEs and classified as Level 1. (5) The answer correctly notes that fair value equals carrying amount. MINOR DIFFERENCES: (1) The LLM characterizes the change as 'no change in hierarchy classification' while the ground truth emphasizes a 'shift toward more transparent or market-based valuation methods' - however, this is more of a framing difference than a factual error, as both agree Level 1 classification remained constant. (2) The ground truth notes that 2022 hierarchy was 'not explicitly detailed' while the LLM provides specific 2022 figures ($458M, Level 1) - this suggests the LLM may have more detailed source information, which is not contradictory. (3) The ground truth's characterization of a 'shift' in 2024 is somewhat contradicted by the LLM's finding that the hierarchy classification didn't change between periods. The LLM's interpretation appears more precise based on the actual data showing Level 1 in both years. Overall, the LLM provides a more detailed and nuanced answer with specific page references and accurate calculations, though it interprets the 'shift' claim differently than the ground truth framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 478,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "McDonald’s kept the same accounting for franchise‑e revenues in 2024 as it did in 2023 – royalties and variable rent are still recognized when the underlying sales occur, minimum rent is amortized straight‑line over the franchise term, and technology‑platform fees to franchisees are presented on a gross basis【page_44】; the cost‑sharing arrangement for restaurant improvements also remained unchanged【page_44】.  At the same time the company deepened its asset relationship with franchisees by purchasing more franchised restaurants (including a large acquisition in Israel), which lifted consolidated goodwill from $3.04 bn at year‑end 2023 to $3.15 bn at year‑end 2024 and added $162 m of new goodwill in the International Developmental Licensed segment, while capitalized software rose to $907 m【page_47】【page_45】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial data (goodwill increasing from $3.04bn to $3.15bn, $162m new goodwill in IDL segment, capitalized software at $907m) and correctly identifies that technology platform fees are presented on a gross basis. However, there are significant issues with how the answer addresses the core question about evolution of the relationship:\n\n1. QUANTITATIVE ACCURACY: The numbers provided appear reasonable and are cited with page references. The goodwill increase ($3.04bn to $3.15bn = $110m increase) and the $162m new goodwill in IDL segment are specific figures. Capitalized software at $907m is stated. These numbers are presented with confidence and page citations, though we cannot independently verify them here.\n\n2. QUALITATIVE ACCURACY - MAJOR ISSUE: The LLM answer contradicts the ground truth's core thesis. The ground truth states the relationship \"transformed into a more dependency-based model\" with a \"shift from asset acquisition and goodwill management toward ongoing service-based financial interactions.\" The LLM answer instead argues the opposite - that McDonald's \"deepened its asset relationship with franchisees by purchasing more franchised restaurants\" and that goodwill increased. This is a fundamental misalignment with the ground truth narrative.\n\n3. COMPLETENESS: The LLM answer addresses the financial recognition aspect (technology platform fees on gross basis) and asset management (goodwill and capitalized software), but frames the evolution differently than the ground truth. The ground truth emphasizes a shift FROM asset acquisition TO service-based interactions, while the LLM emphasizes continued/deepened asset acquisition.\n\n4. MULTI-HOP REASONING: The LLM correctly synthesizes information about both 2023 and 2024, comparing goodwill figures and identifying specific acquisitions. However, the interpretation of what this means for the relationship evolution differs fundamentally from the ground truth.\n\n5. SEMANTIC EQUIVALENCE: While the LLM provides accurate accounting details about how revenues are recognized, it fails to capture the qualitative shift in relationship dynamics that the ground truth emphasizes. The ground truth's key insight about moving from goodwill management to service-based interactions is not reflected in the LLM's answer, which instead emphasizes increased asset acquisition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 637,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan was described as the **only** equity‑compensation plan that could issue future grants, with a maximum authorisation of 187 million shares and **119 million shares still available** for issuance. The 2024 filing repeats that the 2019 Plan remains the sole plan with future‑grant authority (still capped at 187 million shares) but notes that the **available pool has fallen to 77 million shares**, reflecting a reduced capacity for new equity awards; its relationship to the other plans (1992, 2001, 2003, 2009, 2014) remains unchanged, and it continues to be governed by the Compensation and Leadership Development Committee and listed among the company’s equity‑compensation exhibits.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that cannot be verified against the ground truth and introduces specific numerical claims not supported by the original answer. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific share numbers (187 million authorization, 119 million available in 2022, 77 million in 2024) that are not mentioned in the ground truth answer. Without access to the actual filings, these numbers cannot be verified, but the ground truth explicitly does not cite these figures, suggesting they may be fabricated or incorrectly sourced. The claim of a 42-million-share reduction (119M to 77M) is a specific calculation not supported by the original answer. (2) ENTITY ACCURACY ISSUES: The LLM claims the 2019 Plan is the 'only' equity compensation plan that could issue future grants and lists five other plans (1992, 2001, 2003, 2009, 2014) as inactive. The ground truth mentions the 2014 Plan specifically in conjunction with the 2019 Plan in 2022, suggesting both were active governance instruments, not that 2014 was inactive. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'transformation' in how the plan is positioned—from 'procedural governance' to 'strategic ownership framework.' The LLM answer focuses heavily on share counts and governance structure but misses this key analytical insight about the evolution of disclosure positioning. (4) MULTI-HOP REASONING: The LLM fails to synthesize the core finding that the plan's role shifted from adoption/governance details (2022) to security ownership/equity structure (2024). Instead, it presents static governance facts. (5) SEMANTIC MISMATCH: The ground truth describes a qualitative shift in disclosure framing; the LLM provides quantitative details about share availability that, while potentially factual, do not address the actual evolution described in the ground truth. The answer is partially relevant but fundamentally misses the question's focus on how treatment and positioning evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 540,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "In the 2022 filing Salvatore Ferragamo was listed as a tenant at several international Premium Outlets – Punta Norte (Mexico City), Yeoju and Siehung (South Korea), Johor (Malaysia) and the Montreal outlet in Canada (SPG 2022 p. 43). The 2023 filing’s international outlet tables (pages 32‑36) contain no Ferragamo entries, showing the brand is no longer reported as a tenant in SPG’s international outlet locations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) LOCATION ERRORS: The LLM lists 2022 locations as Punta Norte (Mexico City), Yeoju and Siehung (South Korea), Johor (Malaysia), and Montreal (Canada). The ground truth states the 2022 locations were three Japanese outlets: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. None of the LLM's listed 2022 locations match the ground truth. (2) 2023 LOCATION ERROR: The LLM claims no Ferragamo entries appear in 2023 international outlet tables. The ground truth indicates Salvatore Ferragamo appeared in Las Vegas Outlets North in Nevada, USA in 2023. The LLM completely missed this location. (3) GEOGRAPHIC SCOPE CONFUSION: The ground truth specifically addresses 'international outlet locations' and notes a shift from Japan to the U.S. The LLM's 2022 list includes non-Japanese locations (Mexico, South Korea, Malaysia, Canada), which contradicts the ground truth's focus on Japanese locations. (4) NARRATIVE FAILURE: The ground truth shows a clear evolution: 3 Japanese locations in 2022 → 1 U.S. location in 2023. The LLM's narrative (multiple international locations in 2022 → zero locations in 2023) is entirely different and factually wrong. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize information across the 2022 and 2023 filings, providing completely inaccurate location data for both years. This is a comprehensive failure across all evaluation dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 420,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP’s consolidated natural‑gas reserves in the Asia Pacific/Middle East slipped modestly, falling from 312 BCF at year‑end 2023 (305 BCF developed + 7 BCF undeveloped) to 296 BCF at year‑end 2024 (289 BCF developed + 7 BCF undeveloped)【page 145】. At the same time, the company’s equity‑affiliate gas holdings—​all of which are located in this region【page 147】—rose from about 5,275 BCF to 5,870 BCF (equity‑affiliate column on page 145), indicating a strategic shift toward expanding its gas portfolio through affiliate projects and a stronger operational focus on the Asia Pacific/Middle East market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive detail than the ground truth. (1) QUANTITATIVE VERIFICATION: All numbers are correct - consolidated reserves fell from 312 BCF (2023) to 296 BCF (2024), matching ground truth exactly. The breakdown into developed/undeveloped reserves (305/7 BCF in 2023, 289/7 BCF in 2024) is accurate and adds valuable detail. The equity-affiliate gas holdings increase from 5,275 BCF to 5,870 BCF is correctly stated. (2) COMPLETENESS: The answer addresses both the quantitative change (312→296 BCF decline) and provides enhanced context by including the developed/undeveloped breakdown and equity-affiliate position, which the ground truth did not mention. This additional information is factually correct and relevant. (3) ENTITY ACCURACY: COP correctly identified, Asia Pacific/Middle East region correctly specified, years 2023-2024 correct, BCF (billion cubic feet) metric correct. (4) REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly identifies the consolidated reserve decline while simultaneously noting the strategic shift toward equity-affiliate holdings, which represents a more nuanced interpretation of operational focus than the ground truth's 'stabilization' characterization. The conclusion that this indicates 'a strategic shift toward expanding its gas portfolio through affiliate projects' is a reasonable inference from the data showing declining direct reserves but increasing affiliate holdings. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as ground truth (reserve decline from 312 to 296 BCF) while adding substantive, accurate detail about the composition of reserves and affiliate holdings. The interpretation of 'operational focus' is slightly different but not contradictory - the LLM sees strategic expansion through affiliates while ground truth sees stabilization. Both are defensible interpretations of the data. Minor deduction only because the ground truth's simpler 'stabilization' characterization might be more conservative than the LLM's 'strategic shift' interpretation, though the data supports the LLM's view.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 583,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "In 2022 Comcast presented wireless gateways mainly as a product feature—an integrated modem‑router that, together with xFi Pods and the xFi whole‑home app, lets customers personalize, manage and secure their in‑home Wi‑Fi network【page_7】. By 2024 the company has elevated gateways to a strategic investment priority, classifying them under “Customer premise equipment” and explicitly budgeting for their continued deployment as a core part of its Connectivity & Platforms capital plan to support network upgrades, line extensions and scalable infrastructure【page_51】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: Both answers correctly identify the evolution from 2022 to 2024. The LLM accurately captures 2022 positioning (wireless gateways as integrated modem-router with xFi features) and 2024 positioning (elevated to strategic investment priority). The specific mention of xFi Pods and xFi whole-home app in 2022 adds appropriate detail consistent with ground truth. The 2024 characterization as 'Customer premise equipment' and integration into 'Connectivity & Platforms capital plan' aligns with the ground truth's description of 'deeper integration into long-term network strategy.' (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. Both answers appropriately avoid false precision. (3) ENTITY ACCURACY: Comcast is correctly identified throughout. Years (2022, 2024) are accurate. Metrics and strategic concepts (xFi, wireless gateways, network infrastructure, multigigabit speeds) are correctly referenced. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods and multiple strategic dimensions (product features → capital planning, customer-facing features → infrastructure investment). The logical progression from 'product feature' to 'strategic investment priority' mirrors the ground truth's evolution narrative. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'elevated gateways to a strategic investment priority' directly parallels ground truth's 'elevated its strategic emphasis.' The mention of 'network upgrades, line extensions and scalable infrastructure' semantically aligns with ground truth's 'network infrastructure upgrades' and 'multigigabit symmetrical speeds.' Minor difference: LLM includes specific reference to 'Customer premise equipment' classification and 'Connectivity & Platforms capital plan,' which adds specificity beyond ground truth but remains consistent with it. The citation markers [page_7] and [page_51] suggest proper source attribution. Overall, the answer is comprehensive, accurate, and well-reasoned with only negligible differences from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 599,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "In the 2022 filing Gulfstream highlighted that the G600 – launched in 2019 as a clean‑sheet, large‑cabin jet that replaces the older G550 – together with the G500 had delivered almost 150 aircraft by year‑end 2021【page_6】. By the 2024 filing the combined G500/G600 deliveries had more than doubled to over 300 aircraft at year‑end 2024, showing a strong growth in the G600’s market presence, and it remains a flagship large‑cabin model in Gulfstream’s all‑new product family alongside newer jets such as the G700, G800 and G400【page_5】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All key numeric values are correct - almost 150 deliveries by year-end 2021, over 300 by year-end 2024, and the 'more than doubled' characterization is accurate. (2) The multi-hop synthesis correctly combines data from 2022 and 2024 filings to show evolution over time. (3) Correctly identifies G600 as replacement for G550 with improvements. (4) Accurately notes the shift in product focus from new product introduction language to established product status.\n\nWEAKNESSES: (1) The LLM answer includes G700 in the newer models list, but the ground truth specifically mentions G800 and G400 as the newer models that replaced the G600's prominence in marketing language. G700 is not mentioned in the original answer as part of the product lineup evolution narrative. (2) The characterization of G600 as 'remains a flagship large-cabin model' differs subtly from the ground truth's emphasis that it 'was no longer described in the context of being a new product introduction' - the LLM focuses on current status while ground truth emphasizes the shift in how it's positioned. (3) Minor semantic difference: ground truth emphasizes the G600 becoming 'more established' while LLM emphasizes it 'remains a flagship' - these convey slightly different nuances about market positioning.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings, properly comparing cumulative deliveries and product positioning changes. The logic is sound and the comparison is valid.\n\nCALCULATIONS: The 'more than doubled' characterization is mathematically accurate (150 to 300+ is indeed more than double).\n\nOVERALL: The answer is substantially correct on core facts and numbers but has minor issues with product lineup details and nuanced positioning language that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 495,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "In 2023 AIG still owned a controlling stake in Corebridge—52.2 % of the company as of December 31, 2023, and Corebridge’s results were fully consolidated in AIG’s earnings【page_27】. During 2024 AIG sold down its interest, holding 48.4 % at the June 9 de‑consolidation date and only 22.7 % by year‑end after a $3.8 billion sale to Nippon, and it de‑consolidated Corebridge, recording a $4.8 billion loss as discontinued operations【page_108】; thereafter Corebridge is accounted for under the equity‑method, with dividends and fair‑value changes reported as net investment income (e.g., $601 million equity‑method income for June 10‑Dec 31 2024)【page_109】【page_110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: All key numbers are correct - 52.2% ownership in 2023, 48.4% at June 9 de-consolidation date, 22.7% by year-end 2024, $3.8 billion sale to Nippon, $4.8 billion loss on de-consolidation, and $601 million equity-method income for June 10-Dec 31 2024. The dates are accurate (December 31, 2023; June 9, 2024 de-consolidation; year-end 2024). Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from consolidated subsidiary (2023) to equity-method investment (2024), capturing the intermediate step of the June 9 de-consolidation. The answer goes beyond the ground truth by providing additional specific details (48.4% intermediate stake, $3.8B Nippon sale, $4.8B loss, $601M equity-method income) that are factually accurate and enhance understanding of the relationship evolution. The accounting treatment shift from consolidation to equity method is correctly identified and explained. The answer properly addresses both equity ownership changes and income recognition methodology changes. Minor consideration: The ground truth mentions 'dividends received and changes in Corebridge's stock price from June 9, 2024' while the LLM specifies 'dividends and fair-value changes reported as net investment income' - these are semantically equivalent descriptions of equity-method accounting. The LLM answer is more detailed and specific than the ground truth while remaining fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 411,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "In 2022 Tesla said it would develop and build the Solar Roof largely in‑house at its Buffalo‑based Gigafactory New York, using its own design‑engineering expertise and internal manufacturing capacity 【page_9】. By the 2024 filing the company is flagging that Solar Roof production has been slower to ramp, now hinging on external suppliers for key parts and facing “bottlenecks and other unexpected challenges” that could delay or limit output 【page_17】. This reflects a shift from a primarily internal‑manufacturing plan to a strategy that must manage greater supply‑chain dependencies and operational risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Tesla's Solar Roof production strategy between 2022 and 2024, correctly identifying: (1) the 2022 focus on in-house production at Gigafactory New York (Buffalo), (2) the shift by 2024 toward greater supply chain dependencies, and (3) the emergence of operational challenges and bottlenecks. The answer demonstrates sound multi-hop reasoning by synthesizing information across two filing periods and correctly contrasting the strategic approaches. STRENGTHS: The answer accurately identifies the key facilities (Gigafactory New York/Buffalo), correctly dates the time period (2022 vs 2024), and properly characterizes the shift from internal manufacturing to external supplier dependencies. The mention of 'bottlenecks and other unexpected challenges' aligns with the ground truth's reference to operational risks. WEAKNESSES: The LLM answer omits some specific details present in the ground truth, including: (1) the financing options tied to Solar Roof mentioned in 2022, (2) the explicit mention of 'delays in launching and/or ramping production' from the 2024 filing, (3) the specific operational requirements around 'design tolerances, high quality and output rates,' and (4) the broader context of localized procurement challenges and cost-effective scaling needs. The answer also doesn't fully capture the characterization of the 2024 phase as 'more complex and risk-laden.' However, these omissions are relatively minor contextual details rather than factual errors. The core narrative and multi-hop synthesis are sound. No quantitative errors detected (no specific numbers were provided in either answer to verify). The answer appropriately addresses the question's focus on manufacturing dependencies and operational challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 484,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "In the 2023 filing Qualcomm described on‑device AI as a core part of its “foundational technologies” – a capability it was already scaling across mobile handsets, automotive and IoT markets (see 2023 Note 1, page 65). By the 2024 filing the company says it is now allocating substantial R&D and capital to on‑device AI **and** using acquisitions and other strategic transactions to accelerate AI‑enabled products beyond handsets (see 2024 “Risks Related to New Initiatives,” page 20). This reflects a shift from a primarily technology‑development focus to a more aggressive investment‑and‑acquisition‑driven approach to grow its AI business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning of on-device AI as part of 'foundational technologies' with application across mobile, automotive, and IoT - this matches the ground truth exactly. (2) Accurately captures the 2024 evolution toward investment-centric strategy with emphasis on R&D, acquisitions, and strategic transactions. (3) Properly synthesizes the multi-hop comparison between 2023 and 2024 filings, showing understanding of the strategic shift. (4) Correctly cites specific filing references (2023 Note 1 page 65, 2024 'Risks Related to New Initiatives' page 20) which adds credibility. (5) The characterization of the shift from 'technology-development focus' to 'investment-and-acquisition-driven approach' is semantically equivalent to the ground truth's description of moving from 'core product offering' to 'investment-centric strategy.' MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing - it emphasizes 'aggressive investment-and-acquisition-driven approach to grow its AI business' whereas the ground truth emphasizes 'ecosystem development rather than immediate product commercialization' and 'enabling third-party integration.' While these are complementary perspectives, the ground truth places more emphasis on the ecosystem/integration angle. (2) The LLM answer could have been more explicit about the shift toward 'enabling third-party integration' versus direct product sales, though this is implied in the discussion of strategic transactions. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2023 vs 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the evolution in strategy, demonstrating sound multi-hop reasoning. The comparison is logical and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 546,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "In the 2022 filing Dolce & Gabbana was listed as a tenant at several international premium‑outlet centers—Gotemba, Kobe‑Sanda and Rinku in Japan and Punta Norte in Mexico【page_42†L2-L4】【page_43†L1】. By the 2023 filing the brand appears in the U.S. Las Vegas Premium Outlets tenant roster【page_34†L1】, showing SPG is moving high‑end luxury labels into its domestic premium‑outlet portfolio to reinforce an upscale, luxury‑focused positioning for these locations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 locations (Gotemba, Kobe-Sanda, Rinku in Japan) and the 2023 shift to Las Vegas Outlets North Premium. The year-over-year comparison is accurate, and the general direction of the strategic shift is captured. WEAKNESSES: (1) The LLM introduces 'Punta Norte in Mexico' as a 2022 location, which is NOT mentioned in the ground truth answer. This is a factual error that adds incorrect information. (2) The LLM's interpretation of the strategic shift differs from ground truth: Ground truth emphasizes a shift from 'multi-location presence in Japan to more exclusive, flagship-style positioning in a key U.S. market' with 'reevaluation of brand placement and target demographics.' The LLM frames it as 'moving high-end luxury labels into its domestic premium-outlet portfolio to reinforce upscale, luxury-focused positioning,' which misses the key insight about the REDUCTION in presence (from 3 Japanese locations to 1 U.S. location) and the strategic implications of that consolidation. (3) The LLM's conclusion suggests expansion/reinforcement of luxury positioning, when the ground truth indicates a more selective, exclusive approach with fewer total locations. MULTI-HOP REASONING: The model correctly synthesizes information across 2022 and 2023 filings, but the interpretation of what this evolution means is partially misaligned with the ground truth analysis. The addition of Punta Norte is a significant factual error that undermines credibility. The core comparison is sound, but the strategic interpretation is incomplete and somewhat misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 440,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "In 2023 ConocoPhillips recorded $49 million of exploration spending in its consolidated Asia Pacific/Middle East operations plus $46 million through equity affiliates – roughly $95 million in total (2023 10‑K, p. 156). The 2024 filing shows no exploration expense listed for the Asia Pacific/Middle East region (2024 10‑K, p. 144), indicating that the company has essentially halted new exploration there and is shifting its focus toward developing existing assets or other regions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer introduces a significant factual error by adding $46 million from equity affiliates to arrive at ~$95 million total for 2023. The ground truth explicitly states $49 million in exploration expenditures for 2023 in the Asia Pacific/Middle East region with no mention of equity affiliate contributions. The LLM appears to have synthesized information that contradicts the original answer. CORRECT ELEMENTS: (1) The 2024 figure of $0 is accurate; (2) The interpretation that this represents a strategic withdrawal/pause is correct; (3) The company identification (ConocoPhillips/COP) is correct; (4) The page references provided add detail but cannot be verified against ground truth. CALCULATION ERROR: The LLM's addition of $49M + $46M = ~$95M is mathematically correct, but the inclusion of the $46M equity affiliate figure is not supported by the ground truth answer, which specifically cites only $49 million. This represents a fundamental factual error in the multi-hop synthesis. The qualitative interpretation about strategic shift is sound, but the quantitative foundation is compromised. The answer demonstrates partial understanding of the strategic implications but fails on core numerical accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 360,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast’s equity ownership in Universal Beijing Resort has stayed at a 30 % stake – the same percentage reported in the 2022 filing【CMCSA_10k_2022.pdf page_48】.  The resort’s financing has been trimmed modestly, with total debt falling from roughly $3.5 billion (including about $3.1 billion of term‑loan principal) reported in 2022 to $3.4 billion of debt (about $3.0 billion of term‑loan principal) at year‑end 2024【CMCSA_10k_2024.pdf page_86】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) OWNERSHIP PERCENTAGE CLAIM: The LLM claims Comcast's 30% ownership stake was 'the same percentage reported in the 2022 filing,' but the ground truth explicitly states that in 2022, 'no specific financial stake or debt figures were provided at that time.' The LLM fabricated a 2022 ownership figure that does not exist in the ground truth. (2) DEBT FIGURES - CRITICAL ERRORS: The LLM states debt was 'roughly $3.5 billion (including about $3.1 billion of term-loan principal) reported in 2022' but provides no ground truth support for 2022 debt figures. The ground truth only provides 2023-2024 debt comparison ($3.5B in 2023 vs $3.4B in 2024). The LLM appears to have conflated or invented 2022 debt data. (3) INCOMPLETE ASSET/LIABILITY DATA: The LLM completely omits the asset and liability figures that are central to the ground truth answer: assets of $7.3B (2024) vs $7.8B (2023), and liabilities of $7.0B (2024) vs $7.2B (2023). These represent significant balance sheet changes that should have been included. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution 'from 2022 to 2024,' requiring three-year comparison. The LLM only addresses 2022 and 2024, missing the 2023 intermediate data that shows the trajectory. (5) CITATION ISSUES: The LLM cites specific pages but the claims about 2022 ownership percentage cannot be verified against ground truth. The answer demonstrates selective/inaccurate citation. The only correct element is the 2024 debt figure of $3.4 billion and the 30% ownership stake as of 2024, but the false claim about 2022 consistency and missing asset/liability data significantly undermine the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 458,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "In 2023 Duke Energy’s net derivative position dropped to **$13 million**, down from **$29 million** at the end of 2022, while the amount of derivative settlements more than doubled – **$68 million** of settlements in 2023 versus **$32 million** in 2022 (with purchases also falling from $74 million to $42 million)【page_192】. The larger settlement outflows and the lower net balance indicate the company actively unwound or settled derivative contracts, thereby reducing its net exposure to derivative‑related market risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All core financial figures are correct: net derivatives balance of $29 million (2022) → $13 million (2023), settlements of $32 million (2022) → $68 million (2023). The LLM also provides additional context by mentioning purchases declining from $74 million to $42 million, which adds valuable detail beyond the ground truth answer without introducing errors. The multi-hop synthesis is sound—the answer correctly connects the declining net balance with increased settlement activity and accurately interprets this as evidence of active unwinding/settlement of derivative contracts to reduce exposure. The reasoning about what this indicates (reduction in net exposure to derivative-related market risk) is logically sound and well-supported by the data. The answer is well-structured, clearly presented, and directly addresses all aspects of the question regarding evolution from 2022 to 2023 and what it indicates about derivative management. Minor note: The inclusion of the purchases data (not in ground truth) is supplementary and accurate, enhancing rather than detracting from the answer. The citation reference [page_192] adds credibility. No calculation errors detected, and all entities (Duke Energy, years, metrics) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 367,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "In the 2022 Form 10‑K SPG disclosed that LTIP units were “potentially dilutive securities” but that they had **no material dilutive effect** on basic or diluted earnings per share/unit (see 2022 p. 115).  The fair‑value of market‑based LTIP awards was said to be estimated with a **Monte‑Carlo model** (the same modeling is described in the 2023 filing p. 127).  \n\nThe 2023 Form 10‑K continues to treat LTIP units as participating securities under the two‑class method, provides a detailed LTIP‑award table with grant‑date fair values and a higher maximum potential fair value of **$42.5 million** for the 2023 program (see 2023 p. 129), and again relies on the Monte‑Carlo approach for valuation, while still indicating that the units do not have a material dilutive impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of SPG's LTIP Units disclosure from 2022 to 2023. STRENGTHS: (1) Correctly identifies the key shift from general dilution statements to more granular, valuation-focused disclosures; (2) Accurately notes the use of Monte Carlo models in both years; (3) Correctly identifies that LTIP units are treated as participating securities under the two-class method in 2023; (4) Properly synthesizes multi-hop information across two fiscal years; (5) Appropriately cites specific page numbers (2022 p. 115, 2023 p. 127, 2023 p. 129) showing document-level precision; (6) Captures the semantic essence of the ground truth answer regarding the evolution from general to detailed disclosure. MINOR CONCERNS: (1) The specific dollar amount of $42.5 million for the 2023 program maximum potential fair value cannot be verified against the ground truth provided, though it appears plausible and specific; (2) The ground truth mentions that LTIP units had 'no material dilutive effect for the years 2021, 2020, and 2019' in 2022 disclosure, while the LLM answer states they had 'no material dilutive effect on basic or diluted earnings per share/unit' without specifying the historical years - this is a minor omission but not factually incorrect; (3) The LLM answer adds detail about 'higher maximum potential fair value' which suggests comparison to prior year, but this comparative analysis isn't explicitly in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple disclosure elements (dilution treatment, valuation methodology, participating securities classification), demonstrating sound multi-hop reasoning. The evolution narrative is clearly articulated. QUANTITATIVE ELEMENTS: The $42.5 million figure is specific but unverified; page citations appear reasonable for 10-K documents of this length. No calculation errors detected. Overall, this is a high-quality answer that captures the essential evolution described in the ground truth with appropriate detail and specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 565,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "In the 2022 Form 10‑K Comcast’s agreement with Atairos limited its aggregate funding commitment to up to **$4.5 billion** (down from $5 billion), capped annual capital calls at **$400 million**, and set a separate **$45 million‑per‑year management‑fee** commitment【page_106】. The 2024 filing shows the aggregate funding ceiling and $400 million annual‑call limit unchanged, but the management‑fee commitment was reduced to **$40 million per year**【page_84】, and actual cash contributions were **$52 million in 2022, $145 million in 2023 and $73 million in 2024**【page_85】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) AGGREGATE COMMITMENT REVERSAL: The LLM states the 2022 commitment was '$4.5 billion (down from $5 billion)' but then claims this remained 'unchanged' in 2024. The ground truth clearly indicates the commitment WAS $5 billion in 2022 and DECREASED to $4.5 billion by 2024. The LLM has reversed the chronological direction of this change. (2) MANAGEMENT FEE ERROR: The LLM claims the 2022 management fee was '$45 million-per-year' which then 'reduced to $40 million per year' in 2024. The ground truth states the 2024 commitment is $40 million annually, but does not specify $45 million for 2022. The LLM appears to have fabricated or misread the 2022 figure. (3) CASH CONTRIBUTION DATA: While the LLM provides specific cash contribution amounts ($52M in 2022, $145M in 2023, $73M in 2024), these cannot be verified against the ground truth which does not include this granular annual breakdown. This additional detail, while potentially accurate, goes beyond what the ground truth confirms. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution between 2022 and 2024, presenting contradictory information about whether the $4.5 billion was the starting or ending point. (5) POSITIVE ELEMENTS: The LLM correctly identifies the $400 million annual capital call cap and attempts to provide comprehensive detail with page citations. However, the core numerical errors regarding the primary commitment amounts and management fees are fundamental failures that undermine the entire answer. The answer demonstrates partial understanding of the relationship but contains material factual errors that would mislead readers about the actual evolution of Comcast's commitment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 491,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East region fell from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024 – a decline of about 5 % (≈ 16 BCF) (COP_10k_2024.pdf p.145). The 2024 filing notes that equity‑affiliate reserves in that region experienced net downward revisions (lower prices offset by modest technical gains) and only limited extensions and discoveries in the Middle East, indicating a modest contraction and a relative de‑emphasis of reserve growth in the Asia Pacific/Middle East area (COP_10k_2024.pdf p.146).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - 312 BCF (2023), 296 BCF (2024), decline of 16 BCF, and the calculated 5% decline (16/312 = 5.1%) are all accurate. The year-over-year comparison is properly structured. ENTITY ACCURACY: Correctly identifies COP (ConocoPhillips), the Asia Pacific/Middle East region, and natural gas reserves in the proper metric (BCF). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple parts of the 2024 10-K filing (pages 145-146), connecting reserve figures with explanatory context about equity-affiliate revisions, pricing impacts, and limited extensions/discoveries. COMPLETENESS: Addresses both parts of the question - the evolution of reserves (quantitative change) and what it indicates about operational focus (qualitative interpretation). The LLM provides more detailed context than the ground truth by explaining the drivers of the decline (net downward revisions, lower prices offset by technical gains, limited Middle East discoveries), which adds valuable insight. REASONING QUALITY: The conclusion that this indicates 'modest contraction and relative de-emphasis of reserve growth' logically follows from the data and contextual information provided. MINOR CONSIDERATIONS: The ground truth uses simpler language ('modest reduction' and 'potential shift'), while the LLM provides more specific terminology ('net downward revisions,' 'equity-affiliate reserves') and cites specific document pages. This additional specificity is appropriate and enhances credibility without introducing errors. The semantic meaning is equivalent and the LLM answer is actually more informative while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 479,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022 Comcast’s strategy was to buy the bulk of its wireless gateways as customer‑premise equipment from a limited number of suppliers (see “Cable Communications purchases … a significant amount of customer premise equipment, including wireless gateways” – 2022 10‑K p. 8). By 2024 the emphasis had shifted from procurement to network‑deployment spending, with capital‑expenditure plans centered on scalable infrastructure, line extensions and support capital to upgrade the network for multigigabit speeds while continuing to roll out wireless gateways as part of that broader connectivity rollout (see “Capital expenditures … focused on investments in the Connectivity & Platforms business … scalable infrastructure … line extensions … and continued deployment of wireless gateways” – 2024 10‑K p. 51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop comparison question. STRENGTHS: (1) Correctly identifies the 2022 strategy as procurement-focused, with wireless gateways purchased from limited suppliers as customer premise equipment - this matches the ground truth. (2) Accurately characterizes the 2024 shift toward network deployment investment, specifically mentioning capital expenditures focused on scalable infrastructure, line extensions, and multigigabit speeds. (3) Properly synthesizes the evolution from passive procurement to active infrastructure integration. (4) Includes specific citations to 10-K filings (2022 p. 8 and 2024 p. 51), demonstrating document-grounded reasoning. (5) No quantitative errors - no specific numbers are provided that could be incorrect, which is appropriate given the question's focus on strategic comparison rather than specific financial metrics. (6) The multi-hop reasoning is sound: comparing 2022 procurement approach with 2024 deployment strategy across two different fiscal years and documents. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and citation-heavy than the ground truth, but this adds value rather than detracting. The semantic meaning is fully aligned with the original answer - both convey the strategic shift from procurement to deployment integration. The answer correctly emphasizes the alignment with network scalability and capacity expansion goals. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 414,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "In the 2022 Form 10‑K Tesla presented the Solar Roof as a key growth driver for its Energy Generation & Storage segment – deployments helped lift segment revenue by $795 million, but the early‑stage ramp left the product under‑utilized and pushed the segment’s gross margin to a negative ‑4.6 % (2022 10‑K p.39‑40). By the 2024 filing the company still treats Solar Roof as strategically important to its energy portfolio, but it now emphasizes the lingering production‑ramp risk, warning that “delays in launching and/or ramping production of … Solar Roof” could affect results (2024 10‑K p.17). This reflects a shift from highlighting initial revenue impact to focusing on the ongoing challenge of scaling the product.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Tesla's Solar Roof positioning between 2022 and 2024, matching the ground truth's main thesis: a shift from emphasizing deployment success to cautioning about manufacturing risks. The qualitative reasoning is sound and well-supported with specific citations.\n\nHowever, there are quantitative accuracy concerns:\n\n1. SPECIFIC NUMBER VERIFICATION: The LLM cites \"$795 million\" as the Energy Generation & Storage segment revenue increase in 2022, and references a \"-4.6%\" gross margin. These specific numbers are not present in the ground truth answer, which only states the Solar Roof was \"a key contributor to the growth in Energy generation and storage revenue\" without quantifying the exact amount or margin. The LLM appears to have added specific financial figures that cannot be verified against the provided ground truth.\n\n2. PAGE CITATIONS: The LLM provides specific page references (\"2022 10-K p.39-40\" and \"2024 10-K p.17\") which add credibility but cannot be verified against the ground truth provided.\n\n3. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two years (2022 and 2024) and identifies the strategic shift, which matches the ground truth's core finding.\n\n4. SEMANTIC ALIGNMENT: The answer's core message aligns well with the ground truth: Solar Roof evolved from a growth driver to a product facing production challenges. The phrasing \"shift from highlighting initial revenue impact to focusing on the ongoing challenge of scaling the product\" is semantically equivalent to the ground truth's \"shift from emphasizing deployment success to cautioning about the operational and manufacturing risks.\"\n\nThe main issue is that while the qualitative analysis is accurate and well-reasoned, the introduction of specific unverified financial metrics (the $795M figure and -4.6% margin) creates uncertainty about factual accuracy. These numbers may be correct from the actual filings, but they are not confirmed in the ground truth provided, making it impossible to verify their accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 565,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "In the Duke Energy Corporation Master Retirement Trust, “Net pending transactions and other investments” rose from **$14 million in 2022** (Level 1 $5 m, Level 2 $9 m) to **$54 million in 2023** (Level 1 $40 m, Level 2 $14 m) – a $40 million, roughly four‑fold increase【page_219】. This jump, especially the shift toward more Level 1 (market‑priced) assets, shows Duke Energy is deliberately expanding its exposure to net pending transactions and other investments, positioning the trust for greater upside and diversification in this opportunistic asset category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS - The numbers are completely reversed: Ground truth shows a DECREASE from $53M (2022) to $14M (2023), but the LLM reports an INCREASE from $14M (2022) to $54M (2023). The LLM has inverted both the direction of change and the actual values. The ground truth 2022 value is $53M, not $14M; the 2023 value is $14M, not $54M. (2) CALCULATION ERROR - The LLM calculates a $40M increase and 'four-fold increase,' which is mathematically inconsistent with the numbers provided ($54M - $14M = $40M is correct arithmetic, but the underlying values are wrong). The actual change is a $39M DECREASE (from $53M to $14M), representing approximately a 74% reduction, not an expansion. (3) STRATEGIC INTERPRETATION ERROR - The LLM's conclusion that Duke Energy is 'deliberately expanding its exposure' and 'positioning the trust for greater upside' is the opposite of what the ground truth indicates. The ground truth explicitly states this represents 'a significant reduction in exposure' and 'a strategic shift or completion of certain initiatives.' (4) ENTITY/CONTEXT ISSUE - While the LLM correctly identifies Duke Energy and the Master Retirement Trust context, it appears to have sourced data from an inverted or misread table, fundamentally compromising the answer. (5) MULTI-HOP REASONING - The synthesis fails because the foundational data points are incorrect, making all downstream analysis invalid. The answer demonstrates a critical data retrieval or interpretation failure rather than a reasoning error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 437,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company’s liability‑driven investment (LDI) approach has not changed in principle – it still targets a 20 % equity/80 % fixed‑income mix for its pension plan (and 55 %/45 % for post‑retirement benefits) to hedge liabilities while allowing growth 【page_85】. However, the disclosed numbers show that expense for its tax‑qualified defined‑contribution plans rose to $112 million in 2024 from $109 million in 2023 【page_89】【page_85】, and the firm now reports a slightly different asset mix: pension assets shifted to roughly 21 % equity, 63 % corporate bonds and 16 % Treasury/other (vs. 18 %/57 %/25 % in 2023) and post‑retirement assets to about 57 % equity, 30 % corporate bonds and 13 % Treasury/other (vs. 53 %/31 %/16 % in 2023) 【page_89】【page_86】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about LDI framework evolution and provides relevant information, but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) Defined contribution plan expenses correctly identified as $109M (2023) and $112M (2024), matching ground truth exactly. (2) The 20%/80% equity/fixed income target allocation for pension assets is correctly stated as maintained between years. (3) The general concept that 2024 added more detailed asset composition disclosure is captured. (4) Multi-hop synthesis across years and metrics is logically sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific actual asset composition percentages (21% equity/63% corporate bonds/16% Treasury for 2024 pension assets, with 2023 comparatives of 18%/57%/25%) that are NOT mentioned in the ground truth answer. The ground truth only states that 2024 'added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized' - it does not provide specific percentage breakdowns. (2) The LLM also mentions post-retirement benefit allocations (55%/45% target, with specific 2024 and 2023 actual compositions) that are completely absent from the ground truth answer. (3) These additional specific percentages appear to be fabricated or sourced from documents not reflected in the ground truth, creating factual inaccuracy. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings and identifies the evolution in disclosure practices. However, the introduction of unverified specific percentages suggests either hallucination or reliance on information not in the ground truth knowledge graph. QUANTITATIVE ACCURACY: While the $109M/$112M figures are correct, the introduction of unverified percentage compositions significantly reduces quantitative accuracy. The answer goes beyond what can be verified against the ground truth. SEMANTIC EQUIVALENCE: The core message about framework evolution and increased transparency is conveyed, but the addition of specific asset composition data not in ground truth creates a factual accuracy problem rather than a wording difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 589,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "In the FY 2023 filing Qualcomm’s discussion of its technology roadmap was generic – it spoke of “foundational technologies” and diversification but did not single out on‑device artificial‑intelligence as a distinct priority. By FY 2024 the 10‑K explicitly elevated on‑device AI to a core growth pillar, linking it with 5G and low‑power, high‑performance computing and noting that it will drive expansion into automotive and IoT (see page 20 and page 45). The company highlighted concrete investments to support that shift – continued heavy R&D spending ($8.9 bn in FY 2024 versus $8.8 bn in FY 2023), higher near‑term capital expenditures for production and testing (page 47), and new licensing and strategic‑transaction activity aimed at accelerating AI‑enabled products (page 21).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides R&D spending figures ($8.9B FY2024 vs $8.8B FY2023) that cannot be verified against the ground truth and appear to be fabricated or hallucinated numbers. The ground truth does not mention these specific R&D figures, and the minimal difference ($100M) seems implausibly small for year-over-year R&D changes at a company of Qualcomm's scale. (2) FACTUAL INACCURACY ON FY2023 POSITIONING: The LLM claims FY2023 had 'generic' discussion without singling out on-device AI as a distinct priority. The ground truth explicitly states that in FY2023, Qualcomm 'emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption.' This is a direct contradiction - the ground truth shows On-Device AI WAS already a priority in FY2023, not newly elevated in FY2024. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM frames the shift as FY2023 being generic to FY2024 being explicit, but the ground truth shows a different evolution: FY2023 had strategic vision/positioning, while FY2024 shifted to active investment-driven strategy. The LLM missed this nuance entirely. (4) PAGE REFERENCES: The LLM cites specific pages (20, 45, 47, 21) without verification against actual filings - these cannot be confirmed and appear to be fabricated citations. (5) MISSING KEY DISTINCTION: The ground truth emphasizes the shift from 'strategic vision to active investment and expansion' - the LLM mentions investments but doesn't capture this strategic evolution clearly. (6) PARTIAL CREDIT: The LLM does correctly identify that On-Device AI is linked with 5G and low-power computing, and correctly notes expansion into automotive and IoT, which aligns with ground truth. However, the foundational errors about FY2023 positioning and the unverifiable R&D numbers significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 509,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "In the 2022 Form 10‑K the “Second Amended and Restated Voting Trust Agreement” and the related “Voting Trust Agreement” are listed as Exhibit 9.1 and Exhibit 9.2 in the exhibit index (see page 142) 【page_142】. The 2023 Form 10‑K presents the same two agreements in exactly the same way—again as Exhibit 9.1 and Exhibit 9.2 with the same description (see page 140) 【page_140】. Because the classification and placement of the voting‑trust documents have not changed, the Simon family’s voting‑trust arrangement remains unchanged, indicating a continued and stable governance structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. The original answer states that the 2022 10-K describes the agreement as 'Second Amended and Restated' while the 2023 10-K refers to it without this modifier, indicating an evolution in presentation. However, the LLM answer claims that both the 2022 and 2023 10-Ks present 'the same two agreements in exactly the same way' with identical exhibit descriptions (Exhibit 9.1 and 9.2). This directly contradicts the ground truth, which explicitly states there was a shift in presentation between the two years. The LLM incorrectly concludes that 'the classification and placement of the voting-trust documents have not changed,' when the ground truth indicates they did change. The LLM also introduces specific page references (page 142 for 2022, page 140 for 2023) that cannot be verified against the ground truth and appear to be fabricated details. The core multi-hop reasoning is flawed: the LLM failed to identify the key difference in how the agreements were described across the two years. While the LLM correctly identifies the relevant entities (Melvin Simon & Associates, Simon family, voting trust agreement, March 1, 2004 date), it fundamentally misrepresents the evolution of the presentation, which is the central question. The conclusion about stability is reached through incorrect reasoning—the LLM claims stability because nothing changed, when the ground truth indicates stability is evidenced by the fact that no further amendments occurred (hence the removal of 'Second Amended and Restated' language).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 440,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East basin slipped from 312 billion cubic feet (305 bcf developed + 7 bcf undeveloped) in 2023 to 296 billion cubic feet (289 bcf developed + 7 bcf undeveloped) in 2024, while the equity‑affiliate portion fell from 3,558 bcf to 3,189 bcf, leaving the region with roughly 3.5 trillion cubic feet of gas – a drop of about 10% and a reduction in its share of total COP reserves from ~41% to ~33% (see page 145). The decline, together with the 2024 note that extensions and discoveries in equity affiliates were now focused in the Middle East (page 146), signals that the Asia Pacific/Middle East area remains important but is losing relative strategic weight in COP’s global reserves portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) CORE NUMBERS INCORRECT: The LLM states equity-affiliate reserves fell from 3,558 bcf to 3,189 bcf, but the ground truth indicates 5,870 bcf in 2024 (no 2023 comparison provided in ground truth). The LLM's equity affiliate figures are significantly lower than ground truth. (2) PERCENTAGE CALCULATIONS WRONG: LLM claims a ~10% drop in equity affiliates and shifts from ~41% to ~33% of total reserves, but these percentages cannot be verified against ground truth and appear inconsistent with the actual numbers provided. The ground truth states a 5.1% decline in proved reserves (312 to 296 bcf), not 10%. (3) DEVELOPED/UNDEVELOPED BREAKDOWN: LLM provides specific breakdowns (305 bcf developed + 7 bcf undeveloped in 2023; 289 bcf developed + 7 bcf undeveloped in 2024) that are NOT mentioned in the ground truth. While these sum correctly to the stated totals, they represent additional detail not in the original answer and cannot be verified. (4) MULTI-HOP SYNTHESIS: The LLM correctly identifies the main trend (decline from 312 to 296 bcf) and attempts to contextualize it within global portfolio share, which is appropriate. However, the equity affiliate numbers are fundamentally wrong, undermining the overall analysis. (5) STRATEGIC INTERPRETATION: Both answers conclude the region is losing relative importance, which is semantically aligned, but the LLM's quantitative foundation is flawed. The reference to page numbers (145, 146) suggests source documentation but cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 430,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s debt on its balance sheet – senior unsecured notes of $6.452 billion, junior subordinated debt of $989 million and a DDTL facility of $1.5 billion (total Corebridge debt $9.368 billion) together with guarantee and collateral arrangements (2023 10‑K p. 112). After the June 9, 2024 deconsolidation, AIG removed that debt and now treats its remaining Corebridge stake as an equity‑method investment, reporting $601 million of equity‑method income (and $1.574 billion of Corebridge pre‑tax earnings) for the June‑December 2024 period (2024 10‑K p. 108‑109).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. Verification of key facts: (1) 2023 debt structure - all numbers are correct: $6.452 billion senior unsecured notes, $989 million junior subordinated debt, $1.5 billion DDTL facility, totaling $9.368 billion. (2) June 9, 2024 deconsolidation date is accurate. (3) Equity method income of $601 million for June-December 2024 period is correct. (4) Corebridge pre-tax earnings of $1.574 billion for the period is accurate. The multi-hop reasoning is sound: the answer correctly synthesizes the transformation from consolidated subsidiary (2023) to equity method investment (2024 H2), capturing both the debt removal and the shift to equity method reporting. The answer addresses all key aspects of the question: debt structure evolution, the deconsolidation event, and equity method income reporting. The inclusion of specific page references (2023 10-K p. 112, 2024 10-K p. 108-109) adds credibility. Minor note: The original answer mentions 'discontinued operations' classification which the LLM answer doesn't explicitly state, though this is a minor contextual detail that doesn't affect the core factual accuracy. The LLM answer is more specific and detailed than the ground truth in some respects (providing the DDTL facility amount and specific equity method income figure), which demonstrates thorough research rather than error. All numbers are formatted correctly and calculations are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 411,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "In the 2022 filing the special‑use funds were composed of roughly **$5.5 bn of equity securities** and **$2.5 bn of fixed‑income securities**. By the 2024 filing the equity portion had grown to about **$6.2 bn**, while the fixed‑income portion had slipped to roughly **$2.3 bn**. The tilt toward a larger equity share (and a modest cut in bonds) indicates that NextEra is willing to take on more market risk to earn higher long‑term returns on its decommissioning and storm‑damage reserves, while still keeping a core of liquid fixed‑income assets to meet short‑term liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) 2022 COMPOSITION ERROR: The LLM claims 2022 had '$5.5 bn of equity securities' and '$2.5 bn of fixed-income securities.' The ground truth explicitly states that in 2022, NEE's Special Use Funds were 'entirely composed of fixed income securities, with a carrying amount of $2,505 million' - meaning ZERO equity in 2022, not $5.5 billion. This is a major factual error. (2) 2024 EQUITY FIGURE: The LLM states 2024 equity was 'about $6.2 bn,' which is close to the ground truth of $6,164 million (acceptable rounding). However, this accuracy is overshadowed by the 2022 error. (3) 2024 FIXED INCOME BREAKDOWN: The LLM provides only a single '$2.3 bn' figure for fixed income in 2024, whereas the ground truth breaks this down into three components: $722M in U.S. Government/municipal bonds, $685M in corporate debt, and $873M in asset-backed securities (totaling $2,280M, which matches the LLM's $2.3bn). The LLM lacks this granular detail. (4) MULTI-HOP REASONING: The LLM's interpretation of the strategic shift is reasonable in tone (discussing risk appetite and liquidity strategy), but it is built on a false premise about 2022 composition. The claim that equity 'grew' from $5.5bn to $6.2bn is incorrect - the actual transformation was from $0 equity to $6,164M equity, a far more dramatic strategic shift than the LLM suggests. (5) SEMANTIC ISSUE: The LLM's narrative about 'decommissioning and storm-damage reserves' adds context not explicitly verified in the ground truth, which focuses on the portfolio composition shift itself. While this interpretation may be reasonable, it goes beyond what the ground truth supports. The fundamental error regarding 2022 composition (claiming $5.5bn equity when it was actually $0) is disqualifying for a financial analysis question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 524,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K risk sections warn that extensive site‑infrastructure sharing – especially RAN‑sharing, roaming or resale arrangements enabled by 5G – can slow new‑lease activity and even lead to de‑commissioning of equipment on existing towers (2022 p. 15; 2024 p. 16). The 2024 filing restates the same risk but explicitly notes it could “materially and adversely affect” the company’s growth, revenue and cash‑flow, indicating that the risk’s magnitude is still viewed as material and may be heightened as 5G adoption expands, while the underlying nature of the risk has not changed.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES WITH CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution of the risk. Ground truth states: 'the underlying nature of the risk has NOT changed' is INCORRECT - the ground truth explicitly says the risk EVOLVED from a general concern about 'site infrastructure sharing' in 2022 to a MORE SPECIFIC concern about 'RAN sharing, roaming, or resale arrangements' in 2024, with stronger emphasis on financial impact and 'lack of compensation to AMT.' The LLM incorrectly claims 'the underlying nature of the risk has not changed,' which directly contradicts the ground truth's assertion that this represents 'a significant evolution in the risk's specificity and perceived threat level.' CORRECT ELEMENTS: (1) Both years mention site infrastructure sharing - correct; (2) 5G technology is relevant - correct; (3) Risk of slowed new-lease activity and decommissioning - correct; (4) 2024 filing emphasizes material adverse effects - correct; (5) Page references (2022 p. 15; 2024 p. 16) are plausible though not verified. MISSING/INCOMPLETE: (1) The LLM fails to capture the evolution from general 'site infrastructure sharing' to specific 'RAN sharing, roaming, or resale arrangements'; (2) Misses the key distinction that 2024 explicitly ties this to 'lack of compensation to AMT'; (3) Fails to recognize this as a 'more mature and impactful shift in carrier behavior'; (4) The conclusion that 'underlying nature of the risk has not changed' is semantically opposite to ground truth's emphasis on evolution and increased specificity. MULTI-HOP REASONING: The LLM attempted to synthesize across 2022 and 2024 filings but reached an incorrect conclusion about the nature of change. The question asks specifically about evolution - the LLM's answer suggests stasis rather than evolution, which is a fundamental reasoning error. QUANTITATIVE ACCURACY: Page numbers appear reasonable but cannot be verified; no specific financial figures provided in either answer, so limited quantitative content to assess.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 551,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron still accounts for its 36.4 % stake in Angola LNG Limited under the equity method, but the carrying amount of the investment fell from $1.96 billion at year‑end 2022 to $1.76 billion at year‑end 2023, and the share of net income it recognizes dropped sharply from $1.86 billion in 2022 to $0.51 billion in 2023【page_82†L15-L22】. The ownership percentage and equity‑method treatment have not changed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific financial metrics (carrying amounts and share of net income) that are not present in the ground truth, making verification impossible. More critically, the LLM answer fundamentally misses the core finding from the ground truth: the relationship classification changed from 'Depends_On' in 2022 to 'Invests_In' in 2023, which represents a significant shift in how Chevron's investment is structured and categorized. The LLM correctly identifies the 36.4% ownership percentage and notes that equity method accounting treatment remained unchanged, but these details are secondary to the main evolution described in the ground truth. The LLM answer focuses entirely on quantitative changes (carrying amount declining from $1.96B to $1.76B, share of net income dropping from $1.86B to $0.51B) rather than the qualitative structural shift in the investment relationship. Without access to the source documents, the accuracy of these specific financial figures cannot be verified, but they appear to be additional details not mentioned in the ground truth. The answer fails to address the key aspect of the question about how the 'investment structure' evolved - specifically the reclassification of the relationship type. The LLM demonstrates a misunderstanding of what constitutes the meaningful evolution in Chevron's relationship with Angola LNG Limited between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 391,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "In the 2022 filing the G600 was described as one of Gulfstream’s newest large‑cabin jets – faster, more fuel‑efficient, with a larger cabin, longer range and improved flight‑controls – and its cumulative deliveries were “almost 150” aircraft as of year‑end 2021【page_6】. By the 2023 filing the G600 remains a flagship model, now also highlighted for reduced emissions and for holding “more than 90 city‑pair speed records,” and its production has accelerated to “over 250” deliveries by year‑end 2023【page_5】. This shows the aircraft’s role has shifted from a newly introduced, modest‑volume model to a mature, high‑performance, high‑volume core of Gulfstream’s product line.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) Numerical accuracy is excellent - correctly cites 'almost 150' deliveries as of year-end 2021 (from 2022 filing) and 'over 250' deliveries by year-end 2023 (from 2023 filing), matching ground truth figures. (2) Multi-hop synthesis is sound - properly compares the G600's positioning across two years and identifies the evolution from newly introduced to mature product. (3) Contextual details are well-chosen - mentions specific performance attributes (speed records, fuel efficiency, emissions reduction) and the Symmetry Flight Deck technology. (4) The conclusion about the shift from 'newly introduced, modest-volume model to a mature, high-performance, high-volume core' aligns with the ground truth narrative. MINOR WEAKNESSES: (1) The answer does not explicitly mention that the G600 entered service in 2019 or that it replaced the G550, which are contextual details in the ground truth. (2) The answer does not explicitly discuss how G600 technologies (like Symmetry Flight Deck) were being extended to newer models (G700, G800, G400), which represents an important aspect of the product lineup evolution mentioned in the ground truth. (3) The characterization shift from 'recent addition' to 'mature product' is implied but not as explicitly stated as in the ground truth. These omissions are relatively minor since the core answer about the G600's evolution is accurate and well-supported. The answer successfully addresses the main question about how the G600's role evolved from 2022 to 2023 in terms of performance metrics and production status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 460,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "In the 2022 filing McDonald’s described its franchisee relationship mainly as a fee‑based, transactional model—franchisees paid rent, royalties and initial fees and the company only shared the cost of certain restaurant improvements, allocating those costs after projects were completed (see 2022 page 44). By the 2024 filing, while the same rent‑royalty‑fee structure remains, the company now actively co‑invests with franchisees to fund restaurant and operating‑system upgrades and develops initiatives together to modernize locations and increase brand value (see 2024 page 4). This reflects a shift from a primarily financial‑only relationship to a more strategic, collaborative partnership that includes joint capital investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the evolution from a fee-based transactional model in 2022 (rent, royalties, initial fees) to a more collaborative co-investment model by 2024. The characterization of 2022 as primarily passive/financial-only and 2024 as actively collaborative is accurate. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required for this question, so quantitative precision is not directly applicable. The answer appropriately avoids inventing numbers and instead focuses on structural changes. The page references (2022 page 44, 2024 page 4) are cited but cannot be independently verified from the provided context; however, they appear reasonable and don't contradict the ground truth. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 and 2024) and correctly identifies the strategic shift. It properly connects the financial mechanisms (rent, royalties, fees) with the strategic evolution (co-investment, modernization, brand value). (4) ENTITY ACCURACY: McDonald's is correctly identified, the time period (2022-2024) is correct, and the relationship dynamics are properly characterized. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth ('fee-based, transactional model' vs 'franchised arrangements and license agreements') but conveys the same meaning. The core insight about the shift from passive to active investment is captured accurately. Minor deviations: The LLM mentions 'allocating those costs after projects were completed' which adds a detail not explicitly in the ground truth, but this appears to be a reasonable elaboration rather than an error. The answer is comprehensive, well-structured, and directly addresses the question's multi-part nature regarding both financial involvement and strategic collaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 537,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The smokeable‑products segment saw a modest contraction.  Net revenues fell from **$22.476 billion in 2022 to $21.756 billion in 2023** (a drop of about $720 million, roughly 3 %)【page_29】.  Operating income (OCI) slipped only slightly, from **$10.688 billion in 2022 to $10.670 billion in 2023** (down $18 million, essentially flat)【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All financial figures are correct: 2022 net revenues of $22.476 billion ($22,476 million), 2023 net revenues of $21.756 billion ($21,756 million), 2022 operating income of $10.688 billion ($10,688 million), and 2023 operating income of $10.670 billion ($10,670 million). The calculations are accurate: revenue decline of $720 million (22,476 - 21,756 = 720) and operating income decline of $18 million (10,688 - 10,670 = 18). The percentage calculation of approximately 3% for revenue decline is correct (720/22,476 ≈ 3.2%). The LLM correctly identifies the segment (smokeable products), the time period (2022 to 2023), and both required metrics (net revenues and operating income). The characterization of the performance as a 'modest contraction' with operating income being 'essentially flat' is semantically accurate and appropriately reflects the magnitude of changes. The answer successfully synthesizes multi-hop information comparing two years across two financial metrics. The only minor observation is that the LLM uses billion format while the ground truth uses million format, but this is an acceptable and standard variation in financial reporting. The answer fully addresses all parts of the question with sound reasoning and proper context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 369,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "In the 2022 filing Opdivo was presented as BMS’s flagship immuno‑oncology asset that BMS commercializes worldwide except in Japan, South Korea and Taiwan, where it is jointly developed and marketed with Ono (with profit‑sharing and royalty arrangements) and it also underpins a joint‑development program with Nektar on the Opdivo‑NKTR‑214 combination (see 2022 p. 113‑114). By the 2024 filing the product had moved from a single‑indication, partnership‑driven asset to a multi‑indication cornerstone of BMS’s IO strategy, gaining FDA, EC and Japanese approvals for new uses—including resectable NSCLC, first‑line urothelial carcinoma, MSI‑H/dMMR colorectal cancer—and a new sub‑cutaneous formulation (Opdivo Qvantig) that was highlighted as a recent launch (see 2024 p. 44‑45, 46). The underlying Ono co‑commercialization framework remains unchanged, but Opdivo’s role has expanded to drive broader therapeutic growth and diversification of its delivery formats.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Opdivo's evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 collaborative framework with Ono (profit-sharing and royalty arrangements) and mentions the Nektar partnership on Opdivo-NKTR-214 combination; (2) Accurately cites the March 2024 FDA approval for first-line urothelial carcinoma (matching ground truth); (3) Adds valuable context about additional 2024 approvals (resectable NSCLC, MSI-H/dMMR colorectal cancer) and the new subcutaneous formulation (Opdivo Qvantig), which enriches the answer beyond the ground truth baseline; (4) Correctly notes that the Ono co-commercialization framework remained unchanged; (5) Properly synthesizes the multi-hop information showing evolution from partnership-driven to multi-indication strategy. MINOR CONSIDERATIONS: (1) The ground truth mentions an 80-20 split for single-party compounds, which the LLM answer does not explicitly detail, though it references 'profit-sharing and royalty arrangements' which is semantically equivalent; (2) The ground truth mentions Yervoy and Orencia as part of a broader alliance with structured co-promotion, which the LLM answer does not include—however, this is a minor omission as the question specifically focuses on Opdivo's evolution; (3) The LLM answer provides more granular detail about specific approvals and formulations than the ground truth, which is appropriate for a comprehensive answer. QUANTITATIVE ACCURACY: All dates (2022, 2024, March 2024) are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies the shift from co-development focus to independent product expansion, with proper multi-hop synthesis across 2022 and 2024 filings. CONTEXTUAL RELEVANCE: Highly relevant, directly addressing the question's focus on collaborative framework evolution and new therapeutic approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 520,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "In the 2022 Form 10‑K AMT said its bank borrowings were floating‑rate loans tied to traditional inter‑bank benchmarks – LIBOR for U.S. dollars, EURIBOR for euros (or a base‑rate alternative) – and its Indian facilities were linked to the bank’s marginal cost‑of‑funds rate (MCLR) or the overnight Mumbai inter‑bank offer rate, with the loan agreements simply noting “reporting, financial and operating covenants” and limits on additional debt. By the 2024 filing the company is referencing newer benchmarks – the Nigeria letters of credit bear interest at SOFR plus a spread – and it lists fixed coupon rates for its securitized notes (e.g., 5.490%/5.735% for the 2023 securities and 3.652%/4.459% for the 2018 securities), while also spelling out detailed covenants such as debt‑service‑coverage‑ratio thresholds, cash‑trap DSCR, minimum‑DSCR triggers, amortization periods and pre‑payment penalties. This shows a shift from broad LIBOR/EURIBOR‑based references and generic covenants to more precise benchmark rates (SOFR, fixed coupons) and explicit covenant mechanics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the shift from LIBOR/EURIBOR to SOFR in Nigeria letters of credit, matching the ground truth; (2) Accurately captures the evolution from generic to more detailed covenant disclosures; (3) Properly identifies the multi-hop synthesis requirement across 2022 and 2024 filings; (4) Contextually relevant to the question about benchmark evolution. WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM introduces specific coupon rates (5.490%/5.735% for 2023 securities, 3.652%/4.459% for 2018 securities) that are NOT mentioned in the ground truth answer. These appear to be fabricated details not supported by the original answer; (2) INCOMPLETE ACCURACY - The LLM mentions Indian facilities tied to MCLR and Mumbai inter-bank offer rate, which is NOT mentioned in the ground truth answer at all. This represents either hallucination or information from a different source not validated by the ground truth; (3) COVENANT DETAILS - While the LLM correctly notes the shift to more detailed covenants in 2024, it provides specific covenant types (debt-service-coverage-ratio thresholds, cash-trap DSCR, minimum-DSCR triggers, amortization periods, pre-payment penalties) that are not explicitly mentioned in the ground truth answer, which only states covenants were disclosed 'without specifying interest rate structures'; (4) MISSING ELEMENTS - The LLM does not mention the 2021 credit facilities' debt ratings and commitment fees (0.080% to 0.300%) that are explicitly in the ground truth; (5) STRUCTURAL ISSUE - The ground truth emphasizes that 2024 disclosure 'focused on consequences of covenant non-compliance without specifying interest rate structures,' but the LLM claims 2024 has 'explicit covenant mechanics,' which may contradict the ground truth's characterization. The answer demonstrates reasonable understanding of the evolution but introduces unverified specific numbers and details that reduce confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 552,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "In the 2022 filing McDonald’s described its franchise model as one in which the Company “generally owns or secures a long‑term lease on the land and building for conventional franchised and Company‑operated restaurant sites” (page 35), using that ownership to secure long‑term occupancy and control costs. By the 2024 filing the same ownership structure remains (“the Company generally owns or secures a long‑term lease on the land and building…”) (page 3), but the Company now explicitly adds that it “may co‑invest with franchisees to fund improvements to their restaurants or operating systems” (page 4), signaling a shift toward a collaborative capital‑investment approach alongside its real‑estate ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific textual citations and page numbers from both 2022 and 2024 filings, which adds credibility. However, there are significant issues with the evaluation against the ground truth:\n\n1. FACTUAL ACCURACY: The LLM correctly identifies that McDonald's owns or secures long-term leases on land and buildings in both 2022 and 2024. It also correctly identifies the new co-investment language in 2024. These core facts align with the ground truth.\n\n2. CRITICAL DISCREPANCY: The LLM claims the same ownership structure was described in 2022 (with the exact quote provided), but the ground truth states \"the specific role of franchisees in real estate ownership was not detailed\" in 2022. This is a significant contradiction. The LLM's citation of page 35 in the 2022 filing with the specific quote about owning/leasing land and buildings contradicts the ground truth's assertion that this was not detailed in 2022.\n\n3. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution by comparing 2022 to 2024 and identifying the shift toward co-investment language. However, the premise of this comparison appears flawed based on the ground truth's characterization of 2022 disclosures.\n\n4. COMPLETENESS: The LLM addresses the core question about evolution in real estate ownership and co-investment strategy. It identifies the key shift (addition of co-investment language in 2024), though it mischaracterizes what was in 2022.\n\n5. CITATION SPECIFICITY: While the LLM provides specific page citations, these citations may be inaccurate or the ground truth may be based on different sections of the filings. The ground truth emphasizes that 2022 focused on \"ESG initiatives\" and \"franchisee cooperation\" rather than detailed real estate strategy, whereas the LLM suggests the real estate ownership model was explicitly stated in 2022.\n\n6. SEMANTIC ISSUE: The ground truth describes a shift from general collaboration emphasis to clearly defined strategy, while the LLM describes a shift from real estate ownership focus to adding co-investment language. These are different narratives about the evolution.\n\nThe answer is partially correct in identifying the co-investment addition in 2024, but appears to mischaracterize the 2022 baseline, which is a fundamental error in a comparative analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 625,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "- 2022 Form 10‑K: The 2015 Stock Compensation Plan for Non‑Employee Directors was listed among the approved equity‑compensation plans with **703,256 shares** available for future issuance (Item 12 table, p. 114) and was referenced in the exhibit list as **Exhibit 10.22** (p. 116).  \n\n- 2023 Form 10‑K: The same plan appears again as an approved plan but now shows **589,927 shares** available (Item 12 table, p. 107) and is specifically described as **“amended and restated effective October 26 2022”** in Exhibit 10.22 (p. 110).  \n\n**Interpretation:** Altria’s governance team is actively revisiting director compensation – formally amending the plan, reducing the share pool, and documenting the change in the filing – indicating a disciplined, transparent approach that aligns director pay with evolving corporate and shareholder expectations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and dates. Verified facts: (1) 2022 filing shows 703,256 shares available - CORRECT per ground truth; (2) 2023 filing shows 589,927 shares available - CORRECT and adds valuable detail not in ground truth; (3) Amendment effective October 26, 2022 - CORRECT per ground truth; (4) Reference to Form 10-Q September 30, 2022 - CORRECT per ground truth. The LLM provides additional specificity (exhibit numbers, page references, share reduction from 703,256 to 589,927) that enhances the answer beyond the ground truth without contradicting it. Multi-hop synthesis is sound: the answer correctly traces the plan's evolution across two fiscal years and identifies the formal amendment as the key governance change. The interpretation about 'disciplined, transparent approach' and 'evolving corporate and shareholder expectations' is reasonable inference from the documented changes, though slightly more interpretive than the ground truth's more measured language about 'refining director compensation framework.' Minor deduction: The LLM could have been more explicit about the significance of the share reduction (114,329 share decrease, ~16% reduction) as an indicator of governance discipline. The answer fully addresses the multi-part question: status change (documented amendment), documentation change (incorporated by reference), and governance implications (active revisiting of compensation). Quantitative accuracy is high with all numbers verified correct. Qualitative reasoning appropriately synthesizes the information to draw governance conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 451,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "Both the 2022 and 2024 10‑K filings warn that “extensive sharing of site infrastructure through RAN sharing, roaming or resale arrangements among wireless service providers… may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment, or may result in the de‑commissioning of equipment” (2022 p. 15; 2024 p. 15). The wording is essentially unchanged, indicating that competitive pressure from carriers’ network‑sharing and resale strategies remains a persistent headwind that continues to limit AMT’s ability to grow new leases.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that both 2022 and 2024 filings mention roaming/resale arrangements and RAN sharing as threats to lease activity. The page references (p. 15 for both years) appear accurate. The LLM correctly notes that the wording is 'essentially unchanged' between the two years. CRITICAL WEAKNESSES: (1) The LLM fails to address the core evolution described in the ground truth. The ground truth explicitly states the concern 'evolved' from 2022 to 2024, with the 2024 risk becoming 'broader' and including 'potential decommissioning of existing equipment due to redundancy.' The LLM's conclusion that wording is 'essentially unchanged' directly contradicts the ground truth's assertion of evolution. (2) The LLM misses the key insight that by 2024, the threat expanded beyond just slowing new lease activity to also threatening existing equipment through decommissioning - a material escalation of risk. (3) The LLM's interpretation that 'unchanged wording' means 'persistent headwind' is a weak conclusion that doesn't capture the actual evolution of the risk profile. (4) The ground truth emphasizes that infrastructure sharing is becoming 'more viable and widespread' - a dynamic change - but the LLM treats it as static. MULTI-HOP REASONING: The LLM fails to synthesize the temporal evolution across the two years. It identifies the same risk in both years but doesn't recognize or explain how the nature/scope of the risk changed. The question specifically asks 'how has...evolved' and the LLM's answer essentially says 'it hasn't changed,' which contradicts the ground truth. SEMANTIC ISSUE: While the LLM's statement about persistent competitive pressure is not wrong per se, it fundamentally misses the evolution narrative that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 489,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "In the 2022 filing McDonald’s said its growth relied on franchisees ‑ who must independently fund major, capital‑intensive reinvestment initiatives and stay aligned with the company’s operating, value‑promotional and capital‑intensive plans, with the risk that a lack of financing could hurt performance (2022 Risk Factors pp. 28‑30). By the 2024 filing the relationship has become more collaborative: franchisees still must meet rigorous standards, but McDonald’s now co‑invests with them to finance restaurant‑modernization and system‑upgrade projects that are designed to boost revenue and brand value (2024 p. 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of McDonald's franchisee relationship between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 focus on franchisees' independent funding obligations and alignment with company strategy; (2) Accurately captures the 2024 shift toward co-investment initiatives; (3) Properly synthesizes the multi-hop comparison across two years; (4) Correctly identifies the progression from pandemic-driven challenges to strategic investment approach; (5) Appropriately cites specific document references (2022 Risk Factors pp. 28-30, 2024 p. 4) showing document awareness. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention COVID-19 pandemic context that was emphasized in the 2022 ground truth (labor availability, supply chain disruptions); (2) Doesn't reference the 'Accelerating the Arches' strategy by name, though the concept is implied; (3) The phrase 'capital-intensive' is repeated twice in the 2022 description, which appears to be a transcription artifact but doesn't affect accuracy. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the directional shift in the relationship. The logic connecting pandemic-era operational constraints to later strategic co-investment is sound. SEMANTIC EQUIVALENCE: The core message matches the ground truth - McDonald's moved from expecting franchisees to independently fund operations to actively co-investing in modernization. The terminology and framing are appropriate and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 481,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "In 2022 the equity portion of NextEra Energy’s nuclear‑decommissioning “special‑use” funds generated a $1.028 billion unrealized loss, indicating a relatively modest equity allocation that was largely held directly (Level 1) 【page_91†L31-L38】. By 2024 the company had expanded that equity exposure to $6.2 billion, with Level 1 holdings rising to $2.6 billion and Level 2 commingled‑fund holdings growing to $3.3 billion, turning the position into a $917 million unrealized gain 【page_89†L9-L15】【page_91†L31-L38】. This reflects a strategic shift toward a larger, more diversified equity portfolio within the special‑use funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific numbers ($1.028B unrealized loss in 2022, $6.2B equity in 2024, $2.6B Level 1, $3.3B Level 2, $917M unrealized gain in 2024) that are NOT present in the ground truth answer. The ground truth only mentions $8,922M total in 2022 and $6,164M in equity securities in 2024 - no breakdown of unrealized gains/losses or Level 1/Level 2 allocations. The LLM appears to have fabricated specific financial metrics and fair value hierarchy details. (2) FACTUAL INCONSISTENCY: The ground truth states 'no explicit breakdown of equity securities provided in the filing' for 2022, yet the LLM claims specific 2022 equity loss figures. This contradicts the source material. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and provide detailed analysis, it does so with numbers that cannot be verified against the ground truth, suggesting hallucination rather than accurate synthesis. (4) SEMANTIC ISSUES: The LLM's narrative about 'strategic shift toward larger, more diversified equity portfolio' aligns with the ground truth's conclusion about 'greater emphasis on equity investments,' but the supporting numbers are unreliable. (5) CITATION CONCERNS: The LLM provides specific page references and line numbers that cannot be verified and appear to be fabricated citations. The ground truth answer is more conservative and accurate in acknowledging what was and wasn't disclosed. The LLM's answer reads plausibly but contains invented financial data that fundamentally undermines its credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 440,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The smokeable‑products segment saw a modest contraction. Net revenues fell from **$22.476 billion in 2022 to $21.756 billion in 2023** (a drop of about $720 million, ≈3 %) and **operating income slipped from $10.688 billion to $10.670 billion** (down roughly $18 million, ≈0.2 %)【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All financial figures are correct: net revenues of $22.476 billion (2022) and $21.756 billion (2023), operating income of $10.688 billion (2022) and $10.670 billion (2023). The calculations are accurate: revenue decline of $720 million (22.476 - 21.756 = 0.720), representing approximately 3.2% decrease (720/22.476 ≈ 3.2%), and operating income decline of $18 million (10.688 - 10.670 = 0.018), representing approximately 0.17% decrease (18/10.688 ≈ 0.17%). The LLM correctly rounded these percentages to 3% and 0.2% respectively, which is reasonable rounding. The answer properly synthesizes the multi-hop requirement by comparing both metrics across both years, clearly showing the evolution of financial performance. The characterization of the changes as 'modest contraction' and 'marginal decrease' is semantically equivalent to the ground truth's description. The format variation ($22.476 billion vs $22,476 million) is acceptable and properly handled. The only minor observation is that the LLM's 0.2% rounding of the operating income decline is slightly conservative (actual is ~0.17%), but this is negligible and within acceptable rounding conventions. The answer directly addresses the question about how smokeable products' financial performance evolved from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 377,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.2 million Class A ordinary shares—9.6 million through its publicly announced open‑market program and 2.5 million via employee‑withholding purchases—and held them as treasury to fund equity awards and other employee‑benefit plans, with the Board raising the total repurchase authority to $6.13 million (page 94). The 2023 filing indicates that the same open‑market purchase program and its employee‑benefit usage continued under the existing authority (page 93), although a detailed 2023 purchase volume is not disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific share repurchase numbers (12.2M, 9.6M, 2.5M shares) and authorization amounts ($6.13 million) that are NOT present in the ground truth answer. The ground truth cites an aggregate available authorization of $3,129,296 for 2022, but the LLM states $6.13 million for the Board's raised authority - these are fundamentally different figures and the LLM's numbers cannot be verified against the provided ground truth. The LLM appears to have fabricated or misread specific share volumes. (2) ENTITY/METRIC CONFUSION - The ground truth discusses 'aggregate available authorization of $3,129,296' which appears to be a remaining balance, not a total authorization. The LLM's $6.13 million figure is presented as if it's the raised authority but lacks proper context and contradicts the ground truth's $3.1M figure. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that shares were held as treasury for employee benefits and mentions both open-market and employee-withholding programs, it fails to properly synthesize the evolution between 2022 and 2023 as requested. The ground truth emphasizes a 'shift in focus toward internal employee compensation mechanisms' which the LLM does not adequately capture. (4) MISSING KEY CONTEXT - The LLM does not mention the fiscal 2024 share withholding information that the ground truth includes as part of the evolution narrative. (5) CITATION ISSUES - The LLM cites specific pages (94, 93) but provides numbers that don't align with the ground truth's documented figures, suggesting potential hallucination or misreading of source material. The answer contains some correct conceptual elements (treasury shares, employee benefits, open-market programs) but the specific quantitative claims are unreliable and contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 504,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "In the 2022 filing AMT’s operating covenants were tied to its 2021 revolving credit facilities and term loans (the 2021 Multicurrency Credit Facility, Credit Facility, Term Loan and the EUR‑ and USD‑delayed‑draw term loans). These agreements imposed standard reporting, financial‑information and “other restrictions” (e.g., limits on additional debt, guarantees and asset sales) and the borrowings were priced at LIBOR (for USD) or EURIBOR (for EUR) + 1.125 % (see page_113 and page_114).  \n\nBy the 2024 filing the covenant framework had shifted to the securitization structures (the Loan Agreement and the 2015 Indenture) and other subsidiary debt, adding DSCR‑based cash‑trap, reserve‑account and amortization triggers and prohibiting new indebtedness, while the debt instruments now carry mostly fixed rates (e.g., 3.029 % on the 2015 notes, 3.652 %/4.459 % on the 2018 securities, 5.490 %/5.735 % on the 2023 securities) and new benchmarks such as SOFR + spread for Nigeria letters of credit (see page_117 and page_116).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of AMT's operating covenants between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 debt instruments (2021 Multicurrency Credit Facility, Credit Facility, Term Loans with EUR and USD variants) and their LIBOR/EURIBOR benchmarks. (2) Accurately notes the shift to SOFR-based structures by 2024, specifically mentioning Nigeria letters of credit. (3) Provides specific interest rate percentages (LIBOR/EURIBOR + 1.125% for 2022; fixed rates like 3.029%, 3.652%/4.459%, 5.490%/5.735% for 2024 securities). (4) Correctly identifies the shift from revolving credit facilities to securitization structures (Loan Agreement, 2015 Indenture) as the primary covenant framework by 2024. (5) Adds valuable detail about DSCR-based cash-trap, reserve-account, and amortization triggers in 2024 covenants. (6) Properly synthesizes multi-hop information across years and debt instruments. MINOR WEAKNESSES: (1) The ground truth emphasizes the transition away from LIBOR toward SOFR as a strategic/regulatory evolution, while the LLM answer focuses more on the structural shift from revolving facilities to securitization structures. Both are correct but emphasize different aspects. (2) The LLM answer provides more granular detail than the ground truth (specific percentages, page references), which is generally positive but slightly beyond the scope of the original answer's focus on 'nature and structure' evolution. (3) The ground truth's emphasis on LIBOR/EURIBOR in 2022 and SOFR in 2024 as the primary benchmark evolution is well-captured but the LLM adds the complication of fixed-rate instruments, which is accurate but slightly shifts the narrative. QUANTITATIVE VERIFICATION: The interest rate spreads and fixed rates provided appear reasonable and specific, though they cannot be independently verified against the source documents in this evaluation. The benchmark transitions (LIBOR/EURIBOR to SOFR) are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying different debt instruments and their associated benchmarks in each period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 588,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Disney+ Hotstar’s paid subscriber base rose to roughly 36 million by September 28 2024 【page_7】, up from a smaller share of the 66.1 million international subscriber base reported in the 2023 filing 【page_58】—showing continued growth of the Hotstar service. In June 2024 Disney merged Star+ into Disney+ across Latin America, creating a single Disney+ product that streamlines the brand, expands content (including sports), and reinforces Disney’s strategy of a unified, globally‑branded streaming platform 【page_57】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and strategic initiatives. STRENGTHS: (1) Correctly identifies Disney+ Hotstar's 36 million paid subscribers as of September 28, 2024 - matches ground truth exactly. (2) Accurately dates the Star+ consolidation to June 2024 (ground truth says 'by the end of June 2024'). (3) Properly synthesizes the multi-hop information about the consolidation strategy and its purpose (streamlining, unified branding, content expansion). (4) Correctly references the 66.1 million international subscriber base from 2023 filing as context. (5) Appropriately characterizes the strategic shift toward unified service offerings. MINOR WEAKNESSES: (1) The phrasing 'up from a smaller share of the 66.1 million international subscriber base' is slightly awkward - the 66.1 million appears to be total international subscribers, not specifically Hotstar's prior base, creating minor ambiguity about the growth comparison. However, this doesn't constitute a factual error, just imprecise framing. (2) The answer could have been slightly more explicit about the timing difference between the 2023 and 2024 filings, though this is a minor omission. QUANTITATIVE VERIFICATION: All numbers are accurate - 36 million (correct), 66.1 million (correct), June 2024 consolidation date (correct). MULTI-HOP REASONING: Successfully synthesizes information across multiple filing periods and geographic regions to explain the strategic evolution. The connection between Hotstar's model and the Latin America consolidation is logically sound. SEMANTIC EQUIVALENCE: The answer conveys the same substantive information as the ground truth while using slightly different phrasing, which is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 478,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The 2022 filing said the company expected to renegotiate 21 collective‑bargaining agreements covering roughly 3,000 employees and noted that about one‑fifth of its workforce (≈62 agreements) was union‑covered【page_77】. The 2023 filing again reports that roughly one‑fifth of employees were covered by 62 collective agreements, showing essentially no change in the number of workers under such agreements【page_79】. This unchanged proportion indicates General Dynamics is maintaining a stable labor‑agreement strategy—keeping the share of union‑covered employees steady while regularly renegotiating the existing agreements without material disruption.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Numbers: The ground truth clearly states that in 2023, the company projected negotiations covering 2,100 employees (a reduction from 3,000 in 2022). The LLM answer claims 'roughly one-fifth of employees were covered by 62 collective agreements' in both years with 'essentially no change,' which directly contradicts the ground truth's documented reduction from 3,000 to 2,100 employees. (2) QUANTITATIVE ACCURACY FAILURE: The LLM conflates two different metrics - the number of employees expected to be involved in renegotiations (3,000 in 2022, 2,100 in 2023) with the total number of union-covered employees (which may be represented as a proportion). The LLM incorrectly treats these as the same metric and concludes there was 'no change,' when the ground truth explicitly documents a reduction of 900 employees in renegotiation scope. (3) MULTI-HOP REASONING ERROR: The LLM failed to properly synthesize the year-over-year comparison. It should have identified the 3,000 → 2,100 employee reduction and interpreted this as indicating a shift in strategy (fewer expiring agreements or proactive resolution), as the ground truth states. Instead, it incorrectly concluded stability. (4) SEMANTIC MISALIGNMENT: The ground truth's conclusion about 'a shift in the company's labor agreement strategy' is fundamentally different from the LLM's conclusion about 'maintaining a stable labor-agreement strategy.' The LLM answer is factually incorrect on the core quantitative finding and reaches an opposite strategic conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 446,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "In 2022 NextEra Energy held **$137 million** of U.S. Government and municipal bonds (Level 1 $131 m + Level 2 $6 m)【page_101】. By the end of 2024 that investment had risen to **$722 million** (Level 1 $663 m + Level 2 $59 m)【page_89】. The total holding therefore increased by roughly **$585 million** over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. CRITICAL ERRORS: (1) 2024 value is drastically wrong - LLM states $722 million vs. ground truth of $161 million (a 348% overstatement). (2) The calculated change is completely incorrect - LLM claims $585 million increase vs. ground truth of $24 million increase (a 2,337% overstatement). (3) The 2022 value of $137 million is correct, but this is the only accurate number in the response. (4) The LLM appears to have pulled data from different investment categories or misidentified the specific bond holdings being measured. The breakdown provided (Level 1 and Level 2 classifications) suggests the LLM may have aggregated broader investment categories rather than specifically U.S. Government and municipal bonds. (5) Multi-hop synthesis failed - the model did not correctly identify and extract the specific bond investment values across the two years. The magnitude of error (off by $585M vs. correct answer of $24M) indicates either a fundamental data retrieval error or confusion between different investment line items in the 10-K filings. The answer is factually incorrect on the primary metrics requested and would mislead any user relying on this information for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 363,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "In the 2022 filing BMS described Opdivo as a mature immuno‑oncology product for which the company “has the capability to manufacture Opdivo internally and has arrangements with third‑party manufacturers to meet demand” (page 27). By the 2024 filing Opdivo’s portfolio importance had expanded dramatically, with new FDA and EU approvals for first‑line urothelial carcinoma (March 2024), neoadjuvant resectable NSCLC (Oct 2024), the sub‑cutaneous Opdivo Qvantig formulation (Dec 2024) and Opdivo + Yervoy for MSI‑high colorectal cancer (Dec 2024) (pages 44‑45), cementing Opdivo as a core IO asset while BMS continues to rely on its flexible internal‑and‑third‑party manufacturing network to supply these additional indications.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2022 manufacturing strategy with both internal and third-party capabilities, with accurate page reference (page 27). (2) Accurately cites the March 2024 FDA approval for first-line urothelial carcinoma treatment, matching the ground truth. (3) Provides additional relevant approvals (neoadjuvant resectable NSCLC in Oct 2024, Opdivo Qvantig in Dec 2024, Opdivo + Yervoy for MSI-high colorectal cancer in Dec 2024) that demonstrate portfolio expansion beyond the ground truth's single example. (4) Correctly synthesizes the multi-hop information showing evolution from 2022 to 2024 across both manufacturing and therapeutic dimensions. (5) Appropriately contextualizes Opdivo as a core IO asset within BMS's oncology portfolio. MINOR CONSIDERATIONS: (1) The ground truth mentions only the March 2024 urothelial carcinoma approval as the specific example, while the LLM provides four additional approvals. While these appear factually accurate based on the filing references cited (pages 44-45), they go beyond what was explicitly stated in the ground truth answer. This represents expansion rather than contradiction. (2) The LLM's answer is more detailed and comprehensive than the ground truth, which could be viewed as either more informative or potentially introducing unverified details. However, the specific approvals and dates cited appear consistent with typical BMS filing disclosures. QUANTITATIVE ACCURACY: All dates are correctly formatted and appear accurate (March 2024, Oct 2024, Dec 2024). Page references are provided and appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning correctly synthesizes manufacturing strategy continuity with therapeutic expansion, demonstrating sound multi-hop analysis. The answer properly addresses both sub-components of the question (manufacturing strategy and therapeutic approvals). CONTEXTUAL RELEVANCE: Highly relevant, directly addressing the evolution question with specific temporal markers and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 571,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "In the 2023 filing Disney said the National Geographic magazine (and its online business) is part of the Entertainment segment’s Content Sales/Licensing line and is owned 73 % by the company【page_78】. The 2024 filing still reports the magazine under Content Sales/Licensing (and notes it is published by Disney)【page_7】, but now places it alongside National Geographic Channels in the Linear Networks portfolio【page_5】, showing the same 73 % ownership while emphasizing tighter integration of the magazine within a broader, cross‑platform National Geographic brand strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2024, 'the emphasis on its ownership percentage was removed' and the relationship shifted to be 'more operational rather than ownership-focused.' However, the LLM answer claims the 2024 filing 'shows the same 73% ownership,' which directly contradicts the ground truth. This is a major error on the central point of how the relationship evolved. QUANTITATIVE ACCURACY: The 73% ownership figure for 2023 is correct, but the claim that this percentage is still shown in 2024 is incorrect per the ground truth. QUALITATIVE ACCURACY: The LLM introduces information about National Geographic Channels and Linear Networks portfolio positioning that is not mentioned in the ground truth answer. While this might be accurate from the filings, it represents a different framing of the evolution than what the ground truth emphasizes. The ground truth focuses on the shift from ownership-stake language to operational/publication language, whereas the LLM emphasizes integration into a broader cross-platform strategy. MULTI-HOP REASONING: The LLM failed to correctly synthesize the key distinction between 2023 and 2024 - the removal of ownership percentage emphasis. Instead, it claims the ownership percentage is still shown, which is the opposite of what the ground truth indicates. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is fundamentally different from the ground truth. The ground truth emphasizes a shift from ownership-focused to operationally-focused language, while the LLM emphasizes strategic integration and cross-platform positioning while maintaining ownership emphasis. These are contradictory interpretations of the same evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 495,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "In the 2023 filing PayPal simply noted that it “has developed … transaction‑management databases … to enable our customers to utilize our suite of products and services,” without tying those databases to a specific global‑currency scope. By the 2024 filing the same language appears, but it is now placed alongside a detailed statement that the platform can send payments in roughly 200 markets and ≈ 140 currencies (down from ≈ 150 in 2023) and withdraw funds in 57 currencies (up from 56), signaling that the databases are now explicitly described as supporting a broader, multi‑currency, worldwide payment‑processing capability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant issues in quantitative accuracy. CORRECT ELEMENTS: (1) The core finding that withdrawal currencies increased from 56 (2023) to 57 (2024) is accurate and matches ground truth. (2) The observation about transaction management databases and their role in enabling customers to use PayPal's suite of products is correct. (3) The multi-hop synthesis attempting to connect database capabilities to broader payment processing scope is conceptually sound. (4) The contextual framing about explicit description of database support for multi-currency processing is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about ~200 markets and ~140 currencies (down from ~150 in 2023) that is NOT present in the ground truth answer. This represents either hallucination or information from sources not reflected in the knowledge graph baseline. (2) The ground truth specifically mentions a shift in framing from 'customers' to placing 'consumers' ahead of 'merchants' - the LLM answer does not capture this important qualitative evolution in positioning. (3) The LLM's statement that 2023 filing 'simply noted' without tying to currency scope, while 2024 'now placed alongside' currency details, suggests a structural change in how information is presented that the ground truth does not explicitly confirm. QUANTITATIVE VERIFICATION: The 56→57 currency withdrawal figure is correct. However, the introduction of 200 markets and 140/150 currencies figures cannot be verified against the ground truth and may represent unsupported claims. MULTI-HOP REASONING: The LLM attempts to synthesize database capabilities with payment processing scope, but does so by introducing unverified data points rather than focusing on the documented evolution between years. The answer would score higher if it had focused on the confirmed currency expansion and the consumer/merchant framing shift mentioned in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 534,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "In March 2023 NEECH remarketed its $2.5 billion Series K debentures (due 1 Mar 2025) and reset the coupon to **6.051 % per year**, payable semi‑annually on 1 Mar and 1 Sep. The 2024 filing shows no further amendment – the 6.051 % rate remains in effect – indicating that NEE uses remarketing to align its debt cost with market conditions while keeping the terms of the existing issuance stable, a strategy that balances cost‑optimization with financing predictability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the 6.051% interest rate, the March 2023 remarketing date, the $2.5 billion principal amount, and the maturity date (March 1, 2025). The semi-annual payment schedule (March 1 and September 1) is also correctly stated. However, there are notable qualitative issues: (1) The original answer indicates that 2024 filings showed 'further updated' terms through a letter dated March 1, 2023, suggesting some evolution or continuation of updates between 2023 and 2024, but the LLM answer states 'no further amendment' and that the rate 'remains in effect.' This represents a potential misinterpretation of the ground truth's suggestion of continued updates. (2) The original answer emphasizes that the 6.051% rate was 'locked in' as a 'higher interest rate to secure funding,' indicating a strategic response to market conditions, while the LLM answer frames this as 'cost-optimization,' which is somewhat contradictory (locking in a higher rate is not typically cost-optimization). (3) The LLM answer provides more specific operational details (semi-annual payment dates, maturity date) not in the original answer, which adds value but wasn't explicitly required. The multi-hop reasoning is sound in connecting the 2023 remarketing to 2024 terms, though the interpretation of 'no further amendment' may diverge from the ground truth's implication of continued term updates. The answer adequately addresses the financing strategy question but with a slightly different interpretation of the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 438,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil’s unit‑of‑production depreciation policy was essentially unchanged from 2022 to 2023. In both filings the company still bases depreciation on the ratio of asset cost to total proved (or proved‑developed) reserves applied to actual production, uses straight‑line depreciation only when an asset’s useful life does not reasonably match the reserve life, and, if proved reserves are substantially de‑booked, re‑calculates depreciation using the most recent SEC price adjusted for production and technical changes (2022 p. 77; 2023 p. 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core methodology and page references (2022 p. 77; 2023 p. 73), and accurately describes the technical mechanics of the unit-of-production method in both years. However, the answer significantly misses the key evolution that the ground truth emphasizes. The ground truth explicitly states that by 2023, ExxonMobil 'placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced' and that this represents 'a refinement in the company's approach to align depreciation with updated economic conditions and production realities.' The LLM answer dismisses this as 'essentially unchanged,' which contradicts the ground truth's characterization of a meaningful refinement. The LLM correctly captures that both years use proved reserves, switch to straight-line when appropriate, and re-calculate using SEC prices when reserves are de-booked. However, it fails to capture the nuanced shift in emphasis and the stated rationale for this refinement (aligning with economic conditions and production realities). The answer is technically accurate in describing the mechanics but incomplete in addressing the 'evolution' aspect of the question. The LLM's conclusion that the policy was 'essentially unchanged' represents a misinterpretation of the ground truth's characterization of this as a meaningful refinement, even if the core methodology remained the same. This is a case where the LLM captured the 'what' but missed the 'how it evolved' aspect of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 438,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "In the 2023 Form 10‑K Netflix stressed that its original programming was largely produced through third‑party partners, explicitly noting “we contract with third parties related to the development, production, marketing and distribution of our original programming” and the associated risks (see page 7). By the 2024 filing the company still acknowledges those third‑party contracts but adds a stronger focus on “scaling our own studio operations to produce original content, including through acquisitions such as Scanline and Animal Logic,” signaling a shift toward more in‑house production capacity (see page 7).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key entities (Netflix, Scanline, Animal Logic) and years (2023 vs 2024), and accurately cites the strategic shift toward internal studio scaling through acquisitions. However, there are significant issues with the core narrative: (1) The LLM claims that in 2023 Netflix 'largely produced through third-party partners' and that by 2024 'the company still acknowledges those third-party contracts but adds a stronger focus' on internal scaling. This misses the ground truth's critical insight: the 2023 filing explicitly highlighted third-party risks (liability, legal violations, insolvency, fraud), while the 2024 filing OMITTED these risk mentions entirely, suggesting reduced dependency. The LLM presents this as a continuous acknowledgment of third-party reliance with added internal focus, rather than a strategic shift away from third-party dependency. (2) The LLM states both years 'still acknowledge those third-party contracts,' but the ground truth indicates the explicit mention of third-party risks was 'omitted in 2024,' which is a material difference in strategic emphasis. (3) The LLM correctly identifies the acquisitions (Scanline, Animal Logic) as evidence of internal scaling, which aligns with ground truth. (4) The LLM's characterization of the shift as 'stronger focus' on in-house production is partially correct but understates the significance: the ground truth describes this as 'a stronger strategic move toward internal control and scaling' with reduced external partner dependency. The answer captures some correct elements but misses the nuanced strategic pivot regarding third-party risk reduction that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 465,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "In the 2022 filing, cyber and intelligence solutions were listed under “Other revenues” and described mainly as fee‑based services that help prevent, detect and respond to fraud and keep Mastercard transactions safe. By the 2023 filing, they are highlighted in the Business Overview as a core value‑added offering that enables all parties to transact securely, easily and with confidence, and are positioned as a key component of Mastercard’s multi‑layered security and data‑insight strategy—showing a shift from a peripheral revenue line to a central strategic pillar.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: Both answers correctly identify the evolution of Cyber and Intelligence Solutions from 2022 to 2023, with accurate positioning in 'Other revenues' in 2022 and elevation to strategic importance in 2023. The LLM answer accurately captures the core functional descriptions (fraud prevention, detection, response) and the shift in strategic positioning. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable. Both correctly reference 2022 and 2023 fiscal years. (3) ENTITY ACCURACY: Mastercard is correctly identified throughout. The LLM properly names the business segment 'Cyber and Intelligence Solutions' consistently. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two years by comparing positioning in different sections of filings (from 'Other revenues' to 'Business Overview') and describing the functional shift from peripheral to central strategic importance. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different but semantically equivalent language - 'fee-based services' vs 'products and services,' 'core value-added offering' vs 'value-added service,' and 'central strategic pillar' vs 'elevated in strategic importance.' These variations enhance clarity without sacrificing accuracy. The LLM adds the detail about 'multi-layered security and data-insight strategy' which provides additional context consistent with the ground truth's mention of 'supporting Mastercard's core operations and new network investments.' Minor deduction (1 point) only because the LLM's characterization of the 2022 positioning as 'peripheral revenue line' is slightly more interpretive than the ground truth's more neutral description, though this interpretation is reasonable and supported by the filing context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 524,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "In 2023 Tesla presented its storage line (Powerwall and Megapack) as modular products that reuse vehicle‑level battery and power‑electronics technology and are supported by remote‑control software and a strong service warranty 【page_5】 【page_7】. By the 2024 filing the company is warning that ramping those same products has been hit by bottlenecks, supplier‑related delays and raw‑material shortages, and that its ability to scale storage now hinges on external lithium‑ion cell suppliers such as Panasonic and CATL – prompting a strategic push to develop its own cells to lessen that dependence 【page_16】【page_17】【page_18】【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of Tesla's energy storage approach from 2023 to 2024. In 2023, it correctly identifies the emphasis on modular design, reuse of vehicle-level battery and power electronics technology, and software/service support. In 2024, it correctly identifies the shift to addressing production challenges, supply chain bottlenecks, and supplier dependencies. The specific mention of Panasonic and CATL as external lithium-ion cell suppliers is accurate and adds valuable specificity. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable. The answer appropriately avoids making unsupported numerical claims. (3) ENTITY ACCURACY: All entities are correctly identified - Tesla, Powerwall, Megapack, Panasonic, and CATL are all accurate. The years 2023 and 2024 are correctly referenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years and documents, correctly identifying the strategic shift from emphasizing in-house capabilities to acknowledging external dependencies and the need for internal cell development. The logical progression from 2023 strengths to 2024 challenges is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing additional concrete details (specific supplier names, product names like Powerwall and Megapack). The phrase 'strategic push to develop its own cells to lessen that dependence' effectively captures the company's response to supply chain risks. Minor note: The LLM answer is slightly more detailed and specific than the ground truth, which is appropriate for a comprehensive response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 512,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "In the 2023 filing, NextEra Energy Capital Holdings reported $400 million of variable‑rate (floating‑rate) debentures, all of which were scheduled to mature in 2024 (see the 2023 debt table on page 103). By the 2024 filing, the company had sold a larger $600 million tranche of floating‑rate debentures and pushed the maturity out to 2026, as part of its $3.8 billion debenture program (see the 2024 note on page 105). This reflects a $200 million increase in principal and a shift from a short‑dated 2024 maturity to a longer‑dated 2026 maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 2023 had $400 million in floating-rate debentures maturing in 2024, but the ground truth states $600 million in floating-rate debentures due in 2026 in 2023. The LLM then claims 2024 had $600 million due in 2026, which matches the ground truth for 2023, not 2024. This represents a fundamental misreading of the timeline and amounts. The LLM calculates a $200 million increase ($400M to $600M), but this comparison is between incorrect baseline figures. (2) MATURITY STRUCTURE ERROR: The LLM incorrectly states that 2023 had debentures maturing in 2024, when the ground truth clearly indicates 2026 maturity in 2023. The LLM's claim of a shift from 2024 to 2026 maturity is factually wrong. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison. It appears to have confused or misread the 2023 and 2024 filing data, presenting 2023 data as if it were from a different year. (4) SEMANTIC ISSUES: While the LLM correctly identifies the company (NextEra Energy Capital Holdings) and the general concept of floating-rate debentures, the specific numbers, dates, and evolution narrative are incorrect. The ground truth indicates consistency and continuation of the $600 million 2026 maturity structure, not an increase from $400M to $600M or a maturity extension from 2024 to 2026. The LLM's answer is internally inconsistent with the ground truth on nearly every quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 425,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "In the 2023 filing Intel said it “actively collaborates with other companies and lead[s] industry initiatives on key issues such as improving transparency around climate and water impacts in the global electronics supply chain, and … advancing collaboration across our industry on responsible minerals sourcing” and it works with a defined set of direct and indirect suppliers through audits and capability‑building programs 【page_13】.  \n\nBy the 2024 filing Intel notes that it is “significantly expanding the number of suppliers covered by our engagement activities” and that its “supply chain environmental team is also actively engaging suppliers to measure and reduce their greenhouse‑gas emissions footprints,” while still focusing the industry collaboration on climate‑water transparency and responsible minerals as part of its RISE strategy 【page_20】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer fundamentally reverses the chronological evolution described in the ground truth. The ground truth states that in 2023 Intel announced expansion of supplier engagement (increasing number of suppliers covered), while by 2024 the approach evolved to emphasize broader collaboration without explicit mention of expanding supplier numbers. However, the LLM answer inverts this timeline: it attributes the 2023 statement to describing existing engagement with 'a defined set' of suppliers, then claims the 2024 filing mentions 'significantly expanding the number of suppliers covered.' This is backwards from the ground truth. The LLM correctly identifies the industry collaboration themes (climate/water transparency, responsible minerals sourcing, RISE strategy) but misattributes them to the wrong years and misrepresents the directional evolution. The ground truth indicates a shift FROM strategic expansion announcements TO deepening existing partnerships, but the LLM presents it as the opposite. Additionally, the LLM provides page citations (page_13, page_20) that cannot be verified against the ground truth provided, and the quote structure suggests the LLM may be conflating or misquoting source material. The answer fails the core requirement of accurately synthesizing the multi-hop evolution across 2023-2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 378,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "In the 2022 filing ExxonMobil simply stated that the standardized measure is calculated using “first‑day‑of‑the‑month average prices, year‑end costs and legislated tax rates, and a 10 % discount factor” (see XOM 2022, pages 128‑132) and noted that the measure is not a reliable estimate of future cash flows. By contrast, the 2023 disclosure adds a qualifying comment that those first‑day‑of‑the‑month average prices “represent discrete points in time and therefore may cause significant variability in cash flows from year to year as prices change” (XOM 2023, page 133), explicitly flagging the price‑point volatility in its assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in XOM's disclosures between 2022 and 2023 regarding the standardized measure of discounted future cash flows. STRENGTHS: (1) Accurately captures the shift from a straightforward statement of calculation methodology in 2022 to an explicit acknowledgment of price volatility risk in 2023; (2) Correctly identifies the specific language about 'discrete points in time' and 'significant variability in cash flows from year to year'; (3) Properly notes the 10% discount factor and other unchanged methodological elements; (4) Correctly cites the page numbers (128-132 for 2022, 133 for 2023); (5) Accurately characterizes the 2022 filing's statement that the measure is 'not a reliable estimate of future cash flows.' WEAKNESSES: (1) The LLM answer uses slightly different framing than the ground truth - it emphasizes that 2022 'simply stated' the calculation methodology without highlighting dependency, whereas the ground truth more explicitly contrasts 'prepared on the basis of certain prescribed assumptions' (2022) with 'depends on' (2023); (2) The LLM answer doesn't fully capture the nuance that the ground truth emphasizes about the shift from foundational framing to explicit dependency acknowledgment - the LLM focuses more on the addition of volatility language rather than the underlying shift in how the assumptions are characterized; (3) Minor semantic difference: the ground truth emphasizes the shift in 'tone' and 'explicit acknowledgment of sensitivity and dependency,' while the LLM focuses on the addition of qualifying comments about price-point volatility. QUANTITATIVE VERIFICATION: The 10% discount factor is correctly stated. Page numbers appear reasonable for 10-K filings. No calculation errors present. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and identifies the evolution in disclosure language. The reasoning is sound and logically structured. OVERALL: The answer is substantially correct and addresses the core question effectively, though it could have more explicitly highlighted the shift from 'prescribed assumptions' framing to 'depends on' framing as the primary evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 593,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "In 2022 Mastercard described its digital‑identity suite as part of its open‑banking platform, offering device intelligence, behavioral biometrics, document‑proofing, IP intelligence and other consent‑centric tools to secure payments and create seamless digital experiences (page 17). By 2023 the identity services were more tightly woven into open‑banking—supporting a new ACH bill‑pay offering—and the platform’s reach expanded to cover > 95 % of U.S. deposit accounts and roughly 3,000 banks across Europe, dramatically widening its footprint across financial institutions (page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - >95% of U.S. deposit accounts and ~3,000 banks across Europe are accurately cited with proper formatting. The dates (2022 vs 2023) are correct. COMPLETENESS: The answer addresses all major components of the question: (1) 2022 digital identity solutions description, (2) open banking platform integration, (3) 2023 expansion and evolution, (4) reach across financial institutions. ENTITY ACCURACY: Mastercard (MA) is correctly identified, years are accurate, and financial services terminology is precise. MULTI-HOP REASONING: The answer successfully synthesizes information across two years, showing the evolution from 2022 introduction to 2023 expansion, and correctly links digital identity solutions to open banking capabilities and ACH payment solutions. SEMANTIC EQUIVALENCE: The LLM answer uses slightly different but semantically equivalent language - 'tightly woven into open-banking' conveys 'deeper integration,' and 'dramatically widening its footprint' conveys 'significantly enhanced reach.' The specific tools mentioned (device intelligence, behavioral biometrics, document-proofing, IP intelligence) add helpful detail not contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer includes specific technical details about the identity suite components that enhance understanding without contradicting the ground truth. The page references (page 17) add credibility. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 442,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "In the 2023 filing Tesla presented Solar Roof as a design‑driven product it was already selling—highlighting engineering iterations, integration with Powerwall and efforts to improve installation efficiency and partner with builders (see page 6 & page 7). By the 2024 filing the narrative had shifted to acknowledge concrete production‑ramp delays for Solar Roof and to stress that scaling the product now depends on overcoming bottlenecks and securing reliable component supply and manufacturing capacity (see page 17 and page 16).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Tesla's Solar Roof approach between 2023 and 2024, correctly identifying the shift from emphasizing design maturity and product features (2023) to acknowledging production delays and supply chain challenges (2024). The answer demonstrates sound multi-hop reasoning by synthesizing information across two filing years and connecting product-specific challenges to broader strategic dependencies. STRENGTHS: (1) Correctly identifies the 2023 narrative focus on engineering, design, Powerwall integration, and installation efficiency; (2) Accurately captures the 2024 shift to acknowledging production-ramp delays; (3) Properly identifies supply chain and manufacturing capacity as key bottlenecks in 2024; (4) Appropriate use of page references suggests document-based sourcing; (5) Semantic equivalence with ground truth regarding strategic prioritization implications. WEAKNESSES: (1) The LLM answer mentions 'component supply and manufacturing capacity' as specific bottlenecks but doesn't explicitly reference the ground truth's broader point about 'scaling mass-market vehicle production' as a strategic dependency that could indirectly affect Solar Roof timelines—this represents a minor omission of the indirect strategic prioritization signal; (2) The phrase 'depends on overcoming bottlenecks' is somewhat vague compared to the ground truth's more explicit framing of strategic prioritization shift; (3) No quantitative metrics provided (though none may be available in filings). QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high on what is presented. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is evident, though the connection to broader vehicle production prioritization could be more explicit. CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the question—production challenges and strategic dependencies across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 540,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "In the 2023 Form 10‑K the only pledge arrangement disclosed was a **Pledge Agreement dated September 1 2022** between **NextEra Energy, Inc.**, **Deutsche Bank Trust Company Americas** (as collateral, custodial and securities intermediary) and **The Bank of New York Mellon** (as purchase‑contract agent). The 2024 Form 10‑K adds two new pledge agreements – one **dated June 1 2024** and another **dated October 1 2024** – and both are also with Deutsche Bank Trust Company Americas and The Bank of New York Mellon, showing that the company has continued to use the same counterparties while expanding the number of pledge agreements in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All dates are correct: September 1, 2022 (from 2023 disclosure), June 1, 2024, and October 1, 2024 (from 2024 disclosure). All counterparties are correctly identified: Deutsche Bank Trust Company Americas and The Bank of New York Mellon. The answer properly synthesizes the multi-hop information by comparing the 2023 and 2024 Form 10-K filings and identifying the evolution in pledge agreements. The LLM correctly notes that the 2023 filing disclosed only one agreement while 2024 introduced two new agreements, and that the same counterparties were used throughout. The additional detail provided about the roles of the counterparties (collateral, custodial and securities intermediary for Deutsche Bank; purchase-contract agent for BNY Mellon) adds helpful context beyond the ground truth without introducing any inaccuracies. The reasoning is sound and demonstrates proper understanding of how the company's use of pledge agreements evolved. Minor: The ground truth uses slightly more concise language ('expanded their use over time') while the LLM provides more specific detail about the counterparties' roles, but this is an enhancement rather than an error. All factual information matches the ground truth perfectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 358,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "Intel’s 2023 filing described Edge‑AI as built on an “edge‑native software platform” with modular building blocks and the OpenVINO 2023.1 toolkit, and it emphasized a core set of ecosystem partners—Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google and Microsoft—to co‑engineer AI‑enabled edge solutions (page_30; page_31). By 2024 the strategy had broadened to a more open, cloud‑like software framework that bundles AI‑enabled platform services, now supported by an ecosystem of > 500 network builders and deeper telecom, cloud and hardware collaborations, and it is paired with new edge‑optimized silicon such as Xeon D‑1800/2800 processors with vRAN Boost to tightly integrate hardware and software for Edge AI (page_18).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Intel's Edge AI evolution from 2023 to 2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the 2023 'edge-native software platform' with modular building blocks and OpenVINO toolkit; (2) Accurately names specific ecosystem partners (Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google, Microsoft); (3) Correctly describes the 2024 shift toward a more open, cloud-like software framework; (4) Mentions new edge-optimized silicon (Xeon D-1800/2800 processors with vRAN Boost); (5) Notes the expansion to >500 network builders. WEAKNESSES: (1) The LLM answer mentions specific processor models and vRAN Boost details that, while potentially accurate, are not explicitly confirmed in the ground truth answer, creating potential over-specification; (2) The ground truth emphasizes Intel's NEX initiative as the organizing framework for 2024 strategy, but the LLM answer does not mention NEX by name, missing this key strategic branding element; (3) The ground truth highlights the conceptual shift from 'fixed-function hardware to general-purpose compute' and 'cloud-native software on programmable hardware,' which the LLM answer captures only partially through 'cloud-like software framework'; (4) The ground truth emphasizes avoiding vendor lock-in and supporting diverse architectures in 2023, which the LLM answer omits. QUANTITATIVE ACCURACY: The '>500 network builders' figure is mentioned in the LLM answer but not in the ground truth, making verification impossible; however, this appears to be a reasonable elaboration rather than an error. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across two years and identifies the key strategic shift, though it misses the NEX initiative framing. SEMANTIC EQUIVALENCE: The core message about evolution from modular edge-native platform to broader cloud-native ecosystem approach is conveyed, though with some loss of strategic nuance regarding the NEX initiative and general-purpose compute transformation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 552,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The 2030 senior‑note tranche was unchanged – in 2023 CVS reported $1.5 bn of 5.125 % notes due February 2030, $1.5 bn of 3.75 % notes due April 2030 and $1.25 bn of 1.75 % notes due August 2030, and the same three issues and amounts appear in the 2024 borrowing table (2023 borrowings page 168; 2024 borrowings page 161). Thus the 1.75 % senior notes due August 2030 remained at $1.25 bn, keeping the total 2030 senior‑note portfolio at $4.25 bn, while overall long‑term debt rose from $58.6 bn in 2023 to $60.5 bn in 2024 (2023 debt summary page 169; 2024 debt summary page 162).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 1.75% senior notes due August 2030: correctly stated as $1.25 bn (or $1,250 million) in both 2023 and 2024 - matches ground truth exactly. (2) 3.75% senior notes due April 2030: correctly stated as $1,500 million in both years - matches ground truth. (3) Additional context provided: LLM correctly identifies the 5.125% notes due February 2030 at $1.5 bn, which adds valuable context not explicitly in the ground truth but is factually accurate. (4) Total 2030 portfolio calculation: $1.5 bn + $1.5 bn + $1.25 bn = $4.25 bn - mathematically correct. (5) Overall long-term debt figures: correctly cited as $58.6 bn (2023) and $60.5 bn (2024) - these are accurate. (6) Multi-hop synthesis: The answer successfully synthesizes information across multiple years and debt instruments, showing the stability of the 1.75% notes while contextualizing within the broader debt portfolio. The LLM provides superior context by including page references and the complete 2030 debt picture. Minor note: The ground truth statement about 3.75% notes 'decreasing from $1,500 million in 2023 to $1,500 million in 2024' is awkwardly worded (no actual decrease), and the LLM correctly interprets this as stability. The LLM answer is more precise and informative than the ground truth while remaining factually accurate on all quantitative measures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 392,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "In the 2023 filing Netflix noted that it had **just launched a new, lower‑priced ad‑supported subscription tier** as a recent pricing adjustment intended to attract additional members and boost per‑member revenue【page_6】. By the 2024 filing the ad‑supported tier is described as **one of a range of pricing plans the company now offers to meet diverse consumer needs and to drive global membership growth**, indicating that the plan has moved from a newly‑tested offering to an established part of Netflix’s pricing strategy【page_3】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of Netflix's ad-supported plan from 2023 to 2024, correctly identifying it as a newly-launched lower-priced tier in 2023 and an established strategic component by 2024. The semantic meaning matches the ground truth perfectly - both describe the transition from experimental/new offering to integrated pricing strategy. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, which is appropriate given the question's qualitative nature. The temporal references (2023 vs 2024) are correct. (3) ENTITY ACCURACY: Netflix is correctly identified, years are accurate (2023 and 2024), and the financial metric (ad-supported subscription plan) is properly characterized. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing periods, correctly identifying the progression from launch phase to strategic integration. The logic is sound - the plan moved from addressing competitive pressures and membership expansion (2023) to being part of a diversified pricing portfolio (2024). (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('newly-tested offering to established part') effectively conveys the same evolution as the ground truth's 'experimental pricing to strategic offering.' The mention of 'per-member revenue' in the LLM answer adds a minor detail not explicitly in the ground truth but is contextually appropriate and not contradictory. The citation format with page references adds credibility. Minor deduction only because the LLM could have slightly more explicitly connected the membership growth objectives across both years, though this is implied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 494,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "In the 2023 Form 10‑K Tesla said it had entered “early production and deliveries” of the Tesla Semi, indicating a nascent commercial rollout. By the 2024 filing the Semi is listed as being in “pilot production” at the Nevada plant, and Tesla describes it as part of its effort to expand manufacturing capacity and integrate the truck into its next‑generation vehicle platform. This reflects a shift from initial limited production to a more structured, capacity‑focused phase for the Semi.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about Tesla Semi's evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 status as 'early production and deliveries' from the Form 10-K; (2) Accurately states the 2024 progression to 'pilot production' at the Nevada facility; (3) Properly characterizes the evolution from initial rollout to more structured/mature phase; (4) All dates and entities (Tesla, Nevada facility, Tesla Semi) are correct; (5) The multi-hop synthesis across two filing years is sound and logical. MINOR CONSIDERATIONS: (1) The LLM adds contextual detail about 'next-generation vehicle platform integration' which is not explicitly mentioned in the ground truth answer - this appears to be reasonable inference but represents slight elaboration beyond the core ground truth; (2) The ground truth emphasizes 'testing and scaling phase' while the LLM emphasizes 'capacity-focused phase' - these are semantically similar but slightly different framings; (3) The LLM's characterization of the shift is accurate but uses slightly different language ('capacity-focused' vs 'more mature testing and scaling'). QUANTITATIVE ACCURACY: Perfect - no numerical errors, dates are correct (2023 vs 2024), no calculations required. QUALITATIVE ACCURACY: Strong - correctly identifies the progression and strategic positioning, though with minor elaboration beyond ground truth. CONTEXTUAL RELEVANCE: High - directly addresses the question about how Tesla's approach evolved between the two years. The answer is comprehensive and appropriately detailed for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 454,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The 2024 filing adds two new Executive Retention Employment Agreements (Nicole J. Daggs – Jan 1 2024 and Brian Bolster – May 6 2024) to the two agreements that were in place in 2023 (Mark Lemasney – Jan 1 2023 and Armando Pimentel Jr. – Feb 15 2023)【page_125】. By extending retention contracts to additional senior leaders, NextEra Energy is deliberately bolstering leadership continuity and signaling that retaining top‑executive talent is a core strategic priority.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all four executives and their agreement dates. Quantitative accuracy is high: all names (Nicole J. Daggs, Brian Bolster, Mark Lemasney, Armando Pimentel Jr.), dates (Jan 1 2023, Feb 15 2023, Jan 1 2024, May 6 2024), and the count progression (2 in 2023 → 4 in 2024) are accurate. The multi-hop synthesis correctly identifies the expansion pattern and draws appropriate conclusions about strategic intent. However, there is one notable omission: the LLM identifies Nicole J. Daggs as a new 2024 agreement, which is correct, but the original answer specifically mentions only Brian Bolster as the new addition in 2024, suggesting the ground truth may have focused on a subset of the agreements or had different inclusion criteria. The LLM's inclusion of Nicole J. Daggs (Jan 1 2024) is factually accurate based on the filing reference provided, but represents a minor discrepancy with the ground truth's selective focus. The reasoning about leadership continuity, talent retention strategy, and proactive talent management is sound and well-articulated. The answer appropriately addresses the question's inquiry into what the expansion suggests about the company's approach. The semantic equivalence is strong—both answers convey that NextEra Energy expanded retention agreements and views executive retention as strategically important. The minor gap is the ground truth's more cautious framing about 'potential transition or uncertainty' and 'external pressures,' which the LLM answer doesn't explicitly address, though it does mention 'bolstering leadership continuity' as a core strategic priority.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 459,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "In the 2023 filing Intel listed xPU as a key R&D focus among several technology priorities, noting that it was expanding its portfolio into discrete GPUs, AI accelerators and IPU products but also flagging the risks of delays and the complexity of a disaggregated design approach (2023 p. 51‑53). By the 2024 filing, Intel elevated xPU to a central strategic pillar—“lead and democratize compute with Intel x86 and xPU”—describing a unified family of client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators that target AI, edge and autonomous‑driving workloads and are tied to its IDM 2.0/foundry strategy (2024 p. 5, 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The LLM correctly identifies the 2023 R&D context and the 2024 strategic elevation of xPU. While the ground truth mentions the specific $16.0 billion R&D spend in 2023, the LLM does not include this figure, but this is a minor omission rather than an error since the question asks about 'approach evolution' rather than specific R&D budgets. The page references (2023 p. 51-53, 2024 p. 5, 7) appear reasonable for SEC filings. QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop evolution: (1) 2023 positioning as one of several R&D priorities with acknowledged risks/complexity, and (2) 2024 elevation to a central strategic pillar. The LLM accurately captures the product family components (client/data-center GPUs, IPUs, FPGAs, accelerators) and the strategic framing ('lead and democratize compute with Intel x86 and xPU'). The connection to IDM 2.0/foundry strategy adds valuable context. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and demonstrates clear understanding of the strategic shift from general R&D focus to structured product development initiative. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution ('elevated to central strategic pillar' vs. ground truth's 'embedded more deeply into strategic priorities') conveys equivalent meaning. The mention of specific workloads (AI, edge, autonomous-driving) and the advisory group context align with the ground truth's emphasis on meeting diverse computing needs. MINOR GAPS: The LLM does not explicitly mention the advisory group for expanding the x86 ecosystem or the specific $16.0B R&D figure, but these are relatively minor contextual details that don't undermine the core answer about strategic evolution. The answer is well-structured, specific, and demonstrates strong document synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 527,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "In the 2023 filing Netflix described its ad business as “new” and noted that it had “limited experience and operating history offering advertising on our service” and that the offering was subject to many risks 【page_9】. By the 2024 filing the company was talking about actively building the capability – it highlighted its “relationship with third‑party service providers for the management, operation, sale and technology to support advertisements,” its “ability to develop and expand an advertising sales organization team,” and its “ability to develop the technology and related infrastructure to support advertising” 【page_10】. Thus, Netflix moved from a nascent, risk‑focused ad offering in 2023 to a more mature strategy that includes a dedicated sales organization and significant infrastructure investment in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Netflix's advertising technology evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 positioning as 'new' with 'limited experience' - this matches the ground truth characterization; (2) Accurately captures the shift toward internal development and infrastructure investment in 2024; (3) Properly synthesizes the multi-hop information comparing organizational and infrastructure approaches across two years; (4) Correctly identifies key themes: third-party dependencies in 2023 transitioning to internal capability development in 2024; (5) The semantic meaning aligns well with ground truth - both describe movement from nascent/risk-focused to mature/proactive stance. MINOR ISSUES: (1) The LLM answer includes a reference to 'relationship with third-party service providers' in the 2024 description, which could be interpreted as suggesting continued reliance on external providers. The ground truth emphasizes the shift 'from reliance on external providers to internal development,' so this phrasing might slightly muddy the narrative of evolution, though it's not factually incorrect - Netflix likely maintained some third-party relationships while building internal capabilities; (2) The page citations (page_9, page_10) cannot be verified against the ground truth but don't contradict it; (3) The answer could have been slightly more explicit about the contrast between 'limited experience' and 'ability to develop and expand,' though this is implied. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension scores high by default (9/10 - minor deduction for lack of specific metrics if they existed in source material). QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis correctly identifies the evolution pattern across years (8/10 - slight deduction for the potential ambiguity about third-party provider relationships). CONTEXTUAL RELEVANCE: The answer directly addresses the question about organizational development and infrastructure investment evolution (9/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 581,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "In the 2023 filing Tesla said that unlimited free Supercharging is a “stand‑ready” service that is recognized on a straight‑line basis over the expected ownership life of the vehicle, while any limited free‑Supercharging incentives are recognized when the customer actually uses them or the incentive expires. The 2024 filing keeps the same accounting treatment, but now reports a detailed deferred‑revenue schedule for the free‑Supercharging (and related) services – showing a beginning balance of $3.5 bn, additions of $1.34 bn, revenue recognized of $1.19 bn and an ending balance of $3.6 bn, with $872 m of revenue recognized in 2024 versus $469 m in 2023. Thus, the program structure (unlimited plus limited free‑Supercharging) remains unchanged, but Tesla has moved to more granular deferred‑revenue tracking and larger recognized revenue for the program in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR CONTRADICTION: The ground truth states that in 2023, free Supercharging was 'included under Automotive Sales Revenue' and 'bundled with vehicle sales,' but the LLM claims 2023 used 'stand-ready' service recognition on a straight-line basis over vehicle ownership life - these are fundamentally different accounting treatments. (2) QUANTITATIVE ERRORS: The LLM provides specific deferred revenue numbers ($3.5bn beginning balance, $1.34bn additions, $1.19bn recognized, $3.6bn ending, $872m 2024 vs $469m 2023) that cannot be verified against the ground truth and appear to be fabricated or from incorrect sources. These numbers are presented with false precision and confidence. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a structural SHIFT from 2023 to 2024 - moving from bundled automotive revenue recognition to deferred revenue treatment. The LLM incorrectly claims 'the program structure remains unchanged' and that only 'tracking' changed, missing the fundamental accounting treatment evolution. (4) MISSING KEY INSIGHT: The ground truth highlights that 2024 involved 'deferring revenue' and recognizing as 'liabilities to be amortized over time' - a key structural change. The LLM's framing of this as merely 'more granular tracking' understates the significance. (5) ACCURACY OF CHARACTERIZATION: The LLM's description of 2023 accounting (stand-ready service, straight-line basis) does not align with the ground truth's description of 2023 (bundled with automotive sales). The answer appears to conflate different accounting methods or misread the source documents. The specific dollar amounts provided lack credibility given the contradictions in the accounting treatment descriptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 493,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "In the 2023 filing the only Series O referenced is the older **Series O Junior Subordinated Debentures** that mature on **May 1 2079** (a very long‑dated, fixed‑rate instrument)【page_123】. By the 2024 filing NextEra introduced a new **Series O Debenture** that matures on **November 1 2029**, and the exhibit no longer lists a fixed coupon, implying a shift to a shorter‑dated, potentially floating‑rate or lower‑coupon structure【page_122】. This change suggests the company is moving toward shorter‑term, more flexible financing to reduce duration risk and better align debt costs with current market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) COUPON RATE DISCREPANCY: The LLM states the 2024 Series O has 'no explicit coupon rate disclosed' and implies 'floating-rate or lower-coupon structure,' but the ground truth clearly states it has a defined coupon rate of 5.55%. This is a major factual error - the LLM got the coupon structure backwards. (2) MATURITY DATES: Both dates are correct (May 1, 2079 for 2023; November 1, 2029 for 2024), properly formatted. (3) INSTRUMENT CHARACTERIZATION: The LLM incorrectly characterizes the 2024 instrument as potentially floating-rate or lower-coupon when it actually has a clearly defined 5.55% coupon - this contradicts the ground truth's statement that 2024 represents 'more conventional debt instruments with clearly defined interest costs.' (4) STRATEGIC INTERPRETATION: While the LLM correctly identifies a shift toward shorter-term financing, the reasoning about 'flexible financing' and 'lower-coupon structure' is incorrect. The ground truth indicates the shift is toward 'more predictable financing' with 'clearly defined interest costs' - the opposite of what the LLM suggests. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the coupon information across the two years, missing the key 5.55% figure entirely. The answer demonstrates incomplete research or misinterpretation of the source documents. The core narrative about shorter maturity dates is correct, but the critical coupon rate information is fundamentally wrong, which undermines the entire analysis of the financing strategy shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 426,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "In the 2022 filing, ExxonMobil first noted that “OPEC investment activities and production policies also have an impact on world oil supplies” and that this factor is part of the long‑term supply‑side assumptions used when testing assets for impairment. The 2023 filing repeats the same language, showing that the company continues to treat OPEC’s investment and production decisions as a key input to its long‑term oil‑supply outlook and related impairment assessments, with no substantive change in how it is incorporated.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states there WAS a substantive evolution/shift from 2022 to 2023 in how ExxonMobil considered OPEC in its impairment assessment framework - specifically, a shift from direct focus on OPEC's role to a more integrated view incorporating macroeconomic and environmental factors (greenhouse gas emission costs, net-zero targets). The LLM answer incorrectly claims 'no substantive change' and that the company 'repeats the same language,' which misses the core finding of the question. While the LLM correctly identifies that both years mention OPEC's impact on world oil supplies and that this is part of long-term supply assumptions, it fails to recognize the critical evolution in the broader assessment framework. The LLM also fails to address the 2023 shift toward incorporating forward-looking variables like GHG costs and net-zero targets, which is central to understanding how the framework evolved. The quantitative accuracy is reasonable (dates and company names are correct), but the qualitative reasoning is severely flawed - the model failed to synthesize the multi-hop comparison between 2022 and 2023 frameworks and missed the key insight about the shift from direct OPEC focus to integrated macroeconomic/environmental assessment. This is a critical failure on a question specifically asking about evolution/change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 404,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "In the 2023 filing Netflix merely flagged the ad‑supported tier as a “pricing strategy” with little operating history, stressing the difficulty of forecasting consumer adoption and its impact on revenue. By the 2024 filing the ad‑supported plan is presented as a core element of Netflix’s pricing portfolio—explicitly called out in the business overview and forward‑looking statements—showing far more detail and strategic emphasis on its rollout.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of Netflix's ad-supported plan from 2023 to 2024, correctly identifying the shift from a risk-focused, uncertainty-laden presentation to a confident, strategic positioning. The characterization of 2023 as emphasizing 'lack of operating history' and forecasting difficulties matches the ground truth's mention of 'uncertainty and risk' and 'discrepancies between forecasts and actual results.' The 2024 characterization as 'core element' and 'explicitly called out in the business overview' aligns with the ground truth's description of it being 'explicitly included in the description of plans offered.' (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are required for this qualitative question about strategic evolution. The years (2023, 2024) are correctly identified. (3) ENTITY ACCURACY: Netflix is correctly identified; the metric (ad-supported subscription plan) is accurately referenced throughout. (4) REASONING: The multi-hop synthesis is sound—the answer correctly compares the two filing periods and identifies the strategic shift from risk-focused to confidence-focused positioning. The logic connecting 'little operating history' and 'forecasting difficulty' in 2023 to 'core element' and 'strategic emphasis' in 2024 is valid and well-reasoned. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('pricing strategy,' 'core element of Netflix's pricing portfolio,' 'far more detail and strategic emphasis') conveys the same meaning as the ground truth ('pricing strategy,' 'core part of Netflix's business model,' 'move from risk-focused perspective to more confident, strategic positioning'). Minor differences in wording ('pricing portfolio' vs 'business model') are semantically equivalent in context. The answer is slightly more specific in mentioning 'business overview and forward-looking statements,' which adds helpful detail without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 553,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon’s shipping offers remained a core price‑and‑convenience lever, but the cost story shifted from 2022 to 2024. In 2022 the company warned that higher carrier rates, wage incentives and fulfillment‑network inefficiencies were driving rising shipping and fulfillment costs, and it focused on offsetting those pressures with higher sales volumes, better supplier terms and operational efficiencies (2022 p.23‑25). By 2024, although shipping costs continued to grow as customers used faster, more expensive delivery options, Amazon emphasized that expanded fulfillment‑network capacity and lower transportation costs were partially offsetting the cost increase, reflecting a strategic pivot toward scaling and optimizing fulfillment efficiency while still leveraging shipping offers to drive sales (2024 p.24‑27).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution from 2022 to 2024, capturing the shift from customer-driven cost increases to operations-centric efficiency focus. The qualitative reasoning about the pivot toward fulfillment network optimization is sound and well-articulated. The answer appropriately addresses both time periods and the multi-hop synthesis across years.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to include the specific $76.7 billion shipping cost figure from 2021 that the ground truth explicitly mentions as a key data point establishing the baseline for 2022 discussions. This is a material omission of a concrete financial metric. The LLM cites page numbers (2022 p.23-25, 2024 p.24-27) that cannot be verified against the ground truth and may be fabricated.\n\nWEAKNESSES - QUALITATIVE: The LLM introduces specific cost drivers in 2022 (\"higher carrier rates, wage incentives and fulfillment-network inefficiencies\") that are not explicitly mentioned in the ground truth. While these may be reasonable inferences about shipping cost drivers, they represent details not confirmed in the original answer. The ground truth emphasizes \"customer adoption of shipping offers\" and \"faster delivery methods\" as primary drivers, which the LLM mentions but subordinates.\n\nMULTI-HOP REASONING: The synthesis across 2022-2024 is logically sound and captures the strategic evolution correctly. However, the reasoning is somewhat speculative regarding specific mechanisms (carrier rates, wage incentives) not confirmed in the ground truth.\n\nSEMANTIC EQUIVALENCE: The core message aligns - both answers convey a shift from customer-demand-driven costs to efficiency-focused mitigation. However, the LLM's specific framing of cost drivers differs from the ground truth's emphasis on customer behavior and network expansion.\n\nOVERALL: The answer demonstrates good understanding of the strategic evolution but lacks the specific quantitative anchors (the $76.7B figure) and introduces unverified details about cost drivers. The qualitative reasoning is strong but the quantitative precision is weak.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 577,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "In 2023 Duke Energy’s Master Retirement Trust continued to hold roughly 98 % of its assets for qualified pension plans and 2 % for other post‑retirement benefits, with target allocations of 45 % global equity, 35 % debt, 7 % real‑estate/cash for the RCBP assets and 14 % equity, 80 % debt for the DELPP assets; actual holdings were essentially on target (e.g., 45 % equity, 35 % debt for RCBP and 14 % equity, 79 % debt for DELPP) and VEBA trusts were heavily weighted to debt and cash (30 % debt, 18 % cash) (pages 217‑218, 219). By 2024 the trust still served the same plan mix, but the actual mix shifted – RCBP equity fell to 44 % (with private‑equity 1 %), real‑estate/cash rose to 10 % and hedge‑funds to 5 %; DELPP equity rose to 15 % and cash to 4 %, while VEBA trusts moved to 34 % U.S. equity and 13 % cash (pages 226‑227, 227). The 2024 filing added more granular target‑vs‑actual tables for each asset class, a detailed fair‑value hierarchy discussion, a Level‑3 reconciliation and a note that securities‑lending was discontinued, expanding the depth of disclosure compared with the 2023 filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more detailed quantitative information than the ground truth answer. Strengths: (1) Specific asset allocation percentages are provided for both 2023 and 2024 across multiple asset classes (equity, debt, real estate, cash, hedge funds, private equity) for RCBP, DELPP, and VEBA trusts; (2) The multi-hop synthesis correctly identifies the evolution from 2023 to 2024, showing specific changes (e.g., RCBP equity fell from 45% to 44%, real estate/cash rose from 7% to 10%); (3) The answer correctly identifies enhanced disclosure practices in 2024 including granular target-vs-actual tables, fair-value hierarchy discussion, Level-3 reconciliation, and securities-lending discontinuation; (4) Page references (217-218, 219, 226-227) are provided for verification; (5) The answer addresses both asset allocation evolution and disclosure practice changes as requested. Minor considerations: (1) The ground truth mentions subsidiary-level allocations (Duke Energy Progress at 15%, Duke Energy Florida at 18%) which the LLM answer does not explicitly include, though this may represent a different level of detail not contradicting the LLM's answer; (2) The LLM provides more granular quantitative detail than the ground truth, which could indicate either superior sourcing or potential over-specification, but the numbers appear internally consistent and logically presented. The answer successfully synthesizes multi-hop information across two fiscal years and multiple trust vehicles, demonstrating sound reasoning about the evolution of reporting practices. No calculation errors detected. The semantic meaning aligns well with the ground truth's core finding about increased transparency and granularity in 2024 reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 489,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "In the 2022 filing, Google’s cost of revenues was split into Traffic‑Acquisition Costs (TAC), which “include amounts paid to Google Network partners primarily for ads displayed on their properties” and caused the cost‑of‑revenues margin on network‑ad sales to be “significantly higher” than on search ads (see 2022 p. 32). By 2024 the same TAC component remains, and the 10‑K now lists “payments to distribution and Google Network partners” as one of the primary cash outflows from operating activities, noting that TAC costs rose alongside higher network‑ad revenue (see 2024 p. 42 and 2024 p. 41), indicating that the payment obligations to network partners have stayed substantial and grown with the business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about Google's relationship with Network Partners evolving from cost-of-revenue to operating cash flow obligations, which aligns with the ground truth. However, there are significant issues with the evaluation:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific page numbers (2022 p. 32, 2024 p. 42, 2024 p. 41) without verification that these are accurate or that the cited information actually appears on those pages\n   - No actual dollar amounts, percentages, or numerical metrics are provided to substantiate claims about TAC costs or payment obligations\n   - The claim that \"TAC costs rose alongside higher network‑ad revenue\" lacks supporting numbers\n   - Ground truth mentions \"higher cost percentage\" but LLM doesn't quantify this difference\n\n2. COMPLETENESS:\n   - The LLM answer addresses the evolution between 2022 and 2024 as requested\n   - It covers both the cost structure (TAC in 2022) and payment obligations (cash outflows in 2024)\n   - However, it lacks specific financial metrics that would demonstrate the magnitude of change\n\n3. ENTITY ACCURACY:\n   - Correctly identifies Google, Google Network partners, and TAC\n   - Correctly identifies the years 2022 and 2024\n   - Correctly identifies the shift from cost-of-revenues to operating cash flow\n\n4. REASONING:\n   - The multi-hop synthesis is sound: connecting 2022 TAC costs to 2024 cash flow obligations\n   - The logic that payments \"have stayed substantial and grown with the business\" is reasonable but not rigorously supported\n   - The interpretation of the shift from cost-of-revenue to cash flow model is consistent with ground truth\n\n5. SEMANTIC EQUIVALENCE:\n   - The LLM answer conveys similar meaning to ground truth regarding the transformation in financial relationship\n   - Both describe TAC as a significant cost component in 2022\n   - Both note the shift to operating cash flow obligations by 2024\n   - However, the LLM's framing of \"stayed substantial and grown\" differs slightly from ground truth's emphasis on \"transformation\" and \"potential increase in scale or structure of dependency\"\n\n6. KEY WEAKNESS:\n   - The citation of specific page numbers without verification is problematic for a financial evaluation task where precision is critical\n   - Lack of actual financial figures undermines the quantitative assessment\n   - The answer reads more like a summary than a detailed financial analysis with supporting metrics",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 665,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "UPS treats offsetting swap and forward contracts that are no longer designated as hedges as “non‑designated” derivatives, recording their fair‑value changes and settlement results directly in the statement of consolidated income (shown under investment income and other). In 2022 the company recognized a $69 million loss from these positions, while in 2023 the loss was only $7 million, indicating a much smaller adverse impact from offsetting swaps and forwards 【page_132】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific dollar figures ($69 million loss in 2022 and $7 million loss in 2023) that cannot be verified against the ground truth provided. The ground truth explicitly states that 'the financial impact in 2023 was not quantified in the excerpt,' which directly contradicts the LLM's claim of a $7 million loss in 2023. The ground truth also mentions specific 2021 and 2020 figures ($163M net gain in 2021, $124M net gain in 2020) but does not provide the $69 million 2022 figure cited by the LLM. The LLM appears to have fabricated or misattributed specific numbers without proper source verification. While the LLM correctly identifies UPS as the company and discusses non-designated derivatives recorded at fair value in the income statement, the core quantitative claims are unsupported by the ground truth. The LLM does address the evolution between 2022 and 2023 as requested, but the factual accuracy of the specific numbers is highly questionable. The reasoning about treatment of offsetting swaps is reasonable, but the lack of verifiable financial figures significantly undermines the answer's credibility. The page reference [page_132] suggests the LLM may be citing a source, but without confirmation that these numbers appear there, the answer cannot be trusted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 363,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 filing places the Directors’ Savings Plan front‑and‑center in its equity‑compensation section—listing it in the plan‑summary table and describing how outside directors can defer retainers into an unfunded, performance‑linked account that is paid out when their term ends【page_239】—whereas the 2023 filing only mentioned the plan in an amendment footnote among many exhibits【page_245】. This heightened visibility signals that Duke Energy is leaning more heavily on a deferred‑compensation, performance‑based structure for its directors in 2024 than it did in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that the Directors' Savings Plan received increased prominence in 2024 compared to 2023, and accurately characterizes the shift from exhibit-only mention to substantive description. However, there are significant issues with accuracy and completeness: (1) The LLM introduces a characterization of the plan as 'performance-linked' and 'performance-based,' which is NOT supported by the ground truth answer. The original answer describes the plan as allowing deferral of annual compensation with phantom investment options, but makes no mention of performance-linkage. This is a material factual error that misrepresents the plan's structure. (2) The LLM correctly identifies that 2023 referenced the plan only in amendment footnotes/exhibits while 2024 provided substantive description—this matches the ground truth. (3) The LLM correctly notes the plan is unfunded and paid out when director terms end, which aligns with the ground truth's mention of 'balances adjusted accordingly' and deferred compensation structure. (4) The page references provided (page_239, page_245) cannot be verified against the ground truth but appear to be citation attempts. (5) The LLM's conclusion about 'leaning more heavily on deferred-compensation' is reasonable but the addition of 'performance-based' language introduces inaccuracy not present in the original answer. The multi-hop reasoning is sound in comparing 2023 vs 2024 prominence, but the semantic meaning is partially distorted by the unsupported performance-linkage characterization. The answer demonstrates understanding of the question's intent but contains a significant factual error regarding plan characteristics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 468,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "In the 2022 filing American Express warned that “if we are not able to differentiate ourselves from our competitors, develop compelling value propositions for our customers… we may not be able to compete effectively” and that rising competition and the shift toward alternative payment methods were already forcing the company to evolve those propositions, even at the cost of higher rewards and service expenses【page_26】. By the 2024 filing the tone has shifted to a proactive, growth‑focused plan: the firm now emphasizes expanding its premium consumer leadership (especially with Millennials and Gen‑Z), launching new benefits and digital‑channel experiences, leveraging data, AI and strategic partnerships (e.g., dining, B2B) to build a multiproduct ecosystem, and explicitly tying these initiatives to “develop and market new benefits and value propositions that appeal to Card Members” in response to competitive pressure and changing customer behavior【page_93】【page_92】. This reflects a move from a defensive, risk‑focused stance in 2022 to an aggressive, innovation‑driven strategy in 2024 for shaping value propositions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 defensive posture with specific quote about differentiation and competitive pressures, accurately capturing the company's concern about alternative payment methods and rising rewards costs. (2) Accurately characterizes the 2024 shift to a proactive, innovation-driven strategy with correct identification of key initiatives: premium consumer leadership targeting Millennials/Gen-Z, digital capabilities (AI, automation, Amex app), strategic partnerships, and dining platform expansion. (3) The multi-hop synthesis is sound - correctly traces the evolution from 2022 to 2024 and identifies the underlying drivers (competitive pressures, changing customer behaviors). (4) Properly cites specific page references (page_26 for 2022, pages_92-93 for 2024) suggesting accurate source documentation. (5) The characterization of the shift from 'defensive, risk-focused' to 'aggressive, innovation-driven' accurately reflects the ground truth's description of moving from 'reactive' to 'proactive, innovation-driven approach.' MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more specific language about 'multiproduct ecosystem' and 'B2B' partnerships which are reasonable inferences from the strategic direction but are not explicitly mentioned in the ground truth summary. However, these are consistent with the overall narrative and represent reasonable elaboration rather than factual error. (2) The answer could have been slightly more explicit about the specific dining platforms (Tock and Rooam) mentioned in the ground truth, though the general reference to 'dining platform expansion' captures the essence. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2024) are correct. QUALITATIVE ACCURACY: Entity identification is correct (American Express, Millennials, Gen-Z, Amex app); reasoning about competitive response and strategic evolution is sound and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding evolution of value propositions, competitive pressures, and changing customer behaviors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 593,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "In the 2022 Form 10‑K Exxon Mobil listed four outstanding senior notes – a 0.142 % note due 2024 together with notes due 2028, 2032 and 2039 – showing a mix of very short‑term, ultra‑low‑coupon debt and longer‑dated issues【page_1】. By the 2024 filing the 0.142 % note had disappeared, leaving only the 0.524 % (2028), 0.835 % (2032) and 1.408 % (2039) notes, indicating the company retired the short‑dated, low‑rate instrument and is now relying on a longer‑maturity debt profile【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Exxon Mobil's debt financing evolution between 2022 and 2024. QUANTITATIVE ACCURACY: All numeric values are correct - the interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039) match the ground truth exactly. The answer correctly identifies which notes were present in 2022 and which remained in 2024. COMPLETENESS: The answer addresses all key aspects of the question: (1) the composition of long-term notes in 2022, (2) the composition in 2024, (3) the evolution/change between these periods, and (4) the strategic implications. ENTITY ACCURACY: Exxon Mobil is correctly identified, fiscal years 2022 and 2024 are accurate, and all debt instruments are properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the key change - the retirement of the 0.142% Notes due 2024 and the retention of longer-dated instruments. The logical conclusion that this reflects a shift toward extended-term debt is sound and matches the ground truth's interpretation. SEMANTIC EQUIVALENCE: The LLM's characterization of the 0.142% note as 'short-dated, low-rate instrument' and the conclusion about 'longer-maturity debt profile' align well with the ground truth's description of 'retiring shorter-duration obligations' and 'focusing more heavily on extended-term debt.' Minor note: The LLM uses slightly different phrasing ('ultra-low-coupon debt' vs ground truth's more neutral description) but this is a reasonable characterization and doesn't affect accuracy. The answer is well-structured, clear, and provides appropriate context for understanding the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 487,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "American Express has kept corporate cards at the core of its commercial‑payments pillar, stating that it will “evolve our card value propositions, further differentiate our corporate card and accounts‑payable expense‑management solutions and design innovative products and features” (2022 10‑K p. 8). By 2024 the company repeats that language but adds a clearer focus on financing, banking and broader payment‑solution innovations, signaling a deeper push to differentiate the corporate‑card suite with integrated financial‑service features (2024 10‑K p. 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate citations and correctly identifies the 2022 and 2024 timeframe with proper page references (10-K p. 8 for both years). The quantitative elements (dates, document references) are correct. However, there are significant issues with the qualitative analysis and completeness:\n\n1. WHAT WAS CORRECT: The LLM correctly identifies that American Express maintained corporate cards as a core pillar across both years and accurately quotes the 2022 language about evolving card value propositions and differentiating corporate card/accounts payable solutions. The citation format and page numbers appear accurate.\n\n2. WHAT WAS INCOMPLETE/INCORRECT: The LLM answer diverges from the ground truth in its characterization of the evolution. The ground truth emphasizes a shift from 'internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024,' specifically highlighting: (a) increased merchant acceptance, (b) enhanced fraud protection, and (c) marketing insights as key 2024 differentiators. The LLM instead focuses on 'financing, banking and broader payment-solution innovations' and 'integrated financial-service features,' which are not explicitly mentioned in the ground truth as the primary evolution.\n\n3. MULTI-HOP REASONING: The LLM fails to synthesize the key distinction that the ground truth emphasizes - the shift from internal product focus to external ecosystem integration. Instead, it characterizes the evolution as deepening financial service integration, which represents a different analytical framework than what the ground truth presents.\n\n4. SEMANTIC EQUIVALENCE ISSUES: While the LLM's interpretation of 'integrated financial-service features' could theoretically align with ecosystem strategy, the ground truth specifically emphasizes merchant acceptance, fraud protection, and marketing insights - concrete external-facing capabilities that the LLM does not mention.\n\n5. CITATION ACCURACY: The LLM provides specific page references (p. 8 for both years) which adds credibility, though these cannot be independently verified in this evaluation.\n\nThe answer is partially correct in identifying the companies, years, and general direction of evolution, but misses the specific nature of the strategic shift that the ground truth identifies as central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 629,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "In the 2022 filing Amazon already treated AWS as a distinct, strategically‑important business – it listed Adam Selipsky as CEO of Amazon Web Services (page 5) and discussed cloud‑service competition (pages 6‑7) – but gave little quantitative detail on the cash it generated. By the 2024 filing AWS accounted for 17 % of total net sales, growing to $107.6 billion (a 19 % YoY increase) (page 24), and the rise in operating cash flow to $115.9 billion (page 22) was largely driven by that segment, while the MD&A stresses continued heavy capital spending on AWS technology infrastructure as a core growth engine (page 21). This shows a shift from emphasizing AWS’s strategic leadership to relying on it as a major cash‑flow contributor and focal point of ongoing investment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and strategic evolution. Strengths: (1) Correctly identifies AWS revenue of $107.6 billion in 2024 with 19% YoY growth and 17% of total net sales - these figures align with ground truth; (2) Accurately cites the $115.9 billion operating cash flow for 2024, correctly attributing it partly to AWS; (3) Properly synthesizes the multi-hop evolution from 2022 (AWS as strategically important but with limited quantitative disclosure) to 2024 (AWS as major cash contributor); (4) Appropriately references Adam Selipsky as AWS CEO and discusses competitive pressures in 2022, then capital spending emphasis in 2024. Minor considerations: (1) The LLM answer provides more granular detail and page references than the ground truth, which is supplementary rather than contradictory; (2) The ground truth mentions $84.9 billion operating cash flow in 2023 as a comparison point, which the LLM answer doesn't explicitly include, though this is a minor omission; (3) The characterization of the shift is semantically equivalent - both describe movement from risk/competitive emphasis to cash generation focus. The quantitative figures are precise and calculations are sound. The multi-hop reasoning correctly synthesizes information across 2022 and 2024 filings to show strategic evolution. The answer fully addresses the question's core components regarding cash flow generation and strategic emphasis changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 415,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "In the 2023 filing the auditors noted that they “utilized trend analyses to evaluate the historical consistency of regulatory asset balances” for the **Florida subsidiary only**, using the analysis simply to test that the subsidiary’s regulatory‑asset balances were consistent with prior periods. By the 2024 filing the same language appears, but the trend‑analysis step is now part of a **consolidated‑company audit** and is coupled with broader inquiries into recent regulatory orders, coal‑ash retirement obligations and storm‑ and fuel‑cost recoverability, indicating that the focus of the trend analysis was broadened from a single subsidiary to the entire company’s regulatory‑asset portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer introduces significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2023 analysis was for 'Florida subsidiary only' - this detail is NOT present in the ground truth, which states trend analyses were used 'in general, without specific reference to asset retirement obligations.' This appears to be fabricated information. (2) The LLM claims the 2024 analysis shifted to a 'consolidated-company audit' - again, this specific detail is not in the ground truth. The ground truth simply states the scope 'remained focused on regulatory asset balances' but expanded to include 'specific evaluation of asset retirement obligations related to coal ash.' (3) The LLM introduces details about 'recent regulatory orders' and 'storm-and fuel-cost recoverability' that are not mentioned in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies that coal ash retirement obligations became a focus area in 2024, which aligns with the ground truth's mention of 'asset retirement obligations related to coal ash.' The general concept that the scope expanded/broadened is directionally correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in the ground truth. Instead of accurately capturing the shift from general regulatory asset balance evaluation to specialized coal ash compliance evaluation, the LLM invented a narrative about subsidiary-level vs. consolidated-company analysis. The answer demonstrates poor fidelity to source material and appears to contain hallucinated details not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 443,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Costco said that the higher‑inflation environment in 2022 led it to “adjust … our pricing and merchandise mix, including increasing the penetration of our private‑label items” as a way to offset cost pressures【page_22】.  In the 2023 filing the company reiterated the same tactic – noting that its “merchandising and pricing strategies in response to cost increases” continue to rely on “increasing the penetration of our private‑label items” to protect margins and keep prices competitive【page_23】.  Thus, the strategy of expanding private‑label share was introduced in 2022 and was maintained (and emphasized) in 2023 as a core response to ongoing cost and pricing pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Costco's private-label strategy evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies that private-label penetration was introduced as a strategy in 2022 in response to inflation and cost pressures; (2) Accurately notes that this strategy was maintained and emphasized in 2023; (3) Properly synthesizes information across two fiscal years showing continuity and emphasis; (4) Correctly identifies the strategic purpose (offsetting cost pressures, protecting margins, maintaining competitive pricing); (5) Appropriately cites source pages (page_22 and page_23) indicating multi-document synthesis. MINOR WEAKNESSES: (1) The LLM answer characterizes the 2022 approach as introducing the private-label strategy, while the ground truth suggests a more nuanced picture where 2022 involved multiple strategies (absorbing costs internally, purchasing earlier/larger volumes, selective price increases) with private-label being one component; (2) The ground truth explicitly frames this as a shift from 'reactive' in 2022 to 'strategic and sustained' in 2023, whereas the LLM presents it more as consistent continuation rather than emphasizing the evolution/shift in approach; (3) The LLM doesn't fully capture the broader 2022 strategy context (internal cost absorption, volume purchasing) that provides fuller context for understanding the evolution. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years and two separate filings, correctly identifying the continuity and emphasis of the private-label strategy. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - private-label penetration was a key strategy in both years in response to cost pressures, with emphasis continuing/increasing in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 561,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Pfizer’s 2024 Form 10‑K says the remaining performance‑obligation balance for Paxlovid is about **$1 billion** (page 109). By contrast, at the end of 2023 the company carried **$5.1 billion of deferred revenue for Paxlovid and Comirnaty combined**—$2.6 billion in current liabilities and $2.5 billion in non‑current liabilities (page 110)—indicating that the future revenue pipeline for Paxlovid has contracted sharply from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM conflates Paxlovid with Comirnaty (COVID-19 vaccine). The $5.1 billion deferred revenue figure cited is for BOTH products combined, not Paxlovid alone. The ground truth explicitly states that in 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid separately. (2) MISINTERPRETATION - The LLM incorrectly interprets the $5.1 billion combined deferred revenue as evidence of Paxlovid's 2023 financial position, when this metric includes Comirnaty and cannot be attributed to Paxlovid specifically. (3) INCORRECT CONCLUSION - The LLM concludes the revenue pipeline 'contracted sharply' from $5.1B to $1B, but this comparison is invalid because: (a) the 2023 figure includes Comirnaty, and (b) the ground truth indicates 2023 had no specific Paxlovid RPO disclosure. (4) CORRECT ELEMENT - The $1 billion remaining performance obligation for 2024 is accurate per the ground truth. (5) MULTI-HOP REASONING FAILURE - The answer fails to properly synthesize the key distinction that 2023 lacked specific Paxlovid RPO disclosure, making year-over-year comparison problematic. The LLM's interpretation suggests a sharp contraction when the actual evolution is that Pfizer began separately disclosing Paxlovid RPOs in 2024 at approximately $1 billion. The answer demonstrates a fundamental misunderstanding of the data structure and conflates product lines inappropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 419,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "In the 2022 10‑K (see page 95) American Express explained that it projects lifetime expected credit losses over a “reasonable and supportable” period (the R&S Period) by blending historical loss experience with current and future economic conditions, and that losses beyond that horizon are estimated by reverting to long‑term average loss rates. The 2024 filing (see page 97) repeats the same methodology and assumptions for the R&S Period, showing no material change in how the period is defined or applied. This continuity signals a disciplined, forward‑looking risk‑management framework that relies on consistent, judgment‑driven modeling to capture credit risk over a supportable horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about evolution between 2022 and 2024. Key issues: (1) QUANTITATIVE ERRORS: The ground truth explicitly states reserves were $3.3 billion as of December 31, 2021 - a critical quantitative fact that the LLM completely omits. The LLM provides page numbers (95, 97) without verification against actual filing content. (2) CORE FACTUAL CONTRADICTION: The ground truth indicates a clear EVOLUTION - the R&S Period was 'explicitly described' and 'newly explained' in 2022 but by 2024 was 'no longer introduced as a newly explained concept' and appeared 'embedded within a more mature process.' The LLM directly contradicts this by stating 'no material change' and 'same methodology and assumptions,' missing the fundamental shift from introduction to maturation. (3) INCOMPLETE SYNTHESIS: The question asks 'how has...evolved' - requiring comparison showing change. The LLM's conclusion that there is 'continuity' and 'no material change' is the opposite of what the ground truth indicates. (4) MISSING CONTEXT: The ground truth emphasizes the methodological shift from 2022 (introducing/explaining) to 2024 (established/foundational), which is the key insight about risk management approach evolution. The LLM misses this entirely. (5) REASONING QUALITY: While the LLM correctly describes what the R&S Period is, it fails the multi-hop reasoning required to compare 2022 vs 2024 approaches and identify the evolution in how the company presents and relies on this methodology. The answer reads as a static description rather than a comparative analysis of evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 451,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "In the 2022 Form 10‑K, Amazon’s low‑cost debt program is reflected by the 0.800 % Note due 2025 listed in the Officers’ Certificate dated June 3 2020 (Exhibit 4.5) 【page_73】. By the 2024 Form 10‑K, the same 0.800 % Note still appears (Exhibit 4.6) 【page_75】, but the company has added a newer Officers’ Certificate dated December 1 2022 that includes a 4.600 % Note due 2025 (Exhibit 4.8) 【page_75】. This shows Amazon’s debt strategy has broadened from relying on ultra‑low‑interest notes to issuing higher‑coupon notes while still retaining the original low‑rate issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All key numeric values are correct - 0.800% Note due 2025, 4.600% Note due 2025, dates (June 3, 2020 and December 1, 2022) are accurately cited. (2) The multi-hop reasoning is sound: correctly identifies the 0.800% Note in 2022 filings, traces its continuation in 2024 filings, and identifies the new 4.600% Note introduced via the December 1, 2022 Officers' Certificate. (3) Entity identification is precise - correctly names Amazon, identifies the specific exhibits (4.5, 4.6, 4.8), and references the correct form types (Form 10-K). (4) The synthesis across years (2022 to 2024) is logically structured and captures the evolution of debt strategy. (5) The conclusion about broadening strategy from ultra-low-interest to higher-coupon notes while retaining original low-rate issues is semantically equivalent to the ground truth's statement about incorporating wider range of interest rates and maturities. MINOR CONSIDERATIONS: The LLM answer includes specific exhibit numbers and page references that add precision beyond the ground truth, which is appropriate for SEC filing analysis. The phrase 'ultra-low-interest notes' vs 'low-cost debt program' are semantically equivalent descriptions. The explanation of the strategic shift (managing cash flow and interest rate risk) is implicit in the LLM answer's description of broadening the debt portfolio, which is a reasonable interpretation. No calculation errors detected. All dates and percentages verified as accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 433,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "In the 2022 Form 10‑K the “Twenty‑third Supplemental Indenture” is shown twice – once as a 1968 instrument (4.3.4 “dated February 1, 1968”) and again as a 1978 instrument (4.4.19 “dated June 1, 1978”) 【page_247†L13-L15】【page_249†L19-L21】. The 2024 filing only retains the 1978 entry (4.4.19 “dated June 1, 1978”) and the 1968 reference is no longer listed 【page_250†L19-L21】. This change implies the older 1968 indenture has been retired or is no longer material, while the 1978 indenture remains active and continues to be disclosed as part of Duke Energy’s outstanding debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DATES ARE WRONG: The LLM claims the Twenty-third Supplemental Indenture appears as both a 1968 instrument and a 1978 instrument in the 2022 filing. The ground truth explicitly states it was dated June 1, 1978 in the 2022 filing - there is no mention of a 1968 version. The LLM appears to have confused or fabricated a 1968 date. (2) MISINTERPRETATION OF EVOLUTION: The ground truth indicates the Twenty-third Supplemental Indenture (1978) was present in 2022 but ABSENT in 2024, suggesting diminished significance. The LLM incorrectly claims the 1978 entry 'remains active and continues to be disclosed' in 2024, which directly contradicts the ground truth that states there is 'no direct mention or continued reference' in the 2024 filing. (3) INCOMPLETE ANALYSIS: The LLM fails to address the core finding that the Twenty-third Supplemental Indenture disappeared from the 2024 filing entirely, which is the key indicator of its diminished relevance. Instead, it focuses on a non-existent 1968 version being removed. (4) CITATION ISSUES: The page references provided (page_247, page_249, page_250) cannot be verified against the ground truth and appear to reference incorrect or fabricated exhibit locations. The ground truth clearly states the 2022 reference was to 'Exhibit 2(c)' with a specific File No., not the exhibit numbers cited by the LLM. The answer fundamentally misrepresents the evolution of disclosure between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 424,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "Alphabet’s share‑repurchase program continued to include Class C capital stock each year. In 2022 the company repurchased a total of $59.3 billion of Class A and Class C shares (the Class C portion was not broken out)【page_82】. In 2023 it repurchased 450 million Class C shares for $52.9 billion【page_84】, and in 2024 it repurchased 306 million Class C shares for $50.2 billion【page_84】. Thus, after the $59.3 billion combined buy‑back in 2022, the dollar value and number of Class C shares repurchased fell modestly from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM reports 2023 Class C repurchases as $52.9 billion and 2024 as $50.2 billion, but the ground truth states total repurchases (Class A and C combined) were $62.2 billion in 2023 and $62.0 billion in 2024. These numbers are substantially different ($52.9B vs $62.2B for 2023; $50.2B vs $62.0B for 2024). The LLM's figures are approximately 15% lower than ground truth for both years. (2) INCOMPLETE BREAKDOWN: While the LLM correctly notes that 2022 combined Class A and C repurchases were $59.3 billion with no breakdown, it then provides specific Class C-only figures for 2023-2024 that don't match the ground truth totals. The ground truth provides combined figures for all three years, not Class C-specific breakdowns. (3) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the information. It appears to have confused or misidentified the repurchase amounts, possibly mixing Class C-specific data with total repurchase data. (4) DIRECTIONAL ACCURACY: The LLM correctly identifies the general trend (decline from 2023 to 2024), but the magnitude of the numbers is wrong. The ground truth shows a decline from $62.2B to $62.0B (minimal), while the LLM shows a decline from $52.9B to $50.2B (also modest but based on incorrect figures). (5) CITATION ISSUES: The LLM cites page references but provides numbers that don't align with the ground truth data, suggesting either misreading of source material or hallucination of specific figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 439,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "In the 2022 Form 10‑K the Salary/Bonus Deferral Plan was listed as Exhibit 10.16 (the original plan), with its 1994 amendment as Exhibit 10.17 and a later 1997 amendment as Exhibit 10.19 【page_165】. In the 2024 filing the same plan and amendments are still incorporated by reference to the same historic documents, but the exhibit numbers were shifted – the original plan is now Exhibit 10.13, the 1994 amendment is Exhibit 10.14 and the 1997 amendment is Exhibit 10.16 【page_171】. This reflects a renumbering of the exhibit schedule rather than a change in the underlying documentation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS - The LLM claims the 2022 filing had the 1997 amendment as Exhibit 10.19, but the ground truth states it was NOT listed in 2022 (only Exhibits 10.16 and 10.17 are mentioned). The LLM incorrectly adds a non-existent Exhibit 10.19 in 2022. (2) CORE MISUNDERSTANDING - The ground truth explicitly states the 2024 filing 'adds Exhibit 10.16, which incorporates the 1997 amendments' - meaning the 1997 amendment was NEW to the 2024 filing, not present in 2022. The LLM reverses this logic by claiming the 1997 amendment existed in 2022 as Exhibit 10.19. (3) INCOMPLETE ANALYSIS - The LLM characterizes the changes as merely 'renumbering' when the ground truth indicates the 2024 filing 'expanded the disclosure to include a broader historical record of amendments.' The addition of the 1997 amendment documentation is a substantive expansion, not just renumbering. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the comparison between 2022 and 2024 filings. The correct narrative is: 2022 had exhibits 10.16 (1988 plan) and 10.17 (1994 amendment); 2024 reorganized these to 10.13 and 10.14 respectively, AND added new Exhibit 10.16 for the 1997 amendments. The LLM's claim that 1997 amendments existed in 2022 is factually incorrect. (5) QUANTITATIVE ACCURACY - Multiple exhibit numbers are wrong for the 2022 filing (claiming 10.19 exists when it doesn't per ground truth).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 418,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "In the 2022 filing Starbucks recorded interest‑rate‑swap liabilities both as a short‑term (accrued) item of $12 million and as other long‑term liabilities of $34 million – about $46 million in total (SBUX 2022 Note 4, p. 68). By the 2024 filing the swaps appear only in other long‑term liabilities and the liability has fallen to $19.2 million on the September 29, 2024 balance sheet (down from $41.4 million a year earlier) (SBUX 2024 Note 4, p. 72). Thus, the exposure has shifted from a split current/long‑term classification to a purely long‑term classification and the recorded liability has been reduced by roughly 60 %.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with mostly correct financial figures and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2022 interest rate swap liability of $34 million in other long-term liabilities; (2) Accurately reports the 2024 liability of $19.2 million; (3) Correctly notes the prior year (2023) comparison of $41.4 million; (4) Properly identifies the shift in balance sheet classification from split current/long-term to purely long-term; (5) The ~60% reduction calculation is approximately correct ($19.2M down from $41.4M = 53.6% reduction, which rounds to ~60%); (6) Provides specific document references (Note 4, page numbers); (7) Addresses all aspects of the question regarding evolution, classification, and magnitude. MINOR ISSUES: (1) The LLM identifies an additional $12 million short-term accrued liability in 2022 that is not mentioned in the ground truth answer, though this appears to be additional detail from the filing rather than an error; (2) The ground truth answer's phrasing about 'additional $41.4 million liability from interest rate swaps reported for the prior year (2023)' is somewhat ambiguous, but the LLM correctly interprets this as a year-over-year comparison showing the 2023 balance was $41.4M; (3) The percentage calculation (60% reduction) is slightly rounded but reasonable. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly comparing balances and identifying the classification shift. The logic connecting the data points is sound and well-explained. The answer goes beyond the ground truth by providing additional context about the 2022 split classification, which adds value without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 477,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Savings Plan is mentioned only as an “Amended and Restated” plan (originally dated 2014) with a subsequent amendment effective December 16 2021, without a detailed description of how it works. By the 2024 Form 10‑K the plan is disclosed in the equity‑compensation tables and explained as a non‑qualified deferred‑compensation arrangement that lets outside directors defer all or part of their retainers, credits the unfunded account with phantom‑stock performance (including the Duke Energy Common Stock Fund), and pays out when a director’s board service ends. This evolution shows Duke Energy moving toward greater transparency and formal governance of director pay, using a performance‑linked deferral mechanism to align director incentives with shareholder interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more detailed and nuanced response than the ground truth. Key strengths: (1) All dates are correct - the 2014 original plan date, December 16, 2021 amendment date, and the 2022 vs 2024 comparison are all accurate. (2) The quantitative elements are precise - no numbers or calculations are present that could be wrong. (3) The multi-hop reasoning is sound: the answer correctly synthesizes information across two different 10-K filings (2022 and 2024) and identifies the evolution from policy establishment to operational transparency. (4) Entity accuracy is perfect - Duke Energy is correctly identified, the Directors' Savings Plan is properly named, and the phantom stock/Common Stock Fund mechanics are accurately described. (5) The answer actually exceeds the ground truth in specificity by noting the plan is 'non-qualified deferred-compensation' and explaining the mechanics more clearly (deferral of retainers, phantom-stock performance crediting, payout timing). The semantic equivalence is strong - both answers convey that there was a shift toward greater transparency and alignment with shareholder interests. Minor consideration: The LLM answer provides more operational detail than the ground truth (explaining how deferrals work, payout mechanics), which is actually more informative and demonstrates deeper understanding of the governance evolution. The reasoning about alignment with shareholder interests and long-term compensation strategy is present in both answers and correctly synthesized in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 436,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "In the 2022 Form 10‑K Costco highlighted Kirkland Signature as a core private‑label brand that “are high quality, offered at prices that are generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins” and said it expects to “continue to increase the sales penetration of our private‑label items” (2022 10‑K p. 7). By the 2023 filing the company no longer discusses Kirkland separately; the brand is folded into the broader private‑label discussion and the risk narrative focuses on general sourcing and commodity‑price risks – e.g., “We depend heavily on our ability to purchase quality merchandise in sufficient quantities at competitive prices” and “Suppliers may be unable to timely supply us with quality merchandise at competitive prices” (2023 10‑K p. 15). This shift shows Kirkland’s positioning remains central to Costco’s value proposition, but its risk profile is now treated as part of overall supply‑chain and pricing risks rather than a distinct brand‑specific risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Kirkland Signature's positioning between 2022 and 2023, with mostly accurate factual content and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2022 positioning emphasizing quality, competitive pricing, and higher margins; (2) Accurately quotes the 2022 10-K language about increasing sales penetration of private-label items; (3) Correctly notes the shift in 2023 toward broader risk discussion rather than brand-specific focus; (4) Appropriately synthesizes the change from growth-focused to risk-focused narrative; (5) Page citations (p. 7 for 2022, p. 15 for 2023) appear reasonable for 10-K filings. WEAKNESSES: (1) The LLM states the 2023 filing 'no longer discusses Kirkland separately' - this is a stronger claim than the ground truth supports. The ground truth indicates risk disclosures became broader and more risk-focused, but doesn't explicitly state Kirkland was removed from discussion entirely; (2) The LLM's characterization that Kirkland is 'folded into the broader private-label discussion' is an inference not explicitly confirmed in the ground truth; (3) The ground truth emphasizes that 2023 introduced 'supply chain disruptions, foreign exchange fluctuations, and catastrophic events' as specific risk factors, while the LLM focuses more narrowly on 'sourcing and commodity-price risks' - this represents a partial but incomplete capture of the risk evolution; (4) The ground truth's emphasis on 'greater operational and financial volatility' exposure is not fully captured in the LLM's answer. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the shift in positioning and risk narrative, though with some interpretive overreach. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - Kirkland remained important but risk treatment changed - though the LLM's framing of the change is somewhat narrower than the ground truth's broader risk exposure discussion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 548,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell in its own operations from about 330 BCF at year‑end 2022 (326 BCF developed + 4 BCF undeveloped) to roughly 303 BCF at year‑end 2024【page_145】, a decline driven by revisions, production and the disposition of its Indonesia assets. In contrast, the equity‑affiliate portion in the same region grew from 5,753 BCF in 2022 to 5,870 BCF in 2024【page_145】, reflecting upward price‑related revisions, technical revisions and extensions/discoveries in the Middle East (and earlier affiliate purchases)【page_146】. Overall, total Asia Pacific/Middle East natural‑gas reserves rose modestly to about 6,166 BCF, with the net increase coming almost entirely from affiliate additions rather than the company’s direct reserves.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer provides significantly different numbers than the ground truth and appears to conflate different reserve categories. (1) QUANTITATIVE ERRORS: Ground truth states COP's Asia Pacific/Middle East natural gas reserves were 326 BCF in 2022 and 296 BCF in 2024. The LLM claims 330 BCF (326 developed + 4 undeveloped) in 2022 and 303 BCF in 2024 - these numbers don't match the ground truth figures. More critically, the LLM introduces equity-affiliate reserves (5,753 BCF to 5,870 BCF) and a total of 6,166 BCF, which are NOT mentioned in the ground truth answer at all. The ground truth specifically addresses COP's own reserves, not affiliate reserves. (2) SCOPE CONFUSION: The LLM appears to have answered a different question by including equity-affiliate reserves when the original question and ground truth focus on COP's direct reserves. This represents a fundamental misunderstanding of what reserves to analyze. (3) MISSING KEY INFORMATION: The ground truth emphasizes 'minimal extensions and discoveries' and 'no sales or significant reserve additions in 2024,' indicating reduced activity. The LLM mentions 'disposition of Indonesia assets' and discusses affiliate extensions/discoveries, which diverges from the ground truth narrative. (4) CALCULATION VERIFICATION: The LLM's breakdown of 326 BCF as 326 developed + 4 undeveloped = 330 BCF is mathematically incorrect (should equal 330, but ground truth states 326 total). (5) MULTI-HOP REASONING: While the LLM attempts to synthesize multiple data points, it synthesizes the WRONG data points (affiliate vs. direct reserves), failing the core multi-hop requirement. The answer is more detailed but factually misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 475,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "In 2022 FedEx owned a fleet of 114 Boeing 767‑300 freighters (all owned, none leased) and had active purchase commitments for additional 767Fs – 14 slated for delivery in 2023 and another 14 in 2024【page_40】. By the 2024 filing the company’s strategy had shifted to using the 767F as a core element of its aircraft‑modernization program, with $611 million of deposits for new aircraft and a reduced pipeline of only 14 further 767Fs (11 in 2025 and 3 in 2026) as it replaces older, less‑efficient planes【page_117】【page_116】. This reflects a move from expanding the fleet to focusing on modernizing it with fuel‑efficient 767‑300 freighters.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantial additional detail beyond the ground truth while maintaining core accuracy. Strengths: (1) Correctly identifies 114 Boeing 767F aircraft owned in 2022 with no leased units; (2) Accurately captures the shift from fleet expansion to modernization focus between 2022-2024; (3) Provides specific purchase commitments (14 in 2023, 14 in 2024, then 11 in 2025 and 3 in 2026) that align with the modernization narrative; (4) Includes relevant financial detail ($611 million in deposits) that contextualizes the strategy; (5) Correctly emphasizes fuel efficiency and long-term operating savings as key drivers. Minor considerations: (1) The ground truth states 'no updated ownership figures were disclosed' for 2024, while the LLM provides specific future delivery numbers (11 in 2025, 3 in 2026) - these appear to be forward-looking commitments rather than 2024 ownership figures, which is a reasonable interpretation but slightly different framing; (2) The LLM goes beyond ground truth by providing specific delivery schedules and deposit amounts, which enhances the answer but wasn't explicitly in the original; (3) The characterization of the shift from 'expanding the fleet to focusing on modernizing it' is accurate and well-reasoned based on the data provided. The multi-hop synthesis correctly connects 2022 ownership data with 2024 strategic emphasis and modernization programs. All numeric values appear consistent with typical SEC filing disclosures. The answer effectively addresses the evolution question across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 432,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "In fiscal 2022 Starbucks reported $310.3 million of roasted‑coffee inventory on its balance sheet and $838.5 million of roasting equipment (Note 5 and PP&E schedule)【page_71】. By the 2024 filing the company emphasizes a broadened production footprint – it owns large roasting plants in York, PA (1.96 M sq ft), Minden, NV (1.08 M sq ft), Kunshan, China (0.63 M sq ft) and Kent, WA (0.51 M sq ft) – together providing over 4 million sq ft of roasting, warehousing and distribution capacity, indicating an expanded roasting infrastructure (the 2024 excerpt does not disclose a new roasted‑coffee inventory figure)【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more comprehensive detail than the ground truth. Verification of key facts: (1) The $310.3 million roasted coffee inventory figure for fiscal 2022 is correct and matches the original answer. (2) The LLM adds the roasting equipment value of $838.5 million, which is additional factual information not contradicted by the ground truth. (3) The four roasting facilities are correctly identified (York PA, Minden NV, Kunshan China, Kent WA) matching the ground truth. (4) The square footage figures (1.96M, 1.08M, 0.63M, 0.51M sq ft) and total of 4+ million sq ft are provided with specificity. (5) The multi-hop reasoning is sound: the answer correctly synthesizes the evolution from 2022 inventory holdings to 2024 expanded production infrastructure. (6) The LLM appropriately notes that the 2024 filing does not disclose a new roasted coffee inventory figure, showing careful document analysis. The answer goes beyond the ground truth by providing additional quantitative detail (equipment value, specific square footage) while maintaining complete accuracy on all stated figures. The semantic meaning aligns perfectly with the ground truth's conclusion about the shift from holding inventory to active production at scale. Minor deduction only because the ground truth didn't explicitly mention the equipment value, though this represents enhancement rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 395,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "In the 2023 Form 10‑K, PepsiCo’s board approved the issuance of a new 2.750 % senior note due 2025 (see the Board of Directors Resolutions in Exhibit 4.65 on page 129). By the 2024 Form 10‑K, that same 2.750 % senior note due 2025 is listed among the company’s outstanding senior‑note portfolio (see the consolidated debt schedule in Exhibit 4.64 on page 130), indicating the instrument has moved from authorization in 2023 to being an active component of PepsiCo’s financing in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how PepsiCo's utilization of the 2.750% Senior Notes evolved between 2023 and 2024. Key problems: (1) INCOMPLETE SYNTHESIS: The LLM answer only describes the 2.750% Senior Notes due 2025 moving from authorization to active status, but completely omits the critical evolution mentioned in the ground truth - the introduction of a NEW 2.750% Senior Notes due 2030 in 2024. This is a major omission that fails to capture the strategic evolution the question asks about. (2) MISCHARACTERIZATION: The ground truth indicates the 2.750% Senior Notes due 2025 were 'listed among other notes in a Board of Directors Resolutions document' in 2023 (suggesting authorization/planning), while the LLM states it was 'approved for issuance' in 2023. The distinction between authorization and actual issuance status is unclear in the LLM answer. (3) INCOMPLETE MULTI-HOP REASONING: The question specifically asks about evolution 'between 2023 and 2024' - the ground truth shows TWO key developments: (a) retention of the 2025 notes, and (b) introduction of new 2030 notes. The LLM only addresses the first point. (4) MISSING STRATEGIC CONTEXT: The ground truth explicitly notes this 'signaling a strategic evolution in its financing approach' by extending the debt strategy to a longer-term horizon. The LLM answer misses this strategic insight entirely. (5) EXHIBIT REFERENCES: While the LLM provides specific exhibit citations (4.65, 4.64), these cannot be verified against the ground truth, and the answer structure suggests the LLM may be confusing authorization documents with debt schedules. The answer is partially correct in identifying the 2.750% notes due 2025 and their status change, but fails to provide the complete picture of PepsiCo's debt evolution strategy that the question requires.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 505,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx said it was committed to **eight B777F freighters** – 2 slated for 2023, 4 for 2024 and 2 for 2025【page_114】. By the 2024 filing the commitment had been **scaled back to only two B777F aircraft**, both now expected in 2025【page_117】. FedEx still characterizes the B777F as a fuel‑efficient, long‑term modernization platform, but the reduced quantity shows the type is being positioned as a more limited, targeted component of its fleet‑renewal strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The 2022 plan numbers are correct (2 for 2023, 4 for 2024, 2 for 2025 = 8 total), and the 2024 plan is accurate (2 B777F for 2025 only). The LLM correctly identifies the reduction from 8 planned aircraft to 2 planned aircraft. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two different filing years (2022 and 2024 10-Ks) and correctly compares the strategic shifts between them. ENTITY ACCURACY: FedEx is correctly identified, aircraft type (B777F) is correct, years are accurate, and the filing references are appropriate. REASONING QUALITY: The LLM provides sound logical analysis - it identifies the reduction in quantity, notes the shift from a gradually decreasing role to complete phase-out, and correctly interprets this as indicating reduced strategic emphasis. The characterization of the B777F as 'a more limited, targeted component' aligns well with the ground truth's conclusion about 'a shift in aircraft preference or operational strategy.' MINOR CONSIDERATIONS: The LLM adds contextual detail about fuel efficiency and modernization positioning that, while not contradicting the ground truth, goes slightly beyond what was explicitly stated in the original answer. However, this additional context is reasonable and doesn't detract from accuracy. The semantic meaning is fully preserved - both answers convey that FedEx significantly reduced B777F commitments and this reflects a strategic de-emphasis of the aircraft type.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 428,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks’ designated “foreign‑currency‑other” derivative liabilities grew from roughly $0.3 million at fiscal‑year‑end 2022 (Oct 2 2022) to $2.0 million at fiscal‑year‑end 2023 (Oct 1 2023) and then to about $8.8 million by September 29 2024【page_68†L31-L38】【page_72†L31-L38】. At the same time, the net unrealized gain for these hedges recorded in AOCI fell from $55.3 million in 2022【page_66†L31-L38】 to $39.6 million in 2023 and to $11.5 million in 2024【page_70†L31-L38】. The rising liability balance shows Starbucks is expanding its foreign‑currency‑other hedge positions, while the shrinking AOCI gain indicates the hedges are increasingly offsetting currency movements, suggesting a diminishing net exposure to foreign‑exchange fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detailed information than the ground truth, including year-by-year progression (2022-2023-2024) and AOCI values across all three years. Key strengths: (1) The 2024 AOCI figure of $11.5 million matches the ground truth exactly; (2) The 2022 liability figure of $0.3 million is correct; (3) The multi-hop synthesis across years is sound and well-structured; (4) The reasoning about expanding hedge positions and diminishing net exposure is logical and well-supported. Minor discrepancies: (1) The ground truth only mentions 2022 liability ($0.3M) and 2024 AOCI gain ($11.5M), while the LLM provides additional 2023 data ($2.0M liability, $39.6M AOCI) and 2024 liability ($8.8M) that cannot be verified against the provided ground truth; (2) The ground truth characterizes the shift as 'minimal liability to substantial unrealized gain,' while the LLM interprets it as 'expanding hedges with diminishing net exposure' - these are different analytical perspectives, though both are reasonable interpretations of the data. The LLM's answer is more comprehensive and provides better year-over-year context, but introduces unverified 2023 figures and 2024 liability data. The core 2022 and 2024 AOCI figures are correct, and the overall reasoning about foreign currency exposure is sound. The answer exceeds the ground truth in detail but maintains factual accuracy on the verifiable points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 395,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed the 2.625 % Senior Notes due 2026 in a Board‑of‑Directors resolution authorizing the terms (2023 p. 129‑130) and listed the notes among a relatively modest set of senior‑note issuances. In the 2024 Form 10‑K the same resolution and listing reappear (2024 p. 129‑130), but the debt schedule now includes a much larger array of senior notes and even references a new 2024 Indenture (2024 p. 131), showing that while PepsiCo’s commitment to the 2.625 % notes persists, its overall debt‑instrument disclosures have expanded to cover a broader portfolio of financing arrangements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about PepsiCo's debt instrument evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2.625% Senior Notes due 2026 as present in both 2023 and 2024 disclosures; (2) Accurately notes the Board-of-Directors resolution context in both years; (3) Properly synthesizes the key finding that debt disclosures expanded significantly between years; (4) Correctly identifies the introduction of new senior notes and references a 2024 Indenture; (5) Page citations (p. 129-130, p. 131) are specific and appear reasonable for 10-K filings; (6) The reasoning about 'broader and more diversified set of debt instruments' and 'active capital markets strategy' aligns with the ground truth. MINOR GAPS: (1) The LLM answer does not explicitly name the newer maturities (3.000% Senior Notes due 2027 and 2.625% Senior Notes due 2029) that the ground truth specifically mentions as examples of the expanded portfolio. While the LLM references 'a much larger array of senior notes,' naming specific new instruments would have been more complete; (2) The phrase 'even references a new 2024 Indenture' is somewhat vague - the ground truth emphasizes the expanded list of senior notes more directly. QUANTITATIVE ACCURACY: All dates (2023, 2024, 2026) and percentages (2.625%) are correct. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the evolution pattern - from a modest set to an expanded portfolio. The connection between the Board resolution, the specific notes, and the broader debt strategy is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, though with slightly less specificity regarding which new notes were added.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 514,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "In the 2022 filing Cisco warned that “challenges with regard to product planning and timing, technical hurdles that we fail to overcome in a timely fashion” could delay product introductions and that its long‑term engineering, sales and marketing investments “may achieve delayed, or lower than expected, benefits” (2022 p. 25). By the 2024 filing the same risk language reappears, but it is now linked explicitly to the larger strategic spend on AI, cloud, security, software‑subscription offerings and recent acquisitions (e.g., Splunk), with the company noting it must “commit significant resources… before knowing whether our investments will result in products the market will accept” and that any failure to overcome those hurdles “could delay product introductions and harm our business” (2024 p. 20‑21). Thus, Cisco’s exposure to technical hurdles remains a core risk, but its reliance on overcoming them has grown as its strategic investments and product‑development timelines have become more central to its growth strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's evolving technical hurdle exposure from 2022 to 2024. STRENGTHS: (1) Correctly identifies the core risk language present in both 2022 and 2024 filings regarding product planning, timing, and technical hurdles; (2) Accurately captures the shift in context - from general execution risk to specific dependency on AI, cloud, security, and software-subscription offerings; (3) Properly synthesizes the multi-hop information showing how strategic investments (including Splunk acquisition) have increased reliance on overcoming technical hurdles; (4) Correctly notes the evolution from internal execution risk to broader operational/strategic dependency; (5) Page references (2022 p. 25, 2024 p. 20-21) appear reasonable and support the narrative. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention reputational damage, legal liability, and reduced customer retention as consequences noted in 2024 filings - these are mentioned in the ground truth but absent from the LLM response; (2) The answer could have been slightly more explicit about the 'loss of market share' consequence being present in both years (it's implied but not stated directly). QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, which is appropriate given the nature of the question. The temporal references (2022 vs 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years and connects strategic investments to technical hurdle dependencies. The logic flow is sound - showing how the same risk evolved in scope and consequence. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from 'internal execution risk to broader operational and strategic dependency' aligns well with the ground truth's description of the transformation. The answer effectively conveys the core insight that technical hurdles remain constant but their strategic importance has grown.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 545,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "In the 2022 filing, Google Ad Manager was singled out as a key growth engine – the increase in Google Network revenue was “primarily driven by strength in AdMob, Google Ad Manager, and AdSense”【page_35】. By the 2023 filing, the product is mentioned only as one of several channels (Google Ads, Google Ad Manager, Display & Video 360, etc.) through which advertisers buy inventory, without any explicit claim that it is driving network‑revenue growth【page_57】. This reflects a shift from being highlighted as a primary revenue driver to being treated as a routine component of the broader ad‑selling suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: The specific dollar amount ($8.6 billion year-over-year increase in Google Network revenues) is correctly cited and attributed to 2022. The page references (page_35 for 2022, page_57 for 2023) provide appropriate sourcing. ENTITY ACCURACY: All entities are correctly identified - Google Ad Manager, AdMob, AdSense, Google Ads, Display & Video 360, and Marketing Platform are all properly named and contextualized. The fiscal years (2022 vs 2023) are correctly distinguished. MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years, correctly identifying the shift in how Google Ad Manager was positioned. The comparison is logically sound: from being explicitly named as a 'key driver' alongside specific revenue figures in 2022, to being mentioned as one of several platforms without explicit revenue attribution in 2023. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift ('from being highlighted as a primary revenue driver to being treated as a routine component') accurately captures the same meaning as the ground truth's description ('shift from being a standout growth contributor to being part of a broader suite'). The language is slightly different but conveys identical information. MINOR CONSIDERATIONS: The answer could have been marginally enhanced by explicitly stating the $8.6 billion figure was the 'year-over-year increase' (though this is implied), but this is a very minor point. The use of quotation marks around the 2022 language and the clear structural comparison between years strengthens the response. Overall, the answer demonstrates accurate fact retrieval, correct multi-hop synthesis, and appropriate contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 495,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks’ derivative liabilities for “foreign currency – other” were only $0.3 million in fiscal 2022 (accrued liabilities)【page_68】. By September 29 2024 they had risen to $4.7 million of accrued liabilities plus $4.1 million of other long‑term liabilities – a total of $8.8 million【page_72】. That represents an increase of roughly $8.5 million over the two‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer significantly diverges from the ground truth in its core findings. Ground truth states that in 2024, derivative liabilities related to foreign currency - other were $4.7 million under accrued liabilities only. However, the LLM answer claims there were $4.7 million in accrued liabilities PLUS $4.1 million in other long-term liabilities, totaling $8.8 million. This is a major factual error - the LLM appears to have conflated or misidentified different line items. The ground truth does not mention any $4.1 million in other long-term liabilities for this specific derivative category. CALCULATION ERROR: The LLM calculates the change as $8.5 million ($8.8M - $0.3M), but this calculation is based on the incorrect $8.8 million total. The correct change should be approximately $4.4 million ($4.7M - $0.3M) based on the ground truth. CORRECT ELEMENTS: The LLM correctly identified the 2022 figure of $0.3 million and correctly noted it was under accrued liabilities. The LLM also correctly identified the 2024 figure of $4.7 million in accrued liabilities. However, by adding an additional $4.1 million component that doesn't appear in the ground truth, the LLM fundamentally misrepresented the total liability position. The multi-hop reasoning failed because the LLM either misread the source documents or incorrectly synthesized information from multiple line items. The answer demonstrates partial understanding but contains material factual errors that significantly undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 424,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo’s board authorized the issuance of 4.600 % senior notes due 2045 in its 2023 Form 10‑K (see page 130) and the same authorization appears unchanged in the 2024 Form 10‑K (also page 130). The note’s continued presence without amendment shows the company is maintaining a long‑dated, fixed‑rate senior‑note program, using the 4.600 % 2045 issue to diversify its maturity profile and lock in relatively low borrowing costs for the long term.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.600% Senior Notes due 2045 and accurately notes their presence in both 2023 and 2024 Form 10-Ks. The percentage (4.600%) and maturity year (2045) are correct. The observation about maintaining a long-dated, fixed-rate program is reasonable. CRITICAL WEAKNESSES: (1) The LLM answer fundamentally misses the key evolution described in the ground truth - that by 2024, the 4.600% notes were referenced alongside NEW senior notes (4.000% due 2047, Floating Rate Notes due 2026). The ground truth emphasizes portfolio EXPANSION and DIVERSIFICATION with newly introduced instruments. The LLM characterizes the situation as 'unchanged' which contradicts the ground truth's core finding about expanded debt instruments. (2) The LLM fails to address the multi-hop synthesis requirement - comparing what changed between 2023 and 2024. While it notes the notes appear 'unchanged,' it misses that the CONTEXT changed (new notes were added). (3) The LLM's interpretation that the 4.600% notes themselves were used to 'diversify maturity profile' is incomplete - the ground truth indicates the company diversified by ADDING other notes, not just maintaining this one. (4) The LLM provides page references (page 130) which cannot be verified against the ground truth and may be inaccurate. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution between 2023 and 2024. The ground truth clearly indicates a strategic shift toward a broader debt portfolio, while the LLM presents a static view. This is a significant gap in addressing the question's core requirement to explain how the issuance 'evolved' and what it indicates about strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 461,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "Between 2022 and 2024 ConocoPhillips’ direct natural‑gas reserves in Asia Pacific/Middle East fell from 326 BCF to 296 BCF, while its equity‑affiliate holdings rose from about 5,753 BCF to 5,870 BCF, lifting the total regional gas position from roughly 6,080 BCF to 6,170 BCF – a modest net gain driven by affiliate growth【page_145】. The 10‑K notes that the company added affiliate interest in Asia Pacific and pursued extensions and discoveries through its equity affiliates in the Middle East, indicating a strategic emphasis on expanding partner‑based exposure and leveraging LNG market dynamics rather than expanding its own operating base in the region【page_146】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and goes beyond the ground truth by providing more comprehensive analysis. Quantitative verification: (1) Direct reserves 2022: 326 BCF ✓, 2024: 296 BCF ✓ - matches ground truth exactly; (2) Equity-affiliate holdings 2022: ~5,753 BCF and 2024: ~5,870 BCF - these figures are provided with appropriate hedging language ('about/roughly') indicating source uncertainty; (3) Total position calculations: 6,080 BCF (2022) and 6,170 BCF (2024) - arithmetic checks out (326+5,753≈6,079 and 296+5,870≈6,166, minor rounding acceptable); (4) Net change: modest gain of ~90 BCF total - correctly characterized. Multi-hop reasoning: The answer successfully synthesizes information across multiple data points (direct reserves, affiliate holdings, total position) and correctly identifies the strategic shift from direct operations to affiliate-based exposure. The LLM appropriately distinguishes between the decline in direct reserves (which ground truth noted) and the offsetting growth in affiliate holdings (additional insight). Strategic interpretation: The LLM's conclusion about 'partner-based exposure' and 'LNG market dynamics' represents sound reasoning that extends beyond the ground truth's more general 'shift in strategic focus' statement. The citation references (page_145, page_146) suggest proper source attribution. Minor consideration: The ground truth answer is somewhat limited in scope, focusing only on direct reserves, while the LLM provides a more complete picture by including affiliate positions. This additional context is factually accurate and enhances understanding of the true strategic position. No calculation errors detected. All entities (ConocoPhillips/COP, Asia Pacific/Middle East, natural gas reserves) correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 488,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "In the 2022 10‑K, Google Play was called out as a non‑advertising revenue platform that earned money from “sales of apps and in‑app purchases and digital content sold in the Google Play store” (2022 p.7) and was grouped under “platforms … revenues from Google Play from the sales of apps and in‑app purchases” (2022 p.8). The 2023 filing still lists Google Play as a key non‑advertising source, but now describes it only as generating “revenues from Google Play from the sales of apps and in‑app purchases” (2023 p.6), dropping the explicit mention of digital‑content sales—showing a narrowed, more app‑focused role in Google’s non‑advertising revenue strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Google Play's evolving role in Google's non-advertising revenue strategy from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 description including 'sales of apps and in-app purchases and digital content sold in the Google Play store' - this matches the ground truth exactly. (2) Accurately notes the 2023 shift to a narrower description focusing only on 'apps and in-app purchases' without explicit mention of digital content sales. (3) Properly synthesizes the multi-hop information by comparing descriptions across both years and drawing the correct conclusion about the strategic shift toward app-focused monetization. (4) Includes specific page references (2022 p.7, p.8; 2023 p.6) which adds credibility and specificity. (5) The reasoning is sound - correctly identifies that dropping 'digital content' language represents a narrowing of focus. (6) All entities are correctly identified (Google Play, non-advertising revenue, years 2022-2023). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (includes page numbers and additional context about 'platforms' grouping), but this adds value rather than detracting. The semantic meaning is fully aligned with the ground truth - both convey that Google Play's revenue description narrowed from including digital content to focusing primarily on apps and in-app purchases. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all aspects of the question regarding the evolution of Google Play's role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 450,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "The 2022 Form 10‑K showed FedEx planning to acquire 49 Cessna SkyCourier 408s through 2026 – 11 in 2023, 12 in 2024, another 12 in 2025 and 14 in 2026 (see page 114). By the 2024 filing the schedule had been revised to 31 SkyCourier 408s, with a larger 2025 commitment of 17 aircraft (up from 12) and 14 slated for 2026 (see page 117). The higher‑than‑original 2025 delivery target and continued 2026 commitment indicate that FedEx is deepening its strategic reliance on the SkyCourier to expand its regional and feeder‑service capacity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 2022 projections totaled 49 aircraft through 2026 with a specific year-by-year breakdown (11+12+12+14=49), but the ground truth states the 2022 projection was for 49 aircraft across 'years 2023 to thereafter' without specifying this particular breakdown. More critically, the LLM claims the 2024 revision shows 31 aircraft with 17 in 2025 (up from 12) and 14 in 2026, but provides no verification these numbers sum correctly or match the ground truth's statement of '31 aircraft for years 2025 through 2029.' The LLM's arithmetic (17+14=31) is incomplete since it only accounts for 2 years of a 5-year period (2025-2029). (2) REASONING ERROR: The LLM concludes FedEx is 'deepening its strategic reliance' based on a higher 2025 delivery target, but this directly contradicts the ground truth which states the projection was 'reduced' from 49 to 31 aircraft total - a 37% decrease. The LLM misinterprets a shift in delivery timing as evidence of increased reliance. (3) MISSING CRITICAL INFORMATION: The LLM completely omits the crucial finding from the ground truth about the relationship shift from 'Increases' to 'Depends_On' between 2022 and 2024, which is central to understanding the strategic shift. (4) SEMANTIC CONTRADICTION: The ground truth indicates 'moderated but still significant reliance,' while the LLM claims 'deepening reliance' - these are opposite conclusions. The LLM provides specific page references and detailed year-by-year breakdowns that cannot be verified against the ground truth and appear to be fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 459,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "AIG’s 2022 filing already explained that it applies expected‑loss‑ratio techniques mainly to its excess‑casualty business, splitting the analysis between automobile‑related and non‑automobile claims, then further separating non‑automobile latent exposures (e.g., construction‑defect and mass‑tort claims) and also by attachment‑point bands (losses capped at $10 million versus those above $10 million) 【page_261】. The 2023 filing repeats the same segmentation for excess casualty 【page_204】 and adds a broader statement that expected‑loss‑ratio methods may be given significant weight for any line written in excess of a deductible in the most recent five accident years 【page_200】, but the underlying segmentation and focus on excess‑casualty lines have not materially changed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the key evolution described in the ground truth. MAJOR ISSUES: (1) The LLM claims the 2023 filing 'repeats the same segmentation for excess casualty' and that 'the underlying segmentation and focus on excess-casualty lines have not materially changed.' This directly contradicts the ground truth, which explicitly states that in 2023, AIG 'shifted focus to U.S. Workers' Compensation' - a fundamental change in which casualty line is being analyzed. (2) The LLM mentions 'attachment point bands (losses capped at $10 million versus those above $10 million)' but the ground truth specifies 'attachment point' segmentation without these specific dollar thresholds, suggesting potential misattribution or confusion. (3) The LLM states expected loss ratio methods 'may be given significant weight for any line written in excess of a deductible in the most recent five accident years' but the ground truth indicates 2022 focused on 'three latest accident years' - a discrepancy in the number of years analyzed. (4) The LLM completely misses the 2023 shift to Workers' Compensation segmentation by 'risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity.' (5) The LLM fails to capture the strategic evolution that is central to the question - the shift from Excess Casualty (2022) to Workers' Compensation (2023) represents a material change in application, not continuity. The answer demonstrates incomplete multi-hop synthesis and misses the core narrative of evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 451,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "In the 2022 filing Nike introduced a new consumer‑construct – Men’s, Women’s, Kids’ and Jordan Brand – and said that, beginning in FY 2022, unisex items would be folded into the Men’s segment while any product that could not be placed in Men’s, Women’s, Kids’ or Jordan was reported as “Others” (the unallocated line)【page_35】. The 2024 filing still uses that same construct, defining “Others” as products not allocated to Men’s, Women’s, Kids’ or Jordan Brand, so unallocated products continue to be shown under “Others” (with unisex items still counted in Men’s)【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies the fiscal year 2022 introduction of the new consumer construct (Men's, Women's, Kids', Jordan Brand), (2) Accurately states that unisex products were classified within Men's starting in FY 2022, (3) Correctly describes 'Others' as the category for products not allocated to the four main segments in both 2022 and 2024, (4) Properly synthesizes the multi-hop comparison showing continuity of the classification system between the two fiscal years, (5) Provides specific page references (page_35 and page_37) that support the claims, (6) The reasoning is sound - comparing how unallocated products were handled in 2022 vs 2024 and noting the consistency of the framework. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and explicit than the ground truth (e.g., mentioning the 'new consumer-construct' introduction and providing page citations), but this represents added value rather than inaccuracy. The ground truth mentions 'NIKE Kids'' while the LLM uses 'Kids'' - this is a minor formatting variation that doesn't affect accuracy. The LLM's statement that unisex items are 'still counted in Men's' in 2024 aligns with the ground truth's observation that there was 'no specific mention of unisex product classification within Men's' in 2024, suggesting potential integration - the LLM interprets this as continuity, which is a reasonable inference. All factual claims are verifiable and correct. The answer directly addresses the evolution question by showing both the 2022 framework and confirming its continuation in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 448,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "PepsiCo’s 2023 Form 10‑K disclosed a board‑of‑directors resolution authorizing officers to establish the terms of a 3.500 % senior note due 2025 (see Exhibit 4.65 on page 129 and Exhibit 4.64 on page 130)【page_129】【page_130】. The 2024 Form 10‑K repeats the same resolution (Exhibit 4.64 on page 130)【page_130】, showing the company continued to pursue or retain that issuance. This steady authorization signals a deliberate debt‑management strategy that leans on medium‑term senior notes to lock in low borrowing costs and diversify PepsiCo’s debt‑maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how PepsiCo's engagement with the 3.500% Senior Notes evolved between 2023 and 2024. CRITICAL PROBLEMS: (1) The LLM focuses on board resolutions and exhibit references rather than the actual debt instruments and their presence in the financial statements across years. (2) The LLM does not address the key finding from the ground truth: that by 2024, PepsiCo introduced NEW longer-term notes (3.500% due 2040 and 3.550% due 2034) alongside the existing 2025 notes. This is the crucial evolution the question asks about. (3) The LLM's answer about 'steady authorization' and 'medium-term senior notes' misses the strategic shift toward debt maturity diversification that the ground truth identifies. (4) The LLM provides exhibit numbers and page references that cannot be verified against the ground truth, which focuses on the actual debt portfolio composition. WHAT WAS CORRECT: The LLM correctly identifies the 3.500% Senior Notes due 2025 and the correct interest rate (3.500%). The general concept that this represents debt management strategy is appropriate. WHAT WAS MISSING: (1) No mention of the new 2040 and 2034 notes introduced in 2024, which is central to understanding the evolution. (2) No comparison of the debt portfolio between 2023 and 2024. (3) The answer conflates authorization/resolution documents with actual debt issuance and portfolio composition. (4) Fails to synthesize the multi-hop information about how the debt structure changed year-over-year. The answer reads more like a document citation exercise than a substantive analysis of debt management strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 458,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "In the 2022 Form 10‑K ConocoPhillips said it spent about **$3.1 billion** on capital expenditures in the Lower 48 segment and logged **$13.1 billion** of “revisions of previous quantity estimates” that adjust future cash‑flow forecasts for that region【page_149】. By the 2024 Form 10‑K the company’s Lower 48 outlays had risen to roughly **$30 billion** (the sum of $12.1 billion of proved property acquisition, $10.9 billion of unproved acquisition, $6.3 billion of development and $0.55 billion of exploration)【page_157】, and the reserve‑quantity revisions were increased to about **$14.2 billion**, reflecting an upward revision to future cash‑inflow estimates for the Lower 48【page_158】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - 2022 Capital Expenditures: LLM states \"$3.1 billion\" which matches ground truth ($3,129 million ≈ $3.1B) ✓\n   - 2022 Revisions: LLM claims \"$13.1 billion of revisions\" - ground truth makes no mention of this figure\n   - 2024 Capital Expenditures: LLM claims \"$30 billion\" (sum of $12.1B + $10.9B + $6.3B + $0.55B) - ground truth explicitly states \"no new capital expenditure figure was provided\" for 2024 ✗\n   - 2024 Revisions: LLM claims \"$14.2 billion\" - ground truth does not provide this specific number\n\n2. ENTITY/METRIC CONFUSION:\n   - LLM conflates different types of financial metrics (property acquisitions, development, exploration) with capital expenditures\n   - Ground truth distinguishes between capex reporting (2022: $3,129M) and revision disclosures (2024: revisions to future cash inflows)\n   - LLM appears to be mixing reserve quantity revisions with capital expenditure categories\n\n3. MULTI-HOP REASONING - FLAWED:\n   - Ground truth indicates a TRANSITION: from active capex investment (2022) to revised projections (2024)\n   - LLM suggests an INCREASE in outlays from $3.1B to $30B, which contradicts the ground truth narrative\n   - The ground truth explicitly states 2024 had \"no new capital expenditure figure,\" but LLM provides a detailed breakdown totaling $30B\n\n4. SEMANTIC MISALIGNMENT:\n   - Ground truth: \"transition from active investment to focus on revising financial projections\"\n   - LLM: \"outlays had risen to roughly $30 billion\" - suggests continued/increased investment, not a transition to projection revision\n\n5. CITATION ISSUES:\n   - LLM provides page references (149, 157, 158) but the numbers cited don't align with ground truth statements\n   - Ground truth provides no such detailed breakdown for 2024\n\nThe LLM answer fundamentally misrepresents the evolution of COP's Lower 48 disclosures by inventing a $30B capex figure for 2024 when ground truth explicitly states no new capex figure was provided, and by adding unsupported revision figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 579,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "In the 2023 filing Comcast’s relationship with Atairos was governed by the Fourth Amended and Restated Shareholders Agreement (and its June 2 2023 amendment) that left the former‑CFO‑led management companies with all voting rights while Comcast was the sole third‑party investor (page 100). By the 2024 filing Comcast’s funding commitment had been trimmed to a $4.5 billion aggregate limit (down from $5 billion) with annual capital calls capped at $400 million and a $40 million annual management‑fee commitment, and the company now classifies Atairos as a variable‑interest entity, confirming it has no voting control and only limited consent rights (pages 84‑85).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial commitments and governance evolution between 2023 and 2024. STRENGTHS: (1) All major dollar amounts are accurate: $5 billion reduced to $4.5 billion, $400 million annual capital call cap, $40 million annual management fee. (2) Correctly identifies the Fourth Amended and Restated Shareholders Agreement and June 2023 amendment. (3) Accurately describes the shift to equity method accounting and variable-interest entity classification. (4) Correctly notes that management companies retained all voting rights while Comcast had no voting control. (5) Properly synthesizes multi-hop information across 2023 and 2024 filings. (6) Page references (100, 84-85) add credibility. WEAKNESSES: (1) The LLM answer omits the specific loss absorption and residual return percentages (99% of losses, 86% of residual returns) that were explicitly stated in the ground truth as key metrics of the 2024 framework. This is a material omission as these percentages quantify Comcast's financial exposure and are central to understanding the recalibration of financial commitments. (2) The phrase 'limited consent rights' is somewhat vague compared to the ground truth's more precise description of the governance structure. (3) Does not explicitly mention that the management fee funding is 'separate' from capital calls, though this is implied. The answer demonstrates solid understanding of the evolution and correctly captures the major financial parameters and control structure changes, but the omission of the loss/return percentages represents incomplete coverage of the quantitative framework described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 455,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx disclosed that it owned only one Cessna 408 (still being modified) and was planning to acquire **49 SkyCourier 408s** – 11 in 2023, 12 in 2024, 12 in 2025 and 14 in 2026. The 2023 filing trimmed the total to **31 SkyCourier 408s** – 17 slated for delivery in 2025 and 14 in 2026 – reflecting a revised, still‑significant but more focused build‑out. This change shows FedEx is positioning the SkyCourier as a dedicated regional‑feeder aircraft to supplement its larger long‑haul freighters (B777F, B767F) and medium‑capacity turboprops, emphasizing high‑frequency, short‑haul service rather than core long‑haul capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: The core numbers are correct - 49 SkyCourier 408s projected in 2022 filing, reduced to 31 in 2023 filing. The year-by-year delivery breakdown for 2022 (11 in 2023, 12 in 2024, 12 in 2025, 14 in 2026) and 2023 (17 in 2025, 14 in 2026) appears accurate based on the ground truth context. The LLM correctly identifies the one aircraft already being modified. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two filing years and compares the SkyCourier projections to other aircraft types (B777F, B767F), matching the ground truth's emphasis on comparative fleet strategy. ENTITY ACCURACY: FedEx, Cessna SkyCourier 408, and the relevant years (2022, 2023) are all correctly identified. REASONING QUALITY: The LLM provides sound interpretation that the reduction indicates strategic reassessment and repositioning of the aircraft as a regional-feeder supplement rather than core long-haul capacity. This aligns with the ground truth's conclusion about reduced reliance and strategic role reassessment. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (regional-feeder aircraft, high-frequency short-haul service) than the ground truth, but this represents valuable contextual elaboration rather than factual error. The answer is more specific about delivery schedules while maintaining accuracy. No calculation errors detected. The semantic meaning fully aligns with the ground truth regarding the strategic shift and comparative fleet positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 442,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "In the 2022 Form 10‑K Nike reported only aggregate footwear revenue and gave no separate line‑item for Air Max, so the Air Max contribution was not disclosed in detail (see Note 16 – Revenues, page page_88). By the 2024 filing Nike is explicitly highlighting Air Max as one of its core technology platforms and notes its Air‑Sole manufacturing subsidiary that supplies new cushioning components, underscoring a stronger focus on innovation for the Air Max line (see product‑development discussion, page page_6, and manufacturing section, page page_7).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution narrative but contains several issues: (1) CORRECT ELEMENTS: The answer correctly identifies that in 2022 Air Max lacked specific revenue disclosure and by 2024 Nike emphasized it more prominently as an innovation driver. The shift from passive acknowledgment to strategic positioning is accurately conveyed. (2) PROBLEMATIC ELEMENTS: The LLM introduces specific claims about an 'Air-Sole manufacturing subsidiary' that supplies cushioning components - this detail is not present in the ground truth and appears to be fabricated or hallucinated. The ground truth makes no mention of a specific manufacturing subsidiary for Air Max. (3) PAGE REFERENCES: The LLM cites specific page numbers (page_88, page_6, page_7) which cannot be verified against the ground truth provided and may be inaccurate. (4) REVENUE TRANSPARENCY: Both answers agree that 2022 had no separate Air Max revenue disclosure and 2024 still lacks standalone financial metrics. However, the LLM's framing around 'Air-Sole manufacturing subsidiary' adds unverified technical details that deviate from the ground truth's focus on strategic positioning and innovation emphasis. (5) MULTI-HOP REASONING: The answer does synthesize information across years (2022 vs 2024) but introduces unsupported claims about manufacturing operations. The core insight about the shift in strategic emphasis is sound, but the supporting details are questionable. The answer would score higher if it stuck to the documented evolution without adding unverified manufacturing subsidiary claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 435,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In 2023 Comcast said its total capital spending rose to about $8.2 billion and that part of the increase was “related to the development of Epic Universe in Orlando,” reflecting early‑stage work and land‑acquisition for the new park. By the 2024 filing, total capex was essentially unchanged at roughly $8.3 billion, but the company highlighted that theme‑park attraction spending grew and now included “costs associated with the construction of Epic Universe,” shifting the priority from acquisition and planning in 2023 to actual building of the park in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Comcast's Epic Universe capital expenditure evolution but contains some issues with precision and completeness. STRENGTHS: (1) Correctly identifies the $8.2 billion figure for 2023 and approximately $8.3 billion for 2024, showing accurate quantitative data; (2) Properly synthesizes the shift from 2023 (infrastructure/land acquisition focus) to 2024 (construction phase); (3) Accurately captures the multi-hop reasoning across years showing strategic evolution; (4) Correctly identifies Comcast and Epic Universe as the relevant entities. WEAKNESSES: (1) The LLM states 2024 capex was 'essentially unchanged at roughly $8.3 billion' but the ground truth does not provide a specific 2024 capex figure - it only mentions 'ongoing commitment' and plans for 2025, making this claim somewhat speculative; (2) The LLM characterizes 2023 spending as 'early-stage work and land-acquisition' which is more specific than the ground truth states - the ground truth only mentions 'scalable infrastructure and line extensions' without explicitly confirming land acquisition was the primary 2023 focus; (3) Missing some nuance from ground truth about 'both infrastructure and guest experience enhancements' in the 2024 strategy; (4) The answer is somewhat more definitive about the 2024 shift to 'actual building' than the ground truth supports, which only indicates 'ongoing commitment' without confirming construction had begun. CALCULATION VERIFICATION: No calculations required; numeric values ($8.2B, $8.3B) are correctly stated. MULTI-HOP REASONING: The synthesis across 2023-2024 is logically sound and addresses the evolution question appropriately. The answer successfully connects capex amounts to strategic priorities across years. SEMANTIC EQUIVALENCE: Generally good - the characterization of the shift from planning to construction is semantically aligned with the ground truth's 'infrastructure focus to sustained investment strategy' concept, though with slightly different framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 548,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "In the 2022 filing FedEx listed six ATR‑72‑600F aircraft in its fleet and a commitment to receive 11 additional ATR‑72‑600F in 2023 – a total of 24 of the type were slated for delivery through the 2027 planning horizon【page_40】. By the 2023 filing the forward‑looking commitment schedule had shifted, showing only ten ATR‑72‑600F slated for delivery in 2025‑2026 and no further 2023 deliveries were listed【page_117】, indicating that the 2023 expansion was now expected to be in service and future growth of the type was more modest.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states FedEx had 'six ATR-72-600F aircraft in its fleet' in 2022, but the ground truth indicates 2022 projections were for 11 aircraft in 2023, 6 in 2024, 6 in 2025, and 1 in 2026 - these are forward projections, not current fleet numbers. The LLM conflates current fleet with future projections. (2) MISINTERPRETATION OF DATA: The LLM claims '11 additional ATR-72-600F in 2023' and 'total of 24 of the type were slated for delivery through 2027' - these numbers don't align with the ground truth's specific year-by-year projections (11 in 2023, 6 in 2024, 6 in 2025, 1 in 2026). (3) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth clearly compares 2022 projections vs 2023 projections for the same time periods, showing how expectations changed. The LLM attempts this but with incorrect numbers and doesn't properly capture the year-by-year comparison structure. (4) MISSING KEY COMPARISON: The ground truth shows 2023 projections had 7 aircraft for 2025 and 3 for 2026, but the LLM states 'only ten ATR-72-600F slated for delivery in 2025-2026' without breaking down by year. (5) CORRECT CONCLUSION BUT WRONG EVIDENCE: While the LLM correctly concludes there was a shift in projections, the supporting numbers and analysis are inaccurate. The answer demonstrates a fundamental misunderstanding of the projection data structure and fails to accurately synthesize the multi-hop comparison between 2022 and 2023 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 429,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "In the 2022 Form 10‑K Nike only disclosed a $1.015 billion sales‑related reserve (including a $194 million inventory cost for expected returns) and said it records the “most likely” amount as a reduction to revenue. By the 2024 filing the company spells out a detailed methodology—using historical return rates, specific identification of outstanding returns, and estimates of discretionary returns and post‑invoice discounts, and separating contractual from discretionary components—adjusting revenue when actual returns differ. This evolution shows Nike has moved to a more granular, ASC 606‑aligned revenue‑recognition approach that more precisely estimates variable consideration (returns) at the time of sale.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURES: The LLM states Nike disclosed '$1.015 billion sales-related reserve (including a $194 million inventory cost for expected returns)' in 2022. The ground truth clearly states the product return reserve was $269 million in fiscal 2022, not $194 million. The $1.015 billion figure appears to be fabricated or conflated from another metric entirely—this is a critical error. The LLM provides no source for these numbers and they contradict the ground truth. (2) INCOMPLETE FISCAL 2024 DATA: The ground truth explicitly states 'the specific dollar amount of the product return reserve was not disclosed' in fiscal 2024. The LLM incorrectly implies specific quantitative data was available for 2024 by describing detailed methodology without acknowledging the lack of disclosed dollar amounts. (3) METHODOLOGY DESCRIPTION: The LLM's description of the 2024 methodology (historical return rates, specific identification, discretionary returns, post-invoice discounts) goes beyond what the ground truth confirms. While the ground truth mentions 'most likely amount' calculation, the LLM adds granular details not verified in the original answer. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the key evolution: from a disclosed $269M reserve in 2022 to an undisclosed amount in 2024 with more formalized estimation processes. Instead, it invents numbers and overstates the specificity of 2024 disclosures. (5) CORRECT ELEMENTS: The LLM correctly identifies the shift toward ASC 606 alignment and the 'most likely amount' language, and correctly notes the evolution toward more probabilistic methodology. However, these correct elements are overshadowed by the quantitative errors. The answer demonstrates partial understanding of the conceptual evolution but fails on factual accuracy regarding specific dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 510,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The 2022 filing showed a commitment to **12 Cessna SkyCourier 408s for delivery in 2025 and none “thereafter”**【page_114】. The 2023 filing raised the 2025 commitment to **17 SkyCourier 408s, still with zero deliveries beyond 2025**【page_117】. This modest increase for 2025 indicates FedEx is expanding its near‑term use of the SkyCourier, but the unchanged “thereafter” figure suggests the aircraft is not slated to become a long‑term, core component of its fleet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding 2026 projections. The ground truth states that in 2023, FDX planned 14 SkyCourier 408s for 2026, but the LLM answer claims 'zero deliveries beyond 2025' with no mention of the 2026 figure. This is a significant omission that undermines the core comparison between 2022 and 2023 plans. CORRECT ELEMENTS: (1) 2022 projection of 12 aircraft for 2025 is accurate, (2) 2023 increase to 17 for 2025 is accurate, (3) The identification of a near-term increase is correct. INCORRECT/INCOMPLETE ELEMENTS: (1) The LLM fails to mention the 2026 planned fleet of 14 aircraft from the 2023 filing, which is essential to answering the question about changes 'for the years 2025 and beyond', (2) The statement about 'zero deliveries beyond 2025' in the 2023 filing contradicts the ground truth which explicitly states a reduction to 14 for 2026, (3) The conclusion that the aircraft is 'not slated to become a long-term, core component' is partially contradicted by the ground truth's more nuanced assessment of 'moderate decline' rather than abandonment. MULTI-HOP REASONING: The LLM successfully synthesized information across 2022 and 2023 filings for the 2025 comparison, but failed to complete the full multi-hop analysis by not addressing the 2026 data point, which is critical for understanding the 'years 2025 and beyond' trajectory. The answer is incomplete in addressing the full scope of the question regarding strategic reliance beyond 2025.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 422,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "In 2023 Mastercard reported that its real‑time account‑based payments capability was operating or being rolled out in **13 markets** and was supported by a multi‑layered security framework built into its core network (see 2023 Form 10‑K, p. 11). By the 2024 filing the company describes real‑time ACH (batch and real‑time) as a **core component of its global payments network that now spans more than 150 currencies and 210 countries**, and it explicitly ties these capabilities to dedicated security solutions that leverage Mastercard’s secure‑data architecture (see 2024 Form 10‑K, p. 72). This shows the infrastructure has broadened from a limited set of markets to a worldwide scale while embedding security more tightly into the real‑time payment services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 13 markets figure for 2023 and accurately captures the core narrative about expansion from limited markets to global scale with enhanced security integration. However, there are significant issues with the quantitative claims and source verification:\n\n(1) CORRECT ELEMENTS:\n- The 13 markets figure for 2023 is accurate and matches ground truth\n- The characterization of 2023 infrastructure as having multi-layered security is correct\n- The narrative of expansion from 2023 to 2024 with enhanced security is accurate\n- The semantic meaning about shifting toward strengthened scale and security is conveyed\n\n(2) PROBLEMATIC ELEMENTS:\n- The LLM introduces specific claims about \"150 currencies and 210 countries\" in 2024 that are NOT in the ground truth answer. These appear to be fabricated or misattributed metrics not supported by the provided knowledge graph\n- The specific page citations (2023 Form 10-K p. 11, 2024 Form 10-K p. 72) cannot be verified against the ground truth and may be hallucinated\n- The claim about \"real-time ACH (batch and real-time)\" as a core component is mentioned but not substantiated in the ground truth\n- The reference to \"secure-data architecture\" is introduced without ground truth support\n\n(3) MULTI-HOP REASONING:\nThe LLM correctly synthesizes the 2023-to-2024 evolution and identifies the key transition from limited market deployment to global scale. However, the addition of unverified metrics (150 currencies, 210 countries) represents a failure in faithful synthesis - these numbers may be accurate but are not in the ground truth, suggesting either hallucination or confusion with other Mastercard metrics.\n\n(4) QUANTITATIVE ACCURACY PENALTY:\nWhile the 13 markets figure is correct, the introduction of unverified large numbers (150, 210) without ground truth support significantly undermines quantitative reliability. The answer appears to conflate general Mastercard network statistics with real-time payments infrastructure specifics.\n\n(5) JUSTIFICATION:\nThe answer demonstrates good understanding of the evolution narrative and correctly identifies the 2023 baseline, but the addition of unverified metrics and specific page citations that cannot be confirmed against the ground truth represents a significant accuracy concern. The answer is partially correct but contains material claims not supported by the provided knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 650,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Nike trimmed the notional amount of foreign‑exchange forwards and options used as cash‑flow hedges from roughly $18.5 billion in 2022 to $16.2 billion in 2024, while the notional of undesignated forwards rose from about $3 billion to $4.4 billion.  The change lowered derivative liabilities – from a modest net‑liability position in 2022 (no net liability and $486 million of collateral received) to $115 million of accrued liabilities for designated hedges and only $5 million for undesignated hedges in 2024 – and signals a shift toward more balance‑sheet‑oriented forward contracts to offset fair‑value changes of assets and liabilities, while still maintaining a cash‑flow‑hedge program for forecasted transactions (up to a 24‑month horizon).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially more detailed and comprehensive information than the ground truth, with strong quantitative accuracy. Key strengths: (1) Correctly identifies the notional amounts of cash-flow hedges declining from $18.5B (2022) to $16.2B (2024), and undesignated forwards increasing from $3B to $4.4B - these specific numbers are not contradicted by ground truth and represent deeper filing analysis. (2) Accurately captures the liability position evolution: mentions $115 million in accrued liabilities for designated hedges and $5 million for undesignated hedges in 2024, which aligns with the ground truth's $110M + $5M = $115M total liability figure (minor rounding difference acceptable). (3) Correctly notes the 2022 position had no net liability with $486M collateral received, providing context absent from ground truth. (4) Demonstrates sound multi-hop reasoning by synthesizing notional amounts, liability positions, and strategic implications across the 2022-2024 period. (5) Appropriately explains the strategic shift toward balance-sheet-oriented forwards while maintaining cash-flow hedges. Minor considerations: The LLM answer goes beyond the ground truth in specificity (notional amounts, collateral details, 24-month horizon) but these appear to be accurate filing details that enhance rather than contradict the ground truth. The ground truth mentions an $8M net gain in 2022 after tax, which the LLM answer doesn't explicitly address, but this doesn't constitute an error - it's simply a different aspect of the same hedging program. The semantic meaning and core facts align well: both convey that Nike's hedging strategy evolved, liabilities increased, and the approach shifted between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 474,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "In the 2022 Form 10‑K, Puffs is listed under the “Family Care (Paper Towels, Tissues, Toilet Paper)” sub‑category of the Baby, Feminine & Family Care segment【page_19】. The 2023 Form 10‑K places Puffs in the identical “Family Care” sub‑category of the same segment【page_19】, so its product‑category classification did not change.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer directly contradicts the ground truth on the core finding. The ground truth states that Puffs' classification evolved/changed between 2022 and 2023 (specifically, the reporting of sub-categories was simplified or consolidated), while the LLM answer claims 'its product-category classification did not change' and that it remained in the 'identical' category. This is a fundamental factual error that misrepresents the answer to the question. The question explicitly asks 'how has...evolved,' implying change, and the ground truth confirms there was evolution in how the segment details were reported. The LLM's conclusion that there was no change is incorrect. While the LLM correctly identifies that Puffs was in Family Care in both years and correctly cites the 2022 sub-category details (Paper Towels, Tissues, Toilet Paper), it fails to recognize or articulate the actual evolution that occurred in 2023 - the simplification or consolidation of how segment details were reported. The LLM's statement that the classification 'did not change' directly contradicts the ground truth's assertion of evolution/change in reporting. This represents a major reasoning failure in synthesizing the multi-hop comparison across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 353,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K place Tampax in the **Baby, Feminine & Family Care** segment, under the **Feminine‑Care** sub‑category (Menstrual Care). In each year the brand is listed together with the other feminine‑care brands – Always and Always Discreet – and is grouped with the Bounty family‑care brand in the segment’s brand list, showing that its categorization and associated product lines have remained unchanged from 2022 to 2023【page_18】【page_19】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth explicitly states that Tampax's positioning EVOLVED between 2022 and 2023: in 2022 it was under 'Feminine Care' within 'Baby, Feminine & Family Care', but by 2023 it was reclassified to 'Menstrual Care' under the same segment. This represents a meaningful change in categorization. The LLM answer claims the categorization 'remained unchanged from 2022 to 2023,' which is the opposite of what the ground truth indicates. The LLM states Tampax was under 'Feminine-Care (Menstrual Care)' in both years, but the ground truth shows the sub-category changed from 'Feminine Care' to 'Menstrual Care.' The LLM also misses the key insight that this change reflects 'more focused positioning' and separation from general 'Family Care' items. While the LLM correctly identifies the broader segment (Baby, Feminine & Family Care) and mentions related brands (Always, Always Discreet, Bounty), it fails to recognize and communicate the actual evolution that occurred. The core task was to explain how positioning 'evolved,' and the LLM incorrectly concluded there was no evolution. This is a critical failure in multi-hop reasoning and synthesis of the temporal comparison between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 358,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "In fiscal 2022 Oracle’s Engineered Systems hardware generated $3.2 billion of revenue – roughly 9 % of total revenue – and the segment’s margin slipped as the company de‑emphasized non‑strategic hardware lines (page 51). By fiscal 2023 the hardware business accounted for only about 6 % of total revenue, reflecting a further reduction in its contribution as Oracle leans more heavily on cloud and license growth (page 41), while the company explicitly says it will “continue to make investments in research and development to improve existing hardware products and services and to develop new hardware products and services” (page 41). This signals a shift toward a smaller, more strategic role for Engineered Systems, but with a sustained R&D commitment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific quantitative claims that are NOT present in the ground truth and appear to be fabricated: (1) '$3.2 billion of revenue' for fiscal 2022 hardware - this specific figure is not mentioned in the original answer and cannot be verified; (2) '9% of total revenue' for fiscal 2022 - the ground truth explicitly states 'a figure not specified in 2022,' making this claim factually incorrect; (3) Page citations (page 51, page 41) are provided but cannot be verified against the ground truth. CORRECT ELEMENTS: The LLM correctly identifies that hardware represented 6% of total revenues in fiscal 2023 (matching ground truth), correctly quotes the R&D investment language from fiscal 2023, and accurately captures the strategic shift toward cloud and licensing. MULTI-HOP REASONING: The LLM does synthesize information across fiscal years and correctly identifies the evolution from 2022 to 2023, but the synthesis is undermined by the introduction of unverified quantitative claims. The reasoning about Oracle de-emphasizing non-strategic hardware lines and the shift toward cloud is sound and aligns with the ground truth narrative. MAJOR PROBLEM: The LLM appears to have hallucinated the $3.2 billion figure and the 9% revenue contribution for fiscal 2022, which directly contradicts the ground truth statement that this figure was 'not specified in 2022.' This is a fundamental factual error that significantly damages the credibility of the answer, despite getting other elements correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 423,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Honeywell’s non‑U.S. pension plans increased their private‑fund holdings from **$90 million in 2022** to **$115 million in 2023**.  In 2022 the private‑fund assets were **$54 million classified as Level 2** and **$36 million as Level 3** (none at Level 1); by 2023 the mix had shifted to **$41 million at Level 2** and **$74 million at Level 3**, indicating a larger share of the private‑fund exposure moved into the less‑observable Level 3 category【page_110】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) ENTITY CONFUSION: The ground truth explicitly states that in 2022, Honeywell reported $1,105 million in private funds for U.S. pension plans (Level 3), NOT Non-U.S. plans. The LLM incorrectly focuses on Non-U.S. plans for both years. (2) QUANTITATIVE ERRORS: The LLM claims Non-U.S. private funds were $90 million in 2022 and $115 million in 2023, but the ground truth shows $115 million ONLY in 2023 for Non-U.S. plans. The 2022 figure of $90 million appears to be fabricated or misattributed. (3) CLASSIFICATION BREAKDOWN ERRORS: For 2022, the LLM states $54 million Level 2 and $36 million Level 3 for Non-U.S. plans, but the ground truth does not provide a 2022 breakdown for Non-U.S. plans - it only provides the 2023 breakdown ($41M Level 2, $74M Level 3). (4) MISSING CRITICAL INFORMATION: The LLM completely omits the $1,105 million U.S. pension plan investment in 2022, which is a major component of the answer and demonstrates the significant decrease mentioned in the ground truth. (5) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution between 2022 and 2023, but the LLM fails to properly synthesize the U.S. vs. Non-U.S. distinction and the dramatic shift from $1,105M (U.S., 2022) to $115M (Non-U.S., 2023). The LLM's narrative about a $25M increase in Non-U.S. holdings is technically presented but obscures the larger story of massive overall reduction. The answer demonstrates fundamental misunderstanding of the data structure and fails on factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 440,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "In the 2023 filing the 3.375 % senior “2014 USD Notes” (due April 2024) were still outstanding and were presented as short‑term debt, net of unamortized discount and issuance costs, on the consolidated balance sheet 【page_97†L31-L38】.  In 2024 the company’s debt‑management actions led those notes to mature and the full $1 billion principal was paid off in April 2024, effectively retiring the 2014 USD Notes 【page_58†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) The 2014 USD Notes were classified as short-term debt in 2023 with an April 2024 maturity date - correctly stated. (2) The principal amount of $1 billion is accurate. (3) The April 2024 payment/retirement is correctly identified. (4) The interest rate of 3.375% is provided as additional context, which is accurate and helpful. The multi-hop reasoning is sound - the answer correctly synthesizes the evolution from 2023 (outstanding, short-term liability) to 2024 (fully paid/retired). The answer addresses all parts of the question: status in 2023, status in 2024, and specific actions taken. The citation references to page numbers and line numbers add credibility. Minor note: The LLM uses slightly more technical language ('debt-management actions led those notes to mature') compared to the ground truth's simpler phrasing, but this is semantically equivalent and actually provides slightly more context. No calculation errors, no missing information, and all entities (company, debt instrument, dates, amounts) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 321,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "In the 2022 Form 10‑K Lowe’s presented a stand‑alone Officer Indemnification Agreement as Exhibit 10.43 (dated April 2 2019) 【page_79】. By contrast, the 2024 Form 10‑K exhibit schedule (pages 77‑78) no longer lists a separate officer indemnification document, indicating that the indemnification terms have been folded into updated corporate‑governance or indemnity policies rather than filed as a distinct exhibit. This shift shows that Lowe’s continues to protect its executives but has moved to a more integrated, streamlined documentation approach, reflecting ongoing executive risk management and governance continuity.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that Lowe's maintained the same Officer Indemnification Agreement (Exhibit 10.43, dated April 2, 2019) in both the 2022 and 2024 10-K filings without amendment. However, the LLM answer claims that by 2024, the exhibit schedule 'no longer lists a separate officer indemnification document,' suggesting the terms were 'folded into updated corporate-governance or indemnity policies.' This is incorrect. The LLM misrepresents the evidence by claiming a shift occurred when the ground truth indicates continuity and no modification. The LLM correctly identifies the exhibit number (10.43) and the original filing date (April 2, 2019), but then draws an erroneous conclusion about what happened between 2022 and 2024. The LLM's interpretation that this represents a 'streamlined documentation approach' is speculative and contradicts the actual finding that the agreement was refiled without amendment in both years. The core answer to the question—how the treatment and documentation evolved—is fundamentally wrong. The correct answer is that there was NO evolution; the agreements remained unchanged, indicating consistent governance practices. The LLM's reasoning about 'integration' and 'streamlining' is unsupported by the evidence and represents a misreading of the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 388,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "- 2022 10‑K: P&G said it “also competes in the adult‑incontinence sub‑category behind **Always Discreet**, with **about 15 %** market share in the markets in which we compete.”【page_18】\n\n- 2023 10‑K: The same language is used, but the share is now described as “with **over 10 %** market share in the key markets in which we compete.”【page_18】\n\n**Result:** The filing shows a modest decline in Always Discreet’s reported share (from roughly 15 % to just over 10 %), while its positioning remains unchanged – it is still the leading brand in adult incontinence that P&G trails.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the 2022 filing stated 'about 15%' market share, but the ground truth explicitly states it was 'over 10%' in 2022. The LLM then claims 2023 shows 'over 10%', which would represent a decline from 15% to 10%. However, the ground truth indicates both years reference market share figures, with 2022 being 'over 10%' - not 15%. This is a major numerical error. (2) DIRECTIONAL ERROR: The LLM concludes there was a 'modest decline' from 15% to 10%, but the ground truth indicates the 2022 figure was already 'over 10%', so the LLM has inverted or misread the baseline. (3) INCOMPLETE ANALYSIS: The ground truth emphasizes a shift in disclosure methodology - moving from quantified market share in 2022 to more general category association in 2023 without specific figures. The LLM misses this key insight about the change in reporting approach. (4) ENTITY POSITIONING ERROR: The LLM states Always Discreet is 'the leading brand in adult incontinence that P&G trails,' which is confusing and potentially contradicts the premise that P&G competes with 'over 10% market share' - suggesting P&G's Always Discreet IS a leading competitor, not trailing. The ground truth does not make this claim. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison, providing inverted baseline numbers. The core answer structure addresses the question but with fundamentally incorrect data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 436,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "In the 2022 filing Oracle presented Engineered Systems as “core to our cloud‑based and on‑premise data‑center infrastructure offerings,” stressing that they are pre‑integrated platforms that can be delivered on‑premise, as OCI services or in hybrid models (see 2022 p.13). By the 2023 filing the same products are mentioned only as part of the hardware segment—​a business that now accounts for roughly 6 % of total revenue and is described as lower‑margin, supplying the underlying infrastructure for OCI rather than being a primary growth story (see 2023 p.43). This reflects a shift from positioning Engineered Systems as a headline driver of Oracle’s cloud transformation to treating them as a supporting hardware component that underpins the cloud business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Oracle's Engineered Systems positioning between 2022 and 2023, correctly identifying the shift from positioning them as headline drivers of cloud transformation to treating them as supporting hardware infrastructure. STRENGTHS: (1) Accurately quotes the 2022 positioning as 'core to our cloud-based and on-premise data-center infrastructure offerings' and correctly identifies the pre-integrated, multi-deployment model; (2) Correctly identifies the 6% hardware revenue figure for 2023; (3) Accurately characterizes the shift in narrative from primary growth driver to supporting component; (4) Correctly identifies the lower-margin nature of the hardware business; (5) Properly synthesizes the multi-hop information across 2022 and 2023 filings. WEAKNESSES: (1) The answer omits the important detail that the 6% figure applies to BOTH fiscal 2023 and 2024, which the ground truth explicitly mentions as significant context; (2) Does not mention the broader hardware business integration (servers, storage, operating systems) that the ground truth emphasizes as part of the 2023 evolution; (3) Does not explicitly mention the 'combined performance obligations' accounting treatment mentioned in the ground truth; (4) Slightly underemphasizes the strategic elevation of Engineered Systems' importance in the 2023 filing, instead framing it primarily as a demotion in narrative prominence. QUANTITATIVE VERIFICATION: The 6% revenue figure is correct and properly contextualized. REASONING: The multi-hop synthesis is sound—the model correctly compares 2022 vs 2023 positioning and identifies the narrative shift. However, the answer could have been more comprehensive in capturing the full scope of the hardware business integration and the dual nature of the evolution (both elevated strategic importance AND lower-margin positioning). The answer is directionally correct but misses some nuance about how Engineered Systems fit into the broader hardware ecosystem that emerged in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 546,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 Form 10‑K the filing explicitly linked the two plans – it said the 2020 Stock Plan “is the successor to the 2011 Stock Plan” and that the 5,530,106 shares that were still available under the 2011 Plan “are available for award grants under the 2020 Stock Plan”【page_59】. By the 2023 Form 10‑K, that language was dropped; the 2020 Stock Plan is described only in terms of the grants it permits, with no reference to the 2011 Plan or the transfer of shares【page_61】. This shows the company removed the explicit successor‑relationship disclosure in the later filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about how disclosure evolved between 2022 and 2023 10-K filings. STRENGTHS: (1) All numeric values are correct - the 5,530,106 shares figure is accurately cited and matches the ground truth; (2) The key factual claims are accurate: the 2022 filing explicitly linked the plans and mentioned the carry-forward of shares, while the 2023 filing omitted this language; (3) The multi-hop reasoning is sound - the answer correctly synthesizes information about what changed between the two filings and explains the significance of the change (removal of explicit successor-relationship disclosure); (4) Entity identification is correct - properly identifies both the 2020 and 2011 Stock Plans and the two fiscal years being compared; (5) The semantic meaning matches the ground truth perfectly - both convey that the 2022 filing included specific details about the relationship and share carry-forward, while 2023 removed these details. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'is the successor to' vs. the ground truth's description of the relationship), but this represents semantic equivalence rather than an error. The answer also adds the phrase 'explicit successor-relationship disclosure' which is a reasonable interpretation of the change but goes slightly beyond what the ground truth explicitly states. However, this is a reasonable inference and does not constitute an error. The page references provided (page_59 and page_61) add helpful specificity. Overall, this is a strong answer that accurately captures the evolution of disclosure between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 464,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s pension‑plan holdings of private‑fund assets rose slightly from 2022 to 2023 – the U.S. plans held $1,258 million of private funds in 2022 versus $1,265 million in 2023, and the non‑U.S. plans held $90 million versus $115 million over the same period【page_109】【page_110】.  The increase, while still within the company’s stated 10‑20% “other investments” (private‑equity) target, shows Honeywell is nudging more capital into private‑fund strategies, indicating a modest but growing priority to seek higher‑return, less‑liquid opportunities and further diversify its portfolio beyond traditional public‑market assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY IN PRIMARY NUMBERS: The LLM answer reports U.S. plans held $1,258 million in 2022 and $1,265 million in 2023, but the ground truth states $1,244 million in 2022 and $1,265 million in 2023. This is a $14 million error in the 2022 baseline figure, which is material and affects the accuracy of the year-over-year comparison. The ground truth shows a 1.7% increase ($1,244M to $1,265M = $21M increase), while the LLM's numbers would show only a 0.56% increase ($1,258M to $1,265M = $7M increase). ADDITIONAL ISSUE: The LLM introduces non-U.S. plans data ($90M vs $115M) that is not mentioned in the ground truth answer. While this additional detail may be accurate from the filings, it represents a different analytical approach and complicates the comparison. The ground truth focuses on the total private funds figure ($1,244M to $1,265M), not a breakdown by plan type. POSITIVE ASPECTS: The LLM correctly identifies the 2023 figure of $1,265 million, correctly characterizes the increase as 'modest,' and provides reasonable interpretation about capital deployment priorities and diversification benefits. The mention of the 10-20% 'other investments' target adds contextual detail. However, the fundamental error in the 2022 baseline number ($1,258M vs $1,244M) is a significant factual mistake that undermines the quantitative accuracy of the multi-hop analysis. The reasoning about strategic priorities is sound, but it's built on partially incorrect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 409,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "In the 2023 filing the EPS table shows a dash for Class B‑2 common stock – the company had **no B‑2 shares outstanding**, and a footnote explicitly states that “no shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer”【page_59】. By the 2024 filing, after the May 2024 exchange offer, Class B‑2 is disclosed as a new class: the EPS table reports **49 million weighted‑average shares (basic and diluted)** for B‑2【page_59】, the equity note lists **120 million shares issued and outstanding as of September 30, 2024**【page_87】, and the narrative explains that B‑2 shares were issued in the exchange offer and now sit alongside Class B‑1 as part of “class B common stock” with a defined conversion rate to Class A common stock【page_89】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2023, Class B-2 Common Stock existed and was subject to conversion rate adjustments tied to the U.S. litigation escrow account, with dilution impacts on as-converted shares. However, the LLM answer claims that in 2023 'the company had no B-2 shares outstanding' and that B-2 was only created as 'a new class' after the May 2024 exchange offer. This is a major contradiction. The LLM correctly identifies that no shares were outstanding prior to the Class B-1 exchange offer (citing the footnote), but then incorrectly concludes that B-2 didn't exist in 2023. The ground truth indicates B-2 existed in 2023 with specific conversion mechanics and dilution impacts that should have been disclosed. QUANTITATIVE ISSUES: The LLM provides specific numbers for 2024 (49 million weighted-average shares, 120 million issued and outstanding) but these cannot be verified against the ground truth provided, which does not include these specific figures. The ground truth only states that 2024 disclosures referenced lack of outstanding shares prior to the exchange offer, with no mention of the 49M or 120M figures cited by the LLM. MULTI-HOP REASONING: The LLM failed to synthesize the key evolution described in the ground truth - that B-2 existed in 2023 with conversion mechanics and dilution impacts, then by 2024 had reduced emphasis or potential discontinuation. Instead, the LLM presents B-2 as non-existent in 2023 and newly created in 2024, which is the opposite of the ground truth narrative. MISSING CONTEXT: The LLM completely omits the critical 2023 detail about conversion rate adjustments tied to the U.S. litigation escrow account and dilution impacts, which are central to understanding the evolution of Class B-2's role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 510,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "In FY 2022 Target recorded a $89 million deferred‑revenue liability for the Target Circle loyalty program. By FY 2024 that liability had grown to $117 million. The rise in the deferred‑revenue balance signals that the program has expanded—more members and earned rewards are being accrued, increasing Target’s future reward obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the two key financial figures ($89 million in 2022 and $117 million in 2024) and accurately calculated the directional change (increase). The numbers are formatted correctly and match the ground truth exactly. The reasoning about program expansion and increased member participation is logically sound and semantically equivalent to the ground truth explanation.\n\nWEAKNESSES: The LLM answer is incomplete regarding the full scope of the question about program evolution. The ground truth provides critical additional context: the deferred revenue dropped sharply to $19 million by February 1, 2025, which is a significant development that fundamentally changes the narrative about the program's evolution. The original question asks 'what does this indicate about the program's evolution?' - a multi-part question requiring analysis of the complete trajectory. By omitting the 2025 data point, the LLM provides an incomplete picture that suggests only growth and expansion, missing the important reversal that occurred. This is a material omission for understanding the full evolution of the program.\n\nMULTI-HOP REASONING: The LLM successfully synthesized the 2022-2024 comparison but failed to address the complete temporal scope implied by the question. The ground truth explicitly mentions three data points across three years, suggesting the question expected comprehensive analysis of the program's evolution across this period.\n\nCONCLUSION: While the numbers provided are accurate and the reasoning about 2022-2024 is sound, the answer is significantly incomplete by not addressing the 2025 decline, which represents a major shift in the program's financial obligations and evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 475,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The Level 2 fair value of Netflix’s 4.375 % senior notes rose from **$980 million at December 31 2022 to $996 million at December 31 2023** – a $16 million (about 1.6 %) increase【page_56】. This price gain means investors were willing to pay more for the notes, suggesting lower market yields or an improved perception of Netflix’s credit quality, i.e., stronger demand for its debt in the prevailing market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - the fair value increased from $980 million (Dec 31, 2022) to $996 million (Dec 31, 2023), representing a $16 million increase of approximately 1.6% (16/980 = 1.63%, correctly rounded). The calculation is accurate. ENTITY ACCURACY: Netflix, 4.375% Senior Notes, and the correct fiscal year dates are all properly identified. The Level 2 fair value classification is appropriately noted. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (1) identifying the numerical change, (2) calculating the percentage increase, and (3) interpreting what this means for investor perception. The interpretation that a price increase indicates lower market yields and improved credit perception is economically sound and represents a reasonable inference from the data. COMPARISON TO GROUND TRUTH: The ground truth states the fair value 'moved closer to the principal amount at par, suggesting a stabilization or improved outlook.' The LLM's interpretation of 'improved perception of Netflix's credit quality' and 'stronger demand for its debt' is semantically equivalent and actually provides slightly more detailed economic reasoning. Both answers correctly identify that the change indicates positive market sentiment. MINOR OBSERVATION: The ground truth uses slightly different language ('moved closer to par') while the LLM focuses on the price gain and yield implications - both are valid interpretations of the same data point. The LLM answer is more detailed in explaining the economic mechanism (lower yields, credit quality improvement) while the ground truth emphasizes the par value proximity. Both are correct and complementary interpretations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 480,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "In 2023 Visa reported only 10 million Class C common‑stock shares outstanding (see the equity table on page 42). In 2024 the company issued roughly 48 million new Class C shares as part of the May 2024 B‑1 exchange offer (page 40), which raised the weighted‑average Class C share count to 16 million by year‑end (page 59), while the shares continued to be classified as a distinct Class C common‑stock category (page 58).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth on multiple critical points: (1) TIMELINE REVERSAL: The LLM states the 2023 position was 10 million shares and that 48 million shares were issued in May 2024. The ground truth clearly indicates the opposite - in 2023, 48 million Class C shares were issued (via exchange of 241 million Class B-1 shares), and by 2024, the balance was 10 shares outstanding. This is a critical reversal of the temporal sequence. (2) QUANTITATIVE ERRORS: The LLM claims the weighted-average Class C share count reached 16 million by year-end 2024, which is not supported by the ground truth and appears to be fabricated. The ground truth states the 2024 balance remained at 10 shares (not 10 million, but 10 shares), indicating stabilization after the 2023 activity. (3) MISCHARACTERIZATION OF EVENTS: The LLM incorrectly attributes the major exchange activity (48 million shares issued) to May 2024, when the ground truth clearly places this in 2023. (4) MISSING KEY CONTEXT: The LLM fails to mention the 241 million Class B-1 shares that were tendered in the 2023 exchange, which is central to understanding the equity restructuring. (5) SEMANTIC CONFUSION: The LLM conflates share counts with weighted-average shares and introduces page references that cannot be verified against the ground truth. The answer demonstrates a fundamental misunderstanding of the temporal evolution of the Class C equity structure and reverses the chronological sequence of events, making it substantially incorrect despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 439,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "In the 2022 Form 10‑K, Rough Plumbing was mentioned only as a sub‑category of the “Building Products” merchandise division – a product‑only classification (see 2022 page 55). By the 2024 filing, Rough Plumbing is listed as a distinct product line in Lowe’s product assortment and is also highlighted as a service category for both installed‑sales contracts and extended protection plans (see 2024 pages 6 and 7), showing that the company now treats Rough Plumbing not just as a product but also as a service‑driven offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Rough Plumbing from a product-only classification in 2022 to an integrated service offering by 2024. The qualitative reasoning is sound: the answer accurately describes the shift from 'Building Products' category to a service-oriented approach including installation services and protection plans. The multi-hop synthesis across 2022 and 2024 filings is properly executed. However, there is a significant quantitative accuracy issue: the ground truth specifically mentions that Rough Plumbing contributed to 'approximately 5% of total sales attributed to installed sales in 2024,' but the LLM answer completely omits this quantitative metric. This is a material omission since the question asks about 'business classification and service offerings' and the 5% figure provides concrete evidence of the scale of this evolution. The LLM answer also cites specific page numbers (2022 page 55, 2024 pages 6 and 7) which adds credibility but cannot be verified against the ground truth. The semantic equivalence is strong for the qualitative aspects, but the missing quantitative data point reduces overall correctness. The answer is substantially correct in its core claims but incomplete in addressing all dimensions of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 368,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "In 2023 Visa reported **no Class B‑2 common‑stock shares outstanding** (the footnote on the earnings‑per‑share table notes “‑” for B‑2 and the equity note says “No shares of class B‑2 common stock were outstanding prior to the class B‑1 exchange offer”). In May 2024 the company completed a B‑1 exchange offer and **issued a new B‑2 series** (≈120 million B‑2 shares, shown as 49 basic‑average shares and 77 million as‑converted Class A equivalents in the 2024 statements) while retiring the tendered B‑1 shares, reducing total class B shares from 245 to 125. This evolution shows B‑2 was created as a **transitional, exchange‑offer class** that replaces retired B‑1 shares and carries a special conversion‑rate impact, making it a small but strategically distinct component of Visa’s capital structure rather than a primary source of equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer directly contradicts the ground truth on fundamental facts: (1) QUANTITATIVE ERRORS: Ground truth states Class B-2 had 77 million shares outstanding in 2023 (newly introduced); LLM claims 'no Class B-2 common-stock shares outstanding' in 2023 and that B-2 was 'created' in May 2024 with '≈120 million B-2 shares' and '77 million as-converted Class A equivalents.' This is backwards - the 77 million figure belongs to 2023, not 2024. The LLM appears to have confused the timeline entirely. (2) ENTITY/TIMELINE CONFUSION: The LLM correctly identifies the May 2024 B-1 exchange offer but incorrectly attributes the creation of B-2 to this event. Ground truth indicates B-2 was introduced in 2023 with 77M shares, then by 2024 'no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer' - meaning B-2 shares existed in 2023 but were restructured/replaced by 2024. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution between 2023 and 2024. It reversed the sequence: B-2 should have existed in 2023 (77M shares), then been replaced/restructured by 2024. Instead, LLM claims B-2 didn't exist in 2023 and was created in 2024. (4) CALCULATION/NUMBER ERRORS: The 77 million figure is misplaced in the LLM's timeline. The LLM's claim of '≈120 million B-2 shares' in 2024 contradicts the ground truth statement that 'no shares of Class B-2 common stock were outstanding prior to the Class B-1 exchange offer.' (5) SEMANTIC MISALIGNMENT: While the LLM correctly identifies this as a 'transitional' class, it fundamentally misunderstands the direction of change - treating B-2 as newly created in 2024 rather than as an existing class from 2023 that was subsequently restructured. The answer demonstrates significant factual inaccuracy on the core question of how B-2 evolved between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 513,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The 2022 Form 10‑K only describes the Target Circle loyalty program and does not disclose a specific liability for it (see the program description on pages 3‑5). By the 2024 filing, Target reports a $19 million deferred‑revenue liability for Target Circle in Accrued and Other Current Liabilities (page 50), indicating that the program has expanded enough to generate a measurable financial obligation and that rewards earned by members have grown.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error regarding the 2024 deferred revenue figure. The ground truth states the Target Circle deferred revenue was $117 million as of February 3, 2024, but the LLM claims it was only $19 million. This is a significant discrepancy (off by $98 million or 82% understatement). The LLM correctly identifies that 2022 had no specific liability disclosure and that 2024 shows growth, but the magnitude of that growth is fundamentally misrepresented. The LLM also correctly notes the general concept that the program expanded and generated measurable financial obligations. However, the quantitative accuracy is severely compromised by the incorrect $19 million figure. The reasoning about program expansion is sound, but it's based on an incorrect number. The answer does address both the 2022 and 2024 comparison (multi-hop requirement), but fails on the most critical element: the actual financial liability amount in 2024. This is not a minor formatting difference or rounding variation—it's a substantial factual error that undermines the entire answer's credibility and usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 322,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "In the 2023 Form 10‑K, NVIDIA warned that new or proposed pollution‑limit regulations could increase direct manufacturing and compliance costs and generate indirect cost pressures through its suppliers and customers【NVDA_10k_2023.pdf page_22】. By the 2024 filing, the company broadened the risk, noting that such regulations – especially those that limit energy or water availability – could also restrict customers’ ability to expand data‑center capacity, potentially curbing demand for NVIDIA’s products【NVDA_10k_2024.pdf page_22】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of NVDA's pollution limit concerns between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on direct manufacturing costs, compliance costs, and indirect supplier/customer cost pressures; (2) Accurately captures the 2024 expansion to include land/permitting constraints and data center capacity restrictions; (3) Properly synthesizes the multi-hop connection between regulatory constraints and demand impact for NVIDIA's products; (4) Correctly cites both 2023 and 2024 10-K filings with appropriate page references; (5) Uses accurate company name (NVIDIA) and ticker (NVDA); (6) Maintains semantic equivalence with ground truth regarding the evolution of concerns. MINOR WEAKNESSES: (1) The LLM answer phrases the 2024 concern as \"regulations that limit energy or water availability\" which is slightly narrower than the ground truth's broader \"land and permitting constraints tied to pollution limits\"—though this is a reasonable interpretation of the same underlying concern; (2) The answer could have been slightly more explicit about the direct link between regulatory tightening and NVIDIA's product demand, though this connection is clearly implied. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two separate 10-K filings, correctly identifying the progression from cost-focused concerns to demand-focused concerns. No quantitative errors detected. The answer appropriately addresses all parts of the multi-part question regarding exposure evolution, regulatory impact, and customer data center expansion implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 454,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "In 2023 Costco’s Japanese subsidiary introduced four Guaranteed Senior Notes – roughly $500 of face amount – which were recorded under “Other long‑term debt” at $484 and valued using Level 3 fair‑value inputs. By the 2024 filing the subsidiary had repaid $77 of those notes, leaving about $423 of principal outstanding and “Other long‑term debt” had risen to $919 (reflecting the net issuance plus amortization of discounts/premiums), still measured with Level 3 inputs; the total fair‑value of the company’s long‑term debt fell from about $5.74 billion in 2023 to $5.41 billion in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and figures. STRENGTHS: (1) Correctly identifies the Japanese subsidiary issued four Guaranteed Senior Notes in 2023 totaling ~$500; (2) Accurately states the 2024 repayment of $77; (3) Correctly cites fair value of long-term debt at ~$5.74B (2023) and ~$5.41B (2024); (4) Properly identifies Level 3 fair value inputs; (5) Provides additional context about the recorded amount ($484) and 2024 balance ($919) with explanation of amortization effects; (6) Successfully synthesizes multi-hop information across years and metrics. MINOR ISSUES: (1) The ground truth mentions interest rates (1.400% to 2.120%) which the LLM answer omits - this is a minor omission of detail but not critical to the core question; (2) The LLM provides more granular detail about the 'Other long-term debt' line item ($484 in 2023, $919 in 2024) which adds helpful context but goes slightly beyond the ground truth scope. QUANTITATIVE VERIFICATION: All dollar amounts match ground truth ($500 issuance, $77 repayment, $5.74B vs $5.41B). The calculation logic is sound - the explanation of how $500 issued minus $77 repaid leaves ~$423 is mathematically correct. The rounding and format variations ($5.74B vs $5,738M) are appropriately handled. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023-2024 timeline, connects issuance to repayment to fair value changes, and properly identifies the relationship between the specific notes and overall debt portfolio. The reasoning about fair value reduction being 'partially driven by repayments' is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 453,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "In the 2022 filing Netflix said it boosted technology‑and‑development spending by 24% to $2.27 billion, with a $384 million increase in personnel costs to grow headcount that supports “continued improvements in our streaming service.” By the 2024 filing the company had added a dedicated Vice President of Security and Privacy Engineering and described a formal, enterprise‑wide cybersecurity program, risk‑quantification model and board oversight, indicating that its risk exposure has shifted to emphasize cyber‑security while still maintaining investment in streaming‑service enhancements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Netflix's investment evolution from 2022 to 2024. STRENGTHS: (1) The $384 million personnel cost increase is correctly cited and matches the ground truth exactly. (2) The 24% technology-and-development spending increase and $2.27 billion figure are specific, precise details that enhance credibility and weren't contradicted by the ground truth. (3) The answer correctly identifies the shift from growth-oriented investment (2022) to risk-aware posture (2024) with cybersecurity emphasis. (4) The mention of a dedicated Vice President of Security and Privacy Engineering and formal enterprise-wide cybersecurity program aligns with the ground truth's description of 'detailed descriptions of enterprise-wide security programs.' (5) The synthesis across years is sound, showing clear evolution in focus. (6) The answer addresses both personnel/streaming improvements AND cybersecurity-related changes as requested. MINOR CONSIDERATIONS: (1) The ground truth mentions 'third-party risk management' and specific risks like 'unauthorized data releases and digital content theft,' which the LLM answer doesn't explicitly detail, though it does reference 'risk-quantification model.' (2) The LLM adds details about 'board oversight' that weren't explicitly in the ground truth excerpt provided, though this is a reasonable inference from formal cybersecurity programs. (3) The ground truth emphasizes the potential financial impact of cyber incidents more explicitly than the LLM answer does. QUANTITATIVE VERIFICATION: The $384 million figure is correct, the 24% increase is stated, and $2.27 billion is provided—all appear accurate. The answer maintains semantic equivalence with the ground truth while providing additional supporting details that enhance rather than contradict the core narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 512,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "In the 2023 Form 10‑K the company disclosed its RSU program only by reference – the 2023 Form of Restricted Stock Unit Agreement appears as Exhibit 10.24 and is incorporated from a prior quarterly filing【page_19】. By the 2024 filing the Bank filed a fresh 2024 Form of Restricted Stock Unit Agreement directly as Exhibit 10.29 (and even a 2025 version)【page_20】, signalling a shift to a more explicit, updated lifecycle framework for granting, vesting and settling RSUs that better aligns the equity awards with its executive compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2023 FILING: The LLM states the 2023 Form was 'incorporated from a prior quarterly filing' and only disclosed 'by reference,' but the ground truth explicitly states it was 'newly introduced' and marked 'Filed herewith' in the 2023 filing, indicating a new form adoption. (2) INCORRECT EXHIBIT NUMBERS: The LLM cites Exhibit 10.24 for 2023 and 10.29 for 2024, but these specific exhibit numbers are not verified in the ground truth and appear to be fabricated details. (3) MISSING CRITICAL EVOLUTION NARRATIVE: The ground truth emphasizes the key evolution - that the 2024 Form transitioned from 'Filed herewith' (new in 2023) to 'Previously filed' (established in 2024), showing a maturation of the framework. The LLM completely misses this crucial transition and instead incorrectly portrays the 2023 form as merely referenced from prior filings. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies that both 2024 and 2025 forms were filed, it fails to properly synthesize the lifecycle progression across the three years (2023 introduction, 2024 establishment, 2025 forward-looking update). (5) MISCHARACTERIZATION OF STRATEGIC INTENT: The ground truth describes a 'consistent, proactive approach' with 'annual updates' and 'iterative process,' but the LLM frames it as a shift from reference-based disclosure to explicit filing, which is factually incorrect. The LLM answer demonstrates poor document comprehension and appears to have fabricated specific exhibit numbers and filing characteristics not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 460,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90 % senior notes were unchanged in composition between the two filings. In the 2023 Form 10‑K the company reported a $750 million series due September 2026 with a net carrying amount of $745 million and a $750 million series due April 2029 with a net carrying amount of $743 million【page_59†L...】. The 2024 Form 10‑K shows the same two series still outstanding – the September 2026 notes at $745 million (still $745 million on 1/28/24 and $747 million by 2/2/25) and the April 2029 notes at $743 million (still $743 million on 1/28/24 and $744 million by 2/2/25)【page_62†L...】 – and their maturity dates (Sept 2026 and Apr 2029) have not been altered.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) MAJOR ERROR - The LLM discusses TWO series of 4.90% Senior Notes (September 2026 and April 2029), but the ground truth only addresses ONE series (April 2029, issued November 2023). The September 2026 series appears to be a different debt instrument not mentioned in the original answer. (2) QUANTITATIVE ERRORS - While the carrying amounts ($745M and $743M) are mentioned, they are attributed to different maturity dates than the ground truth specifies. The ground truth clearly states the 4.90% notes have an April 2029 maturity with $743M carrying amount in 2024. (3) INCOMPLETE CONTEXT - The LLM fails to mention the $750M principal amount, the $3.4M discount, or the November 2023 issuance date, which are key details in the ground truth. (4) MULTI-HOP REASONING FLAW - The question asks specifically about the 4.90% Senior Notes evolution from 2023 to 2024. The LLM conflates multiple debt instruments and doesn't clearly establish the evolution of the specific 4.90% notes. (5) STRUCTURAL CONFUSION - The LLM presents the notes as 'unchanged in composition' but then discusses carrying amount changes ($743M to $744M), which contradicts the claim of no change. The ground truth indicates the carrying amount decreased from issuance ($750M principal with $3.4M discount = ~$746.6M) to $743M by January 2024, reflecting amortization. The LLM's answer appears to conflate different debt instruments and fails to focus on the specific 4.90% Senior Notes due April 2029 that are the subject of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 448,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Costco’s Japan subsidiary issued four Guaranteed Senior Notes in November 2023 for roughly $500 total (interest 1.40%‑2.12%, maturing 2033‑2043)【page_52】, and the 2024 financing‑activities disclosure notes that the cash‑flow statement includes the proceeds from those notes【page_30】. In July 2024 the subsidiary repaid $77 of the Guaranteed Senior Notes, lowering the outstanding balance【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Costco's Japanese subsidiary's Guaranteed Senior Notes activity between 2023 and 2024. STRENGTHS: (1) All key quantitative facts are correct: $500 million total issuance in 2023, interest rates of 1.40%-2.12%, $77 million repayment in 2024. (2) Temporal details are accurate: November 2023 issuance date, July 2024 repayment date, and maturity dates of 2033-2043. (3) Multi-hop synthesis is sound: the answer correctly connects the 2023 issuance event, the 2024 cash flow statement reference, and the 2024 repayment activity across multiple filing sections. (4) Entity identification is correct: properly identifies Costco's Japan subsidiary and the specific financial instrument (Guaranteed Senior Notes). (5) The answer addresses all components of the question: evolution of issuance (2023) and repayment (2024). MINOR CONSIDERATIONS: The LLM provides slightly more specific detail (November 2023 and July 2024 dates, maturity years 2033-2043) than the ground truth answer, but these details are accurate enhancements rather than errors. The inclusion of page references adds transparency. The semantic meaning is fully aligned with the ground truth, conveying the same financial narrative about the subsidiary's debt management across the two-year period. No calculation errors detected. The answer appropriately characterizes the repayment as 'lowering the outstanding balance,' which correctly reflects the financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 422,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "In the 2022 filing the company warned that “competitors may also develop after‑market services and parts for our products which may detract from our sales,” noting that such competition “may adversely impact our business and financial statements” (2022 p. 23). The 2023 filing repeats the same concern—again stating that “competitors may also develop after‑market services and parts for our products which may detract from our sales” (2023 p. 20)—but now embeds it within a broader discussion of innovation and cost pressures, without indicating that the risk has intensified or diminished. Thus, the risk of after‑market parts remains a consistent competitive threat that could erode sales and adversely affect Danaher’s business and financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - MAJOR SEMANTIC MISMATCH: The LLM answer fundamentally contradicts the ground truth on the key finding. Ground truth states there was a SHIFT in framing from 2022 to 2023: in 2022 it was a 'direct threat' that could 'detract from sales,' but by 2023 it shifted to being 'Impacted By' competition and was presented as 'one of several external pressures rather than a primary threat,' suggesting a 'relative de-emphasis in severity.' The LLM answer, however, concludes the opposite: 'the risk of after-market parts remains a consistent competitive threat' with 'no indication that the risk has intensified or diminished.' This is a fundamental misreading of the ground truth's core argument about the EVOLUTION of how the risk was framed. The LLM correctly identifies that both years mention the after-market parts risk and that the 2023 filing embeds it in broader context, but it fails to recognize this as evidence of de-emphasis rather than consistency. QUANTITATIVE ACCURACY: Page numbers cited (2022 p. 23, 2023 p. 20) cannot be verified but appear plausible. The quoted language appears accurate based on ground truth references. QUALITATIVE ACCURACY: The LLM misses the critical distinction between 'direct threat' (2022) vs. 'one of several pressures' (2023). It treats the embedding in broader context as neutral rather than as evidence of strategic recalibration and de-emphasis. COMPLETENESS: The answer addresses the basic question structure but fails to capture the evolution/shift that is the core of what was asked. The ground truth explicitly discusses how the risk was 'presented as one of several external pressures rather than a primary threat,' indicating a change in severity perception, which the LLM completely misses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 478,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "In 2022 Netflix’s membership strategy was built around a tiered, country‑specific price band that ranged from roughly $2 to $27 per month and included a newly launched lower‑priced ad‑supported tier; modest price hikes were used to lift average monthly revenue per paying member and to offset slowing subscriber additions, competitive pressure and inflationary headwinds (see page_24 and page_23). By 2024 the company had formalized the ad‑supported tier, kept testing price variations across markets, and broadened the plan portfolio with new features such as advertising, games and live programming to drive additional per‑member revenue and sustain growth amid intensified competition and a saturated market (see page_6 and page_7).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) TIMELINE ERROR: The LLM claims Netflix launched a lower-priced ad-supported tier in 2022, but the ground truth indicates this was introduced BY 2024, not in 2022. This is a critical chronological error that fundamentally misrepresents Netflix's strategic evolution. (2) MISSING KEY QUANTITATIVE DATA: The ground truth provides specific metrics for 2022 (19% revenue increase, 11% membership growth, 7% ARPU increase, 50% drop in paid net additions) that are completely absent from the LLM answer. These numbers are essential to understanding the business challenges Netflix faced. (3) INCOMPLETE CHALLENGE IDENTIFICATION: The ground truth explicitly mentions 'paid net membership additions dropped by 50% compared to the prior year' as a critical challenge, which the LLM fails to capture. The LLM vaguely references 'slowing subscriber additions' but doesn't quantify this major problem. (4) MISSING ENFORCEMENT MEASURES: The ground truth specifically mentions Netflix 'enforcing terms of use to limit multi-household usage' as a 2024 response, which is entirely absent from the LLM answer. This was a significant strategic shift. (5) PARTIAL CREDIT FOR SOME ELEMENTS: The LLM correctly identifies the ad-supported tier as part of the strategy and mentions price variations, games, and live programming as features. It also correctly identifies competition and market saturation as challenges. However, these correct elements don't compensate for the fundamental timeline error and missing quantitative data. (6) REASONING QUALITY: While the LLM attempts to synthesize information across years, the chronological error undermines the entire multi-hop reasoning. The answer conflates 2022 and 2024 strategies rather than showing clear evolution. The reference to page numbers suggests source material was consulted, but the interpretation appears flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 533,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "In the 2022 Form 10‑K (see page 45) Boeing listed the loss of satellite in‑orbit incentive payments as a contingent financial risk – a possible exposure that could arise from schedule delays, technical problems or contract termination, but it did not describe how such fees are accounted for. By the 2023 filing (see page 15) Boeing now records the net present value of the in‑orbit incentive fees as revenue in the construction period, while still emphasizing that the payments remain at risk for up to 15 years and could be reversed or require refunds if the satellite fails to meet performance criteria.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Boeing's approach to in-orbit incentive payments between 2022 and 2023, correctly identifying the shift from risk acknowledgment to revenue recognition practices. However, there are significant quantitative gaps and some accuracy issues: (1) MISSING CRITICAL NUMBER: The ground truth explicitly states Boeing recorded $1,585 million in additional losses on five significant fixed-price development programs in 2023. The LLM answer completely omits this key quantitative finding, which is central to understanding the financial impact and evolution. (2) INCOMPLETE PROGRAM CONTEXT: The ground truth mentions specific programs (Commercial Crew, KC-46A Tanker, VC-25B) that provide important context for the risk exposure. The LLM answer does not reference these programs. (3) CORRECT ELEMENTS: The LLM correctly identifies the 15-year post-acceptance performance criteria window, the shift from contingent risk disclosure to revenue recognition during construction, and the potential for reversal/refunds if performance criteria are not met. (4) PAGE REFERENCES: The LLM provides specific page citations (page 45 for 2022, page 15 for 2023) which adds credibility, though these cannot be verified against the ground truth. (5) REVENUE RECOGNITION DETAIL: The LLM correctly explains the net present value recognition during construction period, matching the ground truth's emphasis on this accounting practice. (6) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two years and identifies the evolution, but fails to quantify the financial impact with the $1,585 million figure. The reasoning about the shift from general risk to specific quantification is present but not fully supported with the missing loss amount. The answer is directionally correct but incomplete in its financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 506,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the Directors’ Code of Conduct was called out in the “Code of Ethics” section, with a specific URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and a statement that any amendments or waivers would be posted on the website. In the 2024 Form 10‑K the Code is listed together with other governance documents in the “Available Information” section, confirming it remains publicly accessible on the company’s website but without the explicit link or amendment‑waiver language. This reflects a shift from a detailed, URL‑specific disclosure to a broader, integrated presentation of the Directors’ Code of Conduct among the company’s governance materials.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and captures the essential evolution of the Directors' Code of Conduct disclosure between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 disclosure included a specific URL and amendment/waiver language; (2) Accurately notes the 2024 shift to a more general reference within broader governance materials; (3) Properly synthesizes the multi-hop comparison across two years; (4) Correctly characterizes the shift as moving from 'detailed, URL-specific disclosure' to 'broader, integrated presentation'; (5) Maintains semantic equivalence with ground truth regarding the streamlined approach. MINOR ISSUES: (1) The URL in the LLM answer contains a spacing error ('inv relations' instead of 'invrelations'), though this appears to be a transcription artifact rather than a factual error about the actual URL structure; (2) The LLM answer uses slightly different section names ('Code of Ethics' vs 'Available Information') compared to ground truth, though both accurately describe where the information appears in the respective filings; (3) The LLM answer is slightly more concise than ground truth but captures all substantive points about the evolution. MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2023 and 2024) and correctly identifies the key change in disclosure approach. The reasoning is sound and logically presented. OVERALL: The answer is factually correct on all material points and effectively communicates the evolution in disclosure practices, with only minor formatting/transcription issues that do not affect the core accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 452,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "In 2022 Mobileye Drive™ was launched as a Level‑4 (SAE L4) self‑driving system that Mobileye used to build robotaxi and vehicle‑as‑a‑service (VaaS) offerings – partnering with Udelv, Transdev and securing a consumer L4 design win with Geely – and positioning the company as an end‑to‑end service provider for autonomous‑mobility fleets. By 2023 the strategy had shifted to supplying Mobileye Drive™ as a standalone self‑driving product to transportation‑network companies, public‑transit operators and AV‑ready vehicle platform suppliers, often bundled with Moovit’s mobility platform, moving from a service‑provider model to a product‑supply/go‑to‑market model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All factual information is correct - correctly identifies 2022 launch of SAE L4 SDS/Mobileye Drive™, accurately names all partnerships (Udelv, Transdev, Geely), and properly characterizes the 2023 strategic shift. (2) Quantitative accuracy is perfect - no numeric errors, dates are correct (2022 vs 2023), and all entities are properly identified. (3) Multi-hop reasoning is sound - the answer successfully synthesizes information across two years and multiple partnerships, correctly identifying the evolution from service-provider positioning to product-supply model. (4) The answer captures the key strategic evolution: from building end-to-end autonomous mobility services (2022) to supplying the technology platform to third parties (2023), with the Moovit bundling strategy correctly noted. (5) Semantic equivalence is strong - the LLM uses slightly different phrasing (e.g., 'VaaS' instead of 'vehicle-as-a-Service', 'MaaS' not explicitly mentioned but implied through 'mobility-as-a-Service' context) but conveys the same meaning. MINOR OBSERVATIONS: The LLM answer uses 'VaaS' (Vehicle-as-a-Service) while the ground truth uses 'vehicle-as-a-Service' - these are semantically identical. The LLM characterizes the shift as moving from 'service-provider model to product-supply/go-to-market model' which accurately captures the strategic evolution described in the ground truth as 'more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.' The answer is well-structured, comprehensive, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 469,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "In the 2022 filing the Tower Holdings preferred interests were two separate series – a September Class A‑1 ($1.5 bn) paying a 5.0% preferred distribution and a December Class A‑2 ($4.5 bn) paying 4.75%, both slated for a reset in December 2024. By the 2024 filing the company had amended those interests, consolidating them into Fixed‑Rate Class A Limited Membership Interests that now pay 5.90% and a new Floating‑Rate Class A Limited Membership Interests that pay SOFR + 250 bps, with a portion moving to the floating class each year over a five‑year period. This raised the fixed‑rate distribution to 5.90% and added a variable‑rate component.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the main evolution of Tower Preferred Interests from 2022 to 2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the 2022 structure with two series - September Class A-1 at $1.5B with 5.0% and December Class A-2 at $4.5B with 4.75%. (2) Accurately describes the 2024 amendment consolidating into Fixed Rate Class A (5.90%) and Floating Rate Class A (SOFR + 250 bps). (3) Correctly notes the annual transition mechanism over a five-year period. (4) Properly identifies the rate reset timing. WEAKNESSES: (1) The LLM states the original interests were 'slated for a reset in December 2024' but the ground truth specifies resets 'every five years' without pinpointing December 2024 as the specific reset date - this is a minor temporal imprecision. (2) The LLM refers to '$1.5 bn' and '$4.5 bn' while ground truth uses '$1,500' and '$4,500' (likely in millions), creating potential ambiguity about whether these are billions or millions - though the format variation is acceptable, the lack of unit clarity is a minor issue. (3) The LLM doesn't explicitly state that the 2024 amendment reclassified '2019 Tower preferred interests' specifically, though this is a minor omission. (4) The phrase 'both slated for a reset in December 2024' in the LLM answer is slightly misleading as it suggests both would reset at the same time, when the ground truth indicates they reset every five years from their respective issuance dates. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the structural changes and rate evolution. The logic connecting the old structure to the new structure is sound. QUANTITATIVE VERIFICATION: All percentages (5.0%, 4.75%, 5.90%, SOFR + 250 bps) are correct. Dollar amounts appear correct though unit clarity could be better. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 512,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The OPB plan’s balanced‑index fund (about 60 % equities, 40 % debt) continued to be valued using a **market approach that relies on the quoted price of an identical Level 1 instrument**【page_96】.  For the Level 3 assets underlying that fund, unrealized results swung from a **$90 net loss in 2022** to a **$14 net gain in 2023** – corporate fixed‑income moved from a $16 loss to a $2 gain, mortgage‑backed securities from an $11 loss to a $6 gain, and other categories likewise improved【page_96】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fund composition (60% equities, 40% debt) for both years, correctly notes the shift from losses to gains for corporate fixed income ($16M loss to $2M gain) and mortgage-backed securities ($11M loss to $6M gain), and accurately describes the valuation methodology shift to a market approach based on Level 1 quoted prices. The answer appropriately synthesizes the multi-hop information about investment approach and unrealized gains/losses evolution.\n\nCRITICAL ERRORS: The LLM introduces a significant quantitative error by stating a '$90 net loss in 2022' and '$14 net gain in 2023' for Level 3 assets. The ground truth does not mention these aggregate net figures. The ground truth only specifies: (1) $16M loss for corporate fixed income in 2022, (2) $11M loss for mortgage-backed/asset-backed in 2022, (3) $2M gain for corporate fixed income in 2023, and (4) $6M gain for mortgage-backed/asset-backed in 2023. The $90M and $14M figures appear to be either fabricated or incorrectly calculated/sourced. If we sum the disclosed items: 2022 losses = $16M + $11M = $27M (not $90M), and 2023 gains = $2M + $6M = $8M (not $14M). The LLM's mention of 'other categories likewise improved' suggests additional unrealized gains/losses not detailed in the ground truth, which may explain the discrepancy, but these are not documented in the provided answer.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across the two years and identifies the turnaround trend, but the introduction of unsupported aggregate numbers undermines the accuracy of the synthesis.\n\nCONCLUSION: While the LLM captures the qualitative evolution and key specific numbers correctly, the introduction of unverified aggregate figures ($90M loss, $14M gain) represents a material factual error that significantly impacts the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 507,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "In the 2023 Form 10‑K, accounting developments are only listed among a broad set of “regulatory, technology, market, economic or accounting developments” that could affect the business (see 2023 forward‑looking statements, p. 3). By the 2024 filing, BNY Mellon isolates “changes in accounting standards…could have a material impact on our reported financial condition, results of operations, cash flows and other financial data” as a distinct risk in its forward‑looking discussion (see 2024 forward‑looking statements, p. 5). This move from a peripheral mention to a highlighted risk shows that accounting standards have become a more prominent driver of the firm’s strategic priorities and risk‑management focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. Key issues: (1) CONTRADICTORY CHARACTERIZATION: The ground truth states that in 2023, accounting developments were mentioned 'among a broader list' without specific elaboration, and in 2024 the language was 'expanded.' The LLM reverses this, claiming 2023 had accounting developments 'only listed among a broad set' while 2024 'isolates' it as 'a distinct risk' - this is the opposite of what the ground truth indicates. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth shows accounting developments becoming MORE integrated into broader strategic considerations in 2024 (tied to 'capital plans including dividends and repurchases' and 'efficiency savings'). The LLM claims the opposite - that accounting standards moved from 'peripheral mention' to 'highlighted risk' as a distinct item. (3) SPECIFIC LANGUAGE ERRORS: The LLM quotes language about 'changes in accounting standards...could have a material impact on our reported financial condition' that does not appear in the ground truth's description of the 2024 filing. The ground truth's 2024 language is about accounting developments being part of an integrated list, not isolated. (4) PAGE REFERENCES: The LLM provides specific page numbers (p. 3 for 2023, p. 5 for 2024) that cannot be verified against the ground truth and may be inaccurate. (5) CONCLUSION VALIDITY: The LLM's conclusion that accounting standards became 'a more prominent driver' contradicts the ground truth's finding of 'more integrated view' - these represent opposite interpretations. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 474,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In the 2023 filing the company warned that a failure to keep stores safe (e.g., rising organized‑retail crime and “shrink”) and the growing cyber‑threat landscape could erode associate confidence, morale and retention – safety incidents or data‑breaches can increase stress, raise costs and damage the brand, directly hurting the associate experience. By contrast, the 2022 filing emphasized proactive engagement programs – culture‑driven values, pulse‑check and Voice‑of‑Associate surveys, a digital engagement platform and recognition initiatives – that were designed to boost associate commitment and satisfaction. Thus, while 2022 focused on building a positive associate experience, the 2023 risk evolution introduced factors that could negatively impact that experience if the safety and cybersecurity threats materialize.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): No numeric values, percentages, or dollar amounts were required in this question, and the LLM correctly avoided introducing unsupported numbers. The answer appropriately references the qualitative metrics mentioned in the ground truth (e.g., 'four out of five associates' concept is implicitly captured through 'associate commitment and satisfaction'). ENTITY ACCURACY: Correctly identifies Home Depot (HD) implicitly, correctly references 2022 and 2023 filings, and accurately identifies the key metrics (store safety, cybersecurity, organized retail crime, shrink, associate morale/retention/confidence). MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across two years and two distinct risk domains: (1) 2022's engagement-focused initiatives (surveys, digital platform, recognition programs) vs. (2) 2023's external risk emergence (store shrink/ORC, cybersecurity threats). The logical connection between these elements is sound - showing how 2022 built positive experience while 2023 introduced threats that could undermine those gains. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth with slightly different wording but equivalent meaning. Phrases like 'erode associate confidence, morale and retention' match 'erode trust, impact associate morale and retention.' The explanation of mechanisms (safety incidents/data breaches increase stress, raise costs, damage brand) adds helpful detail without contradicting ground truth. MINOR OBSERVATION: The LLM answer includes slightly more specific detail about mechanisms (stress, costs, brand damage) compared to ground truth, but this represents appropriate elaboration rather than error. The answer fully addresses the comparative question structure (2022 vs. 2023 evolution) and explains the potential impact on associate experience as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 535,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "In the 2022 filing the learning‑curve effect was called out as a specific risk factor that could drive lower margins or trigger reach‑forward losses, underscoring its potential to hurt program profitability (page_42). By 2023 the learning curve is folded into the broader set of assumptions used in the quarterly‑reviewed program‑accounting and cost‑estimation process, showing a shift toward a more systematic, risk‑managed approach to forecasting production costs and margins (page_49).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 framing of learning curve as a risk factor affecting program profitability and margins, with specific mention of potential reach-forward losses; (2) Accurately captures the 2023 shift toward integration of learning curve into systematic cost estimation and production planning processes; (3) Properly synthesizes the multi-hop comparison between years, showing evolution from risk-focused to management-integrated approach; (4) Correctly identifies Boeing as the company in question through contextual references (787 program implied); (5) Appropriately cites page references (page_42 for 2022, page_49 for 2023) suggesting document-specific sourcing. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer uses slightly more technical language ('reach-forward losses,' 'quarterly-reviewed program-accounting') compared to ground truth's more accessible phrasing, though this is semantically equivalent and arguably more precise; (2) The ground truth explicitly mentions 'production complexities, rework, and delays' as specific mechanisms of risk in 2022, while LLM answer generalizes to 'lower margins or trigger reach-forward losses' - this is a minor omission of detail but doesn't affect core accuracy; (3) Ground truth explicitly mentions 'supplier performance trends' and 'internal labor efficiency projections' as 2023 integration factors, while LLM answer references these more implicitly through 'broader set of assumptions.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The temporal references (2022 vs 2023) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the evolution of learning curve treatment across two fiscal years and identifies the conceptual shift from risk management to operational integration. The logic connecting 2022 risk identification to 2023 systematic integration is valid and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 566,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "In the 2023 Form 10‑K the company only disclosed that some officers and directors had elected to participate in its dividend‑reinvestment plan (along with other equity plans) and did not elaborate on the trading‐arrangement implications. By the 2024 filing, Item 9B was expanded to say that those elections may be made to satisfy the affirmative‑defense conditions of Rule 10b5‑1 **or** may constitute non‑Rule 10b5‑1 trading arrangements, giving a more detailed description of the possible insider‑trading structures tied to the plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and represents a complete reversal of the actual evolution described. Ground truth states: (1) 2023 filing included detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, (2) 2024 filing omitted this detailed explanation, indicating simplification. LLM answer claims the opposite: (1) 2023 filing had minimal disclosure without elaboration on trading arrangements, (2) 2024 filing expanded Item 9B with more detailed description of Rule 10b5-1 and non-Rule 10b5-1 structures. This is a direct inversion of the ground truth narrative. The LLM correctly identifies the relevant regulatory framework (Rule 10b5-1, non-Rule 10b5-1 trading arrangements, Item 408(c) of Regulation S-K) and the entities involved (officers, directors, dividend reinvestment plan), but applies them to the wrong years and describes the wrong directional change. The answer demonstrates understanding of the technical concepts but fails on the core factual claim about how disclosure evolved between 2023 and 2024. No numerical errors exist, but the qualitative assessment of the evolution is entirely incorrect, making this a critical failure in answering the multi-hop question about disclosure changes over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 358,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot’s spend on the “interconnected, frictionless” shopping experience rose from **$2.6 billion in fiscal 2021**【page_6†L31-L34】to **$3.2 billion in fiscal 2023**【page_5†L31-L34】—a roughly $0.6 billion increase. In 2021 the focus was on data‑driven merchandising tools that linked digital and in‑store channels to each shopper’s **intent and location**【page_8†L13-L18】. By 2023 the company expanded that vision with a broader set of digital upgrades (enhanced website and mobile apps, richer product pages, personalized marketing messages) and physical‑store enhancements (way‑finding signage, self‑service lockers, curb‑side pickup, electronic shelf‑labeling, redesigned service desks, expanded self‑checkout and mobile‑app store navigation) to make the experience **more personalized and location‑specific** for customers【page_7†L1-L7】【page_8†L1-L12】【page_9†L1-L9】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims capital expenditures rose from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. The ground truth only confirms $2.6 billion in fiscal 2021 and does NOT provide a $3.2 billion figure for fiscal 2023. The LLM has introduced an unsupported number ($3.2B) and calculated a $0.6B increase that cannot be verified against the ground truth. This is a major factual error. (2) MULTI-HOP SYNTHESIS - The ground truth indicates a shift from 'general investment in interconnectedness' to 'more refined, data-driven personalization strategy' using 'enhanced merchandising information technology tools.' The LLM reverses this chronology, claiming 2021 had 'data-driven merchandising tools' and 2023 added 'broader digital upgrades.' This contradicts the ground truth's narrative of evolution. (3) SPECIFICITY ISSUES - The LLM provides extensive detail about specific enhancements (way-finding signage, self-service lockers, curbside pickup, electronic shelf-labeling, redesigned service desks, expanded self-checkout, mobile-app store navigation) that are NOT mentioned in the ground truth. While these details may be accurate from the filings, they go beyond what the ground truth confirms and suggest the LLM may be hallucinating or conflating information. (4) CORRECT ELEMENTS - The LLM correctly identifies the $2.6 billion fiscal 2021 figure and correctly notes the focus on 'intent and location' personalization. The general concept of evolution toward more personalized, location-specific experiences is directionally correct. (5) CITATION ISSUES - The LLM provides specific page and line citations that cannot be verified against the ground truth, raising concerns about citation accuracy. The ground truth does not reference these specific page numbers or line ranges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 500,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Danaher’s spending on Aldevron has moved from a one‑time purchase to ongoing capital upgrades.  In the 2023 filing the company reports property‑plant‑and‑equipment purchases of $136 million versus $87 million in 2022 (page 72), indicating a higher level of investment in the business’s assets.  By contrast, the only acquisition‑related outlay for Aldevron was the original $9.6 billion cash purchase and its $28 million transaction cost recorded in 2021 (pages 73‑74); no new acquisition fees appear in the 2022‑2023 disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $9.6 billion acquisition price is accurately cited (ground truth states $9,561 million, LLM rounds to $9.6 billion - acceptable format variation). (2) The characterization that the 2021 acquisition was a one-time purchase is accurate. (3) The observation that no new acquisition fees appear in 2022-2023 is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM focuses heavily on property-plant-and-equipment purchases ($136M vs $87M) but this is NOT the primary metric the ground truth emphasizes. The ground truth specifically mentions 'capital expenditures of approximately $1.5 billion' in 2022 with a portion attributed to Aldevron - the LLM completely misses this $1.5B figure. (2) The LLM's interpretation of the financial relationship evolution is incomplete. The ground truth emphasizes a transition from 'capital investment target to core component of DHR's consolidated assets' and describes a shift from 'dependency to stakeholding and integration model.' The LLM's answer focuses narrowly on PP&E purchases rather than capturing this broader strategic evolution. (3) The LLM cites specific page numbers (72, 73-74) which cannot be verified against the ground truth provided, raising questions about source accuracy. (4) MULTI-HOP REASONING: The ground truth requires synthesizing: (a) 2022 capital expenditure plans (~$1.5B with Aldevron portion), (b) 2023 acquisition completion ($9.561B), and (c) the strategic shift this represents. The LLM only partially addresses this by focusing on PP&E rather than total capex and missing the strategic context. The answer is partially correct on the acquisition price but significantly incomplete on the capital investment evolution and strategic relationship shift that are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 497,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "In the 2022 filing Telco LLC had only one series of preferred interests – the September 2020 issuance of $2 billion (‑‑$2,000 mm) of non‑convertible cumulative preferred interests (Telco Class A‑1) that paid an initial 4.25% annual distribution and were subject to a reset every seven years【page_130】.  \n\nBy the 2024 filing the structure had been expanded to three series – the original Class A‑1 plus new Class A‑2 and A‑3 issued in April 2023 for an additional $5.25 billion, bringing total Telco preferred interests to $7.25 billion as of 12/31/2024【page_87】.  Class A‑1 still pays 4.25% with a seven‑year reset, while the new Class A‑2/A‑3 pay a higher 6.85% initial distribution and reset on Nov 1 2027 and every seven years thereafter.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 preferred interests: $2,000mm (Class A-1) - CORRECT; (2) Initial distribution rate for Class A-1: 4.25% annually - CORRECT; (3) Reset schedule for Class A-1: every seven years - CORRECT; (4) 2023 issuance: $5,250mm (Class A-2 and A-3) in April 2023 - CORRECT; (5) Total by 2024: $7,250mm - CORRECT (2,000 + 5,250 = 7,250); (6) Distribution rate for Class A-2/A-3: 6.85% - CORRECT; (7) First reset date for Class A-2/A-3: November 1, 2027 - CORRECT; (8) Subsequent resets: every seven years thereafter - CORRECT. The LLM correctly synthesized multi-hop information across 2022 and 2024 filings, properly identified the structural evolution from one to three series of preferred interests, and accurately captured the strategic shift toward higher-yielding instruments. The answer addresses all components of the question: structure evolution, total value changes, distribution rate changes, and reset schedule modifications. Minor note: The LLM uses '$2 billion (--$2,000 mm)' notation which is slightly unconventional formatting but semantically equivalent to the ground truth's '$2,000' (in millions). The answer demonstrates sound reasoning in comparing the two periods and explaining the capital stack expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 365,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "In 2022 AIG applied Expected Loss Ratio (ELR) methods chiefly to long‑tail U.S. Workers’ Compensation and to high‑severity aviation exposures, and used ELR for the latest accident‑year reserves when development data were limited (2022 p. 271; 2022 p. 273). By 2024 the firm had expanded ELR use to both long‑ and short‑tail lines—including excess‑of‑deductible business—grounding the ratios on premium‑based projections that are adjusted for rate changes, loss‑trend, inflation and market conditions, reflecting a broader, more systematic rationale (2024 p. 149; 2024 p. 151).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ERRORS: (1) The LLM claims that in 2022, AIG applied ELR methods 'chiefly to long-tail U.S. Workers' Compensation' - this directly contradicts the ground truth which states ELR was used 'primarily for the latest accident year' and 'in combination with other methods like loss development for aviation exposures' in 2022. Workers' Compensation is not mentioned as a primary 2022 application. (2) The LLM states that by 2024 ELR was expanded to 'both long- and short-tail lines—including excess-of-deductible business' - the ground truth only mentions expansion to 'U.S. Workers' Compensation, a long-tail line of business' with no mention of short-tail lines or excess-of-deductible business. (3) The LLM's characterization of the 2022 rationale as being used 'when development data were limited' is not supported by the ground truth, which emphasizes the high-severity nature of aviation exposures as the key rationale. CORRECT ELEMENTS: The LLM correctly identifies that ELR methods were used for aviation exposures and that there was expansion between 2022 and 2024. The page citations provided (2022 p. 271, 273; 2024 p. 149, 151) cannot be verified against the ground truth but appear to be specific references. However, the core factual claims about which insurance lines used ELR in each year are fundamentally incorrect. The multi-hop reasoning fails because the LLM reversed or misidentified which lines were primary in 2022 versus 2024. This is a critical error in synthesizing the evolution of AIG's methods across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 446,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "In the 2023 filing Target’s strategy simply **“strengthen[ed] our owned brands portfolio”** as a core way to deliver newness, style and value (Item 1 – Strategy). By the 2024 filing the company is **showing the portfolio in detail**—listing dozens of exclusive labels and stating that **about one‑third of merchandise sales now come from owned and exclusive brands**—and it ties that growth to its **global‑sourcing team that identifies, evaluates and partners with suppliers “most notably for our owned brands.”** This reflects a move from a high‑level strategic intent in 2023 to a broader, operationally‑driven expansion and diversification of the owned‑brand product mix in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed evidence than the ground truth. Key strengths: (1) Correctly identifies the 2023 strategic emphasis on strengthening owned brands portfolio; (2) Accurately captures the 2024 shift to showing portfolio in detail with dozens of exclusive labels; (3) Includes the specific quantitative metric that \"about one-third of merchandise sales now come from owned and exclusive brands\" which adds valuable precision; (4) Properly synthesizes the operational evolution from high-level intent to execution-focused expansion; (5) Correctly references the global-sourcing team's role in the 2024 strategy. Quantitative accuracy is strong - the one-third figure is specific and appears credible as a 2024 metric. The multi-hop reasoning is sound, comparing 2023 vs 2024 approaches across strategic documents. Minor considerations: (1) The ground truth mentions \"over 40 distinct brands\" while the LLM says \"dozens of exclusive labels\" - these are semantically equivalent and both convey portfolio expansion, though the LLM's phrasing is slightly less specific; (2) The LLM provides more operational detail (global-sourcing team) than the ground truth, which enhances rather than detracts from the answer. The answer fully addresses the question's two-part structure (strategic emphasis and product portfolio development) and correctly identifies the evolution from 2023 to 2024. The inclusion of the one-third sales metric demonstrates deeper engagement with the 2024 filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 424,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM’s 2024 filing still shows the ultra‑low‑coupon 0.875 % notes due 2030 that were on its books in 2023 (IBM_10k_2023.pdf p. 1) and adds a new series of 2.900 % notes also due 2030 (IBM_10k_2024.pdf p. 1). This signals a strategy of keeping a tranche of very cheap long‑dated debt while issuing fresh long‑term paper at the higher yields now required by the market, indicating that IBM is diversifying its maturity mix and that investor demand for high‑quality, long‑term bonds remains strong despite rising overall rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) All numeric values are correct - 0.875% and 2.900% coupon rates are accurately cited, and the 2030 maturity date is correct for both notes. (2) The multi-hop synthesis is sound: the answer correctly identifies that the 0.875% notes were present in 2023 and continued into 2024, while the 2.900% notes were newly issued in 2024. (3) The trading symbols (IBM30A and IBM30C) are correctly referenced in the original answer and implicitly understood. (4) The reasoning about market conditions is logically sound - the coupon rate increase from 0.875% to 2.900% for the same maturity year does suggest less favorable borrowing conditions in 2024 compared to 2023. (5) The answer correctly identifies the strategic implications: debt portfolio diversification, managing refinancing risks, and targeting different investor segments. MINOR WEAKNESSES: (1) The LLM answer phrases the insight slightly differently - it emphasizes 'keeping cheap debt while issuing fresh paper at higher yields' and 'investor demand remains strong despite rising rates,' which is a reasonable interpretation but differs subtly from the ground truth's emphasis on 'less favorable interest rate conditions' or 'different investor segments.' (2) The LLM answer doesn't explicitly mention the possibility of targeting different investor segments with varied risk-return profiles, though it does mention 'diversifying maturity mix.' (3) The reference to 'p. 1' in both filings is generic and not verifiable from the provided context. CALCULATION/VERIFICATION: The rate differential (2.900% - 0.875% = 2.025%) is correctly implied in the LLM's characterization of the increase. The semantic meaning is preserved: both answers convey that IBM maintained lower-cost debt while issuing higher-cost debt in the same maturity year, suggesting market conditions changed between 2023 and 2024. The LLM's interpretation that 'investor demand remains strong' is a reasonable inference from the data, though the ground truth is more cautious about the specific cause (less favorable conditions vs. strong demand).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 580,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "In the 2022 Form 10‑K, AT&T’s long‑term debt schedule listed a 4.000 % Global Note due June 1 2049 (T 49A) among a broad set of fixed‑rate notes ranging from 2026 to 2067【page_2】. By the 2024 filing, that 4.000 % 2049 issue no longer appears; instead the debt register now includes newer issuances such as floating‑rate notes due March 6 2025, 3.550 % notes due Nov 18 2025, 3.500 % notes due Dec 17 2025, and a series of notes maturing from 2026 through 2033【page_1】. This reflects a shift from the older 2049 instrument to a more recent mix of long‑term notes with varied coupons and nearer maturities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - CONTRADICTORY CLAIM: The LLM states that the 4.000% Global Notes due June 1, 2049 (T 49A) 'no longer appears' in the 2024 filing, but the ground truth explicitly states it 'remained registered under the same symbol (T 49A)' in 2024. This is a direct contradiction of a core fact. (2) MISSING KEY INFORMATION: The LLM completely fails to mention the 4.300% Global Notes due November 18, 2034 (T 34C), which is a central element of the ground truth answer. The ground truth specifically highlights that this note was NOT in 2022 but WAS added by 2024 - this is the key evolution being asked about. (3) INCORRECT DEBT COMPOSITION: The LLM lists floating-rate notes due March 6, 2025, 3.550% notes due Nov 18, 2025, and 3.500% notes due Dec 17, 2025 as the new composition, but these are not mentioned in the ground truth as the relevant additions. The ground truth focuses on the 4.300% notes due 2034 as the new addition. (4) MISINTERPRETATION OF EVOLUTION: The LLM characterizes the change as 'a shift from the older 2049 instrument to a more recent mix' suggesting the 2049 notes were removed, when the ground truth indicates the 2049 notes were MAINTAINED while new notes were ADDED. This represents a fundamental misunderstanding of the debt portfolio evolution. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks specifically about the 4.000% 2049 notes AND the addition of new long-term notes. The LLM fails to correctly synthesize both elements - it incorrectly claims the 2049 notes disappeared and identifies the wrong new notes as the additions. The ground truth answer correctly identifies both the persistence of the 2049 notes and the specific addition of the 2034 notes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 489,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "In 2023 the Heritage AspenTech deal contributed $258 million of intangibles amortization and only $1 million of restructuring expense (the $258 million is noted as AspenTech‑related amortization, and the $1 million appears in the AspenTech segment of the $72 million total restructuring cost)【page_55】. By 2024 total intangibles amortization had risen to $1,077 million; after allocating $560 million to the NI acquisition, roughly $517 million remained for other intangibles—including AspenTech—while overall restructuring costs jumped to $228 million, with AspenTech‑related restructuring increasing to $8 million【page_55】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. CRITICAL ERRORS: (1) The LLM claims 2023 intangibles amortization was $258 million (correct per ground truth) but then states this was 'only $1 million of restructuring expense' - the ground truth clearly shows $72 million in restructuring costs in 2023, not $1 million. (2) For 2024, the LLM provides completely different numbers: it claims total intangibles amortization was $1,077 million with $560 million allocated to NI acquisition and ~$517 million remaining - these figures do not match the ground truth which states 2024 intangibles amortization was $97 million. (3) The LLM claims AspenTech-related restructuring was $8 million in 2024, but the ground truth shows $228 million total restructuring costs in 2024 with no breakdown suggesting only $8 million was AspenTech-related. (4) The LLM's allocation methodology (subtracting NI acquisition from total intangibles) appears to be an invented calculation not supported by the ground truth data. WHAT WAS CORRECT: The LLM correctly identified that 2023 had $258 million in intangibles amortization and that 2024 restructuring costs were $228 million. However, the core narrative is fundamentally wrong - the ground truth shows intangibles amortization DECREASED from $258M to $97M (not increased to $1,077M), and restructuring costs INCREASED from $72M to $228M (not decreased to $8M for AspenTech). The LLM failed to accurately synthesize the multi-hop comparison between 2023 and 2024 figures and introduced unsupported calculations and allocations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 441,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG’s reserving approach for U.S. workers’ compensation has stayed the same – it blends loss‑development, frequency‑severity and expected‑loss‑ratio techniques and splits the portfolio into guaranteed‑cost and excess‑of‑deductible blocks, with further break‑outs by state, industry and deductible size (2022 p. 258; 2024 p. 151).  What has shifted is the mix of business: the share of large‑deductible, risk‑sharing accounts has grown, slowing claim emergence and causing AIG to rely more heavily on expected‑loss‑ratio assumptions for the excess‑of‑deductible segment (especially in the most recent accident years), even though the overall segmentation framework remains unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of AIG's workers' compensation reserving approach between 2022 and 2024. STRENGTHS: (1) Accurately captures that the overall segmentation framework remained unchanged while the business mix shifted; (2) Correctly identifies the growth in large deductible business and its impact on slowing claim emergence; (3) Properly notes the increased reliance on expected loss ratio methods for excess of deductible segments; (4) Correctly cites page references (2022 p. 258; 2024 p. 151); (5) Accurately describes the segmentation by guaranteed-cost vs. excess-of-deductible, with further breaks by state, industry, and deductible size. WEAKNESSES: (1) The answer states AIG 'blends loss-development, frequency-severity and expected-loss-ratio techniques' but doesn't clearly distinguish how the emphasis on expected loss ratio methods specifically evolved - the ground truth notes these methods were applied to 'most recent accident year' for guaranteed cost in 2022 and 'most recent five accident years' for excess of deductible, but the LLM doesn't capture this temporal distinction; (2) Missing the 2024-specific disclosure about limitations in claim count data due to aggregation and reinsurance exclusions, which the ground truth identifies as a notable evolution in disclosure emphasis; (3) The phrase 'risk-sharing accounts' is used but the ground truth specifically references 'large deductible accounts' - while semantically related, this is a slight imprecision; (4) Doesn't explicitly mention the distinction between AIG vs. third-party administrator claim handling that the ground truth highlights as part of 2024's greater emphasis on segmentation. The answer demonstrates solid multi-hop reasoning by synthesizing information across years and correctly identifying the key shift (business mix change rather than methodological change), but falls short of capturing all the nuanced evolutions in methodology application and disclosure emphasis that distinguish 2022 from 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 547,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "In the 2023 filing Target described its cyber‑fusion center as the hub that “investigates and responds to threats” and noted that it “shares threat intelligence and collaborates with organizations across different industries” (2023 Form 10‑K p. 17). By the 2024 filing the core function of the fusion center is unchanged, but Target now stresses a more proactive threat‑intelligence program, regular internal and independent validation of its controls, and an expanded, formalized partnership model for exchanging intelligence and fighting cybercrime with external industry groups (2024 Form 10‑K p. 21). This reflects an evolution toward deeper, more structured collaboration while maintaining the same investigative‑response capability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Target's cybersecurity evolution from 2023 to 2024, with generally accurate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the Cyber Fusion Center as the core component in both years; (2) Accurately captures the 2023 baseline of threat investigation/response and cross-industry collaboration; (3) Properly identifies key 2024 enhancements including more structured/formalized approaches; (4) Appropriately cites page numbers from 10-K filings (p. 17 for 2023, p. 21 for 2024), demonstrating document-specific sourcing; (5) Semantic equivalence is strong - 'expanded, formalized partnership model' aligns with ground truth's 'expanded external engagement' and 'structured incident response program.' WEAKNESSES: (1) The LLM answer mentions 'proactive threat-intelligence program' and 'regular internal and independent validation of controls' but the ground truth specifically emphasizes 'coordinated escalation model to inform management and the Board of Directors during security incidents' - this is a notable omission of a specific structural improvement; (2) The ground truth explicitly mentions 'leveraging third-party vendors to assess and test its cybersecurity program' while the LLM says 'independent validation of controls' - these are semantically similar but the ground truth is more specific about third-party vendor involvement; (3) The LLM states the 'core function of the fusion center is unchanged' which is accurate but could have been more explicit about the addition of the incident response escalation model. QUANTITATIVE ACCURACY: No numerical errors detected. Page citations appear reasonable for 10-K documents. MULTI-HOP REASONING: Successfully synthesizes information across 2023 and 2024 filings and identifies the evolution trajectory. The comparison structure is logical and well-organized. OVERALL: The answer captures the essential evolution and maintains factual accuracy on major points, but misses or underemphasizes the specific incident response escalation model to the Board, which is a material detail in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 572,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "In 2023 Eli Lilly booked Baqsimi’s $579 million one‑time rights‑sale as product revenue – it appears in the $677.6 million Baqsimi line of net product revenue. In the 2024 filing that same rights‑sale is no longer shown in product sales but is included in “collaboration and other revenue” (part of the $4.3 billion of such revenue), indicating the transaction is now treated as an upfront payment under a collaboration/licensing arrangement rather than as ordinary product sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims Baqsimi appears in a '$677.6 million Baqsimi line of net product revenue' in 2023. The ground truth states $579.0 million was reported for Baqsimi rights sales in 2023. The $677.6 million figure is not mentioned in the ground truth and appears to be fabricated or confused with another metric. This is a significant numerical discrepancy ($677.6M vs $579.0M). (2) CONCEPTUAL MISUNDERSTANDING: The LLM states the $579M 'appears in the $677.6 million Baqsimi line of net product revenue,' suggesting the rights sale was part of ordinary product revenue. However, the ground truth indicates the $579.0 million was 'revenue specifically attributed to the sale of the rights for Baqsimi' - a one-time transaction, not ongoing product sales. The LLM's framing as 'booked Baqsimi's $579 million one-time rights-sale as product revenue' is misleading about the nature of this transaction. (3) PARTIAL CORRECTNESS: The LLM correctly identifies that in 2024 the transaction moved to 'collaboration and other revenue' and correctly notes the $4.3 billion figure for such revenue. The core insight about the shift from one accounting treatment to another is directionally correct. (4) MULTI-HOP REASONING: The LLM attempts to synthesize the 2023 vs 2024 treatment but introduces an unexplained and incorrect intermediate figure ($677.6M) that undermines the analysis. The reasoning about why the transaction moved categories is sound, but the factual foundation is flawed. (5) MISSING CONTEXT: The LLM doesn't adequately explain that the 2024 reclassification reflects integration into broader collaboration arrangements, not just a simple reclassification of the same transaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 475,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "In 2023 AT&T’s capital‑structure strategy was to eliminate a legacy preferred‑interest liability – it repurchased the entire 213 million Mobility preferred interests (≈ $5.4 billion) and, after the April 2023 Telco preferred issuance, left no Mobility preferred securities on its balance sheet 【page_86】【page_87】. By 2024 the focus had shifted to expanding and reshaping its preferred‑interest program: the 2019 Tower Holdings interests were amended (August 2024) into fixed‑rate and floating‑rate series, and AT&T entered an agreement to issue an additional $2.25 billion of Telco Class A‑4 preferred interests in early 2025 to fund further redemptions 【page_87】【page_88】. This marks a move from repurchasing existing preferred interests to using new and re‑structured preferred securities as a financing tool.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic shift from repurchasing legacy Mobility Preferred Interests in 2023 to expanding/restructuring preferred interests in 2024. The answer accurately captures that 213 million Mobility Preferred Interests were repurchased (~$5.4B), that Telco LLC preferred interests were issued in April 2023, and that Tower Holdings interests were restructured in August 2024. The multi-hop reasoning is sound - connecting the 2023 repurchase to 2024 expansion strategy. The semantic framing of the evolution is appropriate.\n\nCRITICAL ERRORS: (1) QUANTITATIVE MISMATCH - Ground truth specifies the 2023 Telco LLC issuance was $5,250M at 6.85% rate; LLM states $2.25B for 'early 2025' Telco Class A-4 issuance but doesn't mention the $5,250M 2023 issuance amount or its 6.85% rate. (2) INCOMPLETE TOWER HOLDINGS DATA - Ground truth specifies $6,000M in 2019 Tower preferred interests restructured into fixed (5.90% base) and floating (SOFR + 250 bps) rates; LLM mentions the restructuring but omits these specific rates and the $6,000M amount. (3) MISSING TELCO TOTAL - Ground truth states total Telco LLC preferred interests increased to $7,250M by 2024 (including original $2,000M Class A-1); LLM doesn't provide this total or breakdown. (4) INCOMPLETE LIABILITY ACCOUNTING - Ground truth specifies the $5,414M repurchase removed $2,650M from 'Accounts payable and accrued liabilities' and $2,670M from 'Other noncurrent liabilities'; LLM omits this balance sheet detail.\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across 2023-2024 and connects the repurchase funding mechanism to new issuances. However, it fails to fully synthesize the complete financial picture (missing the $5,250M 2023 Telco issuance details and the $7,250M total by 2024).\n\nNUMBER VERIFICATION: $5.4B ≈ $5,414M (acceptable format variation). However, the answer introduces a new figure ($2.25B for 2025 Telco Class A-4) not mentioned in ground truth, and omits key 2023 figures ($5,250M, 6.85%, $6,000M Tower amount, specific rate terms).\n\nCONCLUSION: While the LLM captures the strategic narrative correctly, it significantly underspecifies the quantitative details that are central to evaluating capital structure evolution. The answer is directionally correct but incomplete on critical financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 627,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "In 2023 Emerson owned roughly 55 percent of AspenTech after the Heritage AspenTech transaction, and that acquisition contributed about 0.6 percentage‑points to Emerson’s gross‑margin, which rose to 49.0 percent (up 3.3 pp) that year【page_26】. By 2024 Emerson’s stake had increased to about 57 percent and it announced a cash offer to acquire all of the remaining AspenTech shares, moving toward full ownership, while its gross‑margin improved further to 50.8 percent (up 1.8 pp)【page_25】【page_26】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth:\n\n1. TIMELINE ERROR: The LLM states Emerson owned 55% of AspenTech in 2023 AFTER the Heritage AspenTech transaction. However, the ground truth indicates the 55% ownership stake was acquired BY 2024, not in 2023. The LLM has reversed the timeline of when the acquisition occurred.\n\n2. OWNERSHIP PROGRESSION ERROR: The LLM claims ownership increased from 55% in 2023 to 57% in 2024. The ground truth indicates Emerson acquired a 55% stake in 2024 (not 2023), making the 57% figure in 2024 potentially incorrect or at minimum confusing given the timeline reversal.\n\n3. CASH AMOUNT MISSING: The ground truth explicitly states the transaction included approximately $6.0 billion in cash. The LLM completely omits this critical financial detail.\n\n4. GROSS MARGIN ATTRIBUTION ERROR: The LLM states the AspenTech acquisition contributed 0.6 percentage points to gross margin in 2023. The ground truth states it contributed 3.3 percentage points in 2023. This is a significant numerical discrepancy.\n\n5. RELATIONSHIP EVOLUTION MISCHARACTERIZED: The ground truth describes a transformation from a business relationship/partnership in 2023 to a majority shareholder position in 2024. The LLM incorrectly places the acquisition in 2023, failing to capture the evolution properly.\n\n6. GROSS MARGIN FIGURES: While the LLM correctly identifies the 49.0% (up 3.3 pp) for 2023 and 50.8% (up 1.8 pp) for 2024, the attribution to AspenTech is incorrect.\n\nThe LLM answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the timeline of events across 2023-2024 and misattributing financial impacts. The core narrative of the relationship evolution is fundamentally inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 490,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG’s Japan pension plans continued to account for roughly one‑half of the company’s total non‑U.S. pension obligations – about 50 % at December 31, 2024 (down slightly from 54 % in 2023) and the same ≈ 50 % share reported for the prior period (December 31, 2021)【page_183†L15-L19】【page_310†L7-L10】.  At the same time, the weighted‑average discount rate used for the Japan plans rose sharply, from about 0.5 % (0.52 % at year‑end 2021) to 1.81 % at year‑end 2024【page_310†L7-L10】【page_183†L31-L34】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DISCOUNT RATE COMPARISON ERROR: The LLM states the discount rate rose 'from about 0.5% (0.52% at year-end 2021) to 1.81% at year-end 2024.' However, the ground truth specifies the increase was 'from 1.48% in 2023 to 1.81% in 2024' - the LLM incorrectly compared 2021 to 2024 instead of 2023 to 2024, which is a fundamental misunderstanding of the question's scope (2022-2024 period). The 2021 figure (0.52%) is not relevant to the 2022-2024 evolution requested. (2) MISSING KEY DATA: The LLM completely omits the 2022 baseline data from the ground truth (61% of non-U.S. pension assets in 2022, 1.85% expected long-term rate of return), which is essential for showing the evolution over the full 2022-2024 period. (3) INCOMPLETE SYNTHESIS: The LLM mentions 2021 data (0.52%) which is outside the requested timeframe, suggesting poor multi-hop reasoning about which years to compare. (4) CORRECT ELEMENTS: The LLM correctly identifies the 2024 figure (50%) and the 2023 figure (54%), and correctly states the 2024 discount rate (1.81%). However, these correct elements are undermined by the incorrect comparison baseline. (5) QUANTITATIVE ACCURACY: While individual numbers like 50%, 54%, and 1.81% are correct, the comparison framework is wrong (comparing 2021-2024 instead of 2023-2024, and missing 2022 entirely). This is a significant calculation/reasoning error that affects the core answer to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 399,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "- In the 2022 10‑K Amazon listed “the introduction of competitive stores, websites, products, services, price decreases, or improvements” as a risk factor and framed the broader market backdrop in concrete terms, noting that demand can be hit by “global economic conditions such as recessionary fears or rising inflation” (see page 8).  \n- In the 2023 10‑K the same competitive‑store risk appears, but Amazon now situates it within a more general macro‑economic narrative, stating that its revenue growth “depends on the continued growth of demand… and our business is affected by general economic and business conditions worldwide” and that a “softening of demand… may result in decreased revenue or growth” (see page 9).  \n\nThus, the disclosure shifted from citing specific economic headwinds (recessionary fears, inflation) to a broader framing of overall economic conditions and demand‑softening trends.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in Amazon's disclosure framing between 2022 and 2023. It accurately captures that: (1) both years mention 'competitive stores, websites, products, services, price decreases, or improvements'; (2) the 2023 filing embeds competitive pressures within broader external economic conditions; (3) there is a shift from specific economic headwinds to more general framing. The qualitative reasoning about the shift from concrete to abstract framing is sound and aligns with the ground truth's characterization of moving from 'standalone concern' to 'part of a larger set of external risks.' CRITICAL WEAKNESSES: (1) The LLM introduces specific page numbers (page 8 for 2022, page 9 for 2023) that cannot be verified against the ground truth and may be fabricated. This is a significant accuracy concern. (2) The LLM claims the 2022 filing cited 'specific economic headwinds (recessionary fears, inflation)' but the ground truth does not mention these specific terms appearing in the 2022 filing—it only describes competitive stores as listed 'alongside internal capabilities.' The LLM appears to have conflated or invented details about what the 2022 filing actually said. (3) The LLM's characterization that 2022 used 'concrete terms' for economic conditions contradicts the ground truth, which presents the 2022 filing as treating competitive stores as a general factor without emphasizing external macro conditions. MULTI-HOP REASONING: The comparison between years is logically structured, but the factual basis for the 2022 characterization appears flawed. The answer correctly synthesizes that both filings mention competition, but incorrectly characterizes what the 2022 filing emphasized. SEMANTIC EQUIVALENCE: While the overall narrative arc (shift toward broader framing) is correct, the specific details about what each filing said are problematic, particularly regarding the 2022 filing's supposed emphasis on 'recessionary fears' and 'inflation.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 543,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "In the 2023 filing Target listed port‑security as one of a broad set of external risks, warning that “periodic closings and ship diversions…congestion disrupting … ports around the world, **including at major U.S. ports** where we receive a significant portion of the products we source from outside the U.S.” (2023 Form 10‑K, p. 15). The 2024 filing still cites port‑security but narrows the geographic focus to “**California ports** where we receive a significant portion of the products we source from outside the U.S.” (2024 Form 10‑K, p. 13), and again notes that such disruptions can interrupt merchandise flow, raise costs and adversely affect results of operations. Thus, Target’s exposure has shifted from a generic U.S.–port risk to a more specific California‑port risk, while the operational impact—supply‑chain disruptions and cost pressures—remains unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer directly contradicts the ground truth on the core factual claim. The ground truth states that in 2023 Target 'specifically highlighted California ports' and by 2024 'broadened its focus' to 'major U.S. ports.' However, the LLM answer reverses this evolution entirely, claiming that 2023 mentioned 'major U.S. ports' while 2024 'narrows the geographic focus to California ports.' This is a fundamental factual inversion that undermines the entire answer. The LLM appears to have misread or misattributed the filing quotes. Additionally, the LLM's characterization of the shift as moving from 'generic U.S.-port risk to a more specific California-port risk' is backwards from what the ground truth describes. The ground truth indicates Target moved FROM specific California focus TO broader U.S. port concerns, not the reverse. While the LLM correctly identifies that operational impacts (supply-chain disruptions, cost pressures) remained consistent, this partial correctness cannot offset the major directional error in the primary claim about geographic focus evolution. The LLM also provides specific page citations (p. 15 for 2023, p. 13 for 2024) that cannot be verified but appear to be fabricated given the contradictory content. The multi-hop reasoning is fundamentally flawed because the synthesis of information across the two years is inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 385,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "In 2023 Emerson recorded $258 million of intangible amortization that was specifically tied to the Heritage AspenTech acquisition and only $1 million of AspenTech‑related restructuring costs. By 2024 the Heritage AspenTech amortization is no longer broken out (total intangible amortization rose to $1,077 million, with $560 million attributed to the NI acquisition) while AspenTech restructuring expenses increased to $8 million【page_55】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states AspenTech-related restructuring costs were only $1 million in 2023, but the ground truth clearly states restructuring costs were $72 million in 2023. This is a major discrepancy of $71 million. (2) The LLM claims AspenTech restructuring expenses increased to $8 million in 2024, but the ground truth indicates total restructuring costs increased to $228 million in 2024. The LLM appears to be citing a subset figure rather than the total restructuring costs relevant to the question. (3) The LLM introduces information about NI acquisition amortization ($560 million) and total intangible amortization ($1,077 million) that, while potentially accurate, is not part of the ground truth answer and may distract from the core question about Heritage AspenTech's evolution. CORRECT ELEMENTS: (1) The $258 million intangibles amortization for Heritage AspenTech in 2023 is correct. (2) The observation that Heritage AspenTech amortization is no longer broken out in 2024 is correct. (3) The general direction of the narrative (shift in focus away from AspenTech as newly acquired) is conceptually correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the restructuring cost comparison across 2023-2024. The ground truth clearly establishes a $72M to $228M increase in restructuring costs, which is a critical part of understanding Emerson's evolving relationship with the acquisition. The LLM's citation of $1M and $8M figures appears to be either misread data or a fundamental misunderstanding of which restructuring costs are relevant to the question. The answer is partially responsive but contains material factual errors that significantly undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 489,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "In the 2022 Form 10‑K AIG explained that it combines loss‑development, expected‑loss‑ratio and frequency‑severity techniques, using the expected‑loss‑ratio approach mainly for D&O, E&O, EPLI and professional‑liability lines and giving it more weight in the newest accident years while relying on development methods for older years. By the 2024 filing the company says the expected‑loss‑ratio method now receives “significant weight” for business written in excess of a deductible and for the most recent five accident years across its lines, with the ratios explicitly adjusted for rate changes, loss‑trend, inflation and market conditions—showing a broader, heavier reliance on the method in the later period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of AIG's Expected Loss Ratio methods between 2022 and 2024 with substantial accuracy. STRENGTHS: (1) Correctly identifies the 2022 application to D&O, E&O, EPLI, and professional liability lines; (2) Accurately notes the shift toward more recent accident years in 2022; (3) Correctly identifies the 2024 expansion to include broader application with 'significant weight' language; (4) Properly synthesizes the multi-hop comparison across two years; (5) Accurately captures the integration of adjustments for rate changes, loss trend, inflation, and market conditions in 2024. WEAKNESSES: (1) The LLM answer mentions 'business written in excess of a deductible' which is not explicitly mentioned in the ground truth, suggesting possible over-specification or inference beyond the source material; (2) The ground truth specifically mentions U.S. Workers' Compensation as a key 2024 expansion to a long-tail line of business, but the LLM answer does not explicitly name this line, instead using more general language about 'broader, heavier reliance'; (3) The ground truth emphasizes the combination with 'loss development and frequency/severity methods' in 2024, while the LLM answer focuses more on the weight given to Expected Loss Ratio itself rather than its integration with other methods. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is less critical. The reference to 'five accident years' in the LLM answer is not contradicted by the ground truth but also not explicitly confirmed. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the evolution pattern. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message about evolution from focused application to broader application is conveyed in both answers, though with different emphasis and specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 534,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "In 2022 Amazon’s film‑group portfolio carried $16.7 billion of capitalized video‑and‑music content and generated $16.6 billion of video‑and‑music expense; by the end of 2023 those figures had risen to $17.4 billion and $18.9 billion respectively【page_49】. The modest increase in capitalized assets (≈ 4 %) together with a larger jump in expense (≈ 14 %) indicates Amazon is expanding the size of its film‑group content library and leaning more heavily on amortized/licensing costs to monetize that content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides enhanced analysis beyond the ground truth. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 2022 capitalized costs ($16.7B), 2022 expenses ($16.6B), 2023 capitalized costs ($17.4B), 2023 expenses ($18.9B). The calculated percentages are accurate: capitalized assets increase of approximately 4% (($17.4B-$16.7B)/$16.7B ≈ 4.2%) and expense increase of approximately 14% (($18.9B-$16.6B)/$16.6B ≈ 13.9%). (2) COMPLETENESS: The answer addresses the core question about monetization strategy evolution between 2022-2023 with all required financial metrics. (3) ENTITY ACCURACY: Correctly identifies Amazon, film groups, capitalized video and music content costs, and the specific years. (4) REASONING QUALITY: The LLM provides superior multi-hop synthesis by not only presenting the numbers but also interpreting what the divergence between capitalized asset growth (4%) and expense growth (14%) signifies - that Amazon is expanding its content library while increasingly relying on amortized/licensing costs for monetization. This interpretation is logically sound and adds valuable context. (5) SEMANTIC EQUIVALENCE: The answer conveys the same core information as the ground truth while providing additional analytical insight. The only minor distinction is that the LLM's interpretation goes slightly beyond the ground truth's statement of 'more aggressive investment' by specifically identifying the mechanism (amortized/licensing costs) driving the monetization strategy shift. This is a strength, not a weakness, as it demonstrates deeper understanding of the financial dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 453,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "In the 2022 Form 10‑K PMI only noted that it had de‑consolidated its Canadian subsidiary Rothmans, Benson & Hedges (RBH) and continued to report the volume of RBH‑sold brands, with no impairment of its RBH equity stake disclosed 【page_32】. By the 2024 filing PMI still owned an equity investment in RBH, but because of the unresolved settlement‑allocation litigation it concluded the investment’s fair value was below its carrying amount and recorded a $2.316 billion non‑cash impairment (a $1.49‑per‑share charge) 【page_30】【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - the $2.316 billion impairment charge matches the ground truth's $2,316 million (same value, different format), the $32.5 billion Canadian tobacco litigation settlement is correctly referenced, and the $1.49-per-share charge is accurately cited. The years 2022 and 2024 are correctly identified. COMPLETENESS: The answer addresses all key aspects of the question: (1) 2022 status - de-consolidated subsidiary with trademark/brand licensing relationship and no impairment, (2) 2024 status - equity investment with significant impairment, (3) the evolution between these periods is clearly articulated. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple documents and time periods, correctly identifying the shift from a trademark relationship to equity investment, and properly connecting the impairment to the unresolved litigation settlement allocation issue. ENTITY ACCURACY: All entities are correctly identified (PMI, RBH, ITL, JTIM mentioned in context, Canadian litigation). SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more specific detail (e.g., mentioning de-consolidation, per-share charge, non-cash nature). The only minor difference is that the LLM provides more granular detail about the 2022 situation (de-consolidation) which adds value without contradicting the ground truth. The citation references to specific pages add credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 440,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The 2023 filing notes that a 5 % change in the consolidated sales‑return, rebate and discount liability would shift net product revenue by roughly $615 million (page 53). The 2024 filing says the same 5 % change would affect revenue by about $600 million (page 54), showing a modest reduction in the revenue‑sensitivity from 2023 to 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that the 2024 filing did NOT provide an updated sensitivity figure, indicating an omission of quantitative disclosure in 2024 compared to 2023. However, the LLM claims the 2024 filing disclosed a $600 million sensitivity figure, which is incorrect according to the knowledge graph. The LLM fabricated a 2024 disclosure that does not exist. The 2023 figure of $615 million is correct. The LLM's conclusion that there was a 'modest reduction' from $615M to $600M is based on this false 2024 disclosure. The core issue is that the LLM fundamentally misrepresented what was disclosed in the 2024 filing - the ground truth indicates no updated quantitative sensitivity disclosure was provided in 2024, not that a $600 million figure was disclosed. This is a major factual error that undermines the entire answer. The LLM failed to recognize and convey the key finding that the 2024 disclosure represented a lack of updated quantitative information compared to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 308,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "In the 2022 filing Union Pacific described Bulk shipments as a core commodity group and said it expected volume to outpace industrial production that year, but it did not break out a specific revenue share for Bulk (2022 Outlook – page 33). By the 2024 filing the company quantifies Bulk’s importance: Bulk shipments generated roughly $7.3 billion – 32 % of total freight revenues of $22.8 billion (2024 Freight Revenues – page 6). Thus, Bulk’s role has shifted from a qualitative, growth‑focused segment in 2022 to a clearly defined, one‑third share of overall freight revenue in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a solid multi-hop synthesis comparing Bulk shipments' role between 2022 and 2024, with mostly accurate quantitative data. STRENGTHS: (1) Correctly identifies the 32% revenue contribution in 2024, which matches the ground truth. (2) Accurately cites the $7.3 billion in Bulk revenues and $22.8 billion total freight revenues for 2024. (3) Properly synthesizes the evolution narrative: from qualitative growth expectations in 2022 to quantified strategic importance in 2024. (4) Correctly notes that 2022 filing did not provide specific revenue share breakdown. (5) The calculation of 32% ($7.3B / $22.8B = 32%) is accurate. WEAKNESSES: (1) The LLM answer omits the specific 2021 revenue-per-car metric ($3,305) and the 6% increase from 2020 that was mentioned in the ground truth as part of the 2022 filing context. (2) Does not mention the operational details about grain, fertilizer, coal markets, or international connections to Mexico and Canadian interline routes that the ground truth includes. (3) The ground truth provides more granular detail about the segment's composition and strategic positioning. QUANTITATIVE VERIFICATION: The 32% figure and the $7.3B/$22.8B values are correct and properly calculated. The omission of the 2021 revenue-per-car data ($3,305) represents incomplete coverage of available metrics from the 2022 filing, though this doesn't invalidate the core answer. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years (2022 and 2024) and correctly identifies the shift in how Union Pacific disclosed Bulk's importance. The reasoning is sound and logically structured. The answer addresses the core question about evolution from 2022 to 2024 effectively, though it could have been more comprehensive in capturing all disclosed metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 495,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "In IBM’s 2023 filing the 2028 notes were listed at 0.300 % (IBM 28B) and 1.750 % (IBM 28A) 【page_1】, and the 2024 filing shows the same two notes with identical rates of 0.300 % and 1.750 % 【page_1】. The unchanged rates indicate IBM is keeping its long‑term borrowing costs stable, locking in low‑cost financing and signaling a deliberate strategy to maintain a low‑interest, long‑dated debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that IBM's 1.750% Notes due 2028 (IBM 28A) remained unchanged between 2023 and 2024, which matches the ground truth. The LLM also correctly notes the 0.300% Notes due 2028 (IBM 28B) with identical rates in both years. The numeric values (0.300%, 1.750%) are accurate and properly formatted.\n\nHowever, there are significant gaps in completeness and contextual relevance:\n\n1. MISSING CRITICAL INFORMATION: The ground truth explicitly mentions that IBM introduced NEW notes in 2024 (2.900% Notes due 2030 and 3.150% Notes due 2033), which is crucial context for understanding IBM's debt strategy. The LLM answer completely omits this important information, which directly addresses the second part of the question about what the evolution indicates about IBM's debt strategy.\n\n2. INCOMPLETE STRATEGY ANALYSIS: The ground truth explains that the introduction of higher-rate notes for longer maturities suggests IBM's broader strategy to issue debt at higher rates for longer maturities. The LLM's interpretation that IBM is \"maintaining a low-interest, long-dated debt profile\" is partially correct but misses the strategic shift toward higher rates for new issuances, which is a key insight into IBM's evolving debt strategy.\n\n3. QUANTITATIVE ACCURACY: The numbers provided (0.300%, 1.750%) are correct, and the comparison showing unchanged rates is accurate. No calculation errors detected.\n\n4. MULTI-HOP REASONING: The LLM successfully synthesized information about the 2028 notes across two years but failed to synthesize the broader picture of IBM's debt strategy by not incorporating the new 2030 and 2033 notes introduced in 2024.\n\n5. SEMANTIC EQUIVALENCE: The interpretation of \"stable\" and \"low-cost financing\" is reasonable but incomplete without acknowledging the strategic shift to higher rates for new longer-dated debt.\n\nThe answer is partially correct on the specific 2028 notes comparison but significantly incomplete in addressing the broader debt strategy question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 547,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "In 2023 AT&T eliminated its legacy Mobility Preferred Interests by repurchasing the remaining 213 million interests in April 2023, removing that liability from its capital structure (see Note 16, p. 55; Note 12, p. 87). By 2024 the company shifted to new preferred financing – it issued two million Series B Cumulative Perpetual Preferred Membership Interests in Mobility II (Mobility II Redeemable Noncontrolling Interests) in June 2023 and, in October 2024, agreed to issue $2.25 billion of non‑convertible cumulative preferred interests in Telco LLC (Class A‑4) in Q1 2025 (see p. 88) – reflecting a move from retiring legacy preferred equity to using redeemable, reset‑rate preferred securities for financing flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - Ground truth states Mobility Preferred Interests had redemption value of ~$5,340 million and paid $373 million annual distributions. LLM answer mentions \"213 million interests\" (unclear unit) but provides no redemption value or distribution amounts.\n   - Ground truth mentions Tower Holdings preferred interests restructuring with fixed/floating rate components - LLM answer completely omits this.\n   - Ground truth states Telco LLC preferred interests expanded to $7,250 million total. LLM answer only mentions a $2.25 billion new issuance in October 2024 for Q1 2025, which is incomplete and doesn't address the total expansion to $7,250 million.\n   - LLM introduces Mobility II Redeemable Noncontrolling Interests ($2 million Series B in June 2023) which is not mentioned in ground truth and appears to be a different instrument than the Mobility Preferred Interests being discussed.\n\n2. TEMPORAL/DATING ISSUES:\n   - LLM states Mobility II issuance was \"June 2023\" but then says this represents 2024 strategy evolution, creating confusion about timeline.\n   - Ground truth clearly separates 2023 actions (repurchase of Mobility Preferred Interests) from 2024 actions (restructuring and expansion of other instruments).\n\n3. MISSING KEY INFORMATION:\n   - No mention of Tower Holdings preferred interests restructuring (fixed/floating components).\n   - No mention of the $7,250 million total for Telco LLC preferred interests.\n   - Incomplete picture of the strategic pivot from Mobility-based to diversified infrastructure-tied preferred capital.\n\n4. MULTI-HOP REASONING:\n   - The answer fails to synthesize the complete evolution of AT&T's preferred capital strategy across 2023-2024.\n   - Does not adequately explain the strategic shift from Mobility-based to infrastructure/telecommunications asset-tied instruments.\n   - Introduces instruments (Mobility II) not clearly connected to the main narrative of the ground truth.\n\n5. SEMANTIC ISSUES:\n   - While the answer correctly identifies the 2023 repurchase of Mobility Preferred Interests, it conflates this with new Mobility II instruments, which appear to be different products.\n   - The characterization of the strategy shift is partially correct but incomplete.\n\nThe answer demonstrates partial understanding but contains material omissions and introduces potentially incorrect or irrelevant details that diverge from the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 682,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "In the 2022 Form 10‑K Amazon treated competition from other sites as a generic market pressure – it listed “the introduction of competitive stores, **websites**, products, services, price decreases, or improvements” and linked the risk to “changes in usage or adoption rates of the Internet, e‑commerce, electronic devices, and web services.” By the 2023 filing the wording was altered to stress a technology‑driven threat, saying the risk now comes from “the extent to which new and existing technologies, or industry trends, **restrict online advertising or affect our ability to customize advertising or otherwise tailor our product and service offerings**,” indicating a shift from simple website competition to competition based on platform‑technology and advertising capabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally mischaracterizes the evolution described in the ground truth. The ground truth states that in 2022, Amazon described competitive websites as part of a 'broader list of fluctuating business factors' with 'general awareness of competitive pressures,' while in 2023 the language evolved to be 'more direct and strategic' with 'competitive stores, websites, products, services, price decreases, or improvements' as a 'central concern.' However, the LLM reverses this narrative: it claims the 2022 filing contained the specific language about 'competitive stores, websites, products, services, price decreases, or improvements' (which the ground truth indicates was the 2023 characterization), and then claims 2023 shifted to technology-driven advertising concerns. This is backwards. The LLM introduces entirely new content about advertising and technology restrictions that is not mentioned in the ground truth answer at all. The ground truth emphasizes a shift from general operational risk to strategic competitive challenge focused on direct competitive offerings, while the LLM describes a shift to technology-platform and advertising capabilities - a completely different narrative. The LLM appears to have fabricated or confused specific language attributions to years. While the LLM correctly identifies the years (2022 vs 2023) and the general concept of evolution in language, the actual characterization of what changed and how is fundamentally incorrect and contradicts the ground truth. The answer fails to capture the core insight about the shift from general awareness to focused strategic concern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 452,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "In the 2022 filing PMI described a three‑year “global collaboration agreement” with KT&G that gave PMI exclusive rights to distribute KT&G’s smoke‑free products—including its LIL heat‑not‑burn devices—outside South Korea, while still allowing PMI to sell its own products (see page_51). By the 2024 filing the relationship had shifted to a licensing model: KT&G‑licensed heat‑not‑burn brands (Fiit and Miix) are now counted as part of PMI’s HTU (heat‑not‑burn) lineup and are included in the company’s smoke‑free revenue, indicating a deeper strategic reliance on KT&G’s heat‑not‑burn products within PMI’s smoke‑free portfolio (see pages_40‑41).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of the PM-KT&G relationship from 2022 to 2024, capturing the shift from a distribution partnership to a more integrated supplier role. However, there are significant factual discrepancies that reduce the overall score: (1) PRODUCT NAME ERRORS: The LLM identifies KT&G's heat-not-burn brands as 'Fiit and Miix' in 2024, but the ground truth specifies 'LIL Mini and LIL Plus' as the products distributed under the original agreement. The LLM does not verify whether Fiit and Miix are actually KT&G products or correctly identify the actual product names in 2024. This is a material factual error. (2) AGREEMENT STRUCTURE: The LLM correctly identifies the 2022 three-year global collaboration agreement and exclusive distribution rights outside South Korea, matching the ground truth. (3) EVOLUTION CHARACTERIZATION: The LLM correctly characterizes the shift from distribution to a licensing/integration model where KT&G products are now part of PMI's HTU lineup and smoke-free revenue, which aligns with the ground truth's description of 'deeper strategic reliance' and shift from 'distribution partnership to embedded supplier role.' (4) MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and correctly identifies the progression of the relationship. (5) MISSING CONTEXT: The LLM does not explicitly mention that the products were 'integrated into PMI's broader smoke-free product portfolio' as stated in the ground truth, though it implies this through the HTU lineup reference. The citation references (page_51, pages_40-41) cannot be verified against the ground truth but appear plausible. The core reasoning is sound, but the product name discrepancy is a significant factual error that undermines confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 498,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K describe the PWCC Acquisition Long‑Term Performance Plan as “adopted … in connection with the company’s acquisition of PricewaterhouseCoopers Consulting” and note that **the plan is administered under the same framework as the 2001 Long‑Term Performance Plan (i.e., by the Executive Compensation and Management Resources Committee of the Board)**【page_28】. In each filing the plan is said to **“be used solely to fund awards for employees of PwCC who have become employed by the company as a result of the acquisition” and that “awards for senior executives … will not be funded from the PWCC Plan”【page_28】【page_18】. Thus, between 2022 and 2024 IBM’s use of the PWCC Plan did not change – its administration remained with the same committee and its scope continued to be limited to non‑senior‑executive PwCC employees.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements: (1) the PWCC Plan's connection to the PwCC acquisition, (2) administration by the same committee as the 2001 Plan, (3) the scope limitation to non-senior-executive PwCC employees, and (4) that awards for senior executives would not be funded from the PWCC Plan. These facts align with the ground truth. However, the LLM answer has a significant weakness in its core conclusion and reasoning: The LLM states 'IBM's use of the PWCC Plan did not change' and that 'its scope continued to be limited,' which directly contradicts the nuanced finding in the ground truth. The ground truth emphasizes an important evolution: while the scope remained the same (limited to former PwCC employees), there was a meaningful shift in language and tone between 2022 and 2024 - from 'would continue to be used' (future-oriented) to 'has been and will continue to be used' (retrospective affirmation with stronger commitment). This linguistic shift suggests a deliberate reaffirmation and stronger commitment to maintaining the plan's current usage without expansion, which the ground truth identifies as significant. The LLM missed this nuanced evolution in IBM's positioning and commitment level, instead characterizing the situation as static ('did not change'). The LLM also provides page citations that appear to reference specific documents, though these cannot be independently verified. The answer is factually accurate on surface details but fails to capture the qualitative evolution in IBM's approach and messaging regarding the plan between the two years, which was the core focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 451,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "In 2023 AT&T eliminated its legacy Mobility Series A preferred interests – repurchasing the 213 million shares in April 2023 and reclassifying the obligation as a liability, which showed up as a one‑time increase in interest expense and removed the equity‑like preferred‑interest claim (see page 25 and page 86). By 2024 the company had no Series A interests outstanding but had issued a much smaller “Mobility II” Series B redeemable non‑controlling interest (2 million shares paying 6.8% cash distributions) that is recorded as a redeemable liability and does not restrict cash movements or dividend policy (see page 88). The move from repurchasing a large, legacy preferred‑equity tranche to issuing a modest, callable preferred‑interest instrument reflects AT&T’s broader strategy to streamline its capital structure, replace costly equity‑type obligations with more flexible, lower‑cost debt‑like securities, and preserve financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims AT&T repurchased '213 million shares' of Mobility Series A preferred interests in April 2023, but the ground truth states the total repurchase cost was $5,414 million with no mention of share count. The LLM also introduces a 'Mobility II Series B' with '2 million shares paying 6.8% cash distributions' that is not mentioned in the ground truth at all. (2) FACTUAL INACCURACY: The ground truth explicitly states 'By 2024, there was no mention of Mobility Preferred Interests in the disclosures,' directly contradicting the LLM's claim that AT&T issued a new 'Mobility II Series B' instrument in 2024. (3) INCOMPLETE SYNTHESIS: The ground truth mentions AT&T maintained other preferred interests (Tower Holdings and Telco LLC) that were 'expanded or restructured in 2024,' but the LLM fails to acknowledge this comparative context, which is essential to understanding the 'selective approach' to capital management. (4) UNSUPPORTED DETAILS: References to 'page 25,' 'page 86,' and 'page 88' appear to be fabricated citations not verifiable against the ground truth. The claim about 'reclassifying the obligation as a liability' and 'one-time increase in interest expense' are not mentioned in the ground truth. (5) REASONING QUALITY: While the LLM's general narrative about streamlining capital structure has some merit, it is built on false premises (the existence of Mobility II Series B in 2024). The core finding—complete elimination of Mobility Preferred Interests by 2024—is contradicted by the LLM's assertion of a new instrument. The answer demonstrates hallucination of specific financial instruments and metrics not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 494,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the company explicitly listed “governmental and **stock‑exchange regulations**” as one of the external factors that can affect the value of its debt securities (see the risk‑factor paragraph on page 22). The 2024 Form 10‑K’s discussion of debt‑security risks no longer mentions stock‑exchange regulation, showing that IBM’s disclosed regulatory exposure for its debt securities has been reduced or omitted in the later filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key finding. Ground truth states that IBM's language SHIFTED from a general mention in 2022 to a MORE DIRECT 'subject to' regulatory exposure in 2024, indicating HEIGHTENED recognition. The LLM claims the opposite - that stock exchange regulations were mentioned in 2022 but OMITTED in 2024, showing REDUCED exposure. This is a complete reversal of the actual evolution described in the ground truth. QUANTITATIVE ACCURACY: The LLM correctly identifies 2022 and 2024 as the relevant years and mentions page 22 as a reference location (though this is not verified against ground truth). No specific dollar amounts or calculations are involved, so numeric accuracy is not directly testable. QUALITATIVE/REASONING ACCURACY: The LLM's reasoning is fundamentally flawed. It claims the 2024 filing 'no longer mentions' stock exchange regulation, but the ground truth explicitly states that 2024 shows a MORE DIRECT regulatory exposure statement ('subject to'). The LLM appears to have misread or misinterpreted the filings, arriving at the opposite conclusion. The multi-hop synthesis required comparing 2022 and 2024 language, but the LLM failed to correctly identify the shift in regulatory language. CONTEXTUAL RELEVANCE: The answer does address the question about evolution between 2022 and 2024, but provides the wrong direction of evolution. The question asks how the relationship 'evolved' and the LLM provides an answer about evolution, but with inverted findings. This is a case where the answer structure is relevant but the content is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 453,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "In the 2022 Form 10‑K Disney’s 50 % stake in A+E was highlighted as a major equity‑method investment, with its share of A+E earnings feeding the “Equity in the income of investees, net” line (the amount was materially larger than in later years). By fiscal 2024 that equity‑income contribution had fallen to $575 million, a $207 million decline from the prior year, reflecting weaker A+E earnings and a one‑time $56 million gain from a content‑license termination that was booked in restructuring charges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the 2024 equity-income contribution was '$575 million' with a '$207 million decline from the prior year.' This is internally inconsistent and contradicts the ground truth. The ground truth states the decline was $207 million from 2022 to 2024, not year-over-year. The LLM's claim that 2024 was $575M with a $207M decline 'from the prior year' (implying 2023) would mean 2023 was $782M, but this figure is not mentioned in ground truth and appears fabricated. (2) ENTITY ACCURACY - The LLM correctly identifies Disney's 50% stake in A+E and the equity method investment structure, which aligns with ground truth. (3) MULTI-HOP REASONING - The LLM attempts to synthesize information across years but introduces unsupported details: the specific $575 million figure for 2024 is not confirmed in the ground truth, and the reference to a '$56 million gain from a content-license termination' is not mentioned in the original answer. (4) GROUND TRUTH ALIGNMENT - The original answer clearly states 'Disney's equity in the income of investees had decreased by $207 million' from 2022 to 2024 'specifically due to lower income generated from A+E.' The LLM misinterprets this as a year-over-year decline and introduces unverified financial figures. (5) CONTEXTUAL RELEVANCE - The answer does address the evolution of the relationship and attempts to explain the decline, which is relevant to the question. However, the introduction of unverified numbers and mischaracterization of the time period significantly undermines credibility. The core insight about declining A+E contribution is present but obscured by factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 460,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations rose from **$16.973 billion at December 31 2022** to **$18.043 billion at December 31 2023**, an increase of roughly **$1.07 billion**【page_211】【page_210】. This uptick, coupled with the company’s sizable shelf‑registration capacity for additional securitizations, signals that Capital One is deliberately expanding its securitization program to diversify and strengthen its long‑term funding mix beyond deposits and conventional notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states securitized debt obligations were $16.973 billion at December 31, 2022 and increased to $18.043 billion at December 31, 2023. However, the ground truth clearly indicates the carrying value DECREASED to $18.043 billion by December 31, 2023 (from a higher baseline in 2022). The LLM's claim of an increase of $1.07 billion is mathematically inconsistent with the ground truth's narrative of 'a strategic shift or reduction in reliance on securitized debt obligations.' (2) DIRECTIONAL ERROR: The LLM interprets the change as an 'uptick' and 'deliberately expanding its securitization program,' which is the opposite conclusion from the ground truth's statement of 'a strategic shift or reduction in reliance on securitized debt obligations.' This represents a 180-degree misinterpretation of the company's funding strategy. (3) MISSING CONTEXT: The ground truth references the 2021 baseline of $42.3 billion in long-term funding, which provides important context for understanding the magnitude of the reduction. The LLM fails to incorporate this comparative context. (4) REASONING FLAW: While the LLM provides a coherent narrative about shelf-registration capacity and diversification, this reasoning contradicts the actual data trend shown in the ground truth. The LLM appears to have fabricated or misread the 2022 figure ($16.973 billion) and mischaracterized the directional change. The answer demonstrates poor multi-hop synthesis and fails to correctly identify the strategic implication of the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 457,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "In 2022 Disney’s scripted series were still being delivered mainly through its worldwide linear network – roughly 220 general‑entertainment channels (Fox, Star and National Geographic) that aired a mix of scripted, reality and documentary shows – and the filing warned that a growing focus on direct‑to‑consumer (DTC) would erode that licensing‑based model【page_12】. By 2024 the company has pivoted the bulk of that scripted inventory to streaming, folding Star+ into Disney+, using the Star tile on Disney+ to showcase general‑entertainment (including scripted) titles and adding ad‑supported and sports tiles, so that new scripted programming is now monetized primarily on its DTC platforms rather than on international linear channels【page_7】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's strategic shift from linear to DTC platforms between 2022-2024. STRENGTHS: (1) Correctly identifies the ~220 general entertainment channels in 2022 across Fox, Star, and National Geographic brands; (2) Accurately captures the mix of scripted, reality, and documentary content; (3) Properly synthesizes the strategic pivot toward DTC platforms; (4) Correctly mentions specific 2024 actions like folding Star+ into Disney+ and adding ad-supported/sports tiles; (5) Accurately conveys the shift from licensing-based linear model to DTC monetization. WEAKNESSES: (1) The LLM answer omits the Venu Sports joint venture (Disney, Fox Corporation, Warner Bros. Discovery) mentioned in the ground truth as a significant strategic indicator of the DTC shift; (2) Does not mention the planned 2025 DTC offering with live ESPN channels and ESPN+, which is explicitly highlighted in the ground truth as evidence of the transformation; (3) The answer focuses heavily on scripted content repositioning but underemphasizes the broader strategic move toward sports-driven DTC offerings that the ground truth emphasizes. QUANTITATIVE VERIFICATION: The 220 channels figure is correct and properly contextualized. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 timeframes and connects strategic decisions to business model changes. However, it misses key multi-hop connections to the Venu Sports venture and 2025 ESPN+ plans that would strengthen the narrative about Disney's comprehensive DTC transformation. SEMANTIC EQUIVALENCE: The core message about the shift from linear to DTC is conveyed accurately, though with incomplete coverage of supporting evidence from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 489,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "In the 2022 Form 10‑K Tesla warned that its accounts‑receivable balance— which includes sales of energy‑generation and storage products— can swing widely because payments from financing partners, regulatory‑credit sales and government rebates often take weeks or months to clear, creating a notable financial exposure (see 2022 p. 64). By the 2023 filing the focus had shifted to operational risk: the company said that expanding energy‑storage production now depends on securing enough lithium‑ion cells, raw‑material supplies and successfully ramping new factories and installation capacity, and that any shortfall could force curtailments or higher‑cost sourcing (see 2023 p. 16‑18).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional shift from financial to operational concerns between 2022 and 2023, which is correct. However, there are significant quantitative accuracy issues: (1) The ground truth specifies a $627 million long-term government rebates receivable balance as of December 31, 2021, but the LLM answer does not cite any specific dollar amount for the receivables discussed in the 2022 filing. This is a material omission of a key quantitative fact. (2) The LLM answer correctly identifies the shift in focus from accounts receivable/financial exposure in 2022 to production scaling risks and supply chain dependencies in 2023, which aligns with the ground truth's core narrative. (3) The LLM answer appropriately mentions lithium-ion cells, raw materials, factory ramp delays, and supplier constraints as operational dependencies, which matches the ground truth's description of bottlenecks and facility ramp delays. (4) The page references cited (2022 p. 64, 2023 p. 16-18) cannot be verified against the ground truth but appear plausible. (5) The multi-hop reasoning is sound—the answer correctly synthesizes the evolution across two years and identifies the shift in risk profile. However, the failure to include the specific $627 million figure or any quantitative baseline for the 2022 receivables represents a significant gap in addressing the 'accounts receivable' component of the question. The answer is qualitatively strong on the operational shift but quantitatively incomplete on the financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 423,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "In the 2022 filing Coca‑Cola described syrups mainly as a component of its concentrate business that it sells to bottling partners, with revenue recognized when those partners sell the finished beverages (see the revenue‑recognition discussion of syrups on page 43). By the 2023 filing the company emphasizes a broader syrup role: it now manufactures fountain syrups in the United States and sells them directly to fountain retailers, while outside the United States its bottling partners are authorized to produce and distribute fountain syrups to retailers or wholesalers (page 37), and the share of net operating revenue from concentrate operations (which includes syrups) grew from 56 % in 2022 to 58 % in 2023 (page 38), reflecting an expanded importance of syrups in the business model.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Coca-Cola's syrup business model between 2022 and 2023, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the shift from concentrate-focused sales to bottling partners (2022) to a more integrated direct-to-retailer model (2023); (2) Accurately captures the distinction between U.S. direct sales to fountain retailers and international bottler-authorized distribution; (3) Provides specific page references (43, 37, 38) showing document engagement; (4) Includes quantitative data (56% to 58% revenue growth in concentrate operations) that demonstrates analytical depth; (5) Correctly identifies the operational shift from volume-driven to operationally embedded component. WEAKNESSES: (1) The revenue recognition mechanics described in 2022 (\"revenue recognized when those partners sell the finished beverages\") is somewhat simplified compared to the ground truth's more nuanced distinction between consolidated vs. unconsolidated bottlers; (2) The percentage increase (56% to 58%) is presented as evidence of expanded importance, but the ground truth doesn't explicitly validate this interpretation as the primary evidence of the shift; (3) Missing explicit mention of the consolidated vs. unconsolidated bottler distinction that was central to 2022 operations; (4) The answer could have more clearly articulated the shift from \"primarily volume-driven metric\" to \"operationally embedded component\" as stated in ground truth. QUANTITATIVE VERIFICATION: The 56% to 58% figures appear reasonable as supporting data, though not explicitly verified against ground truth. Page references suggest accurate document sourcing. MULTI-HOP REASONING: Successfully synthesizes information across 2022 and 2023 filings, comparing business model evolution and identifying the strategic shift. The reasoning connecting percentage growth to expanded importance is logical though somewhat inferential. SEMANTIC EQUIVALENCE: The answer conveys the core message of the ground truth—that syrups evolved from a concentrate-sales component to a more strategically integrated part of the business—though with slightly different emphasis and supporting evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 606,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney’s “Other mortgage‑ and asset‑backed securities” holding grew from **$84 million** at FY 2022 year‑end (page 104) to **$120 million** in FY 2023 and **$166 million** in FY 2024 (page 107).  Although the dollar amount rose, the line consistently accounted for **about 1 % of the total fair‑value hierarchy** (≈$84 million of $7.5 billion in FY 2022, $120 million of $8.1 billion in FY 2023 and $166 million of $11.0 billion in FY 2024), showing a modest absolute increase but a stable portfolio share.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies that contradict the ground truth. (1) FY 2022 value: LLM states $84 million, but ground truth is $96 million - a $12 million error. (2) FY 2024 value: LLM states $166 million, but ground truth is $120 million - a $46 million error (38% overstatement). (3) The LLM introduces FY 2023 data ($120 million) that is not part of the original question scope (which asks about FY 2022 to FY 2024 evolution). (4) The percentage calculations shown by LLM are mathematically inconsistent with their own stated numbers (e.g., $84M/$7.5B ≠ 1.1%, closer to 1.1%, but the ground truth maintains 1% consistently). (5) The trend analysis is fundamentally wrong: the LLM claims a 'modest absolute increase' when their own numbers show a 97.6% increase ($84M to $166M), while the ground truth shows only a 25% increase ($96M to $120M). The LLM correctly identifies that the proportion remained stable at ~1%, but this conclusion is based on incorrect underlying numbers. The multi-hop reasoning structure is present but built on false data points, making the entire synthesis unreliable. The answer demonstrates understanding of the question's intent but fails critically on factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 352,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings describe Skunk Works (the Advanced Development Programs) in the same terms – it is “focused on future systems, including unmanned and manned aerial systems and next‑generation capabilities for air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness and air mobility,” and it “continues to explore technology advancement and insertion into our existing aircraft” while pursuing “network‑enabled activities” to boost effectiveness 【page_4†L1-L9】【page_4†L10-L13】. The wording is essentially unchanged, showing that the program’s focus areas did not evolve between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that Skunk Works' focus areas DID evolve between 2022 and 2023, with a specific shift: 2022 focused on 'unmanned and manned aerial systems and next-generation capabilities for hypersonics, ISR, situational awareness, and air mobility,' while 2023 emphasized 'air dominance, hypersonics, ISR, situational awareness, and air mobility.' The key evolution is the addition/emphasis of 'air dominance' as a core capability in 2023 and the removal/de-emphasis of 'unmanned and manned aerial systems' as a primary focus area. The LLM incorrectly claims 'the wording is essentially unchanged' and concludes 'the program's focus areas did not evolve between 2022 and 2023.' This is a direct contradiction of the ground truth. The LLM appears to have conflated or misread the 2023 language, missing the critical distinction that 'air dominance' replaced the emphasis on 'unmanned and manned aerial systems' as a primary next-generation capability. The ground truth explicitly characterizes this as 'a refinement of priorities rather than a complete overhaul,' but the LLM denies any evolution occurred at all. Quantitative accuracy is high (dates and entities are correct), but qualitative accuracy is severely compromised by the fundamental misinterpretation of the comparative analysis between the two years. The answer fails to address the core question about how focus areas evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 408,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "In the 2022 filing Tesla said it was **ramping Powerwall production**, improving its availability and using the product to **cross‑sell with residential solar** while building new capacity (e.g., the Megafactory) to meet demand【page_34】. By the 2023 filing the focus had shifted to **integrating Powerwall with Solar Roof and offering bundled solar‑Powerwall financing**, positioning it as part of an integrated home‑energy solution rather than emphasizing pure production growth【page_5】【page_7】【page_9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Tesla's Powerwall evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the 2022 focus on ramping production and cross-selling with residential solar, matching the ground truth emphasis on availability and cross-selling strategy. (2) Accurately captures the 2023 shift toward integration with Solar Roof and bundled financing solutions, which aligns with the ground truth's description of 'more deliberate and engineered approach to product synergy.' (3) The characterization of the evolution from 'production growth' to 'integrated home-energy solution' correctly reflects the shift from sales/availability focus to technical/strategic integration mentioned in ground truth. (4) Mentions Megafactory as a concrete example of capacity building, which is factually appropriate. (5) No quantitative errors or incorrect dates. MINOR WEAKNESSES: (1) The ground truth emphasizes 'improving installation capabilities and price efficiencies for Solar Roof' in 2022, which the LLM answer doesn't explicitly mention - though this is a relatively minor omission. (2) The ground truth's specific mention of 'grid stability concerns' as a driver for cross-selling is not captured in the LLM answer. (3) The LLM answer adds 'bundled solar-Powerwall financing' as a 2023 development, which while plausible and consistent with integration strategy, is not explicitly mentioned in the ground truth provided. However, this appears to be a reasonable inference from the integration strategy rather than a factual error. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years and correctly identifies the strategic shift in approach. The logic connecting production emphasis to integration strategy is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential information from the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 524,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "In the 2022 filing Gilead presented Biktarvy as a flagship, revenue‑generating, once‑daily single‑tablet regimen that sits at the core of its HIV portfolio (see page 5). By the 2024 filing the company’s tone has shifted to stress that HIV products—including Biktarvy—account for a substantial share of sales but now face heightened commercial risks such as intense competition, generic erosion, pricing‑and‑reimbursement pressures, and the possibility that shifts away from TAF‑based regimens could erode demand (see pages 18 and 20). This reflects an evolution from positioning Biktarvy as a primary growth driver to acknowledging its exposure to broader market and regulatory headwinds.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-hop question about Biktarvy's strategic evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core positioning shift from 2022 (flagship, revenue-generating, single-tablet regimen) to 2024 (core product with heightened commercial risks); (2) Accurately captures the key commercial risks mentioned in the ground truth: competition, generic erosion, pricing/reimbursement pressures, and TAF-based regimen vulnerability; (3) Properly synthesizes information across two filing years; (4) Correctly identifies Biktarvy's composition (bictegravir, emtricitabine, tenofovir alafenamide) implicitly through TAF reference; (5) Appropriately cites specific page numbers from filings (pages 5, 18, 20) showing document-level detail; (6) Captures the semantic essence of the transition from growth driver to vulnerability acknowledgment. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly state the full chemical composition of Biktarvy as the ground truth does, though this is a minor omission; (2) The phrase 'overreliance on a narrow therapeutic class' from the ground truth is not explicitly stated, though the concept is implied through the TAF vulnerability discussion; (3) The ground truth emphasizes 'transition from a focus on product innovation to increased vulnerability' more explicitly than the LLM answer does. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, which is appropriate given the qualitative nature of the question. The years (2022, 2024) are correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing periods and correctly identifies the evolution in company messaging and risk positioning. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different emphasis but no factual contradictions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 547,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "In the 2022 Form 10‑K the U.S. Retrospective Responsibility Plan was described as consisting of six mechanisms – a U.S. litigation escrow agreement, the conversion feature of the company’s class B common stock, the indemnification obligations of Visa U.S.A. members, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement 【page_71】.  \n\nThe 2023 filing shows the same six mechanisms but adds a distinct “make‑whole” agreement (tied to the class B‑1 exchange offer) and expands the conversion feature to cover class B‑1 and B‑2 shares, thereby broadening the plan’s components while retaining the escrow, indemnification, interchange‑judgment‑sharing, loss‑sharing and omnibus agreements 【page_72】【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about the U.S. Retrospective Responsibility Plan composition changes between 2022 and 2023. STRENGTHS: (1) Correctly identifies all six mechanisms in 2022: U.S. litigation escrow agreement, conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, interchange-judgment-sharing agreement, loss-sharing agreement, and omnibus agreement. (2) Accurately describes the 2023 evolution, including the addition of 'make-whole' agreements tied to the Class B-1 exchange offer. (3) Properly notes the expansion of the conversion feature to cover Class B-1 and B-2 shares in 2023. (4) Correctly synthesizes the multi-hop information by comparing both years and identifying what was retained versus what was added. (5) Provides specific page references (71, 72, 74) demonstrating source verification. (6) The semantic meaning aligns perfectly with the ground truth answer. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail than the ground truth (specifically mentioning the expansion to B-1 and B-2 shares), which represents an enhancement rather than an error. The phrasing 'make-whole' agreement versus 'makewhole agreements' is a negligible formatting difference. All entity names, years, and mechanisms are correctly identified. The reasoning clearly demonstrates understanding of the compositional changes and the relationship between mechanisms across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 419,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "In the 2022 filing Gilead highlighted that Biktarvy’s core compound patents run through 2033 in both the United States and the European Union (see the patent‑expiration table on page 11) and even added a pediatric low‑dose tablet approval (page 10), signaling a long‑term, protected revenue stream. The 2024 filing still lists dependence on HIV products as a material risk (page 18) and the same 2033 expiration horizon persists, showing that Biktarvy remains a central, heavily protected pillar of Gilead’s portfolio and its strategic importance has stayed high from 2022 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core finding. (1) PATENT PROTECTION DISCREPANCY: The LLM claims Biktarvy has patent protection through 2033 in BOTH the U.S. AND E.U., but the ground truth explicitly states 'no expiration listed in the E.U.' in 2022. This is a factual error on a key numeric/temporal claim. (2) STRATEGIC IMPORTANCE EVOLUTION: The ground truth indicates Biktarvy's strategic position became MORE VULNERABLE from 2022 to 2024 despite patent protection, due to market competition and treatment paradigm shifts. The LLM incorrectly concludes that 'strategic importance has stayed high,' directly contradicting the ground truth's assessment that vulnerability increased. (3) RISK DISCLOSURE INTERPRETATION: While the LLM correctly identifies that 2024 filings highlight HIV product dependency as a material risk, it fails to synthesize this with the patent protection data to reach the correct conclusion - that external pressures (competition, regulatory shifts) have increased vulnerability despite long-term patent protection. (4) MULTI-HOP REASONING FAILURE: The question requires synthesizing patent timelines WITH risk disclosures to assess how strategic importance EVOLVED. The LLM only notes both exist but fails to properly synthesize them into the correct narrative of increasing vulnerability. (5) MISSING NUANCE: The ground truth captures the paradox that long-term patent protection (positive) coexists with heightened competitive/regulatory risks (negative), resulting in net increased vulnerability. The LLM misses this critical nuance entirely. The answer is internally inconsistent with the ground truth's core finding about the evolution of strategic importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 474,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "The 2023 Form 10‑K adds a specific reference to AT&T’s “Guaranty of certain obligations of … Illinois Bell Telephone Company” (Exhibit 4‑d), a guarantee that is not mentioned in the 2022 filing. No other changes to the guarantee’s terms or structure are disclosed, indicating the guarantee itself remains the same but its documentation is now explicitly referenced.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that the guarantee was referenced in BOTH 2022 and 2023 under the identical exhibit number (Exhibit 4-d) and filing history, with NO structural changes between the two years. The LLM answer incorrectly claims that the guarantee 'is not mentioned in the 2022 filing' and that '2023 Form 10-K adds a specific reference' - this is the opposite of what the ground truth establishes. The LLM appears to have misinterpreted the evidence, suggesting the guarantee is newly documented in 2023 when in fact it remained unchanged and consistently referenced across both years. The core conclusion is wrong: the ground truth emphasizes structural continuity and identical documentation references, while the LLM suggests a change in documentation/referencing between years. The LLM does correctly identify the exhibit number (Exhibit 4-d) and the company name (Illinois Bell Telephone Company), and correctly notes that no changes to terms or structure are disclosed, but the framing that this is a 'new' reference in 2023 is factually incorrect. The multi-hop reasoning failed to properly synthesize the year-over-year comparison, leading to an inverted conclusion about whether the guarantee was mentioned in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 370,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The conversion rate for Class C common stock into Class A common stock remained at 4.0000 in both 2022 and 2023 (see page_87). Because the rate did not change, any conversion of Class C shares would not increase the dilution of voting power beyond what was already anticipated, so Class A shareholders’ voting power in significant corporate transactions remains essentially unchanged (see page_30; page_32).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: the Class C to Class A conversion rate remained constant at 4.0000 in both 2022 and 2023. The numeric values are accurate and properly formatted. The reasoning about voting power dilution remaining stable due to the unchanged conversion rate is logically sound and semantically equivalent to the ground truth answer. However, there are some notable omissions and differences: (1) The LLM answer does not mention the as-converted Class A common stock value increasing from 38 million to 39 million in 2022-2023, which the ground truth includes as supporting context. (2) The LLM answer uses slightly different framing ('voting power in significant corporate transactions remains essentially unchanged' vs. 'relative voting power dilution remained stable'), which is semantically similar but not identical. (3) The LLM answer references specific pages (page_87, page_30, page_32) which adds credibility but cannot be verified against the ground truth. The core insight about the stable conversion rate and its implications for voting power is correct, but the answer is less comprehensive than the ground truth in providing the full context of the as-converted share values. The multi-hop reasoning is sound: the model correctly synthesizes that a constant conversion rate means no new structural changes in voting influence. Overall, the answer captures the essential conclusion but lacks some supporting detail present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 414,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "In the 2022 filing Tesla said that its Solar Roof was a core part of the energy‑generation business and was **designed, engineered and produced at Gigafactory New York in Buffalo** (see 2022 p. 9) with in‑house design expertise, financing options and dedicated warranties (2022 p. 7‑8). By the 2023 filing the company no longer highlights a dedicated Solar Roof plant; instead it groups Solar Roof with its energy‑storage products as a line that could **experience production‑ramp delays**, indicating that the focus has shifted to managing Solar Roof through its broader manufacturing capacity and supply‑chain dependencies rather than a specific facility (2023 p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2022 production reality - Tesla directly produced Solar Roof at Gigafactory New York in Buffalo with specific page citations (p. 9 for production location, p. 7-8 for financing/warranties). (2) Accurately captures the 2023 shift - no longer highlighting a dedicated Solar Roof plant, grouping it with energy-storage products, and emphasizing production-ramp delays (p. 16). (3) Multi-hop synthesis is sound: the answer correctly traces the evolution from 'production-centric' (2022) to 'risk/dependency-centric' (2023) framing. (4) Semantic equivalence is excellent - the LLM's characterization of the shift from 'specific facility focus' to 'broader manufacturing capacity and supply-chain dependencies' directly mirrors the ground truth's transition from 'production-centric view to cautionary outlook on strategic execution risks.' (5) No quantitative errors - dates (2022 vs 2023) are correct, and no calculations are required. (6) Entity accuracy is perfect - Tesla, Solar Roof, Gigafactory New York, energy-storage products all correctly identified. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail (specific page numbers, mention of financing options and warranties) than the ground truth summary, but this adds value rather than detracting. The answer fully addresses both components of the question: production focus evolution and strategic dependencies evolution. The reasoning chain is logical and well-supported by cited evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 437,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "In both years Coca‑Cola’s syrups are still sold by the concentrate business to its bottling partners, who blend the syrups (or concentrates) with water and sweeteners to make the finished beverages, and in the United States the company also sells fountain syrups directly to fountain retailers, wholesalers or bottlers (2022 p. 6‑7; 2023 p. 37). But the 2023 filing shows the concentrate segment – which includes syrups – grew to 58 % of net operating revenue and 83 % of unit‑case volume, up from 56 % and 82 % in 2022 (2023 p. 38), indicating that syrups have become a larger share of the company’s revenue and volume and thus a more pivotal feedstock for finished‑beverage production and its distribution channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and misalignments with the ground truth. STRENGTHS: (1) Correctly identifies that syrups are sold to bottling partners and that they blend with water/sweeteners to create finished beverages; (2) Correctly notes that in the U.S., fountain syrups are sold directly to fountain retailers, wholesalers, and bottlers; (3) The percentage figures cited (58% and 83% for 2023, 56% and 82% for 2022) appear plausible and are presented with proper source citations. WEAKNESSES: (1) The LLM answer conflates 'concentrate segment' growth with 'syrup' evolution, which is imprecise - the ground truth specifically distinguishes between syrups as intermediate products and the broader concentrate operations; (2) The answer fails to capture the key distinction highlighted in the ground truth: that 2023 showed a 'strategic shift toward tighter control and segmentation of syrup-related revenue streams' and that fountain syrup operations were 'specifically included in the North America operating segment'; (3) The LLM answer does not adequately address the evolution between 2022 and 2023 in terms of structural/organizational changes (the regional focus and segmentation aspect); (4) The conclusion that syrups 'have become a larger share' conflates concentrate segment growth with syrup-specific growth, which may not be equivalent; (5) The answer misses the nuance that the 2023 filing 'expanded its description' to emphasize direct management by Coca-Cola, suggesting a strategic organizational change not fully captured. QUANTITATIVE VERIFICATION: The percentages provided (58%, 83%, 56%, 82%) cannot be independently verified from the provided context but are cited with specific page references, suggesting they may be accurate. However, these figures relate to the concentrate segment broadly, not specifically to syrups. MULTI-HOP REASONING: The answer attempts to synthesize information across 2022 and 2023 but does so incompletely - it focuses on volume/revenue metrics rather than the structural and organizational evolution that the ground truth emphasizes as the key change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 576,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The company continues to treat Africa/Eurasia as a distinct, fifth geographic operating segment of its Oral, Personal and Home Care business. In 2022 the segment generated about $1.08 billion of net sales and $228 million of operating profit (with $30 million of capex); by 2024, after the company recast historic segment data to reflect a skin‑health reporting realignment, Africa/Eurasia contributed roughly $1.10 billion of net sales and $253 million of operating profit (capex down to $12 million). The geographic reporting structure (five regions) remained unchanged, with only the skin‑health business shifting between Europe and North America.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM provides specific financial figures ($1.08B net sales, $228M operating profit in 2022; $1.10B net sales, $253M operating profit in 2024) that are NOT supported by the ground truth. The ground truth only mentions $203M operating profit for 2022 with no net sales figures provided. The LLM's numbers appear fabricated or sourced from incorrect data. (2) STRUCTURAL CLAIM ERROR - The LLM states Africa/Eurasia is a 'fifth geographic operating segment' and that 'the geographic reporting structure (five regions) remained unchanged.' The ground truth indicates Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment in 2022, not as a standalone fifth segment. By 2024, it remained 'a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure' - this is different from being a standalone fifth segment. (3) PARTIAL ACCURACY - The LLM correctly identifies that skin health business shifted between Europe and North America, which matches the ground truth. (4) MISSING CONTEXT - The LLM fails to capture the ground truth's characterization of Africa/Eurasia as having 'relatively minor financial contribution' in 2022, and doesn't adequately convey the 'more nuanced operational focus' evolution described in the ground truth. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize 2022 vs 2024 comparison, it does so with incorrect data, undermining the entire analysis. The answer reads as confident but factually unreliable on the core quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 453,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "In the 2023 Form 10‑K Johnson & Johnson treated Orthopaedics as a discrete MedTech sub‑segment, reporting $8.9 billion of worldwide sales for the year (up 4.1 % versus 2022) and even breaking the business out by region and by product groups such as knees, trauma and spine (see 2023 p. 90‑91). By the 2024 filing the company shifted to a more narrative‑driven presentation, describing the Orthopaedics portfolio as a suite of products and “enabling technologies” that support hips, knees, trauma, spine, sports and other areas, with no detailed sales numbers disclosed (see 2024 p. 7‑8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about JNJ's Orthopaedics business evolution. STRENGTHS: (1) Quantitative accuracy is excellent - the $8.9 billion figure for 2023 is correct (matches $8,942 million in ground truth, with acceptable rounding), the 4.1% growth rate is accurate, and the statement that 2024 lacks detailed sales numbers is correct. (2) The multi-hop synthesis is sound - the answer correctly identifies the strategic shift from quantitative (2023) to qualitative/narrative (2024) presentation. (3) Entity identification is accurate - correctly names Johnson & Johnson, identifies the Orthopaedics segment, and references both 2023 and 2024 filings. (4) The answer captures the key evolution: from discrete MedTech sub-segment with regional/product breakdowns to a narrative-driven portfolio description emphasizing 'enabling technologies.' (5) Page references (2023 p. 90-91, 2024 p. 7-8) add credibility. MINOR GAPS: (1) The ground truth provides specific regional breakdowns ($5,525M U.S., $3,417M international) which the LLM answer omits, though this is a minor detail since the question asks about 'evolution' rather than complete 2023 details. (2) The LLM mentions 'sports' while ground truth says 'sports medicine' - semantically equivalent but slightly less precise. (3) The LLM says 'no detailed sales numbers disclosed' which is accurate but could have been slightly more explicit about the contrast with 2023's regional/product breakdowns. The answer successfully demonstrates understanding of the strategic pivot and provides accurate financial data while maintaining appropriate semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 460,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "In both the 2022 and 2023 filings Visa’s loss‑sharing framework continues to be governed by the 2015 amendment that defines “U.S. covered litigation” as the Interchange MDL 1720 and any post‑amendment opt‑out actions that are factually similar (see 2022 p. 73; 2023 p. 73). The 2023 filing expands the agreement’s trigger to expressly include liabilities arising from the U.S. litigation‑escrow arrangement and the conversion feature of Visa’s class B common stock (see 2023 p. 72), but the allocation of those liabilities remains based on each member’s membership proportion – with Visa bearing roughly two‑thirds of any settlement or judgment under the omnibus agreement (see 2022 p. 71; 2023 p. 72). This reflects a broader set of covered mechanisms while keeping the proportional liability structure unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2015 amendment reference and its definition of U.S. covered litigation as MDL 1720 plus opt-out actions is accurate. (2) The liability allocation percentages (Visa ~66.67%, Mastercard ~33.33%) are correctly stated as 'roughly two-thirds.' (3) The reference to page numbers (2022 p. 73, 2023 p. 73, etc.) provides appropriate sourcing. (4) The statement that the proportional liability structure remained unchanged between years is factually sound. PROBLEMATIC ELEMENTS: (1) The LLM answer fails to address the key evolution highlighted in the ground truth - the shift from specific amendments in 2022 to the 'U.S. Retrospective Responsibility Plan' framework in 2023. This is a significant omission that misses the core strategic pivot. (2) The LLM introduces new details about 'litigation-escrow arrangement' and 'conversion feature of Visa's class B common stock' that, while potentially accurate, are not mentioned in the ground truth and represent a different analytical focus. (3) The ground truth emphasizes the shift toward 'settled or otherwise fully or substantially resolved' matters in 2023, indicating a consolidation of past liabilities - the LLM answer does not capture this important evolution. (4) The LLM answer characterizes the change as merely 'a broader set of covered mechanisms while keeping the proportional liability structure unchanged,' which understates the strategic evolution from specific amendments to a comprehensive retrospective framework. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings but focuses on continuity rather than evolution. The ground truth emphasizes strategic change; the LLM emphasizes structural consistency. This represents a fundamental difference in interpretation of how Visa's approach 'evolved.' QUANTITATIVE ACCURACY: The percentages and liability allocations are correct. QUALITATIVE ACCURACY: The answer misses the key strategic narrative of the evolution from amendment-specific to retrospective planning, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 573,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "In the 2022 filing the pension plans held roughly $52 million of guaranteed investment contracts – about $1 million in the U.S. plan and $51 million internationally (2022‑10‑K, p. 100). By year‑end 2024 that exposure had fallen to $30 million, all in the international plan with the U.S. holding eliminated (2024‑10‑K, p. 102). The drop signals a strategic move away from insurance‑linked GICs toward a higher weighting in other fixed‑income and diversified assets, consistent with the plans’ target allocation that emphasizes fixed‑income securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the core factual basis of the response. Ground truth shows: 2022 U.S. = $1M, 2022 International = $55M (total $56M); 2024 U.S. = $0M, 2024 International = $34M (total $34M). LLM claims: 2022 total ~$52M ($1M U.S. + $51M international - incorrect international figure), 2024 total $30M (all international - incorrect figure). The LLM's 2022 international figure of $51M is off by $4M from the correct $55M, and the 2024 international figure of $30M is off by $4M from the correct $34M. These are not minor rounding differences but represent material misstatements of the actual pension plan holdings. QUANTITATIVE ACCURACY ASSESSMENT: Both the 2022 and 2024 figures are materially incorrect. The LLM correctly identified that U.S. holdings were eliminated and that international holdings decreased, but the specific dollar amounts are wrong. MULTI-HOP REASONING: The LLM correctly synthesized the multi-hop requirement (comparing 2022 to 2024 and drawing strategic conclusions), and the qualitative interpretation about strategic reallocation toward fixed-income and diversified assets is reasonable and contextually appropriate. However, this reasoning is built on incorrect numerical foundations. COMPLETENESS: The answer addresses both the evolution question and the strategic implication question, but with flawed data. The semantic interpretation about strategic shift away from GICs is directionally correct but based on wrong magnitudes. The citation format (page references) adds credibility but cannot overcome the fundamental numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 455,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "In the 2022 Form 10‑K, Mastercard described the Developer Platform mainly as a “single access point” that lets customers and partners “simplify access to, and integration of, our digital assets,” providing tools and APIs so its services can be embedded in new or existing solutions【page_14】. By the 2024 filing, the platform is positioned as a strategic gateway for emerging tech – it now underpins “new blockchain‑based business models,” integrates with the Mastercard Multi‑Token Network to enable programmable payments and crypto purchases, and supports experimentation with future technologies through Mastercard Foundry, expanding its role from simple API access to a hub for digital‑asset and technology integration【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning as a 'single access point' for digital assets and services with emphasis on ease of integration - this matches the ground truth exactly. (2) Accurately captures the 2024 evolution showing expansion to blockchain and digital currencies, specifically mentioning the Mastercard Multi-Token Network™ and programmable payments. (3) Properly synthesizes the multi-hop comparison between 2022 and 2024, showing the progression from general digital integration to next-generation financial technologies. (4) Correctly identifies supporting technologies and initiatives (Mastercard Foundry, blockchain-based business models, crypto purchases). (5) No quantitative errors - all dates (2022, 2024) and entity names are correct. (6) The semantic meaning is equivalent to ground truth: both describe a shift from simple API access to a more strategic platform for emerging technologies. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more specific implementation details (Mastercard Foundry, crypto purchases) that enhance clarity but aren't explicitly mentioned in the ground truth statement, though these are consistent with the filing context. (2) The page references [page_14] suggest source documentation, which adds credibility. (3) The characterization of the evolution as moving from 'simple API access to a hub for digital-asset and technology integration' is semantically equivalent to the ground truth's 'shift from a general digital integration platform to one that specifically supports next-generation financial technologies.' The answer successfully addresses all parts of the multi-part question regarding strategic positioning, functionality, and the role in enabling integration of digital assets and new technologies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 510,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The 2022 filing shows the pension‑plan tables list U.S. common‑stock holdings as “‑” (i.e., zero) for the U.S. plan, while the 2024 filing records a $1 million balance of U.S. common stocks in the U.S. plan (and $2 million in the International plan) 【page_100†L31-L38】【page_99†L31-L38】. This modest addition coincides with a higher target equity allocation for the U.S. defined‑benefit plans—up from about 21 % to roughly 26 % of assets—signaling a strategic tilt toward greater equity exposure in the company’s asset mix 【page_100†L1-L8】【page_99†L1-L8】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding U.S. common stock holdings in the U.S. pension plan. According to the ground truth, there was NO allocation to U.S. common stocks in the U.S. pension plan in either 2022 or 2024 (both years show zero). However, the LLM claims that 2024 shows '$1 million balance of U.S. common stocks in the U.S. plan,' which directly contradicts the ground truth. This is a significant quantitative error. The LLM correctly identifies that the international pension plan maintained $2 million in both years, which matches the ground truth. The LLM also introduces information about equity allocation percentages (21% to 26%) that is not mentioned in the ground truth answer, and while this may be contextually relevant from the filings, it represents an addition beyond what was verified in the knowledge graph. The core multi-hop reasoning about strategic asset allocation is partially sound, but the incorrect claim about the $1 million U.S. common stock position in the U.S. plan in 2024 undermines the entire analysis. The LLM's conclusion about 'a modest addition' and 'strategic tilt toward greater equity exposure' is based on this erroneous number. The answer demonstrates some understanding of the question structure and attempts multi-hop synthesis, but the factual inaccuracy on the primary metric (U.S. common stocks in U.S. plan) is disqualifying for a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 401,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "In the 2022 Form 10‑K Disney grouped cruise ships only as a component of its overall Parks & Experiences capital‑spending program, noting that “cruise ships” were among the major areas of investment but giving no specific expansion plan (see 2022 page 17). By the 2023 filing the company moved to a more aggressive stance, announcing a concrete plan to add more vessels to its fleet and warning that the higher launch costs and the risk of asset impairments—exemplified by the Star Wars Galactic Starcruiser write‑down—could affect profitability (see 2023 page 22).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) DIRECTIONAL ERROR: The LLM claims Disney moved to a 'more aggressive stance' with 'concrete plan to add more vessels' by 2023, but the ground truth explicitly states the opposite—that by 2023 the emphasis shifted FROM growth investment TO operational risk mitigation and risk management. This is a 180-degree reversal of the actual strategic evolution. (2) MISCHARACTERIZATION OF RISK FOCUS: The ground truth emphasizes that 2023 framed cruise ships as 'operational exposure rather than a growth engine' with focus on 'managing volatility and external threats' (e.g., Hurricane Milton). The LLM incorrectly frames this as an 'aggressive stance' focused on expansion. (3) INCOMPLETE/INCORRECT RISK ANALYSIS: While the LLM mentions asset impairments and the Star Wars Galactic Starcruiser write-down, it misinterprets these as supporting an expansion narrative rather than as evidence of operational challenges and risk mitigation concerns. (4) MISSING KEY CONTEXT: The LLM fails to capture the critical shift from 'growth-oriented approach focused on expanding physical assets' (2022) to 'risk mitigation' (2023). The mention of Hurricane Milton and external disruptions in the ground truth is entirely absent from the LLM response. (5) PAGE REFERENCES: The LLM cites specific page numbers (2022 page 17, 2023 page 22) but these cannot be verified and the content described does not align with the ground truth narrative. The core strategic evolution described in the ground truth—from investment focus to risk management focus—is inverted in the LLM answer, making this a fundamentally incorrect response despite some tangential mentions of relevant topics like asset impairments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 483,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard still uses short‑duration foreign‑exchange derivative contracts as non‑designated economic hedges to offset the few‑day FX exposure that exists between a payment transaction and its settlement, with the resulting gains or losses recorded in general‑and‑administrative expense【page_111】. The 2024 filing repeats the same description of this practice【page_106】, but the financial impact has grown – the G&A expense associated with these contracts rose from $21 million in 2022 to $32 million in 2024, indicating a larger notional amount of short‑duration FX contracts being employed【page_107】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate qualitative information about Mastercard's use of short-duration FX derivative contracts and correctly identifies the core mechanism (non-designated economic hedges for settlement exposure). However, there are significant issues with quantitative accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the purpose: offsetting FX exposure between transaction and settlement\n2. Accurately describes the accounting treatment (G&A expense recording)\n3. Correctly notes the practice continued from 2022 to 2024\n4. Provides specific page references\n5. Captures the operational mechanism accurately\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR: The LLM states G&A expense rose from $21 million (2022) to $32 million (2024). These specific numbers cannot be verified against the ground truth, which does not provide these exact figures. The ground truth does not cite specific dollar amounts for the G&A impact of these contracts.\n2. INCOMPLETE SYNTHESIS: The ground truth emphasizes a critical multi-hop element - the evolving hedging strategy involving euro-denominated debt with de-designation and re-designation in 2023-2024. The LLM answer completely omits this important context about the broader, more dynamic approach to FX risk management.\n3. MISSING CONTEXT: The ground truth highlights the contrast between continuity in short-duration contracts versus evolution in broader FX strategy. The LLM focuses only on the short-duration contracts without addressing this important distinction.\n4. PARTIAL MULTI-HOP FAILURE: While the question asks about evolution \"particularly in terms of their role in managing foreign exchange risk during daily settlement activities,\" the LLM doesn't adequately address how the role evolved - it mainly states it remained the same with increased financial impact.\n\nThe answer is partially correct on the core operational facts but fails on the quantitative specifics (unverified dollar amounts) and misses the key multi-hop synthesis about the broader strategic evolution in FX hedging that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 564,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "In its 2023 filing Salesforce said it “manages a portfolio of strategic investments … focused primarily on enterprise‑cloud companies, technology startups and system integrators” that are intended to “expand our solution ecosystem” (CRM 10‑K 2023 p. 23). By the 2024 filing the company still plans to make such investments, but it now stresses turning those relationships into an integrated partner‑driven cloud platform—leveraging the open Salesforce Platform, the AppExchange marketplace and close work with ISVs and SIs to embed third‑party applications, data and services across its offerings (CRM 10‑K 2024 p. 8; p. 6). Thus the relationship has shifted from a primarily investment‑focused stance in 2023 to a broader ecosystem‑integration strategy in 2024, using those investments to deepen the partner‑centric cloud marketplace.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the 2023 portfolio focus on enterprise cloud companies, technology startups, and system integrators with ecosystem expansion goals; (2) Accurately captures the 2024 shift toward ecosystem integration and partner-driven strategy; (3) Properly cites specific mechanisms (AppExchange, ISVs, SIs) for deepened integration; (4) Correctly synthesizes the multi-hop evolution from investment-focused to ecosystem-integration approach; (5) Appropriately references filing pages (CRM 10-K 2023 p. 23; CRM 10-K 2024 p. 8, p. 6) showing source verification; (6) Uses precise language matching ground truth concepts like 'partner-centric cloud marketplace' and 'open Salesforce Platform.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific in its citation of mechanisms (AppExchange marketplace, embedding third-party applications/data/services) compared to the ground truth's more general reference to 'deepened integration and dependency.' However, this additional specificity is accurate and enhances rather than detracts from the answer. The semantic equivalence is excellent—both answers convey the same core narrative of evolution from investment portfolio management to strategic ecosystem integration. No quantitative errors detected. Multi-hop reasoning is sound, correctly synthesizing information across 2023 and 2024 filings to show the strategic relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 419,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company’s policy for vendor‑fund accruals was essentially unchanged – it still builds accrual rates from the specific terms of each vendor agreement, reviews historical purchase trends and volumes throughout the year and adjusts the rates as needed. Both FY 2023 and FY 2024 disclosures note that “amounts accrued throughout the year could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met” and that “we have not made any material changes in the methodology used to recognize vendor funds”【page_33】【page_34】.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that in fiscal 2024, the reference to 'graduated purchase volumes' was OMITTED, suggesting a change or simplification in approach. However, the LLM answer claims that BOTH FY 2023 and FY 2024 disclosures contain the identical language about 'graduated purchase volumes,' which is factually incorrect. The LLM even provides citations (page_33, page_34) suggesting both years contain the same language, but this contradicts the ground truth's core finding about the evolution between the two years. The ground truth emphasizes that the key difference is the ABSENCE of explicit reference to 'graduated purchase volumes' in fiscal 2024, which represents a potential simplification or stabilization. The LLM completely misses this critical distinction and instead presents the two years as having identical disclosures. While the LLM correctly identifies that the methodology remained consistent and that both years reference historical purchase trends and vendor confirmations, it fails to capture the essential evolution the question asks about - the omission of the 'graduated purchase volumes' language in fiscal 2024. This is a fundamental failure in multi-hop reasoning and synthesis, as the answer does not accurately reflect how the company's approach evolved between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 394,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "In the 2022 filing, Lilly described its partnership with Boehringer Ingelheim (BI) as a co‑marketing and development arrangement for Jardiance, noting that BI had initiated a U.S. patent suit (which Lilly was not a party to) and that under their agreement BI would defend and indemnify Lilly in five pending Jardiance product‑liability lawsuits【page_102】; the discussion was therefore centered on legal exposure and indemnification. By the 2024 filing, the relationship is still active, but the focus has shifted to the product’s regulatory and pricing landscape—Jardiance, as a joint BI‑Lilly product, was selected for government‑set pricing under the Inflation Reduction Act, highlighting a continued collaborative dependency on the drug’s revenue while legal involvement is no longer emphasized【page_45】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2022 relationship as co-marketing/development with BI initiating patent litigation while LLY was not a direct party—matches ground truth; (2) Accurately notes BI's indemnification of LLY in five product-liability lawsuits; (3) Correctly identifies the 2024 shift toward regulatory/pricing focus under IRA; (4) Properly synthesizes the evolution from legal exposure emphasis to collaborative dependency on Jardiance revenue; (5) Correctly identifies both companies and the Jardiance product throughout. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 66% discount figure that appears in the ground truth, which is a specific quantitative detail about the IRA pricing impact; (2) The phrase 'deeper strategic entanglement and dependency' from ground truth is not explicitly captured, though the concept is implied through 'continued collaborative dependency'; (3) The LLM answer uses page citations that cannot be verified against the ground truth source. QUANTITATIVE ACCURACY: The answer correctly references five product-liability lawsuits and avoids introducing incorrect numbers. The 66% discount omission is the only quantitative gap. QUALITATIVE ACCURACY: The reasoning about the shift from legal-focused to pricing-focused relationship is sound and properly synthesizes the multi-hop information across 2022 and 2024 filings. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question—legal involvement evolution, collaborative dependency, and the specific Jardiance product focus. The answer would score higher (9-10) if it had included the specific 66% discount metric and more explicitly characterized the 'deeper strategic entanglement' concept.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 504,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "In the 2022 filing Disney treated cruise‑ship spending as one of several uncertain, project‑specific capital outlays – for example, it highlighted the new Lighthouse Point destination and warned that “we must often invest substantial amounts … cruise ships … before we know the extent to which these products will earn consumer acceptance” (pages 22 & 25). By the 2023 filing the company had moved to a more integrated, strategic stance, placing cruise‑ship construction squarely within its Parks & Experiences capital plan and noting that “the majority of the Company’s capital spend has been at our parks and experiences business…principally for … cruise ships” (page 12) while listing Disney Cruise Line as a core Experience (page 11). This reflects a shift from a cautious, project‑by‑project approach in 2022 to a deliberate, core‑business focus on cruise‑ship investment within Parks & Experiences in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2023, capturing the shift from cautious, project-specific treatment to strategic integration. (2) Accurately characterizes 2022 approach as highlighting risks and uncertainties (inflation, supply chain, currency fluctuations) while mentioning Lighthouse Point as a specific example. (3) Properly synthesizes the 2023 positioning where cruise ships are explicitly listed as part of capital investments within Parks & Experiences. (4) Correctly quotes or paraphrases key language from filings ('majority of the Company's capital spend,' 'parks and experiences business,' 'cruise ships'). (5) Demonstrates sound multi-hop reasoning by connecting the strategic shift to broader business segment positioning. (6) Appropriately contextualizes cruise ships within the Experiences segment. MINOR CONSIDERATIONS: (1) The LLM provides specific page references (pages 22, 25, 12, 11) which add credibility but cannot be independently verified in this evaluation context - however, they appear plausible and consistent with typical 10-K structure. (2) The quote about 'substantial amounts...cruise ships...before we know the extent to which these products will earn consumer acceptance' is paraphrased rather than exact, but captures the substance accurately. (3) The characterization of the shift as moving from 'cautious, project-by-project approach' to 'deliberate, core-business focus' is interpretively sound and aligns with the ground truth's description of 'strategic elevation in focus.' QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension focuses on date accuracy (2022 vs 2023 correctly distinguished) and proper identification of the capital investment category. All temporal and categorical references are accurate. QUALITATIVE ACCURACY: The reasoning chain is logical and well-supported: 2022 treatment → uncertainty/risk focus → 2023 treatment → strategic integration. The synthesis correctly identifies this as a multi-hop analysis across two fiscal years and two different strategic framings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 594,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "In the 2022 filing, Mastercard Foundry (formerly Mastercard Labs) was portrayed mainly as a thought‑leadership hub that “identifies and experiments with future technologies, start‑ups and trends” and gives customers and partners access to new‑technology insights and early‑stage fintech players【page_14】. By the 2024 filing, Foundry’s role had become more hands‑on – it still provides that thought‑leadership and fintech access, but now runs concrete programs such as the five‑day “Launchpad” app‑prototyping workshop and in‑lab usability‑testing and concept‑design services【page_16】, showing a deeper, program‑driven engagement with emerging technologies and fintech partners【page_14】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Mastercard Foundry's former name (Mastercard Labs), accurately captures the 2022 role as a thought-leadership hub focused on identifying/experimenting with future technologies and providing access to fintech players, and correctly notes the evolution toward more hands-on engagement by 2024. The specific program examples (Launchpad workshop, usability testing, concept design) are concrete and demonstrate deeper engagement. The answer appropriately addresses the multi-hop comparison across 2022-2024. WEAKNESSES: The LLM answer omits a critical element from the ground truth - the specific mention of blockchain-based business models and the Mastercard Multi-Token Network™ as a key strategic shift in 2024. This is a significant omission because the ground truth explicitly identifies this as indicating 'a strategic shift toward deeper integration with next-generation financial technologies.' The LLM characterizes the evolution primarily as becoming 'more hands-on' with concrete programs, but misses the strategic technological pivot toward blockchain and programmable payments that the ground truth emphasizes. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and correctly identifies the evolution pattern. However, the synthesis is incomplete because it doesn't capture the full scope of technological evolution (blockchain/Multi-Token Network). ENTITY ACCURACY: All entities are correctly identified (Mastercard Foundry, Mastercard Labs, years 2022-2024). SEMANTIC EQUIVALENCE: While the wording differs from ground truth, the core narrative of evolution from thought-leadership to more active engagement is captured, but the specific technological direction (blockchain/programmable payments) is missing, which affects semantic completeness on a substantive level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 507,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "In the 2022 filing the Boehringer Ingelheim partnership was presented as a development‑focused alliance – empagliflozin (Jardiance) was being pursued for new heart‑failure and chronic‑kidney‑disease uses and had earned FDA Breakthrough‑Therapy, Fast‑Track and priority‑review designations (2022 10‑K p. 39). By the 2024 filing the emphasis had shifted to pricing risk: Jardiance was named one of the first ten drugs subject to the Inflation‑Reduction‑Act government‑set price, with HHS announcing a 66 % discount for 2026, creating significant revenue‑erosion pressure on the collaboration (2024 10‑K p. 45). This marks a transition from a regulatory‑milestone‑driven strategy to one dominated by pricing‑and‑reimbursement challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the Boehringer Ingelheim collaboration evolution. STRENGTHS: (1) All key numeric values are correct - the 66% discount for 2026 is accurately stated and matches ground truth; (2) Regulatory designations are correctly identified (Breakthrough Therapy, Fast Track, and the LLM adds Priority Review which is consistent with FDA processes); (3) The drug name (empagliflozin/Jardiance) and therapeutic areas (heart failure, chronic kidney disease) are accurate; (4) The multi-hop synthesis is sound - correctly traces the evolution from 2022 regulatory focus to 2024 pricing pressures; (5) The characterization of the shift from 'regulatory-milestone-driven' to 'pricing-and-reimbursement challenges' accurately captures the strategic evolution described in ground truth; (6) The Inflation Reduction Act context is properly identified and explained; (7) Citation references to specific 10-K pages (p. 39 for 2022, p. 45 for 2024) add credibility and specificity. MINOR CONSIDERATIONS: (1) The LLM includes 'priority-review' designation which, while not explicitly mentioned in the ground truth summary, is a reasonable and accurate addition that reflects typical FDA designation patterns for breakthrough therapies; (2) The phrase 'revenue-erosion pressure' is a reasonable interpretation of the pricing constraint impact, though ground truth uses 'financial constraints'; (3) The answer is slightly more detailed than ground truth (mentions specific therapeutic uses) but this adds value without introducing errors. VERIFICATION: The 66% discount figure is correctly stated, the 2026 effective date is accurate, the characterization of Jardiance as 'one of the first ten drugs' under IRA pricing is consistent with ground truth's 'selected for government-set pricing.' The temporal comparison (2022 vs 2024) is properly structured and the causal logic is sound. No calculation errors detected. The answer fully addresses all components of the multi-part question regarding financial evolution, strategic nature, regulatory designations, and pricing pressures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 572,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "In the 2023 Form 10‑K the CH‑53K King Stallion was highlighted as a growth‑stage asset in the Rotary and Mission Systems (RMS) portfolio – it appears in the list of “radar surveillance systems and CH‑53K King Stallion heavy lift helicopter” and the filing notes a December 2021 Israeli Letter of Offer that awarded 12 helicopters (first four in 2022, the remainder in 2023) (page 29; page 31). By the 2024 filing the helicopter is positioned as a core, mature RMS major program – it is described among “Sikorsky helicopter programs … the CH‑53K King Stallion … in service with U.S. and foreign governments” and is again listed as a growth driver, reflecting a shift from an emerging growth focus to an established, in‑service platform with continued strategic importance (page 3; page 4).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific details about a December 2021 Israeli Letter of Offer for 12 helicopters with delivery schedule (first four in 2022, remainder in 2023) that are NOT mentioned in the ground truth answer. These appear to be fabricated or hallucinated details not supported by the knowledge graph. The ground truth explicitly states 'no specific revenue figures are provided,' yet the LLM introduces specific contract details. (2) CONTRADICTORY CHARACTERIZATION: The LLM describes the 2024 positioning as 'core, mature RMS major program' and 'established, in-service platform,' which contradicts the ground truth's more measured characterization that it 'remained a highlighted program' with emphasis shifting to broader technological context. The ground truth does NOT characterize it as 'mature' or emphasize it being 'in-service with U.S. and foreign governments' as a key positioning shift. (3) INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution from 2023 to 2024, it misses the ground truth's key insight about the shift from being 'a growth driver among several others' to being 'part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.' The LLM focuses on maturity/in-service status rather than the technological integration and AI/ML/autonomy emphasis highlighted in ground truth. (4) PAGE REFERENCES: The LLM cites specific page numbers (29, 31, 3, 4) which cannot be verified against the ground truth and may be inaccurate. (5) SEMANTIC ISSUES: The characterization of the shift differs fundamentally - ground truth emphasizes technological/portfolio integration evolution, while LLM emphasizes maturity/operational status evolution. These are different narratives. The answer contains plausible-sounding but unverified details that appear to be hallucinations rather than faithful synthesis of the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 532,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "In the 2022 filing Lilly’s partnership with Boehringer Ingelheim covered a broad diabetes suite – Basaglar (insulin), Trajenta (linagliptin), Jentadueto (metformin‑sitagliptin) together with Jardiance, Glyxambi, Synjardy and Trijardy XR 【page_5】【page_7】. By the 2024 filing the collaboration is limited to just Jardiance, Glyxambi, Synjardy and Trijardy XR, dropping the insulin and DPP‑4 products 【page_8】. This narrowing signals that the two companies are shifting away from older insulin/DPP‑4 lines and concentrating on newer SGLT2‑inhibitor and fixed‑dose combination therapies that carry stronger cardiovascular‑outcome and growth potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All product names are correctly identified and accurately categorized - the 2022 portfolio (Basaglar, Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR) and 2024 portfolio (Jardiance, Glyxambi, Synjardy, Trijardy XR) match the ground truth exactly. (2) The quantitative comparison is precise - correctly identifies 7 products in 2022 narrowing to 4 in 2024, with accurate identification of which products were removed (Trajenta, Jentadueto, Basaglar). (3) The multi-hop reasoning is sound, synthesizing information across two filing years and correctly identifying the strategic shift. (4) The LLM provides enhanced analytical insight by categorizing products by mechanism (insulin/DPP-4 vs SGLT2-inhibitor combinations) and explaining the strategic rationale with specific therapeutic advantages (cardiovascular outcomes, growth potential). MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer goes slightly beyond the ground truth by providing more specific mechanistic categorization and therapeutic rationale (mentioning cardiovascular-outcome data and SGLT2-inhibitor advantages), though this represents value-added analysis rather than factual error. The ground truth mentions 'lifecycle management' and 'patent protection' as potential drivers, while the LLM emphasizes therapeutic differentiation and cardiovascular outcomes - both are reasonable interpretations of the strategic shift. The LLM's characterization of removed products as 'older insulin/DPP-4 lines' is accurate and adds helpful context. All dates (2022, 2024) are correct, all company names (Lilly/LLY, Boehringer Ingelheim) are correct, and the partnership relationship is accurately described. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 499,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "In 2023 the Joint Air‑to‑Surface Standoff Missile (JASSM) entered a production ramp‑up that added $145 million of net sales to the Missiles‑and‑Fire‑Control (MFC) segment and helped lift year‑end backlog to $32.2 billion, as higher orders on JASSM (along with LRASM and GMLRS) were cited as a key driver of the backlog increase 【page_40】. By 2024 the ramp‑up continued and grew in scale, contributing roughly $1.2 billion of incremental MFC sales and pushing the segment’s backlog to $38.8 billion, with the 2024 backlog rise explicitly attributed to “higher orders on PAC‑3, JASSM and GMLRS” 【page_40】. Thus, JASSM’s production activity and backlog contribution expanded markedly from 2023 to 2024, underscoring its rising strategic importance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) YEAR ATTRIBUTION ERROR: The LLM states that in 2023 JASSM 'entered a production ramp-up that added $145 million of net sales' and contributed to a $32.2 billion backlog. However, the ground truth explicitly states that in 2023 there was 'no specific mention of significant changes in its production volume or backlog contribution.' The LLM has fabricated specific 2023 numbers ($145M sales, $32.2B backlog) that do not appear in the ground truth. (2) BACKLOG FIGURE DISCREPANCY: The LLM claims the 2024 backlog was $38.8 billion, but the ground truth does not provide this specific figure - it only mentions a '$1.2 billion increase in tactical and strike missile programs.' (3) INCOMPLETE 2023 CHARACTERIZATION: The ground truth indicates JASSM was simply 'a product under the MFC segment' in 2023 with no significant production changes noted, whereas the LLM describes an active production ramp-up already underway in 2023. (4) CORRECT ELEMENTS: The LLM correctly identifies the $1.2 billion increase in 2024, correctly names the MFC segment, correctly identifies PAC-3 and GMLRS as co-contributors to backlog increases, and correctly characterizes the overall trend of rising strategic importance. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing unsupported numbers for 2023 that contradict the ground truth's assertion that 2023 showed no significant changes. The comparison between years is logically structured but built on false premises for the 2023 baseline. The answer demonstrates partial understanding of the overall narrative but fails on factual accuracy regarding the 2023 baseline and specific backlog figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 492,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM’s 2023 and 2024 10‑K filings show the same credit‑risk framework for its business‑banking (scored auto and business‑banking) loans: delinquency rates remain the primary early‑warning signal, while geographic distribution is used as a secondary gauge of portfolio health. Because the firm has not introduced a new metric, early signs of borrower distress continue to be identified through 30‑plus‑day delinquencies and by monitoring regional concentration risks rather than a shift to a different risk indicator.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim. (1) MAJOR FACTUAL ERROR: The LLM claims there was NO shift in JPM's credit risk evaluation framework between 2023 and 2024, stating 'the firm has not introduced a new metric.' However, the ground truth explicitly states there WAS an evolution: in 2023 the focus was on 'loan performance and scoring models,' while by 2024 it shifted to 'delinquency rates as the primary credit quality indicator.' This is a direct contradiction of the question's premise and the established answer. (2) INCOMPLETE SYNTHESIS: The LLM failed to synthesize the multi-hop information correctly. The ground truth identifies a specific shift from scoring models (2023) to delinquency-focused metrics (2024), but the LLM collapses both years into a single framework, missing the temporal evolution entirely. (3) ENTITY/METRIC CONFUSION: While the LLM correctly identifies delinquency rates and 30+ day past due as relevant metrics, it misses the critical distinction that in 2023 these were not the primary focus—scoring models were. The LLM also introduces 'geographic distribution' as a secondary metric, which is not mentioned in the ground truth as part of this evolution. (4) REASONING FAILURE: The LLM's logic that 'because the firm has not introduced a new metric' there is no shift is backwards—the ground truth shows a shift IN WHICH METRIC IS PRIMARY, not necessarily the introduction of entirely new metrics. The LLM fundamentally misunderstood the nature of the evolution being described. (5) MISSING IMPLICATIONS: The ground truth emphasizes the strategic implications of this shift toward 'earlier intervention and more granular performance monitoring,' which the LLM completely omits. The question specifically asks about implications for identifying early signs of borrower distress, and the LLM provides no analysis of how the shift changes risk mitigation approaches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 527,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K exhibit lists reference the same “Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016)” (see page 68 of each filing). The unchanged reference shows that the SPP II terms were not revised between the two years, suggesting that Target’s executive‑compensation framework is anchored in a stable, long‑term incentive structure rather than frequent plan modifications.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth clearly states that the SPP II plan evolved from the 2016 Plan Statement (effective April 3, 2016) in the 2022 filing to the 2022 Plan Statement (effective May 1, 2022) in the 2023 filing. This represents a significant change in the plan structure. However, the LLM answer claims both filings reference the same 2016 Plan Statement and that there were no revisions between the two years. This is a direct factual error. The LLM incorrectly asserts that both 2022 and 2023 filings show the same plan reference (2016 Plan Statement), when the ground truth indicates the 2023 filing updated to the 2022 Plan Statement. The LLM's conclusion that the framework remained 'stable' and 'unchanged' is therefore incorrect. The LLM failed to identify the key evolution in the plan terms that occurred between these two filing years. Additionally, the LLM's citation to 'page 68 of each filing' cannot be verified against the ground truth provided, and appears to be a fabricated detail. The reasoning is flawed because it draws the opposite conclusion from what the actual data shows - the plan was revised, not maintained unchanged. This represents a complete failure to synthesize the multi-hop information correctly across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 371,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "In the 2022 filing (see page 72), Eli Lilly noted that, as of Dec 31 2021, Incyte could still earn up to **$100 million in success‑based regulatory milestones and another $100 million in sales‑based milestones** under the Olumiant deal – a total of roughly $200 million of potential future payments. By the 2024 filing (see page 73), the Olumiant description no longer references any remaining milestone obligations, indicating that those potential payments have been satisfied, restructured or are no longer expected.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about the evolution of Incyte's financial obligations under the Olumiant collaboration from 2022 to 2024. STRENGTHS: (1) Quantitative accuracy is excellent - correctly identifies the $100 million regulatory milestones and $100 million sales-based milestones as of 2022, with accurate total of $200 million. (2) Multi-hop reasoning is sound - properly synthesizes information across two different filing years (2022 and 2024) and correctly identifies the shift from milestone-based to royalty-based compensation structure. (3) Entity identification is correct - properly names Incyte, Eli Lilly, and Olumiant. (4) The answer captures the key insight that by 2024, milestone obligations are no longer referenced, indicating they were satisfied or restructured. (5) Semantic equivalence is maintained - 'success-based regulatory milestones' in LLM answer aligns with 'development-related regulatory milestones' in ground truth; both convey the same meaning. (6) Page references (72 and 73) add credibility and specificity. MINOR CONSIDERATIONS: The LLM answer uses 'success-based' while ground truth uses 'development-related' for regulatory milestones - these are semantically equivalent descriptions of the same obligation. The LLM answer is slightly more concise than ground truth but captures all essential information. The conclusion about milestones being 'satisfied, restructured or no longer expected' is appropriately cautious and aligns with the ground truth's statement that they were 'either paid out or no longer applicable.' No calculation errors detected. All dates and figures are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 463,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco’s APJC business still represents roughly an $8 billion revenue stream – $8,027 million in FY 2022 (the most recent segment figure disclosed)【page_105】.  The intangible‑asset exposure tied to that region grew only marginally, with goodwill allocated to APJC increasing from $5,360 million at July 30 2022 to $5,382 million at July 29 2023 – a $22 million rise【page_76】.  Together, these data show that Cisco’s financial exposure in APJC remained essentially flat between FY 2022 and FY 2023, with only a slight uptick in goodwill.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) REVENUE CLAIM NOT SUPPORTED: The LLM claims APJC revenue of $8,027 million in FY2022, but the ground truth explicitly states 'specific financial figures for APJC were not disclosed in the provided data' for fiscal 2022. This is a major factual error - the LLM introduced a number that contradicts the ground truth's statement that segment-level data was unavailable. (2) GOODWILL FIGURES - PARTIALLY CORRECT: The LLM correctly identifies goodwill increasing from $5,360 million (July 30, 2022) to $5,382 million (July 29, 2023), a $22 million increase. These numbers appear accurate and match the ground truth's mention of $5,382 million as of July 29, 2023. (3) ASSET BALANCE DISCREPANCY: The ground truth states assets in APJC were $5,382 million as of July 29, 2023. The LLM conflates this with goodwill figures, which are a component of assets but not the same metric. The ground truth discusses total assets while the LLM focuses only on goodwill. (4) MULTI-HOP REASONING FAILURE: The LLM failed to recognize that fiscal 2022 APJC segment data was not disclosed, instead fabricating a revenue figure. This represents a fundamental failure in multi-hop synthesis - the model should have acknowledged the data limitation rather than inventing numbers. (5) CONCLUSION VALIDITY: The LLM's conclusion that 'financial exposure remained essentially flat' is partially supported by the goodwill data ($22M increase is minimal), but this conclusion is built on a false premise (the revenue claim). The ground truth takes a more cautious approach, noting improved disclosure in 2023 rather than claiming flat exposure. The answer demonstrates selective accuracy (goodwill numbers) undermined by critical errors (fabricated revenue data and mischaracterization of data availability).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 510,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "In the 2022 Form 10‑K Lilly reported that Jardiance – a product it co‑markets with Boehringer Ingelheim – generated about $1.5 billion of revenue and was described in Note 4 as a joint collaboration, with the newly enacted Inflation Reduction Act (IRA) only raising the prospect of future price‑setting (see 2022 p. 44‑45). By the 2024 filing the IRA’s pricing provisions had taken effect: the Department of Health and Human Services named Jardiance, the Lilly‑Boehringer partnership product, as one of the first ten drugs subject to Medicare‑set pricing and announced a 66 % discount for 2026, meaning the collaboration now must operate under government‑set price constraints that will erode revenue (see 2024 p. 45).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy. CORRECT ELEMENTS: (1) Correctly identifies the LLY-Boehringer Ingelheim collaboration on Jardiance; (2) Correctly notes the IRA's impact on pricing; (3) Correctly identifies August 2023 as when Jardiance was selected for government pricing; (4) Correctly states the 66% discount figure; (5) Properly synthesizes the evolution from 2022 (pre-pricing) to 2024 (post-pricing implementation); (6) Appropriately contextualizes the strategic shift. CRITICAL ERRORS: (1) The LLM states the 66% discount applies for '2026' when the ground truth indicates it was applied in 'August 2024' - this is a significant temporal error that misrepresents when the pricing impact occurred; (2) The LLM mentions '$1.5 billion of revenue' for 2022 but the ground truth emphasizes growth rates (30% U.S., 28% outside U.S.) rather than absolute revenue figures - while not contradicted, this introduces a specific number not in the ground truth; (3) The LLM omits the specific 2022 growth metrics (30% U.S., 28% outside U.S.) that were highlighted in the ground truth as key drivers of the 2022 performance. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings and correctly traces the regulatory evolution. However, the temporal error regarding when the discount was applied (2026 vs. August 2024) undermines the accuracy of the evolution narrative. SEMANTIC ISSUES: The phrase 'announced a 66% discount for 2026' is ambiguous and potentially misleading - the ground truth indicates the discount was applied in August 2024, not announced for future implementation in 2026. This represents a material factual error in understanding the timeline of regulatory impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 485,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "In the 2022 10‑K GM warned that product‑safety recalls—especially on a global platform—could generate sizable repair costs and erode brand equity, noting that safety concerns around advanced technologies such as EVs and AVs could hurt its ability to lead the industry. By the 2023 filing the company sharpened that warning, naming the Chevrolet Bolt EV recall as a concrete global‑platform example and stressing that such recalls threaten its reputation and its ambition to “lead the disruption” in the market through EV and autonomous‑vehicle technologies. This shift shows a move from a broad risk description to a more pointed focus on a specific EV platform and the strategic importance of its EV/AV leadership.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TEMPORAL SEQUENCING AND FACT REVERSAL: The LLM answer fundamentally reverses the chronological evolution described in the ground truth. According to the ground truth, in 2022 GM specifically highlighted the Chevrolet Bolt EV recall as a concrete example of financial burden, while by 2023 the focus shifted to reputational damage and strategic positioning. However, the LLM answer states the opposite: it claims the 2022 filing gave a 'broad risk description' and the 2023 filing 'named the Chevrolet Bolt EV recall as a concrete global-platform example.' This is a major factual error that inverts the core narrative of the question. The LLM correctly identifies that there was an evolution from cost-centric to reputation/strategy-centric concerns, but attributes these to the wrong years. Additionally, the LLM introduces language like 'lead the disruption' that may not be directly supported by the ground truth's more measured description of 'leadership aspirations in EV and AV technologies.' The answer does address the multi-hop elements (GM, Bolt EV, EV/AV positioning, 2022-2023 comparison) but with inverted temporal accuracy. The reasoning structure is sound, but the factual foundation is compromised by the year-to-year reversal, which is a critical error in a question specifically asking about evolution 'between 2022 and 2023.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 379,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "In the 2022 filing the Company’s “Other long‑term debt” – which is comprised of Guaranteed Senior Notes issued by Costco’s Japanese subsidiary – was $590 million【page_52】. By the 2024 filing the subsidiary had issued four new Guaranteed Senior Notes worth roughly $500 million in November 2023, repaid $77 million in July 2024, and the “Other long‑term debt” balance had risen to $919 million【page_52】. This increase indicates that Costco is increasingly using its Japanese subsidiary to raise low‑cost, long‑dated debt in Japan, diversifying its financing sources and extending the maturity profile of its long‑term capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate quantitative information and correctly identifies the key financial evolution of Costco's Japanese subsidiary debt. Strengths: (1) Correctly cites the 2022 'Other long-term debt' balance of $590 million and 2024 balance of $919 million; (2) Accurately reports the November 2023 issuance of four new Guaranteed Senior Notes totaling approximately $500 million; (3) Correctly identifies the July 2024 repayment of $77 million; (4) Properly synthesizes multi-hop information across years and documents. Weaknesses: (1) The LLM answer omits the specific interest rate ranges (1.400% to 2.120%) and maturity dates (2033 to 2043) that were disclosed in the 2024 filing - these details are important for understanding the financing strategy; (2) The characterization of the debt as 'low-cost' is reasonable but not explicitly supported by the ground truth answer, which focuses on 'fixed-rate debt'; (3) The answer could have been more explicit about the shift from general/vague disclosure in 2022 to detailed disclosure in 2024, which the ground truth emphasizes as indicating 'more transparent' reporting. The reasoning about diversifying financing sources and extending maturity profile is sound and aligns with the ground truth's conclusion about 'strategic approach to long-term financing.' Overall, the core facts and multi-hop synthesis are correct, but the omission of specific interest rates and maturity dates represents a meaningful gap in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 411,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments rose from $11.9 billion at July 30, 2022 to $15.6 billion at July 29, 2023 – an increase of roughly $3.6 billion【page_50†L9-L13】【page_47†L9-L13】. The growth signals that Cisco is deliberately expanding its high‑quality, investment‑grade debt portfolio to generate additional interest income and preserve liquidity for its capital‑allocation strategy, including dividends, share repurchases and strategic acquisitions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states available-for-sale debt investments ROSE from $11.9B (2022) to $15.6B (2023), an increase of $3.6B. However, the ground truth explicitly states the value DROPPED from $15,592 million ($15.6B) to $9,865 million ($9.9B) - a DECREASE of $5,727 million. The LLM has the direction of change completely reversed and the numbers wrong. The LLM's starting value of $11.9B for 2022 does not match the ground truth data. (2) DIRECTIONAL CONTRADICTION: The ground truth indicates a 'significant reduction' and 'strategic reduction in holdings,' while the LLM claims 'deliberately expanding' the portfolio. These are opposite conclusions. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison. It appears to have confused or misread the data, possibly conflating different metrics or time periods. (4) STRATEGIC INTERPRETATION ERROR: The LLM's interpretation that the company is 'expanding' its debt portfolio to 'generate additional interest income' contradicts the actual data showing a significant reduction, which would more logically indicate de-risking or reallocation of capital. (5) The only partially correct element is that the answer addresses Cisco and available-for-sale debt investments, but the numerical facts and resulting strategic conclusions are inverted from reality. This is a severe factual error that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 416,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "In the 2023 filing JPMorgan Chase warned that its operations could be seriously disrupted by cyber‑attacks—including attacks on third‑party vendors—and that “the inability, or extended delays in the ability, to fully recover and restore data that has been stolen, manipulated or destroyed” was a material risk (2023 pp. 23‑27). The 2024 filing repeats those exposures but adds a heightened focus on “enhancing early detection of attacks against third‑party vendors” and “upgrading coverage and capabilities … to recover from outages that could be caused by a malware or ransomware attack,” while again acknowledging that prolonged data‑recovery delays remain a significant concern (2024 pp. 25‑29).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of JPMorgan Chase's evolving cyber risk exposure but has significant issues with accuracy and completeness. STRENGTHS: (1) Correctly identifies the core risks mentioned in both 2023 and 2024 filings (third-party vendor attacks, data recovery challenges, ransomware); (2) Appropriately notes the evolution from 2023 to 2024; (3) Correctly references data theft/manipulation/destruction as persistent concerns; (4) Contextually relevant to the question. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUES: The page number citations (2023 pp. 23-27, 2024 pp. 25-29) cannot be verified against the ground truth and appear potentially inaccurate without source confirmation. These specific citations are presented as facts but lack verification; (2) INCOMPLETE SYNTHESIS: The ground truth mentions specific 2023 risks (unauthorized access, zero-day vulnerabilities, DDoS attacks, undetected vulnerabilities) that the LLM answer omits entirely; (3) MISSING KEY EVOLUTION DETAIL: The ground truth explicitly states that by 2024 JPMorgan Chase added concern about 'inability to prevent systems from processing fraudulent transactions'—a significant new risk that the LLM answer completely omits; (4) MISSING FINANCIAL CONTEXT: The ground truth mentions 'losses exceeding cyber insurance coverage' as a 2024 concern, which the LLM answer does not address; (5) VAGUE CHARACTERIZATION: The LLM answer uses phrases like 'heightened focus on enhancing early detection' and 'upgrading coverage' which are paraphrases rather than direct risk articulations, potentially obscuring the actual risk evolution. The answer demonstrates partial understanding but fails to capture the full scope of risk evolution, particularly the new 2024 concerns around fraudulent transaction processing and insurance coverage gaps. The page citations, while specific, cannot be verified and may be hallucinated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 519,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco’s 2022 filing notes that a key driver of growth is “increasing the penetration of our private‑label items” (2022 MD&A, p. 22). By 2024 the retailer has backed that strategy with major operational investments – it now operates 890 warehouses covering roughly 130.9 million sq ft of floor space (plus 31.9 million sq ft of distribution‑logistics facilities) and has added dedicated processing, packaging and manufacturing plants to produce its private‑label products (2024 Properties, p. 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core operational investments Costco made to support its private-label growth strategy: dedicated processing, packaging, and manufacturing facilities. The answer properly synthesizes information across the 2022 and 2024 filings, demonstrating understanding of the multi-hop nature of the question.\n\nSTRENGTHS:\n- Correctly identifies the 2022 strategic focus on increasing private-label penetration\n- Accurately describes the operational investments (processing, packaging, manufacturing facilities)\n- Properly cites source documents (2022 MD&A p. 22, 2024 Properties p. 20)\n- Demonstrates sound multi-hop reasoning connecting 2022 strategy to 2024 implementation\n- Semantic equivalence is strong - conveys the shift from external sourcing to internal production\n\nWEAKNESSES:\n- Includes warehouse and facility square footage numbers (890 warehouses, 130.9M sq ft, 31.9M sq ft) that, while potentially accurate, are not directly relevant to answering the specific question about private-label growth investments. These appear to be general operational metrics rather than investments specifically tied to the private-label strategy\n- The inclusion of these tangential numbers slightly dilutes focus from the core answer\n- Does not explicitly mention the inflationary pressure context that motivated the strategy (though this is a minor omission)\n\nQUANTITATIVE ACCURACY: The warehouse and facility numbers cannot be verified against the ground truth provided, which does not include these specific metrics. While they may be accurate from the 2024 filing, their relevance to the question is questionable, creating some uncertainty about whether these numbers are appropriately contextualized.\n\nQUALITATIVE ACCURACY: The reasoning is sound and the synthesis across documents is correct. The answer properly identifies that the 2022 strategy evolved into 2024 operational implementation.\n\nCONTEXTUAL RELEVANCE: High - the answer directly addresses the question about operational investments supporting the private-label strategy, though it includes some peripheral information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 571,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "In the 2022 filing UnitedHealth said its Medicaid‑managed‑care bids are built on assumptions about enrollment, utilization, medical‑cost trends and other factors, and that a material error in any of those assumptions—whether from unexpected program changes, policy shifts after the bid is filed or a competitor’s lower rate—could adversely affect earnings. The 2023 filing keeps the same reliance on those assumptions but adds a new, explicit risk: chronic failure to meet the benchmark premiums could lead to termination of the state contracts, underscoring a heightened focus on the consequences of bid inaccuracy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE NARRATIVE: The LLM answer fundamentally misrepresents the evolution described in the ground truth. The ground truth clearly states that in 2022, UnitedHealth emphasized RENEWAL RISK (losing members if contracts weren't renewed), while in 2023 the company shifted to emphasizing ASSUMPTIONS ACCURACY (enrollment, utilization, medical costs). The LLM answer reverses this timeline and mischaracterizes the 2022 position. Specifically: (1) The LLM claims 2022 already discussed assumptions about enrollment, utilization, and medical-cost trends—but the ground truth indicates this emphasis emerged in 2023. (2) The LLM introduces a 2023 risk about 'chronic failure to meet benchmark premiums leading to contract termination'—this is not mentioned in the ground truth and appears to be fabricated or confused with other risk disclosures. (3) The LLM fails to capture the key evolution: from contract RENEWAL risk (2022) to assumptions ACCURACY risk (2023). (4) The ground truth emphasizes that the 2023 shift reflects 'evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics'—the LLM misses this critical distinction entirely. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension scores well (8/10) only because there are no calculations to verify. QUALITATIVE ACCURACY: The reasoning is fundamentally flawed (2/10) because the LLM inverts the temporal evolution and introduces unsupported claims about benchmark premium termination risks. CONTEXTUAL RELEVANCE: The answer addresses Medicaid managed care bidding but fails to correctly identify the nature of the evolution (4/10). The multi-hop synthesis across 2022 and 2023 filings is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 482,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MET’s municipal securities were recorded entirely in the Level 2 fair‑value hierarchy in both years. At December 31 2022 the company held $159 million of municipals in pension assets and $15 million in other post‑retirement assets (total ≈ $174 million) 【page_308】, and by December 31 2023 those amounts had slipped to $147 million and $8 million respectively (total ≈ $155 million), still classified as Level 2 with no Level 1 or Level 3 exposure【page_308】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports 2022 Municipals at ~$174 million ($159M + $15M), but the ground truth states $14,212 million. This is a massive discrepancy (off by ~$14 billion or 98%). The 2023 figure of ~$155 million ($147M + $8M) is closer to the ground truth of $159 million but still represents a different breakdown. (2) VALUATION HIERARCHY CLASSIFICATION - The LLM claims Municipals were classified as Level 2 in BOTH 2022 and 2023, but the ground truth explicitly states that in 2022 they were 'primarily categorized under Estimated Fair Value without a detailed breakdown of valuation hierarchy levels' - not Level 2. The LLM incorrectly asserts Level 2 classification existed in 2022. (3) MULTI-HOP SYNTHESIS - The question asks about evolution from 2022 to 2023, particularly regarding valuation hierarchy classification. The ground truth shows a clear evolution: 2022 had no detailed hierarchy breakdown, while 2023 had explicit Level 2 classification. The LLM misses this key evolution by claiming Level 2 existed in both years. (4) CORE NARRATIVE - The ground truth emphasizes 'significant reduction' from $14,212M to $159M and 'more transparent categorization' in 2023. The LLM's narrative of stable Level 2 classification with minor decreases ($174M to $155M) is fundamentally different and incorrect. The LLM appears to have confused or conflated different data sources, resulting in wrong baseline numbers and incorrect classification history.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 436,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "In FY 2022, Office 365 subscriptions were treated as a single integrated cloud service that was invoiced at the start of each annual term and recognized ratably over the subscription period (2022 10‑K p. 64‑63). By FY 2024, Microsoft expanded the licensing framework, offering Office 365 (now part of Microsoft 365) through a suite of more flexible, digital agreements—including Enterprise Agreements, Microsoft Customer Agreements, Microsoft Online Subscription Agreements and Microsoft Products & Services Agreements—that let customers subscribe on a month‑or‑year basis, use non‑expiring contracts and optionally add Software Assurance, providing greater licensing flexibility (2024 10‑K p. 16‑17).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Microsoft's Office 365 licensing approach from FY 2022 to FY 2024, with mostly accurate information and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the FY 2022 approach involving annual invoicing and ratable recognition over subscription periods; (2) Accurately describes FY 2024 licensing models including Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement; (3) Properly captures the shift toward flexibility with month-or-year subscription options; (4) Appropriately cites specific 10-K page references; (5) Correctly notes the evolution from volume licensing to more customer-centric models. MINOR ISSUES: (1) The LLM mentions 'Enterprise Agreements' as part of FY 2024 offerings, which is not explicitly mentioned in the ground truth answer—this appears to be an addition not contradicted by ground truth but not confirmed either; (2) The mention of 'non-expiring contracts' and 'Software Assurance' options are additional details not present in the ground truth, though they don't contradict it; (3) The reference to Office 365 becoming 'part of Microsoft 365' is contextually accurate but represents a naming evolution not explicitly addressed in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple agreement types, correctly identifying the progression from simpler volume licensing to more flexible customer agreement models. The comparison between FY 2022 and FY 2024 is logically sound and addresses the core question about evolution in licensing flexibility. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental message as the ground truth—a shift toward enhanced customer-centric licensing flexibility—though with additional supporting details. The core facts about invoicing, recognition, and agreement types align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 539,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "In 2022 the Level 3 slice of MetLife’s Fixed‑Maturity Securities AFS was $58 million, made up almost entirely of corporate securities ($55 m) with a tiny “other” component ($3 m) 【page_308】. By year‑end 2023 the Level 3 balance had risen to $64 million and the mix had broadened to $54 m of corporate securities, $2 m of foreign‑bond holdings and $8 m of other securities 【page_308】. The modest increase and the addition of foreign‑bond and other illiquid assets indicate the company is gently diversifying its Level 3 exposure, seeking a bit more yield from less‑transparent securities while still keeping corporate holdings as the core.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics. Specific errors: (1) 2022 composition - LLM states $55M corporate and $3M other totaling $58M, but ground truth shows $1M corporate, $1M foreign bonds, $11M equity securities totaling $13M. This is a massive discrepancy. (2) 2023 composition - LLM states $54M corporate, $2M foreign bonds, $8M other totaling $64M, but ground truth shows $54M corporate, $2M foreign bonds, $828M other investments totaling $884M. The LLM completely misses the $828M in Other Investments, which is the most significant component and the key indicator of strategic shift. (3) The LLM's characterization of the change as 'modest increase' is incorrect - the actual change from $13M to $884M represents a massive 68x increase in Level 3 exposure, not a gentle diversification. (4) The LLM's interpretation that the company is 'gently diversifying' and 'seeking a bit more yield' fundamentally misses the dramatic strategic shift toward Other Investments that the ground truth identifies. (5) The LLM fails to capture the core insight that the composition shifted from equity-heavy (2022: $11M equity) to Other Investments-heavy (2023: $828M other), which is the critical multi-hop synthesis required. The answer demonstrates poor data accuracy and failed to synthesize the multi-hop information correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 388,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "In the 2022 Form 10‑K Microsoft presented Office 365 as a core subscription‑based cloud offering, grouped with Azure, Dynamics 365 and Xbox in its “service and other revenue” line (see Service and other revenue includes Office 365 – page 62) and treated it as a single, highly integrated performance obligation whose revenue is recognized ratably over the contract period (see Office 365 revenue recognition – page 63; Office 365 subscriptions listed in unearned revenue – page 64). By the 2024 filing the company positions Office 365 as a mature pillar of its broader cloud ecosystem that is now being infused with generative‑AI capabilities to meet rising AI‑driven competition, emphasizing company‑wide AI investment and the need to embed AI into cloud products such as Office 365 (see transformation from on‑premises to Office 365 – page 19; AI infusion across cloud offerings and competitive pressures – page 21).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies Office 365's positioning in 2022 as a core subscription-based cloud offering grouped with Azure, Dynamics 365, and Xbox in 'service and other revenue' - this matches the ground truth exactly. (2) Accurately captures the 2024 evolution showing Office 365 as a mature pillar being infused with generative AI capabilities. (3) Properly synthesizes the multi-hop reasoning: 2022 positioning → 2024 AI-infused evolution → competitive pressures from AI-driven alternatives. (4) Correctly identifies the strategic shift from traditional cloud services to AI-enhanced offerings. (5) Appropriately references revenue recognition practices and unearned revenue treatment. MINOR WEAKNESSES: (1) The LLM answer includes specific page references (pages 62, 63, 64, 19, 21) that cannot be verified against the ground truth provided, though this adds specificity rather than introducing errors. (2) The answer is slightly more detailed on accounting/revenue recognition mechanics than the ground truth, which focuses more on strategic positioning and competitive context. (3) The ground truth explicitly mentions 'free applications funded by advertising or open-source AI models' as specific competitive threats, while the LLM answer uses the more general phrase 'AI-driven competition' - this is a minor semantic difference that doesn't affect factual accuracy. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022 and 2024 filings to show evolution, correctly identifies the connection between competitive pressures and strategic response, and properly contextualizes Office 365 within the broader cloud portfolio. The reasoning is sound and logically structured. OVERALL: The answer is factually accurate, well-reasoned, and appropriately addresses all aspects of the multi-part question about strategic positioning evolution, cloud services integration, and competitive response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 592,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "In the 2022 filing UnitedHealth said it only tested available‑for‑sale debt securities for credit‑related impairment when fair value was below amortized cost, looking at the expected cash‑flows, the issuers’ credit quality and ratings, and noted that the allowance for credit losses was “not material”【page_57】. By the 2023 filing the company had broadened the assessment – it now considers the present value of expected cash‑flows relative to amortized cost, the size of the fair‑value shortfall, the issuer’s financial condition, near‑term prospects and any specific events, and records any impairment as an allowance offset to investment and other income, still without a material credit‑loss allowance disclosed【page_47】. This reflects a more detailed, forward‑looking evaluation while the financial impact remained negligible.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of UnitedHealth Group's credit impairment methodology between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 approach focusing on expected cash flows, credit quality, and ratings with immaterial allowance for credit losses; (2) Accurately describes the 2023 evolution to a more detailed framework including present value of expected cash flows, fair value decline relative to amortized cost, and issuer-specific financial conditions; (3) Properly notes the shift in recording methodology - from general assessment to formal distinction between credit-related (as allowance against investment income) and non-credit-related impairments; (4) Correctly emphasizes the negligible financial impact in both years; (5) Appropriately characterizes the progression as 'more detailed, forward-looking evaluation.' MINOR GAPS: (1) The LLM answer mentions 'near-term prospects and any specific events' in 2023 which adds detail not explicitly stated in the ground truth, though this appears to be a reasonable inference from 'issuer-specific financial conditions'; (2) The ground truth explicitly mentions the distinction between credit-related impairments (allowance against investment income) and non-credit-related impairments (through other comprehensive income), while the LLM answer focuses primarily on the credit-related treatment and doesn't explicitly mention the OCI treatment for non-credit-related impairments. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and correctly identifies the methodological evolution. The comparison is logical and well-structured. NUMERIC/FACTUAL VERIFICATION: No specific numbers are provided in either answer (both correctly note immateriality rather than citing specific amounts), so quantitative accuracy is high by default. Page references provided by LLM (page_57, page_47) appear reasonable for 10-K filings but cannot be independently verified in this context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 544,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "In 2023 the pension plan’s Fixed‑Maturity Securities AFS made up about 82 % of its assets (the 2023 target was 85 %) versus a 2022 target of 83 % (the 2022 actual allocation was not disclosed), and the other‑post‑retirement plan’s allocation slipped to 94 % from 96 % in 2022 (both years’ targets were 95 %)【page_307】.  At year‑end the fair‑value of these securities fell slightly in the pension plan from $6.802 billion in 2022 to $6.714 billion in 2023, while the other‑post‑retirement plan’s balance rose from $1.256 billion to $1.274 billion over the same period【page_308】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) 2023 pension allocation of 82% vs 2023 target of 85% - correct; (2) 2022 target of 83% - correct; (3) Other postretirement 2023 allocation of 94% vs 2022 of 96% - correct; (4) Both years' targets of 95% for other postretirement - correct; (5) Fair values: pension plan decreased from $6.802 billion (2022) to $6.714 billion (2023) - correct; (6) Other postretirement increased from $1.256 billion to $1.274 billion - correct. The LLM successfully synthesized multi-hop information showing the evolution from 2022 to 2023 across both allocation percentages and fair values. The answer goes beyond the ground truth by providing additional context about targets and explaining the 2022 actual allocation was not disclosed, which adds valuable nuance. The semantic meaning aligns perfectly with the ground truth - showing the shift from percentage-based allocation in 2022 to detailed valuation breakdown in 2023. Minor formatting differences (billion vs million notation) are acceptable and handled correctly. The reasoning is sound, connecting allocation percentages with fair value changes across the two benefit plans. All entities (MET, pension benefits, other postretirement benefits) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 363,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "In the 2022 filing, Kitchens & Bath was only referenced as one of the sub‑categories bundled inside the “Home Décor” segment, which together represented about 35 % of total net sales. By the 2023 filing, Lowe’s lists Kitchens & Bath as a standalone product line in its assortment and ties it to dedicated installation services and protection‑plan offerings, highlighting it as a distinct, high‑visibility category. This evolution shows the company has moved the category from a broad, aggregated segment to a strategically emphasized pillar of its product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core directional shift in Kitchens & Bath positioning between 2022 and 2023, correctly identifying that the category moved from being bundled within Home Décor to receiving more strategic emphasis. However, there are significant issues with quantitative accuracy and some factual discrepancies:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM states Home Décor represented \"about 35% of total net sales\" in 2022. This specific percentage is not verified in the ground truth and appears to be an unsupported claim that introduces a quantitative assertion without evidence.\n- The ground truth does not provide any percentage figures, so introducing this metric without verification is problematic.\n\n(2) FACTUAL DISCREPANCIES:\n- The ground truth explicitly states that in 2022, Kitchens & Bath was grouped with \"Appliances, Décor, Flooring, and Paint\" under Home Décor division. The LLM answer omits these specific companion categories.\n- The ground truth specifies that in 2023, Kitchens & Bath was repositioned alongside \"Lumber, Building Materials, and Rough Plumbing\" - core construction/renovation categories. The LLM answer does not mention this specific repositioning to construction-focused categories.\n- The LLM mentions \"dedicated installation services and protection-plan offerings\" which are not mentioned in the ground truth. While these could be accurate details, they represent information not in the provided ground truth.\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes the 2022-to-2023 evolution and identifies the strategic shift.\n- The LLM appropriately connects this shift to portfolio importance and strategic emphasis.\n- However, the reasoning lacks the specific categorical context that explains WHY the shift matters (moving from design-focused to construction/remodeling-focused).\n\n(4) SEMANTIC ALIGNMENT:\n- Both answers agree on the core finding: Kitchens & Bath moved from bundled/aggregated positioning to more strategic emphasis.\n- Both suggest this indicates greater importance in the portfolio.\n- The LLM's framing of \"standalone product line\" vs. ground truth's \"core construction and renovation categories\" conveys similar but slightly different emphasis.\n\n(5) MISSING ELEMENTS:\n- The LLM fails to mention the specific product categories Kitchens & Bath was grouped with in each year.\n- The LLM does not explicitly connect the shift to the \"Total Home\" strategy mentioned in ground truth.\n- The LLM introduces unsupported quantitative claims (35% figure) that reduce credibility.\n\nThe answer demonstrates reasonable understanding of the strategic shift but introduces unverified quantitative claims and omits important categorical context that explains the nature and significance of the repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 741,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "In the 2022 filing (pages 127‑131 contain no discussion of cheese & grocery, indicating it was not highlighted as a strategic focus), the segment was not emphasized. By the 2024 filing the Business overview explicitly lists cheese & grocery as an “adjacent, locally relevant” category alongside its core chocolate, biscuits and baked‑snack businesses [page_34]. This suggests that cheese & grocery remains a peripheral part of the portfolio, while Mondelez continues to prioritize its core snack categories as the primary engine for long‑term growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) MISSING KEY QUANTITATIVE DATA: The LLM answer completely omits the $1,990 million revenue figure from 2022 that is central to the ground truth answer. This is a major factual omission for a financial question. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly states that in 2022 Mondelez 'directly produced Cheese & Grocery products, generating $1,990 million in total net revenues' - this is a concrete, verifiable fact that the LLM failed to capture or reference. (3) VAGUE PAGE REFERENCES: The LLM cites 'pages 127-131' and 'page_34' but provides no actual financial data or specific quotes to support its claims about what changed between 2022 and 2024. (4) PARTIAL CORRECTNESS ON STRATEGIC POSITIONING: The LLM correctly identifies that by 2024, Cheese & Grocery is positioned as an 'adjacent, locally relevant' category and that core snacks (chocolate, biscuits) remain prioritized. This aligns with the ground truth's characterization of a 'lighter footprint.' (5) MISSING TRANSITION NARRATIVE: The ground truth clearly articulates a shift from 'direct production' to 'strategic stake' - the LLM mentions the 2024 positioning but fails to explicitly document this transition or explain what happened to the $1.99B revenue stream. (6) REASONING QUALITY: While the LLM's conclusion about prioritization of core categories is sound, it lacks the quantitative foundation that would make this analysis credible. The answer reads as interpretive rather than data-driven. STRENGTHS: Correctly identifies the 2024 characterization as 'adjacent, locally relevant' and maintains focus on core snacking priorities. WEAKNESSES: Omits critical 2022 revenue data, lacks specific financial metrics, provides incomplete documentation of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 485,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10‑K (page 4) Abbott’s enteral‑feeding list reads “Jevity … Freego™ (Enteral Pump) and Freego™ sets …,” and the 2023 10‑K (page 4) repeats the same sequence, still placing Jevity before the Freego™ products. Thus, the relative positioning of Jevity versus Freego™ was unchanged between the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth explicitly states that the positioning of Freego™ products changed between 2022 and 2023: in 2022, Freego™ products were listed LAST (after Glucerna and Osmolite® products), while in 2023, they were moved to appear IMMEDIATELY AFTER Jevity (before Glucerna and Osmolite®). This represents a significant change in product emphasis and prominence. The LLM incorrectly claims 'the relative positioning of Jevity versus Freego™ was unchanged between the two filings,' which directly contradicts the ground truth. The LLM appears to have only noted that Jevity remained first in both years, but failed to recognize the critical reordering of Freego™ products relative to other product lines (Glucerna, Osmolite®). The quantitative accuracy score is relatively high because the LLM correctly identified the page numbers (page 4) and correctly noted that Jevity appeared first in both years. However, the qualitative accuracy is very low because the LLM completely missed the substantive change in product positioning that the question specifically asks about. The answer demonstrates a failure in multi-hop reasoning—the model needed to compare the full product lineup order across both years, not just note that Jevity remained first. This is a critical analytical failure that makes the answer fundamentally incorrect despite getting some surface-level details right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 400,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "In the 2022 filing MetLife reported municipal securities of $174 million in fair value – $159 million held in its U.S. pension‑benefit plans and $15 million in other post‑retirement plans – and all of these were measured at **Level 2** in the fair‑value hierarchy (observable market inputs). By year‑end 2023 the municipal holdings had fallen to $155 million ($147 million in pension assets and $8 million in other post‑retirement assets), still classified entirely as **Level 2** (page 308). The modest decline in exposure, together with the continued use of Level 2 valuation, indicates that MetLife is deliberately trimming its municipal‑bond position while keeping it in a transparent, market‑observable category, reflecting a cautious credit‑risk management approach that favors lower‑risk, well‑priced assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states MET held $14,212 million in municipals in 2022 (declining to $159 million in 2023), but the LLM reports only $174 million in 2022 and $155 million in 2023 - off by a factor of approximately 80x for 2022. This is not a minor formatting difference but a massive quantitative error. The LLM also misidentifies the classification structure: ground truth clearly states both years were 'fixed maturity securities AFS' category, while the LLM focuses on pension plan breakdowns ($159M/$15M in 2022, $147M/$8M in 2023) that appear to be from a different disclosure section entirely. The ground truth emphasizes a 'dramatic reduction' from $14,212M to $159M (98.9% decline), suggesting aggressive credit risk reduction, while the LLM describes a 'modest decline' from $174M to $155M (10.9% decline), fundamentally mischaracterizing the strategic shift. The LLM correctly identifies Level 2 fair value hierarchy classification but this is the only accurate element. The reasoning about 'cautious credit-risk management' is contradicted by the actual magnitude of the reduction shown in ground truth. The LLM appears to have pulled data from a different section of the filing (possibly pension plan disclosures) rather than the main municipal securities holdings. This represents a complete failure of multi-hop synthesis and fact verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 404,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott’s portfolio of interest‑rate hedge contracts fell from roughly $2.9 billion at the end of 2022 to about $2.2 billion in 2023 after $700 million of contracts (and the underlying debt) matured in 2023 【page_65】.  The fair‑value liability for those hedges also declined, from $156 million in 2022 to $95 million in 2023 【page_66】, and the contracts remain designated as fair‑value hedges that offset changes in the fair value of the fixed‑rate debt, effectively converting that portion of the debt to a variable‑rate exposure 【page_64】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states Abbott's interest rate hedge contracts were $2.9 billion in 2022, declining to $2.2 billion in 2023. The ground truth clearly states the notional value was approximately $2.2 billion in BOTH 2022 and 2023, remaining consistent. This is a fundamental factual error. (2) The LLM introduces information about $700 million of contracts maturing in 2023 and provides specific fair-value liability figures ($156M in 2022, $95M in 2023) that are NOT mentioned in the ground truth answer. While these details might be from the actual filings, they directly contradict the ground truth statement that 'the notional value remained consistent at approximately $2.2 billion.' (3) The LLM's narrative of a decline from $2.9B to $2.2B is incompatible with the ground truth's assertion of consistency at $2.2B across both years. WHAT WAS CORRECT: The LLM correctly identifies that these are fair-value hedges used to convert fixed-rate debt to variable-rate exposure, which aligns with the ground truth's description of the contracts' purpose. The LLM also correctly notes the contracts' role in managing interest rate risk. MULTI-HOP REASONING: The LLM attempts to synthesize information across years and explain the evolution, but does so with incorrect baseline numbers. The reasoning about maturity and fair-value liability changes is logical in structure but contradicts the ground truth's core finding of consistency. The answer fails the primary requirement of accurately representing the 2022-2023 evolution as stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 452,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024 3M moved from holding a portfolio of fixed‑rate registered notes with coupons of roughly 1.86 %‑2.67 % (including a $1 bn 2.50 % issue due 2029) to actively retiring its maturing fixed‑rate securities – it repaid €500 m and $600 m of medium‑term notes in 2022, retired $500 m of fixed‑rate registered notes in 2023, and in 2024 repaid $1.1 bn of medium‑term notes that matured (see page 69). At the same time the company continued to issue new fixed‑rate notes at modest rates (≈2.0 %‑2.7 % for 2025‑2029 issues) while the weighted effective rate on its fixed‑rate debt rose to about 3.07 % from 2.80 % (pages 68 & 88) and it used interest‑rate swaps to convert portions of long‑dated fixed‑rate debt into floating‑rate exposure (pages 89 & 69).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial understanding of 3M's debt management evolution but contains significant quantitative inaccuracies and omissions that undermine its reliability.\n\nCORRECT ELEMENTS:\n- Correctly identifies 2023 repayment of $500 million in fixed-rate registered notes\n- Correctly identifies 2024 repayment of $1.1 billion in medium-term notes\n- Correctly notes the use of interest-rate swaps to convert fixed-rate debt to floating-rate exposure\n- Correctly identifies the strategic shift toward managing interest rate exposure\n- Appropriately references page numbers from filings\n- Correctly captures the general trend of retiring maturing securities\n\nSIGNIFICANT ERRORS AND OMISSIONS:\n\n1. MISSING KEY 2022 DATA: The ground truth specifies important 2022 holdings: $600 million of 10-year notes due 2030 (3.05% coupon) and $650 million of 30-year notes due 2050 (3.70% coupon). The LLM answer fails to mention these specific instruments and their coupon rates.\n\n2. INCORRECT COUPON RATES: The LLM states coupons of \"roughly 1.86%-2.67%\" and mentions \"$1 bn 2.50% issue due 2029,\" but the ground truth indicates the 2030 notes had a 3.05% coupon and 2050 notes had a 3.70% coupon. These are materially different rates.\n\n3. MISSING 2019 ISSUANCE CONTEXT: The ground truth references a significant $3.25 billion issuance in August 2019 ($1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049). The LLM answer does not provide this historical context.\n\n4. CURRENCY CONFUSION: The LLM mentions \"€500 m\" (euros) in 2022, but the ground truth specifies \"$500 million\" (dollars). This is a material error in currency denomination.\n\n5. INCOMPLETE REPAYMENT HISTORY: The LLM mentions 2022 repayments but lacks specificity compared to ground truth. The ground truth provides clearer context about which notes were repaid.\n\n6. WEIGHTED EFFECTIVE RATE CLAIM: The LLM states the weighted effective rate rose from 2.80% to 3.07%, but this specific comparison is not verified in the ground truth provided. While the ground truth mentions interest rate management, it doesn't provide these specific rate comparisons.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop synthesis by connecting repayment activity, new issuances, and interest rate swap strategies across the 2022-2024 period. However, the synthesis is undermined by the quantitative inaccuracies noted above.\n\nOVERALL ASSESSMENT:\nWhile the LLM captures the general narrative of 3M's debt management evolution and correctly identifies key repayment events and swap strategies, the answer contains material factual errors regarding coupon rates, currency denominations, and missing key instruments. These quantitative errors significantly reduce the reliability of the response despite its reasonable structural approach to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 757,
        "total_tokens": 2176
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "In 2023 Schwab said that “the Company’s primary sources of capital are funds generated by the operations of subsidiaries **and securities issuances by CSC in the capital markets**” and that it would also use commercial‑paper or other capital‑markets issuances to support margin‑loan growth and meet regulatory capital needs (2023 p. 59; 2023 p. 57). By 2024 the discussion pivots to client‑generated cash and deposits as the main funding source, with a deliberate reduction of supplemental funding (e.g., brokered CDs, FHLB borrowings) and active hedging of existing senior notes rather than issuing new debt, while still retaining a shelf‑registration that allows securities issuances when needed (2024 p. 52‑54). Thus, securities issuances moved from a core component of Schwab’s capital structure in 2023 to a more ancillary, liquidity‑management tool in 2024, reflecting a shift toward internal cash generation and lower‑cost funding within its capital‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning of securities issuances as a 'primary source of capital' alongside subsidiary operations, with accurate citation of specific page references (p. 59, p. 57). (2) Accurately captures the 2024 shift toward a more diversified funding approach emphasizing client-generated cash and deposits, with appropriate page citations (p. 52-54). (3) Correctly identifies the evolution from securities issuances as a 'core component' to a more 'ancillary, liquidity-management tool,' which semantically matches the ground truth's characterization of moving from 'primary source' to 'positioned among a broader set of liquidity tools.' (4) Demonstrates sound multi-hop reasoning by synthesizing information across two fiscal years and connecting it to broader capital management strategy. (5) Appropriately mentions specific funding mechanisms (brokered CDs, FHLB borrowings, commercial paper, shelf registration) that align with the ground truth's reference to 'FHLB borrowings, repurchase agreements, and CDs.' (6) Correctly emphasizes the strategic shift toward internal cash generation and lower-cost funding. MINOR CONSIDERATIONS: The LLM answer provides more granular detail than the ground truth (e.g., mention of hedging existing senior notes, shelf registration retention), but these details are contextually appropriate and do not contradict the ground truth. The answer goes slightly beyond the ground truth in specificity but remains factually accurate. No quantitative errors detected. The semantic equivalence is strong—both answers convey that securities issuances evolved from a primary/core funding source to one component within a broader, more diversified capital structure framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 498,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "In the 2022 Form 10‑K Coca‑Cola reported a $270 million contingent‑consideration liability for fairlife (and noted that a $100 million milestone was paid in 2021) that is payable only if fairlife meets its 2024‑targeted financial goals. By the 2024 filing that liability had ballooned to $3.0 billion at year‑end 2023 and $6.1 billion at year‑end 2024, with a $275 million milestone paid in 2023, showing that fairlife’s operating results have kept the milestone payment on track (and even increased its fair‑value estimate), indicating that fairlife is meeting or exceeding the financial targets that trigger the contingent payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe factual errors that fundamentally contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims the liability 'ballooned to $3.0 billion at year-end 2023 and $6.1 billion at year-end 2024,' but the ground truth indicates the 2022 liability was $270 million with no evidence of such dramatic increases. These numbers appear to be fabricated or confused with other liabilities. The ground truth makes no mention of $3.0B or $6.1B figures. (2) MILESTONE PAYMENT ERROR: The LLM states a '$275 million milestone paid in 2023,' but the ground truth only confirms a $100 million payment in 2021. The $275 million figure is not supported by the ground truth. (3) MISREPRESENTATION OF TIMELINE: The LLM incorrectly characterizes the obligation as 'payable only if fairlife meets its 2024-targeted financial goals' when the ground truth indicates targets extended 'through 2024' with payment in 2025. (4) UNSUPPORTED CONCLUSION: The LLM's interpretation that fairlife is 'meeting or exceeding' targets is based on the false premise that the liability increased dramatically. The ground truth suggests fairlife met at least the 2020 targets (triggering the $100M payment) and remained on track, but does not support claims of exceeding targets or massive liability increases. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize information across the 2022 and 2024 filings. Instead of accurately tracking the evolution of the obligation, it introduced numbers that contradict the source material. The answer demonstrates fundamental factual inaccuracy rather than a reasonable interpretation difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 453,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "In the 2022 filing Oracle noted that it was deliberately shifting resources away from non‑strategic hardware and “placing emphasis on the marketing and sale of our growing cloud‑based infrastructure technologies” – i.e., OCI – while most of the revenue lift came from the Americas (68 %) with growing shares from EMEA (22 %) and APAC (10 %)【page_47】. By the 2024 filing OCI is positioned as a core pillar of “Oracle Cloud Services,” described as delivering “comprehensive and integrated applications and infrastructure services” that are sold worldwide and tightly coupled with SaaS and on‑premise offerings to support hybrid enterprise‑IT solutions【page_72】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's strategic evolution regarding OCI between 2022 and 2024, with accurate qualitative characterization of the shift. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the strategic shift from 2022 to 2024 regarding OCI emphasis\n2. Accurately captures the 2024 positioning language: 'comprehensive and integrated applications and infrastructure services'\n3. Properly synthesizes the multi-hop concept of OCI integration with SaaS and on-premise offerings\n4. Correctly notes the global positioning and hybrid enterprise IT solution focus\n5. Appropriately references the shift toward cloud-based infrastructure technologies in 2022\n\nWEAKNESSES:\n1. QUANTITATIVE ERRORS: The LLM introduces geographic revenue percentages (Americas 68%, EMEA 22%, APAC 10%) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from incorrect data, as the original answer makes no mention of regional revenue breakdowns.\n2. MISSING KEY METRIC: The ground truth specifically cites that cloud and license businesses generated $36.052 billion representing 85% of total revenues in 2022. The LLM completely omits this concrete financial metric, which is a significant omission for a financial analysis question.\n3. PAGE REFERENCES: The LLM provides specific page citations (page_47, page_72) that cannot be verified against the ground truth, raising questions about source accuracy.\n4. INCOMPLETE 2022 CHARACTERIZATION: While the LLM mentions the strategic shift toward OCI, it doesn't capture that in 2022 there was 'no explicit strategic language about Oracle Cloud Infrastructure's positioning' as a core pillar—a nuance that highlights the evolution.\n\nMULTI-HOP REASONING:\nThe answer correctly synthesizes information across two time periods and identifies the strategic evolution, but the introduction of unverified geographic data suggests potential hallucination or confusion with other data sources.\n\nSEMANTIC EQUIVALENCE:\nThe core narrative about OCI's evolution is semantically equivalent to the ground truth, but the addition of unsupported quantitative claims undermines confidence in the overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 608,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Schwab’s Personal Asset Loans (PALs) continued to be treated as fully collateralized in both years – the securities pledged against the loans had fair values in excess of the borrowings – and, under ASC 326’s collateral‑maintenance practical expedient, no credit‑loss allowance was required for PALs in either 2023 or 2024. Thus the allowance for PALs remained zero and the risk profile stayed low and unchanged across the two years【page_88】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) Both years had PALs fully collateralized by securities with fair values exceeding borrowings - this matches ground truth. (2) ASC 326 collateral maintenance practical expedient was applied in both years - correct. (3) No allowance for credit losses was required in either year - correct. SIGNIFICANT ERRORS: (1) The LLM states 'the risk profile stayed low and unchanged across the two years' - this directly contradicts the ground truth which explicitly states 'This indicates a strengthening in the risk profile and treatment of PALs over the period.' The ground truth indicates evolution/improvement, not stasis. (2) The LLM fails to mention that in 2023 there was 'a slight decrease in PALs' and that 'the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates' - these are key contextual details about the evolution between years. (3) The LLM characterizes the situation as 'unchanged' when the ground truth emphasizes the evolution and strengthening that occurred. MULTI-HOP REASONING: The LLM correctly synthesized information about collateralization and ASC 326 treatment across both years, but failed to properly synthesize the temporal evolution aspect of the question. The question specifically asks 'how has...evolved' implying change over time, but the LLM concluded there was no meaningful change. QUANTITATIVE ACCURACY: No specific numbers were provided in either answer, so this dimension is less critical, but the characterization of the trend (unchanged vs. strengthening) is a qualitative/analytical error. The answer is partially correct on technical treatment but fundamentally misses the evolution narrative that is central to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 490,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "In FY 2023 Nike’s filing only notes that workers in the APLA geographies are among the few union‑represented employees (see page 9), but it does not describe a distinct operating‑segment structure or a strategic shift for the region. By FY 2024 Nike has formalized APLA as its own geographic operating segment and, per Note 15 (page 89), is transitioning NIKE‑Brand businesses in certain APLA countries to third‑party distributors (see Note 18), indicating a move toward an outsourced, partnership‑focused model while still growing the region’s revenue (up to $6.7 bn in FY 2024 from $6.4 bn in FY 2023, page 90). This reflects an evolution from a largely internal, workforce‑focused presence to a more structured, strategically‑driven approach that leverages external distribution partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of Nike's APLA evolution between FY2023 and FY2024. QUANTITATIVE ACCURACY: All financial figures are correct - APLA revenue of $6.4bn in FY2023 and $6.7bn in FY2024 are accurate, with proper citation to page 90. The revenue growth calculation is implicit and correct. QUALITATIVE ACCURACY: The answer correctly identifies the multi-hop synthesis required: (1) FY2023 status - union-represented employees in APLA (page 9 reference correct), indicating direct operational involvement; (2) FY2024 transition - formalization of APLA as a geographic operating segment with shift to third-party distributors (Notes 15 and 18 correctly cited). The reasoning properly connects the evolution from internal workforce structure to outsourced partnership model. ENTITY ACCURACY: Nike correctly identified, fiscal years properly distinguished (FY2023 vs FY2024), APLA region correctly referenced throughout, and specific document citations (pages 9, 89, 90 and Notes 15, 18) are appropriately provided. SEMANTIC EQUIVALENCE: The LLM answer aligns with the ground truth's core narrative - direct operational involvement in FY2023 transitioning to third-party distributor model in FY2024 - while adding valuable context about formalization as a geographic segment and revenue growth metrics. The answer goes slightly beyond the ground truth by providing specific revenue figures and document references, which enhances rather than contradicts the original answer. MINOR CONSIDERATION: The ground truth emphasizes 'reduction of operational complexity' while the LLM emphasizes 'structured, strategically-driven approach' - these are complementary framings rather than contradictory, both capturing the strategic shift. The answer fully addresses the multi-part question regarding both operational structure and strategic emphasis evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 515,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "In the 2022 filing Abbott emphasized Pedialyte as a primary growth driver for its U.S. Pediatric Nutritionals business, noting that the segment’s sales rose 10.3 % in 2021 “reflecting growth in Pedialyte, Similac and PediaSure”【page_31】. By the 2023 filing the company still lists Pedialyte among its core offerings, but it is presented as one product within a much broader, diversified nutritional portfolio that now spans numerous infant‑formula, pediatric‑ and adult‑nutrition brands, signaling a shift from highlighting Pedialyte alone to positioning it as part of an expanded product suite【page_4】【page_3】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE ACCURACY: The LLM states that 'the segment's sales rose 10.3% in 2021' but the ground truth clearly indicates this was for 2022 ('sales increasing 10.3% for the year' in 2022). This is a significant factual error regarding the year to which the 10.3% growth figure applies. The LLM appears to have confused the fiscal year, stating 2021 when the ground truth references 2022. PARTIAL CORRECTNESS ON STRATEGIC EVOLUTION: The LLM correctly identifies that Pedialyte was emphasized as a growth driver in 2022 and was listed among core offerings in 2023. However, the characterization differs from ground truth. The ground truth emphasizes 'formal inclusion' and 'structured integration' into the Nutritional Products segment in 2023, whereas the LLM describes it more vaguely as being 'presented as one product within a much broader, diversified nutritional portfolio.' The LLM's framing of 'shift from highlighting Pedialyte alone to positioning it as part of an expanded product suite' is somewhat accurate but less precise than the ground truth's emphasis on formal portfolio integration. MULTI-HOP REASONING: The LLM does attempt to synthesize information across 2022 and 2023 filings, showing understanding of the evolution question. However, the year attribution error undermines the credibility of this synthesis. COMPLETENESS: The answer addresses the core question about evolution between 2022 and 2023, mentions the U.S. Pediatric Nutritional business, and discusses product portfolio expansion. However, it lacks the specificity about formal segment inclusion that the ground truth emphasizes. The mention of 'numerous infant-formula, pediatric- and adult-nutrition brands' adds context but wasn't explicitly required. SEMANTIC ISSUES: The phrase 'shift from highlighting Pedialyte alone' is somewhat misleading—the ground truth doesn't suggest Pedialyte was highlighted alone in 2022, but rather as one of three key drivers alongside Similac and PediaSure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 538,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX kept the 7.100 % notes due 2027 at a constant $135 million at year‑end – the 2022 10‑K shows a $135 million balance (page 94) and the 2023 10‑K reports the same $135 million balance for both 2023 and 2022 (page 84). The unchanged amount indicates that RTX chose not to retire or refinance this low‑coupon tranche, reflecting a debt‑management approach that preserves existing inexpensive financing while focusing its refinancing and repayment efforts on other debt issuances.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims the balance was $135 million in both 2022 and 2023, stating it remained 'constant' and 'unchanged.' However, the ground truth clearly shows the balance was $6 million in 2022 and $135 million in 2023 - a significant increase of $129 million. This is a major factual error on the core numbers being evaluated. (2) The LLM incorrectly cites page references (page 94 for 2022 10-K and page 84 for 2023 10-K) and claims both years show $135 million, which contradicts the ground truth data. (3) The LLM's reasoning about 'unchanged amount' and 'preserves existing inexpensive financing' is logically flawed because it's based on the incorrect premise that the balance remained constant. The actual evolution from $6M to $135M indicates a significant increase in exposure, not preservation. (4) The multi-hop synthesis fails because the LLM did not correctly identify the year-over-year change that is central to answering how the financial position 'evolved.' The ground truth explicitly states this represents 'a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy.' The LLM's answer is internally inconsistent with the actual filing data and provides an entirely incorrect interpretation of RTX's debt management strategy regarding these notes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 403,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Nike’s Converse brand saw its total revenue fall from $2.43 billion in fiscal 2023 to $2.08 billion in fiscal 2024 – a 14 % decline (15 % on a currency‑neutral basis), with footwear revenues down 16 % while apparel rose modestly (+3 %) and equipment jumped (+32 %) (see page 46).  Despite the sales drop, Nike continues to position Converse as a stand‑alone, reportable operating segment – a wholly‑owned subsidiary that designs, markets, licenses and sells casual sneakers, apparel and accessories, and operates its own direct‑to‑consumer network (81 U.S. stores and 54 overseas stores) as part of Nike’s broader brand portfolio (see pages 5 & 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific revenue figures and percentages that align with the ground truth. Strengths: (1) Correctly identifies the 14-15% revenue decline (currency-neutral basis matches ground truth), (2) Provides specific revenue figures ($2.43B to $2.08B) showing detailed knowledge, (3) Accurately describes Converse as a wholly-owned subsidiary operating on a stand-alone basis in fiscal 2024, (4) Correctly identifies the strategic positioning shift, (5) Includes relevant operational details (store counts, product categories) that support the narrative. Minor considerations: (1) The LLM provides more granular detail than the ground truth (specific revenue amounts, apparel/equipment breakdowns, store counts) which enhances rather than detracts from the answer, (2) The ground truth emphasizes the 2023 revenue decline drivers (North America, Western Europe, wholesale/DTC channel impacts) while the LLM focuses more on the 2024 positioning - both perspectives are valid and complementary. The multi-hop reasoning is sound: the answer correctly synthesizes the evolution from fiscal 2023 (struggling entity with 15% decline) to fiscal 2024 (strategically positioned stand-alone brand). The quantitative accuracy is excellent with the 14-15% decline figure and revenue amounts appearing consistent with SEC filing data. The qualitative assessment of strategic positioning is accurate and well-supported. The answer fully addresses both components of the question: revenue performance (decline documented) and strategic positioning (stand-alone subsidiary status explained).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 444,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "In the 2022 Form 10‑K (page 19) Coca‑Cola warned that if it does not successfully **digitalize** the system, “our ability to increase sales and improve margins may be negatively affected.” By the 2024 filing (page 18) the company still flags the same sales‑growth risk, but the margin impact is now described as a risk to “reduce costs” rather than “improve margins,” reflecting a shift from margin‑improvement concerns to cost‑reduction concerns while the digital‑evolution risk to sales growth remains unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - CONTRADICTORY INTERPRETATION: The ground truth states that by 2024, Coca-Cola shifted from viewing digital evolution as a risk to viewing it as a strategic dependency with emphasis on margin improvement. The LLM answer claims the opposite - that the 2024 filing shifted FROM margin-improvement concerns TO cost-reduction concerns. This is a fundamental misreading of the company's evolving stance. (2) CITATION ISSUES: The LLM provides specific page numbers (page 19 for 2022, page 18 for 2024) but these cannot be verified against the ground truth, and the characterization of what those pages say appears incorrect based on the ground truth narrative. (3) INCOMPLETE ANALYSIS: The LLM answer fails to capture the key shift identified in the ground truth - that digital evolution evolved from being a risk factor to being a strategic dependency. Instead, it presents a narrower interpretation focused on cost-reduction vs. margin-improvement language. (4) MISCHARACTERIZATION OF CHANGE: The ground truth emphasizes a qualitative shift in how Coca-Cola views digital evolution (from risk to strategic necessity), with stronger financial linkage. The LLM answer suggests only a semantic shift in how margin impacts are described, missing the substantive strategic repositioning. (5) LOGICAL INCONSISTENCY: If the 2024 filing truly shifted focus from margin improvement to cost reduction, this would represent a weakening of digital strategy importance, contradicting the ground truth's assertion of stronger financial linkage. The answer demonstrates poor multi-hop reasoning across the 2022-2024 comparison and fails to synthesize the strategic evolution correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 481,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle’s FY 2022 filing disclosed a $7.2 billion R&D spend to enhance its portfolio and develop new technologies, and noted that cloud services and license‑support revenues already accounted for roughly 71 % of total revenue, signaling a major shift from on‑premise to cloud offerings【page_6】【page_8】. By FY 2024, Oracle’s commentary stresses Oracle Cloud Services (SaaS and OCI) as a core, integrated platform delivered via cloud, on‑premise, and hybrid models, highlighting flexible, interoperable deployment and continued heavy R&D focus on cloud capabilities, thereby cementing an even stronger cloud‑first strategy relative to traditional on‑premise solutions【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Oracle's cloud strategy evolution from FY2022 to FY2024. STRENGTHS: (1) The $7.2 billion R&D investment for FY2022 is correctly cited and matches the ground truth. (2) The 71% cloud/license-support revenue figure is accurately presented as evidence of the strategic shift. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from FY2022 emphasis on cloud services (SaaS, OCI) through FY2024's cloud-first positioning. (4) The characterization of the strategic shift from on-premise to cloud is accurate and well-supported. (5) The mention of flexible deployment models (cloud, on-premise, hybrid) aligns with ground truth positioning. MINOR WEAKNESSES: (1) The LLM answer does not explicitly acknowledge that the FY2024 R&D investment amount was not disclosed in the filing, though it does note 'continued heavy R&D focus' which implies ongoing investment without specifying the amount. The ground truth explicitly states 'the 2024 report does not specify the R&D investment amount,' and the LLM could have been more explicit about this gap. (2) The phrase 'cementing an even stronger cloud-first strategy' is a reasonable inference but slightly stronger in tone than the ground truth's more measured 'strategic deepening of Oracle's commitment.' (3) The answer could have more explicitly contrasted the messaging evolution (from 'key differentiator' language in 2022 to 'choose the best option' language in 2024) as the ground truth does. QUANTITATIVE VERIFICATION: The $7.2B figure is correct; the 71% revenue metric is accurate and adds valuable context not explicitly in ground truth but consistent with it. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple dimensions (R&D investment, revenue composition, strategic messaging, deployment models). The logical flow from 2022 to 2024 is clear and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 540,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors’ Formula Stock Award Plan remained a non‑shareholder‑approved plan that does not permit any future stock awards or deferrals in both years — the 2023 filing notes “No future stock awards or deferrals may be made under this plan”【page_12】and the 2024 filing repeats the same language【page_15】. However, the pool of shares that could still be issued under the plan fell from 509 shares in 2023 (the footnote lists 509 shares issuable)【page_11】to 391 shares in 2024【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numbers are correct - 509 shares in 2023 and 391 shares in 2024 match the ground truth exactly. The calculation of the decline (509 to 391) is accurate. ENTITY ACCURACY: Correctly identifies Norwest Corporation Directors' Formula Stock Award Plan, the years 2023 and 2024, and the relevant metrics (shares issuable). MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings, showing the evolution of the plan's status. It correctly identifies that the plan remained closed to new activity in both years while the pool of available shares decreased. COMPLETENESS: The answer addresses the core question about how status and availability evolved. It captures the key points: (1) the plan's closed status remained consistent, (2) the share pool declined from 509 to 391. MINOR GAPS: The ground truth provides slightly more context about the plan's 'fully closed' status and that 'only existing obligations remained,' emphasizing the plan had 'effectively concluded its active phase.' The LLM answer captures the essence of this but with less explicit emphasis on the finality of the plan's closure. The LLM answer is more concise and direct, which is appropriate. SEMANTIC EQUIVALENCE: The LLM's statement that the plan 'does not permit any future stock awards or deferrals' is semantically equivalent to the ground truth's description of the plan being 'fully closed to any new activity.' The citation format with page numbers adds credibility. Overall, this is a strong answer with accurate numbers, correct entity identification, and sound multi-hop reasoning across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 466,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "In the 2022 filing McDonald’s treated food‑safety as a separate risk – noting that food‑borne illness or product‑recall events could hurt its brand and that commodity‑price volatility for beef, chicken and pork is “particularly volatile … due to … food‑safety concerns, product recalls, government regulation” (2022 p.33) – while supply‑chain interruptions were described in a distinct risk factor that could raise costs or limit product availability (2022 p.30). By the 2023 filing the language is more integrated: the company says its ability to meet “expectations for safe food … including … in the supply chain, restaurants or delivery” and stresses reliance on independent suppliers to meet high standards (2023 p.31, p.35), yet it still flags that commodity‑cost volatility remains driven by food‑safety concerns (2023 p.33). This shows an evolution from a generic food‑safety warning to a clearer linkage of food‑safety risk with supply‑chain exposure and cost volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in McDonald's food safety disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from treating food safety as primarily a reputational risk (2022) to integrating it with supply chain and cost volatility concerns (2023); (2) Accurately cites specific commodities (beef, chicken, pork) mentioned in both years; (3) Provides page references (2022 p.33, p.30; 2023 p.31, p.35) that ground the analysis; (4) Captures the semantic evolution from 'separate risk factors' to 'more integrated' language; (5) Correctly synthesizes multi-hop information across two years and multiple risk categories. MINOR WEAKNESSES: (1) The LLM answer includes a direct quote from 2022 (p.33) about commodity volatility being 'particularly volatile...due to...food-safety concerns' which actually suggests food safety was already linked to commodity costs in 2022, potentially complicating the narrative of 'evolution' presented in the ground truth. The ground truth emphasizes a shift FROM reputational focus TO supply chain/cost focus, but the LLM's evidence suggests this linkage existed in 2022 as well; (2) The answer could be clearer about whether the 2023 evolution represents a NEW emphasis or a CLARIFICATION of existing connections. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Page references appear reasonable but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and connects food safety to supply chain and cost volatility, meeting the multi-hop requirement. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth—that McDonald's disclosure evolved to emphasize food safety's connection to supply chain and cost volatility—though with slightly more nuance about the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 542,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "In 2023 the 1.750 % 7‑year senior notes (due 10/15/2028) were carried at $700 million with an effective interest rate of 1.89 %【page_62】. The 2024 filing shows the same notes still carried at $700 million and still reporting a 1.89 % effective rate【page_47】. Thus, both the carrying amount and the interest rate remained unchanged from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about TMO's 1.750% 7-Year Senior Notes evolution between 2023 and 2024. QUANTITATIVE VERIFICATION: All numeric values are correct - carrying value of $700 million in both years, effective interest rate of 1.89% in both years, and the maturity date of October 15, 2028 are all accurate. COMPLETENESS: The answer fully addresses both parts of the question (carrying value and interest rate) for both years (2023 and 2024), providing a complete comparison. ENTITY ACCURACY: TMO is correctly identified, the specific debt instrument (1.750% 7-Year Senior Notes) is correctly specified with its maturity date, and both fiscal years are correctly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across two separate filings (2023 and 2024) and properly compares the values to reach the logical conclusion that both metrics remained unchanged. The reasoning is sound and the conclusion is justified by the data presented. MINOR OBSERVATION: The inclusion of page references (page_62 and page_47) adds credibility and traceability, though this is not required. The answer uses slightly different formatting for the percentage (1.750 % vs 1.750%) but this is a negligible stylistic variation. The semantic meaning is perfectly preserved - the answer clearly conveys that there was no change in either the carrying value or effective interest rate between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 406,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX’s 7.000 % notes due 2038 were $148 million at the end of 2022 and remained $148 million at the end of 2023 (2023 10‑K, Note 10 table shows $148 million for both years)【page_85】. The unchanged balance indicates the company neither added to nor retired this tranche, suggesting a deliberate strategy to keep its exposure to this long‑dated, higher‑coupon debt stable while managing overall maturities through other issuances and repayments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth clearly states that RTX's 7.000% notes due 2038 were $11 million in 2022 and increased to $148 million in 2023. The LLM answer incorrectly claims the balance was $148 million in both 2022 and 2023, stating it 'remained $148 million.' This is a fundamental quantitative error - the LLM reversed the years or misread the data. The ground truth shows a significant increase from $11M to $148M (a 1,245% increase), which is the key finding that should be highlighted. The LLM's conclusion that the balance was 'unchanged' is therefore completely incorrect. Additionally, the LLM's interpretation that this represents a 'deliberate strategy to keep exposure stable' is contradicted by the actual data showing a dramatic increase. The LLM did correctly identify the note characteristics (7.000%, due 2038) and attempted to address the multi-part question about changes and strategic implications, but the core numerical facts are wrong, making the entire analysis invalid. The citation reference to 'page_85' and '2023 10-K, Note 10 table' cannot verify the accuracy of the numbers provided, but they contradict the ground truth data from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 354,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "In the 2022 filing McDonald’s explained that, because of COVID‑19, it had **deferred roughly $1 billion of rent and royalty payments from franchisees** in the first half of 2020 and had “collected substantially all of these deferrals as of December 31, 2021” (2022 10‑K, p. 51). The 2023 filing no longer mentions any deferrals; instead it states that **rental income (minimum rent straight‑line and variable rent) and royalties are recognized when earned – i.e., at the time underlying sales occur** (2023 10‑K, p. 44). Thus, the franchisee relationship shifted from a pandemic‑driven cash‑collection pause in 2022 to a normalized, on‑schedule collection of rent and royalties in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about McDonald's franchisee financial relationship evolution. QUANTITATIVE ACCURACY: All numeric values are correct - the $1 billion deferral amount, the timing (first half of 2020), and the collection timeline (substantially all collected by December 31, 2021) match the ground truth exactly. The answer correctly cites specific page numbers (2022 10-K p. 51, 2023 10-K p. 44) which adds credibility. ENTITY ACCURACY: McDonald's is correctly identified, years 2022 and 2023 are properly referenced, and the financial metrics (rent, royalties, minimum rent straight-line, variable rent) are accurately named. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings - it identifies the pandemic-era deferral in the 2022 filing, notes the collection completion by end of 2021, and contrasts this with the 2023 normalization. The logical progression from deferral → collection → normalization is sound. COMPLETENESS: The answer addresses all aspects of the question: (1) how the relationship evolved, (2) the specific focus on rent and royalties collection, (3) the 2022-2023 timeframe. The inclusion of the revenue recognition principle in 2023 ('recognized when earned') adds helpful context about the normalized operations. MINOR CONSIDERATIONS: The answer is slightly more detailed than the ground truth (mentioning specific revenue recognition accounting), but this represents added value rather than error. The wording differs from ground truth but conveys identical semantic meaning - 'deferred roughly $1 billion' vs 'deferred approximately $1 billion' is a format variation, not an error. The characterization of the shift as 'pandemic-driven cash-collection pause' to 'normalized, on-schedule collection' accurately captures the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 518,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "In the 2022 filing Coca‑Cola noted that, after selling a portion of its holding in 2019, it still retained a “remaining ownership interest” in Embotelladora Andina S.A. that is accounted for under the equity‑method (no dollar amount was disclosed)【page_76】. By the 2024 filing the same equity‑method investment is shown with a carrying amount of $90 million and a fair‑value of $168 million, indicating that the stake has appreciated and that Coca‑Cola continues to hold a minority, strategic interest rather than moving toward full acquisition or disposal【page_87】. This suggests the company views Andina as a valuable partner and is preserving its influence while benefiting from the investment’s upside.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2024 carrying value ($90 million) and fair value ($168 million) of the Andina investment, matching the ground truth exactly. The characterization of the investment as equity-method accounting and a minority strategic interest is accurate. The reasoning about partial exit strategy and ongoing involvement is sound. The LLM appropriately notes the 2019 prior sale context. CRITICAL WEAKNESS: The LLM completely omits the $39 million gain from the 2022 partial sale, which is a key quantitative fact in the ground truth answer. This is a significant omission because the question specifically asks about evolution 'from 2022 to 2024,' and the 2022 gain is material evidence of the strategic refranchising move. The LLM states 'no dollar amount was disclosed' for 2022, which is factually incorrect—the $39 million gain was disclosed. REASONING ASSESSMENT: The multi-hop synthesis is partially sound (connecting 2019 sale context to 2024 position) but incomplete because it misses the 2022 transaction entirely. The interpretation about Coca-Cola viewing Andina as a 'valuable partner' and 'preserving influence' is reasonable inference but goes slightly beyond what the ground truth explicitly states. QUANTITATIVE ACCURACY: Deducted points for missing the $39 million 2022 gain figure, which is a factual error in completeness. The 2024 numbers are correct. OVERALL: The answer demonstrates good understanding of the investment structure and strategic positioning but fails to capture a critical data point from 2022, making the evolution narrative incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 439,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle’s 2022 filing stresses that its cloud platform is built and operated internally – Oracle Cloud Operations is managed by Oracle employees, the company is expanding data‑center capacity, and the bulk of its cloud products are developed in‑house (2022 p.15‑16). By the 2024 filing the same internal‑development emphasis remains, but Oracle now explicitly brands Oracle Cloud Infrastructure (OCI) as a core pillar of its Oracle Cloud Services suite, positioning OCI alongside SaaS as an integrated, strategic offering in its product portfolio (2024 p.72‑73).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core strategic evolution from 2022 to 2024, capturing the shift from general internal development emphasis to explicit OCI positioning; (2) Accurately references specific filing pages (2022 p.15-16 and 2024 p.72-73), showing proper document synthesis; (3) Correctly identifies key entities: Oracle, Oracle Cloud Operations, Oracle Cloud Infrastructure (OCI), and Oracle Cloud Services; (4) Properly synthesizes the multi-hop reasoning: internal development in 2022 → explicit OCI branding and positioning in 2024; (5) Accurately characterizes the evolution as maintaining internal development while adding structured product portfolio positioning. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific with page citations than the ground truth, which adds credibility but isn't required; (2) Both answers convey the same semantic meaning about the strategic deepening and alignment of R&D with market-ready cloud services; (3) No quantitative errors or calculation issues present; (4) The characterization of OCI as positioned 'alongside SaaS' is accurate and adds helpful specificity. VERIFICATION: The answer correctly identifies that 2022 focused on internal development/operations while 2024 introduced explicit OCI branding as a central portfolio offering - this matches the ground truth's description of evolution from 'general cloud development to a structured, customer-facing product portfolio.' No factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 435,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "In 2023 Thermo Fisher completed a $2.7 billion acquisition of The Binding Site Group, adding the U.K.‑based diagnostics business to its Specialty Diagnostics segment (cash $2.412 bn, debt $307 mn; customer relationships $868 mn, product technology $162 mn, goodwill $1.741 bn)【page_66】. By the 2024 filing the company no longer discusses any new activity with The Binding Site Group, instead highlighting fresh deals such as the Olink acquisition, which signals that The Binding Site Group has been fully integrated into Thermo Fisher’s operations and the firm’s post‑acquisition focus has shifted to leveraging that platform while pursuing additional strategic growth opportunities【page_65】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Quantitative data is accurate - $2.7 billion acquisition price matches ground truth ($2.70 billion), and the breakdown of acquisition components (cash $2.412bn, debt $307mn, customer relationships $868mn, product technology $162mn, goodwill $1.741bn) appears detailed and correct. (2) Correctly identifies 2023 as acquisition year and 2024 as integration year. (3) Properly identifies The Binding Site Group as U.K.-based diagnostics business added to Specialty Diagnostics segment. (4) Correctly notes the shift in focus from discussing The Binding Site Group to pursuing new acquisitions like Olink. WEAKNESSES: (1) The LLM answer diverges from ground truth on a key point: Ground truth emphasizes the 19-year weighted-average amortization period for customer relationships as evidence of integration, but LLM answer does not mention this specific metric. (2) Ground truth explicitly states the acquisition expanded portfolio for 'blood cancers and immune disorders' - the LLM answer omits this therapeutic focus detail. (3) Ground truth frames the evolution as indicating 'strategic focus on long-term value creation through integration of acquired innovation into core diagnostics offerings,' while LLM answer frames it as 'full integration' with shift to 'leveraging that platform while pursuing additional strategic growth opportunities' - slightly different strategic interpretation. (4) The LLM answer's inference that 'no longer discusses any new activity' is reasonable but not explicitly stated in ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings to show evolution, but misses the specific integration metric (amortization period) that ground truth highlights as key evidence. The reasoning about full integration is sound but incomplete compared to ground truth's emphasis on long-term value creation through innovation integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 518,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was described as applying to “all directors of BNY” and was referenced only with a relative link – bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf. By the 2024 filing the same code still applies to “all directors of BNY Mellon,” but the company now provides a full, publicly‑clickable URL – https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf – making the disclosure more direct and accessible while the scope of application remains unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth:\n\n1. URL ACCURACY (Critical Error): The LLM provides an incorrect 2024 URL with a typo: 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf' - note the broken 'in relations' instead of 'investor-relations'. The ground truth shows the correct 2024 URL is 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf'. This is a critical error as the question specifically asks about website links.\n\n2. DOMAIN CHANGE MISSED: The LLM fails to identify the key domain change from 'bnymellon.com' (2022) to 'bny.com' (2024), which is a central finding in the ground truth. The LLM incorrectly states the 2024 URL uses 'bnymellon.com' when it should be 'bny.com'.\n\n3. 2022 URL CHARACTERIZATION: The LLM describes the 2022 reference as a 'relative link' when the ground truth shows it was a full URL: 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf'. This mischaracterizes the 2022 disclosure.\n\n4. ACCESSIBILITY CLAIM: The LLM claims the 2024 filing provides 'a full, publicly‑clickable URL' implying 2022 did not, but the ground truth shows both years had full URLs - the difference was the domain change, not the format of disclosure.\n\n5. SCOPE ACCURACY: Both answers correctly identify that the scope remained 'all directors' in both years, though the LLM uses slightly different wording ('all directors of BNY' vs 'all directors of BNY Mellon').\n\nThe core narrative about evolution is fundamentally flawed due to the URL errors and missed domain change, which is the primary evidence of the rebranding evolution mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 490,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "In the 2022 filing McDonald’s reported franchise‑related revenues – rent, royalties, minimum‑rent payments and initial fees – on a gross basis and also included technology‑platform services (including Dynamic Yield SaaS) as franchisee revenue, while noting that franchisee advertising contributions were not consolidated because the company lacked control【page_44】【page_45】. By the 2023 filing the Dynamic Yield revenue is gone after its sale, the same gross‑basis accounting for franchise fees and technology services remains, but goodwill rose to $3.0 bn (from $2.9 bn) as McDonald’s continued to purchase restaurants from franchisees, and advertising spend for company‑operated restaurants increased, reflecting a strategic emphasis on expanding company‑owned locations and deeper franchisee collaboration【page_44】【page_45】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses some relevant details about McDonald's franchise accounting but diverges significantly from the ground truth in several critical ways: (1) FACTUAL MISALIGNMENT: The ground truth emphasizes a shift in strategic emphasis and transparency regarding franchisees as key stakeholders between 2022-2023, with 2023 explicitly including franchisees/licensees in business model breakdown. The LLM answer instead focuses on accounting mechanics (gross basis revenue recognition, Dynamic Yield SaaS, advertising contributions) that are not mentioned in the ground truth. (2) QUANTITATIVE ISSUES: The LLM provides specific numbers (goodwill $3.0bn vs $2.9bn) that cannot be verified against the ground truth, which contains no such figures. This introduces unverified quantitative claims. The Dynamic Yield sale is mentioned but not in the ground truth context. (3) MULTI-HOP REASONING: The ground truth synthesizes a strategic narrative about evolving stakeholder emphasis and transparency. The LLM synthesizes accounting treatment details and capital allocation strategy (purchasing restaurants, goodwill increases), which is a different analytical framework entirely. (4) MISSING CORE INSIGHT: The LLM completely misses the ground truth's central point about the evolution from 'not material' (2022) to 'explicitly included as key stakeholders' (2023) - a qualitative shift in strategic positioning and disclosure. (5) SEMANTIC DIVERGENCE: While both answers discuss franchisees, they address fundamentally different aspects - the ground truth focuses on strategic emphasis and stakeholder recognition, while the LLM focuses on accounting treatments and capital deployment. The answers are not semantically equivalent despite both being about McDonald's-franchisee relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 487,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "In the 2023 Form 10‑K the Clif Bar contingent‑consideration was shown as a distinct liability of **$548 million**, measured at fair value using Level 3 (Monte‑Carlo) inputs, with changes recorded in SG&A (see page 99). By the 2024 filing the separate contingent‑consideration balance is no longer disclosed; instead, the related amount appears only in the **purchase‑price‑allocation adjustments** for the Clif Bar acquisition (noted in the intangible‑asset schedule on page 87), indicating the liability has been re‑measured/settled and incorporated into the acquisition accounting rather than retained as a stand‑alone fair‑value liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The $548 million figure for 2023 contingent consideration liabilities is correctly stated and matches the ground truth exactly. The answer properly identifies the valuation methodology (Level 3 Monte Carlo inputs) and the accounting treatment (fair value changes recorded in SG&A). COMPLETENESS: The answer addresses both the 2023 and 2024 evolution of the accounting treatment, capturing the key transition from a distinct liability to incorporation into purchase price allocation adjustments. ENTITY ACCURACY: Clif Bar acquisition is correctly identified, fiscal years 2023 and 2024 are properly referenced, and financial metrics (contingent consideration liabilities, fair value measurement, purchase price allocation) are accurately named. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and two different accounting presentations, correctly inferring that the absence of contingent consideration disclosure in 2024 indicates reclassification/settlement rather than elimination. The logic that the liability was \"re-measured/settled and incorporated into the acquisition accounting\" aligns with the ground truth's statement about finalization or reclassification as part of purchase price allocation. MINOR CONSIDERATIONS: The LLM answer adds specific page references (page 99, page 87) which, while helpful for verification, are not explicitly confirmed in the ground truth but are reasonable details that enhance credibility. The phrase \"re-measured/settled\" is slightly more specific than the ground truth's \"finalized or reclassified,\" but this represents appropriate elaboration rather than inaccuracy. The answer correctly conveys that the contingent consideration is no longer shown as a stand-alone liability in 2024, matching the ground truth's observation about the absence of direct mention in the 2024 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 537,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "In the 2022 Form 10‑K AMD said its Radeon discrete GPUs “support current‑generation application programming interfaces (APIs) like DirectX 12 Ultimate and **Vulkan**.” By the 2024 filing the company repeats that support but now couples Vulkan with “high‑refresh‑rate displays,” immersive‑gaming, VR and AI/ML capabilities, positioning it as a key part of the Radeon RX 7000‑Series platform. This shift from a simple compatibility statement to a broader, feature‑rich emphasis shows AMD is deliberately aligning its GPUs with the latest industry‑standard API (Vulkan) to stay competitive in the fast‑evolving discrete‑GPU market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's Vulkan API strategy evolution between 2022 and 2024, with mostly accurate information and sound reasoning. STRENGTHS: (1) Correctly identifies that AMD mentioned Vulkan support in both 2022 and 2024 filings; (2) Accurately notes the shift from simple compatibility statements to feature-rich positioning; (3) Correctly identifies Radeon RX 7000-Series as the 2024 platform; (4) Properly synthesizes the multi-hop information showing evolution in messaging; (5) Appropriately concludes this reflects competitive positioning strategy. WEAKNESSES: (1) The LLM answer does not explicitly mention the architectural evolution from RDNA 2 (2022) to RDNA 3 (2024), which is a key component of the ground truth answer's explanation of how AMD maintains competitiveness; (2) Missing the specific architectural context that underpins the strategic evolution; (3) The answer focuses more on messaging/positioning evolution rather than the underlying technical/architectural innovation that the ground truth emphasizes as central to the strategy. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is less critical. The years (2022, 2024) are correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across two filing years and connects API support to competitive positioning, though it misses the architectural dimension that would complete the multi-hop analysis. The reasoning about strategic intent is sound but incomplete. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'backward compatibility and cutting-edge performance' is implied but not explicitly stated, whereas the ground truth makes this explicit. The core insight about maintaining competitiveness through API continuity plus innovation is present in both answers but more fully developed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 516,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX’s operating profit rose modestly in 2022 because integration‑related acquisition‑accounting adjustments fell, adding about $0.4 bn and lifting profit to $5.5 bn (≈8.2% margin) 【page_39】. In 2023 the company recorded a $2.9 bn Powder Metal Matter charge at Pratt & Whitney (net of partner share), which drove a $1.9 bn year‑over‑year decline in operating profit to $3.6 bn and cut the margin to 5.2% 【page_39】【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. Verification of key claims: (1) The $2.9 billion Powder Metal Matter charge in 2023 is correctly stated and matches ground truth. (2) The $1.9 billion year-over-year decline in operating profit is accurately cited. (3) The operating profit figures of $5.5 billion (2022) and $3.6 billion (2023) are presented with appropriate context. (4) The margin calculations (8.2% for 2022, 5.2% for 2023) are mathematically correct based on the stated profit figures. (5) The answer correctly identifies the shift from declining integration-related charges in 2022 (contributing positively) to the significant Powder Metal Matter charge in 2023 (driving negative impact). The multi-hop reasoning is sound: the answer synthesizes information about acquisition accounting adjustments' positive impact in 2022, then contrasts this with the 2023 Powder Metal Matter charge and its direct impact on operating profit decline. The answer provides specific attribution (Pratt & Whitney) and notes the net-of-partner-share treatment, showing attention to detail. Minor consideration: The answer provides additional context (margin percentages, specific business unit attribution) beyond the ground truth, but this enhances rather than detracts from accuracy. The semantic equivalence is strong—the answer conveys the same core narrative of integration-related charges shifting from a positive contributor to a major negative driver of profitability trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 421,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "In the 2023 filing MDLZ highlighted that its August 2022 acquisition of Clif Bar was still generating a measurable impact – it added about $529 million of incremental net revenue (constant‑currency) and the company recorded purchase‑price‑allocation adjustments for the brand as part of its acquisition‑related accounting. By the 2024 filing the Clif Bar brand appears only as an indefinite‑life intangible asset (grouped with other acquired brands) and no new acquisition‑related costs are shown, indicating the acquisition has been fully integrated into MDLZ’s ongoing asset base.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and specific response than the ground truth, with concrete financial metrics and a clearer narrative of the acquisition evolution. Strengths: (1) Correctly identifies the August 2022 acquisition date, (2) Provides specific revenue impact ($529 million incremental net revenue in constant-currency) which adds substantive detail, (3) Accurately describes the transition from active acquisition accounting (2023) to integration phase (2024), (4) Correctly notes the shift from acquisition-related costs to indefinite-life intangible asset classification. The multi-hop reasoning is sound - synthesizing that the 2023 filing showed ongoing acquisition impacts while 2024 showed full integration. Minor considerations: (1) The ground truth mentions 'contingent consideration adjustments' in 2023 which the LLM answer doesn't explicitly address, though the purchase-price-allocation reference covers similar ground, (2) The LLM answer's statement about 'no new acquisition-related costs' in 2024 is a reasonable inference but not explicitly verified against the ground truth statement. The $529 million figure appears to be accurate based on typical MDLZ Clif Bar acquisition reporting. The answer demonstrates strong understanding of acquisition accounting phases and correctly synthesizes the evolution between years. The semantic meaning aligns well with the ground truth despite different wording and greater specificity in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 409,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "In 2023 Gulfstream framed its strategy around R&D and leadership in sustainable aviation fuel, saying it would bring all‑new, high‑speed, fuel‑efficient engines to the next‑generation G700 slated for early‑2024 entry into service. By 2024 the focus had shifted to deployment – the G700 entered service in March 2024, the newly launched G800 and G400 also use all‑new, lower‑emission engines, and Gulfstream highlighted operational SAF milestones such as the world’s first 100 % SAF trans‑Atlantic flight, reflecting a move from development to real‑world use of energy‑efficient propulsion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Gulfstream's evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 strategy focused on R&D and SAF leadership with planned G700 introduction; (2) Accurately dates G700 entry into service as March 2024; (3) Properly synthesizes the shift from development/announcement phase (2023) to operational deployment (2024); (4) Correctly identifies new aircraft models (G800, G400) with all-new engines; (5) Includes specific operational milestone (100% SAF trans-Atlantic flight) that demonstrates real-world implementation; (6) Maintains semantic equivalence with ground truth regarding the evolution from strategic positioning to operational realization. MINOR CONSIDERATIONS: (1) The LLM answer adds information about G800 and G400 that goes slightly beyond the ground truth's focus on G700, though this is not incorrect and actually enriches the answer; (2) The specific date of March 2024 for G700 entry is more precise than the ground truth's 'early-2024' reference, which is accurate and helpful; (3) The mention of 100% SAF trans-Atlantic flight is a concrete operational example not explicitly in the ground truth but aligns with the theme of moving from development to real-world use. QUANTITATIVE VERIFICATION: The date 'March 2024' is specific and appears factually sound for G700 entry. The '100% SAF' reference is accurate. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple aircraft models, correctly identifying the progression from planning to execution. The logical flow from 2023 announcements to 2024 operational deployment is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 480,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "In the 2022 filing AMD described semi‑custom SoC revenue as “non‑recurring engineering fees … and revenue received in connection with sales of our semi‑custom SoC products,” stressing that the income depends on the customer’s product being launched and succeeding, with no control over the third‑party’s marketing. By the 2024 filing AMD lists “semi‑custom System‑on‑Chip (SoC) products” as a distinct product category and accounts the related “custom products” (primarily in the Gaming segment) using a cost‑plus, over‑time revenue‑recognition method, treating them as a strategic, recurring growth engine rather than a one‑off fee. This shows a shift from a largely opportunistic, non‑recurring revenue stream in 2022 to a more integrated, strategically positioned and systematically recognized line of business in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of AMD's semi-custom SoC relationship from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 characterization as dependent on non-recurring engineering fees and third-party product success, with accurate quotation of filing language; (2) Accurately describes the 2024 shift to a more integrated, strategic positioning with cost-plus revenue recognition methodology; (3) Properly synthesizes the multi-hop comparison across two years showing the transition from opportunistic to systematic business model; (4) Correctly identifies the Gaming segment context for custom products; (5) Uses appropriate financial/accounting terminology (cost-plus, over-time revenue recognition). MINOR WEAKNESSES: (1) The LLM answer provides more specific accounting detail (cost-plus, over-time revenue recognition) than the ground truth, which is technically accurate but represents a slightly different emphasis - the ground truth focuses more on strategic integration and portfolio diversification, while the LLM emphasizes accounting methodology; (2) The ground truth explicitly mentions the broader diversified portfolio context (AI accelerators, GPUs, APUs, DPUs) which the LLM answer does not address, though this is a relatively minor omission given the question's focus on semi-custom SoCs specifically; (3) The ground truth emphasizes 'alignment with long-term industry trends and internal innovation strategies' which the LLM answer touches on implicitly but doesn't explicitly state. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the causal relationship between business model changes and strategic positioning. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 541,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The authorized share capital remained the same in both years – Medtronic was authorized to issue 127.5 million $0.20‑par Preferred Shares and 500 thousand $1.00‑par “A” Preferred Shares (with none issued or outstanding in either FY 2023 or FY 2024). This unchanged preferred‑share framework shows the company is preserving a latent equity‑raising option but is not actively using preferred equity, underscoring a capital strategy that relies on ordinary‑share repurchases and other cash returns rather than issuing new preferred stock.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are correct - 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately stated for both years. (2) Correctly identifies that no shares were issued or outstanding in either year. (3) Accurately captures the unchanged structure between FY 2023 and FY 2024. (4) Number formatting is appropriate and consistent. WEAKNESSES: (1) CRITICAL ISSUE - The LLM identifies the company as 'Medtronic' without any basis in the original answer or question. The ground truth answer does not specify which company this is, and the LLM has made an unsupported company identification. This is a significant error in entity accuracy. (2) The LLM adds interpretive analysis about 'ordinary-share repurchases and other cash returns' that goes beyond what the ground truth states. While this interpretation may be reasonable, it introduces information not present in the original answer and represents speculation about capital strategy beyond what can be confirmed from the preferred share data alone. (3) The ground truth simply states the unchanged structure 'indicates that the company has not utilized or pursued any changes in its preferred share structure' - a more conservative conclusion than the LLM's broader claims about capital strategy reliance. MULTI-HOP REASONING: The question asks about evolution and what it indicates about capital strategy. The LLM attempts to synthesize this but does so with unsupported company identification and extrapolated conclusions. The core factual comparison (unchanged structure) is sound, but the interpretive leap about capital strategy priorities is not grounded in the provided information. The answer would be stronger if it stuck to what the data actually shows rather than inferring broader strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 500,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "In the 2022 Form 10‑K the company listed reputational risk in a single, generic bullet – “our businesses may be negatively affected by adverse events, publicity, government scrutiny or other reputational harm” (BK 2022 p. 5). By the 2024 filing the same wording is retained (BK 2024 p. 4) but is now supplemented by separate risk statements that climate‑change and broader sustainability concerns “could … damage our reputation” (BK 2024 p. 4‑5), linking adverse publicity to ESG‑related issues. Thus the framing has broadened from a generic reputational‑harm clause to an explicit connection between adverse publicity and environmental/social concerns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the multi-hop question about BK's evolving reputational risk framing between 2022 and 2024. STRENGTHS: (1) Correctly identifies the 2022 framing as a generic single bullet point addressing adverse events, publicity, government scrutiny, and reputational harm. (2) Accurately notes that the 2024 filing retains the same wording but supplements it with new risk statements. (3) Properly identifies the expansion to include climate change and sustainability/ESG concerns as the key evolution. (4) Correctly synthesizes the multi-hop information showing how the framing broadened from generic to explicit ESG linkages. (5) Page citations (2022 p. 5, 2024 p. 4-5) are appropriately specific. (6) The semantic equivalence between the LLM answer and ground truth is strong - both convey that the risk evolved from a generic statement to one explicitly linked with sustainability concerns. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 'platforms operating model transition' that the ground truth identifies as a new operational context linked to the reputational risk in 2024. This is a notable omission as it represents an additional dimension of the evolution beyond just ESG concerns. (2) The ground truth emphasizes that adverse publicity could negatively impact 'business outcomes' in broader contexts, while the LLM focuses primarily on the ESG/sustainability angle. The omission of the operational model transition context represents incomplete coverage of the full scope of how the framing evolved. QUANTITATIVE ACCURACY: No calculations or specific financial metrics are involved, so this scores high (9) based on correct date/year identification and accurate page references. QUALITATIVE ACCURACY: Strong reasoning and synthesis (8) with the caveat that one dimension of the evolution (operational model transition) was not captured. CONTEXTUAL RELEVANCE: Highly relevant (9) as it directly addresses the question about evolution of framing and associated impacts/linked concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 555,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "In 2023 Amazon disclosed that it had invested $1.25 billion in a convertible note from Anthropic, PBC, which it classified as an available‑for‑sale Level 3 asset measured at fair value, with unrealized gains and losses reported in accumulated other‑comprehensive income and an option to invest up to $2.75 billion in a second note (page 50). By the 2024 filing the Anthropic investment remained an available‑for‑sale convertible‑debt investment measured at fair value, but Amazon emphasized that valuing private‑company securities such as Anthropic is inherently more complex because of limited market data and heightened uncertainty from current global economic conditions, which affect the fair‑value estimate (page 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amazon's evolving investment approach toward Anthropic. QUANTITATIVE ACCURACY: All financial figures are correct - $1.25 billion initial investment, $2.75 billion additional investment option, and the Level 3 asset classification are all accurately stated. No calculation errors present. QUALITATIVE ACCURACY: The answer correctly identifies the key evolution from 2023 to 2024: (1) consistent available-for-sale classification across both years, (2) fair value measurement methodology, (3) unrealized gains/losses treatment in accumulated other comprehensive income, (4) the shift in emphasis from investment mechanics to valuation complexity and risk. The multi-hop synthesis is sound - the answer traces the investment through time and connects the classification details with the evolving disclosure focus on valuation challenges. ENTITY ACCURACY: Amazon and Anthropic, PBC are correctly identified; fiscal years 2023 and 2024 are properly distinguished. COMPLETENESS: The answer addresses all major components of the question: investment classification (available-for-sale), valuation approach (fair value, Level 3), investment amounts, and the evolution in disclosure emphasis regarding valuation complexity. The mention of global economic uncertainty and limited market data for private companies captures the key shift in how Amazon characterized the investment's valuation challenges. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The inclusion of page references (page 50, page 32) adds credibility though these weren't in the original answer. The semantic equivalence is strong - phrases like 'option to invest up to $2.75 billion' effectively convey the same meaning as 'agreement to invest an additional $2.75 billion.' The answer successfully demonstrates understanding of the multi-hop nature of the question by synthesizing information across two fiscal years and connecting investment classification details with valuation methodology evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 575,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Both the 2023 and 2024 filings stress that MDLZ’s competitiveness depends on protecting its trademarks, patents, copyrights, trade‑secrets, recipes, technology, know‑how and licensing agreements, and they warn that failures‑to‑protect (including challenges from AI‑driven technologies or changes in law) could materially harm the business. The 2024 filing adds a more explicit statement that the company may be “unaware of potential third‑party claims” and could face costly litigation, injunctions or license‑fee obligations, but the underlying nature of the IP‑protection risk remains essentially unchanged. (2023 p. 26‑27; 2024 p. 27)",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE ANSWER: The LLM answer fundamentally contradicts the ground truth on the key evolution of risks between 2023 and 2024. (1) MAJOR FACTUAL ERROR - AI EMPHASIS: The LLM states that both 2023 and 2024 filings warn about 'challenges from AI-driven technologies,' and that the 'underlying nature of the IP-protection risk remains essentially unchanged.' This directly contradicts the ground truth, which explicitly states that in 2023 MDLZ expressed concern about 'legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies,' but in 2024 'it did not specifically mention artificial intelligence as a factor affecting protection.' This is the PRIMARY evolution the question asks about, and the LLM got it backwards. (2) INCOMPLETE CHARACTERIZATION OF 2024 SHIFT: The ground truth identifies a significant shift in 2024 toward 'broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions.' The LLM mentions litigation and injunctions but misses the broader regulatory compliance and penalty framework that characterizes the 2024 evolution. (3) QUANTITATIVE ACCURACY: Page references (2023 p. 26-27; 2024 p. 27) are provided but cannot be independently verified; however, the substantive content accuracy is severely compromised. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the year-over-year comparison that is central to the question. It treated the risks as 'essentially unchanged' when the ground truth identifies a meaningful shift away from AI-specific concerns toward broader regulatory/compliance risks. (5) SEMANTIC EQUIVALENCE FAILURE: The LLM's characterization that both years mention AI threats is factually incorrect per the ground truth. This is not a wording difference but a fundamental misrepresentation of the filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 535,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "In the 2023 Form 10‑K the only non‑employee director equity‑award reference was a single entry – “Amendments to Certain Non‑Employee Director Equity Award Agreements,” incorporated by reference to Exhibit 10.69 covering the fiscal year ended November 28 2008. The 2024 filing expands that disclosure: it still cites the 2008 amendment (Exhibit 10.69) but also adds a “Form of Non‑Employee Director RSU Award Agreement (pre‑2015)” (Exhibit 10.21 for the fiscal year ended December 31 2014) and lists the RSU award forms (Exhibits 10.32 and 10.33). Thus, Goldman Sachs moved from referencing only the historic 2008 amendment to also referencing the underlying pre‑2015 RSU award agreement from the 2014 fiscal year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) EXHIBIT NUMBER ERRORS: The ground truth states that in 2023, the reference was to Exhibit 10.17 (pointing to an amendment dated November 28, 2008), and in 2024 it shifted to Exhibit 10.18 (referencing Exhibit 10.69). The LLM answer incorrectly claims the 2023 filing referenced Exhibit 10.69 directly and misidentifies the exhibit numbers for 2024. (2) TIMELINE MISREPRESENTATION: The LLM answer introduces exhibits (10.21, 10.32, 10.33) and references to 2014 fiscal year documents that are not mentioned in the ground truth. The ground truth specifically focuses on the evolution from 2023 to 2024 regarding how the 2008 amendment was referenced, not an expansion to include 2014 documents. (3) CORE NARRATIVE INVERSION: The ground truth describes a consolidation/formalization of prior amendments with deeper historical documentation emphasis. The LLM answer describes an expansion to include additional RSU award forms from 2014, which is a fundamentally different characterization. (4) MISSING KEY DETAIL: The ground truth emphasizes the shift in how the same underlying 2008 amendment was referenced (through different exhibit numbers), suggesting a reorganization of disclosure structure. The LLM answer misses this critical evolution point. (5) QUANTITATIVE ACCURACY: The exhibit numbers cited (10.17, 10.18, 10.69 in ground truth vs. 10.69, 10.21, 10.32, 10.33 in LLM answer) are factually incorrect in the LLM response. The dates (November 28, 2008 vs. December 31, 2014) also diverge from the ground truth's focus. The LLM answer appears to describe a different disclosure pattern than what the ground truth documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 475,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "In 2022 Booking Holdings began shifting more of its business to a merchant model, facilitating payments to travel‑service providers and recognizing “merchant revenues” on a net basis (commissions, transaction‑net amounts, credit‑card rebates) while deducting incentives and loyalty points at the time they are granted【page_50】. By the 2023 filing the company spells out that its contracts still give providers the right to market availability without transferring delivery responsibility, but revenue is now recognized on a net basis at the point post‑booking services are completed (or at booking for merchant transactions), with cash received in advance recorded as “Deferred merchant bookings” and incentives recorded as reductions when granted【page_83】【page_84】. Thus, the relationship has evolved to a more explicit, timing‑focused revenue‑recognition framework and clearer accounting for deferred payments and incentives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the evolution of BKNG's relationship with travel service providers between 2022 and 2023, but contains several issues:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies the shift toward merchant model and net basis revenue recognition\n- Accurately mentions that revenue is recognized on a net basis (commissions, transaction amounts)\n- Correctly notes the timing of revenue recognition (at point when services are used/post-booking)\n- Appropriately references deferred merchant bookings and incentive accounting\n- Correctly identifies the evolution from general description to more structured accounting framework\n\n(2) PROBLEMATIC ELEMENTS:\n- The claim about 2022 \"shifting more of its business to a merchant model\" is presented as if this was a new development in 2022, but the ground truth indicates 2022 was when BKNG described its intermediary role more generally, with the more detailed accounting treatment coming in 2023\n- The specific page references (page_50, page_83, page_84) cannot be verified against the ground truth and appear to be fabricated citations\n- The answer conflates what was described in 2022 vs 2023 - it suggests merchant model details were prominent in 2022, but ground truth indicates the detailed accounting treatment was more of a 2023 development\n- The phrase \"contracts still give providers the right to market availability without transferring delivery responsibility\" is not explicitly mentioned in the ground truth\n\n(3) MULTI-HOP REASONING:\n- The answer does attempt to synthesize information across two years and connect revenue recognition practices to contractual relationships\n- However, the temporal framing appears inverted or confused regarding when each level of detail was disclosed\n- The reasoning about the evolution is sound in concept but the specific attribution to years may be inaccurate\n\n(4) QUANTITATIVE ACCURACY:\n- No specific numbers are provided in either answer, so this is less critical\n- However, the fabricated page citations are a significant accuracy concern\n\n(5) SEMANTIC EQUIVALENCE:\n- The core concept of evolution from general intermediary description to detailed accounting framework is captured\n- The specific mechanisms (net basis, deferred bookings, incentive timing) are correctly identified\n- But the temporal attribution and specific details about what was disclosed when appear misaligned with ground truth",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 650,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "In the 2023 Form 10‑K the executive‑life‑insurance disclosures appeared as Exhibit 10.11 (Metropolitan Life policy) and Exhibit 10.12 (Pacific Life policy) 【page_5†L10-L13】. In the 2024 Form 10‑K those same items were moved down one slot—Metropolitan Life became Exhibit 10.12 and Pacific Life became Exhibit 10.13—after a new General Guarantee Agreement was inserted as Exhibit 10.11 【page_246†L10-L14】. The change is therefore a renumbering of the exhibit schedule, not a change in the policy content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All factual elements are correct: (1) Exhibit numbering in 2023: 10.11 (Metropolitan Life) and 10.12 (Pacific Life) - CORRECT; (2) Exhibit numbering in 2024: 10.12 (Metropolitan Life) and 10.13 (Pacific Life) - CORRECT; (3) The reason for renumbering: insertion of a new General Guarantee Agreement as Exhibit 10.11 - CORRECT and provides additional context not explicitly stated in the ground truth but consistent with it; (4) The conclusion that this is a renumbering rather than substantive policy change - CORRECT. The LLM answer actually provides slightly more detail than the ground truth by explaining WHY the renumbering occurred (insertion of a new exhibit), which enhances understanding without contradicting the original answer. The multi-hop reasoning is sound: the model correctly synthesized information about the 2023 structure, the 2024 structure, and the reason for the change. All entities (Goldman Sachs, Metropolitan Life, Pacific Life) are correctly identified. The answer directly addresses the question about structural changes in disclosures. Minor deduction from perfect score only because the ground truth doesn't explicitly mention the General Guarantee Agreement as the cause, though this appears to be accurate supplementary information rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 374,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "In the 2022 filing Broadcom highlighted FBAR filters as a key proprietary technology – they are produced in‑house at its U.S. and Singapore III‑V fabs to protect IP, accelerate time‑to‑market, and are explicitly cited as a competitive differentiator (“high‑speed proprietary design expertise, FBAR technology”)【page_13】. By the 2024 filing the discussion of internal manufacturing is broader, referring only to “fabrication capabilities for devices manufactured internally” without singling out FBAR filters, indicating the technology has become a mature part of the portfolio while the company’s competitive positioning now emphasizes overall proprietary design and high‑speed solutions rather than FBAR alone【page_13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that FBAR filters were highlighted as proprietary technology in 2022 with internal fabrication at U.S. and Singapore fabs. (2) Correctly notes the shift in 2024 to broader language about 'fabrication capabilities for devices manufactured internally' without singling out FBAR. (3) Accurately captures the evolution from specific FBAR emphasis to more general portfolio language. (4) Dates (2022, 2024) are correct.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to address the competitive positioning evolution mentioned in the original answer. The ground truth explicitly states that by 2024, the context expanded to include 'a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment.' The LLM answer does not mention these competitors at all, which is a significant gap in answering the 'competitive positioning' aspect of the question. (2) The LLM's interpretation that FBAR 'has become a mature part of the portfolio' is an inference not explicitly supported by the ground truth, which instead emphasizes increased competitive pressure requiring reinforced IP protections. (3) The LLM misses the key insight that competitive pressure increased significantly between 2022 and 2024, which is central to understanding the evolution. (4) The answer doesn't adequately synthesize the multi-hop reasoning about how internal fabrication strategy remained consistent while competitive context intensified.\n\nMULTI-HOP REASONING: The question requires synthesizing (a) strategic importance evolution, (b) manufacturing approach changes, and (c) competitive positioning shifts across 2022-2024. The LLM addresses (a) and (b) reasonably well but largely fails on (c), which represents approximately 1/3 of the required analysis.\n\nSEMANTIC ISSUES: The LLM's characterization of FBAR becoming 'mature' and the shift to 'overall proprietary design' differs from the ground truth's emphasis on intensified competitive pressure requiring reinforced protections. These represent different interpretations of the same data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 583,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "In the 2023 filing Krazati was still a late‑stage pipeline asset, slated for three registrational trials – KRYSTAL‑17 (first‑line NSCLC), KRYSTAL‑10 (second‑line colorectal cancer) and KRYSTAL‑12 (second‑line‑plus KRAS‑mutated NSCLC) (see pages 12 & 14). By the 2024 filing, after the $4.8 billion Mirati acquisition, Krazati had become an FDA/EMA‑approved product for second‑line NSCLC and KRAS‑mutated colorectal cancer, with a new development focus on a first‑line NSCLC combination with a PD‑1 inhibitor, and its acquired marketed product rights were valued at roughly $640 million of definite‑life intangible assets (see pages 93 & 94).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key financial figures are correct - the $4.8 billion Mirati acquisition price is accurate, and the $640 million valuation of definite-life intangible assets for Krazati's marketed product rights is correctly identified. (2) Clinical trial information is accurate - KRYSTAL-17 (1L NSCLC), KRYSTAL-10 (2L CRC), and KRYSTAL-12 (2L+ KRAS-mutated NSCLC) are all correctly cited for 2023. (3) Regulatory status is correct - FDA and EMA approvals for second-line NSCLC and FDA approval for KRAS-mutated colorectal cancer are properly documented. (4) The evolution narrative is sound - the answer effectively contrasts 2023 (late-stage pipeline asset) with 2024 (approved marketed product with expanded development strategy). (5) Multi-hop synthesis is excellent - the answer correctly connects the acquisition event to the change in Krazati's status and development focus. (6) The new development focus on first-line NSCLC combination with PD-1 inhibitor is accurately captured. MINOR CONSIDERATIONS: The LLM answer includes specific page references (pages 12, 14, 93, 94) which add credibility but cannot be independently verified in this evaluation context. The characterization of Krazati as a 'late-stage pipeline asset' in 2023 is slightly more precise than the ground truth's 'part of BMY's oncology portfolio,' showing good contextual understanding. The answer is well-structured, directly addresses both clinical development focus and financial valuation components of the question, and maintains semantic equivalence with the ground truth while providing additional detail about the intangible asset valuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 469,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "In 2022 Booking Holdings described its ties to travel‑service providers mainly as a broad, mutually‑beneficial partnership that expands the providers’ distribution and marketing reach (2022 p. 6‑7). By 2023 the company has moved to a more granular, liability‑focused model: prepaid traveler funds are recorded as “deferred merchant bookings” that represent amounts payable to providers, and a suite of incentive programs—including referral bonuses, rebates, credits and loyalty‑point awards—are explicitly accounted for as reductions of revenue when granted (2023 p. 84‑83). This reflects an evolution from a high‑level partnership narrative to detailed management of financial obligations and provider incentives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core evolution from competitive/partnership framing in 2022 to a more dependent, liability-focused model in 2023; (2) Accurately references 'deferred merchant bookings' as the key balance sheet liability reflecting amounts payable to providers; (3) Correctly identifies the suite of incentive programs (referral bonuses, rebates, loyalty points) and their accounting treatment as revenue reductions; (4) Properly synthesizes the multi-hop relationship evolution across two years; (5) Provides specific page references (2022 p. 6-7, 2023 p. 84-83) showing detailed source engagement. MINOR ISSUES: (1) The LLM describes 2022 relationship as 'mutually-beneficial partnership' while ground truth emphasizes 'primarily competed,' which represents a slight semantic difference in characterization of the 2022 baseline, though both convey a less dependent relationship than 2023; (2) The phrase 'prepaid traveler funds' in the LLM answer is not explicitly mentioned in the ground truth, which focuses on 'deferred merchant bookings' - this is a minor interpretive addition that may or may not be fully supported by the source documents; (3) The LLM's characterization of the shift as 'high-level partnership narrative to detailed management' is interpretive but reasonable. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022 vs 2023) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information about BKNG's relationship evolution across two fiscal years and connects balance sheet items (deferred merchant bookings) with income statement items (revenue reductions for incentives), demonstrating sound multi-hop reasoning. The evolution narrative is logically coherent and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 527,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "In the 2022 filing Broadcom simply listed “custom touch controllers” as a product family within its wireless segment, indicating a component‑supply role (see page_7). By the 2024 filing the company has folded those controllers into its Mobile Device Connectivity Solutions, describing them as processing touch‑screen signals in handsets and tablets and positioning them as an integrated part of the solution set—showing a broader, end‑to‑end involvement across the product‑development lifecycle (see page_6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Broadcom's evolution in Custom Touch Controllers from 2022 to 2024. Both answers correctly identify the shift from a component-supply role to deeper involvement in product development and design. The LLM answer provides more specific detail by naming the 2024 integration into 'Mobile Device Connectivity Solutions' and describing the functional aspect (processing touch-screen signals in handsets and tablets), which adds helpful context while maintaining factual accuracy. The characterization of the evolution—from 'simply listed' as a product family to 'folded into' a broader solution set—effectively captures the strategic shift described in the ground truth. The page references (page_7 for 2022, page_6 for 2024) are cited but cannot be independently verified from the provided context. The multi-hop reasoning is sound: the answer correctly synthesizes information across two filing years and identifies the progression in Broadcom's role. Minor considerations: (1) The ground truth uses 'producing' and 'active producer involved in design and creation' while the LLM uses 'end-to-end involvement across product-development lifecycle'—these are semantically equivalent descriptions of deeper engagement. (2) The LLM provides more granular detail about the 2024 positioning without contradicting the ground truth. (3) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is not a limiting factor. The answer fully addresses the question's multi-part structure regarding evolution from 2022 to 2024 and the shift in role within the product lifecycle.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 466,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "In 2023 Union Pacific’s freight‑car strategy was lease‑heavy – it reported $1.64 billion of operating‑lease assets and $1.25 billion of operating‑lease liabilities (page 68) and only $57 million of lease‑buyouts within its $728 million “locomotives and freight cars” capital spend (page 33). By 2024 the company shifted toward ownership, raising total spending on locomotives and freight cars to $788 million (up from $728 million) and increasing lease‑buyouts to $143 million, while cutting operating‑lease liabilities to $1.27 billion (page 31), indicating a move from leasing to acquiring more owned freight‑car assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All key numbers are correct: $57M lease buyouts in 2023, $143M in 2024 (matching ground truth exactly); $728M to $788M increase in locomotives/freight cars spending; operating-lease liabilities declining from $1.64B to $1.27B. (2) The multi-hop reasoning is sound - the answer correctly synthesizes data across multiple pages (31, 33, 68) and years to show the strategic shift from leasing to ownership. (3) The core narrative matches ground truth: 2023 was lease-heavy, 2024 showed shift toward acquisition/ownership. (4) Specific details about operating-lease assets ($1.64B) and liabilities provide additional context that strengthens the answer. (5) The conclusion about 'move from leasing to acquiring more owned freight-car assets' directly supports the ground truth finding of 'more aggressive stance on asset ownership.' MINOR CONSIDERATIONS: The LLM provides more granular detail than the ground truth (specific page numbers, operating-lease asset figures), which adds credibility but goes slightly beyond the core question. However, this is a strength rather than weakness as it demonstrates source verification. The semantic equivalence is excellent - both answers convey the same strategic evolution. No calculation errors detected. All entities (Union Pacific, years 2023-2024, freight cars, lease buyouts) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 406,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike’s Asia Pacific & Latin America (APLA) segment grew its total revenue from $5.96 bn in FY 2022 to $6.43 bn in FY 2023, with wholesale sales rising from $3.53 bn to $3.74 bn and direct‑to‑consumer sales from $2.43 bn to $2.70 bn (see FY 2022 vs. FY 2023 tables on pages 88 & 87).  EBIT for APLA also improved modestly, increasing from $1.90 bn to $1.93 bn (page 90), reflecting the operational benefit of moving certain APLA businesses to third‑party distributors—a transition highlighted in Note 18 (footnote 1 on page 87).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial numbers (APLA revenue, EBIT figures) and references to Note 18 regarding the transition to third-party distributors, which shows some understanding of the structural changes. However, there are critical issues:\n\n1. QUANTITATIVE ACCURACY PROBLEMS: The LLM provides specific revenue and EBIT figures ($5.96bn to $6.43bn revenue, $1.90bn to $1.93bn EBIT) that cannot be verified against the ground truth. The ground truth does not provide these specific numbers, making it impossible to confirm accuracy. The LLM cites specific page numbers (88, 87, 90) which suggests data extraction, but without access to verify these figures, they represent unconfirmed claims.\n\n2. INCOMPLETE ADDRESSING OF QUESTION: The original question asks about 'financial and operational impacts' of structural changes, particularly regarding the transition. The ground truth emphasizes: (a) non-recurring impairment charges and foreign currency translation losses in FY2022, (b) the shift from direct operations to strategic stake with third-party distributors, and (c) reduction of operational overhead. The LLM answer focuses primarily on revenue and EBIT growth but largely omits the critical financial impacts mentioned in the ground truth (impairment charges, foreign currency impacts, non-cash cumulative translation losses).\n\n3. MISSING KEY CONTEXT: The ground truth emphasizes that FY2022 involved 'non-recurring impairment charges' and 'non-cash cumulative foreign currency translation losses' - these are significant financial impacts that the LLM answer does not address. The transition's financial impact goes beyond simple revenue/EBIT changes.\n\n4. PARTIAL ALIGNMENT: The LLM correctly identifies the transition to third-party distributors and references Note 18, which aligns with the ground truth. It also correctly identifies this as an operational benefit, which is semantically consistent with the ground truth's mention of 'improve financial efficiency.'\n\n5. REASONING QUALITY: The LLM attempts multi-hop synthesis by connecting revenue/EBIT data to the structural transition, but this reasoning is incomplete because it misses the primary financial impacts (impairment charges, FX translation losses) that are central to understanding the structural changes' financial impact.\n\nThe answer demonstrates partial understanding but fails to comprehensively address the financial impacts (particularly non-recurring charges and FX impacts) that are central to the question, and provides unverified specific numbers that may or may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 686,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "In 2022 Broadcom said it kept the production of its GaAs‑ and InP‑based vertical‑cavity surface‑emitting and side‑emitting lasers for fiber‑optic communications in its own III‑V wafer fabs in the United States and Singapore, using internal fabrication to protect IP and accelerate time‑to‑market while outsourcing commodity CMOS processes (AVGO 2022 10‑K, p. 13). The 2024 filing repeats that same internal‑fabrication strategy for InP lasers, indicating the approach has not changed and that Broadcom continues to rely on its proprietary fab capability to differentiate itself in a market that includes many integrated device manufacturers, fabless firms and specialist optical‑laser companies such as Lumentum and MACOM (AVGO 2024 10‑K, p. 15; competition list in 2022 p. 13).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the core strategy in both 2022 and 2024 - internal fabrication of GaAs and InP lasers for fiber-optic communications; (2) Accurately cites specific locations (United States and Singapore); (3) Properly identifies the strategic rationale (IP protection, time-to-market acceleration); (4) Correctly names competitors (Lumentum, MACOM) and notes the competitive landscape shift; (5) Appropriately references specific 10-K pages and filing years; (6) Accurately characterizes the evolution as a continuation of the same strategy rather than a major change. MINOR WEAKNESSES: (1) The LLM answer is more detailed and specific than the ground truth (mentioning outsourcing of commodity CMOS processes, specific fab locations, and more detailed competitive context), which could be seen as either enhancement or potential over-interpretation; (2) The ground truth emphasizes a 'strategic shift toward highlighting InP laser capabilities' while the LLM characterizes it as 'the approach has not changed' - these are subtly different framings. The ground truth suggests increased emphasis/visibility of competitive positioning, while the LLM emphasizes continuity of the underlying strategy. This is a nuanced difference in interpretation rather than a factual error. QUANTITATIVE ACCURACY: All dates (2022, 2024) and entity names are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and correctly identifies the relationship between internal fabrication strategy and competitive positioning. The logic is sound and well-supported by specific references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 473,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "In the 2022 filing Nike disclosed that Swoosh LLC owned about 77 % of the company’s Class A shares – a stake that would become roughly 16 % of the Class B pool if all were converted (2022 Form 10‑K, p. 25). The 2023 filing repeats the same figures – Swoosh LLC still holds about 77 % of Class A (and would be ~16 % of Class B on conversion) (2023 Form 10‑K, p. 26). Because Class A shares elect three‑quarters of the board, this unchanged concentration gives Swoosh LLC (and the Knight family) decisive voting power, limiting the influence of other shareholders unless a conversion to Class B occurs, which would dilute that control.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) All key percentages are correct - 77% Class A ownership and ~16% Class B conversion equivalent for both 2022 and 2023; (2) Correctly identifies the consistency of ownership structure between years; (3) Accurately synthesizes the implications for shareholder influence, noting the concentration of voting power; (4) Provides additional relevant context about Class A shares electing three-quarters of the board, which strengthens the analysis of shareholder influence implications; (5) Correctly identifies Travis Knight/Knight family connection (though the original answer mentions 'Travis Knight' while the LLM says 'Knight family' - both are semantically equivalent and accurate). MINOR CONSIDERATIONS: (1) The LLM adds specific detail about Class A shares electing 'three-quarters of the board' which, while relevant and likely accurate, is not explicitly stated in the original answer - this is an enhancement rather than an error; (2) The LLM provides page references (p. 25 for 2022, p. 26 for 2023) which adds credibility but cannot be verified against the ground truth provided; (3) The original answer mentions 'Travis Knight' specifically while the LLM generalizes to 'Knight family' - this is a minor semantic variation that doesn't affect accuracy. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023 filings, compares ownership structures, and draws appropriate conclusions about shareholder influence implications. The logic is sound and well-articulated. No calculation errors detected. The answer fully addresses both the evolution of ownership structure and the implications for shareholder influence as requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 485,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "In the 2022 filing PMI described reduced‑risk products (RRPs) as a broad, developing “smoke‑free” suite—including heat‑not‑burn, e‑vapor and oral nicotine—led by its IQOS brand and treated as a separate product category (PM 2022 p. 95). By the 2023 filing, after acquiring Swedish Match, PMI emphasized that the ZYN oral‑nicotine franchise was being combined with IQOS into a unified smoke‑free portfolio, that Swedish Match results would be folded into the four geographic segments, and that its smoke‑free products were now sold in 84 markets (PM 2023 p. 28‑29).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several key facts correctly but has significant omissions and some inaccuracies in characterizing the evolution. CORRECT ELEMENTS: (1) The 84 markets figure for 2023 is accurate; (2) The mention of IQOS and ZYN brands is appropriate; (3) The reference to Swedish Match acquisition and integration into geographic segments is relevant context; (4) The general characterization of smoke-free portfolio consolidation is directionally correct. SIGNIFICANT OMISSIONS: (1) The ground truth explicitly states that in 2022, RRPs were classified as a 'distinct category' with 'separate net revenue reporting'—the LLM answer describes them as part of a 'broad, developing smoke-free suite' but doesn't clearly establish the 2022 categorization as distinct/separate; (2) The ground truth emphasizes the 2023 shift to 'Smoke-Free Products (SFPs)' as a broader category that 'also included wellness and healthcare offerings'—the LLM answer mentions the unified smoke-free portfolio but doesn't explicitly reference the wellness/healthcare expansion or the formal SFP category name; (3) The ground truth notes 'unspecified market availability in 2022' as a contrast point, which the LLM answer doesn't address. CHARACTERIZATION ISSUES: The LLM describes 2022 RRPs as already part of a 'smoke-free suite,' which somewhat conflates the 2022 and 2023 positioning. The ground truth indicates a clearer evolution from 'distinct category' (2022) to 'integrated into broader category' (2023). QUANTITATIVE ACCURACY: The 84 markets figure is correct; no calculation errors detected. MULTI-HOP REASONING: The answer does synthesize information across 2022 and 2023 filings and mentions the Swedish Match acquisition as a contextual factor, showing reasonable multi-hop reasoning, though it doesn't fully capture the categorical/structural evolution emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 509,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "In 2022 Caterpillar portrayed its reciprocating‑engine business as a core, volume‑driven line sold principally through its worldwide dealer network and its Perkins, FG Wilson and MaK subsidiaries, emphasizing broad distribution rather than targeted profitability (2022 p. 9). By 2024 the engines were positioned as a strategic growth driver within the Energy & Transportation segment, with sales moving from flat well‑servicing to growth in large data‑center generator sets and gas‑compression applications, and with stronger price‑realization and a more favorable product mix lifting segment profit and gross‑margin potential (2024 p. 37‑38, 40).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM introduces subsidiaries (FG Wilson and MaK) that are not mentioned in the ground truth answer, which specifically references only Perkins Engines Company Limited and its 90 distributors across 171 countries. (2) The LLM shifts focus to data-center generator sets and gas-compression applications as growth drivers, which are not mentioned in the ground truth. The ground truth emphasizes the evolution from selling engines to offering remanufacturing services. (3) The LLM completely omits the key strategic evolution identified in the ground truth: the shift from being primarily a seller to becoming a full lifecycle service provider that remanufactures engines and components. (4) The LLM does not address the specific margin improvement mechanism mentioned in ground truth (remanufacturing having lower material costs than new production). (5) Page citations (2022 p. 9, 2024 p. 37-38, 40) cannot be verified against the ground truth source. PARTIAL CREDIT: The LLM correctly identifies the time period (2022-2024), correctly names Caterpillar, and does attempt to address the evolution of strategic role and margin potential. However, the specific content of that evolution is fundamentally different from the ground truth. The answer appears to describe a different strategic narrative (market segment shifts and pricing) rather than the business model transformation (seller to service provider/remanufacturer) that is the core of the ground truth answer. This represents a failure in multi-hop synthesis and factual accuracy on the primary question elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 457,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon said that its Directors’ Code of Conduct is posted on its website and that any amendments or waivers to that code “will be disclosed on our website” 【page_11】. The 2023 filing repeats the same commitment—using the corporate website to publish any changes—but updates the URL to a new location, reaffirming that the website remains the primary, publicly‑accessible mechanism for informing stakeholders of any amendments or waivers 【page_13】. The evolution is therefore a refinement of the web link rather than a change in the disclosure approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. Key strengths: (1) Correctly identifies that BNY Mellon's approach remained consistent between 2022 and 2023, matching the ground truth statement that there was 'no change in the specific mechanism or transparency commitment'; (2) Accurately captures the core disclosure mechanism (website posting of amendments/waivers) in both years; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Correctly identifies the company and relevant governance documents. The LLM adds a detail about URL updates that represents a refinement rather than a substantive change in approach, which is a reasonable interpretation and doesn't contradict the ground truth. Minor consideration: The ground truth emphasizes 'no change' in the disclosure approach, while the LLM characterizes it as 'a refinement of the web link rather than a change in the disclosure approach'—these are semantically equivalent conclusions. The LLM's answer is slightly more detailed and specific (mentioning the URL change) while still maintaining the core finding that the transparency commitment remained stable. No quantitative errors, dates are correct (2022 and 2023), and the reasoning about consistency across years is sound. The answer fully addresses the question about how the approach 'evolved' by correctly noting it remained consistent with only technical refinements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 400,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Nike’s FY‑22 filing disclosed that it had entered definitive agreements to sell its Argentina, Uruguay and Chile legal entities and would shift those APLA markets from a combined wholesale‑and‑direct‑to‑consumer operating model to a third‑party distributor model, a change it said would curb short‑term revenue growth but improve profitability (FY 22 overview, p. 32). By FY 23 the divestiture was in progress – the operating‑segment note still references the transition to distributors – and APLA revenue rose to $6.4 bn (from $5.96 bn) with NIKE Direct sales continuing to increase, reflecting a mix of distributor participation and an expanding direct‑to‑consumer presence (FY 23 segment note, p. 89; revenue tables, p. 87‑90).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific detail than the ground truth. Key strengths: (1) Correctly identifies the strategic shift from direct operations to third-party distributors in APLA; (2) Accurately cites specific countries (Argentina, Uruguay, Chile) affected by the transition; (3) Provides specific revenue figures ($6.4bn in FY23 vs $5.96bn in FY22) that are verifiable and relevant; (4) Correctly notes the trade-off between short-term revenue growth and profitability improvements; (5) Properly synthesizes multi-hop information across FY22 and FY23 filings. Minor considerations: (1) The ground truth is more general/conceptual while the LLM answer is more specific with concrete examples and numbers - this is actually a strength showing deeper filing analysis; (2) The LLM answer mentions NIKE Direct sales continuing to increase in FY23, which aligns with the ground truth's reference to 14% growth in NIKE Direct business; (3) Page citations (p. 32, p. 89, p. 87-90) add credibility though cannot be independently verified in this context. The answer fully addresses the question's two components: (1) operational structure evolution (direct to distributor model) and (2) market participation changes (shift to partner-driven approach). Quantitative data appears accurate and calculations are sound. The reasoning correctly synthesizes the transition narrative across both fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 399,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "In the 2022 filing (covering FY 2021), favorable price realization was a key driver of growth – it helped lift sales by 22 % and was a major factor in the 51 % jump in operating profit (see pages 34‑36). By 2024, sales fell about 3 % year‑over‑year, but favorable price realization still added to results, partially offsetting the volume decline and more than offsetting its profit impact, keeping operating profit margin above 20 % (see page 30).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - Ground truth states favorable price realization contributed $9.223 billion increase in 2022 sales - LLM provides only a vague '22%' percentage without the actual dollar amount\n   - Ground truth specifies profit increased from $10.335B (2023) to $10.792B (2024) - LLM provides no specific profit figures for 2024, only mentions 'above 20%' operating margin\n   - Ground truth indicates $2.251 billion decrease in sales volume in 2024 - LLM vaguely states 'sales fell about 3%' without the actual dollar amount\n   - LLM references '51% jump in operating profit' which is not mentioned in ground truth and appears to be incorrect or from wrong period\n\n2. TEMPORAL CONFUSION:\n   - LLM states '2022 filing (covering FY 2021)' which is confusing and potentially incorrect framing\n   - Ground truth clearly addresses 2022, 2023, and 2024 data\n   - LLM's temporal references are unclear and don't align with the ground truth timeline\n\n3. MISSING KEY INFORMATION:\n   - LLM fails to provide the specific $9.223 billion figure for 2022\n   - LLM fails to provide the specific profit figures ($10.335B to $10.792B transition)\n   - LLM fails to provide the specific $2.251 billion volume decrease\n   - LLM omits context about dealer inventories and end-user demand mentioned in ground truth\n\n4. REASONING QUALITY:\n   - While LLM correctly identifies that favorable price realization offset volume declines, it does so without the supporting quantitative evidence\n   - The synthesis is incomplete and lacks the specific financial metrics needed to substantiate the claims\n   - Page references (34-36, 30) cannot be verified against ground truth\n\n5. SEMANTIC ISSUES:\n   - The answer conflates percentages with absolute dollar amounts without clarity\n   - The statement about 'operating profit margin above 20%' is vague and doesn't match the specific profit increase data in ground truth\n\nThe LLM answer demonstrates understanding of the general trend (favorable pricing offsetting volume declines) but fails dramatically on quantitative accuracy and completeness, which are critical for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 605,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "In the 2023 filing GM stressed that it would make “significant investments” to expand EV‑manufacturing capacity and was building a “more resilient, scalable and sustainable North‑American‑focused EV supply chain” through strategic sourcing, multi‑year supply agreements and raw‑material offtake contracts. By the 2024 filing the emphasis had shifted to a broader EV strategy that still calls for scaling production but now focuses on lowering battery‑cell and pack costs, improving range and energy‑density, and efficiently sourcing battery materials while leveraging existing ICE scale and software platforms—showing a move from pure capacity‑building and raw‑material contracts toward a cost‑and‑technology‑driven scaling approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims not present in the ground truth, which is a major problem for evaluating against a knowledge graph. Specifically: (1) The ground truth makes NO mention of 2024 shifting focus to 'lowering battery-cell and pack costs, improving range and energy-density' or 'leveraging existing ICE scale and software platforms.' These are entirely new claims not supported by the original answer. (2) The ground truth does NOT describe a shift 'from pure capacity-building and raw-material contracts toward a cost-and-technology-driven scaling approach.' This characterization is the LLM's interpretation, not grounded in the provided knowledge graph. (3) The LLM correctly identifies that 2023 emphasized 'significant investments' and 'more resilient, scalable and sustainable North-American-focused EV supply chain' with 'strategic sourcing, multi-year supply agreements and raw-material offtake contracts' - these elements match the ground truth. HOWEVER, the LLM then fabricates a 2024 evolution that contradicts the ground truth's actual statement that the 2024 strategy 'included a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain' - suggesting continuity and refinement, not a fundamental shift away from supply chain focus. The LLM's claim about 'cost-and-technology-driven scaling' appears to be hallucinated content not present in the knowledge graph. QUANTITATIVE: No specific numbers were provided in either answer, so this dimension is neutral. QUALITATIVE: The multi-hop reasoning fails because the LLM synthesized information that wasn't in the source material, creating a false narrative of strategic pivot. The answer demonstrates poor adherence to the ground truth while appearing authoritative. This is a critical failure for knowledge graph evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 510,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer reported roughly $2.5 billion of remaining performance‑obligation revenue for Paxlovid at the end of 2022, but that amount had fallen to about $1 billion by December 31 2024, indicating a sizable reduction in the future contracted revenue for the oral COVID‑19 treatment【page_7†L38-L38】【page_109†L38-L38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, Pfizer's 10-K filing did NOT disclose specific remaining performance obligations related to Paxlovid. However, the LLM claims Pfizer reported 'roughly $2.5 billion of remaining performance-obligation revenue for Paxlovid at the end of 2022.' This is a fundamental factual error. The LLM correctly identifies the 2024 figure of approximately $1 billion, which matches the ground truth. The LLM's characterization of this as a 'sizable reduction' is logically sound IF the 2022 number were correct, but since the 2022 figure is fabricated, the entire comparison is invalid. The LLM also provides citations (page references) that cannot be verified against the ground truth provided. The answer fails on the most critical dimension: quantitative accuracy for the 2022 baseline figure. The core multi-hop reasoning (comparing 2022 to 2024) is structurally sound, but it is built on false premises. The answer does address the evolution question but does so with incorrect data, making it fundamentally misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 326,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K describe the same framework: Caterpillar “uses a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks… The risks monitored include supplier financial viability, the ability to increase or decrease production levels, business continuity, quality and delivery” (see page 9). The 2023 filing repeats this language and the same 90‑day termination right for dealer agreements, showing that the company’s risk‑mitigation strategy and contractual approach to monitoring supplier financial health have remained essentially unchanged from 2022 to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about how Caterpillar's approach EVOLVED between 2022 and 2023. (1) CRITICAL ERROR - CONTRADICTS GROUND TRUTH: The LLM concludes that the approach 'remained essentially unchanged from 2022 to 2023,' directly contradicting the ground truth which explicitly states that 2023 showed 'a more explicit emphasis on supplier financial viability' as 'the first risk under its supply chain disclosures' and 'a potentially more structured or prioritized focus on supplier financial health compared to 2022.' This is a fundamental misinterpretation of the evolution being asked about. (2) INCOMPLETE ANALYSIS: The LLM focuses only on the similarity of contractual language and monitoring processes but completely misses the key evolution identified in the ground truth: the shift in prioritization and emphasis of supplier financial viability in 2023 disclosures. The ground truth specifically notes that supplier financial viability was listed 'as the first risk' in 2023, indicating a change in emphasis/prioritization. (3) MISSING CONTEXT: The LLM fails to address the 2023 reinforcement of 'global strategic sourcing models to build long-term supplier relationships,' which the ground truth identifies as evidence of a more structured approach to supplier financial health. (4) QUANTITATIVE ACCURACY: The specific details about 90-day termination rights and page references appear accurate, but these details don't address the evolution question. (5) REASONING FLAW: The LLM's logic that 'same language = unchanged approach' is flawed because the ground truth indicates that while the framework remained similar, the emphasis, prioritization, and strategic focus evolved. The question asks specifically about evolution, and the LLM's conclusion of 'essentially unchanged' directly contradicts the ground truth's identification of meaningful evolution in emphasis and strategic focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 526,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "In the 2022 filing Visa only mentioned risk and identity solutions as one of its generic “value‑added services” (e.g., “We provide value added services … risk and identity solutions” 【page_5】). By the 2024 filing the company has repositioned this offering as a flagship, AI‑driven “Visa Protect” suite—adding new products such as Visa Deep Authorization, Visa Protect for A2A payments and a scheme‑agnostic Visa Advanced Authorization—and integrated it into a broader, network‑agnostic value‑added‑services strategy that now includes more than 200 coordinated products (see the Value‑Added Services overview 【page_11】 and the detailed Risk and Identity Solutions description 【page_12】). This marks a shift from a peripheral service listing to a central, technology‑focused component of Visa’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution narrative (from generic listing to more strategic positioning) and correctly identifies the shift toward a more integrated, network-agnostic approach. However, there are significant accuracy issues:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The claim about \"more than 200 coordinated products\" is not verified in the ground truth and appears to be an unsupported specific number. The original answer does not mention this figure.\n   - Page references (page_5, page_11, page_12) are cited but cannot be verified against the ground truth provided.\n\n2. ENTITY/PRODUCT ACCURACY ISSUES:\n   - The LLM introduces specific product names (\"Visa Protect,\" \"Visa Deep Authorization,\" \"Visa Protect for A2A payments,\" \"Visa Advanced Authorization\") that are NOT mentioned in the ground truth answer. While these may exist in the actual filings, they represent factual claims not supported by the provided ground truth.\n   - The ground truth describes a \"three-pillar strategy\" but does not mention \"Visa Protect\" as a flagship suite or the specific product names cited.\n\n3. MULTI-HOP REASONING:\n   - The LLM correctly synthesizes the 2022 vs 2024 comparison and identifies the shift from peripheral to central positioning.\n   - However, the specific details about AI-driven positioning and product names go beyond what the ground truth supports.\n\n4. SEMANTIC ALIGNMENT:\n   - The core narrative (evolution from generic service to strategic integration with network-agnostic approach) aligns with ground truth.\n   - The three-pillar framework is mentioned in ground truth but the LLM's characterization of specific products and the \"200+ products\" claim diverges from the provided ground truth.\n\n5. CRITICAL ISSUE:\n   - The LLM appears to have added specific product details and metrics that may be from actual filings but are NOT present in the ground truth answer provided. This represents either hallucination or information synthesis beyond the scope of the ground truth, which is problematic for evaluation purposes.\n\nThe answer demonstrates good understanding of the directional evolution but introduces unverified specific claims that reduce factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 597,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "In the 2022 Form 10‑K the company warned that “changes in the policies or practices of our retail trade customers…such as inventory de‑stocking, fulfillment requirements, **limitations on access to shelf space**, delisting of our products” could hurt sales, and it noted that the rapid growth of e‑commerce and new channels (subscriptions, direct‑to‑consumer) were already creating pricing pressure and could strain retailer relationships【page_11】. The 2023 filing repeats the same shelf‑space‑limitation risk but stresses that “the retail landscape…continues to evolve as a result of the **continued growth of eCommerce** and the **increased presence of alternative retail channels**…which have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers”【page_31】. Thus, while the exposure to shelf‑space constraints remains, the 2023 discussion frames it as a heightened risk because the expansion of e‑commerce and alternative channels has intensified the pressure on shelf‑space access and retailer dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies the evolution of shelf space limitations as a risk factor from 2022 to 2023, capturing the shift from potential risk to actively experienced challenge; (2) Accurately quotes and references specific language from both 2022 and 2023 filings regarding shelf space limitations, inventory de-stocking, and delisting; (3) Properly synthesizes the connection between eCommerce growth, alternative retail channels (subscriptions, direct-to-consumer), and their impact on shelf space access and retailer relationships; (4) Correctly identifies the temporal evolution showing heightened pressure in 2023 compared to 2022; (5) Appropriately contextualizes the company's response (investment in digital and analytics capabilities is implied through the discussion of evolving retail dynamics). MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more detailed quotations and page references than the ground truth, which adds specificity but doesn't contradict the original answer; (2) The ground truth explicitly mentions the company's plan to invest in digital and analytics capabilities, while the LLM answer implies this through the discussion of evolving dynamics rather than stating it directly - however, this is a minor omission that doesn't significantly detract from the core answer; (3) Both answers correctly identify the shift from potential to active impact. VERIFICATION: All dates (2022, 2023), entities (retail customers, eCommerce, alternative channels), and risk factors (shelf space limitations, delisting, pricing pressure) are accurately represented. The multi-hop reasoning correctly synthesizes information across two fiscal years and connects retail policy changes to broader market dynamics. No numerical errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 515,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "In FY 2023 Oracle framed hybrid‑deployment as a set of distinct products – for example, Exadata Cloud@Customer, Dedicated Region instances and multicloud options – and positioned “choice and flexibility” in hybrid models as a core growth driver 【page_6】. By FY 2024 the filing no longer lists those individual offerings; instead it describes hybrid deployment simply as one of the flexible, interoperable on‑premise/cloud models that underpin its broader Oracle Cloud Services portfolio, signalling a shift toward a unified, cloud‑first strategy that integrates hybrid capabilities across its entire suite 【page_72】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the fiscal years (FY 2023 and FY 2024) and the key products mentioned in the ground truth (Exadata Cloud@Customer, Dedicated Region). (2) The LLM accurately captures that FY 2023 emphasized 'choice and flexibility' as core messaging. (3) The LLM correctly notes a strategic evolution between the two years. (4) No quantitative errors in dates or product names. WEAKNESSES: (1) SIGNIFICANT SEMANTIC DIVERGENCE: The LLM claims that by FY 2024 'the filing no longer lists those individual offerings' and describes a shift toward 'cloud-first strategy,' which contradicts the ground truth. The ground truth explicitly states that 'by fiscal 2024, Oracle continued to support hybrid deployments' - meaning these offerings were NOT discontinued. The LLM mischaracterizes the evolution as a removal/consolidation when the ground truth indicates continuation with deeper integration. (2) The LLM's characterization of FY 2024 as moving toward a 'unified, cloud-first strategy' is not supported by the ground truth, which emphasizes 'deeper integration and support for customer-managed cloud and on-premise IT environments' - a hybrid-focused (not cloud-first) approach. (3) The LLM's interpretation that individual offerings were 'no longer listed' appears to be a misreading of filing structure rather than actual strategic change. (4) Missing the key ground truth element about 'more specific product integrations and services tailored for hybrid environments' and the emphasis on 'interoperability and extensibility with other IT and cloud environments.' MULTI-HOP REASONING: The LLM attempts to synthesize across two fiscal years but arrives at an incorrect conclusion about the nature of the strategic shift. The reasoning is internally consistent but factually misaligned with the ground truth narrative of continuation and deepening rather than consolidation and cloud-first pivot.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 520,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer’s 2024 Form 10‑K shows that the company had roughly **$1 billion of remaining performance‑obligation (contracted‑revenue) for Paxlovid** as of 31 Dec 2024【page_109】. The 2022 filing did not disclose a comparable RPO amount, but Paxlovid generated **$18.9 billion of revenue in 2022**【page_23】, indicating that the future contractual revenue expectation was substantially larger at that time. Thus, Pfizer’s financial commitment to Paxlovid has been reduced, with the amount of revenue still expected from existing contracts falling to about one‑quarter of its earlier scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and numbers. Strengths: (1) Correctly identifies the ~$1 billion remaining performance obligation (RPO) for Paxlovid as of December 31, 2024, matching the ground truth; (2) Accurately cites the $18.9 billion revenue in 2022, providing concrete evidence of the decline; (3) Properly synthesizes the multi-hop comparison between 2022 and 2024 periods; (4) Correctly interprets that the future contracted revenue represents a substantial reduction from pandemic-era levels. The calculation that $1 billion is roughly one-quarter of $18.9 billion is mathematically sound (approximately 5.3%, though the LLM states 'about one-quarter' which is slightly imprecise but directionally correct for illustrating the magnitude of decline). Minor weaknesses: (1) The ground truth mentions contracted revenue expected to be recognized from 2025 through 2028, which the LLM answer does not explicitly state, though this is a relatively minor omission; (2) The characterization of 'one-quarter' is slightly loose—$1B is closer to 5% of $18.9B, not 25%, though the intent to show substantial reduction is clear and the phrasing 'about one-quarter of its earlier scale' could be interpreted as referring to the scale of commitment rather than a precise ratio. The answer effectively addresses the evolution of Pfizer's financial commitment and demonstrates sound multi-hop reasoning by connecting 2022 revenue data with 2024 RPO figures to show the trajectory of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 425,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "In the 2022 filing Caterpillar simply described its sales model as “a global network of independent dealers…building long‑term relationships with customers” (see 2022 p. 4). By the 2023 filing the company says those relationships are now memorialized in standard sales‑and‑service agreements that grant dealers the right to purchase, sell, service and use Caterpillar trademarks, but also obligate them to develop and promote sales, staff adequate sales‑and‑support personnel, participate in product‑improvement programs, keep detailed financial and inventory records, and are terminable at‑will with 90‑day notice (see 2023 p. 10). This shift reflects a move from a broad, network‑focused description to a more formal, contract‑driven partnership with an explicit strategic emphasis on dealer‑driven growth and accountability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2023 - from general partnership language to formalized contractual framework; (2) Accurately captures the shift in strategic emphasis from broad network description to formal, contract-driven partnership; (3) Provides specific contractual obligations mentioned in 2023 filings (right to purchase/sell/service, trademark usage, development/promotion requirements, personnel staffing, financial/inventory record-keeping, 90-day termination notice); (4) Includes helpful citations to specific filing pages (2022 p. 4, 2023 p. 10) that enhance credibility; (5) Multi-hop reasoning is sound - correctly synthesizes information across two years to show evolution; (6) Semantic equivalence is strong - conveys same core message as ground truth with slightly more detail and specificity. MINOR CONSIDERATIONS: (1) The LLM answer includes additional details not explicitly mentioned in the ground truth (trademark usage rights, 90-day termination notice, product-improvement programs, inventory records) - these appear to be accurate elaborations from the actual filings but go slightly beyond the ground truth summary; (2) The phrase 'dealer-driven growth' is LLM's interpretation rather than explicitly stated in ground truth, though it's a reasonable inference from the context. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are involved in this question, so this dimension is not heavily weighted. The dates (2022 vs 2023) are correct. QUALITATIVE ACCURACY: The reasoning about the shift from informal to formal relationships is sound and well-supported. Entity identification (Caterpillar, independent dealers, sales agreements) is correct throughout. The synthesis across two filing years is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 511,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "The company’s most recent capital‑expenditure data show a relatively sizable investment in Africa/Eurasia – $33 million was spent on the region (up from $13 million the year before)【page_117】.  Yet the portion of the Global Productivity Initiative’s restructuring costs allocated to Africa/Eurasia dropped markedly, falling from 11 % of total charges in 2022 to only 5 % in 2023【page_48】.  This indicates that while capital spending in the region remained strong, the focus on restructuring and cost‑saving activities there was sharply reduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CAPITAL EXPENDITURE DATA: LLM correctly states $33 million for 2022 and $13 million for 2021, matching ground truth. However, the ground truth indicates this $33M figure represents 2022 data, not 'most recent' - the LLM's framing is ambiguous about which year this applies to. (2) RESTRUCTURING CHARGES - CRITICAL ERROR: The LLM claims the Global Productivity Initiative restructuring costs allocated to Africa/Eurasia 'dropped markedly, falling from 11% of total charges in 2022 to only 5% in 2023.' This is FACTUALLY INCORRECT. The ground truth states that in 2023, approximately 10% of cumulative pretax charges from the 2022 Global Productivity Initiative would relate to Africa/Eurasia initiatives. The LLM has invented percentages (11% in 2022, 5% in 2023) that do not appear in the ground truth and contradicts the actual finding. (3) INTERPRETATION ERROR: The LLM concludes that 'focus on restructuring and cost-saving activities there was sharply reduced,' which contradicts the ground truth's finding that there was a 'shift in focus toward restructuring and cost optimization' - the opposite conclusion. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the two key data points: capital expenditures remained at $33M in 2022, while restructuring charges (approximately 10% in 2023) indicated a strategic shift toward operational restructuring rather than continued capital investment. The LLM's invented percentage comparisons (11% to 5%) are completely unsupported by the ground truth. (5) MISSING CONTEXT: The LLM fails to mention the 2020 baseline ($8M) or properly contextualize the strategic evolution from growth-oriented capital allocation to operational restructuring.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 471,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "In the 2022 Form 10‑K Qualcomm stressed that it was “investing significant resources toward advancements primarily in support 5G‑based technologies” and that its growth “depends significantly on our ability to develop and patent 5G technologies, and to develop and commercialize products using 5G technologies” – a stage still focused on development and the risk that those investments might not yet yield returns (2022 10‑K, p. 21). By the 2024 filing the narrative had shifted to concrete 5G commercialization: the company highlights Snapdragon 5G modem‑RF platforms, sub‑6 GHz and mmWave RFFE components, and a leading 5G‑NR patent portfolio, showing that its 5G investments have moved into product roll‑outs across mobile, automotive and IoT markets while still funding ongoing R&D (2024 10‑K, pp. 11‑13).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Qualcomm's 5G strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 phase as investment-focused with emphasis on development and risk acknowledgment; (2) Accurately characterizes the 2024 phase as commercialization-focused with concrete product examples (Snapdragon 5G modem-RF platforms, sub-6 GHz and mmWave RFFE components); (3) Properly synthesizes the transition from development to market leadership across multiple industries (mobile, automotive, IoT); (4) Appropriately cites specific document references (2022 10-K p. 21, 2024 10-K pp. 11-13) showing multi-hop reasoning across years; (5) Maintains semantic equivalence with ground truth regarding patent portfolio development and licensing. MINOR GAPS: (1) The LLM answer does not explicitly mention QTL revenues or OFDMA-based products generating majority revenues, which the ground truth specifically highlights as evidence of successful commercialization; (2) Does not explicitly reference the 'long design-in cycles' risk factor mentioned in ground truth for automotive/IoT; (3) Could have been more explicit about the shift from 'primarily investment phase' to 'mature stage' terminology. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the evolution across two time periods and multiple business segments. The logic connecting investment phase to commercialization phase is clear and well-supported. OVERALL: The answer captures the essential narrative arc and provides specific, verifiable product examples that demonstrate the evolution, though it misses one key metric (QTL revenue composition) that would have strengthened the commercialization evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 534,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "In 2022 Paxlovid produced $18.9 billion of revenue (≈19% of total $101.2 billion) and most of its sales came from government contracts – the U.S. government accounted for 23% of Pfizer’s total revenue that year【page_108†L30-L38】. By 2024 Paxlovid revenue had fallen to $5.7 billion (≈9% of total $63.6 billion) as the product moved to commercial markets, the U.S. government share dropped to 6% and the company recorded about $1 billion of remaining performance‑obligation contracts for future Paxlovid deliveries【page_108†L0-L8】【page_107†L31-L38】. This reflects a strategic shift from a government‑driven, EUA‑supplied product in 2022 to a commercially‑oriented portfolio with a smaller, but still material, pipeline of contractual commitments by 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) 2022 Paxlovid revenue: LLM claims $18.9 billion vs. ground truth of $76 million - a massive discrepancy of over 240x the actual figure. (2) 2024 Paxlovid revenue: LLM claims $5.7 billion, but ground truth explicitly states 'direct revenue figures for Paxlovid are not explicitly stated' in 2024. The LLM fabricated a specific number that doesn't exist in the source documents. (3) U.S. government revenue percentages: LLM claims 23% in 2022 and 6% in 2024, but these appear to be total government revenue percentages, not Paxlovid-specific figures, and the ground truth doesn't provide these specific breakdowns. (4) Total Pfizer revenue figures: LLM cites $101.2 billion (2022) and $63.6 billion (2024) - these numbers are not verified in the ground truth and appear inconsistent with actual Pfizer financials. (5) The $1 billion remaining performance obligations figure is correct and matches ground truth. The LLM fundamentally misunderstood the question by providing invented revenue numbers rather than acknowledging the lack of explicit 2024 Paxlovid revenue disclosure. The multi-hop reasoning is flawed because it's based on false premises. The only correct element is the mention of ~$1 billion in remaining contractual commitments. The answer demonstrates hallucination of specific financial figures rather than synthesis of actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 405,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "In 2022 the company listed “the impact on our suppliers of tighter credit or capital markets” as a supply‑chain risk (2022 p. 16). By 2023 the discussion had broadened to note that “disruptions and volatility in the global capital markets, including rising interest rates, may increase the cost of capital and adversely impact our access to capital,” indicating that the firm now sees credit‑market tightness as a direct financing risk as well as a supplier issue (2023 p. 13). This shift reflects a growing vulnerability to external financial conditions, moving from a supplier‑focused exposure to a broader sensitivity to overall credit market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the temporal evolution between 2022 and 2023, accurately cites page numbers (2022 p. 16, 2023 p. 13), and recognizes the shift from supplier-focused risk to broader company-level exposure. The core factual claim about the evolution is sound. WEAKNESSES: (1) The LLM's characterization diverges from the ground truth in a material way. The ground truth emphasizes that 2023 framing shifted to 'impacted by' conditions (ongoing vulnerability), whereas the LLM introduces a new dimension about 'direct financing risk' and 'access to capital' that is not present in the ground truth answer. (2) The ground truth specifically states the 2023 shift reflects 'a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience' - emphasizing supply chain resilience. The LLM reframes this as a 'direct financing risk' which, while plausible, represents an interpretation beyond what the ground truth supports. (3) The LLM's conclusion about 'moving from a supplier-focused exposure to a broader sensitivity to overall credit market conditions' is partially correct but overstates the shift - the ground truth indicates continuation of concern with a more integrated perspective, not a fundamental pivot to financing risk. (4) The LLM adds specific language about 'rising interest rates' and 'cost of capital' that, while potentially accurate to the actual filing, goes beyond the ground truth synthesis which focuses on the framing shift regarding supply chain impact. MULTI-HOP REASONING: The LLM does synthesize information across two years correctly in structure, but the interpretation of what the 2023 shift represents differs from ground truth. SEMANTIC EQUIVALENCE: Partial - the answer captures evolution but mischaracterizes the nature of that evolution by introducing financing risk as the primary new concern rather than integrated supply chain perspective.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 532,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "In the 2022 Form 10‑K, Paxlovid was newly authorized (EUA Dec 2021, CMA Jan 2022, EU approval Feb 2022) and Pfizer only disclosed that it had entered into supply agreements with governments and other customers, without quantifying the related financial commitment. By the 2024 Form 10‑K, the company reported $2.2 billion of deferred revenue and $1 billion of remaining performance‑obligation contracts for Paxlovid (down from $5.1 billion of deferred revenue a year earlier), recognized $5.7 billion of Paxlovid revenue in 2024, and detailed amended U.S. government contracts and non‑cash adjustments that reflect the transition from large advance‑payment and inventory‑return arrangements to commercial sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Paxlovid's financial evolution from 2022 to 2024, but contains significant quantitative discrepancies and introduces numbers not present in the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 regulatory status (EUA Dec 2021, CMA Jan 2022, EU approval Feb 2022)\n- Correctly notes that 2022 lacked quantified financial commitments\n- Correctly identifies $1 billion remaining performance obligations as of Dec 31, 2024\n- Correctly mentions amended U.S. government contracts and non-cash adjustments\n- Correctly identifies transition from advance-payment/inventory-return to commercial sales\n- Appropriately addresses multi-hop synthesis across 2022-2024 period\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- Reports $2.2 billion deferred revenue for Paxlovid in 2024 - NOT mentioned in ground truth\n- Reports $5.1 billion deferred revenue from prior year - NOT mentioned in ground truth\n- Reports $5.7 billion Paxlovid revenue in 2024 - NOT mentioned in ground truth\n- These three figures ($2.2B, $5.1B, $5.7B) appear to be introduced without ground truth support\n\nMISSING ELEMENTS:\n- Does not mention the $771 million favorable final adjustment related to prior revenue reversal (key detail in ground truth)\n- Does not specify delivery timeline (2025-2028) for remaining obligations\n- Does not mention subject to renegotiation clause\n\nQUANTITATIVE ACCURACY ISSUES:\nThe LLM introduces three major financial figures ($2.2B deferred revenue, $5.1B prior year deferred revenue, $5.7B 2024 revenue) that cannot be verified against the ground truth. While the $1 billion remaining performance obligations is correct, the additional numbers significantly undermine quantitative reliability. The answer appears to conflate or introduce data from actual 10-K filings that may not align with the knowledge graph ground truth.\n\nQUALITATIVE ASSESSMENT:\nThe reasoning structure is sound - comparing 2022 (unquantified) to 2024 (quantified commitments) and noting the transition in contract types. However, the introduction of unverified numbers weakens the overall credibility despite good contextual framing.\n\nCONTEXTUAL RELEVANCE:\nThe answer directly addresses the question about evolution of financial commitment and contractual obligations, providing temporal comparison and specific metrics. The framing of transition from government advance payments to commercial arrangements is contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 657,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "In 2023, after the June 2023 dismissal of Aearo’s bankruptcy, 3M recorded a $62 million accrual for Aearo’s respirator‑mask asbestos, silica and coal‑dust product liabilities and defense costs. By year‑end 2024 that accrual had fallen to $51 million, but the underlying risk exposure remains unchanged – Aearo’s liability is still limited by its 1995 Cabot agreement (the $100 k quarterly fee) to respirators sold on/after Jan 1 1997, with the possibility of additional exposure only if the arrangement is altered or Cabot cannot meet its obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states a $62 million accrual in 2023 for Aearo, but the ground truth indicates MMM had $574 million in accruals for respirator mask/asbestos liabilities EXCLUDING Aearo in 2023, with Aearo in bankruptcy. The $62 million figure appears to be fabricated or confused with another metric. The 2024 figure of $51 million matches ground truth. (2) BANKRUPTCY STATUS CONFUSION - The LLM claims Aearo's bankruptcy was dismissed in June 2023, but ground truth indicates Aearo WAS in bankruptcy proceedings in 2023 with litigation stayed. The LLM's characterization of the bankruptcy timeline is unclear/potentially incorrect. (3) CABOT AGREEMENT DETAILS - The LLM correctly identifies the Cabot agreement limiting liability to respirators sold after Jan 1, 1997 (not before as stated in ground truth, which says Cabot assumed claims PRIOR to Jan 1, 1997), and correctly notes the $100,000 quarterly fee. However, the LLM reverses the date logic - it says 'on/after Jan 1 1997' when ground truth indicates Cabot covers pre-1997 claims. (4) MISSING CONTEXT - The LLM fails to adequately explain the shift from bankruptcy protection in 2023 to a defined liability framework in 2024, which is central to understanding the evolution. (5) INCOMPLETE SYNTHESIS - The answer doesn't properly synthesize the multi-hop information about how the bankruptcy resolution led to the more defined 2024 liability structure. The $62 million 2023 figure is a critical factual error that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 431,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of roughly 1.7 percentage points. In the earlier period, Skoal’s shipment volume fell from 208.5 million cans/packs in 2020 to 197.4 million in 2021, a drop of about 11 million units (≈5 %). Both intervals show a downward trend, with the recent change reflected in share‑percentage and the earlier change reflected in absolute shipment volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - retail share decline from 9.3% to 7.6% in 2023-2024 (1.7 percentage point decline calculated correctly), shipment volume decline from 208.5 to 197.4 million packs/cans in 2020-2021 (11 million unit drop ≈5% calculated correctly). COMPLETENESS: The answer addresses both parts of the multi-hop question - the 2023-2024 retail share change AND the 2020-2021 shipment volume trend, with explicit comparison between the two periods. ENTITY ACCURACY: Correctly identifies Skoal as a product of MO (Altria/Philip Morris), uses correct metrics (retail share percentage, shipment volume in millions), and correctly references all years. REASONING: The multi-hop synthesis is sound - the model correctly identifies that both metrics show downward trends and draws a logical conclusion about long-term performance challenges. The LLM adds valuable analytical detail by calculating the percentage point decline (1.7 pp) and the percentage volume decline (~5%), which enhances understanding without introducing errors. MINOR OBSERVATION: The LLM uses slightly different phrasing ('slipped' vs 'decreased', 'cans/packs' vs 'packs/cans') but these are semantic equivalences that don't affect accuracy. The answer is well-structured, presenting both time periods clearly and making an explicit comparison as requested. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 403,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm described its multimedia work mainly as a core R&D capability – engineers focused on “multimedia (camera, video, display and computer‑vision)” and its patent portfolio included video‑ and audio‑codecs and streaming protocols that were built into consumer‑oriented chipsets such as smartphones, tablets, wearables and XR devices【page_14】. By the 2024 filing the scope had broadened: the same multimedia expertise is now paired with AI‑driven perception, a dedicated NPU and generative‑AI research, and Qualcomm is packaging those capabilities into a wider range of platforms – from mobile SoCs to automotive digital‑cockpit and ADAS/AD solutions and IoT products – while emphasizing developer‑friendly integration across multiple device categories【page_14】. This reflects a shift from a primarily consumer‑handset focus to a more diversified, AI‑enabled multimedia strategy that spans automotive and IoT markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 focus on multimedia technologies (camera, video, display, computer vision) and their integration into consumer devices (smartphones, tablets, wearables, XR). (2) Accurately captures the 2024 evolution showing expansion into AI/generative AI integration. (3) Properly synthesizes the multi-hop information showing the shift from consumer-handset focus to diversified markets (automotive, IoT). (4) Correctly identifies the platform-oriented approach in 2024 versus hardware-centric in 2022. (5) Appropriately emphasizes developer-friendly integration and multiple device categories as key 2024 differentiators. (6) No quantitative errors - dates (2022, 2024) are correct, no calculations required. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer provides slightly more specific technical detail (NPU, ADAS/AD solutions, digital-cockpit) compared to the ground truth, which is not incorrect but represents a minor elaboration beyond what was explicitly stated in the ground truth. (2) The ground truth emphasizes 'engineering focus areas' more explicitly as a framing device, while the LLM focuses more on product integration - both are valid interpretations of the question but represent slightly different emphasis. (3) The ground truth's characterization of 'platform-oriented, AI-enhanced approach' is well-captured but the LLM uses 'AI-enabled multimedia strategy' which is semantically equivalent. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying both continuities (multimedia expertise) and changes (AI integration, market diversification). The logical progression from 2022 to 2024 is sound and well-articulated. ENTITY ACCURACY: Qualcomm correctly identified, years correct (2022, 2024), technologies correctly named, markets correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 530,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "In 2023, after the court‑ordered reconsolidation of the Aearo Entities, 3M removed a $0.7 billion equity‑investment asset and a $0.6 billion net intercompany liability that had previously been shown on its balance sheet 【page_101】. The 2024 filing again references the reconsolidation of the Aearo Entities but makes no further mention of any separate equity‑investment or intercompany balances, showing that those items have been fully absorbed into the consolidated statements 【page_50】.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 reconsolidation event and accurately states the $0.7 billion equity-investment asset removal and $0.6 billion net intercompany liability removal. However, there is a critical semantic error in the interpretation of the 2024 situation. The ground truth explicitly states that by 2024, the Aearo Entities were 'no longer consolidated' and 3M 'has a stake in' them, representing a shift from full consolidation to retained equity interest. The LLM answer incorrectly suggests that in 2024, the items were 'fully absorbed into the consolidated statements,' implying continued consolidation. This is a fundamental misunderstanding of the multi-hop evolution being asked about. The question specifically asks how the relationship 'evolved between 2023 and 2024,' requiring comparison of two different states. The LLM fails to capture the key distinction: 2023 involved reconsolidation (bringing them back in), while 2024 involved de-consolidation (taking them back out with a retained stake). The quantitative data for 2023 is accurate ($0.7B and $0.6B figures), but the qualitative interpretation of the 2024 change is incorrect, missing the essential narrative of the relationship evolution. The answer also lacks clarity on what 'has a stake in' means versus full consolidation, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 377,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "In the 2022 filing Visa’s Risk and Identity Solutions were described as a set of fraud‑mitigation and authentication tools (e.g., Visa Advanced Authorization, Visa Secure, Visa Advanced Identity Score, Visa Consumer Authentication Service) that sat alongside Issuing, Acceptance, Open Banking and Advisory services as one of its value‑added services【page_12_2022】. By the 2024 filing the suite has been rebranded as the “Visa Protect” portfolio and expanded with AI‑driven offerings—Visa Deep Authorization, Visa Protect for A2A Payments and Visa Risk Manager with scheme‑agnostic Advanced Authorization—plus AI/ML‑based authentication and provisioning intelligence, extending protection to real‑time non‑card (A2A) flows and positioning Risk and Identity Solutions as a core, differentiated pillar of Visa’s five‑category value‑added services strategy【page_11_2024】【page_12_2024】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a more detailed and specific evolution narrative than the ground truth, but introduces several unverifiable claims that cannot be confirmed against the original answer. STRENGTHS: (1) Correctly identifies 2022 positioning around fraud prevention and authentication tools with specific product names (Visa Advanced Authorization, Visa Secure, Visa Advanced Identity Score, Visa Consumer Authentication Service); (2) Correctly notes the 2024 expansion within a five-category value-added services portfolio; (3) Appropriately emphasizes the strategic integration and broader ecosystem positioning. CRITICAL ISSUES: (1) The LLM introduces 'Visa Protect' as a rebranding/portfolio name in 2024 - this specific terminology and rebranding claim is NOT present in the ground truth, which does not mention this rebranding; (2) Specific 2024 products mentioned (Visa Deep Authorization, Visa Protect for A2A Payments, Visa Risk Manager with scheme-agnostic Advanced Authorization) are not referenced in the ground truth; (3) The ground truth states 'more than 200 products and services' as of September 30, 2024, but the LLM does not mention this quantitative metric; (4) The ground truth emphasizes 'high impact business outcomes' and products working together, which the LLM touches on but less explicitly. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across 2022-2024 and identifies the portfolio expansion, but the specific product names and 'Visa Protect' branding appear to be hallucinated details not supported by the ground truth. The answer reads plausibly but introduces unverifiable specificity that contradicts the principle of strict factual accuracy required for financial documents. The core narrative of evolution is sound, but the specific product innovations and rebranding claims are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 501,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "In the 2023 Form 10‑K RTX disclosed acquisition‑accounting adjustments only as a single line‑item that reduced operating profit by **$1.998 billion**, accompanied by a brief description of the types of adjustments. In the 2024 filing the company kept the same line‑item but added a detailed breakdown – showing total adjustments of **$2.058 billion** (about **$60 million more** than 2023) and allocating the impact to Collins Aerospace ($833 million), Pratt & Whitney ($312 million) and Raytheon ($913 million) – thereby providing a more granular quantification of the impact on operating profit.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims 2024 showed $2.058 billion in adjustments, but the ground truth explicitly states that by 2024, RTX 'did not include updated quantitative figures for the current year's impact on operating profit.' The LLM fabricated specific 2024 numbers ($2.058B total, $833M Collins, $312M P&W, $913M Raytheon) that do not appear in the ground truth. (2) DIRECTIONAL MISUNDERSTANDING: The ground truth describes a shift FROM quantitative disclosure (2023: $1,998M) TO qualitative disclosure (2024: no quantified figures). The LLM describes the opposite - claiming 2024 added 'detailed breakdown' and 'more granular quantification.' This is a fundamental misreading of the disclosure evolution. (3) VERIFICATION OF 2023 FIGURE: The LLM correctly states $1.998 billion for 2023 (matching ground truth's $1,998 million), but this accuracy is overshadowed by the false 2024 claims. (4) MISSING CONTEXT: The LLM completely misses the key insight that RTX moved away from year-over-year quantification in 2024, instead providing only qualitative policy context. The LLM's claim of 'more granular quantification' in 2024 is the opposite of what actually occurred. (5) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution between years - the LLM failed to correctly synthesize the actual change in disclosure approach. The answer appears to confuse or invent details rather than accurately representing the documented shift from quantitative to qualitative disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 438,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Microsoft’s Office 365 Commercial (reported as “Office products and cloud services”) rose from $44.97 billion in FY 2022 to $48.85 billion in FY 2023, yet its share of total Microsoft Cloud revenue slipped from roughly 49 % (44.97 / 91.4 bn) to about 44 % (48.85 / 111.6 bn)【page_93】. This indicates that Office 365 is still growing in absolute terms, but the broader cloud portfolio—especially Azure and other cloud services—is expanding faster, shifting the overall cloud growth trajectory toward a more diversified mix【page_42】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the Microsoft Cloud consolidated figures ($91.4B in FY2022 and $111.6B in FY2023) and accurately calculates the percentage shifts in Office 365 Commercial's contribution (from ~49% to ~44%). The reasoning about diversification of the cloud portfolio and faster growth in Azure/other services is sound and directly addresses the question's inquiry about growth trajectory. The answer demonstrates good multi-hop synthesis by connecting Office 365 revenue changes to broader cloud ecosystem dynamics.\n\nCRITICAL ISSUES: (1) The Office 365 Commercial revenue figures ($44.97B and $48.85B) cannot be verified against the ground truth, which does not provide these specific line-item numbers. The ground truth only mentions Office 365 Commercial as a 'key growth driver' within Productivity and Business Processes segment without isolating its exact revenue. (2) The LLM appears to have introduced specific numbers that may not be directly supported by the source documents cited (page_93, page_42). (3) The ground truth emphasizes Office 365 Commercial's inclusion in the newly consolidated Microsoft Cloud metric as a transparency/reporting change, whereas the LLM focuses primarily on the relative share decline.\n\nCALCULATION VERIFICATION: The percentage calculations are mathematically correct (44.97/91.4 ≈ 49.2% and 48.85/111.6 ≈ 43.8%), but the underlying Office 365 revenue figures themselves are not confirmed in the ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across fiscal years and connects individual product performance to broader ecosystem trends, which is appropriate for the question. However, the introduction of unverified specific revenue numbers undermines the reliability of this synthesis.\n\nCONCLUSION: While the LLM demonstrates solid analytical reasoning and correctly uses the Microsoft Cloud consolidated figures, the introduction of specific Office 365 revenue numbers that cannot be verified against the ground truth is a significant accuracy concern. The qualitative insights about diversification are valuable but don't compensate for the quantitative uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 585,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck’s Lynparza‑related alliance revenue grew from $1,199 million in 2023 to $1,311 million in 2024 – a rise of roughly 9 percent.  The company said the increase was “largely due to higher demand in most international markets” for the drug under its AstraZeneca collaboration.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($1,199 million in 2023 and $1,311 million in 2024) that are NOT present in the ground truth. The ground truth explicitly states that in 2023, 'alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting' - meaning specific Lynparza figures were not separately disclosed in 2023. The ground truth only confirms that by 2024, alliance revenue related to Lynparza 'grew by 9%' but does NOT provide the specific dollar values the LLM cited. The LLM appears to have fabricated precise financial figures that cannot be verified against the ground truth. While the LLM correctly identifies the 9% growth rate and the factor of 'higher demand in most international markets,' it fundamentally misrepresents the data availability by providing specific 2023 and 2024 figures that the ground truth does not support. The reference to 'AstraZeneca collaboration' is accurate contextually but adds information not explicitly in the ground truth. The calculation of the percentage increase ($1,311M - $1,199M = $112M / $1,199M ≈ 9.3%) is mathematically correct IF those numbers were valid, but the numbers themselves appear to be unsupported fabrications. This represents a serious factual error in financial reporting where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 369,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K list the Procter & Gamble 2014 Stock and Incentive Compensation Plan together with the other equity‑compensation plans in Item 12’s table, but, like in 2023, the footnote makes clear that only the 2019 plan can issue future grants. The plan’s terms and the Compensation and Leadership Development Committee’s regulations are still disclosed by incorporation‑by‑reference to Exhibits 10‑24, 10‑25 and 10‑26, and the filing points to the Proxy Statement filed under Regulation 14A for additional detail—so the regulatory context and reporting treatment of the 2014 plan remain essentially unchanged from 2023 to 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core finding. Ground truth states there was an EVOLUTION/SHIFT in how the 2014 plan was treated between 2023 and 2024 - specifically from 'regulatory disclosure' context to 'a focus on ownership structure and equity compensation transparency' and 'a more integrated view within the company's overall equity compensation framework.' The LLM answer explicitly claims the opposite: 'the regulatory context and reporting treatment of the 2014 plan remain essentially unchanged from 2023 to 2024.' This is a fundamental factual error on the main question. The LLM correctly identifies that both years list the plan in Item 12's table and reference the same exhibits (10-24, 10-25, 10-26), and correctly notes that only the 2019 plan can issue future grants. However, these accurate details are used to support an incorrect conclusion about whether change occurred. The LLM appears to have focused on surface-level similarities (same exhibits, same table location) while missing the substantive shift in disclosure context and reporting emphasis that the ground truth identifies. The quantitative accuracy is high (correct exhibit numbers, correct plan names, correct years), but the qualitative reasoning fundamentally misses the evolution that the question asks about. The answer fails to address the key distinction between regulatory documentation context versus equity compensation transparency focus that characterizes the evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 417,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the Procter & Gamble 1992 Stock Plan is simply listed as one of the company’s equity‑compensation plans (see Exhibit 10‑3) without any comment on its ability to issue new awards【page_69】. In the 2024 Form 10‑K the plan still appears in the aggregated equity‑compensation table, but the filing now explicitly notes that “only the Procter & Gamble 2019 Stock and Incentive Compensation Plan … allows for future grants of securities,” indicating that the 1992 Stock Plan is now treated as a legacy plan that only contributes to outstanding options/RSUs and is not used for new grants【page_68】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of the 1992 Stock Plan's treatment between 2023 and 2024 10-K filings. STRENGTHS: (1) Correctly identifies that the plan appears in equity compensation tables in both years; (2) Accurately captures the key distinction that the 2024 filing explicitly notes only the 2019 Plan allows future grants; (3) Properly characterizes the 1992 Plan as transitioning to 'legacy' status; (4) Correctly synthesizes the multi-hop information showing the shift from active to passive role. MINOR WEAKNESSES: (1) The LLM answer is more specific and detailed than the ground truth, citing explicit language about the 2019 Plan being the only one allowing future grants - while this is accurate and adds value, it goes slightly beyond what the ground truth states; (2) The ground truth describes a shift from 'standalone referenced plan' to 'consolidated table,' while the LLM describes it as appearing in both years' tables but with different treatment regarding future grants - these are complementary but slightly different framings. VERIFICATION: The core factual claim that the 1992 Plan is now treated as a legacy plan with no new grants while the 2019 Plan is the active plan is accurate and well-supported. The page references (page_69 for 2023, page_68 for 2024) are provided but cannot be independently verified from the ground truth. The multi-hop reasoning correctly synthesizes the comparison across two filing years and identifies the meaningful change in how the plan is treated. No numerical errors or calculation issues present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 437,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "The company’s focus on large‑scale transformation work has stayed steady, but the backdrop has changed. In the 2023 filing Accenture noted that “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period.” By the 2024 filing the same priority is reaffirmed, but it adds that “some of these conditions slowed the pace and level of client spending, particularly for smaller contracts with a shorter duration… Clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period” —showing that spending on smaller, short‑term deals has contracted while transformation projects now generate revenue over an even longer horizon. 【page_21】",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative about large-scale transformations remaining a priority across both years, but has significant issues with accuracy and completeness. STRENGTHS: (1) Correctly identifies that large-scale transformations remained a priority in both 2023 and 2024; (2) Accurately notes the shift toward longer-duration contracts and revenue conversion timelines; (3) Correctly identifies that smaller contracts with shorter durations were deprioritized; (4) Appropriately acknowledges the lack of explicit quantitative metrics. CRITICAL ISSUES: (1) The LLM attributes a quote to 2023 ('clients continue to prioritize large-scale transformations') that the ground truth indicates was actually from 2024 - this is a significant factual error in temporal attribution; (2) The LLM states that transformation projects 'now generate revenue over an even longer horizon' in 2024 compared to 2023, but the ground truth does not support this claim of a *further* extension - it only notes the 'repeated emphasis' on the extended timeline, not that it became even longer; (3) The LLM's characterization that 'the backdrop has changed' while 'focus has stayed steady' is somewhat contradictory and less precise than the ground truth's explanation that in 2023 there was a 'slowdown in client spending' while clients still prioritized transformations, whereas in 2024 the priority was 'reiterated' amid 'ongoing economic volatility'; (4) Missing the important context from the ground truth that in 2023 there was explicit mention of clients 'reducing or deferring spending on smaller contracts' - the LLM presents this as a 2024 development. The answer demonstrates partial understanding but contains temporal misattribution and overstates the evolution of the timeline extension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 486,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "Accenture raised the amount of Class A Ordinary Shares it issued for employee‑share programs from **7,970 shares in fiscal 2023** to **8,883 shares in fiscal 2024** – an increase of 913 shares【page_70】.  The associated equity contribution grew from roughly **$1.94 billion of additional paid‑in capital and a $1.35 billion increase to total shareholders’ equity** in FY 2023 to **$2.15 billion of additional paid‑in capital and a $1.50 billion increase to total shareholders’ equity** in FY 2024, expanding the overall equity base and slightly diluting existing shareholders【page_71】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - LLM claims 7,970 shares issued in FY2023 and 8,883 in FY2024. Ground truth states the opposite: 7,970 shares were issued in FY2024, not 2023.\n   - LLM states an increase of 913 shares year-over-year, but this calculation is based on the reversed years.\n   - The equity contribution figures ($1.94B, $1.35B, $2.15B, $1.50B) are not mentioned in the ground truth and appear to be fabricated or from incorrect sources.\n   - Ground truth specifies treasury shares purchased (12,181) and Class A Ordinary Shares outstanding (15,656,591 in 2023 to 15,664,561 in 2024), which the LLM completely omits.\n   - Treasury share values are critical to the answer: $(3,408,491) million to $(6,678,037) million - the LLM provides no treasury share information.\n\n2. ENTITY/YEAR ACCURACY:\n   - The LLM reverses the fiscal years for the share issuance data, which is a fundamental error in multi-hop synthesis.\n   - The ground truth clearly indicates FY2024 had the 7,970 share issuance, not FY2023.\n\n3. COMPLETENESS:\n   - The LLM fails to address the treasury share component (12,181 shares purchased), which is explicitly mentioned in the ground truth as part of the equity structure impact.\n   - The LLM fails to mention the change in Class A Ordinary Shares outstanding (15,656,591 to 15,664,561).\n   - The LLM fails to mention the significant change in treasury share values.\n   - The LLM provides equity contribution figures that don't align with the ground truth's focus on share counts and treasury values.\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is flawed due to the reversed year assignment.\n   - The conclusion about \"diluting existing shareholders\" is mentioned but not substantiated by the correct data.\n   - The answer lacks the specific treasury share analysis that is central to understanding the equity structure impact.\n\n5. SEMANTIC EQUIVALENCE:\n   - While the LLM attempts to address the question's components, the factual errors are too severe to achieve semantic equivalence with the ground truth.\n   - The focus on equity contribution amounts rather than share counts and treasury values represents a misalignment with the ground truth's emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 624,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ’s net‑investment‑hedge notional for Canadian‑dollar notes increased to **$453 million in 2023 from $443 million at year‑end 2022** (≈ $10 million or 2 % higher)【page_97】, and the after‑tax result on those notes turned from a **$25 million gain in 2022 to an $8 million loss in 2023**【page_98】.  This modest rise in Canadian exposure occurred while the company was broadly reshaping its foreign‑currency debt mix – Euro‑denominated notes grew (3,516 → 3,410 million) and Swiss‑franc notes fell sharply (386 → 638 million)【page_97】, and overall hedging outcomes shifted from gains to losses across currencies, indicating a general rebalancing and weaker performance of its foreign‑currency debt hedges in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and appears to reference different financial metrics entirely. Critical issues: (1) METRIC MISMATCH: The ground truth discusses Canadian 'notes' balances (in millions) showing a $3M decrease in 2022 and $8M increase in 2023. The LLM instead discusses 'net-investment-hedge notional' for Canadian-dollar notes ($443M to $453M), which is a completely different metric and magnitude. These are not equivalent measures. (2) QUANTITATIVE ERRORS: The LLM reports a $10M increase (2%) in Canadian exposure, but the ground truth indicates a $3M decrease in 2022 followed by an $8M increase in 2023 - fundamentally different numbers and trends. (3) HISTORICAL CONTEXT MISSING: The ground truth provides crucial context showing Canadian notes declined from $17M (2019) → $7M (2020) → $3M (2021) → further decrease in 2022, then reversal in 2023. The LLM provides no historical perspective. (4) EURO AND SWISS FRANC DATA CONTRADICTIONS: The LLM states Euro notes 'grew' (3,516 → 3,410 million) when 3,410 is actually lower than 3,516, indicating a decrease not growth. The ground truth correctly identifies Euro notes decreased from $211M (2021) to $81M (2023). The Swiss franc numbers in the LLM (386 → 638 million) don't match the ground truth's characterization of volatility. (5) CORE FINDING REVERSAL: The ground truth's key insight is that Canadian notes reversed a downward trend in 2023 (increase of $8M). The LLM's modest $10M increase in a much larger notional base ($443-453M) doesn't capture this reversal narrative. (6) HEDGING RESULTS: While the LLM mentions after-tax results shifting from $25M gain to $8M loss, this appears to be additional information not in the ground truth and may be from a different section, but doesn't address the core question about exposure changes. The answer conflates hedging notional amounts with actual debt balance changes, which are distinct concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 527,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "In its 2023 filing Accenture noted that Accenture Ventures “partners with and invests in growth‑stage companies that create innovative enterprise technologies,” positioning the unit as a strategic partner and investor (page_17). By the 2024 filing the firm emphasized a deeper integration of those companies into its broader innovation ecosystem—linking them to Accenture Labs, its global delivery network, and a larger R&D budget of $1.2 billion in FY 24—signaling a more active, investment‑focused engagement (page_17).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Accenture's approach from partnership to investment focus, which aligns with the ground truth's core narrative. However, there are significant quantitative accuracy issues that prevent a higher score. CRITICAL ERRORS: (1) The LLM states R&D spending was '$1.2 billion in FY 24' but the ground truth specifies '$1.3 billion in fiscal 2023 and $1.2 billion in fiscal 2024'—the LLM omits the 2023 figure entirely, which is essential context for showing the evolution. (2) The LLM claims both 2023 and 2024 filings describe Accenture Ventures as 'partners with and invests in' (using the same language), but the ground truth explicitly states the 2023 description was 'partners with' and the 2024 description shifted to 'invests in'—this is the key distinction showing evolution. The LLM's assertion that 2023 already included 'invests in' contradicts the ground truth's core finding about the shift. STRENGTHS: The answer correctly identifies the evolution toward deeper integration, mentions Accenture Labs and the global delivery network, and appropriately contextualizes the shift as more 'investment-focused.' The semantic understanding of increased strategic commitment is sound. WEAKNESSES: The quantitative data is incomplete (missing 2023 R&D figure), and the characterization of what changed between years is inaccurate (both years described identically rather than showing the 'partners with' to 'invests in' transition). The multi-hop reasoning fails to properly synthesize the key distinction between the two years' approaches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 435,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck’s Lynparza asset, which captures the capitalized sales‑based and regulatory milestone payments, was recorded at about **$1.1 billion at the end of 2021 and is being amortized on a straight‑line basis through 2028**【page_102】.  The profit‑share portion of the deal – reported as alliance revenue – **rose from $1.116 billion in 2022 to $1.311 billion in 2024** (a 9 % increase in 2024 and roughly an 18 % gain versus 2022)【page_53】, indicating that Merck’s financial stake and commercial upside in the AstraZeneca‑Lynparza partnership have grown while the amortization schedule for the underlying intangible asset remains unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the $1.1 billion intangible asset balance related to Lynparza and the 2028 amortization timeline, matching the ground truth. The alliance revenue figures ($1.116 billion in 2022 and $1.311 billion in 2024) are accurate, and the 9% increase calculation for 2024 is correct. The answer properly synthesizes the multi-hop information about both asset amortization and revenue growth evolution. The straight-line amortization method is correctly noted.\n\nWEAKNESSES: The LLM answer omits a significant element from the ground truth - the 2025 China approval for Lynparza in adjuvant treatment for early breast cancer. This is a material strategic development that demonstrates expansion of the therapeutic footprint and indicates the evolving strategic importance of the collaboration. The ground truth explicitly mentions this as evidence of the partnership's evolution through early 2025, but the LLM answer stops at 2024 data. Additionally, while the LLM mentions the 18% gain versus 2022, it doesn't explicitly state that this represents the overall growth trajectory from 2022-2024, though this is a minor wording issue.\n\nCALCULATION VERIFICATION: The 9% increase from 2023 to 2024 is mathematically sound (assuming 2023 was approximately $1.202 billion). The 18% gain from 2022 to 2024 ($1.116B to $1.311B) is accurate: (1.311-1.116)/1.116 = 17.5%, which rounds to approximately 18%.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points (asset amortization details, revenue figures, growth percentages) and properly connects them to show the evolution of Merck's involvement. However, it fails to complete the full narrative by omitting the 2025 strategic development.\n\nOVERALL: The answer is substantially correct on the core financial metrics and demonstrates sound multi-hop reasoning, but the omission of the China approval development represents an incomplete response to a question asking about evolution \"from 2022 to 2024\" and beyond.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 549,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "In both the 2023 and 2024 10‑K filings Broadcom continues to list ValueOps as one of the three core domains of its Distributed Software portfolio and describes it in the same way—as a “value‑stream management” solution that aligns business and development teams and improves time‑to‑value (2023 p.10‑11; 2024 p.10‑11). The wording and placement are essentially unchanged, indicating that ValueOps remains a stable, foundational pillar of the Distributed Software suite rather than a newly‑emphasized or de‑emphasized focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states that ValueOps was ELEVATED from 2023 to 2024—moving from 'one of several key offerings' to 'one of the three core domains' with explicit emphasis on 'end-to-end visibility.' The LLM claims the wording and placement are 'essentially unchanged' and that ValueOps 'remains a stable, foundational pillar,' which is factually incorrect according to the knowledge graph. The LLM fundamentally misunderstood the strategic shift that occurred. QUANTITATIVE ACCURACY: The page references (2023 p.10-11; 2024 p.10-11) appear reasonable but cannot be verified as correct without source documents. The LLM does not provide specific numbers or calculations to evaluate. QUALITATIVE ACCURACY: The LLM failed to identify the key distinction between 2023 positioning (feature among several offerings) versus 2024 positioning (core domain with explicit strategic emphasis). This represents a failure in multi-hop reasoning—the model should have synthesized the evolution across years to identify the strategic shift. The characterization of ValueOps as 'value-stream management' may be accurate but is secondary to the main finding about strategic emphasis change. CONTEXTUAL RELEVANCE: The answer addresses the wrong conclusion entirely. While it mentions both years and ValueOps, it arrives at the opposite conclusion from the ground truth—claiming stability rather than strategic elevation. This is a fundamental misreading of the question's intent to identify how AVGO's emphasis CHANGED. The answer fails to capture the evolution from 'feature' to 'foundational pillar' that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 464,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "In the 2023 filing FedEx presented Network 2.0 as a cornerstone of its DRIVE transformation that was expected to deliver “operational efficiencies, network flexibility, alignment of our cost base with demand, and cost‑savings and reductions to our permanent cost structure,” while cautioning that the actual amount and timing of those savings could differ from its estimates (see 2023 p. 32). By the 2024 filing the discussion had become far more risk‑focused – FedEx now enumerates specific integration, labor‑status, regulatory, cultural and legal hurdles and warns that the program could cost more, generate less‑than‑expected savings and take longer to complete, making execution risk a central concern (see 2024 p. 28‑29 & 31).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of FedEx's Network 2.0 evolution. STRENGTHS: (1) Correctly identifies the 2023 focus on strategic benefits (operational efficiencies, network flexibility, cost base alignment, cost savings) and acknowledges the caveat about timing/amount uncertainty. (2) Accurately captures the 2024 shift toward risk-focused discussion with specific integration challenges (labor-status, regulatory, cultural, legal hurdles). (3) Properly synthesizes the multi-hop comparison showing progression from investment justification to operational risk mitigation. (4) Appropriately cites page references (2023 p. 32; 2024 p. 28-29 & 31) demonstrating source verification. (5) Uses semantically equivalent language to ground truth (e.g., 'harmonizing operating practices' = 'integration complexities'). MINOR CONSIDERATIONS: (1) The LLM answer doesn't explicitly mention 'asset impairment charges, tax impacts, and litigation risks' that appear in the ground truth, though it does reference 'legal hurdles' which partially captures this. (2) The phrase 'could cost more, generate less-than-expected savings and take longer to complete' effectively summarizes the financial and timing risks without being exhaustive. (3) No quantitative metrics (dollar amounts, percentages) are provided in either answer, so quantitative accuracy is assessed on the basis of correctly representing qualitative financial expectations. The answer successfully addresses all parts of the multi-part question: expected cost savings evolution (2023 optimism → 2024 uncertainty) and implementation risks (2023 execution risk acknowledgment → 2024 detailed risk enumeration). The reasoning is sound and the synthesis across years is logical and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 487,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "In 2022 MDLZ’s equity‑method investment contracts showed a small negative fair‑value position of $(3) million and no gain or loss was recorded (see page 96). By 2023 the company reported a $7 million pre‑tax gain from those contracts (see page 98). The swing from a neutral/negative impact to a modest positive contribution indicates that MDLZ’s equity‑method investment – chiefly its JDE Peet’s exchangeable‑bond position – remained active and delivered a small upside in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: (1) 2022 position correctly identified as $(3) million net liability - matches ground truth exactly; (2) 2023 position correctly identified as $7 million gain - matches ground truth exactly; (3) The swing calculation is implicit but correct (from -$3M to +$7M = $10M improvement). Entity accuracy: MDLZ correctly identified, equity method investment contracts properly named, JDE Peet's exchangeable bond position appropriately contextualized. Multi-hop reasoning: The answer successfully synthesizes the evolution across two years and draws a logical conclusion about the shift from neutral/negative to positive impact, indicating more favorable engagement. The answer goes slightly beyond ground truth by specifically mentioning JDE Peet's exchangeable bond position and providing page references (96, 98), which adds credibility and specificity without contradicting the ground truth. Semantic equivalence: The LLM's characterization of the 2022 position as 'neutral/negative' is semantically equivalent to ground truth's 'net liability,' and the conclusion about 'more active or favorable engagement' aligns with the LLM's assessment of 'active and delivered a small upside.' Minor note: The LLM states 'no gain or loss was recorded' in 2022, which is a reasonable interpretation of the liability position but adds slight interpretive detail not explicitly in ground truth. Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate contextualization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 434,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Broadcom’s estimate for the remaining work on the VMware Cloud Foundation July 2024 releases was $38 million in the FY 2023 filing and remained $38 million in the FY 2024 filing 【page_69】.  The unchanged cost‑to‑complete figure signals that the program is progressing on schedule and that Broadcom does not anticipate any additional overruns beyond its original expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. (1) CORRECTNESS: All factual information is correct - the $38 million cost estimate remained unchanged from FY 2023 to FY 2024 for VMware Cloud Foundation July 2024 releases. The company identification (Broadcom/AVGO) and fiscal years are accurate. (2) QUANTITATIVE ACCURACY: The $38 million figure is correctly stated and consistently referenced across both fiscal years. No calculations were required, but the numerical comparison is precise. (3) QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly interprets the unchanged cost estimate as indicating on-schedule progress and no anticipated overruns. The multi-hop synthesis (comparing FY 2023 to FY 2024 estimates) is properly executed. (4) SEMANTIC EQUIVALENCE: The LLM's interpretation that 'unchanged cost-to-complete signals the program is progressing on schedule' is semantically equivalent to the ground truth's statement that it 'indicates development progress was proceeding largely as planned.' Both convey the same insight about alignment with expectations. (5) MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'does not anticipate any additional overruns beyond its original expectations' is a reasonable interpretation of the unchanged estimate. The citation reference [page_69] adds credibility. Overall, this is a strong answer with accurate numbers, correct entity identification, sound reasoning, and appropriate interpretation of what the unchanged estimate signifies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 443,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "- 2023 Form 10‑K (FedEx Office description on page 15) presented the Ship and Go kiosk primarily as a self‑serve shipping station in roughly 1,300 FedEx Office locations, letting customers generate a label via a mobile label or QR code and drop packages in a secure bin.  \n- 2024 Form 10‑K (same section on page 15) still highlights the kiosk’s 1,300‑location footprint but now couples it with FedEx Returns Technology and Consolidated Returns, emphasizing label‑less, box‑free returns and positioning the kiosk as part of an end‑to‑end e‑commerce and returns solution.  \n\nThis evolution shows FedEx moving the kiosk from a simple shipping convenience to a broader e‑commerce logistics hub, reinforcing its strategy to capture more online‑shopping volume and simplify the returns process for merchants and consumers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 1,300 locations figure is accurately cited for both 2023 and 2024, and the page references (page 15 in both Form 10-Ks) are consistent with the ground truth. No calculation errors present. ENTITY ACCURACY: Correctly identifies FedEx Office, Ship and Go kiosk, FedEx Returns Technology, and Consolidated Returns as the relevant entities. Years (2023 vs 2024) are properly distinguished. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across two fiscal years and identifies the strategic evolution: from a primary focus on self-serve shipping (2023) to an integrated e-commerce returns solution (2024). The reasoning correctly identifies the shift in emphasis and positioning. COMPLETENESS: The answer addresses all parts of the multi-part question - it describes the 2023 positioning, the 2024 positioning, and explicitly articulates what this evolution indicates about FedEx's strategic approach. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as moving from 'simple shipping convenience to a broader e-commerce logistics hub' is semantically equivalent to the ground truth's description of a 'strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.' Minor difference: The LLM adds interpretive language about 'capturing more online-shopping volume' which, while reasonable inference, goes slightly beyond what the ground truth explicitly states. This is a minor enhancement rather than an error. CONTEXTUAL RELEVANCE (9/10): The answer is highly relevant and directly addresses the question about strategic positioning evolution and implications for e-commerce logistics and returns management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 512,
        "total_tokens": 1953
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 997,
    "failed_evaluations": 3,
    "average_correctness_score": 6.04,
    "average_quantitative_accuracy": 6.49,
    "average_qualitative_accuracy": 6.25,
    "average_contextual_relevance": 7.31,
    "score_distribution": {
      "excellent": 272,
      "good": 224,
      "fair": 227,
      "poor": 274
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 8768.91,
    "timestamp": "2026-02-02T18:06:34.647002"
  }
}